PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	PG	WC	SC	GA	UT	PM
J	Koomyart, I; Nagamizu, H; Khuwijitjaru, P; Kobayashi, T; Shiga, H; Yoshii, H; Adachi, S				Koomyart, Intira; Nagamizu, Hironori; Khuwijitjaru, Pramote; Kobayashi, Takashi; Shiga, Hirokazu; Yoshii, Hidefumi; Adachi, Shuji			Compositions, flavour and antiradical properties of products from subcritical water treatment of raw Isada krill	INTERNATIONAL JOURNAL OF FOOD SCIENCE AND TECHNOLOGY			English	Article						Antiradical activity; flavour evaluation; Isada krill (Euphausia pacifica); subcritical water	AMINO-ACIDS; VOLATILE COMPONENTS; ANTARCTIC KRILL; SQUID VISCERA; ORGANIC-ACIDS; FATTY-ACIDS; RICE BRAN; HYDROLYSIS; BIOMASS; SHRIMP	Comparative analysis of subcritical water (SCW) treatment and ambient pressure boiling one of raw Isada krill was performed for the nutritive, flavour and antiradical properties of krill extracts and residues as well as the molecular mass and odour intensity of the extract. SCW treatment was performed for 10min in a batch-type vessel in the temperature range of 100-240 degrees C, using a 1:1 weight ratio of raw krill to water. Higher protein and lipid contents were obtained by SCW treatment relative to boiling. The lipid content of the SCW extracts increased with increasing treatment temperature. Protein was the main component in these extracts, and the highest protein content was achieved by SCW treatment at 200 degrees C. High-molecular-mass species decomposed under SCW treatment at high temperatures with consequent generation of smaller molecules. The antiradical activity of the SCW extract, determined by DPPH and ABTS assays, increased with increasing treatment temperature. The krill extracts and residues exhibited shrimp-like flavour, and the most desirable flavour was obtained by SCW treatment at 140 degrees C or 160 degrees C for 10min. The treatment would be applicable for the production of seasonings from Isada krill.	[Koomyart, Intira; Nagamizu, Hironori; Kobayashi, Takashi; Adachi, Shuji] Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Kyoto 6068502, Japan; [Khuwijitjaru, Pramote] Silpakorn Univ, Fac Engn & Ind Technol, Dept Food Technol, Nakhon Pathom 73000, Thailand; [Shiga, Hirokazu; Yoshii, Hidefumi] Kagawa Univ, Dept Appl Biol Sci, Fac Agr, Kagawa 7610795, Japan	Adachi, S (reprint author), Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Kyoto 6068502, Japan.	adachi@kais.kyoto-u.ac.jp	Khuwijitjaru, Pramote/B-8831-2008		'The Creation of Innovative Technology for Marine Products Industry', Program for Revitalization Promotion, Japan Science and Technology Agency (JST)	This project was supported by 'The Creation of Innovative Technology for Marine Products Industry', Program for Revitalization Promotion, Japan Science and Technology Agency (JST).	Ali-Nehari A, 2011, AFR J BIOTECHNOL, V10, P18450, DOI 10.5897/AJB10.2450; Mekonnen TH, 2015, J CHEM TECHNOL BIOT, V90, P476, DOI 10.1002/jctb.4333; Yoshida H, 1999, BIOTECHNOL PROGR, V15, P1090, DOI 10.1021/bp9900920; Thiansilakul Y, 2007, J FOOD BIOCHEM, V31, P266, DOI 10.1111/j.1745-4514.2007.00111.x; Khuwijitjaru P, 2002, BIOSCI BIOTECH BIOCH, V66, P1723, DOI 10.1271/bbb.66.1723; Faithong N, 2010, FOOD CHEM, V119, P133, DOI 10.1016/j.foodchem.2009.06.056; Arnao MB, 2001, FOOD CHEM, V73, P239, DOI 10.1016/S0308-8146(00)00324-1; Plaza M, 2010, FOOD RES INT, V43, P1123, DOI 10.1016/j.foodres.2010.02.005; Tou JC, 2007, NUTR REV, V65, P63, DOI 10.1301/nr.2007.feb.63-77; Toor SS, 2011, ENERGY, V36, P2328, DOI 10.1016/j.energy.2011.03.013; Pourali O, 2009, FOOD CHEM, V115, P1, DOI 10.1016/j.foodchem.2008.11.099; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Yoshida H, 2004, J CHEM ENG JPN, V37, P253, DOI 10.1252/jcej.37.253; Morita K, 2001, FOOD RES INT, V34, P473, DOI 10.1016/S0963-9969(01)00072-2; AOAC, 2006, OFFICIAL METHODS ANA; Chen Y C, 2009, J FOOD SCI, V74, P31; Cripps GC, 1999, MAR ECOL PROG SER, V181, P177, DOI 10.3354/meps181177; ISO, 1999, 64961999 ISO; KAWAMURA Y, 1981, AGR BIOL CHEM TOKYO, V45, P93; Kim M. C., 2010, J FOOD SCI NUTR, V15, P304; Kim Ryoung-Hee, 2013, Fisheries and Aquatic Sciences, V16, P71, DOI 10.5657/FAS.2013.0071; Koomyart I, 2014, J FOOD PROCESS ENG, V37, P567, DOI 10.1111/jfpe.12110; KUBOTA K, 1986, AGR BIOL CHEM TOKYO, V50, P2867; Naknean P., 2013, INT FOOD RES J, V20, P1077; Tachihara T, 2004, CHEM BIODIVERS, V1, P2024, DOI 10.1002/cbdv.200490155; Tavakoli O, 2006, GREEN CHEM, V8, P100, DOI 10.1039/b507441j; Uddin MS, 2010, J ENVIRON BIOL, V31, P675; vansBoekel MAJS, 2006, BIOTECHNOL ADV, V24, P230; Wiboonsirikul J, 2007, J AGR FOOD CHEM, V55, P8759, DOI 10.1021/jf072041l	29	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0950-5423	1365-2621		INT J FOOD SCI TECH	Int. J. Food Sci. Technol.	JUL	2015	50	7					1632	1639		10.1111/ijfs.12799		8	Food Science & Technology	Food Science & Technology	CK6WP	WOS:000356369700015		
J	Bamai, YA; Araki, A; Kawai, T; Tsuboi, T; Yoshioka, E; Kanazawa, A; Cong, S; Kishi, R				Bamai, Yu Ait; Araki, Atsuko; Kawai, Toshio; Tsuboi, Tazuru; Yoshioka, Eiji; Kanazawa, Ayako; Cong, Shi; Kishi, Reiko			Comparisons of urinary phthalate metabolites and daily phthalate intakes among Japanese families	INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH			English	Article						Children; Phthalate metabolites; Mother-child pairs; Father-child pairs; Phthalate exposure	NUTRITION EXAMINATION SURVEY; DEUTERIUM-LABELED DEHP; DI(2-ETHYLHEXYL)PHTHALATE DEHP; NATIONAL-HEALTH; PREGNANT-WOMEN; CREATININE CONCENTRATIONS; SPECIES-DIFFERENCES; INTERNAL EXPOSURE; DANISH CHILDREN; SCHOOL-CHILDREN	We measured urinary phthalate metabolites, including di-n-butyl phthalate (DnBP), di-isobutyl phthalate, benzyl butyl phthalate (BBzP), and di(2-ethylhexyl) phthalate (DEHP), from 178 school-aged children and their 284 family members using gas chromatography-mass spectrometry, and we calculated daily phthalate intakes. The highest median levels of phthalate metabolites were for mono-isobutyl phthalate in all participants except schoolchildren, where the highest levels were for mono-(2-ethyl-5-oxohexyl) phthalate (MEOHP). Comparing the schoolchildren with their parents, the schoolchildren had significantly higher urinary metabolites for MEOHP, mono-(2-ethyl-5-carboxypentyl) phthalate, and EDEHP. Regarding daily intakes, the schoolchildren had significantly higher daily intakes of DnBP, BBzP, and EDEHP. All phthalate metabolite and sums of metabolite levels in the schoolchildren were positively correlated with their mothers' levels, except for MEHP, whereas fathers were less correlated with their children. The DEHP intake in this study was higher than that of most other studies. Moreover, 10% of the children and 3% of the adults exceeded the Reference Dose (RfD) value (20 mu g/kg/day) of the U.S. Environmental Protection Agency, which indicates that it is important to focus on children's DEHP exposure because the children exceeded the RID more than adults among the same families who shared similar exposure sources. Our results will contribute to considerations of the regulations for some phthalates and the actual phthalate exposure levels in the Japanese population. (C) 2015 Elsevier GmbH. All rights reserved.	[Bamai, Yu Ait; Araki, Atsuko; Kanazawa, Ayako; Kishi, Reiko] Hokkaido Univ Ctr Environm & Hlth Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan; [Bamai, Yu Ait; Yoshioka, Eiji; Cong, Shi] Hokkaido Univ, Dept Publ Hlth Sci, Grad Sch Med, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Kawai, Toshio; Tsuboi, Tazuru] Osaka Occupat Hlth Serv Ctr, Japan Ind Safety & Hlth Assoc, Nishi Ku, Osaka 5500001, Japan; [Yoshioka, Eiji] Asahikawa Med Univ, Dept Hlth Sci, Asahikawa, Hokkaido 0788510, Japan	Kishi, R (reprint author), Hokkaido Univ Ctr Environm & Hlth Sci, Kita Ku, Kita 12,Nishi 7, Sapporo, Hokkaido 0600812, Japan.	rkishi@med.hokudai.ac.jp					Ait Bamai Yu, 2014, Sci Total Environ, V468-469, P147, DOI 10.1016/j.scitotenv.2013.07.107; Adibi JJ, 2008, ENVIRON HEALTH PERSP, V116, P467, DOI 10.1289/ehp.10749; Kim M, 2014, SCI TOTAL ENVIRON, V470, P1408, DOI 10.1016/j.scitotenv.2013.07.037; Hsu NY, 2012, INDOOR AIR, V22, P186, DOI 10.1111/j.1600-0668.2011.00753.x; Huang PC, 2009, ENVIRON INT, V35, P14, DOI 10.1016/j.envint.2008.05.012; Guo Y, 2011, ENVIRON INT, V37, P893, DOI 10.1016/j.envint.2011.03.005; Koch HM, 2007, J EXPO SCI ENV EPID, V17, P378, DOI 10.1038/sj.jes.7500526; Bertelsen RJ, 2013, ENVIRON HEALTH PERSP, V121, P251, DOI 10.1289/ehp.1205256; Boas M, 2010, ENVIRON HEALTH PERSP, V118, P1458, DOI 10.1289/ehp.0901331; Lin S, 2011, CHEMOSPHERE, V82, P947, DOI 10.1016/j.chemosphere.2010.10.073; Koch HM, 2011, INT J HYG ENVIR HEAL, V214, P188, DOI 10.1016/j.ijheh.2011.01.009; Wittassek M, 2007, INT J HYG ENVIR HEAL, V210, P35, DOI 10.1016/j.ijheh.2006.11.009; Becker K, 2004, INT J HYG ENVIR HEAL, V207, P409, DOI 10.1078/1438-4639-00309; Adibi JJ, 2003, ENVIRON HEALTH PERSP, V111, P1719, DOI 10.1289/ehp.6235; Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723; Casas L, 2011, ENVIRON INT, V37, P858, DOI 10.1016/j.envint.2011.02.012; Serrano SE, 2014, INT J ENV RES PUB HE, V11, P6193, DOI 10.3390/ijerph110606193; Mage DT, 2008, J EXPO SCI ENV EPID, V18, P360, DOI 10.1038/sj.jes.7500614; Becker K, 2009, INT J HYG ENVIR HEAL, V212, P685, DOI 10.1016/j.ijheh.2009.08.002; Colacino JA, 2010, ENVIRON HEALTH PERSP, V118, P998, DOI 10.1289/ehp.0901712; Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4; Calafat AM, 2006, ENVIRON HEALTH PERSP, V114, P1783, DOI 10.1289/ehp.9059; Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337; Koch HM, 2004, INT J HYG ENVIR HEAL, V207, P15, DOI 10.1078/1438-4639-00270; Koch HM, 2012, ARCH TOXICOL, V86, P1829, DOI 10.1007/s00204-012-0908-1; Mage DT, 2004, J EXPO ANAL ENV EPID, V14, P457, DOI 10.1038/sj.jea.7500343; Hines EP, 2009, ENVIRON HEALTH PERSP, V117, P86, DOI 10.1289/ehp.11610; Zota AR, 2014, ENVIRON HEALTH PERSP, V122, P235, DOI 10.1289/ehp.1306681; Ukawa S, 2013, INT ARCH OCC ENV HEA, V86, P777, DOI 10.1007/s00420-012-0814-0; Cho SC, 2010, ENVIRON HEALTH PERSP, V118, P1027, DOI 10.1289/ehp.0901376; Langer S, 2014, INT J HYG ENVIR HEAL, V217, P78, DOI 10.1016/j.ijheh.2013.03.014; Koch HM, 2004, ARCH TOXICOL, V78, P123, DOI 10.1007/00204-003-0522-3; Song NR, 2013, ENVIRON INT, V54, P65, DOI 10.1016/j.envint.2013.01.007; Sathyanarayana S, 2008, PEDIATRICS, V121, pE260, DOI 10.1542/peds.2006-3766; Koch HM, 2013, INT J HYG ENVIR HEAL, V216, P672, DOI 10.1016/j.ijheh.2012.12.002; Beko G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062442; Bizzari S.N., 2013, CHEM EC HDB PLASTICI; CDC, 2013, 4 CDCP; E. Commission, 2004, EUR UN RISK ASS REP; Frederiksen H, 2011, ENVIRON RES, V111, P656, DOI 10.1016/j.envres.2011.03.005; GRAY TJB, 1982, TOXICOL LETT, V11, P141, DOI 10.1016/0378-4274(82)90119-9; Hatch EE, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-27; http://www.mhlw.go.jp/toukei/youranfindexyk_2_1.html, 2013, INF JAP PLAST IND; Ito Y, 2005, ARCH TOXICOL, V79, P147, DOI 10.1007/s00204-004-0615-7; Japan Ministry of Health Law, 2002, MIN NOT NO 267 MHLW; Japan Plasticizer Industry Association and Ministry of Economy Tal, 2014, INF JAP PLAST IND; Kasper-Sonnenberg M, 2012, INT J HYG ENVIR HEAL, V215, P373, DOI 10.1016/j.ijheh.2011.09.004; Koch HM, 2006, INT J ANDROL, V29, P155, DOI 10.1111/j.1365-2605.2005.00607.x; Koch HM, 2003, INT J HYG ENVIR HEAL, V206, P77, DOI 10.1078/1438-4639-00205; Kohn MC, 2000, ENVIRON HEALTH PERSP, V108, pA440, DOI 10.1289/ehp.108-a440b; OISHI S, 1993, TOXICOL LETT, V66, P47, DOI 10.1016/0378-4274(93)90078-C; Sathyanarayana S, 2008, ENVIRON RES, V108, P413, DOI 10.1016/j.envres.2008.07.002	52	0	0	ELSEVIER GMBH, URBAN & FISCHER VERLAG	JENA	OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY	1438-4639	1618-131X		INT J HYG ENVIR HEAL	Int. J. Hyg. Environ. Health.	JUL	2015	218	5					461	470		10.1016/j.ijheh.2015.03.013		10	Public, Environmental & Occupational Health; Infectious Diseases	Public, Environmental & Occupational Health; Infectious Diseases	CK9GB	WOS:000356547500004		
J	Chijiwa, T; Kawai, K; Noguchi, A; Sato, H; Hayashi, A; Cho, H; Shiozawa, M; Kishida, T; Morinaga, S; Yokose, T; Katayama, M; Takenaka, N; Suemizu, H; Yamada, R; Nakamura, Y; Ohtsu, T; Takano, Y; Imai, K; Miyagi, Y; Nakamura, M				Chijiwa, Tsuyoshi; Kawai, Kenji; Noguchi, Akira; Sato, Hidemitsu; Hayashi, Akimune; Cho, Haruhiko; Shiozawa, Manabu; Kishida, Takeshi; Morinaga, Soichiro; Yokose, Tomoyuki; Katayama, Makoto; Takenaka, Nobuo; Suemizu, Hiroshi; Yamada, Roppei; Nakamura, Yoshiyasu; Ohtsu, Takashi; Takano, Yasuo; Imai, Kohzoh; Miyagi, Yohei; Nakamura, Masato			Establishment of patient-derived cancer xenografts in immunodeficient NOG mice	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						patient-derived xenograft; NOG mice; tumor model; cancer xenopatients; anticancer therapies	HUMAN TUMOR XENOGRAFTS; NOD/SCID/GAMMA(NULL)(C) MOUSE; MODEL; ENGRAFTMENT; CELLS	Viable and stable human cancer cell lines and animal models combined with adequate clinical information are essential for future advances in cancer research and patient care. Conventional in vitro cancer cell lines are commonly available; however, they lack detailed information on the patient from which they originate, including disease phenotype and drug sensitivity. Patient-derived xenografts (PDX) with clinical information (so-called 'cancer xenopatients') are a promising advance that may accelerate the development of anticancer therapies. We established 61 PDX lines from 116 surgically removed tumor tissues inoculated subcutaneously into NOG mice (53% success rate). PDX lines were established from various types of epithelial tumors and also from sarcomas, including gastrointestinal stromal tumors and Ewing/PNET sarcomas. The metastatic tumors yielded PDX lines more effectively (65%) than the primary tumors (27%, P<0.001). In our PDX models, morphological characteristics, gene expression profiles, and genetic alteration patterns were all % well preserved. In eight cases (7%), the transplantable xenografts for several generations were composed of large monotonous nonepithelial cells of human origin, revealed to be Epstein-Barr virus infection-associated lymphoproliferative lesions. Despite this, PDX linked with clinical information offer many advantages for preclinical studies investigating new anticancer drugs. The fast and efficient establishment of individual PDX may also contribute to future personalized anticancer therapies.	[Chijiwa, Tsuyoshi; Kawai, Kenji; Suemizu, Hiroshi; Nakamura, Masato] Cent Inst Expt Anim, Kawasaki Ku, Kawasaki, Kanagawa 2100821, Japan; [Noguchi, Akira; Yokose, Tomoyuki] Kanagawa Canc Ctr, Dept Pathol, Asahi Ku, Yokohama, Kanagawa 2418515, Japan; [Sato, Hidemitsu; Hayashi, Akimune] Kanagawa Canc Ctr, Dept Neurosurg, Asahi Ku, Yokohama, Kanagawa 2418515, Japan; [Cho, Haruhiko; Shiozawa, Manabu; Morinaga, Soichiro] Kanagawa Canc Ctr, Dept Gastrointestinal Surg, Asahi Ku, Yokohama, Kanagawa 2418515, Japan; [Kishida, Takeshi] Kanagawa Canc Ctr, Dept Urol, Asahi Ku, Yokohama, Kanagawa 2418515, Japan; [Yamada, Roppei; Nakamura, Yoshiyasu; Ohtsu, Takashi; Takano, Yasuo; Imai, Kohzoh; Miyagi, Yohei] Kanagawa Canc Ctr, Res Inst, Asahi Ku, Yokohama, Kanagawa 2418515, Japan; [Katayama, Makoto; Takenaka, Nobuo] Kawasaki Municipal Hosp, Dept Neurosurg, Kawasaki, Kanagawa 2100013, Japan; [Nakamura, Masato] Tokai Univ, Sch Med, Dept Regenerat Med, Isehara, Kanagawa 2591193, Japan	Miyagi, Y (reprint author), Kanagawa Canc Ctr, Res Inst, Asahi Ku, 2-3-2 Nakao, Yokohama, Kanagawa 2418515, Japan.	miyagi@gancen.asahi.yokohama.jp			JSPS [25430098, 26430097]	The authors thank Ms. Aki Namiki, Miyuki Kon, Takayo Shimamura, and Manami Ino at the Kanagawa Cancer Center for their assistance in tissue preparation and obtaining informed consent from patients involved in the study. This work was partly supported by JSPS Grant-in-Aid for Scientific Research (C), numbers 25430098 and 26430097.	Morton CL, 2007, NAT PROTOC, V2, P247, DOI 10.1038/nprot.2007.25; Marangoni E, 2007, CLIN CANCER RES, V13, P3989, DOI 10.1158/1078-0432.CCR-07-0078; Johnson JI, 2001, BRIT J CANCER, V84, P1424, DOI 10.1054/bjoc.2001.1796; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Sausville EA, 2006, CANCER RES, V66, P3351, DOI 10.1158/0008-5472.CAN-05-3627; Dangles-Marie V, 2007, CANCER RES, V67, P398, DOI 10.1158/0008-5472.CAN-06-0594; Kubo A, 2011, ANAL BIOANAL CHEM, V400, P1895, DOI 10.1007/s00216-011-4895-5; Kobayashi S, 2012, STEM CELLS, V30, P2631, DOI 10.1002/stem.1257; Galimi F, 2011, CLIN CANCER RES, V17, P3146, DOI 10.1158/1078-0432.CCR-10-3377; Bertotti A, 2011, CANCER DISCOV, V1, P508, DOI 10.1158/2159-8290.CD-11-0109; Yoshida T, 2005, CANCER RES, V65, P9611, DOI 10.1158/0008-5472.CAN-05-0817; Fujii E, 2014, EXP ANIM TOKYO, V63, P289; Bibby MC, 2004, EUR J CANCER, V40, P852, DOI 10.1016/j.ejca.2003.11.021; Bankert RB, 2002, FRONT BIOSCI, V7, pc44; Chijiwa Tsuyoshi, 2009, Int J Oncol, V34, P5; Cho H, 2012, INT J CLIN ONCOL, V17, P294, DOI 10.1007/s10147-011-0296-1; Fujii E, 2008, PATHOL INT, V58, P559, DOI 10.1111/j.1440-1827.2008.02271.x; ITOH T, 1993, CANCER, V72, P2686, DOI 10.1002/1097-0142(19931101)72:9<2686::AID-CNCR2820720927>3.0.CO;2-T; Jin KT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028384; MUELLER BM, 1991, CANCER METAST REV, V10, P193, DOI 10.1007/BF00050791; Scott Clare L, 2013, Front Oncol, V3, P295, DOI 10.3389/fonc.2013.00295; Suemizu H, 2007, INT J ONCOL, V31, P741; Tokunaga T, 1998, J NATL CANCER I, V90, P400, DOI 10.1093/jnci/90.5.400	23	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	JUL	2015	47	1					61	70		10.3892/ijo.2015.2997		10	Oncology	Oncology	CK8DG	WOS:000356468100007		
J	Yamamuro, S; Okamoto, Y; Sano, E; Ochiai, Y; Ogino, A; Ohta, T; Hara, H; Ueda, T; Nakayama, T; Yoshino, A; Katayama, Y				Yamamuro, Shun; Okamoto, Yutaka; Sano, Emiko; Ochiai, Yushi; Ogino, Akiyoshi; Ohta, Takashi; Hara, Hiroyuki; Ueda, Takuya; Nakayama, Tomohiro; Yoshino, Atsuo; Katayama, Yoichi			Characterization of glioma stem-like cells from human glioblastomas	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						malignant glioma; brain-tumor stem cells; glioma stem-like cells	TUMOR-INITIATING CELLS; GENE-EXPRESSION; MARKER CD133; CANCER; TEMOZOLOMIDE; IDENTIFICATION; RADIOTHERAPY; RESISTANCE	Glioma stem-like cells (GSCs) could have potential for tumorigenesis, treatment resistance, and tumor recurrence (GSC hypothesis). However, the mechanisms underlying such potential has remained elusive and few ultrastructural features of the cells have been reported in detail. We therefore undertook observations of the antigenic characteristics and ultrastructural features of GSCs isolated from human glioblastomas. Tumor spheres formed by variable numbers of cells, exhibiting a variable appearance in both their size and shape, were frequently seen in GSCs expressing the stem cell surface markers CD133 and CD15. Increased cell nucleus atypia, mitochondria, rough endoplasmic reticulum, coated vesicles, and microvilli, were noted in the GSCs. Furthermore, cells at division phases and different phases of the apoptotic process were occasionally observed. These findings could imply that GSCs have certain relations with human neural stem cells (NSCs) but are primitively different from undifferentiated NSCs. The data may provide support for the GSC hypothesis, and also facilitate the establishment of future glioblastoma treatments targeting GSCs.	[Yamamuro, Shun; Ochiai, Yushi; Ogino, Akiyoshi; Ohta, Takashi; Yoshino, Atsuo; Katayama, Yoichi] Nihon Univ, Sch Med, Dept Neurol Surg, Tokyo 1738610, Japan; [Hara, Hiroyuki] Nihon Univ, Sch Med, Dept Funct Morphol, Tokyo 1738610, Japan; [Nakayama, Tomohiro] Nihon Univ, Sch Med, Dept Pathol Microbiol, Div Compan Diagnost, Tokyo 1738610, Japan; [Okamoto, Yutaka] New Energy & Ind Technol Dev Org, Kawasaki, Kanagawa, Japan; [Sano, Emiko; Ueda, Takuya] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Chiba, Japan	Yoshino, A (reprint author), Nihon Univ, Sch Med, Dept Neurol Surg, Itabashi Ku, 30-1 Oyaguchi Kamimachi, Tokyo 1738610, Japan.	yoshino.atsuo@nihon-u.ac.jp			Health Sciences Research Institute, Inc., Yokohama; Japan for Division of Companion Diagnostics; Department of Pathology of Microbiology, Nihon University School of Medicine	This study was financially supported in part by a grant from the Health Sciences Research Institute, Inc., Yokohama, Japan for Division of Companion Diagnostics, Department of Pathology of Microbiology, Nihon University School of Medicine. We wish to thank Dr Hiroyuki Suzuki (Nihon University School of Medicine), Mr. Nobuo Miyazaki (Toray Industries Inc.) and Mr. Hiroyuki Satake (Toray Industries Inc.) for their valuable advice.	Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Arum CJ, 2010, NEOPLASIA, V12, P434, DOI 10.1593/neo.91824; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Singh SK, 2003, CANCER RES, V63, P5821; Villalva C, 2012, INT J MOL SCI, V13, P6983, DOI 10.3390/ijms13066983; Yoshino A, 2010, INT J ONCOL, V36, P1367, DOI 10.3892/ijo_00000621; Zeppernick F, 2008, CLIN CANCER RES, V14, P123, DOI 10.1158/1078-0432.CCR-07-0932; Vescovi AL, 2006, NAT REV CANCER, V6, P425, DOI 10.1038/nrc1889; Dimov I, 2011, THESCIENTIFICWORLDJO, V11, P930, DOI 10.1100/tsw.2011.42; Eramo A, 2006, CELL DEATH DIFFER, V13, P1238, DOI 10.1038/sj.cdd.4401872; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Zhang QB, 2006, CELL RES, V16, P909, DOI 10.1038/sj.cr.7310104; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Beier D, 2007, CANCER RES, V67, P4010, DOI 10.1158/0008-5472.CAN-06-4180; Yuki K, 2009, CANCER LETT, V284, P71, DOI 10.1016/j.canlet.2009.04.020; Son MJ, 2009, CELL STEM CELL, V4, P440, DOI 10.1016/j.stem.2009.03.003; Kim KJ, 2011, NEUROPATHOLOGY, V31, P494, DOI 10.1111/j.1440-1789.2010.01194.x; Gritti A, 2002, J PHYSIOLOGY-PARIS, V96, P81, DOI 10.1016/S0928-4257(01)00083-3; Lobo MVT, 2003, J HISTOCHEM CYTOCHEM, V51, P89; Natsume A, 2012, ONCOGENE, V31, P2715, DOI 10.1038/onc.2011.466; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; He J, 2011, ONCOL REP, V26, P1305, DOI 10.3892/or.2011.1393; Jin X, 2013, BIOCHEM BIOPH RES CO, V433, P496, DOI 10.1016/j.bbrc.2013.03.021; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Mao XG, 2009, TRANSL ONCOL, V2, P247, DOI 10.1593/tlo.09136; Pavon LF, 2010, CANCER BIOTHER RADIO, V25, P289, DOI 10.1089/cbr.2009.0697; Yang B, 2012, ULTRASTRUCT PATHOL, V36, P404, DOI 10.3109/01913123.2012.708011; Zaguia F, 2011, CANCER BIOL THER, V11, P1, DOI 10.4161/cbt.11.1.14498; Zhao YD, 2008, ULTRASTRUCT PATHOL, V32, P241, DOI 10.1080/01913120802289165	30	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	JUL	2015	47	1					91	96		10.3892/ijo.2015.2992		6	Oncology	Oncology	CK8DG	WOS:000356468100010		
J	Suzuki, SI; Matsusaka, S; Hirai, M; Shibata, H; Takagi, K; Mizunuma, N; Hatake, K				Suzuki, Shun-Ichi; Matsusaka, Satoshi; Hirai, Mitsuharu; Shibata, Harumi; Takagi, Koichi; Mizunuma, Nobuyuki; Hatake, Kiyohiko			A novel approach to detect KRAS/BRAF mutation for colon cancer: Highly sensitive simultaneous detection of mutations and simple pre-treatment without DNA extraction	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						colon cancer; KRAS mutation; BRAF mutation; QProbe method	METASTATIC COLORECTAL-CANCER; SINGLE NUCLEOTIDE POLYMORPHISMS; RAPID DETECTION SYSTEM; KRAS P.G13D MUTATION; AUTOMATED DETECTION; PROGNOSTIC-FACTOR; TARGETED THERAPY; K-RAS; CETUXIMAB; INHIBITION	It has been reported that colon cancer patients with KRAS and BRAF mutations that lie downstream of epidermal growth factor receptor (EGFR) acquire resistance against therapy with anti-EGFR antibodies, cetuximab and panitumumab. On the other hand, some reports say KRAS codon 13 mutation (p.G13D) has lower resistance against anti-EGFR antibodies, thus there is a substantial need for detection of specific KRAS mutations. We have established a state-of-the-art measurement system using QProbe (QP) method that allows simultaneous measurement of KRAS codon 12/13, p.G13D and BRAF mutation, and compared this method against Direct Sequencing (DS) using 182 specimens from colon cancer patients. In addition, 32 biopsy specimens were processed with a novel pre-treatment method without DNA purification in order to detect KRAS/BRAF. As a result of KRAS mutation measurement, concordance rate between the QP method and DS method was 81.4% (144/177) except for the 5 specimens that were undeterminable. Among them, 29 specimens became positive with QP method and negative with DS method. BRAF was measured with QP method only, and the mutation detection rate was 3.9% (6/153). KRAS measurement using a simple new pre-treatment method without DNA extraction resulted in 31 good results out of 32, all of them matching with the DS method. We have established a simple but highly sensitive simultaneous detection system for KRAS/BRAF. Moreover, introduction of the novel pre-treatment technology eliminated the inconvenient DNA extraction process. From this research achievement, we not only anticipate quick and accurate results returned in the clinical field but also contribution in improving the test quality and work efficiency.	[Suzuki, Shun-Ichi] ARKRAY Mkt Inc, Mkt Div, Shinjuku Ku, Tokyo 1600004, Japan; [Matsusaka, Satoshi; Mizunuma, Nobuyuki] Japanese Fdn Canc Res, Canc Inst Hosp, Gastroenterol Ctr, Koto Ku, Tokyo 1358550, Japan; [Hirai, Mitsuharu] ARKRAY Inc, Div Res & Dev, Kamigyo Ku, Kyoto 6020008, Japan; [Shibata, Harumi; Takagi, Koichi; Hatake, Kiyohiko] Japanese Fdn Canc Res, Canc Chemotherapy Ctr, Clin Chemotherapy, Koto Ku, Tokyo 1358550, Japan	Matsusaka, S (reprint author), Japanese Fdn Canc Res, Canc Inst Hosp, Gastroenterol Ctr, Koto Ku, 3-10-6 Ariake, Tokyo 1358550, Japan.	satoshi.matsusaka@jfcr.or.jp					Akagi Kiwamu, 2011, Rinsho Byori, V59, P757; Berg M, 2012, DISCOV MED, V76, P207; Siena S, 2009, J NATL CANCER I, V101, P1308, DOI 10.1093/jnci/djp280; Lievre A, 2008, J CLIN ONCOL, V26, P374, DOI 10.1200/JCO.2007.12.5906; Suzuki S, 2012, SENSORS-BASEL, V12, P16614, DOI 10.3390/s121216614; Heinemann V, 2009, CANCER TREAT REV, V35, P262, DOI 10.1016/j.ctrv.2008.11.005; De Roock W, 2010, JAMA-J AM MED ASSOC, V304, P1812, DOI 10.1001/jama.2010.1535; Evans WE, 1999, SCIENCE, V286, P487, DOI 10.1126/science.286.5439.487; Tanaka R, 2008, LEUKEMIA RES, V32, P1462, DOI 10.1016/j.leukres.2007.12.019; Grothey A, 2013, LANCET, V381, P303, DOI 10.1016/S0140-6736(12)61900-X; Baines AT, 2011, FUTURE MED CHEM, V3, P1787, DOI [10.4155/fmc.11.121, 10.4155/FMC.11.121]; Yokota T, 2011, BRIT J CANCER, V104, P856, DOI 10.1038/bjc.2011.19; Mao C, 2013, CANCER-AM CANCER SOC, V119, P714, DOI 10.1002/cncr.27804; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Ong FS, 2012, EXPERT REV MOL DIAGN, V12, P593, DOI [10.1586/erm.12.59, 10.1586/ERM.12.59]; Benvenuti S, 2007, CANCER RES, V67, P2643, DOI 10.1158/0008-5472.CAN-06-4158; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Yoshino T, 2012, LANCET ONCOL, V13, P993, DOI 10.1016/S1470-2045(12)70345-5; De Stefano A, 2014, WORLD J GASTROENTERO, V20, P9732, DOI 10.3748/wjg.v20.i29.9732; Bando H, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-405; Borden EC, 2010, NAT REV DRUG DISCOV, V9, P343, DOI 10.1038/nrd3168; Gazdar AF, 2010, CANCER METAST REV, V29, P37, DOI 10.1007/s10555-010-9201-z; Jiang YX, 2010, BIOMARK MED, V4, P535, DOI [10.2217/bmm.10.74, 10.2217/BMM.10.74]; Kurata S, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.6.e34; Patel Gargi Surendra, 2013, Cancer Manag Res, V5, P387, DOI 10.2147/CMAR.S35025; Takahashi H, 2013, J VIRAL HEPATITIS, V20, pe124, DOI 10.1111/jvh.12026; Tanaka R, 2011, CANCER LETT, V312, P228, DOI 10.1016/j.canlet.2011.08.009; Ureshino N, 2010, ONCOL RES, V19, P111, DOI 10.3727/096504011X12935427587687; Ureshino N, 2011, ONCOL REP, V26, P609, DOI 10.3892/or.2011.1341; Yokota T, 2012, ANTI-CANCER AGENT ME, V12, P163	30	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	JUL	2015	47	1					97	105		10.3892/ijo.2015.2978		9	Oncology	Oncology	CK8DG	WOS:000356468100011		
J	Yoshizawa, S; Fujiwara, K; Sugito, K; Uekusa, S; Kawashima, H; Hoshi, R; Watanabe, Y; Hirano, T; Furuya, T; Masuko, T; Ueno, T; Fukuda, N; Soma, M; Ozaki, T; Koshinaga, T; Nagase, H				Yoshizawa, Shinsuke; Fujiwara, Kyoko; Sugito, Kiminobu; Uekusa, Shota; Kawashima, Hiroyuki; Hoshi, Reina; Watanabe, Yosuke; Hirano, Takayuki; Furuya, Takeshi; Masuko, Takayuki; Ueno, Takahiro; Fukuda, Noboru; Soma, Masayoshi; Ozaki, Toshinori; Koshinaga, Tsugumichi; Nagase, Hiroki			Pyrrole-imidazole polyamide-mediated silencing of KCNQ1OT1 expression induces cell death in Wilms' tumor cells	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						KCNQIOT1; KvDMR; Pyrrole-imidazole polyamides; Wilms' tumor	BECKWITH-WIEDEMANN-SYNDROME; HUMAN-CHROMOSOME 11P15.5; HEPATOCELLULAR-CARCINOMA; DOWN-REGULATION; CDK INHIBITORS; NONCODING RNA; ANNEXIN-V; GROWTH; P57(KIP2); CANCER	KvDMR (an intronic CpG island within the KCNQI gene) is one of the imprinting control regions on human chromosome 11p15.5. Since KvDMR exists within the promoter region of KCNQIOT1 (antisense transcript of KCNQI), it is likely that genomic alterations of this region including deletion, paternal uniparental disomy and de-methylation in maternal allele lead to aberrant overexpression of KCNQIOT1. Indeed, de-methylation of KvDMR accompanied by uncontrolled overexpression of KCNQIOT1 occurs frequently in Beckwith-Wiedemann syndrome (BWS), and around 10% of BWS patients developed embryonal tumors (Wilms' tumor or hepatoblastoma). These observations strongly suggest that silencing of KCNQIOTI expression might suppress its oncogenic potential. In the present study, we designed two pyrrole-imidazole (PI) polyamides, termed P1-a and PI-b, which might have the ability to bind to CCAAT boxes of the KCNQIOT1 promoter region, and investigated their possible antitumor effect on Wilms' tumor-derived G401 cells. Gel retardation assay demonstrated that P1-a and P1-b specifically bind to their target sequences. Microscopic observations showed the efficient nuclear access of these PI polyamides. Quantitative real-time PCR analysis revealed that the expression level of KCNQIOTI was significantly decreased when treated with P1-a and P1-b simultaneously but not with either P1-a or P1-b single treatment. Consistent with these results, the combination of P1-a and P1-b resulted in a significant reduction in viability of G401 cells in a dose-dependent manner. Furthermore, FACS analysis demonstrated that combinatory treatment with P1-a and P1-b induces cell death as compared with control cells. Taken together, our present observations strongly suggest that the combinatory treatment with PI polyamides targeting KCNQIOTI might be a novel therapeutic strategy to cure patients with tumors overexpressing KCNQIOTI.	[Yoshizawa, Shinsuke; Sugito, Kiminobu; Uekusa, Shota; Kawashima, Hiroyuki; Hoshi, Reina; Watanabe, Yosuke; Hirano, Takayuki; Furuya, Takeshi; Masuko, Takayuki; Koshinaga, Tsugumichi] Nihon Univ, Sch Med, Dept Pediat Surg, Tokyo 1738610, Japan; [Fujiwara, Kyoko; Soma, Masayoshi] Nihon Univ, Sch Med, Dept Med, Div Gen Med, Tokyo 1738610, Japan; [Fujiwara, Kyoko; Sugito, Kiminobu; Ueno, Takahiro; Fukuda, Noboru; Soma, Masayoshi; Koshinaga, Tsugumichi] Nihon Univ, Sch Med, Res Inst Med Sci, Innovat Therapy Res Grp, Tokyo 1738610, Japan; [Ueno, Takahiro; Fukuda, Noboru] Nihon Univ, Sch Med, Dept Med, Div Nephrol Hypertens & Endocrinol, Tokyo 1738610, Japan; [Ozaki, Toshinori] Chiba Canc Ctr, Res Inst, Lab DNA Damage Signaling, Chiba 2608717, Japan; [Nagase, Hiroki] Chiba Canc Ctr, Res Inst, Canc Genet Lab, Chiba 2608717, Japan	Fujiwara, K (reprint author), Nihon Univ, Sch Med, Dept Med, Div Gen Med,Itabashi Ku, 30-1 Oyaguchi Kamicho, Tokyo 1738610, Japan.	fujiwara.kyoko@nihon-u.ac.jp; hnagase@chiba-cc.jp			MEXT	This work was supported by the Academic Frontier Project for 2006 Project for Private Universities, a matching fund subsidy from MEXT (to H.N.), and MEXT-Supported Program for the Strategic Research Foundation at Private Universities (2011-2015) to K.F., K.S., T.U., N.F., M.S., T.K., and H.N.	Murty MSRC, 2004, BIOL PHARM BULL, V27, P468, DOI 10.1248/bpb.27.468; Dervan PB, 2001, BIOORGAN MED CHEM, V9, P2215, DOI 10.1016/S0968-0896(01)00262-0; Guo H, 2011, CARCINOGENESIS, V32, P1897, DOI 10.1093/carcin/bgr220; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; Higashimoto K, 2006, CYTOGENET GENOME RES, V113, P306, DOI 10.1159/000090846; DeBaun MR, 1998, J PEDIATR-US, V132, P398, DOI 10.1016/S0022-3476(98)70008-3; Matsuda H, 2011, KIDNEY INT, V79, P46, DOI 10.1038/ki.2010.330; Kanduri C, 2011, SEMIN CELL DEV BIOL, V22, P343, DOI 10.1016/j.semcdb.2011.02.020; Fitzpatrick GV, 2002, NAT GENET, V32, P426, DOI 10.1038/ng988; Weksberg R, 2010, EUR J HUM GENET, V18, P8, DOI 10.1038/ejhg.2009.106; Chiesa N, 2012, HUM MOL GENET, V21, P10, DOI 10.1093/hmg/ddr419; Mancini-DiNardo D, 2006, GENE DEV, V20, P1268, DOI 10.1101/gad.1416906; Dobbelstein M, 2014, NAT REV DRUG DISCOV, V13, P179, DOI 10.1038/nrd4201; Dervan PB, 2003, CURR OPIN STRUC BIOL, V13, P284, DOI 10.1016/S0959-440X(03)00081-2; Choufani S, 2010, AM J MED GENET C, V154C, P343, DOI 10.1002/ajmg.c.30267; Arima T, 2005, NUCLEIC ACIDS RES, V33, P2650, DOI 10.1093/nar/gki555; ARCAMONE F, 1964, NATURE, V203, P1064, DOI 10.1038/2031064a0; Bando T, 2002, CHEM-EUR J, V8, P4781, DOI 10.1002/1521-3765(20021018)8:20<4781::AID-CHEM4781>3.0.CO;2-J; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Aubry JP, 1999, CYTOMETRY, V37, P197, DOI 10.1002/(SICI)1097-0320(19991101)37:3<197::AID-CYTO6>3.0.CO;2-L; Zhang PM, 1998, GENE DEV, V12, P3162, DOI 10.1101/gad.12.20.3162; Mohammad F, 2012, DEVELOPMENT, V139, P2792, DOI 10.1242/dev.079566; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Lee MP, 1999, P NATL ACAD SCI USA, V96, P5203, DOI 10.1073/pnas.96.9.5203; Diaz-Meyer N, 2003, J MED GENET, V40, P797, DOI 10.1136/jmg.40.11.797; Du MJ, 2004, GENOMICS, V84, P288, DOI 10.1016/j.ygeno.2004.03.008; Du MJ, 2003, HUM MOL GENET, V12, P1927, DOI 10.1093/hmg/ddg194; Farooqi AA, 2014, ONCOTARGETS THER, V7, P2035, DOI 10.2147/OTT.S49652; Jacob KJ, 2013, CLIN GENET, V84, P326, DOI 10.1111/cge.12143; Jin RJ, 2008, CANCER RES, V68, P3601, DOI 10.1158/0008-5472.CAN-08-0073; Nakano S, 2006, CANCER SCI, V97, P1147, DOI 10.1111/j.1349-7006.2006.00305.x; Rump P, 2005, AM J MED GENET A, V136A, P95, DOI 10.1002/ajmg.a.30729; Scott RH, 2008, J MED GENET, V45, P106, DOI 10.1136/jmg.2007.053207; Soejima H, 2004, ONCOGENE, V23, P4380, DOI 10.1038/sj.onc.1207576; Wan J, 2013, DNA CELL BIOL, V32, P628, DOI 10.1089/dna.2013.2118; Wang XF, 2010, CANCER SCI, V101, P759, DOI 10.1111/j.1349-7006.2009.01435.x; Weksberg R, 2001, HUM MOL GENET, V10, P2989, DOI 10.1093/hmg/10.26.2989	37	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	JUL	2015	47	1					115	121		10.3892/ijo.2015.3018		7	Oncology	Oncology	CK8DG	WOS:000356468100013		
J	Nagano, K; Imai, S; Zhao, XLL; Yamashita, T; Yoshioka, Y; Abe, Y; Mukai, Y; Kamada, H; Nakagawa, S; Tsutsumi, Y; Tsunoda, SI				Nagano, Kazuya; Imai, Sunao; Zhao, Xiluli; Yamashita, Takuya; Yoshioka, Yasuo; Abe, Yasuhiro; Mukai, Yohei; Kamada, Haruhiko; Nakagawa, Shinsaku; Tsutsumi, Yasuo; Tsunoda, Shin-Ichi			Identification and evaluation of metastasis-related proteins, oxysterol binding protein-like 5 and calumenin, in lung tumors	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						metastasis; lung cancer; antibody proteomics technology; oxysterol binding protein-like 5; calumenin	EPH RECEPTOR A10; CANCER METASTASIS; MOLECULAR CHAPERONE; PANCREATIC-CANCER; PROSTATE-CANCER; POOR-PROGNOSIS; EXPRESSION; CELLS; METABOLISM; CARCINOMA	Metastasis is an important prognosis factor in lung cancer, therefore, it is imperative to identify target molecules and elucidate molecular mechanism of metastasis for developing new therapeutics and diagnosis methods. We searched for metastasis-related proteins by utilizing a novel antibody proteome technology developed in our laboratory that facilitated efficient screening of useful target proteins. Two-dimensional differential in-gel electrophoresis (2D-DIGE) analysis identified sixteen proteins, which were highly expressed in metastatic lung cancer cells, as protein candidates. Monoclonal single-chain variable fragments (scFvs) binding to candidates were isolated from a scFv-displaying phage library by affinity selection. Tissue microarray analysis of scFvs binding to candidates revealed that oxysterol binding protein-like 5 (OSBPL5) and calumenin (CALU) were expressed at a significantly higher levels in the lung tissues of metastasis-positive cases than that in the metastasis-negative cases (OSBPL5; p=0.0156, CALU; p=0.0055). Furthermore, 80% of OSBPL5 and CALU double-positive cases were positive for lymph node metastasis. Consistent with these observations, overexpression of OSBPL5 and CALU promoted invasiveness of lung cancer cells. Conversely, knockdown of these proteins using respective siRNAs reversed the invasiveness of the lung cancer cells. Moreover, these proteins were expressed in lung tumor tissues, but not in normal lung tissues. In conclusion, OSBPL5 and CALU are related to metastatic potential of lung cancer cells, and they could be useful targets for cancer diagnosis and also for development of drugs against metastasis.	[Nagano, Kazuya; Imai, Sunao; Zhao, Xiluli; Yamashita, Takuya; Yoshioka, Yasuo; Abe, Yasuhiro; Mukai, Yohei; Kamada, Haruhiko; Tsutsumi, Yasuo; Tsunoda, Shin-Ichi] Natl Inst Biomed Innovat, Lab Biopharmaceut Res, Osaka 5670085, Japan; [Yoshioka, Yasuo; Nakagawa, Shinsaku; Tsutsumi, Yasuo; Tsunoda, Shin-Ichi] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan; [Yoshioka, Yasuo; Kamada, Haruhiko; Nakagawa, Shinsaku; Tsutsumi, Yasuo; Tsunoda, Shin-Ichi] Osaka Univ, Ctr Adv Med Engn & Informat, Suita, Osaka 5650871, Japan	Tsunoda, SI (reprint author), Natl Inst Biomed Innovat, Lab Biopharmaceut Res, 7-6-8 Saito Asagi, Osaka 5670085, Japan.	tsunoda@nibio.go.jp			Project for Development of Innovative Research on Cancer Therapeutics, Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science; Health Labor Sciences Research Grants from Ministry of Health, Labor and Welfare of Japan	This study was supported in part by Grants-in-Aid for Scientific Research from the Project for Development of Innovative Research on Cancer Therapeutics, the Ministry of Education, Culture, Sports, Science and Technology of Japan, and from the Japan Society for the Promotion of Science. This study was also supported in part by Health Labor Sciences Research Grants from the Ministry of Health, Labor and Welfare of Japan.	Ando T, 2006, ONCOL REP, V15, P1551; Tsuji T, 2009, CANCER RES, V69, P7135, DOI 10.1158/0008-5472.CAN-09-1618; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74; Kuramochi M, 2001, NAT GENET, V27, P427, DOI 10.1038/86934; Honore B, 2009, BIOESSAYS, V31, P262, DOI 10.1002/bies.200800186; Imai S, 2011, BIOMATERIALS, V32, P162, DOI 10.1016/j.biomaterials.2010.09.030; Fairn GD, 2008, CELL MOL LIFE SCI, V65, P228, DOI 10.1007/s00018-007-7325-2; Wu WG, 2002, CLIN EXP METASTAS, V19, P319, DOI 10.1023/A:1015515119300; Steeg PS, 2003, NAT REV CANCER, V3, P55, DOI 10.1038/nrc967; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Cappello F, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-139; ROCHEFORT H, 1990, CANCER METAST REV, V9, P321, DOI 10.1007/BF00049522; Ding SJ, 2004, PROTEOMICS, V4, P982, DOI 10.1002/pmic.200300653; HIRAI KI, 1991, CLIN EXP METASTAS, V9, P517, DOI 10.1007/BF01768580; Hanash S, 2003, NATURE, V422, P226, DOI 10.1038/nature01514; Tsutsumi S, 2007, CANCER SCI, V98, P1536, DOI 10.1111/j.1349-7006.2007.00561.x; Nagano K, 2014, J CONTROL RELEASE, V189, P72, DOI 10.1016/j.jconrel.2014.06.010; Yamashita T, 2012, BIOCHEM BIOPH RES CO, V421, P140, DOI 10.1016/j.bbrc.2012.03.144; Imai S, 2006, BIOL PHARM BULL, V29, P1325, DOI 10.1248/bpb.29.1325; Shibata K, 2010, J CLIN PATHOL, V63, P1054, DOI 10.1136/jcp.2010.078600; Koga F, 2009, ANTICANCER RES, V29, P797; Hindler K, 2006, ONCOLOGIST, V11, P306, DOI 10.1634/theoncologist.11-3-306; Castilla C, 2010, UROLOGY, V76, p[1017, e1]; Hashimoto T, 2004, PATHOBIOLOGY, V71, P267, DOI 10.1159/000080061; Ishikawa S, 2010, CANCER SCI, V101, P898, DOI 10.1111/j.1349-7006.2009.01475.x; Koga Y, 2008, CANCER SCI, V99, P2387, DOI 10.1111/j.1349-7006.2008.00987.x; Lee GH, 2010, ONCOGENE, V29, P2130, DOI 10.1038/onc.2009.491; Nagano K, 2013, CANCER MED-US, V2, P972, DOI 10.1002/cam4.156; Nagano K, 2014, BIOCHEM BIOPH RES CO, V450, P545, DOI 10.1016/j.bbrc.2014.06.007; TERAOKA S, 1994, INT J ONCOL, V5, P501; TERAOKA S, 1995, JPN J CANCER RES, V86, P419; TOROSIAN MH, 1995, ONCOL REP, V2, P1141; Yamashita T, 2012, PHARMAZIE, V67, P253, DOI 10.1691/ph.2012.1630; Yoshida Y, 2011, BIOCHEM BIOPH RES CO, V405, P610, DOI 10.1016/j.bbrc.2011.01.077; Zheng SQ, 2010, ANTICANCER RES, V30, P713	35	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	JUL	2015	47	1					195	203		10.3892/ijo.2015.3000		9	Oncology	Oncology	CK8DG	WOS:000356468100022		
J	Hattori, Y; Shibuya, K; Kojima, K; Miatmoko, A; Kawano, K; Ozaki, KI; Yonemochi, E				Hattori, Yoshiyuki; Shibuya, Kazuhiko; Kojima, Kaori; Miatmoko, Andang; Kawano, Kumi; Ozaki, Kei-Ichi; Yonemochi, Etsuo			Zoledronic acid enhances antitumor efficacy of liposomal doxorubicin	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						zoledronic acid; doxorubicin; liposome; tumor-associated macrophage	ANGIOGENESIS INHIBITOR SU5416; COMBINATION THERAPY; CANCER; BISPHOSPHONATE; MACROPHAGES; TUMORS; DETERMINANTS; VASCULATURE; PROGRESSION; CELLS	Previously, we found that the injection of zoledronic acid (ZOL) into mice bearing tumor induced changes of the vascular structure in the tumor. In this study, we examined whether ZOL treatment could decrease interstitial fluid pressure (IFP) via change of tumor vasculature, and enhance the antitumor efficacy of liposomal doxorubicin (Doxil (R)). When ZOL solution was injected at 40 mu g/mouse per day for three consecutive days into mice bearing murine Lewis lung carcinoma LLC tumor, depletion of macrophages in tumor tissue and decreased density of tumor vasculature were observed. Furthermore, ZOL treatments induced inflammatory cytokines such as interleukin (IL)-10 and -12, granulocyte-macrophage colony-stimulating factor (GM-CSF) and tumor necrosis factor (TNF)-alpha in serum of LLC tumor-bearing mice, but not in normal mice, indicating that ZOL treatments might induce an inflammatory response in tumor tissue. Furthermore, ZOL treatments increased antitumor activity by Doxil in mice bearing a subcutaneous LLC tumor, although they did not significantly increase the tumor accumulation of doxorubicin (DXR). These results suggest that ZOL treatments might increase the therapeutic efficacy of Doxil via improvement of DXR distribution in a tumor by changing the tumor vasculature. ZOL treatment can be an alternative approach to increase the antitumor effect of liposomal drugs.	[Hattori, Yoshiyuki; Shibuya, Kazuhiko; Kojima, Kaori; Miatmoko, Andang; Kawano, Kumi; Yonemochi, Etsuo] Hoshi Univ, Inst Med Chem, Shinagawa Ku, Tokyo 1428501, Japan; [Ozaki, Kei-Ichi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Pharmaceut Sci, Lab Cell Regulat, Nagasaki 8528521, Japan	Hattori, Y (reprint author), Hoshi Univ, Inst Med Chem, Shinagawa Ku, Ebara 2-4-41, Tokyo 1428501, Japan.	yhattori@hoshi.ac.jp		Hattori, Yoshiyuki/0000-0002-4731-0407	Japan Society for the Promotion of Science (KAKENHI) [26460046]	We thank Ms. Akira Kiyota for assistance in the experimental work. This study was supported in part by a Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science (KAKENHI grant no. 26460046).	Tanvetyanon T, 2006, ANN ONCOL, V17, P897, DOI 10.1093/annonc/mdj105; Kato M, 2012, INT J PHARMACEUT, V423, P428, DOI 10.1016/j.ijpharm.2011.12.015; Taniguchi Y, 2010, CANCER SCI, V101, P2207, DOI 10.1111/j.1349-7006.2010.01646.x; Kobayashi N, 2010, CANCER RES, V70, P7073, DOI 10.1158/0008-5472.CAN-09-4687; Ohara Y, 2012, INT J CANCER, V131, P2402, DOI 10.1002/ijc.27502; Ottewell PD, 2012, BREAST CANCER RES TR, V133, P523, DOI 10.1007/s10549-011-1782-x; Bezzi M, 2003, J BIOL CHEM, V278, P43603, DOI 10.1074/jbc.M308114200; Backman U, 2008, ANTICANCER RES, V28, P1551; Zhang W, 2010, CLIN CANCER RES, V16, P3420, DOI 10.1158/1078-0432.CCR-09-2904; Kano MR, 2007, P NATL ACAD SCI USA, V104, P3460, DOI 10.1073/pnas.0611660104; Ogawara K, 2008, INT J PHARM, V359, P234, DOI 10.1016/j.ijpharm.2008.03.025; Jain RK, 2001, NAT MED, V7, P987, DOI 10.1038/nm0901-987; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Giraudo E, 2004, J CLIN INVEST, V114, P623, DOI 10.1172/JCI200422087; Wood J, 2002, J PHARMACOL EXP THER, V302, P1055, DOI 10.1124/jpet.102.035295; Santini D, 2003, CLIN CANCER RES, V9, P2893; Coscia M, 2010, J CELL MOL MED, V14, P2803, DOI 10.1111/j.1582-4934.2009.00926.x; Goel S, 2011, PHYSIOL REV, V91, P1071, DOI 10.1152/physrev.00038.2010; Clezardin P, 2010, CURR PHARM DESIGN, V16, P3007, DOI 10.2174/138161210793563545; Condeelis I, 2006, CELL, V124, P263; Corso A, 2005, HEMATOLOGY, V10, P215, DOI 10.1080/10245330500094714; Dicuonzo G, 2003, J INTERF CYTOK RES, V23, P649, DOI 10.1089/107999003322558782; Hattori Y, 2015, J LIPOSOME RES, V25, P131, DOI 10.3109/08982104.2014.954128; Ogawara KI, 2014, J PHARM SCI-US, V103, P2464, DOI 10.1002/jps.24071; Ottewell PD, 2008, J NATL CANCER I, V100, P1167, DOI 10.1093/jnci/djn240; Reid IR, 2010, J CLIN ENDOCR METAB, V95, P4380, DOI 10.1210/jc.2010-0597; Riganti C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060975; Rogers Michael J., 2000, Cancer, V88, P2961, DOI 10.1002/1097-0142(20000615)88:12+<2961::AID-CNCR12>3.0.CO;2-L; Shang Bingxue, 2012, Front Med, V6, P67, DOI 10.1007/s11684-012-0176-8; Thompson K, 2006, MOL PHARMACOL, V69, P1624, DOI 10.1124/mol.105.020776; Ross J R, 2004, Health Technol Assess, V8, P1; Yoshizawa Y, 2012, MOL PHARMACEUT, V9, P3486, DOI 10.1021/mp300318q	32	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	JUL	2015	47	1					211	219		10.3892/ijo.2015.2991		9	Oncology	Oncology	CK8DG	WOS:000356468100024		
J	Miyake, T; Honma, Y; Urano, T; Kato, N; Suzumiya, J				Miyake, Takaaki; Honma, Yoshio; Urano, Takeshi; Kato, Nobuo; Suzumiya, Junji			Combined treatment with tamoxifen and a fusicoccin derivative (ISIR-042) to overcome resistance to therapy and to enhance the antitumor activity of 5-fluorouracil and gemcitabine in pancreatic cancer cells	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						tamoxifen; fusicoccin derivative; lipid peroxidation; pancreatic cancer cells; xenograft	NITRIC-OXIDE SYNTHASE; ESTROGEN-RECEPTOR; INDUCED APOPTOSIS; STEM-CELLS; PHASE-II; ADENOCARCINOMA; PROTEINS; BINDING; LOCALIZATION; EXPRESSION	Although progress has been made in chemotherapeutic strategies against pancreatic cancer, overall survival has not significantly improved over the past decade. Thus, the development of better therapeutic regimens remains a high priority. Pancreatic cancer cell lines were treated with tamoxifen, a novel antitumor fusicoccin derivative (ISIR-042), and anticancer drugs, and their effects on cell growth, signaling and gene expression were determined. Xenografts of Panc-1 cells were treated with tamoxifen, ISIR-042 and 5-fluorouracil (5FU) to determine the effects on tumor growth. The inhibition of the growth of pancreatic cancer cells induced by tamoxifen was effectively reduced by a-tocopherol, a membrane stabilizer. ISIR-042 produced synergistic effects with tamoxifen in inhibiting cell growth. Tamoxifen elevated lipid peroxidation and the release of cytochrome c, and these effects of tamoxifen were reduced by a-tocopherol. IS! R-042 significantly inhibited colony formation and the expression of sternness-related genes of pancreatic cancer cells. The triple combination of tamoxifen, ISIR-042, and 5FU or gemcitabine was effective at inhibiting cell growth and the appearance of drug-resistant cells. This combined treatment significantly inhibited the growth of Pane-1 cells as xenografts without apparent adverse effects. The triple combination of tamoxifen and ISIR-042 with 5FU or gemcitabine may be highly effective against pancreatic cancer by overcoming resistance to therapy.	[Miyake, Takaaki; Honma, Yoshio; Suzumiya, Junji] Shimane Univ, Sch Med, Dept Hematol Oncol, Izumo, Shimane 6938501, Japan; [Urano, Takeshi] Shimane Univ, Sch Med, Dept Biochem, Izumo, Shimane 6938501, Japan; [Kato, Nobuo] Osaka Univ, Inst Sci & Ind Res, Osaka 5670047, Japan	Honma, Y (reprint author), Shimane Univ, Sch Med, Dept Hematol Oncol, 89-1 Enya, Izumo, Shimane 6938501, Japan.	biohonma@med.shimane-u.ac.jp			SUIGAN project, Shimane University, Japan	This work was supported in part by the SUIGAN project, Shimane University, Japan.	Mandlekar S, 2001, APOPTOSIS, V6, P469, DOI 10.1023/A:1012437607881; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; RADI R, 1991, ARCH BIOCHEM BIOPHYS, V288, P481, DOI 10.1016/0003-9861(91)90224-7; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Fujita N, 2003, J BIOL CHEM, V278, P49254, DOI 10.1074/jbc.M306614200; Kohli L, 2013, CANCER RES, V73, P4395, DOI 10.1158/0008-5472.CAN-12-3765; Atkinson J, 2010, MOL NUTR FOOD RES, V54, P641, DOI 10.1002/mnfr.200900439; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Seimiya H, 2000, EMBO J, V19, P2652, DOI 10.1093/emboj/19.11.2652; Lee CJ, 2008, TRANSL ONCOL, V1, P14, DOI 10.1593/tlo.08103; Rittinger K, 1999, MOL CELL, V4, P153, DOI 10.1016/S1097-2765(00)80363-9; Tomao S, 2002, ANTICANCER RES, V22, P2361; Lamy R, 2001, GASTROEN CLIN BIOL, V25, P912; Morad SAF, 2013, BBA-MOL CELL BIOL L, V1831, P1657, DOI 10.1016/j.bbalip.2013.07.016; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Ghafourifar P, 1999, J BIOL CHEM, V274, P31185, DOI 10.1074/jbc.274.44.31185; Lu YH, 2013, CANCER LETT, V340, P113, DOI 10.1016/j.canlet.2013.07.009; Nazarewicz RR, 2007, CANCER RES, V67, P1282, DOI 10.1158/0008-5472.CAN-06-3099; Buege J A, 1978, Methods Enzymol, V52, P302; Avgeropoulos N G, 1999, Oncologist, V4, P209; BENZ C, 1986, CANCER RES, V46, P2276; Bozic I, 2013, ELIFE, V2, DOI 10.7554/eLife.00747; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Eckel F, 2000, J EXP CLIN CANC RES, V19, P295; Evans Douglas B., 1997, P1054; GREENWAY B, 1981, BRIT MED J, V283, P751; Hattori M, 2013, TUMORI, V99, P239, DOI 10.1700/1283.14199; Herreros-Villanueva M, 2014, WORLD J GASTROENTERO, V20, P2247, DOI 10.3748/wjg.v20.i9.2247; Honma Y, 2003, CANCER RES, V63, P3659; Horimi T, 1996, HEPATO-GASTROENTEROL, V43, P1225; Kawakami K, 2012, ANTI-CANCER AGENT ME, V12, P791; Maccarrone M, 1998, FEBS LETT, V434, P421, DOI 10.1016/S0014-5793(98)01026-6; Mikulski SM, 1996, ONCOL REP, V3, P17; Molzan M, 2013, ACS CHEM BIOL, V8, P1869, DOI 10.1021/cb4003464; OECKING C, 1994, FEBS LETT, V352, P163, DOI 10.1016/0014-5793(94)00949-X; Singh S, 1997, BRIT J SURG, V84, P1085, DOI 10.1002/bjs.1800840812; Tian Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084457	37	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	JUL	2015	47	1					315	324		10.3892/ijo.2015.2979		10	Oncology	Oncology	CK8DG	WOS:000356468100035		
J	Yamamoto, N; Nishikawa, R; Chiyomaru, T; Goto, Y; Fukumoto, I; Usui, H; Mitsuhashi, A; Enokida, H; Nakagawa, M; Shozu, M; Seki, N				Yamamoto, Noriko; Nishikawa, Rika; Chiyomaru, Takeshi; Goto, Yusuke; Fukumoto, Ichiro; Usui, Hirokazu; Mitsuhashi, Akira; Enokida, Hideki; Nakagawa, Masayuki; Shozu, Makio; Seki, Naohiko			The tumor-suppressive microRNA-1/133a cluster targets PDE7A and inhibits cancer cell migration and invasion in endometrial cancer	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						endometrial cancer; microRNA; microRNA-1; microRNA-133a; tumor suppressor; phosphodiesterase 7A	CAMP-SPECIFIC PHOSPHODIESTERASE; INTRACELLULAR CAMP; PROSTATE-CANCER; PROTEIN-KINASE; CARCINOMA; IDENTIFICATION; EXPRESSION; ACTIVATION; RECEPTORS; MIR-1	In developed countries, endometrial cancer (EC) is the most common malignancy among women. Unopposed estrogen therapy, obesity, nulliparity, diabetes mellitus and arterial hypertension have been linked to an increased risk of EC. However, the molecular mechanisms of EC oncogenesis and metastasis have not yet been fully elucidated. Our recent studies of microRNA (miRNA) expression signatures revealed that the microRNA-1/133a (miR-1/133a) cluster is frequently downregulated in various types of human cancers. However, the functional role of the miR-1/133a cluster in EC cells is still unknown. Thus, the aim of this study was to investigate the functional significance of the miR-1/133a cluster and its regulated molecular targets, with an emphasis on the contributions of miR-1/133a to EC oncogenesis and metastasis. We found that the expression levels of miR-1 and miR-133a were significantly reduced in EC tissues. Moreover, restoration of mature miR-1 or miR-133a miRNAs significantly inhibited cancer cell migration and invasion, suggesting that these clustered miRNAs act as tumor suppressors. Prediction of miRNA targets revealed that phosphodiesterase 7A (PDE7A) was a potential target gene regulated by both miR-I and miR-133a. PDE7A was confirmed to be overexpressed in EC clinical specimens and silencing of PDE7A significantly inhibited cancer cell migration and invasion. Our data demonstrated that downregulation of the miR-1/133a cluster promoted cancer cell migration and invasion via overexpression of PDE7A in EC cells. Elucidation of the molecular networks regulated by tumor-suppressive miRNAs will provide insights into the molecular mechanisms of EC oncogenesis and metastasis.	[Yamamoto, Noriko; Nishikawa, Rika; Goto, Yusuke; Fukumoto, Ichiro; Seki, Naohiko] Chiba Univ, Grad Sch Med, Dept Funct Genom, Chiba 2608670, Japan; [Yamamoto, Noriko; Usui, Hirokazu; Mitsuhashi, Akira; Shozu, Makio] Chiba Univ, Grad Sch Med, Dept Reprod Med, Chiba 2608670, Japan; [Chiyomaru, Takeshi; Enokida, Hideki; Nakagawa, Masayuki] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Urol, Kagoshima 890, Japan	Seki, N (reprint author), Chiba Univ, Grad Sch Med, Dept Funct Genom, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	naoseki@faculty.chiba-u.jp			KAKENHI [24592590]	This study was supported by the KAKENHI (C), 24592590.	Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Hidaka H, 2012, ONCOTARGET, V3, P44; Murata K, 1999, CLIN EXP METASTAS, V17, P525, DOI 10.1023/A:1006626529536; Savai R, 2010, EXPERT OPIN INV DRUG, V19, P117, DOI 10.1517/13543780903485642; McEwan DG, 2007, CANCER RES, V67, P5248, DOI 10.1158/0008-5472.CAN-07-0097; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Safavi M, 2013, EXPERT OPIN DRUG DIS, V8, P733, DOI 10.1517/17460441.2013.787986; Berg A, 2015, ONCOTARGET, V6, P1327; Creasman WT, 2006, INT J GYNECOL OBSTET, V95, pS105, DOI 10.1016/S0020-7292(06)60031-3; Zhang LZ, 2008, P NATL ACAD SCI USA, V105, P19532, DOI 10.1073/pnas.0806152105; Dong HL, 2010, BIOCHEM PHARMACOL, V79, P321, DOI 10.1016/j.bcp.2009.09.001; Yoshino H, 2011, BRIT J CANCER, V104, P808, DOI 10.1038/bjc.2011.23; Friedman JM, 2009, SWISS MED WKLY, V139, P466, DOI smw-12794; Kinoshita T, 2012, ONCOTARGET, V3, P1386; Nohata N, 2011, INT J ONCOL, V39, P1099, DOI 10.3892/ijo.2011.1096; Howe AK, 2004, BBA-MOL CELL RES, V1692, P159, DOI 10.1016/j.bbamcr.2004.03.005; Makker V, 2013, INT J GYNECOL CANCER, V23, P929, DOI 10.1097/IGC.0b013e3182915c20; Yamanaka Y, 2002, CANCER LETT, V176, P143, DOI 10.1016/S0304-3835(01)00764-9; Nishikawa R, 2014, INT J ONCOL, V45, P401, DOI 10.3892/ijo.2014.2437; Kinoshita T, 2013, BRIT J CANCER, V109, P2636, DOI 10.1038/bjc.2013.607; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Cheng XD, 2008, ACTA BIOCH BIOPH SIN, V40, P651, DOI 10.1111/j.1745-7270.2008.00438.x; [Anonymous], 2008, SCIENCE, DOI [DOI 10.1126/SCIENCE.1151651), 10.1126/science.1151651]; Dabizzi S, 2003, CANCER RES, V63, P4281; Azevedo MF, 2014, ENDOCR REV, V35, P195, DOI 10.1210/er.2013-1053; Goto M, 2010, EUR J PHARMACOL, V633, P93, DOI 10.1016/j.ejphar.2010.01.024; Timoshenko AV, 2003, EXP CELL RES, V289, P265, DOI 10.1016/S0014-4827(03)00269-6; Kojima S, 2012, BRIT J CANCER, V106, P405, DOI 10.1038/bjc.2011.462; Banno K, 2013, INT J CLIN ONCOL, V18, P186, DOI 10.1007/s10147-013-0526-9; Bloom TJ, 1996, P NATL ACAD SCI USA, V93, P14188, DOI 10.1073/pnas.93.24.14188; Glavas NA, 2001, P NATL ACAD SCI USA, V98, P6319, DOI 10.1073/pnas.101131098; Han P, 2006, J BIOL CHEM, V281, P15050, DOI 10.1074/jbc.M601333200; Han P, 1997, J BIOL CHEM, V272, P16152, DOI 10.1074/jbc.272.26.16152; Itesako T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084311; Karaayvaz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035158; Marko Doris, 1998, Cell Biochemistry and Biophysics, V28, P75, DOI 10.1007/BF02737806; Mataki H, 2015, J HUM GENET, V60, P53, DOI 10.1038/jhg.2014.111; McCawley LJ, 2000, MOL PHARMACOL, V58, P145; Murali R, 2014, LANCET ONCOL, V15, pE268, DOI 10.1016/S1470-2045(13)70591-6; Ou Y, 2014, UROL ONCOL, V32; Rose PG, 1996, NEW ENGL J MED, V335, P640, DOI 10.1056/NEJM199608293350907; Sasaki T, 2000, BIOCHEM BIOPH RES CO, V271, P575, DOI 10.1006/bbrc.2000.2661	43	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	JUL	2015	47	1					325	334		10.3892/ijo.2015.2986		10	Oncology	Oncology	CK8DG	WOS:000356468100036		
J	Ishikawa, C; Senba, M; Barnes, BJ; Mori, N				Ishikawa, Chie; Senba, Masachika; Barnes, Betsy J.; Mori, Naoki			Constitutive expression of IRF-5 in HTLV-1-infected T cells	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						human T-cell leukemia virus type 1; adult T-cell; leukemia; Tax; interferon regulatory factor-5; tumor necrosis factor	INTERFERON REGULATORY FACTOR; VIRUS TYPE-I; TRANSCRIPTION FACTOR; FACTOR FAMILY; HTLV-I; RHEUMATOID-ARTHRITIS; LEUKEMIA; TYPE-1; TAX; GENE	Human T-cell leukemia virus type 1 (HTLV-I) is the etiologic agent of adult T-cell leukemia (ATL), an aggressive and fatal leukemia of T cells. Interferon regulatory factor (IRF)-5 plays a critical role in the induction of interferon genes in viral infected cells. We examined the specific mechanisms underlying the expression and regulation of 1RF-5 in HTLV-1-infected T cells. IRF-5 was constitutively transcribed into three distinct alternatively spliced isoforms (VI, V3 and V4) in HTLV-1-infected T-cell lines but not in uninfected 1-cell lines. IRF-5 was also upregulated in HTLV-I-infected 1-cell lines at protein level. Nuclear IRF-5 expression was noted in ATL cells present in lymph nodes and skin lesions. IRF-5 mRNA expression was induced following infection of T cells with HTLV-I, and specifically by viral oncoprotein Tax. Tax also activated V3 promoter. Microarray analysis of IRF-5-expressing uninfected T cells demonstrated that IRF-5 induced the expression of tumor necrosis factor family cytokines. The results suggest that IRF-5 is a Tax-regulated gene, and its expression may be associated with the pathogenesis of ATL.	[Ishikawa, Chie] Univ Ryukyus, Transdisciplinary Res Org Subtrop & Isl Studies, Nishihara, Okinawa 9030213, Japan; [Senba, Masachika] Nagasaki Univ, Inst Trop Med, Dept Pathol, Nagasaki 8528523, Japan; [Barnes, Betsy J.] Rutgers Biomed & Hlth Sci, Dept Microbiol Biochem & Mol Genet, Newark, NJ 07103 USA; [Ishikawa, Chie; Mori, Naoki] Univ Ryukyus, Grad Sch Med, Dept Microbiol & Oncol, Nishihara, Okinawa 9030215, Japan	Mori, N (reprint author), Univ Ryukyus, Grad Sch Med, Dept Microbiol & Oncol, 207 Uehara, Nishihara, Okinawa 9030215, Japan.	cheizo@lab.u-ryukyu.ac.jp; naokimori50@gmail.com	Ishikawa, Chie/P-8521-2015		JSPS KAKENHI [90542358, 25461428]	The authors thank Keisuke Kidoguchi and Takano Ohta for their excellent assistance. We also thank Drs Martin Schmidt, Kayoko Matsumoto and Yuetsu Tanaka for providing expression vectors for IRF-5 and Tax, and Tax antibody, as well as Dr Masataka Nakamura for providing JPX-9, Dr Michiyuki Maeda for providing ED-40515(-), and Fujisaki Cell Center, Hayashibara Biochemical Laboratories, Inc. (Okayama, Japan) for providing C5/MJ, HUT-102 and MT-1. Recombinant human IL-2 was kindly provided by Takeda Pharmaceutical Company Ltd. (Osaka, Japan). This work was supported in part by JSPS KAKENHI grant numbers 90542358 and 25461428.	ALBRECHT H, 1992, J VIROL, V66, P6191; Yanai H, 2007, P NATL ACAD SCI USA, V104, P3402, DOI 10.1073/pnas.0611559104; Mori N, 1996, BLOOD, V87, P3410; Tsuboi K, 2000, LEUKEMIA, V14, P449, DOI 10.1038/sj.leu.2401696; Dawidowicz K, 2011, ANN RHEUM DIS, V70, P117, DOI 10.1136/ard.2010.129171; Krausgruber T, 2010, BLOOD, V115, P4421, DOI 10.1182/blood-2010-01-263020; Shin SH, 2010, J KOREAN MED SCI, V25, P1152, DOI 10.3346/jkms.2010.25.8.1152; Grumont RJ, 2000, J EXP MED, V191, P1281, DOI 10.1084/jem.191.8.1281; Battistini A, 2009, J INTERF CYTOK RES, V29, P765, DOI 10.1089/jir.2009.0030; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Kimura R, 2011, BBA-MOL CELL RES, V1813, P1543, DOI 10.1016/j.bbamcr.2011.04.008; Baba M, 2008, J VIROL, V82, P3843, DOI 10.1128/JVI.02013-07; Grassmann R, 2005, ONCOGENE, V24, P5976, DOI 10.1038/sj.onc.1208978; Hu GD, 2009, J BIOL CHEM, V284, P2767, DOI 10.1074/jbc.M804744200; Mancl ME, 2005, J BIOL CHEM, V280, P21078, DOI 10.1074/jbc.M500543200; Mori T, 2002, ONCOGENE, V21, P2914, DOI 10.1038/sj/onc/1205459; Graham RR, 2006, NAT GENET, V38, P550, DOI 10.1038/ng1782; Barnes BJ, 2003, CANCER RES, V63, P6424; Kreher S, 2014, P NATL ACAD SCI USA, V111, pE4513, DOI 10.1073/pnas.1406985111; Takaoka A, 2008, CANCER SCI, V99, P467, DOI 10.1111/j.1349-7006.2007.00720.x; Barnes BJ, 2001, J BIOL CHEM, V276, P23382, DOI 10.1074/jbc.M101216200; Kannian P, 2010, VIRUSES-BASEL, V2, P2037, DOI 10.3390/v2092037; Bazzoni F, 1996, NEW ENGL J MED, V334, P1717; BRENNER CA, 1989, BIOTECHNIQUES, V7, P1096; Currer R, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00406; Hasunuma T, 1998, Int Rev Immunol, V17, P291, DOI 10.3109/08830189809054407; Hieshima K, 2008, J IMMUNOL, V180, P931; Iki S, 2005, VIROLOGY, V343, P106, DOI 10.1016/j.virol.2005.08.010; Imaizumi Y, 2001, JPN J CANCER RES, V92, P1284; Ishikawa C, 2013, BBA-MOL CELL RES, V1833, P1542, DOI 10.1016/j.bbamcr.2013.03.006; IWAKURA Y, 1995, J IMMUNOL, V155, P1588; Massimino M, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-21; Matsumoto K, 1997, J VIROL, V71, P4445; Ohsugi T, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00049; OHTANI K, 1989, NUCLEIC ACIDS RES, V17, P1589, DOI 10.1093/nar/17.4.1589; Ramos JC, 2007, BLOOD, V109, P3060, DOI 10.1182/blood-2006-07-036368; Saikh KU, 2003, J INFECT DIS, V188, P1562, DOI 10.1086/379196; Santos SB, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-7; Seki N, 1999, J INFECT DIS, V180, P880, DOI 10.1086/314917; Sharma S, 2002, J IMMUNOL, V169, P3120; Sharma S, 2000, AIDS RES HUM RETROV, V16, P1613, DOI 10.1089/08892220050193047; Subrata LS, 2005, LIVER INT, V25, P633, DOI 10.1111/j.1478-3231.2005.01080.x; Suzuki Keiko, 2010, BMC Res Notes, V3, P294, DOI 10.1186/1756-0500-3-294; Suzuki S, 2010, J BIOL CHEM, V285, P4441, DOI 10.1074/jbc.M109.031476; TANAKA Y, 1990, JPN J CANCER RES, V81, P225; TSCHACHLER E, 1989, BLOOD, V73, P194; Tsukasaki K, 2001, CANCER RES, V61, P3770; Watters KM, 2010, AIDS RES HUM RETROV, V26, P593, DOI 10.1089/aid.2009.0212; Yamagata T, 1996, MOL CELL BIOL, V16, P1283; Yamashita M, 2010, CANCER SCI, V101, P1708, DOI 10.1111/j.1349-7006.2010.01581.x; Yokosawa N, 1998, ARCH VIROL, V143, P1985, DOI 10.1007/s007050050434; Yoshida T, 2001, INT J CANCER, V91, P99, DOI 10.1002/1097-0215(20010101)91:1<99::AID-IJC1016>3.0.CO;2-O	52	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	JUL	2015	47	1					361	369		10.3892/ijo.2015.3020		9	Oncology	Oncology	CK8DG	WOS:000356468100040		
J	Matsushima, M; Kikuchi, E; Matsumoto, K; Hattori, S; Takeda, T; Kosaka, T; Miyajima, A; Oya, M				Matsushima, Masashi; Kikuchi, Eiji; Matsumoto, Kazuhiro; Hattori, Seiya; Takeda, Toshikazu; Kosaka, Takeo; Miyajima, Akira; Oya, Mototsugu			Intravesical dual PI3K/mTOR complex 1/2 inhibitor NVP-BEZ235 therapy in an orthotopic bladder cancer model	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						bladder cancer; intravesical therapy; mTOR; novel antitumor agents; NVP-BEZ235	RENAL-CELL CARCINOMA; GENE-THERAPY; UROTHELIAL CARCINOMA; MAMMALIAN TARGET; CALMETTE-GUERIN; RAPAMYCIN PATHWAY; TUMOR-GROWTH; IN-VIVO; MTOR; IMMUNOTHERAPY	NVP-BEZ235 is an inhibitor of both phosphatidylinositol 3-kinase (PI3K) and mammalian target of rapamycin complex 1/2 (mTORC1/2), and its antitumor activity is expected to be higher than that of mTORC1 inhibitors because it inhibits the upregulation of pAkt through mTORC2. We examined the efficacy of intravesical NVP-BEZ235 therapy in the treatment of bladder cancer using an orthotopic bladder cancer model. The cytotoxic effects of various concentrations of NVP-BEZ235 in MBT-2 cells were examined using a WST assay. The expression of pAkt, pS6 and p4EBP1 was evaluated in MBT-2 cells treated with NVP-BEZ235 using western blotting. Orthotopic models were established by implanting MBT-2 cells into the bladders of female C3H/He mice. We assigned C3H/He mice to 2 groups: a control group treated with vehicle control (n=15), and a group intravesically administered 40 mu M (18.78 mg/l) of NVP-BEZ235 (n=15). NVP-BEZ235 inhibited the viability of MBT-2 cells in a dose-dependent manner. Furthermore, the expression of pAkt, pS6, and p4EBP1 was inhibited in NVP-BEZ235-treated MBT-2 cells. Bladder weights were significantly lower in the NVP-BEZ235-treated group than in the control group (P<0.05). An analysis of the tumor tissues revealed that the NVP-BEZ235 treatment strongly reduced pAkt, pS6 and p4EBP1 levels. An immunohistochemical analysis showed that NVP-BEZ235 significantly inhibited the expression of pS6. Intravesically administered NVP-BEZ235 exerted significant antitumor effects in the orthotopic bladder cancer model by inhibiting the PI3K/Akt/mTOR pathway. The intravesical instillation of a dual PI3K/mTORC1/2 inhibitor may represent a novel therapy for the treatment of bladder cancer.	[Matsushima, Masashi; Kikuchi, Eiji; Matsumoto, Kazuhiro; Hattori, Seiya; Takeda, Toshikazu; Kosaka, Takeo; Miyajima, Akira; Oya, Mototsugu] Keio Univ, Sch Med, Dept Urol, Shinjuku Ku, Tokyo 1608582, Japan	Kikuchi, E (reprint author), Keio Univ, Sch Med, Dept Urol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	eiji-k@kb3.so-net.ne.jp			KAKENHI from Ministry of Education, Science, Sports, Culture and Technology of Japan [25861450]	The study was supported in part by Grants-in Aid for Scientific Research (KAKENHI, no. 25861450) from the Ministry of Education, Science, Sports, Culture and Technology of Japan.	Abe H, 2013, INT J UROL, V20, P944, DOI 10.1111/iju.12187; Bai XC, 2010, CELL MOL LIFE SCI, V67, P239, DOI 10.1007/s00018-009-0163-7; Cho DC, 2010, CLIN CANCER RES, V16, P3628, DOI 10.1158/1078-0432.CCR-09-3022; Gerullis H, 2012, MED ONCOL, V29, P2870, DOI 10.1007/s12032-012-0216-x; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/JCI34739, 10.1172/jCI34739]; Hansel DE, 2010, AM J PATHOL, V176, P3062, DOI 10.2353/ajpath.2010.090872; Alexandroff AB, 1999, LANCET, V353, P1689, DOI 10.1016/S0140-6736(98)07422-4; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Stein JP, 2006, WORLD J UROL, V24, P296, DOI 10.1007/s00345-006-0061-7; Bohle A, 2003, J UROLOGY, V170, P964, DOI 10.1097/01.ju.0000073852.24341.4a; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Sun CH, 2011, HISTOPATHOLOGY, V58, P1054, DOI 10.1111/j.1365-2559.2011.03856.x; Dalbagni G, 2002, J CLIN ONCOL, V20, P3193, DOI 10.1200/JCO.2002.02.066; Hsu CC, 2013, INT J UROL, V20, P552, DOI 10.1111/iju.12085; Horiguchi Y, 2008, HUM CELL, V21, P57, DOI 10.1111/j.1749-0774.2008.00055.x; Seeliger H, 2007, CANCER METAST REV, V26, P611, DOI 10.1007/s10555-007-9077-8; Serra V, 2008, CANCER RES, V68, P8022, DOI 10.1158/0008-5472.CAN-08-1385; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; Mansure JJ, 2009, CANCER BIOL THER, V8, P2339, DOI 10.4161/cbt.8.24.9987; Fahmy M, 2013, HUM PATHOL, V44, P1766, DOI 10.1016/j.humpath.2012.11.026; Courtney KD, 2010, J CLIN ONCOL, V28, P1075, DOI 10.1200/JCO.2009.25.3641; CONNOR J, 1993, J EXP MED, V177, P1127, DOI 10.1084/jem.177.4.1127; CHIN J, 1991, J UROLOGY, V145, P1297; Chiong E, 2011, CLIN CANCER RES, V17, P2863, DOI 10.1158/1078-0432.CCR-09-3202; Fechner G, 2009, UROLOGY, V73, P665, DOI 10.1016/j.urology.2008.09.070; FIDLER IJ, 1990, CANCER RES, V50, P6130; Gupta S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081081; Horiguchi Y, 2000, GENE THER, V7, P844, DOI 10.1038/sj.gt.3301157; Horinaga M, 2005, UROLOGY, V66, P461, DOI 10.1016/j.urology.2005.03.052; Hsieh JT, 2000, UROL CLIN N AM, V27, P103, DOI 10.1016/S0094-0143(05)70238-X; Korkolopoulou P, 2012, BJU INT, V110, pE1237, DOI 10.1111/j.1464-410X.2012.11569.x; Makhlin I, 2011, BJU INT, V108, pE84, DOI 10.1111/j.1464-410X.2010.09844.x; Matsumoto K, 2011, HUM GENE THER, V22, P1423, DOI 10.1089/hum.2011.013; Park Se Jun, 2011, Korean J Urol, V52, P466, DOI 10.4111/kju.2011.52.7.466; Ratliff TL, 2000, CLIN INFECT DIS, V31, pS106, DOI 10.1086/314065; Seager CM, 2009, CANCER PREV RES, V2, P1008, DOI 10.1158/1940-6207.CAPR-09-0169; Vasconcelos-Nobrega C, 2013, UROL ONCOL-SEMIN ORI, V31, P1212, DOI 10.1016/j.urolonc.2011.11.002; Wada Y, 2012, INT J UROL, V19, P284, DOI 10.1111/j.1442-2042.2012.02962.x; Weldon T E, 1975, Urology, V5, P824, DOI 10.1016/0090-4295(75)90367-2	39	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	JUL	2015	47	1					377	383		10.3892/ijo.2015.2995		7	Oncology	Oncology	CK8DG	WOS:000356468100042		
J	Kawakami, K; Fujita, Y; Kato, T; Mizutani, K; Kameyama, K; Tsumoto, H; Miura, Y; Deguchi, T; Ito, M				Kawakami, Kyojiro; Fujita, Yasunori; Kato, Taku; Mizutani, Kosuke; Kameyama, Koji; Tsumoto, Hiroki; Miura, Yuri; Deguchi, Takashi; Ito, Masafumi			Integrin beta 4 and vinculin contained in exosomes are potential markers for progression of prostate cancer associated with taxane-resistance	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						castration-resistant prostate cancer; taxane-resistance; exosomes; integrin beta 4; vinculin	ATTENUATES PACLITAXEL-RESISTANCE; MITOXANTRONE PLUS PREDNISONE; PC3 CELLS; PANCREATIC ADENOCARCINOMA; IDENTIFICATION; MECHANISMS; EXPRESSION; INVASION; GENES	Treatment with taxanes for castration-resistant prostate cancer often leads to the development of resistance. It has been recently demonstrated that exosomes present in the body fluids contain proteins and RNAs in the cells from which they are derived and could serve as a diagnostic marker for various diseases. In the present study, we aimed to identify proteins contained in exosomes that could be markers for progression and taxane-resistance of prostate cancer. Exosomes were isolated by differential centrifugation from the culture medium of taxane-resistant human prostate cancer PC-3 cells (PC-3R) and their parental PC-3 cells. Isolated exosomes were subjected to iTRAQ-based quantitative proteomic analysis. Exosomes were also isolated from the culture medium by using anti-CD9 antibody-conjugated magnetic beads. Protein expression was knocked down by siRNA transfection followed by analysis of the silencing effects. Proteomic analysis showed that integrin beta 4 (ITGB4) and vinculin (VCL) were upregulated in exosomes derived from PC-3R cells compared to PC-3 cells. The elevation of ITGB4 and VCL was confirmed in exosomes captured by anti-CD9 antibody from the culture medium of PC-3R cells. Silencing of ITGB4 and VCL expression did not affect proliferation and taxane-resistance of PC-3R cells, but ITGB4 knockdown attenuated both cell migration and invasion and VCL knockdown reduced invasion. Our results suggest that ITGB4 and VCL in exosomes could be useful markers for progression of prostate cancer associated with taxane-resistance, providing the basis for development of an exosome-based diagnostic system.	[Kawakami, Kyojiro; Fujita, Yasunori; Tsumoto, Hiroki; Miura, Yuri; Ito, Masafumi] Tokyo Metropolitan Inst Gerontol, Res Team Mech Aging, Tokyo 1730015, Japan; [Kato, Taku; Mizutani, Kosuke; Kameyama, Koji; Deguchi, Takashi] Gifu Univ, Grad Sch Med, Dept Urol, Gifu 5011193, Japan; [Kato, Taku] Gifu Univ, Grad Sch Med, Dept Informat Clin Med, Gifu 5011193, Japan	Ito, M (reprint author), Tokyo Metropolitan Inst Gerontol, Res Team Mech Aging, Itabashi Ku, 35-2 Sakae Cho, Tokyo 1730015, Japan.	mito@tmig.or.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan	The present study was supported in part by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The authors are grateful to Mr. Yasuo Hasegawa for his technical support for electron microscopy.	Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; Peng XA, 2011, INT REV CEL MOL BIO, V287, P191, DOI 10.1016/B978-0-12-386043-9.00005-0; Cruz-Monserrate Z, 2007, MODERN PATHOL, V20, P656, DOI 10.1038/modpathol.3800782; Srichai MB, 2010, CELL-EXTRACELLULAR MATRIX INTERACTIONS IN CANCER, P19, DOI 10.1007/978-1-4419-0814-8_2; Marin-Aguilera M, 2012, MOL CANCER THER, V11, P329, DOI 10.1158/1535-7163.MCT-11-0289; Lipscomb EA, 2005, CANCER METAST REV, V24, P413, DOI 10.1007/s10555-005-5133-4; Berthold DR, 2008, J CLIN ONCOL, V26, P242, DOI 10.1200/JCO.2007.12.4008; Denzer K, 2000, J CELL SCI, V113, P3365; Kim JJ, 2013, J CELL BIOCHEM, V114, P1286, DOI 10.1002/jcb.24464; Gleason B, 2005, J HISTOCHEM CYTOCHEM, V53, P799, DOI 10.1369/jhc.4B6522.2005; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Kojima K, 2010, PROSTATE, V70, P1501, DOI 10.1002/pros.21185; Goldmann WH, 2013, CELL BIOL INT, V37, P397, DOI 10.1002/cbin.10064; Mizutani K, 2014, ANTICANCER RES, V34, P3419; Fujita Y, 2010, J BIOL CHEM, V285, P19076, DOI 10.1074/jbc.M109.079525; Blagosklonny MV, 2005, CELL CYCLE, V4, P1693, DOI 10.4161/cc.4.12.2259; Kirby M, 2011, INT J CLIN PRACT, V65, P1180, DOI 10.1111/j.1742-1241.2011.02799.x; Chien AJ, 2008, SEMIN ONCOL, V35, pS1, DOI 10.1053/j.seminoncol.2008.02.010; Yoshioka T, 2013, J CLIN INVEST, V123, P682, DOI 10.1172/JCI60720; Blagosklonny MV, 2011, ONCOTARGET, V2, P1352; Chang H, 2011, BREAST CANCER RES TR, V125, P55, DOI 10.1007/s10549-010-0825-z; Banyard J, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-387; Chien AJ, 2008, SEMIN ONCOL, V35, pS39; Geisler C, 2015, BIOMED RES INT, V2015; Kumano M, 2013, ONCOL LETT, V6, P1482, DOI 10.3892/ol.2013.1542; Ruiz C, 2011, J PATHOL, V223, P543, DOI 10.1002/path.2828; Siegel R, 2014, CA-CANCER J CLIN, V2014, P9, DOI DOI 10.3322/CAAC.21208; Thery C., 2006, CURR PROTOC CELL BIO, P22, DOI DOI 10.1002/0471143030.CB0322S30; Vlassov AV, 2012, BBA-GEN SUBJECTS, V1820, P940, DOI 10.1016/j.bbagen.2012.03.017; Yoshioka Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4591	31	2	2	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	JUL	2015	47	1					384	390		10.3892/ijo.2015.3011		7	Oncology	Oncology	CK8DG	WOS:000356468100043		
J	Rienthong, S; Boonin, C; Chaiyasirinrote, B; Satproedprai, N; Mahasirimongkol, S; Yoshida, H; Kondo, Y; Namwat, C; Rienthong, D				Rienthong, S.; Boonin, C.; Chaiyasirinrote, B.; Satproedprai, N.; Mahasirimongkol, S.; Yoshida, H.; Kondo, Y.; Namwat, C.; Rienthong, D.			Evaluation of a novel line-probe assay for genotyping-based diagnosis of Mycobacterium tuberculosis in Thailand	INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE			English	Article						M. tuberculosis; drug susceptibility testing; rapid test	DRUG-RESISTANT TUBERCULOSIS; MGIT 960 SYSTEM; MULTIDRUG-RESISTANT; PYRAZINAMIDE RESISTANCE; ISONIAZID RESISTANCE; RAPID DETECTION; NONTUBERCULOUS MYCOBACTERIA; FLUOROQUINOLONE RESISTANCE; MAJOR MECHANISM; DNA PROBES	SETTING: The Supranational Tuberculosis Reference Laboratory (NTRL), Bangkok, and Chiangrai Prachanukroh Hospital, Chiangrai, Thailand OBJECTIVE: To evaluate the diagnostic performance of newly developed line-probe assay (LiPA) kits in tuberculosis (TB) endemic settings. DESIGN: LiPA kits were used to evaluate 404 clinical isolates of Mycobacterium species and 163 sputum samples in Thailand. RESULTS: LiPA kits were able to identify M. tuberculosis, M. avium, M. intracellulare and M. kansasii with 100% sensitivity and specificity when compared with the commercially available AccuProbe assay. Testing of the LiPA kits for their ability to detect mutations in clinical isolates resistant to anti-tuberculosis drugs such as rifampicin, isoniazid, pyrazinamide and fluoroquinolones showed that the assay had very high sensitivity (65.9-100%) and specificity (98.2-100%) compared with drug susceptibility testing and DNA sequencing. LiPA had a sensitivity of 75.0-85.7% and a specificity of 96.4-100% in testing clinical sputum samples. CONCLUSION: The novel LiPA kits have high sensitivity and specificity, and may enhance the rapid detection of first- and second-line anti-tuberculosis drug resistance, improving the selection of suitable chemotherapy agents to treat multidrug-resistant and extensively drug-resistant TB.	[Rienthong, S.; Boonin, C.; Namwat, C.; Rienthong, D.] Minist Publ Hlth, Dept Dis Control, Supra Natl TB Reference Lab, Bangkok, Thailand; [Chaiyasirinrote, B.] TB HIV Res Fdn, Chiangrai, Thailand; [Satproedprai, N.; Mahasirimongkol, S.] Minist Publ Hlth, Dept Med Sci, Med Life Sci Inst, Nonthaburi, Thailand; [Yoshida, H.; Kondo, Y.] Nipro Corp, Res & Dev Lab, Shiga 5250055, Japan	Kondo, Y (reprint author), Nipro Corp, Res & Dev Lab, 3023 Nojicho, Shiga 5250055, Japan.	kondo-yuji@nipro.co.jp			Nipro Corporation, Shiga, Japan [3R11010]	This study as supported by a grant from Nipro Corporation, Shiga, Japan (Grant No. 3R11010).	Ando H, 2011, J MED MICROBIOL, V60, P184, DOI 10.1099/jmm.0.024729-0; Ando H, 2014, MOL MICROBIOL, V91, P538, DOI 10.1111/mmi.12476; Anek-vorapong R, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-123; Ando H, 2011, MOL MICROBIOL, V79, P1615, DOI 10.1111/j.1365-2958.2011.07547.x; Cheng SJ, 2000, ANTIMICROB AGENTS CH, V44, P528, DOI 10.1128/AAC.44.3.528-532.2000; Chedore P, 2010, J CLIN MICROBIOL, V48, P300, DOI 10.1128/JCM.01775-09; Chetchotisakd P, 2007, CLIN INFECT DIS, V45, P421, DOI 10.1086/520030; Pai M, 2009, CLIN CHEST MED, V30, P701, DOI 10.1016/j.ccm.2009.08.016; Hirano K, 1999, J CLIN MICROBIOL, V37, P2663; Simons SO, 2012, J CLIN MICROBIOL, V50, P428, DOI 10.1128/JCM.05435-11; Piersimoni C, 2013, J CLIN MICROBIOL, V51, P291, DOI 10.1128/JCM.01838-12; Caminero JA, 2010, LANCET INFECT DIS, V10, P621, DOI 10.1016/S1473-3099(10)70139-0; Sreevatsan S, 1997, ANTIMICROB AGENTS CH, V41, P636; Zhang Y, 2003, INT J TUBERC LUNG D, V7, P6; Chen J, 2012, BRAZ J INFECT DIS, V16, P136, DOI 10.1590/S1413-86702012000200005; Hazbon MH, 2006, ANTIMICROB AGENTS CH, V50, P2640, DOI 10.1128/AAC.00112-06; SAITO H, 1989, J CLIN MICROBIOL, V27, P994; Morgan M, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-62; Hoek KGP, 2011, MOL DIAGN THER, V15, P189, DOI 10.2165/11593780-000000000-00000; DRAKE TA, 1987, J CLIN MICROBIOL, V25, P1442; Drobniewski F, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-190; Guillemin I, 1998, ANTIMICROB AGENTS CH, V42, P2084; Hirano K, 1998, TUBERCLE LUNG DIS, V78, P117, DOI 10.1016/S0962-8479(98)80004-X; Jones D, 2002, CLIN CHEST MED, V23, P665, DOI 10.1016/S0272-5231(02)00015-1; Jonmalung J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-223; Kelley CL, 1997, ANTIMICROB AGENTS CH, V41, P2057; Kim H, 2012, JPN J INFECT DIS, V65, P72; Malik S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039754; Mitarai S, 2011, J CLIN MICROBIOL, V50, P884; Ristola MA, 1999, J INFECTION, V39, P61, DOI 10.1016/S0163-4453(99)90104-4; Tortoli E, 1996, J CLIN MICROBIOL, V34, P2838; Zhang Y, 2000, MOL GENETICS MYCOBAC, P234	32	0	0	INT UNION AGAINST TUBERCULOSIS LUNG DISEASE (I U A T L D)	PARIS	68 BOULEVARD SAINT-MICHEL,, 75006 PARIS, FRANCE	1027-3719	1815-7920		INT J TUBERC LUNG D	Int. J. Tuberc. Lung Dis.	JUL	2015	19	7					817	822		10.5588/ijtld.14.0311		6	Infectious Diseases; Respiratory System	Infectious Diseases; Respiratory System	CL0NT	WOS:000356640100013		
J	Kowada, A				Kowada, A.			Cost-effectiveness of tobacco cessation support combined with tuberculosis screening among contacts who smoke	INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE			English	Article						nicotine replacement therapy; interferon-gamma release assay; chemoprophylaxis; TB control; public health	GAMMA RELEASE ASSAY; CONTROLLED-TRIAL; STOP SMOKING; INFECTION; METAANALYSIS; TB; DIAGNOSIS; THERAPY; RISK	SETTING: Tobacco smoking is associated with significantly increased risks of latent tuberculous infection, active tuberculosis (TB), TB recurrence and mortality. Tobacco cessation interventions not only increase health benefits, they also reduce the risk of TB. OBJECTIVE: To assess the cost-effectiveness of nicotine replacement therapy (NRT) combined with TB screening strategies using interferon-gamma release assays (IGRAs; QuantiFERON (R)-TB Gold In-Tube [OFT] and T-SPOT (R).TB [T-SPOT]) and comparing these with the tuberculin skin test (TST) among TB contacts who smoke. DESIGN: Decision trees and Markov models were constructed from a public health perspective. The target population was a hypothetical cohort of 20-year-old contacts who smoke until the age of 70 years, with or without NRT. The main outcome measure of effectiveness was quality-adjusted life-years (QALYs). The incremental cost-effectiveness ratio was compared. RESULTS: QFT alone led to lower costs but fewer QALYs. TST alone and TST+NRT were absolutely dominated. IGRAs+NRT yielded greater benefits than IGRAs alone, and T-SPOT+NRT yielded the greatest benefits. Cost-effectiveness was sensitive to NRT effectiveness and rate of mortality reduction using NRT. CONCLUSION: TB screening using an IGRA combined with NRT is more cost-effective among contacts who smoke. Positive smoking cessation interventions are recommended for their cost-effectiveness in low-incidence countries.	[Kowada, A.] Ota City Off, Dept Gen Affairs, Hlth Management Div, Tokyo, Japan	Kowada, A (reprint author), Ota City Off, Dept Gen Affairs, Tokyo, Japan.	kowadaa@gmail.com					Yen YF, 2014, INT J TUBERC LUNG D, V18, P492, DOI 10.5588/ijtld.13.0694; Siddiqi K, 2013, ANN INTERN MED, V158, P667, DOI 10.7326/0003-4819-158-9-201305070-00006; Pai M, 2008, ANN INTERN MED, V149, P177; Diel R, 2010, CHEST, V137, P952, DOI 10.1378/chest.09-2350; THOMPSON NJ, 1982, B WORLD HEALTH ORGAN, V60, P555; Gupta PC, 2000, B WORLD HEALTH ORGAN, V78, P877; Bates MN, 2007, ARCH INTERN MED, V167, P335, DOI 10.1001/archinte.167.4.335; Diel R, 2011, EUR RESPIR J, V37, P88, DOI 10.1183/09031936.00115110; Fox GJ, 2013, EUR RESPIR J, V41, P140, DOI 10.1183/09031936.00070812; Leung CC, 2010, ARCH INTERN MED, V170, P287, DOI 10.1001/archinternmed.2009.506; Horsburgh CR, 2004, NEW ENGL J MED, V350, P2060, DOI 10.1056/NEJMsa031667; Fountain FF, 2005, CHEST, V128, P116, DOI 10.1378/chest.128.1.116; Guo N, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-14; Horne DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049050; Igakutsushin-sya, 2010, MED INS REIMB TABL J; Japanese Circulation Society the Japan Lung Cancer Society the Japanese Cancer Association and the Japanese Respiratory Society, 2012, STAND PROC DOC NONSM; Kowada A, 2013, NEPHROL DIAL TRANSPL, V28, P682, DOI 10.1093/ndt/gfs479; Kowada A, 2010, MOL DIAGN THER, V14, P367, DOI 10.2165/11586190-000000000-00000; Kowada A, 2014, J INFECTION, V68, P32, DOI 10.1016/j.jinf.2013.08.009; Kowada A, 2013, EPIDEMIOL INFECT, V141, P2224, DOI 10.1017/S0950268812002907; Kowada A, 2008, MOL DIAGN THER, V12, P235; Lin HH, 2007, PLOS MED, V4, P173, DOI 10.1371/journal.pmed.0040020; Lindsay RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093137; Ministry of Health Labour and Welfare, 2015, BAS SURV WAG STRUCT; Ministry of Health Labour and Welfare, ANN REP VACC RAT; Murray RL, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4004; Research Institute of Tuberculosis, 2009, TUB SURV 2009; Siddiqi K, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-160; Statistics Bureau Ministry of Internal Affairs and Communications, 2010, LIF TABL 2009; Tattevin P, 1999, CHEST, V115, P1248, DOI 10.1378/chest.115.5.1248; Tuberculosis Research Committee, 2009, KEKKAKU, V84, P617; W. H. Organization, 2010, GLOB STAT REP NONC D; Wen CP, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-156; World Health Organization, 2014, WHOHTMTB201408	34	1	1	INT UNION AGAINST TUBERCULOSIS LUNG DISEASE (I U A T L D)	PARIS	68 BOULEVARD SAINT-MICHEL,, 75006 PARIS, FRANCE	1027-3719	1815-7920		INT J TUBERC LUNG D	Int. J. Tuberc. Lung Dis.	JUL	2015	19	7					857	863		10.5588/ijtld.14.0518		7	Infectious Diseases; Respiratory System	Infectious Diseases; Respiratory System	CL0NT	WOS:000356640100019		
J	Barpanda, P; Dwibedi, D; Ghosh, S; Kee, Y; Okada, S				Barpanda, Prabeer; Dwibedi, Debasmita; Ghosh, Swatilekha; Kee, Yongho; Okada, Shigeto			Lithium metal borate (LiMBO3) family of insertion materials for Li-ion batteries: a sneak peak	IONICS			English	Review						Li-ion battery; Polyanion; Borate; LiMBO3; Polymorphism; Capacity	CATHODE MATERIAL; ELECTROCHEMICAL PERFORMANCE; MICROWAVE SYNTHESIS; CRYSTAL-STRUCTURE; ELECTRODE MATERIALS; HEXAGONAL LIMNBO3; MANGANESE BORATE; LIFEBO3; PYROPHOSPHATE; TEMPERATURE	Rechargeable lithium-ion battery remains the leading electrochemical energy-storage device, albeit demanding steady effort of design and development of superior cathode materials. Polyanionic framework compounds are widely explored in search for such cathode contenders. Here, lithium metal borate (LiMBO3) forms a unique class of insertion materials having the lowest weight polyanion (i. e., BO33-), thus offering the highest possible theoretical capacity (ca. 220 mAh/g). Since the first report in 2001, LiMBO3 has rather slow progress in comparison to other polyanionic cathode systems based on PO4, SO4, and SiO4. The current review gives a sneak peak to the progress on LiMBO3 cathode systems in the last 15 years highlighting their salient features and impediments in cathode implementation. The synthesis and structural aspects of borate family are described along with the critical analysis of the electrochemical performance of borate family of insertion materials.	[Barpanda, Prabeer; Dwibedi, Debasmita; Ghosh, Swatilekha] Indian Inst Sci, Faraday Mat Lab, MRC, Bangalore 560012, Karnataka, India; [Kee, Yongho; Okada, Shigeto] Kyushu Univ, IMCE, Kasuga, Fukuoka 8168580, Japan	Barpanda, P (reprint author), Indian Inst Sci, Faraday Mat Lab, MRC, CV Raman Ave, Bangalore 560012, Karnataka, India.		Barpanda, Prabeer/D-2781-2014	Barpanda, Prabeer/0000-0003-0902-3690	Department of Science and Technology (Govt. of India) under the Indo-Israel S&T cooperation project [DST/INT/ISR/P-10/2014]; Ministry of Human Resource Development (MHRD); University Grant Commission (UGC); Department of Atomic Energy	We are grateful to the Department of Science and Technology (Govt. of India) for financial support under the Indo-Israel S&T cooperation project (DST/INT/ISR/P-10/2014). DD and SG thank Ministry of Human Resource Development (MHRD) and University Grant Commission (UGC), respectively, for fellowship support at the Indian Institute of Science. PB thanks Department of Atomic Energy for a DAE-BRNS Young Scientist Fellowship support.	Afyon S, 2014, J MATER CHEM A, V2, P18946, DOI 10.1039/c4ta04209c; Afyon S, 2013, J POWER SOURCES, V224, P145, DOI 10.1016/j.jpowsour.2012.09.099; Afyon S, 2014, SOLID STATE IONICS, V256, P103, DOI 10.1016/j.ssi.2014.01.010; Belkebir A, 1996, NEW J CHEM, V20, P311; Bo SH, 2014, INORG CHEM, V53, P6585, DOI 10.1021/ic500169g; Barpanda P, 2012, ADV ENERGY MATER, V2, P841, DOI 10.1002/aenm.201100772; Yamada A, 2011, J MATER CHEM, V21, P10690, DOI 10.1039/c1jm11131k; Barpanda P, 2012, J MATER CHEM, V22, P13455, DOI 10.1039/c2jm32566g; Janssen Y, 2012, J AM CHEM SOC, V134, P12516, DOI 10.1021/ja301881c; Seo DH, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.205127; Chung SC, 2012, PHYS CHEM CHEM PHYS, V14, P8678, DOI 10.1039/c2cp40489c; Yamada A, 2010, ADV MATER, V22, P3583, DOI 10.1002/adma.201001039; Nyten A, 2006, J MATER CHEM, V16, P3483, DOI 10.1039/b605578h; Kobayashi G, 2009, ADV FUNCT MATER, V19, P395, DOI 10.1002/adfm.200801522; Tamaru M, 2012, J MATER CHEM, V22, P24526, DOI 10.1039/c2jm35260e; Tarascon JM, 2010, CHEM MATER, V22, P724, DOI 10.1021/cm9030478; Zhang B, 2014, J POWER SOURCES, V261, P249, DOI 10.1016/j.jpowsour.2014.03.082; Tao L, 2014, J MATER CHEM A, V2, P2060, DOI 10.1039/c3ta13021e; Legagneur V, 2001, SOLID STATE IONICS, V139, P37, DOI 10.1016/S0167-2738(00)00813-4; Nishimura S, 2010, J AM CHEM SOC, V132, P13596, DOI 10.1021/ja106297a; Ma T, 2015, J POWER SOURCES, V282, P95, DOI 10.1016/j.jpowsour.2015.02.013; Bo SH, 2012, J MATER CHEM, V22, P8799, DOI 10.1039/c2jm16436a; Aravindan V, 2012, IONICS, V18, P27, DOI 10.1007/s11581-011-0594-7; Whittingham MS, 2004, CHEM REV, V104, P4271, DOI 10.1021/cr020731c; Recham N, 2010, NAT MATER, V9, P68, DOI [10.1038/nmat2590, 10.1038/NMAT2590]; Ma R, 2013, CERAM INT, V39, P9309, DOI 10.1016/j.ceramint.2013.05.046; Barpanda P, 2011, ANGEW CHEM INT EDIT, V50, P2526, DOI 10.1002/anie.201006331; Padhi AK, 1997, J ELECTROCHEM SOC, V144, P1188, DOI 10.1149/1.1837571; MANTHIRAM A, 1989, J POWER SOURCES, V26, P403, DOI 10.1016/0378-7753(89)80153-3; Padhi AK, 1998, J ELECTROCHEM SOC, V145, P1518, DOI 10.1149/1.1838513; Barpanda P, 2010, J MATER CHEM, V20, P1659, DOI 10.1039/b922063a; Nyten A, 2005, ELECTROCHEM COMMUN, V7, P156, DOI 10.1016/j.elecom.2004.11.008; Dong YZ, 2008, ELECTROCHIM ACTA, V53, P2339, DOI 10.1016/j.electacta.2007.09.050; Barpanda P, 2011, NAT MATER, V10, P772, DOI [10.1038/nmat3093, 10.1038/NMAT3093]; Isono M, 2010, J POWER SOURCES, V195, P593, DOI 10.1016/j.jpowsour.2009.07.038; Goodenough JB, 2013, J AM CHEM SOC, V135, P1167, DOI 10.1021/ja3091438; Dong YZ, 2008, J ALLOY COMPD, V461, P585, DOI 10.1016/j.jallcom.2007.07.099; Amatucci GG, 1997, SOLID STATE IONICS, V104, P13, DOI 10.1016/S0167-2738(97)00407-4; SOKOLOVA EV, 1980, KRISTALLOGRAFIYA+, V25, P1285; Aravindan V, 2010, B KOREAN CHEM SOC, V31, P1506, DOI 10.5012/bkcs.2010.31.6.1506; Barpanda P., 2013, J ELECTROCHEM SOC, V160, P3095; Barpanda P, 2012, J SOLID STATE ELECTR, V16, P1743, DOI 10.1007/s10008-011-1598-y; Barpanda P, 2015, ISR J CHEM, V55, P537, DOI 10.1002/ijch.201400157; Bo SH, 2014, ACS APPL MATER INTER, V6, P10840, DOI 10.1021/am500860a; Bondareva O. S., 1978, Soviet Physics - Crystallography, V23; Chen L, 2010, J ALLOY COMPD, V494, P415, DOI 10.1016/j.jallcom.2010.01.065; Debart A, 2003, CHEM MATER, V15, P3683, DOI 10.1021/cm030057v; Karthikeyan K, 2014, RSC ADV, V4, P31851, DOI 10.1039/c4ra04400b; Kasanskaja EV, 1978, DOKL AKAD NAUK SSSR, V238, P1340; Kim JC, 2014, CHEM MATER, V26, P4200, DOI 10.1021/cm5014174; Kim J.C., 2011, J ELECTROCHEM SOC, V158, pA309; Lee KJ, 2013, CURR APPL PHYS, V13, P1440, DOI 10.1016/j.cap.2013.04.027; Lee YS, 2014, MATER LETT, V132, P401, DOI 10.1016/j.matlet.2014.06.137; Lee YS, 2014, ELECTRON MATER LETT, V10, P253, DOI 10.1007/s13391-013-3170-7; LEHMANN HA, 1966, Z ANORG ALLG CHEM, V348, P42, DOI 10.1002/zaac.19663480106; Li SL, 2013, J POWER SOURCES, V236, P54, DOI 10.1016/j.jpowsour.2013.02.027; Muslim A, 2014, RARE METAL MAT ENG, V43, P2095; NORRESTAM R, 1989, Z KRISTALLOGR, V187, P103, DOI 10.1524/zkri.1989.187.1-2.103; Okada S, 2003, J POWER SOURCES, V119, P621, DOI 10.1016/S0378-7753(03)00308-2; Palos AI, 2002, J SOLID STATE ELECTR, V6, P134, DOI 10.1007/s100080100208; Piffard Y, 1998, ACTA CRYSTALLOGR C, V54, P1561, DOI 10.1107/S0108270198007458; Ramesh TN, 2010, ELECTROCHEM SOLID ST, V13, P43; Rowsell JLC, 2001, J POWER SOURCES, V97-8, P254, DOI 10.1016/S0378-7753(01)00532-8; Rowsell JLC, 2001, J MATER CHEM, V11, P3228, DOI 10.1039/b100707f; Tang AP, 2015, J POWER SOURCES, V275, P888, DOI 10.1016/j.jpowsour.2014.11.087; Te Y, 2013, CHEM MATER, V25, P3623; Yamashita Y., 2013, ECS ELECTROCHEM LETT, V2, pA75	67	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0947-7047	1862-0760		IONICS	Ionics	JUL	2015	21	7					1801	1812		10.1007/s11581-015-1463-6		12	Chemistry, Physical; Electrochemistry; Physics, Condensed Matter	Chemistry; Electrochemistry; Physics	CL1SL	WOS:000356724600001		
J	Nagai, K; Muratsu, H; Matsumoto, T; Takahara, S; Kuroda, R; Kurosaka, M				Nagai, Kanto; Muratsu, Hirotsugu; Matsumoto, Tomoyuki; Takahara, Shunsuke; Kuroda, Ryosuke; Kurosaka, Masahiro			Influence of Intraoperative Soft Tissue Balance on Postoperative Active Knee Extension in Posterior-Stabilized Total Knee Arthroplasty	JOURNAL OF ARTHROPLASTY			English	Article						soft tissue balance; active knee extension; offset type tensor; posterior-stabilized; total knee arthroplasty; flexion contracture	FLEXION CONTRACTURE; NATURAL-HISTORY; JOINT GAP; DEFORMITY	We evaluated the influence of intraoperative soft tissue balance on postoperative active knee extension using Offset Repo-Tensor (R) among 73 varus osteoarthritic knees underwent primary posterior-stabilized total knee arthroplasty. The joint center gap between osteotomized surfaces and the component gap after femoral trial component placement were measured using a joint distraction force of 40 lb. The active knee extension angle was measured 4 weeks after surgery. The postoperative extension angle was not correlated with the joint center gap at 0 degrees, but positively correlated with the component gap at 0 degrees, and the joint looseness at 0 degrees which was calculated by subtracting insert thickness fromthe component gap. Thus, intraoperative soft tissue measurement with femoral trial component placement would be useful to predict the postoperative knee extension angle. (C) 2015 Elsevier Inc. All rights reserved.	[Nagai, Kanto; Muratsu, Hirotsugu; Takahara, Shunsuke] Steel Mem Hirohata Hosp, Dept Orthopaed Surg, Himeji, Hyogo 6711122, Japan; [Nagai, Kanto; Matsumoto, Tomoyuki; Kuroda, Ryosuke; Kurosaka, Masahiro] Kobe Univ, Grad Sch Med, Dept Orthopaed Surg, Kobe, Hyogo 657, Japan	Muratsu, H (reprint author), Steel Mem Hirohata Hosp, Dept Orthopaed Surg, Hirohata Ku, 3-1 Yumesaki Cho, Himeji, Hyogo 6711122, Japan.						Anania A, 2013, INT ORTHOP, V37, P1917, DOI 10.1007/s00264-013-1993-3; McPherson E J, 1994, J Arthroplasty, V9, P499, DOI 10.1016/0883-5403(94)90096-5; Matsumoto T, 2006, J BIOMECH ENG-T ASME, V128, P867, DOI 10.1115/1.2354201; Tokuhara Y, 2004, J BONE JOINT SURG BR, V86B, P1133, DOI 10.1302/0301-620X.86B8.15246; Smith CK, 2010, J ARTHROPLASTY, V25, P1137, DOI 10.1016/j.arth.2009.05.030; Matsumoto T, 2007, KNEE SURG SPORT TR A, V15, P1013, DOI 10.1007/s00167-007-0331-y; Muratsu H, 2010, CLIN BIOMECH, V25, P926, DOI 10.1016/j.clinbiomech.2010.06.020; TEW M, 1987, J BONE JOINT SURG BR, V69, P395; Magit D, 2007, J AM ACAD ORTHOP SUR, V15, P682; Ritter MA, 2007, J ARTHROPLASTY, V22, P1092, DOI 10.1016/j.arth.2006.11.009; Bengs BC, 2006, J ARTHROPLASTY, V21, P161, DOI 10.1016/j.arth.2005.06.008; Song SJ, 2014, J ARTHROPLASTY, V29, P360, DOI 10.1016/j.arth.2013.06.023; Takayama K, 2012, KNEE SURG SPORT TR A, V20, P532, DOI 10.1007/s00167-011-1594-x; Asano H, 2008, KNEE SURG SPORT TR A, V16, P51, DOI 10.1007/s00167-007-0387-8; Asano H, 2008, KNEE SURG SPORT TR A, V16, P999, DOI 10.1007/s00167-008-0591-1; Dorr LD, 1986, CLIN ORTHOP RELAT RE, V5; Insall J, 1979, CLIN ORTHOP RELAT RE, V68; INSALL JN, 1985, CLIN ORTHOP RELAT R, P13; Lam LO, 2003, KNEE, V10, P181, DOI 10.1016/S0968-0160(02)00102-3; Mitsuyasu H, 2011, J BONE JOINT SURG BR, V93B, P1210, DOI 10.1302/0301-620X.93B9.25822; Muratsu H, 2003, T ORTHOP RES SOC, V28, P242; Nagai K, 2014, J ARTHROPLASTY, V29, P520, DOI 10.1016/j.arth.2013.07.025; Nagai K, 2013, INT ORTHOP, V37, P2153, DOI 10.1007/s00264-013-2018-y; Okamoto S, 2014, KNEE SURG SPORT TR A, V22, P3174, DOI 10.1007/s00167-014-2858-z; Schroer WC, 2013, J ARTHROPLASTY, V28, P116, DOI 10.1016/j.arth.2013.04.056	25	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	0883-5403	1532-8406		J ARTHROPLASTY	J. Arthroplast.	JUL	2015	30	7					1155	1159		10.1016/j.arth.2015.01.053		5	Orthopedics	Orthopedics	CK4HG	WOS:000356184300015		
J	Nakamura, S; Ito, H; Yoshitomi, H; Kuriyama, S; Komistek, RD; Matsuda, S				Nakamura, Shinichiro; Ito, Hiromu; Yoshitomi, Hiroyuki; Kuriyama, Shinichi; Komistek, Richard D.; Matsuda, Shuichi			Analysis of the Flexion Gap on In Vivo Knee Kinematics Using Fluoroscopy	JOURNAL OF ARTHROPLASTY			English	Article						Total knee arthroplasty; Kinematics; Flexion gap; Ligament balance; Medial collateral ligament; Fluoroscopy	MULTICENTER ANALYSIS; AXIAL RADIOGRAPHY; DISTAL FEMUR; ARTHROPLASTY; REPLACEMENTS; ASYMMETRY; ROTATION; OUTCOMES; LAXITY; SYSTEM	There is a paucity of information on the relationships between postoperative knee laxity and in vivo knee kinematics. The correlations were analyzed in 22 knees with axial radiographs and fluoroscopy based 3D model fitting approach after a tri-condylar total knee arthroplasty. During deep knee bend activities, the medial flexion gap had significant correlations with the medial contact point (r = 0.529, P = 0.011) and axial rotation at full extension. During kneeling activities, a greater medial flexion gap caused larger anterior translation at complete contact (r = 0.568, P = 0.011). Meanwhile, the lateral flexion gap had less effect. In conclusion, laxity of the medial collateral ligament should be avoided because the magnitude of medial flexion stability was crucial for postoperative knee kinematics. (C) 2015 Elsevier Inc. All rights reserved.	[Nakamura, Shinichiro; Ito, Hiromu; Yoshitomi, Hiroyuki; Kuriyama, Shinichi; Matsuda, Shuichi] Kyoto Univ, Grad Sch Med, Dept Orthoped Surg, Kyoto, Japan; [Nakamura, Shinichiro; Komistek, Richard D.] Univ Tennessee, Ctr Musculoskeletal Res, Knoxville, TN USA	Nakamura, S (reprint author), Kyoto Univ, Grad Sch Med, Dept Orthoped Surg, Sakyo Ku, 54 Shogoin Kawaharacho, Kyoto, Japan.				Kyocera Medical	The authors would like to thank M. Kobayashi for data collection. The authors also would like to thank A. Sharma, S.M. Zingde and M.R. Anderle for their technical assistance. Kyocera Medical provided funds and benefits in partial or total support of the research material in this study.	Akagi M, 2000, J BONE JOINT SURG AM, V82A, P1626; Akagi M, 2002, J BONE JOINT SURG BR, V84B, P561, DOI 10.1302/0301-620X.84B4.12016; Akagi M, 2002, J ARTHROPLASTY, V17, P627, DOI 10.1054/arth.2002.32694; Mahfouz MR, 2003, IEEE T MED IMAGING, V22, P1561, DOI 10.1109/TMI.2003.820027; Shelburne KB, 2004, J BIOMECH, V37, P313, DOI 10.1016/j.jbiomech.2003.07.001; Dennis DA, 1998, CLIN ORTHOP RELAT R, P47; Dennis DA, 2010, CLIN ORTHOP RELAT R, V468, P102, DOI 10.1007/s11999-009-1112-3; Nakamura S, 2010, KNEE, V17, P274, DOI 10.1016/j.knee.2010.02.015; Tokuhara Y, 2004, J BONE JOINT SURG BR, V86B, P1133, DOI 10.1302/0301-620X.86B8.15246; Nakamura S, 2014, INT ORTHOP, V38, P761, DOI 10.1007/s00264-013-2179-8; Komistek RD, 2013, J ARTHROPLASTY, V28, P624, DOI 10.1016/j.arth.2012.08.011; Dennis DA, 2004, CLIN ORTHOP RELAT R, P180, DOI 10.1097/01.blo.0000148777.98244.84; Kanekasu K, 2005, CLIN ORTHOP RELAT R, P193, DOI 10.1097/01.blo.0000156819.24866.8b; Romero J, 2007, J ARTHROPLASTY, V22, P235, DOI 10.1016/j.arth.2006.04.024; Berger RA, 2001, ORTHOP CLIN N AM, V32, P639, DOI 10.1016/S0030-5898(05)70233-9; Freeman MAR, 2003, CLIN ORTHOP RELAT R, P35, DOI 10.1097/01.blo.0000063598.67412.0d; Nowakowski AM, 2012, J ORTHOP RES, V30, P522, DOI 10.1002/jor.21564; Boldt JG, 2006, INT ORTHOP, V30, P420, DOI 10.1007/s00264-006-0085-z; Okazaki K, 2006, J ORTHOP SCI, V11, P264, DOI 10.1007/s00776-006-1009-x; Nakamura S, 2010, J ARTHROPLASTY, V25, P486, DOI 10.1016/j.arth.2008.12.006; Hoff WA, 1998, CLIN BIOMECH, V13, P455, DOI 10.1016/S0268-0033(98)00009-6; Dennis DA, 2003, CLIN ORTHOP RELAT R, P114, DOI 10.1097/01.blo.0000062385.79828.72; Crossett LS, 2002, ORTHOPEDICS, V25, pS251; GROOD ES, 1983, J BIOMECH ENG-T ASME, V105, P136; INSALL JN, 1985, CLIN ORTHOP RELAT R, P13; Kobayashi T, 2012, J ARTHROPLASTY, V27, P260, DOI 10.1016/j.arth.2011.04.025; Moro-oka T, 2010, KNEE SURG SPORT TR A, V18, P375, DOI 10.1007/s00167-009-0977-8; Nagamine R, 1998, J Orthop Sci, V3, P194, DOI 10.1007/s007760050041; Nakamura S, 2014, J ARTHROPLASTY, V9, P1871; Nakamura S, 2014, KNEE, V21, P162, DOI 10.1016/j.knee.2013.08.016; Nakamura S, 2014, CLIN BIOMECH, V29, P400, DOI 10.1016/j.clinbiomech.2014.02.003; Nishio Y, 2014, J ARTHROPLASTY, V29, P702, DOI 10.1016/j.arth.2013.06.035; Nowakowski AM, 2011, J ORTHOP SCI, V16, P56, DOI 10.1007/s00776-010-0015-1; Tokuhara Y, 2006, J BONE JOINT SURG BR, V88B, P1327, DOI 10.1302/0301-620X.88B10.17793	34	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	0883-5403	1532-8406		J ARTHROPLASTY	J. Arthroplast.	JUL	2015	30	7					1237	1242		10.1016/j.arth.2015.01.046		6	Orthopedics	Orthopedics	CK4HG	WOS:000356184300031		
J	Takano, H; Mise, K; Hagiwara, K; Hirata, N; Watanabe, S; Toriyabe, M; Shiratori-Takano, H; Ueda, K				Takano, Hideaki; Mise, Kou; Hagiwara, Kenta; Hirata, Naoya; Watanabe, Shoko; Toriyabe, Minami; Shiratori-Takano, Hatsumi; Ueda, Kenji			Role and Function of LitR, an Adenosyl B-12-Bound Light-Sensitive Regulator of Bacillus megaterium QM B1551, in Regulation of Carotenoid Production	JOURNAL OF BACTERIOLOGY			English	Article							SIGMA(B)-DEPENDENT STRESS-RESPONSE; NON-PHOTOTROPHIC BACTERIA; THERMUS-THERMOPHILUS HB8; MYXOCOCCUS-XANTHUS; TRANSCRIPTIONAL REGULATOR; INDUCED CAROTENOGENESIS; SIGMA-FACTOR; DNA-BINDING; BIOSYNTHESIS; SUBTILIS	The LitR/CarH family of proteins is a light-sensitive MerR family of transcriptional regulators that contain an adenosyl B-12 (coenzyme B-12 or AdoB(12))-binding domain at the C terminus. The genes encoding these proteins are found in phylogenetically diverse bacterial genera; however, the biochemical properties of these proteins from Gram-positive bacteria remain poorly understood. We performed genetic and biochemical analyses of a homolog of the LitR protein from Bacillus megaterium QM B1551, a Gram-positive endospore-forming soil bacterium. Carotenoid production was induced by illumination in this bacterium. In vivo analysis demonstrated that LitR plays a central role in light-inducible carotenoid production and serves as a negative regulator of the light-inducible transcription of crt and litR itself. Biochemical evidence showed that LitR in complex with AdoB(12) binds to the promoter regions of litR and the crt operon in a light-sensitive manner. In vitro transcription experiments demonstrated that AdoB(12)-LitR inhibited the specific transcription of the crt promoter generated by a sigma(A)-containing RNA polymerase holoenzyme under dark conditions. Collectively, these data indicate that the AdoB(12)-LitR complex serves as a photoreceptor with DNA-binding activity in B. megaterium QM B1551 and that its function as a transcriptional repressor is fundamental to the light-induced carotenoid production. IMPORTANCE Members of the LitR/CarH family are AdoB(12)-based photosensors involved in light-inducible carotenoid production in nonphototrophic Gram-negative bacteria. Our study revealed that Bacillus LitR in complex with AdoB(12) also serves as a transcriptional regulator with a photosensory function, which indicates that the LitR/CarH family is generally involved in the light-inducible carotenoid production of nonphototrophic bacteria.	[Takano, Hideaki; Mise, Kou; Hagiwara, Kenta; Hirata, Naoya; Watanabe, Shoko; Toriyabe, Minami; Shiratori-Takano, Hatsumi; Ueda, Kenji] Nihon Univ, Coll Bioresource Sci, Life Sci Res Ctr, Fujisawa, Kanagawa, Japan	Takano, H (reprint author), Nihon Univ, Coll Bioresource Sci, Life Sci Res Ctr, Fujisawa, Kanagawa, Japan.	takano.hideaki@nihon-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan; Noda Institute for Scientific Research; NAGASE Science and Technology Development Foundation; Charitable Trust of the Araki Medical and Biochemical Research Memorial Fund;  [25450113]	This study was supported by a Grant-in-Aid for Scientific Research (C) (grant 25450113) to H.T. and by the High-Tech Research Center Project of the Ministry of Education, Culture, Sports, Science and Technology, Japan, the Noda Institute for Scientific Research, the NAGASE Science and Technology Development Foundation, and the Charitable Trust of the Araki Medical and Biochemical Research Memorial Fund.	Agari Y, 2012, PROTEINS, V80, P1490, DOI 10.1002/prot.24049; Takano H, 2011, J BACTERIOL, V193, P2451, DOI 10.1128/JB.01125-10; Duc LH, 2006, FEMS MICROBIOL LETT, V255, P215, DOI 10.1111/j.1574-6968.2005.00091.x; Khaneja R, 2010, J APPL MICROBIOL, V108, P1889, DOI 10.1111/j.1365-2672.2009.04590.x; Eppinger M, 2011, J BACTERIOL, V193, P4199, DOI 10.1128/JB.00449-11; Shinkai A, 2007, J BACTERIOL, V189, P3891, DOI 10.1128/JB.01739-06; GueroutFleury AM, 1996, GENE, V180, P57, DOI 10.1016/S0378-1119(96)00404-0; Gaidenko TA, 2006, J BACTERIOL, V188, P6387, DOI 10.1128/JB.00691-06; Avila-Perez M, 2006, J BACTERIOL, V188, P6411, DOI 10.1128/JB.00716-06; Ortiz-Guerrero JM, 2011, P NATL ACAD SCI USA, V108, P7565, DOI 10.1073/pnas.1018972108; Biedendieck R, 2010, MICROB BIOTECHNOL, V3, P24, DOI 10.1111/j.1751-7915.2009.00125.x; Takano H, 2005, J BACTERIOL, V187, P1825, DOI 10.1128/JB.187.5.1825-1832.2005; Perez-Marin MC, 2008, MOL MICROBIOL, V67, P804, DOI 10.1111/j.1365-2958.2007.06086.x; Galbis-Martinez M, 2012, J BACTERIOL, V194, P1427, DOI 10.1128/JB.06662-11; Edge R, 1997, J PHOTOCH PHOTOBIO B, V41, P189, DOI 10.1016/S1011-1344(97)00092-4; Forouhar Farhad, 2007, Journal of Structural and Functional Genomics, V8, P37, DOI 10.1007/s10969-007-9018-3; HALDENWANG WG, 1995, MICROBIOL REV, V59, P1; Cole JR, 2005, NUCLEIC ACIDS RES, V33, pD294, DOI 10.1093/nar/gki038; Diez AI, 2013, EUR BIOPHYS J BIOPHY, V42, P463, DOI 10.1007/s00249-013-0897-x; WITTCHEN KD, 1995, APPL MICROBIOL BIOT, V42, P871, DOI 10.1007/s002530050345; Shiratori H, 2006, APPL ENVIRON MICROB, V72, P3702, DOI 10.1128/AEM.72.5.3702-3709.2006; Armstrong GA, 1997, ANNU REV MICROBIOL, V51, P629, DOI 10.1146/annurev.micro.51.1.629; BROWN BJ, 1980, J BACTERIOL, V142, P508; Cervantes M, 2002, J BACTERIOL, V184, P2215, DOI 10.1128/JB.184.8.2215-2224.2002; Maniatis T., 1982, MOL CLONING LAB MANU; Mendoza-Vargas A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007526; MITCHELL C, 1986, APPL ENVIRON MICROB, V52, P64; Moore SJ, 2012, BIOCHEM SOC T, V40, P581, DOI 10.1042/BST20120066; Nishiyama M, 1999, FEMS MICROBIOL LETT, V172, P179, DOI 10.1111/j.1574-6968.1999.tb13467.x; Pane L, 1996, Boll Soc Ital Biol Sper, V72, P303; Raux E, 1998, BIOCHEM J, V335, P159; Steiger S, 2012, J APPL MICROBIOL, V113, P888, DOI 10.1111/j.1365-2672.2012.05377.x; Suzuki N, 2007, J GEN APPL MICROBIOL, V53, P81, DOI 10.2323/jgam.53.81; Takano H, 2006, BIOSCI BIOTECH BIOCH, V70, P2320, DOI 10.1271/bbb.60230; Takano H, 2006, J IND MICROBIOL BIOT, V33, P88, DOI 10.1007/s10295-005-0005-z; Takano H, 2015, APPL MICROBIOL BIOT, V99, P2329, DOI 10.1007/s00253-014-6325-z; Takano Hideaki, 2014, Microbiology, V160, P2650, DOI 10.1099/mic.0.082263-0	37	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0021-9193	1098-5530		J BACTERIOL	J. Bacteriol.	JUL	2015	197	14					2301	2315		10.1128/JB.02528-14		15	Microbiology	Microbiology	CK8YP	WOS:000356526600007		
J	Daimon, Y; Narita, SI; Akiyama, Y				Daimon, Yasushi; Narita, Shin-ichiro; Akiyama, Yoshinori			Activation of Toxin-Antitoxin System Toxins Suppresses Lethality Caused by the Loss of sigma(E) in Escherichia coli	JOURNAL OF BACTERIOLOGY			English	Article							EXTRACYTOPLASMIC-STRESS-RESPONSE; MESSENGER-RNA CLEAVAGE; CELL-DEATH; TRANSLATION; RSEA; MODEL; GENE; ENDORIBONUCLEASE; DEGRADATION; RIBOSOMES	sigma(E), an alternative sigma factor that governs a major signaling pathway in envelope stress responses in Gram-negative bacteria, is essential for growth of Escherichia coli not only under stressful conditions, such as elevated temperature, but also under normal laboratory conditions. A mutational inactivation of the hicB gene has been reported to suppress the lethality caused by the loss of sigma(E). hicB encodes the antitoxin of the HicA-HicB toxin-antitoxin (TA) system; overexpression of the HicA toxin, which exhibits mRNA interferase activity, causes cleavage of mRNAs and an arrest of cell growth, while simultaneous expression of HicB neutralizes the toxic effects of overproduced HicA. To date, however, how the loss of HicB rescues the cell lethality in the absence of sigma(E) and, more specifically, whether HicA is involved in this process remain unknown. Here we showed that simultaneous disruption of hicA abolished suppression of the sigma(E) essentiality in the absence of hicB, while ectopic expression of wild-type HicA, but not that of its mutant forms without mRNA interferase activity, restored the suppression. Furthermore, HicA and two other mRNA interferase toxins, HigB and YafQ, suppressed the sigma(E) essentiality even in the presence of chromosomally encoded cognate antitoxins when these toxins were overexpressed individually. Interestingly, when the growth media were supplemented with low levels of antibiotics that are known to activate toxins, E. coli cells with no suppressor mutations grew independently of sigma(E). Taken together, our results indicate that the activation of TA system toxins can suppress the sigma(E) essentiality and affect the extracytoplasmic stress responses. IMPORTANCE sigma(E) is an alternative sigma factor involved in extracytoplasmic stress responses. Unlike other alternative sigma factors, sigma(E) is indispensable for the survival of E. coli even under unstressed conditions, although the exact reason for its essentiality remains unknown. Toxin-antitoxin (TA) systems are widely distributed in prokaryotes and are composed of two adjacent genes, encoding a toxin that exerts harmful effects on the toxin-producing bacterium itself and an antitoxin that neutralizes the cognate toxin. Curiously, it is known that inactivation of an antitoxin rescues the sigma(E) essentiality, suggesting a connection between TA systems and sigma(E) function. We demonstrate here that toxin activation is necessary for this rescue and suggest the possible involvement of TA systems in extracytoplasmic stress responses.	[Daimon, Yasushi; Narita, Shin-ichiro; Akiyama, Yoshinori] Kyoto Univ, Inst Virus Res, Kyoto 606, Japan; [Narita, Shin-ichiro] Univ Morioka, Fac Nutr Sci, Takizawa, Iwate, Japan	Narita, SI (reprint author), Kyoto Univ, Inst Virus Res, Kyoto 606, Japan.	snarita@morioka-u.ac.jp; yakiyama@virus.kyoto-u.ac.jp			JSPS KAKENHI [24370054, 24570152]; Institute for Fermentation, Osaka, Japan	This work was supported by JSPS KAKENHI grants 24370054 (to Y.A.) and 24570152 (to S.-I.N.) and by research grants from the Institute for Fermentation, Osaka, Japan (to Y.A.).	AIBA H, 1981, J BIOL CHEM, V256, P1905; Jorgensen MG, 2009, J BACTERIOL, V191, P1191, DOI 10.1128/JB.01013-08; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; De Las Penas Alejandro, 1997, Journal of Bacteriology, V179, P6862; Hazan R, 2004, J BACTERIOL, V186, P3663, DOI 10.1128/JB.186.11.3663-3669.2004; DeLasPenas A, 1997, MOL MICROBIOL, V24, P373, DOI 10.1046/j.1365-2958.1997.3611718.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Kanehara K, 2002, GENE DEV, V16, P2147, DOI 10.1101/gad.1002302; Ramos A, 2000, EMBO J, V19, P997, DOI 10.1093/emboj/19.5.997; Vesper O, 2011, CELL, V147, P147, DOI 10.1016/j.cell.2011.07.047; Santos-Beneit F, 2008, MICROBIOL-SGM, V154, P2356, DOI 10.1099/mic.0.2008/019539-0; Makarova KS, 2006, BIOINFORMATICS, V22, P2581, DOI 10.1093/bioinformatics/btl418; Yamaguchi Y, 2011, NAT REV MICROBIOL, V9, P779, DOI 10.1038/nrmicro2651; Raivio TL, 2005, MOL MICROBIOL, V56, P1119, DOI 10.1111/j.1365-2958.2005.04625.x; OGURA T, 1983, P NATL ACAD SCI-BIOL, V80, P4784, DOI 10.1073/pnas.80.15.4784; Hayden JD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001573; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Sat B, 2001, J BACTERIOL, V183, P2041, DOI 10.1128/JB.183.6.2041-2045.2001; Hu Y, 2012, ENVIRON MICROBIOL, V14, P669, DOI 10.1111/j.1462-2920.2011.02618.x; Flynn JM, 2004, GENE DEV, V18, P2292, DOI 10.1101/gad.1240104; Maisonneuve E, 2011, P NATL ACAD SCI USA, V108, P13206, DOI 10.1073/pnas.1100186108; Wang XX, 2011, NAT CHEM BIOL, V7, P359, DOI [10.1038/nchembio.560, 10.1038/NCHEMBIO.560]; Ades SE, 1999, GENE DEV, V13, P2449, DOI 10.1101/gad.13.18.2449; Missiakas D, 1997, MOL MICROBIOL, V24, P355, DOI 10.1046/j.1365-2958.1997.3601713.x; Armalyte J, 2012, J BACTERIOL, V194, P1523, DOI 10.1128/JB.06104-11; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.18624.8172-8180.2004; Butt A, 2014, BIOCHEM J, V459, P333, DOI 10.1042/BJ20140073; Wang XX, 2012, NAT CHEM BIOL, V8, P855, DOI 10.1038/NCHEMBIO.1062; Button JE, 2007, J BACTERIOL, V189, P1523, DOI 10.1128/JB.01534-06; Hurley JM, 2009, J BIOL CHEM, V284, P18605, DOI 10.1074/jbc.M109.008763; Christensen SK, 2001, P NATL ACAD SCI USA, V98, P14328, DOI 10.1073/pnas.251327898; Aizenman E, 1996, P NATL ACAD SCI USA, V93, P6059, DOI 10.1073/pnas.93.12.6059; Goeders N, 2014, TOXINS, V6, P304, DOI 10.3390/toxins6010304; SHIMOIKE T, 1995, J BIOL CHEM, V270, P5519; Fineran PC, 2009, P NATL ACAD SCI USA, V106, P894, DOI 10.1073/pnas.0808832106; Masuda H, 2012, MOL MICROBIOL, V84, P979, DOI 10.1111/j.1365-2958.2012.08068.x; Gogol EB, 2011, P NATL ACAD SCI USA, V108, P12875, DOI 10.1073/pnas.1109379108; Prysak MH, 2009, MOL MICROBIOL, V71, P1071, DOI 10.1111/j.1365-2958.2008.06572.x; MIZUSAWA S, 1983, P NATL ACAD SCI-BIOL, V80, P358, DOI 10.1073/pnas.80.2.358; Zhang YL, 2005, J BIOL CHEM, V280, P3143, DOI 10.1074/jbc.M411811200; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Alba BM, 2002, GENE DEV, V16, P2156, DOI 10.1101/gad.1008902; Baba Tomoya, 2006, Mol Syst Biol, V2; Bibi-Triki S, 2014, J BACTERIOL, V196, P3712, DOI 10.1128/JB.01932-14; Bury-Mone S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000651; Christensen-Dalsgaard M, 2006, MOL MICROBIOL, V62, P397, DOI 10.1111/j.1365-2958.2006.05385.x; DUNCAN BK, 1978, J BACTERIOL, V134, P1039; MAURIZI MR, 1990, J BIOL CHEM, V265, P12536; Miller J. H., 1972, EXPT MOL GENETICS; Nieto C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011289; Rhodius VA, 2006, PLOS BIOL, V4, P43, DOI 10.1371/journal.pbio.0040002; Schifano JM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4538; Thomason L., 2007, CURR PROTOC MOL BIOL; WU TT, 1966, GENETICS, V54, P405	54	1	1	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0021-9193	1098-5530		J BACTERIOL	J. Bacteriol.	JUL	2015	197	14					2316	2324		10.1128/JB.00079-15		9	Microbiology	Microbiology	CK8YP	WOS:000356526600008		
J	Dammika, AJ; Kawarai, K; Yamaguchi, H; Matsumoto, Y; Yoshioka, T				Dammika, Abeykoon Jalath; Kawarai, Kosuke; Yamaguchi, Hiroki; Matsumoto, Yasunao; Yoshioka, Tsutomu			Analytical Damping Evaluation Complementary to Experimental Structural Health Monitoring of Bridges	JOURNAL OF BRIDGE ENGINEERING			English	Article						Field measurement; Damping analysis; Modal damping ratio; Steel bridges; Damage detection; Structural health monitoring (SHM)	EIGENSYSTEM REALIZATION-ALGORITHM; SYSTEM-IDENTIFICATION; DAMAGE DETECTION	Structural health monitoring (SHM) of bridges by visual inspection is not necessarily reliable as many damages are not discovered during the periodic inspection of bridges. A technique to assist in visual inspection is vibration-based SHM. It is believed that structural damages lead to changes in stiffness and damping properties, and change the dynamic characteristics of structures, such as natural frequency, mode shape, and modal damping ratio. Although changes in the modal damping ratio can be used as damage indicators in the field of vibration-based SHM, the method's accuracy remains concerning. This study investigated the analytical modal damping evaluation as a complementary method to the experimental SHM of bridges. An energy-based damping model was introduced to estimate the damping parameters of a steel arch bridge, such as the equivalent loss factors of structural components, and the modal damping ratios of the bridge were then analytically evaluated using the damping parameters. The results confirmed that the proposed methodology can identify the damping sources in steel bridges and their contributions to each modal damping ratio, and complements the experimental SHM of bridges. (c) 2014 American Society of Civil Engineers.	[Dammika, Abeykoon Jalath; Kawarai, Kosuke; Yamaguchi, Hiroki] Saitama Univ, Dept Civil & Environm Engn, Saitama 3388570, Japan; [Matsumoto, Yasunao] Saitama Univ, Dept Civil & Environm Engn, Sakura Ku, Saitama 3388570, Japan; [Yoshioka, Tsutomu] Nippon Engn Consultants Co Ltd, Toshima Ku, Tokyo 1700003, Japan	Matsumoto, Y (reprint author), Saitama Univ, Dept Civil & Environm Engn, Sakura Ku, 255 Shino Okubo, Saitama 3388570, Japan.	dammikaaj@gmail.com; kosuke34sg@gmail.com; hiroki@mail.saitama-u.ac.jp; ymatsu@mail.saitama-u.ac.jp; yoshioka@ne-con.co.jp					Curadelli RO, 2008, ENG STRUCT, V30, P3497, DOI 10.1016/j.engstruct.2008.05.024; Yang JN, 2003, EARTHQUAKE ENG STRUC, V32, P1443, DOI 10.1002/eqe.287; Allemang RJ, 2003, SOUND VIB, V37, P14; Siringoringo DM, 2008, ENG STRUCT, V30, P462, DOI 10.1016/j.engstruct.2007.03.004; Astaneh-Asl A., 2008, P 7 INT C STEEL BRID; Carden EP, 2004, STRUCT HEALTH MONIT, V3, P355, DOI 10.1177/1475921704047500; Doebling S.W., 1996, LA13070MS LOS AL NAT; Frizzarin M, 2010, STRUCT CONTROL HLTH, V17, P368, DOI 10.1002/stc.296; JUANG JN, 1985, J GUID CONTROL DYNAM, V8, P620, DOI 10.2514/3.20031; Kawashima K., 1994, P 9 US JAP BRIDG ENG, P211; Lingmi Z., 2004, P INT MOD AN C 22 SO; Nashif A. D., 1985, VIBRATION DAMPLING, P45; Pappa R., 1981, SHOCK VIBRATION B, V51, P43; PAPPA RS, 1993, J GUID CONTROL DYNAM, V16, P852, DOI 10.2514/3.21092; Sakamoto H., 1986, J JAPAN SOC CIV ENG, V375, P93; Yamaguchi H, 2002, P SOC PHOTO-OPT INS, V4753, P1612; Yamaguchi H., 1997, STRUCTURAL ENG EARTH, V14, p201s; Yamaguchi H, 1997, J WIND ENG IND AEROD, V72, P289, DOI 10.1016/S0167-6105(97)00249-3; Yoshioka T., 2010, P 5 WORLD C STRUCT C	19	0	0	ASCE-AMER SOC CIVIL ENGINEERS	RESTON	1801 ALEXANDER BELL DR, RESTON, VA 20191-4400 USA	1084-0702	1943-5592		J BRIDGE ENG	J. Bridge Eng.	JUL	2015	20	7							04014095	10.1061/(ASCE)BE.1943-5592.0000691		12	Engineering, Civil	Engineering	CK7DY	WOS:000356392700005		
J	Suzuki, M				Suzuki, Masachika			Identifying roles of international institutions in clean energy technology innovation and diffusion in the developing countries: matching barriers with roles of the institutions	JOURNAL OF CLEANER PRODUCTION			English	Article						Clean energy; Climate change; Technology development; Innovation; Developing countries	FRAMEWORK; POLICY; INDIA; FAILURES; MARKET; CDM	The development of clean energy technologies is a central issue in climate change negotiation. The signatory countries to the United Nations Convention on Climate Change agreed to organize the Technology Executive Committee and the Climate Technology Centre and Network. The objectives of this paper are twofold. The first objective is to show a broad landscape of barriers in technology development. The paper summarizes the results of key case studies that were conducted to uncover technology-specific barriers in technology development. These case studies include both technologies for industrial use such as wind, bio-energy and building energy efficiency and technologies for individual use such as Light Emitting Diodes and photovoltaic panels. The case studies also contain technologies at the innovation stage such as Integrated Gasification Combined Cycle and Carbon Capture and Storage. The second objective of this paper is to highlight and define roles of international institutions in overcoming identified barriers in clean energy technology development. In this paper four areas of focus for international institutions are discussed, including: 1) increasing R&D cooperation at the innovation stage, 2) facilitation of intellectual property rights, 3) supporting finance, and 4) enhancing the enabling environment at the diffusion stage. (C) 2014 Elsevier Ltd. All rights reserved.	Sophia Univ, Grad Sch Global Environm Studies, Chiyoda Ku, Tokyo 1028554, Japan	Suzuki, M (reprint author), Sophia Univ, Grad Sch Global Environm Studies, Chiyoda Ku, 7-1 Kioi Cho, Tokyo 1028554, Japan.	Suzuki@genv.sophia.ac.jp			Global Environment Research Fund of the Ministry of the Environment, Japan [S-6-3]	This work was supported by the Global Environment Research Fund of the Ministry of the Environment, Japan (S-6-3). In addition, several anonymous reviewers provided their valuable comments in the review process. The author wishes to thank the reviewers for their remarks.	Jagadeesh A, 2000, ENERG POLICY, V28, P157, DOI 10.1016/S0301-4215(00)00007-0; Balachandra P, 2010, RENEW ENERG, V35, P1842, DOI 10.1016/j.renene.2009.12.020; Haites E, 2006, CLIM POLICY, V6, P327; Seres S, 2009, ENERG POLICY, V37, P4919, DOI 10.1016/j.enpol.2009.06.052; Ockwell DG, 2010, GLOBAL ENVIRON CHANG, V20, P729, DOI 10.1016/j.gloenvcha.2010.04.009; Foxon TJ, 2005, ENERG POLICY, V33, P2123, DOI 10.1016/j.enpol.2004.04.011; Schneider M, 2008, ENERG POLICY, V36, P2930, DOI 10.1016/j.enpol.2008.04.009; Karakosta C, 2010, RENEW SUST ENERG REV, V14, P1546, DOI 10.1016/j.rser.2010.02.001; Jaffe AB, 2005, ECOL ECON, V54, P164, DOI 10.1016/j.ecolecon.2004.12.027; Morsink K, 2011, ENERG POLICY, V39, P1, DOI 10.1016/j.enpol.2010.09.043; Youngman R, 2007, CLIM POLICY, V7, P488; Reddy S, 2004, RENEW ENERG, V29, P1431, DOI 10.1016/j.renene.2003.12.003; Painuly JP, 2001, RENEW ENERG, V24, P73, DOI 10.1016/S0960-1481(00)00186-5; Worrell E, 2001, ENERG POLICY, V29, P29, DOI 10.1016/S0301-4215(00)00097-5; Rennings K, 2000, ECOL ECON, V32, P319, DOI 10.1016/S0921-8009(99)00112-3; Benioff R., 2010, STRENGTHENING CLEAN; Borras S., 2004, SCI PUBL POLICY, V31, P425, DOI 10.3152/147154304781779787; Carlsson B, 1991, J EVOLUTIONARY EC, V1, P93, DOI DOI 10.1007/BF01224915; Carmody J., 2007, INVESTING CLEAN ENER; Dalhammar C., 2009, ADV TECHNOLOGY TRANS; de Coninck H., 2008, ENERGY POLICY, V36; Doornbosch R., 2008, WHAT ROLE PUBLIC FIN; Doukas H, 2009, RENEW SUST ENERG REV, V13, P1138, DOI 10.1016/j.rser.2008.05.002; Flamos A, 2008, ASIA EUR J, V6, P261, DOI 10.1007/s10308-008-0177-z; FREEMAN C, 1995, CAMBRIDGE J ECON, V19, P5; Gonzalez PD, 2009, ECOL ECON, V68, P861, DOI 10.1016/j.ecolecon.2008.07.004; Gtriple C, 2010, ENG PRIV SECT CAP SC; Guerin TF, 2001, TECHNOL FORECAST SOC, V67, P55, DOI 10.1016/S0040-1625(99)00096-7; ICTSD, 2008, CLIM CHANG TECHN TRA; Institute for Prospective Technological Studies, 2004, I PROSP TECHN STUD T; IPCC, 2001, METH TECHN ISS TECHN; Jain K., 2011, IMRE AL C 2011; Kanie N., 2013, GLOBAL ENV RES, V17; Kathuria V, 2002, TECHNOL FORECAST SOC, V69, P405, DOI 10.1016/S0040-1625(01)00137-8; Krasner S., 1983, INT REGIMES; Lewis J., 2007, COMP WIND POWER IND; Lewis J., 2007, STUD COMPAR INT DEV, V42, P3; Luken R., 2008, J CLEAN PROD, V16, P67; Lundvall A., 1988, TECHNICAL CHANGE EC; Morey J., 2011, MOVING CLIMATE INNOV; Ockwell D., 2009, UK INDIA COLLABORATI; Ockwell D, 2007, UK INDIA COLLABORATI; OECD/IEA, 2001, TECHN BORD CAS STUD; Oliver M, 1999, ENERG POLICY, V27, P371, DOI 10.1016/S0301-4215(99)00038-5; Olz S., 2010, DEPLOYING RENEWABLES; Painuly J.P., 2002, IMPLEMENTATION RENEW; Ravindranath NH, 2009, ENERGY, V34, P1003, DOI 10.1016/j.energy.2008.12.012; Seres S., 2010, CONTRIBUTION CLEAN D; Sunderasan S., 2005, RENEW SUST ENERG REV, V9, P215; Suurs Roald A A, 2009, Technological Forecasting and Social Change, V76, DOI 10.1016/j.techfore.2009.03.002; Suzuki M., 2011, LUND C EARTH SYST GO; Suzuki M., 2010, EC MANAGEMENT SERIES; Suzuki M., 2012, ADDRESSING PORTFOLIO; Thorne S, 2008, ENERG POLICY, V36, P2831, DOI 10.1016/j.enpol.2008.02.031; UN, 2009, CLIM CHANG TECHN DEV; UNEP Riso Centre on Energy Climate and Sustainable Development, 2011, DIFF REN EN TECHN CA; UNFCCC, 2011, C PART ITS 16 SESS H; UNFCCC, 2009, FCCCSB2009INF2; UNFCCC, 2011, BEN CLEAN DEV MECH; UNFCCC, 2003, FCCCTP20032; Usha K., 2002, ENERGY SUSTAIN DEV, V6, P59; WIPO, 2007, AD REC WIPO DEV AG	62	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0959-6526	1879-1786		J CLEAN PROD	J. Clean Prod.	JUL 1	2015	98						229	240		10.1016/j.jclepro.2014.08.070		12	Engineering, Environmental; Environmental Sciences	Engineering; Environmental Sciences & Ecology	CK4LC	WOS:000356194300024		
J	Tanemoto, M; Higaki, M; Amano, K; Toyoki, D; Arai, S; Tomioka, S; Uchida, S				Tanemoto, Masayuki; Higaki, Masato; Amano, Keiko; Toyoki, Daigo; Arai, Shigeyuki; Tomioka, Satoru; Uchida, Shunya			Sonographic detection of a radiolucent object in dialysis vascular access	JOURNAL OF CLINICAL ULTRASOUND			English	Article						angioplasty; balloon catheter; ultrasonography; vascular access	PERCUTANEOUS TREATMENT; FISTULAS; ANGIOPLASTY; ULTRASOUND; PATENCY	Percutaneous endovascular angioplasty is a valuable tool to salvage dialysis vascular access failure, but is accident-prone if performed by unskilled operators. We report a case of vascular access failure caused by the plastic protective tube of a balloon catheter, which had been mistakenly left in the vasculature and was undetectable on radiography but was detected by ultrasonography. (c) 2014 Wiley Periodicals, Inc.	[Tanemoto, Masayuki; Higaki, Masato; Amano, Keiko; Toyoki, Daigo; Arai, Shigeyuki; Tomioka, Satoru; Uchida, Shunya] Teikyo Univ, Sch Med, Dept Internal Med, Div Nephrol,Itabashi Ku, Tokyo 1738605, Japan	Tanemoto, M (reprint author), Teikyo Univ, Sch Med, Dept Internal Med, Div Nephrol,Itabashi Ku, 2-11-1 Kaga, Tokyo 1738605, Japan.						Haage P, 2000, KIDNEY INT, V57, P1169, DOI 10.1046/j.1523-1755.2000.00944.x; Huijbregts HJT, 2008, CLIN J AM SOC NEPHRO, V3, P714, DOI 10.2215/CJN.02950707; Malik J, 2005, KIDNEY INT, V67, P1554, DOI 10.1111/j.1523-1755.2005.00236.x; Nakai S, 2012, THER APHER DIAL, V16, P11, DOI 10.1111/j.1744-9987.2011.01050.x; Jones CA, 2005, KIDNEY INT, V67, P1684, DOI 10.1111/j.1523-1755.2005.00265.x; Biuckians A, 2008, J VASC SURG, V47, P415, DOI 10.1016/j.jvs.2007.10.041; Chan KE, 2011, CLIN J AM SOC NEPHRO, V6, P2669, DOI 10.2215/CJN.02860311; Falk A, 2011, J VASC ACCESS, V12, P1, DOI 10.5301/JVA.2010.5966; Gadallah MF, 1998, AM J KIDNEY DIS, V32, P273, DOI 10.1053/ajkd.1998.v32.pm9708612; GLANZ S, 1984, RADIOLOGY, V152, P637; Gorin DR, 2012, J VASC SURG, V55, P1701, DOI 10.1016/j.jvs.2011.12.016; HUNTER DW, 1984, RADIOLOGY, V152, P631; Turmel-Rodrigues Luc, 2003, Tech Vasc Interv Radiol, V6, P42, DOI 10.1053/tvir.2003.36434; Wang HJ, 2006, AM J KIDNEY DIS, V48, P652, DOI 10.1053/j.ajkd.2006.07.013	14	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0091-2751	1097-0096		J CLIN ULTRASOUND	J. Clin. Ultrasound	JUL-AUG	2015	43	6					397	399		10.1002/jcu.22184		3	Acoustics; Radiology, Nuclear Medicine & Medical Imaging	Acoustics; Radiology, Nuclear Medicine & Medical Imaging	CL1BH	WOS:000356676900009		
J	Liu, XF; Yamamoto, D; Saito, M; Imagawa, T; Ablola, A; Tandoc, AO; Segubre-Mercado, E; Lupisan, SP; Okamoto, M; Furuse, Y; Saito, M; Oshitani, H				Liu, Xiaofang; Yamamoto, Dai; Saito, Mariko; Imagawa, Toshifumi; Ablola, Adrianne; Tandoc, Amado O., III; Segubre-Mercado, Edelwisa; Lupisan, Socorro P.; Okamoto, Michiko; Furuse, Yuki; Saito, Mayuko; Oshitani, Hitoshi			Molecular detection and characterization of sapovirus in hospitalized children with acute gastroenteritis in the Philippines	JOURNAL OF CLINICAL VIROLOGY			English	Article						Sapovirus; Gastroenteritis; Recombination; The Philippines	RECOMBINANT SAPOVIRUS; GENETIC DIVERSITY; UNITED-KINGDOM; JAPAN; CALICIVIRUSES; POPULATION; INFECTIONS; NOROVIRUS; GENOTYPE; VIRUS	Background: Human sapovirus (SaV) is a causative agent of acute gastroenteritis. Recently, SaV detection has been increasing worldwide due to the emerging SaV genotype I.2. However, SaV infection has not been reported in the Philippines. Objectives: To evaluate the prevalence and genetic diversity of SaV in hospitalized children aged less than 5 years with acute gastroenteritis. Study design: Stool samples were collected from children with acute gastroenteritis at three hospitals in the Philippines from June 2012 to August 2013. SaV was detected by reverse transcription real-time PCR, and the polymerase and capsid gene sequences were analyzed. Full genome sequencing and recombination analysis were performed on possible recombinant viruses. Results: SaV was detected in 7.0% of the tested stool samples (29/417). In 10 SaV-positive cases, other viruses were also detected, including rotavirus (n = 6), norovirus (n = 2), and human astrovirus (n = 2). Four known SaV genotypes (GI.1 [7], GI.2 [2], GII.1 [12], and GV [2]) and one novel recombinant (n = 3) were identified by polymerase and capsid gene sequence analysis. Full genome sequencing revealed that the 5' nontranslated region (NTR) and nonstructural protein region of the novel recombinant were closely related to the GII.1 Bristol/98/UK variant, whereas the structural protein region and 3' NTR were closely related to the GII.4 Kumamoto6/Mar2003/JPN variant. Discussion and conclusions: SaV was regularly detected in hospitalized children due to acute gastroenteritis during the study period. A novel recombinant, SaV GII.1/GII.4, was identified in three cases at two different study sites. (C) 2015 The Authors. Published by Elsevier B.V.	[Liu, Xiaofang; Saito, Mariko; Imagawa, Toshifumi; Okamoto, Michiko; Furuse, Yuki; Saito, Mayuko; Oshitani, Hitoshi] Tohoku Univ, Grad Sch Med, Dept Virol, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Yamamoto, Dai] Kushiro City Gen Hosp, Dept Pediat, Kushiro, Hokkaido 0850822, Japan; [Saito, Mariko] FCC, Tohoku RITM Collaborating Res Ctr Emerging & Reem, Alabang 1781, Muntinlupa, Philippines; [Ablola, Adrianne; Segubre-Mercado, Edelwisa] FCC, Res Inst Trop Med, Mol Biol Lab, Alabang 1781, Muntinlupa, Philippines; [Tandoc, Amado O., III] FCC, Res Inst Trop Med, Dept Virol, Alabang 1781, Muntinlupa, Philippines; [Lupisan, Socorro P.] FCC, Res Inst Trop Med, Alabang 1781, Muntinlupa, Philippines	Saito, M (reprint author), Tohoku Univ, Grad Sch Med, Dept Virol, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	msaitop@med.tohoku.ac.jp			Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) from Ministries of Education, Culture, Sports, Science, and Technology (MEXT) of Japan	This study was supported by the Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) from the Ministries of Education, Culture, Sports, Science, and Technology (MEXT) of Japan.	Oka T, 2006, J MED VIROL, V78, P1347, DOI 10.1002/jmv.20699; Svraka S, 2010, J CLIN MICROBIOL, V48, P2191, DOI 10.1128/JCM.02427-09; Kirkwood CD, 2005, J MED VIROL, V77, P96, DOI 10.1002/jmv.20419; Tam CC, 2012, CLIN INFECT DIS, V54, P1275, DOI 10.1093/cid/cis028; Li LL, 2011, J GEN VIROL, V92, P2534, DOI 10.1099/vir.0.034611-0; Simmonds P, 2008, NUCLEIC ACIDS RES, V36, P2530, DOI 10.1093/nar/gkn096; Bull RA, 2005, EMERG INFECT DIS, V11, P1079; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Chan MCW, 2006, J VIROL METHODS, V134, P146, DOI 10.1016/j.jviromet.2005.12.013; Okada M, 2006, ARCH VIROL, V151, P2503, DOI 10.1007/s00705-006-0820-1; Chang KO, 2004, P NATL ACAD SCI USA, V101, P8733, DOI 10.1073/pnas.0401126101; Iturriza-Gomara M, 2004, J CLIN VIROL, V31, P259, DOI 10.1016/j.jcv.2004.04.009; Oka T, 2015, CLIN MICROBIOL REV, V28, P32, DOI 10.1128/CMR.00011-14; Lole KS, 1999, J VIROL, V73, P152; Bucardo F., 2014, PLOS ONE; CHIBA S, 1979, J MED VIROL, V4, P249, DOI 10.1002/jmv.1890040402; Dey S.K., 2011, EPIDEMIOL INFECT, V140, P74; Dey SK, 2011, CLIN LAB, V57, P91; Gallimore CI, 2006, J MED VIROL, V78, P673, DOI 10.1002/jmv.20592; Gustavsson L, 2011, J CLIN VIROL, V51, P275, DOI 10.1016/j.jcv.2011.05.025; Hansman GS, 2005, EMERG INFECT DIS, V11, P1916; Hansman GS, 2007, EMERG INFECT DIS, V13, P786; Hansman GS, 2008, VIRUS RES, V137, P261, DOI 10.1016/j.virusres.2008.07.002; Johnsen CK, 2009, J CLIN VIROL, V46, P265, DOI 10.1016/j.jcv.2009.07.008; Katayama K, 2004, EMERG INFECT DIS, V10, P1874; Lee LE, 2012, EMERG INFECT DIS, V18, P873, DOI 10.3201/eid1805.111843; Malasao R, 2008, J MED VIROL, V80, P1749, DOI 10.1002/jmv.21244; Oka T, 2009, MICROBIOL IMMUNOL, V53, P417, DOI 10.1111/j.1348-0421.2009.00133.x; Oka T., 2011, ARCH VIROL, V157, P349; Pang X.L., 2004, J INFECT DIS, V199, P547; Phan TG, 2007, INFECT GENET EVOL, V7, P542, DOI 10.1016/j.meegid.2007.02.004; Sakai Y, 2001, PEDIATR INFECT DIS J, V20, P849, DOI 10.1097/00006454-200109000-00005; Wang G, 2014, J CLIN VIROL, V59, P250, DOI 10.1016/j.jcv.2014.01.007; Zintz Carmelann, 2005, Infection Genetics and Evolution, V5, P281, DOI 10.1016/j.meegid.2004.06.010	34	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1386-6532	1873-5967		J CLIN VIROL	J. Clin. Virol.	JUL	2015	68						83	88		10.1016/j.jcv.2015.05.001		6	Virology	Virology	CK3FF	WOS:000356101300018		
J	Sato, M; Honzumi, K; Sato, T; Hashimoto, K; Watanabe, M; Miyazaki, K; Kawasaki, Y; Hosoya, M				Sato, Masatoki; Honzumi, Ken; Sato, Toshiko; Hashimoto, Koichi; Watanabe, Masahiro; Miyazaki, Kyohei; Kawasaki, Yukihiko; Hosoya, Mitsuaki			Quantitative analysis of influenza A (H3N2) E119V and R292K variants in clinical specimens by real-time reverse transcription polymerase chain reaction	JOURNAL OF CLINICAL VIROLOGY			English	Article						Resistant virus; Neuraminidase inhibitor; Oseltamivir; Zanamivir; Antiviral therapy; Polymerase chain reaction	RANDOMIZED CONTROLLED-TRIAL; NEURAMINIDASE INHIBITOR RESISTANCE; INTRAVENOUS PERAMIVIR; VIRUS-INFECTION; OSELTAMIVIR RESISTANCE; ORAL OSELTAMIVIR; DOUBLE-BLIND; B INFECTION; VIRAL LOAD; CHILDREN	Background: Because influenza virus isolates after cell culture are required to determine their susceptibility to neuraminidase inhibitors, the differences in normal or low-susceptibility variant population frequencies between clinical samples and isolates have not been considered. Objectives: To identify variations in low-susceptibility populations in clinical samples after initiation of oseltamivir and zanamivir therapy by quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR). Study design: We measured the populations of the low-susceptibility influenza A H3N2 variants E119V and R292K by qRT-PCR using 305 nasal aspiration samples collected over time from 13, 16, and 11 patients treated with no neuraminidase inhibitors, oseltamivir, and zanamivir, respectively. The variant population in the isolates was also determined when the population of low-susceptibility variants in the clinical samples increased following treatment. Moreover, the susceptibility of all isolates was measured. Results: The E119V variant was detected in only one patient during oseltamivir therapy, exhibiting decreased susceptibility to oseltamivir. Prior to treatment, R292K variants were detected in all clinical samples; however, they comprised only a small fraction of the total population. The proportion of the R292K variant in clinical samples increased for 6/27 (22.2%) patients treated with oseltamivir or zanamivir, whereas an increase in the proportion of the R292K variant in virus isolates was observed in only one patient. Conclusions: Discrepancies in the proportion of R292K variants between clinical samples and isolates should be suspected in clinical settings. qRT-PCR is useful for quantitative analysis of drug-resistant influenza virus and for immediate notification of the result. (C) 2015 Elsevier B.V. All rights reserved.	[Sato, Masatoki; Honzumi, Ken; Sato, Toshiko; Hashimoto, Koichi; Miyazaki, Kyohei; Kawasaki, Yukihiko; Hosoya, Mitsuaki] Fukushima Med Univ, Dept Pediat, Fukushima 9601295, Japan; [Watanabe, Masahiro] Fukushima South Aizu Hosp, Dept Pediat, Minamiaizu 9670006, Japan	Sato, M (reprint author), Fukushima Med Univ, Dept Pediat, 1 Hikarigaoka, Fukushima 9601295, Japan.	smasatoki@yahoo.co.jp; ken_honzumi@yahoo.co.jp; ts3005@fmu.ac.jp; don@fmu.ac.jp; nabe5658@fmu.ac.jp; watarikko0421@gmail.com; kyuki@fmu.ac.jp; mhosoya@fmu.ac.jp					Kohno S, 2011, ANTIMICROB AGENTS CH, V55, P2803, DOI [10.1128/AAC.01718-10, 10.1128/AAC.00360-11]; Watanabe A, 2010, CLIN INFECT DIS, V51, P1167, DOI 10.1086/656802; Takahashi T, 2008, J CLIN MICROBIOL, V46, P1698, DOI 10.1128/JCM.02214-07; van der Vries E, 2013, J MOL DIAGN, V15, P347, DOI 10.1016/j.jmoldx.2012.11.007; Tamura D, 2011, CLIN INFECT DIS, V52, P432, DOI 10.1093/cid/ciq183; Nicholson KG, 2000, LANCET, V355, P1845, DOI 10.1016/S0140-6736(00)02288-1; Stephenson I, 2009, CLIN INFECT DIS, V48, P389, DOI 10.1086/596311; Gooskens J, 2009, J INFECT DIS, V199, P1435, DOI 10.1086/598684; Kiso M, 2004, LANCET, V364, P759, DOI 10.1016/S0140-6736(04)16934-1; FRANK AL, 1981, J INFECT DIS, V144, P433; Baz M, 2006, CLIN INFECT DIS, V43, P1555, DOI 10.1086/508777; Hayden FG, 1997, NEW ENGL J MED, V337, P874, DOI 10.1056/NEJM199709253371302; Hurt AC, 2010, J VIROL, V84, P9427, DOI 10.1128/JVI.00373-10; Sugaya N, 2010, ANTIMICROB AGENTS CH, V54, P2575, DOI 10.1128/AAC.01755-09; Monto AS, 2006, ANTIMICROB AGENTS CH, V50, P2395, DOI 10.1128/AAC.01339-05; Whitley RJ, 2001, PEDIATR INFECT DIS J, V20, P127, DOI 10.1097/00006454-200102000-00002; Whitley RJ, 2013, CLIN INFECT DIS, V56, P1197, DOI 10.1093/cid/cis1220; Deyde VM, 2007, J INFECT DIS, V196, P249, DOI 10.1086/518936; de Jong MD, 2014, CLIN INFECT DIS, V59, pE172, DOI 10.1093/cid/ciu632; Deyde VM, 2009, ANTIVIR RES, V81, P16, DOI 10.1016/j.antiviral.2008.08.008; Duan S, 2011, ANTIMICROB AGENTS CH, V55, P4718, DOI 10.1128/AAC.00316-11; Ghedin E, 2011, J INFECT DIS, V203, P168, DOI 10.1093/infdis/jiq040; HALL CB, 1979, J INFECT DIS, V140, P610; Hedrick JA, 2000, PEDIATR INFECT DIS J, V19, P410, DOI 10.1097/00006454-200005000-00005; Ito Y, 2000, CLIN INFECT DIS, V30, P185, DOI 10.1086/313618; McKimm-Breschkin J, 2003, ANTIMICROB AGENTS CH, V47, P2264, DOI 10.1128/AAC.47.7.2264-2272.2003; Sato M, 2015, ANTIMICROB AGENTS CH, V59, P1648, DOI 10.1128/AAC.04263-14; Sato M, 2005, PEDIATR INFECT DIS J, V24, P931, DOI 10.1097/01.inf.0000180976.81055.ce; Sato M, 2014, PEDIATR INFECT DIS J, V33, pE168, DOI 10.1097/INF.0000000000000266; Sugaya N, 2012, ANTIMICROB AGENTS CH, V56, P369, DOI 10.1128/AAC.00132-11; Tashiro M, 2009, ANTIVIR THER, V14, P751, DOI 10.3851/IMP1194; The National Institute of Infectious Diseases, MAN DET INFL VIR; Treanor JJ, 2000, JAMA-J AM MED ASSOC, V283, P1016, DOI 10.1001/jama.283.8.1016	33	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1386-6532	1873-5967		J CLIN VIROL	J. Clin. Virol.	JUL	2015	68						97	103		10.1016/j.jcv.2015.05.018		7	Virology	Virology	CK3FF	WOS:000356101300021		
J	Furukawa, H; Takeuchi, T; Yano, E; Muto, S				Furukawa, Hirokazu; Takeuchi, Takeaki; Yano, Eiji; Muto, Shinsuke			FACTORS INFLUENCING PSYCHOLOGICAL DISTRESS AFTER THE GREAT EAST JAPAN EARTHQUAKE AND TSUNAMI	JOURNAL OF COMMUNITY PSYCHOLOGY			English	Article							DISASTER; TURKEY	Studies have explored the association between various characteristics and psychological distress that follows natural disasters. However, this has not been clarified in subjects who continue to reside in seriously damaged houses. We investigated factors associated with psychological distress after the Great East Japan Earthquake and Tsunami. Participants included 2,773 home evacuees in Ishinomaki. Information regarding subjects' demographics; social and community networks; living and working conditions; general socioeconomic, cultural, and environmental conditions; and psychological distress was obtained. Logistic regression analyses showed that female gender (odds ratio [OR], 2.70; 95% confidence interval [CI] [2.14, 3.42]), loss of pleasure (OR, 1.32; 95% CI [1.07, 1.63]), change in family structure (OR, 1.49; 95% CI [1.17, 1.89]), and change in work status (OR, 1.24; 95% CI [1.02, 1.52]) were significant factors in psychological distress. This information might facilitate the development of countermeasures against psychological distress associated with natural disasters. (C) 2015 Wiley Periodicals, Inc.	[Furukawa, Hirokazu] Naruto Univ Educ, Naruto, Japan; [Takeuchi, Takeaki; Yano, Eiji] Teikyo Univ, Sch Med, Tokyo 1738605, Japan; [Takeuchi, Takeaki; Yano, Eiji] Teikyo Univ, Sch Publ Hlth, Tokyo 1738605, Japan; [Muto, Shinsuke] Teikyo Ishinomaki Res Grp, You Home Clin, Ishinomaki, Miyagi, Japan; [Muto, Shinsuke] Hlth & Life Revival Council Ishonomaki Dist RCI, Ishinomaki, Miyagi, Japan	Takeuchi, T (reprint author), Grad Sch Med, Itabashi Ku, 2-11-1 Kaga, Tokyo 1738605, Japan.	takeakij@post.harvard.edu			Japanese Society of Public Health	All authors declare that they have no conflicts of interest. This study was financially supported by the Japanese Society of Public Health (Special Grant for public health project for the Great East Japan Earthquake) in 2012.	Foa EB, 2006, J CLIN PSYCHIAT, V67, P15; Salcioglu E, 2003, J NERV MENT DIS, V191, P154, DOI 10.1097/00005053-200303000-00003; Norris FH, 2002, PSYCHIATRY, V65, P207, DOI 10.1521/psyc.65.3.207.20173; Oyama Mari, 2012, Environmental Health and Preventive Medicine, V17, P118, DOI 10.1007/s12199-011-0225-y; Bland SH, 1997, J NERV MENT DIS, V185, P188, DOI 10.1097/00005053-199703000-00008; CARR VJ, 1995, PSYCHOL MED, V25, P539; Dahlgren H., 2007, I FUTURE STUDIES POL; KARANCI AN, 1995, DISASTERS, V19, P8, DOI 10.1111/j.1467-7717.1995.tb00328.x; National Police Agency, 2012, COUNT GREAT E JAP EA; Nohara Masaru, 2011, Western Pac Surveill Response J, V2, P24, DOI 10.5365/WPSAR.2011.2.4.002	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0090-4392	1520-6629		J COMMUNITY PSYCHOL	J. Community Psychol.	JUL	2015	43	5					521	526		10.1002/jcop.21695		6	Public, Environmental & Occupational Health; Psychology, Multidisciplinary; Social Work	Public, Environmental & Occupational Health; Psychology; Social Work	CL1UR	WOS:000356730900001		
J	Sugiura, K; Akiyama, M				Sugiura, Kazumitsu; Akiyama, Masashi			Update on autosomal recessive congenital ichthyosis: mRNA analysis using hair samples is a powerful tool for genetic diagnosis	JOURNAL OF DERMATOLOGICAL SCIENCE			English	Review						ABCA12 promoter; Autosomal recessive congenital ichthyosis; Congenital ichthyosiform erythroderma; Harlequin ichthyosis; Hair samples; Lamellar ichthyosis	GENERALIZED PUSTULAR PSORIASIS; DORFMAN-CHANARIN-SYNDROME; HARLEQUIN ICHTHYOSIS; LAMELLAR ICHTHYOSIS; TRANSPORTER ABCA12; COLLODION BABY; TGM1 MUTATIONS; ERYTHRODERMA; DISEASE; PROTEIN	Research on the molecular genetics and pathomechanisms of autosomal recessive congenital ichthyosis (ARCI) has advanced considerably and several causative genes and molecules underlying the disease have been identified. Three major ARCI phenotypes are harlequin ichthyosis (HI), lamellar ichthyosis (LI), and congenital ichthyosiform erythroderma (CIE): Skin barrier defects are involved in the pathogenesis of ARCI. In this review, the causative genes of ARCI and its phenotypes as well as recent advances in the field are summarized. The known causative molecules underlying ARCI include ABCA12, TGM1, ALOXE3, ALOX12B, NIPAL4, CYP4F22, PNPLA1, CERS3, and LIPN. It is important to examine genetic associations and to elucidate the pathomechanisms of ARCI to establish effective therapies and beneficial genetic counseling. Next-generation sequencing is a promising method that enables the detection of causative disease mutations, even in cases of unexpected concomitant genetic diseases. For genetic diagnosis, obtaining mRNA from hair follicle epithelial cells, which are analogous to keratinocytes in the interfollicular epidermis, is convenient and minimally invasive in patients with ARCI. We confirmed that our mRNA analysis method using hair follicle samples can be applied not only to keratinization disorders, but also to other genetic diseases in the dermatology field. Studies that suggest potential next-generation therapies using ARCI model mice are also reviewed. (C) 2015 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.	[Sugiura, Kazumitsu; Akiyama, Masashi] Nagoya Univ, Showa Ku, Grad Sch Med, Dept Dermatol, Nagoya, Aichi 4668550, Japan	Akiyama, M (reprint author), Nagoya Univ, Showa Ku, Grad Sch Med, Dept Dermatol, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	makiyama@med.nagoya-u.ac.jp	Sugiura, Kazumitsu /M-8913-2014	Sugiura, Kazumitsu /0000-0002-5207-4592	Ministry of Education, Culture, Sports, Science, and Technology of Japan [23249058]; Ministry of Health, Labour, and Welfare (Research on Measures for Intractable Disease), Japan [H26-itaku (nan)-ippan-027]	This study was supported in part by a Grant-in-Aid for Scientific Research (A) 23249058 (to M.A.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and by the grant H26-itaku (nan)-ippan-027 (to K.S.) from the Ministry of Health, Labour, and Welfare (Research on Measures for Intractable Disease), Japan.	Akiyama M, 2001, BRIT J DERMATOL, V144, P401, DOI 10.1046/j.1365-2133.2001.04037.x; Akiyama M, 2006, J DERMATOL SCI, V42, P83, DOI 10.1016/j.jdermsci.2006.01.003; Akiyama M, 2008, BRIT J DERMATOL, V158, P864, DOI 10.1111/j.1365-2133.2008.08439.x; Akiyama M, 2008, AM J PATHOL, V173, P1349, DOI 10.2353/ajpath.2008.080005; Akiyama M, 2010, HUM MUTAT, V31, P1090, DOI 10.1002/humu.21326; Israeli S, 2011, AM J HUM GENET, V88, P482, DOI 10.1016/j.ajhg.2011.02.011; RUSSELL LJ, 1995, NAT GENET, V9, P279, DOI 10.1038/ng0395-279; HUBER M, 1995, SCIENCE, V267, P525, DOI 10.1126/science.7824952; Sugiura K, 2014, J DERMATOL SCI, V74, P187, DOI 10.1016/j.jdermsci.2014.02.006; Sugiura K, 2013, J DERMATOL SCI, V72, P193, DOI 10.1016/j.jdermsci.2013.06.008; Aufenvenne K, 2013, AM J HUM GENET, V93, P620, DOI 10.1016/j.ajhg.2013.08.003; Kelsell DP, 2005, AM J HUM GENET, V76, P794; DORFMAN ML, 1974, ARCH DERMATOL, V110, P261, DOI 10.1001/archderm.110.2.261; Takeichi T, 2013, EXP DERMATOL, V22, P825, DOI 10.1111/exd.12276; CHANARIN I, 1975, BRIT MED J, V1, P553; Akiyama M, 2005, J CLIN INVEST, V115, P1777, DOI 10.1172/JCI14834; Sugiura K, 2013, J DERMATOL SCI, V72, P197, DOI 10.1016/j.jdermsci.2013.06.013; Akiyama M, 2003, J INVEST DERMATOL, V121, P1029, DOI 10.1046/j.1523-1747.2003.12520.x; Klar J, 2009, AM J HUM GENET, V85, P248, DOI 10.1016/j.ajhg.2009.06.021; Lefevre C, 2001, AM J HUM GENET, V69, P1002, DOI 10.1086/324121; Oji V, 2010, J AM ACAD DERMATOL, V63, P607, DOI 10.1016/j.jaad.2009.11.020; Lefevre C, 2003, HUM MOL GENET, V12, P2369, DOI 10.1093/hmg/ddg235; Vahlquist A, 2010, J INVEST DERMATOL, V130, P438, DOI 10.1038/jid.2009.346; Sugiura K, 2013, J INVEST DERMATOL, V133, P2514, DOI 10.1038/jid.2013.230; Krieg P, 2013, J INVEST DERMATOL, V133, P172, DOI 10.1038/jid.2012.250; SCHAFFER JE, 1994, CELL, V79, P427, DOI 10.1016/0092-8674(94)90252-6; Eckl KM, 2013, J INVEST DERMATOL, V133, P2202, DOI 10.1038/jid.2013.153; Sugiura K, 2014, J DERMATOL SCI, V75, P199, DOI 10.1016/j.jdermsci.2014.05.009; Akiyama M, 2008, EXP DERMATOL, V17, P373, DOI 10.1111/j.1600-0625.2007.00691.x; Takeichi T, 2013, J DERMATOL SCI, V69, P259, DOI 10.1016/j.jdermsci.2012.11.004; Jobard F, 2002, HUM MOL GENET, V11, P107, DOI 10.1093/hmg/11.1.107; Li H, 2013, J DERMATOL SCI, V69, P195, DOI 10.1016/j.jdermsci.2012.11.593; Cottle DL, 2015, HUM MOL GENET, V24, P436, DOI 10.1093/hmg/ddu459; Grall A, 2012, NAT GENET, V44, P140; KIM IG, 1992, J BIOL CHEM, V267, P7710; Lefevre C, 2006, HUM MOL GENET, V15, P767, DOI 10.1093/hmg/ddi491; Milstone LM, 2013, J AM ACAD DERMATOL, V69, P808, DOI 10.1016/j.jaad.2013.06.017; Numata S, 2015, J DERMATOL SCI; Radner FPW, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003536; Sasaki K, 2012, J DERMATOL SCI, V65, P156, DOI 10.1016/j.jdermsci.2011.12.006; Shibata A, 2014, J AM ACAD DERMATOL, V70, P387, DOI 10.1016/j.jaad.2013.10.055; Shibata A, 2014, ACTA DERM VENEREOL; Shimizu Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep06737; Shimizu Y, 2013, J DERMATOL, V40, P582, DOI 10.1111/1346-8138.12169; Sugiura K, 2014, ACTA DERM VENEREOL; Sugiura K, 2013, J DERMATOL SCI, V69, P181, DOI 10.1016/j.jdermsci.2012.12.002; Takeichi T, 2014, BR J DERMATOL; Tanahashi K, 2014, ACTA DERM-VENEREOL, V94, P589, DOI 10.2340/00015555-1765; Ujihara M, 2010, J DERMATOL SCI, V57, P102, DOI [10.1016/j.jdermsci.2009.10.016, 10.1016/j.dermsci.2009.10.016]; Yanagi T, 2010, AM J PATHOL, V177, P106, DOI 10.2353/ajpath.2010.091120	50	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0923-1811	1873-569X		J DERMATOL SCI	J. Dermatol. Sci.	JUL	2015	79	1					4	9		10.1016/j.jdermsci.2015.04.009		6	Dermatology	Dermatology	CL0LZ	WOS:000356635500001		
J	Takazawa, Y; Ogawa, E; Saito, R; Uchiyama, R; Ikawa, S; Uhara, H; Okuyama, R				Takazawa, Yuko; Ogawa, Eisaku; Saito, Rumiko; Uchiyama, Ryuhei; Ikawa, Shuntaro; Uhara, Hisashi; Okuyama, Ryuhei			Notch down-regulation in regenerated epidermis contributes to enhanced expression of interleukin-36 alpha and suppression of keratinocyte differentiation during wound healing	JOURNAL OF DERMATOLOGICAL SCIENCE			English	Article						Notch pathway; Wound healing; Keratinocyte; Cytokine; Keratin	GENERALIZED PUSTULAR PSORIASIS; TUMOR-SUPPRESSOR; SKIN-DISEASE; STEM-CELLS; IN-VIVO; INFLAMMATION; ACTIVATION; MECHANISMS; REPAIR; PATHOGENESIS	Background: Notch signaling controls a number of cellular processes, including cell fate decisions, proliferation, differentiation, and survival/apoptosis, in multiple tissues. In the epidermis, Notch1 functions as a molecular switch that controls the transition of cells from an undifferentiated state into a differentiated state. Objective: To clarify the functions of Notch in the regenerated epidermis during wound healing. Methods: Wounds on mouse skin were immunostained. To investigate the functions of Notch, Notch was inhibited in primary keratinocytes by treatment with a gamma-secretase inhibitor and by small interfering RNA-mediated knockdown, and was activated by a recombinant adenovirus approach. Results: Notch1 and Notch2 were down-regulated in the regenerated epidermis during wound healing. To clarify the significance of this down-regulation, we examined its effect on expression of the interleukin (IL)-1 family of proinflammatory cytokines because wounds are exposed to pathogens from the outside world. Among the IL-1 family, IL-36 alpha expression was induced by Notch inhibition. This was consistent with the decreased IL-36 alpha expression in Notch-overexpressing keratinocytes. Notch down-regulation in the regenerated epidermis may reinforce defense against stress from the outside world by inducing IL-36 alpha expression. Next, we examined the effects of Notch down-regulation on keratinocyte growth and differentiation. Notch down-regulation did not alter keratinocyte proliferation. On the other hand, Notch1 down-regulation suppressed induction of spinous layer-specific keratins (keratin1 and keratin10) in keratinocytes, which was consistent with the decreased expression of these keratins in the regenerated epidermis. The reduced levels of these keratins would increase cellular flexibility. Conclusion: Notch down-regulation in the epidermis appears to contribute to tissue regeneration during wound healing. (C) 2015 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.	[Takazawa, Yuko; Ogawa, Eisaku; Uchiyama, Ryuhei; Uhara, Hisashi; Okuyama, Ryuhei] Shinshu Univ, Dept Dermatol, Sch Med, Matsumoto, Nagano 3908621, Japan; [Saito, Rumiko] Tohoku Univ, Tohoku Med Megabank Org, Sendai, Miyagi 980, Japan; [Ikawa, Shuntaro] Tohoku Univ, Inst Dev Aging & Canc, Dept Project Programs, Sendai, Miyagi 980, Japan	Okuyama, R (reprint author), Shinshu Univ, Dept Dermatol, Sch Med, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	rokuyama@shinshu-u.ac.jp	井川, 俊太郎/L-5911-2015		Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government [26461686]	This study was supported by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government (to RO, grant number 26461686).	Pan YH, 2004, DEV CELL, V7, P731, DOI 10.1016/j.devcel.2004.09.014; Onoufriadis A, 2011, AM J HUM GENET, V89, P432, DOI 10.1016/j.ajhg.2011.07.022; Blumberg H, 2010, J IMMUNOL, V185, P4354, DOI 10.4049/jimmunol.1000313; Santoro MM, 2005, EXP CELL RES, V304, P274, DOI 10.1016/j.yexcr.2004.10.033; Blumberg H, 2007, J EXP MED, V204, P2603, DOI 10.1084/jem.20070157; Okuyama R, 2008, J DERMATOL SCI, V49, P187, DOI 10.1016/j.jdermsci.2007.05.017; Tomic-Canic M, 1998, J DERMATOL SCI, V17, P167, DOI 10.1016/S0923-1811(98)00016-4; Okuyama R, 2004, DEV CELL, V6, P551, DOI 10.1016/S1534-5807(04)00098-X; Pink AE, 2012, J INVEST DERMATOL, V132, P2459, DOI 10.1038/jid.2012.162; Johnston A, 2011, J IMMUNOL, V186, P2613, DOI 10.4049/jimmunol.1003162; Vigne S, 2012, BLOOD, V120, P3478, DOI 10.1182/blood-2012-06-439026; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Rangarajan A, 2001, EMBO J, V20, P3427, DOI 10.1093/emboj/20.13.3427; Ezratty EJ, 2011, CELL, V145, P1129, DOI 10.1016/j.cell.2011.05.030; Nickoloff BJ, 2006, J INVEST DERM SYMP P, V11, P16, DOI 10.1038/sj.jidsymp.5650010; Groves RW, 1996, J CLIN INVEST, V98, P336, DOI 10.1172/JCI118797; Demehri S, 2009, CANCER CELL, V16, P55, DOI 10.1016/j.ccr.2009.05.016; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; Koster MI, 2007, ANNU REV CELL DEV BI, V23, P93, DOI 10.1146/annurev.cellbio.23.090506.123357; ODLAND G, 1968, J CELL BIOL, V39, P135, DOI 10.1083/jcb.39.1.135; Watt FM, 2008, CURR OPIN CELL BIOL, V20, P171, DOI 10.1016/j.ceb.2008.01.010; Okuyama R, 2007, ONCOGENE, V26, P4478, DOI 10.1038/sj.onc.1210235; Blanpain C, 2006, GENE DEV, V20, P3022, DOI 10.1101/gad.1477606; Carrier Y, 2011, J INVEST DERMATOL, V131, P2428, DOI 10.1038/jid.2011.234; Freedberg IM, 2001, J INVEST DERMATOL, V116, P633, DOI 10.1046/j.1523-1747.2001.01327.x; Marrakchi S, 2011, NEW ENGL J MED, V365, P620, DOI 10.1056/NEJMoa1013068; Dotto GP, 2008, ONCOGENE, V27, P5115, DOI 10.1038/onc.2008.225; Chigurupati S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001167; Coulombe PA, 2003, J INVEST DERMATOL, V121, P219; DINARELLO CA, 1993, NEW ENGL J MED, V328, P106; Kolev Vihren, 2008, Nat Cell Biol, V10, P902, DOI 10.1038/ncb1750; KUPPER TS, 1995, J INVEST DERMATOL, V105, pS62, DOI 10.1111/1523-1747.ep12316087; Mazur PK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013578; Wong P, 2003, J CELL BIOL, V163, P327, DOI 10.1083/jcb.200305032; Yugaw T, 2013, MOL CELL BIOL, V33, P4434, DOI 10.1128/MCB.00577-13	35	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0923-1811	1873-569X		J DERMATOL SCI	J. Dermatol. Sci.	JUL	2015	79	1					10	19		10.1016/j.jdermsci.2015.04.003		10	Dermatology	Dermatology	CL0LZ	WOS:000356635500002		
J	Amagai, Y; Oida, K; Matsuda, A; Jung, K; Kakutani, S; Tanaka, T; Matsuda, K; Jang, H; Ahn, G; Xia, Y; Kawashima, H; Shibata, H; Matsuda, H; Tanaka, A				Amagai, Yosuke; Oida, Kumiko; Matsuda, Akira; Jung, Kyungsook; Kakutani, Said; Tanaka, Takao; Matsuda, Kenshiro; Jang, Hyosun; Ahn, Ginae; Xia, Yan; Kawashima, Hiroshi; Shibata, Hiroshi; Matsuda, Hiroshi; Tanaka, Akane			Dihomo-gamma-linolenic acid prevents the development of atopic dermatitis through prostaglandin D-1 production in NC/Tnd mice	JOURNAL OF DERMATOLOGICAL SCIENCE			English	Article						Atopic dermatitis; Dihomo-gamma-linolenic acid; Prostaglandin D-1; NC/Tnd mouse	DP1 RECEPTOR AGONIST; SKIN MAST-CELLS; NC/NGA MICE; SCRATCHING BEHAVIOR; ARACHIDONIC-ACID; EPITHELIAL-CELLS; INFLAMMATION; RELEASE; SUPPLEMENTATION; DISEASE	Background: Atopic dermatitis (AD) is a chronic and relapsing skin disorder with pruritic skin symptoms. We previously reported that dihomo-gamma-linolenic acid (DGLA) prevented the development of AD in NC/Tnd mice, though the mechanism remained unclear. Objective: We attempted to investigate the mechanism of preventive effect of DGLA on AD development in NC/Tnd mice. Methods: The clinical outcomes of NC/Tnd mice that were given diets containing DGLA, arachidonic acid, or eicosapentaenoic acid were compared. Lipid mediator contents in the skin in each group were also quantified. In addition, release of lipid mediators from RBL-2H3 mast cells treated with either DGLA or prostaglandin D-1 (PGD(1)) was measured. Furthermore, effect of PGD(1) on gene expression of thymic stromal lymphopoietin (TSLP) in PAM212 keratinocyte cells was determined. Results: Only DGLA containing diet suppressed the development of dermatitis in vivo. By quantifying the 20-carbon fatty acid-derived eicosanoids in the skin, the application of DGLA was found to upregulate PGD(1), which correlated with a better outcome in NC/Tnd mice. Moreover, we confirmed that mast cells produced PGD(1) after DGLA exposure, thereby exerting a suppressive effect on immunoglobulin E-mediated degranulation. PGD(1) also suppressed gene expression of TSLP in keratinocytes. Conclusion: These results suggest that oral administration of DGLA causes preventive effects on AD development in NC/Td mice by regulating the PGD(1) supply. (C) 2015 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.	[Amagai, Yosuke; Oida, Kumiko; Matsuda, Kenshiro; Jang, Hyosun; Ahn, Ginae; Xia, Yan; Matsuda, Hiroshi; Tanaka, Akane] Tokyo Univ Agr & Technol, Grad Sch Bioapplicat & Syst Engn, Cooperat Major Adv Hlth Sci, Tokyo, Japan; [Matsuda, Akira; Matsuda, Hiroshi] Inst Agr, Div Anim Life Sci, Lab Vet Mol Pathol & Therapeut, Tokyo, Japan; [Jung, Kyungsook; Tanaka, Akane] Tokyo Univ Agr & Technol, Inst Agr, Div Anim Life Sci, Lab Comparat Anim Med, Tokyo, Japan; [Kakutani, Said; Tanaka, Takao; Kawashima, Hiroshi; Shibata, Hiroshi] Suntory Wellness Ltd, Inst Hlth Care Sci, Osaka, Japan	Matsuda, H (reprint author), Tokyo Univ Agr & Technol, Grad Sch Bioapplicat & Syst Engn, Cooperat Major Adv Hlth Sci, Tokyo, Japan.	hiro@cc.tuat.ac.jp; akane@cc.tuat.ac.jp					Amagai Y, 2008, BIOCHEM BIOPH RES CO, V366, P857, DOI 10.1016/j.bbrc.2007.12.053; Trak-Fellermeier MA, 2004, EUR RESPIR J, V23, P575, DOI 10.1183/09031936.04.00074404; BERTHJONES J, 1993, LANCET, V341, P1557, DOI 10.1016/0140-6736(93)90697-F; YU K, 1995, J BIOL CHEM, V270, P23975; Serra-Pages M, 2012, J LEUKOCYTE BIOL, V92, P1155, DOI 10.1189/jlb.0212109; Monneret G, 2001, BLOOD, V98, P1942, DOI 10.1182/blood.V98.6.1942; Mandal AK, 2004, J EXP MED, V199, P1317, DOI 10.1084/jem.20031666; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Cork MJ, 2009, J INVEST DERMATOL, V129, P1892, DOI 10.1038/jid.2009.133; Sala-Vila A, 2008, CLIN EXP ALLERGY, V38, P1432, DOI 10.1111/j.1365-2222.2008.03072.x; Shimizu T, 2009, ANNU REV PHARMACOL, V49, P123, DOI 10.1146/annurev.pharmtox.011008.145616; Hirai H, 2001, J EXP MED, V193, P255, DOI 10.1084/jem.193.2.255; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Fujitani Y, 2002, J IMMUNOL, V168, P443; Ring J, 2012, J EUR ACAD DERMATOL, V26, P1045, DOI 10.1111/j.1468-3083.2012.04635.x; Hata AN, 2003, J PHARMACOL EXP THER, V306, P463, DOI 10.1124/jpet.103.050955; Arai I, 2004, EUR J PHARMACOL, V505, P229, DOI 10.1016/j.ejphar.2004.10.031; BENYON RC, 1989, BRIT J PHARMACOL, V97, P898; BENYON RC, 1987, BRIT J PHARMACOL, V92, P635; Chisaguano AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078245; Flower RJ, 1975, BRIT J PHARMACOL, V55, P239; Honma Y, 2005, EUR J PHARMACOL, V518, P56, DOI 10.1016/j.ejphar.2005.06.006; Kakutani S, 2010, PROSTAG LEUKOTR ESS, V83, P23, DOI 10.1016/j.plefa.2010.02.032; Kawashima H, 2008, LIPIDS, V43, P37, DOI 10.1007/s11745-007-3129-2; Kim ND, 2007, THESCIENTIFICWORLDJO, V7, P1307, DOI 10.1100/tsw.2007.181; Matsuda H, 1997, INT IMMUNOL, V9, P461, DOI 10.1093/intimm/9.3.461; MORITA Y, 1981, J IMMUNOL, V127, P1339; Orito K, 2004, BRIT J DERMATOL, V150, P33, DOI 10.1111/j.1365-2133.2004.05744.x; ORTEGA E, 1989, EUR J IMMUNOL, V19, P2251, DOI 10.1002/eji.1830191211; SCHAFER L, 1991, J INVEST DERMATOL, V96, P10, DOI 10.1111/1523-1747.ep12514648; Schmid-Ott G, 2001, J ALLERGY CLIN IMMUN, V108, P455, DOI 10.1067/mai.2001.117800; Sugimoto M, 2005, EXP DERMATOL, V14, P898, DOI 10.1111/j.1600-0625.2005.00375.x; Sugimoto M, 2007, EUR J PHARMACOL, V564, P196, DOI 10.1016/j.ejphar.2007.01.080; SUGINO H, 1988, NEUROCHEM INT, V12, P5, DOI 10.1016/0197-0186(88)90141-6; Takaoka A, 2007, EXP DERMATOL, V16, P331, DOI 10.1111/j.1600-0625.2006.00540.x; Tateishi N, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-30; TERRANOVA VP, 1980, CELL, V22, P719, DOI 10.1016/0092-8674(80)90548-6; Ulven T, 2006, CURR TOP MED CHEM, V6, P1427; Van Gool CJAW, 2004, BRIT J DERMATOL, V150, P728, DOI 10.1111/j.0007-0963.2004.05851.x; VERGROESEN AJ, 1977, NUTR REV, V35, P1; Wang YH, 2006, IMMUNITY, V24, P827, DOI 10.1016/j.immuni.2006.03.019; YOSHIMURA M, 1993, J BIOL CHEM, V268, P4604	42	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0923-1811	1873-569X		J DERMATOL SCI	J. Dermatol. Sci.	JUL	2015	79	1					30	37		10.1016/j.jdermsci.2015.03.010		8	Dermatology	Dermatology	CL0LZ	WOS:000356635500004		
J	Fujisawa, Y; Yoshino, K; Kiyohara, Y; Kadono, T; Murata, Y; Uhara, H; Hatta, N; Uchi, H; Matsushita, S; Takenouchi, T; Hayashi, T; Fujimoto, M; Ohara, K				Fujisawa, Yasuhiro; Yoshino, Koji; Kiyohara, Yoshio; Kadono, Takafumi; Murata, Yozo; Uhara, Hisashi; Hatta, Naohito; Uchi, Hiroshi; Matsushita, Shigeto; Takenouchi, Tatsuya; Hayashi, Toshihiko; Fujimoto, Manabu; Ohara, Kuniaki			The role of sentinel lymph node biopsy in the management of invasive extramammary Paget's disease: Multi-center, retrospective study of 151 patients	JOURNAL OF DERMATOLOGICAL SCIENCE			English	Article						Extramammary Paget's disease; Sentinel lymph node; Lymphadenopathy	BREAST-CANCER; MELANOMA; LYMPHADENECTOMY; DISSECTION	Background: Although extramammary Paget's disease (EMPD) mostly presents as intraepithelial carcinoma, we sometimes encounter patients with invasive EMPD (iEMPD) who have lymph node metastasis and may develop distant metastasis. Although sentinel lymph node biopsy (SLNB) is widely accepted for various cancers, there is no large study that has assessed its role in iEMPD. Objective: The main objective of this study is to assess the role of SLNB in patients with iEMPD. Materials and methods: We retrospectively collected data on 151 iEMPD patients treated from 1998 to 2012 in 11 institutes in Japan. All 151 patients received curative surgery for their primary tumor and none of them had distant metastasis. SLNB was performed on the 107 patients without lymphadenopathy to determine their LN status. The 44 other patients with lymphadenopathy underwent one of the following procedures to determine their LN status: SLNB in 22 cases, immediate LN dissection in 21, and LN biopsy in 1. Results: Compared to those without lymphadenopathy, patients with lymphadenopathy had advanced primary tumors (nodule in the primary tumor, thicker tumor, deeper invasion level, and lymphovascular invasion). The rate of LN metastasis in patients with lymphadenopathy was 80%, compared to 15% in patients without lymphadenopathy who underwent SLNB. Compared to those with negative SLN, patients with positive SLN had advanced primary tumors (nodule in the primary tumor, deeper invasion level, and lymphovascular invasion). Multivariate analysis revealed that dermal invasion (odds ratio 5.8, p = 0.04) and lymphovascular invasion (odds ratio 18.0, p = 0.0023) were independent factors associated with SLN positivity. Notably, there was no difference in survival between patients with or without SLN metastasis (p = 0.71). On the other hand, patients with lymphadenopathy showed worse survival than those with positive SLN (p = 0.045). Conclusion: Clinical lymphadenopathy was strongly correlated with pathological LN metastasis and also associated with worse survival than absence of lymphadenopathy. The rate of occult LN metastasis detected by SLNB was 15%. Survival was not affected by SLN status even when an advanced primary tumor was present in patients with positive SLN. Our results raise the possibility that SLNB and subsequent LN dissection improved the survival of patients with early stage lymphatic spread. Our study indicates that SLNB should be considered for iEMPD if lymphadenopathy is not apparent. (C) 2015 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.	[Fujisawa, Yasuhiro; Fujimoto, Manabu] Univ Tsukuba, Tsukuba, Ibaraki, Japan; [Yoshino, Koji; Ohara, Kuniaki] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Tokyo, Japan; [Kiyohara, Yoshio] Shizuoka Canc Ctr, Shizuoka, Japan; [Kadono, Takafumi] Univ Tokyo, Tokyo, Japan; [Murata, Yozo] Hyogo Canc Ctr, Akashi, Hyogo, Japan; [Uhara, Hisashi] Shinshu Univ, Nagano, Japan; [Hatta, Naohito] Toyama Prefectural Cent Hosp, Toyama, Japan; [Uchi, Hiroshi] Kyushu Univ, Fukuoka 812, Japan; [Matsushita, Shigeto] Kagoshima Med Ctr, Natl Hosp Org, Kagoshima, Japan; [Takenouchi, Tatsuya] Niigata Canc Ctr Hosp, Niigata, Japan; [Hayashi, Toshihiko] Hokkaido Univ, Sapporo, Hokkaido, Japan	Fujisawa, Y (reprint author), Univ Tsukuba, Tsukuba, Ibaraki, Japan.	fujisan@rrid.tsukuba.ac.jp					Ewing T, 2004, GYNECOL ONCOL, V95, P755, DOI 10.1016/j.ygyno.2004.09.008; Hatta N, 2008, BRIT J DERMATOL, V158, P313, DOI 10.1111/j.1365-2133.2007.08314.x; Morton DL, 2006, NEW ENGL J MED, V355, P1307, DOI 10.1056/NEJMoa060992; Giuliano AE, 1997, J CLIN ONCOL, V15, P2345; Murali R, 2012, ANN SURG, V255, P128, DOI 10.1097/SLA.0b013e3182306c72; Cornwell LB, 2011, AM SURGEON, V77, P874; Baron M, 2006, Gynecol Obstet Fertil, V34, P619, DOI 10.1016/j.gyobfe.2006.03.027; Connolly JL, 2006, ARCH PATHOL LAB MED, V130, P287; DEANS GT, 1994, BRIT J SURG, V81, P500, DOI 10.1002/bjs.1800810405; Guenther JM, 1999, AM SURGEON, V65, P991; Hatta N, 2004, DERMATOL SURG, V30, P1329, DOI 10.1111/j.1524-4725.2004.30377.x; Kudo G, 2002, CLIN NUCL MED, V27, P909, DOI 10.1097/01.RLU.0000037341.67981.00; Morton DL, 2014, NEW ENGL J MED, V370, P599, DOI 10.1056/NEJMoa1310460; Nakamura Y, 2012, BRIT J DERMATOL, V167, P954, DOI 10.1111/j.1365-2133.2012.11017.x; Tsujino Y, 2007, J DERMATOL, V34, P712, DOI 10.1111/j.1346-8138.2007.00366.x; Tsutsumida A, 2003, DERMATOL SURG, V29, P21, DOI 10.1046/j.1524-4725.2003.29001.x; Zhu Y, 2009, BRIT J DERMATOL, V161, P577, DOI 10.1111/j.1365-2133.2009.09203.x	17	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0923-1811	1873-569X		J DERMATOL SCI	J. Dermatol. Sci.	JUL	2015	79	1					38	42		10.1016/j.jdermsci.2015.03.014		5	Dermatology	Dermatology	CL0LZ	WOS:000356635500005		
J	Kamata, Y; Tominaga, M; Sakaguchi, A; Umehara, Y; Negi, O; Ogawa, H; Takamori, K				Kamata, Yayoi; Tominaga, Mitsutoshi; Sakaguchi, Azumi; Umehara, Yoshie; Negi, Osamu; Ogawa, Hideoki; Takamori, Kenji			Retinoid-related orphan receptor alpha is involved in induction of semaphorin 3A expression in normal human epidermal keratinocytes	JOURNAL OF DERMATOLOGICAL SCIENCE			English	Letter							CHOLESTEROL SULFATE; ATOPIC-DERMATITIS; ROR-ALPHA; ITCH		[Kamata, Yayoi; Tominaga, Mitsutoshi; Sakaguchi, Azumi; Umehara, Yoshie; Ogawa, Hideoki; Takamori, Kenji] Juntendo Univ, Grad Sch Med, Inst Environm & Gender Specif Med, Urayasu, Chiba 2790021, Japan; [Negi, Osamu; Takamori, Kenji] Juntendo Univ, Urayasu Hosp, Urayasu, Chiba 2790021, Japan	Takamori, K (reprint author), Juntendo Univ, Urayasu Hosp, 2-1-1 Tomioka, Urayasu, Chiba 2790021, Japan.	ktakamor@juntendo.ac.jp					Negi O, 2012, J DERMATOL SCI, V66, P37, DOI 10.1016/j.jdermsci.2012.01.007; Hanyu O, 2012, BIOCHEM BIOPH RES CO, V428, P99, DOI 10.1016/j.bbrc.2012.10.013; Ikoma A, 2006, NAT REV NEUROSCI, V7, P535, DOI 10.1038/nrn1950; Giguere V, 1999, ENDOCR REV, V20, P689, DOI 10.1210/er.20.5.689; Strott CA, 2003, J LIPID RES, V44, P1268, DOI 10.1194/jlr.R300005-JLR200; Jetten Anton M, 2009, Nucl Recept Signal, V7, pe003, DOI 10.1621/nrs.07003; LEWIN GR, 1993, TRENDS NEUROSCI, V16, P353, DOI 10.1016/0166-2236(93)90092-Z; Solt LA, 2012, TRENDS ENDOCRIN MET, V23, P619, DOI 10.1016/j.tem.2012.05.012; Tominaga M, 2014, J DERMATOL, V41, P205, DOI 10.1111/1346-8138.12317; Xiong GF, 2012, CANCER RES, V72, P1728, DOI 10.1158/0008-5472.CAN-11-2762	10	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0923-1811	1873-569X		J DERMATOL SCI	J. Dermatol. Sci.	JUL	2015	79	1					84	86		10.1016/j.jdermsci.2015.03.015		3	Dermatology	Dermatology	CL0LZ	WOS:000356635500011		
J	Akasaka, E; Minakawa, S; Rokunohe, D; Toyomaki, Y; Matsuzaki, Y; Sawamura, D; Nakano, H				Akasaka, Eijiro; Minakawa, Satoko; Rokunohe, Daiki; Toyomaki, Yuka; Matsuzaki, Yasushi; Sawamura, Daisuke; Nakano, Hajime			Superficial epidermolytic ichthyosis caused by a novel KRT2 mutation	JOURNAL OF DERMATOLOGICAL SCIENCE			English	Letter							KERATIN 2E; SIEMENS; BULLOSA; DOMAIN; PHENOTYPE		[Akasaka, Eijiro; Minakawa, Satoko; Rokunohe, Daiki; Toyomaki, Yuka; Matsuzaki, Yasushi; Sawamura, Daisuke; Nakano, Hajime] Hirosaki Univ, Dept Dermatol, Grad Sch Med, Hirosaki, Aomori 0368562, Japan	Nakano, H (reprint author), Hirosaki Univ, Dept Dermatol, Grad Sch Med, 5 Zaifu Cho, Hirosaki, Aomori 0368562, Japan.	hnakano@hirosaki-u.ac.jp					Akiyama M, 2005, BRIT J DERMATOL, V152, P1353, DOI 10.1111/j.1365-2133.2005.06598.x; Sung JY, 2013, J DERMATOL SCI, V70, P220, DOI 10.1016/j.jdermsci.2013.03.001; Smith FJD, 1998, J INVEST DERMATOL, V111, P817, DOI 10.1046/j.1523-1747.1998.00371.x; Suga Y, 2000, EXP DERMATOL, V9, P11, DOI 10.1034/j.1600-0625.2000.009001011.x; Takizawa Y, 2000, J INVEST DERMATOL, V114, P193, DOI 10.1046/j.1523-1747.2000.00817.x; Whittock NV, 2001, BRIT J DERMATOL, V145, P330, DOI 10.1046/j.1365-2133.2001.04327.x	6	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0923-1811	1873-569X		J DERMATOL SCI	J. Dermatol. Sci.	JUL	2015	79	1					86	88		10.1016/j.jdermsci.2015.04.006		3	Dermatology	Dermatology	CL0LZ	WOS:000356635500012		
J	Okamura, K; Abe, Y; Fukai, K; Tsuruta, D; Suga, Y; Nakamura, M; Funasaka, Y; Oka, M; Suzuki, N; Wataya-Kaneda, M; Seishima, M; Hozumi, Y; Kawaguchi, M; Suzuki, T				Okamura, Ken; Abe, Yuko; Fukai, Kazuyoshi; Tsuruta, Daisuke; Suga, Yasushi; Nakamura, Motonobu; Funasaka, Yoko; Oka, Masahiro; Suzuki, Noriyuki; Wataya-Kaneda, Mari; Seishima, Mariko; Hozumi, Yutaka; Kawaguchi, Masakazu; Suzuki, Tamio			Mutation analyses of patients with dyschromatosis symmetrica hereditaria: Ten novel mutations of the ADAR1 gene	JOURNAL OF DERMATOLOGICAL SCIENCE			English	Letter									[Okamura, Ken; Abe, Yuko; Hozumi, Yutaka; Kawaguchi, Masakazu; Suzuki, Tamio] Yamagata Univ, Dept Dermatol, Fac Med, Yamagata 9909585, Japan; [Fukai, Kazuyoshi; Tsuruta, Daisuke] Osaka City Univ, Grad Sch Med, Dept Dermatol, Osaka 558, Japan; [Suga, Yasushi] Juntendo Univ, Urayasu Hosp, Dept Dermatol, Urayasu, Japan; [Nakamura, Motonobu] Univ Occupat & Environm Hlth, Dept Dermatol, Kitakyushu, Fukuoka 807, Japan; [Funasaka, Yoko] Nippon Med Sch, Dept Dermatol, Tokyo 113, Japan; [Oka, Masahiro] Kobe Univ, Div Dermatol, Grad Sch Med, Kobe, Hyogo 657, Japan; [Suzuki, Noriyuki] Toyohashi Municipal Hosp, Dept Dermatol, Toyohashi, Aichi, Japan; [Wataya-Kaneda, Mari] Osaka Univ, Grad Sch Med, Dept Dermatol, Osaka, Japan; [Seishima, Mariko] Gifu Univ, Grad Sch Med, Dept Dermatol, Gifu, Japan	Okamura, K (reprint author), Yamagata Univ, Dept Dermatol, Fac Med, 2-2-2 Iida Nishi, Yamagata 9909585, Japan.	k-okamura@med.id.yamagata-u.ac.jp					Hayashi M, 2013, J DERMATOL, V40, P336, DOI 10.1111/j.1346-8138.2012.01661.x; Oyama M, 1999, BRIT J DERMATOL, V140, P491; George CX, 2011, J INTERF CYTOK RES, V31, P99, DOI 10.1089/jir.2010.0097; Sharma R, 2011, J DERMATOL SCI, V64, P70, DOI 10.1016/j.jdermsci.2011.06.013; BASS BL, 1988, CELL, V55, P1089, DOI 10.1016/0092-8674(88)90253-X; Kawaguchi M, 2012, J DERMATOL SCI, V66, P244, DOI 10.1016/j.jdermsci.2012.01.009; Miyamura Y, 2003, AM J HUM GENET, V73, P693, DOI 10.1086/378209; Murata I, 2009, J DERMATOL SCI, V53, P76, DOI 10.1016/j.jdermsci.2008.07.011; Suzuki N, 2005, J INVEST DERMATOL, V124, P1186, DOI 10.1111/j.0022-202X.2005.23732.x; Tomita Y, 2004, AM J MED GENET C, V131C, P75, DOI 10.1002/ajmg.c.30036	10	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0923-1811	1873-569X		J DERMATOL SCI	J. Dermatol. Sci.	JUL	2015	79	1					88	90		10.1016/j.jdermsci.2015.04.004		3	Dermatology	Dermatology	CL0LZ	WOS:000356635500013		
J	Morita, Y				Morita, Yosuke			A TOPOLOGICAL NECESSARY CONDITION FOR THE EXISTENCE OF COMPACT CLIFFORD-KLEIN FORMS	JOURNAL OF DIFFERENTIAL GEOMETRY			English	Article							HOMOGENEOUS SPACES; PROPER ACTIONS; REDUCTIVE TYPE; MANIFOLDS	We provide a necessary condition for the existence of a compact Clifford-Klein form of a given homogeneous space of reductive type. The key to the proof is to combine a result of Kobayashi and Ono with the observation that a fiber bundle with contractible fiber induces an isomorphism between the cohomology rings of the total space and the base space. We give some examples: SL(p+ q,R)ISO(p,q)(p,q : odd), for instance of homogeneous spaces that do not admit compact Clifford Klein forms.	Univ Tokyo, Grad Sch Math Sci, Meguro Ku, Tokyo 1538914, Japan	Morita, Y (reprint author), Univ Tokyo, Grad Sch Math Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1538914, Japan.	ymorita@ms.u-tokyo.ac.jp			MEXT, Japan	The author expresses his sincere gratitude to Professor Toshiyuki Kobayashi for his advice and encouragement. This work was supported by the Program for Leading Graduate Schools, MEXT, Japan.	BOREL A, 1953, ANN MATH, V57, P115, DOI 10.2307/1969728; Benoist Y, 1996, ANN MATH, V144, P315, DOI 10.2307/2118594; Borel A., 1963, TOPOLOGY, V2, P111, DOI 10.1016/0040-9383(63)90026-0; BOREL A, 1962, ANN MATH, V75, P485, DOI 10.2307/1970210; Cartan H., 1951, C TOP ESP FIBR BRUX, P57; Constantine D., 2013, LONDON MATH SOC LECT; Golubyatnikov V.P., 2012, TOPOLOGICAL LIB 3, P191; Guillemin V., 1999, SUPERSYMMETRY EQUIVA; Kobayashi T., 1992, REPRESENTATION THEOR, P59; Kobayashi T., 1990, J FAC SCI U TOKYO IA, V37, P71; Kobayashi T., 1996, PERSPECTIVES MATH, V17; KOBAYASHI T, 1989, MATH ANN, V285, P249, DOI 10.1007/BF01443517; Kobayashi T., 2009, SUGAKU EXPOSITIONS, V57, p[267, 1]; Kobayashi T., 1996, J LIE THEORY, V6, P147; Kobayashi T., 1993, J GEOM PHYS, V12, P133, DOI 10.1016/0393-0440(93)90011-3; Kobayashi T, 2005, PURE APPL MATH Q, V1, P591; KOBAYASHI T, 1992, DUKE MATH J, V67, P653, DOI 10.1215/S0012-7094-92-06728-7; KULKARNI RS, 1981, ADV MATH, V40, P10, DOI 10.1016/0001-8708(81)90031-1; Labourie F, 1995, MATH RES LETT, V2, P75; Labourie F, 1995, GEOM FUNCT ANAL, V5, P955, DOI 10.1007/BF01902217; Labourie F., 1996, S MATH, VXXXVI, P267; Leray J., 1951, C TOP ESP FIBR BRUX, P101; Margulis G, 1997, B SOC MATH FR, V125, P447; MOSTOW GD, 1962, ANN MATH, V76, P446, DOI 10.2307/1970368; Shalom Y, 2000, ANN MATH, V152, P113, DOI 10.2307/2661380; Zimmer R. J., 1994, J AM MATH SOC, V7, P159, DOI 10.2307/2152724	26	0	0	INT PRESS BOSTON, INC	SOMERVILLE	PO BOX 43502, SOMERVILLE, MA 02143 USA	0022-040X	1945-743X		J DIFFER GEOM	J. Differ. Geom.	JUL	2015	100	3					533	545				13	Mathematics	Mathematics	CK9KY	WOS:000356560200005		
J	Homma, Y; Otani, N; Ishimatsu, S				Homma, Yosuke; Otani, Norio; Ishimatsu, Shinichi			A CASE REPORT OF ACUTE VITAMIN A INTOXICATION DUE TO OCEAN PERCH LIVER INGESTION	JOURNAL OF EMERGENCY MEDICINE			English	Article						acute intoxication; vitamin A; toxicology; retinol; natural toxins; poisoning; desquamation; facial flushing	HYPERVITAMINOSIS-A; SAFETY	Background: Chronic vitamin A intoxication is well known; however, there are few reports of acute vitamin A intoxication due to the ingestion of food rich in vitamin A, particularly in adults. Case Report: We report a case of a 27-year-old man presenting with chief complaints of flushing, headache, nausea, and joint pain. He had consumed 800 g of grilled ocean perch liver the day before and had experienced numbness shortly after. Although physical examination revealed only facial flushing, we suspected acute vitamin A intoxication due to his diet history. On day 2 after ingestion, his serum retinol levels were elevated at 1577 ng/mL, which confirmed vitamin A intoxication. He returned for follow-up on day 4 after ingestion, by which time his presenting symptoms had improved, but he had developed desquamation of his facial skin. Why Should an Emergency Physician Be Aware of This?: Emergency physicians should consider acute vitamin A intoxication in the differential diagnosis of patients with headache, flushing, desquamation, nausea, and vomiting of unknown etiology. Complete diet histories and checking vitamin A levels are essential for diagnosis. This report highlights the diagnostic difficulties associated with vitamin A intoxication and the importance of an accurate diet history. (C) 2015 Elsevier Inc.	[Homma, Yosuke] Tokyo Bay Urayasu Ichikawa Med Ctr, Dept Emergency Med, Urayasu, Chiba 2790001, Japan; [Otani, Norio; Ishimatsu, Shinichi] St Lukes Int Hosp, Dept Emergency & Crit Care Med, Tokyo, Japan	Homma, Y (reprint author), Tokyo Bay Urayasu Ichikawa Med Ctr, Dept Emergency Med, 3-4-32 Todaijima, Urayasu, Chiba 2790001, Japan.						Allison A, 2007, CLIN MANAGEMENT POIS, V4th, P1089; HATHCOCK JN, 1990, AM J CLIN NUTR, V52, P183; Gerster H, 1997, INT J VITAM NUTR RES, V67, P71; BIESALSKI HK, 1989, TOXICOLOGY, V57, P117, DOI 10.1016/0300-483X(89)90161-3; Penniston KL, 2006, AM J CLIN NUTR, V83, P191; Myhre AM, 2003, AM J CLIN NUTR, V78, P1152; BAXI SC, 1982, WESTERN J MED, V137, P429; BENDICH A, 1989, AM J CLIN NUTR, V49, P358; Cameron C, 1998, EMERGENCY TOXICOLOGY, V2nd, P607; CARPENTER TO, 1987, J PEDIATR-US, V111, P507, DOI 10.1016/S0022-3476(87)80109-9; MISBAH SA, 1984, J NEUROL NEUROSUR PS, V47, P216, DOI 10.1136/jnnp.47.2.216; RODAHL K, 1949, NATURE, V164, P530, DOI 10.1038/164530a0	12	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0736-4679	1090-1280		J EMERG MED	J. Emerg. Med.	JUL	2015	49	1					15	17		10.1016/j.jemermed.2014.12.056		3	Emergency Medicine	Emergency Medicine	CK7YA	WOS:000356451600016		
J	Inokuchi, R; Hatano, T; Fukuda, N; Yamaguchi, T; Nakajima, S; Yahagi, N				Inokuchi, Ryota; Hatano, Takashi; Fukuda, Naoyuki; Yamaguchi, Tetsuo; Nakajima, Susumu; Yahagi, Naoki			NONINFECTIOUS FUNICULITIS	JOURNAL OF EMERGENCY MEDICINE			English	Article									[Inokuchi, Ryota; Fukuda, Naoyuki; Yamaguchi, Tetsuo] JR Gen Hosp, Dept Emergency & Crit Care Med, Tokyo, Japan; [Inokuchi, Ryota; Fukuda, Naoyuki; Nakajima, Susumu; Yahagi, Naoki] Tokyo Univ Hosp, Dept Emergency & Crit Care Med, Tokyo 1138655, Japan; [Fukuda, Naoyuki] JR Gen Hosp, Dept Urol, Tokyo, Japan	Inokuchi, R (reprint author), Tokyo Univ Hosp, Dept Emergency & Crit Care Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.						Araki Azumi, 2013, Hinyokika Kiyo, V59, P141; Bostwick DG, 2014, UROLOGIC SURG PATHOL, V3rd, P836; Chan PTK, 2002, J ANDROL, V23, P453; Eddy Kathleen, 2011, Can Urol Assoc J, V5, pE74, DOI 10.5489/cuaj.10116; Wilensky AO, 1923, ANN SURG, V78, P785, DOI 10.1097/00000658-192312000-00009	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0736-4679	1090-1280		J EMERG MED	J. Emerg. Med.	JUL	2015	49	1					E33	E34		10.1016/j.jemermed.2015.02.001		2	Emergency Medicine	Emergency Medicine	CK7YA	WOS:000356451600010		
J	Oka, A; Okazaki, K; Takeno, A; Kumanomido, S; Kusunoki, R; Sato, S; Ishihara, S; Kinoshita, Y; Nishina, M				Oka, Akihiko; Okazaki, Koichi; Takeno, Ayumu; Kumanomido, Satoshi; Kusunoki, Ryusaku; Sato, Shuichi; Ishihara, Shunji; Kinoshita, Yoshikazu; Nishina, Masayoshi			CROWNED DENS SYNDROME: REPORT OF THREE CASES AND A REVIEW OF THE LITERATURE	JOURNAL OF EMERGENCY MEDICINE			English	Article						pseudogout; neck pain; calcification; computed tomography	CRYSTAL DEPOSITION DISEASE; ACUTE NECK PAIN; TRANSVERSE LIGAMENT; COMPUTED-TOMOGRAPHY; CERVICAL-SPINE; MENINGITIS; CALCIFICATION; PSEUDOGOUT; CHONDROCALCINOSIS; MANIFESTATION	Background: Patients with crowned dens syndrome (CDS), which is pseudogout of the atlantoaxial junction induced by "crown-like" calcifications around the dens, present with symptoms of severe neck pain, rigidity, and high fever. CDS patients are often misdiagnosed as having meningitis or polymyalgia rheumatica, leading to potentially unnecessary invasive procedures for diagnosis and treatment. Case Report: We report 3 patients with CDS who had characteristic findings on computed tomography (CT), all of whom quickly recovered with nonsteroidal anti-inflammatory drug (NSAID) administration. In addition, we reviewed 72 published cases, including our patients. CDS typically occurs in elderly people (mean age 71.4 years). Common symptoms include neck pain (100%), neck rigidity (98%), and fever (80.4%), and most show elevated inflammatory markers (88.3%) on serum laboratory tests. Neck pain on rotation is a characteristic and helpful symptom in the diagnosis. The most useful modality is CT (97.1%), showing linear calcium deposits around the dens, mostly in the transverse ligament of atlas (TLA). CT number is especially helpful to distinguish a normal TLA (35-110 HU) from a calcified one (202-258 HU) in our cases. The most effective treatment is NSAID administration (85%), which usually leads to marked resolution of symptoms within days or weeks. Why Should an Emergency Physician Be Aware of This?: Due to acute and severe symptoms, CDS patients often present to an emergency department. To avoid unnecessary invasive procedures for diagnosis and treatment, CDS should be considered in the differential diagnosis of febrile neck pain. (C) 2015 Elsevier Inc.	[Oka, Akihiko; Takeno, Ayumu; Kumanomido, Satoshi; Kusunoki, Ryusaku; Nishina, Masayoshi] Shimane Univ, Fac Med, Dept Emergency & Crit Care Med, Izumo, Shimane 6938501, Japan; [Okazaki, Koichi] Shimane Univ, Fac Med, Dept Internal Med 4, Izumo, Shimane 6938501, Japan; [Sato, Shuichi; Ishihara, Shunji; Kinoshita, Yoshikazu] Shimane Univ, Fac Med, Dept Internal Med 2, Izumo, Shimane 6938501, Japan	Oka, A (reprint author), Shimane Univ, Fac Med, Dept Emergency & Crit Care Med, Izumo, Shimane 6938501, Japan.						Ali Sayed, 2011, J Radiol Case Rep, V5, P30, DOI 10.3941/jrcr.v5i8.802; Scutellari PN, 2007, RADIOL MED, V112, P195, DOI 10.1007/s11547-007-0135-7; Constantin A, 1996, ANN RHEUM DIS, V55, P137, DOI 10.1136/ard.55.2.137; Cote P, 1998, SPINE, V23, P1689, DOI 10.1097/00007632-199808010-00015; Wu DW, 2005, ARTHRIT RHEUM-ARTHR, V53, P133, DOI 10.1002/art.20915; Salaffi F, 2008, CLIN EXP RHEUMATOL, V26, P1040; Aouba A, 2004, RHEUMATOLOGY, V43, P1508, DOI 10.1093/rheumatology/keh370; Sato Y, 2004, INTERNAL MED, V43, P865, DOI 10.2169/internalmedicine.43.865; Gutierrez M, 2010, RHEUMATOLOGY, V49, P610, DOI 10.1093/rheumatology/kep324; Sekijima Y, 2010, J NEUROL SCI, V296, P79, DOI 10.1016/j.jns.2010.05.028; Goto S, 2007, J BONE JOINT SURG AM, V89A, P2732, DOI 10.2106/JBJS.F01322; Matsumura M, 2012, NEW ENGL J MED, V367, pE34, DOI 10.1056/NEJMicm1100764; BOUVET JP, 1985, ARTHRITIS RHEUM, V28, P1417, DOI 10.1002/art.1780281215; Arauz-Rivera R, 2012, J AM GERIATR SOC, V60, P374, DOI 10.1111/j.1532-5415.2011.03811.x; Baysal T, 2000, EUR RADIOL, V10, P1003, DOI 10.1007/s003300051052; BURGUET JL, 1985, NEURORADIOLOGY, V27, P112; CIRICILLO SF, 1989, J NEUROSURG, V71, P141, DOI 10.3171/jns.1989.71.1.0141; De Geeter F, 2007, CLIN NUCL MED, V32, P854; Frey ME, 2009, PM&R, V1, P379, DOI 10.1016/j.pmrj.2009.01.014; Garcia-Gonzalez E, 2013, JCR-J CLIN RHEUMATOL, V19, P357, DOI 10.1097/RHU.0b013e3182a2a0d5; Ishikawa K, 2010, INTERNAL MED, V49, P2023, DOI 10.2169/internalmedicine.49.3924; Kakitsubata Y, 2000, RADIOLOGY, V216, P213; Kobayashi Y, 2001, SKELETAL RADIOL, V30, P295; Kuriyama A, 2014, CAN MED ASSOC J, V186, P293, DOI 10.1503/cmaj.122147; MALCA SA, 1995, ACTA NEUROCHIR, V135, P126, DOI 10.1007/BF02187755; Morita T, 2013, SPINE J, V13, P1161, DOI 10.1016/j.spinee.2013.05.034; Mula M, 2001, NEUROLOGY, V56, P275; Oda Y, 2012, INTERNAL MED, V51, P231, DOI 10.2169/internalmedicine.51.6547; Penas Martinez E, 2012, REUMATOL CLIN, V8, P48; Roverano S, 2010, JCR-J CLIN RHEUMATOL, V16, P7, DOI 10.1097/RHU.0b013e3181c9484f; Sato T, 2005, INTERNAL MED, V44, P160, DOI 10.2169/internalmedicine.44.160; Siau K, 2011, RHEUMATOL INT, V31, P85, DOI 10.1007/s00296-009-1145-7; Takahashi Teruyuki, 2013, Case Rep Neurol, V5, P40, DOI 10.1159/000348745; Taniguchi A, 2010, J NEUROL, V257, P132, DOI 10.1007/s00415-009-5304-2; Uh M, 2013, CLIN RHEUMATOL, V32, P711, DOI 10.1007/s10067-013-2179-5; Unlu Z, 2009, SOUTH MED J, V102, P949, DOI 10.1097/SMJ.0b013e3181b08c26; Yamazaki Y, 2013, CEPHALALGIA, V33, P425, DOI 10.1177/0333102412475240	37	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0736-4679	1090-1280		J EMERG MED	J. Emerg. Med.	JUL	2015	49	1					E9	E13		10.1016/j.jemermed.2015.02.005		5	Emergency Medicine	Emergency Medicine	CK7YA	WOS:000356451600003		
J	Acharya, SM; Kundu, K; Sreekrishnan, TR				Acharya, S. M.; Kundu, K.; Sreekrishnan, T. R.			Improved Stability of Anaerobic Digestion through the Use of Selective Acidogenic Culture	JOURNAL OF ENVIRONMENTAL ENGINEERING			English	Article						Anaerobic digestion; Volatile fatty acid-degrading cultures; Two-stage reactor; Shock load; Archaeal community analysis	METHANOGENIC POPULATION-DYNAMICS; COMMUNITY STRUCTURE; PROPIONIC-ACID; WASTE-WATER; PERFORMANCE; REACTOR; BIOAUGMENTATION; TEMPERATURE; DEGRADATION; BIOREACTOR	Accumulation of volatile fatty acids (VFAs) under overloading conditions in anaerobic reactors is a common problem. There is a need to stop this accumulation to improve reactor stability. In this study, propionate-, butyrate-, and acetate-degrading cultures were enriched and used as inocula in a mesophilic two-stage reactor to improve system stability. The performance of a test reactor was compared with that of a control reactor that was not seeded with specific VFA-degrading inocula under normal and overloading conditions. The reactors were fed with simulated wastewater having a chemical oxygen demand (COD) of 10,000 mg L-1. The test reactor inoculated with VFA-degrading cultures showed better performance in terms of methane production, COD removal, and VFA degradation. Also, after two consecutive organic shocks (influent COD 20,000 mg L-1) the test reactor recovered within four days and low levels of VFAs, especially propionate (429 mg L-1), were observed. In contrast, in the control reactor the concentration of VFA did not decline to preshock levels, even after five days of two consecutive shocks. PCR-denaturing gradient gel electrophoresis analysis using 16S rRNA gene amplicons also indicated a significant difference in archaeal community structure in the control and test reactors. Methanosarcinaceae was found dominant in the test reactor whereas in the control reactor an equal abundance of both Methanosaetaceae and Methanosarcinaceae was observed. Specific methanogenic activity also suggested higher acetoclastic and hydrogenotrophic activity of the sludge in the test reactor. Overall, using enriched culture as inocula resulted in a more balanced and robust methanogenic consortium and in improved system stability, with efficient degradation of the high concentration of VFAs. (C) 2015 American Society of Civil Engineers.	[Acharya, S. M.; Kundu, K.; Sreekrishnan, T. R.] Indian Inst Technol Delhi, Dept Biochem Engn & Biotechnol, New Delhi 110016, India; [Acharya, S. M.] Univ Tokyo, Grad Sch Engn, Dept Urban Engn, Bunkyo Ku, Tokyo 1138656, Japan; [Kundu, K.] Helmholtz Zentrum Munchen, German Res Ctr, Inst Groundwater Ecol, D-85764 Neuherberg, Germany	Sreekrishnan, TR (reprint author), Indian Inst Technol Delhi, Dept Biochem Engn & Biotechnol, New Delhi 110016, India.	shwethamacharya@gmail.com; kankana.kundu@helmholtz-muenchen.de; sreekrishnan_t_r@hotmail.com			Ministry of Human Resources Development (MHRD), Government of India	The authors wish to acknowledge the Ministry of Human Resources Development (MHRD), Government of India, for providing financial assistance during this project.	Amani T, 2011, BIORESOURCE TECHNOL, V102, P3716, DOI 10.1016/j.biortech.2010.11.111; Angelidaki I., 2007, AN BIOD ACT INH ABAI; Arnaiz C, 2003, ENVIRON TECHNOL, V24, P1431; Schauer-Gimenez AE, 2010, WATER RES, V44, P3555, DOI 10.1016/j.watres.2010.03.037; Blume F, 2010, J APPL MICROBIOL, V109, P441, DOI 10.1111/j.1365-2672.2010.04682.x; Tale VP, 2011, WATER RES, V45, P5249, DOI 10.1016/j.watres.2011.07.035; Francioso O, 2010, J HAZARD MATER, V175, P740, DOI 10.1016/j.jhazmat.2009.10.071; Azbar N, 2001, J ENVIRON ENG-ASCE, V127, P240, DOI 10.1061/(ASCE)0733-9372(2001)127:3(240); Kundu K, 2012, BIORESOURCE TECHNOL, V118, P502, DOI 10.1016/j.biortech.2012.05.047; Leitao RC, 2006, BIORESOURCE TECHNOL, V97, P1105, DOI 10.1016/j.biortech.2004.12.007; Zeeman G, 1999, WATER SCI TECHNOL, V39, P187, DOI 10.1016/S0273-1223(99)00101-8; Pandey PK, 2011, BIOMASS BIOENERG, V35, P2705, DOI 10.1016/j.biombioe.2011.03.017; de Bok FAM, 2006, APPL ENVIRON MICROB, V72, P7540, DOI 10.1128/AEM.01133-06; Padmasiri SI, 2007, WATER RES, V41, P134, DOI 10.1016/j.watres.2006.09.021; Lau IWC, 1997, WATER RES, V31, P2626, DOI 10.1016/S0043-1354(97)00110-3; THIELE JH, 1988, APPL ENVIRON MICROB, V54, P20; Schauer M, 2000, FEMS MICROBIOL ECOL, V33, P51, DOI 10.1111/j.1574-6941.2000.tb00726.x; Kundu K, 2013, BIORESOURCE TECHNOL, V129, P538, DOI 10.1016/j.biortech.2012.11.118; Bagi Z, 2007, APPL MICROBIOL BIOT, V76, P473, DOI 10.1007/s00253-007-1009-6; Verstraete W, 2005, WATER SCI TECHNOL, V52, P59; Wang L, 2006, BIOMASS BIOENERG, V30, P177, DOI 10.1016/j.biombioe.2005.11.010; Kundu K, 2013, J BIOTECHNOL, V168, P616, DOI 10.1016/j.jbiotec.2013.08.023; Nielsen HB, 2007, BIOMASS BIOENERG, V31, P820, DOI 10.1016/j.biombioe.2007.04.004; Cresson R, 2009, J APPL MICROBIOL, V106, P863, DOI 10.1111/j.1365-2672.2008.04055.x; Ma JX, 2009, WATER RES, V43, P3239, DOI 10.1016/j.watres.2009.04.046; BOONE DR, 1987, APPL ENVIRON MICROB, V53, P1589; APHA-American Public Health Association AWWA - American Water Works Association WEF - Water Environment Federation, 1995, STANDARD METHODS EXA; FYNN G, 1990, BIOTECHNOL LETT, V12, P621, DOI 10.1007/BF01030763; Kim M, 2004, J ENVIRON ENG-ASCE, V130, P960, DOI 10.1061/(ASCE)0733-9372(2004)130:9(960); MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695; Pullammanappallil PC, 2001, BIORESOURCE TECHNOL, V78, P165, DOI 10.1016/S0960-8524(00)00187-5; Tepe N, 2008, WATER SCI TECHNOL, V57, P589, DOI 10.2166/wst.2008.008; Vavilin VA, 2008, ANTON LEEUW INT J G, V94, P593, DOI 10.1007/s10482-008-9279-2	33	0	0	ASCE-AMER SOC CIVIL ENGINEERS	RESTON	1801 ALEXANDER BELL DR, RESTON, VA 20191-4400 USA	0733-9372	1943-7870		J ENVIRON ENG	J. Environ. Eng.-ASCE	JUL	2015	141	7							04015001	10.1061/(ASCE)EE.1943-7870.0000932		8	Engineering, Environmental; Engineering, Civil; Environmental Sciences	Engineering; Environmental Sciences & Ecology	CK7EX	WOS:000356395500005		
J	Suwazono, Y; Nogawa, K; Morikawa, Y; Nishijo, M; Kobayashi, E; Kido, T; Nakagawa, H; Nogawa, K				Suwazono, Yasushi; Nogawa, Kazuhiro; Morikawa, Yuko; Nishijo, Muneko; Kobayashi, Etsuko; Kido, Teruhiko; Nakagawa, Hideaki; Nogawa, Koji			Renal tubular dysfunction increases mortality in the Japanese general population living in cadmium non-polluted areas	JOURNAL OF EXPOSURE SCIENCE AND ENVIRONMENTAL EPIDEMIOLOGY			English	Article						cadmium; cohort study; Cox's proportional hazard model; mortality; renal dysfunction	JINZU RIVER-BASIN; URINARY CADMIUM; FOLLOW-UP; ENVIRONMENTAL CADMIUM; CANCER INCIDENCE; ASSOCIATION; INHABITANTS; RESIDENTS; BETA-2-MICROGLOBULIN; TOXICITY	The aim of this study was to establish the cause-effect relationship between renal tubular dysfunction and mortality. A 19-year cohort study was conducted in 900 men and 1313 women in 1993 or 1994 who lived in two cadmium non-polluted areas in Japan. Hazard ratio (HR) and 95% confidence interval (95% CI) of urinary beta 2-microglobulin (beta 2-MG) and N-acetyl-beta-glucosaminidase (NAG) for mortality were calculated using a proportional hazard regression. Forward stepwise model selection was applied to the potential covariates such as age, body mass index, mean arterial pressure, various lifestyle factors and present illness. Simultaneously, the dose-effect relationship between renal tubular markers and urinary cadmium at baseline was evaluated using multiple regression analyses. In men, HR was significant for beta 2-MG (HR corresponding to an increase of 100 mu g/g cre: 1.02) and NAG (HR corresponding to an increase of 1 IU/g cre: 1.05). In women, a significant HR was observed for beta 2-MG (HR corresponding to an increase of 100 mg/g cre: 1.01) and NAG (HR corresponding to an increase of 1 IU/g cre: 1.02). Dose-effect relationships were significant for urinary cadmium and all renal tubular markers in men and women. The present study indicated that renal tubular dysfunction was significantly related to mortality in the general population of cadmium non-polluted areas in Japan.	[Suwazono, Yasushi; Nogawa, Kazuhiro; Kobayashi, Etsuko; Nogawa, Koji] Chiba Univ, Grad Sch Med, Dept Occupat & Environm Med, Chiba 2608670, Japan; [Suwazono, Yasushi] Chiba Univ, Ctr Prevent Med Sci, Chiba 2608670, Japan; [Morikawa, Yuko; Nishijo, Muneko; Nakagawa, Hideaki] Kanazawa Med Univ, Dept Epidemiol & Publ Hlth, Uchinada, Ishikawa, Japan; [Kido, Teruhiko] Kanazawa Univ, Sch Hlth Sci, Dept Community Hlth Nursing, Kanazawa, Ishikawa 9201192, Japan	Suwazono, Y (reprint author), Chiba Univ, Grad Sch Med, Dept Occupat & Environm Med, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	suwa@faculty.chiba-u.jp					Akerstrom M, 2013, ENVIRON HEALTH PERSP, V121, P187, DOI 10.1289/ehp.1205418; Jarup L, 2009, TOXICOL APPL PHARM, V238, P201, DOI 10.1016/j.taap.2009.04.020; Chaumont A, 2013, ENVIRON HEALTH PERSP, V121, P1047, DOI 10.1289/ehp.1306607; Akesson AA, 2005, ENVIRON HEALTH PERSP, V113, P1627, DOI 10.1289/ehp.8033; Nishijo M, 2006, OCCUP ENVIRON MED, V63, P545, DOI 10.1136/oem.2006.026591; Suwazono Y, 2006, ENVIRON HEALTH PERSP, V114, P1072, DOI 10.1289/ehp.9028; Li Q, 2011, CHINESE MED J-PEKING, V124, P3504, DOI 10.3760/cma.j.issn.0366-6999.2011.21.013; Filipsson AF, 2003, CRIT REV TOXICOL, V33, P505, DOI 10.1080/10408440390242360; Arisawa K, 2001, INT ARCH OCC ENV HEA, V74, P255, DOI 10.1007/s004200000225; Arisawa K, 2007, TOXICOL LETT, V173, P168, DOI 10.1016/j.toxlet.2007.07.007; Bonness RW, 1945, J BIOL CHEM, V158, P581; CRUMP KS, 1984, FUND APPL TOXICOL, V4, P854, DOI 10.1016/0272-0590(84)90107-6; Ishihara T, 2001, TOXICOLOGY, V163, P23, DOI 10.1016/S0300-483X(01)00367-5; IWATA K, 1991, TOHOKU J EXP MED, V164, P93, DOI 10.1620/tjem.164.93; IWATA K, 1992, BRIT J IND MED, V49, P736; IWATA K, 1991, TOHOKU J EXP MED, V164, P319, DOI 10.1620/tjem.164.319; Kido T., 1984, J KANAZAWA MED U, V9, P70; Kobayashi E, 2002, TOXICOL LETT, V129, P85, DOI 10.1016/S0378-4274(01)00520-3; Matsuda K, 2003, ARCH ENVIRON HEALTH, V58, P218, DOI 10.3200/AEOH.58.4.218-222; Matsuda T, 2002, ENVIRON RES, V88, P156, DOI 10.1006/enrs.2002.4336; Meaney E, 2000, HEART, V84, P64, DOI 10.1136/heart.84.1.64; NAKAGAWA H, 1993, ARCH ENVIRON HEALTH, V48, P428; NAKAGAWA H, 1990, ARCH ENVIRON HEALTH, V45, P283; Nakagawa H, 2006, ENVIRON RES, V100, P323, DOI 10.1016/j.envres.2005.08.014; NISHIJO M, 1995, OCCUP ENVIRON MED, V52, P181; Nishijo M, 2004, BIOMETALS, V17, P535, DOI 10.1023/B:BIOM.0000045734.44764.ab; Nordberg GF, 2007, HANDBOOK ON THE TOXICOLOGY OF METALS, 3RD EDITION, P445, DOI 10.1016/B978-012369413-3/50078-1; Sakuragi S, 2012, INT ARCH OCC ENV HEA, V85, P941, DOI 10.1007/s00420-012-0734-z; Suwazono Y, 2011, INT J HYG ENVIR HEAL, V214, P175, DOI 10.1016/j.ijheh.2010.09.002; U.S. Environmental Protection Agency, 1995, EPA630R94007; World Health Organization, 1992, ENV HLTH CRIT, P17	31	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1559-0631	1559-064X		J EXPO SCI ENV EPID	J. Expo. Sci. Environ. Epidemiol.	JUL-AUG	2015	25	4					399	404		10.1038/jes.2014.44		6	Environmental Sciences; Public, Environmental & Occupational Health; Toxicology	Environmental Sciences & Ecology; Public, Environmental & Occupational Health; Toxicology	CK8TT	WOS:000356512100005		
J	Tonouchi, A; Yokoyama, N; Hashidate, H; Matsuzawa, N; Katayanagi, N; Otani, T				Tonouchi, A.; Yokoyama, N.; Hashidate, H.; Matsuzawa, N.; Katayanagi, N.; Otani, T.			Gastroenterology: Carcinosarcoma of the gallbladder presenting as a cholecysto-colic fistula	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Editorial Material									[Tonouchi, A.; Yokoyama, N.; Hashidate, H.; Matsuzawa, N.; Katayanagi, N.; Otani, T.] Niigata City Gen Hosp, Dept Digest Surg, Niigata, Japan	Tonouchi, A (reprint author), Niigata City Gen Hosp, Dept Digest Surg, Niigata, Japan.							0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	JUL	2015	30	7					1112	1112		10.1111/jgh.12906		1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CL0BP	WOS:000356603800003		
J	Takahashi, K; Sato, H; Sato, Y; Takeuchi, M; Takeda, SR; Mizuno, K; Hashimoto, S; Hasegawa, G; Kobayashi, M				Takahashi, K.; Sato, H.; Sato, Y.; Takeuchi, M.; Takeda, S-R; Mizuno, K.; Hashimoto, S.; Hasegawa, G.; Kobayashi, M.			Gastroenterology: Histopathological investigation of distal esophageal spasm (DES) using per-oral endoscopic myotomy (POEM)	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Editorial Material									[Takahashi, K.; Sato, H.; Sato, Y.; Takeuchi, M.] Niigata Univ, Med & Dent Hosp, Div Gastroenterol, Niigata, Japan; [Takeda, S-R; Mizuno, K.; Hashimoto, S.; Kobayashi, M.] Niigata Univ, Med & Dent Hosp, Dept Endoscopy, Niigata, Japan; [Hasegawa, G.] Niigata Univ, Grad Sch Med & Dent Sci, Div Cellular & Mol Pathol, Dept Cellular Funct, Niigata, Japan	Takahashi, K (reprint author), Niigata Univ, Med & Dent Hosp, Div Gastroenterol, Niigata, Japan.							0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	JUL	2015	30	7					1113	1113		10.1111/jgh.12926		1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CL0BP	WOS:000356603800004		
J	Arima, K; Chikamoto, A; Hashimoto, D; Kaida, T; Higashi, T; Taki, K; Takeyama, H; Okabe, H; Nitta, H; Hayashi, H; Beppu, T; Baba, H				Arima, K.; Chikamoto, A.; Hashimoto, D.; Kaida, T.; Higashi, T.; Taki, K.; Takeyama, H.; Okabe, H.; Nitta, H.; Hayashi, H.; Beppu, T.; Baba, H.			Hepatology: Hepatocellular carcinoma with duodenal metastasis	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Editorial Material									[Arima, K.; Chikamoto, A.; Hashimoto, D.; Kaida, T.; Higashi, T.; Taki, K.; Takeyama, H.; Okabe, H.; Nitta, H.; Hayashi, H.; Beppu, T.; Baba, H.] Kumamoto Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, Kumamoto, Japan	Arima, K (reprint author), Kumamoto Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, Kumamoto, Japan.							0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	JUL	2015	30	7					1115	1115		10.1111/jgh.12868		1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CL0BP	WOS:000356603800006		
J	Okimoto, E; Ishimura, N; Morito, Y; Mikami, H; Shimura, S; Uno, G; Tamagawa, Y; Aimi, M; Oshima, N; Kawashima, K; Kazumori, H; Sato, S; Ishihara, S; Kinoshita, Y				Okimoto, Eiko; Ishimura, Norihisa; Morito, Yoshiya; Mikami, Hironobu; Shimura, Shino; Uno, Goichi; Tamagawa, Yuji; Aimi, Masahito; Oshima, Naoki; Kawashima, Kousaku; Kazumori, Hideaki; Sato, Shuichi; Ishihara, Shunji; Kinoshita, Yoshikazu			Prevalence of gastroesophageal reflux disease in children, adults, and elderly in the same community	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Article						gastroesophageal reflux disease (GERD); GerdQ; Izumo Scale; obesity; prevalence	FUNCTIONAL GASTROINTESTINAL DISORDERS; GENDER-RELATED DIFFERENCES; IRRITABLE-BOWEL-SYNDROME; EROSIVE ESOPHAGITIS; GERD SYMPTOMS; RISK-FACTORS; JAPANESE; OBESITY; QUESTIONNAIRE; EPIDEMIOLOGY	Background and AimThe prevalence of gastroesophageal reflux disease (GERD) in adults is increasing in Japan as well as worldwide likely due to increasing obesity and the decreasing rate of Helicobacter pylori infection. However, data regarding the prevalence of GERD in children and adolescents in Japan are lacking. We investigated the prevalence of GERD in children, adults, and elderly living in the same community. MethodsWe surveyed employees of Shimane University Hospital and a related facility and their families using the Gastroesophageal Reflux Disease Questionnaire (GerdQ) and Izumo Scale instruments with demographic information (age, sex, body height, and body weight) and information regarding concurrent medication being taken for GERD. The presence of GERD was defined as a GerdQ score of 8. ResultsA total of 1859 subjects (771 males, 1088 females; 6-96 years old) were eligible for assessment. The prevalence of GERD in those under 20 years old was 4.4%, which was approximately one third of the rate in adults (11.6%). GERD prevalence was closely associated with obesity in adults, but not in subjects under 20 years old. GERD and other gastrointestinal symptoms frequently overlapped in both adults and younger subjects. ConclusionWe found that the prevalence of GERD in subjects under 20 years of age was lower than that in adults and not associated with obesity. Nevertheless, it is important to be aware of symptoms such as heartburn and/or regurgitation when children and adolescents seek routine clinical care.	[Okimoto, Eiko; Ishimura, Norihisa; Morito, Yoshiya; Mikami, Hironobu; Shimura, Shino; Uno, Goichi; Tamagawa, Yuji; Aimi, Masahito; Oshima, Naoki; Kawashima, Kousaku; Sato, Shuichi; Ishihara, Shunji; Kinoshita, Yoshikazu] Shimane Univ, Dept Gastroenterol & Hepatol, Sch Med, Izumo, Shimane 6938501, Japan; [Kazumori, Hideaki] Matsue Seikyo Gen Hosp, Dept Internal Med, Matsue, Shimane, Japan	Ishimura, N (reprint author), Shimane Univ, Dept Gastroenterol & Hepatol, Sch Med, 89-1 Enya Cho, Izumo, Shimane 6938501, Japan.	ishimura@med.shimane-u.ac.jp					Eslick GD, 2012, OBES REV, V13, P469, DOI 10.1111/j.1467-789X.2011.00969.x; Katz PO, 2013, AM J GASTROENTEROL, V108, P308, DOI 10.1038/ajg.2012.444; Mayer EA, 1999, ALIMENT PHARM THERAP, V13, P65, DOI 10.1046/j.1365-2036.1999.00008.x; Talley NJ, 2004, AM J GASTROENTEROL, V99, P1807, DOI 10.1111/j.1572-0241.2004.30388.x; Jones R, 2009, ALIMENT PHARM THER, V30, P1030, DOI 10.1111/j.1365-2036.2009.04142.x; Cole TJ, 2000, BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Niigaki M, 2013, J GASTROENTEROL, V48, P463, DOI 10.1007/s00535-012-0671-3; Lee YC, 2009, GUT, V58, P174, DOI 10.1136/gut.2008.162305; Yoshioka T, 2013, J BONE MINER METAB, V31, P153, DOI 10.1007/s00774-012-0393-x; El-Serag HB, 2005, AM J GASTROENTEROL, V100, P1243, DOI 10.1111/j.1572-0241.2005.41703.x; Quitadamo P, 2012, J PEDIATR GASTR NUTR, V55, P72, DOI 10.1097/MPG.0b013e3182549c44; Balasubramanian G, 2012, AM J GASTROENTEROL, V107, P1655, DOI 10.1038/ajg.2012.299; Mishima I, 2005, SCAND J GASTROENTERO, V40, P1005, DOI 10.1080/00365520510023260; Meleine M, 2014, WORLD J GASTROENTERO, V20, P6725, DOI 10.3748/wjg.v20.i22.6725; Goh KL, 2014, J GASTROEN HEPATOL, V29, P1969, DOI 10.1111/jgh.12655; Fujiwara Y, 2009, J GASTROENTEROL, V44, P518, DOI 10.1007/s00535-009-0047-5; Bai Y, 2013, J GASTROEN HEPATOL, V28, P626, DOI 10.1111/jgh.12125; Nakajima S, 2010, J GASTROEN HEPATOL, V25, pS138, DOI 10.1111/j.1440-1746.2010.06244.x; Sherman PM, 2009, AM J GASTROENTEROL, V104, P1278, DOI 10.1038/ajg.2009.129; Ghezzi M, 2011, RESP MED, V105, P972, DOI 10.1016/j.rmed.2011.01.016; El-Serag HB, 2014, GUT, V63, P871, DOI 10.1136/gutjnl-2012-304269; Jung HK, 2011, J NEUROGASTROENTEROL, V17, P14, DOI 10.5056/jnm.2011.17.1.14; Singh S, 2013, CLIN GASTROENTEROL H, V11, P1399, DOI 10.1016/j.cgh.2013.05.009; Nelson SP, 2000, ARCH PEDIAT ADOL MED, V154, P150; Kinoshita Y, 2011, J GASTROENTEROL, V46, P1092, DOI 10.1007/s00535-011-0429-3; Deal L, 2005, J PEDIATR GASTR NUTR, V41, P178, DOI 10.1097/01.mpg.0000172885.77795.0f; Chen JH, 2014, J GASTROEN HEPATOL, V29, P269, DOI 10.1111/jgh.12330; Chiu JY, 2014, PEDIATR NEONATOL, V55, P439, DOI 10.1016/j.pedneo.2014.01.004; Debley JS, 2006, PEDIATR PULM, V41, P475, DOI 10.1002/ppul.20399; Ercelep OB, 2014, DIS ESOPHAGUS, V27, P403, DOI 10.1111/j.1442-2050.2012.01402.x; Furuta K, 2009, THERAPEUTIC RES, V30, P1651; Furuta K, 2012, J GASTROENTEROL, V47, P144, DOI 10.1007/s00535-011-0476-9; Furuta Kenji, 2009, Nihon Shokakibyo Gakkai Zasshi, V106, P1478; Ho Wayne, 2008, Gastroenterol Hepatol (N Y), V4, P572; Inokuchi M, 2009, ANN HUM BIOL, V36, P139, DOI 10.1080/03014460802635213; Ishihara S, 2012, J GASTROENTEROL, V47, P1084, DOI 10.1007/s00535-012-0573-4; Kakuta E, 2011, INTERNAL MED, V50, P1517, DOI 10.2169/internalmedicine.50.5390; Kinoshita Y, 2012, J GASTROENTEROL, V47, P377, DOI 10.1007/s00535-011-0503-x; Kinoshita Y, 2011, INTERNAL MED, V50, P2269, DOI 10.2169/internalmedicine.50.5678; Kinoshita Y, 1997, GUT, V41, P452; Kleinman L, 2011, J PEDIATR GASTR NUTR, V52, P514, DOI 10.1097/MPG.0b013e318205970e; Lovell RM, 2012, AM J GASTROENTEROL, V107, P1793, DOI 10.1038/ajg.2012.336; Martigne L, 2012, EUR J PEDIATR, V171, P1767, DOI 10.1007/s00431-012-1807-4; Matsuura B, 2013, J GASTROEN HEPATOL, V28, P48, DOI 10.1111/jgh.12238; Miwa H, 2012, J GASTROENTEROL, V47, P862, DOI 10.1007/s00535-012-0625-9; Phatak UP, 2014, INT J OBESITY, V38, P1324, DOI 10.1038/ijo.2014.67; Sharma Praveen Kumar, 2011, Indian J Gastroenterol, V30, P128, DOI 10.1007/s12664-010-0065-5; Shiota S, 2013, EXPERT REV GASTROENT, V7, P35, DOI [10.1586/egh.12.67, 10.1586/EGH.12.67]; Suzuki H, 2013, UNITED EUR GASTROENT, V1, P175, DOI 10.1177/2050640613485238; Thrift AP, 2013, AM J GASTROENTEROL, V108, P915, DOI 10.1038/ajg.2013.72	50	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	JUL	2015	30	7					1140	1146		10.1111/jgh.12899		37	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CL0BP	WOS:000356603800001		
J	Toyoda, H; Kumada, T; Tada, T; Kiriyama, S; Tanikawa, M; Hisanaga, Y; Kanamori, A; Kitabatake, S; Ito, T				Toyoda, Hidenori; Kumada, Takashi; Tada, Toshifumi; Kiriyama, Seiki; Tanikawa, Makoto; Hisanaga, Yasuhiro; Kanamori, Akira; Kitabatake, Shusuke; Ito, Takanori			Risk factors of hepatocellular carcinoma development in non-cirrhotic patients with sustained virologic response for chronic hepatitis C virus infection	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Article						antiviral therapy; chronic hepatitis C; hepatocellular carcinoma; risk factors; sustained virologic response	SIMPLE NONINVASIVE INDEX; INTERFERON THERAPY; LONG-TERM; SIGNIFICANT FIBROSIS; LIVER-BIOPSY; HISTOLOGIC IMPROVEMENT; PEGYLATED INTERFERON; UNITED-STATES; GENOTYPE 1; FOLLOW-UP	Background and AimHepatocellular carcinoma (HCC) can develop in patients with chronic hepatitis C after they have achieved a sustained virologic response (SVR) to antiviral therapy, that is eradication of hepatitis C virus (HCV). Thus, surveillance for HCC remains necessary after SVR. We investigated factors that are predictive of HCC in HCV-infected patients who achieved SVR. MethodsThe incidence and risk factors for HCC were evaluated in 522 patients who achieved SVR with interferon-based antiviral therapy for HCV. Patients maintained regular follow-up every 6 months for HCC surveillance. The FIB-4 index and aspartate aminotransferase to platelet count ratio index were calculated based on laboratory data at the time that SVR was documented (SVR24). ResultsPatients continued follow-up visits for 1.0-22.9 years (median, 7.2 years) after SVR. HCC developed in 18 patients. The incidence of HCC was 1.2% at 5 years and 4.3% at 10 years. The use of peginterferon or ribavirin for treatment and a history of antiviral therapy prior to the course when SVR was achieved were not associated with the incidence of HCC after SVR. The presence of diabetes mellitus (risk ratio 2.08; P=0.0451) and FIB-4 index calculated at the time of SVR24 (risk ratio 1.73; P=0.0198) were associated with a higher likelihood of HCC after SVR by multivariate analysis. ConclusionsPatients with diabetes mellitus and patients with the elevation of FIB-4 index at SVR24 are at higher risk of HCC after SVR. Surveillance for HCC should be continued in this patient subpopulation.	[Toyoda, Hidenori; Kumada, Takashi; Tada, Toshifumi; Kiriyama, Seiki; Tanikawa, Makoto; Hisanaga, Yasuhiro; Kanamori, Akira; Kitabatake, Shusuke; Ito, Takanori] Ogaki Municipal Hosp, Dept Gastroenterol, Ogaki, Gifu 5038502, Japan	Toyoda, H (reprint author), Ogaki Municipal Hosp, Dept Gastroenterol, 4-86 Minaminokawa, Ogaki, Gifu 5038502, Japan.	hmtoyoda@spice.ocn.ne.jp					American Diabetes Association, 2010, DIABETES CARE S1, V33, pS11, DOI DOI 10.2337/DC10-S011; Iwasaki Y, 2004, LIVER INT, V24, P603, DOI 10.1111/j.1478-3231.2004.0956.x; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Vallet-Pichard A, 2007, HEPATOLOGY, V46, P32, DOI 10.1002/hep.21669; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Sebastiani G, 2006, J HEPATOL, V44, P686, DOI 10.1016/j.jhep.2006.01.007; Ikeda M, 2005, J GASTROENTEROL, V40, P148, DOI 10.1007/s00535-004-1519-2; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Marcellin P, 1997, ANN INTERN MED, V127, P875; Poynard T, 2003, LANCET, V362, P2095, DOI 10.1016/S0140-6736(03)15109-4; Pekow JR, 2007, CANCER, V109, P2490, DOI 10.1002/cncr.22701; Shiratori Y, 2000, ANN INTERN MED, V132, P517; Aleman S, 2013, CLIN INFECT DIS, V57, P230, DOI 10.1093/cid/cit234; Tokita H, 2005, J GASTROEN HEPATOL, V20, P752, DOI 10.1111/j.1400-1746.2005.03800.x; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep20933; Kasahara A, 1998, HEPATOLOGY, V27, P1394, DOI 10.1002/hep.510270529; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; Lok AS, 2012, NEW ENGL J MED, V366, P216, DOI 10.1056/NEJMoa1104430; El-Serag HB, 1999, NEW ENGL J MED, V340, P745, DOI 10.1056/NEJM199903113401001; Akuta N, 2012, HEPATOLOGY, V56, P2134, DOI 10.1002/hep.25949; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Hung CH, 2011, INT J CANCER, V128, P2344, DOI 10.1002/ijc.25585; Ogawa E, 2013, J HEPATOL, V58, P495, DOI 10.1016/j.jhep.2012.10.017; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Asahina Y, 2010, HEPATOLOGY, V52, P518, DOI 10.1002/hep.23691; Makiyama A, 2004, CANCER, V101, P1616, DOI 10.1002/cncr.20537; Imai Y, 1998, ANN INTERN MED, V129, P94; Singal AG, 2010, CLIN GASTROENTEROL H, V8, P280, DOI 10.1016/j.cgh.2009.11.018; Masuzaki R, 2009, HEPATOLOGY, V49, P1954, DOI 10.1002/hep.22870; Ikeda K, 1999, HEPATOLOGY, V29, P1124, DOI 10.1002/hep.510290439; van der Meer AJ, 2012, JAMA-J AM MED ASSOC, V308, P2584, DOI 10.1001/jama.2012.144878; El-Serag H, 2003, ANN INTERN MED, V139, P817; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Akuta N, 2007, INTERVIROLOGY, V50, P361, DOI 10.1159/000107707; Yoshida H, 1999, ANN INTERN MED, V131, P174; Fattovich G, 1997, GASTROENTEROLOGY, V112, P463, DOI 10.1053/gast.1997.v112.pm9024300; Kokudo N, 2009, J GASTROENTEROL, V44, P119, DOI 10.1007/s00535-008-2244-z; Bravo AA, 2001, NEW ENGL J MED, V344, P495, DOI 10.1056/NEJM200102153440706; Degasperi E, 2014, J HEPATOL, V60, pS418; Gane EJ, 2013, NEW ENGL J MED, V368, P34, DOI 10.1056/NEJMoa1208953; Gebo KA, 2002, HEPATOLOGY, V36, pS161, DOI 10.1053/jhep.2002.36989; Kumada T, 2013, J GASTROEN HEPATOL, V28, P357, DOI 10.1111/jgh.12057; Okanoue T, 2003, J GASTROEN HEPATOL, V18, P121, DOI 10.1046/j.1440-1746.2003.02954.x; Shiffman ML, 1997, HEPATOLOGY, V26, P780, DOI 10.1002/hep.510260335; The French METAVIR Cooperative Study Group, 1994, HEPATOLOGY, V20, P15, DOI DOI 10.1002/HEP.1840200104.PUBMED:8020885; Toyoda H, 2001, J GASTROEN HEPATOL, V16, P1131, DOI 10.1046/j.1440-1746.2001.02595.x; Toyoda H, 2014, HEPATOLOGY, V60, P762, DOI 10.1002/hep.27064; Toyoda H, 2000, J VIRAL HEPATITIS, V7, P414, DOI 10.1046/j.1365-2893.2000.00241.x; Van der Meer AJ, 2013, HEPATOLOGY, V58, p280A; Zeuzem S, 2013, NEW ENGL J MED, V369, P630, DOI 10.1056/NEJMoa1213557	50	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	JUL	2015	30	7					1183	1189		10.1111/jgh.12915		7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CL0BP	WOS:000356603800015		
J	Kanogawa, N; Ogasawara, S; Chiba, T; Saito, T; Motoyama, T; Suzuki, E; Ooka, Y; Tawada, A; Kanda, T; Mikami, S; Azemoto, R; Kaiho, T; Shinozaki, M; Ohtsuka, M; Miyazaki, M; Yokosuka, O				Kanogawa, Naoya; Ogasawara, Sadahisa; Chiba, Tetsuhiro; Saito, Tomoko; Motoyama, Tenyu; Suzuki, Eiichiro; Ooka, Yoshihiko; Tawada, Akinobu; Kanda, Tatsuo; Mikami, Shigeru; Azemoto, Ryosaku; Kaiho, Takashi; Shinozaki, Masami; Ohtsuka, Masayuki; Miyazaki, Masaru; Yokosuka, Osamu			Sustained virologic response achieved after curative treatment of hepatitis C virus-related hepatocellular carcinoma as an independent prognostic factor	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Article						hepatitis C virus; hepatocellular carcinoma; interferon; Milan criteria; sustained virologic response	INTERFERON THERAPY; INTRAHEPATIC RECURRENCE; RADIOFREQUENCY ABLATION; COMPLETE RESECTION; ALPHA-INTERFERON; TUMOR ABLATION; CHRONIC HCV; INFECTION; METAANALYSIS; JAPAN	Background and AimWhether an antiviral interferon (IFN)-based therapy (IBT) after curative treatment of hepatocellular carcinoma (HCC) improves the prognosis in patients with hepatitis C virus (HCV)-related HCC remains to be elucidated. MethodsA total of 178 patients within the Milan criteria underwent curative treatment for HCV-related HCC. Both the time to beyond the Milan criteria (TTBMC) and overall survival (OS) were compared between the sustained virologic response (SVR) (IFN with SVR, n=22), non-SVR (IFN without SVR, n=19), and non-IBT (control, n=82) groups using propensity score matching analysis. Prognostic factors to predict survival were also determined by the Cox proportional-hazards model. ResultsTTBMC in the IFN with SVR group was significantly longer than those in the control and IFN without SVR groups (P<0.001 and P=0.006, respectively), although no significant difference existed between the IFN without SVR and control groups. Similarly, OS of the IFN with SVR group was significantly longer than that of the control and IFN without SVR groups (P<0.001 and P=0.029, respectively), although no significant difference existed between the IFN without SVR and control groups. The Cox proportional-hazards model identified SVR as an independent prognostic factor in these patients. The IFN with SVR group showed a 0.096-fold decrease in mortality risk compared with the control group (95% confidence intervals=0.023-0.405; P=0.001). ConclusionElimination of HCV after curative treatment of patients with HCC within the Milan criteria inhibits recurrence and contributes to a preferential prognosis.	[Kanogawa, Naoya; Ogasawara, Sadahisa; Chiba, Tetsuhiro; Saito, Tomoko; Motoyama, Tenyu; Suzuki, Eiichiro; Ooka, Yoshihiko; Tawada, Akinobu; Kanda, Tatsuo; Yokosuka, Osamu] Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chiba 2608670, Japan; [Ohtsuka, Masayuki; Miyazaki, Masaru] Chiba Univ, Grad Sch Med, Dept Gen Surg, Chiba 2608670, Japan; [Mikami, Shigeru] Kikkoman Gen Hosp, Dept Gastroenterol, Noda, Chiba, Japan; [Azemoto, Ryosaku] Kimitsu Chuo Hosp, Dept Gastroenterol, Kisarazu, Japan; [Kaiho, Takashi] Kimitsu Chuo Hosp, Dept Surg, Kisarazu, Japan; [Shinozaki, Masami] Numazu City Hosp, Dept Gastroenterol, Numazu, Japan	Chiba, T (reprint author), Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	techiba@faculty.chiba-u.jp			MSD K.K. (Tokyo, Japan); Chugai Pharmaceutical Co., Ltd. (Tokyo, Japan); Mitsubishi Tanabe Pharma (Osaka, Japan); Corporation, Janssen Pharmaceutical K.K. (Tokyo, Japan); Bristol-Myers Squibb (Tokyo, Japan)	Professor Osamu Yokosuka received grant support from MSD K.K. (Tokyo, Japan), Chugai Pharmaceutical Co., Ltd. (Tokyo, Japan), Mitsubishi Tanabe Pharma (Osaka, Japan), Corporation, Janssen Pharmaceutical K.K. (Tokyo, Japan), and Bristol-Myers Squibb (Tokyo, Japan). The remaining authors disclose no conflicts.	Akamatsu M, 2004, EUR J GASTROEN HEPAT, V16, P459, DOI 10.1097/01.meg.0000108303.52416.8d; Kumada T, 1997, HEPATOLOGY, V25, P87, DOI 10.1002/hep.510250116; Hagihara H, 2011, INT J CLIN ONCOL, V16, P210, DOI 10.1007/s10147-010-0150-x; Mazzaferro V, 2006, HEPATOLOGY, V44, P1543, DOI 10.1002/hep.21415; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Shiratori Y, 2003, ANN INTERN MED, V138, P299; Kudo M, 2011, DIGEST DIS, V29, P339, DOI 10.1159/000327577; Omata M, 2010, HEPATOL INT, V4, P439, DOI 10.1007/s12072-010-9165-7; Zhang CH, 2009, INT J CANCER, V124, P2982, DOI 10.1002/ijc.24311; Singal AK, 2010, ALIMENT PHARM THER, V32, P851, DOI 10.1111/j.1365-2036.2010.04414.x; Poon RTP, 1999, ANN SURG, V229, P216, DOI 10.1097/00000658-199902000-00009; Shimada M, 1996, GASTROENTEROLOGY, V111, P720, DOI 10.1053/gast.1996.v111.pm8780578; Heim MH, 2013, NAT REV IMMUNOL, V13, P535, DOI 10.1038/nri3463; SHIRATORI Y, 1995, HEPATOLOGY, V22, P1027, DOI 10.1016/0270-9139(95)90605-3; Shiina S, 2012, AM J GASTROENTEROL, V107, P569, DOI 10.1038/ajg.2011.425; Hung CH, 2005, J GASTROEN HEPATOL, V20, P1553, DOI 10.1111/j.1440-1746.2005.03925.x; Ikeda K, 2000, HEPATOLOGY, V32, P228, DOI 10.1053/jhep.2000.9409; Manns M, 2014, LANCET, V384, P414, DOI 10.1016/S0140-6736(14)60538-9; Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355; Raimondi S, 2009, J HEPATOL, V50, P1142, DOI 10.1016/j.jhep.2009.01.019; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Kiyosawa K, 2004, GASTROENTEROLOGY, V127, pS17, DOI 10.1053/j.gastro.2004.09.012; Lee MH, 2010, J CLIN ONCOL, V28, P4587, DOI 10.1200/JCO.2010.29.1500; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Nishiguchi S, 2005, INTERVIROLOGY, V48, P71, DOI 10.1159/000082098; Minagawa M, 2003, ANN SURG, V238, P703, DOI 10.1097/01.sla.0000094549.11754.e6; Llovet JM, 2012, J HEPATOL, V56, P908; Feld JJ, 2014, NEW ENGL J MED, V370, P1594, DOI 10.1056/NEJMoa1315722; Jeong SC, 2007, WORLD J GASTROENTERO, V13, P5343; Jiang SJ, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-240; Kudo Masatoshi, 2008, Oncology, V75 Suppl 1, P30, DOI 10.1159/000173422; Kudo M, 2007, ONCOLOGY-BASEL, V72, P132, DOI 10.1159/000111719; Kumada H, 2010, HEPATOL RES, V40, P8, DOI 10.1111/j.1872-034X.2009.00634.x; Lee SS, 2002, J HEPATOL, V37, P500, DOI 10.1016/S0168-8278(02)00211-8; Martinot-Peignoux M, 1998, J HEPATOL, V29, P214, DOI 10.1016/S0168-8278(98)80006-8; Miyake Y, 2010, J VIRAL HEPATITIS, V17, P287, DOI 10.1111/j.1365-2893.2009.01181.x; NAGASUE N, 1993, GASTROENTEROLOGY, V105, P488; Shiratori Y, 1997, GASTROENTEROLOGY, V113, P558, DOI 10.1053/gast.1997.v113.pm9247476; Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218; Suou T, 2001, HEPATOL RES, V20, P301, DOI 10.1016/S1386-6346(00)00148-0; Tanimoto Y, 2012, ANN SURG ONCOL, V19, P418, DOI 10.1245/s10434-011-1866-1; Thomas DL, 2010, LANCET, V376, P1441, DOI 10.1016/S0140-6736(10)61497-3; Zhuang LP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061361	43	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	JUL	2015	30	7					1197	1204		10.1111/jgh.12925		8	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CL0BP	WOS:000356603800017		
J	Enkhbold, C; Morine, Y; Utsunomiya, T; Imura, S; Ikemoto, T; Arakawa, Y; Saito, Y; Yamada, S; Ishikawa, D; Shimada, M				Enkhbold, Chinbold; Morine, Yuji; Utsunomiya, Tohru; Imura, Satoru; Ikemoto, Tetsuya; Arakawa, Yusuke; Saito, Yu; Yamada, Shinichiro; Ishikawa, Daichi; Shimada, Mitsuo			Dysfunction of liver regeneration in aged liver after partial hepatectomy	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Article						aging; autophagy; ER stress; liver regeneration; partial hepatectomy	ENDOPLASMIC-RETICULUM STRESS; CELL-DEATH; AUTOPHAGY; APOPTOSIS; PROLIFERATION; SENESCENCE; EXPRESSION; GROWTH; CANCER; MICE	Background and AimA remarkable feature of the liver is its regenerative capacity following partial hepatectomy. However, the regenerative capacity of many organs and tissues loses its natural ability to divide with aging. In this study, we investigated the association of aging with endoplasmic reticulum stress, the cell cycle, autophagy, and apoptosis-related genes during liver regeneration after hepatectomy. MethodsBalb/c 4-week and 40-week-old male mice were subjected to 70% hepatectomy. Animals were sacrificed at 24, 48, and 72h after hepatectomy. Immunohistochemical stainings for proliferating cell nuclear antigen, LC3, Atg5, and caspase-3 were used to quantify protein expression. Real-time reverse transcription-polymerase chain reaction was used to detect p16, CHOP, LC3, Atg5, hepatocyte growth factor, cMet, cyclin D1, cyclin A2, and caspase-3 expression. ResultsAfter hepatectomy, old group showed a lower survival rate and significantly lower expression of hepatocyte growth factor, cMet, cyclin D1, cyclin A2, proliferating cell nuclear antigen labeling index, and SMP30 compared with young group. The liver weight/body weight ratio was significantly lower at 48h and 72h after hepatectomy and was accompanied by markedly elevated levels of the liver cell injury markers, LC3 and caspase-3. Immunohistochemical results showed that LC3, Atg5, and caspase-3 protein expression were higher in old group than in young group. ConclusionThese results revealed that impaired liver regeneration was due to aging, which was expressed by decreased cell cycle and increased autophagy and apoptosis. Therefore, understanding the molecular basis for aged liver regeneration might provide a new therapeutic option for old patients.	[Enkhbold, Chinbold; Morine, Yuji; Utsunomiya, Tohru; Imura, Satoru; Ikemoto, Tetsuya; Arakawa, Yusuke; Saito, Yu; Yamada, Shinichiro; Ishikawa, Daichi; Shimada, Mitsuo] Univ Tokushima, Grad Sch, Dept Surg, Inst Hlth Biosci, Tokushima 7708503, Japan	Morine, Y (reprint author), Univ Tokushima, Grad Sch, Dept Surg, Inst Hlth Biosci, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan.	ymorine@tokushima-u.ac.jp			Japan Society for the Promotion of Science [21462091, 23390324]	This work was supported in part by Grants-in-Aid for Scientific Research (C) (21462091) and Scientific Research (B) (23390324) from the Japan Society for the Promotion of Science.	Ito M, 2009, ARCH TOXICOL, V83, P151, DOI 10.1007/s00204-008-0341-7; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Bhogal RH, 2012, AUTOPHAGY, V8, P545, DOI 10.4161/auto.19012; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Rayess H, 2012, INT J CANCER, V130, P1715, DOI 10.1002/ijc.27316; Lin JH, 2008, ANNU REV PATHOL-MECH, V3, P399, DOI 10.1146/annurev.patho1.3.121806.151434; Cuervo AM, 2005, AUTOPHAGY, V1, P131; Saelens X, 2004, ONCOGENE, V23, P2861, DOI 10.1038/sj.onc.1207523; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JC126390; Sharpless NE, 2004, EXP GERONTOL, V39, P1751, DOI 10.1016/j.exger.2004.06.025; Enari M, 1998, NATURE, V391, P43; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; ZARNEGAR R, 1991, BIOCHEM BIOPH RES CO, V177, P559, DOI 10.1016/0006-291X(91)92020-K; Galehdar Z, 2010, J NEUROSCI, V30, P16938, DOI 10.1523/JNEUROSCI.1598-10.2010; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Xiong YJ, 2010, HEPATOLOGY, V51, P836, DOI 10.1002/hep.23380; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Capparelli C, 2012, CELL CYCLE, V11, P3599, DOI 10.4161/cc.21884; Passegue E, 2000, EMBO J, V19, P2969, DOI 10.1093/emboj/19.12.2969; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987; Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172; Suzuki A, 2012, J SURG RES, V173, P267, DOI 10.1016/j.jss.2010.10.012; Weber A, 2010, HEPATOLOGY, V51, P1226, DOI 10.1002/hep.23479; Chandra D, 2006, CELL, V125, P1333, DOI 10.1016/j.cell.2006.05.026; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI DOI 10.1002/HEP.20969; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Nejak-Bowen K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059836; Patijn GA, 1998, HEPATOLOGY, V28, P707, DOI 10.1002/hep.510280317; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Sanchez-Hidalgo JM, 2012, J SURG RES, V175, P1; Zhang JL, 2013, J SURG RES, V183, P929, DOI 10.1016/j.jss.2013.02.043	35	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	JUL	2015	30	7					1217	1224		10.1111/jgh.12930		8	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CL0BP	WOS:000356603800020		
J	Kaibori, M; Ishizaki, M; Iida, H; Matsui, K; Sakaguchi, T; Inoue, K; Mizuta, T; Ide, Y; Iwasaka, J; Kimura, Y; Hayashi, F; Habu, D; Kon, M				Kaibori, Masaki; Ishizaki, Morihiko; Iida, Hiroya; Matsui, Kosuke; Sakaguchi, Tatsuma; Inoue, Kentaro; Mizuta, Toshihiko; Ide, Yasushi; Iwasaka, Junji; Kimura, Yutaka; Hayashi, Fumikazu; Habu, Daiki; Kon, Masanori			Effect of Intramuscular Adipose Tissue Content on Prognosis in Patients Undergoing Hepatocellular Carcinoma Resection	JOURNAL OF GASTROINTESTINAL SURGERY			English	Article						Hepatectomy; Liver cancer; Predictors; Skeletal muscle fat accumulation; Intramuscular adipose tissue content	DIABETES-MELLITUS; SKELETAL-MUSCLE; INSULIN-RESISTANCE; OXIDATIVE STRESS; LIVER-DISEASE; CANCER; RECURRENCE; HEPATITIS; OBESITY; RISK	It has recently been reported that myosteatosis, the infiltration of fat in skeletal muscle, is associated with insulin resistance and type 2 diabetes mellitus. The present study investigated the effect of skeletal muscle fat accumulation on short- and long-term outcomes following partial hepatectomy for hepatocellular carcinoma (HCC) and aimed to identify prognostic factors. The records of 141 HCC patients who underwent hepatectomy were retrospectively reviewed. Clinicopathological and outcome data from 71 patients with high intramuscular adipose tissue content (IMAC) were compared with those from 70 patients with low IMAC. The 5-year overall survival rate was 46 % among patients with high IMAC and 75 % among those with low IMAC. The 5-year disease-free survival rates in these groups were 18 and 38 %, respectively. Multivariate analysis revealed that high IMAC was predictive of an unfavorable prognosis. High IMAC was significantly correlated with liver dysfunction, higher intraoperative blood loss, the need for blood transfusion, and comorbid diabetes mellitus. Greater fat accumulation in skeletal muscle was predictive of worse overall survival after partial hepatectomy in patients with HCC, even with adjustment for other known predictors. The identification of patients with greater skeletal muscle fat accumulation before hepatectomy could permit early preventive strategies to maintain muscle quality and thus improve prognosis and patient selection for hepatectomy.	[Kaibori, Masaki; Ishizaki, Morihiko; Iida, Hiroya; Matsui, Kosuke; Sakaguchi, Tatsuma; Inoue, Kentaro; Kon, Masanori] Kansai Med Univ, Hirakata Hosp, Dept Surg, Hirakata, Osaka 5731191, Japan; [Mizuta, Toshihiko; Ide, Yasushi] Saga Univ, Saga Med Sch, Dept Internal Med, Saga 8498501, Japan; [Iwasaka, Junji] Kansai Med Univ, Dept Internal Med 2, Hirakata, Osaka 5731191, Japan; [Kimura, Yutaka] Kansai Med Univ, Hirakata Hosp, Hlth Sci Ctr, Hirakata, Osaka 5731191, Japan; [Hayashi, Fumikazu; Habu, Daiki] Osaka City Univ, Grad Sch Human Life Sci, Dept Nutr Med, Osaka 5458585, Japan	Kaibori, M (reprint author), Kansai Med Univ, Hirakata Hosp, Dept Surg, 2-5-1 Shinmachi, Hirakata, Osaka 5731191, Japan.	kaibori@hirakata.kmu.ac.jp					Valgimigli M, 2002, FREE RADICAL RES, V36, P939, DOI 10.1080/107156021000006653; TaylorRobinson SD, 1997, LANCET, V350, P1142, DOI 10.1016/S0140-6736(05)63789-0; Montano-Loza AJ, 2012, CLIN GASTROENTEROL H, V10, P166, DOI 10.1016/j.cgh.2011.08.028; Englesbe MJ, 2010, J AM COLL SURGEONS, V211, P271, DOI 10.1016/j.jamcollsurg.2010.03.039; Miljkovic I, 2010, CURR OPIN CLIN NUTR, V13, P260, DOI 10.1097/MCO.0b013e328337d826; Kaibori M, 2013, AM J SURG, V206, P202, DOI 10.1016/j.amjsurg.2012.07.035; Avramoglu RK, 2006, CLIN CHIM ACTA, V368, P1, DOI 10.1016/j.cca.2005.12.026; Goodpaster BH, 1997, DIABETES, V46, P1579, DOI 10.2337/diabetes.46.10.1579; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI200421625]; Huo TI, 2003, AM J GASTROENTEROL, V98, P2293, DOI 10.1016/S0002-9270(03)00694-4; Yang YX, 2004, GASTROENTEROLOGY, V127, P1044, DOI 10.1053/j.gastro.2004.07.011; Tan BHL, 2009, CLIN CANCER RES, V15, P6973, DOI 10.1158/1078-0432.CCR-09-1525; Hickman IJ, 2004, GUT, V53, P413, DOI 10.1136/gut.2003.027581; van Vledder MG, 2012, BRIT J SURG, V99, P550, DOI 10.1002/bjs.7823; Lonardo A, 2004, GASTROENTEROLOGY, V126, P586, DOI 10.1053/j.gastro.2003.11.020; Katz SC, 2009, ANN SURG, V249, P617, DOI 10.1097/SLA.0b013e31819ed22f; Harimoto N, 2013, BRIT J SURG, V100, P1523, DOI 10.1002/bjs.9258; KELLEY DE, 1991, AM J CLIN NUTR, V54, P509; Tran TT, 1996, CANCER EPIDEM BIOMAR, V5, P1013; Kawamura Y, 2008, J GASTROEN HEPATOL, V23, P1739, DOI 10.1111/j.1440-1746.2008.05436.x; Kitajima Y, 2013, J GASTROEN HEPATOL, V28, P1507, DOI 10.1111/jgh.12227; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Pan DA, 1997, DIABETES, V46, P983, DOI 10.2337/diabetes.46.6.983; Giovannucci E, 2003, HORM METAB RES, V35, P694; Prado CMM, 2008, LANCET ONCOL, V9, P629, DOI [10.1016/S1470-2045(08)70153-0, 10.1016/51470-2045(08)70153-0]; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Bruix J, 2009, LANCET, V373, P614, DOI 10.1016/S0140-6736(09)60381-0; Sabel MS, 2011, ANN SURG ONCOL, V18, P3579, DOI 10.1245/s10434-011-1976-9; Bosch X, 1999, SEMIN LIVER DIS, V19, P271; Chuang TY, 2005, BRIT J DERMATOL, V153, P552, DOI 10.1111/j.1365-2133.2005.06738.x; Couinaud C., 1957, LE FOIE ETUDES ANATO; Ei-Serag H., 1999, NEW ENGL J MED, V340, P745; Facciorusso Antonio, 2013, Curr Diabetes Rev, V9, P382; Kaibori M, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-119; Kawaguchi Takumi, 2011, World J Hepatol, V3, P99, DOI 10.4254/wjh.v3.i5.99; Kitajima Y, 2010, J GASTROENTEROL, V45, P218, DOI 10.1007/s00535-009-0147-2; Komura T, 2007, AM J GASTROENTEROL, V102, P1939, DOI 10.1111/j.1572-0241.2007.01354.x; Marchesini G, 2005, ANN MED, V37, P333, DOI 10.1080/078590510011445; MULLER MJ, 1994, EUR J CLIN CHEM CLIN, V32, P749; Petersen KF, 2006, AM J MED, V119, p10S, DOI 10.1016/j.amjmed.2006.01.009; Phillips DIW, 1996, METABOLISM, V45, P947, DOI 10.1016/S0026-0495(96)90260-7; Schiel R, 2005, EUR J MED RES, V10, P339; Sobin LH, 1997, TNM CLASSIFICATION M; Strasberg SM, 2000, HPB, V2, P333, DOI DOI 10.1080/136518202760378489; Swerdlow AJ, 2005, BRIT J CANCER, V92, P2070, DOI 10.1038/sj.bjc.6602611; Timmers S, 2008, PHYSIOL BEHAV, V94, P242, DOI 10.1016/j.physbeh.2007.12.002; Tung-Ping PR, 2000, ANN SURG, V232, P10, DOI DOI 10.1097/00000658-200007000-00003]	47	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1091-255X	1873-4626		J GASTROINTEST SURG	J. Gastrointest. Surg.	JUL	2015	19	7					1315	1323		10.1007/s11605-015-2838-8		9	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CK8AH	WOS:000356458900014		
J	Someya, S; Nagao, M; Shibata, C; Tanaka, N; Sasaki, H; Kikuchi, D; Miyachi, T; Naitoh, T; Unno, M				Someya, Soutoku; Nagao, Munenori; Shibata, Chikashi; Tanaka, Naoki; Sasaki, Hiroyuki; Kikuchi, Daisuke; Miyachi, Tomohiro; Naitoh, Takeshi; Unno, Michiaki			Intracolonic Administration of the TRPA1 Agonist Allyl Isothiocyanate Stimulates Colonic Motility and Defecation in Conscious Dogs	JOURNAL OF GASTROINTESTINAL SURGERY			English	Article						Allyl isothiocyanate; Giant migrating contractions; TRPA1	GIANT MIGRATING CONTRACTIONS; CHANNELS; RECEPTOR; PAIN; NERVES	The aim of the present study was to investigate the effects of the intracolonic transient receptor potential (TRP) A1 agonist allyl isothiocyanate (AITC) on colonic motility and defecation. The effects of AITC administered into the proximal colonic lumen on colonic motility and defecation were studied in neurally intact dogs equipped with strain-gauge force transducers on the colon, with or without various antagonists. Effects of intracolonic AITC were also studied in dogs with either transection/re-anastomosis (T/R) between the proximal and middle colon and complete extrinsic denervation of an ileocolonic segment. AITC increased colonic motility and induced giant migrating contractions (GMCs) with defecations in 75 % of experiments in neurally intact dogs. These effects were inhibited by atropine, hexamethonium, ondansetron, and HC-030031 but unaltered by capsazepine. In dogs with T/R, the increase in colonic motility was inhibited in the middle-distal colon. In dogs with extrinsic denervation, the increase in colonic motility in the distal colon was decreased. Intracolonic AITC stimulates colonic motility and defecation via cholinergic, serotonergic, and TRPA1 pathways. Continuity of colonic enteric neurons plays an essential role in the intracolonic AITC-induced colonic motor response, while extrinsic nerves are important in occurrence and propagation of GMCs.	[Someya, Soutoku; Nagao, Munenori; Shibata, Chikashi; Tanaka, Naoki; Sasaki, Hiroyuki; Kikuchi, Daisuke; Miyachi, Tomohiro; Naitoh, Takeshi; Unno, Michiaki] Tohoku Univ, Grad Sch Med, Dept Surg, Aoba Ku, Sendai, Miyagi 9808574, Japan	Nagao, M (reprint author), Tohoku Univ, Grad Sch Med, Dept Surg, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	mnagao@surg1.med.tohoku.ac.jp	Unno, Michiaki/A-8633-2010	Unno, Michiaki/0000-0002-2145-6416	Japan Society for the Promotion of Science [23591953]	This work was supported by Grant-In-Aid 23591953 from the Japan Society for the Promotion of Science.	Uchida K, 2011, ENDOCR J, V58, P1021; Cortright DN, 2007, BBA-MOL BASIS DIS, V1772, P978, DOI 10.1016/j.bbadis.2007.03.003; Tominaga M, 2004, J NEUROBIOL, V61, P3, DOI 10.1002/neu.20079; Caterina MJ, 1997, NATURE, V389, P816; Shigetomi E, 2012, NAT NEUROSCI, V15, P70, DOI 10.1038/nn.3000; GALLIGAN JJ, 1989, GASTROENTEROLOGY, V97, P1135; Doihara H, 2009, EUR J PHARMACOL, V617, P124, DOI 10.1016/j.ejphar.2009.06.038; Hayashi K, 2010, SURGERY, V147, P789, DOI 10.1016/j.surg.2009.11.019; KARAUS M, 1987, GASTROENTEROLOGY, V92, P925; Kikuchi D, 2014, SURG TODAY, V44, P152, DOI 10.1007/s00595-013-0493-9; Kikuchi D, 2013, TOHOKU J EXP MED, V230, P197, DOI 10.1620/tjem.230.197; MATSUSHIMA Y, 1989, Japanese Journal of Smooth Muscle Research, V25, P137; Nagao M, 2007, DIGEST DIS SCI, V52, P2204, DOI 10.1007/s10620-006-9154-9; Penuelas A, 2007, EUR J PHARMACOL, V576, P143, DOI 10.1016/j.ejphar.2007.08.015; SARNA SK, 1984, AM J PHYSIOL, V246, pG355; SARR MG, 1989, J SURG RES, V47, P266, DOI 10.1016/0022-4804(89)90119-4; SHIBATA C, 1993, J GASTROINTEST MOTIL, V5, P9; Shibata C, 1999, DIGEST DIS SCI, V44, P1083, DOI 10.1023/A:1026651518373; SHIBATA C, 1991, GASTROENTEROLOGY, V101, P1571; Tabe Y, 2010, INT J COLORECTAL DIS, V25, P53, DOI 10.1007/s00384-009-0799-7; Taylor-Clark TE, 2010, J PHYSIOL-LONDON, V588, P423, DOI 10.1113/jphysiol.2009.183301; Yongwoo J, 2012, ARCH PARM RES, V35, P1823	22	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1091-255X	1873-4626		J GASTROINTEST SURG	J. Gastrointest. Surg.	JUL	2015	19	7					1342	1349		10.1007/s11605-015-2813-4		8	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CK8AH	WOS:000356458900017		
J	Sarli, BV; Kawakatsu, Y				Sarli, Bruno Victorino; Kawakatsu, Yasuhiro			Orbit Transfer Optimization for Asteroid Missions Using Weighted Cost Function	JOURNAL OF GUIDANCE CONTROL AND DYNAMICS			English	Article							TRAJECTORIES	This paper presents a method of trajectory optimization based on the well-known primer vector theory, which is modified to accommodate weights in the cost function. This change arises from the need of a fast and accurate analysis obtained with an indirect method that takes into account the velocity increment used for departure from the planet and, particularly for flyby missions, the disregard of the last rendezvous impulse. A detailed derivation of the weighted cost function and its gradient is presented, followed by a discussion on the values of the weights specifically for flyby and rendezvous missions. To test the optimization method, realistic test cases are selected and their results compared against a trajectory using the solution of the Lambert problem and optimization by a nonlinear programming solver. The proposed method showed a fast design of a trajectory with a midcourse impulse, which costs less than the trajectories calculated by the other two methods.	[Sarli, Bruno Victorino] Grad Univ Adv Studies, Dept Space & Astronaut Sci, Sagamihara, Kanagawa 2525210, Japan; [Kawakatsu, Yasuhiro] Japan Aerosp Explorat Agcy, Dept Space Flight Syst, Sagamihara, Kanagawa 2525210, Japan	Sarli, BV (reprint author), Grad Univ Adv Studies, Dept Space & Astronaut Sci, Sagamihara, Kanagawa 2525210, Japan.	sarli@ac.jaxa.jp; kawakatsu.yasuhiro@jaxa.jp					Byrd RH, 1999, SIAM J OPTIMIZ, V9, P877, DOI 10.1137/S1052623497325107; Byrd RH, 2000, MATH PROGRAM, V89, P149, DOI 10.1007/PL00011391; Battin R., 1999, AIAA ED SERIES, P295; Blume WH, 2005, SPACE SCI REV, V117, P23, DOI 10.1007/s11214-005-3386-4; Glandorf D. R., 1968, AIAA J, V7, P363, DOI 10.2514/3.5109AIAJAH0001-1452; JEZEWSKI DJ, 1968, AIAA J, V6, P2160, DOI 10.2514/3.4949; JEZEWSKI DJ, 1971, AIAA J, V9, P760; Kirk D. E., 2004, OPTIMAL CONTROL THEO, P227; Lawden D. F., 1963, OPTIMAL TRAJECTORIES, p[5, 59]; LION PM, 1968, AIAA J, V6, P127; Vallado D. A., 2007, FUNDAMENTAL ASTRODYN, P448	11	0	0	AMER INST AERONAUTICS  ASTRONAUTICS	RESTON	1801 ALEXANDER BELL DRIVE, STE 500, RESTON, VA 22091-4344 USA	0731-5090	1533-3884		J GUID CONTROL DYNAM	J. Guid. Control Dyn.	JUL	2015	38	7					1241	1250		10.2514/1.G000359		10	Engineering, Aerospace; Instruments & Instrumentation	Engineering; Instruments & Instrumentation	CK4HB	WOS:000356183800007		
J	Fujiwara, N; Nakagawa, H; Kudo, Y; Tateishi, R; Taguri, M; Watadani, T; Nakagomi, R; Kondo, M; Nakatsuka, T; Minami, T; Sato, M; Uchino, K; Enooku, K; Kondo, Y; Asaoka, Y; Tanaka, Y; Ohtomo, K; Shiina, S; Koike, K				Fujiwara, Naoto; Nakagawa, Hayato; Kudo, Yotaro; Tateishi, Ryosuke; Taguri, Masataka; Watadani, Takeyuki; Nakagomi, Ryo; Kondo, Mayuko; Nakatsuka, Takuma; Minami, Tatsuya; Sato, Masaya; Uchino, Koji; Enooku, Kenichiro; Kondo, Yuji; Asaoka, Yoshinari; Tanaka, Yasuo; Ohtomo, Kuni; Shiina, Shuichiro; Koike, Kazuhiko			Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma	JOURNAL OF HEPATOLOGY			English	Article						Hepatocellular carcinoma; Body composition; Prognosis; Body mass index	SKELETAL-MUSCLE DEPLETION; HEPATITIS-C PATIENTS; BODY-MASS INDEX; COMPUTED-TOMOGRAPHY; INSULIN-RESISTANCE; PROGNOSTIC-FACTOR; RISK-FACTOR; OBESITY; MORTALITY; CANCER	Background & Aims: Obesity defined by body mass index (BMI) significantly increases the risk of hepatocellular carcinoma (HCC). In contrast, not only obesity but also underweight is associated with poor prognosis in patients with HCC. Differences in body composition rather than BMI were suggested to be true determinants of prognosis. However, this hypothesis has not been demonstrated conclusively. Methods: We measured skeletal muscle index (SMI), mean muscle attenuation (MA), visceral adipose tissue index, subcutaneous adipose tissue index, and visceral to subcutaneous adipose tissue area ratios (VSR) via computed tomography in a large-scale retrospective cohort of 1257 patients with different stages of HCC, and comprehensively analyzed the impact of body composition on the prognoses. Results: Among five body composition components, low SMI (called sarcopenia), low MA (called intramuscular fat [IMF] deposition), and high VSR (called visceral adiposity) were significantly associated with mortality, independently of cancer stage or Child-Pugh class. A multivariate analysis revealed that sarcopenia (hazard ratio [HR], 1.52; 95% confidence interval [CI], 1.18-1.96; p = 0.001), IMF deposition (HR, 1.34; 95% CI, 1.05-1.71; p = 0.020), and visceral adiposity (HR, 1.35; 95% CI, 1.09-1.66; p = 0.005) but not BMI were significant predictors of survival. The prevalence of poor prognostic body composition components was significantly higher in underweight and obese patients than in normal weight patients. Conclusions: Sarcopenia, IMF deposition, and visceral adiposity independently predict mortality in patients with HCC. Body composition rather than BMI is a major determinant of prognosis in patients with HCC. (C) 2015 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.	[Fujiwara, Naoto; Nakagawa, Hayato; Kudo, Yotaro; Tateishi, Ryosuke; Nakagomi, Ryo; Kondo, Mayuko; Nakatsuka, Takuma; Minami, Tatsuya; Sato, Masaya; Uchino, Koji; Enooku, Kenichiro; Kondo, Yuji; Asaoka, Yoshinari; Tanaka, Yasuo; Koike, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo 1138655, Japan; [Taguri, Masataka] Yokohama City Univ, Grad Sch Med, Dept Biostat & Epidemiol, Yokohama, Kanagawa 232, Japan; [Watadani, Takeyuki; Ohtomo, Kuni] Univ Tokyo, Grad Sch Med, Dept Radiol, Tokyo 1138655, Japan; [Shiina, Shuichiro] Juntendo Univ, Dept Gastroenterol, Tokyo, Japan	Tateishi, R (reprint author), Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	tateishi-tky@umin.ac.jp	Nakagawa, Hayato/I-2837-2012		Health Sciences Research Grants of The Ministry of Health, Labour and Welfare of Japan (Research on Hepatitis); Japanese Society of Gastroenterology; Tokyo Society of Medical Sciences; Kanae Foundation for the Promotion of Medical Science	This work was supported by Health Sciences Research Grants of The Ministry of Health, Labour and Welfare of Japan (Research on Hepatitis), grants from the Japanese Society of Gastroenterology, The Tokyo Society of Medical Sciences, and Kanae Foundation for the Promotion of Medical Science.	Grundy SM, 2004, ARTERIOSCL THROM VAS, V24, pE13, DOI 10.1161/01.ATV.0000111245.75752.C6; Nielsen S, 2004, J CLIN INVEST, V113, P1582, DOI 10.1172/JCI200421047; Hayashi F, 2013, HEPATOL RES, V43, P1264, DOI 10.1111/hepr.12085; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Ho DE, 2007, POLIT ANAL, V15, P199, DOI 10.1093/pan/mpl013; Zoico E, 2010, J GERONTOL A-BIOL, V65, P295, DOI 10.1093/gerona/glp155; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI [10.1016/S1470-2045(10)70218-7, 10.1016/51470-2045(10)70218-7]; Romero-Corral A, 2006, LANCET, V368, P666, DOI 10.1016/S0140-6736(06)69251-9; Ahima RS, 2013, SCIENCE, V341, P856, DOI 10.1126/science.1241244; Arano T, 2011, INT J CANCER, V129, P2226, DOI 10.1002/ijc.25861; Mitsiopoulos N, 1998, J APPL PHYSIOL, V85, P115; Gilsanz V, 2010, J CLIN ENDOCR METAB, V95, P1595, DOI 10.1210/jc.2009-2309; Ohki T, 2009, GUT, V58, P839, DOI 10.1136/gut.2008.164053; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Torzilli G, 1999, HEPATOLOGY, V30, P889, DOI 10.1002/hep.510300411; Cepeda MS, 2003, AM J EPIDEMIOL, V158, P280, DOI 10.1093/aje/kwg115; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; Hubbard JM, 2014, J CLIN ONCOL, V32, P2611, DOI 10.1200/JCO.2014.55.4261; Sergi G, 2005, J GERONTOL A-BIOL, V60, P866; Martin L, 2013, J CLIN ONCOL, V31, P1539, DOI 10.1200/JCO.2012.45.2722; Goodpaster BH, 2001, J APPL PHYSIOL, V90, P2157; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Kelley DE, 2002, ANNU REV NUTR, V22, P325, DOI 10.1146/annurev.nutr.22.010402.102912; Tran TT, 2008, CELL METAB, V7, P410, DOI 10.1016/j.cmet.2008.04.004; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Nakagawa H, 2012, WORLD J GASTROENTERO, V18, P4071, DOI 10.3748/wjg.v18.i31.4071; Carnethon MR, 2012, JAMA-J AM MED ASSOC, V308, P581, DOI 10.1001/jama.2012.9282; Fedirko V, 2014, HEPATOLOGY, V60, P1222, DOI 10.1002/hep.27079; Fujishima T, 2005, J GASTROENTEROL, V40, P266, DOI 10.1007/s00535-004-1533-4; Hakimi AA, 2013, JNCI-J NATL CANCER I, V105, P1862, DOI 10.1093/jnci/djt310; Iritani S, 2015, J GASTROENTEROL, V50, P323, DOI 10.1007/s00535-014-0964-9; Itoh S, 2014, ANN SURG ONCOL, V21, P3063, DOI 10.1245/s10434-014-3686-6; LAUSEN B, 1992, BIOMETRICS, V48, P73, DOI 10.2307/2532740; Meza-Junco J, 2013, J CLIN GASTROENTEROL, V47, P861, DOI 10.1097/MCG.0b013e318293a825; Nakagawa H, 2015, J GASTROEN HEPATOL, V30, P379, DOI 10.1111/jgh.12719; Oda E, 2006, CIRC J, V70, P150, DOI 10.1253/circj.70.150; Ohki T, 2008, CLIN GASTROENTEROL H, V6, P459, DOI [10.1016/j.cgh.2008.02.012, 10.1016/j.cgh.2008.02.0.12]; Tateishi R, 2015, J GASTROENTEROL, V50, P350, DOI 10.1007/s00535-014-0973-8; Teratani T, 2004, LIVER INT, V24, P619, DOI 10.1111/j.1478-3231.2004.0959.x	39	5	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-8278	1600-0641		J HEPATOL	J. Hepatol.	JUL	2015	63	1					131	140		10.1016/j.jhep.2015.02.031		10	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CK6CC	WOS:000356314400018		
J	Isaji, T; Abe, M; Amaya, T; Hirao, T				Isaji, Tadayuki; Abe, Masashi; Amaya, Toru; Hirao, Toshikazu			Hydrogen Peroxide Generation Using Polyaniline/Transition Metal Nanohybrid Electrodes	JOURNAL OF INORGANIC AND ORGANOMETALLIC POLYMERS AND MATERIALS			English	Article						Polyaniline; Transition metal; Nanohybrid; Hydrogen peroxide	SULFONIC ACID)/GOLD NANOPARTICLES; CONJUGATED COMPLEX-SYSTEMS; OXYGEN REDUCTION; AQUEOUS-MEDIA; CATALYTIC APPLICATION; GOLD NANOPARTICLES; SUPEROXIDE ION; REDOX; OXIDATION; POLYANILINES	The present study summarizes the preparation of p-toluenesulfonic acid (p-TsOH) doped PANI/M (M = Pt, Pd, Ag, and Ni) nanohybrid electrodes and the activity for hydrogen peroxide generation using the electrodes. The activity depended on the kinds of the metals. The improvement of durability was suggested in the case of PANI/Ag and PANI/Ni nanohybrids as compared to that of PANI. The UV-Vis absorption spectra for the electrode films gave the information of the redox behavior of PANI before and after the reactions. The obtained results are considered to be valuable for the sterilization use.	[Isaji, Tadayuki; Amaya, Toru; Hirao, Toshikazu] Osaka Univ, Grad Sch Engn, Dept Appl Chem, Suita, Osaka 5650871, Japan; [Isaji, Tadayuki; Abe, Masashi] Nissan Chem Ind Co Ltd, Sodegaura, Chiba 111, Japan	Hirao, T (reprint author), Osaka Univ, Grad Sch Engn, Dept Appl Chem, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	hirao@chem.eng.osaka-u.ac.jp					Amaya T, 2011, SYNLETT, P435, DOI 10.1055/s-0030-1259541; Amaya T, 2012, HETEROCYCLES, V86, P927, DOI 10.3987/COM-12-S(N)71; Amaya T, 2008, MACROMOL SYMP, V270, P88, DOI 10.1002/masy.200851011; Zhang J, 2014, J MATER CHEM A, V2, P1242, DOI 10.1039/c3ta14065b; Nakano H, 2004, ELECTROCHIM ACTA, V50, P749, DOI 10.1016/j.electacta.2004.03.060; Hashimoto K, 2005, JPN J APPL PHYS 1, V44, P8269, DOI 10.1143/JJAP.44.8269; Hirao T, 1999, TETRAHEDRON LETT, V40, P3009, DOI 10.1016/S0040-4039(99)00405-0; Amaya T, 2012, TETRAHEDRON LETT, V53, P6144, DOI 10.1016/j.tetlet.2012.09.002; Drelinkiewicz A, 2009, REACT FUNCT POLYM, V69, P630, DOI 10.1016/j.reactfunctpolym.2009.04.007; Morozan A, 2011, ENERG ENVIRON SCI, V4, P1238, DOI 10.1039/c0ee00601g; Amaya T, 2007, TETRAHEDRON LETT, V48, P2729, DOI 10.1016/j.tetlet.2007.02.059; Chen SG, 2012, J AM CHEM SOC, V134, P13252, DOI 10.1021/ja306501x; XIA YN, 1995, CHEM MATER, V7, P443, DOI 10.1021/cm00051a002; Kang ET, 1998, PROG POLYM SCI, V23, P277, DOI 10.1016/S0079-6700(97)00030-0; Amaya T, 2013, TETRAHEDRON LETT, V54, P2409, DOI 10.1016/j.tetlet.2013.02.098; Kongkanand A, 2005, J PHYS CHEM B, V109, P23190, DOI 10.1021/jp053229f; Khomenko VG, 2005, ELECTROCHIM ACTA, V50, P1675, DOI 10.1016/j.electacta.2004.10.024; Pelaez M, 2012, APPL CATAL B-ENVIRON, V125, P331, DOI 10.1016/j.apcatb.2012.05.036; Saio D, 2010, ADV SYNTH CATAL, V352, P2177, DOI 10.1002/adsc.201000451; Cabiscol Elisa, 2000, International Microbiology, V3, P3; Higuchi M, 1996, MACROMOLECULES, V29, P8277, DOI 10.1021/ma960761f; HIRAO T, 1995, TETRAHEDRON LETT, V36, P5925, DOI 10.1016/0040-4039(95)01143-6; Hirao T, 1999, SYNTHETIC MET, V106, P67, DOI 10.1016/S0379-6779(99)00107-1; Hirao T, 2001, SYNTHETIC MET, V123, P373, DOI 10.1016/S0379-6779(01)00314-9; Isaji T, 2014, B CHEM SOC JPN, V87, P1130, DOI 10.1246/bcsj.20140106; Amaya T, 2015, J INORG ORGANOMET P, V25, P145, DOI 10.1007/s10904-014-0123-z; Kawashima N, 1998, COLLOID SURFACE B, V11, P297, DOI 10.1016/S0927-7765(98)00047-2; Manisankar P, 2005, J MOL CATAL A-CHEM, V232, P45, DOI 10.1016/j.molcata.2005.01.001; Ohki N, 2002, ELECTROCHEMISTRY, V70, P23; Ono H, 2001, ELECTROCHEMISTRY, V69, P953; Otsuka S, 1996, CHEM LETT, P615, DOI 10.1246/cl.1996.615; Saio D, 2009, J INORG ORGANOMET P, V19, P79, DOI 10.1007/s10904-008-9241-9; Shchukin DG, 2002, ELECTROCHEM COMMUN, V4, P402, DOI 10.1016/S1388-2481(02)00327-2; Shen XL, 2004, TETRAHEDRON LETT, V45, P4733, DOI 10.1016/j.tetlet.2004.04.073; Zhang GQ, 2007, REACT FUNCT POLYM, V67, P1008, DOI 10.1016/j.reactfunctpolym.2007.06.004	35	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1574-1443	1574-1451		J INORG ORGANOMET P	J. Inorg. Organomet. Polym. Mater.	JUL	2015	25	4					855	859		10.1007/s10904-015-0172-y		5	Polymer Science	Polymer Science	CK5VV	WOS:000356294900030		
J	Houjou, H; Yagi, K; Yoshikawa, I; Mutai, T; Araki, K				Houjou, Hirohiko; Yagi, Keisuke; Yoshikawa, Isao; Mutai, Toshiki; Araki, Koji			Solid-State Characterization of a Fused Salphen-Nickel Metallopolymer Prepared via Transmetalation in a Heterogeneous Reaction System	JOURNAL OF INORGANIC AND ORGANOMETALLIC POLYMERS AND MATERIALS			English	Article						Schiff bases; Metallopolymer; Transmetalation; Solid-state absorption spectroscopy; IR spectroscopy; Normal-mode analysis	SCHIFF-BASE COMPLEXES; SALEN COMPLEXES; CONJUGATED METALLOPOLYMERS; REDOX POLYMERS; TRANSITION; TAUTOMERISM; FRAMEWORKS; OXIDATION; LIGANDS; ZN(II)	A nickel-containing metallopolymer with fully pi-conjugated fused salphen ligands was prepared from the corresponding zinc-containing metallopolymer by means of transmetalation. As a model for the metallopolymer, an analogous fused tetrasalphen-nickel complex was also prepared. Solid-thin-film absorption microspectroscopy was used to confirm that the transmetalation reaction had occurred and to determine the degree of polymerization, which was estimated to be 8-15. Combined with theoretical normal-mode analysis, comparison of the FT-IR spectra of a series of model complexes with different nuclearities revealed two diagnostic peaks that could be used to validate the polynuclearity of the nickel-containing metallopolymer.	[Houjou, Hirohiko; Yagi, Keisuke; Yoshikawa, Isao; Mutai, Toshiki; Araki, Koji] Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo 1538505, Japan	Houjou, H (reprint author), Univ Tokyo, Inst Ind Sci, Meguro Ku, 4-6-1 Komaba, Tokyo 1538505, Japan.	houjou@iis.u-tokyo.ac.jp	Houjou, Hirohiko/O-8488-2015; 	Yoshikawa, Isao/0000-0002-9183-7636	Japan Society for the Promotion of Science [24550222]	T. Mutai gratefully acknowledges the financial support from the Japan Society for the Promotion of Science (Grants-in-Aid for Scientific Research C: 24550222). The authors are grateful to Dr. Y. Taninouchi and Prof. T. H. Okabe for measurement of XRF, and to Dr. G. Hayashi and Prof. A. Okamoto for measurement of MALDI-TOF-MS.	AbdElAziz AS, 2005, MACROMOL CONTAIN MET, V5, P1; Escudero-Adan EC, 2007, INORG CHEM, V46, P7265, DOI 10.1021/ic701245r; Leung ACW, 2007, J INORG ORGANOMET P, V17, P57, DOI 10.1007/s10904-006-9092-1; Houjou H, 2011, INORG CHEM, V50, P5298, DOI 10.1021/ic200798d; [Anonymous], OP SOURC JAV VIEW CH; Gradinaru J, 2007, INORG CHEM, V46, P884, DOI 10.1021/ic062035r; Yan Y, 2010, COORDIN CHEM REV, V254, P1072, DOI 10.1016/j.ccr.2009.12.024; Clegg W, 2010, CHEM-EUR J, V16, P6828, DOI 10.1002/chem.201000030; Cheng JH, 2014, INORG CHEM, V53, P3210, DOI 10.1021/ic5000815; Whittell GR, 2007, ADV MATER, V19, P3439, DOI 10.1002/adma.200702876; Trujillo A, 2010, INORG CHEM, V49, P2750, DOI 10.1021/ic902126a; Shimazaki Y, 2003, J AM CHEM SOC, V125, P10512, DOI 10.1021/ja035806o; Rotthaus O, 2006, CHEM-EUR J, V12, P6953, DOI 10.1002/chem.200600258; WOHRLE D, 1983, MAKROMOL CHEM, V184, P763; Clarke RM, 2014, DALTON T, V43, P9380, DOI 10.1039/c4dt00591k; Houjou H, 2009, INORG CHEM, V48, P10703, DOI 10.1021/ic901937p; Alecu IM, 2010, J CHEM THEORY COMPUT, V6, P2872, DOI 10.1021/ct100326h; AUDEBERT P, 1991, NEW J CHEM, V15, P235; Kurahashi T, 2011, J AM CHEM SOC, V133, P8307, DOI 10.1021/ja2016813; Dunn TJ, 2011, INORG CHEM, V50, P6746, DOI 10.1021/ic200785g; Thomas RM, 2010, J AM CHEM SOC, V132, P16520, DOI 10.1021/ja1058422; Lin HC, 2007, DALTON T, P781, DOI 10.1039/b615380a; Kingsborough RP, 1999, J AM CHEM SOC, V121, P8825, DOI 10.1021/ja991285m; Wezenberg SJ, 2008, ANGEW CHEM INT EDIT, V47, P2354, DOI 10.1002/anie.200702468; Hirao T, 2002, COORDIN CHEM REV, V226, P81, DOI 10.1016/S0010-8545(01)00436-2; Lalonde M, 2013, J MATER CHEM A, V1, P5453, DOI 10.1039/c3ta10784a; Costes JP, 2005, INORG CHEM, V44, P1973, DOI 10.1021/ic048578n; Decortes A., 2010, ANGEW CHEM INT EDIT, V49, P2; Dumar F., 2014, EUR J INORG CHEM, V4186; Frisch M.J., 2009, GAUSSIAN 09; Glaser T, 2013, COORDIN CHEM REV, V257, P140, DOI 10.1016/j.ccr.2012.05.005; GOLDSBY KA, 1988, J COORD CHEM, V19, P83; Hofmeier H, 2005, CHEM COMMUN, P2423, DOI 10.1039/b419171d; Holliday BJ, 2005, CHEM COMMUN, P23, DOI 10.1039/b408479a; Houjou H, 2009, EUR J INORG CHEM, P533, DOI 10.1002/ejic.200801030; Houjou H, 2013, ORG ELECTRON, V14, P3472, DOI 10.1016/j.orgel.2013.09.022; Lee W., 2005, J AM CHEM SOC, V127, P16091; Leung ACW, 2003, MACROMOL SYMP, V196, P229, DOI 10.1002/masy.200390163; MANECKE G, 1970, MAKROMOLEKUL CHEM, V133, P61; O'Sullivan TJ, 2009, CHEM COMMUN, P1903, DOI 10.1039/b818952h; Peng Q, 2005, MACROMOL CHEM PHYSIC, V206, P2373, DOI 10.1002/macp.200500363; Pickup PG, 1999, J MATER CHEM, V9, P1641, DOI 10.1039/a902244i; Whiteoak C. J., 2014, CHEM SOC REV, V41, P622; Yagi K, 2012, MACROMOL RAPID COMM, V33, P540, DOI 10.1002/marc.201100766	44	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1574-1443	1574-1451		J INORG ORGANOMET P	J. Inorg. Organomet. Polym. Mater.	JUL	2015	25	4					906	911		10.1007/s10904-015-0187-4		6	Polymer Science	Polymer Science	CK5VV	WOS:000356294900036		
J	Kumara, RP; Saitoh, S; Aoyama, H; Shinzato, N; Tokuda, G				Kumara, Rohitha P.; Saitoh, Seikoh; Aoyama, Hiroaki; Shinzato, Naoya; Tokuda, Gaku			Predominant expression and activity of vacuolar H+-ATPases in the mixed segment of the wood-feeding termite Nasutitermes takasagoensis	JOURNAL OF INSECT PHYSIOLOGY			English	Article						Transcriptome; Termite; Mixed segment; V-ATPase; Gut	SECRETING EPITHELIAL-CELLS; PROTON PUMP; PLASMA-MEMBRANE; HOUSEKEEPING GENES; GRANULE MEMBRANE; V-ATPASE; GUT; IDENTIFICATION; ACIDIFICATION; SHIRAKI	The mixed segment is a unique part of the gut present only in the most apical lineage of termites and consists of a complex of overlapping mesenteric and proctodeal epithelia. In spite of its unique structure, the physiological functions of the mixed segment have been poorly studied. We performed transcriptome analysis to identify functional enzymes acting in the mixed segment of the wood-feeding higher termite Nasutitermes takasagoensis. We sequenced the transcripts (4563 isotigs) of the mixed segment and compared them with those of the midgut (4813 isotigs) and the first proctodeal segment (3629 isotigs). We found that vacuolar H+-ATPase (V-ATPase) subunits were predominant in the mixed segment, which was confirmed by RT-qPCR analysis. The V-ATPase activity in these three tissues was in a good agreement with the expression patterns, suggesting that V-ATPase is a prevalent enzyme in the mixed segment of the termites. The results confirmed the proposed role of the mixed segment as a transporting epithelium. (C) 2015 Elsevier Ltd. All rights reserved.	[Kumara, Rohitha P.; Tokuda, Gaku] Univ Ryukyus, Grad Sch Sci & Engn, Nishihara, Okinawa 9030213, Japan; [Kumara, Rohitha P.; Saitoh, Seikoh; Aoyama, Hiroaki; Shinzato, Naoya; Tokuda, Gaku] Univ Ryukyus, COMB, Trop Biosphere Res Ctr, Nishihara, Okinawa 9030213, Japan	Tokuda, G (reprint author), Univ Ryukyus, COMB, Trop Biosphere Res Ctr, Nishihara, Okinawa 9030213, Japan.	tokuda@comb.u-ryukyu.ac.jp			Center of Molecular Biosciences at the University of the Ryukyus; KAKENHI from JSPS [26292177]; Narishige Zoological Science Award	We would like to thank Masaru Hojo, Yukihiro Kinjo, Takahiro Hosokawa, and Maori Yamada for their assistance with termites, informatics support, and helpful feedback. This research was supported by Grants from Center of Molecular Biosciences at the University of the Ryukyus, KAKENHI No. 26292177 from JSPS, and Narishige Zoological Science Award.	Stevens TH, 1997, ANNU REV CELL DEV BI, V13, P779, DOI 10.1146/annurev.cellbio.13.1.779; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Liu L, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/251364; BRUNE A, 1995, APPL ENVIRON MICROB, V61, P2681; CZOLIJ R, 1985, APPL ENVIRON MICROB, V49, P1226; Tokuda G, 2001, ZOOL SCI, V18, P869, DOI 10.2108/zsj.18.869; Finn RD, 2014, NUCLEIC ACIDS RES, V42, pD222, DOI 10.1093/nar/gkt1223; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; LIN H, 1993, J EXP BIOL, V180, P163; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Boudko DY, 2001, P NATL ACAD SCI USA, V98, P15354, DOI 10.1073/pnas.261253998; OHKUMA S, 1982, P NATL ACAD SCI-BIOL, V79, P2758, DOI 10.1073/pnas.79.9.2758; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; Pace Karen E., 2004, Glycoconjugate Journal, V19, P607; Yin YB, 2012, NUCLEIC ACIDS RES, V40, pW445, DOI 10.1093/nar/gks479; BOWMAN BJ, 1992, J BIOENERG BIOMEMBR, V24, P361, DOI 10.1007/BF00762529; Kohler T, 2012, APPL ENVIRON MICROB, V78, P4691, DOI 10.1128/AEM.00683-12; Baumann O, 2012, J INSECT PHYSIOL, V58, P450, DOI 10.1016/j.jinsphys.2011.11.015; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Brune A, 2014, NAT REV MICROBIOL, V12, P168, DOI 10.1038/nrmicro3182; WIECZOREK H, 1991, J BIOL CHEM, V266, P15340; Kamhawi S, 2004, CELL, V119, P329, DOI 10.1016/j.cell.2004.10.009; BIGNELL DE, 1983, J ZOOL, V201, P445; Brown D, 1996, J EXP BIOL, V199, P2345; BIGNELL DE, 1980, J INVERTEBR PATHOL, V36, P426, DOI 10.1016/0022-2011(80)90049-X; Bignell David E., 1994, P131; BROWN D, 1987, J CELL BIOL, V105, P1637, DOI 10.1083/jcb.105.4.1637; CIDON S, 1983, J BIOL CHEM, V258, P2892; Cummings R.D., 2009, ESSENTIALS GLYCOBIOL, P403; DEAN GE, 1984, J BIOL CHEM, V259, P9569; FORGAC M, 1992, J BIOENERG BIOMEMBR, V24, P341, DOI 10.1007/BF00762527; FORGAC M, 1983, P NATL ACAD SCI-BIOL, V80, P1300, DOI 10.1073/pnas.80.5.1300; GLUCK SL, 1992, J BIOENERG BIOMEMBR, V24, P351, DOI 10.1007/BF00762528; GRASSE PIERRE-P, 1954, ANN SCI NAT ZOOL, V16, P345; HARIKUMAR P, 1983, J BIOL CHEM, V258, P403; HARVEY WR, 1983, J EXP BIOL, V106, P91; Hojo M, 2012, INSECT MOL BIOL, V21, P545, DOI 10.1111/j.1365-2583.2012.01162.x; Holmgren N, 1909, HANDLINGAR, V44, P1; KANE PM, 1992, J BIOENERG BIOMEMBR, V24, P383, DOI 10.1007/BF00762531; Kappler A, 1999, APPL SOIL ECOL, V13, P219, DOI 10.1016/S0929-1393(99)00035-9; Kim DH, 2013, J INVERTEBR PATHOL, V114, P226, DOI 10.1016/j.jip.2013.08.002; Lo N, 2011, BIOLOGY OF TERMITES: A MODERN SYNTHESIS, P51, DOI 10.1007/978-90-481-3977-4_3; Moffett DF, 2010, EPITHELIAL TRANSPORT PHYSIOLOGY, P91, DOI 10.1007/978-1-60327-229-2_5; Onken Horst, 2008, Journal of Insect Science (Tucson), V8, P1, DOI 10.1673/031.008.4601; Tokuda G, 2000, APPL ENVIRON MICROB, V66, P2199, DOI 10.1128/AEM.66.5.2199-2207.2000; Tokuda G, 2004, MOL ECOL, V13, P3219, DOI 10.1111/j.1365-294X.2004.02276.x; Tokuda G, 2012, J INSECT PHYSIOL, V58, P147, DOI 10.1016/j.jinsphys.2011.10.012; Tokuda G, 1997, ZOOL SCI, V14, P83, DOI 10.2108/zsj.14.83; Vandesompele J., 2002, GENOME BIOL, V18, P3, DOI DOI 10.1186/GB-2002-3-7-RESEARCH0034; WIECZOREK H, 1992, J EXP BIOL, V172, P335; Wieczorek H, 2000, J EXP BIOL, V203, P127; XIE XS, 1983, J BIOL CHEM, V258, P4834; YAMAOKA I, 1980, Zoological Magazine (Tokyo), V89, P308	54	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-1910	1879-1611		J INSECT PHYSIOL	J. Insect Physiol.	JUL	2015	78						1	8		10.1016/j.jinsphys.2015.04.012		8	Entomology; Physiology; Zoology	Entomology; Physiology; Zoology	CK9EZ	WOS:000356544700001		
J	Kosakai, K; Tsujiuchi, Y; Yoshino, M				Kosakai, Kumiko; Tsujiuchi, Yuuki; Yoshino, Masami			Nitric oxide augments single Ca2+ channel currents via cGMP-dependent protein kinase in Kenyon cells isolated from the mushroom body of the cricket brain	JOURNAL OF INSECT PHYSIOLOGY			English	Article						Mushroom body; Cricket; Kenyon cell; L-type Ca2+ channel; Nitric oxide	LONG-TERM-MEMORY; GRYLLUS-BIMACULATUS; POTASSIUM CHANNELS; OLFACTORY MEMORY; APIS-MELLIFERA; ANTENNAL LOBE; INSECT BRAIN; MODULATION; SYSTEM; CALCIUM	Behavioral and pharmacological studies in insects have suggested that the nitric oxide (NO)/cyclic GMP (cGMP) signaling pathway is involved in the formation of long-term memory (LTM) associated with olfactory learning. However, the target molecules of NO and the downstream signaling pathway are still not known. In this study, we investigated the action of NO on single voltage-dependent Ca2+ channels in the intrinsic neurons known as Kenyon cells within the mushroom body of the cricket brain, using the cell-attached configuration of the patch-clamp technique. Application of the NO donor S-nitrosoglutathione (GSNO) increased the open probability (NPo) of single Ca2+ channel currents. This GSNO-induced increase was blocked by ODQ a soluble guanylate cyclase (sGC) inhibitor, suggesting that the NO generated by GSNO acts via sGC to raise cGMP levels. The membrane-permeable cGMP analog 8-Bro-cGMP also increased the NPo of single Ca2+ channel currents. Pretreatment of cells with KT5823, a protein kinase G blocker, abolished the excitatory effect of GSNO. These results suggest that NO augments the activity of single Ca2+ channels via the cGMP/PKG signaling pathway. To gain insight into the physiological role of NO, we examined the effect of GSNO on action potentials of Kenyon cells under current-clamp conditions. Application of GSNO increased the frequency of action potentials elicited by depolarizing current injections, indicating that NO acts as a modulator resulting in a stimulatory signal in Kenyon cells. We discuss the increased Ca2+ influx through these Ca2+ channels via the NO/cGMP signaling cascade in relation to the formation of olfactory LTM. (C) 2015 Elsevier Ltd. All rights reserved.	[Kosakai, Kumiko] Tokyo Gakugei Univ, Senior High Sch, Tokyo 1540002, Japan; [Tsujiuchi, Yuuki; Yoshino, Masami] Tokyo Gakugei Univ, Dept Biol, Tokyo 1848501, Japan	Yoshino, M (reprint author), Tokyo Gakugei Univ, Dept Biol, Tokyo 1848501, Japan.	myoshi@u-gakugel.ac.jp			 [21570074]	We thank Professor Dr. Makoto Mizunami (Hokkaido University) for helpful discussion. This work was supported by a Grant-in-Aid for Scientific Research (C), 21570074. The present experiments were performed under the Guiding Principles for the Care and Use of Animals in the Field of Physiological Sciences recommended by the Physiological Society of Japan.	Prast H, 2001, PROG NEUROBIOL, V64, P51, DOI 10.1016/S0301-0082(00)00044-7; Takahashi T, 2009, J NEUROSCI METH, V179, P9, DOI 10.1016/j.jneumeth.2009.01.002; Matsumoto Y, 2002, J EXP BIOL, V205, P1429; Unoki S, 2006, EUR J NEUROSCI, V24, P2031, DOI 10.1111/j.1460-9568.2006.05099.x; Unoki S, 2005, EUR J NEUROSCI, V22, P1409, DOI 10.1111/j.1460-9568.2005.04318.x; ROBITAILLE R, 1993, NEURON, V11, P645, DOI 10.1016/0896-6273(93)90076-4; Contestabile A, 2004, NEUROCHEM INT, V45, P903, DOI 10.1016/j.neuint.2004.03.021; Nakamura A, 2013, J NEUROPHYSIOL, V109, P1735, DOI 10.1152/jn.00915.2012; Garthwaite J, 2008, EUR J NEUROSCI, V27, P2783, DOI 10.1111/j.1460-9568.2008.06285.x; Jaggar JH, 2000, AM J PHYSIOL-CELL PH, V278, pC235; Cassenaer S, 2007, NATURE, V448, P709, DOI 10.1038/nature05973; Matsumoto Y, 2006, LEARN MEMORY, V13, P35, DOI 10.1101/lm.130506; Cassenaer S, 2012, NATURE, V482, P47, DOI 10.1038/nature10776; Artinian L, 2012, EUR J NEUROSCI, V36, P3333, DOI 10.1111/j.1460-9568.2012.08260.x; Aoki K, 2008, J NEUROPHYSIOL, V100, P1211, DOI 10.1152/jn.90459.2008; Ledoux J, 2006, PHYSIOLOGY, V21, P69, DOI 10.1152/physiol.00040.2005; Inoue S, 2014, J INSECT PHYSIOL, V68, P44, DOI 10.1016/j.jinsphys.2014.06.013; Muller U, 1996, NEURON, V16, P541, DOI 10.1016/S0896-6273(00)80073-2; Bicker G, 1996, EUR J NEUROSCI, V8, P2635, DOI 10.1111/j.1460-9568.1996.tb01558.x; Cayre M, 2005, EUR J NEUROSCI, V21, P2893, DOI 10.1111/j.1460-9568.2005.04153.x; ELPHICK MR, 1993, BRAIN RES, V619, P344, DOI 10.1016/0006-8993(93)91632-3; Furhgott R.F., 1980, NATURE, V288, P373; Hedrick MS, 1998, NEUROSCI LETT, V251, P81, DOI 10.1016/S0304-3940(98)00485-6; Klyachko VA, 2001, NEURON, V31, P1015, DOI 10.1016/S0896-6273(01)00449-4; Kosakai K, 2008, J INSECT PHYSIOL, V54, P1479, DOI 10.1016/j.jinsphys.2008.08.003; Matsumoto Y, 2000, J EXP BIOL, V203, P2581; Matsumoto Y, 2002, J COMP PHYSIOL A, V188, P295, DOI 10.1007/s00359-002-0303-0; McLean DL, 2000, J EXP BIOL, V203, P705; MULLER U, 1995, EUR J NEUROSCI, V7, P2240, DOI 10.1111/j.1460-9568.1995.tb00645.x; Nighorn A, 1998, J NEUROSCI, V18, P7244; Ott SR, 2007, EUR J NEUROSCI, V25, P181, DOI 10.1111/j.1460-9568.2006.05271.x; ROBERTSON JD, 1994, P ROY SOC B-BIOL SCI, V256, P269, DOI 10.1098/rspb.1994.0080; Terazima E, 2010, J INSECT PHYSIOL, V56, P1746, DOI 10.1016/j.jinsphys.2010.07.001; Wenzel B, 2005, J COMP NEUROL, V488, P129, DOI 10.1002/cne.20600; Zhong LR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078727	35	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-1910	1879-1611		J INSECT PHYSIOL	J. Insect Physiol.	JUL	2015	78						26	32		10.1016/j.jinsphys.2015.04.009		7	Entomology; Physiology; Zoology	Entomology; Physiology; Zoology	CK9EZ	WOS:000356544700004		
J	Shinmoto, H; Oshio, K; Tamura, C; Soga, S; Okamura, T; Yamada, K; Kaji, T; Mulkern, RV				Shinmoto, Hiroshi; Oshio, Koichi; Tamura, Chiharu; Soga, Shigeyoshi; Okamura, Teppei; Yamada, Kentaro; Kaji, Tastumi; Mulkern, Robert V.			Diffusion-weighted imaging of prostate cancer using a statistical model based on the gamma distribution	JOURNAL OF MAGNETIC RESONANCE IMAGING			English	Article						prostate neoplasms; magnetic resonance imaging; diffusion-weighted imaging; statistical model; non-Gaussian diffusion	COEFFICIENT VALUES; MR SIGNAL; DIFFERENTIATION; TRANSITION; TISSUES; ZONES	PurposeTo assess the adequacy of a statistical model based on the gamma distribution for diffusion signal decays of prostate cancer (PCa) using b-values ranging up to 2000 sec/mm(2), and to evaluate the differences in gamma model parameters for PCa, benign prostatic hyperplasia (BPH), and peripheral zone (PZ). Materials and MethodsTwenty-six patients with histologically proven PCa underwent diffusion-weighted magnetic resonance imaging using five b-values (0, 500, 1000, 1500, 2000 sec/mm(2)). The acquired signal decay curves were fit with both gamma and truncated Gaussian models and a statistical comparison between the two fits was performed. The acquired parameters using the gamma model (mean, standard deviation, the area fraction for D<1.0 mm(2)/s [Frac<1.0], the area fraction of D>3.0 mm(2)/s [Frac>3.0]) were compared between PCa, BPH, and PZ. ResultsThe gamma model provided a statistically improved fit over the truncated Gaussian model in PCa. The mean and the standard deviation were significantly lower in PCa than in BPH and PZ (P<0.01). Frac<1.0 was significantly higher in PCa than in BPH and PZ, and Frac>3.0 was significantly lower in PCa than in BPH and PZ (P<0.01). ConclusionA statistical model based on the gamma distribution proved suitable for describing diffusion signal decay curves of PCa. This approach may provide better correlation between diffusion signal decay and histological information in the prostate gland. J. Magn. Reson. Imaging 2015;42:56-62. (c) 2014 Wiley Periodicals, Inc.	[Shinmoto, Hiroshi; Tamura, Chiharu; Soga, Shigeyoshi; Okamura, Teppei; Yamada, Kentaro; Kaji, Tastumi] Natl Def Med Coll, Dept Radiol, Tokorozawa, Saitama 3598513, Japan; [Oshio, Koichi] Keio Univ, Sch Med, Dept Diagnost Radiol, Tokyo, Japan; [Mulkern, Robert V.] Harvard Univ, Sch Med, Dept Radiol, Childrens Hosp, Boston, MA 02115 USA; [Mulkern, Robert V.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Radiol, Boston, MA 02115 USA	Shinmoto, H (reprint author), Natl Def Med Coll, Dept Radiol, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan.	shinmoto@ga2.so-net.ne.jp					Jensen JH, 2010, NMR BIOMED, V23, P698, DOI 10.1002/nbm.1518; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; ShinMoto H, 2009, MAGN RESON IMAGING, V27, P355, DOI 10.1016/j.mri.2008.07.008; Shinmoto H, 2012, AM J ROENTGENOL, V199, pW496, DOI 10.2214/AJR.11.8347; Rosenkrantz AB, 2012, RADIOLOGY, V264, P126, DOI 10.1148/radiol.12112290; Issa B, 2002, J MAGN RESON IMAGING, V16, P196, DOI 10.1002/jmri.10139; Tamura C, 2014, J MAGN RESON IMAGING, V40, P723, DOI 10.1002/jmri.24379; Oto A, 2010, RADIOLOGY, V257, P715, DOI 10.1148/radiol.10100021; Dopfert J, 2011, MAGN RESON IMAGING, V29, P1053, DOI 10.1016/j.mri.2011.06.001; Tanimoto A, 2007, J MAGN RESON IMAGING, V25, P146, DOI 10.1002/jmri.20793; Haider MA, 2007, AM J ROENTGENOL, V189, P323, DOI 10.2214/AJR.07.2211; Sato C, 2005, J MAGN RESON IMAGING, V21, P258, DOI 10.1002/jmri.20251; Mulkern RV, 2009, MAGN RESON IMAGING, V27, P1151, DOI 10.1016/j.mri.2009.05.003; Tamada T, 2008, J MAGN RESON IMAGING, V28, P720, DOI 10.1002/jmri.21503; Mulkern RV, 2006, MAGN RESON IMAGING, V24, P563, DOI 10.1016/j.mri.2005.12.008; Bourne RM, 2013, MAGN RESON MED; Oshio K, 2014, MAGN RESON MED SCI; Oshio K, 2012, P 20 ANN M ISMRM MEL; Oshio K, 2014, P JOINT ANN M ISMRM; Yablonskiy DA, 2010, NMR BIOMED, V23, P661, DOI 10.1002/nbm.1520; Yablonskiy DA, 2003, MAGNET RESON MED, V50, P664, DOI 10.1002/mrm.10578	21	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1053-1807	1522-2586		J MAGN RESON IMAGING	J. Magn. Reson. Imaging	JUL	2015	42	1					56	62		10.1002/jmri.24761		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CL0IN	WOS:000356625500006		
J	Sukenari, T; Horii, M; Ikoma, K; Kido, M; Hayashi, S; Hara, Y; Yamasaki, T; Matsuda, K; Kawata, M; Kubo, T				Sukenari, Tsuyoshi; Horii, Motoyuki; Ikoma, Kazuya; Kido, Masamitsu; Hayashi, Shigeki; Hara, Yusuke; Yamasaki, Tetsuro; Matsuda, Ken-ichi; Kawata, Mitsuhiro; Kubo, Toshikazu			Cortical bone water changes in ovariectomized rats during the early postoperative period: Objective evaluation using sweep imaging with Fourier transform	JOURNAL OF MAGNETIC RESONANCE IMAGING			English	Article						bone water; cortical bone; osteoporosis; ovariectomy; sweep imaging with Fourier transform	MECHANICAL-PROPERTIES; MINERAL DENSITY; FRACTURE RISK; TIME-COURSE; OSTEOPOROSIS; METAANALYSIS; MRI; OSTEOPENIA; TURNOVER; WEIGHT	PurposeTo evaluate the cortical bone signal-to-noise ratio (SNR) in ovariectomized (OVX) rats during the early postoperative period as a method to measure bone quality using the sweep imaging with Fourier transform (SWIFT) technique. Materials and MethodsTwelve-week-old female Sprague-Dawley rats (n = 64) were divided into sham and OVX groups. Preoperative tetracycline was immediately administered subcutaneously to distinguish new cortical bone area, and tibial samples were collected at 2, 4, 8, and 12 weeks postoperatively. Magnetic resonance imaging (MRI) was performed using proton density-weighted imaging (PDWI) and SWIFT to obtain cross-sectional images of the tibial diaphysis. The cortical bone SNR was calculated. Bone histomorphometry was performed. ResultsHistomorphometry findings showed that the new bone area was significantly greater at 8 and 12 weeks postoperatively in the OVX group (P < 0.05) while the porosity area decreased gradually in both groups (P < 0.001). The difference of SNR receiving PDWI did not reach statistical significance (P = 0.057). The SWIFT technique showed that the SNR was significantly higher at 8 and 12 weeks postoperatively in the OVX group (P < 0.05) and was correlated with the new bone area (R-2 = 0.430). ConclusionThe SWIFT findings suggest that the SWIFT technique may depict early changes in cortical bone quality. J. Magn. Reson. Imaging 2015;42:128-135. (c) 2014 Wiley Periodicals, Inc.	[Sukenari, Tsuyoshi; Horii, Motoyuki; Ikoma, Kazuya; Kido, Masamitsu; Hayashi, Shigeki; Hara, Yusuke; Yamasaki, Tetsuro; Kubo, Toshikazu] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Orthopaed, Kyoto, Japan; [Matsuda, Ken-ichi; Kawata, Mitsuhiro] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Anat & Neurobiol, Kyoto, Japan	Ikoma, K (reprint author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Orthopaed, Kamigyo Ku, 465 Kajii Cho, Kyoto, Japan.	kazuya@koto.kpu-m.ac.jp					Heine PA, 2000, P NATL ACAD SCI USA, V97, P12729, DOI 10.1073/pnas.97.23.12729; Lelovas PP, 2008, COMPARATIVE MED, V58, P424; Cowin SC, 1999, J BIOMECH, V32, P217, DOI 10.1016/S0021-9290(98)00161-4; Vestergaard P, 2007, OSTEOPOROSIS INT, V18, P427, DOI 10.1007/s00198-006-0253-4; MUELLER KH, 1966, J BONE JOINT SURG AM, VA 48, P140; Kumamoto K, 2010, J BONE MINER METAB, V28, P1, DOI 10.1007/s00774-009-0125-z; Nguyen ND, 2007, J BONE MINER RES, V22, P1147, DOI 10.1359/JBMR.070412; Weiger M, 2011, MAGN RESON MED, V66, P379, DOI 10.1002/mrm.22799; Li M, 1997, BONE, V20, P55, DOI 10.1016/S8756-3282(96)00317-1; Idiyatullin D, 2006, J MAGN RESON, V181, P342, DOI 10.1016/j.jmr.2006.05.014; TIMMINS PA, 1977, CALC TISS RES, V23, P1, DOI 10.1007/BF02012759; Rautiainen J, 2013, RADIOLOGY, V269, P113, DOI 10.1148/radiol.13121433; Klibanski A, 2001, JAMA-J AM MED ASSOC, V285, P785; Comelekoglu U, 2007, CLIN RHEUMATOL, V26, P380, DOI 10.1007/s10067-006-0367-2; Weiger M, 2013, MAGN RESON MED, V70, P328, DOI 10.1002/mrm.24816; WRONSKI TJ, 1989, BONE, V10, P295, DOI 10.1016/8756-3282(89)90067-7; Kanis JA, 2004, J BONE MINER RES, V19, P893, DOI 10.1359/JBMR.040134; Saito M, 2010, OSTEOPOROSIS INT, V21, P195, DOI 10.1007/s00198-009-1066-z; Horch RA, 2010, MAGN RESON MED, V64, P680, DOI 10.1002/mrm.22459; Techawiboonwong A, 2008, RADIOLOGY, V248, P824, DOI 10.1148/radiol.2482071995; WRONSKI TJ, 1988, CALCIFIED TISSUE INT, V43, P179, DOI 10.1007/BF02571317; PARFITT AM, 1987, J BONE MINER RES, V2, P595; Du JA, 2010, J MAGN RESON, V207, P304, DOI 10.1016/j.jmr.2010.09.013; Cenci S, 2000, J CLIN INVEST, V106, P1229, DOI 10.1172/JCI11066; Martin TJ, 2005, TRENDS MOL MED, V11, P76, DOI 10.1016/j.molmed.2004.12.004; Brouwers JEM, 2009, OSTEOPOROSIS INT, V20, P1823, DOI 10.1007/s00198-009-0882-5; DICKENSON RP, 1981, J BONE JOINT SURG BR, V63, P233; Du J, 2013, MAGN RESON MED, V70, P697, DOI 10.1002/mrm.24497; GRAY JM, 1981, AM J PHYSIOL, V240, pE474; Idiyatullin D, 2008, J MAGN RESON, V193, P267, DOI 10.1016/j.jmr.2008.05.009; KE HZ, 1993, BONE MINER, V21, P189, DOI 10.1016/S0169-6009(08)80230-9; Li M, 1996, ANAT REC, V245, P472; Luhach I, 2014, MAGN RESON MED, V72, P858, DOI 10.1002/mrm.24979; Marshall D, 1996, BRIT MED J, V312, P1254; Peng ZQ, 1997, BONE, V20, P207, DOI 10.1016/S8756-3282(96)00369-9; Riggs BL, 2002, J BONE MINER RES, V17, P11, DOI 10.1359/jbmr.2002.17.1.11; Samnegard E, 2001, BONE, V28, P251, DOI 10.1016/S8756-3282(00)00446-4	37	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1053-1807	1522-2586		J MAGN RESON IMAGING	J. Magn. Reson. Imaging	JUL	2015	42	1					128	135		10.1002/jmri.24765		8	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CL0IN	WOS:000356625500015		
J	Takayama, Y; Nishie, A; Asayama, Y; Ushijima, Y; Okamoto, D; Fujita, N; Morita, K; Shirabe, K; Kotoh, K; Kubo, Y; Okuaki, T; Honda, H				Takayama, Yukihisa; Nishie, Akihiro; Asayama, Yoshiki; Ushijima, Yasuhiro; Okamoto, Daisuke; Fujita, Nobuhiro; Morita, Koichiro; Shirabe, Ken; Kotoh, Kazuhiro; Kubo, Yuichiro; Okuaki, Tomoyuki; Honda, Hiroshi			T-1 rho Relaxation of the liver: A Potential Biomarker of Liver Function	JOURNAL OF MAGNETIC RESONANCE IMAGING			English	Article						T-1 rho (T(1)rho); liver function; liver fibrosis; liver necroinflammation; chronic liver disease; MRI	GD-EOB-DTPA; IN-VIVO; HEPATOCELLULAR-CARCINOMA; ARTICULAR-CARTILAGE; TISSUE ELASTICITY; SPIN-LOCKING; FIBROSIS; DISEASE; T1-RHO; OSTEOARTHRITIS	PurposeTo investigate the diagnostic potential of T-1 relaxation for assessing liver function, liver fibrosis, or liver necroinflammation in patients with chronic liver disease (CLD). Materials and MethodsWe obtained T-1 maps of the liver for 53 patients with or without CLD. We measured the T-1 values of the liver and correlated them with the results of laboratory tests and histological examinations. Pearson's correlation coefficients (r) were calculated between the T-1 values and blood serum parameters including the retention rates at 15 minutes after an injection of indocyanine green (ICG-R15). Spearman's rank correlation coefficients were calculated between the T-1 values and the scores of liver fibrosis or liver necroinflammation. ResultsThe T-1 values showed significant positive correlations with the serum levels of total bilirubin (r=0.31, P<0.05), direct bilirubin (r=0.32, P<0.05), and ICG-R15 (r=0.46, P<0.05), and significant negative correlations with the serum levels of albumin (r=-0.33, P<0.05) and -glutamyl transpeptidase (r=-0.28, P<0.05). However, there were no significant correlations between the T-1 value and the scores of liver fibrosis (P=0.95) or liver necroinflammation (P=0.86). ConclusionT(1) relaxation has potential as a biomarker of liver function in patients with CLD. However, it may not be suitable to estimate liver fibrosis or liver necroinflammation. J. Magn. Reson. Imaging 2015;42:188-195. (c) 2014 Wiley Periodicals, Inc.	[Takayama, Yukihisa] Kyushu Univ, Grad Sch Med Sci, Dept Radiol Informat & Network, Fukuoka 8128582, Japan; [Nishie, Akihiro; Asayama, Yoshiki; Ushijima, Yasuhiro; Okamoto, Daisuke; Fujita, Nobuhiro; Morita, Koichiro; Honda, Hiroshi] Kyushu Univ, Grad Sch Med Sci, Dept Clin Radiol, Fukuoka 8128582, Japan; [Shirabe, Ken] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 8128582, Japan; [Kotoh, Kazuhiro] Kyushu Univ, Grad Sch Med Sci, Dept Med & Bioregulatory Sci, Fukuoka 8128582, Japan; [Kubo, Yuichiro] Kyushu Univ, Grad Sch Med Sci, Dept Anat Pathol, Pathol Sci, Fukuoka 8128582, Japan; [Okuaki, Tomoyuki] Philips Elect Japan, Tokyo, Japan	Nishie, A (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Clin Radiol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	anishie@radiol.med.kyushu-u.ac.jp			JSPS KAKENHI [26461796]	Contract grant sponsor: Grant-in-Aid for Scientific Research (C), JSPS KAKENHI; Contract grant number: 26461796.	Arda K, 2011, AM J ROENTGENOL, V197, P532, DOI 10.2214/AJR.10.5449; Duvvuri U, 2001, P NATL ACAD SCI USA, V98, P12479, DOI 10.1073/pnas.221471898; Yoshioka K, 2012, HEPATOL RES, V42, P233, DOI 10.1111/j.1872-034X.2011.00928.x; Li X, 2007, OSTEOARTHR CARTILAGE, V15, P789, DOI 10.1016/j.joca.2007.01.011; Witschey WRT, 2007, J MAGN RESON, V186, P75, DOI 10.1016/j.jmr.2007.01.015; Manduca A, 2001, MED IMAGE ANAL, V5, P237, DOI 10.1016/S1361-8415(00)00039-6; Pakin SK, 2006, MAGN RESON MED, V56, P563, DOI 10.1002/mrm.20982; Faria SC, 2009, RADIOGRAPHICS, V29, P1615, DOI 10.1148/rg.296095512; Boll DT, 2009, RADIOGRAPHICS, V29, P1591, DOI 10.1148/rg.296095513; Wang YXJ, 2011, RADIOLOGY, V259, P712, DOI 10.1148/radiol.11101638; Tomimaru Y, 2006, WORLD J SURG, V30, P1729, DOI 10.1007/s00268-005-0123-9; Schneider PD, 2004, SURG CLIN N AM, V84, P355, DOI 10.1016/S0039-6109(03)00224-X; Nestrasil I, 2010, J NEUROL, V257, P964, DOI 10.1007/s00415-009-5446-2; Borthakur A, 2006, J MAGN RESON IMAGING, V24, P1011, DOI 10.1002/jmri.20751; Rauscher I, 2014, EUR J RADIOL, V83, P900, DOI 10.1016/j.ejrad.2014.02.017; Tsushima H, 2012, RHEUMATOL INT, V32, P2867, DOI 10.1007/s00296-011-2140-3; Zhao F, 2012, EUR RADIOL, V22, P1709, DOI 10.1007/s00330-012-2419-0; Takayama Y, 2012, EUR J RADIOL, V81, P3035, DOI 10.1016/j.ejrad.2012.03.026; Nishie A, 2012, J MAGN RESON IMAGING, V36, P664, DOI 10.1002/jmri.23691; Wallace K, 2008, BIOCHEM J, V411, P1, DOI 10.1042/BJ20071570; Starley BQ, 2010, HEPATOLOGY, V51, P1820, DOI 10.1002/hep.23594; Akella SVS, 2001, MAGNET RESON MED, V46, P419, DOI 10.1002/mrm.1208; Allkemper T, 2014, RADIOLOGY, V271, P408, DOI 10.1148/radiol.13130342; Seyama Y, 2009, HEPATOL RES, V39, P107, DOI 10.1111/j.1872-034X.2008.00441.x; Takayama Y, 2013, EUR J RADIOL, V82, pE192, DOI 10.1016/j.ejrad.2012.11.031; Bansal MB, 2011, SHERLOCK'S DISEASES OF THE LIVER AND BILIARY SYSTEM, 12TH EDITION, P94; Charagundla SR, 2003, J MAGN RESON, V162, P113, DOI 10.1016/S1090-7807(02)00197-0; Deng M, 2012, BRIT J RADIOL, V85, pE590, DOI 10.1259/bjr/98745548; Duvvuri U, 2001, CANCER RES, V61, P7747; Kudo Masatoshi, 2008, Oncology, V75 Suppl 1, P1, DOI 10.1159/000181865; Markkola AT, 1996, RADIOLOGY, V200, P369; SANTYR GE, 1989, MAGNET RESON MED, V12, P25, DOI 10.1002/mrm.1910120104; Sasaki N, 1999, J NUCL MED, V40, P1652; Sirlin CB, 2011, RADIOLOGY, V259, P619, DOI 10.1148/radiol.11110547; SZYPERSKI T, 1993, J BIOMOL NMR, V3, P151; Takayama Y, 2014, J MAGN RESON IMAGING; TSUKUMA H, 1993, NEW ENGL J MED, V328, P1797, DOI 10.1056/NEJM199306243282501; Yin Meng, 2009, Top Magn Reson Imaging, V20, P79, DOI 10.1097/RMR.0b013e3181c4737e; Yuan J, 2012, ACTA RADIOL, V53, P675, DOI 10.1258/ar.2012.120108	39	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1053-1807	1522-2586		J MAGN RESON IMAGING	J. Magn. Reson. Imaging	JUL	2015	42	1					188	195		10.1002/jmri.24739		8	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CL0IN	WOS:000356625500023		
J	Ichikawa, S; Motosugi, U; Morisaka, H; Sano, K; Ichikawa, T; Enomoto, N; Matsuda, M; Fujii, H; Onishi, H				Ichikawa, Shintaro; Motosugi, Utaroh; Morisaka, Hiroyuki; Sano, Katsuhiro; Ichikawa, Tomoaki; Enomoto, Nobuyuki; Matsuda, Masanori; Fujii, Hideki; Onishi, Hiroshi			MRI-based staging of hepatic fibrosis: Comparison of intravoxel incoherent motion diffusion-weighted imaging with magnetic resonance elastography	JOURNAL OF MAGNETIC RESONANCE IMAGING			English	Article						hepatic fibrosis; diffusion-weighted imaging (DWI); intravoxel incoherent motion (IVIM); magnetic resonance elastography (MRE); magnetic resonance imaging (MRI)	LIVER FIBROSIS; PRELIMINARY EXPERIENCE; PORTAL-HYPERTENSION; B VALUES; CIRRHOSIS; STIFFNESS; QUANTIFICATION; REPEATABILITY; FEASIBILITY; DISEASE	PurposeTo evaluate the use of intravoxel incoherent motion (IVIM) imaging for staging hepatic fibrosis, and compare its staging ability with that of magnetic resonance elastography (MRE). Materials and MethodsThis study included 129 patients with pathologically staged liver fibrosis, and 53 patients with healthy livers. All patients underwent both MRE and IVIM imaging. Four diffusivity indices were calculated with 11 b-values; slow diffusion coefficient related to molecular diffusion (D), fast diffusion coefficient related to perfusion in micro-vessels (D*), perfusion-related diffusion fraction (f), and apparent diffusion coefficient (ADC). Receiver operating characteristic curve analysis was performed to determine the accuracy of IVIM imaging and MRE for staging hepatic fibrosis. ResultsD*, f, and ADC values decreased significantly with fibrosis stage (P < 0.0124), and liver stiffness increased (P < 0.0001). The Az value of MRE was significantly higher than that of D* for all fibrosis stages (D* vs. MRE for F1, 0.851 vs. 0.992 [P < 0.0001]; F2, 0.898 vs. 0.998 [P = 0.0003]; F3, 0.904 vs. 0.995 [P = 0.0004]; F4, 0.885 vs. 0.996 [P < 0.0001]). ConclusionIVIM imaging is a useful technique for evaluating hepatic fibrosis, but MRE is better able to discriminate fibrosis stages than IVIM imaging. J. Magn. Reson. Imaging 2015;42:204-210. (c) 2014 Wiley Periodicals, Inc.	[Ichikawa, Shintaro; Motosugi, Utaroh; Morisaka, Hiroyuki; Sano, Katsuhiro; Ichikawa, Tomoaki; Onishi, Hiroshi] Univ Yamanashi, Dept Radiol, Chuo, Yamanashi 4093898, Japan; [Enomoto, Nobuyuki] Univ Yamanashi, Dept Internal Med 1, Chuo, Yamanashi 4093898, Japan; [Matsuda, Masanori; Fujii, Hideki] Univ Yamanashi, Dept Surg 1, Chuo, Yamanashi 4093898, Japan	Motosugi, U (reprint author), Univ Yamanashi, Dept Radiol, 1110 Shimokato, Chuo, Yamanashi 4093898, Japan.	UMotosugi@uwhealth.org					Yin M, 2007, CLIN GASTROENTEROL H, V5, P1207, DOI 10.1016/j.cgh.2007.06.012; Lemke A, 2011, MAGN RESON IMAGING, V29, P766, DOI 10.1016/j.mri.2011.03.004; Girometti R, 2007, RADIOL MED, V112, P394, DOI 10.1007/s11547-007-0149-1; Standish RA, 2006, GUT, V55, P569, DOI 10.1136/gut.2005.084475; Nakagawa H, 2009, INT J CANCER, V125, P2264, DOI 10.1002/ijc.24720; Regev A, 2002, AM J GASTROENTEROL, V97, P2614; Dyvorne HA, 2013, RADIOLOGY, V266, P920, DOI 10.1148/radiol.12120686; Talwalkar JA, 2009, AM J ROENTGENOL, V193, P122, DOI 10.2214/AJR.07.3504; Shire NJ, 2011, J MAGN RESON IMAGING, V34, P947, DOI 10.1002/jmri.22716; Koinuma M, 2005, J MAGN RESON IMAGING, V22, P80, DOI 10.1002/jmri.20344; Manduca A, 2001, MED IMAGE ANAL, V5, P237, DOI 10.1016/S1361-8415(00)00039-6; Chen J, 2011, RADIOLOGY, V259, P749, DOI 10.1148/radiol.11101942; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Wang QB, 2012, HEPATOLOGY, V56, P239, DOI 10.1002/hep.25610; Moteki T, 2006, J MAGN RESON IMAGING, V24, P637, DOI 10.1002/jmri.20682; Yoon JH, 2014, J COMPUT ASSIST TOMO, V38, P110, DOI 10.1097/RCT.0b013e3182a589be; Venkatesh SK, 2008, AM J ROENTGENOL, V190, P1534, DOI 10.2214/AJR.07.3123; Taouli B, 2007, AM J ROENTGENOL, V189, P799, DOI 10.2214/AJR.07.2086; Hines CDG, 2010, J MAGN RESON IMAGING, V31, P725, DOI 10.1002/jmri.22066; Motosugi U, 2013, MAGN RESON MED SCI, V12, P161, DOI 10.2463/mrms.2012-0085; Luciani A, 2008, RADIOLOGY, V249, P891, DOI 10.1148/radiol.2493080080; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Lewin M, 2007, HEPATOLOGY, V46, P658, DOI 10.1002/hep.21747; Chow AM, 2012, J MAGN RESON IMAGING, V36, P159, DOI 10.1002/jmri.23607; Watanabe H, 2011, RADIOLOGY, V259, P142, DOI 10.1148/radiol.10100621; Patel J, 2010, J MAGN RESON IMAGING, V31, P589, DOI 10.1002/jmri.22081; Bravo AA, 2001, NEW ENGL J MED, V344, P495, DOI 10.1056/NEJM200102153440706; Fujimoto K, 2011, RADIOLOGY, V258, P739, DOI 10.1148/radiol.10100853; Goshima S, 2012, HEPATOLOGY, V55, P328, DOI 10.1002/hep.24677; Ichikawa S, 2012, MAGN RESON MED SCI, V11, P291; Kakite S, 2014, J MAGN RESON IMAGING; LesBihan D, 2008, RADIOLOGY, V249, P748; LESBIHAN D, 1992, MAGN RESON MED, V27, P171; LesBihan D, 1986, RADIOLOGY, V161, P401; MORENO AH, 1960, SURG GYNECOL OBSTET, V111, P443; Motosugi U, 2011, JPN J RADIOL, V29, P639, DOI 10.1007/s11604-011-0607-5; Motosugi U, 2010, JPN J RADIOL, V28, P623, DOI 10.1007/s11604-010-0478-1; Rouviere O, 2006, RADIOLOGY, V240, P440, DOI 10.1148/radiol.2402050606; Sandrasegaran K, 2009, AM J ROENTGENOL, V193, P1556, DOI 10.2214/AJR.09.2436; TSUKUMA H, 1993, NEW ENGL J MED, V328, P1797, DOI 10.1056/NEJM199306243282501; Zang Y, 2013, MAGN RESON IMAGING, V31, P1017	41	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1053-1807	1522-2586		J MAGN RESON IMAGING	J. Magn. Reson. Imaging	JUL	2015	42	1					204	210		10.1002/jmri.24760		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CL0IN	WOS:000356625500025		
J	Wang, YH; Yu, MQ; Qiao, Q; You, F; Li, CL; Xu, ZF; Matsugi, K; Yu, JK				Wang, Yuehua; Yu, Meiqi; Qiao, Qi; You, Fei; Li, Cailing; Xu, Zhefeng; Matsugi, Kazuhiro; Yu, Jinku			Effect of Plastic Deformation on the Crystal Structure and Crystallization Activation Energy of Ni-W-P Alloy Coating	JOURNAL OF MATERIALS ENGINEERING AND PERFORMANCE			English	Article						effective activation energy; large plastic deformation; Ni-W-P alloy; phase transformation; thermal analysis	PHASE-TRANSFORMATION BEHAVIOR; CORROSION-RESISTANCE; THERMAL-STABILITY; WEAR BEHAVIOR; ELECTRODEPOSITION; MICROSTRUCTURE; MECHANISM; HARDNESS; STEEL; LASER	Jet electrodeposition method was used to prepare Ni-W-P amorphous alloy coating and effects of plastic deformation on the crystal structure and crystallization kinetics were investigated. Based on the results of differential scanning calorimeter, x-ray diffractometer and transmission electron microscope, it can be seen that when the plastic deformation is up to 20%, the Ni-W-P amorphous alloy coating begins to crystallize. An increase of plastic deformation will lead to a decrease of crystallization temperature as well as a decrease of crystallization activation energy calculated by Kissinger equation. The effective activation energy is reduced from 268.63 kJ/mol in the as-deposited state to 246.63 kJ/mol in the cold deformation up to 40%. Analyses were presented to discuss the possible mechanism for the effect of plastic deformation on the crystallization kinetics of the Ni-W-P amorphous alloy coatings.	[Wang, Yuehua; Yu, Meiqi; Qiao, Qi; You, Fei; Li, Cailing; Yu, Jinku] Yanshan Univ, State Key Lab Metastable Mat Sci & Technol, Qinhuangdao 066004, Hebei, Peoples R China; [Yu, Meiqi; Xu, Zhefeng; Matsugi, Kazuhiro] Hiroshima Univ, Grad Sch Engn, Higashihiroshima 7398527, Japan	Wang, YH (reprint author), Yanshan Univ, State Key Lab Metastable Mat Sci & Technol, Qinhuangdao 066004, Hebei, Peoples R China.	yujinku@ysu.edu.cn	Xu, Zhefeng/N-2182-2014	Xu, Zhefeng/0000-0003-0640-4578	colleges and universities of science and technology research projects of Hebei Province in China [ZD2014055]	The authors would like to thank the financial support from the colleges and universities of science and technology research projects of Hebei Province in China under Grant No. ZD2014055.	Eskandari M, 2009, MAT SCI ENG A-STRUCT, V519, P46, DOI 10.1016/j.msea.2009.04.038; Valiev RZ, 2006, PROG MATER SCI, V51, P881, DOI 10.1016/j.pmatsci.2006.02.003; Ordine AP, 2006, ELECTROCHIM ACTA, V51, P1480, DOI 10.1016/j.electacta.2005.02.129; Palaniappa M, 2008, WEAR, V265, P735, DOI 10.1016/j.wear.2008.01.002; Tien SK, 2004, SURF COAT TECH, V177, P532, DOI 10.1016/j.surfcoat.2003.09.032; YOSHIZAWA Y, 1988, J APPL PHYS, V64, P6044, DOI 10.1063/1.342149; Xie S, 2008, ACTA MATER, V56, P5202, DOI 10.1016/j.actamat.2008.07.009; Palaniappa M, 2007, MAT SCI ENG A-STRUCT, V460, P638, DOI 10.1016/j.msea.2007.01.134; Balaraju JN, 2012, SURF COAT TECH, V206, P2682, DOI 10.1016/j.surfcoat.2011.11.024; Belyakov A, 2008, ISIJ INT, V48, P1071, DOI 10.2355/isijinternational.48.1071; Chen WY, 2004, SURF COAT TECH, V177, P222, DOI 10.1016/j.surfcoat.2003.09.036; He FJ, 2014, WEAR, V311, P14, DOI 10.1016/j.wear.2013.12.024; Jing TF, 2006, MAT SCI ENG A-STRUCT, V432, P216, DOI 10.1016/j.msea.2006.06.047; Li Q, 2012, PHASE TRANSIT, V85, P619, DOI 10.1080/01411594.2011.651796; Liu H., 2014, T IMF, V93, P212; Liu H, 2010, T NONFERR METAL SOC, V20, P1024, DOI 10.1016/S1003-6326(09)60252-1; Liu H, 2013, SURF COAT TECH, V219, P31, DOI 10.1016/j.surfcoat.2012.12.048; Liu JJ, 2010, J ELECTROANAL CHEM, V642, P103, DOI 10.1016/j.jelechem.2010.02.017; Papachristos VD, 2000, MAT SCI ENG A-STRUCT, V279, P217, DOI 10.1016/S0921-5093(99)00583-3; Wu FB, 2004, SURF COAT TECH, V177, P312, DOI 10.1016/j.surfcoat.2003.09.010; Yao H, 2011, ADV MATER RES-SWITZ, V189-193, P373, DOI 10.4028/www.scientific.net/AMR.189-193.373; Yu JK, 2009, J MATER PROCESS TECH, V209, P14, DOI 10.1016/j.jmatprotec.2008.01.021; Zhang S, 2011, APPL SURF SCI, V257, P9213, DOI 10.1016/j.apsusc.2011.06.006	23	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1059-9495	1544-1024		J MATER ENG PERFORM	J. Mater. Eng. Perform.	JUL	2015	24	7					2653	2657		10.1007/s11665-015-1551-9		5	Materials Science, Multidisciplinary	Materials Science	CL0BF	WOS:000356602800009		
J	Nishida, T; Otsuki, N; Ohara, H; Garba-Say, ZM; Nagata, T				Nishida, Takahiro; Otsuki, Nobuaki; Ohara, Hiroki; Garba-Say, Zoulkanel Moussa; Nagata, Tomohiro			Some Considerations for Applicability of Seawater as Mixing Water in Concrete	JOURNAL OF MATERIALS IN CIVIL ENGINEERING			English	Article						Mixed with seawater; Blast furnace slag; Water shortage	ENVIRONMENT	According to the report of the World Meteorological Organization (WMO), more than half of the world's population will not have enough drinking water by 2025. To save drinking water, use of seawater in the concrete industry seems imperative. In the present study, the possibilities of seawater as a material of concrete are discussed as a result of the literature-based and experimental investigations. From the results of the literature-based study, more than half of the papers collected in this study had positive opinions about concrete mixed with seawater by adding the mineral admixture such as blast furnace slag (BFS). In addition, some results of long-term exposure tests indicated the high possibility of using seawater as a material of concrete. The experimental data obtained in this study indicated that the addition of BFS might contribute significantly to the corrosion resistance of steel bar, because of the low oxygen environment around steel bar and chloride immobilization.	[Nishida, Takahiro; Otsuki, Nobuaki; Garba-Say, Zoulkanel Moussa; Nagata, Tomohiro] Tokyo Inst Technol, Grad Sch Sci & Engn, Meguro Ku, Tokyo 1528552, Japan; [Ohara, Hiroki] JGC Corp, Int Project Div, Nishi Ku, Yokohama, Kanagawa 2206001, Japan	Nishida, T (reprint author), Tokyo Inst Technol, Grad Sch Sci & Engn, Meguro Ku, 2-12-1-S6-11 Ookayama, Tokyo 1528552, Japan.	nishida@ide.titech.ac.jp; otsuki@ide.titech.ac.jp; ohara.hiroki@jgc.co.jp; moussagarbasay.z.aa@m.titech.ac.jp; nagata.t.ab@m.titech.ac.jp					STERN M, 1957, J ELECTROCHEM SOC, V104, P56, DOI 10.1149/1.2428496; David H., 2013, CIVIL ENG, V83, P44; Gayner J. F. C., 1979, PRECAST CONCR, V10, P169; Gonzalez JA, 1998, CEMENT CONCRETE RES, V28, P577, DOI 10.1016/S0008-8846(98)00014-3; Kaushik S, 1995, CEMENT CONCRETE COMP, V17, P177, DOI 10.1016/0958-9465(95)00015-5; Kobayashi K., 1984, DOBOKUSEKO, V25, P20; Mori Y., 1981, J CEM ASS, V35, P341; Neville A., 2001, CONCR INT AM CONCR I, V23, P48; Nippon Slag Association, 2012, UT BLAST FURN SLAG C, P42; Noma H., 1994, EFFECT ARTIFICIAL SE, P3337; NOVOKSHCHENOV V, 1995, MATER STRUCT, V28, P392, DOI 10.1007/BF02473074; Ozaki S., 1984, 60 YEAR OLD CONCRETE, P173; Seki H., 1976, CORROSION REINFORCIN, P1; Tarek T. U., 2004, ACI MATER J, V101, P226; Yamamoto K., 1980, KENCHIKUSHI JITSUMU, V3, P68; Yamato T., 1987, SPECIAL PUBLICATION, V1, P901; Yoda A., 1981, J CEM ASS, V35, P333	17	0	0	ASCE-AMER SOC CIVIL ENGINEERS	RESTON	1801 ALEXANDER BELL DR, RESTON, VA 20191-4400 USA	0899-1561	1943-5533		J MATER CIVIL ENG	J. Mater. Civ. Eng.	JUL	2015	27	7							B4014004	10.1061/(ASCE)MT.1943-5533.0001006		7	Construction & Building Technology; Engineering, Civil; Materials Science, Multidisciplinary	Construction & Building Technology; Engineering; Materials Science	CK7OF	WOS:000356421200002		
J	Sekijima, K; Satoh, M; Izumo, J				Sekijima, Kenzo; Satoh, Masatoshi; Izumo, Junich			Shear-Reinforcing Effect of Continuous Fiber Rope on Reinforced Concrete Beams	JOURNAL OF MATERIALS IN CIVIL ENGINEERING			English	Article						Continuous fiber rope; Vinylon fiber; Aramid fiber; Reinforced concrete beam; Shear reinforcing effect		Continuous fiber rope (CF rope) made of aramid fiber or vinylon fiber has been developed to apply for the reinforcement of concrete members and structures. It is characterized by a light weight, high tensile strength, and excellent durability compared with reinforcing steel bar. It has also good transportability, and it is flexible to be easily arranged at the construction site. The purpose of this study is to investigate the shear-reinforcing effect of CF rope. First, the reinforced concrete (RC) beams without shear reinforcement were tested. Then, the RC beams wound with CF rope at shear span were tested. Moreover, the shear-reinforcing effect of CF rope on the RC beams that were predamaged in shear assuming seismic retrofitting was also investigated. Through the test results, we confirmed that CF rope was effective for the RC beams without shear reinforcement and the predamaged RC beams in shear.	[Sekijima, Kenzo] Kanto Gakuin Univ, Inst Sci & Technol, Kanazawa Ku, Yokohama, Kanagawa 2368501, Japan; [Satoh, Masatoshi; Izumo, Junich] Kanto Gakuin Univ, Dept Civil & Environm Engn, Kanazawa Ku, Yokohama, Kanagawa 2368501, Japan	Sekijima, K (reprint author), Kanto Gakuin Univ, Inst Sci & Technol, Kanazawa Ku, Mutsuurahigashi 1-50-1, Yokohama, Kanagawa 2368501, Japan.	r069009@kanto-gakuin.ac.jp; m1245001@kanto-gakuin.ac.jp; izumo@kanto-gakuin.ac.jp					Japan Society of Civil Engineers (JSCE), 1997, REC DES CONSTR CONCR; Japan Society of Civil Engineers (JSCE), 2001, REC UPGR CONCR STRUC; Niwa J, 2006, FDN CONCRETE STRUCTU; Phong N. H, 2006, P JCI, V28, P1171	4	0	0	ASCE-AMER SOC CIVIL ENGINEERS	RESTON	1801 ALEXANDER BELL DR, RESTON, VA 20191-4400 USA	0899-1561	1943-5533		J MATER CIVIL ENG	J. Mater. Civ. Eng.	JUL	2015	27	7							B4014008	10.1061/(ASCE)MT.1943-5533.0001099		6	Construction & Building Technology; Engineering, Civil; Materials Science, Multidisciplinary	Construction & Building Technology; Engineering; Materials Science	CK7OF	WOS:000356421200009		
J	Zhang, PG; Zhang, YM; Sun, ZM				Zhang, Peigen; Zhang, Yamei; Sun, Zhengming			Spontaneous Growth of Metal Whiskers on Surfaces of Solids: A Review	JOURNAL OF MATERIALS SCIENCE & TECHNOLOGY			English	Review						Metal whiskers; Microelectronics failure; Growth mechanism; Health hazard; MAX phase	SHORT-CIRCUIT CHARACTERISTICS; FREESTANDING GA NANORIBBONS; LEAD-FREE ELECTRONICS; TIN WHISKER; ROOM-TEMPERATURE; MAX PHASES; SN-WHISKERS; STRESS EVOLUTION; SMELTER WORKERS; CR2GAC SURFACES	Spontaneous metal whisker growth phenomenon has been studied for similar to 70 years, but still resists interpretations, which has haunted the electronics-rich systems from the birth of the industry since whiskers may lead to short circuits and hence other disasters. In addition to reliability problems, threat of Pb whiskers to human health is also significant due to the toxicity of the element and its geometry as well as its nanometer size. This issue becomes more attention drawing and urgent due to the restrictions on Pb use in EU, Japan etc., which phases out the Pb-addition practice to mitigate Sn whiskers. This paper reviews the origin of the whiskering phenomenon and whisker-induced problems, ranging from early in the World War II to the present; details the development of this issue in the electronics-rich systems including the phenomenon, problems and remedies; pictures the long history of the developments of the growth mechanisms and models which are full of hardship and contradictions. New aspects on the spontaneous whisker growth in some different substrates, such as in brasses and MAX phase materials are reviewed in more details. The latter was found to be a promising system to understand the whisker growth phenomenon, with new growth models proposed that may shed new light to the intricate battle field of the metal whisker research in general. Copyright (C) 2015, The editorial office of Journal of Materials Science & Technology. Published by Elsevier Limited. All rights reserved.	[Zhang, Peigen; Sun, Zhengming] Southeast Univ, Sch Mat Sci & Engn, Jiangsu Key Lab Adv Metall Mat, Nanjing 211189, Jiangsu, Peoples R China; [Zhang, Yamei; Sun, Zhengming] Southeast Univ, Sch Mat Sci & Engn, Jiangsu Key Lab Construct Mat, Nanjing 211189, Jiangsu, Peoples R China; [Sun, Zhengming] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058569, Japan	Sun, ZM (reprint author), Southeast Univ, Sch Mat Sci & Engn, Jiangsu Key Lab Adv Metall Mat, Nanjing 211189, Jiangsu, Peoples R China.	szm19104@163.com			National Natural Science Foundation of China [51272043]; Jiangsu Planned Projects for Postdoctoral Research Funds [1302008A]; China Postdoctoral Science Foundation [2014M551484]; Fundamental Research Funds for the Central Universities [3212004603]	The research is supported by the National Natural Science Foundation of China (No. 51272043), Jiangsu Planned Projects for Postdoctoral Research Funds (1302008A), China Postdoctoral Science Foundation (2014M551484), and the Fundamental Research Funds for the Central Universities (3212004603).	AMELINCKX S, 1957, PHILOS MAG, V2, P355, DOI 10.1080/14786435708243825; Pecht M, 2010, MICROELECTRON RELIAB, V50, P317, DOI 10.1016/j.microrel.2010.01.006; Osenbach JW, 2007, IEEE T ELECTRON PACK, V30, P23, DOI 10.1109/TEPM.2006.890637; Jiang B, 2007, PHIL MAG LETT, V87, P657, DOI 10.1080/09500830701432607; Qi HY, 2008, MICROELECTRON RELIAB, V48, P663, DOI 10.1016/j.microrel.2008.02.003; Liu M, 2009, MICROELECTRON RELIAB, V49, P667, DOI 10.1016/j.microrel.2009.03.012; Manton WI, 2000, ENVIRON RES, V82, P60, DOI 10.1006/enrs.1999.4003; Barsoum MW, 2000, PROG SOLID STATE CH, V28, P201, DOI 10.1016/S0079-6786(00)00006-6; Kim KS, 2006, MICROELECTRON RELIAB, V46, P1080, DOI 10.1016/j.microrel.2005.08.007; Boettinger WJ, 2005, ACTA MATER, V53, P5033, DOI 10.1016/j.actamat.2005.07.016; Shibutani T, 2008, MICROELECTRON RELIAB, V48, P1033, DOI 10.1016/j.microrel.2008.04.009; Chason E, 2013, PROG SURF SCI, V88, P103, DOI 10.1016/j.progsurf.2013.02.002; ESHELBY JD, 1953, PHYS REV, V91, P755, DOI 10.1103/PhysRev.91.755.2; Li CF, 2013, ACTA MATER, V61, P589, DOI 10.1016/j.actamat.2012.09.080; Susan D, 2013, METALL MATER TRANS A, V44A, P1485, DOI 10.1007/s11661-012-1488-7; Fang T, 2006, MICROELECTRON RELIAB, V46, P846, DOI 10.1016/j.microrel.2005.06.002; Barsoum MW, 1996, J AM CERAM SOC, V79, P1953, DOI 10.1111/j.1151-2916.1996.tb08018.x; Buchovecky EJ, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3136865; Chason E, 2011, JOM-US, V63, P62, DOI 10.1007/s11837-011-0178-z; FISHER RM, 1954, ACTA METALL MATER, V2, P368, DOI 10.1016/0001-6160(54)90053-X; Radovic M, 2013, AM CERAM SOC BULL, V92, P20; Zeng K, 2002, MAT SCI ENG R, V38, P55, DOI 10.1016/S0927-796X(02)00007-4; Smetana J, 2007, IEEE T ELECTRON PACK, V30, P11, DOI 10.1109/TEPM.2006.890645; Bunyan D, 2013, T I MET FINISH, V91, P249, DOI 10.1179/0020296713Z.000000000119; Hoffman EN, 2012, NUCL ENG DES, V244, P17, DOI 10.1016/j.nucengdes.2011.12.009; Horvath B, 2013, MICROELECTRON RELIAB, V53, P1009, DOI 10.1016/j.microrel.2013.03.008; [Anonymous], 2011, NATL HIGHWAY TRAFFIC; Lee BZ, 1998, ACTA MATER, V46, P3701, DOI 10.1016/S1359-6454(98)00045-7; Chason E, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2912528; Tu KN, 2005, MAT SCI ENG A-STRUCT, V409, P131, DOI 10.1016/j.msea.2005.06.074; Soderholm P, 2007, RELIAB ENG SYST SAFE, V92, P1, DOI 10.1016/j.ress.2005.11.004; TU KN, 1994, PHYS REV B, V49, P2030, DOI 10.1103/PhysRevB.49.2030; Sun ZM, 2011, INT MATER REV, V56, P143, DOI 10.1179/1743280410Y.0000000001; Wei CC, 2008, J MATER RES, V23, P2017, DOI 10.1557/JMR.2008.0253; Barsoum MW, 1999, J PHYS CHEM SOLIDS, V60, P429, DOI 10.1016/S0022-3697(98)00313-8; LINDBORG U, 1976, ACTA METALL MATER, V24, P181, DOI 10.1016/0001-6160(76)90021-3; Li CF, 2013, J ALLOY COMPD, V550, P231, DOI 10.1016/j.jallcom.2012.09.092; Barsoum MW, 1997, SCRIPTA MATER, V37, P1583, DOI 10.1016/S1359-6462(97)00288-1; Schroeder V, 2006, IEEE T ELECTRON PACK, V29, P231, DOI 10.1109/TEPM.2006.887397; Galyon GT, 2005, IEEE T ELECTRON PACK, V28, P17, DOI 10.1109/TEPM.2005.847443; Suganuma K, 2011, ACTA MATER, V59, P7255, DOI 10.1016/j.actamat.2011.08.017; Osenbach JW, 2005, IEEE T ELECTRON PACK, V28, P36, DOI 10.1109/TEPM.2005.847438; Tu KN, 2007, J MATER SCI-MATER EL, V18, P269, DOI 10.1007/s10854-006-9029-z; Galyon GT, 2005, IEEE T ELECTRON PACK, V28, P94, DOI 10.1109/TEPM.2005.847440; Jiang B, 2008, MICROELECTRON RELIAB, V48, P105, DOI 10.1016/j.microrel.2007.02.002; Vo N, 2005, IEEE T ELECTRON PACK, V28, P3, DOI 10.1109/TEPM.2005.846462; KAKESHITA T, 1982, J MATER SCI, V17, P2560, DOI 10.1007/BF00543888; Osenbach JW, 2009, J APPL PHYS, V106, DOI 10.1063/1.3248277; Hua L, 2011, MICROELECTRON RELIAB, V51, P2274, DOI 10.1016/j.microrel.2011.06.023; Jadhav N, 2012, J ELECTRON MATER, V41, P588, DOI 10.1007/s11664-011-1829-0; Liu M, 2009, J ELECTRON MATER, V38, P2353, DOI 10.1007/s11664-009-0926-9; Sun ZM, 2010, INT J APPL CERAM TEC, V7, P704, DOI 10.1111/j.1744-7402.2010.02555.x; Barsoum MW, 1997, J MATER SYNTH PROCES, V5, P197; Schetty R, 2001, CIRCUIT WORLD, V27, P17, DOI 10.1108/03056120110367131; El-Sherif RM, 2004, ELECTROCHIM ACTA, V49, P5139, DOI 10.1016/j.electacta.2004.06.027; Grigg J, 2004, ARCH DIS CHILD, V89, P244, DOI 10.1136/adc.2002.022202; Han S, 2012, J ELECTRON MATER, V41, P2508, DOI 10.1007/s11664-012-2179-2; Chuang TH, 2006, SCRIPTA MATER, V55, P983, DOI 10.1016/j.scriptamat.2006.08.024; Sheng GTT, 2002, J APPL PHYS, V92, P64, DOI 10.1063/1.1481202; Arnold S. M., 1959, P IEEE EL COMP C, P75; Arnold S.M., 1966, PLATING, V53, P96; Arnold S.M., 1956, GROWTH PROPERTIES ME; Arnold S.M., 1959, P IEEE EL COMP C; Baan RA, 2004, MUTAT RES-FUND MOL M, V553, P43, DOI 10.1016/j.mrfmmm.2004.06.019; Baated A, 2011, J MATER SCI-MATER EL, V22, P1685, DOI 10.1007/s10854-011-0346-5; BAKER GS, 1957, ACTA METALL MATER, V5, P353, DOI 10.1016/0001-6160(57)90001-9; Barsoum MW, 2013, MAX PHASES: PROPERTIES OF MACHINABLE TERNARY CARBIDES AND NITRIDES, P1, DOI 10.1002/9783527654581; Barsoum MW, 1999, SCIENCE, V284, P937, DOI 10.1126/science.284.5416.937; Barsoum MW, 2001, AM SCI, V89, P334, DOI 10.1511/2001.28.736; Barsoum MW, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.206104; Barsoum MW, 1997, SCRIPTA MATER, V36, P535, DOI 10.1016/S1359-6462(96)00418-6; Blech I. A., 1975, J CRYST GROWTH, V32, P161; Boguslavsky I., 2003, APEX C MARCH; Britton S., 1974, T I MET FINISH, V52, P95; Britton S., 1957, METALLURGIA, V56, P163; Brusse J., 2002, AESF SUR FIN P ORL F; Brusse J., 2003, PRESENTATION SLIDES, P8; Brusse J., 2008, SLID 2 INT S TIN WHI; Brusse J., 2007, METAL WHISKERS FAILU; Brusse J., 2004, IT Professional, V6, DOI 10.1109/MITP.2004.95; Brusse J., 2002, SLID P AESF SUR FIN; Brusse J., 2003, SLIDES P AESF SUR FI; Brusse J.A., 2002, CARTS 2002 22 CAPACI; Buchovecky E, 2009, J ELECTRON MATER, V38, P2676, DOI 10.1007/s11664-009-0911-3; Carty Sharon Silke, 2012, HUFFINGTON POST; Chan J, 2000, OCCUP MED-OXFORD, V50, P398; Chen K, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.066104; Cheng J, 2011, J ELECTRON MATER, V40, P2069, DOI 10.1007/s11664-011-1708-8; Cheng J., 2011, TIN WHISKERS ELECT P; Cheng YT, 2002, APPL PHYS LETT, V81, P3248, DOI 10.1063/1.1515885; Choi W.J., 2005, STRUCTURE KINETICS T; Cobb H. L., 1946, MONTHLY REV AM ELECT, V33, P28; COMPTON K, 1951, CORROSION, V7, P327; Courey KJ, 2009, IEEE T ELECTRON PACK, V32, P41, DOI 10.1109/TEPM.2008.2009224; Courey KJ, 2008, IEEE T ELECTRON PACK, V31, P32, DOI 10.1109/TEPM.2007.914210; Crandall E.R., 2013, FACTORS GOVERNING TI; Daddona P., 2005, REACTOR SHUTDOWN DOM; Daddona P., 2005, THE DAY; Diehl R.P., 1993, MET FINISH, V91, P37; Dietz K., 2006, CircuiTree, V19; Diyatmika W., 2013, MICR PACK ASS CIRC T; Downs J.R., 1994, MET FINISH, V92, P23; Dudek MA, 2009, ACTA MATER, V57, P4588, DOI 10.1016/j.actamat.2009.06.031; Dunn B., 1975, MET MATER, V34, P32; Dunn B. D., 1976, Circuit World, V2, DOI 10.1108/eb043543; Ellis W., 1958, GROWTH PERFECTION CR, P102; Ellis W.C., 1958, INT C CRYST GROWTH C; El-Raghy T., 1999, SCIENCE, V285, p1355i; Ercker L., 1951, TREATIES ORES ASSAYI, V2nd; European commission directives, 2003, OFF J EUR UNION L, V37, P19; Eveloy V, 2005, IEEE T COMPON PACK T, V28, P884, DOI 10.1109/TCAPT.2005.859353; Fang T., 2005, THESIS U MARYLAND; FRANK FC, 1953, PHILOS MAG, V44, P854; FRANKS J, 1956, NATURE, V177, P984, DOI 10.1038/177984a0; FRANKS J, 1958, ACTA METALL MATER, V6, P103, DOI 10.1016/0001-6160(58)90120-2; Fukuda Y., 2006, TIN WHISKERS ELECT L, P551; Galyon G. T., 2005, 2005 EL COMP TECHN C; George E, 2014, MICROELECTRON RELIAB, V54, P214, DOI 10.1016/j.microrel.2013.07.134; GERHARDSSON L, 1986, SCI TOTAL ENVIRON, V50, P65, DOI 10.1016/0048-9697(86)90352-9; GERHARDSSON L, 1995, J TRACE ELEM MED BIO, V9, P136; Gidlow DA, 2004, OCCUP MED-OXFORD, V54, P76, DOI 10.1093/occmed/kqh019; Glazunova V., 1963, ZH PRIKL KHIM, V36, P543; Glazunova V.K., 1962, Kristallografiya, V7; GRANDJEAN P, 1978, ENVIRON RES, V17, P303, DOI 10.1016/0013-9351(78)90033-6; Hada Y., 1978, 26 ANN NAT REL C; Heath Linda M, 2003, Rev Environ Health, V18, P231; Hilty R.D., 2004, NEMI LEAD FRES SUMM; Hoffman E.N., 2005, 51 IEEE HOLM C 26 28; Hong W.S., 2012, J ELECT MAT, V42, P332; Howard HP, 2011, ACTA MATER, V59, P1957, DOI 10.1016/j.actamat.2010.11.061; Jacobsen K., 2008, GUARDIAN; Jadhav N, 2010, IEEE T ELECTRON PACK, V33, P183, DOI 10.1109/TEPM.2010.2043847; Jadhav N, 2013, J ELECTRON MATER, V42, P312, DOI 10.1007/s11664-012-2267-3; JEDEC/IPC, 2006, CURR TIN WHISK THEOR, P1; Jiang B, 2007, J MATER SCI-MATER EL, V18, P513, DOI 10.1007/s10854-006-9099-y; Jo JL, 2014, J ELECTRON MATER, V43, P1, DOI 10.1007/s11664-013-2706-9; Kadesch J.S., 2001, NASA EEE LINKS NEWSL, V6, P1; Kim KS, 2006, THIN SOLID FILMS, V504, P350, DOI 10.1016/j.tsf.2005.09.088; Kim KS, 2008, MICROELECTRON RELIAB, V48, P111, DOI 10.1016/j.microrel.2007.01.088; KOONCE SE, 1953, J APPL PHYS, V24, P365, DOI 10.1063/1.1721283; KOONCE SE, 1954, J APPL PHYS, V25, P134, DOI 10.1063/1.1721508; Kuyucak S, 1996, CAN METALL QUART, V35, P1, DOI 10.1016/0008-4433(95)00023-2; LeBret JB, 2003, J MATER RES, V18, P585, DOI 10.1557/JMR.2003.0076; LEE C, 2006, 2006 IEEE INT C, P697; Leidecker H., 2006, SLIDES; Leidecker H., 2000, P IMAPS NORD 37 IMPA; Levine B., 2002, ELECT NEWS, V48; Li QQ, 2014, J MATER SCI-MATER EL, V25, P1222, DOI 10.1007/s10854-014-1713-9; Li SB, 2007, J MATER RES, V22, P3226, DOI 10.1557/JMR.2007.0402; Liang H., 2007, CIRCUIT INF, V11, P55; Liang J, 2007, J MATER SCI-MATER EL, V18, P599, DOI 10.1007/s10854-007-9153-4; LINDBORG U, 1975, METALL TRANS A, V6, P1581, DOI 10.1007/BF02641971; [刘萌 LIU Meng], 2009, [材料科学与工程学报, Journal of Materials Science and Engineering], V27, P314; Liu M, 2009, J ALLOY COMPD, V486, P590, DOI 10.1016/j.jallcom.2009.07.012; Livingston H., 2003, BAE SYSTEM INFORM EL; Mathew S., 2007, HDP 07; Mathew S., 2007, INT S HIGH DENS PACK; Matkowski P., 2005, 29 INT C IMPAS POL C; McDowell M.E., 1993, P AER APPL C; Monchoux J.P., 2002, ACTA MAT, V50, P3161, DOI 10.1016/S1359-6454(02)00129-5; Moriuchi H, 2007, J ELECTRON MATER, V36, P220, DOI 10.1007/s11664-006-0030-3; MURAKAMI M, 1978, THIN SOLID FILMS, V55, P101, DOI 10.1016/0040-6090(78)90078-0; MURAKAMI M, 1977, THIN SOLID FILMS, V46, P109, DOI 10.1016/0040-6090(77)90346-7; Nabaro F.R.N., 1958, INT C CRYST GROWTH C; Nakadaira Y, 2008, MICROELECTRON RELIAB, V48, P83, DOI 10.1016/j.microrel.2007.01.091; Nordwall B., 1986, AVIATION WEEK S 0620, P65; Nowotny V.H., 1971, PROG SOLID STATE CHE, V5, P27, DOI 10.1016/0079-6786(71)90016-1; Osenbach JW, 2007, J MATER SCI-MATER EL, V18, P283, DOI 10.1007/s10854-006-9030-6; Osenbach JW, 2010, IEEE T ELECTRON PACK, V33, P16, DOI 10.1109/TEPM.2009.2032919; Osenbach JW, 2011, JOM-US, V63, P57, DOI 10.1007/s11837-011-0177-0; PEACH MO, 1952, J APPL PHYS, V23, P1401, DOI 10.1063/1.1702147; Pei F, 2014, SCRIPTA MATER, V93, P16, DOI 10.1016/j.scriptamat.2014.08.019; Pinol LA, 2011, IEEE T COMP PACK MAN, V1, P2028, DOI 10.1109/TCPMT.2011.2167338; PITT CH, 1964, J APPL PHYS, V35, P459, DOI 10.1063/1.1713337; Reynolds HL, 2010, IEEE T ELECTRON PACK, V33, P1, DOI 10.1109/TEPM.2009.2030179; Robertson Jordan, US TODAY; Robertson Jordan, 2007, OCALA STAR BANNER; Rovner SL, 2007, CHEM ENG NEWS, V85, P30, DOI 10.1021/cen-v085n029.p030; Rozen M., 1968, PLATING, V55, P1155; Sabbagh N., 1975, MET FINISH, V73, P27; Saka M, 2007, SCRIPTA MATER, V56, P1031, DOI 10.1016/j.scriptamat.2007.02.036; Saunders N., 1990, B ALLOY PHASE DIAGRA, V11, P278; Schetty R, 2009, 2009 11TH ELECTRONICS PACKAGING TECHNOLOGY CONFERENCE (EPTC 2009), P225, DOI 10.1109/EPTC.2009.5416547; Shi HC, 2011, J ELECTRON MATER, V40, P1962, DOI 10.1007/s11664-011-1701-2; Shi H.C., 2011, J CHIN NONFERR MET, V21, P1021; Shibutani T, 2008, MICROELECTRON RELIAB, V48, P1613, DOI 10.1016/j.microrel.2008.06.004; Shibutani T, 2006, IEEE T ELECTRON PACK, V29, P259, DOI 10.1109/TEPM.2006.887357; Shin JW, 2009, J MATER RES, V24, P1522, DOI 10.1557/JMR.2009.0172; Shin S.J., 2010, J MECHAN SCI TECHNOL, V23, P2885; Sienes G., 1960, J PHYS SOC JPN, V15, P1199; Skwarek A, 2013, ACTA PHYS POL A, V123, P430; SMITH HG, 1958, J APPL PHYS, V29, P679, DOI 10.1063/1.1723249; Stupian G.W., 1992, TR9229257, P1; Stupian G.W., 1992, TR9229257; Su P., 2011, GROWTH MECH MITIGATI, P125; Sun Z. M., 2007, ACTA MAT, V55, P3387; Sun ZM, 2006, J MATER RES, V21, P1629, DOI 10.1557/JMR.2006.0220; Sun ZM, 2005, J MATER RES, V20, P1087, DOI 10.1557/JMR.2005.0149; Sun Z.M., 2013, MAT RES LETT, V1, P109; Sun ZM, 2005, J MATER RES, V20, P2618, DOI 10.1557/JMR.2005.0326; Thomas DA, 2002, MICROELECTRON RELIAB, V42, P641, DOI 10.1016/S0026-2714(02)00040-9; Wang Y., 2013, J MATER SCI, V49, P1099; Westinghouse Electric Company, 2005, NUCL TECHN B; Westinghouse Electric Company, 2002, NUCL TECHN B; Whitlaw K., 2002, P SESF SUR FIN; Woodrow T.A., 2005, IPC JEDEC 8 INT C LE; Wu CML, 2007, J MATER SCI-MATER EL, V18, P77, DOI 10.1007/s10854-006-9022-6; Wu JY, 2005, Z METALLKD, V96, P847; Xian AP, 2009, J MATER RES, V24, P2775, DOI 10.1557/JMR.2009.0334; Xu C., 2002, CIRCUITREE MAGAZINE, V15; Xue P, 2012, SOLDER SURF MT TECH, V24, P280, DOI 10.1108/09540911211262566; Ye H., 2013, SURF MT TECHNOL, V25, P139; [叶焕 Ye Huan], 2013, [焊接学报, Transactions of the China Welding Institution], V34, P59; Ye H, 2013, MATER LETT, V98, P78, DOI 10.1016/j.matlet.2013.01.065; Zhang J., 2012, J MATER RES, V24, P39; Zhang P, 2015, J ALLOY COMPD, V619, P488, DOI 10.1016/j.jallcom.2014.09.082; Zhang P., IN PRESS; Zhang Y., 2002, P IPC SMEMA COUNC AP; Zhang Y., 2004, CIRCUITTREE, V17, P70; Zhao Zi-shou, 2012, Chinese Journal of Nonferrous Metals, V22	220	0	0	JOURNAL MATER SCI TECHNOL	SHENYANG	72 WENHUA RD, SHENYANG 110015, PEOPLES R CHINA	1005-0302			J MATER SCI TECHNOL	J. Mater. Sci. Technol.	JUL	2015	31	7					675	698		10.1016/j.jmst.2015.04.001		24	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CL0CP	WOS:000356606700001		
J	Ojima, Y; Suparman, A; Nguyen, MH; Sakka, M; Sakka, K; Taya, M				Ojima, Yoshihiro; Suparman, Asep; Minh Hong Nguyen; Sakka, Makiko; Sakka, Kazuo; Taya, Masahito			Exopolysaccharide assay in Escherichia coli microcolonies using a cleavable fusion protein of GFP-labeled carbohydrate-binding module	JOURNAL OF MICROBIOLOGICAL METHODS			English	Article						Carbohydrate-binding module; Exopolysaccharide; Escherichia coli; Microcolony	LINKED LECTINSORBENT ASSAY; BACTERIAL BIOFILMS; MATRIX	A fused protein composed of a carbohydrate-binding module and green fluorescence protein (GFP) was developed to measure the exopolysaccharides (EPShs) present in Escherichia coli microcolonies. The cleavage of the GFP part of this protein using a site-specific protease allowed for the non-invasive and quantitative evaluation of the EPShs. (C) 2015 Elsevier B.V. Al! rights reserved.	[Ojima, Yoshihiro; Suparman, Asep; Minh Hong Nguyen; Taya, Masahito] Osaka Univ, Grad Sch Engn Sci, Div Chem Engn, Toyonaka, Osaka 5608531, Japan; [Sakka, Makiko; Sakka, Kazuo] Mie Univ, Grad Sch Bioresources, Appl Microbiol Lab, Tsu, Mie 5148507, Japan	Ojima, Y (reprint author), Osaka Univ, Grad Sch Engn Sci, Div Chem Engn, 1-3 Machikaneyama Cho, Toyonaka, Osaka 5608531, Japan.	ojima@cheng.es.osaka-u.ac.jp					Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006; Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008; Masuko T, 2005, ANAL BIOCHEM, V339, P69, DOI 10.1016/j.ab.2004.12.001; Liu Y, 2004, J BIOTECHNOL, V110, P251, DOI 10.1016/j.jbiotec.2004.02.012; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Burton E, 2007, J IND MICROBIOL BIOT, V34, P1, DOI 10.1007/s10295-006-0086-3; Mika F, 2013, INT J MOL SCI, V14, P4560, DOI 10.3390/ijms14034560; Chen X, 2002, APPL MICROBIOL BIOT, V59, P718, DOI 10.1007/s00253-002-1044-2; Jahn A, 1995, WATER SCI TECHNOL, V32, P157; Leriche V, 2000, APPL ENVIRON MICROB, V66, P1851, DOI 10.1128/AEM.66.5.1851-1856.2000; Nguyen MH, 2014, J BIOSCI BIOENG, V118, P400, DOI 10.1016/j.jbiosc.2014.03.005; Sakka M, 2011, APPL ENVIRON MICROB, V77, P4260, DOI 10.1128/AEM.00226-11; Strathmann M, 2002, J MICROBIOL METH, V50, P237, DOI 10.1016/S0167-7012(02)00032-5; Thomas VL, 1997, CURR MICROBIOL, V35, P249, DOI 10.1007/s002849900248	14	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-7012	1872-8359		J MICROBIOL METH	J. Microbiol. Methods	JUL	2015	114						75	77		10.1016/j.mimet.2015.05.013		3	Biochemical Research Methods; Microbiology	Biochemistry & Molecular Biology; Microbiology	CK9IC	WOS:000356552800016		
J	Zhang, C; Sun, CM; Su, R; Pham, TD				Zhang, Chao; Sun, Changming; Su, Ran; Pham, Tuan D.			Clustered nuclei splitting via curvature information and gray-scale distance transform	JOURNAL OF MICROSCOPY			English	Article						Cell nuclei; clump splitting; curvature information based weighting; curvature weighting; grey-scale distance transform based on summation; image segmentation; shortest path	ACTIVE CONTOUR MODELS; EUCLIDEAN DISTANCE; IMAGE SEGMENTATION; ALGORITHMS; TIME; CLASSIFICATION; MICROSCOPY; BALLOONS	Clusters or clumps of cells or nuclei are frequently observed in two dimensional images of thick tissue sections. Correct and accurate segmentation of overlapping cells and nuclei is important for many biological and biomedical applications. Many existing algorithms split clumps through the binarization of the input images; therefore, the intensity information of the original image is lost during this process. In this paper, we present a curvature information, gray scale distance transform, and shortest path splitting line-based algorithm which can make full use of the concavity and image intensity information to find out markers, each of which represents an individual object, and detect accurate splitting lines between objects using shortest path and junction adjustment. The proposed algorithm is tested on both synthetic and real nuclei images. Experiment results show that the performance of the proposed method is better than that of marker-controlled watershed method and ellipse fitting method.	[Zhang, Chao] Univ New S Wales, Sch Engn & Informat Technol, Canberra, ACT 2600, Australia; [Zhang, Chao; Sun, Changming] CSIRO Computat Informat, N Ryde, NSW 2113, Australia; [Su, Ran] Bioinformat Inst, Singapore 138671, Singapore; [Pham, Tuan D.] Univ Aizu, Res Ctr Adv Informat Sci & Technol, Aizu Res Cluster Med Engn & Informat, Fukushima, Japan	Zhang, C (reprint author), Univ New S Wales, Sch Engn & Informat Technol, Canberra, ACT 2600, Australia.	kone.zhang@gmail.com	Sun, Changming/A-3276-2008; Su, Ran/L-2323-2015	Sun, Changming/0000-0001-5943-1989; Su, Ran/0000-0001-5922-0364			ADAMS R, 1994, IEEE T PATTERN ANAL, V16, P641, DOI 10.1109/34.295913; Grady L, 2006, IEEE T PATTERN ANAL, V28, P1768, DOI 10.1109/TPAMI.2006.233; ARCELLI C, 1988, COMPUT VISION GRAPH, V43, P361, DOI 10.1016/0734-189X(88)90089-8; Vincent L, 1993, IEEE T IMAGE PROCESS, V2, P176, DOI 10.1109/83.217222; Jung C, 2010, IEEE T BIO-MED ENG, V57, P2825, DOI 10.1109/TBME.2010.2060486; Chan TF, 2001, IEEE T IMAGE PROCESS, V10, P266, DOI 10.1109/83.902291; Li J, 2009, PATTERN RECOGN, V42, P349, DOI 10.1016/j.patcog.2008.07.017; Vila M, 2000, EUR J NEUROSCI, V12, P337, DOI 10.1046/j.1460-9568.2000.00901.x; Cheng JR, 2009, IEEE T BIO-MED ENG, V56, P741, DOI 10.1109/TBME.2008.2008635; Al-Kofahi Y, 2010, IEEE T BIO-MED ENG, V57, P841, DOI 10.1109/TBME.2009.2035102; Yang XD, 2006, IEEE T CIRCUITS-I, V53, P2405, DOI 10.1109/TCSI.2006.884469; Cloppet F, 2010, PATTERN RECOGN LETT, V31, P755, DOI 10.1016/j.patrec.2010.01.022; Kumar S, 2006, PATTERN RECOGN, V39, P1088, DOI 10.1016/j.patcog.2005.11.014; Caselles V, 1997, INT J COMPUT VISION, V22, P61, DOI 10.1023/A:1007979827043; Wang H, 2012, PATTERN RECOGN, V45, P2780, DOI 10.1016/j.patcog.2011.12.020; Bai XZ, 2009, PATTERN RECOGN, V42, P2434, DOI 10.1016/j.patcog.2009.04.003; COHEN LD, 1993, IEEE T PATTERN ANAL, V15, P1131, DOI 10.1109/34.244675; Jung C, 2010, IEEE T BIO-MED ENG, V57, P2600, DOI 10.1109/TBME.2010.2060336; Schupp S, 2000, INT C PATT RECOG, P622; Ip HHS, 1996, ELECTRON LETT, V32, P1564, DOI 10.1049/el:19961077; Bai XZ, 2013, AIP CONF PROC, V1559, P67, DOI 10.1063/1.4824997; BORGEFORS G, 1986, COMPUT VISION GRAPH, V34, P344, DOI 10.1016/S0734-189X(86)80047-0; BREU H, 1995, IEEE T PATTERN ANAL, V17, P529, DOI 10.1109/34.391389; COHEN LD, 1991, CVGIP-IMAG UNDERSTAN, V53, P211, DOI 10.1016/1049-9660(91)90028-N; Ikonen L, 2007, PATTERN RECOGN LETT, V28, P604, DOI 10.1016/j.patrec.2006.10.010; Kass M., 1988, INT J COMPUT VISION, V1, P321, DOI DOI 10.1007/BF00133570; Kim J. S., 2007, MACH VISION APPL, V19, P181; Malpica N, 1997, CYTOMETRY, V28, P289, DOI 10.1002/(SICI)1097-0320(19970801)28:4<289::AID-CYTO3>3.0.CO;2-7; Meyer F., 1990, Journal of Visual Communication and Image Representation, V1, DOI 10.1016/1047-3203(90)90014-M; NIBLACK CW, 1992, CVGIP-GRAPH MODEL IM, V54, P420, DOI 10.1016/1049-9652(92)90026-T; ROSENFEL.A, 1966, J ACM, V13, P471; RAGNEMALM I, 1993, PATTERN RECOGN LETT, V14, P883, DOI 10.1016/0167-8655(93)90152-4; Selig B, 2012, J MICROSC-OXFORD, V246, P298, DOI 10.1111/j.1365-2818.2012.03621.x; SOILLE P, 1994, PATTERN RECOGN LETT, V15, P1235, DOI 10.1016/0167-8655(94)90113-9; Zhang C., 2012, P IM VIS COMP NZ, P49; Zimmer C, 2005, IEEE T PATTERN ANAL, V27, P1838, DOI 10.1109/TPAMI.2005.214; Zucker S. W., 1976, Computer Graphics and Image Processing, V5, DOI 10.1016/S0146-664X(76)80014-7	37	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-2720	1365-2818		J MICROSC-OXFORD	J. Microsc..	JUL	2015	259	1					36	52		10.1111/jmi.12246		17	Microscopy	Microscopy	CK6AN	WOS:000356310200005		
J	Takeuchi, M; Kishino, S; Park, SB; Kitamura, N; Ogawa, J				Takeuchi, Michiki; Kishino, Shigenobu; Park, Si-Bum; Kitamura, Nahoko; Ogawa, Jun			Characterization of hydroxy fatty acid dehydrogenase involved in polyunsaturated fatty acid saturation metabolism in Lactobacillus plantarum AKU 1009a	JOURNAL OF MOLECULAR CATALYSIS B-ENZYMATIC			English	Article						Lactic acid bacteria; Hydroxy fatty acid; Oxo fatty acid; Short-chain dehydrogenase/reductase	CONJUGATED LINOLEIC-ACID; ALCOHOL-DEHYDROGENASE; BACTERIA; PURIFICATION	Hydroxy fatty acid dehydrogenase, which is involved in polyunsaturated fatty acid saturation metabolism in Lactobacillus plantarum AKU 1009a, was cloned, expressed, purified, and characterized. The enzyme preferentially catalyzed NADH-dependent hydrogenation of oxo fatty acids over NAD(+)-dependent dehydrogenation of hydroxy fatty acids. In the dehydrogenation reaction, fatty acids with an internal hydroxy group such as 10-hydroxy-cis-12-octadecenoic acid, 12-hydroxy-cis-9-octadecenoic acid, and 13-hydroxy-cis-9-octadecenoic acid served as better substrates than those with alpha- or beta-hydroxy groups such as 3-hydroxyoctadecanoic acid or 2-hydroxyeicosanoic acid. The apparent Km value for 10-hydroxy-cis-12-octadecenoic acid (HYA) was estimated to be 38 mu M with a k(cat) of 7.6 x 10(-3) s(-1). The apparent K-m value for 10-oxo-cis-12-octadecenoic acid (KetoA) was estimated to be 1.8 mu M with a k(cat) of 5.7 x 10(-1) s(-1). In the hydrogenation reaction of KetoA, both (R)- and (S)-HYA were generated, indicating that the enzyme has low stereoselectivity. This is the first report of a dehydrogenase with a preference for fatty acids with an internal hydroxy group. (C) 2015 Elsevier B.V. All rights reserved.	[Takeuchi, Michiki; Kishino, Shigenobu; Kitamura, Nahoko; Ogawa, Jun] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Sakyo Ku, Kyoto 6068502, Japan; [Kishino, Shigenobu; Park, Si-Bum] Kyoto Univ, Grad Sch Agr, Lab Ind Microbiol, Sakyo Ku, Kyoto 6068502, Japan; [Ogawa, Jun] Kyoto Univ, Res Unit Physiol Chem, Kyoto 6068502, Japan	Ogawa, J (reprint author), Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Sakyo Ku, Kitashirakawa Oiwakecho, Kyoto 6068502, Japan.	ogawa@kais.kyoto-u.ac.jp		Kishino, Shigenobu/0000-0002-4587-2422	Industrial Technology Research Grant Program [07A08005a]; New Energy and Industrial Technology Development Organization (NEDO) of Japan; Centers of Excellence for Microbial-Process Development Pioneering Future Production Systems from the Ministry of Education, Culture, Sports, Science, and Technology of Japan [J13]; Bio-Oriented Technology Research Advancement Institution of Japan; Science and Technology Promotion Program for Agriculture Forestry, Fisheries and Food Industry from the Ministry of Agriculture, Forestry and Fisheries of Japan [26002A]; Advanced Low Carbon Technology Research and Development Program of Japan; Japan Society for the Promotion of Science for Young Scientists [26686, 1401985];  [19780056];  [16688004];  [18208009]	This work was supported, in part, by the Industrial Technology Research Grant Program in 2007 (Grant 07A08005a to S.K.); the Project for the Development of a Technological Infrastructure for Industrial Bioprocesses on Research and Development of New Industrial Science and Technology Frontiers (S.S.) from the New Energy and Industrial Technology Development Organization (NEDO) of Japan; Scientific Research Grants in Aid 19780056 (to S.K.), 16688004 (to J.O.), and 18208009 (to S.S.); the Centers of Excellence for Microbial-Process Development Pioneering Future Production Systems from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (J13 to S.S.); the Bio-Oriented Technology Research Advancement Institution of Japan (J.O.); Science and Technology Promotion Program for Agriculture Forestry, Fisheries and Food Industry from the Ministry of Agriculture, Forestry and Fisheries of Japan (26002A to J.O.); Advanced Low Carbon Technology Research and Development Program of Japan (S.K.); M.T. (26686) and S.K. (1401985) received Research Fellowship from the Japan Society for the Promotion of Science for Young Scientists.	Kim YI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031317; LEE KN, 1994, ATHEROSCLEROSIS, V108, P19, DOI 10.1016/0021-9150(94)90034-5; Ogawa J, 2005, J BIOSCI BIOENG, V100, P355, DOI 10.1263/jbb.100.355; Kishino S, 2011, BIOSCI BIOTECH BIOCH, V75, P318, DOI 10.1271/bbb.100699; Schlieben NH, 2005, J MOL BIOL, V349, P801, DOI 10.1016/j.jmb.2005.04.029; GEMAL AL, 1981, J AM CHEM SOC, V103, P5454, DOI 10.1021/ja00408a029; Kishino S, 2002, J AM OIL CHEM SOC, V79, P159, DOI 10.1007/s11746-002-0451-4; Pennacchio A, 2008, APPL ENVIRON MICROB, V74, P3949, DOI 10.1128/AEM.00217-08; Kallberg Y, 2002, EUR J BIOCHEM, V269, P4409, DOI 10.1046/j.1432-1033.2002.03130.x; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Takeuchi M, 2013, EUR J LIPID SCI TECH, V115, P386, DOI 10.1002/ejlt.201200414; IP C, 1991, CANCER RES, V51, P6118; Kishino S, 2013, P NATL ACAD SCI USA, V110, P17808, DOI 10.1073/pnas.1312937110; Ogawa J, 2001, APPL ENVIRON MICROB, V67, P1246, DOI 10.1128/AEM.67.3.1246-1252.2001; Kishino S, 2011, BIOCHEM BIOPH RES CO, V416, P188, DOI 10.1016/j.bbrc.2011.11.022; Park Y, 1997, LIPIDS, V32, P853, DOI 10.1007/s11745-997-0109-x; Itoh N, 2012, APPL MICROBIOL BIOT, V93, P1075, DOI 10.1007/s00253-011-3447-4; Urano N, 2011, J BIOSCI BIOENG, V111, P266, DOI 10.1016/j.jbiosc.2010.11.005; CURTIS RG, 1953, J CHEM SOC, P457, DOI 10.1039/jr9530000457; Kishino S, 2003, BIOSCI BIOTECH BIOCH, V67, P179, DOI 10.1271/bbb.67.179; Pariza M.W., 1990, ANTIMUTAGENESIS ANTI, P167; Song J.- W., 2013, ANGEW CHEM, V125, P2594; Takeuchi M., 2014, J BIOSCI BIOENG, DOI [10.1016/j.jbiosc.2014.10.022, DOI 10.1016/JJBLOSC.2014.10.022]	23	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1381-1177	1873-3158		J MOL CATAL B-ENZYM	J. Mol. Catal. B-Enzym.	JUL	2015	117						7	12		10.1016/j.molcatb.2015.03.020		6	Biochemistry & Molecular Biology; Chemistry, Physical	Biochemistry & Molecular Biology; Chemistry	CK9GZ	WOS:000356549900002		
J	Kimura, K; Orita, T; Liu, Y; Yang, Y; Tokuda, K; Kurakazu, T; Noda, T; Yanai, R; Morishige, N; Takeda, A; Ishibashi, T; Sonoda, KH				Kimura, Kazuhiro; Orita, Tomoko; Liu, Yang; Yang, Yang; Tokuda, Kazuhiro; Kurakazu, Taishi; Noda, Takeshi; Yanai, Ryoji; Morishige, Naoyuki; Takeda, Atsunobu; Ishibashi, Tatsuro; Sonoda, Koh-Hei			Attenuation of EMT in RPE cells and subretinal fibrosis by an RAR-gamma agonist	JOURNAL OF MOLECULAR MEDICINE-JMM			English	Article						Retinal pigment epithelial cell; Transforming growth factor-beta (TGF-beta); Epithelial-mesenchymal transition; Extracellular matrix; Subretinal fibrosis; Age-related macular degeneration	GROWTH-FACTOR-BETA; PIGMENT EPITHELIAL-CELLS; HUMAN TENON FIBROBLASTS; TRANS-RETINOIC ACID; MACULAR DEGENERATION; PROLIFERATIVE VITREORETINOPATHY; MESENCHYMAL TRANSITION; CONTRACTION; INHIBITION; INDUCTION	Subretinal fibrosis contributes to the loss of vision associated with age-related macular degeneration (AMD). Retinal pigment epithelial (RPE) cells play a key role in the pathogenesis of AMD including the fibrotic reaction. We examined the role of retinoic acid receptor-gamma (RAR-gamma) in the epithelial-mesenchymal transition (EMT) and other fibrosis-related processes in mouse RPE cells cultured in a type I collagen gel. Transforming growth factor-beta 2 (TGF-beta 2)-induced collagen gel contraction mediated by the RPE cells was inhibited by the RAR-gamma agonist R667 in a concentration- and time-dependent manner. Expression of the mesenchymal markers alpha-smooth muscle actin and fibronectin, the release of interleukin-6, and the phosphorylation of paxillin, mitogen-activated protein kinases (ERK, p38, and JNK), Smad2, and AKT induced by TGF-beta 2 were also suppressed by the RAR-gamma agonist. Furthermore, gelatin zymography and immunoblot analysis revealed that the TGF-beta 2-induced release of matrix metalloproteinase (MMP)-2, MMP-3, MMP-8, and MMP-9 from RPE cells was inhibited by R667, and the MMP inhibitor GM6001 attenuated TGF-beta 2-induced RPE cell contraction. Finally, immunohistofluorescence analysis with antibodies to glial fibrillary acidic protein showed that R667 inhibited the development of subretinal fibrosis in a mouse model in vivo. Our results thus suggest that RAR-gamma agonists may prove effective for the treatment of subretinal fibrosis associated with AMD.	[Kimura, Kazuhiro; Orita, Tomoko; Liu, Yang; Tokuda, Kazuhiro; Kurakazu, Taishi; Noda, Takeshi; Yanai, Ryoji; Morishige, Naoyuki; Sonoda, Koh-Hei] Yamaguchi Univ, Grad Sch Med, Dept Ophthalmol, Ube, Yamaguchi 7558505, Japan; [Yang, Yang; Takeda, Atsunobu; Ishibashi, Tatsuro] Kyushu Univ, Grad Sch Med Sci, Dept Ophthalmol, Higashi Ku, Fukuoka 8128582, Japan	Kimura, K (reprint author), Yamaguchi Univ, Grad Sch Med, Dept Ophthalmol, 1-1-1 Minami Kogushi, Ube, Yamaguchi 7558505, Japan.	k.kimura@yamaguchi-u.ac.jp			Takeda Science Foundation	This study was supported by Takeda Science Foundation. We thank Yukari Mizuno and Shizuka Murata for technical assistance.	King RE, 2005, CHEM-BIOL INTERACT, V151, P143, DOI 10.1016/j.cbi.2004.11.003; Campagne MV, 2014, J PATHOL, V232, P151, DOI 10.1002/path.4266; Schambach F, 2007, EUR J IMMUNOL, V37, P2396, DOI 10.1002/eji.200737621; Hinz B, 2001, MOL BIOL CELL, V12, P2730; Kamato D, 2013, CELL SIGNAL, V25, P2017, DOI 10.1016/j.cellsig.2013.06.001; BAUDOUIN C, 1993, OPHTHALMIC RES, V25, P52; Chen F, 2007, DEVELOPMENT, V134, P2969, DOI 10.1242/dev.006221; Jo YJ, 2011, INVEST OPHTH VIS SCI, V52, P6089, DOI 10.1167/iovs.10-5189; Yao HW, 2004, LIFE SCI, V76, P29, DOI 10.1016/j.lfs.2004.06.019; Lan HY, 2011, CONTRIB NEPHROL, V170, P75, DOI 10.1159/000324949; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Liu Y, 2006, EXP EYE RES, V83, P1196, DOI 10.1016/j.exer.2006.06.008; Kijlstra A, 2005, OCUL IMMUNOL INFLAMM, V13, P3, DOI 10.1080/09273940590909185; Ramachandran C, 2011, MOL VIS, V17, P1877; Liu Y, 2008, INVEST OPHTH VIS SCI, V49, P1429, DOI 10.1167/iovs.07-0451; Thomas PE, 2007, AM J PHYSIOL-LUNG C, V293, pL417, DOI 10.1152/ajplung.00489.2006; Kimura K, 2014, INVEST OPHTH VIS SCI, V55, P2621, DOI 10.1167/iovs.13-13501; [Anonymous], 1982, SCAN ELECTRON MICROS; Ngo P, 2006, METH MOL B, V341, P103; Lee H, 2007, INVEST OPHTH VIS SCI, V48, P4291, DOI 10.1167/iovs.07-0086; Saika S, 2004, LAB INVEST, V84, P1245, DOI 10.1038/labinvest.3700156; BENSON MT, 1992, CURR EYE RES, V11, P173, DOI 10.3109/02713689208999529; Clagett-Dame M, 2006, J NEUROBIOL, V66, P739, DOI 10.1002/neu.20241; Conde I, 2004, INT J ONCOL, V25, P1183; Eckes Beate, 2010, Fibrogenesis Tissue Repair, V3, P4, DOI 10.1186/1755-1536-3-4; Giambernardi TA, 2001, MATRIX BIOL, V20, P577, DOI 10.1016/S0945-053X(01)00166-4; Hammer M, 2008, GRAEF ARCH CLIN EXP, V246, P105, DOI 10.1007/s00417-007-0639-9; Hong YJ, 2014, INVEST OPHTH VIS SCI, V55, P5016, DOI 10.1167/iovs.14-14005; Huang Z, 2008, CELL SIGNAL, V20, P2002, DOI 10.1016/j.cellsig.2008.07.014; Kaiser PK, 1996, INT OPHTHALMOL CLIN, V36, P145, DOI 10.1097/00004397-199603610-00015; Lim WK, 2004, AM J OPHTHALMOL, V138, P475, DOI 10.1016/j.ajo.2004.04.013; Liu Y, 2014, INVEST OPHTH VIS SCI, V55, P4199, DOI 10.1167/iovs.13-13572; Lotan R, 1997, ENVIRON HEALTH PERSP, V105, P985, DOI 10.2307/3433315; Miller JW, 2010, JPN J OPHTHALMOL, V54, P523, DOI 10.1007/s10384-010-0863-4; Simoni D, 2001, CURR PHARM DESIGN, V7, P1823, DOI 10.2174/1381612013397168; Soderpalm AK, 2000, INVEST OPHTH VIS SCI, V41, P937; STODTLER M, 1994, INT OPHTHALMOL, V18, P323; Suzuki Ryujiro, 2004, Treat Respir Med, V3, P17, DOI 10.2165/00151829-200403010-00003; Zhang H, 2012, INT J OPHTHALMOL-CHI, V5, P307, DOI 10.3980/j.issn.2222-3959.2012.03.11	39	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0946-2716	1432-1440		J MOL MED	J. Mol. Med.	JUL	2015	93	7					749	758		10.1007/s00109-015-1289-8		10	Genetics & Heredity; Medicine, Research & Experimental	Genetics & Heredity; Research & Experimental Medicine	CK9AC	WOS:000356530700006		
J	Uehara, H; Horiai, K; Sakamoto, Y				Uehara, Hiromichi; Horiai, Koui; Sakamoto, Yukihiro			Vibrational-rotational spectra of (CS)-C-13 and global multi-isotopologue analysis	JOURNAL OF MOLECULAR SPECTROSCOPY			English	Article						CS; Vibrational-rotational; High-resolution; Breakdown; Born-Oppenheimer approximation	MILLIMETER-WAVE SPECTROSCOPY; OPTIMAL FITTING PARAMETERS; DIATOMIC-MOLECULES; CARBON MONOSULFIDE; DIPOLE-MOMENT; DUNHAM COEFFICIENTS; MICROWAVE-SPECTRUM; ISOTOPE DEPENDENCE; INFRARED-SPECTRA; CS	In total, 626 vibrationalrotational spectral lines of the Delta v = 1 transitions of (CS)-C-13-S-32 up to band v = 5-4 have been measured with a Fourier-transform spectrometer at resolution 0.010 cm(-1). To calibrate accurately the spectral lines, a separate observation of the vibrational-rotational bands of (CS)-C-12-S-32 was made with simultaneous recording of the N2O spectrum in absorption, to serve as wavenumber standards, with dual sample cells at resolution 0.008 cm(-1). The spectral wavenumbers of (CS)-C-12-S-32 in turn become calibration standards. All present vibrationalrotational spectra of (CS)-C-13-S-32 and (CS)-C-12-S-32, the reported vibrationalrotational spectra of (CS)-C-12-S-32, (CS)-C-12-S-33, (CS)-C-12-S-34, and (CS)-C-13-S-32, and the reported rotational spectra of (CS)-C-12-S-32, (CS)-C-12-S-33, (CS)-C-12-S-34, (CS)-C-12-S-36, (CS)-C-13-S-32, (CS)-C-13-S-33 and (CS)-C-13-S-34 were subjected to a global multi-isotopologue analysis, which reduced them to molecular parameters in a single set. The wavenumbers of 39-74 spectral lines, in total, comprising data of seven isotopologues were fitted with 22 isotopically invariant, traditional molecular parameters in a single set. As the normalized standard deviation is 1.38, the obtained fit is satisfactory. To facilitate the calculation of spectral wavenumbers, the values of the Dunham coefficients of 42 Y-ij for each of (CS)-C-12-S-32, (CS)-C-12-S-33, (CS)-C-12-S-34, (CS)-C-12-S-36, (CS)-C-13-S-32, (CS)-C-13-S-33, (CS)-C-13-S-34, (CS)-C-13-S-36, (CS)-C-14-S-32, (CS)-C-14-S-33, (CS)-C-14-S-34 and (CS)-C-14-S-36, of which the spectra of the latter five isotopologues are not yet reported, were back-calculated with uncertainties using the evaluated 22 molecular parameters. The physical significance of the conventional treatments of the adiabatic and nonadiabatic corrections for Delta(C)(01) and Delta(S)(01) is discussed. (C) 2015 Elsevier Inc. All rights reserved.	[Uehara, Hiromichi; Horiai, Koui; Sakamoto, Yukihiro] Josai Univ, Fac Sci, Dept Chem, Sakado, Saitama 3500295, Japan	Uehara, H (reprint author), Josai Univ, Fac Sci, Dept Chem, Keyakidai 1-1, Sakado, Saitama 3500295, Japan.	huehara@josai.ac.jp					Ahrens V, 1999, Z NATURFORSCH A, V54, P131; MOCKLER RC, 1955, PHYS REV, V98, P1837, DOI 10.1103/PhysRev.98.1837; Ogilvie JF, 2000, ADV CHEM PHYS, V111, P475; COXON JA, 1992, CHEM PHYS, V167, P327, DOI 10.1016/0301-0104(92)80206-B; Dunham JL, 1932, PHYS REV, V41, P721, DOI 10.1103/PhysRev.41.721; WATSON JKG, 1980, J MOL SPECTROSC, V80, P411, DOI 10.1016/0022-2852(80)90152-6; BIRD GR, 1953, PHYS REV, V91, P222; BOGEY M, 1982, J MOL SPECTROSC, V95, P35, DOI 10.1016/0022-2852(82)90234-X; BOGEY M, 1981, CHEM PHYS LETT, V81, P256, DOI 10.1016/0009-2614(81)80247-3; BURKHOLDER JB, 1987, J MOL SPECTROSC, V124, P450, DOI 10.1016/0022-2852(87)90155-X; BUSTREEL R, 1979, CHEM PHYS LETT, V67, P178, DOI 10.1016/0009-2614(79)87132-8; Cohen E. R., 2007, QUANTITIES UNITS SYM; Dewar J, 1910, P R SOC LOND A-CONTA, V83, P526, DOI 10.1098/rspa.1910.0041; Herman RM, 1998, ADV CHEM PHYS, V103, P187, DOI 10.1002/9780470141625.ch2; Horiai K, 2011, CHEM PHYS, V380, P92, DOI 10.1016/j.chemphys.2010.12.011; KEWLEY R, 1963, J CHEM PHYS, V39, P2856, DOI 10.1063/1.1734116; Kim E, 2003, J MOL SPECTROSC, V219, P296, DOI 10.1016/S0022-2852(03)00027-4; KIRSCHNER SM, 1977, J MOL SPECTROSC, V65, P306, DOI 10.1016/0022-2852(77)90199-0; Losanitsch SM, 1907, BER DTSCH CHEM GES, V40, P4656, DOI 10.1002/cber.190704004113; Maroulis G, 2000, MOL PHYS, V98, P481; MCGURK J, 1973, J CHEM PHYS, V58, P1420, DOI 10.1063/1.1679374; McTaggard F.K., 1967, PLASMA CHEM ELECT DI; RAM RS, 1995, J MOL SPECTROSC, V173, P146, DOI 10.1006/jmsp.1995.1225; TIEMANN E, 1982, CHEM PHYS, V67, P133, DOI 10.1016/0301-0104(82)85027-1; TODD TR, 1977, J MOL SPECTROSC, V66, P162, DOI 10.1016/0022-2852(77)90330-7; TODD TR, 1979, J MOL SPECTROSC, V74, P190, DOI 10.1016/0022-2852(79)90049-3; Uehara H., 2012, RECENT RES DEV CHEM, V6, P79; Uehara H, 2001, J MOL SPECTROSC, V207, P143, DOI 10.1006/jmsp.2001.8333; Uehara H, 2004, B CHEM SOC JPN, V77, P2189, DOI 10.1246/bcsj.77.2189; Uehara H, 2009, J PHYS CHEM A, V113, P10435, DOI 10.1021/jp9026018; Uehara H, 2004, B CHEM SOC JPN, V77, P1821, DOI 10.1246/bcsj.77.1821; WATSON JKG, 1973, J MOL SPECTROSC, V45, P99, DOI 10.1016/0022-2852(73)90179-3; WINKEL RJ, 1984, CAN J PHYS, V62, P1414; WINNEWIS.G, 1968, J MOL SPECTROSC, V28, P266, DOI 10.1016/0022-2852(68)90011-8; YAMADA C, 1979, J MOL SPECTROSC, V74, P203, DOI 10.1016/0022-2852(79)90050-X	35	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-2852	1096-083X		J MOL SPECTROSC	J. Mol. Spectrosc.	JUL	2015	313						19	39		10.1016/j.jms.2015.04.007		21	Physics, Atomic, Molecular & Chemical; Spectroscopy	Physics; Spectroscopy	CK9MS	WOS:000356564800004		
J	Murakami, T; Sango, K; Watabe, K; Niimi, N; Takaku, S; Li, ZH; Yamamura, K; Sunada, Y				Murakami, Tatsufumi; Sango, Kazunori; Watabe, Kazuhiko; Niimi, Naoko; Takaku, Shizuka; Li, Zhenghua; Yamamura, Ken-ichi; Sunada, Yoshihide			Schwann cells contribute to neurodegeneration in transthyretin amyloidosis	JOURNAL OF NEUROCHEMISTRY			English	Article						amyloidosis; dorsal root ganglia; neurodegeneration; Schwann cell; transthyretin	PERIPHERAL NERVOUS-SYSTEM; ROOT GANGLION NEURONS; ELECTRON MICROSCOPE; TISSUE-CULTURE; MOUSE MODEL; POLYNEUROPATHY; DISEASE; PROTEASOME; DEPOSITION; PROTEINS	Familial amyloidotic polyneuropathy (FAP) is one of the transthyretin (TTR) amyloidoses characterized by extracellular amyloid deposits and peripheral nerve involvement. Recently, we found significant expression of the TTR gene in Schwann cells of the peripheral nervous system. We hypothesized that local expression of variant TTR in Schwann cells may contribute to neurodegeneration in FAP. Schwann cells derived from the dorsal root ganglia (DRG) of transgenic mice expressing variant human TTR in a mouse null background were cultured long term to obtain spontaneously immortalized cell lines. We established an immortalized Schwann cell line, TgS1, derived from the transgenic mice. TgS1 cells synthesized variant TTR and secreted it into the medium. As sensory neuropathy usually arises early in FAP, we examined the effect of the conditioned medium derived from TgS1 cells on neurite outgrowth from DRG sensory neurons. Conditioned medium derived from TgS1 cells inhibited neurite outgrowth from the sensory neurons. TTR deposition in the DRG of aged transgenic mice was investigated by immunohistochemistry. TTR aggregates were observed in the cytoplasm of Schwann cells and satellite cells. Proteasome inhibition induced TTR aggregates as aggresomes in TgS1 cells. In conclusion, local variant TTR gene expression in Schwann cells might trigger neurodegeneration in FAP. We established a spontaneously immortalized Schwann cell line derived from familial amyloidotic polyneuropathy transgenic mice. Conditioned medium from the cells contained variant transthyretin (TTR), and inhibited neurite outgrowth of neurons. TTR aggregates were observed in the Schwann cells and satellite cells of aged mice. Proteasome inhibition induced TTR aggregates as aggresomes in the cultured cells. These results support the hypothesis that Schwann cells contribute to neurodegeneration in familial amyloidotic polyneuropathy (FAP).	[Murakami, Tatsufumi; Sunada, Yoshihide] Kawasaki Med Univ, Dept Neurol, Kurashiki, Okayama 7010192, Japan; [Sango, Kazunori; Watabe, Kazuhiko; Niimi, Naoko; Takaku, Shizuka] Tokyo Metropolitan Inst Med Sci, Dept Sensory & Motor Syst, ALS Neuropathy Project, Tokyo 113, Japan; [Li, Zhenghua; Yamamura, Ken-ichi] Kumamoto Univ, Inst Resource Dev & Anal, Div Dev Genet, Kumamoto, Japan	Murakami, T (reprint author), Kawasaki Med Univ, Dept Neurol, 577 Matsushima, Kurashiki, Okayama 7010192, Japan.	tatsum@med.kawasaki-m.ac.jp			Kawasaki Medical School [25-28, 26-1]; KAKENHI [23591260]	We thank Keiko Isoda, Nobuhisa Iwachido, and Taiji Suda of the Electron Microscopy Center, and Kazuko Yamane and Wakami Yamaguchi of the Physiological Function Research Center for technical assistance. This work was supported by Research Project Grants from Kawasaki Medical School [25-28, 26-1]; and KAKENHI [23591260]. The authors have no potential conflicts of interest to declare.	Koike H, 2012, J NEUROL NEUROSUR PS, V83, P152, DOI 10.1136/jnnp-2011-301299; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Sekijima Y, 2005, CELL, V121, P73, DOI 10.1016/j.cell.2005.01.018; Reixach N, 2004, P NATL ACAD SCI USA, V101, P2817, DOI 10.1073/pnas.0400062101; Sousa MM, 2001, AM J PATHOL, V159, P1993; Sango K, 2008, HISTOCHEM CELL BIOL, V130, P669, DOI 10.1007/s00418-008-0484-x; Selkoe DJ, 2003, NATURE, V426, P900, DOI 10.1038/nature02264; Sousa MM, 2003, PROG NEUROBIOL, V71, P385, DOI 10.1016/j.pneurobio.2003.11.002; Lee SM, 2011, J CELL SCI, V124, P3319, DOI 10.1242/jcs.087114; COLON W, 1992, BIOCHEMISTRY-US, V31, P8654, DOI 10.1021/bi00151a036; Andersson K, 2002, BIOCHEM BIOPH RES CO, V294, P309, DOI 10.1016/S0006-291X(02)00465-5; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; CARVALHO J, 1976, BRAIN, V99, P1, DOI 10.1093/brain/99.1.1; COIMBRA A, 1971, BRAIN, V94, P199, DOI 10.1093/brain/94.2.199; COIMBRA A, 1971, BRAIN, V94, P207, DOI 10.1093/brain/94.2.207; Fleming CE, 2009, J NEUROSCI, V29, P3220, DOI 10.1523/JNEUROSCI.6012-08.2009; Fleming CE, 2007, J NEUROCHEM, V103, P831, DOI 10.1111/j.1471-4159.2007.04828.x; Fortun J, 2005, J NEUROCHEM, V92, P1531, DOI 10.1111/j.1471-4159.2004.02987.x; Goncalves NP, 2014, EXP NEUROL, V257, P76, DOI 10.1016/j.expneurol.2014.04.030; Inoue S, 1998, J STRUCT BIOL, V124, P1, DOI 10.1006/jsbi.1998.4052; Kohno K, 1997, AM J PATHOL, V150, P1497; Murakami T, 2008, NEUROSCI LETT, V436, P335, DOI 10.1016/j.neulet.2008.03.063; Murakami T, 2010, BRAIN RES, V1348, P222, DOI 10.1016/j.brainres.2010.06.017; MURAKAMI T, 1995, PATHOL INT, V45, P1, DOI 10.1111/j.1440-1827.1995.tb03373.x; Murakami T., 2014, SCHWANN CELL DEV PAT, P103; Plante-Bordeneuve V, 2011, LANCET NEUROL, V10, P1086, DOI 10.1016/S1474-4422(11)70246-0; Pokrzywa M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014343; Samara C, 2013, FRONT CELL NEUROSCI, V7, DOI [10.3389/fncel.2013.00228, 10.3389/fnce1.2013.00228]; Sango K, 2011, J NEUROSCI RES, V89, P898, DOI 10.1002/jnr.22605; SOBUE G, 1990, BRAIN, V113, P903, DOI 10.1093/brain/113.4.903; Sousa MM, 2008, EXP NEUROL, V214, P362, DOI 10.1016/j.expneurol.2008.08.019; Takahashi K, 1974, Rinsho Shinkeigaku, V14, P266; Takaku S, 2013, NEUROCHEM INT, V62, P330, DOI 10.1016/j.neuint.2013.01.008; TOYOOKA K, 1995, ACTA NEUROPATHOL, V90, P516; Watabe K, 2003, NEUROPATHOLOGY, V23, P68, DOI 10.1046/j.1440-1789.2003.00478.x; WATABE K, 1995, J NEUROSCI RES, V41, P279, DOI 10.1002/jnr.490410215	36	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	JUL	2015	134	1					66	74		10.1111/jnc.13068		9	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	CK6WH	WOS:000356368800008		
J	Uchida, Y; Ito, K; Ohtsuki, S; Kubo, Y; Suzuki, T; Terasaki, T				Uchida, Yasuo; Ito, Katsuaki; Ohtsuki, Sumio; Kubo, Yoshiyuki; Suzuki, Takashi; Terasaki, Tetsuya			Major involvement of Na+-dependent multivitamin transporter (SLC5A6/SMVT) in uptake of biotin and pantothenic acid by human brain capillary endothelial cells	JOURNAL OF NEUROCHEMISTRY			English	Article						biotin; human blood-brain barrier; luminal uptake; pantothenic acid; SLC5A6; structure of inhibitor	BASAL GANGLIA DISEASE; TARGETED ABSOLUTE PROTEOMICS; BARRIER TRANSPORTERS; QUANTITATIVE ATLAS; PROTEIN EXPRESSION; JUNCTION PROTEINS; BLOOD; RECEPTORS; MUTATIONS	The purpose of this study was to clarify the expression of Na+-dependent multivitamin transporter (SLC5A6/SMVT) and its contribution to the supply of biotin and pantothenic acid to the human brain via the blood-brain barrier. DNA microarray and immunohistochemical analyses confirmed that SLC5A6 is expressed in microvessels of human brain. The absolute expression levels of SLC5A6 protein in isolated human and monkey brain microvessels were 1.19 and 0.597fmol/g protein, respectively, as determined by a quantitative targeted absolute proteomics technique. Using an antibody-free method established by Kubo etal. (2015), we found that SLC5A6 was preferentially localized at the luminal membrane of brain capillary endothelium. Knock-down analysis using SLC5A6 siRNA showed that SLC5A6 accounts for 88.7% and 98.6% of total [H-3]biotin and [H-3]pantothenic acid uptakes, respectively, by human cerebral microvascular endothelial cell line hCMEC/D3. SLC5A6-mediated transport in hCMEC/D3 was markedly inhibited not only by biotin and pantothenic acid, but also by prostaglandin E2, lipoic acid, docosahexaenoic acid, indomethacin, ketoprofen, diclofenac, ibuprofen, phenylbutazone, and flurbiprofen. This study is the first to confirm expression of SLC5A6 in human brain microvessels and to provide evidence that SLC5A6 is a major contributor to luminal uptake of biotin and pantothenic acid at the human blood-brain barrier. In humans, it was unclear (not concluded) about what transport system at the blood-brain barrier (BBB) is responsible for the brain uptakes of two vitamins, biotin and pantothenic acid, which are necessary for brain proper function. This study clarified for the first time that the solute carrier 5A6/Na+-dependent multivitamin transporter SLC5A6/SMVT is responsible for the supplies of biotin and pantothenic acid into brain across the BBB in humans. DHA, docosahexaenoic acid; NSAID, non-steroidal anti-inflammatory drug; PGE2, prostaglandin E2.	[Uchida, Yasuo; Ito, Katsuaki; Terasaki, Tetsuya] Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi 9808578, Japan; [Ohtsuki, Sumio] Kumamoto Univ, Fac Life Sci, Kumamoto, Japan; [Kubo, Yoshiyuki] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Toyama 930, Japan; [Suzuki, Takashi] Tohoku Univ, Grad Sch Med, Dept Pathol & Histotechnol, Sendai, Miyagi 9808578, Japan	Terasaki, T (reprint author), Tohoku Univ, Grad Sch Pharmaceut Sci, Div Membrane Transport & Drug Targeting, Aoba Ku, 6-3 Aoba, Sendai, Miyagi 9808578, Japan.	terasaki.tetsuya@m.tohoku.ac.jp			Japanese Society for the Promotion of Science [KAKENHI: 18109002, KAKENHI: 24249011]	We thank Dr Pierre-Olivier Couraud (Institut Cochin, Paris, France) for kindly providing hCMEC/D3 cell line. We also thank A. Nutomi for secretarial assistance. This study was supported in part by Grant-in-Aids for Scientific Research (S) [KAKENHI: 18109002] and Scientific Research (A) [KAKENHI: 24249011] from the Japanese Society for the Promotion of Science. Tetsuya Terasaki and Sumio Ohtsuki are full professors at Tohoku University and Kumamoto University, and are also directors of Proteomedix Frontiers Co., Ltd. This study was not supported by Proteomedix Frontiers Co., Ltd., and their positions at Proteomedix Frontiers Co., Ltd. did not influence the design of the study, the collection of the data, the analysis or interpretation of the data, the decision to submit the manuscript for publication, or the writing of the manuscript and did not present any financial conflicts. The other authors declare no competing interests.	Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Ito K, 2011, J PHARM SCI-US, V100, P3939, DOI 10.1002/jps.22487; Hosoya K, 2010, PHARM RES-DORDR, V27, P2715, DOI 10.1007/s11095-010-0272-x; Uchida Y, 2011, J NEUROCHEM, V117, P333, DOI 10.1111/j.1471-4159.2011.07208.x; VIANI A, 1992, BRIT J CLIN PHARMACO, V33, P299; Kamiie J, 2008, PHARM RES, V25, P1469, DOI 10.1007/s11095-008-9532-4; Prasad PD, 1998, J BIOL CHEM, V273, P7501, DOI 10.1074/jbc.273.13.7501; Ozand PT, 1998, BRAIN, V121, P1267, DOI 10.1093/brain/121.7.1267; Pugliese A, 2008, CELL BIOCHEM FUNCT, V26, P741, DOI 10.1002/cbf.1465; Ohtsuki S, 2013, MOL PHARMACEUT, V10, P289, DOI 10.1021/mp3004308; Zeng WQ, 2005, AM J HUM GENET, V77, P16, DOI 10.1086/431216; Ohtsuki S, 2011, J PHARM SCI-US, V100, P3547, DOI 10.1002/jps.22612; Spector R, 2007, J NEUROCHEM, V103, P425, DOI 10.1111/j.1471-4159.2007.04773.x; Benet L. Z, 1996, GOODMAN GILMANS PHAR, P1707; Daberkow RL, 2003, J NUTR, V133, P2703; desCarvalho F D., 2011, J BIOL CHEM, V286, P131; Geier EG, 2013, CLIN PHARMACOL THER, V94, P636, DOI 10.1038/clpt.2013.175; Hoshi Y, 2013, J PHARM SCI-US, V102, P3343, DOI 10.1002/jps.23575; Kubo Y., 2015, J PHARM SCI, DOI [10.1002/jps.24398, DOI 10.1002/JPS.24398]; NODA S, 1988, J NEUROL NEUROSUR PS, V51, P582, DOI 10.1136/jnnp.51.4.582; Park S, 2005, DRUG METAB DISPOS, V33, P1547, DOI 10.1124/dmd.105.005231; Paroder V, 2006, P NATL ACAD SCI USA, V103, P7270, DOI 10.1073/pnas.0602365103; Shimizu S, 1990, Nihon Shokakibyo Gakkai Zasshi, V87, P2540; SPECTOR R, 1986, J NEUROCHEM, V47, P966; SPECTOR R, 1987, J NEUROCHEM, V48, P400, DOI 10.1111/j.1471-4159.1987.tb04107.x; Subramanian VS, 2006, AM J PHYSIOL-CELL PH, V291, pC851, DOI 10.1152/ajpcell.00105.2006; Terasaki T, 2003, DRUG DISCOV TODAY, V8, P944, DOI 10.1016/S1359-6446(03)02858-7; Uchida Yasuo, 2013, Fluids Barriers CNS, V10, P21, DOI 10.1186/2045-8118-10-21; Wolf B., 2013, GENEREVIEWS	29	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	JUL	2015	134	1					97	112		10.1111/jnc.13092		16	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	CK6WH	WOS:000356368800011		
J	Matsuura, T; Kawasaki, M; Hashimoto, H; Ishikura, T; Yoshimura, M; Ohkubo, JI; Maruyama, T; Motojima, Y; Sabanai, K; Mori, T; Ohnishi, H; Sakai, A; Ueta, Y				Matsuura, T.; Kawasaki, M.; Hashimoto, H.; Ishikura, T.; Yoshimura, M.; Ohkubo, J. -I.; Maruyama, T.; Motojima, Y.; Sabanai, K.; Mori, T.; Ohnishi, H.; Sakai, A.; Ueta, Y.			Fluorescent Visualisation of Oxytocin in the Hypothalamo-neurohypophysial/-spinal Pathways After Chronic Inflammation in Oxytocin-Monomeric Red Fluorescent Protein 1 Transgenic Rats	JOURNAL OF NEUROENDOCRINOLOGY			English	Article						oxytocin; fluorescent protein; arthritic rats; chronic inflammation	CONTROLLING PENILE ERECTION; CORD NEURONAL ACTIVITIES; INDUCED ANTINOCICEPTION; ARGININE-VASOPRESSIN; KNOCKOUT MICE; DORSAL-HORN; FUSION GENE; EXPRESSION; RECEPTOR; INNERVATION	Oxytocin (OXT) is a well-known neurohypophysial hormone that is synthesised in the paraventricular (PVN) and supraoptic nuclei (SON) of the hypothalamus. The projection of magnocellular neurosecretory cells, which synthesise OXT and arginine vasopressin in the PVN and SON, to the posterior pituitary plays an essential role in mammalian labour and lactation through its peripheral action. However, previous studies have shown that parvocellular OXTergic cells in the PVN, which project to the medulla and spinal cord, are involved in various physiological functions (e.g. sensory modulation and autonomic). In the present study, we examined OXT expression in the PVN, SON and spinal cord after chronic inflammation from adjuvant arthritis (AA). We used transgenic rats that express OXT and the monomeric red fluorescent protein 1 (mRFP1) fusion gene to visualise both the magnocellular and parvocellular OXTergic pathways. OXT-mRFP1 fluorescence intensity was significantly increased in the PVN, SON, dorsal horn of the spinal cord and posterior pituitary in AA rats. The levels of OXT-mRFP1 mRNA were significantly increased in the PVN and SON of AA rats. These results suggested that OXT was up-regulated in both hypothalamic magnocellular neurosecretory cells and parvocellular cells by chronic inflammation, and also that OXT in the PVN-spinal pathway may be involved in sensory modulation. OXT-mRFP1 transgenic rats are a very useful model for visualising the OXTergic pathways from vesicles in a single cell to terminals in invitro preparations.	[Matsuura, T.; Hashimoto, H.; Yoshimura, M.; Ohkubo, J. -I.; Maruyama, T.; Motojima, Y.; Ueta, Y.] Univ Occupat & Environm Hlth, Sch Med, Dept Physiol, Kitakyushu, Fukuoka 8078555, Japan; [Matsuura, T.; Kawasaki, M.; Ishikura, T.; Motojima, Y.; Sabanai, K.; Mori, T.; Ohnishi, H.; Sakai, A.] Univ Occupat & Environm Hlth, Sch Med, Dept Orthopaed, Kitakyushu, Fukuoka 8078555, Japan	Matsuura, T (reprint author), Univ Occupat & Environm Hlth, Sch Med, Dept Physiol, Yahatanishi Ku, 1-1 Iseigaoka, Kitakyushu, Fukuoka 8078555, Japan.	yoichi@med.uoeh-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) [25113721]; Japan Society for the Promotion of Science (JSPS), Japan [25293055, 24592289, 25462391]; University of Occupational and Environmental Health (UOEH) Research Grant for Advanced Research from the UOEH, Japan; University of Occupational and Environmental Health Research Grant for the Promotion of Occupational Health	We thank Dr Roger Tsien (University of California, San Diego, CA, USA) for supplying the mRFP1 clone. This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas 'fluorescence live imaging' number 25113721 of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) and Grants-in-Aid for Scientific Research (B) number 25293055, (C) number 24592289 and (C) number 25462391 from the Japan Society for the Promotion of Science (JSPS), Japan, a University of Occupational and Environmental Health (UOEH) Research Grant for Advanced Research from the UOEH, Japan and a University of Occupational and Environmental Health Research Grant for the Promotion of Occupational Health to M.K.	SAPER CB, 1976, BRAIN RES, V117, P305, DOI 10.1016/0006-8993(76)90738-1; Condes-Lara M, 2009, EUR J NEUROSCI, V30, P1056, DOI 10.1111/j.1460-9568.2009.06899.x; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; UETA Y, 1995, ENDOCRINOLOGY, V136, P4182, DOI 10.1210/en.136.10.4182; Suzuki H, 2009, J NEUROENDOCRINOL, V21, P183, DOI [10.1111/j.1365-2826.2009.01818.x, 10.1111/j.1365-2826.2009.01841.x]; Long JZ, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-20; Hallbeck M, 2001, J COMP NEUROL, V433, P222, DOI 10.1002/cne.1137; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Higashida H, 2010, J NEUROENDOCRINOL, V22, P373, DOI 10.1111/j.1365-2826.2010.01976.x; Tang Y, 1998, NEUROSCIENCE, V82, P241; TRIBOLLET E, 1989, J NEUROSCI, V9, P1764; Neugebauer V, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-8; Gimpl G, 2001, PHYSIOL REV, V81, P629; Pedersen CA, 2006, GENES BRAIN BEHAV, V5, P274, DOI 10.1111/j.1601-183X.2005.00162.x; Gutierrez S, 2013, ANESTHESIOLOGY, V118, P152, DOI 10.1097/ALN.0b013e318278cd21; Katoh A, 2014, J NEUROENDOCRINOL, V26, P341, DOI 10.1111/jne.12150; Breton JD, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-19; Carter CS, 2009, DEV NEUROSCI-BASEL, V31, P332, DOI 10.1159/000216544; CHOWDREY HS, 1995, BRIT J PHARMACOL, V116, P2417; Condes-Lara M, 2005, BRAIN RES, V1045, P124, DOI 10.1016/j.brainres.2005.03.020; Condes-Lara M, 2009, BRAIN RES, V1247, P38, DOI 10.1016/j.brainres.2008.10.030; Condes-Lara M, 2003, BRAIN RES, V976, P75, DOI 10.1016/S0006-8993(03)02690-8; DeLaTorre S, 2009, PAIN, V144, P320, DOI 10.1016/j.pain.2009.05.002; Engle MP, 2012, REGION ANESTH PAIN M, V37, P515, DOI 10.1097/AAP.0b013e318266352d; Gao L, 2004, REGUL PEPTIDES, V120, P53, DOI 10.1016/j.regpep.2004.02.011; Ho JM, 2013, ENDOCRINOLOGY, V154, P589, DOI 10.1210/en.2012-1751; HOGERVORST EJM, 1992, INT IMMUNOL, V4, P719, DOI 10.1093/intimm/4.7.719; HOSOYA Y, 1995, EXP BRAIN RES, V107, P9; Jojart J, 2009, ACTA BIOL HUNG, V60, P333, DOI 10.1556/ABiol.60.2009.4.1; Kabashima N, 1997, J PHYSIOL-LONDON, V504, P113, DOI 10.1111/j.1469-7793.1997.113bf.x; Kasai M, 2001, NEUROSCI RES, V41, P345, DOI 10.1016/S0168-0102(01)00291-7; Katoh A, 2011, ENDOCRINOLOGY, V152, P2768, DOI 10.1210/en.2011-0006; Kiss Alexander, 2005, Endocr Regul, V39, P97; Lund I, 2002, EUR J NEUROSCI, V16, P330, DOI 10.1046/j.1460-9568.2002.02087.x; MILLAN MJ, 1985, NEUROSCI LETT, V54, P33; Miranda-Cardenas Y, 2006, PAIN, V122, P182, DOI 10.1016/j.pain.2006.01.029; Moreno-Lopez Y, 2013, NEUROPEPTIDES, V47, P117, DOI 10.1016/j.npep.2012.09.008; Paxinos G, 1998, RAT BRAIN STEREOTAXI; Petersson M, 2005, MATURITAS, V51, P426, DOI 10.1016/j.maturitas.2004.10.005; Puder BA, 2001, J NEUROSCI RES, V64, P53, DOI 10.1002/jnr.1053; REITER MK, 1994, EUR J NEUROSCI, V6, P98, DOI 10.1111/j.1460-9568.1994.tb00251.x; Rojas-Piloni Gerardo, 2010, Neurosci Lett, V476, P32, DOI 10.1016/j.neulet.2010.03.076; ROUSSELOT P, 1990, BRAIN RES, V529, P178, DOI 10.1016/0006-8993(90)90825-V; Schorscher-Petcu A, 2010, J NEUROSCI, V30, P8274, DOI 10.1523/JNEUROSCI.1594-10.2010; Sofroniew M.V., 1981, Acta Histochemica Supplementband, V24, P79; SWANSON LW, 1979, J COMP NEUROL, V188, P87, DOI 10.1002/cne.901880108; Tribollet E, 1997, NEUROSCIENCE, V78, P499, DOI 10.1016/S0306-4522(96)00591-X; Veronneau-Longueville F, 1999, NEUROSCIENCE, V93, P1437, DOI 10.1016/S0306-4522(99)00262-6; Wrobel L, 2011, NEUROSCI LETT, V495, P49, DOI 10.1016/j.neulet.2011.03.033; Yu SQ, 2003, BRAIN RES, V983, P13, DOI 10.1016/S0006-8993(03)03019-1	50	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-8194	1365-2826		J NEUROENDOCRINOL	J. Neuroendocrinol.	JUL	2015	27	7					636	646		10.1111/jne.12290		11	Endocrinology & Metabolism; Neurosciences	Endocrinology & Metabolism; Neurosciences & Neurology	CL2YH	WOS:000356813500008		
J	Kuwabara, S; Misawa, S; Mori, M				Kuwabara, Satoshi; Misawa, Sonoko; Mori, Masahiro			Paranodal destruction and axo-glial dysjunction in a subtype of CIDP with anticontaction-1 antibodies	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Editorial Material							NERVE		[Kuwabara, Satoshi; Misawa, Sonoko; Mori, Masahiro] Chiba Univ, Grad Sch Med, Dept Neurol, Chiba 2608670, Japan	Kuwabara, S (reprint author), Chiba Univ, Grad Sch Med, Dept Neurol, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	kuwabara-s@faculty.chiba-u.jp					Querol L, 2013, ANN NEUROL, V73, P370, DOI 10.1002/ana.23794; Boyle MET, 2001, NEURON, V30, P385, DOI 10.1016/S0896-6273(01)00296-3; Susuki K, 2007, J NEUROSCI, V27, P3956, DOI 10.1523/JNEUROSCI.4401-06.2007; Uncini A, 2013, CLIN NEUROPHYSIOL, V124, P1928, DOI 10.1016/j.clinph.2013.03.025; Doppler K, 2015, J NEUROL NEUROSUR PS, V86, P720, DOI 10.1136/jnnp-2014-309916; Kuwabara S, 1999, EUR NEUROL, V41, P163, DOI 10.1159/000008042; SIMA AAF, 1986, J CLIN INVEST, V77, P474, DOI 10.1172/JCI112326	7	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	JUL	2015	86	7					707	707		10.1136/jnnp-2015-310448		1	Clinical Neurology; Psychiatry; Surgery	Neurosciences & Neurology; Psychiatry; Surgery	CK4FU	WOS:000356179000003		
J	Sakuma, H; Tanuma, N; Kuki, I; Takahashi, Y; Shiomi, M; Hayashi, M				Sakuma, Hiroshi; Tanuma, Naoyuki; Kuki, Ichiro; Takahashi, Yukitoshi; Shiomi, Masashi; Hayashi, Masaharu			Intrathecal overproduction of proinflammatory cytokines and chemokines in febrile infection-related refractory status epilepticus	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Letter							EPILEPSY SYNDROME FIRES; ENCEPHALOPATHY; CHILDHOOD		[Sakuma, Hiroshi; Tanuma, Naoyuki; Hayashi, Masaharu] Tokyo Metropolitan Inst Med Sci, Dept Brain Dev & Neural Regenerat, Tokyo 1568506, Japan; [Tanuma, Naoyuki] Tokyo Metropolitan Fuchu Med Ctr Disabled, Dept Pediat, Tokyo, Japan; [Kuki, Ichiro] Osaka City Gen Hosp, Dept Child Neurol, Osaka, Japan; [Takahashi, Yukitoshi] Shizuoka Inst Epilepsy & Neurol Disorder, Natl Epilepsy Ctr, Shizuoka, Japan; [Shiomi, Masashi] Aizenbashi Hosp, Dept Pediat, Osaka, Japan	Sakuma, H (reprint author), Tokyo Metropolitan Inst Med Sci, Dept Brain Dev & Neural Regenerat, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan.	sakuma-hs@igakuken.or.jp					Nabbout R, 2011, LANCET NEUROL, V10, P99, DOI 10.1016/S1474-4422(10)70214-3; Vezzani A, 2011, NAT REV NEUROL, V7, P31, DOI 10.1038/nrneurol.2010.178; Kramer U, 2011, EPILEPSIA, V52, P1956, DOI 10.1111/j.1528-1167.2011.03250.x; van Baalen A, 2010, EPILEPSIA, V51, P1323, DOI 10.1111/j.1528-1167.2010.02535.x; Sakuma H, 2010, ACTA NEUROL SCAND, V121, P251, DOI 10.1111/j.1600-0404.2009.01198.x	5	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	JUL	2015	86	7					820	822		10.1136/jnnp-2014-309388		3	Clinical Neurology; Psychiatry; Surgery	Neurosciences & Neurology; Psychiatry; Surgery	CK4FU	WOS:000356179000022		
J	Nogami, K; Taniguchi, S				Nogami, Kentaro; Taniguchi, Shogo			Stellate Ganglion Block, Compared With Xenon Light Irradiation, Is a More Effective Treatment of Neurosensory Deficits Resulting From Orthognathic Surgery, as Measured by Current Perception Threshold	JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article							SAGITTAL SPLIT OSTEOTOMY; PERIPHERAL NEUROPATHY; TRIGEMINAL NERVE; RECOVERY; SENSIBILITY; INJURY; TESTS	Purpose: The aim of this study was to evaluate the relative effectiveness of stellate ganglion blockade (SGB) versus xenon light irradiation (XLI) for the treatment of neurosensory deficits resulting from orthognathic surgery as determined by a comparison of prospective measurements of electrical current perception thresholds (CPTs) and ranged CPTs (R-CPTs). Materials and Methods: CPT and R-CPT in the mental foramen area were measured during electrical stimulation at 98 different sites on the body in patients who had undergone orthognathic surgery. After surgery, patients were assigned to the SGB group or the XLI group. CPT and R-CPT of the 2 groups were measured at stimulation frequencies of 2,000, 250, and 5 Hz before surgery, 1 week after surgery, and after 10 treatment sessions. Furthermore, the influence of surgical factors, such as genioplasty and a surgically exposed inferior alveolar nerve (IAN), was examined in the 2 groups. Results: Patients' CPTand R-CPT values indicated a considerable amount of sensory disturbance in most cases after surgery. The change in magnitude of all CPT and R-CPT values for the SGB group decreased considerably compared with that for the XLI group after treatment. There was no correlation between CPT or R-CPT values and surgical factors (eg, genioplasty and exposure of the IAN). Conclusion: SGB of the IAN could be an effective method for treating neurosensory deficits after orthognathic surgery on the IAN. (C) 2015 American Association of Oral and Maxillofacial Surgeons	[Nogami, Kentaro; Taniguchi, Shogo] Fukuoka Dent Coll, Dept Diagnost & Gen Care, Sect Anesthesiol, Fukuoka, Fukuoka 8140193, Japan	Nogami, K (reprint author), Fukuoka Dent Coll, Dept Diagnost & Gen Care, Sect Anesthesiol, Sawara Ku, 2-15-1 Tamura, Fukuoka, Fukuoka 8140193, Japan.	nogamik@college.fdcnet.ac.jp					Akagi D, 2007, EUR J VASC ENDOVASC, V33, P625, DOI 10.1016/j.ejvs.2006.11.031; Ylikontiola L, 1998, INT J ORAL MAX SURG, V27, P417; Kim SG, 2007, J ORAL MAXIL SURG, V65, P2438, DOI 10.1016/j.joms.2007.05.030; Blomqvist JE, 1998, PLAST RECONSTR SURG, V102, P325, DOI 10.1097/00006534-199808000-00005; Caissie R, 2007, J ORAL MAXIL SURG, V65, P2254, DOI 10.1016/j.jams.2006.09.010; de Beukelaer JGP, 1998, ORAL SURG ORAL MED O, V85, P366, DOI 10.1016/S1079-2104(98)90058-0; Fontana CR, 2013, J ALTERN COMPLEM MED, V19, P376, DOI 10.1089/acm.2011.0531; Hanamatsu N, 2002, REGION ANESTH PAIN M, V27, P268, DOI 10.1053/rapm.2002.31206; Jacks SC, 1998, J ORAL MAXIL SURG, V56, P700, DOI 10.1016/S0278-2391(98)90799-6; Kanai Akifumi, 2012, Masui, V61, P693; KARAS ND, 1990, J ORAL MAXIL SURG, V48, P124; KATIMS JJ, 1987, ARCH PHYS MED REHAB, V68, P210; Masoumipoor M, 2014, LASER MED SCI, V29, P1593; MASSON EA, 1991, DIABETIC MED, V8, pS63; Matsutomo R, 2005, J INT MED RES, V33, P442; Park JW, 2011, ORAL SURG ORAL MED O, V111, P24, DOI 10.1016/j.tripleo.2010.03.045; Robinson LR, 2004, CLIN NEUROPHYSIOL, V57, P173; ROSENBERG A, 1994, J CRANIO MAXILL SURG, V22, P286, DOI 10.1016/S1010-5182(05)80078-2; Saeki Shigeru, 2006, Masui, V55, P1104; Sakamoto E, 2004, INT P 11 INT PAIN CL, P495; Teerijoki-Oksa T, 2002, INT J ORAL MAX SURG, V31, P33, DOI 10.1054/ijom.2001.0157; Yamashita T, 2002, SPINE, V27, P1567, DOI 10.1097/01.BRS.0000018483.20260.6B; Ylikontiola L, 2000, ORAL SURG ORAL MED O, V90, P275, DOI 10.1067/moe.2000.108920	23	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-2391	1531-5053		J ORAL MAXIL SURG	J. Oral Maxillofac. Surg.	JUL	2015	73	7					1267	1274		10.1016/j.joms.2015.01.012		8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CK5ZI	WOS:000356306900012		
J	Kondo, N; Hiraiwa-Hasegawa, M				Kondo, Noriko; Hiraiwa-Hasegawa, Mariko			The influence of social dominance on calling rate in the Large-billed Crow (Corvus macrorhynchos)	JOURNAL OF ORNITHOLOGY			English	Article						Dominance hierarchy; Vocalization; Status signal; Badge of status; Vocal communication; Corvid	COMMON RAVENS; DAWN CHORUS; VOCALIZATIONS; SONG; BEHAVIOR; SIGNALS; SIZE	Individual animals of social species that form dominance hierarchies use status signals to advertise their dominance status to conspecifics. Bird species often have a visual status signal known as a "badge of status." However, the hierarchies of some social species are fluid, and dominance status may change depending on the composition of the group. In such situations, vocal signals are more suitable as a status signal because they are readily modifiable by the signaler. In this study, we investigated the relationship between social dominance rank and calling rate in the Large-billed Crow (Corvus macrorhynchos) by observing a captive flock of Large-billed Crows and determining the dominance rank of each individual. The number of vocalizations each individual produced during the study period were also recorded. Our results revealed that there was a clear linear dominance hierarchy within the flock and that more dominant crows produced sequential-note calls more frequently than their subordinate counterparts. Contact call rate, however, was not affected by dominance status. These results suggest that sequential-note calls function as status signals in groups of Large-billed Crows.	[Kondo, Noriko; Hiraiwa-Hasegawa, Mariko] Grad Univ Adv Studies, Dept Evolutionary Studies Biosyst, Hayama, Kanagawa 2400193, Japan; [Kondo, Noriko] Japan Soc Promot Sci, Chiyoda Ku, Tokyo 1028472, Japan	Kondo, N (reprint author), Grad Univ Adv Studies, Dept Evolutionary Studies Biosyst, Hayama, Kanagawa 2400193, Japan.	nrk.kondo@gmail.com			KAKENHI [25-5437]	This study was financially supported by KAKENHI (#25-5437) to N. K. We thank Dr. Eiichi Izawa for allowing us to use the facility of Keio University.	Nakagawa S, 2007, BEHAV ECOL, V18, P831, DOI 10.1093/beheco/arm050; Cornell HN, 2012, P ROY SOC B-BIOL SCI, V279, P499, DOI 10.1098/rspb.2011.0957; Hoeschele M, 2010, ANIM BEHAV, V79, P657, DOI 10.1016/j.anbehav.2009.12.015; Braun A, 2012, ANIM BEHAV, V84, P1507, DOI 10.1016/j.anbehav.2012.09.024; ROHWER S, 1975, EVOLUTION, V29, P593, DOI 10.2307/2407071; MITANI JC, 1993, ANIM BEHAV, V45, P735, DOI 10.1006/anbe.1993.1088; Kitchen DM, 2003, BEHAV ECOL SOCIOBIOL, V53, P374, DOI 10.1007/s00265-003-0588-1; Tringali A, 2012, ANIM BEHAV, V84, P1517, DOI 10.1016/j.anbehav.2012.09.025; Tibbetts EA, 2008, BIOL LETTERS, V4, P237, DOI 10.1098/rsbl.2008.0048; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Kondo N, 2012, P ROY SOC B-BIOL SCI, V279, P1937, DOI 10.1098/rspb.2011.2419; MOLLER AP, 1987, ANIM BEHAV, V35, P1637, DOI 10.1016/S0003-3472(87)80056-8; HEINRICH B, 1991, BEHAV ECOL SOCIOBIOL, V28, P13; Aureli F, 2008, CURR ANTHROPOL, V49, P627, DOI 10.1086/586708; DEVRIES H, 1995, ANIM BEHAV, V50, P1375, DOI 10.1016/0003-3472(95)80053-0; Otter K, 1997, BEHAV ECOL, V8, P167, DOI 10.1093/beheco/8.2.167; ROELL A, 1978, BEHAVIOUR, V64, P1; Kondo N, 2009, JPN PSYCHOL RES, V51, P197, DOI 10.1111/j.1468-5884.2009.00399.x; Bradbury J.W., 2011, PRINCIPLES ANIMAL CO; BROWN ED, 1985, Z TIERPSYCHOL, V68, P115; CHAMBERL.DR, 1971, AUK, V88, P613; CONNER RN, 1985, CONDOR, V87, P379, DOI 10.2307/1367219; Dalziell AH, 2008, ANIM BEHAV, V75, P489, DOI 10.1016/j.anbehav.2007.05.014; Enggist-Dueblin P, 2002, ANIM BEHAV, V64, P831, DOI 10.1006/anbe.2002.2016; Fedurek P, 2014, BEHAV ECOL SOCIOBIOL, V68, P1; FICKEN MS, 1987, CONDOR, V89, P500, DOI 10.2307/1368640; Gwinner E., 1964, Zeitschrift fuer Tierpsychologie, V21, P657; Hahn AH, 2013, BEHAVIOUR, V150, P1601, DOI 10.1163/1568539X-00003111; Heinrich B., 1999, MIND OF THE RAVEN; Kondo N, 2010, ORNITHOL SCI, V9, P83; Kondo N, 2010, BEHAVIOUR, V147, P1051, DOI 10.1163/000579510X505427; Kuroda N, 1990, JUNGLE CROWS TOKYO; LEONARD ML, 1995, ANIM BEHAV, V49, P1283, DOI 10.1006/anbe.1995.0160; LORENZ KONRAD, 1932, JOUR ORNITHOLOGIE, V80, P50, DOI 10.1007/BF01995022; Massen JJM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4679; Murphy TG, 2009, BEHAV ECOL, V20, P1348, DOI 10.1093/beheco/arp140; Rendall D, 2002, COGNITIVE ANIMAL, P307; Seddon N, 2002, BEHAVIOUR, V139, P1331, DOI 10.1163/156853902321104190; Soma Masayo, 2003, Japanese Journal of Ornithology, V52, P97, DOI 10.3838/jjo.52.97; Whiting MJ, 2003, LIZARD SOCIAL BEHAVIOR, P47	40	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0021-8375	1439-0361		J ORNITHOL	J. Ornithol.	JUL	2015	156	3					775	782		10.1007/s10336-015-1191-8		8	Ornithology	Zoology	CK7WS	WOS:000356447100021		
J	Hasegawa, M; Arai, E				Hasegawa, Masaru; Arai, Emi			Experimentally reduced male ornamentation increased paternal care in the Barn Swallow	JOURNAL OF ORNITHOLOGY			English	Article						Dynamic trait; Hirundo rustica gutturalis; Parental care; Plumage coloration; Sexual selection	MALE HOUSE SPARROWS; FINCHES CARPODACUS-MEXICANUS; HIRUNDO-RUSTICA-GUTTURALIS; SEXUALLY SELECTED TRAITS; MULTIPLE MALE ORNAMENTS; DIFFERENTIAL ALLOCATION; PLUMAGE COLOR; PARENTAL CARE; REPRODUCTIVE EFFORT; BADGE SIZE	It has recently been demonstrated that male ornaments feedback on their physiological state and this is expected to be followed by behavioral alterations in paternal care. However, only a few studies have shown the effects of experimental manipulation of ornamentation on paternal care behavior. The present study investigated the effects of experimental manipulation of the size of a male ornament, the red throat patch, on the feeding rates of nestlings by male and female Barn Swallows (Hirundo rustica gutturalis). First, we observed a dynamic change in male throat patch height during the breeding season, indicating that behavioral alterations in response to changes in throat patch height may be beneficial for male Swallows. Second, males with an experimentally reduced throat patch, but not their mates, fed their nestlings significantly more often compared with control individuals. In addition, we found a significant interaction between treatment and male body size: i.e., the effects of a reduced throat patch height varied depending on male body size. Among males with a reduced throat patch, male feeding rate increased with body size, but this was not the case in control males. This interaction is consistent with the idea that small males have low behavioral flexibility, and might contribute on positive correlation between throat ornamentation and male body size, given that behavioral flexibility is adaptive. The current finding indicates that males can increase paternal care in response to a seasonal decrease in ornamentation and this differential behavioral flexibility among males may facilitate the honesty of ornamentation.	[Hasegawa, Masaru] Grad Univ Adv Studies, Dept Evolutionary Studies Biosyst, Hayama, Kanagawa 2400115, Japan; [Arai, Emi] Tohoku Univ, Grad Sch Life Sci, Div Ecol & Evolutionary Biol, Sendai, Miyagi 980, Japan	Hasegawa, M (reprint author), Grad Univ Adv Studies, Dept Evolutionary Studies Biosyst, 1560-35 Kamiyamaguchi, Hayama, Kanagawa 2400115, Japan.	perorobomusadiobe@gmail.com					Andersson M., 1994, SEXUAL SELECTION; Johnsen A, 2005, ANIM BEHAV, V70, P877, DOI 10.1016/j.anbehav.2005.01.005; Sanz JJ, 2001, BEHAV ECOL, V12, P171, DOI 10.1093/beheco/12.2.171; Harris WE, 2009, PHILOS T R SOC B, V364, P1039, DOI 10.1098/rstb.2008.0299; Safran RJ, 2005, SCIENCE, V309, P2210, DOI 10.1126/science.1115090; Griffith SC, 1999, P ROY SOC B-BIOL SCI, V266, P765; Stoehr AM, 2000, BEHAV ECOL SOCIOBIOL, V48, P407, DOI 10.1007/s002650000247; Arai E, 2009, BIRD STUDY, V56, P411, DOI 10.1080/00063650902968342; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3; Soler JJ, 1998, ANIM BEHAV, V56, P1435, DOI 10.1006/anbe.1998.0938; Maguire SE, 2010, J AVIAN BIOL, V41, P74, DOI 10.1111/j.1600-048X.2009.04806.x; SAINO N, 1995, BEHAV ECOL SOCIOBIOL, V36, P151, DOI 10.1007/BF00177791; Vitousek MN, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0539; LESSELLS CM, 1987, AUK, V104, P116; BURLEY N, 1986, AM NAT, V127, P415, DOI 10.1086/284493; Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x; Johnstone RA, 2006, BEHAV ECOL, V17, P818, DOI 10.1093/beheco/arl009; Kose M, 1999, BEHAV ECOL SOCIOBIOL, V45, P430, DOI 10.1007/s002650050581; Safran RJ, 2004, BEHAV ECOL, V15, P455, DOI 10.1093/beheco/arh035; Sheldon BC, 2000, TRENDS ECOL EVOL, V15, P397, DOI 10.1016/S0169-5347(00)01953-4; Galeotti P, 1997, ANIM BEHAV, V53, P687, DOI 10.1006/anbe.1996.0304; Magrath MJL, 2003, TRENDS ECOL EVOL, V18, P424, DOI 10.1016/S0169-5347(03)00124-1; Andersson S, 2002, AM NAT, V160, P683, DOI 10.1086/342817; Ducrest AL, 2008, TRENDS ECOL EVOL, V23, P502, DOI 10.1016/j.tree.2008.06.001; Rubenstein DR, 2008, TRENDS ECOL EVOL, V23, P655, DOI 10.1016/j.tree.2008.07.010; McGraw KJ, 2004, CAN J ZOOL, V82, P734, DOI 10.1139/Z04-043; WINGFIELD JC, 1987, AM SCI, V75, P602; HEGNER RE, 1987, AUK, V104, P462; Hasegawa M, 2012, J ETHOL, V30, P143, DOI 10.1007/s10164-011-0307-8; Schuett W, 2010, BIOL REV, V85, P217, DOI 10.1111/j.1469-185X.2009.00101.x; Hasegawa M, 2010, ORNITHOL SCI, V9, P141, DOI 10.2326/osj.9.141; Arai E, 2015, J ORNITHOL, V156, P419, DOI 10.1007/s10336-014-1140-y; Biernaskie JM, 2014, P ROY SOC LOND B BIO, V281, P1790; DELOPE F, 1993, EVOLUTION, V47, P1152, DOI 10.2307/2409981; Eikenaar C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023288; Foley JD, 1984, FUNDAMENTALS INTERAC; Galvan I, 2008, BIOL LETTERS, V4, P12, DOI 10.1098/rsbl.2007.0504; Griffith SC, 2001, ANIM BEHAV, V61, P987, DOI 10.1006/anbe.2000.1666; Hasegawa Masaru, 2008, Ornithological Science, V7, P117, DOI 10.2326/1347-0558-7.2.117; Hasegawa M, 2011, THESIS U TSUKUBA; Hasegawa M, 2013, J ETHOL, V31, P79, DOI 10.1007/s10164-012-0352-y; Hasegawa M, 2014, J ORNITHOL, V155, P389, DOI 10.1007/s10336-013-1019-3; Hasegawa M, 2014, BEHAVIOUR, V151, P591, DOI 10.1163/1568539X-00003150; Hasegawa M, 2005, THESIS U TSUKUBA; Hasegawa M, 2013, ZOOL SCI, V30, P93; Hasegawa M, 2010, ORNITHOL SCI, V9, P161, DOI 10.2326/osj.9.161; Hill G. E., 2006, BIRD COLORATION, V2; Kose M, 1999, ANIM BEHAV, V58, P1201, DOI 10.1006/anbe.1999.1249; McGraw K., 2006, BIRD COLORATION; Moller A. P., 1994, SEXUAL SELECTION BAR; MOLLER AP, 1992, BEHAV ECOL SOCIOBIOL, V31, P271; MOLLER AP, 1988, ANIM BEHAV, V36, P996, DOI 10.1016/S0003-3472(88)80059-9; MOLLER AP, 1989, NATURE, V339, P132; Montgomerie R, 2006, BIRD COLORATION; Qvarnstrom A, 1997, P ROY SOC B-BIOL SCI, V264, P1225, DOI 10.1098/rspb.1997.0169; R Development Core Team, 2011, R LANG ENV STAT COMP; SAINO N, 1995, ANIM BEHAV, V49, P465, DOI 10.1006/anbe.1995.0060; Savari L, 2009, ACTA ORNITHOL, V44, P59, DOI DOI 10.3161/000164509X464894; Searcy WA, 2005, MG BEH ECOL, P1; Tajima Kazuyoshi, 2003, Ornithological Science, V2, P65, DOI 10.2326/osj.2.65; Turner A., 2006, BARN SWALLOW; WATSON A, 1981, ORNIS SCAND, V12, P55, DOI 10.2307/3675905	62	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0021-8375	1439-0361		J ORNITHOL	J. Ornithol.	JUL	2015	156	3					795	804		10.1007/s10336-015-1178-5		10	Ornithology	Zoology	CK7WS	WOS:000356447100023		
J	Watanuki, Y; Yamamoto, T; Yamashita, A; Ishii, C; Ikenaka, Y; Nakayama, SMM; Ishizuka, M; Suzuki, Y; Niizuma, Y; Meathrel, CE; Phillips, RA				Watanuki, Yutaka; Yamamoto, Takashi; Yamashita, Ai; Ishii, Chihiro; Ikenaka, Yoshinori; Nakayama, Shouta M. M.; Ishizuka, Mayumi; Suzuki, Yuya; Niizuma, Yasuaki; Meathrel, C. E.; Phillips, R. A.			Mercury concentrations in primary feathers reflect pollutant exposure in discrete non-breeding grounds used by Short-tailed Shearwaters	JOURNAL OF ORNITHOLOGY			English	Article						Geolocator; Trophic level; Northern North Pacific; Monitoring	TRANS-EQUATORIAL MIGRATION; STABLE-ISOTOPE SIGNATURES; CONTAMINANTS; COLONY; SEASON	We measured mercury concentrations ([Hg]) and nitrogen stable isotope ratios (delta N-15) in the primary feathers of Short-tailed Shearwaters (Puffinus tenuirostris) that were tracked year-round. The [Hg] were highest in 14 birds that used the Okhotsk and northern Japan Seas during the non-breeding period (2.5 +/- A 1.4 mu g/g), lowest in nine birds that used the eastern Bering Sea (0.8 +/- A 0.2 mu g/g), and intermediate in five birds that used both regions (1.0 +/- A 0.5 mu g/g), with no effects of delta N-15. The results illustrate that samples from seabirds can provide a useful means of monitoring pollution at a large spatial scale.	[Watanuki, Yutaka; Yamamoto, Takashi; Yamashita, Ai; Suzuki, Yuya] Hokkaido Univ, Grad Sch Fisheries Sci, Hakodate, Hokkaido 0418611, Japan; [Yamamoto, Takashi] Natl Inst Polar Res, Arctic Environm Res Ctr, Tachikawa, Tokyo 1908518, Japan; [Ishii, Chihiro; Ikenaka, Yoshinori; Nakayama, Shouta M. M.; Ishizuka, Mayumi] Hokkaido Univ, Grad Sch Vet Med, Sapporo, Hokkaido 0600818, Japan; [Niizuma, Yasuaki] Meijyo Univ, Fac Agr, Tenpaku Ku, Nagoya, Aichi 4688502, Japan; [Meathrel, C. E.] La Trobe Univ, Wodonga, Vic 3086, Australia; [Phillips, R. A.] British Antarctic Survey, Nat Environm Res Council, Cambridge CB3 0ET, England	Watanuki, Y (reprint author), Hokkaido Univ, Grad Sch Fisheries Sci, Minato Cho 3-1-1, Hakodate, Hokkaido 0418611, Japan.	ywata@fish.hokudai.ac.jp			La Trobe University Animal Ethics Project AEC [10/32 (W)]; JSPS [20241001, 22405007]; GRENE	We thank R. Bruce, B. Nishizawa, and A. Ito for field assistance, and L. Hardy for recovering geolocator from a beached bird. Research was carried out under La Trobe University Animal Ethics Project AEC 10/32 (W) and Tasmanian Department of Primary Industries Permits to Take Wildlife for Scientific Purpose FA10161 and FA11212 held by CE Meathrel. The study was supported by JSPS (#20241001, #22405007) and the GRENE project.	Bond AL, 2010, ENVIRON POLLUT, V158, P1182, DOI 10.1016/j.envpol.2010.01.004; Bearhop S, 2000, MAR ECOL PROG SER, V195, P261, DOI 10.3354/meps195261; Hedd A, 2012, MAR ECOL PROG SER, V449, P277, DOI 10.3354/meps09538; Burger J, 1997, ENVIRON RES, V75, P160, DOI 10.1006/enrs.1997.3778; Jaeger I, 2009, SCI TOTAL ENVIRON, V407, P4744, DOI 10.1016/j.scitotenv.2009.04.004; Laurier FJG, 2004, MAR CHEM, V90, P3, DOI 10.1016/j.marchem.2004.02.025; Bourgeois K, 2014, J ORNITHOL, V155, P265, DOI 10.1007/s10336-013-1011-y; Carey Mark J., 2011, Notornis, V58, P8; Carey MJ, 2014, EMU, V114, P352, DOI 10.1071/MU13115; Gonzalez-Solis J, 2011, MAR ECOL PROG SER, V435, P251, DOI 10.3354/meps09233; Leat EHK, 2013, MAR ECOL PROG SER, V491, P277, DOI 10.3354/meps10455; Marchant S, 1990, HDB AUSTR NZ ANTAR A, V1, P632; Phillips R. A., 2008, AQUAT CONSERV, V17, P6; Ramos R, 2009, OECOLOGIA, V159, P345, DOI 10.1007/s00442-008-1215-7; Ricca MA, 2008, SCI TOTAL ENVIRON, V406, P308, DOI 10.1016/j.scitotenv.2008.06.030	15	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0021-8375	1439-0361		J ORNITHOL	J. Ornithol.	JUL	2015	156	3					847	850		10.1007/s10336-015-1205-6		4	Ornithology	Zoology	CK7WS	WOS:000356447100029		
J	Tsutsumi, R; Horikawa, YT; Kume, K; Tanaka, K; Kasai, A; Kadota, T; Tsutsumi, YM				Tsutsumi, Rie; Horikawa, Yousuke T.; Kume, Katsuyoshi; Tanaka, Katsuya; Kasai, Asuka; Kadota, Takako; Tsutsumi, Yasuo M.			Whey Peptide-Based Formulas With-3 Fatty Acids Are Protective in Lipopolysaccharide-Mediated Sepsis	JOURNAL OF PARENTERAL AND ENTERAL NUTRITION			English	Article						whey peptide; sepsis; lipopolysaccharide; antioxidants; critical care; enteral formulas	MULTIPLE ORGAN FAILURE; SEPTIC SHOCK; PARENTERAL-NUTRITION; RESISTANCE EXERCISE; SKELETAL-MUSCLE; DIAMINE OXIDASE; PROTEIN; MITOCHONDRIA; AUTOPHAGY; INJURY	Background: Sepsis and septic shock syndrome are among the leading causes of death in critically ill patients. Lipopolysaccharide (LPS) released by bacteria within the colon may translocate across a compromised epithelium, leading to oxidative stress, inflammation, sepsis, and eventually death. Methods: We examined the effects of a whey-based enteral formula high in cysteine (antioxidant precursor) and the addition of -3 fatty acids, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), against a mouse model of LPS-induced sepsis. Mice were fed either a whey-based diet with EPA-DHA (PAF), a whey-based diet without EPA-DHA (PSTD), or a casein-based control diet (CONT). Results: Mice fed PAF or PSTD were protected against LPS-induced weight loss. Whey-based diets suppressed inflammatory cytokine release and oxidative stress damage. Furthermore, PAF and PSTD were able to inhibit autophagy, a mechanism in which the cell recycles damaged organelles. These anti-inflammatory and antioxidative effects of PSTD and PAF resulted in decreased liver inflammation and intestinal damage and promoted protective microbiota within the intestines. Conclusions: These data suggest a clinical role for whey peptide-based diets in promoting healing and recovery in critically ill patients.	[Tsutsumi, Rie] Univ Tokushima, Grad Sch, Dept Nutr, Tokushima 7708503, Japan; [Horikawa, Yousuke T.; Kume, Katsuyoshi; Tanaka, Katsuya; Kasai, Asuka; Kadota, Takako; Tsutsumi, Yasuo M.] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Anesthesiol, Tokushima 7708503, Japan	Tsutsumi, YM (reprint author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Anesthesiol, 3-18-15 Kuramoto, Tokushima 7708503, Japan.	tsutsumi@tokushima-u.ac.jp			Japan Society for the Promotion of Sciences; Tokyo JSPS KAKENHI [24650489, 25462405]; Nestle Japan, Nestle Health Science Company	This work was supported by the Japan Society for the Promotion of Sciences, Tokyo JSPS KAKENHI 24650489 (RT) and 25462405 (YMT), and Nestle Japan, Nestle Health Science Company.	Kishta OA, 2013, NUTRITION, V29, P918, DOI 10.1016/j.nut.2012.11.009; LUK GD, 1983, J CLIN INVEST, V71, P1308, DOI 10.1172/JCI110881; Takayanagi T, 2011, JPEN-PARENTER ENTER, V35, P516, DOI 10.1177/0148607110381599; Crouser ED, 2004, MITOCHONDRION, V4, P729, DOI 10.1016/j.mito.2004.07.023; Farnfield MM, 2009, NUTRIENTS, V1, P263, DOI 10.3390/nu1020263; Romanello V, 2010, EMBO J, V29, P1774, DOI 10.1038/emboj.2010.60; Casaer MP, 2011, NEW ENGL J MED, V365, P506, DOI 10.1056/NEJMoa1102662; Kaser A, 2002, LIVER, V22, P380, DOI 10.1034/j.1600-0676.2002.01666.x; Rice TW, 2012, JAMA-J AM MED ASSOC, V307, P795, DOI 10.1001/jama.2012.137; Han DW, 2002, WORLD J GASTROENTERO, V8, P961; Callahan LA, 2005, AM J RESP CRIT CARE, V172, P861, DOI 10.1164/rccm.200410-1344OC; Sandri M, 2010, FEBS LETT, V584, P1411, DOI 10.1016/j.febslet.2010.01.056; Tappy L, 2007, CRIT CARE MED, V35, pS531, DOI 10.1097/01.CCM.0000278062.28122.A4; WONG CW, 1995, J DAIRY RES, V62, P359; Singer P, 2010, CURR OPIN CLIN NUTR, V13, P170, DOI 10.1097/MCO.0b013e3283357535; Yang L, 2012, LIFE SCI, V91, P389, DOI 10.1016/j.lfs.2012.08.003; Fredriksson K, 2006, AM J PHYSIOL-ENDOC M, V291, pE1044, DOI 10.1152/ajpendo.00218.2006; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Albillos A, 2003, HEPATOLOGY, V37, P208, DOI 10.1053/jhep.2003.50038; Blagosklonny MV, 2013, AUTOPHAGY, V9, P260, DOI 10.4161/auto.22783; Boirie Y, 1997, P NATL ACAD SCI USA, V94, P14930, DOI 10.1073/pnas.94.26.14930; Angus DC, 2001, CRIT CARE MED, V29, P1303, DOI 10.1097/00003246-200107000-00002; TAKAGI K, 1994, CLIN CHIM ACTA, V226, P67, DOI 10.1016/0009-8981(94)90103-1; Martin GS, 2012, EXPERT REV ANTI-INFE, V10, P701, DOI [10.1586/eri.12.50, 10.1586/ERI.12.50]; Grumati P, 2010, NAT MED, V16, P1313, DOI 10.1038/nm.2247; Anthony JC, 2001, J NUTR, V131, p856S; Aoyama M, 2009, SHOCK, V32, P401, DOI 10.1097/SHK.0b013e31819c358a; Balk RA, 2004, DM-DIS MON, V50, P168, DOI 10.1016/j.disamonth.2003.12.003; Bengmark S, 2013, NUTRIENTS, V5, P162, DOI 10.3390/nu5010162; de Aguilar-Nascimento JE, 2012, NUTRITION, V28, P840, DOI 10.1016/j.nut.2012.01.013; Brealey D, 2003, CURR INFECT DIS REP, V5, P365, DOI 10.1007/s11908-003-0015-9; Eisner F, 2011, J GASTROINTEST SURG, V15, P853, DOI 10.1007/s11605-011-1431-z; Fredriksson K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003686; Galley HF, 2010, CRIT CARE, V14, DOI 10.1186/cc9098; Hoffman JR, 2010, AMINO ACIDS, V38, P771, DOI 10.1007/s00726-009-0283-2; Hwang TL, 2012, NUTRIENTS, V4, P231, DOI 10.3390/nu4030231; Mofarrahi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047265; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Oz HS, 2009, JPEN-PARENTER ENTER, V33, P380, DOI 10.1177/0148607108327194; Rinaldi S, 2009, CURR DRUG TARGETS, V10, P872; Schetz M, 2013, CRIT CARE, V17, DOI 10.1186/cc11828; SCHUMER W, 1971, SURG GYNECOL OBSTETR, V133, P433; Su GL, 2002, AM J PHYSIOL-GASTR L, V283, pG256, DOI 10.1152/ajpgi.00550.2001	43	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0148-6071	1941-2444		JPEN-PARENTER ENTER	J. Parenter. Enter. Nutr.	JUL	2015	39	5					552	561		10.1177/0148607114520993		10	Nutrition & Dietetics	Nutrition & Dietetics	CK8SE	WOS:000356507600006		
J	Yamada, T; Shimizu, K; Ogura, H; Asahara, T; Nomoto, K; Yamakawa, K; Hamasaki, T; Nakahori, Y; Ohnishi, M; Kuwagata, Y; Shimazu, T				Yamada, Tomoki; Shimizu, Kentaro; Ogura, Hiroshi; Asahara, Takashi; Nomoto, Koji; Yamakawa, Kazuma; Hamasaki, Toshimitsu; Nakahori, Yasutaka; Ohnishi, Mitsuo; Kuwagata, Yasuyuki; Shimazu, Takeshi			Rapid and Sustained Long-Term Decrease of Fecal Short-Chain Fatty Acids in Critically Ill Patients With Systemic Inflammatory Response Syndrome	JOURNAL OF PARENTERAL AND ENTERAL NUTRITION			English	Article						short-chain fatty acid; gut microbiota; systemic inflammatory response syndrome; critically ill; dysmotility; enteritis	PERIOPERATIVE SYNBIOTIC TREATMENT; LONGITUDINAL DATA-ANALYSIS; HUMAN COLON; INFECTIOUS COMPLICATIONS; CRITICAL ILLNESS; ORGAN FAILURE; SEVERE SIRS; BUTYRATE; SEPSIS; CANCER	Background: The gut is an important target organ for injury after severe insult. Short-chain fatty acids (SCFAs) are end-products of fermentation of dietary fibers by anaerobic microbiota. They are related to intestinal energy, motility, and transport and to protective effects against infection and inflammation. However, there are few clinical data on SCFAs in critically ill patients. We evaluated serial change in fecal SCFAs in patients with severe systemic inflammatory response syndrome (SIRS). Patients and Methods: This study included 140 intensive care unit (ICU) patients who fulfilled the criteria of SIRS and had a serum C-reactive protein level of >10 mg/dL. A fecal sample was used for quantitative measurement of fecal SCFA (butyrate, propionate, and acetate) concentrations by high-performance liquid chromatography. Fecal SCFAs were evaluated weekly for 6 weeks after admission. Data obtained from patients were compared with corresponding data from healthy volunteers. Results: SIRS resulted from infection in 78 patients, trauma in 30, burns in 12, and other causes in 20. Fecal concentrations of butyrate, propionate, and acetate in these patients decreased significantly compared with those in healthy volunteers and remained low throughout the 6 weeks of the patients' ICU stay. Fecal concentrations of SCFAs in the patients with gastrointestinal complications, including enteritis and dysmotility, were lower than those in the patients without gastrointestinal complications. Conclusions: Concentrations of fecal SCFAs in patients with severe SIRS were significantly lower than those in healthy volunteers over a 6-week period. Maintenance of SCFAs may have therapeutic potential to prevent gastrointestinal complications in critically ill patients.	[Yamada, Tomoki; Shimizu, Kentaro; Ogura, Hiroshi; Yamakawa, Kazuma; Ohnishi, Mitsuo; Shimazu, Takeshi] Osaka Univ, Grad Sch, Dept Traumatol & Acute Crit Med, Osaka 5650871, Japan; [Asahara, Takashi; Nomoto, Koji] Yakult Cent Inst Microbiol Res, Tokyo, Japan; [Hamasaki, Toshimitsu] Osaka Univ, Grad Sch Med, Dept Biomed Stat, Osaka 5650871, Japan; [Nakahori, Yasutaka] Osaka Gen Med Ctr, Dept Emergency & Crit Care, Osaka, Japan; [Kuwagata, Yasuyuki] Kansai Med Univ, Dept Emergency & Crit Care Med, Hirakata, Osaka, Japan	Yamada, T (reprint author), Osaka Univ, Grad Sch, Dept Traumatol & Acute Crit Med, Yamadaoka 2-15, Osaka 5650871, Japan.	tomoki27@hp-emerg.med.osaka-u.ac.jp	Hamasaki, Toshimitsu/N-3851-2015	Hamasaki, Toshimitsu/0000-0002-4928-1160	Ministry of Education, Culture, Sports, Science, and Technology in Japan	This study was supported by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology in Japan.	BONE RC, 1992, CRIT CARE MED, V20, P864; Hayakawa M, 2011, DIGEST DIS SCI, V56, P2361, DOI 10.1007/s10620-011-1649-3; Beale RJ, 2008, CRIT CARE MED, V36, P131, DOI 10.1097/01.CCM.0000297954.45251.A9; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; ROEDIGER WEW, 1980, GUT, V21, P793, DOI 10.1136/gut.21.9.793; Macfarlane S, 2003, P NUTR SOC, V62, P67, DOI 10.1079/PNS2002207; Husebye E, 2001, AM J PHYSIOL-GASTR L, V280, pG368; Marteau P, 2001, APPL ENVIRON MICROB, V67, P4939, DOI 10.1128/AEM.67.10.4939-4942.2001; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Archer SY, 1998, P NATL ACAD SCI USA, V95, P6791, DOI 10.1073/pnas.95.12.6791; Singh N, 2014, IMMUNITY, V40, P128, DOI 10.1016/j.immuni.2013.12.007; Vernia P, 2003, EUR J CLIN INVEST, V33, P244, DOI 10.1046/j.1365-2362.2003.01130.x; Kanauchi O, 2008, ONCOL REP, V20, P793, DOI 10.3892/or_0000076; MACFARLANE GT, 1992, J APPL BACTERIOL, V72, P57, DOI 10.1111/j.1365-2672.1992.tb05187.x; Nguyen NQ, 2007, CRIT CARE MED, V35, P483, DOI 10.1097/01.CCM.0000253410.36492.E9; Shimizu K, 2011, DIGEST DIS SCI, V56, P1171, DOI 10.1007/s10620-010-1418-8; Hotchkiss RS, 1999, CRIT CARE MED, V27, P1230, DOI 10.1097/00003246-199907000-00002; Hamer HM, 2008, ALIMENT PHARM THERAP, V27, P104, DOI 10.1111/j.1365-2036.2007.03562.x; Cavaglieri CR, 2003, LIFE SCI, V73, P1683, DOI 10.1016/S0024-3205(03)00490-9; Sugawara G, 2006, ANN SURG, V244, P706, DOI 10.1097/01.sla.0000219039.20924.88; Fruhwald S, 2007, INTENS CARE MED, V33, P36, DOI 10.1007/s00134-006-0452-7; Usami M, 2011, JPEN-PARENTER ENTER, V35, P317, DOI 10.1177/0148607110379813; D'Argenio G, 1999, ADV EXP MED BIOL, V472, P149; Clark JA, 2007, SHOCK, V28, P384, DOI 10.1097/shk.013e31805569df; Kim MH, 2013, GASTROENTEROLOGY, V145, P396, DOI 10.1053/j.gastro.2013.04.056; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; Pryde SE, 2002, FEMS MICROBIOL LETT, V217, P133, DOI 10.1111/j.1574-6968.2002.tb11467.x; Shimizu K, 2006, J TRAUMA, V60, P126, DOI 10.1097/01.ta.0000197374.99755.fe; Azuma R, 1970, P 1 INT C CULT COLL, P493; Cummings JH, 2004, PHYSL CLIN ASPECTS S; KAMATH PS, 1988, GASTROENTEROLOGY, V95, P1496; MITSUOKA T, 1977, ZBL BAKT-INT J MED M, V238, P228; MOORE WEC, 1978, AM J CLIN NUTR, V31, pS33; O'Keefe Stephen J D, 2011, World J Gastrointest Pathophysiol, V2, P138, DOI 10.4291/wjgp.v2.i6.138; Osuka A, 2012, CRIT CARE, V16, DOI 10.1186/cc11413; Roy Claude C, 2006, Nutr Clin Pract, V21, P351, DOI 10.1177/0115426506021004351; Samonte VA, 2004, CRIT CARE MED, V32, P2267, DOI 10.1097/01.CCM.0000145579.66001.05; Shimizu K, 2011, NEUROGASTROENT MOTIL, V23, pe157; Shimizu K, 2009, DIGEST DIS SCI, V54, P1071, DOI 10.1007/s10620-008-0460-2; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	40	1	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0148-6071	1941-2444		JPEN-PARENTER ENTER	J. Parenter. Enter. Nutr.	JUL	2015	39	5					569	577		10.1177/0148607114529596		9	Nutrition & Dietetics	Nutrition & Dietetics	CK8SE	WOS:000356507600008		
J	Hashimoto, D; Chikamoto, A; Ohmuraya, M; Abe, S; Nakagawa, S; Beppu, T; Takamori, H; Hirota, M; Baba, H				Hashimoto, Daisuke; Chikamoto, Akira; Ohmuraya, Masaki; Abe, Shinya; Nakagawa, Shigeki; Beppu, Toru; Takamori, Hiroshi; Hirota, Masahiko; Baba, Hideo			Impact of Postoperative Weight Loss on Survival After Resection for Pancreatic Cancer	JOURNAL OF PARENTERAL AND ENTERAL NUTRITION			English	Article						pancreatic cancer; body weight; prognosis; operation	BODY-MASS INDEX; LONG-TERM SURVIVAL; DISTAL PANCREATECTOMY; FAT DISTRIBUTION; RISK; OBESITY; PANCREATICODUODENECTOMY; ADENOCARCINOMA; COMPLICATIONS; SURGERY	Background: The aim of this study was to assess the effects of postoperative body weight loss on long-term survival after resection for pancreatic cancer. Methods: A total of 93 patients with primary pancreatic cancer underwent pancreatic resection between April 2005 and December 2011. Patient characteristics, preoperative body mass index, and changes in postoperative body weight were evaluated retrospectively and correlated with long-term survival. Results: There was no significant association between survival and preoperative body mass index. Body weight fell by 8.4% at 2 months after surgery and by 9.0% at 4 months after surgery. Severe postoperative body weight losses, both at 2 months (P = .033) and 4 months (P = .014) after surgery, were significantly associated with poor prognosis, especially among patients with stage IA-IIA pancreatic cancer (n = 43) (P = .005 at 2 months and P < .001 at 4 months). Additionally, severe body weight loss tended to be associated with shorter survival among patients with stage IIB-III pancreatic cancer (n = 50), although the difference was not significant. Multivariate analysis revealed that postoperative body weight loss was an independent prognostic factor. Conclusions: The results of this study demonstrated that pancreatic cancer patients with severe postoperative body weight loss have poorer postoperative outcomes.	[Hashimoto, Daisuke; Chikamoto, Akira; Abe, Shinya; Nakagawa, Shigeki; Beppu, Toru; Baba, Hideo] Kumamoto Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, Kumamoto 8608556, Japan; [Ohmuraya, Masaki] Kumamoto Univ, Grad Sch Med Sci, Inst Resource Dev & Anal, Kumamoto 8608556, Japan; [Takamori, Hiroshi] Saiseikai Kumamoto Hosp, Dept Surg, Kumamoto, Kumamoto, Japan; [Hirota, Masahiko] Kumamoto Reg Med Ctr, Dept Surg, Kumamoto, Japan	Baba, H (reprint author), Kumamoto Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan.	hdobaba@kumamoto-u.ac.jp					Hartwig W, 2011, ANN SURG, V254, P311, DOI 10.1097/SLA.0b013e31821fd334; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Bassi C, 2005, SURGERY, V138, P8, DOI 10.1016/j.surg.2005.05.001; House MG, 2008, J GASTROINTEST SURG, V12, P270, DOI 10.1007/s11605-007-0421-7; Ferrone CR, 2008, J GASTROINTEST SURG, V12, P701, DOI 10.1007/s11605-007-0384-8; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Motoi F, 2012, BRIT J SURG, V99, P524, DOI 10.1002/bjs.8654; Katz MHG, 2009, ANN SURG ONCOL, V16, P836, DOI 10.1245/s10434-008-0295-2; Bickenbach KA, 2013, ANN SURG ONCOL, V20, P780, DOI 10.1245/s10434-012-2653-3; Pausch T, 2012, SURGERY, V152, pS81, DOI 10.1016/j.surg.2012.05.028; Sledzianowski JF, 2005, SURGERY, V137, P180, DOI 10.1016/j.surg.2004.06.063; Bergstrom A, 2001, INT J CANCER, V91, P421, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1053>3.0.CO;2-T; Gaujoux S, 2012, ANN SURG ONCOL, V19, P2908, DOI 10.1245/s10434-012-2301-y; Mullen JT, 2008, ANN SURG ONCOL, V15, P2164, DOI 10.1245/s10434-008-9990-2; Park JW, 2013, BRIT J SURG, V100, P1064, DOI 10.1002/bjs.9146; Dalal S, 2012, J PAIN SYMPTOM MANAG, V44, P181, DOI 10.1016/j.jpainsymman.2011.09.010; DeOliveira ML, 2006, ANN SURG, V244, P931, DOI 10.1097/01.sla.0000246856.03918.9a; Garcea Giuseppe, 2008, JOP, V9, P99; Hassenpflug M, 2012, SURGERY, V152, pS164, DOI 10.1016/j.surg.2012.05.026; HUBERT HB, 1983, CIRCULATION, V67, P968; Japanese Pancreas Society, 2009, GEN RUL STUD PANCR C; Li DH, 2009, JAMA-J AM MED ASSOC, V301, P2553, DOI 10.1001/jama.2009.886; Lin J, 2004, CANCER CAUSE CONTROL, V15, P581, DOI 10.1023/B:CACO.0000036168.23351.f1; MANSON JAE, 1990, NEW ENGL J MED, V322, P882, DOI 10.1056/NEJM199003293221303; Noun Roger, 2008, JOP, V9, P468; Ramsey AM, 2011, J GASTROINTEST SURG, V15, P1633, DOI 10.1007/s11605-011-1502-1	26	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0148-6071	1941-2444		JPEN-PARENTER ENTER	J. Parenter. Enter. Nutr.	JUL	2015	39	5					598	603		10.1177/0148607114520992		6	Nutrition & Dietetics	Nutrition & Dietetics	CK8SE	WOS:000356507600012		
J	Kitano, T; Nakagawa, K; Wada, M; Moriyama, M				Kitano, Toshio; Nakagawa, Keisuke; Wada, Mayuko; Moriyama, Michiko			Closed reduction of slipped capital femoral epiphysis: high-risk factor for avascular necrosis	JOURNAL OF PEDIATRIC ORTHOPAEDICS-PART B			English	Article						avascular necrosis; classification; closed reduction; risk factor; slipped capital femoral epiphysis; timing of treatment; treatment method	OSTEONECROSIS; STABILIZATION	How should we treat acute/unstable slipped capital femoral epiphysis (SCFE) without the development of avascular necrosis (AVN)? To answer this question, we investigated the risk factors of AVN development after SCFE. Seventy-six hips of 64 patients were classified using two kinds of classification systems, Loder's classification based on instability and the conventional classification based on the duration of symptom, because both classifications are related to AVN development. Of 21 unstable SCFEs, seven hips developed AVN. Of 35 hips defined as acute or acute on chronic, nine hips developed AVN. Two stable SCFEs of Loder's classification developed AVN, one was acute and the other was acute on chronic. No hips of chronic SCFE developed AVN. The factor that had influenced AVN development was only closed reduction, whether purposefully or inadvertently, in an acute or unstable SCFE. On the basis of the findings of this study, one should not embark on any modality of closed reduction for an unstable or acute form of SCFE, as there is a high risk for occurrence of AVN. For the same reason, a traction table should not be used for SCFE fixation, so as to avoid an inadvertent reduction or force that can lead to AVN.	[Kitano, Toshio; Nakagawa, Keisuke; Wada, Mayuko; Moriyama, Michiko] Osaka City Gen Hosp, Dept Pediat Orthopaed Surg, Osaka 5340021, Japan	Kitano, T (reprint author), Osaka City Gen Hosp, Dept Pediat Orthopaed Surg, Miyakojima Ku, 2-13-22 Miyakojima Hondori, Osaka 5340021, Japan.	tkitano@med.osaka-cu.ac.jp					AADALEN RJ, 1974, J BONE JOINT SURG AM, VA 56, P1473; Ziebarth K, 2009, CLIN ORTHOP RELAT R, V467, P704, DOI 10.1007/s11999-008-0687-4; LODER RT, 1993, J BONE JOINT SURG AM, V75A, P1134; Kalogrianitis S, 2007, J PEDIATR ORTHOP B, V16, P6; Tokmakova KP, 2003, J BONE JOINT SURG AM, V85A, P798; Phillips SA, 2001, J BONE JOINT SURG BR, V83B, P1046, DOI 10.1302/0301-620X.83B7.11640; Kennedy JG, 2001, J PEDIATR ORTHOPED, V21, P189, DOI 10.1097/00004694-200103000-00011; Loder RT, 2006, ORTHOP CLIN N AM, V37, P211, DOI 10.1016/j.ocl.2005.09.003; Herrera-Soto JA, 2008, J PEDIATR ORTHOPED, V28, P723, DOI 10.1097/BPO.0b013e318186bda3; CARNEY BT, 1991, J BONE JOINT SURG AM, V73A, P667; Palocaren T, 2010, J PEDIATR ORTHOPED, V30, P31, DOI 10.1097/BPO.0b013e3181c537b0; Sankar WN, 2010, J PEDIATR ORTHOPED, V30, P544, DOI 10.1097/BPO.0b013e3181e4f372; Maeda S, 2001, J PEDIATR ORTHOPED, V21, P664, DOI 10.1097/00004694-200109000-00021; Aronsson DD, 1996, CLIN ORTHOP RELAT R, P99; Ballard J, 2002, J BONE JOINT SURG BR, V84B, P1176, DOI 10.1302/0301-620X.84B8.12904; Casey B H, 1972, J Bone Joint Surg Br, V54, P607; Lowndes S, 2009, BRIT MED BULL, V90, P133, DOI 10.1093/bmb/ldp012; Rattey T, 1996, J BONE JOINT SURG AM, V78A, P398; Ziebarth K, 2012, CLIN ORTHOP RELAT R, V470, P2274, DOI 10.1007/s11999-012-2339-y	19	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1060-152X	1473-5865		J PEDIATR ORTHOP B	J. Pediatr. Orthop.-Part B	JUL	2015	24	4					281	285		10.1097/BPB.0000000000000170		5	Orthopedics; Pediatrics	Orthopedics; Pediatrics	CK6WG	WOS:000356368700002		
J	Fukiage, K; Fukuda, A; Harada, Y; Suzuki, S; Futami, T				Fukiage, Kenichi; Fukuda, Atsushi; Harada, Yuki; Suzuki, Shigeo; Futami, Tohru			Femoral head volume indicates the severity of developmental dysplasia of the hip by a method using three-dimensional magnetic resonance imaging	JOURNAL OF PEDIATRIC ORTHOPAEDICS-PART B			English	Article						developmental dysplasia of the hip; femoral head; hip dislocation; magnetic resonance imaging; multiple-echo data image combination	CONGENITAL DISLOCATION; MRI; OSTEOARTHRITIS; RELIABILITY; VALIDATION; CARTILAGE; INFANTS; ANATOMY	The aims of this study were to quantify the femoral head volume (FHV) in developmental dysplasia of the hip (DDH) and to estimate its relation with the severity of the disease. Fifty-one patients (age range 2-11 months) with unilateral DDH were evaluated using three-dimensional MRI. The relation among FHV, age, severity, and displacement was investigated. The affected FHV gradually decreased according to severity. Cephalad displacement of the femoral head correlated negatively with FHV. This new approach showed severity-dependent growth disturbance of the femoral head. This quantification is a promising technique for understanding the pathology of DDH.	[Fukiage, Kenichi; Harada, Yuki; Futami, Tohru] Shiga Med Ctr Children, Dept Pediat Orthopaed, Moriyama, Shiga, Japan; [Fukuda, Atsushi] Shiga Med Ctr Children, Dept Radiol, Moriyama, Shiga, Japan; [Suzuki, Shigeo] Mizuno Mem Hosp, Dept Pediat Orthopaed, Tokyo, Japan	Fukiage, K (reprint author), 5-7-30 Moriyama, Moriyama, Shiga 5240022, Japan.	fuki8187@gmail.com					Argenson JN, 2005, J BONE JOINT SURG BR, V87B, P1192, DOI 10.1302/0301-620X.87B9.15928; Gao MC, 2012, CHINESE MED J-PEKING, V125, P3217, DOI 10.3760/cma.j.issn.0366-6999.2012.18.004; Bae KT, 2009, CLIN J AM SOC NEPHRO, V4, P719, DOI 10.2215/CJN.03750708; Bowers ME, 2007, J BIOMECH, V40, P2811, DOI 10.1016/j.jbiomech.2007.01.016; Mahan ST, 2008, PEDIATRICS, V121, P177, DOI 10.1542/peds.2007-1618; COOPERMAN DR, 1983, CLIN ORTHOP RELAT R, P79; den Hartogh MD, 2014, RADIAT ONCOL, V9, DOI 10.1186/1748-717X-9-63; Egawa H, 2009, CLIN ORTHOP RELAT R, V467, P181, DOI 10.1007/s11999-008-0522-y; Fairbank HAT, 1930, BRIT J SURG, V17, P380, DOI 10.1002/bjs.1800176705; FINLAY HVL, 1967, BRIT MED J, V4, P377; Fujinaga Y, 2014, J MAGN RESON IMAGING, V39, P972, DOI 10.1002/jmri.24217; Fukiage K, 2014, J PEDIATR ORTHOP B, V23, P107, DOI 10.1097/BPB.0000000000000028; Fukuda A, 2014, J PEDIATR ORTHOP B, V23, P37, DOI 10.1097/BPB.0000000000000001; Graichen H, 2004, ARTHRITIS RHEUM, V50, P811, DOI 10.1002/art.20191; Kim Hui-Taek, 2011, Clin Orthop Surg, V3, P202, DOI 10.4055/cios.2011.3.3.202; LANGENSKIOLD A, 1962, J BONE JOINT SURG BR, V44, P209; Lin CJ, 1997, J PEDIATR ORTHOPED, V17, P152, DOI 10.1097/00004694-199703000-00003; Loder Randall T, 2014, J Child Orthop, V8, P11, DOI 10.1007/s11832-014-0558-3; Nagamine Satomi, 2011, Open Orthop J, V5, P134, DOI 10.2174/1874325001105010134; Slattery III WH, 2003, OTOL NEUROTOL, V24, P670; Slattery WH, 2003, OTOL NEUROTOL, V24, P666, DOI 10.1097/00129492-200307000-00022; SOMERVILLE EW, 1953, J BONE JOINT SURG BR, V35, P568; SUZUKI S, 1993, J BONE JOINT SURG BR, V75, P483; Suzuki S, 1999, J PEDIATR ORTHOPED, V19, P88; WILKINSON JA, 1963, J BONE JOINT SURG BR, V45, P268	25	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1060-152X	1473-5865		J PEDIATR ORTHOP B	J. Pediatr. Orthop.-Part B	JUL	2015	24	4					286	290		10.1097/BPB.0000000000000174		5	Orthopedics; Pediatrics	Orthopedics; Pediatrics	CK6WG	WOS:000356368700003		
J	Homma, Y; Baba, T; Ishii, S; Matsumoto, M; Kaneko, K				Homma, Yasuhiro; Baba, Tomonori; Ishii, Seiya; Matsumoto, Mikio; Kaneko, Kazuo			Avulsion fracture of the lesser trochanter in a skeletally immature freestyle footballer	JOURNAL OF PEDIATRIC ORTHOPAEDICS-PART B			English	Article						apophyseal injury; freestyle football; lesser trochanter; sports injury	PELVIS; PAIN; HIP	We report the case of a skeletally immature freestyle footballer who presented with avulsion fracture of the lesser trochanter. The patient had precursor symptom before onset during a ball juggling. Nonoperative treatment demonstrated good clinical course. This new sporting activity involves kicking the ball continuously, typically with both the hip and the knee in flexion. This repetitive movement might cause continuous stretching stress of the iliopsoas muscle at the apophysis of the lesser trochanter, causing disruption at this site. This new sporting activity in this age cohort may have higher prevalence of this type of injury due to its unique repetitive hip flexion movement.	[Homma, Yasuhiro; Baba, Tomonori; Ishii, Seiya; Matsumoto, Mikio; Kaneko, Kazuo] Juntendo Univ, Dept Orthopaed Surg, Tokyo 1130033, Japan	Homma, Y (reprint author), Juntendo Univ, Dept Orthopaed Surg, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1130033, Japan.	yhomma@juntendo.ac.jp					Afra R, 1999, J BONE JOINT SURG AM, V81A, P1299; PALETTA GA, 1995, CLIN SPORT MED, V14, P591; Rossi F, 2001, SKELETAL RADIOL, V30, P127; Stafford GH, 2011, J BONE JOINT SURG BR, V93B, P1300, DOI 10.1302/0301-620X.93B10.26714; Katoh M, 2009, J PHYS THER SCI, V21, P239; Byrne AM, 2012, INT J CLIN PAEDIAT, V1, P46; DIMON JH, 1972, CLIN ORTHOP RELAT R, P144; Khemka A, 2014, J HIP PRESERV SURG, V1, P27; Lee Soyoung, 2013, Ann Rehabil Med, V37, P143, DOI 10.5535/arm.2013.37.1.143; Papacostas NC, 2013, J EMERG MED, V45, P256, DOI 10.1016/j.jemermed.2013.01.021; Quarrier NF, 1998, J ORTHOP SPORT PHYS, V28, P168; Salter R B, 1992, Instr Course Lect, V41, P351; SPEED K, 1952, Ill Med J, V102, P114; Suarez JC, 2013, J AM ACAD ORTHOP SUR, V21, P558, DOI 10.5435/JAAOS-21-09-558; Vazquez E, 2013, CJEM, V15, P123	15	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1060-152X	1473-5865		J PEDIATR ORTHOP B	J. Pediatr. Orthop.-Part B	JUL	2015	24	4					304	307		10.1097/BPB.0000000000000154		4	Orthopedics; Pediatrics	Orthopedics; Pediatrics	CK6WG	WOS:000356368700007		
J	Niki, H; Aoki, H; Hirano, T; Akiyama, Y; Fujiya, H				Niki, Hisateru; Aoki, Haruhito; Hirano, Takaaki; Akiyama, Yui; Fujiya, Hiroto			Peroneal spastic flatfoot in adolescents with accessory talar facet impingement: a preliminary report	JOURNAL OF PEDIATRIC ORTHOPAEDICS-PART B			English	Article						accessory anterolateral talar facet; accessory talar facet impingement; focal abutting bone marrow edema; peroneal spastic flatfoot; subtalar arthroscopy; talocalcaneal impingement	TALOCALCANEAL; FOOT	This study analyzed imaging, arthroscopic findings, and treatment responses for peroneal spastic flatfoot (PSFF) caused by talocalcaneal impingement at the accessory anterolateral talar facet (AALTF) (accessory talar facet impingement) in 13 adolescents without histories of trauma and tarsal coalition. The AALTF was determined with computed tomography and MRI. Focal abutting bone marrow edema (FABME) on MRI around the AALTF was confirmed. In seven patients who underwent AALTF resection, subtalar arthroscopy was performed. All experienced alleviation PSFF after treatment; reduction in FABME was observed. AALTF resection alone is beneficial for PSFF caused by accessory talar facet impingement when peroneal spasms are restored by an injection of local anesthesia.	[Niki, Hisateru; Aoki, Haruhito; Hirano, Takaaki; Akiyama, Yui] St Marianna Univ, Sch Med, Dept Orthopaed Surg, Kawasaki, Kanagawa 2168511, Japan; [Fujiya, Hiroto] St Marianna Univ, Sch Med, Dept Sports Med, Kawasaki, Kanagawa 2168511, Japan	Niki, H (reprint author), St Marianna Univ, Sch Med, Dept Orthopaed Surg, Miyamae Ku, 2-16-1 Sugao, Kawasaki, Kanagawa 2168511, Japan.	h2niki@marianna-u.ac.jp					Niki H, 2005, J ORTHOP SCI, V10, P466, DOI 10.1007/s00776-005-0937-1; Malicky ES, 2002, J BONE JOINT SURG AM, V84A, P2005; Martus JE, 2008, J BONE JOINT SURG AM, V90A, P2452, DOI 10.2106/JBJS.G.01230; HARRIS RI, 1955, J BONE JOINT SURG AM, V37, P169; Kinoshita M, 2005, J ORTHOP SCI, V10, P550, DOI 10.1007/s00776-005-0918-4; Steven M, 1996, FOOT ANKLE INT, V17, P286; Martus Jeffrey E, 2008, Iowa Orthop J, V28, P1; Niki H, 2013, J ORTHOP SCI, V18, P552, DOI 10.1007/s00776-013-0398-x; Nishizawa S, 2012, J JPN SOC SURG FOOT, V33, P157; Sarrafian SK, 2011, OSTEOLOGY SARRAFIANS, P53; Sewell RBS, 1904, J ANAT PHYSIOL, V39, P74; Shurnas PS, 2007, ARTHRITIC CONDITION, P1073	12	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1060-152X	1473-5865		J PEDIATR ORTHOP B	J. Pediatr. Orthop.-Part B	JUL	2015	24	4					354	361		10.1097/BPB.0000000000000178		8	Orthopedics; Pediatrics	Orthopedics; Pediatrics	CK6WG	WOS:000356368700016		
J	Holanda, LM; Lesseux, GG; Magnavita, ET; Ribeiro, RA; Nakatsuji, S; Kuga, K; Fisk, Z; Oseroff, SB; Urbano, RR; Rettori, C; Pagliuso, PG				Holanda, L. M.; Lesseux, G. G.; Magnavita, E. T.; Ribeiro, R. A.; Nakatsuji, S.; Kuga, K.; Fisk, Z.; Oseroff, S. B.; Urbano, R. R.; Rettori, C.; Pagliuso, P. G.			Conduction electron spin resonance in the alpha-Yb1-xFexAlB4 (0 <= x <= 0.50) and alpha-LuAlB4 compounds	JOURNAL OF PHYSICS-CONDENSED MATTER			English	Article						conduction electron spin resonance; heavy fermions; non-Fermi-liquid regime; intermetallic compounds	SYSTEM BETA-YBALB4; HEAVY; ABSORPTION; METALS	beta-YbAlB4 has become one of the most studied heavy fermion systems since its discovery due to its remarkable physical properties. This system is the first reported Yb-based heavy-fermion superconductor (HFS) for which the low-T superconducting state emerges from a non-fermi-liquid (NFL) normal state associated with quantum criticality Nakatsuji et al 2008 Nature 4 603. Additionally, it presents a striking and unprecedented electron spin resonance (ESR) signal which behaves as a conduction electron spin resonance (CESR) at high temperatures and acquires features of the Yb3+ local moment ESR at low temperatures. The latter, also named Kondo quasiparticles spin resonance (KQSR), has been defined as a 4f-ce strongly coupled ESR mode that behaves as a local probe of the Kondo quasiparticles in a quantum critical regime, Holanda et al 2011 Phys. Rev. Lett. 107 026402. Interestingly, beta-YbAlB4 possesses a previously known structural variant, namely the alpha-YbAlB4, phase which is a paramagnetic Fermi liquid (FL) at low temperatures Macaluso et al 2007 Chem. Mater. 19 1918. However, it has been recently suggested that the alpha-YbAlB4 phase may be tuned to NFL behavior and/or magnetic ordering as the compound is doped with Fe. Here we report ESR studies on the alpha-Yb1-xFexAlB4 (0 <= x <= 0.50) series as well as on the reference compound alpha-LuAlB4. For all measured samples, the observed ESR signal behaves as a CESR in the entire temperature range (10K less than or similar to T less than or similar to 300 K) in clear contrast with what has been observed for beta-YbAlB4. This striking result indicates that the proximity to a quantum critical point is crucial to the occurrence of a KQSR signal.	[Holanda, L. M.; Lesseux, G. G.; Urbano, R. R.; Rettori, C.; Pagliuso, P. G.] Univ Estadual Campinas, Inst Fis Gleb Wataghin, BR-13083859 Campinas, SP, Brazil; [Holanda, L. M.] Univ Fed Rural Semiarido UFERSA, BR-59900000 Pau Dos Ferros, RN, Brazil; [Magnavita, E. T.; Ribeiro, R. A.; Rettori, C.] Univ Fed Abc, CCNH, BR-09210580 Santo Andre, SP, Brazil; [Nakatsuji, S.; Kuga, K.] Univ Tokyo, Inst Solid State Phys, Kashiwa, Chiba 2778581, Japan; [Fisk, Z.] Univ Calif Irvine, Irvine, CA 92697 USA; [Oseroff, S. B.] San Diego State Univ, San Diego, CA 92182 USA	Holanda, LM (reprint author), Univ Estadual Campinas, Inst Fis Gleb Wataghin, BR-13083859 Campinas, SP, Brazil.	lesseuxgg@gmail.com			FAPESP (Brazil); CNPq (Brazil); CAPES (Brazil); AFOSR MURI (USA); NSF (USA)	We thank FAPESP, CNPq, and CAPES (Brazil), AFOSR MURI and NSF (USA) for their financial support.	Huber DL, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.125417; Thompson JD, 2012, J PHYS SOC JPN, V81, DOI 10.1143/JPSJ.81.011002; von Lohneysen H, 2007, REV MOD PHYS, V79, P1015, DOI 10.1103/RevModPhys.79.1015; Watanabe S, 2014, J PHYS SOC JPN, V83, DOI 10.7566/JPSJ.83.103708; Coleman P, 2001, J PHYS-CONDENS MAT, V13, pR723, DOI 10.1088/0953-8984/13/35/202; FEHER G, 1955, PHYS REV, V98, P337, DOI 10.1103/PhysRev.98.337; Ramires A, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.176404; DYSON FJ, 1955, PHYS REV, V98, P349, DOI 10.1103/PhysRev.98.349; ELLIOTT RJ, 1954, PHYS REV, V96, P266, DOI 10.1103/PhysRev.96.266; Nakatsuji S, 2008, NAT PHYS, V4, P603, DOI 10.1038/nphys1002; Continentino MA, 2005, BRAZ J PHYS, V35, P197, DOI 10.1590/S0103-97332005000100018; FREDKIN DR, 1972, PHYS REV LETT, V29, P1390, DOI 10.1103/PhysRevLett.29.1390; Hewson A.C., 1997, KONDO PROBLEM HEAVY; Holanda LM, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.026402; Holanda LM, 2013, J PHYS-CONDENS MAT, V25, DOI 10.1088/0953-8984/25/21/216001; Huber DL, 2014, J PHYS-CONDENS MAT, V26, DOI 10.1088/0953-8984/26/38/382201; Kuga K, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.224413; Kuga K, 2013, J KOREAN PHYS SOC, V63, P549, DOI 10.3938/jkps.63.549; Macaluso RT, 2007, CHEM MATER, V19, P1918, DOI 10.1021/cm062244+; Monod P, 1978, J PHYS-PARIS, V39, pC6; O'Farrell ECT, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.176405; Ramirez A, 2012, PHYS REV LETT, V112; Tomokuni K, 2013, PHYS REV LETT, V109	23	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0953-8984	1361-648X		J PHYS-CONDENS MAT	J. Phys.-Condes. Matter	JUL 1	2015	27	25							255601	10.1088/0953-8984/27/25/255601		5	Physics, Condensed Matter	Physics	CK2YU	WOS:000356082300014		
J	Watanabe, S; Iga, J; Ishii, K; Numata, S; Shimodera, S; Fujita, H; Ohmori, T				Watanabe, Shin-ya; Iga, Jun-ichi; Ishii, Kazuo; Numata, Shusuke; Shimodera, Shinji; Fujita, Hirokazu; Ohmori, Tetsuro			Biological tests for major depressive disorder that involve leukocyte gene expression assays	JOURNAL OF PSYCHIATRIC RESEARCH			English	Article						Major depressive disorder; Healthy subjects; Leukocyte gene expression; Biomarker; Diagnostic test; PCR array	ENDOTHELIAL GROWTH-FACTOR; MESSENGER-RNA EXPRESSION; CELLULAR PRION PROTEIN; PERIPHERAL LEUKOCYTES; SEROTONIN TRANSPORTER; ASSOCIATION ANALYSIS; STRESS; BLOOD; CYTOKINES	Background: Development of easy-to-use biological diagnostic tests for major depressive disorder (MDD) may facilitate MDD diagnosis and delivery of optimal treatment. Here, we examined leukocyte gene expression to develop a biological diagnostic test for MDD. Methods: 25 drug-naive MDD patients (MDDs) and 25 age- and sex-matched healthy subjects (Controls) participated in a pilot study. A subsequent replication study involved 20 MDDs and 18 Controls. We used custom-made PCR array plates to examine mRNA levels of 40 candidate genes in leukocyte samples to assess whether any combination of these genes could be used to differentiate MDDs from Controls based on expression profiles. Results: Among 40 candidate genes, we identified a set of seven genes (PDGFC, SLC6A4, PDLIM5, ARKGA P24, PRNP, HDAC5, and IL1R2), each of which had expression levels that differed significantly between MDD and Control samples in the pilot study. To identify genes whose expression best differentiated between MDDs and Controls, a linear discriminant function was developed to discriminate between MDDs and Controls based on the standardized values of gene expression after Z-score transformation. Ultimately, five genes (PDGFC, SLC6A4, ARHGAP24, PRNP, and HDAC5) were selected for a multi-assay diagnostic test. In the pilot study, this diagnostic test demonstrated sensitivity and specificity of 80% and 92%, respectively. The replication study yielded nearly identical results, sensitivity of 85% and specificity. of 89%. Conclusions: Using leukocyte gene expression profiles, we could differentiate MDDs from Controls with adequate sensitivity and specificity. Additional markers not yet identified might further improve the performance of this test. (C) 2015 Elsevier Ltd. All rights reserved.	[Watanabe, Shin-ya; Iga, Jun-ichi; Numata, Shusuke; Ohmori, Tetsuro] Univ Tokushima, Sch Med, Dept Psychiat, Course Integrated Brain Sci, Tokushima 7708503, Japan; [Ishii, Kazuo] Tokyo Univ Agr & Technol, Fac Agr, Dept Appl Biol Sci, Fuchu, Tokyo 1838509, Japan; [Shimodera, Shinji; Fujita, Hirokazu] Kochi Univ, Kochi Med Sch, Dept Neuropsychiat, Kochi 780, Japan	Iga, J (reprint author), Univ Tokushima, Sch Med, Dept Psychiat, Course Integrated Brain Sci, 18-15 Kuramoto Cho 3, Tokushima 7708503, Japan.	igajunichi@hotmail.com			Japanese Ministry of Health, Labor and Welfare; Japanese Ministry of Education, Culture, Sports, Science and Technology	The authors would like to thank Mrs. Akemi Okada for her technical assistance. This work was supported by a Health and Labor Science Research Grant from the Japanese Ministry of Health, Labor and Welfare (TO) and a Grants-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology (KI).	Levinson DF, 2006, BIOL PSYCHIAT, V60, P84, DOI 10.1016/j.biopsych.2005.08.024; Miller AH, 2010, BRAIN BEHAV IMMUN, V24, P1, DOI 10.1016/j.bbi.2009.09.009; Watson S, 2006, PSYCHONEUROENDOCRINO, V31, P889, DOI 10.1016/j.psyneuen.2006.03.001; Belzeaux R, 2010, J PSYCHIATR RES, V44, P1205, DOI 10.1016/j.jpsychires.2010.04.011; Connor TJ, 1998, LIFE SCI, V62, P583, DOI 10.1016/S0024-3205(97)00990-9; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Iga J, 2007, PROG NEURO-PSYCHOPH, V31, P628, DOI 10.1016/j.pnpbp.2006.12.014; Papakostas GI, 2013, MOL PSYCHIATR, V18, P332, DOI 10.1038/mp.2011.166; Faravelli C, 2013, PSYCHIAT RES, V210, P1301, DOI 10.1016/j.psychres.2013.09.027; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Hobara T, 2010, J PSYCHIATR RES, V44, P263, DOI 10.1016/j.jpsychires.2009.08.015; Whitney AR, 2003, P NATL ACAD SCI USA, V100, P1896, DOI 10.1073/pnas.252784499; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Iga J, 2007, PROG NEURO-PSYCHOPH, V31, P658, DOI 10.1016/j.pnpbp.2006.12.011; Galecki P, 2013, PROG NEURO-PSYCHOPH, V45, P117, DOI 10.1016/j.pnpbp.2013.04.011; Raison CL, 2003, AM J PSYCHIAT, V160, P1554, DOI 10.1176/appi.ajp.160.9.1554; Arzt E, 2001, J CLIN INVEST, V108, P1729; Cepoiu M, 2008, J GEN INTERN MED, V23, P25, DOI 10.1007/s11606-007-0428-5; Hepgul N, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-28; Iga J, 2005, NEUROSCI LETT, V389, P12, DOI 10.1016/j.neulet.2005.06.048; Iga J, 2006, NEUROSCI LETT, V400, P203, DOI 10.1016/j.neulet.2006.02.044; Iga JI, 2008, ANN MED, V40, P336, DOI 10.1080/07853890802082088; Ingram RJ, 2009, FASEB J, V23, P1672, DOI 10.1096/fj.08-116087; Lee C, 2013, TRENDS MOL MED, V19, P474, DOI 10.1016/j.molmed.2013.04.006; Numata S, 2009, AM J MED GENET B, V150B, P527, DOI 10.1002/ajmg.b.30852; Ohmori Tetsuro, 2005, J Med Invest, V52 Suppl, P266, DOI 10.2152/jmi.52.266; Shibata T, 2013, PROG NEURO-PSYCHOPH, V43, P222, DOI 10.1016/j.pnpbp.2013.01.003; Spijker S, 2010, BIOL PSYCHIAT, V68, P179, DOI 10.1016/j.biopsych.2010.03.017; Tsao CW, 2006, PROG NEURO-PSYCHOPH, V30, P899, DOI 10.1016/j.pnpbp.2006.01.029; Tsutsui S, 2008, AM J PATHOL, V173, P1029, DOI 10.2353/ajpath.2008.071062; Watanabe S, 2014, HUM PSYCHOPHARM CLIN, V29, P190, DOI 10.1002/hup.2381	32	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-3956	1879-1379		J PSYCHIATR RES	J. Psychiatr. Res.	JUL-AUG	2015	66-67						1	6		10.1016/j.jpsychires.2015.03.004		6	Psychiatry	Psychiatry	CL2AT	WOS:000356746700001		
J	Niitsu, T; Fabbri, C; Serretti, A				Niitsu, Tomihisa; Fabbri, Chiara; Serretti, Alessandro			Predictors of switch from depression to mania in bipolar disorder	JOURNAL OF PSYCHIATRIC RESEARCH			English	Article						Bipolar depression; Manic switch; Manic symptom; Panic attack; Venlafaxine; Suicide; Rapid-cycling; Amphetamine use; Onset	TREATMENT ENHANCEMENT PROGRAM; INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW; STEP-BD; ANXIETY DISORDERS; MOOD-STABILIZERS; PANIC DISORDER; GLOBAL BURDEN; FOLLOW-UP; DSM-IV; ANTIDEPRESSANTS	Manic switch is a relevant issue when treating bipolar depression. Some risk factors have been suggested, but unequivocal findings are lacking. We therefore investigated predictors of switch from depression to mania in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) sample. Manic switch was defined as a depressive episode followed by a (hypo)manic or mixed episode within the following 12 weeks. We assessed possible predictors of switch using generalized linear mixed models (GLMM). 8403 episodes without switch and 512 episodes with switch (1720 subjects) were included in the analysis. Several baseline variables were associated with a higher risk of switch. They were younger age, previous history of: rapid cycling, severe manic symptoms, suicide attempts, amphetamine use and some pharmacological and psychotherapeutic treatments. During the current depressive episode, the identified risk factors were: any possible mood elevation, multiple mania-associated symptoms with at least moderate severity, and comorbid panic attacks. In conclusion, our study suggests that both characteristics of the disease history and clinical features of the current depressive episode may be risk factors for manic switch. (C) 2015 Elsevier Ltd. All rights reserved.	[Niitsu, Tomihisa; Fabbri, Chiara; Serretti, Alessandro] Univ Bologna, Dept Biomed & NeuroMotor Sci, I-40123 Bologna, Italy; [Niitsu, Tomihisa] Chiba Univ, Grad Sch Med, Res Ctr Child Mental Dev, Chiba, Japan	Serretti, A (reprint author), Univ Bologna, Dept Biomed & NeuroMotor Sci, Viale Carlo Pepoli 5, I-40123 Bologna, Italy.	alessandro.serretti@unibo.it			SENSHIN Medical Research Foundation, Japan	The work of Dr. Niitsu was supported by a grant for research abroad from SENSHIN Medical Research Foundation, Japan. The funding body had no role in the study design, the collection of data, the writing of this report and decision to submit it for publication.	Miklowitz DJ, 2007, ARCH GEN PSYCHIAT, V64, P419, DOI 10.1001/archpsyc.64.4.419; Sachs GS, 2002, BIPOLAR DISORD, V4, P323, DOI 10.1034/j.1399-5618.2002.01195.x; Gijsman HJ, 2004, AM J PSYCHIAT, V161, P1537, DOI 10.1176/appi.ajp.161.9.1537; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Nemeroff CB, 2001, AM J PSYCHIAT, V158, P906; MacKinnon DF, 2003, AM J PSYCHIAT, V160, P1696, DOI 10.1176/appi.ajp.160.9.1696; Sachs GS, 2003, BIOL PSYCHIAT, V53, P1028, DOI 10.1016/S0006-3223(03)00165-3; Sala R, 2012, J PSYCHIATR RES, V46, P865, DOI 10.1016/j.jpsychires.2012.03.024; Goldberg JF, 2009, AM J PSYCHIAT, V166, P173, DOI 10.1176/appi.ajp.2008.08050746; Leverich GS, 2006, AM J PSYCHIAT, V163, P232, DOI 10.1176/appi.ajp.163.2.232; Salvadore G, 2010, J CLIN PSYCHIAT, V71, P1488, DOI 10.4088/JCP.09r05259gre; van Rossum I, 2008, EUR PSYCHIAT, V23, P360, DOI 10.1016/j.eurpsy.2008.02.005; Uher R, 2013, PSYCHOL MED, V43, P789, DOI 10.1017/S0033291712001523; Simon NM, 2004, AM J PSYCHIAT, V161, P2222, DOI 10.1176/appi.ajp.161.12.2222; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6; Post RM, 2006, BRIT J PSYCHIAT, V189, P124; Sachs GS, 2007, NEW ENGL J MED, V356, P1711, DOI 10.1056/NEJMoa064135; Gao KM, 2008, BIPOLAR DISORD, V10, P907, DOI 10.1111/j.1399-5618.2008.00637.x; Vrieze SI, 2012, PSYCHOL METHODS, V17, P228, DOI 10.1037/a0027127; Miklowitz DJ, 2007, AM J PSYCHIAT, V164, P1340, DOI 10.1176/appi.apj.2007.07020311; Perlis RH, 2006, AM J PSYCHIAT, V163, P217, DOI 10.1176/appi.ajp.163.2.217; Sidor MM, 2011, J CLIN PSYCHIAT, V72, P156, DOI 10.4088/JCP.09r05385gre; Fagiolini A, 2013, J AFFECT DISORDERS, V148, P161, DOI 10.1016/j.jad.2013.02.001; Vieta E, 2009, J AFFECT DISORDERS, V118, P118, DOI 10.1016/j.jad.2009.02.007; PEET M, 1994, BRIT J PSYCHIAT, V164, P549, DOI 10.1192/bjp.164.4.549; Perlis RH, 2010, NEUROPSYCHOPHARMACOL, V35, P2545, DOI 10.1038/npp.2010.122; Asghar SJ, 2003, HUM PSYCHOPHARM CLIN, V18, P291, DOI 10.1002/hup.480; Boerlin HL, 1998, J CLIN PSYCHIAT, V59, P374, DOI 10.4088/JCP.v59n0706; Bonnin CM, 2013, EUR ARCH PSY CLIN N, V264, P247; Bottlender R, 2004, J AFFECT DISORDERS, V78, P149, DOI 10.1016/S0165-0327(02)00265-3; Bottlender R, 2001, J AFFECT DISORDERS, V63, P79, DOI 10.1016/S0165-0327(00)00172-5; Bowden CL, 2012, CNS NEUROSCI THER, V18, P243, DOI 10.1111/j.1755-5949.2011.00257.x; Conus P, 2013, BIPOLAR DISORD, V16, P548; Ferrari AJ, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-16; Goes FS, 2012, PSYCHOL MED, V42, P1449, DOI 10.1017/S0033291711002637; Houston JP, 2007, J PSYCHIATR RES, V41, P616, DOI 10.1016/j.jpsychires.2005.08.009; JACOBS D, 1986, PSYCHOL MED, V16, P323; Keck PE, 2005, J CLIN PSYCHIAT, V66, P611; Kleine-Budde K, 2013, BIPOLAR DISORD, V16, P337; MacKinnon DF, 2003, ARCH GEN PSYCHIAT, V60, P921, DOI 10.1001/archpsyc.60.9.921; MacKinnon DF, 2005, BIPOLAR DISORD, V7, P441, DOI 10.1111/j.1399-5618.2005.00236.x; Maj M, 2002, AM J PSYCHIAT, V159, P1711, DOI 10.1176/appi.ajp.159.10.1711; Miklowitz DJ, 2006, PSYCHIAT SERV, V57, P959, DOI 10.1176/appi.ps.57.7.959; Nwulia EA, 2008, BIPOLAR DISORD, V10, P597, DOI 10.1111/j.1399-5618.2008.00600.x; Sachs GS, 2000, POSTGRAD MED, P1; Sachs GS, 2004, ACTA PSYCHIAT SCAND, V110, P7, DOI 10.1111/j.1600-0447.2004.00409.x; Serretti A, 2003, PROG NEURO-PSYCHOPH, V27, P751, DOI 10.1016/S0278-5846(03)00104-0; Stange JP, 2013, J PSYCHIATR RES, V47, P1329, DOI 10.1016/j.jpsychires.2013.05.016; Stroup WW, 2012, GEN LINEAR MIXED MOD; Valentí Marc, 2012, J Clin Psychiatry, V73, pe271, DOI 10.4088/JCP.11m07166	50	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-3956	1879-1379		J PSYCHIATR RES	J. Psychiatr. Res.	JUL-AUG	2015	66-67						45	53		10.1016/j.jpsychires.2015.04.014		9	Psychiatry	Psychiatry	CL2AT	WOS:000356746700006		
J	Kouidrat, Y; Amad, A; Arai, M; Miyashita, M; Lalau, JD; Loas, G; Itokawa, M				Kouidrat, Youssef; Amad, Ali; Arai, Makoto; Miyashita, Mitsuhiro; Lalau, Jean-Daniel; Loas, Gwenole; Itokawa, Masanari			Advanced glycation end products and schizophrenia: A systematic review	JOURNAL OF PSYCHIATRIC RESEARCH			English	Review						Schizophrenia; Advanced glycation end products; RAGE; Oxidative stress; Antioxidant defense system; Cardiovascular risk	ENHANCED CARBONYL STRESS; OXIDATIVE STRESS; CARDIOVASCULAR-DISEASE; METABOLIC ABNORMALITIES; ADVANCED GLYCOXIDATION; SKIN AUTOFLUORESCENCE; RAGE; MECHANISMS; RECEPTOR; ENDPRODUCTS	Oxidative stress has become an exciting area of research on schizophrenia, which is a highly prevalent condition that affects approximately 1% of the worldwide population. Advanced glycation end products (AGEs), which are considered metabolic biomarkers of increased oxidative stress, have a pathogenic role in the development and progression of different oxidative stress-based diseases including atherosclerosis, diabetes, neurodegenerative disorders and schizophrenia. AGE formation and accumulation as well as the activation of its receptor (RAGE) can lead to signaling through several inflammatory signaling pathways and further damaging effects. This systematic review is based on a search conducted in July 2014 in which 6 studies were identified that met our criteria. In this work, we describe how recent methodological advances regarding the role of AGEs may contribute to a better understanding of the pathophysiology of schizophrenia and provide a different approach in the comprehension of the relationship between cardiovascular disease and schizophrenia. These latest findings may lead to new directions for future research on novel diagnostic and treatment strategies. (C) 2015 Elsevier Ltd. All rights reserved.	[Kouidrat, Youssef; Lalau, Jean-Daniel] Univ Picardie Jules Verne, Dept Endocrinol, CHU Amiens, Amiens, France; [Kouidrat, Youssef] Hop Maritime Berck, AP HP, Dept Nutr, F-62600 Berck Sur Mer, France; [Amad, Ali] Kings Coll London, Inst Psychiat Psychol & Neurosci, London WC2R 2LS, England; [Arai, Makoto; Miyashita, Mitsuhiro; Itokawa, Masanari] Tokyo Metropolitan Inst Med Sci, Project Schizophrenia & Affect Disorder Res, Tokyo 113, Japan; [Loas, Gwenole] ULB, Erasme Hosp, Dept Psychiat, B-1070 Brussels, Belgium	Kouidrat, Y (reprint author), Univ Picardie Jules Verne, Dept Endocrinol, Amiens, France.	youssef.kouidrat@gmail.com					Angeloni C., 2014, BIOMED RES INT, V2014; Ceriello A, 2004, ARTERIOSCL THROM VAS, V24, P816, DOI 10.1161/01.ATV.0000122852.22604.78; de Vos LC, 2014, ARTERIOSCL THROM VAS, V34, P933, DOI 10.1161/ATVBAHA.113.302731; van Os J, 2009, LANCET, V374, P635, DOI 10.1016/S0140-6736(09)60995-8; Yamagishi S, 2012, BBA-GEN SUBJECTS, V1820, P663, DOI 10.1016/j.bbagen.2011.03.014; Singh R, 2001, DIABETOLOGIA, V44, P129, DOI 10.1007/s001250051591; Clynes R, 2007, CURR MOL MED, V7, P743; Wu JQ, 2013, PROG NEURO-PSYCHOPH, V46, P200, DOI 10.1016/j.pnpbp.2013.02.015; Steiner J, 2009, BIOL PSYCHIAT, V65, P1107, DOI 10.1016/j.biopsych.2008.10.044; Saruwatari J, 2013, NEUROPSYCH DIS TREAT, V9, P1683, DOI 10.2147/NDT.S52585; Beisswenger PJ, 2013, DIABETES CARE, V36, P3234, DOI 10.2337/dc12-2689; Goldberg T, 2004, J AM DIET ASSOC, V104, P1287, DOI 10.1016/j.jada.2004.05.214; Uribarri J, 2010, J AM DIET ASSOC, V110, P911, DOI 10.1016/j.jada.2010.03.018; Arai M, 2010, ARCH GEN PSYCHIAT, V67, P589, DOI 10.1001/archgenpsychiatry.2010.62; Gysin R, 2007, P NATL ACAD SCI USA, V104, P16621, DOI 10.1073/pnas.0706778104; Hambsch B, 2011, SEMIN CELL DEV BIOL, V22, P302, DOI 10.1016/j.semcdb.2011.02.005; Kulak A, 2013, ANTIOXID REDOX SIGN, V18, P1428, DOI 10.1089/ars.2012.4858; Kalea AZ, 2009, CLIN SCI, V116, P621, DOI 10.1042/CS20080494; Yao JK, 1998, SCHIZOPHR RES, V32, P1, DOI 10.1016/S0920-9964(98)00030-9; Li JL, 2012, J NEUROL SCI, V317, P1, DOI 10.1016/j.jns.2012.02.018; Del Turco S, 2012, BIOFACTORS, V38, P266, DOI 10.1002/biof.1018; Ott C, 2014, REDOX BIOL, V2, P411, DOI 10.1016/j.redox.2013.12.016; Herold K, 2007, J LEUKOCYTE BIOL, V82, P204, DOI 10.1189/jlb.1206751; Meerwaldt R, 2004, DIABETOLOGIA, V47, P1324, DOI 10.1007/s00125-004-1451-2; Jaisson S, 2010, CLIN CHEM, V56, P1401, DOI 10.1373/clinchem.2010.145201; Yao JK, 2006, DIS MARKERS, V22, P83; Vancampfort D, 2013, WORLD PSYCHIATRY, V12, P240, DOI 10.1002/wps.20069; Ciobica A, 2011, PSYCHIAT DANUB, V23, P237; Steiner J, 2014, PROG NEURO-PSYCHOPH, V48, P287, DOI 10.1016/j.pnpbp.2012.09.016; Dipasquale S, 2013, J PSYCHIATR RES, V47, P197, DOI 10.1016/j.jpsychires.2012.10.005; Zimmermann U, 2003, J PSYCHIAT RES, V37, P193, DOI 10.1016/S0022-3956(03)00018-9; Basta G, 2008, ATHEROSCLEROSIS, V196, P9, DOI 10.1016/j.atherosclerosis.2007.07.025; Brown S, 2010, BRIT J PSYCHIAT, V196, P116, DOI 10.1192/bjp.bp.109.067512; Daffu G, 2013, INT J MOL SCI, V14, P19891, DOI 10.3390/ijms141019891; De Hert M, 2011, WORLD PSYCHIATRY, V10, P52; Sugamura K, 2011, FREE RADICAL BIO MED, V51, P978, DOI 10.1016/j.freeradbiomed.2011.05.004; Emiliani FE, 2014, CURR OPIN PSYCHIATR, V27, P185, DOI 10.1097/YCO.0000000000000054; Moher D, 2009, ANN INTERN MED, V151, P264; Vistoli G, 2013, FREE RADICAL RES, V47, P3, DOI 10.3109/10715762.2013.815348; Arroll MA, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-91; Arsov S, 2014, CLIN CHEM LAB MED, V52, P11, DOI 10.1515/cclm-2012-0832; Chuah YK, 2013, INT J INFLAM, V2013, DOI [10.1155/2013/403460, DOI 10.1155/2013/403460]; Emanuele E, 2011, NEUROSCI LETT, V487, P99, DOI 10.1016/j.neulet.2010.10.003; Engelen L, 2013, DIABETES OBES METAB, V15, P677, DOI 10.1111/dom.12058; Hegab Zeinab, 2012, World J Cardiol, V4, P90, DOI 10.4330/wjc.v4.i4.90; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Itokawa M, 2014, BIOCHEM SOC T, V42, P468, DOI 10.1042/BST20140044; Jack M, 2012, TRANSL RES, V159, P355, DOI 10.1016/j.trsl.2011.12.004; Katsuta N, 2014, SCHIZOPHRENIA BULL, V40, P1366, DOI 10.1093/schbul/sbt234; Kizer JR, 2014, ATHEROSCLEROSIS, V235, P116, DOI 10.1016/j.atherosclerosis.2014.04.013; Kouidrat Y, 2013, J PSYCHIATR RES, V47, P1044, DOI 10.1016/j.jpsychires.2013.03.016; Kouidrat Y., 2014, SCHIZOPHR RES TREAT, V2014; Loas G, 2010, COMPR PSYCHIAT, V51, P151, DOI 10.1016/j.comppsych.2009.05.009; Mahajan N, 2013, INT J CARDIOL, V168, P1788, DOI 10.1016/j.ijcard.2013.05.013; Miyashita M, 2014, PSYCHIAT CLIN NEUROS, V68, P83, DOI [10.1111/pcn.12081, 10.1111/pcn.12087]; Miyashita M, 2014, SCHIZOPHRENIA BULL, V40, P1040, DOI 10.1093/schbul/sbt129; Ponath G, 2007, J NEUROIMMUNOL, V184, P214, DOI 10.1016/j.jneuroim.2006.12.011; Prasad A, 2012, CARDIOL REV, V20, P177, DOI 10.1097/CRD.0b013e318244e57c; Prasad Kailash, 2014, Int J Angiol, V23, P11, DOI 10.1055/s-0033-1363423; Rabbani N, 2014, BIOCHEM SOC T, V42, P419, DOI 10.1042/BST20140008; Ramasamy Ravichandran, 2012, Curr Heart Fail Rep, V9, P107, DOI 10.1007/s11897-012-0089-5; Stirban Alin, 2014, Mol Metab, V3, P94, DOI 10.1016/j.molmet.2013.11.006; Sweating J, 2013, SCHIZOPHR RES, V150, P398; Wang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050790	64	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-3956	1879-1379		J PSYCHIATR RES	J. Psychiatr. Res.	JUL-AUG	2015	66-67						112	117		10.1016/j.jpsychires.2015.04.023		6	Psychiatry	Psychiatry	CL2AT	WOS:000356746700014		
J	Chen, WF; Yamamoto, T; Fisher, M; Liao, JL; Carr, J				Chen, Wei F.; Yamamoto, Takumi; Fisher, Mark; Liao, Junlin; Carr, Jennifer			The "Octopus" Lymphaticovenular Anastomosis: Evolving Beyond the Standard Supermicrosurgical Technique	JOURNAL OF RECONSTRUCTIVE MICROSURGERY			English	Article						supermicrosurgery; lymphaticovenular anastomosis; LVA; lymphedema surgery	UPPER-EXTREMITY-LYMPHEDEMA; UPPER-LIMB LYMPHEDEMA; NODE FLAP; LYMPHOGRAPHY; MANAGEMENT; BYPASS	BackgroundSupermicrosurgical lymphaticovenular anastomosis (LVA) is a promising treatment modality for lymphedema. However, its practice is restricted by the surgeon/equipment-related factors, and its effectiveness limited by technical constraints. We conducted a pilot study to evaluate the feasibility of a modified octopus LVA technique in addressing the above problems. MethodNine consecutive lymphedema patients underwent LVA procedure using the octopus technique. Six had the upper extremity disease; three had the lower extremity disease. Except for one patient having primary lower extremity lymphedema, all had secondary disease related to cancer treatment. Disease severity ranged from Campisi stage Ib to IV. Qualitative and quantitative assessments were performed preoperatively, at 1, 3, and 6 months. ResultsA total of 130 lymphaticovenular drainage pathways were created in 39 octopus LVAs. All patients experienced prompt relief of lymphedema symptoms during the 1st postoperative week and continued to improve during the study period. None had postoperative complications. All had disease regression as demonstrated by statistically significant decrease in limb measurements (p=0.0003) and severity down-staging. The modified technique was found to be easier than the standard supermicrosurgical technique and could be performed using a standard surgical microscope. ConclusionThe octopus technique is a viable, effective technical alternative to the standard LVA technique. It may greatly simplify this technically challenging procedure.	[Chen, Wei F.; Fisher, Mark; Liao, Junlin; Carr, Jennifer] Univ Iowa Hosp & Clin, Dept Surg, Div Plast & Reconstruct Surg, Iowa City, IA 52242 USA; [Yamamoto, Takumi] Univ Tokyo, Grad Sch Med, Dept Plast & Reconstruct Surg, Bunkyo Ku, Tokyo, Japan	Chen, WF (reprint author), Univ Iowa Hosp & Clin, Dept Surg, Div Plast & Reconstruct Surg, 200 Hawkins Dr,1537 JCP, Iowa City, IA 52242 USA.	wei-chen@uiowa.edu					Yamamoto T, 2011, PLAST RECONSTR SURG, V127, P1987, DOI 10.1097/PRS.0b013e31820cf5c6; Hara H, 2013, PLAST RECONSTR SURG, V132, P1612, DOI 10.1097/PRS.0b013e3182a97edc; Campisi C, 2001, MICROSURG, V21, P135, DOI 10.1002/micr.1025; Penha TRL, 2013, J RECONSTR MICROSURG, V29, P99, DOI 10.1055/s-0032-1329919; Lin CH, 2009, PLAST RECONSTR SURG, V123, P1265, DOI 10.1097/PRS.0b013e31819e6529; Gharb BB, 2011, ANN PLAS SURG, V67, P589, DOI 10.1097/SAP.0b013e3181f88e8a; Yamamoto T, 2014, ANN PLAS SURG, V72, P67, DOI 10.1097/SAP.0b013e3182605580; Cheng MH, 2013, PLAST RECONSTR SURG, V131, P1286, DOI 10.1097/PRS.0b013e31828bd3b3; Chang DW, 2010, PLAST RECONSTR SURG, V126, P752, DOI 10.1097/PRS.0b013e3181e5f6a9; Yamamoto T, 2013, MICROSURG, V33, P130, DOI 10.1002/micr.22040; Koshima I, 2000, J RECONSTR MICROSURG, V16, P437; Armer JM, 2005, CANCER INVEST, V23, P76, DOI 10.1081/CNV-200048707; Yamamoto T, 2011, PLAST RECONSTR SURG, V128, P941, DOI 10.1097/PRS.0b013e3182268cd9; Yamamoto T, 2014, ANN PLAS SURG, V73, P46, DOI 10.1097/SAP.0b013e31826caff1; Cheng MH, 2012, GYNECOL ONCOL, V126, P93, DOI 10.1016/j.ygyno.2012.04.017; Yamamoto T, 2011, J PLAST RECONSTR AES, V64, P812, DOI 10.1016/j.bjps.2010.10.011; Yamamoto T, 2011, ANN PLAS SURG, V67, P637, DOI 10.1097/SAP.0b013e318208fd75; Ayestaray B, 2014, J RECONSTR MICROSURG, V30, P551, DOI 10.1055/s-0034-1370356; Chang DW, 2013, PLAST RECONSTR SURG, V132, P1305, DOI 10.1097/PRS.0b013e3182a4d626; Chen WF, 2014, J PLAST RECONSTR AES, V67, P973, DOI 10.1016/j.bjps.2014.03.024; Masia J, 2014, J RECONSTR MICROSURG, V30, P53, DOI 10.1055/s-0033-1354742; Mihara M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041126; Mihara M, 2012, PLAST RECONSTR SURG, V129, p404E, DOI 10.1097/PRS.0b013e31823af16b; Nagase Takashi, 2005, Int J Clin Oncol, V10, P304, DOI 10.1007/s10147-005-0518-5; Yamamoto T, 2015, MICROSURG, V35, P129, DOI 10.1002/micr.22272; Yamamoto T, 2014, MICROSURG, V34, P404, DOI 10.1002/micr.22215; Yamamoto T, 2013, ANN PLAS SURG, V70, P47, DOI 10.1097/SAP.0b013e3182275d23	27	1	1	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0743-684X	1098-8947		J RECONSTR MICROSURG	J. Reconstr. Microsurg.	JUL	2015	31	6					450	457		10.1055/s-0035-1548746		8	Surgery	Surgery	CK8UV	WOS:000356515300008		
J	Hsiao, PC; Hayashi, KK; Nishi, R; Lin, XC; Nakashima, M				Hsiao, Po-Chien; Hayashi, K. Kazuhiro; Nishi, Ryousuke; Lin, Xu-Chuan; Nakashima, Masayoshi			Investigation of Concrete-Filled Double-Skin Steel Tubular Columns with Ultrahigh-Strength Steel	JOURNAL OF STRUCTURAL ENGINEERING			English	Article						Composite columns; Construction; Beam columns; High strength steel; Tubes; Cyclic loads; Metal and composite structures	BEAM-COLUMNS; TUBE COLUMNS; STUB COLUMNS; BEHAVIOR; PERFORMANCE; INNER; SHS	Concrete-filled steel tubular (CFT) columns have been used increasingly in building structures because of their construction efficiency and provision of high stiffness and strength. A relatively new configuration design with inserted inner steel tubes, so-called concrete-filled double-skin steel tubes (CFDSTs), has been developed in the field. To promote the seismic capability of the CFT/CFDST columns further, the authors present results from an experimental investigation of CFT and CFDST columns using ultrahigh-strength steel. Eight scaled column specimens were examined by subjecting them to combined axial and flexural cyclic loadings. The performance of the CFT and CFDST design configurations using high-strength steel was comparable and both provide large moment capacities and elastic deformation capacities. The ultimate member moment capacity could be predicted accurately using a proposed simple formulation based on the concept of the superposed strength method. Various performance parameters are evaluated and discussed, and the influence of compressive strength of the concrete core, applied axial loads, and inserted inner steel tubes on the seismic behavior of the column members is clarified by the experimental results.	[Hsiao, Po-Chien; Hayashi, K. Kazuhiro; Nishi, Ryousuke; Nakashima, Masayoshi] Kyoto Univ, Disaster Prevent Res Inst, Uji, Kyoto 6110011, Japan; [Lin, Xu-Chuan] China Earth Quake Adm, Inst Engn Mech, Sanhe 065201, Peoples R China; [Nakashima, Masayoshi] Univ Tokyo, Earthquake Res Inst, Tokyo 113, Japan	Hsiao, PC (reprint author), Kyoto Univ, Disaster Prevent Res Inst, Uji, Kyoto 6110011, Japan.	pchsiao@uw.edu					BOYD PF, 1995, ACI STRUCT J, V92, P355; Marson J, 2004, J BRIDGE ENG, V9, P14, DOI 10.1061/(ASCE)1084-0702(2004)9:1(14); Hu HT, 2011, MAR STRUCT, V24, P319, DOI 10.1016/j.marstruc.2011.05.001; Han LH, 2005, J CONSTR STEEL RES, V61, P423, DOI 10.1016/j.jcsr.2004.10.004; WEI S, 1995, J STRUCT ENG-ASCE, V121, P1806, DOI 10.1061/(ASCE)0733-9445(1995)121:12(1806); Han LH, 2003, THIN WALL STRUCT, V41, P801, DOI 10.1016/S0263-8231(03)00030-2; MANDER JB, 1988, J STRUCT ENG-ASCE, V114, P1804; Tao Z, 2006, J CONSTR STEEL RES, V62, P631, DOI 10.1016/j.jcsr.2005.11.008; Roeder CW, 2010, J STRUCT ENG-ASCE, V136, P1545, DOI 10.1061/(ASCE)ST.1943-541X.0000263; Tao Z, 2004, J CONSTR STEEL RES, V60, P1129, DOI 10.1016/j.jcsr.2003.11.008; PRION HGL, 1994, CAN J CIVIL ENG, V21, P207; Elchalakani M, 2001, J CONSTR STEEL RES, V57, P1141, DOI 10.1016/S0143-974X(01)00035-9; Han LH, 2006, ENG STRUCT, V28, P1698, DOI 10.1016/j.engstruct.2006.03.004; O'Shea MD, 2000, J STRUCT ENG-ASCE, V126, P1295, DOI 10.1061/(ASCE)0733-9445(2000)126:11(1295); Elremaily A, 2002, J CONSTR STEEL RES, V58, P1567, DOI 10.1016/S0143-974X(02)00005-6; Deierlein G, 2011, STEEL CONSTRUCTION, V4, P171, DOI [10.1002/stco.201110023, DOI 10.1002/STCO.201110023]; Fujimoto T, 2004, J STRUCT ENG-ASCE, V130, P203, DOI 10.1061/(ASCE)0733-9445(2004)130:2(203); Furlong RW, 1967, J STRUCTURAL DIVISIO, V93, P113; Montague P., 1975, J MECH ENG SCI, V20, P21, DOI [10.1243/JMES_JOUR_1978_020_005_02, DOI 10.1243/JMES_JOUR_1978_020_005_02]; Morino S., 1997, EXPT STUDIES CFT COL, P1106; Nakamura T., 1976, B DISASTER PREVENTIO, V26, P163; Nashioka K., 2000, STEEL WORLD, V5, P61; Richard F. E., 1928, STUDY FAILURE CONCRE; Zhang GW, 2009, ACI STRUCT J, V106, P151; Zhao XL, 2002, THIN WALL STRUCT, V40, P815, DOI 10.1016/S0263-8231(02)00030-7	25	0	0	ASCE-AMER SOC CIVIL ENGINEERS	RESTON	1801 ALEXANDER BELL DR, RESTON, VA 20191-4400 USA	0733-9445	1943-541X		J STRUCT ENG	J. Struct. Eng.	JUL	2015	141	7							04014166	10.1061/(ASCE)ST.1943-541X.0001126		8	Construction & Building Technology; Engineering, Civil	Construction & Building Technology; Engineering	CK7OM	WOS:000356421900004		
J	Takeuchi, T; Matsui, R				Takeuchi, Toru; Matsui, Ryota			Cumulative Deformation Capacity of Steel Braces under Various Cyclic Loading Histories	JOURNAL OF STRUCTURAL ENGINEERING			English	Article						Circular hollow section brace; H-section brace; Local buckling; Loading history; Cumulative deformation capacity; Fracture; Seismic effects	FRACTURE; SIMULATION; BEHAVIOR; MEMBERS; FORCE; MODEL	The postbuckling behavior of seismic-resistant braces in steel frames under a cyclic axial force is often evaluated by time-history analyses; however, brace fracture is seldom considered. The authors previously proposed a physical model for predicting the moment of fracture of circular-tube braces after buckling using phenomenological hysteresis. However, the accuracy of that model was confirmed only against the test results of the gradually increasing amplitude loading protocol, and its applicability under other loading histories has not yet been verified. In this study, cyclic loading tests were carried out until fracture on circular-tube and H-section braces under various loading histories, followed by FEM analyses. The validity of the proposed formulas for evaluating the strain-concentration index under various loading histories was examined. The proposed method was used for predicting the moment of fracture and the cumulative deformation capacity until fracture, and the predictions agreed well with the test results.	[Takeuchi, Toru; Matsui, Ryota] Tokyo Inst Technol, Dept Architecture & Bldg Engn, Meguro Ku, Tokyo 1528552, Japan	Takeuchi, T (reprint author), Tokyo Inst Technol, Dept Architecture & Bldg Engn, Meguro Ku, M1-29,2-12-1 O Okayama, Tokyo 1528552, Japan.	ttoru@arch.titech.ac.jp					Tremblay R, 2002, J CONSTR STEEL RES, V58, P665, DOI 10.1016/S0143-974X(01)00104-3; Takeuchi T, 2011, J STRUCT ENG-ASCE, V137, P1311, DOI 10.1061/(ASCE)ST.1943-541X.0000380; Fell BV, 2009, J STRUCT ENG-ASCE, V135, P19, DOI 10.1061/(ASCE)0733-9445(2009)135:1(19); Li G, 2013, J STRUCT ENG-ASCE, V139, P526, DOI 10.1061/(ASCE)ST.1943-541X.0000664; Hsiao PC, 2013, EARTHQ ENG STRUCT D, V42, P183, DOI 10.1002/eqe.2202; Elchalakani M, 2003, J STRUCT ENG-ASCE, V129, P507, DOI 10.1061/(ASCE)0733-9445(2003)129:4(507); JAIN AK, 1978, J STRUCT DIV-ASCE, V104, P897; JAIN AK, 1980, J STRUCT DIV-ASCE, V106, P1777; Japanese Industrial Standard (JIS), 2010, SS400 JIS; Kanvinde AM, 2007, J STRUCT ENG-ASCE, V133, P656, DOI 10.1061/(ASCE)0733-9445(2007)133:5(656); KATO B, 1994, J STRUCT CONSTR ENG, V458, P127; POPOV EP, 1979, J STRUCT DIV-ASCE, V105, P2261; PRATHUANGSIT D, 1978, J STRUCT DIV-ASCE, V104, P883; Saeki E., 1995, J STRUCTURAL CONSTRU, V472, p[139, 1340]; SHIBATA M, 1982, INT J SOLIDS STRUCT, V18, P217; Takeuchi T., 2008, J STRUCT CONSTR ENG, V73, P1875, DOI [10.3130/aijs.73.1875 1340-4202, DOI 10.3130/AIJS.73.1875]; Tang X, 1989, J STRUCTURAL ENG, V102, P1960, DOI [10.1061/(ASCE)0733-9445(1989)115:8(1960), DOI 10.1061/(ASCE)0733-9445(1989)115:8(1960)]; Timoshenko S. P., 1961, THEORY ELASTIC STABI; URIZ P, 2004, J STEEL STRUCT, V4, P239	19	0	0	ASCE-AMER SOC CIVIL ENGINEERS	RESTON	1801 ALEXANDER BELL DR, RESTON, VA 20191-4400 USA	0733-9445	1943-541X		J STRUCT ENG	J. Struct. Eng.	JUL	2015	141	7							04014175	10.1061/(ASCE)ST.1943-541X.0001146		11	Construction & Building Technology; Engineering, Civil	Construction & Building Technology; Engineering	CK7OM	WOS:000356421900014		
J	Chen, LC; Kinoshita, M; Noda, M; Ninomiya, S; Hiraoka, K				Chen, Lee Chuin; Kinoshita, Masato; Noda, Masato; Ninomiya, Satoshi; Hiraoka, Kenzo			Rapid Online Non-Enzymatic Protein Digestion Analysis with High Pressure Superheated ESI-MS	JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY			English	Article						High pressure electrospray; Pressurized superheated water; Site-specific protein Digestion; Non-enzymatic digestion; Acid hydrolysis	IONIZATION MASS-SPECTROMETRY; SUPER-ATMOSPHERIC PRESSURE; PERFORMANCE LIQUID-CHROMATOGRAPHY; STATIC DIELECTRIC-CONSTANT; ASSISTED ACID-HYDROLYSIS; CHEMICAL DIGESTION; SUBCRITICAL WATER; AQUEOUS-SOLUTIONS; ASPARTIC-ACID; CLEAVAGE	Recently, we reported a new ESI ion source that could electrospray the super-heated aqueous solution with liquid temperature much higher than the normal boiling point (J. Am. Soc. Mass Spectrom. 25, 1862-1869). The boiling of liquid was prevented by pressurizing the ion source to a pressure greater than atmospheric pressure. The maximum operating pressure in our previous prototype was 11atm, and the highest achievable temperature was 180 degrees C. In this paper, a more compact prototype that can operate up to 27atm and 250 degrees C liquid temperatures is constructed, and reproducible MS acquisition can be extended to electrospray temperatures that have never before been tested. Here, we apply this super-heated ESI source to the rapid online protein digestion MS. The sample solution is rapidly heated when flowing through a heated ESI capillary, and the digestion products are ionized by ESI in situ when the solution emerges from the tip of the heated capillary. With weak acid such as formic acid as solution, the thermally accelerated digestion (acid hydrolysis) has the selective cleavage at the aspartate (Asp, D) residue sites. The residence time of liquid within the active heating region is about 20s. The online operation eliminates the need to transfer the sample from the digestion reactor, and the output of the digestive reaction can be monitored and manipulated by the solution flow rate and heater temperature in a near real-time basis.	[Chen, Lee Chuin; Ninomiya, Satoshi] Univ Yamanashi, Dept Interdisciplinary Res, Grad Sch, Kofu, Yamanashi 4008511, Japan; [Kinoshita, Masato; Noda, Masato] Univ Yamanashi, Fac Engn, Kofu, Yamanashi 4008511, Japan; [Hiraoka, Kenzo] Univ Yamanashi, Clean Energy Res Ctr, Kofu, Yamanashi 4008511, Japan	Chen, LC (reprint author), Univ Yamanashi, Dept Interdisciplinary Res, Grad Sch, Kofu, Yamanashi 4008511, Japan.	leechuin@yamanashi.ac.jp			JSPS [26505003]; Ministry of Education, Culture, Sports, Science, and Technology of the Japanese government	The authors acknowledge support for this work by the Grants-in-Aid for Scientific Research (Kakenhi, Kadai no. 26505003) from JSPS, and the Program to Disseminate Tenure Tracking System from the Ministry of Education, Culture, Sports, Science, and Technology of the Japanese government.	Alam A, 2010, ANAL CHEM, V82, P8922, DOI 10.1021/ac1017106; Zhong HY, 2005, J AM SOC MASS SPECTR, V16, P471, DOI 10.1016/j.jasms.2004.12.017; MIRZA UA, 1993, ANAL CHEM, V65, P1, DOI 10.1021/ac00049a003; GOODWIN RD, 1987, J PHYS CHEM REF DATA, V16, P799; Li AQ, 2001, ANAL CHEM, V73, P5395, DOI 10.1021/ac010619z; Bandura AV, 2006, J PHYS CHEM REF DATA, V35, P15, DOI 10.1063/1.1928231; Hua L, 2006, PROTEOMICS, V6, P586, DOI 10.1002/pmic.200500304; Miller DJ, 1997, ANAL CHEM, V69, P623, DOI 10.1021/ac960729j; FERNANDEZ DP, 1995, J PHYS CHEM REF DATA, V24, P33; RAMIRES MLV, 1995, J PHYS CHEM REF DATA, V24, P1377; Remily-Wood E, 2009, J AM SOC MASS SPECTR, V20, P2106, DOI 10.1016/j.jasms.2009.07.007; UEMATSU M, 1980, J PHYS CHEM REF DATA, V9, P1291; Smith RM, 1996, ANAL COMMUN, V33, P327, DOI 10.1039/ac9963300327; Smith RM, 1997, J CHROMATOGR A, V785, P49, DOI 10.1016/S0021-9673(97)00570-0; Hauser NJ, 2008, J PROTEOME RES, V7, P1867, DOI 10.1021/pr700671z; Benesch JLP, 2003, ANAL CHEM, V75, P2208, DOI 10.1021/ac034132x; BLACKBURN S, 1954, BIOCHEM J, V58, P227; Chen LC, 2011, J AM SOC MASS SPECTR, V22, P539, DOI 10.1007/s13361-010-0058-8; Chen LC, 2011, J AM SOC MASS SPECTR, V22, P2108, DOI 10.1007/s13361-011-0253-2; Chen LC, 2012, J MASS SPECTROM, V47, P1083, DOI 10.1002/jms.3062; Chen LC, 2013, J MASS SPECTROM, V48, P392, DOI 10.1002/jms.3173; Chen LC, 2014, J AM SOC MASS SPECTR, V25, P1862, DOI 10.1007/s13361-014-0974-0; Ewing MB, 2004, J CHEM ENG DATA, V49, P486, DOI 10.1021/je034144f; Frahm JL, 2005, J AM SOC MASS SPECTR, V16, P772, DOI 10.1016/j.jasms.2005.02.002; Hauser NJ, 2008, J PROTEOME RES, V7, P1012, DOI 10.1021/pr700596e; IKONOMOU MG, 1994, J AM SOC MASS SPECTR, V5, P791, DOI 10.1016/1044-0305(94)87001-2; INGLIS AS, 1983, METHOD ENZYMOL, V91, P324; LEE ED, 1992, RAPID COMMUN MASS SP, V6, P727, DOI 10.1002/rcm.1290061204; Lide D. R., 2007, CRC HDB CHEM PHYS; Miller DJ, 1998, J CHEM ENG DATA, V43, P1043, DOI 10.1021/je980094g; PARTRIDGE SM, 1950, NATURE, V165, P62, DOI 10.1038/165062a0; Rahman MM, 2013, ANALYST, V138, P6316, DOI 10.1039/c3an00699a; Rahman M.M., 2013, ANALYST, V139, P610; Schultz J, 1967, METHOD ENZYMOL, V9, P255; Swatkoski S, 2007, J PROTEOME RES, V6, P4525, DOI 10.1021/pr0704682; Swatkoski S, 2006, ANAL CHEM, V78, P181, DOI 10.1021/ac051521d; Swatkoski S, 2008, J PROTEOME RES, V7, P579, DOI 10.1021/pr070502c; VARGAFTIK NB, 1983, J PHYS CHEM REF DATA, V12, P817; Wang N, 2010, J AM SOC MASS SPECTR, V21, P1573, DOI 10.1016/j.jasms.2010.04.014	39	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1044-0305	1879-1123		J AM SOC MASS SPECTR	J. Am. Soc. Mass Spectrom.	JUL	2015	26	7					1085	1091		10.1007/s13361-015-1111-4		7	Biochemical Research Methods; Chemistry, Analytical; Chemistry, Physical; Spectroscopy	Biochemistry & Molecular Biology; Chemistry; Spectroscopy	CK9CQ	WOS:000356538500005		
J	Kikuchi, S; Koga, N; Seino, H; Ohno, S				Kikuchi, Shin; Koga, Nobuyoshi; Seino, Hiroshi; Ohno, Shuji			Kinetic study on liquid sodium-silica reaction for safety assessment of sodium-cooled fast reactor	JOURNAL OF THERMAL ANALYSIS AND CALORIMETRY			English	Article						Sodium-cooled fast reactor; Sodium-concrete reaction; Kinetics; DSC; XRD; Videoscope	SOLID-STATE REACTIONS; SURFACE PRODUCT LAYER; THERMAL-DECOMPOSITION; ARRHENIUS PARAMETERS; CONCRETE; MODEL; MECHANISM; DEHYDRATION; TEMPERATURE	In this study, the kinetic behavior of the sodium (Na)-silica (SiO2) reaction was investigated for an assessment method of reactivity/stability of siliceous concrete against the sodium-concrete reaction (SCR) by postulating a severe accidental condition in the sodium-cooled fast reactor (SFR). The reaction behavior was tracked using a differential scanning calorimetry (DSC) equipped with a videoscope for viewing the changes in the sample during the reaction. The reaction was characterized as a partially overlapping multistep process controlled by physico-geometrical reaction scheme. The kinetic behavior in view of the change in the temperature at the maximum reaction rate with heating rate was analyzed using the simplified Kissinger method and the approximated Ozawa method. Further by separating the kinetic data for the overall reaction into five component reaction stages, the kinetic information for the second and third reaction stages was extracted. By comparing the kinetic results, it was revealed that the kinetic results determined from the kinetic data at the maximum reaction rate can be interpreted as is for the major reaction stage (the third reaction stage) controlled by an autocatalytic reaction. In addition, the second reaction stage was characterized as a possible premonitory process for the major reaction stage. Through the comprehensive interpretation of the kinetic results, significance of the kinetic analysis for the Na-SiO2 reaction using DSC for the reactivity/stability evaluation against SCR and for the safety assessment of SFR is discussed.	[Kikuchi, Shin; Seino, Hiroshi; Ohno, Shuji] Japan Atom Energy Agcy, Fast Reactor Computat Engn Dept, Higashi Ibaraki, Ibaraki 3111393, Japan; [Koga, Nobuyoshi] Hiroshima Univ, Grad Sch Educ, Higashihiroshima 7398524, Japan	Kikuchi, S (reprint author), Japan Atom Energy Agcy, Fast Reactor Computat Engn Dept, 4002 Narita, Higashi Ibaraki, Ibaraki 3111393, Japan.	kikuchi.shin@jaea.go.jp; nkoga@hiroshima-u.ac.jp					[Anonymous], 1957, ANAL CHEM; Vyazovkin S, 2014, THERMOCHIM ACTA, V590, P1, DOI 10.1016/j.tca.2014.05.036; MALEK J, 1992, THERMOCHIM ACTA, V203, P25, DOI 10.1016/0040-6031(92)85182-U; Koga N, 2013, J THERM ANAL CALORIM, V111, P1463, DOI 10.1007/s10973-012-2500-6; Koga N, 2012, J PHYS CHEM B, V116, P14477, DOI 10.1021/jp3052517; KOGA N, 1991, J THERM ANAL, V37, P1103, DOI 10.1007/BF01932804; Haneefa KM, 2013, NUCL ENG DES, V258, P76, DOI 10.1016/j.nucengdes.2013.01.018; Sanchez-Jimenez PE, 2010, POLYMER, V51, P3998, DOI 10.1016/j.polymer.2010.06.020; Kitabayashi S, 2014, J PHYS CHEM C, V118, P17847, DOI 10.1021/jp505937k; KOGA N, 1991, THERMOCHIM ACTA, V188, P333, DOI 10.1016/0040-6031(91)87091-A; SESTAK J, 1990, J THERM ANAL, V36, P1997; Koga N, 2013, J THERM ANAL CALORIM, V113, P1527, DOI 10.1007/s10973-012-2882-5; Bale CW, 2009, CALPHAD, V33, P295, DOI 10.1016/j.calphad.2008.09.009; Koga N, 2002, THERMOCHIM ACTA, V388, P41, DOI 10.1016/S0040-6031(02)00051-5; Noda Y, 2014, J PHYS CHEM C, V118, P5424, DOI 10.1021/jp500322p; Wada T, 2013, J PHYS CHEM A, V117, P1880, DOI 10.1021/jp3123924; Yoshikawa M, 2014, J PHYS CHEM C, V118, P8059, DOI 10.1021/jp501407p; Bae JH, 1998, J KOREAN NUCL SOC, V30, P568; Bin Jenn S, 1977, J NUCL MATER, V67, P13, DOI [10.1016/0022-3115(77)90157-x, DOI 10.1016/0022-3115(77)90157-X]; CASSELMAN C, 1982, NUCL ENG DES, V68, P207, DOI 10.1016/0029-5493(82)90032-2; CHASANOV MG, 1977, J NUCL MATER, V66, P217, DOI 10.1016/0022-3115(77)90154-4; Chase MWJ, 1986, JANAF THERMOCHEMIC 2; CHAWLA TC, 1985, NUCL ENG DES, V88, P85, DOI 10.1016/0029-5493(85)90047-0; Das SK, 2009, CONSTR BUILD MATER, V23, P3375, DOI 10.1016/j.conbuildmat.2009.06.021; DAVIES G, 1988, CEMENT CONCRETE RES, V18, P621, DOI 10.1016/0008-8846(88)90055-5; GLASSER LSD, 1981, CEMENT CONCRETE RES, V11, P1; Doyle C. D., 1961, J APPL POLYM SCI, V5, P285, DOI 10.1002/app.1961.070051506; Friedman H. L., 1964, J POLYM SCI C, V6, P183, DOI DOI 10.1002/P0LC.5070060121; Galwey AK, 2006, INT J CHEM KINET, V38, P464, DOI 10.1002/kin.20176; Kikuchi S., 2013, J POWER ENERGY SYST, V7, P79; KOGA N, 1994, THERMOCHIM ACTA, V244, P1, DOI 10.1016/0040-6031(94)80202-5; Koga N., 2013, THERMAL ANAL MICRO N, P1; KOGA N, 1991, THERMOCHIM ACTA, V182, P201, DOI 10.1016/0040-6031(91)80005-4; MIYAHARA S, 1992, NUCL TECHNOL, V97, P212; OZAWA T, 1965, B CHEM SOC JPN, V38, P1881, DOI 10.1246/bcsj.38.1881; Perez-Maqueda LA, 2006, J PHYS CHEM A, V110, P12456, DOI 10.1021/jp064792g; Sestak J, 2011, J THERM ANAL CALORIM, V110, P5, DOI [10.1007/s10973-011-2089-1, DOI 10.1007/S10973-011-2089-1]; Sestak J., 1971, THERMOCHIM ACTA, V3, P1, DOI DOI 10.1016/0040-6031(71)85051-7; Suo-Anttila AJ, 1983, NUREGCR3379; Svoboda R, 2013, J THERM ANAL CALORIM, V114, P285, DOI 10.1007/s10973-012-2892-3; Ukai S, 1987, INT C MAT NUCL REACT; Unemoto T, 1983, PNCTJ2708301; Westrich HR, 1983, NUREGCR3401; Zhang Bin, 2006, Nuclear Science and Techniques, V17, DOI 10.1016/S1001-8042(06)60012-2	44	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1388-6150	1572-8943		J THERM ANAL CALORIM	J. Therm. Anal. Calorim.	JUL	2015	121	1					45	55		10.1007/s10973-014-4387-x		11	Thermodynamics; Chemistry, Analytical; Chemistry, Physical	Thermodynamics; Chemistry	CK7YZ	WOS:000356455000006		
J	Sugie, Y; Miyake, A				Sugie, Yuji; Miyake, Atsumi			Effect of the density of nitric acid on thermal behavior during sulfamate nitration	JOURNAL OF THERMAL ANALYSIS AND CALORIMETRY			English	Article						Ammonium dinitramide; Sulfamate; Nitration; Reaction calorimetry; Protonation	OXIDIZER AMMONIUM DINITRAMIDE; DECOMPOSITION; MECHANISM; PRESSURE	Ammonium dinitramide (ADN) has attracted significant interest as a potential oxidizer for next-generation rocket propellants, since it is a halogen-free alternative to the widely used oxidizer ammonium perchlorate. Because ADN synthesis requires N-nitration generates a very unstable intermediate to form the N-(NO2)(2) group, this study used a reaction calorimeter to assess the heat of decomposition during the nitration of potassium sulfamate with various nitration agents (HNO3/H2SO4 and HNO3) by using the HNO3 density between 1.52 and 1.38 gcm(-3). The heat of decomposition of potassium sulfamate in HNO3 was found to decrease with decreasing HNO3 density. In contrast, the heat of decomposition did not decrease with density in HNO3/H2SO4, since a significant temperature rise was generated when combining the lower density HNO3 with H2SO4. The heat of decomposition in high-density HNO3 (1.52 gcm(-3)) was greater than that in the mixed acid, likely because protonation of the potassium sulfate nitrogen by H2SO4 inhibited the subsequent nitration step.	[Sugie, Yuji] Japan Carlit, Chuo Ku, Tokyo 1040031, Japan; [Miyake, Atsumi] Yokohama Natl Univ, Hodogaya Ku, Yokohama, Kanagawa 2408501, Japan	Sugie, Y (reprint author), Japan Carlit, Chuo Ku, 1-17-10 Kyobashi, Tokyo 1040031, Japan.	sugie-yuji-jp@ynu.jp; atsumi@ynu.ac.jp					Alavi S, 2003, J CHEM PHYS, V119, P232, DOI 10.1063/1.1577330; Jones DEG, 2005, PROPELL EXPLOS PYROT, V30, P140, DOI 10.1002/prep.200400096; Yang R, 2005, COMBUST EXPLO SHOCK+, V41, P657, DOI 10.1007/s10573-005-0079-y; Okada K, 2014, SCI TECHNOL ENERG MA, V75, P1; Iwata Y, 2013, SCI TECHNOL ENERG MA, V74, P160; BOTTARO JC, 1991, SYNTHETIC COMMUN, V21, P945, DOI 10.1080/00397919108019779; Lobbecke S, 1997, PROPELL EXPLOS PYROT, V22, P184, DOI 10.1002/prep.19970220317; Pavlov AN, 1999, RUSS CHEM B+, V48, P50, DOI 10.1007/BF02494399; Matsunaga H, 2013, J THERM ANAL CALORIM, V113, P1387, DOI 10.1007/s10973-013-3186-0; Sugie Y, 2014, J THERM ANAL CALORIM, V116, P1213, DOI 10.1007/s10973-014-3688-4; Bottaro J. C., 1996, CHEM IND, V10, P249; Cupery ME, 1938, IND ENG CHEM, V30, P627, DOI 10.1021/ie50342a005; GARRETT M, 1964, J PHYS CHEM-US, V68, P824, DOI 10.1021/j100786a020; Hatano H, 1996, SCI TECHNOL ENERG MA, V57, P160; Langlet A., 1999, U. S. Patent, Patent No. 5976483; Matsunaga H, 2014, J THERM ANAL CALORIM, V116, P1227, DOI 10.1007/s10973-013-3626-x; Ostmark H, 2000, J ENERG MATER, V18, P123, DOI 10.1080/07370650008216116; Schmitt R. J., 1994, U.S. Patent, Patent No. 5316749; Suzuki S., 1997, U. S. Patent, Patent No. 5659080; Tanaka K, 2013, J THERM ANAL CALORIM, V113, P1395, DOI 10.1007/s10973-013-2995-5	20	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1388-6150	1572-8943		J THERM ANAL CALORIM	J. Therm. Anal. Calorim.	JUL	2015	121	1					275	279		10.1007/s10973-015-4564-6		5	Thermodynamics; Chemistry, Analytical; Chemistry, Physical	Thermodynamics; Chemistry	CK7YZ	WOS:000356455000032		
J	Shiota, K; Matsunaga, H; Miyake, A				Shiota, Kento; Matsunaga, Hiroki; Miyake, Atsumi			Thermal analysis of ammonium nitrate and basic copper(II) nitrate mixtures	JOURNAL OF THERMAL ANALYSIS AND CALORIMETRY			English	Article						Ammonium nitrate; Basic copper nitrate; Diamine copper nitrate; Gas-generating agents; Thermal analysis; Evolved gas analysis	SPRAY-DRIED PARTICLES; DECOMPOSITION MECHANISM; COMBUSTION MECHANISM; POTASSIUM-NITRATE; BURNING RATE; DINITRAMIDE; OXIDIZER; BEHAVIOR; PRESSURE; PROPELLANT	Basic copper nitrate [Cu(NO3)(2)center dot 3Cu(OH)(2), BCN] is a widely used oxidizer for gas-generating compounds. The oxidizers that replace some BCN with ammonium nitrate (NH4NO3, AN) have been investigated to increase the performance of the gas-generating agents. The purpose of this study was to understand the thermal behavior and stability of AN/BCN mixtures. To this end, mixtures prepared by two kinds of methods, with and without heat treatment, were analyzed by X-ray powder diffraction to investigate composition of samples, and differential scanning calorimetry and thermogravimetry-differential thermal analysis with mass spectrometry (TG-DTA-MS) to investigate the thermal behavior and evolved gases. It was found that [Cu(NH3)(2)](NO3)(2) was formed in the sample with thermal treatment. The samples with and without heating exhibited different decomposition processes. It is considered that the residual AN and the amount of [Cu(NH3)(2)](NO3)(2) in the mixture affected the decomposition behavior.	[Shiota, Kento; Matsunaga, Hiroki; Miyake, Atsumi] Yokohama Natl Univ, Grad Sch Environm & Informat Sci, Hodogaya Ku, Yokohama, Kanagawa 2408501, Japan	Miyake, A (reprint author), Yokohama Natl Univ, Grad Sch Environm & Informat Sci, Hodogaya Ku, 79-7 Tokiwadai, Yokohama, Kanagawa 2408501, Japan.	atsumi@ynu.ac.jp					Matsunaga H, 2013, J THERM ANAL CALORIM, V111, P1183, DOI 10.1007/s10973-012-2441-0; GHOSE J, 1981, J THERM ANAL, V20, P459, DOI 10.1007/BF01912894; Oxley JC, 2002, THERMOCHIM ACTA, V384, P23, DOI 10.1016/S0040-6031(01)00775-4; Wada Y, 2010, SCI TECHNOL ENERG MA, V71, P39; Izato Y, 2013, PROPELL EXPLOS PYROT, V38, P129, DOI 10.1002/prep.201100106; Miyata Y, 2011, J ENERG MATER, V29, P344, DOI 10.1080/07370652.2010.530340; Wada Y, 2010, SCI TECHNOL ENERG MA, V71, P83; Pandey M, 2012, J THERM ANAL CALORIM, V107, P135, DOI 10.1007/s10973-011-1718-z; Bottaro JC, 1997, J AM CHEM SOC, V119, P9405, DOI 10.1021/ja9709278; Matsunaga H, 2013, J THERM ANAL CALORIM, V113, P1387, DOI 10.1007/s10973-013-3186-0; Kajiyama K, 2013, J THERM ANAL CALORIM, V113, P1475, DOI 10.1007/s10973-013-3201-5; Sugie Y, 2014, J THERM ANAL CALORIM, V116, P1213, DOI 10.1007/s10973-014-3688-4; Badica P, 2002, J MATER SCI, V37, P585, DOI 10.1023/A:1013777826319; Barnes MW, 1997, US Patent, Patent No. [5,635,668, 5635668]; Barnes MW, 1997, US Patent, Patent No. [5,608,183, 5608183]; Bucerius KM, 1996, US Patent, Patent No. [5,542,999, 5542999]; Dyukarev SS, 1999, RUSS J INORG CHEM+, V44, P883; Fujisato K, 2014, PROPELL EXPLOS PYROT, V39, P714, DOI 10.1002/prep.201300134; Fujisato K, 2014, PROPELL EXPLOS PYROT, V39, P518, DOI 10.1002/prep.201300148; Golovina N, 2009, CENT EUR J ENERG MAT, V6, P45; Golovina NI, 2007, RUSS J APPL CHEM+, V80, P24, DOI 10.1134/S1070427207010053; ILCHEVA L, 1979, J THERM ANAL, V16, P205, DOI 10.1007/BF01909647; Izato Y, 2014, SCI TECHNOL ENERG MA, V75, P128; Kohga M, 2011, COMBUST FLAME, V158, P15; Lvov BV, 1995, SPECTROCHIM ACTA B, V50, P1459, DOI 10.1016/0584-8547(95)01402-0; Matsunaga H, 2014, J THERM ANAL CALORIM, V116, P1227, DOI 10.1007/s10973-013-3626-x; Matsunaga H, 2011, SCI TECHNOL ENERG MA, V72, P131; Mei XL, 2013, J THERM ANAL CALORIM, V114, P131, DOI 10.1007/s10973-012-2851-z; Nagayama S, 2014, J THERM ANAL CALORIM, V118, P1215, DOI 10.1007/s10973-014-4127-2; Nagayama S, 2014, J THERM ANAL CALORIM, V118, P1221, DOI 10.1007/s10973-014-4115-6; Nakamura H, 2002, KAYAKU GAKKAISHI, V63, P87; Oommen C, 1999, J HAZARD MATER, V67, P253, DOI 10.1016/S0304-3894(99)00039-4; Ostmark H, 2000, J ENERG MATER, V18, P123, DOI 10.1080/07370650008216116; Oxley JC, 1997, J PHYS CHEM A, V101, P5642; Pak Z, 1993, P AIAA SAE ASME ASEE; Ryu SK, 2004, CARBON SCI, V5, P180; Sinditskii VP, 2005, PROPELL EXPLOS PYROT, V30, P269, DOI 10.1002/prep.200500017; Sinditskii VP, 2006, J PROPUL POWER, V22, P769, DOI 10.2514/1.17950; SOUTHERN TM, 1970, J INORG NUCL CHEM, V32, P3783, DOI 10.1016/0022-1902(70)80552-8; Sudhakar AOR, 2006, THERMOCHIM ACTA, V451, P5, DOI 10.1016/j.tca.2006.08.013; Taylor RD, 2011, U. S. Patent, Patent No. [7,998,292 B2, 7998292]; Vorozhtsov A, 2005, P 1 EUR C AER SCI MO	42	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1388-6150	1572-8943		J THERM ANAL CALORIM	J. Therm. Anal. Calorim.	JUL	2015	121	1					281	286		10.1007/s10973-015-4536-x		6	Thermodynamics; Chemistry, Analytical; Chemistry, Physical	Thermodynamics; Chemistry	CK7YZ	WOS:000356455000033		
J	Izato, Y; Miyake, A				Izato, Yu-ichiro; Miyake, Atsumi			Thermal decomposition mechanism of ammonium nitrate and potassium chloride mixtures	JOURNAL OF THERMAL ANALYSIS AND CALORIMETRY			English	Article						Ammonium nitrate; Potassium chloride; Mixing hazard; Evolved gas analysis	NITRATE/ADDITIVE MIXTURES; BURNING CHARACTERISTICS; COMBUSTION MECHANISM; CARBON MIXTURES; NITRIC-ACID; PHASE; TEMPERATURE	The thermal decomposition of ammonium nitrate (AN) and potassium chloride (KCl) mixtures was investigated. The thermal properties were studied using differential scanning calorimetry (DSC), and the evolved gas was analyzed using thermogravimetry with mass spectrometry and pressurized DSC coupled with mass spectrometry (TG-DTA-MS and PDSC-MS). DSC measurements of AN/KCl mixtures in sealed and sealed-separated sample pans showed a sharp exothermic decomposition and lower onset temperature than pure AN, whereas AN/KCl in an open pan exhibited an endothermic reaction. In the sealed-separated pan, a separator with a pinhole divided the KCl and AN physically and the evolved gas could interact with both AN and KCl. TG-DTA-MS results revealed that HCl gas was evolved from AN/KCl, which indicated that the reaction of KCl with HNO3 dissociated from AN formed HCl, and subsequent destabilization of AN. However, the TG-DTA-MS results did not indicate the violent exothermic reaction due to using an open pan and ordinary pressure conditions. PDSC-MS was used to observe two exothermic reactions of AN/KCl and analyze the evolved gases from the reactions. A violent first exothermic reaction was accompanied by a large amount of N-2 and N2O gases without H2O, and a second exothermic reaction accompanied by H2O, N2O, and other gases occurred subsequently. The reactions are , which have a lower energy barrier by 103 kJ mol(-1) than the energy barrier that is needed for HNO3 homolysis cleavage, which is triggered by pure AN decomposition, . We therefore concluded that AN reacts with KCl to produce Cl radicals via HCl and NO2Cl, and the Cl radical triggers a radical chain reaction of AN.	[Izato, Yu-ichiro; Miyake, Atsumi] Yokohama Natl Univ, Grad Sch Environm & Informat Sci, Hodogaya Ku, Yokohama, Kanagawa 2408501, Japan	Izato, Y (reprint author), Yokohama Natl Univ, Grad Sch Environm & Informat Sci, Hodogaya Ku, 79-7 Tokiwadai, Yokohama, Kanagawa 2408501, Japan.	izato-yuichiro-hk@ynu.jp; atsumi@ynu.ac.jp					Ikeda K, 2014, SCI TECHNOL ENERG MA, V75, P59; MacNeil JH, 1997, J AM CHEM SOC, V119, P9738, DOI 10.1021/ja971618k; Oxley JC, 2009, J ENERG MATER, V27, P17, DOI 10.1080/07370650802328814; Sinditskii VP, 2012, COMBUST EXPLO SHOCK+, V48, P81, DOI 10.1134/S001050821201011X; FENTER FF, 1994, J PHYS CHEM-US, V98, P9801, DOI 10.1021/j100090a014; OXLEY JC, 1994, J PHYS CHEM-US, V98, P3901, DOI 10.1021/j100065a054; Skarlis SA, 2014, THERMOCHIM ACTA, V584, P58, DOI 10.1016/j.tca.2014.04.004; Marlair G, 2005, J HAZARD MATER, V123, P13, DOI 10.1016/j.jhazmat.2005.03.028; FRIEDEL RA, 1959, ANAL CHEM, V31, P1128, DOI 10.1021/ac60150a615; Cagnina S, 2013, PHYS CHEM CHEM PHYS, V15, P10849, DOI 10.1039/c3cp50368b; Izato Y, 2013, PROPELL EXPLOS PYROT, V38, P129, DOI 10.1002/prep.201100106; Fujisato K, 2014, SCI TECHNOL ENERG MA, V75, P28; KOROBAN VA, 1994, PROPELL EXPLOS PYROT, V19, P307, DOI 10.1002/prep.19940190608; Izato Y, 2009, SCI TECHNOL ENERG MA, V70, P101; Hasue K, 2013, SCI TECHNOL ENERG MA, V74, P113; Dechy N, 2004, J HAZARD MATER, V111, P131, DOI 10.1016/j.jhazmat.2004.02.039; Wada Y, 2010, SCI TECHNOL ENERG MA, V71, P83; Li XR, 2005, PROCESS SAF ENVIRON, V83, P31, DOI 10.1205/psep.04060; Sun JH, 2005, J HAZARD MATER, V127, P204, DOI 10.1016/j.jhazmat.2005.07.028; Kajiyama K, 2013, J THERM ANAL CALORIM, V113, P1475, DOI 10.1007/s10973-013-3201-5; BROWER KR, 1989, J PHYS CHEM-US, V93, P4029, DOI 10.1021/j100347a033; Mirvakili A, 2014, J IND ENG CHEM, V20, P2452, DOI 10.1016/j.jiec.2013.10.026; Chemical Safety Board, 2014, PREL FIND US CHEM SA; Ikeda K, 2014, SCI TECHNOL ENERG MA, V75, P83; Izato Y, 2014, SCI TECHNOL ENERG MA, V75, P128; KEENAN AG, 1969, J AM CHEM SOC, V91, P3168, DOI 10.1021/ja01040a011; Miyake A, 2010, INT J ENERG MAT CHEM, V9, P467; Oommen C, 1999, J HAZARD MATER, V67, P253, DOI 10.1016/S0304-3894(99)00039-4; Patil DG, 1992, PROPELL EXPLOS PYROT, V17, P99, DOI 10.1002/prep.19920170302; Sinditskii VP, 2005, PROPELL EXPLOS PYROT, V30, P269, DOI 10.1002/prep.200500017; Wagman DD, 1982, J PHYS CHEM REF DATA, V11, P67	31	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1388-6150	1572-8943		J THERM ANAL CALORIM	J. Therm. Anal. Calorim.	JUL	2015	121	1					287	294		10.1007/s10973-015-4739-1		8	Thermodynamics; Chemistry, Analytical; Chemistry, Physical	Thermodynamics; Chemistry	CK7YZ	WOS:000356455000034		
J	Babasaki, Y; Iizuka, Y; Miyake, A				Babasaki, Yuta; Iizuka, Yoshiaki; Miyake, Atsumi			Influence of organic acid on the thermal behavior of dimethyl sulfoxide	JOURNAL OF THERMAL ANALYSIS AND CALORIMETRY			English	Article						Dimethyl sulfoxide; Accelerating rate calorimeter; Differential scanning calorimetry; Decomposition; Organic acid	DECOMPOSITION; DMSO; SOLVENT; HAZARDS	Dimethyl sulfoxide (DMSO) has been extensively used as a solvent because of its high-performance characteristics. However, there have been accidents when DMSO has been used in some chemical processes (Lam et al. in J Therm Anal Calorim 85:25-30, 2006; http://riscad.db.aist.go.jp/PHP_EN/index.php). Although the decomposition mechanism of DMSO under acidic conditions is known (Santosusso et al. in Tetrahedron Lett 48:4255-4258, 1974), the number of studies about thermal behavior of DMSO under acidic condition is not large. The purpose of this investigation is to understand the decomposition thermal behavior of DMSO under acidic conditions. Thermal analysis using an accelerating rate calorimeter (ARC) was carried out with acids chosen for their acid dissociation degree constant (pKa), which is a typical parameter of acid strength. ARC data show that the self-heat rate increased and the exothermic onset temperature decreased with decreasing pKa. Additionally, the exothermic onset temperature and pKa had good linear correlation. To verify the initial exothermic reaction, differential scanning calorimetry (DSC) analysis was carried out. DSC results showed that the exothermic onset temperature was due to decomposition of DMSO. The activation energy of the decomposition reaction was calculated from the ARC results (self-heat rate). Our data indicate that the activation energy of the decomposition reaction decreased with decreasing pKa. Therefore, thermal hazards of DMSO increase with the decrease in pKa, with good linear correlation.	[Babasaki, Yuta; Miyake, Atsumi] Yokohama Natl Univ, Grad Sch Environm & Informat Sci, Hodogaya Ku, Yokohama, Kanagawa 2408501, Japan; [Iizuka, Yoshiaki] PHA Consulting Co Ltd, Aikawa, Kanagawa 2400303, Japan	Miyake, A (reprint author), Yokohama Natl Univ, Grad Sch Environm & Informat Sci, Hodogaya Ku, 79-7 Tokiwadai, Yokohama, Kanagawa 2408501, Japan.	atsumi@ynu.ac.jp					AIDA T, 1973, TETRAHEDRON LETT, P3853; Bollyn M, 2006, ORG PROCESS RES DEV, V10, P1299, DOI 10.1021/op060158p; Wang Z, 2012, ORG PROCESS RES DEV, V16, P1994, DOI 10.1021/op300016m; OLMSTEAD WN, 1980, J ORG CHEM, V45, P3295, DOI 10.1021/jo01304a032; TOWNSEND DI, 1980, THERMOCHIM ACTA, V37, P1, DOI 10.1016/0040-6031(80)85001-5; Grewer T, 1999, J LOSS PREVENT PROC, V12, P391, DOI 10.1016/S0950-4230(99)00011-X; Majetich G, 1997, J ORG CHEM, V62, P4321, DOI 10.1021/jo970135w; TRAYNELIS VJ, 1964, J ORG CHEM, V29, P221, DOI 10.1021/jo01024a505; Bordwell G., 1988, ACCOUNTS CHEM RES, V21, P456; Brogli F, 1980, P 3 INT S LOSS PREV, V2, P665; Fierz H, 1994, INT CHEM ENG SYMP SE, V134, P563; Grewer T., 1994, THERMAL HAZARDS CHEM, P210; HEAD DL, 1973, TETRAHEDRON LETT, P1405; Iizuka Y, 2000, J JPN SOC SAF ENG, V39, P91; Lam TT, 2006, J THERM ANAL CALORIM, V85, P25, DOI 10.1007/s10973-005-7338-8; Lowe GO, 1975, J ORG CHEM, V40, P2096; National Institute of Advanced Industrial Science and Technology Japan Science and Technology Agency, REL INF SYST CHEM AC; Ooizumi N, 2014, J THERM ANAL CALORIM, DOI [10.1007/s1097301439394, DOI 10.1007/S1097301439394]; Ooizumi N, 2011, SCI TECHNOL ENERG MA, V72, P111; Santosusso MT, 1974, TETRAHEDRON LETT, V48, P4255; Townsend I, 1991, J THEM ANAL, V37, P2031; Whiting FL, 1982, J THERM ANAL, V24, P111; Yang XW, 2013, THERMOCHIM ACTA, V559, P76, DOI 10.1016/j.tca.2013.02.027; Yiannios NC, 1963, J ORG CHEM, V28, P3246	24	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1388-6150	1572-8943		J THERM ANAL CALORIM	J. Therm. Anal. Calorim.	JUL	2015	121	1					295	301		10.1007/s10973-015-4561-9		7	Thermodynamics; Chemistry, Analytical; Chemistry, Physical	Thermodynamics; Chemistry	CK7YZ	WOS:000356455000035		
J	Matsunaga, H; Izato, Y; Habu, H; Miyake, A				Matsunaga, Hiroki; Izato, Yu-ichiro; Habu, Hiroto; Miyake, Atsumi			Thermal decomposition characteristics of mixtures of ammonium dinitramide and copper(II) oxide	JOURNAL OF THERMAL ANALYSIS AND CALORIMETRY			English	Article						Ammonium dinitramide; Copper(II) oxide; Solid propellant; Thermal decomposition; Thermal analysis; Evolved gas analysis	ENERGETIC MATERIALS; BURNING RATE; LITHIUM PERCHLORATE; NITRATE; MECHANISM; COMBUSTION; PRESSURE; OXIDIZER; KINETICS; SALTS	Ammonium dinitramide (ADN) is one of the most promising new solid oxidizers for rocket propellants, since its oxygen balance and energy content are relatively high, and it does not contain halogens. To gain a better understanding of the thermal decomposition mechanism of ADN, the thermal decomposition of ADN and copper(II) oxide (CuO) mixtures was investigated. The thermal behavior and activation energy associated with the decomposition of ADN/CuO mixtures were analyzed using sealed cell differential scanning calorimetry (SC-DSC). SC-DSC results showed that CuO affects the thermal characteristics of ADN and promotes its decomposition. Thermogravimetry-differential thermal analysis-evolved gas analysis was also performed, and in addition, the decomposition behavior was observed using hot stage microscopy. From the results, a thermal decomposition mechanism was proposed for ADN/CuO. In this mechanism, copper dinitramide Cu[N(NO2)(2)](2) is generated at the surface of the CuO almost simultaneously with the melting of the ADN. Next, a significant exothermic reaction occurs, associated with the decomposition of Cu[N(NO2)(2)](2), followed by decomposition of CuO via [Cu(NH3)(2)](NO3)(2) and Cu(NO3)(2).	[Matsunaga, Hiroki; Izato, Yu-ichiro; Miyake, Atsumi] Yokohama Natl Univ, Grad Sch Environm & Informat Sci, Hodogaya Ku, Yokohama, Kanagawa 2408501, Japan; [Matsunaga, Hiroki] Japan Soc Promot Sci, Chiyoda Ku, Tokyo 1020083, Japan; [Habu, Hiroto] Japan Aerosp Explorat Agcy JAXA, ISAS, Div Space Flight Syst, Sagamihara, Kanagawa 2525210, Japan	Miyake, A (reprint author), Yokohama Natl Univ, Grad Sch Environm & Informat Sci, Hodogaya Ku, 79-7 Tokiwadai, Yokohama, Kanagawa 2408501, Japan.	atsumi@ynu.ac.jp					ADDISON CC, 1958, J CHEM SOC, P3099, DOI 10.1039/jr9580003099; Mishra IB, 2002, THERMOCHIM ACTA, V384, P47, DOI 10.1016/S0040-6031(01)00776-6; Matsunaga H, 2013, J THERM ANAL CALORIM, V111, P1183, DOI 10.1007/s10973-012-2441-0; Ikeda K, 2014, SCI TECHNOL ENERG MA, V75, P59; Pagoria PF, 2002, THERMOCHIM ACTA, V384, P187, DOI 10.1016/S0040-6031(01)00805-X; Vyazovkin S, 1997, J PHYS CHEM A, V101, P5653, DOI 10.1021/jp962547z; Talawar MB, 2009, J HAZARD MATER, V161, P589, DOI 10.1016/j.jhazmat.2008.04.011; Lobbecke S, 1997, PROPELL EXPLOS PYROT, V22, P184, DOI 10.1002/prep.19970220317; Miyata Y, 2011, J ENERG MATER, V29, P344, DOI 10.1080/07370652.2010.530340; Jackson JG, 1995, SPECTROCHIM ACTA B, V50, P1449, DOI 10.1016/0584-8547(95)01405-5; Tompa AS, 2000, THERMOCHIM ACTA, V357, P177, DOI 10.1016/S0040-6031(00)00387-7; Pandey M, 2012, J THERM ANAL CALORIM, V107, P135, DOI 10.1007/s10973-011-1718-z; Bottaro JC, 1997, J AM CHEM SOC, V119, P9405, DOI 10.1021/ja9709278; Pavlov AN, 1999, RUSS CHEM B+, V48, P50, DOI 10.1007/BF02494399; Matsunaga H, 2013, J THERM ANAL CALORIM, V113, P1387, DOI 10.1007/s10973-013-3186-0; Kajiyama K, 2013, J THERM ANAL CALORIM, V113, P1475, DOI 10.1007/s10973-013-3201-5; Guery JF, 2010, ACTA ASTRONAUT, V66, P201, DOI 10.1016/j.actaastro.2009.05.028; Sugie Y, 2014, J THERM ANAL CALORIM, V116, P1213, DOI 10.1007/s10973-014-3688-4; BRILL TB, 1993, COMBUST FLAME, V92, P178, DOI 10.1016/0010-2180(93)90206-I; Dyukarev SS, 1999, RUSS J INORG CHEM+, V44, P883; Friedman H. L., 1964, J POLYM SCI C, V6, P183, DOI DOI 10.1002/P0LC.5070060121; Fujisato K, 2014, PROPELL EXPLOS PYROT, V39, P714, DOI 10.1002/prep.201300134; Fujisato K, 2014, PROPELL EXPLOS PYROT, V39, P518, DOI 10.1002/prep.201300148; Izato Y, 2014, SCI TECHNOL ENERG MA, V75, P128; Katsumi T, 2013, SCI TECHNOL ENERG MA, V74, P1; Kazakov AI, 1998, RUSS CHEM B+, V47, P379, DOI 10.1007/BF02495639; Kazakov AI, 1999, PROPELL EXPLOS PYROT, V24, P37, DOI 10.1002/(SICI)1521-4087(199902)24:1<37::AID-PREP37>3.3.CO;2-0; Matsunaga H, 2014, J THERM ANAL CALORIM, V116, P1227, DOI 10.1007/s10973-013-3626-x; Matsunaga H, 2011, SCI TECHNOL ENERG MA, V72, P131; Matsunaga H, 2013, P NEW TREND RES EN M, P268; Miyata Y, 2007, SCI TECHNOL ENERG MA, V68, P125; Miyata Y, 2007, SCI TECHNOL ENERG MA, V68, P131; Morozov IV, 2004, MENDELEEV COMMUN, V14, P138, DOI 10.1070/MC2004v014n04ABEH001951; Oommen C, 1999, J HAZARD MATER, V67, P253, DOI 10.1016/S0304-3894(99)00039-4; Oxley JC, 1997, J PHYS CHEM A, V101, P5642; Pak Z, 1993, P AIAA SAE ASME ASEE; Sackheim RL, 2014, J PROPUL POWER, V30, P265, DOI 10.2514/1.B35086; Santhosh G, 2008, J THERM ANAL CALORIM, V94, P263, DOI 10.1007/s10973-007-8941-7; Schoyer HFR, 2002, J PROPUL POWER, V18, P131, DOI 10.2514/2.5908; Shmakov AG, 2002, COMBUST EXPLO SHOCK+, V38, P284, DOI 10.1023/A:1015697618376; Starunin VA, 1999, COMBUST FLAME, V117, P429; stmark H, 2000, J ENERG MATER, V18, P123; Venkatachalam S, 2004, PROPELL EXPLOS PYROT, V29, P178, DOI 10.1002/prep.200400043	43	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1388-6150	1572-8943		J THERM ANAL CALORIM	J. Therm. Anal. Calorim.	JUL	2015	121	1					319	326		10.1007/s10973-015-4645-6		8	Thermodynamics; Chemistry, Analytical; Chemistry, Physical	Thermodynamics; Chemistry	CK7YZ	WOS:000356455000038		
J	Mizuta, R; Izato, Y; Miyake, A				Mizuta, Ryo; Izato, Yu-ichiro; Miyake, Atsumi			Thermal ignition behavior of waste woods mixed with unsaturated fatty acids	JOURNAL OF THERMAL ANALYSIS AND CALORIMETRY			English	Article						Waste wood; Unsaturated fatty acid; Oxidation; Spontaneous ignition; Isothermal calorimetry	REFUSE-DERIVED FUEL; OXIDATION; BIOMASS; JAPAN; OXIDE	In the Great East Japan Earthquake on March 11, 2011, large amounts of disaster waste were generated by the earthquake and subsequent tsunami. Much of the mixed wood waste was stored in a temporary storage facility for an extended period of time, and fire broke out due to spontaneous ignition. Consequently, it is now the practice that when a metropolitan epicentral earthquake occurs, disaster waste will be generated and stored locally. Fire caused by the same type of spontaneous ignition is a grave cause for concern. Thus, in order to prevent such fires, we evaluated the thermal behavior of the oxidation heat of the wood that was believed to be the cause of the heat generation in disaster waste. As a result of studies using TG-DTA and TAM, it was revealed that the thermal danger of wood increases due to increases in the temperature and in the concentration of unsaturated fatty acids in the wood. It is thought that the oxidation heat of the unsaturated fatty acids contained in the waste wood contributed to heat generation near 70 A degrees C after heat generation by fermentative bacteria.	[Mizuta, Ryo; Izato, Yu-ichiro; Miyake, Atsumi] Yokohama Natl Univ, Grad Sch Environm & Informat Sci, Hodogaya Ku, Yokohama, Kanagawa 2408501, Japan	Miyake, A (reprint author), Yokohama Natl Univ, Grad Sch Environm & Informat Sci, Hodogaya Ku, 79-7 Tokiwadai, Yokohama, Kanagawa 2408501, Japan.	atsumi@ynu.ac.jp			Fire Technology and Safety Laboratory of Tokyo Fire Department	The authors express their thanks to the Fire Technology and Safety Laboratory of Tokyo Fire Department for their help and support in performing experiments.	Friedman H. L., 1964, J POLYM SCI C, V6, P183, DOI DOI 10.1002/P0LC.5070060121; Fu ZM, 2006, THERMOCHIM ACTA, V440, P68, DOI 10.1016/j.tca.2005.10.010; Hernandez-Atonal FD, 2007, CHEM ENG SCI, V62, P627, DOI 10.1016/j.ces.2006.09.025; Iwata Y, 2012, SAF ENG, V39, P21; Japan Oil Chemist's Society, 2001, HDB OIL CHEM LIQ SUR, V4th; Kitao K, 1963, MATERIALS, V12, P51; Koseki H, 2007, REPORT NATL RES I FI, V103, P36; Li XR, 2006, J HAZARD MATER, V135, P15, DOI 10.1016/j.jhazinat.2005.11.034; Li XR, 2009, J LOSS PREVENT PROC, V22, P1, DOI 10.1016/j.jlp.2008.09.004; Migita N, 1968, WOOD CHEM; Nakayama J, 2012, J THERM ANAL CALORIM, V110, P321, DOI 10.1007/s10973-011-2162-9; Murasawa N, 2013, FIRE SAFETY J, V59, P178, DOI 10.1016/j.firesaf.2013.03.020; Murasawa N, 2014, WASTE BIOMASS VALORI, V5, P223, DOI 10.1007/s12649-013-9233-z; Nakayama J, 2013, J THERM ANAL CALORIM, V113, P1403, DOI 10.1007/s10973-013-3091-6; Roduit B, 2006, J THERM ANAL CALORIM, V85, P195, DOI 10.1007/s10973-005-7388-y; Sakka M, 2006, BIOSCI BIOTECH BIOCH, V70, P2868, DOI 10.1271/bbb.60261; Shimizu Y, 2009, J LOSS PREVENT PROC, V22, P86, DOI 10.1016/j.jlp.2008.09.003; Yasuda K, 1999, KNOWLEDGE OIL FAT PR	18	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1388-6150	1572-8943		J THERM ANAL CALORIM	J. Therm. Anal. Calorim.	JUL	2015	121	1					361	369		10.1007/s10973-015-4788-5		9	Thermodynamics; Chemistry, Analytical; Chemistry, Physical	Thermodynamics; Chemistry	CK7YZ	WOS:000356455000043		
J	Demircan, O; Ashibe, S; Kosui, T; Nakai, A				Demircan, Ozgur; Ashibe, Shinsuke; Kosui, Tatsuya; Nakai, Asami			Mechanical properties of biaxial weft-knitted and cross-ply thermoplastic composites	JOURNAL OF THERMOPLASTIC COMPOSITE MATERIALS			English	Article						Biaxial weft-knitted thermoplastic composites; twisting; unidirectional composites; tensile and impact properties; optical microscopy		Within the scope of experiments, two kinds of biaxial weft-knitted (BWK) fabrics with aramid (AR) and polyamide (PA) 66 stitch fibers were used as reinforcement systems to fabricate thermoplastic composites with PA66 resin yarn. Then, the final composite became BWK with AR stitch yarn and cross-ply. The mechanical properties of composites were investigated by conducting tensile and three-point bending impact tests on specimens. In all specimens, PA66 was commingled with AR yarn. AR was used as reinforcement. In preliminary studies, AR unidirectional composites with AR/PA66 commingled fibers and with various twisting angles were produced and appropriate twisting angle was found out by conducting tensile test on specimens. Due to the random multiple cracks that changed the fracture behavior of BWK composites with AR stitch, the tensile properties of the BWK composites with AR stitch became lower compared with the cross-ply. However, the three-point bending impact properties of the BWK composites with AR stitch fiber were higher compared with the cross-ply.	[Demircan, Ozgur] Kyoto Inst Technol, Grad Sch Sci & Technol, Dept Adv Fibrosci, Sakyo Ku, Kyoto 606, Japan; [Demircan, Ozgur] Sabanci Univ, Fac Engn & Nat Sci, Mat Sci & Engn Program, TR-34956 Istanbul, Turkey; [Demircan, Ozgur] Ondokuz Mayis Univ, Fac Engn, Dept Mat Sci & Engn, Samsun, Turkey; [Ashibe, Shinsuke; Kosui, Tatsuya] Shima Seiki Mfg Ltd, R&D New Technol Applicat, Wakayama, Japan; [Nakai, Asami] Gifu Univ, Fac Engn, Dept Mech Engn, Gifu 50111, Japan	Demircan, O (reprint author), Sabanci Univ, Fac Engn & Nat Sci, Mat Sci & Engn Program, TR-34956 Istanbul, Turkey.	ozgurd@sabanciuniv.edu					Abounaim M, 2010, COMPOS SCI TECHNOL, V70, P363, DOI 10.1016/j.compscitech.2009.11.008; Khondker OA, 2006, COMPOS PART A-APPL S, V37, P2285, DOI 10.1016/j.compositesa.2005.12.032; Haller P, 2006, COMPOS PART B-ENG, V37, P278, DOI 10.1016/j.compositesb.2006.01.003; Hufenbach W, 2009, COMPOS SCI TECHNOL, V69, P1422, DOI 10.1016/j.compscitech.2008.09.033; Rios CR, 2007, COMPOS PART A-APPL S, V38, P1773, DOI 10.1016/j.compositesa.2006.02.027; Bernhardsson J, 2000, J THERMOPLAST COMPOS, V13, P292, DOI 10.1106/X5VY-2TF0-Y3UA-D5DQ; Demircan O, 2011, P ASME 2011 INT MECH; Demircan O, 2011, EFFECT STITCH REINFO; Demircan O, 2012, 8 AS AUSTR C COMP MA; Hamada H, 2000, J REINF PLAST COMP, V19, P364, DOI 10.1106/FQTH-LFTG-UKLR-D55M; Hou M, 1997, COMPOS PART A-APPL S, V28, P695, DOI 10.1016/S1359-835X(97)00013-4; Khondker OA, 2001, COMPOS PART A-APPL S, V32, P1513, DOI 10.1016/S1359-835X(01)00051-3; Khondker OA, 2004, COMPOS PART A-APPL S, V35, P1195, DOI 10.1016/j.compositesa.2004.03.004; LI JJ, 2010, J TEXT I, V101, P33; Xue P, 2002, COMPOS PART A-APPL S, V33, P113, DOI 10.1016/S1359-835X(01)00067-7; Ye L, 1995, APPL COMPOSITE MAT, V1, P415, DOI DOI 10.1007/BF00706502; Fan ZX, 2007, J THERMOPLAST COMPOS, V20, P473, DOI 10.1177/0892705707082326; Zaixia F, 2006, J THERMOPLAST COMPOS, V19, P113, DOI 10.1177/0892705706055446; Fan ZX, 2007, J THERMOPLAST COMPOS, V20, P487, DOI 10.1177/0892705707082327	19	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0892-7057	1530-7980		J THERMOPLAST COMPOS	J. Thermoplast. Compos. Mater.	JUL	2015	28	7					1058	1074		10.1177/0892705713519119		17	Materials Science, Composites	Materials Science	CK7NA	WOS:000356418000011		
J	Demircan, O; Ashibe, S; Kosui, T; Nakai, A				Demircan, Ozgur; Ashibe, Shinsuke; Kosui, Tatsuya; Nakai, Asami			Effect of various loop lengths on mechanical properties of biaxial weft-knitted thermoplastic composites	JOURNAL OF THERMOPLASTIC COMPOSITE MATERIALS			English	Article						Knitting; loop length; biaxial weft-knitted composites; thermoplastic composites; tensile; bending and impact properties	REINFORCED POLYPROPYLENE COMPOSITES; TENSILE PROPERTIES; DEFORMATION; BEHAVIOR; IMPACT; YARNS	Within the scope of experiments, five kinds of biaxial weft-knitted (BWK) fabrics with various loop lengths (8.0, 9.2, 10.5, 11.9, and 13.5 mm) were used as reinforcement systems to fabricate thermoplastic composites with polypropylene (PP) resin yarn. Then, the final composite became BWK composite with various loop lengths. The mechanical properties of the composites were investigated by conducting tensile, three-point bending, and three-point bending impact tests on specimens. In all specimens, PP was commingled with glass yarn. Glass was used as the reinforcement material. Fiber volume fraction of weft fibers with the 8.0 mm loop length was the highest compared with the other four types of specimens. Because of the higher volume fraction of the BWK composites with the 8.0 mm loop lengths, tensile, three-point bending, and three-point bending impact properties of the 8.0 mm loop were higher than the other four types (9.2, 10.5, 11.9, and 13.5 mm) of composite structures.	[Demircan, Ozgur] Kyoto Inst Technol, Grad Sch Sci & Technol, Dept Adv Fibrosci, Kyoto 606, Japan; [Demircan, Ozgur] Sabanci Univ, Fac Engn & Nat Sci, Mat Sci & Engn Program, TR-34956 Istanbul, Turkey; [Demircan, Ozgur] Ondokuz Mayis Univ, Fac Engn, Dept Mat Sci & Engn, Samsun, Turkey; [Ashibe, Shinsuke; Kosui, Tatsuya] Shima Seiki Mfg Ltd, R&D New Technol Applicat, Wakayama, Japan; [Nakai, Asami] Gifu Univ, Fac Engn, Dept Mech Engn, Gifu 50111, Japan	Demircan, O (reprint author), Sabanci Univ, Fac Engn & Nat Sci, Mat Sci & Engn Program, TR-34956 Istanbul, Turkey.	ozgurd@sabanciuniv.edu					Abounaim M, 2011, COMPOS SCI TECHNOL, V71, P511, DOI 10.1016/j.compscitech.2010.12.029; Abounaim M, 2010, COMPOS SCI TECHNOL, V70, P363, DOI 10.1016/j.compscitech.2009.11.008; Khondker OA, 2006, COMPOS PART A-APPL S, V37, P2285, DOI 10.1016/j.compositesa.2005.12.032; Haller P, 2006, COMPOS PART B-ENG, V37, P278, DOI 10.1016/j.compositesb.2006.01.003; Hufenbach W, 2009, COMPOS SCI TECHNOL, V69, P1422, DOI 10.1016/j.compscitech.2008.09.033; Anwar KO, 1997, 11 C COMP MAT ICCM 1, P388; Bernhardsson J, 2000, J THERMOPLAST COMPOS, V13, P292, DOI 10.1106/X5VY-2TF0-Y3UA-D5DQ; Cheng KB, 2000, J THERMOPLAST COMPOS, V13, P378, DOI 10.1106/MHKX-74A6-PKEM-J7PL; Demircan O, 2011, P ASME 2011 INT MECH; Demircan O, 2014, ADV COMPOS MATER, V23, P239, DOI 10.1080/09243046.2013.851062; Demircan O, 2012, 8 AS AUSTR C COMP MA; Hou M, 1997, COMPOS PART A-APPL S, V28, P695, DOI 10.1016/S1359-835X(97)00013-4; Hufenbach W, 2006, MECH COMPOS MATER, V42, P151, DOI 10.1007/s11029-006-0026-3; Karger-Kocsis J, 1998, COMPOS PART A-APPL S, V29, P1319, DOI 10.1016/S1359-835X(98)00042-6; KargerKocsis J, 1997, APPL COMPOS MATER, V4, P209, DOI 10.1007/BF02481390; Khondker OA, 2001, COMPOS PART A-APPL S, V32, P1513, DOI 10.1016/S1359-835X(01)00051-3; Kim JK, 1998, IMPACT RESPONSE DY 1; Li HX, 2010, J REINF PLAST COMP, V29, P1820, DOI 10.1177/0731684409335402; LI JJ, 2010, J TEXT I, V101, P33; Spacer DJ., 2001, KNITTING TECHNOLOGY, V3rd; Takano N, 2004, COMPOS SCI TECHNOL, V64, P2153, DOI 10.1016/j.compscitech.2004.03.016; Xue P, 2002, COMPOS PART A-APPL S, V33, P113, DOI 10.1016/S1359-835X(01)00067-7; Yao L, 2007, J MATER SCI, V42, P6494, DOI 10.1007/s10853-007-1534-9; Ye L, 1995, APPL COMPOSITE MAT, V1, P415, DOI DOI 10.1007/BF00706502; Fan ZX, 2007, J THERMOPLAST COMPOS, V20, P473, DOI 10.1177/0892705707082326; Zaixia F, 2006, J THERMOPLAST COMPOS, V19, P113, DOI 10.1177/0892705706055446; Fan ZX, 2007, J THERMOPLAST COMPOS, V20, P487, DOI 10.1177/0892705707082327	27	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0892-7057	1530-7980		J THERMOPLAST COMPOS	J. Thermoplast. Compos. Mater.	JUL	2015	28	7					1075	1088		10.1177/0892705714526918		14	Materials Science, Composites	Materials Science	CK7NA	WOS:000356418000012		
J	Tang, KS; Xu, YQ; Wang, PF; Wang, F				Tang, Keshuang; Xu, Yanqing; Wang, Pengfei; Wang, Fen			Impacts of Flashing Green on Dilemma Zone Behavior at High-Speed Intersections: Empirical Study in China	JOURNAL OF TRANSPORTATION ENGINEERING			English	Article						Flashing green; Dilemma zone; High-speed intersections; Driver behavior	SIGNALIZED INTERSECTIONS; DRIVER BEHAVIOR; LIGHT; PROTECTION; SYSTEM; PHASE; AMBER	This study investigated the impacts of flashing green on dilemma zone (DZ) behavior at the high-speed intersections with insufficient yellow interval. 360 high-resolution vehicle trajectories, used in the study, were obtained from an extensive survey at a typical rural high-speed intersection in Shanghai. Results indicate that with the presence of a flashing green signal, the measured behavioral parameters related to DZ determination at the onset of yellow tend to be remarkably smaller. The vast majority of drivers reacted to the onset of flashing green, instead of yellow onset. Flashing green significantly reduced the area of Type I DZ at the onset of yellow, while enlarged the areas of option zone and Type II DZ. Time to stop line at the onset of flashing green positively affected the stopping probability. Flashing green induced conservative stops by 30%, while encouraged aggressive passes slightly.	[Tang, Keshuang; Xu, Yanqing; Wang, Fen] Tongji Univ, Dept Traff Engn, Shanghai 201804, Peoples R China; [Wang, Pengfei] Tohoku Univ, Grad Sch Informat Sci, Aoba Ku, Sendai, Miyagi 9808579, Japan	Tang, KS (reprint author), Tongji Univ, Dept Traff Engn, 4800 Caoan Rd, Shanghai 201804, Peoples R China.	tang@tongji.edu.cn; 6xuyanqing@tongji.edu.cn; wpf.plan.civil@gmail.com; 0112wangfen@tongji.edu.cn			Natural Science Foundation of China [51208380]; National Key Technology Support Program [2014BAG03B02]	This study was jointly supported by the Natural Science Foundation of China (No. 51208380) and National Key Technology Support Program (No. 2014BAG03B02). The authors are grateful to Professor Hideki Nakamura at Nagoya University for providing the image-processing software for data reduction.	Factor R, 2012, TRANSPORT RES F-TRAF, V15, P279, DOI 10.1016/j.trf.2012.01.003; Ma WJ, 2010, J TRANSP ENG-ASCE, V136, P1049, DOI 10.1061/(ASCE)TE.1943-5436.0000181; Newton C, 1997, ACCIDENT ANAL PREV, V29, P201, DOI 10.1016/S0001-4575(96)00073-5; Lum KM, 2006, TRANSPORT RES F-TRAF, V9, P29, DOI 10.1016/j.trf.2005.08.007; Papaioannou P, 2007, ACCIDENT ANAL PREV, V39, P147, DOI 10.1016/j.aap.2006.06.014; Chiou YC, 2010, ACCIDENT ANAL PREV, V42, P1057, DOI 10.1016/j.aap.2009.12.013; Koll H, 2004, ACCIDENT ANAL PREV, V36, P273, DOI 10.1016/S0001-4575(03)00005-8; Tang KS, 2012, TRANSPORT RES REC, P85, DOI 10.3141/2317-11; GAZIS D, 1960, OPER RES, V8, P112, DOI 10.1287/opre.8.1.112; Appiah J, 2011, TRANSPORT RES REC, P19, DOI 10.3141/2250-03; Bonneson J.A, 1994, TRAFFIC DETECTOR DES; Chang M. S., 1985, TRANSPORT RES REC, V1027, P20; HAKKERT AS, 1978, TRAFFIC ENG CONTROL, V19, P212; Hurwitz DS, 2011, J TRANSP ENG-ASCE, V137, P277, DOI 10.1061/(ASCE)TE.1943-5436.0000219; Li PF, 2010, J TRANSP ENG-ASCE, V136, P448, DOI 10.1061/(ASCE)TE.1943-5436.0000066; Li ZX, 2013, TRANSPORT RES REC, P60, DOI 10.3141/2355-07; MAHALEL D, 1985, ACCIDENT ANAL PREV, V17, P373, DOI 10.1016/0001-4575(85)90091-0; Mahalel D., 1985, TRAFFIC ENG CONTROL, V26, P79; McCoy PT, 2003, TRANSPORT RES REC, P11; Parsonson P. S., 1974, J TRANSPORTATION ENG, V44, P8; Quiroga C., 2003, RED LIGHT RUNNING PO; Sharma A., 2011, J TRANSP ENG, P467, DOI [10.1061/(ASCE)TE.1943-5436.0000343, DOI 10.1061/(ASCE)TE.1943-5436]; Sharma A, 2009, TRANSP RES RECORD, P93, DOI 10.3141/2130-12; Sunkai SR, 2005, TRANSPORT RES REC, P176; Van der Horst R., 1986, TRAFFIC ENG CONTROL, V27, P615; Yan XD, 2009, TRANSPORT RES F-TRAF, V12, P50, DOI 10.1016/j.trf.2008.07.002; Zegeer C.V., 1977, EFFECTIVENESS GREEN	27	0	0	ASCE-AMER SOC CIVIL ENGINEERS	RESTON	1801 ALEXANDER BELL DR, RESTON, VA 20191-4400 USA	0733-947X	1943-5436		J TRANSP ENG	J. Transp. Eng.	JUL	2015	141	7							04015005	10.1061/(ASCE)TE.1943-5436.0000770		7	Engineering, Civil; Transportation Science & Technology	Engineering; Transportation	CK7OU	WOS:000356422700003		
J	Minoda, Y; Iwaki, H; Ikebuchi, M; Yoshida, T; Mizokawa, S; Itokazu, M; Nakamura, H				Minoda, Yukihide; Iwaki, Hiroyoshi; Ikebuchi, Mitsuhiko; Yoshida, Taku; Mizokawa, Shigekazu; Itokazu, Maki; Nakamura, Hiroaki			Mobile-bearing prosthesis and intraoperative gap balancing are not predictors of superior knee flexion: a prospective randomized study	KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY			English	Article						Total knee arthroplasty; Mobile-bearing; Gap balancing; Knee flexion angle	FIXED-BEARING; ARTHROPLASTY; RANGE; REPLACEMENT; MOTION; METAANALYSIS; KINEMATICS; MOVEMENT; OUTCOMES; SYSTEM	Range of motion is a crucial measure of the outcome of total knee arthroplasty. Gap balancing technique and mobile-bearing prosthesis can improve postoperative range of motion. The purpose of this study was to determine the factors that are predictive of the postoperative range of motion. A total of 94 knees with varus osteoarthritis were prospectively randomized to receive either a posterior-stabilized mobile-bearing or a posterior-stabilized fixed-bearing prosthesis. All preoperative and postoperative protocols and operative techniques were identical in the two groups. Extension and flexion joint gaps were measured using a tensor device during the operation. Multiple regression analysis was conducted to determine the best predictors of the knee flexion angle 2 years after the operation. The independent variables were type of prosthesis (mobile-bearing or fixed-bearing), difference between flexion and extension joint gaps (mm), age, gender, body mass index (BMI), preoperative and intraoperative knee flexion angles, change in posterior condylar offset, and posterior tilt of the tibial plateau. The mean difference between flexion and extension joint gaps was 0.8 +/- A 1.3 (mean +/- A SD) mm for mobile-bearing and 0.8 +/- A 1.9 mm for fixed-bearing prosthesis. The mean flexion angle for mobile-bearing and fixed-bearing groups was 120 +/- A 16A degrees and 116 +/- A 20A degrees preoperatively (n.s.), 142 +/- A 9A degrees and 141 +/- A 12A degrees intraoperatively (n.s.), and 129 +/- A 10A degrees and 128 +/- A 13A degrees at 2 years postoperatively (p = 0.773), respectively. Predictors were identified in the following three categories: (1) preoperative flexion angle, (2) intraoperative radiographic flexion angle, and (3) BMI (R = 0.603, p < 0.001). Mobile-bearing prosthesis and optimal gap balancing did not result in superior postoperative flexion angle. Better preoperative and intraoperative flexion angles and lower BMI were the significant predictors for better postoperative flexion angle. Therapeutic study, Level I.	[Minoda, Yukihide; Iwaki, Hiroyoshi; Ikebuchi, Mitsuhiko; Yoshida, Taku; Mizokawa, Shigekazu; Itokazu, Maki; Nakamura, Hiroaki] Osaka City Univ, Grad Sch Med, Dept Orthopaed Surg, Osaka 5458585, Japan	Minoda, Y (reprint author), Osaka City Univ, Grad Sch Med, Dept Orthopaed Surg, 1-4-3 Asahi Machi Abeno Ku, Osaka 5458585, Japan.	yminoda@msic.med.osaka-cu.ac.jp					Bellemans J, 2002, J BONE JOINT SURG BR, V84B, P50, DOI 10.1302/0301-620X.84B1.12432; INSALL JN, 1989, CLIN ORTHOP RELAT R, P13; Smith H, 2011, J ARTHROPLASTY, V26, P1205, DOI 10.1016/j.arth.2010.12.017; Asano H, 2004, J ARTHROPLASTY, V19, P558, DOI 10.1016/j.arth.2004.01.003; Dennis DA, 2010, CLIN ORTHOP RELAT R, V468, P102, DOI 10.1007/s11999-009-1112-3; EWALD FC, 1989, CLIN ORTHOP RELAT R, P9; Matsumoto T, 2009, J BONE JOINT SURG BR, V91B, P475, DOI 10.1302/0301-620X.91B4.21862; Matziolis G, 2011, KNEE SURG SPORT TR A, V19, P1504, DOI 10.1007/s00167-011-1554-5; Ishii Y, 2011, KNEE SURG SPORT TR A, V19, P2002, DOI 10.1007/s00167-011-1395-2; Wen Y, 2011, ARCH ORTHOP TRAUM SU, V131, P1341, DOI 10.1007/s00402-011-1328-z; Acker SM, 2011, J ARTHROPLASTY, V26, P319, DOI 10.1016/j.arth.2010.08.003; Kim TK, 2010, J ARTHROPLASTY, V25, P458, DOI 10.1016/j.arth.2009.01.018; HARVEY IA, 1993, J BONE JOINT SURG BR, V75, P950; Joseph J, 2013, KNEE, V20, P401, DOI 10.1016/j.knee.2013.06.007; Jennings LM, 2007, P I MECH ENG H, V221, P305, DOI 10.1243/09544119JEIM215; Higuchi H, 2009, INT ORTHOP, V33, P997, DOI 10.1007/s00264-009-0772-7; Delport HP, 2006, J BONE JOINT SURG BR, V88B, P1016, DOI 10.1302/0301-620X.88B8; Matsuda S, 2013, CLIN ORTHOP RELAT R, V471, P127, DOI 10.1007/s11999-012-2533-y; Tibesku CO, 2011, KNEE SURG SPORT TR A, V19, P1488, DOI 10.1007/s00167-011-1462-8; Ritter MA, 2003, J BONE JOINT SURG AM, V85A, P1278; Pang HN, 2011, KNEE SURG SPORT TR A, V19, P1496, DOI 10.1007/s00167-011-1483-3; Kim YH, 2005, J BONE JOINT SURG AM, V87A, P1470, DOI 10.2106/JBJS.D.02707; Dennis DA, 2007, CLIN ORTHOP RELAT R, P53, DOI 10.1097/BLO.0b013e31812f85d; Smith TO, 2010, KNEE SURG SPORT TR A, V18, P325, DOI 10.1007/s00167-009-0909-7; Bistolfi Alessandro, 2013, J Bone Joint Surg Am, V95, pe83, DOI 10.2106/JBJS.L.00327; Callaghan J J, 2001, Instr Course Lect, V50, P431; Chen LB, 2013, ORTHOP SURG, V5, P112, DOI 10.1111/os.12040; KOSHINO T, 1979, INT ORTHOP, V3, P37; Kurita M, 2012, INT ORTHOP, V36, P2465, DOI 10.1007/s00264-012-1673-8; Lee DH, 2013, J ARTHROPLASTY, V28, P1717, DOI 10.1016/j.arth.2013.04.019; Matsumoto T, 2011, KNEE SURG SPORT TR A, V19, P880, DOI 10.1007/s00167-010-1224-z; Minoda Y, 2012, KNEE, V19, P832, DOI 10.1016/j.knee.2012.03.007; PARSLEY BS, 1992, CLIN ORTHOP RELAT R, P204; RITTER MA, 1979, CLIN ORTHOP RELAT R, P115; Ritter M A, 1987, J Arthroplasty, V2, P95, DOI 10.1016/S0883-5403(87)80015-3; Russell RD, 2014, KNEE SURG SPORT TR A, V22, P1644, DOI 10.1007/s00167-013-2378-2; Sansone V, 2004, J ARTHROPLASTY, V19, P678, DOI 10.1016/j.arth.2004.01.011	37	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0942-2056	1433-7347		KNEE SURG SPORT TR A	Knee Surg. Sports Traumatol. Arthrosc.	JUL	2015	23	7					1986	1992		10.1007/s00167-014-2838-3		7	Orthopedics; Sport Sciences; Surgery	Orthopedics; Sport Sciences; Surgery	CK8BJ	WOS:000356462300015		
J	Tanaka, T; Kumagae, Y; Chazono, M; Kitasato, S; Kakuta, A; Marumo, K				Tanaka, T.; Kumagae, Y.; Chazono, M.; Kitasato, S.; Kakuta, A.; Marumo, K.			A novel evaluation system to monitor bone formation and beta-tricalcium phosphate resorption in opening wedge high tibial osteotomy	KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY			English	Article						beta-TCP; Opening wedge HTO; Osirix; Bone formation	CERAMIC IMPLANTS; LONG-TERM; HYDROXYAPATITE; SUBSTITUTE; KNEE	The aim of this study was to establish an evaluation system to monitor bone formation and beta-tricalcium phosphate (TCP) resorption in opening high tibial osteotomy (HTO). From 2003 to 2005, opening HTO was performed in 36 patients using a Puddu plate and beta-TCP blocks with 60 and 75 % porosity. Thirty-one patients were used for evaluation. All patients underwent CT examination at 2 weeks and 6 years. The CT image data were divided into three areas, and CT values of each area were analysed using the imaging software, Osirix. CT image analysis at 2 weeks showed that the mean CT-attenuation values (in Hounsfield units) of the implanted area with beta-TCP of 60 % porosity, the implanted area with beta-TCP of 75 % porosity, and cancellous bone were, 1,694.0 +/- A 94.2, 1,010.9 +/- A 81.1, and 178.0 +/- A 45.1, respectively. Six years after surgery, these values were 574.1 +/- A 273.5, 168.8 +/- A 75.1, and 174.9 +/- A 69.3, respectively. beta-TCP with 75 % porosity was completely resorbed and replaced by bone. beta-TCP with 60 % porosity was resorbed, but approximately 1/3 still remained even 6 years after surgery. The imaging software, Osirix, enabled scanning of the whole area to measure CT values. This system is the first to quantitatively evaluate beta-TCP resorption and bone formation in opening HTO. Laboratory studies.	[Tanaka, T.; Kumagae, Y.; Chazono, M.] NHO Utsunomiya Natl Hosp, Dept Orthopaed Surg, Utsunomiya, Tochigi 3291193, Japan; [Kitasato, S.; Kakuta, A.; Marumo, K.] Jikei Univ, Sch Med, Dept Orthopaed Surg, Tokyo 1058461, Japan	Tanaka, T (reprint author), NHO Utsunomiya Natl Hosp, Dept Orthopaed Surg, 2160 Shimo Okamoto, Utsunomiya, Tochigi 3291193, Japan.	tanakat@e-utunomiya.hosp.go.jp					Gaasbeek RDA, 2005, BIOMATERIALS, V26, P6713, DOI 10.1016/j.biomaterials.2005.04.056; Meidinger G, 2011, KNEE SURG SPORT TR A, V19, P333, DOI 10.1007/s00167-010-1335-6; KITSUGI T, 1993, BIOMATERIALS, V14, P216, DOI 10.1016/0142-9612(93)90026-X; COVENTRY MB, 1965, J BONE JOINT SURG AM, VA 47, P984; Matsumine A, 2004, J BONE JOINT SURG BR, V86B, P719, DOI 10.1302/0301-620X.86B5.14242; Aryee S, 2008, BIOMATERIALS, V29, P3497, DOI 10.1016/j.biomaterials.2008.05.027; AURORI BF, 1985, CLIN ORTHOP RELAT R, P153; Gaasbeek RDA, 2005, KNEE SURG SPORT TR A, V13, P689, DOI 10.1007/s00167-004-0599-0; HOOGENDOORN HA, 1984, CLIN ORTHOP RELAT R, P281; JACKSON JP, 1961, J BONE JOINT SURG BR, V43, P746; Karcher HL, 1997, BRIT MED J, V314, P1300; Koshino T, 2003, J BONE JOINT SURG AM, V85, P75; Kraal T, 2008, KNEE, V15, P201, DOI 10.1016/j.knee.2008.02.005; KRAMER MS, 1981, CLIN PHARMACOL THER, V29, P111; Marmotti A, 2013, KNEE SURG SPORT TR A, V21, P237, DOI 10.1007/s00167-012-2150-z; Onodera J, 2014, KNEE SURG SPORT TR A, V22, P2763, DOI 10.1007/s00167-013-2681-y; Tanaka T, 2008, J BIOMED MATER RES B, V86B, P453, DOI 10.1002/jbm.b.31041; Tanaka T, 2006, JIKEIKAI MED J, V53, P23; van Hemert WLW, 2004, KNEE, V11, P451, DOI 10.1016/j.knee.2004.08.004; WRIGHT JG, 1991, J BONE JOINT SURG BR, V73, P721; Zorzi AR, 2010, ARTIF ORGANS, V35, P301	21	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0942-2056	1433-7347		KNEE SURG SPORT TR A	Knee Surg. Sports Traumatol. Arthrosc.	JUL	2015	23	7					2007	2011		10.1007/s00167-014-2870-3		5	Orthopedics; Sport Sciences; Surgery	Orthopedics; Sport Sciences; Surgery	CK8BJ	WOS:000356462300018		
J	Abe, SK; Murakami, Y; Morgan, D; Shibuya, K				Abe, Sarah Krull; Murakami, Yuki; Morgan, David; Shibuya, Kenji			Rethinking the global tracking system on development assistance to reproductive, maternal, newborn, and child health	LANCET GLOBAL HEALTH			English	Editorial Material							OFFICIAL DEVELOPMENT ASSISTANCE; COUNTDOWN		[Abe, Sarah Krull; Shibuya, Kenji] Univ Tokyo, Grad Sch Med, Dept Global Hlth Policy, Tokyo, Japan; [Murakami, Yuki; Morgan, David] Org Econ Cooperat & Dev, Directorate Employment Labour & Social Affairs, Hlth Div, Paris, France	Shibuya, K (reprint author), Univ Tokyo, Grad Sch Med, Dept Global Hlth Policy, Tokyo, Japan.	shibuyak@m.u-tokyo.ac.jp		Abe, Sarah K./0000-0003-3991-2739			Piva P, 2009, B WORLD HEALTH ORGAN, V87, P930, DOI 10.2471/BLT.08.058677; Farag M, 2009, HEALTH AFFAIR, V28, P1045, DOI 10.1377/hlthaff.28.4.1045; Arregoces L, 2015, LANCET GLOB HEALTH, V3, pE410, DOI 10.1016/S2214-109X(15)00057-1; Sridhar D, 2010, J LAW MED ETHICS, V38, P459, DOI 10.1111/j.1748-720X.2010.00505.x; Horton R, 2014, LANCET, V383, P2196; Pitt C, 2010, LANCET, V376, P1485, DOI 10.1016/S0140-6736(10)61302-5; Grepin KA, 2014, GLOBALIZATION HEALTH, V10, DOI 10.1186/s12992-014-0084-6; Hsu J, 2012, LANCET, V380, P1157, DOI 10.1016/S0140-6736(12)61415-9; Institute for Health Metrics and Evaluation, 2014, FIN GLOB HLTH 2013 T; Morgan D, 2014, STRENGTHENING RESOUR; Oliveira-Cruz V, 2003, J INT DEV, V15, P67, DOI 10.1002/jid.966; The Partnership for Maternal Newborn & Child Health, 2014, PMNCH 2014 ACC REP T	12	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2214-109X			LANCET GLOB HEALTH	Lancet Glob. Health	JUL	2015	3	7					E350	E351				2	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CK6CH	WOS:000356314900006		
J	Iwata, S				Iwata, Seizi			And mockery: a two-layer account	LANGUAGE SCIENCES			English	Article						Sarcastic irony; Echoic use; Metarepresentation; Pretenf-play; Non-serious linguistic act	VERBAL IRONY; PRETENSE THEORY; CONVERSATION; ECHO	When the utterance "I'm the President," which is seriously meant, is responded to with "And I'm the First Lady," the validity of that utterance is challenged with sarcasm. This type of and locution, referred to as and mockery, has been analyzed in terms of quotation of the illocutionary act (Haiman, 1998) or metarepresentation/echo (Noh, 2000), but both analyses are problematic. Rather, a two-layer account, which is built upon Clark's (1996) theory of non-serious linguistic acts, better accounts for why and mockery conveys what it does. The proposed account naturally extends to variations involving an echo question, an echo declarative, or an if conditional. Furthermore, the proposed account sheds new light on the debate between echoic theory and pretense theory, which have been two major theories of verbal irony. (C) 2015 Elsevier Ltd. All rights reserved.	Kansai Univ, Fac Letters Gen Dept Humanities, Dept English Linguist & Literature, Suita, Osaka 5648680, Japan	Iwata, S (reprint author), Kansai Univ, Fac Letters Gen Dept Humanities, Dept English Linguist & Literature, 3-3-35 Yamate Cho, Suita, Osaka 5648680, Japan.	s_iwata@kcc.zaq.ne.jp			Japan Society for the Promotion of Science [25370558]	I would like to express my gratitude to Tony Higgins, who acted as an informant and suggested stylistic improvements. Thanks are also due to two anonymous reviewers, whose comments helped me to improve the paper quite a lot. This work is financially supported by Grant-in-Aid for Scientific Research (C), No. 25370558, 2013-2015 from Japan Society for the Promotion of Science.	Akatsuka N., 1991, INTERDISCIPLINARY AP, P25; Akatsuka N., 1986, CONDITIONALS, P333, DOI 10.1017/CBO9780511753466.018; Wilson D, 2006, LINGUA, V116, P1722, DOI 10.1016/j.lingua.2006.05.001; Clift R, 1999, LANG SOC, V28, P523; Kotthoff H, 2003, J PRAGMATICS, V35, P1387, DOI 10.1016/S0378-2166(02)00182-0; GIBBS RW, 1986, J EXP PSYCHOL GEN, V115, P3, DOI 10.1037/0096-3445.115.1.3; CLARK HH, 1984, J EXP PSYCHOL GEN, V113, P121, DOI 10.1037/0096-3445.113.1.121; LEWIS D, 1979, J PHILOS LOGIC, V8, P339; Attardo S, 2000, J PRAGMATICS, V32, P793, DOI 10.1016/S0378-2166(99)00070-3; Partington A, 2007, J PRAGMATICS, V39, P1547, DOI 10.1016/j.pragma.2007.04.009; KUMONNAKAMURA S, 1995, J EXP PSYCHOL GEN, V124, P3, DOI 10.1037//0096-3445.124.1.3; CLARK HH, 1990, LANGUAGE, V66, P764, DOI 10.2307/414729; WILSON D, 1992, LINGUA, V87, P53, DOI 10.1016/0024-3841(92)90025-E; Carston R, 1999, J LINGUIST, V35, P365, DOI 10.1017/S0022226799007653; Colson HL, 2002, J PRAGMATICS, V34, P111, DOI 10.1016/S0378-2166(02)80008-X; Gibbs RW, 2012, INTERPRETING FIGURATIVE MEANING, P1, DOI 10.1017/CBO9781139168779; Currie G., 2006, ARCHITECTURE IMAGINA, P111; Declerck R., 2001, CONDITIONALS COMPREH; Dynel M., 2013, DEV LINGUISTIC HUMOU, P289; Garmendia J., 2013, RES TRENDS INTERCULT, P85; Gibbs Jr R.W., 2000, METAREPRESENTATIONS, P389; Gibbs R., 1994, POETICS MIND FIGURAT; Haiman J., 1998, TALK CHEAP SARCASM A; Haiman J., 1990, COGN LINGUIST, V1, P181, DOI 10.1515/cogl.1990.1.2.181; Hamamoto H., 1998, RELEVANCE THEORY APP, P257; Iwata S, 2003, LINGUIST PHILOS, V26, P185, DOI 10.1023/A:1022851819941; Kapogianni E., 2011, PRAGMATICS HUMOUR DI, P51; Kartunen L., 1972, SYNTAX SEMANTICS, V1, P1; Noh E.-J., 2000, METAREPRESENATATION; Noh EJ, 1998, PRAG BEYOND NEW SER, V58, P271; Quirk R, 1972, GRAMMAR CONT ENGLISH; Sadock J.M., 1977, CHICAGO LINGUISTIC S, V13, P545; Seto K., 1998, RELEVANCE THEORY APP, P240; Simons M, 2001, LINGUIST PHILOS, V24, P597, DOI 10.1023/A:1017597811833; Smith N., 1983, AUST J LINGUIST, V3, P1, DOI 10.1080/07268608308599297; SPERBER D., 1986, RELEVANCE COMMUNICAT; Sperber D., 1998, RELEVANCE THEORY APP, P283, DOI DOI 10.1075/PBNS.37.16SPE; SPERBER D, 1984, J EXP PSYCHOL GEN, V113, P130, DOI 10.1037//0096-3445.113.1.130; Sperber Dan, 1981, RADICAL PRAGMATICS, P295; Sweetser E. E., 1990, ETYMOLOGY PRAGMATICS; Tobin V, 2012, VIEWPOINT IN LANGUAGE: A MULTIMODAL PERSPECTIVE, P25; Wilson D., 2004, HDB PRAGMATICS, P607; Wilson D., 2012, MEANING RELEVANCE, P230; Wilson D., 2000, METAREPRESENTATIONS, P411; Wilson Deirdre, 1988, MENTAL REPRESENTATIO, P133; Wilson Deirdre, 2012, MEANING RELEVANCE, P123, DOI [DOI 10.1017/CBO9781139028370.008, 10.1017/CBO9781139028370.008]; Yamanashi M., 1998, RELEVANCE THEORY APP, P271	47	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0388-0001	1873-5746		LANG SCI	Lang. Sci.	JUL	2015	50						30	48		10.1016/j.langsci.2015.02.001		19	Linguistics; Language & Linguistics	Linguistics	CK4JR	WOS:000356190600003		
J	Nakata, T				Nakata, Tatsuya			Effects of feedback timing on second language vocabulary learning: Does delaying feedback increase learning?	LANGUAGE TEACHING RESEARCH			English	Article						Delayed feedback; timing of feedback; vocabulary learning	MULTIPLE-CHOICE TESTS; LONG-TERM RETENTION; CORRECTIVE FEEDBACK; DISTRIBUTED PRACTICE; RETRIEVAL; CONFIDENCE; BENEFITS; SCIENCE	Feedback, or information given to learners regarding their performance, is found to facilitate second language (L2) learning. Research also suggests that the timing of feedback (whether it is provided immediately or after a delay) may affect learning. The purpose of the present study was to identify the optimal feedback timing for L2 vocabulary learning. This study differs from previous feedback timing studies in two important respects. First, unlike some previous studies, feedback timing was not confounded with lag to test (interval between the last encounter with a given item and the posttest). Second, in order to test the view that delayed feedback may be particularly effective when learners make few errors during learning, the present study manipulated the frequency of practice to influence learning phase performance. In this study, 98 Japanese college students studied 16 English-Japanese word pairs. Immediate feedback was given immediately after each response, whereas delayed feedback was withheld until all target items were practised. Learning was measured by posttests administered immediately, 1 week, and 4 weeks after the treatment. Results suggested that when lag to test is controlled, feedback timing may have little effect on L2 vocabulary learning regardless of the frequency of errors during learning.	Kansai Univ, Fac Foreign Language, Suita, Osaka 5648680, Japan	Nakata, T (reprint author), Kansai Univ, Fac Foreign Language, 3-3-35 Yamate Cho, Suita, Osaka 5648680, Japan.	nakata@kansai-u.ac.jp			Faculty Research Grants from Victoria University of Wellington [109605]	This work was supported by Faculty Research Grants from Victoria University of Wellington (grant number 109605).	Nation ISP, 2006, CAN MOD LANG REV, V63, P59; Rolin-Ianziti J, 2010, LANG TEACH RES, V14, P183, DOI 10.1177/1362168809353874; Skinner BF, 1954, HARVARD EDUC REV, V24, P86; Metcalfe J, 2007, PSYCHON B REV, V14, P225, DOI 10.3758/BF03194056; Pashler H, 2005, J EXP PSYCHOL LEARN, V31, P3, DOI 10.1037/0278-7393.31.1.3; Lyster R, 2013, LANG TEACHING, V46, P1, DOI 10.1017/S0261444812000365; Evans NW, 2010, LANG TEACH RES, V14, P445, DOI 10.1177/1362168810375367; Cepeda NJ, 2006, PSYCHOL BULL, V132, P354, DOI 10.1037/0033-2909.132.3.354; Butler AC, 2007, J EXP PSYCHOL-APPL, V13, P273, DOI 10.1037/1076-898X.13.4.273; Roediger HL, 2010, CURR ISS MEM, P13; Barcroft J, 2007, LANG LEARN, V57, P35, DOI 10.1111/j.1467-9922.2007.00398.x; Li SF, 2010, LANG LEARN, V60, P309, DOI 10.1111/j.1467-9922.2010.00561.x; Cull WL, 1996, J EXP PSYCHOL-APPL, V2, P365, DOI 10.1037/1076-898X.2.4.365; Cepeda NJ, 2009, EXP PSYCHOL, V56, P236, DOI 10.1027/1618-3169.56.4.236; Cepeda NJ, 2008, PSYCHOL SCI, V19, P1095, DOI 10.1111/j.1467-9280.2008.02209.x; Metcalfe J, 2009, MEM COGNITION, V37, P1077, DOI 10.3758/MC.37.8.1077; Karpicke JD, 2007, J EXP PSYCHOL LEARN, V33, P704, DOI 10.1037/0278-7393.33.4.704; Kornell N, 2009, APPL COGNITIVE PSYCH, V23, P1297, DOI 10.1002/acp.1537; Carpenter SK, 2011, MEM COGNITION, V39, P1211, DOI 10.3758/s13421-011-0092-1; Cohen J., 1988, STAT POWER ANAL BEHA; DeKeyser R., 2007, PRACTICE 2 LANGUAGE, P1; Ellis R., 1999, STUDIES 2 LANGUAGE A, V21, P285, DOI DOI 10.1017/S0272263199002077; Karpicke J. D., 2009, 81 ANN M MIDW PSYCH; KULHAVY RW, 1972, J EDUC PSYCHOL, V63, P505, DOI 10.1037/h0033243; KULIK JA, 1988, REV EDUC RES, V58, P79, DOI 10.3102/00346543058001079; Lee I, 2013, LANG TEACHING, V46, P108, DOI 10.1017/S0261444812000390; Mory E. H., 2004, HDB RES ED COMMUNICA, P745; Nakata T., 2013, THESIS VICTORIA U WE; ONEILL M, 1976, J EDUC RES, V70, P72; PHYE G, 1970, J EDUC PSYCHOL, V61, P380, DOI 10.1037/h0029798; Quinn P., 2013, AM ASS APPL LING C D; Rohrer D, 2005, APPL COGNITIVE PSYCH, V19, P361, DOI 10.1002/acp.1083; Sheen Y., 2012, 2 LANG RES FOR C PIT; SWINDELL LK, 1993, CONTEMP EDUC PSYCHOL, V18, P363, DOI 10.1006/ceps.1993.1026; Webb S., 2012, ENCY APPL LINGUISTIC, P1656	35	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1362-1688	1477-0954		LANG TEACH RES	Lang. Teach Res.	JUL	2015	19	4					416	434		10.1177/1362168814541721		19	Education & Educational Research; Linguistics	Education & Educational Research; Linguistics	CL0BV	WOS:000356604400003		
J	Hagiwara, A				Hagiwara, Akiko			Effect of visual support on the processing of multiclausal sentences	LANGUAGE TEACHING RESEARCH			English	Article						Automatization; L2 processing; morphemes; multimedia learning theory; visual support	ACQUISITION; VOCABULARY; MEMORY; COMPREHENSION; ATTENTION; MODALITY; GRAMMAR; WORDS	Processing morphemic elements is one of the most difficult parts of second language acquisition (DeKeyser, 2005; Larsen-Freeman, 2010). This difficulty gains prominence when second language (L2) learners must perform under time pressure, and difficulties arise in using grammatical knowledge. To solve the problem, the current study used the tenets of multimedia learning theory (Mayer, 2005) to help L2 learners' reconstruct multiclausal sentences. This theory assumes that limitations in cognitive capacity are reduced when information is given to learners both visually and aurally. Given this assumption, the current study examined whether pictorial information helps L2 learners process morphemic elements in multiclausal sentences presented aurally. Thirty-two learners of Japanese engaged in elicited imitation both with and without pictorial support. The results revealed that the learners performed significantly better with pictorial support, lending support to multimedia learning theory for L2 learners' processing of morphemic elements. However, a limited effect of pictorial support was found for the processing of an element that the L2 learners had learned recently, and that was in sentence-final position, suggesting that these types of items are difficult to automatize regardless of cognitive support.	Int Christian Univ, Japanese Language Program, Mitaka, Tokyo 1818585, Japan	Hagiwara, A (reprint author), Int Christian Univ, Japanese Language Program, 10-2,Osawa 3 Chome, Mitaka, Tokyo 1818585, Japan.	ahagiwara@icu.ac.jp					Altarriba J, 2011, LANG LEARN LANG TEAC, V30, P21; LEWANDOWSKY S, 1989, PSYCHOL REV, V96, P25, DOI 10.1037/0033-295X.96.1.25; MOUSAVI SY, 1995, J EDUC PSYCHOL, V87, P319, DOI 10.1037/0022-0663.87.2.319; DeKeyser RM, 2005, LANG LEARN, V55, P1, DOI 10.1111/j.0023-8333.2005.00294.x; Ellis R, 2006, STUD SECOND LANG ACQ, V28, P339, DOI 10.1017/S0272263106060141; Moreno R, 1999, J EDUC PSYCHOL, V91, P358, DOI 10.1037//0022-0663.91.2.358; Baddeley A. D, 1986, WORKING MEMORY; Bley-Vroman R., 1994, RES METHODOLOGY 2 LA, P245; Cohen J., 1988, STAT POWER ANAL BEHA; COWAN N, 1993, MEM COGNITION, V21, P162, DOI 10.3758/BF03202728; DeKeyser R., 2009, HDB 2 LANGUAGE TEACH, P119, DOI 10.1002/9781444315783.ch8; Ellis N. C, 2002, STUDIES 2 LANGUAGE A, V24, P143, DOI DOI 10.1017/S0272263102002024; FRICK RW, 1984, MEM COGNITION, V12, P507, DOI 10.3758/BF03198313; Jiang N, 2007, LANG LEARN, V57, P1, DOI 10.1111/j.1467-9922.2007.00397.x; Johnston J., 2007, L2 LISTENING SUBSKIL; Jones L, 2004, LANG LEARN TECHNOL, V8, P122; Jones LC, 2002, MOD LANG J, V86, P546, DOI 10.1111/1540-4781.00160; Klafehn T., 2003, THESIS U HAWAII MANO; Kondo K, 2004, WASEDA U NIHONGO KEN, V5, P77; Lardiere Donna, 1998, SECOND LANG RES, V14, P1, DOI DOI 10.1191/026765898674105303; Larsen-Freeman D, 2010, LANG LEARN, V60, P221; Levelt William J. M., 1989, SPEAKING INTENTION A; Makino S., 1986, DICT BASIC JAPANESE; MARTIN M, 1980, ACTA PSYCHOL, V44, P99, DOI 10.1016/0001-6918(80)90061-X; Mayer R. E., 2005, CAMBRIDGE HDB MULTIM, P169, DOI DOI 10.1017/CBO9780511816819.010; Mayer R.E., 2001, MULTIMEDIA LEARNING; Mine F., 2007, J JAPANESE LANGUAGE, V134, P90; Mori J., 1999, NEGOTIATING AGREEMEN; PENNEY CG, 1989, MEM COGNITION, V17, P398, DOI 10.3758/BF03202613; Plass D., 2003, COMPUT HUM BEHAV, V19, P221; Prevost P, 2000, SECOND LANG RES, V16, P103, DOI DOI 10.1191/026765800677556046; Rast R. M., 2003, EUROSLA YB, V3, P131, DOI 10.1075/eurosla.3.09ras; Segalowitz N., 2005, HDB BILINGUALISM PSY, P371; Spitze K., 1981, TESL TALK Q TEACHERS, V12, P32; VanPatten B., 2002, LANG LEARN, V52, P775; VanPatten Bill, 2004, PROCESSING INSTRUCTI, P5; West D., 2012, LANGUAGE COGNITION, V4, P203; Yamauchi H., 2009, PROFISSHENSHI KARA M; Yuan YL, 2010, LANG LEARN, V60, P446, DOI 10.1111/j.1467-9922.2010.00564.x; ZOBL H, 1994, LANG LEARN, V44, P159	40	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1362-1688	1477-0954		LANG TEACH RES	Lang. Teach Res.	JUL	2015	19	4					455	472		10.1177/1362168814541715		18	Education & Educational Research; Linguistics	Education & Educational Research; Linguistics	CL0BV	WOS:000356604400005		
J	Kawahigashi, Y				Kawahigashi, Yasuyuki			A Remark on Gapped Domain Walls Between Topological Phases	LETTERS IN MATHEMATICAL PHYSICS			English	Article						conformal field theory; gapped domain walls; modular invariants; topological phases; modular tensor category	LOCAL CONFORMAL NETS; MODULAR INVARIANTS; ALPHA-INDUCTION; TENSOR CATEGORIES; HOPF-ALGEBRAS; SUBFACTORS; CLASSIFICATION; GRAPHS; C-LESS-THAN-1; ANALOG	We give a mathematical definition of a gapped domain wall between topological phases and a gapped boundary of a topological phase. We then provide answers to some recent questions studied by Lan, Wang and Wen in condensed matter physics based on works of Davydov, Muger, Nikshych and Ostrik. In particular, we identify their tunneling matrix and a coupling matrix of Rehren, and show that their conjecture does not hold.	[Kawahigashi, Yasuyuki] Univ Tokyo, Grad Sch Math Sci, Tokyo 1538914, Japan; [Kawahigashi, Yasuyuki] Univ Tokyo, Kavli IPMU WPI, Kashiwa, Chiba 2778583, Japan	Kawahigashi, Y (reprint author), Univ Tokyo, Grad Sch Math Sci, Tokyo 1538914, Japan.	yasuyuki@ms.u-tokyo.ac.jp	Kawahigashi, Yasuyuki/A-7675-2010	Kawahigashi, Yasuyuki/0000-0002-7196-3416	JSPS	Supported in part by Research Grants and the Grants-in-Aid for Scientific Research, JSPS.	Levin M, 2013, PHYS REV X, V3, DOI 10.1103/PhysRevX.3.021009; Kawahigashi Y, 2004, ANN MATH, V160, P493; Bais FA, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.045316; JONES VFR, 1983, INVENT MATH, V72, P1, DOI 10.1007/BF01389127; Fuchs J, 2013, COMMUN MATH PHYS, V321, P543, DOI 10.1007/s00220-013-1723-0; Kitaev A, 2012, COMMUN MATH PHYS, V313, P351, DOI 10.1007/s00220-012-1500-5; Kirillov A, 2002, ADV MATH, V171, P183, DOI 10.1006/aima.2002.2072; LONGO R, 1995, REV MATH PHYS, V7, P567, DOI 10.1142/S0129055X95000232; Izumi M, 2002, REV MATH PHYS, V14, P733, DOI 10.1142/S0129055X02001375; Etingof P, 2005, ANN MATH, V162, P581; Davydov A, 2013, J REINE ANGEW MATH, V677, P135, DOI 10.1515/crelle.2012.014; Ostrik V, 2003, TRANSFORM GROUPS, V8, P177, DOI 10.1007/s00031-003-0515-6; Bakalov B., 2001, LECT TENSOR CATEGORI; Barkeshli M, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.241103; Bischoff M., ARXIV14108848; Bockenhauer J, 1998, COMMUN MATH PHYS, V197, P361, DOI 10.1007/s002200050455; Bockenhauer J, 2000, COMMUN MATH PHYS, V213, P267, DOI 10.1007/s002200000241; Bockenhauer J, 1999, COMMUN MATH PHYS, V208, P429, DOI 10.1007/s002200050765; Bockenhauer J, 1999, COMMUN MATH PHYS, V205, P183, DOI 10.1007/s002200050673; Bockenhauer J, 2000, COMMUN MATH PHYS, V210, P733, DOI 10.1007/s002200050798; Bockenhauer J, 2001, PUBL RES I MATH SCI, V37, P1, DOI 10.2977/prims/1145476688; Bockenhauer J, 1999, COMMUN MATH PHYS, V200, P57, DOI 10.1007/s002200050523; Davydov A, 2013, SEL MATH-NEW SER, V19, P237, DOI 10.1007/s00029-012-0093-3; Davydov A, 2014, J MATH PHYS, V55, DOI 10.1063/1.4895764; Davydov A., ARXIV14128505; Evans DE, 2003, COMMUN MATH PHYS, V237, P309, DOI 10.1007/s00220-003-0862-0; Evans D E, 1998, QUANTUM SYMMETRIES O; Hung L.-Y., ARXIV150202026; Hung LY, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.076401; Izumi M, 2000, COMMUN MATH PHYS, V213, P127, DOI 10.1007/s002200000234; Kawahigashi Y., ARXIV150305675; Kawahigashi Y, 2004, COMMUN MATH PHYS, V244, P63, DOI 10.1007/s00220-003-0979-1; Kawahigashi Y, 2001, COMMUN MATH PHYS, V219, P631, DOI 10.1007/PL00005565; Kong L, 2014, NUCL PHYS B, V886, P436, DOI 10.1016/j.nuclphysb.2014.07.003; Lan T, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.115119; Lan T, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.076402; LONGO R, 1994, COMMUN MATH PHYS, V159, P133, DOI 10.1007/BF02100488; Rehren K.-H., 2000, MATH PHYS MATH PHYS, P341; Turaev V, 2010, QUANTUM INVARIANTS K; XU F, 1998, COMMUN MATH PHYS, V192, P347	40	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0377-9017	1573-0530		LETT MATH PHYS	Lett. Math. Phys.	JUL	2015	105	7					893	899		10.1007/s11005-015-0766-x		7	Physics, Mathematical	Physics	CK7ZB	WOS:000356455300001		
J	Nakamura, S; Fukui, T; Kawaguchi, K; Fukumoto, K; Hirakawa, A; Yokoi, K				Nakamura, Shota; Fukui, Takayuki; Kawaguchi, Koji; Fukumoto, Koichi; Hirakawa, Akihiro; Yokoi, Kohei			Does ground glass opacity-dominant feature have a prognostic significance even in clinical T2aN0M0 lung adenocarcinoma?	LUNG CANCER			English	Article						Lung cancer; Adenocarcinoma; GGO-dominant tumor; Ground glass opacity; High-resolution computed tomography; Lepidic growth pattern	RESOLUTION COMPUTED-TOMOGRAPHY; THIN-SECTION CT; BRONCHIOLOALVEOLAR CARCINOMA; WEDGE RESECTION; TUMOR SIZE; CANCER; SURVIVAL; CLASSIFICATION; METASTASIS; PREDICTOR	Introduction: Recent studies have demonstrated that ground glass opacity (GGO)-dominant tumors correspond to pathologically low-grade adenocarcinomas and that patients with resected tumors have an excellent prognosis. However, almost all of those studies were limited to tumors measuring <= 3.0 cm. The purpose of this study was to characterize lung adenocarcinomas >3.0 cm in diameter with GGO-dominant features and evaluate the prognosis of patients with such tumors. Methods: One hundred and thirteen patients with cT2aN0M0 lung adenocarcinoma underwent surgical resection between 2005 and 2011. Twenty-five had tumors with a >= 50% GGO component (GGO-dominant group) and the remaining had solid-dominant tumors (Solid-dominant group). The clinicopathological findings and prognosis of the two groups were evaluated. Results: The tumors in the GGO-dominant group rarely exhibited pathological invasiveness, such as lymphatic (n = 1), vascular (n = 0) and pleural invasion (n = 5) or lymph node metastasis (n = 0). On the other hand, the tumors in the solid-dominant group frequently exhibited pathological invasiveness, including lymphatic (n = 26), vascular (n = 16) and plural invasion (n = 52) and lymph node metastasis (n = 18). There were significant differences in all of the characteristics between the two groups (lymphatic; p = 0.0026, vascular; p = 0.0214, and pleural invasion; p = 0.0004, and lymph node metastases; p = 0.0086, respectively). In the GGO-dominant group, 24 patients were alive without recurrence, while the remaining died of another cancer. Recurrence occurred in 34 patients in the solid-dominant group, and 16 died of the disease. The 5-year survival rate was 96% in the GGO-dominant group, compared to 71% in the solid-dominant group (p = 0.0120). Conclusions: In the GGO-dominant group, the malignant potential was low and the patients had a favorable prognosis after surgery, similar to the patients with GGO-dominant tumors diagnosed as cT1a-bN0M0. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	Nagoya Univ, Grad Sch Med, Dept Thorac Surg, Nagoya, Aichi 4668550, Japan; Nagoya Univ, Grad Sch Med, Ctr Adv Med & Clin Res, Biostat & Bioinformat Sect, Nagoya, Aichi 4668550, Japan	Nakamura, S (reprint author), Nagoya Univ, Grad Sch Med, Dept Thorac Surg, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	shota197065@med.nagoya-u.ac.jp					ADLER B, 1992, AM J ROENTGENOL, V159, P275; Vazquez M, 2009, LUNG CANCER, V64, P148, DOI 10.1016/j.lungcan.2008.08.009; Matsuguma H, 2002, J THORAC CARDIOV SUR, V124, P278, DOI 10.1067/mtc.122298; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Aoki T, 2001, RADIOLOGY, V220, P803, DOI 10.1148/radiol.2203001701; Tsutani Y, 2012, J THORAC CARDIOV SUR, V143, P607, DOI 10.1016/j.jtcvs.2011.10.037; Watanabe S, 2002, ANN THORAC SURG, V73, P1071, DOI 10.1016/S0003-4975(01)03623-2; Henschke CI, 1999, LANCET, V354, P99, DOI 10.1016/S0140-6736(99)06093-6; Suzuki K, 2000, ANN THORAC SURG, V69, P893, DOI 10.1016/S0003-4975(99)01331-4; Sone S, 1998, LANCET, V351, P1242, DOI 10.1016/S0140-6736(97)08229-9; Kuriyama K, 1999, AM J ROENTGENOL, V173, P465; Asamura H, 2013, J THORAC CARDIOV SUR, V146, P24, DOI 10.1016/j.jtcvs.2012.12.047; NOGUCHI M, 1995, CANCER, V75, P2844, DOI 10.1002/1097-0142(19950615)75:12<2844::AID-CNCR2820751209>3.0.CO;2-#; Kaneko M, 1996, RADIOLOGY, V201, P798; Sakurai H, 2004, AM J SURG PATHOL, V28, P198, DOI 10.1097/00000478-200402000-00007; Maeyashiki T, 2013, EUR J CARDIO-THORAC, V43, P915, DOI 10.1093/ejcts/ezs516; Sakurai H, 2004, ANN THORAC SURG, V78, P1728, DOI 10.1016/j.athoracsur.2004.05.017; Kodama K, 2001, LUNG CANCER-J IASLC, V33, P17, DOI 10.1016/S0169-5002(01)00185-4; Matsuguma H, 2013, ANN THORAC SURG, V95, P1878, DOI 10.1016/j.athoracsur.2013.02.022; Nakamura S, 2013, J THORAC ONCOL, V8, P1551, DOI 10.1097/JTO.0000000000000020; Tsutani Y, 2014, CHEST, V145, P66, DOI 10.1378/chest.13-1094; Yamato Y, 2001, ANN THORAC SURG, V71, P971, DOI 10.1016/S0003-4975(00)02507-8	22	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0169-5002	1872-8332		LUNG CANCER	Lung Cancer	JUL	2015	89	1					38	42		10.1016/j.lungcan.2015.04.011		5	Oncology; Respiratory System	Oncology; Respiratory System	CK9FP	WOS:000356546300008		
J	Inoue, A; Sugawara, S; Maemondo, M; Mori, Y; Oizumi, S; Harada, M; Taima, K; Morikawa, N; Ishida, T; Kinoshita, I; Watanabe, H; Suzuki, T; Nakagawa, T; Saito, R; Nukiwa, T				Inoue, Akira; Sugawara, Shunichi; Maemondo, Makoto; Mori, Yoshiaki; Oizumi, Satoshi; Harada, Masao; Taima, Kageaki; Morikawa, Naoto; Ishida, Takashi; Kinoshita, Ichiro; Watanabe, Hiroshi; Suzuki, Toshiro; Nakagawa, Taku; Saito, Ryota; Nukiwa, Toshihiro			Randomized phase II trial comparing amrubicin with re-challenge of platinum doublet in patients with sensitive-relapsed small-cell lung cancer: North Japan Lung Cancer Study Group trial 0702	LUNG CANCER			English	Article							2ND-LINE TREATMENT; TOPOTECAN; CHEMOTHERAPY; CISPLATIN	Purpose: Amrubicin and re-challenge of platinum doublet are both effective treatments for sensitive-relapsed small-cell lung cancer (SCLC). However, no comparative study of these treatments has been reported. This randomized study was conducted to select the most suitable regimen for future evaluation. Patients and methods: SCLC patients who had relapsed more than 90 days after their first-line platinum-doublet regimen were randomized to receive amrubicin (40 mg/m(2), days 1-3) or re-challenge with platinum doublet. Primary endpoint was objective response rate (ORR), with secondary endpoints of progression-free survival (PFS), overall survival and toxicity profiles. We assumed that an ORR of 50% indicates potential usefulness, while that of 30% would constitute the lower limit of interest (alpha 0.1; beta 0.1). Initial estimated accrual was 28 patients to each arm. Results: From February 2008 to June 2013,60 patients were enrolled and 57 patients (27 amrubicin and 30 re-challenge) were found to be evaluable for efficacy and safety. The ORR and PFS were 67% (90% confidence interval, 52-82) and 5.4 months in the amrubicin group, and 43% (90% confidence interval, 28-58) and 5.1 months in the re-challenge group, respectively. Although grade 3 febrile neutropenia was observed in 19% of patients in the amrubicin group, these episodes were transient and manageable. Non-hematological toxicities were generally moderate and no treatment-related death was observed in either group. Conclusion: Only amrubicin met the primary endpoint. Moreover, amrubicin demonstrated superior efficacy over re-challenge of platinum with acceptable levels of toxicity. Further evaluation of amrubicin for sensitive-relapsed SCLC is warranted. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Inoue, Akira; Saito, Ryota; Nukiwa, Toshihiro] Tohoku Univ, Sch Med, Dept Palliat Med, Aoba Ku, Sendai, Miyagi 9808574, Japan; Sendai Kousei Hosp, Dept Pulm Med, Sendai, Miyagi, Japan; [Maemondo, Makoto] Miyagi Canc Ctr, Dept Resp Med, Natori, Miyagi 9811293, Japan; [Mori, Yoshiaki] Iwate Cent Prefectural Hosp, Dept Resp Med, Morioka, Iwate, Japan; [Oizumi, Satoshi] Hokkaido Univ, Sch Med, Dept Med 1, Sapporo, Hokkaido 060, Japan; [Harada, Masao] Hokkaido Canc Ctr, Dept Resp Med, Sapporo, Hokkaido, Japan; [Taima, Kageaki] Hirosaki Univ, Dept Resp Med, Hirosaki, Aomori, Japan; [Morikawa, Naoto] Iwate Med Univ, Sch Med, Dept Internal Med, Div Pulm Med Allergy & Rheumatol, Morioka, Iwate 020, Japan; [Ishida, Takashi] Fukushima Med Univ Hosp, Dept Pulm Med, Fukushima, Japan; [Kinoshita, Ichiro] Hokkaido Univ, Sch Med, Dept Med Oncol, Sapporo, Hokkaido 060, Japan; [Watanabe, Hiroshi] Saka Gen Hosp, Dept Resp Med, Shiogama, Japan; [Suzuki, Toshiro] Isawa Hosp, Dept Resp Med, Oshu, Japan; [Nakagawa, Taku] Omagari Kosei Med Ctr, Dept Thorac Surg, Daisen, Japan	Inoue, A (reprint author), Tohoku Univ, Sch Med, Dept Palliat Med, Aoba Ku, 1-1 Seiryocho, Sendai, Miyagi 9808574, Japan.	akinoue@idac.tohoku.ac.jp					Tiseo M, 2007, J THORAC ONCOL, V2, P764, DOI 10.1097/JTO.0b013e3180986262; Hanna N, 2006, J CLIN ONCOL, V24, P2038, DOI 10.1200/JCO.2005.04.8595; Govindan R, 2006, J CLIN ONCOL, V24, P4539, DOI 10.1200/JCO.2005.04.4859; Jotte R, 2011, J CLIN ONCOL, V29, P287, DOI 10.1200/JCO.2010.29.8851; Inoue A, 2008, J CLIN ONCOL, V26, P5401, DOI 10.1200/JCO.2008.18.1974; von Pawel J, 2014, J CLIN ONCOL, V32, P4012, DOI 10.1200/JCO.2013.54.5392; POSTMUS PE, 1987, EUR J CANCER CLIN ON, V23, P1409, DOI 10.1016/0277-5379(87)90128-3; GIACCONE G, 1987, EUR J CANCER CLIN ON, V23, P1697, DOI 10.1016/0277-5379(87)90452-4; Rossi A, 2012, J CLIN ONCOL, V30, P1692, DOI 10.1200/JCO.2011.40.4905; von Pawel J, 1999, J CLIN ONCOL, V17, P658; Onoda S, 2006, J CLIN ONCOL, V24, P5448, DOI 10.1200/JCO.2006.08.4145; Ardizzoni A, 2014, EUR J CANCER, V50, P2211, DOI 10.1016/j.ejca.2014.06.002; Ardizzoni A, 2003, CLIN CANCER RES, V9, P143; Kato T, 2006, P AM SOC CLIN ONCOL, V24; Kubota K, 1997, J CLIN ONCOL, V15, P292; Noda Kazumasa, 2002, New England Journal of Medicine, V346, P85, DOI 10.1056/NEJMoa003034; Yana T, 2007, INVEST NEW DRUG, V25, P253, DOI 10.1007/s10637-006-9012-9	17	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0169-5002	1872-8332		LUNG CANCER	Lung Cancer	JUL	2015	89	1					61	65		10.1016/j.lungcan.2015.04.012		5	Oncology; Respiratory System	Oncology; Respiratory System	CK9FP	WOS:000356546300012		
J	Tamura, T; Kurishima, K; Watanabe, H; Shiozawa, T; Nakazawa, K; Ishikawa, H; Satoh, H; Hizawa, N				Tamura, Tomohiro; Kurishima, Koichi; Watanabe, Hiroko; Shiozawa, Toshihiro; Nakazawa, Kensuke; Ishikawa, Hiroichi; Satoh, Hiroaki; Hizawa, Nobuyuki			Characteristics of clinical N0 metastatic non-small cell lung cancer	LUNG CANCER			English	Article						Non-small-cell lung cancer; Clinical NO; Metastasis; Survival; Metastatic site; Adrenal gland; Prognostic factor	POSITRON-EMISSION-TOMOGRAPHY; FORTHCOMING 7TH EDITION; MEDIASTINAL LYMPH-NODES; COMPUTED-TOMOGRAPHY; TNM CLASSIFICATION; ADRENAL METASTASES; PROGNOSTIC-FACTORS; STAGING PROJECT; METAANALYSIS; CARCINOMA	Objectives: Non-small cell lung cancer (NSCLC) patients who have clinically no mediastinal lymph node metastasis but have distant metastasis are occasionally found in clinical practice. Such clinical N0 metastatic NSCLC may be a different subtype from the clinical N1-3 patients with regional lymph node metastasis. The aim of this study was to evaluate the prognosis, clinical features, and incidence of clinical N0 NSCLC patients with metastasis. Methods: All metastatic NSCLC patients (n = 761) diagnosed at our hospitals from April 1999 to August 2012 were retrospectively analyzed. They were divided into two groups: N0 and N1-3. Staging was recorded according to the UICC 7th edition of the TNM classification. Differences between the two groups were analyzed using a Chi-square test. Prognostic factors were analyzed by the Kaplan-Meier method and Cox proportional hazards analysis. A probability value less than 0.05 was considered to be significant. Results: A total of 761 patients with NSCLC were registered. 124 patients (16.3%) were N0 and 637(83.7%) were N1-3. There were no differences between the two groups in age, sex, smoking history, performance status, and histological type. The ratio of adrenal gland metastasis was low in the N0 group (N0 73%, N1-3 13.4%, p = 0.002). Median survival time was longer in the N0 group (N0 11.9 months vs N1-3 7.2 months, p < 0.001). N0 was an independent favorable prognostic factor. Conclusion: Metastatic NSCLC patients with clinical N0 had a favorable prognosis and a lower ratio of adrenal gland metastasis than those with clinical N1-3. Our results suggest that a certain type of adrenal metastasis may result from direct lymphatic spread from a primary lung tumor. About one sixth of metastatic NSCLC cases are clinical N0. Therefore, clinical evaluations for detecting metastasis are important even in clinical N0 patients. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Tamura, Tomohiro; Watanabe, Hiroko; Shiozawa, Toshihiro; Nakazawa, Kensuke; Hizawa, Nobuyuki] Univ Tsukuba, Fac Med, Div Resp Med, Mito, Ibaraki 3100015, Japan; [Kurishima, Koichi; Ishikawa, Hiroichi] Tsukuba Med Ctr, Div Resp Med, Tsukuba, Ibaraki, Japan; [Satoh, Hiroaki] Univ Tsukuba, Mito Med Ctr, Div Resp Med, Mito, Ibaraki 3100015, Japan	Satoh, H (reprint author), Univ Tsukuba, Mito Med Ctr, Div Resp Med, Miya Machi 3-2-7, Mito, Ibaraki 3100015, Japan.	hirosato@md.tsukuba.ac.jp					Goldstraw P, 2007, J THORAC ONCOL, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Billing PS, 2001, J THORAC CARDIOV SUR, V122, P548, DOI 10.1067/mtc.2001.116201; Suzuki K, 2011, J THORAC ONCOL, V6, P751, DOI 10.1097/JTO.0b013e31821038ab; Rusch VW, 2007, J THORAC ONCOL, V2, P603, DOI 10.1097/JTO.0b013e31807ec803; DALES RE, 1990, AM REV RESPIR DIS, V141, P1096; KIYONO K, 1988, AM J ROENTGENOL, V150, P771; van Tinteren H, 2002, LANCET, V359, P1388, DOI 10.1016/S0140-6736(02)08352-6; Salah S, 2012, LUNG CANCER, V75, P9, DOI 10.1016/j.lungcan.2011.07.014; Mordant P, 2012, EUR J CARDIO-THORAC, V41, P617, DOI 10.1093/ejcts/ezr042; Gould MK, 2003, ANN INTERN MED, V139, P879; Matsuda A, 2014, JPN J CLIN ONCOL, V44, P388, DOI 10.1093/jjco/hyu003; Birim O, 2005, ANN THORAC SURG, V79, P375, DOI 10.1016/j.athoracsur.2004.06.041; Iwasaki A, 2004, EUR J CARDIO-THORAC, V26, P488, DOI 10.1016/j.ejcts.2004.05.049; Allemani C, 2015, LANCET, V385, P977, DOI 10.1016/S0140-6736(14)62038-9; Mitsudomi T, 2010, JPN J CLIN ONCOL, V40, P101, DOI 10.1093/jjco/hyp174; Little AG, 2007, LUNG CANCER, V57, P253, DOI 10.1016/j.lungcan.2007.03.012; MCLOUD TC, 1992, RADIOLOGY, V182, P319; GLAZER GM, 1985, AM J ROENTGENOL, V144, P261; Bille A, 2009, EUR J CARDIO-THORAC, V36, P440, DOI 10.1016/j.ejcts.2009.04.003; Ashworth AB, 2014, CLIN LUNG CANCER, V15, P346, DOI 10.1016/j.cllc.2014.04.003; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KAROLYI P, 1990, J SURG ONCOL, V43, P154, DOI 10.1002/jso.2930430306; Kocijancic I, 2003, EUR J SURG ONCOL, V29, P87, DOI 10.1053/ejso.2002.1372; Li CG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107276; Li CT, 2011, J CANCER, V2, P52, DOI 10.7150/jca.2.52; Merritt RE, 2013, ANN THORAC SURG, V96, P1171, DOI [10.1016/j.athoracsur.2013.05.044, 10.1016/j.athoracsur.2013.05.04]; MEYER KK, 1958, J THORAC SURG, V35, P726; Okamoto T, 2005, LUNG CANCER-J IASLC, V47, P85, DOI 10.1016/j.lungcan.2004.06.006; ONUIGBO WI, 1961, CANCER RES, V21, P1077; Paul NS, 2012, RADIOL CLIN N AM, V50, P935, DOI 10.1016/j.rcl.2012.06.007; Silvestri GA, 2007, CHEST, V132, p178S, DOI 10.1378/chest.07-1360; WARREN S, 1964, ARCH PATHOL, V78, P467; World Health Organizations, 1999, INT HISTOLOGICAL CLA, V3rd; Yatabe Y, 2015, J THORAC ONCOL, V10, P438, DOI 10.1097/JTO.0000000000000422	34	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0169-5002	1872-8332		LUNG CANCER	Lung Cancer	JUL	2015	89	1					71	75		10.1016/j.lungcan.2015.04.002		5	Oncology; Respiratory System	Oncology; Respiratory System	CK9FP	WOS:000356546300014		
J	Kanaya, G; Nakamura, Y; Koizumi, T; Yamada, K				Kanaya, Gen; Nakamura, Yasuo; Koizumi, Tomoyoshi; Yamada, Katsumasa			Seasonal changes in infaunal community structure in a hypertrophic brackish canal: Effects of hypoxia, sulfide, and predator-prey interaction	MARINE ENVIRONMENTAL RESEARCH			English	Article						Eutrophication; Oxygen depletion; Macrozoobenthos; Trophic interaction; Stable isotopes; Succession; Sulphide	ARMANDIA SP POLYCHAETA; STABLE-ISOTOPE RATIOS; INTERTIDAL SAND FLAT; ORGANIC ENRICHMENT; TOKYO BAY; BENTHIC MACROFAUNA; TEMPORAL-CHANGES; TIDAL FLAT; LONG-TERM; ESTUARINE	We conducted a one-year survey of macrozoobenthic community structure at 5 stations in a eutrophic canal in inner Tokyo Bay, focusing on the impacts of hypoxia, sediment H2S, and species interaction in the littoral soft-bottom habitats. Complete defaunation or decreasing density of less-tolerant taxa occurred under hypoxia during warmer months, especially at subtidal or sulfidic stations; this was followed by rapid recolonization by opportunistic polychaetes in fall-winter. Sedimentary H2S increased the mortality of macroinvertebrates under hypoxia or delayed population recovery during recolonization. The density of several polychaetes (e.g., Pseudopolydora reticulate) declined in winter, coincident with immigration of the predator Armandia lanceolate. This suggests that absence of A. lanceolate under moderate hypoxia enabled the proliferation of prey taxa. We conclude that oxygen concentration, sediment H2S, and hypoxia-induced changes in species interactions are potential drivers for spatio-temporal changes in macrozoobenthic assemblage structure in hypoxia-prone soft-bottom communities. (C) 2015 Elsevier Ltd. All rights reserved.	[Kanaya, Gen; Nakamura, Yasuo; Yamada, Katsumasa] Natl Inst Environm Studies, Tsukuba, Ibaraki 3058506, Japan; [Koizumi, Tomoyoshi] Nihon Mikuniya Corp, Takatsu Ku, Kawasaki, Kanagawa 2130001, Japan; [Yamada, Katsumasa] FRA, Seikai Natl Fisheries Res Inst, Nagasaki 8512213, Japan	Kanaya, G (reprint author), Natl Inst Environm Studies, 16-2 Onogawa, Tsukuba, Ibaraki 3058506, Japan.	gen@nies.go.jp					Ando H., 2009, LONG TERM CHANGES BO, P18; Ysebaert T, 2002, MAR ECOL PROG SER, V244, P105, DOI 10.3354/meps244105; Kodama K, 2010, ECOTOXICOLOGY, V19, P479, DOI 10.1007/s10646-009-0438-7; Sturdivant SK, 2013, MAR ECOL PROG SER, V490, P53, DOI 10.3354/meps10470; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Yokoyama H, 2005, MAR ECOL PROG SER, V296, P115, DOI 10.3354/meps296115; Gray JS, 2002, MAR ECOL PROG SER, V238, P249, DOI 10.3354/meps238249; Ritter C, 2005, J EXP MAR BIOL ECOL, V323, P57, DOI 10.1016/j.jembe.2005.02.018; Kanaya G, 2007, MAR ECOL PROG SER, V345, P117, DOI 10.3354/meps07025; Levin LA, 2001, ECOSYSTEMS, V4, P430, DOI 10.1007/s10021-001-0021-4; Aikins S, 2002, MAR ECOL PROG SER, V245, P171, DOI 10.3354/meps245171; Como S, 2009, ESTUAR COAST SHELF S, V83, P638, DOI 10.1016/j.ecss.2009.05.024; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; GRASSLE JF, 1974, J MAR RES, V32, P253; Van Colen C, 2010, MAR POLLUT BULL, V60, P178, DOI 10.1016/j.marpolbul.2009.09.028; Vaquer-Sunyer R, 2010, LIMNOL OCEANOGR, V55, P1075, DOI 10.4319/lo.2010.55.3.1075; Hargrave BT, 2008, MAR POLLUT BULL, V56, P810, DOI 10.1016/j.marpolbul.2008.02.006; Altieri AH, 2006, ECOLOGY, V87, P717, DOI 10.1890/05-0226; Kodama K, 2012, MAR ENVIRON RES, V76, P80, DOI 10.1016/j.marenvres.2011.08.007; Yokoyama H, 2005, MAR ECOL PROG SER, V304, P101, DOI 10.3354/meps304101; Ishii Mitsuhiro, 2008, Bulletin of the Japanese Society of Fisheries Oceanography, V72, P189; Van Colen C, 2008, MAR ECOL PROG SER, V372, P31, DOI 10.3354/meps07640; Beukema JJ, 1999, J SEA RES, V42, P235, DOI 10.1016/S1385-1101(99)00027-1; Cinar ME, 2012, J MAR BIOL ASSOC UK, V92, P1457, DOI 10.1017/S0025315412000264; Clarke K. R., 2006, PRIMER V6 USER MANUA; DAUER DM, 1984, B MAR SCI, V34, P170; Desroy N, 1998, J EXP MAR BIOL ECOL, V228, P257, DOI 10.1016/S0022-0981(98)00033-1; Endoh T., 2004, J GEOGR, V113, P785; Fauchald K., 1979, Oceanography and Marine Biology an Annual Review, V17, P193; Gamenick I, 1996, MAR ECOL PROG SER, V144, P73, DOI 10.3354/meps144073; Kanaya G, 2013, MAR POLLUT BULL, V71, P179, DOI 10.1016/j.marpolbul.2013.03.018; Kanaya G, 2011, ESTUAR COAST SHELF S, V92, P169, DOI 10.1016/j.ecss.2010.12.029; Kikuchi E, 2006, LIMNOLOGY, V7, P103, DOI 10.1007/s10201-006-0169-x; LLANSO RJ, 1991, J EXP MAR BIOL ECOL, V153, P165, DOI 10.1016/0022-0981(91)90223-J; Nakamura Y, 2009, J JAP SOC WATER ENV, V32, P549; Pearson T.H., 1978, Oceanography and Marine Biology an Annual Review, V16, P229; TAMAKI A, 1985, MAR ECOL PROG SER, V27, P123, DOI 10.3354/meps027123; TAMAKI A, 1985, J EXP MAR BIOL ECOL, V87, P67, DOI 10.1016/0022-0981(85)90193-5; Villnas A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044920; Yuhara Takeshi, 2013, Japanese Journal of Benthology, V68, P16	40	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0141-1136	1879-0291		MAR ENVIRON RES	Mar. Environ. Res.	JUL	2015	108						14	23		10.1016/j.marenvres.2015.04.006		10	Environmental Sciences; Marine & Freshwater Biology; Toxicology	Environmental Sciences & Ecology; Marine & Freshwater Biology; Toxicology	CK9FF	WOS:000356545300002		
J	Gotoh, K; Niwa, T; Anai, Y				Gotoh, Koji; Niwa, Toshio; Anai, Yosuke			Numerical simulation of fatigue crack propagation under biaxial tensile loadings with phase differences	MARINE STRUCTURES			English	Article						Fatigue; Fatigue crack growth; Biaxial fatigue; Phase difference; Strip yield mode; RPG stress criterion		Fatigue crack propagation under the biaxial tensile loading, which loading directions are normal and parallel to the initial crack position, is highlighted in this study. Most of in-service structures and vessels are subjected to many types of loading. Generally, these loadings have different axial components with different phases. However, the structural integrities of structures and vessels are evaluated according to design codes based on theoretical and experimental investigations under a uniaxial loading condition. Most of these codes are based on the S-N curves approach. An approach that does not use S-N curves has been favored by researchers, with the fracture mechanics approach preferred for evaluating the fatigue life of structures. An advanced fracture mechanics approach was developed based on the Re-tensile Plastic zone Generating (RPG) stress criterion for fatigue crack propagation. In this study, fatigue crack propagation tests under biaxial loading with six different phase and loading conditions are performed and the effect of the phase difference under biaxial loading is evaluated. A numerical simulation method of fatigue crack propagation based on the RPG stress criterion under different biaxial loading phase conditions is presented and compared to measured data. (C) 2015 Elsevier Ltd. All rights reserved.	[Gotoh, Koji] Kyushu Univ, Dept Marine Syst Engn, Nishi Ku, Fukuoka 8190395, Japan; [Niwa, Toshio] Natl Maritime Res Inst, Maintenance Res Technol Grp, Mitaka, Tokyo 1810004, Japan; [Anai, Yosuke] Natl Maritime Res Inst, Struct Anal & Proc Res Grp, Mitaka, Tokyo 1810004, Japan	Gotoh, K (reprint author), Kyushu Univ, Dept Marine Syst Engn, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.	gotoh@nams.kyushu-u.ac.jp			Japan Society for the Promotion of Science [21676007]	This research was funded by a Grant-in-Aid for Young Scientists (S) (No. 21676007) from the Japan Society for the Promotion of Science.	SONSINO CM, 1995, INT J FATIGUE, V17, P55, DOI 10.1016/0142-1123(95)93051-3; Toyosada M, 2004, INT J FATIGUE, V26, P993, DOI 10.1016/j.ijfatigue.2003.12.005; HOSHIDE T, 1981, FATIGUE ENG MATER, V4, P355, DOI 10.1111/j.1460-2695.1981.tb01132.x; [Anonymous], 2008, ASTME64708; Toyosada M, 2004, INT J FATIGUE, V26, P983, DOI 10.1016/j.ijfatigue.2003.12.006; Brown MW, 1985, ASTM STP, P135; Newman Jr JC, 1994, 104156 NASA; Newman Jr JC, 1981, 198181941 NASA; Tada H., 2000, STRESS ANAL CRACKS H; Takahashi I, 1999, FATIGUE FRACT ENG M, V22, P869, DOI 10.1046/j.1460-2695.1999.00224.x; Yuuki R, 1984, ZAIRYOU, V33, P1271; Yuuki R, 1988, ZAIR MAT SCI RES, V37, P1084	12	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0951-8339	1873-4170		MAR STRUCT	Mar. Struct.	JUL	2015	42						53	70		10.1016/j.marstruc.2015.03.003		18	Engineering, Marine; Engineering, Civil	Engineering	CK4NH	WOS:000356200000003		
J	Ariga, K; Ji, QM; Nakanishi, W; Hill, JP; Aono, M				Ariga, Katsuhiko; Ji, Qingmin; Nakanishi, Waka; Hill, Jonathan P.; Aono, Masakazu			Nanoarchitectonics: a new materials horizon for nanotechnology	MATERIALS HORIZONS			English	Review							25TH ANNIVERSARY ARTICLE; AMPHIPHILE NANOARCHITECTONICS; QUANTUM DOTS; NANOMATERIALS; MOLECULES; GRAPHENE; ASSEMBLIES; DESIGN; NANOCOMPOSITES; CONDUCTANCE	Nanoarchitectonics is introduced as a rising tide within current nanomaterials science. Physical phenomena operate quite differently at the nanoscale (compared to in the macroscopic and microscopic regimes) with behaviours of nanoscopic objects being strongly influenced by thermal/statistical fluctuations and mutual interactions between components. Nanoarchitectonic methods, and the materials that they produce, contrast strongly with those of conventional nanotechnology. In this review, to illustrate the potential of nanoarchitectonics for future technologies, examples of nanoarchitectonics are introduced which are categorized as (i) atomic or molecular manipulation as a route to leading nanotechnologies, (ii) materials creation in the realization of materials nanoarchitectonics, and (iii) advanced device materials.	[Ariga, Katsuhiko; Ji, Qingmin; Nakanishi, Waka; Hill, Jonathan P.; Aono, Masakazu] NIMS, World Premier Int Ctr Mat Nanoarchitecton WPI MAN, Tsukuba, Ibaraki 3050044, Japan	Ariga, K (reprint author), NIMS, World Premier Int Ctr Mat Nanoarchitecton WPI MAN, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan.	ARIGA.Katsuhiko@nims.go.jp; AONO.Masakazu@nims.go.jp	ARIGA, Katsuhiko/H-2695-2011		World Premier International Research Center Initiative (WPI Initiative), MEXT, Japan	This work was partly supported by World Premier International Research Center Initiative (WPI Initiative), MEXT, Japan.	Zeng SW, 2014, CHEM SOC REV, V43, P3426, DOI 10.1039/c3cs60479a; Hanggi P, 2009, REV MOD PHYS, V81, P387, DOI 10.1103/RevModPhys.81.387; Ji QM, 2010, ANGEW CHEM INT EDIT, V49, P9737, DOI 10.1002/anie.201004929; Ariga K, 2013, LANGMUIR, V29, P8459, DOI 10.1021/la4006423; Nakaya M, 2010, ADV MATER, V22, P1622, DOI 10.1002/adma.200902960; Okawa Y, 2011, J AM CHEM SOC, V133, P8227, DOI 10.1021/ja111673x; Heeger AJ, 2014, ADV MATER, V26, P10, DOI 10.1002/adma.201304373; Ramanathan M, 2013, PHYS CHEM CHEM PHYS, V15, P10580, DOI 10.1039/c3cp50620g; Magoga M, 1999, PHYS REV B, V59, P16011, DOI 10.1103/PhysRevB.59.16011; Avinash MB, 2014, NANOSCALE, V6, P13348, DOI 10.1039/c4nr04340e; Tappertzhofen S, 2013, ACS NANO, V7, P6396, DOI 10.1021/nn4026614; Howorka S, 2013, LANGMUIR, V29, P7344, DOI 10.1021/la3045785; Ji Q, 2008, J AM CHEM SOC, V130, P2376, DOI 10.1021/ja076139s; Ariga K, 2011, J NANOSCI NANOTECHNO, V11, P1, DOI 10.1166/jnn.2011.3839; Chen XQ, 2011, SCI TECHNOL ADV MAT, V12, DOI 10.1088/1468-6996/12/4/044604; Jariwala D, 2014, ACS NANO, V8, P1102, DOI 10.1021/nn500064s; Ohno T, 2011, NAT MATER, V10, P591, DOI [10.1038/nmat3054, 10.1038/NMAT3054]; Ariga K, 2013, CHEM SOC REV, V42, P6322, DOI 10.1039/c2cs35475f; Marconi UMB, 2008, PHYS REP, V461, P111, DOI 10.1016/j.physrep.2008.02.002; Jiang LL, 2014, NANOSCALE, V6, P1922, DOI 10.1039/c3nr04555b; Ariga K, 2014, NEW J CHEM, V38, P5149, DOI 10.1039/c4nj00864b; Aono M, 2011, SCI TECHNOL ADV MAT, V12, DOI 10.1088/1468-6996/12/4/040301; Zhang HL, 2013, NANO ENERGY, V2, P693, DOI 10.1016/j.nanoen.2013.08.004; Zerkoune L, 2014, NANOMATERIALS-BASEL, V4, P741, DOI 10.3390/nano4030741; Shrestha LK, 2013, CHEM-ASIAN J, V8, P1662, DOI 10.1002/asia.201300247; Crawford NF, 2014, COORDIN CHEM REV, V263, P13, DOI 10.1016/j.ccr.2013.07.023; Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232; Nakanishi W, 2014, NANO TODAY, V9, P378, DOI 10.1016/j.nantod.2014.05.002; Ariga K, 2014, CHEM LETT, V43, P36, DOI 10.1246/cl.130987; Ariga K, 2014, APL MATER, V2, DOI 10.1063/1.4868177; Lang XJ, 2014, CHEM SOC REV, V43, P473, DOI 10.1039/c3cs60188a; Ariga K, 2012, B CHEM SOC JPN, V85, P1, DOI 10.1246/bcsj.20110162; Ma RZ, 2014, ADV MATER, V26, P4173, DOI 10.1002/adma.201400054; Hasegawa T, 2012, ADV MATER, V24, P252, DOI 10.1002/adma.201102597; Maiti UN, 2014, ADV MATER, V26, P40, DOI 10.1002/adma.201303265; Ariga K, 2014, CHEM MATER, V26, P519, DOI 10.1021/cm401999f; Ariga K, 2012, ADV MATER, V24, P158, DOI 10.1002/adma.201102617; Wang DW, 2014, ENERG ENVIRON SCI, V7, P576, DOI 10.1039/c3ee43463j; Vazquez H, 2012, NAT NANOTECHNOL, V7, P663, DOI [10.1038/nnano.2012.147, 10.1038/NNANO.2012.147]; Ariga K, 2012, CHEM MATER, V24, P728, DOI 10.1021/cm202281m; Stephenson T, 2014, ENERG ENVIRON SCI, V7, P209, DOI 10.1039/c3ee42591f; Wang SH, 2014, ADV MATER, V26, P2818, DOI 10.1002/adma.201305303; Weiss PS, 2007, ACS NANO, V1, P1, DOI 10.1021/nn700131b; Ariga K, 2013, ADV MATER, V25, P6477, DOI 10.1002/adma.201302283; Ariga K., 2014, NPG ASIA MATER, V4, pe17; Avizienis AV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042772; Biju V, 2014, CHEM SOC REV, V43, P744, DOI 10.1039/c3cs60273g; Borges J, 2014, CHEM REV, V114, P8883, DOI 10.1021/cr400531v; Geng FX, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2641; Hecht S, 2003, ANGEW CHEM INT EDIT, V42, P24, DOI 10.1002/anie.200390045; Ishihara S, 2013, J AM CHEM SOC, V135, P18040, DOI 10.1021/ja4099752; Karagiannis P, 2014, CHEM REV, V114, P3318, DOI 10.1021/cr400344n; Kujawa P, 2013, LANGMUIR, V29, P7354, DOI 10.1021/la4014619; Li YF, 2015, CHEM SOC REV, V44, P103, DOI 10.1039/c4cs00215f; Lim SY, 2015, CHEM SOC REV, V44, P362, DOI 10.1039/c4cs00269e; Liu MJ, 2015, NATURE, V517, P68, DOI 10.1038/nature14060; Nakaya M, 2011, ACS NANO, V5, P7830, DOI [10.1021/nn201869g, 10.1021/nn2018699]; Neucheva OA, 2013, J PHYS CHEM C, V117, P26040, DOI 10.1021/jp407445u; Pandey AP, 2014, J NANOSCI NANOTECHNO, V14, P828, DOI 10.1166/jnn.2014.9014; Rajendran R, 2014, J MATER CHEM A, V2, P18480, DOI 10.1039/c4ta03996c; Wu WZ, 2014, NATURE, V514, P470, DOI 10.1038/nature13792; Zhao GJ, 2013, LANGMUIR, V29, P7411, DOI 10.1021/la303762a	62	7	7	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2051-6347	2051-6355		MATER HORIZ	Mater. Horizons	JUL	2015	2	4					406	413		10.1039/c5mh00012b		8	Chemistry, Multidisciplinary; Materials Science, Multidisciplinary	Chemistry; Materials Science	CL0EG	WOS:000356611500003		
J	Kazama, I				Kazama, Itsuro			Roles of lymphocyte Kv1.3-channels in gut mucosal immune system: Novel therapeutic implications for inflammatory bowel disease	MEDICAL HYPOTHESES			English	Article							K+-CHANNEL CURRENTS; GATED POTASSIUM CHANNEL; MURINE THYMOCYTES; DENDRITIC CELLS; KV1.3 BLOCKER; T-LYMPHOCYTES; COLITIS; PATHOGENESIS; INHIBITORS; GENETICS	In the gastrointestinal mucosal immune system, T-lymphocytes are activated to produce pro-inflammatory cytokines, and the over-activation of the lymphocytes is primarily responsible for the development of inflammatory bowel disease (IBD). Despite our understanding of the molecular involvement in the activation of lymphocytes, we know little about the physiological involvement. Circulating T-lymphocytes or those derived from thymus predominantly express delayed rectifier Kt-channels (kv1.3) in their plasma membranes and these channels play crucial roles in inducing the lymphocyte activation and proliferation. In the pathogenesis of chronic renal failure, these channels, which are overexpressed in proliferating lymphocytes within the kidneys, are responsible for the progression of the disease. Since the over-activation of cellular immunity is also involved in the pathogenesis of IBD, T-lymphocytes in the gastrointestinal mucosa could share the same stimulatory mechanisms with those in the inflamed kidneys. Therefore, we hypothesize here that T-lymphocytes in the gastrointestinal mucosa would also be stimulated by the activation of the Kv1.3-channels expressed in their plasma membranes, and that the overexpression of the channels would contribute to the development of IBD. Our hypothesis is unique because it sheds light for the first time on a physiological mechanism by which T-lymphocytes are activated in the gut mucosal immune system. It is also important because our idea could have novel therapeutic implications for IBD, in which the over-activation of the lymphocytes is responsible for the pathogenesis. (C) 2015 Elsevier Ltd. All rights reserved.	Tohoku Univ Grad Sch Med, Dept Physiol 1, Aoba Ku, Sendai, Miyagi, Japan	Kazama, I (reprint author), Tohoku Univ Grad Sch Med, Dept Physiol 1, Aoba Ku, Seiryo Cho, Sendai, Miyagi, Japan.	kazaitsu@med.tohoku.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology in Japan (MEXT KAKENHI) [25860155]	This work is supported by Grant-in-Aid for Young Scientists (B) (Grant Number: 25860155) from the Ministry of Education, Culture, Sports, Science, and Technology in Japan (MEXT KAKENHI) to IK	Di Sabatino A, 2009, J IMMUNOL, V183, P3454, DOI 10.4049/jimmunol.0802887; Di Sabatino A, 2007, GASTROENTEROLOGY, V133, P1175, DOI 10.1053/j.gastro.2007.08.018; LEWIS RS, 1995, ANNU REV IMMUNOL, V13, P623, DOI 10.1146/annurev.iy.13.040195.003203; Villalonga N, 2010, BIOCHEM PHARMACOL, V80, P858, DOI 10.1016/j.bcp.2010.05.012; Kazama I, 2013, IMMUNOPHARM IMMUNOT, V35, P28, DOI 10.3109/08923973.2012.723011; Kazama I, 2012, IMMUNOPHARM IMMUNOT, V34, P874, DOI 10.3109/08923973.2012.666249; Kazama I, 2012, J PHYSIOL SCI, V62, P267, DOI 10.1007/s12576-012-0195-x; Chassaing B, 2011, GASTROENTEROLOGY, V140, P1720, DOI 10.1053/j.gastro.2011.01.054; Cario E, 2010, INFLAMM BOWEL DIS, V16, P1583, DOI 10.1002/ibd.21282; Cahalan MD, 2001, J CLIN IMMUNOL, V21, P235, DOI 10.1023/A:1010958907271; Kazama I, 2014, PHARMACOL REP, V66, P712, DOI 10.1016/j.pharep.2014.03.002; Kalman K, 1998, J BIOL CHEM, V273, P32697, DOI 10.1074/jbc.273.49.32697; Coombes JL, 2008, NAT REV IMMUNOL, V8, P435, DOI 10.1038/nri2335; Mouhat S, 2006, MOL PHARMACOL, V69, P354, DOI 10.1124/mol.105.017210; Kazama I, 2013, PHARM BIOL, V51, P760, DOI 10.3109/13880209.2013.764539; Cho JH, 2008, NAT REV IMMUNOL, V8, P458, DOI 10.1038/nri2340; Hu L, 2007, J IMMUNOL, V179, P4563; Schmitz A, 2005, MOL PHARMACOL, V68, P1254, DOI 10.1124/mol.105.015669; DECOURSEY TE, 1984, NATURE, V307, P465, DOI 10.1038/307465a0; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; Jang SH, 2011, EUR J PHARMACOL, V651, P26, DOI 10.1016/j.ejphar.2010.10.066; Han S, 2008, J BIOL CHEM, V283, P19058, DOI 10.1074/jbc.M802054200; Schenk M, 2008, BEST PRACT RES CL GA, V22, P391, DOI 10.1016/j.bpg.2007.11.002; Brenna O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054543; CAHALAN MD, 1985, J PHYSIOL-LONDON, V358, P197; Chandy KG, 2001, TOXICON, V39, P1269, DOI 10.1016/S0041-0101(01)00120-9; Grgic I, 2009, TRANSPL P, V41, P2601, DOI 10.1016/j.transproceed.2009.06.025; Hamilton D, 2014, J PHYSIOL SCI, V64, P13, DOI 10.1007/s12576-013-0285-4; Heap GA, 2009, HUM MOL GENET, V18, pR101, DOI 10.1093/hmg/ddp001; Hyodo T, 2010, AM J PHYSIOL-RENAL, V299, pF1258, DOI 10.1152/ajprenal.00374.2010; Kazama I, 2014, J PHYSL SCI; Kazama I, 2012, INT J NEPHROL, V2012; Kazama I, 2014, NEPHRON EXP NEPHROL; Koch Hansen L, 2014, J CROHNS COLITIS; Moriyama I, 2008, LAB INVEST, V88, P652, DOI 10.1038/labinvest.2008.38; PRICE M, 1989, P NATL ACAD SCI USA, V86, P10171, DOI 10.1073/pnas.86.24.10171; Watanabe T, 2010, INT ARCH ALLERGY IMM, V151, P98, DOI 10.1159/000235999; Wershil BK, 2008, J ALLERGY CLIN IMMUN, V121, pS380, DOI 10.1016/j.jaci.2007.10.023	38	1	1	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0306-9877	1532-2777		MED HYPOTHESES	Med. Hypotheses	JUL	2015	85	1					61	63		10.1016/j.mehy.2015.03.023		3	Medicine, Research & Experimental	Research & Experimental Medicine	CK3JF	WOS:000356111700011		
J	Arthofer, W; Bertini, L; Caruso, C; Cicconardi, F; Delph, LF; Fields, PD; Ikeda, M; Minegishi, Y; Proietti, S; Ritthammer, H; Schlick-Steiner, BC; Steiner, FM; Wachter, GA; Wagner, HC; Weingartner, LA				Arthofer, Wolfgang; Bertini, Laura; Caruso, Carla; Cicconardi, Francesco; Delph, Lynda F.; Fields, Peter D.; Ikeda, Minoru; Minegishi, Yuki; Proietti, Silvia; Ritthammer, Heike; Schlick-Steiner, Birgit C.; Steiner, Florian M.; Wachter, Gregor A.; Wagner, Herbert C.; Weingartner, Laura A.		Genomic-Resources-Dev-Consortium	Genomic Resources Notes accepted 1 February 2015-31 March 2015	MOLECULAR ECOLOGY RESOURCES			English	Article								This article documents the public availability of (i) raw transcriptome sequence data, assembled contigs and BLAST hits of the Antarctic plant Colobanthus quitensis grown in two different climatic conditions, (ii) the draft genome sequence data (raw reads, assembled contigs and unassembled reads) and RAD-tag read data of the marbled flounder Pseudopleuronectes yokohamae, (iii) transcriptome resources from four white campion (Silene latifolia) individuals from two morphologically divergent populations and (iv) nuclear DNA markers from 454 sequencing of reduced representation libraries (RRL) based on amplified fragment length polymorphism (AFLP) PCR products of four species of ants in the genus Tetramorium.	[Genomic-Resources-Dev-Consortium] Mol Ecol Resources Editorial Off, Vancouver, BC V6T 1Z4, Canada; [Arthofer, Wolfgang; Cicconardi, Francesco; Ritthammer, Heike; Schlick-Steiner, Birgit C.; Steiner, Florian M.; Wachter, Gregor A.; Wagner, Herbert C.] Univ Innsbruk, Inst Ecol, Mol Ecol Grp, A-6020 Innsbruck, Austria; [Bertini, Laura; Caruso, Carla; Proietti, Silvia] Univ Tuscia, Dept Ecol & Biol Sci, I-01100 Viterbo, Italy; [Delph, Lynda F.; Weingartner, Laura A.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Fields, Peter D.] Univ Virginia, Dept Biol, Charlottesville, VA 22904 USA; [Fields, Peter D.] Univ Basel, Inst Zool, CH-4051 Basel, Switzerland; [Ikeda, Minoru; Minegishi, Yuki] Tohoku Univ, Grad Sch Agr Sci, Tohoku Ecosyst Associated Marine Sci, Oshika, Miyagi 9862242, Japan; [Proietti, Silvia] Univ Utrecht, Fac Sci, Dept Biol, Plant Microbe Interact, NL-3584 CH Utrecht, Netherlands	Arthofer, W (reprint author), Univ Innsbruk, Inst Ecol, Mol Ecol Grp, Technikerstr 25, A-6020 Innsbruck, Austria.							0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1755-098X	1755-0998		MOL ECOL RESOUR	Mol. Ecol. Resour.	JUL	2015	15	4					1014	1015		10.1111/1755-0998.12419		2	Biochemistry & Molecular Biology; Ecology; Evolutionary Biology	Biochemistry & Molecular Biology; Environmental Sciences & Ecology; Evolutionary Biology	CL1CJ	WOS:000356679800028		
J	Saez, C; Lehmer, BD; Bauer, FE; Stern, D; Gonzales, A; Rreza, I; Alexander, DM; Matsuda, Y; Geach, JE; Harrison, FA; Hayashino, T				Saez, C.; Lehmer, B. D.; Bauer, F. E.; Stern, D.; Gonzales, A.; Rreza, I.; Alexander, D. M.; Matsuda, Y.; Geach, J. E.; Harrison, F. A.; Hayashino, T.			An extragalactic spectroscopic survey of the SSA22 field	MONTHLY NOTICES OF THE ROYAL ASTRONOMICAL SOCIETY			English	Article						techniques: imaging spectroscopy; surveys; galaxies: active; galaxies: clusters: general; X-rays: galaxies	ACTIVE GALACTIC NUCLEI; VLT DEEP SURVEY; ABSORPTION-LINE QUASARS; LYMAN-BREAK GALAXIES; DIGITAL SKY SURVEY; LY-ALPHA BLOBS; REDSHIFT RADIO GALAXIES; STAR-FORMING GALAXIES; FAINT X-RAY; DIFFERENTIAL REFRACTION	We present Very Large Telescope VIMOS, Keck DEIMOS and Keck LRIS multi-object spectra of 367 sources in the field of the z a parts per thousand 3.09 protocluster SSA22. Sources are spectroscopically classified via template matching, allowing new identifications for 206 extragalactic sources, including 36 z > 2 Lyman-break galaxies (LBGs) and Lyman alpha emitters (LAEs), eight protocluster members, and 94 X-ray sources from the similar to 400 ks Chandra deep survey of SSA22. Additionally, in the area covered by our study, we have increased by a parts per thousand 4, 13, and 6 times the number of reliable redshifts of sources at 1.0 < z < 2.0, at z > 3.4, and with X-ray emission, respectively. We compare our results with past spectroscopic surveys of SSA22 to investigate the completeness of the LBGs and the X-ray properties of the new spectroscopically classified sources in the SSA22 field.	[Saez, C.] Univ Maryland, Dept Astron, College Pk, MD 20742 USA; [Lehmer, B. D.] Johns Hopkins Univ, Baltimore, MD 21218 USA; [Lehmer, B. D.] NASA Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Bauer, F. E.] Pontificia Univ Catolica Chile, Fac Fis, Inst Astrofis, Santiago 306 22, Chile; [Bauer, F. E.] Millennium Inst Astrophys, Santiago, Chile; [Bauer, F. E.] Space Sci Inst, Boulder, CO 80301 USA; [Stern, D.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Gonzales, A.] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; [Rreza, I.; Harrison, F. A.] CALTECH, Cahill Ctr Astrophys, Pasadena, CA 91125 USA; [Alexander, D. M.] Univ Durham, Dept Phys, Durham DH1 3LE, England; [Matsuda, Y.] Natl Astron Observ Japan, Mitaka, Tokyo 1818588, Japan; [Matsuda, Y.] Grad Univ Adv Studies SOKENDAI, Mitaka, Tokyo 1810015, Japan; [Geach, J. E.] Univ Hertfordshire, Sci Technol Res Inst, Ctr Astrophys Res, Hatfield AL10 9AB, Herts, England; [Hayashino, T.] Tohoku Univ, Inst Astron, Aoba Ku, Sendai, Miyagi 9808578, Japan	Saez, C (reprint author), Univ Maryland, Dept Astron, College Pk, MD 20742 USA.	csaez@astro.umd.edu			CONICYT-Chile [FONDECYT 3120198, Becas Chile 74140006, Anillo ACT1101, Basal-CATA PFB-06/2007, FONDECYT 1141218, Gemini-CONICYT 32120003, 'EMBIGGEN" Anillo ACT1101]; Millennium Institute of Astrophysics (MAS)' - Iniciativa Cientifica Milenio del Ministerio de Economia, Fomento y Turismo [IC120009]; NASA; ESO Telescopes at the Paranal Observatory [085.A-0616, 089.A-0405]; W.M. Keck Foundation	We would like to thank Ezequiel Treister and the anonymous referee for helpful discussions regarding the interpretations of our results. We would also like to thank Scott Chapman for providing radio images of the SSA22 field. CS acknowledges support from CONICYT-Chile (FONDECYT 3120198, Becas Chile 74140006, and the Anillo ACT1101). FEB acknowledges support from CONICYT-Chile (Basal-CATA PFB-06/2007, FONDECYT 1141218, Gemini-CONICYT 32120003, 'EMBIGGEN" Anillo ACT1101), and Project IC120009 'Millennium Institute of Astrophysics (MAS)' funded by the Iniciativa Cientifica Milenio del Ministerio de Economia, Fomento y Turismo. The work of DS was carried out at Jet Propulsion Laboratory, California Institute of Technology, under a contract with NASA. JEG thanks the Royal Society.; Based on observations made with ESO Telescopes at the Paranal Observatory under programme IDs 085.A-0616 and 089.A-0405. Some of the data presented herein were obtained at the W.M. Keck Observatory, which is operated as a scientific partnership among the California Institute of Technology, the University of California and the National Aeronautics and Space Administration. The Observatory was made possible by the generous financial support of the W.M. Keck Foundation. The authors wish to recognize and acknowledge the very significant cultural role and reverence that the summit of Mauna Kea has always had within the indigenous Hawaiian community. We are most fortunate to have the opportunity to conduct observations from this mountain.	Adelman-McCarthy JK, 2008, ASTROPHYS J SUPPL S, V175, P297, DOI 10.1086/524984; Akiyama M, 2000, ASTROPHYS J, V532, P700, DOI 10.1086/308606; Kraemer SB, 2000, ASTROPHYS J, V532, P256, DOI 10.1086/308572; Steffen AT, 2006, ASTRON J, V131, P2826, DOI 10.1086/503627; Marconi A, 2004, MON NOT R ASTRON SOC, V351, P169, DOI 10.1111/j.1365-2966.2004.07765.x; Hewett PC, 2006, MON NOT R ASTRON SOC, V367, P454, DOI 10.1111/j.1365-2966.2005.09969.x; Steidel CC, 2000, ASTROPHYS J, V532, P170, DOI 10.1086/308568; Gallagher SC, 2006, ASTROPHYS J, V644, P709, DOI 10.1086/503762; FRANCIS PJ, 1991, ASTROPHYS J, V373, P465, DOI 10.1086/170066; Stern D, 2005, ASTROPHYS J, V631, P163, DOI 10.1086/432523; Tamura Y, 2010, ASTROPHYS J, V724, P1270, DOI 10.1088/0004-637X/724/2/1270; Lehmer BD, 2009, ASTROPHYS J, V691, P687, DOI 10.1088/0004-637X/691/1/687; Ranalli P, 2003, ASTRON ASTROPHYS, V399, P39, DOI 10.1051/0004-6361:20021600; Stern D, 1999, ASTRON J, V117, P1122, DOI 10.1086/300770; Le Fevre O, 2005, ASTRON ASTROPHYS, V439, P845, DOI 10.1051/0004-6361:20041960; Faber SM, 2003, P SOC PHOTO-OPT INS, V4841, P1657, DOI 10.1117/12.460346; Tamura Y, 2009, NATURE, V459, P61, DOI 10.1038/nature07947; Alexander DM, 2001, ASTRON J, V122, P2156, DOI 10.1086/323540; Lehmer BD, 2009, MON NOT R ASTRON SOC, V400, P299, DOI 10.1111/j.1365-2966.2009.15449.x; Shapley AE, 2003, ASTROPHYS J, V588, P65, DOI 10.1086/373922; Kraemer SB, 1998, ASTROPHYS J, V508, P232, DOI 10.1086/306389; Matsuda Y, 2005, ASTROPHYS J, V634, pL125, DOI 10.1086/499071; Le Fevre O, 2005, ASTRON ASTROPHYS, V439, P877, DOI 10.1051/0004-6361:20041962; Webb TMA, 2009, ASTROPHYS J, V692, P1561, DOI 10.1088/0004-637X/692/2/1561; Page KL, 2005, MON NOT R ASTRON SOC, V364, P195, DOI 10.1111/j.1365-2966.2005.09550.x; White RL, 1997, ASTROPHYS J, V475, P479, DOI 10.1086/303564; Lawrence A, 2007, MON NOT R ASTRON SOC, V379, P1599, DOI 10.1111/j.1365-2966.2007.12040.x; Steidel CC, 2003, ASTROPHYS J, V592, P728, DOI 10.1086/375772; Barger AJ, 2005, ASTRON J, V129, P578, DOI 10.1086/426915; Masters D, 2011, PUBL ASTRON SOC PAC, V123, P638, DOI 10.1086/660023; Richards GT, 2006, ASTROPHYS J SUPPL S, V166, P470, DOI 10.1086/506525; Gibson RR, 2009, ASTROPHYS J, V692, P758, DOI 10.1088/0004-637X/692/1/758; Matsuda Y, 2004, ASTRON J, V128, P569, DOI 10.1086/422020; Martini P, 2009, ASTROPHYS J, V701, P66, DOI 10.1088/0004-637X/701/1/66; Bielby R, 2013, MON NOT R ASTRON SOC, V430, P425, DOI 10.1093/mnras/sts639; OKE JB, 1995, PUBL ASTRON SOC PAC, V107, P375, DOI 10.1086/133562; MACCACARO T, 1988, ASTROPHYS J, V326, P680, DOI 10.1086/166127; Geach JE, 2005, MON NOT R ASTRON SOC, V363, P1398, DOI 10.1111/j.1365-2966.2005.09538.x; Bauer FE, 2004, ASTRON J, V128, P2048, DOI 10.1086/424859; Bauer FE, 2002, ASTRON J, V124, P2351, DOI 10.1086/343778; Cassata P, 2015, ASTRON ASTROPHYS, V573, DOI [10.1051/0004-6361/201423824, 10.1051/0004-6361/20143824]; Le Fevre O, 2013, ASTRON ASTROPHYS, V559, DOI 10.1051/0004-6361/201322179; Cassata P, 2011, ASTRON ASTROPHYS, V525, DOI 10.1051/0004-6361/201014410; Chapman SC, 2003, ASTROPHYS J, V585, P57, DOI 10.1086/345980; Chapman SC, 2004, ASTROPHYS J, V606, P85, DOI 10.1086/382778; Chapman SC, 2001, ASTROPHYS J, V548, pL17, DOI 10.1086/318919; Cooper M. C., 2012, SPEC2D DEEP2 DEIMOS; Digby-North JA, 2010, MON NOT R ASTRON SOC, V407, P846, DOI 10.1111/j.1365-2966.2010.16977.x; FILIPPENKO AV, 1982, PUBL ASTRON SOC PAC, V94, P715, DOI 10.1086/131052; Garilli B, 2008, ASTRON ASTROPHYS, V486, P683, DOI 10.1051/0004-6361:20078878; Governato F, 1998, NATURE, V392, P359; Hayashino T, 2004, ASTRON J, V128, P2073, DOI 10.1086/424935; Kubo M, 2013, ASTROPHYS J, V778, DOI 10.1088/0004-637X/778/2/170; Le Fevre O., 2003, SPIE, V4841, P1670; Lehmer BD, 2012, ASTROPHYS J, V752, DOI 10.1088/0004-637X/752/1/46; Lehmer BD, 2013, ASTROPHYS J, V765, DOI 10.1088/0004-637X/765/2/87; Martini P, 2013, ASTROPHYS J, V768, DOI 10.1088/0004-637X/768/1/1; Matsuda Y, 2011, MON NOT R ASTRON SOC, V410, pL13, DOI 10.1111/j.1745-3933.2010.00969.x; MCCARTHY PJ, 1993, ANNU REV ASTRON ASTR, V31, P639; Mineo S, 2014, MON NOT R ASTRON SOC, V437, P1698, DOI 10.1093/mnras/stt1999; Nestor DB, 2011, ASTROPHYS J, V736, DOI 10.1088/0004-637X/736/1/18; Newman JA, 2013, ASTROPHYS J SUPPL S, V208, DOI 10.1088/0067-0049/208/1/5; Pickles AJ, 1998, PUBL ASTRON SOC PAC, V110, P863, DOI 10.1086/316197; Saez C, 2012, ASTROPHYS J, V759, DOI 10.1088/0004-637X/759/1/42; Sanchez-Janssen R, 2014, ASTRON ASTROPHYS, V566, DOI 10.1051/0004-6361/201423459; Scodeggio M, 2005, PUBL ASTRON SOC PAC, V117, P1284, DOI 10.1086/496937; Steidel CC, 1998, ASTROPHYS J, V492, P428, DOI 10.1086/305073; Stern D, 2000, ASTROPHYS J, V537, P73, DOI 10.1086/309001; Szokoly GP, 2005, ASTRON ASTROPHYS, V443, P703, DOI 10.1051/0004-6361:20042565; Tamura Y, 2013, MON NOT R ASTRON SOC, V430, P2768, DOI 10.1093/mnras/stt077; Uchimoto YK, 2012, ASTROPHYS J, V750, DOI 10.1088/0004-637X/750/2/116; Vanden Berk DE, 2001, ASTRON J, V122, P549, DOI 10.1086/321167; Yamada T, 2012, ASTROPHYS J, V751, DOI 10.1088/0004-637X/751/1/29	73	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-8711	1365-2966		MON NOT R ASTRON SOC	Mon. Not. Roy. Astron. Soc.	JUL 1	2015	450	3					2615	2630		10.1093/mnras/stv747		16	Astronomy & Astrophysics	Astronomy & Astrophysics	CK6LJ	WOS:000356339300029		
J	Mazzali, PA; Sullivan, M; Filippenko, AV; Garnavich, PM; Clubb, KI; Maguire, K; Pan, YC; Shappee, B; Silverman, JM; Benetti, S; Hachinger, S; Nomoto, K; Pian, E				Mazzali, P. A.; Sullivan, M.; Filippenko, A. V.; Garnavich, P. M.; Clubb, K. I.; Maguire, K.; Pan, Y. -C.; Shappee, B.; Silverman, J. M.; Benetti, S.; Hachinger, S.; Nomoto, K.; Pian, E.			Nebular spectra and abundance tomography of the Type Ia supernova SN 2011fe: a normal SN Ia with a stable Fe core	MONTHLY NOTICES OF THE ROYAL ASTRONOMICAL SOCIETY			English	Article						radiative transfer; techniques: spectroscopic; supernovae: general; superno-vae: individual: (SN 2011fe)	CHANDRASEKHAR-MASS MODELS; HIGH-RESOLUTION SPECTROSCOPY; LIGHT CURVES; DELAYED-DETONATION; WHITE-DWARFS; ASYMMETRIC EXPLOSION; CIRCUMSTELLAR MEDIUM; INFRARED-EMISSION; PROGENITOR SYSTEM; SYNTHETIC SPECTRA	A series of optical and one near-infrared nebular spectra covering the first year of the Type Ia supernova SN 2011fe are presented and modelled. The density profile that proved best for the early optical/ultraviolet spectra, 'rho-11fe', was extended to lower velocities to include the regions that emit at nebular epochs. Model rho-11fe is intermediate between the fast deflagration model W7 and a low-energy delayed-detonation. Good fits to the nebular spectra are obtained if the innermost ejecta are dominated by neutron-rich, stable Fe-group species, which contribute to cooling but not to heating. The correct thermal balance can thus be reached for the strongest [Fe ii] and [Fe iii] lines to be reproduced with the observed ratio. The Ni-56 mass thus obtained is similar to 0.47 +/- A 0.05 M-aS (TM). The bulk of Ni-56 has an outermost velocity of similar to 8500 km s(-1). The mass of stable iron is similar to 0.23 +/- A 0.03 M-aS (TM). Stable Ni has low abundance, similar to 10(-2) M-aS (TM). This is sufficient to reproduce an observed emission line near 7400 angstrom. A sub-Chandrasekhar explosion model with mass 1.02 M-aS (TM) and no central stable Fe does not reproduce the observed line ratios. A mock model where neutron-rich Fe-group species are located above Ni-56 following recent suggestions is also shown to yield spectra that are less compatible with the observations. The densities and abundances in the inner layers obtained from the nebular analysis, combined with those of the outer layers previously obtained, are used to compute a synthetic bolometric light curve, which compares favourably with the light curve of SN 2011fe.	[Mazzali, P. A.] Liverpool John Moores Univ, Astrophys Res Inst, Liverpool L3 5RF, Merseyside, England; [Mazzali, P. A.] Max Planck Inst Astrophys, D-85748 Garching, Germany; [Sullivan, M.] Univ Southampton, Sch Phys & Astron, Southampton SO17 1BJ, Hants, England; [Filippenko, A. V.; Clubb, K. I.] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; [Garnavich, P. M.] Univ Notre Dame, Dept Phys, Notre Dame, IN 46556 USA; [Maguire, K.] ESO, D-85748 Garching, Germany; [Pan, Y. -C.] Univ Illinois, Dept Astron, Urbana, IL 61801 USA; [Shappee, B.] Carnegie Observ, Pasadena, CA 91101 USA; [Silverman, J. M.] Univ Texas Austin, Dept Astron, Austin, TX 78712 USA; [Benetti, S.] Ist Nazl Astrofis OAPd, I-35122 Padua, Italy; [Hachinger, S.] Univ Wurzburg, Inst Math, D-97074 Wurzburg, Germany; [Hachinger, S.] Univ Wurzburg, Inst Theoret Phys & Astrophys, D-97074 Wurzburg, Germany; [Nomoto, K.] Univ Tokyo, Kavli IPMU, Kashiwa, Chiba 2778583, Japan; [Pian, E.] Inst Space Astrophys & Cosm Phys, I-40129 Bologna, Italy; [Pian, E.] Scuola Normale Super Pisa, I-56126 Pisa, Italy	Mazzali, PA (reprint author), Liverpool John Moores Univ, Astrophys Res Inst, IC2 Liverpool Sci Pk,146 Brownlow Hill, Liverpool L3 5RF, Merseyside, England.	P.Mazzali@ljmu.ac.uk		Benetti, Stefano/0000-0002-3256-0016; Pian, Elena/0000-0001-8646-4858	Royal Society; EU/FP7-ERC [615929]; Richard & Rhoda Goldman Fund; Christopher R. Redlich Fund; TABASGO Foundation; NSF [AST-1211916]; German Ministry of Education and Research (BMBF) via a Minerva ARCHES award; NASA through Hubble Fellowship - Space Telescope Science Institute [HF-51348.001]; NASA [NAS 5-26555]; NSF Astronomy and Astrophysics Postdoctoral Fellowship [AST-1302771]; PRIN-INAF; project 'Transient Universe: unveiling new types of stellar explosions with PESSTO'	We would like to thank S. Bradley Cenko, Isaac Shivvers, Ori Fox, Pat Kelly, and Daniel Cohen for assistance with the observations. MS acknowledges support from the Royal Society and EU/FP7-ERC grant number [615929]. AVF is grateful for support from the Richard & Rhoda Goldman Fund, the Christopher R. Redlich Fund, the TABASGO Foundation, and NSF grant AST-1211916. SH is supported by the German Ministry of Education and Research (BMBF) via a Minerva ARCHES award. BS is a Hubble, Carnegie-Princeton Fellow, and supported by NASA through Hubble Fellowship grant HF-51348.001, awarded by the Space Telescope Science Institute, which is operated by the Association of Universities for Research in Astronomy, Inc., for NASA, under contract NAS 5-26555. JMS is supported by an NSF Astronomy and Astrophysics Postdoctoral Fellowship under award AST-1302771. SB is partially supported by the PRIN-INAF 2014 with the project 'Transient Universe: unveiling new types of stellar explosions with PESSTO'. The William Herschel Telescope is operated on the island of La Palma by the Isaac Newton Group in the Spanish Observatorio del Roque de los Muchachos of the Instituto de Astrofisica de Canarias; we are grateful to the staff there, as well as at Lick Observatory, for their excellent assistance.	Kerzendorf WE, 2009, ASTROPHYS J, V701, P1665, DOI 10.1088/0004-637X/701/2/1665; WADE RA, 1988, ASTROPHYS J, V324, P411, DOI 10.1086/165905; Iwamoto K, 1999, ASTROPHYS J SUPPL S, V125, P439, DOI 10.1086/313278; Seitenzahl IR, 2013, MON NOT R ASTRON SOC, V429, P1156, DOI 10.1093/mnras/sts402; Motohara K, 2006, ASTROPHYS J, V652, pL101, DOI 10.1086/509919; Gerardy CL, 2007, ASTROPHYS J, V661, P995, DOI 10.1086/516728; Tsvetkov DY, 2013, CONTRIB ASTRON OBS S, V43, P94; Mazzali PA, 2008, MON NOT R ASTRON SOC, V386, P1897, DOI 10.1111/j.1365-2966.2008.13199.x; Mazzali PA, 2007, ASTROPHYS J, V661, P892, DOI 10.1086/517912; Maeda K, 2006, ASTROPHYS J, V640, P854, DOI 10.1086/500187; Woosley SE, 2007, ASTROPHYS J, V662, P487, DOI 10.1086/513732; Kasen D, 2007, ASTROPHYS J, V656, P661, DOI 10.1086/510375; Schlegel DJ, 1998, ASTROPHYS J, V500, P525, DOI 10.1086/305772; Leloudas G, 2009, ASTRON ASTROPHYS, V505, P265, DOI 10.1051/0004-6361/200912364; Stehle M, 2005, MON NOT R ASTRON SOC, V360, P1231, DOI 10.1111/j.1365-2966.2005.09116.x; Hamuy M, 2003, NATURE, V424, P651, DOI 10.1038/nature01854; Benetti S, 2005, ASTROPHYS J, V623, P1011, DOI 10.1086/428608; Ruiz-Lapuente P, 2004, NATURE, V431, P1069, DOI 10.1038/nature03006; Matheson T, 2000, ASTRON J, V120, P1499, DOI 10.1086/301519; Sasdelli M, 2014, MON NOT R ASTRON SOC, V445, P711, DOI 10.1093/mnras/stu1777; Cappellaro E, 1997, ASTRON ASTROPHYS, V328, P203; Mazzali PA, 2014, MON NOT R ASTRON SOC, V439, P1959, DOI 10.1093/mnras/stu077; Marietta E, 2000, ASTROPHYS J SUPPL S, V128, P615, DOI 10.1086/313392; Munari U, 2013, NEW ASTRON, V20, P30, DOI 10.1016/j.newast.2012.09.003; Li WD, 2011, NATURE, V480, P348, DOI 10.1038/nature10646; Dilday B, 2012, SCIENCE, V337, P942, DOI 10.1126/science.1219164; Seifert W, 2003, P SOC PHOTO-OPT INS, V4841, P962, DOI 10.1117/12.459494; Mazzali PA, 2007, SCIENCE, V315, P825, DOI 10.1126/science.1136259; SHIGEYAMA T, 1992, ASTROPHYS J, V386, pL13, DOI 10.1086/186281; LIVNE E, 1995, ASTROPHYS J, V452, P62, DOI 10.1086/176279; Maeda K, 2010, NATURE, V466, P82, DOI 10.1038/nature09122; Silverman JM, 2012, MON NOT R ASTRON SOC, V425, P1789, DOI 10.1111/j.1365-2966.2012.21270.x; Nugent PE, 2011, NATURE, V480, P344, DOI 10.1038/nature10644; Johansson J, 2013, MON NOT R ASTRON SOC, V431, pL43, DOI 10.1093/mnrasl/slt005; Gamezo VN, 2005, ASTROPHYS J, V623, P337, DOI 10.1086/428767; Axelrod T. S., 1980, THESIS U CALIFORNIA; Bloom JS, 2012, ASTROPHYS J LETT, V744, DOI 10.1088/2041-8205/744/2/L17; Brown PJ, 2012, ASTROPHYS J, V753, DOI 10.1088/0004-637X/753/1/22; Chomiuk L, 2012, ASTROPHYS J, V750, DOI 10.1088/0004-637X/750/2/164; Deng J, 2004, ASTROPHYS J, V605, pL37, DOI 10.1086/420698; Ellis R. S, 2008, APJ, V674, P52; FILIPPENKO AV, 1982, PUBL ASTRON SOC PAC, V94, P715, DOI 10.1086/131052; Fink M, 2010, ASTRON ASTROPHYS, V514, DOI 10.1051/0004-6361/200913892; Folatelli G, 2012, ASTROPHYS J, V745, DOI 10.1088/0004-637X/745/1/74; Foley RJ, 2013, ASTROPHYS J LETT, V769, DOI 10.1088/2041-8205/769/1/L1; Horesh A, 2012, ASTROPHYS J, V746, DOI 10.1088/0004-637X/746/1/21; Isern J, 2013, ASTRON ASTROPHYS, V552, DOI 10.1051/0004-6361/201220303; Kasen D, 2010, ASTROPHYS J, V708, P1025, DOI 10.1088/0004-637X/708/2/1025; KHOKHLOV A, 1993, ASTRON ASTROPHYS, V270, P223; Kushnir D, 2013, ASTROPHYS J LETT, V778, DOI 10.1088/2041-8205/778/2/L37; Margutti R, 2012, ASTROPHYS J, V751, DOI 10.1088/0004-637X/751/2/134; Matheson T, 2012, ASTROPHYS J, V754, DOI 10.1088/0004-637X/754/1/19; Mazzali P. A., 1993, Astronomy and Astrophysics, V269; Mazzali PA, 2011, MON NOT R ASTRON SOC, V416, P881, DOI 10.1111/j.1365-2966.2011.19000.x; Mazzali PA, 2001, ASTROPHYS J, V547, P988, DOI 10.1086/318428; Mazzali PA, 2012, MON NOT R ASTRON SOC, V424, P2926, DOI 10.1111/j.1365-2966.2012.21433.x; Mazzali PA, 1998, ASTROPHYS J, V499, pL49, DOI 10.1086/311345; McClelland CM, 2013, ASTROPHYS J, V767, DOI 10.1088/0004-637X/767/2/119; Miller J. S., 1993, 66 LICK OBS; Nugent P, 1997, ASTROPHYS J, V485, P812, DOI 10.1086/304459; Pakmor R, 2011, ASTRON ASTROPHYS, V528, DOI 10.1051/0004-6361/201015653; Parrent JT, 2012, ASTROPHYS J LETT, V752, DOI 10.1088/2041-8205/752/2/L26; Patat F, 2013, ASTRON ASTROPHYS, V549, DOI 10.1051/0004-6361/201118556; Pauldrach AWA, 1996, ASTRON ASTROPHYS, V312, P525; Pereira R, 2013, ASTRON ASTROPHYS, V554, DOI 10.1051/0004-6361/201221008; PHILLIPS MM, 1993, ASTROPHYS J, V413, pL105, DOI 10.1086/186970; Pinto PA, 2000, ASTROPHYS J, V530, P757, DOI 10.1086/308380; Piro AL, 2013, ASTROPHYS J, V769, DOI 10.1088/0004-637X/769/1/67; Pogge RW, 2012, PROC SPIE, V8446, DOI 10.1117/12.925693; Richmond Michael W., 2012, Journal of the American Association of Variable Star Observers, V40; Ropke FK, 2012, ASTROPHYS J LETT, V750, DOI 10.1088/2041-8205/750/1/L19; Rosswog S, 2009, ASTROPHYS J LETT, V705, pL128, DOI 10.1088/0004-637X/705/2/L128; Shappee BJ, 2013, ASTROPHYS J LETT, V762, DOI 10.1088/2041-8205/762/1/L5; Shappee BJ, 2011, ASTROPHYS J, V733, DOI 10.1088/0004-637X/733/2/124; Silverman JM, 2013, ASTROPHYS J SUPPL S, V207, DOI 10.1088/0067-0049/207/1/3; Tanaka M, 2011, MON NOT R ASTRON SOC, V410, P1725, DOI 10.1111/j.1365-2966.2010.17556.x; Thompson TA, 2011, ASTROPHYS J, V741, DOI 10.1088/0004-637X/741/2/82; Woosley SE, 2011, ASTROPHYS J, V734, DOI 10.1088/0004-637X/734/1/38	78	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-8711	1365-2966		MON NOT R ASTRON SOC	Mon. Not. Roy. Astron. Soc.	JUL 1	2015	450	3					2631	2643		10.1093/mnras/stv761		13	Astronomy & Astrophysics	Astronomy & Astrophysics	CK6LJ	WOS:000356339300030		
J	Guglielmo, V; Poggianti, BM; Moretti, A; Fritz, J; Calvi, R; Vulcani, B; Fasano, G; Paccagnella, A				Guglielmo, Valentina; Poggianti, Bianca M.; Moretti, Alessia; Fritz, Jacopo; Calvi, Rosa; Vulcani, Benedetta; Fasano, Giovanni; Paccagnella, Angela			The star formation history of galaxies: the role of galaxy mass, morphology and environment	MONTHLY NOTICES OF THE ROYAL ASTRONOMICAL SOCIETY			English	Article						galaxies: clusters: general; galaxies: evolution; galaxies: formation; galaxies: star formation	DIGITAL SKY SURVEY; SIMILAR-TO 1; RESOLUTION GALACTIC SPECTRA; BRIGHTEST CLUSTER SAMPLE; COLOR-DENSITY RELATION; MAXIMUM A-POSTERIORI; STELLAR MASS; FORMING GALAXIES; LUMINOSITY FUNCTION; REDSHIFT SURVEY	We analyse the star formation history (SFH) of galaxies as a function of present-day environment, galaxy stellar mass and morphology. The SFH is derived by means of a non-parametric spectrophotometric model applied to individual galaxies at z similar to 0.04-0.1 in the WIde-field Nearby Galaxy-cluster Survey (WINGS) clusters and the Padova Millennium Galaxy and Group Catalogue (PM2GC) field. The field reconstructed evolution of the star formation rate density (SFRD) follows the values observed at each redshift, except at z > 2, where our estimate is similar to 1.7 x higher than the high-z observed value. The slope of the SFRD decline with time gets progressively steeper going from low-mass to high-mass haloes. The decrease of the SFRD since z = 2 is due to (1) quenching - 50 per cent of the SFRD in the field and 75 per cent in clusters at z > 2 originated in galaxies that are passive today - and (2) the fact that the average SFR of today's star-forming galaxies has decreased with time. We quantify the contribution to the SFRD(z) of galaxies of today's different masses and morphologies. The current morphology correlates with the current star formation activity but is irrelevant for the past stellar history. The average SFH depends on galaxy mass, but galaxies of a given mass have different histories depending on their environment. We conclude that the variation of the SFRD(z) with environment is not driven by different distributions of galaxy masses and morphologies in clusters and field, and must be due to an accelerated formation in high-mass haloes compared to low-mass ones even for galaxies that will end up having the same galaxy mass today.	[Guglielmo, Valentina; Poggianti, Bianca M.; Moretti, Alessia; Fasano, Giovanni] Astron Observ Padova, INAF, I-35122 Padua, Italy; [Guglielmo, Valentina; Moretti, Alessia; Paccagnella, Angela] Univ Padua, Dept Phys & Astron, I-35122 Padua, Italy; [Fritz, Jacopo] Univ Ghent, Sterrenkundig Observat Vakgroep Fys Sterrenkunde, B-S99000 Ghent, Belgium; [Fritz, Jacopo] UNAM, CRyA, Ctr Radioastron & Astrofis, Michoacan 58089, Mexico; [Calvi, Rosa] Univ La Laguna, Dept Astrofis, Inst Astrofis Canarias, E-38200 San Cristobal la Laguna, Spain; [Vulcani, Benedetta] Univ Tokyo, UTIAS, Kavli Inst Phys & Math Universe WPI, Kashiwa, Chiba 2778582, Japan	Guglielmo, V (reprint author), Astron Observ Padova, INAF, I-35122 Padua, Italy.	valentina.guglielmo@oapd.inaf.it		Fasano, Giovanni/0000-0002-5660-1054; Moretti, Alessia/0000-0002-1688-482X	Istituto Nazionale di Astrofisica; World Premier International Research Center Initiative (WPI), MEXT, Japan; Kakenhi from the Japan Society for the Promotion of Science (JSPS) [26870140]	We acknowledge the anonymous referee for her/his careful report, important suggestions and comments which helped us improving our work. We thank Joe Liske, Simon Driver and the whole MGC team for making easily accessible a great data set. We are grateful to the rest of the WINGS team for help and useful discussions. VG and BMP acknowledge financial support from the Istituto Nazionale di Astrofisica through a PhD Cycle 30th grant. BV was supported by the World Premier International Research Center Initiative (WPI), MEXT, Japan and by the Kakenhi Grant-in-Aid for Young Scientists (B)(26870140) from the Japan Society for the Promotion of Science (JSPS).	Abramson L. E., 2014, APJ, V801, pL12; SALPETER EE, 1955, ASTROPHYS J, V121, P161, DOI 10.1086/145971; Madau P, 2014, ANNU REV ASTRON ASTR, V52, P415, DOI 10.1146/annurev-astro-081811-125615; Noeske KG, 2007, ASTROPHYS J, V660, pL43, DOI 10.1086/517926; Cappellari M, 2012, NATURE, V484, P485, DOI 10.1038/nature10972; Franx M, 2008, ASTROPHYS J, V688, P770, DOI 10.1086/592431; Omand CMB, 2014, MON NOT R ASTRON SOC, V440, P843, DOI 10.1093/mnras/stu331; Daddi E, 2007, ASTROPHYS J, V670, P156, DOI 10.1086/521818; Sanchez-Blazquez P, 2006, MON NOT R ASTRON SOC, V371, P703, DOI 10.1111/j.1365-2966.2006.10699.x; Sobral D, 2011, MON NOT R ASTRON SOC, V411, P675, DOI 10.1111/j.1365-2966.2010.17707.x; Mcgee SL, 2011, MON NOT R ASTRON SOC, V413, P996, DOI 10.1111/j.1365-2966.2010.18189.x; Wyder TK, 2005, ASTROPHYS J, V619, pL15, DOI 10.1086/424735; Koleva M, 2009, ASTRON ASTROPHYS, V501, P1269, DOI 10.1051/0004-6361/200811467; Calvi R, 2011, MON NOT R ASTRON SOC, V416, P727, DOI 10.1111/j.1365-2966.2011.19088.x; MacArthur LA, 2009, MON NOT R ASTRON SOC, V395, P28, DOI 10.1111/j.1365-2966.2009.14519.x; Lilly SJ, 1996, ASTROPHYS J, V460, pL1, DOI 10.1086/309975; Sobral D, 2013, MON NOT R ASTRON SOC, V428, P1128, DOI 10.1093/mnras/sts096; Tojeiro R, 2009, ASTROPHYS J SUPPL S, V185, P1, DOI 10.1088/0067-0049/185/1/1; JACOBY GH, 1984, ASTROPHYS J SUPPL S, V56, P257, DOI 10.1086/190983; Thomas D, 2005, ASTROPHYS J, V621, P673, DOI 10.1086/426932; Fritz J, 2007, ASTRON ASTROPHYS, V470, P137, DOI 10.1051/0004-6361:20077097; Gavazzi G, 2006, ASTRON ASTROPHYS, V446, P839, DOI [10.1051/0004-6361:20053843, 10.1051/004-6361:20053843]; Fasano G, 2012, MON NOT R ASTRON SOC, V420, P926, DOI 10.1111/j.1365-2966.2011.19798.x; Smith RJ, 2012, MON NOT R ASTRON SOC, V419, P3167, DOI 10.1111/j.1365-2966.2011.19956.x; SPITZER L, 1951, ASTROPHYS J, V113, P413, DOI 10.1086/145406; Papovich C, 2001, ASTROPHYS J, V559, P620, DOI 10.1086/322412; Driver SP, 2013, MON NOT R ASTRON SOC, V430, P2622, DOI 10.1093/mnras/sts717; BERTELLI G, 1994, ASTRON ASTROPHYS SUP, V106, P275; Poggianti BM, 2006, ASTROPHYS J, V642, P188, DOI 10.1086/500666; Fasano G, 2006, ASTRON ASTROPHYS, V445, P805, DOI 10.1051/0004-6361:20053816; Ocvirk P, 2006, MON NOT R ASTRON SOC, V365, P46, DOI 10.1111/j.1365-2966.2005.09182.x; Zibetti S, 2009, MON NOT R ASTRON SOC, V400, P1181, DOI 10.1111/j.1365-2966.2009.15528.x; Springel V, 2005, NATURE, V435, P629, DOI 10.1038/nature03597; Brinchmann J, 2004, MON NOT R ASTRON SOC, V351, P1151, DOI 10.1111/j.1365-2966.2004.07881.x; Panter B, 2007, MON NOT R ASTRON SOC, V378, P1550, DOI 10.1111/j.1365-2966.2007.11909.x; Varela J, 2009, ASTRON ASTROPHYS, V497, P667, DOI 10.1051/0004-6361/200809876; Reddy NA, 2009, ASTROPHYS J, V692, P778, DOI 10.1088/0004-637X/692/1/778; Cucciati O, 2006, ASTRON ASTROPHYS, V458, P39, DOI [10.1051/0004-6361:20065161, 10.1051/00004-6361:20065161]; Sanders DB, 2003, ASTRON J, V126, P1607, DOI 10.1086/376841; Calvi R, 2012, MON NOT R ASTRON SOC, V419, pL14, DOI 10.1111/j.1745-3933.2011.01168.x; Yang XH, 2007, ASTROPHYS J, V671, P153, DOI 10.1086/522027; Bernardi M, 2003, ASTRON J, V125, P1849, DOI 10.1086/374256; Cooper MC, 2006, MON NOT R ASTRON SOC, V370, P198, DOI 10.1111/j.1365-2966.2006.10485.x; Baldry IK, 2006, MON NOT R ASTRON SOC, V373, P469, DOI 10.1111/j.1365-2966.2006.11081.x; Sobral D, 2014, MON NOT R ASTRON SOC, V437, P3516, DOI 10.1093/mnras/stt2159; Allen JT, 2015, MON NOT R ASTRON SOC, V446, P1567, DOI 10.1093/mnras/stu2057; Smith RJ, 2009, MON NOT R ASTRON SOC, V400, P1690, DOI 10.1111/j.1365-2966.2009.15580.x; CARDELLI JA, 1989, ASTROPHYS J, V345, P245, DOI 10.1086/167900; Heavens AF, 2000, MON NOT R ASTRON SOC, V317, P965, DOI 10.1046/j.1365-8711.2000.03692.x; Sanchez-Blazquez P, 2009, ASTRON ASTROPHYS, V499, P47, DOI 10.1051/0004-6361/200811355; Hopkins AM, 2006, ASTROPHYS J, V651, P142, DOI 10.1086/506610; DAVIS M, 1976, ASTROPHYS J, V208, P13, DOI 10.1086/154575; Thomas D, 2010, MON NOT R ASTRON SOC, V404, P1775, DOI 10.1111/j.1365-2966.2010.16427.x; Finn RA, 2005, ASTROPHYS J, V630, P206, DOI 10.1086/431642; Madau P, 1996, MON NOT R ASTRON SOC, V283, P1388; Colless M, 2001, MON NOT R ASTRON SOC, V328, P1039, DOI 10.1046/j.1365-8711.2001.04902.x; Salim S, 2007, ASTROPHYS J SUPPL S, V173, P267, DOI 10.1086/519218; Ocvirk P, 2006, MON NOT R ASTRON SOC, V365, P74, DOI 10.1111/j.1365-2966.2005.09323.x; Abazajian K, 2003, ASTRON J, V126, P2081, DOI 10.1086/378165; Dahlen T, 2007, ASTROPHYS J, V654, P172, DOI 10.1086/508854; Heavens A, 2004, NATURE, V428, P625, DOI 10.1038/nature02474; Driver SP, 2005, MON NOT R ASTRON SOC, V360, P81, DOI 10.1111/j.1365-2966.2005.08990.x; Wetzel AR, 2012, MON NOT R ASTRON SOC, V424, P232, DOI 10.1111/j.1365-2966.2012.21188.x; Ebeling H, 1996, MON NOT R ASTRON SOC, V281, P799; Cowie LL, 1996, ASTRON J, V112, P839, DOI 10.1086/118058; Yang XH, 2008, ASTROPHYS J, V676, P248, DOI 10.1086/528954; Schiminovich D, 2005, ASTROPHYS J, V619, pL47, DOI 10.1086/427077; Haines CP, 2007, MON NOT R ASTRON SOC, V381, P7, DOI 10.1111/j.1365-2966.2007.12189.x; Lara-Lopez MA, 2013, MON NOT R ASTRON SOC, V434, P451, DOI 10.1093/mnras/stt1031; Ebeling H, 1998, MON NOT R ASTRON SOC, V301, P881, DOI 10.1046/j.1365-8711.1998.01949.x; Ebeling H, 2000, MON NOT R ASTRON SOC, V318, P333; Tojeiro R, 2007, MON NOT R ASTRON SOC, V381, P1252, DOI 10.1111/j.1365-2966.2007.12323.x; Cava A, 2009, ASTRON ASTROPHYS, V495, P707, DOI 10.1051/0004-6361:200810997; Bothwell MS, 2011, MON NOT R ASTRON SOC, V415, P1815, DOI 10.1111/j.1365-2966.2011.18829.x; Bouwens RJ, 2014, ASTROPHYS J, V795, DOI 10.1088/0004-637X/795/2/126; Bouwens RJ, 2012, ASTROPHYS J, V754, DOI 10.1088/0004-637X/754/2/83; Bouwens RJ, 2012, ASTROPHYS J LETT, V752, DOI 10.1088/2041-8205/752/1/L5; Bressan A, 1998, ASTRON ASTROPHYS, V332, P135; Bundy K, 2015, ASTROPHYS J, V798, DOI 10.1088/0004-637X/798/1/7; Burgarella D., 2013, ASTRON ASTROPHYS, V554, P70; Calvi R, 2013, MON NOT R ASTRON SOC, V432, P3141, DOI 10.1093/mnras/stt667; Fernandes RC, 2013, ASTRON ASTROPHYS, V557, DOI 10.1051/0004-6361/201220616; Cid-Fernandes R., 2004, MNRAS, V355, P273, DOI 10.1111/j.1365-2966.2004.08321.x; Conroy C, 2013, ANNU REV ASTRON ASTR, V51, P393, DOI 10.1146/annurev-astro-082812-141017; Cooper MC, 2010, MON NOT R ASTRON SOC, V409, P337, DOI 10.1111/j.1365-2966.2010.17312.x; Cucciati O., 2012, ASTRON ASTROPHYS, V539, pAA31; De Lucia G., 2007, Monthly Notices of the Royal Astronomical Society, V374, DOI 10.1111/j.1365-2966.2006.11199.x; De Lucia G., 2007, MNRAS, V375, P214; Dressler A, 1997, ASTROPHYS J, V490, P577, DOI 10.1086/304890; DRESSLER A, 1980, ASTROPHYS J, V236, P351, DOI 10.1086/157753; Fasano G, 2007, ASTR SOC P, V374, P495; Ferland G. J., 1996, HAZY BRIEF INTRO CLO; Fritz J., 2011, ASTRON ASTROPHYS, V526, pAA45; Fritz J., 2014, ASTRON ASTROPHYS, V566, pAA32; Delgado RMG, 2014, ASTRON ASTROPHYS, V562, DOI 10.1051/0004-6361/201322011; Gruppioni C, 2013, MON NOT R ASTRON SOC, V432, P23, DOI 10.1093/mnras/stt308; Hao CN, 2011, ASTROPHYS J, V741, DOI 10.1088/0004-637X/741/2/124; Iovino A., 2010, ASTRON ASTROPHYS, V509, pAA40; Karim A, 2011, ASTROPHYS J, V730, DOI 10.1088/0004-637X/730/2/61; Kauffmann G, 2006, MON NOT R ASTRON SOC, V367, P1394, DOI 10.1111/j.1365-2966.2006.10061.x; Kodama T, 2001, MON NOT R ASTRON SOC, V321, P18, DOI 10.1046/j.1365-8711.2001.03981.x; La Barbera F, 2014, MON NOT R ASTRON SOC, V445, P1977, DOI 10.1093/mnras/stu1626; Lin L, 2014, ASTROPHYS J, V782, DOI 10.1088/0004-637X/782/1/33; Magnelli B, 2013, ASTRON ASTROPHYS, V553, DOI 10.1051/0004-6361/201321371; Magnelli B, 2011, ASTRON ASTROPHYS, V528, DOI 10.1051/0004-6361/200913941; Marziani P, 2013, ASTRON NACHR, V334, P412, DOI 10.1002/asna.201211869; Muzzin A, 2012, ASTROPHYS J, V746, DOI 10.1088/0004-637X/746/2/188; OEMLER A, 1974, ASTROPHYS J, V194, P1, DOI 10.1086/153216; Oesch PA, 2010, ASTROPHYS J LETT, V714, pL47, DOI 10.1088/2041-8205/714/1/L47; Pasquali A, 2010, MON NOT R ASTRON SOC, V407, P937, DOI 10.1111/j.1365-2966.2010.17074.x; Peng YJ, 2012, ASTROPHYS J, V757, DOI 10.1088/0004-637X/757/1/4; Peng YJ, 2010, ASTROPHYS J, V721, P193, DOI 10.1088/0004-637X/721/1/193; Poggianti BM, 2013, ASTROPHYS J, V762, DOI 10.1088/0004-637X/762/2/77; Poggianti BM, 2001, ASTROPHYS J, V550, P195, DOI 10.1086/319740; Popesso P., 2014, ASTRON ASTROPHYS, V574, pA105; Popesso P., 2014, ARXIV14078231; Robotham ASG, 2011, MON NOT R ASTRON SOC, V413, P2570, DOI 10.1111/j.1365-2966.2011.18327.x; Rodighiero G, 2011, ASTROPHYS J LETT, V739, DOI 10.1088/2041-8205/739/2/L40; Sanchez SF, 2012, ASTRON ASTROPHYS, V538, DOI 10.1051/0004-6361/201117353; Schenker A., 2013, APJ, V768, P196; Speagle JS, 2014, ASTROPHYS J SUPPL S, V214, DOI 10.1088/0067-0049/214/2/15; Takeuchi TT, 2003, ASTROPHYS J, V587, pL89, DOI 10.1086/375181; Tojeiro R, 2013, MON NOT R ASTRON SOC, V432, P359, DOI 10.1093/mnras/stt484; van der Wel A, 2009, ASTROPHYS J, V698, P1232, DOI 10.1088/0004-637X/698/2/1232; Vulcani B, 2015, ASTROPHYS J, V798, DOI 10.1088/0004-637X/798/1/52; Vulcani B, 2014, ASTROPHYS J, V788, DOI 10.1088/0004-637X/788/1/57; Vulcani B, 2011, MON NOT R ASTRON SOC, V413, P921, DOI 10.1111/j.1365-2966.2010.18182.x; Wake DA, 2012, ASTROPHYS J LETT, V751, DOI 10.1088/2041-8205/751/2/L44; Whitaker KE, 2012, ASTROPHYS J LETT, V754, DOI 10.1088/2041-8205/754/2/L29; Wilman DJ, 2005, MON NOT R ASTRON SOC, V358, P88, DOI 10.1111/j.1365-2966.2005.08745.x; Wuyts S, 2012, ASTROPHYS J, V753, DOI 10.1088/0004-637X/753/2/114	131	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-8711	1365-2966		MON NOT R ASTRON SOC	Mon. Not. Roy. Astron. Soc.	JUL 1	2015	450	3					2749	2763		10.1093/mnras/stv757		15	Astronomy & Astrophysics	Astronomy & Astrophysics	CK6LJ	WOS:000356339300039		
J	Liu, XK; Pan, CZ; Li, R; Shan, HY; Wang, Q; Fu, LP; Fan, ZH; Kneib, JP; Leauthaud, A; Van Waerbeke, L; Makler, M; Moraes, B; Erben, T; Charbonnier, A				Liu, Xiangkun; Pan, Chuzhong; Li, Ran; Shan, Huanyuan; Wang, Qiao; Fu, Liping; Fan, Zuhui; Kneib, Jean-Paul; Leauthaud, Alexie; Van Waerbeke, Ludovic; Makler, Martin; Moraes, Bruno; Erben, Thomas; Charbonnier, Aldee			Cosmological constraints from weak lensing peak statistics with Canada-France-Hawaii Telescope Stripe 82 Survey	MONTHLY NOTICES OF THE ROYAL ASTRONOMICAL SOCIETY			English	Article						gravitational lensing: weak; dark matter; large-scale structure of Universe	NONLINEAR CLUSTER INVERSION; GALAXY SHAPE MEASUREMENT; DARK-MATTER HALOS; COSMIC SHEAR; GRAVITATIONAL DISTORTIONS; MASS RECONSTRUCTION; CFHTLS-WIDE; COUNTS; CATALOG; MODEL	We derived constraints on cosmological parameters using weak lensing peak statistics measured on the similar to aEuro parts per thousand 130 deg(2) of the Canada-France-Hawaii Telescope Stripe 82 Survey. This analysis demonstrates the feasibility of using peak statistics in cosmological studies. For our measurements, we considered peaks with signal-to-noise ratio in the range of nu = [3, 6]. For a flat I > cold dark matter model with only (Omega(m), sigma(8)) as free parameters, we constrained the parameters of the following relation I (8) pound = sigma(8)(Omega(m)/0.27)(alpha) to be I (8) pound = 0.82 +/- 0.03 and alpha = 0.43 +/- 0.02. The alpha value found is considerably smaller than the one measured in two-point and three-point cosmic shear correlation analyses, showing a significant complement of peak statistics to standard weak lensing cosmological studies. The derived constraints on (Omega(m), sigma(8)) are fully consistent with the ones from either WMAP9 or Planck. From the weak lensing peak abundances alone, we obtained marginalized mean values of tex-math id="TM0002" notation="LaTeX"$\Omega _{\rm m}=0.38<^>{+0.27}_{-0.24}$/tex-math and sigma(8) = 0.81 +/- 0.26. Finally, we also explored the potential of using weak lensing peak statistics to constrain the mass-concentration relation of dark matter haloes simultaneously with cosmological parameters.	[Liu, Xiangkun; Pan, Chuzhong; Fan, Zuhui] Peking Univ, Dept Astron, Beijing 100871, Peoples R China; [Li, Ran; Wang, Qiao] Chinese Acad Sci, Max Planck Inst Astrophys, Key Lab Computat Astrophys, Partner Grp,Natl Astron Observ, Beijing 100012, Peoples R China; [Shan, Huanyuan; Kneib, Jean-Paul] Ecole Polytech Fed Lausanne, Observ Sauverny, Lab Astrophys LASTRO, CH-1290 Versoix, Switzerland; [Fu, Liping] Shanghai Normal Univ, Shanghai Key Lab Astrophys, Shanghai 200234, Peoples R China; [Fan, Zuhui] Collaborat Innovat Ctr Modern Astron & Space Expl, Nanjing 210093, Jiangsu, Peoples R China; [Kneib, Jean-Paul] Aix Marseille Univ, CNRS, LAM, UMR 7326, F-13388 Marseille, France; [Leauthaud, Alexie] Univ Tokyo, Kavli Inst Phys & Math Universe Kavli IPMU, WPI, Kashiwa, Chiba 2778582, Japan; [Van Waerbeke, Ludovic] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z1, Canada; [Makler, Martin; Charbonnier, Aldee] Ctr Brasileiro Pesquisas Fis, BR-22290180 Rio De Janeiro, RJ, Brazil; [Moraes, Bruno] UCL, Dept Phys & Astron, London WC1E 6BT, England; [Moraes, Bruno] Minist Educ Brazil, CAPES Fdn, BR-70040020 Brasilia, DF, Brazil; [Erben, Thomas] Univ Bonn, Argelander Inst Astron, D-53121 Bonn, Germany; [Charbonnier, Aldee] Univ Fed Rio de Janeiro, Observ Valongo, BR-20080090 Rio De Janeiro, RJ, Brazil	Liu, XK (reprint author), Peking Univ, Dept Astron, Beijing 100871, Peoples R China.	lxk98479@pku.edu.cn; fanzuhui@pku.edu.cn	Makler, Martin/G-2639-2012; Shan, Huanyuan/G-3353-2015	Makler, Martin/0000-0003-2206-2651; Shan, Huanyuan/0000-0001-8534-837X	ICRA/CBPF/MCTI; FINEP; FAPERJ [E-26/110.516/2-2012]; Laboratrio Interinstitucional de e-Astronomia (LIneA); NSFC of China [11333001, 11173001, 11033005, 11103011]; Strategic Priority Research Program 'The Emergence of Cosmological Structures' of the Chinese Academy of Sciences [XDB09000000]; Marie Curie International Incoming Fellowship within the 7th European Community Framework Programme; NSFC [11333001, 11103012, 11303033]; Shanghai Research grant of STCSM [13JC1404400]; Youth Innovation Promotion Association of CAS; World Premier International Research Centre Initiative (WPI Initiative), MEXT, Japan; ERC advanced grant LIDA; CNRS; CAPES Foundation [12174-13-0]; CNPq [486586/2013-8]; Ministry of Finance of Peoples Republic of China [ZDYZ2008-2]	Based on observations obtained with MegaPrime/MegaCam, a joint project of CFHT and CEA/DAPNIA, at the CFHT, which is operated by the National Research Council (NRC) of Canada, the Institut National des Science de l'Univers of the Centre National de la Recherche Scientifique (CNRS) of France and the University of Hawaii. The Brazilian partnership on CFHT is managed by the Laboratorio Nacional de Astrofisica (LNA). This work made use of the CHE cluster, managed and funded by ICRA/CBPF/MCTI, with financial support from FINEP and FAPERJ. We thank the support of the Laboratrio Interinstitucional de e-Astronomia (LIneA). We thank the CFHTLenS team for their pipeline development and verification upon which much of this surveys pipeline was built.; We thank the referee for the constructive comments and suggestions. We thank the useful discussions with Z. Haiman and J. Liu. XKL, CZP and ZHF acknowledge the support from NSFC of China under the grants 11333001, 11173001 and 11033005, and from the Strategic Priority Research Program 'The Emergence of Cosmological Structures' of the Chinese Academy of Sciences, grant no. XDB09000000. HYS acknowledges the support by a Marie Curie International Incoming Fellowship within the 7th European Community Framework Programme, and NSFC of China under grants 11103011. LPF acknowledges the support from NSFC grants 11103012 and 11333001, and Shanghai Research grant 13JC1404400 of STCSM. LR acknowledges the support from NSFC grant 11303033 and the support from Youth Innovation Promotion Association of CAS. AL acknowledges the support by World Premier International Research Centre Initiative (WPI Initiative), MEXT, Japan. JPK acknowledges support from the ERC advanced grant LIDA and from CNRS. BM acknowledges financial support from the CAPES Foundation grant 12174-13-0. MM is partially supported by CNPq (grant 486586/2013-8) and FAPERJ (grant E-26/110.516/2-2012).; The MCMC calculations are partly done on the Laohu supercomputer at the Centre of Information and Computing at National Astronomical Observatories, Chinese Academy of Sciences, funded by Ministry of Finance of Peoples Republic of China under grant ZDYZ2008-2. The N-body simulations are performed on the Shuguang cluster at Shanghai Normal University, Shanghai, China.	Ade PAR, 2014, ASTRON ASTROPHYS, V571, DOI 10.1051/0004-6361/201321591; Albrecht A., 2006, ARXIVASTROPH0609591; Amendola L, 2013, LIVING REV RELATIV, V16; KAISER N, 1993, ASTROPHYS J, V404, P441, DOI 10.1086/172297; Crocce M, 2006, MON NOT R ASTRON SOC, V373, P369, DOI 10.1111/j.1365-2966.2006.11040.x; Jauzac M, 2012, MON NOT R ASTRON SOC, V426, P3369, DOI 10.1111/j.1365-2966.2012.21966.x; Li R, 2014, MON NOT R ASTRON SOC, V438, P2864, DOI 10.1093/mnras/stt2395; Lewis A, 2000, ASTROPHYS J, V538, P473, DOI 10.1086/309179; Duffy AR, 2008, MON NOT R ASTRON SOC, V390, pL64, DOI 10.1111/j.1745-3933.2008.00537.x; Van Waerbeke L, 2013, MON NOT R ASTRON SOC, V433, P3373, DOI 10.1093/mnras/stt971; Marian L, 2012, MON NOT R ASTRON SOC, V423, P1711, DOI 10.1111/j.1365-2966.2012.20992.x; Bartelmann M, 2001, PHYS REP, V340, P291, DOI 10.1016/S0370-1573(00)00082-X; Fu LP, 2014, MON NOT R ASTRON SOC, V441, P2725, DOI 10.1093/mnras/stu754; Yang XY, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.023511; Hartlap J, 2007, ASTRON ASTROPHYS, V464, P399, DOI 10.1051/0004-6361:20066170; Hennawi JF, 2005, ASTROPHYS J, V624, P59, DOI 10.1086/428749; Hamana T, 2012, MON NOT R ASTRON SOC, V425, P2287, DOI 10.1111/j.1365-2966.2012.21582.x; Lin CA, 2015, ASTRON ASTROPHYS, V576, DOI 10.1051/0004-6361/201425188; BARDEEN JM, 1986, ASTROPHYS J, V304, P15, DOI 10.1086/164143; [Anonymous], 2002, PHYS REV D; Kratochvil JM, 2010, PHYS REV D, V81, DOI 10.1103/PhysRevD.81.043519; Seitz C, 1997, ASTRON ASTROPHYS, V318, P687; Tang JY, 2005, ASTROPHYS J, V635, P60, DOI 10.1086/497285; Navarro JF, 1996, ASTROPHYS J, V462, P563, DOI 10.1086/177173; Marian L, 2009, ASTROPHYS J LETT, V698, pL33, DOI 10.1088/0004-637X/698/1/L33; Marian L, 2010, ASTROPHYS J, V709, P286, DOI 10.1088/0004-637X/709/1/286; Jullo E, 2014, MON NOT R ASTRON SOC, V437, P3969, DOI 10.1093/mnras/stt2207; Kitching TD, 2014, MON NOT R ASTRON SOC, V442, P1326, DOI 10.1093/mnras/stu934; Fan ZH, 2010, ASTROPHYS J, V719, P1408, DOI 10.1088/0004-637X/719/2/1408; KAISER N, 1995, ASTROPHYS J, V449, P460, DOI 10.1086/176071; Sheth RK, 1999, MON NOT R ASTRON SOC, V308, P119, DOI 10.1046/j.1365-8711.1999.02692.x; Wittman D, 2006, ASTROPHYS J, V643, P128, DOI 10.1086/502621; de Jong JTA, 2013, EXP ASTRON, V35, P25, DOI 10.1007/s10686-012-9306-1; Heymans C, 2012, MON NOT R ASTRON SOC, V427, P146, DOI 10.1111/j.1365-2966.2012.21952.x; Miyazaki S, 2007, ASTROPHYS J, V669, P714, DOI 10.1086/521621; White M, 2002, ASTROPHYS J, V575, P640, DOI 10.1086/341351; Miller L, 2007, MON NOT R ASTRON SOC, V382, P315, DOI 10.1111/j.1365-2966.2007.12363.x; Hilbert S, 2012, MON NOT R ASTRON SOC, V426, P2870, DOI 10.1111/j.1365-2966.2012.21841.x; Erben T, 2013, MON NOT R ASTRON SOC, V433, P2545, DOI 10.1093/mnras/stt928; Schneider P, 1998, MON NOT R ASTRON SOC, V296, P873, DOI 10.1046/j.1365-8711.1998.01422.x; Hamana T, 2004, MON NOT R ASTRON SOC, V350, P893, DOI 10.1111/j.1365-2966.2004.07691.x; SEITZ C, 1995, ASTRON ASTROPHYS, V297, P287; Weinberg DH, 2013, PHYS REP, V530, P87, DOI 10.1016/j.physrep.2013.05.001; Dietrich JP, 2010, MON NOT R ASTRON SOC, V402, P1049, DOI 10.1111/j.1365-2966.2009.15948.x; Yang XY, 2011, PHYS REV D, V84, DOI 10.1103/PhysRevD.84.043529; Semboloni E, 2011, MON NOT R ASTRON SOC, V410, P143, DOI 10.1111/j.1365-2966.2010.17430.x; Navarro JF, 1997, ASTROPHYS J, V490, P493, DOI 10.1086/304888; BOND JR, 1987, MON NOT R ASTRON SOC, V226, P655; Gavazzi R, 2007, ASTRON ASTROPHYS, V462, P459, DOI 10.1051/0004-6361:20065677; Bard D, 2013, ASTROPHYS J, V774, DOI 10.1088/0004-637X/774/1/49; BARTELMANN M, 1995, ASTRON ASTROPHYS, V303, P643; Bhattacharya S, 2013, ASTROPHYS J, V766, DOI 10.1088/0004-637X/766/1/32; Bohringer H, 2014, ASTRON ASTROPHYS, V570, DOI 10.1051/0004-6361/201323155; Cardone VF, 2015, ASTRON ASTROPHYS, V574, DOI 10.1051/0004-6361/201424699; Fox L., 1968, CHEBYSHEV POLYNOMIAL; Fu L, 2008, ASTRON ASTROPHYS, V479, P9, DOI 10.1051/0004-6361:20078522; Geller MJ, 2010, ASTROPHYS J, V709, P832, DOI 10.1088/0004-637X/709/2/832; Hand N, 2015, PHYS REV D, V91, DOI 10.1103/PhysRevD.91.062001; Hasselfield M, 2013, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2013/07/008; Henry JP, 2000, ASTROPHYS J, V534, P565, DOI 10.1086/308783; Hilbert S., 2009, ASTRON ASTROPHYS, V449, P31; Hinshaw G, 2013, ASTROPHYS J SUPPL S, V208, DOI 10.1088/0067-0049/208/2/19; Jee MJ, 2013, ASTROPHYS J, V765, DOI 10.1088/0004-637X/765/1/74; Kilbinger M, 2013, MON NOT R ASTRON SOC, V430, P2200, DOI 10.1093/mnras/stt041; Liu J, 2015, PHYS REV D, V91, DOI 10.1103/PhysRevD.91.063507; Liu XK, 2014, ASTROPHYS J, V784, DOI 10.1088/0004-637X/784/1/31; LSST Dark Energy Science Collaboration, 2012, ARXIV12110310 LSST D; LSST Science Collaboration, 2009, ARXIV09120201; Mainini R, 2014, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2014/08/063; Maturi M, 2010, ASTRON ASTROPHYS, V519, DOI 10.1051/0004-6361/200912866; Miller L, 2013, MON NOT R ASTRON SOC, V429, P2858, DOI 10.1093/mnras/sts454; Petri A, 2013, PHYS REV D, V88, DOI 10.1103/PhysRevD.88.123002; Ade PAR, 2014, ASTRON ASTROPHYS, V571, DOI 10.1051/0004-6361/201321521; Press W. H., 2007, NUMERICAL RECIPES; Reichardt CL, 2013, ASTROPHYS J, V763, DOI 10.1088/0004-637X/763/2/127; Rozo E, 2010, ASTROPHYS J, V708, P645, DOI 10.1088/0004-637X/708/1/645; Rykoff ES, 2014, ASTROPHYS J, V785, DOI 10.1088/0004-637X/785/2/104; Shan HY, 2012, ASTROPHYS J, V748, DOI 10.1088/0004-637X/748/1/56; Shan HY, 2014, MON NOT R ASTRON SOC, V442, P2534, DOI 10.1093/mnras/stu1040; Squires G., 1996, Astrophysical Journal, V473, DOI 10.1086/178127; The Dark Energy Survey Collaboration, 2005, ARXIVASTROPH0510346; Van Waerbeke L, 2000, MON NOT R ASTRON SOC, V313, P524; Vikhlinin A, 2009, ASTROPHYS J, V692, P1060, DOI 10.1088/0004-637X/692/2/1060	83	3	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-8711	1365-2966		MON NOT R ASTRON SOC	Mon. Not. Roy. Astron. Soc.	JUL 1	2015	450	3					2888	2902		10.1093/mnras/stv784		15	Astronomy & Astrophysics	Astronomy & Astrophysics	CK6LJ	WOS:000356339300049		
J	Mandelbaum, R; Rowe, B; Armstrong, R; Bard, D; Bertin, E; Bosch, J; Boutigny, D; Courbin, F; Dawson, WA; Donnarumma, A; Conti, IF; Gavazzi, R; Gentile, M; Gill, MSS; Hogg, DW; Huff, EM; Jee, MJ; Kacprzak, T; Kilbinger, M; Kuntzer, T; Lang, D; Luo, WT; March, MC; Marshall, PJ; Meyers, JE; Miller, L; Miyatake, H; Nakajima, R; Mboula, FMN; Nurbaeva, G; Okura, Y; Stephane, H; Rhodes, J; Schneider, MD; Shan, HY; Sheldon, ES; Simet, M; Starck, JL; Sureau, F; Tewes, M; Adami, KZ; Zhang, J; Zuntz, J				Mandelbaum, Rachel; Rowe, Barnaby; Armstrong, Robert; Bard, Deborah; Bertin, Emmanuel; Bosch, James; Boutigny, Dominique; Courbin, Frederic; Dawson, William A.; Donnarumma, Annamaria; Conti, Ian Fenech; Gavazzi, Raphael; Gentile, Marc; Gill, Mandeep S. S.; Hogg, David W.; Huff, Eric M.; Jee, M. James; Kacprzak, Tomasz; Kilbinger, Martin; Kuntzer, Thibault; Lang, Dustin; Luo, Wentao; March, Marisa C.; Marshall, Philip J.; Meyers, Joshua E.; Miller, Lance; Miyatake, Hironao; Nakajima, Reiko; Ngole Mboula, Fred Maurice; Nurbaeva, Guldariya; Okura, Yuki; Paulin-Henriksson, Stephane; Rhodes, Jason; Schneider, Michael D.; Shan, Huanyuan; Sheldon, Erin S.; Simet, Melanie; Starck, Jean-Luc; Sureau, Florent; Tewes, Malte; Adami, Kristian Zarb; Zhang, Jun; Zuntz, Joe			GREAT3 results - I. Systematic errors in shear estimation and the impact of real galaxy morphology	MONTHLY NOTICES OF THE ROYAL ASTRONOMICAL SOCIETY			English	Article						gravitational lensing: weak; methods: data analysis; techniques: image processing; cosmology: observations	WEAK LENSING ANALYSIS; SPACE-TELESCOPE OBSERVATIONS; IMAGE-ANALYSIS COMPETITION; SPREAD FUNCTION CORRECTION; ELLIPTIC-WEIGHTED HOLICS; DIGITAL SKY SURVEY; SHAPE MEASUREMENTS; COSMIC SHEAR; NOISE BIAS; GRAVITATIONAL SHEAR	We present first results from the third GRavitational lEnsing Accuracy Testing (GREAT3) challenge, the third in a sequence of challenges for testing methods of inferring weak gravitational lensing shear distortions from simulated galaxy images. GREAT3 was divided into experiments to test three specific questions, and included simulated space- and ground-based data with constant or cosmologically varying shear fields. The simplest (control) experiment included parametric galaxies with a realistic distribution of signal-to-noise, size, and ellipticity, and a complex point spread function (PSF). The other experiments tested the additional impact of realistic galaxy morphology, multiple exposure imaging, and the uncertainty about a spatially varying PSF; the last two questions will be explored in Paper II. The 24 participating teams competed to estimate lensing shears to within systematic error tolerances for upcoming Stage-IV dark energy surveys, making 1525 submissions overall. GREAT3 saw considerable variety and innovation in the types of methods applied. Several teams now meet or exceed the targets in many of the tests conducted (to within the statistical errors). We conclude that the presence of realistic galaxy morphology in simulations changes shear calibration biases by similar to 1 per cent for a wide range of methods. Other effects such as truncation biases due to finite galaxy postage stamps, and the impact of galaxy type as measured by the S,rsic index, are quantified for the first time. Our results generalize previous studies regarding sensitivities to galaxy size and signal-to-noise, and to PSF properties such as seeing and defocus. Almost all methods' results support the simple model in which additive shear biases depend linearly on PSF ellipticity.	[Mandelbaum, Rachel; Lang, Dustin; Simet, Melanie] Carnegie Mellon Univ, Dept Phys, McWilliams Ctr Cosmol, Pittsburgh, PA 15213 USA; [Rowe, Barnaby; Kacprzak, Tomasz] UCL, Dept Phys & Astron, London WC1E 6BT, England; [Armstrong, Robert; Bosch, James; Miyatake, Hironao] Princeton Univ, Dept Astrophys Sci, Princeton, NJ 08544 USA; [Bard, Deborah; Gill, Mandeep S. S.; Marshall, Philip J.; Meyers, Joshua E.] Stanford Univ, Kavli Inst Particle Astrophys & Cosmol, Dept Phys, Stanford, CA 94305 USA; [Bard, Deborah; Boutigny, Dominique; Gill, Mandeep S. S.] SLAC Natl Accelerator Lab, Menlo Pk, CA 94025 USA; [Bertin, Emmanuel; Donnarumma, Annamaria; Gavazzi, Raphael] Univ Paris 06, Inst Astrophys Paris, UMR CNRS 7095, F-75014 Paris, France; [Boutigny, Dominique] CNRS IN2P3, USR 6402, IN2P3, Ctr Calcul, F-69622 Villeurbanne, France; [Courbin, Frederic; Gentile, Marc; Kuntzer, Thibault; Nurbaeva, Guldariya; Shan, Huanyuan] Ecole Polytech Fed Lausanne, Astrophys Lab, Observ Sauverny, CH-1290 Versoix, Switzerland; [Dawson, William A.; Schneider, Michael D.] Lawrence Livermore Natl Lab, Livermore, CA 94551 USA; [Conti, Ian Fenech; Adami, Kristian Zarb] Univ Malta, ISSA, Msida 2080, Msd, Malta; [Hogg, David W.] NYU, Dept Phys, Ctr Cosmol & Particle Phys, New York, NY 10003 USA; [Huff, Eric M.] Ohio State Univ, Ctr Cosmol & AstroParticle Phys CCAPP, Columbus, OH 43210 USA; [Huff, Eric M.] Ohio State Univ, Dept Phys, Columbus, OH 43210 USA; [Jee, M. James] Univ Calif Davis, Dept Phys, Davis, CA 95616 USA; [Kacprzak, Tomasz] ETH, Inst Astron, CH-8093 Zurich, Switzerland; [Kilbinger, Martin; Ngole Mboula, Fred Maurice; Paulin-Henriksson, Stephane; Starck, Jean-Luc; Sureau, Florent] CEA Saclay, Lab AIM, UMR CEA CNRS Paris 7, Irfu,SAp SEDI,Serv Astrophys, F-91191 Gif Sur Yvette, France; [Luo, Wentao] Shanghai Astron Observ, Key Lab Res Galaxies & Cosmol, Shanghai 200030, Peoples R China; [March, Marisa C.] Univ Penn, David Rittenhouse Lab, Philadelphia, PA 19104 USA; [Miller, Lance; Adami, Kristian Zarb] Univ Oxford, Dept Phys, Oxford OX1 3RH, England; [Miyatake, Hironao] Univ Tokyo, Kavli Inst Phys & Math Universe, WPI, Kashiwa, Chiba 2778582, Japan; [Nakajima, Reiko; Tewes, Malte] Argelander Inst Astron, D-53121 Bonn, Germany; [Okura, Yuki] Natl Astron Observ Japan, Tokyo 1818588, Japan; [Rhodes, Jason] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Rhodes, Jason] CALTECH, Pasadena, CA 91125 USA; [Sheldon, Erin S.] Brookhaven Natl Lab, Upton, NY 11973 USA; [Zhang, Jun] Shanghai Jiao Tong Univ, Dept Phys & Astron, Ctr Astron & Astrophys, Shanghai 200240, Peoples R China; [Zuntz, Joe] Univ Manchester, Jodrell Bank Ctr Astrophys, Manchester M13 9PL, Lancs, England	Mandelbaum, R (reprint author), Carnegie Mellon Univ, Dept Phys, McWilliams Ctr Cosmol, 5000 Forbes Ave, Pittsburgh, PA 15213 USA.	rmandelb@andrew.cmu.edu; barney@barnabyrowe.net	Mandelbaum, Rachel/N-8955-2014; Zhang, Jun/O-3283-2015; Shan, Huanyuan/G-3353-2015; Hogg, David/B-5580-2014; 	Mandelbaum, Rachel/0000-0003-2271-1527; Shan, Huanyuan/0000-0001-8534-837X; Rowe, Barnaby/0000-0002-7042-9174; Hogg, David/0000-0003-2866-9403; Kilbinger, Martin/0000-0001-9513-7138	PASCAL-2 network; NASA via the Strategic University Research Partnership (SURP) Program of the Jet Propulsion Laboratory, California Institute of Technology; IST Programme of the European Community, under the PASCAL2 Network of Excellence [IST-2007-216886]; National Science Foundation [PHYS-1066293, PHY-0969487]; NASA through a grant from the Space Telescope Science Institute [HST-AR-12857.01-A]; NASA [NAS5-26555]; Alfred P. Sloan Fellowship from the Sloan Foundation; Department of Energy Early Career Award Program; European Research Council [240672]; Japan Society for the Promotion of Science (JSPS) Postdoctoral Fellowships for Research Abroad; JSPS Research Fellowships for Young Scientists; Agence Nationale de la Recherche (ANR Grant 'AMALGAM'); Centre National des Etudes Spatiales (CNES); Deutsche Forschungsgemeinschaft (DFG) [Hi 1495/2-1]; Swiss National Science Foundation (SNSF) [CRSII2_147678, 200020_146813, 200021_146770]; US Department of Energy at Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; US Department of Energy at SLAC National Accelerator Laboratory [DE-AC02-76SF00515]; Marie Curie International Incoming Fellowship within the Seventh European Community Framework Programme; NSFC of China [11103011]; national science foundation of China [11273018, 11433001]; national basic research programme of China [2013CB834900, 2015CB857001]; European Research Council grant SparseAstro [ERC-228261]	We thank Gary Bernstein and Mike Jarvis for providing helpful feedback on this paper, Peter Freeman for providing guidance on the statistical interpretation of results, and the anonymous referee for making suggestions that improved the presentation of results in the paper. We thank the PASCAL-2 network for its sponsorship of the challenge. This project was supported in part by NASA via the Strategic University Research Partnership (SURP) Program of the Jet Propulsion Laboratory, California Institute of Technology; and by the IST Programme of the European Community, under the PASCAL2 Network of Excellence, IST-2007-216886. This article only reflects the authors' views. This work was supported in part by the National Science Foundation under Grant no. PHYS-1066293 and the hospitality of the Aspen Center for Physics.; RM was supported during the development of the GREAT3 challenge in part by program HST-AR-12857.01-A, provided by NASA through a grant from the Space Telescope Science Institute, which is operated by the Association of Universities for Research in Astronomy, Incorporated, under NASA contract NAS5-26555, and in part through an Alfred P. Sloan Fellowship from the Sloan Foundation; her work on the final analysis of results was supported by the Department of Energy Early Career Award Program. BR, JZuntz, and TKacprzak acknowledge support from the European Research Council in the form of a Starting Grant with number 240672. HM acknowledges support from Japan Society for the Promotion of Science (JSPS) Postdoctoral Fellowships for Research Abroad and JSPS Research Fellowships for Young Scientists. The Amalgam@IAP Team (AD, EB, RG) acknowledges the Agence Nationale de la Recherche (ANR Grant 'AMALGAM') and Centre National des Etudes Spatiales (CNES) for financial support. MT acknowledges support from the Deutsche Forschungsgemeinschaft (DFG) grant Hi 1495/2-1. TKuntzer, MGentile, HYS, and FC acknowledge support from the Swiss National Science Foundation (SNSF) under grants CRSII2_147678, 200020_146813 and 200021_146770. Part of the work carried out by the MBI team was performed under the auspices of the US Department of Energy at Lawrence Livermore National Laboratory under contract number DE-AC52-07NA27344 and SLAC National Accelerator Laboratory under contract number DE-AC02-76SF00515. HYS acknowledges the support by a Marie Curie International Incoming Fellowship within the Seventh European Community Framework Programme, and NSFC of China under grants 11103011. JEM was supported by National Science Foundation grant PHY-0969487. JZhang is supported by the national science foundation of China (Grant no. 11273018, 11433001), and the national basic research programme of China (Grant no. 2013CB834900, 2015CB857001). J-LS, MK, FS, and FMNM were supported by the European Research Council grant SparseAstro (ERC-228261). EMH is grateful to Christopher Hirata for insightful discussion and feedback on the MetaCalibration idea.	Albrecht A., 2006, ASTROPH0609591; Bundy K, 2005, ASTROPHYS J, V625, P621, DOI 10.1086/429549; Refregier A, 2012, MON NOT R ASTRON SOC, V425, P1951, DOI 10.1111/j.1365-2966.2012.21483.x; Zhang PJ, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.141302; Hoekstra H, 2000, ASTROPHYS J, V532, P88, DOI 10.1086/308556; Abazajian KN, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.041301; Bartelmann M, 2001, PHYS REP, V340, P291, DOI 10.1016/S0370-1573(00)00082-X; Foreman-Mackey D, 2013, PUBL ASTRON SOC PAC, V125, P306, DOI 10.1086/670067; Massey R, 2007, MON NOT R ASTRON SOC, V380, P229, DOI 10.1111/j.1365-2966.2007.12072.x; Heymans C, 2006, MON NOT R ASTRON SOC, V368, P1323, DOI 10.1111/j.1365-2966.2006.10198.x; Melchior P, 2012, MON NOT R ASTRON SOC, V424, P2757, DOI 10.1111/j.1365-2966.2012.21381.x; Bernstein GM, 2014, MON NOT R ASTRON SOC, V438, P1880, DOI 10.1093/mnras/stt2326; [Anonymous], 2002, PHYS REV D; Mandelbaum R, 2005, MON NOT R ASTRON SOC, V361, P1287, DOI 10.1111/j.1365-2966.2005.09282.x; Voigt LM, 2010, MON NOT R ASTRON SOC, V404, P458, DOI 10.1111/j.1365-2966.2010.16300.x; Scoville N, 2007, ASTROPHYS J SUPPL S, V172, P38, DOI 10.1086/516580; VanWaerbeke L, 1997, ASTRON ASTROPHYS, V317, P303; Melchior P, 2010, ASTRON ASTROPHYS, V510, DOI 10.1051/0004-6361/200912785; Zuntz J, 2013, MON NOT R ASTRON SOC, V434, P1604, DOI 10.1093/mnras/stt1125; Massey R, 2010, REP PROG PHYS, V73, DOI 10.1088/0034-4885/73/8/086901; Hirata CM, 2004, MON NOT R ASTRON SOC, V353, P529, DOI 10.1111/j.1365-2966.2004.08090.x; Bridle S, 2010, MON NOT R ASTRON SOC, V405, P2044, DOI 10.1111/j.1365-2966.2010.16598.x; KAISER N, 1995, ASTROPHYS J, V449, P460, DOI 10.1086/176071; Lackner CN, 2012, MON NOT R ASTRON SOC, V421, P2277, DOI 10.1111/j.1365-2966.2012.20450.x; Bernstein GM, 2002, ASTRON J, V123, P583, DOI 10.1086/338085; Starck JL, 2006, ASTRON ASTROPHYS, V451, P1139, DOI 10.1051/0004-6361:20052997; Koekemoer AM, 2007, ASTROPHYS J SUPPL S, V172, P196, DOI 10.1086/520086; Bertin E, 1996, ASTRON ASTROPHYS SUP, V117, P393, DOI 10.1051/aas:1996164; Hogg DW, 2013, PUBL ASTRON SOC PAC, V125, P719, DOI 10.1086/671228; Schechter PL, 2011, PUBL ASTRON SOC PAC, V123, P812, DOI 10.1086/661111; Luppino GA, 1997, ASTROPHYS J, V475, P20, DOI 10.1086/303508; Zhang J, 2011, MON NOT R ASTRON SOC, V414, P1047, DOI 10.1111/j.1365-2966.2011.18436.x; Schneider P, 1998, MON NOT R ASTRON SOC, V296, P873, DOI 10.1046/j.1365-8711.1998.01422.x; Bridle S, 2009, ANN APPL STAT, V3, P6, DOI 10.1214/08-AOAS222; Kacprzak T, 2012, MON NOT R ASTRON SOC, V427, P2711, DOI 10.1111/j.1365-2966.2012.21622.x; Scoville N, 2007, ASTROPHYS J SUPPL S, V172, P1, DOI 10.1086/516585; Massey R, 2007, MON NOT R ASTRON SOC, V376, P13, DOI 10.1111/j.1365-2966.2006.11315.x; Reyes R, 2012, MON NOT R ASTRON SOC, V425, P2610, DOI 10.1111/j.1365-2966.2012.21472.x; Rhodes J, 2000, ASTROPHYS J, V536, P79, DOI 10.1086/308902; Graff P, 2014, MON NOT R ASTRON SOC, V441, P1741, DOI 10.1093/mnras/stu642; Hoekstra H, 2008, ANNU REV NUCL PART S, V58, P99, DOI 10.1146/annurcv.nucl.58.110707.171151; Refregier A, 2003, ANNU REV ASTRON ASTR, V41, P645, DOI 10.1146/annurev.astro.41.111302.102207; Bernstein GM, 2010, MON NOT R ASTRON SOC, V406, P2793, DOI 10.1111/j.1365-2966.2010.16883.x; Bertin E, 2011, ASTR SOC P, V442, P435; Cropper M, 2013, MON NOT R ASTRON SOC, V431, P3103, DOI 10.1093/mnras/stt384; Eddy W., 1982, COMPSTAT, P42; Fruchter AS, 2011, PUBL ASTRON SOC PAC, V123, P497; Gentile M, 2012, ARXIV12114847; HAYKIN S., 2009, NEURAL NETWORKS LEAR; Heymans C, 2013, MON NOT R ASTRON SOC, V432, P2433, DOI 10.1093/mnras/stt601; High FW, 2007, PUBL ASTRON SOC PAC, V119, P1295, DOI 10.1086/523112; Hirata C, 2003, MON NOT R ASTRON SOC, V343, P459, DOI 10.1046/j.1365-8711.2003.06683.x; Hoekstra H, 1998, ASTROPHYS J, V504, P636, DOI 10.1086/306102; Huterer D, 2002, PHYS REV D, V65, DOI 10.1103/PhysRevD.65.063001; Jee MJ, 2013, ASTROPHYS J, V765, DOI 10.1088/0004-637X/765/1/74; Kacprzak T, 2014, MON NOT R ASTRON SOC, V441, P2528, DOI 10.1093/mnras/stu588; Kaiser N, 2000, ASTROPHYS J, V537, P555, DOI 10.1086/309041; Kitching T., 2010, ANN APPL STAT, V5, P2231; Kitching TD, 2013, ASTROPHYS J SUPPL S, V205, DOI 10.1088/0067-0049/205/2/12; Kitching TD, 2012, MON NOT R ASTRON SOC, V423, P3163, DOI 10.1111/j.1365-2966.2012.21095.x; Lauer TR, 1999, PUBL ASTRON SOC PAC, V111, P227, DOI 10.1086/316319; Laureijs R., 2011, ARXIV11103193; LSST Science Collaboration, 2009, ARXIV09120201; Mandelbaum R, 2014, ASTROPHYS J SUPPL S, V212, DOI 10.1088/0067-0049/212/1/5; Mandelbaum R, 2012, MON NOT R ASTRON SOC, V420, P1518, DOI 10.1111/j.1365-2966.2011.20138.x; Massey R, 2013, MON NOT R ASTRON SOC, V429, P661, DOI 10.1093/mnras/sts371; Melchior P, 2011, MON NOT R ASTRON SOC, V412, P1552, DOI 10.1111/j.1365-2966.2010.17875.x; Miller L, 2013, MON NOT R ASTRON SOC, V429, P2858, DOI 10.1093/mnras/sts454; Nissen S., 2003, TECH REP IMPLEMENTAT; Nurbaeva G., 2014, ARXIV14113193; Nurbaeva G, 2011, ASTRON ASTROPHYS, V531, DOI 10.1051/0004-6361/201116556; Okura Y, 2013, ASTROPHYS J, V771, DOI 10.1088/0004-637X/771/1/37; Okura Y, 2012, ASTROPHYS J, V748, DOI 10.1088/0004-637X/748/2/112; Okura Y, 2011, ASTROPHYS J, V730, DOI 10.1088/0004-637X/730/1/9; Rojas R., 1996, NEURAL NETWORKS SYST; Rowe B, 2011, ASTROPHYS J, V741, DOI 10.1088/0004-637X/741/1/46; Rowe BTP, 2015, ASTRON COMPUT, V10, P121, DOI 10.1016/j.ascom.2015.02.002; Sheldon ES, 2014, MON NOT R ASTRON SOC, V444, pL25, DOI 10.1093/mnrasl/slu104; Spergel D., 2013, ARXIV13055422; Tewes M, 2012, ASTRON ASTROPHYS, V544, DOI 10.1051/0004-6361/201219278; Zhang J, 2011, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2011/11/041; Zhang J, 2010, MON NOT R ASTRON SOC, V403, P673, DOI 10.1111/j.1365-2966.2009.16168.x; Zhang J, 2015, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2015/01/024; Zhang J, 2008, MON NOT R ASTRON SOC, V383, P113, DOI 10.1111/j.1365-2966.2007.12585.x	84	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-8711	1365-2966		MON NOT R ASTRON SOC	Mon. Not. Roy. Astron. Soc.	JUL 1	2015	450	3					2963	3007		10.1093/mnras/stv781		45	Astronomy & Astrophysics	Astronomy & Astrophysics	CK6LJ	WOS:000356339300054		
J	Kurtz, DW; Shibahashi, H; Murphy, SJ; Bedding, TR; Bowman, DM				Kurtz, Donald W.; Shibahashi, Hiromoto; Murphy, Simon J.; Bedding, Timothy R.; Bowman, Dominic M.			A unifying explanation of complex frequency spectra of gamma Dor, SPB and Be stars: combination frequencies and highly non-sinusoidal light curves	MONTHLY NOTICES OF THE ROYAL ASTRONOMICAL SOCIETY			English	Article						asteroseismology; stars: emission-line; Be; stars: interiors; stars: oscillations	DELTA-SCUTI STARS; TO-CORE ROTATION; FIELD-OF-VIEW; DORADUS STARS; ASTEROSEISMIC MEASUREMENT; MAIN-SEQUENCE; KEPLER	There are many Slowly Pulsating B (SPB) stars and gamma Dor stars in the Kepler mission data set. The light curves of these pulsating stars have been classified phenomenologically into stars with symmetric light curves and with asymmetric light curves. In the same effective temperature ranges as the gamma Dor and SPB stars, there are variable stars with downward light curves that have been conjectured to be caused by spots. Among these phenomenological classes of stars, some show 'frequency groups' in their amplitude spectra that have not previously been understood. While it has been recognized that non-linear pulsation gives rise to combination frequencies in a Fourier description of the light curves of these stars, such combination frequencies have been considered to be a only a minor constituent of the amplitude spectra. In this paper, we unify the Fourier description of the light curves of these groups of stars, showing that many of them can be understood in terms of only a few base frequencies, which we attribute to g-mode pulsations, and combination frequencies, where sometimes a very large number of combination frequencies dominate the amplitude spectra. The frequency groups seen in these stars are thus tremendously simplified. We show observationally that the combination frequencies can have amplitudes greater than the base frequency amplitudes, and we show theoretically how this arises. Thus for some gamma Dor and SPB stars, combination frequencies can have the highest observed amplitudes. Among the B stars are pulsating Be stars that show emission lines in their spectra from occasional ejection of material into a circumstellar disc. Our analysis gives strong support to the understanding of these pulsating Be stars as rapidly rotating SPB stars, explained entirely by g-mode pulsations.	[Kurtz, Donald W.; Bowman, Dominic M.] Univ Cent Lancashire, Jeremiah Horrocks Inst, Preston PR1 2HE, Lancs, England; [Shibahashi, Hiromoto] Univ Tokyo, Sch Sci, Dept Astron, Bunkyo Ku, Tokyo 1130033, Japan; [Murphy, Simon J.; Bedding, Timothy R.] Univ Sydney, Sch Phys, Sydney Inst Astron, Sydney, NSW 2006, Australia; [Murphy, Simon J.; Bedding, Timothy R.] Aarhus Univ, Dept Phys & Astron, Stellar Astrophys Ctr, DK-8000 Aarhus C, Denmark	Kurtz, DW (reprint author), Univ Cent Lancashire, Jeremiah Horrocks Inst, Preston PR1 2HE, Lancs, England.	dwkurtz@uclan.ac.uk			Japan Society for the Promotion of Science (JSPS); Australian Research Council; Danish National Research Foundation [DNRF106]; ASTERISK project (ASTERoseismic Investigations with SONG and Kepler) - European Research Council [267864]	DWK thanks the Japan Society for the Promotion of Science (JSPS) for an Invitation Fellowship, during which much of this work was carried out at the University of Tokyo. We thank professor Hideyuki Saio and Dr Masao Takata for useful discussions. This research was supported by the Australian Research Council. Funding for the Stellar Astrophysics Centre is provided by the Danish National Research Foundation (grant agreement no.: DNRF106). The research is supported by the ASTERISK project (ASTERoseismic Investigations with SONG and Kepler) funded by the European Research Council (grant agreement no.: 267864).	Aerts C, 2006, ESA SP, V624, P131; Aerts C., 2010, ASTRON ASTROPHYS LIB; SIMON NR, 1981, ASTROPHYS J, V248, P291, DOI 10.1086/159153; Bouabid MP, 2013, MON NOT R ASTRON SOC, V429, P2500, DOI 10.1093/mnras/sts517; Kurtz DW, 2014, MON NOT R ASTRON SOC, V444, P102, DOI 10.1093/mnras/stu1329; Papics PI, 2012, ASTRON NACHR, V333, P1053, DOI 10.1002/asna.201211809; Pigulski A, 2009, ACTA ASTRONOM, V59, P33; Shibahashi H, 2012, MON NOT R ASTRON SOC, V422, P738, DOI 10.1111/j.1365-2966.2012.20654.x; Saio H, 2015, MON NOT R ASTRON SOC, V447, P3264, DOI 10.1093/mnras/stu2696; Degroote P, 2009, ASTRON ASTROPHYS, V506, P471, DOI 10.1051/0004-6361/200911884; Balona LA, 2012, MON NOT R ASTRON SOC, V422, P1092, DOI 10.1111/j.1365-2966.2012.20682.x; Balona LA, 2011, MON NOT R ASTRON SOC, V413, P2403, DOI 10.1111/j.1365-2966.2011.18311.x; Balona LA, 2011, MON NOT R ASTRON SOC, V415, P3531, DOI 10.1111/j.1365-2966.2011.18973.x; Bedding T. R., 2014, PREPRINT; Bradley PA, 2015, ASTRON J, V149, DOI 10.1088/0004-6256/149/2/68; Breger M, 2006, ASTRON ASTROPHYS, V460, P167, DOI 10.1051/0004-6361:20065808; Breger M, 2012, ASTROPHYS J, V759, DOI 10.1088/0004-637X/759/1/62; Debosscher J, 2011, ASTRON ASTROPHYS, V529, DOI 10.1051/0004-6361/201015647; Dylan Kee N., 2014, PREPRINT; Huber D, 2014, ASTROPHYS J SUPPL S, V211, DOI 10.1088/0067-0049/211/1/2; KURTZ DW, 1985, MON NOT R ASTRON SOC, V213, P773; Lenz P., 2004, P IAU S, V224, P786; McNamara BJ, 2012, ASTRON J, V143, DOI 10.1088/0004-6256/143/4/101; Montgomery MH, 2005, ASTROPHYS J, V633, P1142, DOI 10.1086/466511; Breger M, 2014, ASTROPHYS J, V783, DOI 10.1088/0004-637X/783/2/89; Montgomery M. H., 1999, DELTA SCUTI STAR NEW, V13, P28; Murphy SJ, 2013, MON NOT R ASTRON SOC, V432, P2284, DOI 10.1093/mnras/stt587; Rivinius T, 2003, ASTRON ASTROPHYS, V411, P229, DOI 10.1051/0004-6361:20031285; Tkachenko A, 2013, ASTRON ASTROPHYS, V556, DOI 10.1051/0004-6361/201220978; Unno W., 1989, NONRADIAL OSCILLATIO; Van Reeth T, 2015, ASTRON ASTROPHYS, V574, DOI 10.1051/0004-6361/201424585; Wu YQ, 2001, MON NOT R ASTRON SOC, V323, P248, DOI 10.1046/j.1365-8711.2001.04224.x	32	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-8711	1365-2966		MON NOT R ASTRON SOC	Mon. Not. Roy. Astron. Soc.	JUL 1	2015	450	3					3015	3029		10.1093/mnras/stv868		15	Astronomy & Astrophysics	Astronomy & Astrophysics	CK6LJ	WOS:000356339300056		
J	Kobae, Y; Kawachi, M; Saito, K; Kikuchi, Y; Ezawa, T; Maeshima, M; Hata, S; Fujiwara, T				Kobae, Yoshihiro; Kawachi, Miki; Saito, Katsuharu; Kikuchi, Yusuke; Ezawa, Tatsuhiro; Maeshima, Masayoshi; Hata, Shingo; Fujiwara, Toru			Up-regulation of genes involved in N-acetylglucosamine uptake and metabolism suggests a recycling mode of chitin in intraradical mycelium of arbuscular mycorrhizal fungi	MYCORRHIZA			English	Article						Arbuscular mycorrhizal fungi; Chitin recycling; N-acetylglucosamine (GlcNAc) transporter; Rhizophagus irregularis	MEDICAGO-TRUNCATULA ROOTS; SACCHAROMYCES-CEREVISIAE; CANDIDA-ALBICANS; CELL-WALL; ORGAN-CULTURES; GLOMUS SP; TRANSPORTER; PLANT; EXPRESSION; SYMBIOSIS	Arbuscular mycorrhizal (AM) fungi colonize roots and form two kinds of mycelium, intraradical mycelium (IRM) and extraradical mycelium (ERM). Arbuscules are characteristic IRM structures that highly branch within host cells in order to mediate resource exchange between the symbionts. They are ephemeral structures and at the end of their life span, arbuscular branches collapse from the tip, fungal cytoplasm withdraws, and the whole arbuscule shrinks into fungal clumps. The exoskeleton of an arbuscule contains structured chitin, which is a polymer of N-acetylglucosamine (GlcNAc), whereas a collapsed arbuscule does not. The molecular mechanisms underlying the turnover of chitin in AM fungi remain unknown. Here, a GlcNAc transporter, RiNGT, was identified from the AM fungus Rhizophagus irregularis. Yeast mutants defective in endogenous GlcNAc uptake and expressing RiNGT took up C-14-GlcNAc, and the optimum uptake was at acidic pH values (pH 4.0-4.5). The transcript levels of RiNGT in IRM in mycorrhizal Lotus japonicus roots were over 1000 times higher than those in ERM. GlcNAc-6-phosphate deacetylase (DAC1) and glucosamine-6-phosphate isomerase (NAG1) genes, which are related to the GlcNAc catabolism pathway, were also induced in IRM. Altogether, data suggest the existence of an enhanced recycling mode of GlcNAc in IRM of AM fungi.	[Kobae, Yoshihiro; Fujiwara, Toru] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo 1138657, Japan; [Kawachi, Miki; Maeshima, Masayoshi] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Saito, Katsuharu] Shinshu Univ, Fac Agr, Nagano 3994598, Japan; [Kikuchi, Yusuke; Ezawa, Tatsuhiro] Hokkaido Univ, Grad Sch Agr, Sapporo, Hokkaido 0608589, Japan; [Hata, Shingo] Ryukoku Univ, Inst Agr, Fushimi Ku, Kyoto 6128577, Japan	Kobae, Y (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo 1138657, Japan.	akobae@mail.ecc.u-tokyo.ac.jp	Ezawa, Tatsuhiro/B-7735-2012	Ezawa, Tatsuhiro/0000-0001-6188-7635	project Network of Center of Carbon Dioxide Resource Studies in Plants (NC-CARP) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics for Agricultural Innovation) [PMI-0003]; Ministry of Education, Culture, Sports, Science and Technology of Japan [22128006]; Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry	This work was supported in part by the project Network of Center of Carbon Dioxide Resource Studies in Plants (NC-CARP) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. This work was also supported by the Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics for Agricultural Innovation, PMI-0003); the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant in Aid for Scientific Research on Innovative Areas 'Genome Science and Genetic Bases for the Evolution of Complex Adaptive Traits', No. 22128006); and the Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry to K.S. We thank E. Boles (University of Frankfurt) for providing EBY.VW4000. We appreciated the much help by the research assistant Ms. Reika Oguchi (Shinshu University). The authors thank Stefan Reuscher (Nagoya University) for proofreading.	ALEXANDER T, 1989, CAN J BOT, V67, P2505; Gutjahr C, 2013, ANNU REV CELL DEV BI, V29, P593, DOI 10.1146/annurev-cellbio-101512-122413; Kobae Y, 2010, PLANT CELL PHYSIOL, V51, P341, DOI 10.1093/pcp/pcq013; SAITO M, 1995, NEW PHYTOL, V129, P425, DOI 10.1111/j.1469-8137.1995.tb04313.x; Hogekamp C, 2011, PLANT PHYSIOL, V157, P2023, DOI 10.1104/pp.111.186635; Helber N, 2011, PLANT CELL, V23, P3812, DOI 10.1105/tpc.111.089813; Tisserant E, 2013, P NATL ACAD SCI USA, V110, P20117, DOI 10.1073/pnas.1313452110; Alvarez FJ, 2007, MOL BIOL CELL, V18, P965, DOI 10.1091/mbc.E06-10-0931; Schussler A, 2006, NATURE, V444, P933, DOI 10.1038/nature05364; Rasmussen S, 2012, NEW PHYTOL, V196, P7, DOI 10.1111/j.1469-8137.2012.04250.x; Vierheilig H, 2005, PHYSIOL PLANTARUM, V125, P393, DOI 10.1111/j.1399-3054.2005.00564.x; Olsson PA, 1999, SOIL BIOL BIOCHEM, V31, P1879, DOI 10.1016/S0038-0717(99)00119-4; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Wieczorke R, 1999, FEBS LETT, V464, P123, DOI 10.1016/S0014-5793(99)01698-1; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; Maillet F, 2011, NATURE, V469, P58, DOI 10.1038/nature09622; TISDALL JM, 1980, AUST J SOIL RES, V18, P423, DOI 10.1071/SR9800423; Shibuya N, 2001, PHYSIOL MOL PLANT P, V59, P223, DOI 10.1006/pmpp.2001.0364; Kikuchi Y, 2014, NEW PHYTOL, V204, P638, DOI 10.1111/nph.12937; BONFANTEFASOLO P, 1990, MYCOL RES, V94, P157; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Tisserant E, 2012, NEW PHYTOL, V193, P755, DOI 10.1111/j.1469-8137.2011.03948.x; MA H, 1987, GENE, V58, P201, DOI 10.1016/0378-1119(87)90376-3; Duo-Chuan L, 2006, MYCOPATHOLOGIA, V161, P345, DOI 10.1007/s11046-006-0024-y; Adams DJ, 2004, MICROBIOL-SGM, V150, P2029, DOI 10.1099/mic.0.26980-0; TOTH R, 1984, AM J BOT, V71, P449, DOI 10.2307/2443320; Mio T, 1998, J BIOL CHEM, V273, P14392, DOI 10.1074/jbc.273.23.14392; Bago B, 2005, SOIL BIOL, V4, P111; Bonanomi A, 2001, PLANT BIOLOGY, V3, P194, DOI 10.1055/s-2001-12902; Bonfante-Fasolo P., 1984, VA MYCORRHIZAE, P5; Elfstrand M, 2005, NEW PHYTOL, V167, P557, DOI 10.1111/j.1469-8137.2005.01397.x; Genre A, 2013, NEW PHYTOL, V198, P179, DOI 10.1111/nph.12146; Gilmore SA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003799; Guttenberger M, 2000, PLANTA, V211, P299, DOI 10.1007/s004250000324; Kobae Y, 2014, SOIL SCI PLANT NUTR, V60, P843, DOI 10.1080/00380768.2014.949854; Kobae Y, 2014, PLANT CELL PHYSIOL, V55, P1945, DOI 10.1093/pcp/pcu123; Kobae Y, 2014, PLANT CELL PHYSIOL, V55, P1497, DOI 10.1093/pcp/pcu081; Konopka JB, 2012, SCIENTIFICA, V2012, DOI DOI 10.6064/2012/489208; Krajinski F, 2014, PLANT CELL, V26, P1808, DOI 10.1105/tpc.113.120436; Lenardon MD, 2007, MOL MICROBIOL, V66, P1164, DOI 10.1111/j.1365-2958.2007.05990.x; Mio T, 2000, BBA-GENE STRUCT EXPR, V1492, P369, DOI 10.1016/S0167-4781(00)00120-2; MOSSE B, 1975, PHYSIOL PLANT PATHOL, V5, P215, DOI 10.1016/0048-4059(75)90088-0; Munro CA, 2003, FUNGAL GENET BIOL, V40, P146, DOI 10.1016/S1087-1845(03)00083-5; Rich MK, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00238; Salzer P, 2000, MOL PLANT MICROBE IN, V13, P763, DOI 10.1094/MPMI.2000.13.7.763; Scarcelli JJ, 2012, FEMS YEAST RES, V12, P305, DOI 10.1111/j.1567-1364.2011.00778.x; Smith SE, 2001, AUST J PLANT PHYSIOL, V28, P683; Solaiman MZ, 2000, J PLANT RES, V113, P443; TANAKA K, 1990, MOL CELL BIOL, V10, P4303; Treseder KK, 2010, SOIL BIOL BIOCHEM, V42, P1657, DOI 10.1016/j.soilbio.2010.06.005; Wahl R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000303	51	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0940-6360	1432-1890		MYCORRHIZA	Mycorrhiza	JUL	2015	25	5					411	417		10.1007/s00572-014-0623-2		7	Mycology	Mycology	CK0YQ	WOS:000355932200008		
J	Wada, T; Murata, N; Suzuki, T; Uehara, H; Nitani, H; Niwa, Y; Uo, M; Asakura, K				Wada, Takahiro; Murata, Naoyoshi; Suzuki, Takuya; Uehara, Hiromitsu; Nitani, Hiroaki; Niwa, Yasuhiro; Uo, Motohiro; Asakura, Kiyotaka			Improvement of a Real Gas-Sensor for the Origin of Methane Selectivity Degradation by mu-XAFS Investigation	NANO-MICRO LETTERS			English	Article						Micro gas sensor; Micro-XAFS; Pd/Al2O3; Deactivation	X-RAY OPTICS; THIN-FILM BILAYER; POLYCAPILLARY-OPTICS; MICRO-XANES; FLUORESCENCE; SURFACE; BEAMLINE; CATALYST; FACILITY; HEATER	We have directly investigated the chemical state of the Pd species in a real mu-gas sensor device by examining the mu-fluorescence X-ray absorption fine structure. The mu-gas sensor device was heavily damaged by a heating process in which the temperature was ill-controlled, resulting in decrease of methane selectivity. We found that the PdO in the fresh mu-gas sensor was reduced to Pd metal particles as the methane selectivity decreased. Based on the investigation results, we modified the device structure so as to heat up homogeneously. The lifetime of the sensor was then successfully increased by more than 5 years.	[Wada, Takahiro; Uo, Motohiro] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Tokyo 1138549, Japan; [Murata, Naoyoshi; Suzuki, Takuya] Fuji Elect Co Ltd, Corp R&D Headquarters, Tokyo 1918502, Japan; [Uehara, Hiromitsu; Asakura, Kiyotaka] Hokkaido Univ, Catalysis Res Ctr, Sapporo, Hokkaido 0010021, Japan; [Nitani, Hiroaki; Niwa, Yasuhiro] KEK, Inst Mat Struct Sci, Photon Factory, Tsukuba, Ibaraki 3050801, Japan	Wada, T (reprint author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Tokyo 1138549, Japan.	wada.abm@tmd.ac.jp; askr@cat.hokudai.ac.jp	Asakura, Kiyotaka/G-6052-2010	Asakura, Kiyotaka/0000-0003-1077-5996	New Energy and Industrial Technology Development Organization (NEDO)	All XAFS measurements were conducted at the Photon Factory, High Energy Accelerator Organization under Proposal Number 2012G680. The investigation was performed under the support of the New Energy and Industrial Technology Development Organization (NEDO).	Sun TX, 2008, SPECTROCHIM ACTA B, V63, P76, DOI 10.1016/j.sab.2007.11.003; Wang CX, 2010, SENSORS-BASEL, V10, P2088, DOI 10.3390/s100302088; Cheng L, 2007, SPECTROCHIM ACTA B, V62, P817, DOI 10.1016/j.sab.2007.06.010; Sugiyama T, 2015, BIOMETALS, V28, P11, DOI 10.1007/s10534-014-9796-6; HAMILTON WC, 1965, ACTA CRYSTALLOGR, V18, P502, DOI 10.1107/S0365110X65001081; Sun TX, 2006, J APPL PHYS, V99, DOI 10.1063/1.2193050; Gao N, 1996, APPL PHYS LETT, V69, P1529, DOI 10.1063/1.117994; Ding X, 2000, P SOC PHOTO-OPT INS, V4144, P174, DOI 10.1117/12.405891; JONES MG, 1991, APPL CATAL, V70, P277; Suzuki T, 2005, SENSOR ACTUAT B-CHEM, V109, P185, DOI 10.1016/j.snb.2005.05.013; Sun TX, 2007, CHEM PHYS LETT, V439, P412, DOI 10.1016/j.cplett.2007.03.105; KUMAKHOV MA, 1990, NUCL INSTRUM METH B, V48, P283, DOI 10.1016/0168-583X(90)90123-C; KUMAKHOV MA, 1990, PHYS REP, V191, P289, DOI 10.1016/0370-1573(90)90135-O; Jehng JM, 1996, J MOL CATAL A-CHEM, V110, P41, DOI 10.1016/1381-1169(96)00061-1; Tsuji K, 2007, SPECTROCHIM ACTA B, V62, P549, DOI 10.1016/j.sab.2007.02.014; Schields PJ, 2002, POWDER DIFFR, V17, P70, DOI 10.1154/1.1482080; Peng S, 2014, ANAL CHEM, V86, P362, DOI 10.1021/ac403188k; Bjeoumikhov A, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1938847; Gao N., 2005, XRAY SPECTROMETRY RE, P89; GIBSON WM, 1993, P SOC PHOTO-OPT INS, V1736, P172, DOI 10.1117/12.140473; Hirao N., 2011, J SURF ANAL, V17, P227; Kim JC, 1997, SENSOR ACTUAT B-CHEM, V45, P271, DOI 10.1016/S0925-4005(97)00325-0; Kobayashi M., 2009, Jpn. Patent, Patent No. [JP4376093, 4376093]; Murata N, 2013, PHYS CHEM CHEM PHYS, V15, P17938, DOI 10.1039/c3cp52490f; Nomura M, 2007, AIP CONF PROC, V882, P896; Okumura K, 2004, J PHYS CHEM B, V108, P6250, DOI 10.1021/jp037187b; Silversmit G, 2009, J SYNCHROTRON RADIAT, V16, P237, DOI 10.1107/S0909049508043306; Sun TX, 2014, NUCL INSTRUM METH B, V323, P25, DOI 10.1016/j.nimb.2014.01.013; Suzuki T., 2006, Jpn. Patent, Patent No. [JP3812215, 3812215]; Tabata S, 2005, SENSOR ACTUAT B-CHEM, V109, P190, DOI 10.1016/j.snb.2005.05.012; Taguchi T, 2007, AIP CONF PROC, V882, P162; Uo M, 2010, CHEM LETT, V39, P852, DOI 10.1246/cl.2010.852; Vincze L, 2002, J ANAL ATOM SPECTROM, V17, P177, DOI 10.1039/b110210a	33	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	2311-6706	2150-5551		NANO-MICRO LETT	Nano-Micro Lett.	JUL	2015	7	3					255	260		10.1007/s40820-015-0035-7		6	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Science & Technology - Other Topics; Materials Science; Physics	CL2UV	WOS:000356802100004		
J	Wakamura, T; Akaike, H; Omori, Y; Niimi, Y; Takahashi, S; Fujimaki, A; Maekawa, S; Otani, Y				Wakamura, T.; Akaike, H.; Omori, Y.; Niimi, Y.; Takahashi, S.; Fujimaki, A.; Maekawa, S.; Otani, Y.			Quasiparticle-mediated spin Hall effect in a superconductor	NATURE MATERIALS			English	Article							FERROMAGNET	In some materials the competition between superconductivity and magnetism brings about a variety of unique phenomena such as the coexistence of superconductivity and magnetism in heavy-fermion superconductors(1) or spin-triplet supercurrent in ferromagnetic Josephson junctions(2-4). Recent observations of spin-charge separation in a lateral spin valve with a superconductor(5,6) evidence that these remarkable properties are applicable to spintronics(7), although there are still fewworks exploring this possibility. Here, we report the experimental observation of the quasiparticle-mediated spin Hall effect in a superconductor, NbN. This compound exhibits the inverse spin Hall (ISH) effect(8) even below the superconducting transition temperature. Surprisingly, the ISH signal increases by more than 2,000 times compared with that in the normal state with a decrease of the injected spin current. The effect disappears when the distance between the voltage probes becomes larger than the charge imbalance length(9,10), corroborating that the huge ISH signals measured are mediated by quasiparticles.	[Wakamura, T.; Omori, Y.; Niimi, Y.; Otani, Y.] Univ Tokyo, Inst Solid State Phys, Kashiwa, Chiba 2778581, Japan; [Akaike, H.; Fujimaki, A.] Nagoya Univ, Dept Quantum Engn, Nagoya, Aichi 4648603, Japan; [Takahashi, S.] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan; [Maekawa, S.] Japan Sci & Technol, CREST, Tokyo 1020075, Japan; [Maekawa, S.] Japan Atom Energy Agcy, Adv Sci Res Ctr, Tokai, Ibaraki 3191195, Japan; [Otani, Y.] RIKEN, CEMS, Wako, Saitama 3510198, Japan	Otani, Y (reprint author), Univ Tokyo, Inst Solid State Phys, Kashiwa, Chiba 2778581, Japan.	yotani@issp.u-tokyo.ac.jp	Takahashi, Saburo/A-8472-2011; Niimi, Yasuhiro/E-1548-2014; OTANI, Yoshichika/I-5884-2012	Niimi, Yasuhiro/0000-0003-1659-0634; OTANI, Yoshichika/0000-0001-8008-1493	KAKENHI	The authors acknowledge helpful discussions with H. Adachi, S. Hikino and Y. Ohnuma. We also would like to thank Y. Iye and S. Katsumoto for the use of the lithography facilities. This work is partly supported by KAKENHI.	Akaike H, 2013, IEEE T APPL SUPERCON, V23, DOI 10.1109/TASC.2013.2242511; Niimi Y, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.156602; Jedema FJ, 2002, NATURE, V416, P713, DOI 10.1038/416713a; Takahashi S, 2008, J PHYS SOC JPN, V77, DOI 10.1143/JPSJ.77.031009; Kimura T, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.156601; Matsuda Y, 2007, J PHYS SOC JPN, V76, DOI 10.1143/JPSJ.76.051005; Robinson JWA, 2010, SCIENCE, V329, P59, DOI 10.1126/science.1189246; Wakamura T, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.036602; Khaire TS, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.137002; Cadden-Zimansky P, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.237003; Liu LQ, 2012, SCIENCE, V336, P555, DOI 10.1126/science.1218197; Valenzuela SO, 2006, NATURE, V442, P176, DOI 10.1038/nature04937; Yang H, 2010, NAT MATER, V9, P586, DOI [10.1038/nmat2781, 10.1038/NMAT2781]; Keizer RS, 2006, NATURE, V439, P825, DOI 10.1038/nature04499; Quay CHL, 2013, NAT PHYS, V9, P84, DOI 10.1038/nphys2518; Saitoh E, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2199473; Arutyunov KY, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.104509; Cirlden-Zimansky P, 2007, NEW J PHYS, V9, P116; Hubler F, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.184524; Hubler F, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.207001; Kontani H., 2009, PHYS REV LETT, V102; Niimi Y, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.054401; SHOJI A, 1992, APPL PHYS LETT, V60, P1624, DOI 10.1063/1.107220; Takahashi S, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.010110; Takahashi S, 2002, J MAGN MAGN MATER, V240, P100, DOI 10.1016/S0304-8853(01)00714-4; Takahashi S., 1999, PHYS REV LETT, V88; Tinkham M., 2004, INTRO SUPERCONDUCTIV; Wakamura T, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.063002; Yamashita T, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.172509; Hikino S, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.020512	30	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1476-1122	1476-4660		NAT MATER	Nat. Mater.	JUL	2015	14	7					675	+		10.1038/NMAT4276		5	Chemistry, Physical; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Materials Science; Physics	CL0KI	WOS:000356631200016		
J	Huang, ZF; Bartels, M; Xu, R; Osterhoff, M; Kalbfleisch, S; Sprung, M; Suzuki, A; Takahashi, Y; Blanton, TN; Salditt, T; Miao, JW				Huang, Zhifeng; Bartels, Matthias; Xu, Rui; Osterhoff, Markus; Kalbfleisch, Sebastian; Sprung, Michael; Suzuki, Akihiro; Takahashi, Yukio; Blanton, Thomas N.; Salditt, Tim; Miao, Jianwei			Grain rotation and lattice deformation during photoinduced chemical reactions revealed by in situ X-ray nanodiffraction	NATURE MATERIALS			English	Article							THIN-FILMS; GROWTH; RESOLUTION; SILVER; GOLD; NANOCRYSTALS; MICROSCOPY	In situ X-ray diffraction (XRD) and transmission electron microscopy (TEM) have been used to investigate many physical science phenomena, ranging from phase transitions, chemical reactions and crystal growth to grain boundary dynamics(1-6). A major limitation of in situ XRD and TEM is a compromise that has to be made between spatial and temporal resolution(1-6). Here, we report the development of in situ X-ray nanodiffraction to measure high-resolution diffraction patterns from single grains with up to 5 ms temporal resolution. We observed, for the first time, grain rotation and lattice deformation in chemical reactions induced by X-ray photons: Br- + hv -> Br + e(-) and e(-) + Ag+ -> Ag-0. The grain rotation and lattice deformation associated with the chemical reactions were quantified to be as fast as 3.25 rad s(-1) and as large as 0.5 angstrom, respectively. The ability to measure high-resolution diffraction patterns from individual grains with a temporal resolution of several milliseconds is expected to find broad applications in materials science, physics, chemistry and nanoscience.	[Huang, Zhifeng; Xu, Rui; Miao, Jianwei] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA; [Huang, Zhifeng; Xu, Rui; Miao, Jianwei] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA; [Bartels, Matthias; Osterhoff, Markus; Kalbfleisch, Sebastian; Salditt, Tim] Univ Gottingen, Inst Rontgenphys, D-37077 Gottingen, Germany; [Sprung, Michael] DESY, D-22607 Hamburg, Germany; [Suzuki, Akihiro; Takahashi, Yukio] Osaka Univ, Grad Sch Engn, Dept Precis Sci & Technol, Suita, Osaka 5650871, Japan; [Blanton, Thomas N.] Eastman Kodak Co, Kodak Technol Ctr, Rochester, NY 14650 USA	Miao, JW (reprint author), Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA.	miao@physics.ucla.edu	Osterhoff, Markus/F-7967-2015	Osterhoff, Markus/0000-0002-7865-515X	DARPA PULSE program from AMRDEC; Helmholtz Society [VH-VI-403, DFG SFB755]; Office of Basic Energy Sciences of the US Department of Energy [DE-FG02-13ER46943]; ONR MURI [N00014-14-1-0675]; NSF [DMR-1437263]	We thank I. Vartaniants for stimulating discussions and A. Zozulya for help with the experiments. This work was supported by the DARPA PULSE program through a grant from AMRDEC and Helmholtz Society grants VH-VI-403 and DFG SFB755. This work was also partially funded by the Office of Basic Energy Sciences of the US Department of Energy (Grant No. DE-FG02-13ER46943), ONR MURI (Grant No. N00014-14-1-0675) and NSF (Grant No. DMR-1437263).	Leite ER, 2003, APPL PHYS LETT, V83, P1566, DOI 10.1063/1.1605241; Rocha TCR, 2007, J PHYS CHEM C, V111, P6989, DOI 10.1021/jp0702696; Patterson AL, 1939, PHYS REV, V56, P978, DOI 10.1103/PhysRev.56.978; KIRKLAND AI, 1993, P ROY SOC LOND A MAT, V440, P589, DOI 10.1098/rspa.1993.0035; Gross KJ, 2000, J ALLOY COMPD, V297, P270, DOI 10.1016/S0925-8388(99)00598-8; KE M, 1995, NANOSTRUCT MATER, V5, P689, DOI 10.1016/0965-9773(95)00281-I; Clark JN, 2013, SCIENCE, V341, P56, DOI 10.1126/science.1236034; Shan ZW, 2004, SCIENCE, V305, P654, DOI 10.1126/science.1098741; Zheng HM, 2009, SCIENCE, V324, P1309, DOI 10.1126/science.1172104; Williamson MJ, 2003, NAT MATER, V2, P532, DOI 10.1038/nmat944; Harris KE, 1998, ACTA MATER, V46, P2623, DOI 10.1016/S1359-6454(97)00467-9; Scott MC, 2012, NATURE, V483, P444, DOI 10.1038/nature10934; Diao JK, 2003, NAT MATER, V2, P656, DOI 10.1038/nmat977; Schmidt S, 2004, SCIENCE, V305, P229, DOI 10.1126/science.1098627; Larson BC, 2002, NATURE, V415, P887, DOI 10.1038/415887a; Offerman SE, 2002, SCIENCE, V298, P1003, DOI 10.1126/science.1076681; Miao JW, 2015, SCIENCE, V348, P530, DOI 10.1126/science.aaa1394; Kraft P, 2009, J SYNCHROTRON RADIAT, V16, P368, DOI 10.1107/S0909049509009911; Chen CC, 2013, NATURE, V496, P74, DOI 10.1038/nature12009; Margulies L, 2001, SCIENCE, V291, P2392, DOI 10.1126/science.1057956; Ice GE, 2011, SCIENCE, V334, P1234, DOI 10.1126/science.1202366; BERRY CR, 1950, ACTA CRYSTALLOGR, V3, P219, DOI 10.1107/S0365110X50000549; BURLEY G, 1963, J RES NBS A PHYS CH, VA 67, P301, DOI 10.6028/jres.067A.032; Gurney R. W., P R SOC LOND A, V64; HUBERMAN ML, 1989, PHYS REV LETT, V62, P1403, DOI 10.1103/PhysRevLett.62.1403; Hull D., 2011, INTRO DISLOCATIONS; James T.H., 1977, THEORY PHOTOGRAPHIC; Kruger S. P., 2010, OPT EXPRESS, V18, P13492; PEARSON WB, 1958, HDB LATTICE SPACINGS, P39907; Reimers J. N., J ELECTROCHEM SOC, V139; Salditt T, 2011, OPT EXPRESS, V19, P9656, DOI 10.1364/OE.19.009656; Shvindlerman L.S., 2009, GRAIN BOUNDARY MIGRA; Shyjumon I, 2006, EUR PHYS J D, V37, P409, DOI 10.1140/epjd/e2005-00319-x; Williams D.B., 2009, TRANSMISSION ELECT M	34	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1476-1122	1476-4660		NAT MATER	Nat. Mater.	JUL	2015	14	7					691	+		10.1038/NMAT4311		6	Chemistry, Physical; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Materials Science; Physics	CL0KI	WOS:000356631200019		
J	Akashi, YJ; Nef, HM; Lyon, AR				Akashi, Yoshihiro J.; Nef, Holger M.; Lyon, Alexander R.			Epidemiology and pathophysiology of Takotsubo syndrome	NATURE REVIEWS CARDIOLOGY			English	Review							TAKO-TSUBO CARDIOMYOPATHY; APICAL BALLOONING SYNDROME; ACUTE MYOCARDIAL-INFARCTION; STRESS-INDUCED CARDIOMYOPATHY; TERM-FOLLOW-UP; ST-SEGMENT ELEVATION; LEFT-VENTRICULAR DYSFUNCTION; COUPLED RECEPTOR KINASE-5; IN-HOSPITAL MORTALITY; CLINICAL CHARACTERISTICS	Takotsubo syndrome is an acute cardiac syndrome first described in 1990 and characterized by transient left ventricular dysfunction affecting more than one coronary artery territory, often in a circumferential apical, mid-ventricular, or basal distribution. Several pathophysiological explanations have been proposed for this syndrome and its intriguing appearance, and awareness is growing that these explanations might not be mutually exclusive. The reversible apical myocardial dysfunction observed might result from more than one pathophysiological phenomenon. The pathophysiology of Takotsubo syndrome is complex and integrates neuroendocrine physiology, potentially involving the cognitive centres of the brain, and including the hypothalamic-pituitary-adrenal axis. Cardiovascular responses are caused by the sudden sympathetic activation and surge in concentrations of circulating catecholamines. The multiple morphological changes seen in the myocardium match those seen after catecholamine-induced cardiotoxicity. The acute prognosis and recurrence rate are now known to be worse than initially thought, and much still needs to be learned about the epidemiology and the underlying pathophysiology of this fascinating condition in order to improve diagnostic and treatment pathways.	[Akashi, Yoshihiro J.] St Marianna Univ, Sch Med, Dept Internal Med, Div Cardiol,Miyamae Ku, Kawasaki, Kanagawa 2168511, Japan; [Nef, Holger M.] Univ Giessen Klinikum, Med Klin 1, Kardiol & Angiol, D-35392 Giessen, Germany; [Lyon, Alexander R.] Royal Brompton Hosp, NIHR Cardiovasc Biomed Res Unit, London SW3 6NP, England; [Lyon, Alexander R.] Univ London Imperial Coll Sci Technol & Med, London SW3 6NP, England	Akashi, YJ (reprint author), St Marianna Univ, Sch Med, Dept Internal Med, Div Cardiol,Miyamae Ku, 2-16-1 Sugao, Kawasaki, Kanagawa 2168511, Japan.	yoakashi-circ@umin.ac.jp	Akashi, Yoshihiro/E-5227-2011	Akashi, Yoshihiro/0000-0001-7670-7326			Akashi YJ, 2005, EUR J HEART FAIL, V7, P1171, DOI 10.1016/j.ejheart.2005.03.011; Angelini P, 2008, CATHETER CARDIO INTE, V71, P342, DOI 10.1002/ccd.21338; Sharkey SW, 2010, J AM COLL CARDIOL, V55, P333, DOI 10.1016/j.jacc.2009.08.057; Spinelli L, 2010, EUR J HEART FAIL, V12, P13, DOI 10.1093/eurjhf/hfp173; Wilkinson DJC, 1998, ARCH GEN PSYCHIAT, V55, P511, DOI 10.1001/archpsyc.55.6.511; Kosuge M, 2014, J ELECTROCARDIOL, V47, P684, DOI 10.1016/j.jelectrocard.2014.03.004; Johnson NP, 2013, INT J CARDIOL, V164, P345, DOI 10.1016/j.ijcard.2011.07.029; Jaguszewski M, 2014, EUR HEART J, V35, P999, DOI 10.1093/eurheartj/eht392; Song BG, 2010, HEART LUNG, V39, P188, DOI 10.1016/j.hrtlng.2009.07.006; Eshtehardi P, 2009, INT J CARDIOL, V135, P370, DOI 10.1016/j.ijcard.2008.03.088; Shimizu M, 2014, CIRC J, V78, P943, DOI 10.1253/circj.CJ-13-1296; Ling SH, 2006, CLIN SCI, V111, P107, DOI 10.1042/CS20050084; Schultz T, 2012, CARDIOLOGY, V122, P180, DOI 10.1159/000338814; Tamura A, 2011, AM J CARDIOL, V108, P630, DOI 10.1016/j.amjcard.2011.04.006; Paur H, 2012, CIRCULATION, V126, P697, DOI 10.1161/CIRCULATIONAHA.112.111591; Bybee KA, 2004, AM J CARDIOL, V94, P343, DOI 10.1016/j.amjcard.2004.04.030; Sharkey SW, 2005, CIRCULATION, V111, P472, DOI 10.1161/01.CIR.0000153801.51470.EB; Tsuchihashi K, 2001, J AM COLL CARDIOL, V38, P11, DOI 10.1016/S0735-1097(01)01316-X; Schneider B, 2014, INT J CARDIOL, V176, P199, DOI 10.1016/j.ijcard.2014.07.002; Maron BJ, 2006, CIRCULATION, V113, P1807, DOI 10.1161/CIRCULATIONAHA.106.174287; Akashi YJ, 2010, ANNU REV MED, V61, P271, DOI 10.1146/annurev.med.041908.191750; Wittstein IS, 2005, NEW ENGL J MED, V352, P539, DOI 10.1056/NEJMoa043046; Ueyama T, 2003, J CARDIOVASC PHARM, V42, pS117, DOI 10.1097/00005344-200312001-00024; Sharma V, 2013, J EMERG MED, V45, pE95, DOI 10.1016/j.jemermed.2012.11.017; Parodi G, 2011, CHEST, V139, P887, DOI 10.1378/chest.10-1041; Kawai S, 2007, CIRC J, V71, P990, DOI 10.1253/circj.71.990; Dib C, 2009, AM HEART J, V157, P933, DOI 10.1016/j.ahj.2008.12.023; Deshmukh A, 2012, AM HEART J, V164, P66, DOI 10.1016/j.ahj.2012.03.020; Singh K, 2014, INT J CARDIOL, V174, P696, DOI 10.1016/j.ijcard.2014.04.221; Patel SM, 2013, J CARD FAIL, V19, P306, DOI 10.1016/j.cardfail.2013.03.007; Previtali M, 2011, AM J CARDIOL, V107, P120, DOI 10.1016/j.amjcard.2010.08.055; Omerovic E, 2011, SCAND CARDIOVASC J, V45, P67, DOI 10.3109/14017431.2011.565794; Singh K, 2014, AM J CARDIOL, V113, P1420, DOI 10.1016/j.amjcard.2014.01.419; El Mahmoud R, 2008, AM HEART J, V156, P543, DOI 10.1016/j.ahj.2008.05.002; Ogura R, 2003, CIRC J, V67, P687; Kurisu S, 2002, AM HEART J, V143, P448, DOI 10.1067/mhj.2002.120403; Liggett SB, 2008, NAT MED, V14, P510, DOI 10.1038/nm1750; Brinjikji W, 2012, AM HEART J, V164, P215, DOI 10.1016/j.ahj.2012.04.010; Lyon AR, 2008, NAT CLIN PRACT CARD, V5, P22, DOI 10.1038/ncpcardio1066; Prasad A, 2008, AM HEART J, V155, P408, DOI 10.1016/j.ahj.2007.11.008; Abe Y, 2003, J AM COLL CARDIOL, V41, P737, DOI 10.1016/S0735-1097(02)02925-X; Mitsuma W, 2007, AM J CARDIOL, V100, P106, DOI 10.1016/j.amjcard.2007.02.062; Szardien S, 2013, INT J CARDIOL, V168, P1685, DOI 10.1016/j.ijcard.2013.03.075; Brouri F, 2004, EUR J PHARMACOL, V485, P227, DOI 10.1016/j.ejphar.2003.11.063; Previtali M, 2009, INT J CARDIOL, V134, P91, DOI 10.1016/j.ijcard.2008.01.037; Kawano H, 2003, HEART VESSELS, V18, P32, DOI 10.1007/s003800300005; Nef HM, 2010, NAT REV CARDIOL, V7, P187, DOI 10.1038/nrcardio.2010.16; Murakami T, 2014, J CARDIOL, V63, P269, DOI 10.1016/j.jjcc.2013.09.003; Kneale BJ, 2000, J AM COLL CARDIOL, V36, P1233, DOI 10.1016/S0735-1097(00)00849-4; Redfors B, 2014, INT J CARDIOL, V174, P330, DOI 10.1016/j.ijcard.2014.04.103; Parodi G, 2014, INT J CARDIOL, V172, P282, DOI 10.1016/j.ijcard.2013.12.239; Patten RD, 2004, CIRC RES, V95, P692, DOI 10.1161/01.RES.0000144126.57786.89; Kurowski V, 2007, CHEST, V132, P809, DOI 10.1378/chest.07-0608; Baudry A, 2010, SCIENCE, V329, P1537, DOI 10.1126/science.1193692; Chesley A, 2000, CIRC RES, V87, P1172; Gianni M, 2006, EUR HEART J, V27, P1523, DOI 10.1093/eurheartj/ehl032; Regnante RA, 2009, AM J CARDIOL, V103, P1015, DOI 10.1016/j.amjcard.2008.12.020; Kosuge M, 2010, J AM COLL CARDIOL, V55, P2514, DOI 10.1016/j.jacc.2009.12.059; Ueyama T, 2007, CIRC J, V71, P565, DOI 10.1253/circj.71.565; Desmet WJR, 2003, HEART, V89, P1027, DOI 10.1136/heart.89.9.1027; Lee PH, 2010, J AM SOC ECHOCARDIOG, V23, P766, DOI 10.1016/j.echo.2010.05.002; Elliott P, 2008, EUR HEART J, V29, P270, DOI 10.1093/eurheartj/ehm342; Akashi YJ, 2008, CIRCULATION, V118, P2754, DOI 10.1161/CIRCULATIONAHA.108.767012; Abraham J, 2009, J AM COLL CARDIOL, V53, P1320, DOI 10.1016/j.jacc.2009.02.020; Kam KWL, 2004, J PHARMACOL EXP THER, V309, P8, DOI 10.1124/jpet.103.058339; Elesber AA, 2007, J AM COLL CARDIOL, V50, P448, DOI 10.1016/j.jacc.2007.03.050; Pilgrim TM, 2008, INT J CARDIOL, V124, P283, DOI 10.1016/j.ijcard.2007.07.002; Nef HM, 2007, EUR HEART J, V28, P2456, DOI 10.1093/eurheartj/ehl570; Shao YZ, 2013, INT J CARDIOL, V168, P1943, DOI 10.1016/j.ijcard.2012.12.092; Isogai T, 2014, INT J CARDIOL, V176, P413, DOI 10.1016/j.ijcard.2014.07.110; Bai M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046921; Bellandi Benedetta, 2012, G Ital Cardiol (Rome), V13, P59, DOI 10.1714/1015.11057; Brenner R, 2012, CLIN CARDIOL, V35, P340, DOI 10.1002/clc.21986; Cacciotti L, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001165; Chan C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068504; Citro R, 2014, JACC-CARDIOVASC IMAG, V7, P119, DOI 10.1016/j.jcmg.2013.09.020; Citro R, 2012, J AM GERIATR SOC, V60, P93, DOI 10.1111/j.1532-5415.2011.03730.x; Cocco G, 2007, EUR J INTERN MED, V18, P369, DOI 10.1016/j.ejim.2007.02.021; Dote K, 1991, J Cardiol, V21, P203; Eitel I, 2011, JAMA-J AM MED ASSOC, V306, P277, DOI 10.1001/jama.2011.992; Figtree GA, 2013, EUR J HEART FAIL, V15, P730, DOI 10.1093/eurjhf/hft040; Hertting K, 2006, INT J CARDIOL, V112, P282, DOI 10.1016/j.ijcard.2005.09.006; Heubach JF, 2003, N-S ARCH PHARMACOL, V367, P380, DOI 10.1007/s00210-002-0681-4; Heubach JF, 2004, MOL PHARMACOL, V65, P1313, DOI 10.1124/mol.65.5.1313; Ieva R, 2013, INT J CARDIOL, V167, pE55, DOI 10.1016/j.ijcard.2013.03.138; Jabara R, 2009, J INVASIVE CARDIOL, V21, P216; Kurisu S, 2004, CIRC J, V68, P77, DOI 10.1253/circj.68.77; Land S., 2014, AM J PHYSL HEART CIR; MORI H, 1993, CARDIOVASC RES, V27, P192, DOI 10.1093/cvr/27.2.192; Nef HM, 2009, EUR J HEART FAIL, V11, P758, DOI 10.1093/eurjhf/hfp076; Nef HM, 2008, J MOL CELL CARDIOL, V44, P395, DOI 10.1016/j.yjmcc.2007.10.015; Nef HM, 2006, MOL CELL BIOCHEM, V282, P53, DOI 10.1007/s11010-006-1171-7; Nef J. M., 2009, EUR HEART J, V30, P2155; Nishida J., HEART VESSE IN PRESS; Nunez-Gil IJ, 2012, REV ESP CARDIOL, V65, P996, DOI [10.1016/j.recesp.2012.04.016, 10.1016/j.rec.2012.04.010]; Otalvaro L, 2011, J THORAC IMAG, V26, pW83, DOI 10.1097/RTI.0b013e3181eebc2d; Patel Sandeep M, 2013, Eur Heart J Acute Cardiovasc Care, V2, P147, DOI 10.1177/2048872613475891; Primetshofer D, 2010, WIEN KLIN WOCHENSCHR, V122, P37, DOI 10.1007/s00508-009-1275-7; Pullara A, 2013, MINERVA MED, V104, P537; Randhawa MS, 2014, J CARD FAIL, V20, P2, DOI 10.1016/j.cardfail.2013.12.004; Redfors B, 2013, MED HYPOTHESES, V81, P954, DOI 10.1016/j.mehy.2013.09.003; Redfors B, 2014, EUR HEART J-CARD IMG, V15, P152, DOI 10.1093/ehjci/jet079; Samardhi H, 2012, INTERN MED J, V42, P35, DOI 10.1111/j.1445-5994.2011.02474.x; Santoro F, 2014, CLIN CARDIOL, V37, P434, DOI 10.1002/clc.22280; Schneider B, 2013, INT J CARDIOL, V166, P584, DOI 10.1016/j.ijcard.2011.11.027; Schneider B, 2013, HEART FAIL CLIN, V9, P137, DOI 10.1016/j.hfc.2012.12.005; Showkathali R, 2014, EUR J INTERN MED, V25, pE78, DOI 10.1016/j.ejim.2014.03.006; Spedicato L, 2008, J CARDIOVASC MED, V9, P916, DOI 10.2459/JCM.0b013e3283027f8e; Stiermaier T, 2014, AM J CARDIOL, V114, P1204, DOI 10.1016/j.amjcard.2014.07.040; Sverrisdottir YB, 2012, CLIN AUTON RES, V22, P259, DOI 10.1007/s10286-012-0162-x; Takashio S, 2012, AM J CARDIOL, V109, P1651, DOI 10.1016/j.amjcard.2012.01.393; Teh AW, 2010, HEART LUNG CIRC, V19, P63, DOI 10.1016/j.hlc.2009.10.002; Vriz O, 2013, J CARDIOVASC MED, V14, P576, DOI 10.2459/JCM.0b013e3283595ab8; Wright PT, 2014, CIRC J, V78, P1550, DOI 10.1253/circj.CJ-14-0623	114	7	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1759-5002	1759-5010		NAT REV CARDIOL	Nat. Rev. Cardiol.	JUL	2015	12	7					387	397		10.1038/nrcardio.2015.39		11	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CK9UA	WOS:000356583800003		
J	Fujisawa, N; Yamagata, T; Takano, S; Saito, K; Morita, R; Fujiwara, K; Inada, F				Fujisawa, Nobuyuki; Yamagata, Takayuki; Takano, Shotaro; Saito, Kengo; Morita, Ryo; Fujiwara, Kazutoshi; Inada, Fumio			The influence of material hardness on liquid droplet impingement erosion	NUCLEAR ENGINEERING AND DESIGN			English	Article								This paper describes the experimental study on the liquid droplet impingement erosion of metal materials to understand the influence of material hardness on the erosion rate. The experiment is carried out using a water spray jet apparatus with a condition of relatively thin liquid film thickness. The metal materials tested are pure aluminum, aluminum alloy, brass, mild steel, carbon steel and stainless steel. The liquid droplets considered are 30 +/- 5 mu m in volume average diameter of water, which is the same order of droplet diameter in the actual pipeline in nuclear/fossil power plants. In order to understand the influence of material hardness on the liquid droplet impingement erosion, the scanning electron microscope (SEM) observation on the eroded surface and the measurement of erosion rate are carried out in the terminal stage of erosion. The experimental results indicate that the erosion rates are expressed by the droplet velocity, volume flux, Vickers hardness and the liquid film thickness, which are fundamentals of the liquid droplet impingement erosion. The empirical formula shows that the power index for droplet velocity dependency is found to be 7 with a scattering from 5 to 9 depending on the materials, while the power index for Vickers hardness dependency is found as -4.5. (C) 2015 Elsevier B.V. All rights reserved.	[Fujisawa, Nobuyuki; Yamagata, Takayuki] Niigata Univ, Visualizat Res Ctr, Nishi Ku, Niigata 9502181, Japan; [Takano, Shotaro; Saito, Kengo] Niigata Univ, Grad Sch Sci & Technol, Nishi Ku, Niigata 9502181, Japan; [Morita, Ryo; Fujiwara, Kazutoshi; Inada, Fumio] Cent Res Inst Elect Power Ind, Komae, Tokyo 2018511, Japan	Fujisawa, N (reprint author), Niigata Univ, Visualizat Res Ctr, Nishi Ku, 8050 Ikarashi 2 Nocho, Niigata 9502181, Japan.	fujisawa@eng.niigata-u.ac.jp; yamagata@eng.niigata-u.ac.jp			JSPS [24360391]	This research was supported by the JSPS Grant-in-aid for Scientific Research B (No. 24360391) in the fiscal years 2012-2014. The authors would like to express thanks to Prof. Emeritus T. Ikohagi from Tohoku University for the helpful discussion on this topic.	FIELD JE, 1985, P ROY SOC LOND A MAT, V401, P225, DOI 10.1098/rspa.1985.0096; ASTM, 2005, ANN BOOK ASTM STAND, P1; Fujisawa N, 2013, NUCL ENG DES, V265, P909, DOI 10.1016/j.nucengdes.2013.07.039; Fujisawa N, 2012, NUCL ENG DES, V250, P101, DOI 10.1016/j.nucengdes.2012.06.022; Fujisawa N., 2012, E J ADV MAINTENANCE, V4, P79; Hattori S, 2010, WEAR, V269, P310, DOI 10.1016/j.wear.2010.04.020; Heymann F. J., 1979, P 5 INT C ER SOL LIQ; Ikohagi T., 2011, P 8 INT C FLOW DYN, P402; Isomoto Y., 2008, ZAIRYO TO KANKYO, V57, P146, DOI 10.3323/jcorr.57.146; Itoh H., 1993, T JSME A, V59, P2736; JSME, 2005, COD POW GEN FAC RUL, P48; Miyata H., 2008, ZAIRYO TO KANKYO, V57, P138, DOI 10.3323/jcorr.57.138; Morita R., 2011, L10018 CRIEPI; Sanchez-Caldera L. E., 1984, THESIS MIT	14	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0029-5493			NUCL ENG DES	Nucl. Eng. Des.	JUL	2015	288						27	34		10.1016/j.nucengdes.2015.03.016		8	Nuclear Science & Technology	Nuclear Science & Technology	CK9GL	WOS:000356548500003		
J	Ebisawa, K; Teragaki, T; Nomura, S; Abe, H; Shigemori, M; Shimomoto, M				Ebisawa, K.; Teragaki, T.; Nomura, S.; Abe, H.; Shigemori, M.; Shimomoto, M.			Concept and methodology for evaluating core damage frequency considering failure correlation at multi units and sites and its application	NUCLEAR ENGINEERING AND DESIGN			English	Article								The Tohoku earthquake (Mw9.0) occurred on March 11, 2011 and caused a large tsunami. The Fukushima Daiichi Nuclear Power Plant with six units were overwhelmed by the tsunami and core damage occurred. Authors proposed the concept and method for evaluating core damage frequency (CDF) considering failure correlation at the multi units and sites. Based on the above method, one of authors developed the procedure for evaluating the failure correlation coefficient and response correlation coefficient between the multi components under the strong seismic motion. These method and failure correlation coefficients were applied to two different BWR units and their CDF was evaluated by seismic probabilistic risk assessment technology. Through this quantitative evaluation, the validity of the method and failure correlation coefficient was confirmed. (C) 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).	[Ebisawa, K.; Teragaki, T.; Nomura, S.; Abe, H.] Japan Nucl Safety Org, Inc Adm Agcy, Tokyo, Japan; [Shigemori, M.; Shimomoto, M.] Mizuho Informat & Res Inst, Chiyoda Ku, Tokyo, Japan	Abe, H (reprint author), 1-9-9 Roppongi,Minatoku, Tokyo 1068450, Japan.	Hiroshi_abe@nsr.go.jp					Atomic Energy Society of Japan, 2009, SEISM PSA IMPL STAND; Atomic Energy Society of Japan, 2011, TSUN PRA IMPL STAND; Bohn M.P., 1983, NUREGCR3428; Ebisawa K., 2012, KOREAN NUCL SOC NUCL, V44; Ebisawa K., 2012, P ON YEAR 2011 GREAT; Ebisawa K., 2012, 15 WORLD C EARTHQ EN; Fleming K.N., 1999, P ORG EC COOP DEV NU; Fleming K.N., 2005, ANS INT TOP M PROB S; Hakata T., 2006, RELIABILITY ENG SYST; Hirano M., 2008, 14 WORLD C EARTHQ EN; Japan Nuclear Energy Safety Organization (JNES), 2014, JNESRE20132047; Japanese Government, 2011, JAP GOV IAEA MIN C N; JNES, 2014, JNESRE20132048; Jung J.E.Y.a.J.H.W.S., 2003, RELIAB ENG SYST SAFE, V82, P165; Kameda H., 2012, P ON YEAR 2011 GREAT; Kawamura S., 2014, JANSI ANN C 2014 STE; Narumiya Y., 2014, PSAM 12 HON US; Schroer S., 2012, EVENT CLASSIFICATION; Suzuki K., 2010, SEISM S 10 SESS C 6	19	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0029-5493			NUCL ENG DES	Nucl. Eng. Des.	JUL	2015	288						82	97		10.1016/j.nucengdes.2015.01.002		16	Nuclear Science & Technology	Nuclear Science & Technology	CK9GL	WOS:000356548500008		
J	Qian, SX; Kanamaru, S; Kasahara, N				Qian, Shaoxiang; Kanamaru, Shinichiro; Kasahara, Naoto			High-accuracy CFD prediction methods for fluid and structure temperature fluctuations at T-junction for thermal fatigue evaluation	NUCLEAR ENGINEERING AND DESIGN			English	Article							TRANSVERSE JET; MIXING TEE; CROSS-FLOW	Temperature fluctuations generated by the mixing of hot and cold fluids at a T-junction, which is widely used in nuclear power and process plants, can cause thermal fatigue failure. The conventional methods for evaluating thermal fatigue tend to provide insufficient accuracy, because they were developed based on limited experimental data and a simplified one-dimensional finite element analysis (FEA). CFD/FEA coupling analysis is expected as a useful tool for the more accurate evaluation of thermal fatigue. The present paper aims to verify the accuracy of proposed numerical methods of simulating fluid and structure temperature fluctuations at a T-junction for thermal fatigue evaluation. The dynamic Smagorinsky model (DSM) is used for large eddy simulation (LES) sub-grid scale (SGS) turbulence model, and a hybrid scheme (HS) is adopted for the calculation of convective terms in the governing equations. Also, heat transfer between fluid and structure is calculated directly through thermal conduction by creating a mesh with near wall resolution (NWR) by allocating grid points within the thermal boundary sub-layer. The simulation results show that the distribution of fluid temperature fluctuation intensity and the range of structure temperature fluctuation are remarkably close to the experimental results. Moreover, the peak frequencies of power spectrum density (PSD) of both fluid and structure temperature fluctuations also agree well with the experimental results. Therefore, the numerical methods used in the present paper are of sufficiently high accuracy to be suitable for the CFD prediction of highly fluctuating flow and temperature fields. (C) 2015 Elsevier B.V. All rights reserved.	[Qian, Shaoxiang; Kanamaru, Shinichiro] JGC Corp, Proc Technol Div, EN Technol Ctr, Nishi Ku, Yokohama, Kanagawa 2206001, Japan; [Kasahara, Naoto] Univ Tokyo, Sch Engn, Nucl Engn & Management, Bunkyo Ku, Tokyo 1138656, Japan	Qian, SX (reprint author), JGC Corp, Proc Technol Div, EN Technol Ctr, Nishi Ku, 2-3-1 Minato Mirai, Yokohama, Kanagawa 2206001, Japan.	qian.shaoxiang@jgc.com			Japanese government	CFD simulations were carried out using the modified multiphysics CFD software, FrontFlow/Red (FFR), which was developed as a part of the FSIS project paid for by a grant from the Japanese government. Its program source code is open and available from website.	Kamide H, 2009, NUCL ENG DES, V239, P58, DOI 10.1016/j.nucengdes.2008.09.005; Chapuliot S, 2005, NUCL ENG DES, V235, P575, DOI 10.1016/j.nucengdes.2004.09.011; FRIC TF, 1994, J FLUID MECH, V279, P1, DOI 10.1017/S0022112094003800; GERMANO M, 1991, PHYS FLUIDS A-FLUID, V3, P1760, DOI 10.1063/1.857955; RHIE CM, 1983, AIAA J, V21, P1525, DOI 10.2514/3.8284; Hu LW, 2006, INT J HEAT FLUID FL, V27, P54, DOI 10.1016/j.ijheatfluidflow.2005.08.001; Blanchard JN, 1999, EXP FLUIDS, V26, P63, DOI 10.1007/s003480050265; Bredberg J., 2000, P ASME HEAT TRANSF D, V366-5; De Chant LJ, 2005, APPL MATH COMPUT, V161, P463, DOI 10.1016/j.amc.2003.12.109; Faidy C., 2000, INT C FAT REACT COMP; FSIS (Frontier Simulation Software for Industrial Science), 2008, SOFTW PUBL; Igarashi M., 2002, P 10 INT C NUCL ENG; JNES (Japan Nuclear Energy Safety Organization), 2003, TROUBL NUCL POW PLAN; JSME, 2003, S0172003 JSME; Jungclaus D., 1998, P NEA CSNI SPEC M EX, P465; Kasahara N, 2008, NUCL ENG DES, V238, P287, DOI 10.1016/j.nucengdes.2006.09.018; KELSO RM, 1995, PHYS FLUIDS, V7, P153, DOI 10.1063/1.868736; Kimura N., 2009, 13 INT TOP M NUCL RE; LILLY DK, 1992, PHYS FLUIDS A-FLUID, V4, P633, DOI 10.1063/1.858280; Maegawa M., 2006, P 19 S MAINT EQ JAP, P12; Majander P, 2006, INT J HEAT FLUID FL, V27, P402, DOI 10.1016/j.ijheatfluidflow.2006.01.004; Nakamura A., 2010, P 7 KOR S NUCL THERM; Nakamura A., 2013, P JSME 2013 ANN M OK; Patankar S. V., 1980, NUMERICAL HEAT TRANS; Qian S., 2012, P ASME 2012 PRESS VE; Qian SX, 2015, J PRESS VESS-T ASME, V137, DOI 10.1115/1.4028067; Qian S., 2010, P ASME 2010 PRESS VE; Shibarnoto H, 2008, NUCL ENG DES, V238, P299, DOI 10.1016/j.nucengdes.2006.09.019; Smagorinsky J., 1963, MON WEATHER REV, V91, P99, DOI [DOI 10.1175/1520-0493(1963)091<0099:GCEWTP>2.3.C0;2, 10.1175/1520-0493(1963)091&LT;0099:GCEWTP&GT;2.3.CO;2(1963)]; Tanaka M., 2009, J POWER ENERGY SYSTE, V3, P237	30	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0029-5493			NUCL ENG DES	Nucl. Eng. Des.	JUL	2015	288						98	109		10.1016/j.nucengdes.2015.04.006		12	Nuclear Science & Technology	Nuclear Science & Technology	CK9GL	WOS:000356548500009		
J	Guo, R; Oka, Y				Guo, Rui; Oka, Yoshiaki			CFD analysis of coolant channel geometries for a tightly packed fuel rods assembly of Super FBR	NUCLEAR ENGINEERING AND DESIGN			English	Article							SUPERCRITICAL-WATER; HEAT-TRANSFER; NUMERICAL-ANALYSIS; LIGHT-WATER; REACTOR; BUNDLE; TUBES	This paper presents the CFD investigation on three cross-sectional geometries of coolant channels in the newly designed tightly packed fuel rods assembly for high breeding of a supercritical-pressure light water cooled fast breeding reactor (Super FBR). The calculations addressed the turbulence models and mesh conditions validated against the experimental data. The cladding temperatures and pressure drop are compared. It is concluded that geometry B (triangle with round corner) is superior to the other two (round and triangle with sharp corner) due to its excellent thermal hydraulic characteristics. (C) 2015 Elsevier B.V. All rights reserved.	[Guo, Rui; Oka, Yoshiaki] Waseda Univ, Grad Sch Adv Sci & Engn, Cooperat Major Nucl Energy, Tokyo 1698555, Japan	Guo, R (reprint author), Waseda Univ, Grad Sch Adv Sci & Engn, Cooperat Major Nucl Energy, 3-4-1 Ohkubo, Tokyo 1698555, Japan.	guorui@asagi.waseda.jp					Ampomah-Amoako E, 2013, ANN NUCL ENERGY, V59, P211, DOI 10.1016/j.anucene.2013.04.008; YAMAGATA K, 1972, INT J HEAT MASS TRAN, V15, P2575, DOI 10.1016/0017-9310(72)90148-2; Cheng X, 2007, NUCL ENG DES, V237, P240, DOI 10.1016/j.nucengdes.2006.06.011; Yang J, 2007, NUCL ENG DES, V237, P420, DOI 10.1016/j.nucengdes.2006.08.003; Dobashi K, 1998, ANN NUCL ENERGY, V25, P487, DOI 10.1016/S0306-4549(97)00079-0; Mokry S, 2010, NUCL ENG DES, V240, P568, DOI 10.1016/j.nucengdes.2009.09.003; Sharabi M, 2009, ANN NUCL ENERGY, V36, P60, DOI 10.1016/j.anucene.2008.10.006; CD-Adapco, 2013, STAR CCM VERS 8 02 U, P2201; Gou JL, 2011, NUCL ENG DES, V241, P1656, DOI 10.1016/j.nucengdes.2011.02.013; Gu HY, 2010, NUCL ENG DES, V240, P364, DOI 10.1016/j.nucengdes.2008.08.022; Kim S. H., 2004, P ICAPP04 JUN 13 17; Kitoh K., 1997, P 5 INT C NUCL ENG N; KOSHIZUKA S, 1995, INT J HEAT MASS TRAN, V38, P3077, DOI 10.1016/0017-9310(95)00008-W; [梁法春 Liang Fachun], 2004, [动力工程, Power engineering], V24, P869; Palko D., 2008, SCI TECHNOL NUCL INS, V2008, P1; Roelofs F., 2004, CFD ANAL HEAT TRANSF; Wagner W., 1998, PROPERTIES WATER STE; Oka Y, 2013, J NUCL SCI TECHNOL, V50, P15, DOI 10.1080/00223131.2013.750053; Yoshida Taishi, 2013, P 2013 21 INT C NUCL; Zhu XJ, 2014, NUCL ENG DES, V270, P198, DOI 10.1016/j.nucengdes.2014.01.009	20	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0029-5493			NUCL ENG DES	Nucl. Eng. Des.	JUL	2015	288						119	129		10.1016/j.nucengdes.2015.04.005		11	Nuclear Science & Technology	Nuclear Science & Technology	CK9GL	WOS:000356548500011		
J	Murakami, T; Eguchi, Y; Oyama, K; Watanabe, O				Murakami, T.; Eguchi, Y.; Oyama, K.; Watanabe, O.			Reduced-scale water test of natural circulation for decay heat removal in loop-type sodium-cooled fast reactor	NUCLEAR ENGINEERING AND DESIGN			English	Article							CONVECTION TEST; PHENIX REACTOR	Water tests of a loop-type sodium-cooled fast reactor have been conducted to physically evaluate the natural circulation characteristics. The water test apparatus was manufactured as a 1/10-scale mock-up of the Japan Sodium-Cooled Fast Reactor, which adopts a decay heat removal system (DHRS) utilizing natural circulation. Tests simulating a variety of events and operation conditions clarified the thermal hydraulic characteristics and core-cooling performance of the natural circulation in the primary loop. Operation conditions such as the duration of the pump flow coast-down and the activation time of the DHRS affect the natural circulation characteristics. A long pump flow coast-down cools the upper plenum of the reactor vessel (RV). This causes the loss of the buoyant force in the RV. The test result indicates that a long pump flow coast-down tends to result in a rapid increase in the core temperature because of the loss of the buoyant force. The delayed activation of the DHRS causes a decrease in the natural circulation flow rate and a temperature rise in the RV. Flow rate deviation and a reverse flow appear in the parallel cold-leg piping in some events, which cause thermal stratification in the cold-leg piping. The DHRS prevents the core temperature from fatally rise even for the most severe design-basis event, in which sodium leakage in a secondary loop of the DHRS and the opening failure of a single damper of the air cooler occur simultaneously. In the water test for the case of siphon break in the primary loop, which is one of the design extension conditions, a circulation flow consisting of ascendant and descendant flows in the core channels suppresses the rise in the core temperature instead of the primary coolant loop. However, the test result suggests that the present DHRS has insufficient performance to remove the decay heat in the case of siphon break. Repeated tests have shown that the results of the water test have sufficiently high reproducibility in terms of the flow rate of the primary loop to be used for the verification of numerical codes. (C) 2015 Elsevier B.V. All rights reserved.	[Murakami, T.; Eguchi, Y.] Cent Res Inst Elect Power Ind, Abiko, Chiba 1646, Japan; [Oyama, K.; Watanabe, O.] Mitsubishi FBR Syst Inc, Shibuya Ku, Tokyo, Japan	Murakami, T (reprint author), Cent Res Inst Elect Power Ind, Abiko, Chiba 1646, Japan.	murakami@criepi.denken.or.jp; eguchi@criepi.denken.or.jp; kazuhiro_oyama@mfbr.mhi.co.jp; osamu4_watanabe@mfbr.mhi.co.jp					Briggs L., 2013, P INT C FAST REACT R; Eguchi Y, 1997, NUCL ENG DES, V178, P295, DOI 10.1016/S0029-5493(97)00234-3; GREWAL S, 1982, CHEM ENG COMMUN, V17, P343, DOI 10.1080/00986448208911637; Ichimiya M., 2007, NUCL ENG TECHNOL, V37, P171; Koga T., 2011, 14 INT TOP M NUCL RE; Ohyama K., 2009, P INT C FAST REACT R; Tenchine D, 2013, NUCL ENG DES, V258, P189, DOI 10.1016/j.nucengdes.2013.02.010; Tenchine D, 2012, NUCL ENG DES, V253, P23, DOI 10.1016/j.nucengdes.2012.08.001; Watanabe O., 2011, 14 INT TOP M NUCL RE; Yamada F, 2014, NUCL TECHNOL, V188, P292, DOI 10.13182/NT13-56; Yamaguchi A., 1989, Fourth International Topical Meeting on Nuclear Reactor Thermal-Hydraulics. NURETH-4	11	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0029-5493			NUCL ENG DES	Nucl. Eng. Des.	JUL	2015	288						220	231		10.1016/j.nucengdes.2015.04.007		12	Nuclear Science & Technology	Nuclear Science & Technology	CK9GL	WOS:000356548500019		
J	Kojima, TM; Ikeda, T; Kanai, Y; Yamazaki, Y				Kojima, Takao M.; Ikeda, Tokihiro; Kanai, Yasuyuki; Yamazaki, Yasunori			Ion guiding in curved glass capillaries	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM INTERACTIONS WITH MATERIALS AND ATOMS			English	Article						Capillary; Ion guiding; Insulator	HIGHLY-CHARGED IONS; NANOCAPILLARIES; PET	Straight and curved glass capillaries were tested for the guiding of 8 keV Ar8+ ion beams. The straight capillary was about 50 mm long and 0.87 mm/1.1 mm in inner/outer diameter. One of the two curved capillaries was similar, but was curved with a 270 mm radius. The other was 53 mm long, had diameters of 2.34 mm/2.99 mm, and was curved with a 150 mm radius. The corresponding bending angles of the two curved capillaries were 9.6 degrees and 17.5 degrees, respectively. Transmission through the straight capillary disappeared when the tilt angle was larger than 5 degrees. The curved capillaries guided the ion beams into their corresponding bending angles, which were much larger than 5 degrees, with transmission efficiencies of a few tens percent. This demonstrates the possibility of developing a new scheme of simple small beam deflectors and related beam optics. (C) 2014 Elsevier B.V. All rights reserved.	[Kojima, Takao M.; Kanai, Yasuyuki; Yamazaki, Yasunori] RIKEN, Atom Phys Lab, Wako, Saitama 3510198, Japan; [Ikeda, Tokihiro] RIKEN, Nishina Ctr Accelerator Based Sci, Wako, Saitama 3510198, Japan	Kojima, TM (reprint author), RIKEN, Atom Phys Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.				Grant of Special Projects for Basic Science of RIKEN "Development and Applications of Exotic Quantum Beams"; JSPS KAKENHI [25350545g]	The authors thank Mr. Yoshio Natsume and Mr. Jun Kimura of Hamamatsu Photonics Co. Ltd. for manufacturing and providing the curved capillaries. This work was partly supported by the Grant of Special Projects for Basic Science of RIKEN "Development and Applications of Exotic Quantum Beams", and JSPS KAKENHI Grant Number 25350545.	Schiessl K, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.062902; Sahana MB, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.040901; Stolterfoht N, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.022712; Hellhammer R, 2007, NUCL INSTRUM METH B, V258, P159, DOI 10.1016/j.nimb.2006.12.091; Kanai Y, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.012711; Bereczky RJ, 2009, NUCL INSTRUM METH B, V267, P317, DOI 10.1016/j.nimb.2008.10.080; Stolterfoht N, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.133201; Lemell C, 2013, PROG SURF SCI, V88, P237, DOI 10.1016/j.progsurf.2013.06.001; Arnau A., 1997, Surface Science Reports, V27, DOI 10.1016/S0167-5729(97)00002-2; Fursatz M, 2007, J PHYS CONF SER, V58, P319, DOI 10.1088/1742-6596/58/1/071; Gruber E, 2014, J PHYS CONF SER, V488, DOI 10.1088/1742-6596/488/13/132013; Gruber E, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.062901; Hellhammer R, 2005, NUCL INSTRUM METH B, V232, P235, DOI 10.1016/j.nimb.2005.03.051; Ikeda T, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2362642; Ikeda T, 2007, J PHYS CONF SER, V58, P68, DOI 10.1088/1742-6596/58/1/010; Kojima TM, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/35/355201; Krause HF, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.042901; Schiessl K., 2005, NUCL INSTRUM METH B, V258, P150; Vikor G, 2005, NUCL INSTRUM METH B, V233, P218, DOI 10.1016/j.nimb.2005.03.109	19	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-583X	1872-9584		NUCL INSTRUM METH B	Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms	JUL 1	2015	354						16	19		10.1016/j.nimb.2014.11.031		4	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Atomic, Molecular & Chemical; Physics, Nuclear	Instruments & Instrumentation; Nuclear Science & Technology; Physics	CK4KY	WOS:000356193900004		
J	Umigishi, M; Hirano, Y; Ishii, K; Ogawa, H				Umigishi, Mika; Hirano, Yoshimi; Ishii, Kunikazu; Ogawa, Hidemi			Energy distribution of an ion beam extracted into air with a large bore metal capillary	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM INTERACTIONS WITH MATERIALS AND ATOMS			English	Article						Large bore metal capillary; Ion beams extracted into air with capillary; Energy distributions; Two-dimensional intensity distributions		In order to clarify the transmission properties of an ion beam extracted with a large bore metal capillary into air, we measured the energy distributions of extracted 4.0 MeV alpha particles using a pinhole slit. The metal capillary we used is a conventional injection needle with 500 mu m inner diameter. As a result, we obtained two-dimensional intensity distributions of the ion beam extracted into air with this large bore metal capillary and the energy spectra at each position. We discuss the result of two-dimensional intensity distributions and report the difference of the energy spectra at the center part and at the edge. (C) 2014 Elsevier B.V. All rights reserved.	[Umigishi, Mika; Hirano, Yoshimi] Nara Womens Univ, Grad Sch Humanities & Sci, Nara 6308506, Japan; [Ishii, Kunikazu; Ogawa, Hidemi] Nara Womens Univ, Dept Phys, Nara 6308506, Japan	Ishii, K (reprint author), Nara Womens Univ, Dept Phys, Nara 6308506, Japan.						Nebiki T, 2003, J VAC SCI TECHNOL A, V21, P1671, DOI 10.1116/1.1597889; Lemell C, 2013, PROG SURF SCI, V88, P237, DOI 10.1016/j.progsurf.2013.06.001; Bohr N., 1948, MAT FYS MEDD DAN VID, V18, P8; Fujita N, 2011, PHYS SCRIPTA, VT144, DOI 10.1088/0031-8949/2011/T144/014033; Fujita N, 2011, NUCL INSTRUM METH B, V269, P1023, DOI 10.1016/j.nimb.2010.11.065; Ishii K, 2011, NUCL INSTRUM METH B, V269, P1026, DOI 10.1016/j.nimb.2010.11.066; Ziegler J. F., SRIM 2013	7	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-583X	1872-9584		NUCL INSTRUM METH B	Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms	JUL 1	2015	354						64	66		10.1016/j.nimb.2014.11.054		3	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Atomic, Molecular & Chemical; Physics, Nuclear	Instruments & Instrumentation; Nuclear Science & Technology; Physics	CK4KY	WOS:000356193900015		
J	Hirano, Y; Umigishi, M; Ishii, K; Ogawa, H				Hirano, Y.; Umigishi, M.; Ishii, K.; Ogawa, H.			Measurements of an ion beam diameter extracted into air through a large-bore metal capillary	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM INTERACTIONS WITH MATERIALS AND ATOMS			English	Article						Capillary optics; In-air measurements; MeV micro ion beams; Particle Induced X-ray Emission (PIXE)	GLASS-CAPILLARY; MICRO-PIXE; OPTICS	To extract an ion beam into air, the technique using a single macro-capillary has been paid attention. We have expanded the bore of the metal capillary up to 500 mu m circle divide inlet diameter to increase the beam intensity and have measured the intensity distributions of the extracted 3 MeV proton beam. Furthermore, we have tilted the capillary angle and measured the intensity distributions of the ion beam. In this article, we will present the experimental results together with the simulation which takes the tilt angles of the capillary into account. (C) 2014 Elsevier B.V. All rights reserved.	[Hirano, Y.; Umigishi, M.] Nara Womens Univ, Grad Sch Humanities & Sci, Nara 6308506, Japan; [Ishii, K.; Ogawa, H.] Nara Womens Univ, Dept Phys, Nara 6308506, Japan	Ishii, K (reprint author), Nara Womens Univ, Dept Phys, Nara 6308506, Japan.						Fujita N, 2013, NUCL INSTRUM METH B, V315, P332, DOI 10.1016/j.nimb.2013.05.079; Lemell C, 2013, PROG SURF SCI, V88, P237, DOI 10.1016/j.progsurf.2013.06.001; Fujita N, 2011, NUCL INSTRUM METH B, V269, P1023, DOI 10.1016/j.nimb.2010.11.065; Hasegawa J, 2011, NUCL INSTRUM METH B, V269, P3087, DOI 10.1016/j.nimb.2011.04.073; Ishii K, 2001, NUCL INSTRUM METH B, V181, P448, DOI 10.1016/S0168-583X(01)00623-1; Nebiki T, 2006, NUCL INSTRUM METH B, V249, P226, DOI 10.1016/j.nimb.2006.04.003	6	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-583X	1872-9584		NUCL INSTRUM METH B	Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms	JUL 1	2015	354						67	70		10.1016/j.nimb.2014.11.008		4	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Atomic, Molecular & Chemical; Physics, Nuclear	Instruments & Instrumentation; Nuclear Science & Technology; Physics	CK4KY	WOS:000356193900016		
J	Ogawa, H; Amano, S; Ishii, K; Kaneko, T				Ogawa, H.; Amano, S.; Ishii, K.; Kaneko, T.			Forward-backward correlated secondary electron emission depending on the emergence angle of 1 MeV/u light ions	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM INTERACTIONS WITH MATERIALS AND ATOMS			English	Article						Secondary electron; Emission statistics; Energy loss	THIN CARBON FOIL; ENERGY-LOSS; DEPENDENCE; SCATTERING; H-0; PROTONS; IMPACT; H+	The statistical distributions of the number of forward- and backward-emitted secondary electrons (SE's) from a thin carbon foil have been measured simultaneously in coincidence with foil-transmitted H-1(+), He-4(2+) and Li-6(3+) at a fixed velocity of 1 MeV/u. The emergence angles of the projectiles, theta(em), were varied from 0 to 2 [mrad] for H+ and from 0 to 1 [mrad] for He2+ and Li3+ ions. Irrespective of ion species, measured total SE yields, that is, the average number of simultaneous emitted electrons per projectile, increase with increasing theta(em) both in the forward and backward directions. This trend is consistent with the calculated theta(em)-dependent energy losses of protons penetrating a thin carbon foil. As for the forward-or backward-emitted SE yields, we have obtained a negative forward-backward(F-B) correlation, except for the theta(em) = 0.0 [mrad] emergence of H+ projectiles where a positive correlation has been observed. The negative F-B correlation becomes prominent with increasing the atomic number of the projectile, Z(p). In addition, this correlation appears to become slightly stronger with increasing theta(em). The observed F-B correlation and its Z(p) - and theta(em)-dependences are interpreted from the point of view of production of high energy internal SE's. (C) 2014 Elsevier B.V. All rights reserved.	[Ogawa, H.; Ishii, K.] Nara Womens Univ, Dept Phys, Nara 6308506, Japan; [Amano, S.] Nara Womens Univ, Grad Sch Hum & Sci, Nara 6308506, Japan; [Kaneko, T.] Okayama Univ Sci, Grad Sch Sci, Okayama 7000005, Japan	Ogawa, H (reprint author), Nara Womens Univ, Dept Phys, Nara 6308506, Japan.	ogawa@cc.nara-wu.ac.jp			Nara Women's University	The authors would like to acknowledge J. Karimata for his assistance in the operation of the accelerator. This work is partially supported financially by Nara Women's University Intramural Grant for Project Research, 2013.	SIGMUND P, 1974, NUCL INSTRUM METHODS, V119, P541, DOI 10.1016/0029-554X(74)90805-2; Barrue F, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.032902; Devooght J., 1991, SPRINGER TRACTS MODE, V122; ECKARDT JC, 1984, NUCL INSTRUM METH B, V2, P168, DOI 10.1016/0168-583X(84)90181-2; GEISSEL H, 1987, NUCL INSTRUM METH B, V27, P333, DOI 10.1016/0168-583X(87)90573-8; GEISSEL H, 1985, NUCL INSTRUM METH B, V12, P38, DOI 10.1016/0168-583X(85)90697-4; Hasselkamp D., 1991, SPRINGER TRACTS MODE, V123; IFEROV GA, 1990, NUCL INSTRUM METH B, V48, P43, DOI 10.1016/0168-583X(90)90069-7; IFEROV GA, 1983, PHYS LETT A, V97, P283, DOI 10.1016/0375-9601(83)90689-8; Ishiwari R., 1991, NUCL INSTRUM METH B, V51, P209; KOZOCHKINA AA, 1991, NUCL INSTRUM METH B, V62, P51, DOI 10.1016/0168-583X(91)95927-6; Krebs K.H., 1962, Annalen der Physik, V10; LAKITS G, 1989, REV SCI INSTRUM, V60, P3151, DOI 10.1063/1.1140546; LANTSCHNER GH, 1987, PHYS REV A, V36, P4667, DOI 10.1103/PhysRevA.36.4667; Ogawa H, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.012902; Ogawa H, 2014, J PHYS B-AT MOL OPT, V47, DOI 10.1088/0953-4075/47/8/085201; Ogawa H, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.052901; Ogawa H, 2000, NUCL INSTRUM METH B, V164, P279, DOI 10.1016/S0168-583X(99)01036-8; Ogawa H, 2002, NUCL INSTRUM METH B, V193, P85, DOI 10.1016/S0168-583X(02)00731-0; Ogawa H, 2009, NUCL INSTRUM METH B, V267, P2612, DOI 10.1016/j.nimb.2009.05.054; ROTHARD H, 1993, RADIAT EFF DEFECT S, V126, P373, DOI 10.1080/10420159308219745; SAKAMOTO N, 1992, NUCL INSTRUM METH B, V69, P84, DOI 10.1016/0168-583X(92)95741-9; Sternglass E. J., 1975, PHYS REV, V108, P1; YAMAZAKI Y, 1993, PHYS REV LETT, V70, P2702, DOI 10.1103/PhysRevLett.70.2702; YAMAZAKI Y, 1987, NUCL INSTRUM METH A, V262, P118, DOI 10.1016/0168-9002(87)90200-2	25	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-583X	1872-9584		NUCL INSTRUM METH B	Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms	JUL 1	2015	354						96	99		10.1016/j.nimb.2014.09.025		4	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Atomic, Molecular & Chemical; Physics, Nuclear	Instruments & Instrumentation; Nuclear Science & Technology; Physics	CK4KY	WOS:000356193900022		
J	Tomita, S; Shiina, Y; Tamura, S; Kinoshita, R; Ishii, S; Sasa, K				Tomita, Shigeo; Shiina, Yoko; Tamura, Shinya; Kinoshita, Ryo; Ishii, Satoshi; Sasa, Kimikazu			Measurement of backward secondary-electron yield under molecular ion impact coincident with emerging projectiles	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM INTERACTIONS WITH MATERIALS AND ATOMS			English	Article						Secondary electrons; Molecular ions; Cluster effect; Vicinage effect	EMISSION; PROTONS; FOIL	We have measured the backward yield of secondary electrons induced by 1 MeV C-2(+) coincident with the emerging projectiles. The total electron yield decreased by a few percent with the number of detected projectiles, which indicates the contribution of inner-shell electron excitation to the secondary-electron yield. The inner-shell contribution for the C-2(+) impact was approximately the same as that for the C+ impact, whereas the cluster effect on the total secondary electron yield remains. (C) 2014 Elsevier B.V. All rights reserved.	[Tomita, Shigeo; Shiina, Yoko; Tamura, Shinya; Kinoshita, Ryo] Univ Tsukuba, Inst Appl Phys, Tsukuba, Ibaraki 3058573, Japan; [Ishii, Satoshi; Sasa, Kimikazu] Univ Tsukuba, Tandem Accelerator Complex, Tsukuba, Ibaraki 3058577, Japan	Tomita, S (reprint author), Univ Tsukuba, Inst Appl Phys, Tennodai 1-1-1, Tsukuba, Ibaraki 3058573, Japan.	tomita@bk.tsukuba.ac.jp			JSPS KAKENHI [24651098]	We would like to thank Prof. Kaneko and Dr. Narumi for their serious and kindly discussions. The authors thank all staff at UTTAC for their technical supports. This work was supported by JSPS KAKENHI Grant Number 24651098.	Arai H, 2009, J PHYS SOC JPN, V78, DOI 10.1143/JPSJ.78.104301; Desclaux J., 1973, ATOM DATA NUCL DATA, V12, P311, DOI 10.1016/0092-640X(73)90020-X; Jacquet D, 2002, NUCL INSTRUM METH B, V193, P227, DOI 10.1016/S0168-583X(02)00755-3; Kimura K, 1998, PHYS REV A, V58, P1282, DOI 10.1103/PhysRevA.58.1282; Ogawa H, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.052901; ROTHARD H, 1990, PHYS REV A, V41, P2521, DOI 10.1103/PhysRevA.41.2521; Takahashi Y., 2009, EPL, P63001; Tomita S, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.044901; Tomita S, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.060901; Ziegler J. F., 1985, STOPPING RANGE IONS	10	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-583X	1872-9584		NUCL INSTRUM METH B	Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms	JUL 1	2015	354						109	111		10.1016/j.nimb.2014.11.018		3	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Atomic, Molecular & Chemical; Physics, Nuclear	Instruments & Instrumentation; Nuclear Science & Technology; Physics	CK4KY	WOS:000356193900025		
J	Fujimura, Y; Yoshizaki, H; Nakagawa, S; Okamoto, Y; Ishikawa, N; Saitoh, Y; Hori, F; Iwase, A				Fujimura, Y.; Yoshizaki, H.; Nakagawa, Shou; Okamoto, Y.; Ishikawa, N.; Saitoh, Y.; Hori, F.; Iwase, A.			EXAFS study on solute precipitation in FeCu alloy induced by energetic electron bombardments and thermal aging	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM INTERACTIONS WITH MATERIALS AND ATOMS			English	Article						EXAFS; FeCu alloy; Cu precipitation; Thermal aging; Electron-irradiation	RAY-ABSORPTION SPECTROSCOPY; COPPER PRECIPITATION; IRRADIATIONS	The extended X-ray absorption fine structure (EXAFS) measurement is a useful tool for the observation of local atomic arrangements around selected atoms. We performed EXAFS measurements for the electron-irradiated and the thermally-aged Fe-0.6 wt.% Cu alloy and compared the experimental result with that of the simulation by the FEFF simulation code in order to investigate the local atomic structure around Cu atoms. Cu precipitates which were produced by the thermal aging at 773 K transformed from the bcc structure to the fcc structure as the precipitates grow large enough. However, for electron-irradiated specimens, although the hardness greatly increased, the transformation of Cu precipitates from the bcc to the fcc structure was not clearly confirmed. This result indicates that small sized Cu precipitates which had the bcc structure were produced by the electron irradiation and they could hardly coarsen during the irradiation. (C) 2014 Elsevier B.V. All rights reserved.	[Fujimura, Y.; Yoshizaki, H.; Nakagawa, Shou; Hori, F.; Iwase, A.] Osaka Prefecture Univ, Dept Mat Sci, Sakai, Osaka 5998531, Japan; [Okamoto, Y.] Japan Atom Energy Agcy, Quantum Beam Sci Ctr, Tokai, Ibaraki 3191195, Japan; [Ishikawa, N.] Japan Atom Energy Agcy, Nucl Sci & Engn Ctr, Tokai, Ibaraki 3191195, Japan; [Saitoh, Y.] Japan Atom Energy Agcy, Takasaki Adv Radiat Res Inst, Takasaki, Gumma 3701292, Japan	Fujimura, Y (reprint author), Osaka Prefecture Univ, Dept Mat Sci, Sakai, Osaka 5998531, Japan.	su110030@edu.osakafu-u.ac.jp			Kansai Research Foundation for technical promotion (KRF)	The authors thank the technical staff of the electron accelerator at Takasaki Advanced Radiation Research Institute, Japan Atomic Energy Agency for their help. The authors are grateful to Kansai Research Foundation for technical promotion (KRF) for the financial support. This research has been done under the collaboration program between Osaka Prefecture University and Japan Atomic Energy Agency.	Lin SD, 2009, APPL CATAL A-GEN, V360, P226, DOI 10.1016/j.apcata.2009.03.025; ZABINSKY SI, 1995, PHYS REV B, V52, P2995, DOI 10.1103/PhysRevB.52.2995; Haider P, 2007, J CATAL, V250, P313, DOI 10.1016/j.jcat.2007.07.001; Ressler T, 1998, J SYNCHROTRON RADIAT, V5, P118, DOI 10.1107/S0909049597019298; Cammelli S, 2010, NUCL INSTRUM METH B, V268, P632, DOI 10.1016/j.nimb.2009.12.008; Harris VG, 1996, PHYS REV B, V54, P6929, DOI 10.1103/PhysRevB.54.6929; Hori F, 1996, J NUCL MATER, V228, P215, DOI 10.1016/S0022-3115(95)00219-7; MAURY F, 1994, J PHYS-CONDENS MAT, V6, P569, DOI 10.1088/0953-8984/6/2/027; MAURY F, 1991, SCRIPTA METALL MATER, V25, P1839, DOI 10.1016/0956-716X(91)90314-Q; Mayoral M.H., 2010, J NUCL MATER, V399, P146; Radiguet B, 2007, J NUCL MATER, V360, P104, DOI 10.1016/j.jnucmat.2006.09.007; Rice PM, 1997, J NUCL MATER, V244, P219, DOI 10.1016/S0022-3115(96)00753-2; Tobita T, 2014, J NUCL MATER, V452, P241, DOI 10.1016/j.jnucmat.2014.05.020; Tobita T, 2001, J NUCL MATER, V299, P267, DOI 10.1016/S0022-3115(01)00694-8; Wang RS, 2013, NUCL INSTRUM METH B, V307, P545, DOI 10.1016/j.nimb.2012.11.090	15	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-583X	1872-9584		NUCL INSTRUM METH B	Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms	JUL 1	2015	354						120	124		10.1016/j.nimb.2014.11.043		5	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Atomic, Molecular & Chemical; Physics, Nuclear	Instruments & Instrumentation; Nuclear Science & Technology; Physics	CK4KY	WOS:000356193900028		
J	Suzuki, TT; Sakai, O; Ichinokura, S; Hirahara, T; Hasegawa, S				Suzuki, T. T.; Sakai, O.; Ichinokura, S.; Hirahara, T.; Hasegawa, S.			Target element dependent spin-orbit coupling in polarized He-4(+) ion scattering	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM INTERACTIONS WITH MATERIALS AND ATOMS			English	Article						Low energy ion scattering; Electron-spin; Spin-orbit coupling; Atomic collision	LOW-ENERGY HE+; SURFACE-STRUCTURE; SPECTROSCOPY	We studied low-energy (1.57 keV) electron-spin polarized He-4(+) ion scattering on various 5d transition metal targets. The scattered ion intensity generally differed between the incident He+ ions with up and down spins. This spin dependent ion scattering is attributed to the spin orbit coupling (SOC) that acts transiently on the He+ 1s electron spin in the He+-target binary collision. We observed that the amplitude of the spin dependence in ion scattering, i.e., the spin asymmetry, differs between 5d transition metal targets. This target element dependence of the spin asymmetry is discussed in terms of re-ionization of He-0, which originates from the neutralization of the He+ ion during the He+-target collision. Since the re-ionization is spin independent process, it degrades the effective spin polarization of the He+ ion beam. This explains smaller spin asymmetry with the target on which He-0 is re-ionized with higher rate. (C) 2014 Elsevier B.V. All rights reserved.	[Suzuki, T. T.; Sakai, O.] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050044, Japan; [Ichinokura, S.; Hasegawa, S.] Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan; [Hirahara, T.] Tokyo Inst Technol, Dept Phys, Meguro Ku, Tokyo 1528551, Japan	Suzuki, TT (reprint author), Natl Inst Mat Sci, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan.	suzuki.taku@nims.go.jp	Hirahara, Toru/D-7445-2011	Hirahara, Toru/0000-0002-2574-1708	KAKENHI [24560036]	This work was partially supported by KAKENHI 24560036.	Brongersma HH, 2007, SURF SCI REP, V62, P63, DOI 10.1016/j.surfrep.2006.12.002; NIEHUS H, 1993, SURF SCI REP, V17, P213, DOI 10.1016/0167-5729(93)90024-J; Houssiau L, 1998, PHYS REV LETT, V81, P5153, DOI 10.1103/PhysRevLett.81.5153; Ichinokura S., 2014, RADIATION E IN PRESS; Kessler J., 1976, POLARIZED ELECT; ONELLION M, 1984, PHYS REV LETT, V52, P380, DOI 10.1103/PhysRevLett.52.380; RABALAIS JW, 1990, SCIENCE, V250, P521, DOI 10.1126/science.250.4980.521; SOUDA R, 1989, PHYS REV B, V40, P4119, DOI 10.1103/PhysRevB.40.4119; Suzuki T, 2007, NUCL INSTRUM METH A, V575, P343, DOI 10.1016/j.nima.2007.03.003; Suzuki T, 2008, SURF SCI, V602, P579, DOI 10.1016/j.susc.2007.11.004; Suzuki TT, 2010, SURF SCI, V604, P1767, DOI 10.1016/j.susc.2010.07.002; Suzuki TT, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.176101; TSUNEYUKI S, 1986, PHYS REV B, V34, P5758, DOI 10.1103/PhysRevB.34.5758	13	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-583X	1872-9584		NUCL INSTRUM METH B	Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms	JUL 1	2015	354						163	166		10.1016/j.nimb.2014.11.055		4	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Atomic, Molecular & Chemical; Physics, Nuclear	Instruments & Instrumentation; Nuclear Science & Technology; Physics	CK4KY	WOS:000356193900038		
J	Imai, M; Sataka, M; Matsuda, M; Okayasu, S; Kawatsura, K; Takahiro, K; Komaki, K; Shibata, H; Nishio, K				Imai, M.; Sataka, M.; Matsuda, M.; Okayasu, S.; Kawatsura, K.; Takahiro, K.; Komaki, K.; Shibata, H.; Nishio, K.			Equilibrium and non-equilibrium charge-state distributions of 2.0 MeV/u carbon ions passing through carbon foils	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM INTERACTIONS WITH MATERIALS AND ATOMS			English	Article						Charge transfer; Equilibrium charge-state distribution; Non-equilibrium charge-state distribution; Mean charge	HEAVY-IONS; CROSS-SECTIONS; EXCITED-STATES; SOLID TARGETS; FRACTIONS; PASSAGE; MEDIA	Both equilibrium and non-equilibrium charge-state distributions were studied experimentally for 2.0 MeV/u carbon ions after passing through carbon foils. Measured charge-state distribution established the equilibrium at a target thickness of 10 mu g/cm(2) and this remained unchanged until a maximum target thickness of 98 mu g/cm(2). The equilibrium charge-state distribution, the equilibrium mean charge-state, and the width and skewness of the equilibrium distribution were compared with predictions using existing semi-empirical formulae as well as simulation results, including the ETACHA code. It was found that charge-state distributions, mean charge states, and distribution widths for C2+, C3+, and C4+ incident ions merged into quasi-equilibrium values at a target thickness of 5.7 mu g/cm(2) in the pre-equilibrium region and evolved simultaneously to the 'real equilibrium' values for all of the initial charge states, including C5+ and C6+ ions, as previously demonstrated for sulfur projectile ions at the same velocity (Imai et al., 2009). Two kinds of simulation, ETACHA and solution of rate equations taking only single electron transfers into account, were used, and both of them reproduced the measured charge evolution qualitatively. The quasi-equilibrium behavior could be reproduced with the ETACHA code, but not with solution of elementary rate equations. (C) 2014 Elsevier B.V. All rights reserved.	[Imai, M.; Shibata, H.] Kyoto Univ, Dept Nucl Engn, Nishikyo Ku, Kyoto 6158540, Japan; [Sataka, M.; Matsuda, M.; Okayasu, S.; Nishio, K.] Japan Atom Energy Agcy, Tokai, Ibaraki 3191195, Japan; [Kawatsura, K.] Kansai Gaidai Univ, Hirakata, Osaka 5731001, Japan; [Takahiro, K.] Kyoto Inst Technol, Dept Chem & Mat Technol, Sakyo Ku, Kyoto 6068585, Japan; [Komaki, K.] RIKEN, Atom Phys Lab, Wako, Saitama 3510198, Japan; [Shibata, H.] Osaka Univ, Inst Sci & Ind Res, Ibaraki, Osaka 5670047, Japan	Imai, M (reprint author), Kyoto Univ, Dept Nucl Engn, Nishikyo Ku, Kyoto 6158540, Japan.	imai@nucleng.kyoto-u.ac.jp					BETZ HD, 1972, REV MOD PHYS, V44, P465, DOI 10.1103/RevModPhys.44.465; Novikov NV, 2013, PHYS LETT A, V377, P463, DOI 10.1016/j.physleta.2012.12.019; Ziegler JF, 2010, NUCL INSTRUM METH B, V268, P1818, DOI 10.1016/j.nimb.2010.02.091; SHIMA K, 1986, ATOM DATA NUCL DATA, V34, P357, DOI 10.1016/0092-640X(86)90010-0; ROZET JP, 1989, J PHYS B-AT MOL OPT, V22, P33, DOI 10.1088/0953-4075/22/1/007; Rozet JP, 1996, NUCL INSTRUM METH B, V107, P67, DOI 10.1016/0168-583X(95)00800-4; Schiwietz G, 2001, NUCL INSTRUM METH B, V175, P125, DOI 10.1016/S0168-583X(00)00583-8; SHIMA K, 1982, NUCL INSTRUM METHODS, V200, P605, DOI 10.1016/0167-5087(82)90493-8; BAUDINETROBINET Y, 1981, NUCL INSTRUM METHODS, V190, P197, DOI 10.1016/0029-554X(81)90221-4; BAUDINETROBINET Y, 1983, PHYS REV A, V28, P2169, DOI 10.1103/PhysRevA.28.2169; Imai M, 2007, NUCL INSTRUM METH B, V256, P11, DOI 10.1016/j.nimb.2006.11.117; Imai M, 2009, NUCL INSTRUM METH B, V267, P2675, DOI 10.1016/j.nimb.2009.05.035; Imai M, 2005, NUCL INSTRUM METH B, V230, P63, DOI [10.1016/j.nimb.2004.12.018, 10.1016/nimb.2004.12.018]; Kramer M, 2010, EUR PHYS J D, V60, P195, DOI 10.1140/epjd/e2010-00077-8; Leon A, 1998, ATOM DATA NUCL DATA, V69, P217, DOI 10.1006/adnd.1998.0780; Miyoshi T, 2007, NUCL INSTRUM METH B, V258, P329, DOI 10.1016/j.nimb.2007.01.284; Miyoshi T, 2006, NUCL INSTRUM METH B, V251, P79, DOI 10.1016/j.nimb.2006.06.017; NIKOLAEV VS, 1968, PHYS LETT A, VA 28, P277, DOI 10.1016/0375-9601(68)90282-X; Osmani O, 2011, NUCL INSTRUM METH B, V269, P813, DOI 10.1016/j.nimb.2010.12.015; Sato Y, 2004, NUCL INSTRUM METH B, V225, P439, DOI 10.1016/j.nimb.2004.05.028; Sato Y, 2003, NUCL INSTRUM METH B, V201, P571, DOI 10.1016/S0168-583X(02)02225-5; Schiwietz G., 2004, Nuclear Instruments & Methods in Physics Research, Section B (Beam Interactions with Materials and Atoms), V226, DOI 10.1016/j.nimb.2004.05.043; Schmitt C, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.052711; Schmitt C, 2011, NUCL INSTRUM METH B, V269, P721, DOI 10.1016/j.nimb.2011.02.001; Schmitt C, 2010, NUCL INSTRUM METH B, V268, P1551, DOI 10.1016/j.nimb.2010.02.003; Shevelko VP, 2005, J PHYS B-AT MOL OPT, V38, P2675, DOI 10.1088/0953-4075/38/15/008; SHIMA K, 1989, PHYS REV A, V40, P3557, DOI 10.1103/PhysRevA.40.3557; SHIMA K, 1984, NUCL INSTRUM METH B, V2, P222, DOI 10.1016/0168-583X(84)90194-0; SHIMA K, 1992, ATOM DATA NUCL DATA, V51, P173, DOI 10.1016/0092-640X(92)90001-X; SUGIYAMA Y, 1989, NUCL INSTRUM METH A, V281, P512, DOI 10.1016/0168-9002(89)91485-X; TO KX, 1976, PHYS SCRIPTA, V14, P277, DOI 10.1088/0031-8949/14/6/006; Wittkower A. B., 1973, Atomic Data, V5, DOI 10.1016/S0092-640X(73)80001-4	32	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-583X	1872-9584		NUCL INSTRUM METH B	Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms	JUL 1	2015	354						172	176		10.1016/j.nimb.2014.12.045		5	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Atomic, Molecular & Chemical; Physics, Nuclear	Instruments & Instrumentation; Nuclear Science & Technology; Physics	CK4KY	WOS:000356193900040		
J	Kitayama, T; Nakajima, K; Suzuki, M; Narumi, K; Saitoh, Y; Matsuda, M; Sataka, M; Tsujimoto, M; Isoda, S; Kimura, K				Kitayama, T.; Nakajima, K.; Suzuki, M.; Narumi, K.; Saitoh, Y.; Matsuda, M.; Sataka, M.; Tsujimoto, M.; Isoda, S.; Kimura, K.			Temperature of thermal spikes in amorphous silicon nitride films produced by 1.11 MeV C-60(3+), impacts	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM INTERACTIONS WITH MATERIALS AND ATOMS			English	Article						Ion track; C60; a-SiN	MOLECULAR-DYNAMICS SIMULATION; GOLD NANODISPERSED TARGETS; HEAVY-ION IRRADIATION; NANOCLUSTERS; DESORPTION; NM; CLUSTERS; LAYERS	Gold nanoparticles with an average diameter of 3.6 nm were deposited on amorphous silicon nitride (a-SiN) films. Thee samples were irradiated with 1.11 MeV C-60(3+) ions to a fluence of similar to 5 x 10(10) ions/cm(2) and observed using transmission electron microscopy (TEM). The ion tracks were clearly seen as bright spots and the gold nanoparticles disappeared from a surface area with a diameter of similar to 20 nm around each ion track. The disappeared nanoparticles were collected by a foil placed in front of the sample. Gold particles of circular shape with a diameter of several nm were observed on the collector foil using TEM, suggesting that the gold nanoparticles were emitted as liquid droplets from the a-SiN film upon impact of the C-60 ion. In view of the previous molecular dynamics simulations (Anders et al., 2009), this indicates that the surface temperature rises above the melting point of gold in the region with a diameter of 20 nm around the ion impact position. (C) 2014 Elsevier B.V. All rights reserved.	[Kitayama, T.; Nakajima, K.; Suzuki, M.; Kimura, K.] Kyoto Univ, Dept Micro Engn, Kyoto 6158540, Japan; [Narumi, K.; Saitoh, Y.] Japan Atom Energy Agcy, Takasaki Adv Radiat Res Inst, Takasaki, Gumma 3701292, Japan; [Matsuda, M.; Sataka, M.] Japan Atom Energy Agcy, Nucl Sci Res Inst, Naka, Ibaraki 3191195, Japan; [Tsujimoto, M.; Isoda, S.] Kyoto Univ, Inst Integrated Cell Mat Sci, Kyoto 6068501, Japan	Kimura, K (reprint author), Kyoto Univ, Dept Micro Engn, Kyoto 6158540, Japan.	kimura@kues.kyoto-u.ac.jp			JSPS KAKENHI [26246025]	This work was performed under the shared use program of JAEA facilities. The authors are grateful to the crews of the 400-kV ion implanter at JAEA/Takasaki for the C<INF>60</INF>-ion irradiation. They are also grateful to the technical staff of the accelerator facilities at JAEA/Tokai for the 420-MeV Au-ion irradiation. This work was supported by JSPS KAKENHI Grant Number 26246025.	Satpati B, 2003, NUCL INSTRUM METH B, V212, P332, DOI 10.1016/S0168-583X(03)01491-5; Anders C, 2009, NUCL INSTRUM METH B, V267, P2503, DOI 10.1016/j.nimb.2009.05.010; Nakajima K, 2014, NUCL INSTRUM METH B, V332, P117, DOI 10.1016/j.nimb.2014.02.042; Canut B, 1997, NUCL INSTRUM METH B, V122, P335, DOI 10.1016/S0168-583X(96)00576-9; Toulemonde M, 2000, NUCL INSTRUM METH B, V166, P903, DOI 10.1016/S0168-583X(99)00799-5; WANG ZG, 1994, J PHYS-CONDENS MAT, V6, P6733, DOI 10.1088/0953-8984/6/34/006; Schiwietz G, 2004, NUCL INSTRUM METH B, V225, P4, DOI 10.1016/j.nimb.2004.05.041; Baranov I, 2005, NUCL INSTRUM METH B, V230, P495, DOI 10.1016/j.nimb.2004.12.090; Baranov I, 2008, NUCL INSTRUM METH B, V266, P1993, DOI 10.1016/j.nimb.2008.03.094; Baranov I, 2006, NUCL INSTRUM METH B, V245, P184, DOI 10.1016/j.nimb.2005.11.128; Baranov I, 2007, NUCL INSTRUM METH B, V263, P389, DOI 10.1016/j.nimb.2007.07.001; BARANOV IA, 1992, NUCL INSTRUM METH B, V65, P177, DOI 10.1016/0168-583X(92)95031-L; Canut B, 2008, NUCL INSTRUM METH B, V266, P2819, DOI 10.1016/j.nimb.2008.03.125; Kissel R, 2001, INT J MASS SPECTROM, V208, P29, DOI 10.1016/S1387-3806(01)00376-1; Kitayama T., UNPUB; Toulemonde M., 2006, MAT FYS MEDD K DAN V, V52, P263; Urbassek HM, 2011, NUCL INSTRUM METH B, V269, P947, DOI 10.1016/j.nimb.2010.12.010; Ziegler J. F., 1985, STOPPING RANGE IONS; Zimmermann S, 2008, INT J MASS SPECTROM, V272, P91, DOI 10.1016/j.ijms.2008.01.004	19	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-583X	1872-9584		NUCL INSTRUM METH B	Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms	JUL 1	2015	354						183	186		10.1016/j.nimb.2014.11.002		4	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Atomic, Molecular & Chemical; Physics, Nuclear	Instruments & Instrumentation; Nuclear Science & Technology; Physics	CK4KY	WOS:000356193900042		
J	Furukawa, T; Ito, G; Goto, M; Majima, T; Tanuma, H; Matsumoto, J; Shiromaru, H; Hansen, K; Azuma, T				Furukawa, T.; Ito, G.; Goto, M.; Majima, T.; Tanuma, H.; Matsumoto, J.; Shiromaru, H.; Hansen, K.; Azuma, T.			Cooling dynamics of photo-excited negative carbon cluster ions stored in an ion storage ring	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM INTERACTIONS WITH MATERIALS AND ATOMS			English	Article						Carbon cluster anion; Radiative cooling; Depletion cooling; Inverse internal conversion; Recurrent fluorescence	THERMIONIC EMISSION; SPECTRA; SPECTROSCOPY; ANIONS	A newly found fast radiative cooling process of C-6(-) is studied by simulation based on statistical sharing of the internal energy by the vibrational modes both in the electronic ground and excited states. For comparison, a contrasting slow cooling of C6H- is simulated by the same procedure. The simulation demonstrates a distinct difference in the time evolution of energy distributions between C-6(-) and C6H-, and well reproduces the observed fast cooling of C-6(-) by recurrent electronic transitions and the slow cooling of C6H- by vibrational de-excitation. (C) 2014 Elsevier B.V. All rights reserved.	[Furukawa, T.; Ito, G.; Majima, T.; Tanuma, H.; Azuma, T.] Tokyo Metropolitan Univ, Dept Phys, Hachioji, Tokyo 1920397, Japan; [Goto, M.; Azuma, T.] RIKEN, Atom Mol & Opt Phys Lab, Wako, Saitama 3510198, Japan; [Matsumoto, J.; Shiromaru, H.] Tokyo Metropolitan Univ, Dept Chem, Hachioji, Tokyo 1920397, Japan; [Hansen, K.] Univ Gothenburg, Dept Phys, S-41296 Gothenburg, Sweden	Azuma, T (reprint author), RIKEN, Atom Mol & Opt Phys Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.				Japanese Society for the Promotion of Science [26220607]; TMU	This work was in part supported by Grant-in-Aid for Scientific Research (No. 26220607) from the Japanese Society for the Promotion of Science, and the TMU Research Program Grant 2013-2014 "Ion storage experiments for interstellar chemistry."	Andersen JU, 2002, J PHYS B-AT MOL OPT, V35, pR1, DOI 10.1088/0953-4075/35/5/201; Campbell EEB, 2000, ANNU REV PHYS CHEM, V51, P65, DOI 10.1146/annurev.physchem.51.1.65; Goto M, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4817196; LEGER A, 1988, PHYS REV LETT, V60, P921, DOI 10.1103/PhysRevLett.60.921; Taylor TR, 1998, J CHEM PHYS, V108, P10018, DOI 10.1063/1.476462; ARNOLD DW, 1991, J CHEM PHYS, V95, P8753, DOI 10.1063/1.461211; Ito G, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.183001; MARTIN JML, 1995, CHEM PHYS LETT, V242, P570, DOI 10.1016/0009-2614(95)00801-A; Martin S, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.063003; Fuentealba P, 1998, PHYS REV A, V58, P4232, DOI 10.1103/PhysRevA.58.4232; Cao ZX, 2001, PHYS CHEM CHEM PHYS, V3, P1403, DOI 10.1039/b009604k; Herbst E., 2008, APJ, V679, P6710; Moon JH, 2007, J AM SOC MASS SPECTR, V18, P1063, DOI 10.1016/j.jasms.2007.03.012; Najafian K, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4867499; SCHMATZ S, 1995, CHEM PHYS LETT, V235, P5, DOI 10.1016/0009-2614(95)00081-E; Szczepanski J, 1997, J PHYS CHEM A, V101, P1841, DOI 10.1021/jp963200z	16	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-583X	1872-9584		NUCL INSTRUM METH B	Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms	JUL 1	2015	354						192	196		10.1016/j.nimb.2014.12.016		5	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Atomic, Molecular & Chemical; Physics, Nuclear	Instruments & Instrumentation; Nuclear Science & Technology; Physics	CK4KY	WOS:000356193900044		
J	Nikko, M; Nakajima, K; Kimura, K				Nikko, Masataka; Nakajima, Kaoru; Kimura, Kenji			A compact high-resolution elastic recoil detection system for lithium depth profiling	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM INTERACTIONS WITH MATERIALS AND ATOMS			English	Article						ERDA; Li; High resolution		A compact high-resolution elastic recoil detection analysis (ERDA) system was developed for precise Li analysis. 200-400 key He+ ions were used as primary ions and the energy spectra of recoiled Li ions were measured using a magnetic spectrometer. Due to,its dispersion the background originating from the scattered primary ions is reduced. The recoiled ions of the substrate other than Li, which may also contribute to the background, were rejected by a thin mylar foil placed in front of a focal plane detector. An electrostatic quadrupole lens was installed at the entrance of the magnetic spectrometer to improve the depth resolution by correcting the effect of the kinematic broadening; The performance of the developed high-resolution ERDA was examined by measuring several samples. A thin Li layer (1.5 x 10(15) cm(-2)) deposited on a graphite surface was clearly observed and the detection limit was estimated to be less than 0.01 ML under typical measurement conditions. The depth resolution was estimated to be 0.5 nm at the surface and was better than 3 nm in the surface region within 5 nm from the surface. (C) 2014 Elsevier B.V. All rights reserved.	[Nikko, Masataka; Nakajima, Kaoru; Kimura, Kenji] Kyoto Univ, Dept Micro Engn, Kyoto 6158540, Japan	Kimura, K (reprint author), Kyoto Univ, Dept Micro Engn, Kyoto 6158540, Japan.	kimura@kues.kyoto-u.ac.jp			JSPS KAKENHI [25286020]	This work was supported by JSPS KAKENHI Grant Number 25286020.	Schiettekatte F, 2008, NUCL INSTRUM METH B, V266, P1880, DOI 10.1016/j.nimb.2007.11.075; Giangrandi S, 2008, NUCL INSTRUM METH B, V266, P5144, DOI 10.1016/j.nimb.2008.08.018; Tarascon JM, 2001, NATURE, V414, P359, DOI 10.1038/35104644; Dollinger G, 2004, NUCL INSTRUM METH B, V219, P333, DOI 10.1016/j.nimb.2004.01.079; Dollinger G, 1998, EUROPHYS LETT, V42, P25, DOI 10.1209/epl/i1998-00547-6; L'Ecuyer J., 1976, J APPL PHYS, V47, P382; LOFFLER M, 1973, NUCL INSTRUM METHODS, V111, P1, DOI 10.1016/0029-554X(73)90090-6; MARION JB, 1968, NUCL REACTION ANAL G; Ziegler J. F., 1985, STOPPING RANGE IONS	9	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-583X	1872-9584		NUCL INSTRUM METH B	Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms	JUL 1	2015	354						240	243		10.1016/j.nimb.2014.11.003		4	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Atomic, Molecular & Chemical; Physics, Nuclear	Instruments & Instrumentation; Nuclear Science & Technology; Physics	CK4KY	WOS:000356193900054		
J	Yoshizaki, H; Hashimoto, A; Kaneno, Y; Semboshi, S; Hori, F; Saitoh, Y; Iwase, A				Yoshizaki, H.; Hashimoto, A.; Kaneno, Y.; Semboshi, S.; Hori, F.; Saitoh, Y.; Iwase, A.			Energetic ion beam induced crystal phase transformation and resulting hardness change in Ni3Al intermetallic compound	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM INTERACTIONS WITH MATERIALS AND ATOMS			English	Article						Ni3Al; Ion irradiation; Order-disorder transformation; Vickers hardness; Thermal annealing	ELECTRON-IRRADIATION; ALLOY SYSTEM; MICROSTRUCTURE; AMORPHIZATION; EVOLUTION	The Ni3Al bulk intermetallic compound was irradiated with 5.4-MeV Al, 10-MeV I and 16-MeV Au ions at room temperature. The effect of irradiation on the lattice structure was observed by X-ray diffraction (XRD). The change in Vickers hardness by irradiation was estimated. A crystal structure analysis showed that, the Ni3Al lattice structure transforms from an ordered L1(2) lattice structure to a disordered A1 (fcc) lattice structure by energetic ion irradiation. The relative degree of order correlates well with the density of energy that was elastically deposited by irradiation. The Vickers hardness tends to decrease with an increase in ion fluence. The hardness is not correlated with the elastically deposited energy. The effect of annealing at elevated temperatures on the irradiation induced crystal phase transformation and the Vickers hardness is also discussed. (C) 2014 Elsevier B.V. All rights reserved.	[Yoshizaki, H.; Hashimoto, A.; Kaneno, Y.; Hori, F.; Iwase, A.] Osaka Prefecture Univ, Dept Mat Sci, Sakai, Osaka 5998531, Japan; [Semboshi, S.] Tohoku Univ, Inst Mat Res, Kansai Ctr, Sakai, Osaka 5998531, Japan; [Saitoh, Y.] Japan Atom Energy Agcy, Takasaki Adv Radiat Res Inst, Takasaki, Gunma 3701292, Japan	Yoshizaki, H (reprint author), Osaka Prefecture Univ, Dept Mat Sci, Sakai, Osaka 5998531, Japan.	su110040@edu.osakafu-u.ac.jp					Abromeit C, 2000, J NUCL MATER, V276, P104, DOI 10.1016/S0022-3115(99)00173-7; Shibuya S, 2006, ACTA MATER, V54, P861, DOI 10.1016/j.actamat.2005.10.016; Moronaga T, 2012, INTERMETALLICS, V21, P80, DOI 10.1016/j.intermet.2011.09.012; Nunomura Y, 2004, INTERMETALLICS, V12, P389, DOI 10.1016/j.intermet.2003.12.011; Fujioka K, 2013, MAT SCI ENG A-STRUCT, V588, P239, DOI 10.1016/j.msea.2013.09.037; ARDELL AJ, 1992, MAT SCI ENG A-STRUCT, V152, P212, DOI 10.1016/0921-5093(92)90070-H; CARPENTER GJC, 1981, SCRIPTA METALL MATER, V15, P549, DOI 10.1016/0036-9748(81)90201-5; ERIDON J, 1987, NUCL INSTRUM METH B, V19-20, P626, DOI 10.1016/S0168-583X(87)80126-X; Ewert JC, 1998, APPL PHYS LETT, V73, P3363, DOI 10.1063/1.122770; Hashimoto A, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.05FC08; Hashimoto A., 2013, T MAT RES SOC JPN, V38, P329; Hashimoto A, 2014, NUCL INSTRUM METH B, V338, P72, DOI 10.1016/j.nimb.2014.08.008; KOIKE J, 1988, J NON-CRYST SOLIDS, V106, P230, DOI 10.1016/0022-3093(88)90265-7; LIU HC, 1983, ACTA METALL MATER, V31, P863, DOI 10.1016/0001-6160(83)90114-1; Motta AT, 1999, J NUCL MATER, V270, P174, DOI 10.1016/S0022-3115(98)00657-6; Muller S, 1999, J NUCL MATER, V271, P241, DOI 10.1016/S0022-3115(98)00711-9; XU GB, 1993, J ALLOY COMPD, V194, P401, DOI 10.1016/0925-8388(93)90025-I; Xu YB, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.11RH02	18	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-583X	1872-9584		NUCL INSTRUM METH B	Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms	JUL 1	2015	354						287	291		10.1016/j.nimb.2014.11.067		5	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Atomic, Molecular & Chemical; Physics, Nuclear	Instruments & Instrumentation; Nuclear Science & Technology; Physics	CK4KY	WOS:000356193900064		
J	Ishiyama, H; Jeong, SC; Watanabe, YX; Hirayama, Y; Imai, N; Miyatake, H; Oyaizu, M; Osa, A; Otokawa, Y; Matsuda, M; Nishio, K; Makii, H; Sato, TK; Kuwata, N; Kawamura, J; Nakao, A; Ueno, H; Kim, YH; Kimura, S; Mukai, M				Ishiyama, H.; Jeong, S. C.; Watanabe, Y. X.; Hirayama, Y.; Imai, N.; Miyatake, H.; Oyaizu, M.; Osa, A.; Otokawa, Y.; Matsuda, M.; Nishio, K.; Makii, H.; Sato, T. K.; Kuwata, N.; Kawamura, J.; Nakao, A.; Ueno, H.; Kim, Y. H.; Kimura, S.; Mukai, M.			In situ lithium diffusion measurement in solid ionic conductors using short-lived radiotracer beam of Li-8	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM INTERACTIONS WITH MATERIALS AND ATOMS			English	Article						Lithium diffusion; Lithium radiotracer; Implantation; Lithium ionic conductors; Lithium ion battery	PULSED-LASER DEPOSITION; THIN-FILMS; LICOO2	We developed an in situ radiotracer method for diffusion studies in solids using short-lived alpha-emitting Li-8 tracer. In the method, while implanting a pulsed Li-8 beam into a solid material of interest, the alpha particles emitted into the implantation side of the sample surface were detected as a function of time. By changing the implantation depth and the detection angle against the sample surface according to lithium diffusivity (deep implantation and large angle with a large solid angle, or shallow implantation and small angle with a narrow solid angle), the method can be sensitive to a wide range of diffusion length ranging from micrometer scale to nanometer scale per second. The feasibility of the method was demonstrated by measuring the lithium diffusion coefficients to the order of 10(-12) cm(2)/s in lithium ionic conductors. (C) 2014 Elsevier B.V. All rights reserved.	[Ishiyama, H.; Jeong, S. C.; Watanabe, Y. X.; Hirayama, Y.; Imai, N.; Miyatake, H.; Oyaizu, M.] High Energy Accelerator Res Org KEK, Inst Particle & Nucl Studies, Tsukuba, Ibaraki 3050801, Japan; [Osa, A.; Otokawa, Y.; Matsuda, M.; Nishio, K.; Makii, H.; Sato, T. K.] JAEA, Tokai, Ibaraki 3191195, Japan; [Kuwata, N.; Kawamura, J.] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Sendai, Miyagi 9808577, Japan; [Nakao, A.; Ueno, H.] RIKEN, Nishina Ctr Accelerator Based Sci, Wako, Saitama 3510198, Japan; [Kim, Y. H.] Seoul Natl Univ, Seoul 151747, South Korea; [Kimura, S.; Mukai, M.] Univ Tsukuba, Tsukuba, Ibaraki 3058577, Japan	Jeong, SC (reprint author), High Energy Accelerator Res Org KEK, Inst Particle & Nucl Studies, Oho 1-1, Tsukuba, Ibaraki 3050801, Japan.	sunchan.jeong@kek.jp	Ueno, Hideki/A-7472-2015		Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan [25390036]; Institute of Material Structure Science (IMSS) at High Energy Accelerator Res. Org. (KEK) in Japan	This work is supported by Grants-In-Aid # 25390036 from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan, and by another grant from Institute of Material Structure Science (IMSS) at High Energy Accelerator Res. Org. (KEK) in Japan. The experiment was performed under the shared use program of JAEA facilities in Japan.	Xia H, 2006, J POWER SOURCES, V159, P1422, DOI 10.1016/j.jpowsour.2005.12.012; Wenwer F, 1996, MEAS SCI TECHNOL, V7, P632, DOI 10.1088/0957-0233/7/4/021; BONNER TW, 1948, PHYS REV, V73, P885, DOI 10.1103/PhysRev.73.885; Ichikawa S, 2003, NUCL INSTRUM METH B, V204, P372, DOI 10.1016/S0168-583X(02)01976-6; Ishiyama H, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.010205; Jeong SC, 2003, JPN J APPL PHYS 1, V42, P4576, DOI 10.1143/JJAP.42.4576; Jeong SC, 2008, JPN J APPL PHYS, V47, P6413, DOI 10.1143/JJAP.47.6413; Jeong S.C., 20111 TRIAC COLL KEK; Kawamura J, 2004, SOLID STATE IONICS, V175, P273, DOI 10.1016/j.ssi.2004.05.034; Nakamura K, 2000, SOLID STATE IONICS, V135, P143, DOI 10.1016/S0167-2738(00)00293-9; Sato H, 1997, J POWER SOURCES, V68, P540, DOI 10.1016/S0378-7753(96)02589-X; Sugiyama J, 2013, J PHYS SOC JPN, V82, DOI 10.7566/JPSJS.82SA.SA023; Tujin C., 1997, DEFECT DIFFUS FORUM, V141-142, P1; Watanabe YX, 2007, EUR PHYS J-SPEC TOP, V150, P259, DOI 10.1140/epjst/e2007-00317-2; Ziegler J. F., 1985, STOPPING RANGE IONS	15	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-583X	1872-9584		NUCL INSTRUM METH B	Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms	JUL 1	2015	354						297	300		10.1016/j.nimb.2014.10.031		4	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Atomic, Molecular & Chemical; Physics, Nuclear	Instruments & Instrumentation; Nuclear Science & Technology; Physics	CK4KY	WOS:000356193900066		
J	Furue, R; Jia, YL; McCreary, JP; Schneider, N; Richards, KJ; Muller, P; Cornuelle, BD; Avellaneda, NM; Stammer, D; Liu, CY; Kohl, A				Furue, Ryo; Jia, Yanli; McCreary, Julian P.; Schneider, Niklas; Richards, Kelvin J.; Mueller, Peter; Cornuelle, Bruce D.; Avellaneda, Nidia Martinez; Stammer, Detlef; Liu, Chuanyu; Koehl, Armin			Impacts of regional mixing on the temperature structure of the equatorial Pacific Ocean. Part 1: Vertically uniform vertical diffusion	OCEAN MODELLING			English	Article						Diffusion; Rossby waves; Kelvin waves; Advection; Pycnoline; Ocean general circulation models	NORTH PACIFIC; TROPICAL PACIFIC; SUBSURFACE COUNTERCURRENTS; INDONESIAN THROUGHFLOW; CIRCULATION MODELS; FLUX MEASUREMENTS; SCALE STRUCTURES; EASTERN PACIFIC; TSUCHIYA JET; EL-NINO	We investigate the sensitivity of numerical model solutions to regional changes in vertical diffusion. Specifically, we vary the background diffusion coefficient, kappa(b), within spatially distinct subregions of the tropical Pacific, assess the impacts of those changes, and diagnose the processes that account for them. Solutions respond to a diffusion anomaly, delta kappa(b), in three ways. Initially, there is a fast response (several months), due to the interaction of rapidly propagating, barotropic and gravity waves with eddies and other mesoscale features. It is followed by a local response (roughly one year), the initial growth and spatial pattern of which can be explained by one-dimensional (vertical) diffusion. At this stage, temperature and salinity anomalies are generated that are either associated with a change in density ("dynamical" anomalies) or without one ("spiciness" anomalies). In a final adjustment stage, the dynamical and spiciness anomalies spread to remote regions by radiation of Rossby and Kelvin waves and by advection, respectively. In near equilibrium solutions, dynamical anomalies are generally much larger in the latitude band of the forcing, but the impact of off equatorial forcing by delta kappa(b) on the equatorial temperature structure is still significant. Spiciness anomalies spread equator ward within the pycnocline, where they are carried to the equator as part of the subsurface branch of the Pacific Subtropical Cells, and spiciness also extends to the equator via western-boundary currents. Forcing near and at the equator generates strong dynamical anomalies, and sometimes additional spiciness anomalies, at pycnocline depths. The total response of the equatorial temperature structure to delta kappa(b) in various regions depends on the strength and spatial pattern of the generation of each signal within the forcing region as well as On the processes of its spreading to the equator.	[Furue, Ryo; Jia, Yanli; McCreary, Julian P.; Schneider, Niklas; Richards, Kelvin J.] Univ Hawaii, Int Pacific Res Ctr, Honolulu, HI 96822 USA; [Mueller, Peter] Univ Hawaii, Dept Oceanog, Honolulu, HI 96822 USA; [Cornuelle, Bruce D.; Avellaneda, Nidia Martinez] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Stammer, Detlef; Liu, Chuanyu; Koehl, Armin] Univ Hamburg, Inst Oceanog, Hamburg, Germany; [Furue, Ryo] JAMSTEC, Applicat Lab, Yokohama, Kanagawa 2360001, Japan	Furue, R (reprint author), JAMSTEC, 3173-25 Showa Machi, Yokohama, Kanagawa 2360001, Japan.	furue@hawaii.edu	Kohl, Armin/I-9378-2014		NASA Grant [NNX10AE97G]; JAMSTEC-IPRC Collaborative Study (JICS); Japan Agency for Marine-Earth Science and Technology (JAMSTEC); NASA [NNX07AG53G]; NOAA [NA11NMF4320128]	This work is supported by NASA Grant NNX10AE97G. It is also partially supported by JAMSTEC-IPRC Collaborative Study (JICS). We thank Kunihiro Aoki, Shota Katsura, and Young Ho Kim (alphabetical order) for fruitful discussion. Comments from anonymous reviewers helped improve the manuscript. RF, YJ, JPM, NS, and KJR are partially supported by the Japan Agency for Marine-Earth Science and Technology (JAMSTEC), by NASA through Grant NNX07AG53G, and by NOAA through Grant NA11NMF4320128, which sponsor research at the International Pacific Research Center. The authors wish to acknowledge use of the Ferret program for analysis and graphics in this paper. Ferret is a product of NOAA's Pacific Marine Environmental Laboratory. (Information is available at http://ferret.pmeLnoaa.goviFerreti.)	ANDERSON DLT, 1976, MON WEATHER REV, V104, P907, DOI 10.1175/1520-0493(1976)104<0907:TLLJAA>2.0.CO;2; Jayne SR, 2001, GEOPHYS RES LETT, V28, P811, DOI 10.1029/2000GL012044; Ffield A, 1996, J PHYS OCEANOGR, V26, P1924, DOI 10.1175/1520-0485(1996)026<1924:TMSITI>2.0.CO;2; McCreary JP, 2002, J PHYS OCEANOGR, V32, P2379, DOI 10.1175/1520-0485(2002)032<2379:DOTPSC>2.0.CO;2; Lu P, 1995, J PHYS OCEANOGR, V25, P3076, DOI 10.1175/1520-0485(1995)025<3076:IOTIOT>2.0.CO;2; MCCREARY JP, 1994, J PHYS OCEANOGR, V24, P466; FFIELD A, 1992, J PHYS OCEANOGR, V22, P184, DOI 10.1175/1520-0485(1992)022<0184:VMITIT>2.0.CO;2; Roemmich D, 2009, PROG OCEANOGR, V82, P81, DOI 10.1016/j.pocean.2009.03.004; Jochum M, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005030; Liu CY, 2012, J PHYS OCEANOGR, V42, P1186, DOI 10.1175/JPO-D-11-0162.1; Spall MA, 2000, J MAR RES, V58, P957, DOI 10.1357/002224000763485764; Nonaka M, 2000, GEOPHYS RES LETT, V27, P3747, DOI 10.1029/2000GL011488; LARGE WG, 1994, REV GEOPHYS, V32, P363, DOI 10.1029/94RG01872; TSUCHIYA M, 1981, J PHYS OCEANOGR, V11, P794, DOI 10.1175/1520-0485(1981)011<0794:TOOTPE>2.0.CO;2; Hoteit I, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005437; KAWASE M, 1987, J PHYS OCEANOGR, V17, P2294, DOI 10.1175/1520-0485(1987)017<2294:EODOCD>2.0.CO;2; Suga T, 2000, PROG OCEANOGR, V47, P223, DOI 10.1016/S0079-6611(00)00037-9; Richards KJ, 2009, J CLIMATE, V22, P3703, DOI 10.1175/2009JCLI2702.1; Fedorov AV, 2010, NATURE, V463, P1066, DOI 10.1038/nature08831; Maximenko NA, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033267; Meehl GA, 2001, CLIM DYNAM, V17, P515, DOI 10.1007/PL00007929; MCCREARY JP, 1981, PHILOS T R SOC A, V298, P603, DOI 10.1098/rsta.1981.0002; Kohl A, 2008, J PHYS OCEANOGR, V38, P1913, DOI 10.1175/2008JPO3775.1; Kohl A, 2007, J PHYS OCEANOGR, V37, P313, DOI 10.1175/JPO3014.1; LARGE WG, 1982, J PHYS OCEANOGR, V12, P464, DOI 10.1175/1520-0485(1982)012<0464:SALHFM>2.0.CO;2; Friedrich T, 2011, OCEAN MODEL, V39, P262, DOI 10.1016/j.ocemod.2011.04.012; Furue R, 2007, J PHYS OCEANOGR, V37, P531, DOI 10.1175/JPO3024.1; FURUE R, 1995, J GEOPHYS RES-OCEANS, V100, P10567; Furue R, 2009, J PHYS OCEANOGR, V39, P2024, DOI 10.1175/2009JPO4065.1; GODFREY JS, 1993, J PHYS OCEANOGR, V23, P1087, DOI 10.1175/1520-0485(1993)023<1087:WDTITA>2.0.CO;2; Hasumi H, 1999, J GEOPHYS RES-OCEANS, V104, P23367, DOI 10.1029/1999JC900191; Hoteit I, 2008, J ATMOS OCEAN TECH, V25, P131, DOI 10.1175/2007JTECHO528.1; Jia Y., 2014, IMPACTS REGI UNPUB 2; Johnson GC, 2002, PROG OCEANOGR, V52, P31, DOI 10.1016/S0079-6611(02)00021-6; Kashino Y, 1996, J GEOPHYS RES-OCEANS, V101, P12391, DOI 10.1029/95JC03797; Kim Y. H., 2014, RESPONSE ENSO TIDAL; LARGE WG, 1981, J PHYS OCEANOGR, V11, P324, DOI 10.1175/1520-0485(1981)011<0324:OOMFMI>2.0.CO;2; LUKAS R, 1986, PROG OCEANOGR, V16, P63, DOI 10.1016/0079-6611(86)90007-8; LUYTEN J, 1986, J PHYS OCEANOGR, V16, P1551, DOI 10.1175/1520-0485(1986)016<1551:GDBCWA>2.0.CO;2; Manucharyan GE, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2011JC007295; Marshall J, 1997, J GEOPHYS RES-OCEANS, V102, P5753, DOI 10.1029/96JC02775; McCreary JP, 2007, PROG OCEANOGR, V75, P70, DOI 10.1016/j.pocean.2007.05.004; Montes I, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005710; Nakano H, 2005, J PHYS OCEANOGR, V35, P474, DOI 10.1175/JPO2698.1; Penven P, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2005JC002945; Richards KJ, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024645; Richards KJ, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050439; Sasaki W, 2013, CLIM DYNAM, V41, P443, DOI 10.1007/s00382-012-1593-8; Sasaki W, 2012, OCEAN MODEL, V57-58, P29, DOI 10.1016/j.ocemod.2012.09.002; Schneider N, 2004, J CLIMATE, V17, P1083, DOI 10.1175/1520-0442(2004)017<1083:TROTCT>2.0.CO;2; Taguchi B, 2014, J CLIMATE, V27, P7568, DOI 10.1175/JCLI-D-13-00102.1; TALLEY LD, 1985, J PHYS OCEANOGR, V15, P633, DOI 10.1175/1520-0485(1985)015<0633:VOTSNP>2.0.CO;2; Tatebe H, 2010, OCEAN MODEL, V35, P245, DOI 10.1016/j.ocemod.2010.07.011; TSUCHIYA M, 1975, J MAR RES, V33, P145; Tsuchiya M., 1968, J HOPKINS OCEANOGRAP, V4; TSUCHIYA M, 1972, J GEOPHYS RES, V77, P5981, DOI 10.1029/JC077i030p05981; Wyrtki K., 1962, MAR FRESHWATER RES, V13, P18, DOI [10.1071/MF9620018, DOI 10.1071/MF9620018]	57	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1463-5003	1463-5011		OCEAN MODEL	Ocean Model.	JUL	2015	91						91	111		10.1016/j.ocemod.2014.10.002		21	Meteorology & Atmospheric Sciences; Oceanography	Meteorology & Atmospheric Sciences; Oceanography	CK2SR	WOS:000356063100005		
J	Jia, YL; Furue, R; McCreary, JP				Jia, Yanli; Furue, Ryo; McCreary, Julian P., Jr.			Impacts of regional mixing on the temperature structure of the equatorial Pacific Ocean. Part 2: Depth-dependent vertical diffusion	OCEAN MODELLING			English	Article						Diffusion; Rossby waves; Kelvin waves; Advection; Pycnocline; Ocean general circulation models	TROPICAL CYCLONES; FLUX MEASUREMENTS; SCALE STRUCTURES; EL-NINO; THERMOCLINE; MODEL; PARAMETERIZATION; UNDERCURRENT; SENSITIVITY; PYCNOCLINE	In this study, we use an ocean model to explore how vertical mixing influences temperature in the eastern equatorial Pacific Ocean. Our approach is to change the background diffusion coefficient from a constant value kappa(b) to kappa(b) + delta kappa(Z) in various subregions of the tropical Pacific, and then to determine the resulting temperature changes in the near equilibrium response. In a companion paper (Fume et al., 2015), we consider the impacts of depth-independent kappa(b), anomalies. Here, we examine the impacts of depth-dependent anomalies that are confined above, or centered on, the mid-depth of the pycnocline. During the first year of adjustment, solutions develop a local temperature response that results largely from the one-dimensional balance delta T-t - (delta kappa T-Z)(Z) - delta kappa T-Z(Z) + delta kappa T-ZZ, with a similar equation for salinity. At this stage, delta kappa generates temperature and salinity anomalies that are either associated with a density change (dynamical anomalies) or without one (spiciness anomalies). Subsequently, dynamical and spiciness anomalies spread to remote regions by wave radiation and advection, respectively. For positive delta kappa anomalies confined above the mid-pycnocline, delta kappa T-Z(Z) tends to produce positive temperature anomalies, which spread to the equator dynamically (by wave radiation) and are still apparent in near-equilibrium solutions. For delta kappa anomalies confined within the pycnocline (with monopole, dipole, and tripole profiles), the response is dominated by delta kappa T-Z(Z), owing to delta kappa having a smaller vertical scale than T and to the depth range where delta kappa is large not overlapping well with that where vertical bar T-ZZ vertical bar is; the resulting temperature anomalies tend to shift the pycnocline vertically (dipole profile) or to alter its thickness (monopole and tripole profiles). Positive anomalies from all subregions contribute to an increase of near-surface(upper 50 in) temperature in the eastern equatorial Pacific, the amplitude and location of the warming depending on the depth range of the warming band generated within the locally forced subregion. (C) 2015 The Authors. Published by Elsevier B.V.	[Jia, Yanli; Furue, Ryo; McCreary, Julian P., Jr.] Univ Hawaii, Int Pacific Res Ctr, Honolulu, HI 96822 USA; [Furue, Ryo] JAMSTEC, APL, Yokohama, Kanagawa, Japan	Jia, YL (reprint author), Univ Hawaii, Int Pacific Res Ctr, Honolulu, HI 96822 USA.	yjia@hawaii.edu			NASA [NNX10AE97G, NNX07AG53G]; Japan Agency for Marine-Earth Science and Technology (JAMSTEC); NOAA [NA11NMF4320128]	This work is supported by NASA Grant NNX10AE97G. We thank Bruce Cornuelle, Armin Kohl, Chuanyu Liu, Nidia Martinez Avellaneda, Peter Muller, Kelvin Richards, Niklas Schneider, and Detlef Stammer for fruitful discussion. Anonymous reviewers' comments helped improve the manuscript. The authors are partially supported by the Japan Agency for Marine-Earth Science and Technology (JAMSTEC), by NASA through Grant NNX07AG53G, and by NOAA through Grant NA11NMF4320128, which sponsor research at the International Pacific Research Center. The authors wish to acknowledge use of the Ferret program for analysis and graphics in this paper. Ferret is a product of NOAA's Pacific Marine Environmental Laboratory. (Information is available at http://ferret.pmel.noaa.gov/Ferrrt/.)	Sriver RL, 2007, NATURE, V447, P577, DOI 10.1038/nature05785; Liu CY, 2012, J PHYS OCEANOGR, V42, P1186, DOI 10.1175/JPO-D-11-0162.1; LARGE WG, 1994, REV GEOPHYS, V32, P363, DOI 10.1029/94RG01872; Moum JN, 2009, NAT GEOSCI, V2, P761, DOI 10.1038/NGEO657; Richards KJ, 2009, J CLIMATE, V22, P3703, DOI 10.1175/2009JCLI2702.1; Sriver RL, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2010JC006106; Fedorov AV, 2010, NATURE, V463, P1066, DOI 10.1038/nature08831; Whalen CB, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053196; Meehl GA, 2001, CLIM DYNAM, V17, P515, DOI 10.1007/PL00007929; Kohl A, 2008, J PHYS OCEANOGR, V38, P1913, DOI 10.1175/2008JPO3775.1; Ledwell JR, 1998, J GEOPHYS RES-OCEANS, V103, P21499, DOI 10.1029/98JC01738; Kohl A, 2007, J PHYS OCEANOGR, V37, P313, DOI 10.1175/JPO3014.1; LARGE WG, 1982, J PHYS OCEANOGR, V12, P464, DOI 10.1175/1520-0485(1982)012<0464:SALHFM>2.0.CO;2; BRYAN F, 1987, J PHYS OCEANOGR, V17, P970, DOI 10.1175/1520-0485(1987)017<0970:PSOPEO>2.0.CO;2; CUMMINS PF, 1990, J PHYS OCEANOGR, V20, P817, DOI 10.1175/1520-0485(1990)020<0817:SOTGOG>2.0.CO;2; Furue R., 2015, OCEAN MODELL; GREGG MC, 1976, J GEOPHYS RES-OC ATM, V81, P1180, DOI 10.1029/JC081i006p01180; GREGG MC, 1985, NATURE, V318, P140, DOI 10.1038/318140a0; Jones J. H., 1973, Journal of Physical Oceanography, V3, DOI 10.1175/1520-0485(1973)003<0286:VMITEU>2.0.CO;2; Kanari S., 1992, J OCEANOGR, V48, P117, DOI 10.1007/BF02239000; Kelley DE, 1999, J PHYS OCEANOGR, V29, P1759, DOI 10.1175/1520-0485(1999)029<1759:ABEOVM>2.0.CO;2; LARGE WG, 1981, J PHYS OCEANOGR, V11, P324, DOI 10.1175/1520-0485(1981)011<0324:OOMFMI>2.0.CO;2; Manucharyan GE, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2011JC007295; Marshall J, 1997, J GEOPHYS RES-OCEANS, V102, P5753, DOI 10.1029/96JC02775; MOUM JN, 1989, J GEOPHYS RES-OCEANS, V94, P2005, DOI 10.1029/JC094iC02p02005; Richards KJ, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050439; Sasaki W, 2013, CLIM DYNAM, V41, P443, DOI 10.1007/s00382-012-1593-8; Sasaki W, 2012, OCEAN MODEL, V57-58, P29, DOI 10.1016/j.ocemod.2012.09.002; Sriver RL, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL042836	29	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1463-5003	1463-5011		OCEAN MODEL	Ocean Model.	JUL	2015	91						112	127		10.1016/j.ocemod.2015.02.007		16	Meteorology & Atmospheric Sciences; Oceanography	Meteorology & Atmospheric Sciences; Oceanography	CK2SR	WOS:000356063100006		
J	Kellam, M				Kellam, Marisa			Parties for hire: How particularistic parties influence presidents' governing strategies	PARTY POLITICS			English	Article						Empirical research; Latin America; office goals; presidential cabinets; theory construction	PARLIAMENTARY DEMOCRACIES; LATIN-AMERICA; BRAZIL; GOVERNMENT; BEHAVIOR; IDEOLOGY; SURVIVAL; POLITICS; CABINET; HAZARDS	I argue that political parties oriented towards particularistic goods affect coalition government in presidential systems. Particularistic parties hire out their support on some item(s) of the presidential agenda in exchange for locally targeted policies or resources under the control of presidents. They are relatively cheap coalition partners for presidents in policy terms and their representation in the legislature provides presidents with coalitional flexibility. My empirical analysis of cabinets in 10 Latin American countries shows that when particularistic parties hold a larger share of the legislative seats minority presidents are less likely to form majority governments and more likely to change the party composition of their cabinets.	[Kellam, Marisa] Waseda Univ, Inst Adv Study, Tokyo, Japan	Kellam, M (reprint author), Waseda Univ, Waseda Inst Adv Study, Shinjuku Ku, 169-8050 Nishi Waseda, Tokyo, Japan.	mkellam@pols.tamu.edu					Acosta AM, 2011, LAT AM POLIT SOC, V53, P87, DOI 10.1111/j.1548-2456.2011.00118.x; Aleman Eduardo, 2011, J POLITICS LATIN AM, V3, P3; Almeida A, 2003, PRESIDENTIAL I UNPUB; Ames B., 2001, DEADLOCK DEMOCRACY B; AMES B, 1995, AM J POLIT SCI, V39, P406, DOI 10.2307/2111619; Negretto GL, 2006, LAT AM POLIT SOC, V48, P63, DOI 10.1353/lap.2006.0037; STEPAN A, 1993, WORLD POLIT, V46, P1, DOI 10.2307/2950664; Raile ED, 2011, POLIT RES QUART, V64, P323, DOI 10.1177/1065912909355711; Pereira C, 2004, COMP POLIT STUD, V37, P781, DOI 10.1177/0010414004266866; Desposato SW, 2006, AM J POLIT SCI, V50, P62, DOI 10.1111/j.1540-5907.2006.00170.x; Cheibub JA, 2004, BRIT J POLIT SCI, V34, P565, DOI 10.1017/S0007123404000195; [Anonymous], LAT AM NEWSL; Cox GW, 2001, COMP POLIT, V33, P171, DOI 10.2307/422377; Diermeier D, 2000, J ECON THEORY, V94, P46, DOI 10.1006/jeth.2000.2682; Kitschelt H, 2000, COMP POLIT STUD, V33, P845, DOI 10.1177/001041400003300607; Keele L, 2010, POLIT ANAL, V18, P189, DOI 10.1093/pan/mpp044; Altman D, 2000, PARTY POLIT, V6, P259, DOI 10.1177/1354068800006003001; Zucco C, 2009, J POLIT, V71, P1076, DOI 10.1017/S0022381609090896; Figueiredo AC, 2000, COMP POLIT, V32, P151, DOI 10.2307/422395; Box-Steffensmeier JM, 2001, AM J POLIT SCI, V45, P972, DOI 10.2307/2669335; Carey J, 1995, ELECT STUD, V14, P471; Caviedes C, 1979, POLITICS CHILE SOCIO; Cheibub JA, 2002, COMP POLIT STUD, V35, P284, DOI 10.1177/0010414002035003002; Coppedge M., 1997, 244 U NOTR DAM KELL; Deheza GI, 1997, THESIS I U EUROPEO; Evans Diana, 2004, GREASING WHEELS USIN; Faundez J, 1997, PRESIDENTIALISM DEMO; Figueiredo Argelina Cheibub, 2007, BRAZILIAN POLITICAL, V1, P182; Garcia MR, 1998, 7 PROYECT CORDES GOB; Geddes B, 1994, POLITICIANS DILEMMA; Gibson EEC, 2000, STUDIES COMP INT DEV, V35; Hochstetler K, 2006, COMP POLITICS, V38; KING G, 1990, AM J POLIT SCI, V34, P846, DOI 10.2307/2111401; Kitschelt H, 2006, PATRONS, CLIENTS, AND POLICIES: PATTERNS OF DEMOCRATIC ACCOUNTABILITY AND POLITICAL COMPETITION, P1; Laver Michael, 1990, MULTIPARTY GOVT POLI; Linz Juan J., 1994, FAILURE PRESIDENTIAL; Londregan J, 2000, IDEOLOGY LEGISLATIVE; Lyne MM, 2008, AM J POLIT SCI, V52, P290, DOI 10.1111/j.1540-5907.2008.00313.x; Mainwaring S, 1993, COMP POLITICAL STUDI, V26; Mainwaring Scott, 1997, PRESIDENTIALISM DEMO; Martinez-Gallardo C, 2012, COMP POLIT STUD, V45, P62, DOI 10.1177/0010414011421306; McDonald RH, 1971, PARTY SYSTEMS ELECT; McKelvey R, 1976, ECON THEOR, V12, P472; Mejia Acosta A, 2009, INFORMAL COALITIONS; Mejia Acosta A, 2006, INFORMAL I DEMOCRACY; Morgenstern Scott, 2004, PATTERNS LEGISLATIVE; Neto Amorim, 2006, COMP POLIT STUD, V39, P415; Neto OA, 2001, PARTY POLIT, V7, P213, DOI 10.1177/1354068801007002004; Pop-Eleches Grigore, 2009, EC CRISIS REFORM IMF; Shugart Matthew Soberg, 1992, PRESIDENTS ASSEMBLIE; Taylor MM, 1996, ELECT STUD, V15, P327, DOI 10.1016/0261-3794(96)00003-0; Warwick P. V., 1994, GOVT SURVIVAL PARLIA	52	1	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1354-0688	1460-3683		PARTY POLIT	Party Polit.	JUL	2015	21	4					515	526		10.1177/1354068813487109		12	Political Science	Government & Law	CK7ME	WOS:000356415700002		
J	Kuwahara, K; Kimura, T				Kuwahara, Koichiro; Kimura, Takeshi			The organ-protective effect of N-type Ca2+ channel blockade	PHARMACOLOGY & THERAPEUTICS			English	Review						N-type Ca2+ channel; Voltage-dependent Ca2+ channel; Sympathetic nerve; Hypertension	OMEGA-CONOTOXIN GVIA; ELECTRICALLY-EVOKED RELEASE; ENDOGENOUS DOPAMINE RELEASE; SENSITIVE CALCIUM CHANNELS; CHICK SENSORY NEURONS; ROOT GANGLION NEURONS; GUINEA-PIG ATRIA; SYNAPTIC-TRANSMISSION; HYPERTENSIVE PATIENTS; HEART-FAILURE	The six subtypes of voltage-dependent Ca2+ channels (VDCCs) mediate a wide range of physiological responses. N-type VDCCs (NCCs) were originally identified as a high voltage-activated Ca2+ channel selectively blocked by omega-conotoxin (omega-CTX)-GVIA. Predominantly localized in the nervous system, NCCs are key regulators of neurotransmitter release. Both pharmacological blockade with omega-CTX-GVIA and, more recently, mice lacking CNCNA1B, encoding the alpha 1B subunit of NCC, have been used to assess the physiological and pathophysiological functions of NCCs, revealing in part their significant roles in sympathetic nerve activation and nociceptive transmission. The evidence now available indicates that NCCs are a potentially useful therapeutic target for the treatment of several pathological conditions. Efforts are therefore being made to develop effective NCC blockers, including both synthetic omega-CTX-GVIA derivatives and small-molecule inhibitors. Cilnidipine, for example, is a dihydropyridine L-type VDCC blocking agent that also possesses significant NCC blocking ability. As over-activation of the sympathetic nervous system appears to contribute to the pathological processes underlying cardiovascular, renal and metabolic diseases, NCC blockade could be a useful approach to treating these ailments. In this review article, we provide an overview of what is currently known about the physiological and pathophysiological activities of NCCs and the potentially beneficial effects of NCC blockade in several disease conditions, in particular cardiovascular diseases. (C) 2015 Published by Elsevier Inc.	[Kuwahara, Koichiro; Kimura, Takeshi] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto 6068507, Japan	Kuwahara, K (reprint author), Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Sakyo Ku, 54 Shogoin Kawaharacho, Kyoto 6068507, Japan.	kuwa@kuhp.kyoto-u.ac.jp			Japan Society for the Promotion of Science [26293187, 26670400]; Japanese Ministry of Health, Labor and Welfare; SENSHIN Medical Research Foundation	This study was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science 26293187 and 26670400, by a grant from the Japanese Ministry of Health, Labor and Welfare, and by grants from the SENSHIN Medical Research Foundation.	Ando Katsuyuki, 2013, Curr Hypertens Rev, V9, P210; Ando K, 2013, INT J MED SCI, V10, P1209, DOI 10.7150/ijms.5508; Hayashi K, 2007, CIRC RES, V100, P342, DOI 10.1161/01.RES.0000256155.31133.49; Yamamoto T, 2009, CURR TOP MED CHEM, V9, P377; Uneyama H, 1997, BRIT J PHARMACOL, V122, P37, DOI 10.1038/sj.bjp.0701342; AUGUSTINE GJ, 1987, ANNU REV NEUROSCI, V10, P633; ZHANG JF, 1993, NEUROPHARMACOLOGY, V32, P1075, DOI 10.1016/0028-3908(93)90003-L; Hatakeyama S, 2001, NEUROREPORT, V12, P2423, DOI 10.1097/00001756-200108080-00027; Canale MP, 2013, INT J ENDOCRINOL, DOI 10.1155/2013/865965; Cassidy JS, 2014, P NATL ACAD SCI USA, V111, P8979, DOI 10.1073/pnas.1403731111; MILLER RJ, 1987, SCIENCE, V235, P46, DOI 10.1126/science.2432656; WILLIAMS ME, 1992, NEURON, V8, P71, DOI 10.1016/0896-6273(92)90109-Q; COHN JN, 1984, NEW ENGL J MED, V311, P819, DOI 10.1056/NEJM198409273111303; Epstein M, 2006, CLIN J AM SOC NEPHRO, V1, P940, DOI 10.2215/CJN.00240106; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; KOMURO H, 1992, SCIENCE, V257, P806, DOI 10.1126/science.1323145; White WB, 2003, HYPERTENSION, V41, P1021, DOI 10.1161/01.HYP.0000067463.13172.EA; Katayama K, 2006, KIDNEY INT, V70, P151, DOI 10.1038/sj.ki.5000349; WILLIAMS ME, 1992, SCIENCE, V257, P389, DOI 10.1126/science.1321501; Dzau VJ, 2006, CIRCULATION, V114, P2850, DOI 10.1161/CIRCULATIONAHA.106.655688; OLIVERA BM, 1985, SCIENCE, V230, P1338, DOI 10.1126/science.4071055; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Gromada J, 1997, J GEN PHYSIOL, V110, P217, DOI 10.1085/jgp.110.3.217; VARADI G, 1995, TRENDS PHARMACOL SCI, V16, P43, DOI 10.1016/S0165-6147(00)88977-4; Ishikawa T, 2005, J PHYSIOL-LONDON, V568, P199, DOI 10.1113/jphysiol.2005.089912; Iwasaki S, 2000, J NEUROSCI, V20, P59; Kinoshita H, 2009, CIRCULATION, V120, P743, DOI 10.1161/CIRCULATIONAHA.109.857011; Just A, 2000, AM J PHYSIOL-REG I, V279, pR2214; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Evans RM, 2006, TRENDS NEUROSCI, V29, P617, DOI 10.1016/j.tins.2006.08.006; Adams DJ, 2013, BBA-BIOMEMBRANES, V1828, P1619, DOI 10.1016/j.bbamem.2013.01.019; Vignali S, 2006, J PHYSIOL-LONDON, V572, P691, DOI 10.1113/jphysiol.2005.102368; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; Kim C, 2001, MOL CELL NEUROSCI, V18, P235, DOI 10.1006/mcne.2001.1013; Saegusa H, 2001, EMBO J, V20, P2349, DOI 10.1093/emboj/20.10.2349; Wright JT, 2002, JAMA-J AM MED ASSOC, V288, P2421, DOI 10.1001/jama.288.19.2421; JULIUS S, 1993, HYPERTENSION, V21, P886; FOX AP, 1987, J PHYSIOL-LONDON, V394, P173; Fujii S, 1997, J PHARMACOL EXP THER, V280, P1184; Chiang CS, 2009, CIRC RES, V104, P522, DOI 10.1161/CIRCRESAHA.108.184051; Mesirca P, 2014, PFLUG ARCH EUR J PHY, V466, P791, DOI 10.1007/s00424-014-1482-6; Mori Y, 2002, TRENDS CARDIOVAS MED, V12, P270, DOI 10.1016/S1050-1738(02)00173-1; Serone AP, 1999, BRIT J PHARMACOL, V127, P927, DOI 10.1038/sj.bjp.0702629; AOSAKI T, 1989, PFLUG ARCH EUR J PHY, V414, P150, DOI 10.1007/BF00580957; Aritomi S, 2011, HYPERTENS RES, V34, P193, DOI 10.1038/hr.2010.191; Barg S, 2000, DIABETES, V49, P1500, DOI 10.2337/diabetes.49.9.1500; BOND A, 1992, EUR J PHARMACOL, V218, P179, DOI 10.1016/0014-2999(92)90163-X; CARBONE E, 1984, NATURE, V310, P501, DOI 10.1038/310501a0; CLASBRUMMEL B, 1989, BRIT J PHARMACOL, V96, P101; DOOLEY DJ, 1988, EUR J PHARMACOL, V148, P261, DOI 10.1016/0014-2999(88)90572-9; DUTAR P, 1989, EUR J PHARMACOL, V174, P261, DOI 10.1016/0014-2999(89)90318-X; Fan YY, 2010, J HYPERTENS, V28, P1034, DOI 10.1097/HJH.0b013e328336ade3; Fujita T, 2007, KIDNEY INT, V72, P1543, DOI 10.1038/sj.ki.5002623; FUJITA Y, 1993, NEURON, V10, P585, DOI 10.1016/0896-6273(93)90162-K; HERDON H, 1989, N-S ARCH PHARMACOL, V340, P36; Himing L. D., 1988, SCIENCE, V239, P57; Holmer SR, 1997, J HYPERTENS, V15, P1471, DOI 10.1097/00004872-199715120-00015; HOLZ GG, 1988, J NEUROSCI, V8, P463; HONG SJ, 1995, BRIT J PHARMACOL, V116, P1577; HORNE AL, 1991, BRIT J PHARMACOL, V103, P1733; Ino M, 2001, P NATL ACAD SCI USA, V98, P5323, DOI 10.1073/pnas.081089398; ISHIBASHI H, 1995, NEUROREPORT, V6, P1621, DOI 10.1097/00001756-199508000-00008; Jafri SM, 2004, HEART FAIL REV, V9, P115, DOI 10.1023/B:HREV.0000046366.31764.ca; JULIUS S, 1988, J CARDIOVASC PHARM, V12, pS121; Kamp MA, 2005, EUR J NEUROSCI, V21, P1617, DOI 10.1111/j.1460-9568.2005.03984.x; KERR LM, 1988, EUR J PHARMACOL, V146, P181, DOI 10.1016/0014-2999(88)90501-8; Kojima S, 2004, HYPERTENS RES, V27, P379, DOI 10.1291/hypres.27.379; KOMATSU M, 1989, ENDOCRINOLOGY, V125, P2008; KON V, 1989, MINER ELECTROL METAB, V15, P33; Konda T, 2005, NEPHRON PHYSIOL, V101, pp1; Konda T, 2009, AM J NEPHROL, V30, P155, DOI 10.1159/000210396; Kuwahara K, 2003, EMBO J, V22, P6310, DOI 10.1093/emboj/cdg601; Kuwahara K, 2005, J PHARMACOL SCI, V99, P211, DOI 10.1254/jphs.FMJ05002X4; Lee S, 2013, CURR NEUROPHARMACOL, V11, P606, DOI 10.2174/1570159X11311060005; Le Quang K, 2011, CARDIOVASC RES, V91, P420, DOI 10.1093/cvr/cvr082; LUEBKE JI, 1993, NEURON, V11, P895, DOI 10.1016/0896-6273(93)90119-C; MAGGI CA, 1990, NEUROSCI LETT, V114, P203, DOI 10.1016/0304-3940(90)90072-H; Mills L. R., 1994, NEUROSCIENCE, V14, P6815; Mori Y, 1996, JPN J PHARMACOL, V72, P83, DOI 10.1254/jjp.72.83; Murakami M, 2007, BIOCHEM BIOPH RES CO, V354, P1016, DOI 10.1016/j.bbrc.2007.01.087; Nagahama Takahiko, 2000, Arzneimittel-Forschung, V50, P248; Nagai H, 2005, HYPERTENS RES, V28, P361, DOI 10.1291/hypres.28.361; Nakayama H, 2009, J CLIN INVEST, V119, P3787, DOI 10.1172/JCI39724; Nattel S, 2014, CARDIOVASC RES, V104, P1, DOI 10.1093/cvr/cvu197; Nishida M, 2013, BIOCHEM BIOPH RES CO, V434, P210, DOI 10.1016/j.bbrc.2013.03.040; NOWYCKY MC, 1985, NATURE, V316, P440, DOI 10.1038/316440a0; Penn RD, 2000, PAIN, V85, P291, DOI 10.1016/S0304-3959(99)00254-7; PRUNEAU D, 1990, J CARDIOVASC PHARM, V16, P675, DOI 10.1097/00005344-199010000-00022; RAMANADHAM S, 1994, CELL CALCIUM, V15, P259, DOI 10.1016/0143-4160(94)90065-5; Rose GW, 2001, HYPERTENS RES, V24, P377, DOI 10.1291/hypres.24.377; SANTICIOLI P, 1992, NEUROSCI LETT, V136, P161, DOI 10.1016/0304-3940(92)90039-A; Schricker K, 1996, BRIT J PHARMACOL, V119, P744; Spalding A, 1998, HYPERTENSION, V31, P603; Stomello M, 1983, HYPERTENSION, V5; Takahara A, 2003, HYPERTENS RES, V26, P743, DOI 10.1291/hypres.26.743; Takahashi E, 2005, INT J MOL MED, V15, P937; TAKEMURA M, 1989, NEUROSCIENCE, V32, P405, DOI 10.1016/0306-4522(89)90089-4; Taylor JT, 2005, AM J PHYSIOL-ENDOC M, V289, pE900, DOI 10.1152/ajpendo.00101.2005; TOTH PT, 1993, NATURE, V364, P635, DOI 10.1038/364635a0; TURNER TJ, 1993, P NATL ACAD SCI USA, V90, P9518, DOI 10.1073/pnas.90.20.9518; Uneyama H, 1999, EUR J PHARMACOL, V373, P93, DOI 10.1016/S0014-2999(99)00237-X; VEGA T, 1995, EUR J PHARMACOL, V276, P231, DOI 10.1016/0014-2999(95)00032-G; Watanabe K, 1995, Nihon Yakurigaku Zasshi, V106, P393; WESSLER I, 1990, N-S ARCH PHARMACOL, V341, P288; Whorlow SL, 1996, EUR J PHARMACOL, V315, P11, DOI 10.1016/S0014-2999(96)00592-4; WOODWARD JJ, 1988, BRAIN RES, V475, P141, DOI 10.1016/0006-8993(88)90207-7; Yahagi N, 1998, J AUTONOM NERV SYST, V68, P43, DOI 10.1016/S0165-1838(97)00120-3; Yamada Y, 2014, CARDIOVASC RES, V104, P183, DOI 10.1093/cvr/cvu185; Yamazaki T, 1997, BRAIN RES, V761, P329, DOI 10.1016/S0006-8993(97)00443-5; Yang SN, 2005, AM J PHYSIOL-ENDOC M, V288, pE16, DOI 10.1152/ajpendo.00042.2004; Zhou XY, 2002, J HYPERTENS, V20, P993, DOI 10.1097/00004872-200205000-00035	111	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0163-7258			PHARMACOL THERAPEUT	Pharmacol. Ther.	JUL	2015	151						1	7		10.1016/j.pharmthera.2015.02.001		7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CK9FO	WOS:000356546200001		
J	Hasemi, A; Miura, H; Ishizawa, M; Kosuga, M; Umino, N; Hasegawa, A				Hasemi, Akiko; Miura, Hidetoshi; Ishizawa, Mari; Kosuga, Masahiro; Umino, Norihito; Hasegawa, Akira			Crustal structure in and around the Onikobe geothermal area, northeastern Honshu, Japan, inferred from the spatial variation of coda decay	PHYSICS OF THE EARTH AND PLANETARY INTERIORS			English	Article						Q(c); Scattering; Onikobe; Caldera; Low-Q zone; Lower crust	CENTRAL CALIFORNIA; INVERSION METHOD; NORTHERN HONSHU; SCATTERING; WAVE; EARTHQUAKES; ARC	The Onikobe area is an active geothermal area situated in the Ou backbone range of northeastern Honshu, Japan. It is home to calderas from the Tertiary to Quaternary eras and active volcanoes. A systematic spatial variation of Q(c) has been found in this area: Q(c) values are lower at stations in and around calderas than at other stations. The amplitude of coda waves with high Q(c)s decreases more slowly after a lapse time of around 7-10 s than that with low Q(c)s. In the present study, to determine causes for these coda decay variations, coda envelopes were synthesized in a structure model in which high attenuation zones existed beneath the Onikobe and Sanzugawa calderas and where scattering coefficients were higher in the lower crust than in the upper crust. Using hypocenters shallower than 10 km, envelopes were calculated for 256 station-hypocenter pairs with epicentral distances of less than 10 km. It was assumed that the coda waves were composed of S-S scattered waves, and that the scattering was single and isotropic. The observed features of the Q(c) distribution were reproduced in the synthesis, and synthesized envelopes were found to mostly coincide with observed decay curves. The top of high attenuation zones was thus estimated as being deeper than 7.5 km. The structure assumed for the synthesis was consistent with that of previous studies. We consider that the structure model used was appropriate, and that high attenuation zones beneath calderas and the reflective lower crust caused the spatial variation of the Q(c) and decay curves in the Onikobe area. We also consider that studies using coda decay would be beneficial in detecting high attenuation zones and the reflective lower crust. (C) 2015 Elsevier B.V. All rights reserved.	[Hasemi, Akiko] Yamagata Univ, Fac Sci, Dept Earth & Environm Sci, Yamagata 9908560, Japan; [Miura, Hidetoshi; Ishizawa, Mari] Yamagata Univ, Earth & Environm Sci, Grad Sch Sci, Yamagata 9908560, Japan; [Kosuga, Masahiro] Hirosaki Univ, Earthquake & Volcano Observ, Fac Sci & Technol, Aomori 0368561, Japan; [Umino, Norihito; Hasegawa, Akira] Tohoku Univ, Res Ctr Predict Earthquakes & Volcan Erupt, Grad Sch Sci, Sendai, Miyagi 9808578, Japan	Hasemi, A (reprint author), Yamagata Univ, Fac Sci, Dept Earth & Environm Sci, Yamagata 9908560, Japan.	hasemi@sci.kj.yamagata-u.ac.jp					AKI K, 1969, J GEOPHYS RES, V74, P615, DOI 10.1029/JB074i002p00615; Nakajima J, 2003, J VOLCANOL GEOTH RES, V127, P1, DOI 10.1016/S0377-0273(03)00155-0; Ito K, 1999, TECTONOPHYSICS, V306, P423, DOI 10.1016/S0040-1951(99)00069-4; AKI K, 1975, J GEOPHYS RES, V80, P3322, DOI 10.1029/JB080i023p03322; Takemura S, 2009, GEOPHYS J INT, V178, P950, DOI 10.1111/j.1365-246X.2009.04210.x; Asano Y, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002761; HASEGAWA A, 1978, TECTONOPHYSICS, V47, P43, DOI 10.1016/0040-1951(78)90150-6; De Siena L, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006938; Hasegawa A., 1999, EARTH MON, V27, P5; Horiuchi S, 1997, J GEOPHYS RES-SOL EA, V102, P18071, DOI 10.1029/97JB00974; HOSHIBA M, 1991, PHYS EARTH PLANET IN, V67, P123, DOI 10.1016/0031-9201(91)90066-Q; Iwasaki T, 2001, GEOPHYS RES LETT, V28, P2329, DOI 10.1029/2000GL012783; IWASAKI T, 1994, J GEOPHYS RES-SOL EA, V99, P22187, DOI 10.1029/94JB00732; MATUMOTO T, 1971, GEOL SOC AM BULL, V82, P2905, DOI 10.1130/0016-7606(1971)82[2905:SBWOIT]2.0.CO;2; MAYEDA K, 1992, J GEOPHYS RES-SOL EA, V97, P6643, DOI 10.1029/91JB03094; Miura H., 2003, J SEISMOL SOC JPN, V55, P351; Mooney WD, 1992, CONTINENTAL LOWER CR, V23, P45; NISHIGAMI K, 1991, GEOPHYS RES LETT, V18, P2225, DOI 10.1029/91GL02823; Nishigami K, 2000, J GEOPHYS RES-SOL EA, V105, P7983, DOI 10.1029/1999JB900381; Obara K, 1997, PHYS EARTH PLANET IN, V104, P109, DOI 10.1016/S0031-9201(97)00059-9; Onodera M., 1998, J SEISMOL SOC JPN, V51, P265; Sato H., 1977, Journal of Physics of the Earth, V25; Sato H., 1998, SEISMIC WAVE PROPAGA; STECK LK, 1989, B SEISMOL SOC AM, V79, P1559; Tramelli A, 2009, B SEISMOL SOC AM, V99, P1962, DOI 10.1785/0120080273; UMINO N., 1998, J SEISMOL SOC JPN, V51, P253; WESSEL P, 1998, EOS T AGU, V0079; Yamada Y., 1986, MISCELLANEOUS MAP SE; Yoshida T., 2001, TOHOKU GEOPHYS J, V36, P111; YOUNG CY, 1980, J GEOPHYS RES, V85, P2459, DOI 10.1029/JB085iB05p02459	30	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0031-9201	1872-7395		PHYS EARTH PLANET IN	Phys. Earth Planet. Inter.	JUL	2015	244						23	31		10.1016/j.pepi.2015.04.006		9	Geochemistry & Geophysics	Geochemistry & Geophysics	CK9KI	WOS:000356558600003		
J	Noritake, F; Kawamura, K; Matsukage, KN				Noritake, Fumiya; Kawamura, Katsuyuki; Matsukage, Kyoko N.			Elastic anomalies of anorthite: Molecular dynamics simulations	PHYSICS OF THE EARTH AND PLANETARY INTERIORS			English	Article						Anorthite; High-pressure; High-temperature; Molecular dynamics	HIGH-PRESSURE; CRYSTAL-STRUCTURE; SPONTANEOUS STRAIN; THERMAL-EXPANSION; SILICATE-GLASSES; PHASE-TRANSITION; HIGH-TEMPERATURE; SIO2 GLASS; CHEMISTRY; PLAGIOCLASE	We investigated the elastic anomalies of anorthite using molecular dynamics simulations in which the temperature and pressure induced P (1) over bar /I (1) over bar phase transitions were reproduced. The resulting changes in structure were investigated as functions of pressure and temperature. It was found that the temperature-induced elastic anomaly is caused by two different thermal expansion behaviors of atomic motion, that is, increased distance between nearest neighbor atoms and increased Si-O-Al angle. Furthermore, the pressure-induced elastic anomaly was found to be caused by a decrease in the Si-O-Al angle in six-membered rings, which is similar to the cases of vitreous silica or acidic silicate liquids. (C) 2015 Elsevier B.V. All rights reserved.	[Noritake, Fumiya; Kawamura, Katsuyuki] Okayama Univ, Grad Sch Environm & Life Sci, Kita Ku, Okayama 7008530, Japan; [Matsukage, Kyoko N.] Kyoto Univ, Grad Sch Human & Environm Studies, Sakyo Ku, Kyoto 6068501, Japan	Noritake, F (reprint author), Okayama Univ, Grad Sch Environm & Life Sci, Kita Ku, 3-1-1 Tsushimanaka, Okayama 7008530, Japan.	f.noritake@s.okayama-u.ac.jp			 [251856]	We thank Y. Ichikawa for useful discussion of this work. We thank two anonymous reviewers for their valuable comments. This work was supported by a Grant-in-Aid for JSPS fellows, 251856.	ALMENNINGEN A, 1963, ACTA CHEM SCAND, V17, P2455, DOI 10.3891/acta.chem.scand.17-2455; ANGEL RJ, 1989, PHYS CHEM MINER, V16, P539, DOI 10.1007/BF00202208; Angel RJ, 1997, J APPL CRYSTALLOGR, V30, P461, DOI 10.1107/S0021889897000861; Gobechiya ER, 2008, CRYSTALLOGR REP+, V53, P404, DOI 10.1134/S1063774508030073; Nakajima J, 2003, J VOLCANOL GEOTH RES, V127, P1, DOI 10.1016/S0377-0273(03)00155-0; CHRISTY AG, 1995, ACTA CRYSTALLOGR B, V51, P753, DOI 10.1107/S0108768195001728; MEADE C, 1992, PHYS REV LETT, V69, P1387, DOI 10.1103/PhysRevLett.69.1387; ZHA CS, 1994, PHYS REV B, V50, P13105, DOI 10.1103/PhysRevB.50.13105; WINTER JK, 1979, AM MINERAL, V64, P573; MYSEN BO, 1990, EARTH-SCI REV, V27, P281, DOI 10.1016/0012-8252(90)90055-Z; LEVIEN L, 1981, AM MINERAL, V66, P324; Burt JB, 2006, AM MINERAL, V91, P319, DOI 10.2138/am.2006.1875; FOIT FF, 1973, AM MINERAL, V58, P665; GEISINGER KL, 1985, PHYS CHEM MINER, V11, P266, DOI 10.1007/BF00307405; GIBBS GV, 1977, Z KRISTALLOGR, V145, P108, DOI 10.1524/zkri.1977.145.1-2.108; HACKWELL TP, 1995, AM MINERAL, V80, P239; HARIYA Y, 1968, AM J SCI, V266, P193; KUBICKI JD, 1993, AM MINERAL, V78, P253; Ma C, 2011, AM MINERAL, V96, P709, DOI 10.2138/am.2011.3693; Matsukage K.N., 2015, AM MINERAL IN PRESS; MCMILLAN P, 1984, AM MINERAL, V69, P622; Miyake A, 1999, PHYS CHEM MINER, V26, P624, DOI 10.1007/s002690050227; Nakano M, 2003, APPL CLAY SCI, V23, P15, DOI 10.1016/S0169-1317(03)00082-6; Noritake F, 2012, J NON-CRYST SOLIDS, V358, P3109, DOI 10.1016/j.jnoncrysol.2012.08.027; PAPIKE JJ, 1976, REV GEOPHYS, V14, P37, DOI 10.1029/RG014i001p00037; PEACOR DR, 1963, AM MINERAL, V48, P588; REDFERN SAT, 1987, PHYS CHEM MINER, V14, P189, DOI 10.1007/BF00308224; Tribaudino M, 2011, AM MINERAL, V96, P992, DOI 10.2138/am.2011.3722; TSUNEYUKI S, 1989, NATURE, V339, P209, DOI 10.1038/339209a0; Tsuneyuki S., 1996, MOL ENG, V6, P157; WAINWRIG.JE, 1971, Z KRISTALLOGR KRIST, V133, P75, DOI 10.1524/zkri.1971.133.133.75; WRIGHT AF, 1981, J SOLID STATE CHEM, V36, P371, DOI 10.1016/0022-4596(81)90449-7	32	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0031-9201	1872-7395		PHYS EARTH PLANET IN	Phys. Earth Planet. Inter.	JUL	2015	244						32	41		10.1016/j.pepi.2015.05.002		10	Geochemistry & Geophysics	Geochemistry & Geophysics	CK9KI	WOS:000356558600004		
J	Townsend, JP; Tsuchiya, J; Bina, CR; Jacobsen, SD				Townsend, Joshua P.; Tsuchiya, Jun; Bina, Craig R.; Jacobsen, Steven D.			First-principles investigation of hydrous post-perovskite	PHYSICS OF THE EARTH AND PLANETARY INTERIORS			English	Article						Hydrogen; Post-perovskite; Lower mantle; Elasticity	EARTHS LOWER MANTLE; WATER STORAGE CAPACITY; ELASTIC PROPERTIES; HIGH-PRESSURE; SEISMIC ANISOTROPY; LOWERMOST-MANTLE; PHASE-TRANSITION; GAMMA-PHASE; AB-INITIO; RINGWOODITE	A stable, hydrogen-defect structure of post-perovskite (hy-ppv, Mg1-xSiH2xO3) has been determined by first-principles calculations of the vibrational and elastic properties up to 150 GPa. Among three potential hy-ppv structures analyzed, one was found to be stable at pressures relevant to the lower-mantle D '' region. Hydrogen has a pronounced effect on the elastic properties of post-perovskite due to magnesium defects associated with hydration, including a reduction of the zero-pressure bulk (K-0) and shear (G(0)) moduli by 5% and 8%, respectively, for a structure containing similar to 1 wt.% H2O. However, with increasing pressure the moduli of hy-ppv increase significantly relative to ppv, resulting in a structure that is only 1% slower in bulk compressional velocity and 2.5% slower in shear-wave velocity than ppv at 120 GPa. In contrast, the reduction of certain anisotropic elastic constants (C-ij) in hy-ppv increases with pressure (notably, C-55, C-66, and C-23), indicating that hydration generally increases elastic anisotropy in hy-ppv at D '' pressures. Calculated infrared absorption spectra show two O-H stretching bands at similar to 3500 cm(-1) that shift with pressure to lower wavenumber by about 2 cm(-1)/GPa. At 120 GPa the hydrogen bonds in hy-ppv are still asymmetric. The stability of a hy-ppv structure containing 1-2 wt.% H2O at D '' pressures implies that post-perovskite may be a host for recycled or primordial hydrogen near the Earth's core-mantle boundary. (C) 2015 Elsevier B.V. All rights reserved.	[Townsend, Joshua P.; Bina, Craig R.; Jacobsen, Steven D.] Northwestern Univ, Dept Earth & Planetary Sci, Evanston, IL 60208 USA; [Tsuchiya, Jun] Ehime Univ, Geodynam Res Ctr, Matsuyama, Ehime 790, Japan	Townsend, JP (reprint author), Northwestern Univ, Dept Earth & Planetary Sci, Evanston, IL 60208 USA.	joshua@earth.northwestern.edu	Jacobsen, Steven/F-3443-2013	Jacobsen, Steven/0000-0002-9746-958X	EAPSI Program of the U.S. National Science Foundation (NSF) [1209633]; Japan Society for the Promotion of Science; Premier Research Institute for Ultrahigh-pressure Sciences (PRIUS); NSF [EAR-1452344, EAR-0847951]; Carnegie/DOE Alliance Center (CDAC); David and Lucile Packard Foundation; Alexander Von Humboldt Foundation	JPT was supported by the EAPSI Program of the U.S. National Science Foundation (NSF) Grant Number 1209633 and the Japan Society for the Promotion of Science, and by the Premier Research Institute for Ultrahigh-pressure Sciences (PRIUS) joint research program carried out at the Geodynamics Research Center, Ehime University. This research was supported by NSF Grants EAR-1452344 (SDJ), EAR-0847951 (CRB), the Carnegie/DOE Alliance Center (CDAC), the David and Lucile Packard Foundation, and by the Alexander Von Humboldt Foundation.	Grocholski B, 2012, P NATL ACAD SCI USA, V109, P2275, DOI 10.1073/pnas.1109204109; Bolfan-Casanova N, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017182; Murakami M, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021956; Brodholt JP, 2000, J GEOPHYS RES-SOL EA, V105, P18977, DOI 10.1029/2000JB900057; Gonnermann HM, 2007, NATURE, V449, P1037, DOI 10.1038/nature06240; Pearson DG, 2014, NATURE, V507, P221, DOI 10.1038/nature13080; Murakami M, 2004, SCIENCE, V304, P855, DOI 10.1126/science.1095932; Oganov AR, 2004, NATURE, V430, P445, DOI 10.1038/nature02701; MONKHORST HJ, 1976, PHYS REV B, V13, P5188, DOI 10.1103/PhysRevB.13.5188; Litasov K, 2003, EARTH PLANET SC LETT, V211, P189, DOI 10.1016/S0012-821X(03)00200-0; Perdew JP, 1996, PHYS REV B, V54, P16533, DOI 10.1103/PhysRevB.54.16533; CRAIG H, 1978, GEOPHYS RES LETT, V5, P897, DOI 10.1029/GL005i011p00897; Zhang L, 2013, P NATL ACAD SCI USA, V110, P6292, DOI 10.1073/pnas.1304402110; TROULLIER N, 1991, PHYS REV B, V43, P1993, DOI 10.1103/PhysRevB.43.1993; Garth T, 2014, GEOLOGY, V42, P207, DOI 10.1130/G34730.1; Libowitzky E, 1999, MONATSH CHEM, V130, P1047, DOI 10.1007/s007060050263; Hernandez ER, 2013, EARTH PLANET SC LETT, V364, P37, DOI 10.1016/j.epsl.2013.01.005; Tsuchiya T, 2004, EARTH PLANET SC LETT, V224, P241, DOI 10.1016/j.epsl.2004.05.017; Bolfan-Casanova N, 2000, EARTH PLANET SC LETT, V182, P209, DOI 10.1016/S0012-821X(00)00244-2; WEIDNER DJ, 1984, J GEOPHYS RES, V89, P7852, DOI 10.1029/JB089iB09p07852; Garnero EJ, 2008, SCIENCE, V320, P626, DOI 10.1126/science.1148028; Tsuchiya J, 2005, AM MINERAL, V90, P44, DOI 10.2138/am.2005.1628; Williams Q, 2001, ANNU REV EARTH PL SC, V29, P365, DOI 10.1146/annurev.earth.29.1.365; Blanchard M, 2009, AM MINERAL, V94, P83, DOI 10.2138/am.2009.3020; Baroni S, 2001, REV MOD PHYS, V73, P515, DOI 10.1103/RevModPhys.73.515; Murakami M, 2002, SCIENCE, V295, P1885, DOI 10.1126/science.1065998; Ferot A, 2012, EARTH PLANET SC LETT, V349, P218, DOI 10.1016/j.epsl.2012.06.022; Stackhouse S, 2005, EARTH PLANET SC LETT, V230, P1, DOI 10.1016/j.epsl.2004.11.021; Inoue T, 1998, EARTH PLANET SC LETT, V160, P107, DOI 10.1016/S0012-821X(98)00077-6; Parai R, 2012, EARTH PLANET SC LETT, V317, P396, DOI 10.1016/j.epsl.2011.11.024; Giannozzi P, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/39/395502; HOHENBERG P, 1964, PHYS REV B, V136, pB864, DOI 10.1103/PhysRev.136.B864; Karki BB, 2001, REV GEOPHYS, V39, P507, DOI 10.1029/2000RG000088; Inoue T, 2010, PHYS EARTH PLANET IN, V183, P245, DOI 10.1016/j.pepi.2010.08.003; Nowacki A, 2010, NATURE, V467, P1091, DOI 10.1038/nature09507; Born M., 1954, DYNAMICAL THEORY CRY; Ganskow G, 2010, AM MINERAL, V95, P747, DOI 10.2138/am.2010.3420; Gibbs GV, 2003, PHYS CHEM MINER, V30, P305, DOI 10.1007/s00269-003-0318; HILL R, 1952, P PHYS SOC LOND A, V65, P349, DOI 10.1088/0370-1298/65/5/307; Jacobsen SD, 2004, PHYS EARTH PLANET IN, V143, P47, DOI 10.1016/j.pepi.2003.07.019; Karki B.B., 2000, PHYS REV B, V62, P750; Kohlstedt DL, 1996, CONTRIB MINERAL PETR, V123, P345, DOI 10.1007/s004100050161; KOHN W, 1965, PHYS REV, V140, P1133, DOI 10.1103/PhysRev.140.A1133; Kudoh Y, 1999, PHYS CHEM MINER, V26, P382, DOI 10.1007/s002690050198; Li L, 2009, PHYS EARTH PLANET IN, V177, P103, DOI 10.1016/j.pepi.2009.07.007; Mao WL, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025770; Musgrave M.J.P., 1970, CRYSTAL ACOUSTICS; Nishi M, 2014, NAT GEOSCI, V7, P224, DOI [10.1038/ngeo2074, 10.1038/NGEO2074]; Nomura R, 2014, SCIENCE, V343, P522, DOI 10.1126/science.1248186; Schmandt B, 2014, SCIENCE, V344, P1265, DOI [10.1126/science.1253358, 10.1126/science.1253258]; Tenner TJ, 2012, CONTRIB MINERAL PETR, V163, P297, DOI 10.1007/s00410-011-0675-7; Tsuchiya J, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB005841; Umemoto K, 2011, AM MINERAL, V96, P1475, DOI 10.2138/am.2011.3720; Verma AK, 2009, EARTH PLANET SC LETT, V285, P140, DOI 10.1016/j.epsl.2009.06.009; Wookey J, 2005, NATURE, V438, P1004, DOI 10.1038/nature04345	55	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0031-9201	1872-7395		PHYS EARTH PLANET IN	Phys. Earth Planet. Inter.	JUL	2015	244						42	48		10.1016/j.pepi.2015.03.010		7	Geochemistry & Geophysics	Geochemistry & Geophysics	CK9KI	WOS:000356558600005		
J	Ishise, M; Miyake, H; Koketsu, K				Ishise, Motoko; Miyake, Hiroe; Koketsu, Kazuki			Dual subduction tectonics and plate dynamics of central Japan shown by three-dimensional P-wave anisotropic structure	PHYSICS OF THE EARTH AND PLANETARY INTERIORS			English	Article						P-wave azimuthal anisotropy; Seismic tomography; Japan subduction zone; Philippine Sea slab; Pacific slab	PHILIPPINE SEA PLATE; KANTO-TOKAI DISTRICT; SEISMIC TOMOGRAPHY; VELOCITY STRUCTURE; OCEANIC-CRUST; HI-NET; EARTHQUAKE; BENEATH; MOTION; TOKYO	The central Japanese subduction zone is characterized by a complex tectonic setting affected by the dual subduction of oceanic plates and collisions between the island arcs. To better understand of the subduction system, we performed an anisotropic tomography analysis using P-wave arrival times from local earthquakes to determine the three-dimensional structure of P-wave azimuthal anisotropy in the overriding plate and the Pacific and Philippine Sea (PHS) slabs. The principal characteristics of anisotropy in the subducted and subducting plates are (1) in the overriding plate, the distribution pattern of fast direction of crustal anisotropy coincides with that of the strike of geological structure, (2) in the two oceanic plates, fast propagation directions of P-wave were sub-parallel to the directions of seafloor spreading. Additionally, our tomographic images demonstrate that (1) the bottom of the Median Tectonic Line, the longest fault zone in Japan, reaches to the lower crust, and seems to link to the source region of an inter-plate earthquake along the PHS slab, (2) the segmentation of the PHS slab the Izu Islands arc, the Nishi-Shichito ridge, and the Shikoku basin - due to the formation history, is reflected in the regional variation of anisotropy. The tomographic study further implies that there might be a fragment of the Pacific slab suggested by a previous study beneath the Tokyo metropolitan area. The overall findings strongly indicate that seismic anisotropy analysis provide potentially useful information to understand a subduction zone. (C) 2015 Elsevier B.V. All rights reserved.	[Ishise, Motoko; Miyake, Hiroe; Koketsu, Kazuki] Univ Tokyo, Earthquake Res Inst, Bunkyo Ku, Tokyo 1130032, Japan	Ishise, M (reprint author), Univ Tokyo, Earthquake Res Inst, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.	ishise@eri.u-tokyo.ac.jp			Japan Society for the Promotion of Science (JSPS) Research Fellowship for Young Scientists	We would like to thank two anonymous reviewers and two editors (G. Helffrich and V. Cormier). This manuscript was greatly improved by careful reviews of them. All the figures in this paper are plotted using GMT (Wessel and Smith, 1998). We used seismic data from the National Research Institute for Earth Science and Disaster Prevention, Hokkaido University, Hirosaki University, Tohoku University, University of Tokyo, Nagoya University, Kyoto University, Kochi University, Kyushu University, Kagoshima University, the National Institute of Advanced Industrial Science and Technology, Tokyo Metropolitan Government, Shizuoka Prefectural Government, Kanagawa Prefectural Government, the City of Yokohama, the Japan Marine Science and Technology Center, and the Japan Meteorological Agency. M.I. is supported by a Japan Society for the Promotion of Science (JSPS) Research Fellowship for Young Scientists.	Abe K., 1978, Journal of Physics of the Earth, V26; Nakamichi H, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2005JB004161; LEVEQUE JJ, 1993, GEOPHYS J INT, V115, P313, DOI 10.1111/j.1365-246X.1993.tb05605.x; Kamiya S, 2000, GEOPHYS RES LETT, V27, P819, DOI 10.1029/1999GL011080; WALD DJ, 1995, B SEISMOL SOC AM, V85, P159; Ishise M, 2008, PHYS EARTH PLANET IN, V166, P83, DOI 10.1016/j.pepi.2007.11.003; Furumura T, 2007, B SEISMOL SOC AM, V97, P863, DOI 10.1785/0120060166; Obara K, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1854197; Tsukahara H, 1996, TECTONOPHYSICS, V262, P281, DOI 10.1016/0040-1951(96)00014-5; HESS HH, 1964, NATURE, V203, P629, DOI 10.1038/203629a0; Katayama I, 2009, NATURE, V461, P1114, DOI 10.1038/nature08513; Faccenda M, 2008, NATURE, V455, P1097, DOI 10.1038/nature07376; SENO T, 1993, J GEOPHYS RES-SOL EA, V98, P17941, DOI 10.1029/93JB00782; CRAMPIN S, 1978, GEOPHYS J ROY ASTR S, V53, P467, DOI 10.1111/j.1365-246X.1978.tb03754.x; KANESHIMA S, 1990, J GEOPHYS RES-SOLID, V95, P11121, DOI 10.1029/JB095iB07p11121; Nakajima J, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB006101; Kobayashi R, 2005, EARTH PLANETS SPACE, V57, P261; Earthquake Research Committee, 2013, LIST LONG TERM EV; Fujii T., 2001, KAGAKU, V71, P1595; FUKAO Y, 1983, NATURE, V303, P413, DOI 10.1038/303413a0; Furumura T., 2007, J GEOGR, V116, P576; Hacker R.H., 2003, J GEOPHYS RES, V108; Hori S, 2006, TECTONOPHYSICS, V417, P85, DOI 10.1016/j.tecto.2005.08.027; HORIE A, 1982, J PHYS EARTH, V30, P255; Hurukawa N., 1990, J SEISMOL SOC JPN 2, V43, P413; IIDAKA T, 1993, J PHYS EARTH, V41, P103; Ikari K., 1991, J GEOGR, V100, P475; ISHIDA M, 1992, J GEOPHYS RES-SOL EA, V97, P489, DOI 10.1029/91JB02567; ISHIDA M, 1988, J GEOPHYS RES-SOLID, V93, P2076, DOI 10.1029/JB093iB03p02076; Ishise M., 2008, AGU FALL M; Ishise M, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037749; Ishise M., 2006, EOS T AGU S, V87; Ishise M, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003599; Ito T., 2010, J GEOGR, V119, P235, DOI [10.5026/jgeography.119.235, DOI 10.5026/JGEOGRAPHY.119.235]; Johnson J., 2011, J GEOPHYS RES, V116; Kamiya S, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2005JB004219; Kimura H, 2006, TECTONOPHYSICS, V417, P101, DOI 10.1016/j.tecto.2005.06.013; Koketsu K, 2009, TECTONOPHYSICS, V472, P290, DOI 10.1016/j.tecto.2008.05.037; Matsubara M, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2005JB003673; Matsumura S, 1997, TECTONOPHYSICS, V273, P271, DOI 10.1016/S0040-1951(96)00277-6; Nakajima J, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006863; Nakajima J, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048754; Nakanishi M., 1989, J GEOPHYS RES, V15, P437, DOI DOI 10.1029/JB094IB11P15437; Noguchi S, 1998, B EARTHQ RES I TOKYO, V73, P73; Okada Y, 2004, EARTH PLANETS SPACE, V56, pXV; Okino K, 1999, GEOPHYS RES LETT, V26, P2287, DOI 10.1029/1999GL900537; Sakai S., 2009, B EARTHQ RES I TOKYO, V84, P57; Sato H, 2005, SCIENCE, V309, P462, DOI 10.1126/science.1110489; Sekiguchi S, 2001, TECTONOPHYSICS, V341, P19, DOI 10.1016/S0040-1951(01)00182-2; Sekine S., 2005, REPORT NATL RES I EA, V68, P137; Sella GF, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2000JB000033; Song TRA, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052639; Suzuki H., 1992, J SEISMOL SOC JPN, V45, P33; Tamura Y., 2010, J PETROL; Tanaka Y., 2005, EOS T AGU S, V86; Tanaka Y., 2008, THESIS U TOKYO, P109; The Headquarters for Earthquake Research Promotion, 2005, NAT SEISM HAZ MAPS J; THURBER CH, 1983, J GEOPHYS RES, V88, P8226, DOI 10.1029/JB088iB10p08226; Toda S, 2008, NAT GEOSCI, V1, P771, DOI 10.1038/ngeo318; TSUKAHARA H, 1987, TECTONOPHYSICS, V135, P329, DOI 10.1016/0040-1951(87)90116-8; Tsukahara H., 1991, J SEISMOL SOC JPN, V44, P221; Ueda Y., 2005, REPT HYDRO OCEANOGR, V41, P1; Ueno H., 2002, Q J SEISMOL, V65, P123; UM J, 1987, B SEISMOL SOC AM, V77, P972; Wakamatsu K., 2005, JAPAN ENG GEOMORPHOL; Wang Z, 2006, EARTH PLANET SC LETT, V241, P789, DOI 10.1016/j.epsl.2005.11.015; WESSEL P, 1998, EOS T AGU, V0079; Yamamoto S, 2009, GONDWANA RES, V16, P572, DOI 10.1016/j.gr.2009.05.014; Yoshii T., 1972, J PHYS EARTH, V20, P47	69	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0031-9201	1872-7395		PHYS EARTH PLANET IN	Phys. Earth Planet. Inter.	JUL	2015	244						49	68		10.1016/j.pepi.2015.03.008		20	Geochemistry & Geophysics	Geochemistry & Geophysics	CK9KI	WOS:000356558600006		
J	Hung, CH; Kobayashi, K; Wada, H; Nakamura, Y				Hung, Chun-Hsien; Kobayashi, Koichi; Wada, Hajime; Nakamura, Yuki			Isolation and characterization of a phosphatidylglycerophosphate phosphatase1, PGPP1, in Chlamydomonas reinhardtii	PLANT PHYSIOLOGY AND BIOCHEMISTRY			English	Article						Chlamydomonas reinhardtii; Chloroplast; Phosphatidylglycerol; Phosphatidylglycerophosphate phosphatase; Photosynthesis	ARABIDOPSIS-THALIANA; CARDIOLIPIN SYNTHASE; THYLAKOID MEMBRANES; PHOTOSYSTEM-II; BIOSYNTHESIS; MITOCHONDRIA; REQUIREMENT; PHOTOSYNTHESIS; CHLOROPLASTS; LOCALIZATION	Phosphatidylglycerol (PG) is the exclusive phospholipid synthesized in chloroplasts and plays important roles in photosynthesis. However, phosphatidylglycerophosphate phosphatase (PGPP), which catalyzes the final step of PG biosynthesis, is a missing piece in photosynthetic eukaryotes. Here, we isolated a previously uncharacterized haloacid dehalogenase-like phosphatase, designated CrPGPP1, as a putative PGPP in Chlamydomonas reinhardtii. CrPGPP1 complemented growth and lipid compositional defects in Delta gep4, a yeast mutant of PGPP, which indicates that CrPGPP1 is a functional PGPP. Two aspartic acid residues, which are both essential for the yeast PGPP (Gep4p) activity, are also conserved in the putative catalytic motif of CrPGPP1. Site-specific mutagenesis showed that the first but not the second aspartic acid residue was required for CrPGPP1 to complement the growth defect of Delta gep4 mutant, which highlights the distinct molecular features of CrPGPP1. Our results suggest that CrPGPP1 is a functional PGPP in C. reinhardtii, for the first PGPP in photosynthetic eukaryotes. (C) 2015 Elsevier Masson SAS. All rights reserved.	[Hung, Chun-Hsien; Nakamura, Yuki] Acad Sinica, Inst Plant & Microbial Biol, Taipei 11529, Taiwan; [Kobayashi, Koichi; Wada, Hajime] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo 1138654, Japan; [Wada, Hajime] Japan Sci & Technol Agcy, CREST, Saitamd, Japan; [Nakamura, Yuki] Japan Sci & Technol Agcy, PRESTO, Saitama, Japan	Nakamura, Y (reprint author), Acad Sinica, Inst Plant & Microbial Biol, 128 Sec 2 Acad Rd, Taipei 11529, Taiwan.	nakamura@gate.sinica.edu.tw	Wada, Hajime/K-2186-2015; Kobayashi, Koichi/A-8514-2011		CREST; PRESTO; Japan Science and Technology Agency; core budget of Institute of Plant and Microbial Biology, Academia Sinica	The authors thank Kazue Kanehara for critically reading the manuscript. This research was supported by CREST (to H.W) and PRESTO (to Y.N), Japan Science and Technology Agency, and the core budget of Institute of Plant and Microbial Biology, Academia Sinica (to Y.N).	Pineau B, 2013, PLANT CELL, V25, P4195, DOI 10.1105/tpc.113.118018; Osman C, 2010, EMBO J, V29, P1976, DOI 10.1038/emboj.2010.98; Haselier A, 2010, PLANT PHYSIOL, V153, P1372, DOI 10.1104/pp.110.156422; Riekhof WR, 2005, EUKARYOT CELL, V4, P242, DOI 10.1128/EC.4.2.242-252.2005; Hagio M, 2002, PLANT CELL PHYSIOL, V43, P1456, DOI 10.1093/pcp/pcf185; Gombos Z, 2002, BIOCHEMISTRY-US, V41, P3796, DOI 10.1021/bi011884h; Sato N, 2000, P NATL ACAD SCI USA, V97, P10655, DOI 10.1073/pnas.97.19.10655; Nakamura Y, 2007, J BIOL CHEM, V282, P29013, DOI 10.1074/jbc.M70438520; Nakamura Y, 2003, LIPIDS, V38, P1107, DOI 10.1007/s11745-006-1166-x; Xu CC, 2002, PLANT PHYSIOL, V129, P594, DOI 10.1104/pp.002725; Nakamura Y, 2009, P NATL ACAD SCI USA, V106, P20978, DOI 10.1073/pnas.0907173106; Tanoue R, 2014, FEBS LETT, V588, P1680, DOI 10.1016/j.febslet.2014.03.010; Zhou YH, 2013, PLANT J, V75, P867, DOI 10.1111/tpj.12248; Pan RH, 2014, PLANT CELL, V26, P391, DOI 10.1105/tpc.113.121095; ANDREWS J, 1985, PLANT PHYSIOL, V79, P259, DOI 10.1104/pp.79.1.259; Katayama K, 2004, FEBS LETT, V577, P193, DOI 10.1016/j.febslet.2004.10.009; Hagio M, 2000, PLANT PHYSIOL, V124, P795, DOI 10.1104/pp.124.2.795; Babiychuk E, 2003, PLANT J, V33, P899, DOI 10.1046/j.1365-313X.2003.01680.x; FOLCH J, 1957, J BIOL CHEM, V226, P497; GRIEBAU R, 1994, PLANT PHYSIOL, V105, P1269; Hung CH, 2013, FEBS LETT, V587, P2364, DOI 10.1016/j.febslet.2013.06.002; Kobayashi K., 2014, PLANT CELL REP, V34, P631; May A, 2012, BBA-PROTEINS PROTEOM, V1824, P319, DOI 10.1016/j.bbapap.2011.10.003; MOORE TS, 1974, PLANT PHYSIOL, V54, P164, DOI 10.1104/pp.54.2.164; Ostrander DB, 2001, J BIOL CHEM, V276, P25262, DOI 10.1074/jbc.M103689200; Wu F, 2006, PLANT PHYSIOL, V141, P1274, DOI 10.1104/pp.106.083451	26	1	1	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	PARIS	23 RUE LINOIS, 75724 PARIS, FRANCE	0981-9428			PLANT PHYSIOL BIOCH	Plant Physiol. Biochem.	JUL	2015	92						56	61		10.1016/j.plaphy.2015.04.002		6	Plant Sciences	Plant Sciences	CK3OB	WOS:000356124300007		
J	Shida, T; Fukuda, A; Saito, T; Ito, H; Kato, A				Shida, Takuhiro; Fukuda, Ai; Saito, Tamao; Ito, Hidetaka; Kato, Atsushi			AtRBP1, which encodes an RNA-binding protein containing RNA-recognition motifs, regulates root growth in Arabidopsis thaliana	PLANT PHYSIOLOGY AND BIOCHEMISTRY			English	Article						Arabidopsis thaliana; RNA-binding protein; RNA ligand; RNA-recognition motif; Root growth	ABIOTIC STRESS CONDITIONS; MESSENGER-RNA; ORYZA-SATIVA; GENE-EXPRESSION; FLOWERING TIME; FCA; PLANTS; TRANSCRIPTS; TOLERANCE; SEQUENCE	AtRBP1 is an RNA-binding protein containing RNA-recognition motifs in Arabidopsis thaliana, homologues of which are not observed in metazoa. Transgenic plants expressing artificial microRNAs for repressing AtRBP1 expression displayed a stunted primary root phenotype during germination. Transgenic plants overexpressing AtRBP1 also displayed the same phenotype. Tight regulation of the AtRBP1 transcript may be required for normal root growth. An in vitro binding assay showed that AtRBP1 preferentially binds to sequences containing UUAGG, GUAGG and/or UUAGU. In vivo selection of RNAs bound to AtRBP1 suggests that transcripts of At3g06780, At4g15910, At5g11760 and At5g07350 are target RNAs of AtRBP1. (C) 2015 Elsevier Masson SAS. All rights reserved.	[Shida, Takuhiro] Hokkaido Univ, Grad Sch Life Sci, Biosyst Sci Course, Sapporo, Hokkaido 0600810, Japan; [Fukuda, Ai; Ito, Hidetaka; Kato, Atsushi] Hokkaido Univ, Fac Sci, Dept Biol Sci, Sapporo, Hokkaido 0600814, Japan; [Saito, Tamao] Sophia Univ, Fac Sci & Technol, Dept Mat & Life Sci, Chiyoda Ku, Tokyo 1208554, Japan; [Ito, Hidetaka] Japan Sci & Technol Agcy, PRESTO, Saitama 3320012, Japan	Kato, A (reprint author), Hokkaido Univ, Fac Sci, Dept Biol Sci, Kita Ku, Kita10 Nishi8, Sapporo, Hokkaido 0600810, Japan.	atsushi@sci.hokudai.ac.jp			 [2511970103]	We are very grateful to Dr. Detlef Weigel for the gift of pRS300 to make artificial microRNA. This work was supported in part by grants-in-aid for scientific research in Innovative Area (2511970103) to H. I.	Ali GS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000471; Yang DH, 2014, PLANT SCI, V214, P106, DOI 10.1016/j.plantsci.2013.10.006; Day IS, 2012, PLANT J, V71, P936, DOI 10.1111/j.1365-313X.2012.05042.x; Crofts AJ, 2010, PLANTA, V231, P1261, DOI 10.1007/s00425-010-1125-x; Cook KB, 2011, NUCLEIC ACIDS RES, V39, pD301, DOI 10.1093/nar/gkq1069; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Quesada V, 2003, EMBO J, V22, P3142, DOI 10.1093/emboj/cdg305; Ambrosone A, 2012, PLANT SCI, V182, P12, DOI 10.1016/j.plantsci.2011.02.004; Nicaise V, 2013, EMBO J, V32, P701, DOI 10.1038/emboj.2013.15; Kwak KJ, 2005, J EXP BOT, V56, P3007, DOI 10.1093/jxb/eri298; Frey NFD, 2010, PLANT CELL, V22, P1575, DOI 10.1105/tpc.109.070680; Kwon C, 2004, J BIOL CHEM, V279, P12812, DOI 10.1074/jbc.M312011200; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; Kato A, 1999, GENE, V239, P309, DOI 10.1016/S0378-1119(99)00403-5; Jung HJ, 2013, J PLANT PHYSIOL, V170, P179, DOI 10.1016/j.jplph.2012.09.002; Kim JY, 2007, PLANT J, V50, P439, DOI 10.1111/j.1365-313X.2007.03057.x; Kim JY, 2010, J EXP BOT, V61, P2317, DOI 10.1093/jxb/erq058; Laluk K, 2011, PLANT PHYSIOL, V156, P2053, DOI 10.1104/pp.111.177501; Terzi LC, 2009, PLANT J, V59, P163, DOI 10.1111/j.1365-313X.2009.03859.x; Lorkovic ZJ, 2002, NUCLEIC ACIDS RES, V30, P623, DOI 10.1093/nar/30.3.623; Macknight R, 2002, PLANT CELL, V14, P877, DOI 10.1105/tpc.010456; Bardou F, 2014, DEV CELL, V30, P166, DOI 10.1016/j.devcel.2014.06.017; Macknight R, 1997, CELL, V89, P737, DOI 10.1016/S0092-8674(00)80256-1; Ascano M, 2013, CURR OPIN GENET DEV, V23, P20, DOI 10.1016/j.gde.2013.01.003; Baltz AG, 2012, MOL CELL, V46, P674, DOI 10.1016/j.molcel.2012.05.021; Kishore S, 2010, BRIEF FUNCT GENOMICS, V9, P391, DOI 10.1093/bfgp/elq028; Chen Y, 2005, FEBS J, V272, P2088, DOI 10.1111/j.1742-4658.2005.04650.x; Streitner C, 2012, NUCLEIC ACIDS RES, V40, P11240, DOI 10.1093/nar/gks873; Hackmann C, 2014, PLANT CELL ENVIRON, V37, P696, DOI 10.1111/pce.12188; Lorkovic ZJ, 2009, TRENDS PLANT SCI, V14, P229, DOI 10.1016/j.tplants.2009.01.007; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; BECHTOLD N, 1993, CR ACAD SCI III-VIE, V316, P1194; Doroshenk KA, 2014, PLANT MOL BIOL, V85, P381, DOI 10.1007/s11103-014-0191-z; HOLSTERS M, 1978, MOL GEN GENET, V163, P181, DOI 10.1007/BF00267408; Kim JS, 2008, PLANT J, V55, P455, DOI 10.1111/j.1365-313X.2008.03518.x; Mans C., 2005, FEBS J, V272, P2118; Morris RT, 2011, PLANT SCI, V180, P204, DOI 10.1016/j.plantsci.2010.08.004; Qi YP, 2010, MOL PLANT MICROBE IN, V23, P1573, DOI 10.1094/MPMI-05-10-0106; Schuttpelz M, 2008, J AM CHEM SOC, V130, P9507, DOI 10.1021/ja801994z; Simpson GG, 2003, CELL, V113, P777, DOI 10.1016/S0092-8674(03)00425-2; Suzuki M, 2000, PLANT CELL PHYSIOL, V41, P282; TSAI DE, 1991, NUCLEIC ACIDS RES, V19, P4931, DOI 10.1093/nar/19.18.4931; Walker NS, 2007, NUCLEIC ACIDS RES, V35, pD852, DOI 10.1093/nar/gkl795	43	0	0	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	PARIS	23 RUE LINOIS, 75724 PARIS, FRANCE	0981-9428			PLANT PHYSIOL BIOCH	Plant Physiol. Biochem.	JUL	2015	92						62	70		10.1016/j.plaphy.2015.04.009		9	Plant Sciences	Plant Sciences	CK3OB	WOS:000356124300008		
J	Tamaki, S; Maruta, T; Sawa, Y; Shigeoka, S; Ishikawa, T				Tamaki, Shun; Maruta, Takanori; Sawa, Yoshihiro; Shigeoka, Shigeru; Ishikawa, Takahiro			Biochemical and physiological analyses of NADPH-dependent thioredoxin reductase isozymes in Euglena gracilis	PLANT SCIENCE			English	Article						Euglena gracilis; NADPH-dependent thioredoxin reductase; Thioredoxin system; Redox regulation	C-2-CYS PEROXIREDOXIN SYSTEM; PLASMODIUM-FALCIPARUM; GLUTATHIONE-REDUCTASE; ARABIDOPSIS-THALIANA; IDENTIFICATION; TRYPANOSOMATIDS; PHOTOSYNTHESIS; CHLOROPLASTS; SEQUENCES; ASCORBATE	At least four peroxiredoxins that are coupled with the thioredoxin (Trx) system have been shown to play a key role in redox metabolism in the unicellular phytoflagellate Euglena gracilis. In order to clarify Trx-mediated redox regulation in this alga, we herein identified three NADPH-dependent thioredoxin reductases (NTRs) using a homologous search and characterized their enzymatic properties and physiological roles. Each Euglena NTR protein belonged to the small, large, and NTRC types, and were named EgNTR1, EgNTR2, and EgNTRC, respectively. EgNTR2 was phylogenetically different from the known NTRs in eukaryotic algae. EgNTR1 was predicted to be localized in mitochondria, EgNTR2 in the cytosol, and EgNTRC in plastids. The catalytic efficiency of EgNTR2 for NADPH was 30-46-fold higher than those of EgNTR1 and truncated form of EgNTRC, suggested that large type EgNTR2 reduced Trx more efficiently. The silencing of EgNTR2 gene expression resulted in significant growth inhibition and cell hypertrophy in Euglena cells. These results suggest that EgNTRs function in each cellular compartment and are physiologically important, particularly in the cytosol. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Tamaki, Shun; Maruta, Takanori; Sawa, Yoshihiro; Ishikawa, Takahiro] Shimane Univ, Fac Life & Environm Sci, Dept Life Sci & Biotechnol, Matsue, Shimane 6908504, Japan; [Shigeoka, Shigeru] Kinki Univ, Dept Adv Biosci, Fac Agr, Nara 6318505, Japan; [Maruta, Takanori; Shigeoka, Shigeru; Ishikawa, Takahiro] Japan Sci & Technol Agcy JST, Core Res Evolut Sci & Technol, Chiyoda Ku, Tokyo 1020076, Japan	Ishikawa, T (reprint author), Shimane Univ, Fac Life & Environm Sci, Dept Life Sci & Biotechnol, 1060 Nishikawatsu, Matsue, Shimane 6908504, Japan.	ishikawa@life.shimane-u.ac.jp			Core Research for Evolutional Science and Technology (CREST) Program "Creation of Basic Technology for Improved Bioenergy Production; Functional Analysis and Regulation of Algae and Other Aquatic Microorganisms" of the Japan Science and Technology Agency (JST)	This work was supported in by the Core Research for Evolutional Science and Technology (CREST) Program "Creation of Basic Technology for Improved Bioenergy Production through Functional Analysis and Regulation of Algae and Other Aquatic Microorganisms" of the Japan Science and Technology Agency (JST).	Amer E.S., 2000, EUR J BIOCHEM, V267, P6102, DOI DOI 10.1046/J.1432-1327.2000.01701.X.PMID:11012661; Pascual MB, 2011, PLANT PHYSIOL, V155, P1806, DOI 10.1104/pp.110.171082; Jacquot JP, 2009, TRENDS PLANT SCI, V14, P336, DOI 10.1016/j.tplants.2009.03.005; TESSIER LH, 1991, EMBO J, V10, P2621; Schurmann P, 2008, ANTIOXID REDOX SIGN, V10, P1235, DOI 10.1089/ars.2007.1931; TAKEDA T, 1995, PLANT CELL PHYSIOL, V36, P1089; INUI H, 1982, FEBS LETT, V150, P89, DOI 10.1016/0014-5793(82)81310-0; Reichheld JP, 2005, FEBS LETT, V579, P337, DOI 10.1016/j.febslet.2004.11.094; Serrato AJ, 2002, BIOCHEM J, V367, P491, DOI 10.1042/BJ20020103; Cejudo FJ, 2012, FEBS LETT, V586, P2974, DOI 10.1016/j.febslet.2012.07.003; Durnford DG, 2006, EUKARYOT CELL, V5, P2079, DOI 10.1128/EC.00222-06; Serrato AJ, 2004, J BIOL CHEM, V279, P43821, DOI 10.1074/jbc.M404696200; Ishikawa T, 2010, BIOCHEM J, V426, P125, DOI 10.1042/BJ20091406; Reichheld JP, 2007, PLANT CELL, V19, P1851, DOI 10.1105/tpc.107.050849; CRAMER M, 1952, ARCH MIKROBIOL, V17, P384, DOI 10.1007/BF00410835; Laloi C, 2001, P NATL ACAD SCI USA, V98, P14144, DOI 10.1073/pnas.241340898; Bhatt I, 2011, BIOTECHNOL ADV, V29, P850, DOI 10.1016/j.biotechadv.2011.07.002; Holmgren A, 2010, FREE RADICAL BIO MED, V49, P1617, DOI 10.1016/j.freeradbiomed.2010.09.005; NAKANO Y, 1987, J BIOCHEM-TOKYO, V102, P1053; Montrichard F, 1999, FEBS LETT, V442, P29, DOI 10.1016/S0014-5793(98)01606-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Dos Santos CV, 2006, TRENDS PLANT SCI, V11, P329, DOI 10.1016/j.tplants.2006.05.005; Araie H, 2008, J BIOL CHEM, V283, P35329, DOI 10.1074/jbc.M805472200; Castro H, 2008, ANTIOXID REDOX SIGN, V10, P1593, DOI 10.1089/ars.2008.2050; DWYER MR, 1970, BIOCHIM BIOPHYS ACTA, V216, P392, DOI 10.1016/0005-2728(70)90231-8; Gilberger TW, 1997, J BIOL CHEM, V272, P29584, DOI 10.1074/jbc.272.47.29584; KOREN LE, 1967, J PROTOZOOL, VS 14, P17; Krnacova K, 2012, J MOL EVOL, V75, P119, DOI 10.1007/s00239-012-9523-2; Machida T, 2009, BIOSCI BIOTECH BIOCH, V73, P695, DOI 10.1271/bbb.80761; Michalska J, 2009, P NATL ACAD SCI USA, V106, P9908, DOI 10.1073/pnas.0903559106; Muller S, 1996, MOL BIOCHEM PARASIT, V80, P215, DOI 10.1016/0166-6851(96)02694-1; Ondarza RN, 1999, BIOTECHNOL APPL BIOC, V30, P47; Ondarza RN, 2006, EXP PARASITOL, V114, P141, DOI 10.1016/j.exppara.2006.03.001; Richter AS, 2013, PLANT PHYSIOL, V162, P63, DOI 10.1104/pp.113.217141; SHIGEOKA S, 1987, J GEN MICROBIOL, V133, P227; Snider GW, 2014, BIOCHEMISTRY-US, V53, P601, DOI 10.1021/bi400931k; Sugiyama A, 2010, J VET MED SCI, V72, P755; Tamaki S, 2014, BIOSCI BIOTECH BIOCH, V78, P593, DOI 10.1080/09168451.2014.890037; Wulff RP, 2011, BIOCHEMISTRY-US, V50, P3713, DOI 10.1021/bi200058a	39	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-9452			PLANT SCI	Plant Sci.	JUL	2015	236						29	36		10.1016/j.plantsci.2015.03.016		8	Biochemistry & Molecular Biology; Plant Sciences	Biochemistry & Molecular Biology; Plant Sciences	CK9JO	WOS:000356556600003		
J	Takano, S; Matsuda, S; Funabiki, A; Furukawa, J; Yamauchi, T; Tokuji, Y; Nakazono, M; Shinohara, Y; Takamure, I; Kato, K				Takano, Sho; Matsuda, Shuichi; Funabiki, Atsushi; Furukawa, Jun-ichi; Yamauchi, Takaki; Tokuji, Yoshihiko; Nakazono, Mikio; Shinohara, Yasuro; Takamure, Itsuro; Kato, Kiyoaki			The rice RCN11 gene encodes beta 1,2-xylosyltransferase and is required for plant responses to abiotic stresses and phytohormones	PLANT SCIENCE			English	Article						beta 1,2-Xylosyltransferase; N-Glycan; Rice; Low temperature; Abiotic stresses; Root aerenchyma formation	HEAT-SHOCK RESPONSE; ARABIDOPSIS-THALIANA BETA-1,2-XYLOSYLTRANSFERASE; ENDOPLASMIC-RETICULUM; SIGNAL-TRANSDUCTION; SEED DORMANCY; ORYZA-SATIVA; AERENCHYMA FORMATION; MOLECULAR-CLONING; PROTEIN RESPONSE; LINKED GLYCANS	Seed germination rates and plant development and growth under abiotic stress are important aspects of crop productivity. Here, our characterization of the rice (Oryza sativa L) mutant reduced culm number11 (rcn11) showed that RCN11 controls growth of plants exposed to abnormal temperature, salinity and drought conditions. RCN11 also mediates root aerenchyma formation under oxygen-deficient conditions and ABA sensitivity during seed germination. Molecular studies showed that the rcn11 mutation resulted from a 966-bp deletion that caused loss of function of beta 1,2-xylosyltransferase (OsXylT). This enzyme is located in the Golgi apparatus where it catalyzes the transfer of xylose from UDP-xylose to the core beta-linked mannose of N-glycans. RCN11/OsXylT promoter activity was observed in the basal part of the shoot containing the shoot and axillary meristems and in the base of crown roots. The level of RCN11/OsXylT expression was regulated by multiple phytohormones and various abiotic stresses suggesting that plant specific N-glycosylation is regulated by multiple signals in rice plants. The present study is the first to demonstrate that rice beta 1,2-linked xylose residues on N-glycans are critical for seed germination and plant development and growth under conditions of abiotic stress. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Takano, Sho; Matsuda, Shuichi; Funabiki, Atsushi; Kato, Kiyoaki] Obihiro Univ Agr & Vet Med, Dept Agroenvironm Sci, Obihiro, Hokkaido 0808555, Japan; [Furukawa, Jun-ichi; Shinohara, Yasuro] Hokkaido Univ, Grad Sch Adv Life Sci, Lab Adv Chem Biol, Sapporo, Hokkaido 0600810, Japan; [Yamauchi, Takaki; Nakazono, Mikio] Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Tokuji, Yoshihiko] Obihiro Univ Agr & Vet Med, Dept Food Sci, Obihiro, Hokkaido 0808555, Japan; [Takamure, Itsuro] Hokkaido Univ, Grad Sch Agr, Sapporo, Hokkaido 0608589, Japan	Kato, K (reprint author), Obihiro Univ Agr & Vet Med, Dept Agroenvironm Sci, 2-11 Nishi, Obihiro, Hokkaido 0808555, Japan.	kiyoaki@obihiro.ac.jp	Tokuji, Yoshihiko/F-6744-2015	Tokuji, Yoshihiko/0000-0001-6476-3363	Ministry of Education, Culture, Sports, Science and Technology [24380001]	This study was supported in part by a Grant-in-Aid for Scientific Research (B) from The Ministry of Education, Culture, Sports, Science and Technology (No. 24380001). We thank Dr. Tsuyoshi Nakagawa for providing pGWBs, Dr. Akihiro Nakano for providing ST-mRFP and Dr. Tadasu Urashima for his encouragement during the present study. We thank Mr. Glen Hill for English correction.	Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Hubbard KE, 2010, GENE DEV, V24, P1695, DOI 10.1101/gad.1953910; Schoberer J, 2013, PLANT PHYSIOL, V161, P1737, DOI 10.1104/pp.112.210757; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Takada S, 2001, DEVELOPMENT, V128, P1127; Ito Y, 2006, GENE, V382, P57, DOI 10.1016/j.gene.2006.06.020; Koornneef M, 2002, CURR OPIN PLANT BIOL, V5, P33, DOI 10.1016/S1369-5266(01)00219-9; Toki S, 2006, PLANT J, V47, P969, DOI 10.1111/j.1365-313X.2006.02836.x; Sugio A, 2009, PLANT CELL, V21, P642, DOI 10.1105/tpc.108.062596; Fanata WID, 2013, PLANT J, V73, P966, DOI 10.1111/tpj.12087; To JPC, 2004, PLANT CELL, V16, P658, DOI 10.1105/tpc.018978; Sweere U, 2001, SCIENCE, V294, P1108, DOI 10.1126/science.1065022; JUSTIN SHFW, 1987, NEW PHYTOL, V106, P465, DOI 10.1111/j.1469-8137.1987.tb00153.x; Gubler F, 2005, CURR OPIN PLANT BIOL, V8, P183, DOI 10.1016/j.pbi.2005.01.011; Deng Y, 2011, P NATL ACAD SCI USA, V108, P7247, DOI 10.1073/pnas.1102117108; Park SY, 1996, PLANT PHYSIOL, V111, P515; He DL, 2011, PROTEOMICS, V11, P2693, DOI 10.1002/pmic.201000598; Dirnberger D, 2002, PLANT MOL BIOL, V50, P273, DOI 10.1023/A:1016061815748; Bailey-Serres J, 2012, PLANT PHYSIOL, V160, P1698, DOI 10.1104/pp.112.208173; Mittler R, 2012, TRENDS BIOCHEM SCI, V37, P118, DOI 10.1016/j.tibs.2011.11.007; Wilson IBH, 2001, GLYCOBIOLOGY, V11, P261, DOI 10.1093/glycob/11.4.261; Caesar K, 2011, J EXP BOT, V62, P5571, DOI 10.1093/jxb/err238; Kumar SV, 2010, CELL, V140, P136, DOI 10.1016/j.cell.2009.11.006; Fujii H, 2009, NATURE, V462, P660, DOI 10.1038/nature08599; Che P, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001140; Kim H, 2012, J EXP BOT, V63, P1013, DOI 10.1093/jxb/err338; Klingler JP, 2010, J EXP BOT, V61, P3199, DOI 10.1093/jxb/erq151; Hirose N, 2007, PLANT CELL PHYSIOL, V48, P523, DOI 10.1093/pcp/pcm022; Ozawa K, 2012, PLANT CELL PHYSIOL, V53, P755, DOI 10.1093/pcp/pcs016; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Leonard R, 2004, PLANT MOL BIOL, V55, P631, DOI 10.1007/s11103-004-1558-3; Kang JS, 2008, P NATL ACAD SCI USA, V105, P5933, DOI 10.1073/pnas.0800237105; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; Holdsworth MJ, 2008, TRENDS PLANT SCI, V13, P7, DOI 10.1016/j.tplants.2007.11.002; Armstrong W, 2000, ANN BOT-LONDON, V86, P687, DOI 10.1006/anbo.2000.1236; Finch-Savage WE, 2006, NEW PHYTOL, V171, P501, DOI 10.1111/j.1469-8137.2006.01787.x; Drew MC, 2000, TRENDS PLANT SCI, V5, P123, DOI 10.1016/S1360-1385(00)01570-3; Conde A, 2011, PLANT CELL PHYSIOL, V52, P1583, DOI 10.1093/pcp/pcr107; Saidi Y, 2009, PLANT CELL, V21, P2829, DOI 10.1105/tpc.108.065318; Colmer TD, 2009, FUNCT PLANT BIOL, V36, P665, DOI 10.1071/FP09144; Sun WN, 2002, BBA-GENE STRUCT EXPR, V1577, P1, DOI 10.1016/S0167-4781(02)00417-7; Hwang I, 2001, NATURE, V413, P383, DOI 10.1038/35096500; Bencur P, 2005, BIOCHEM J, V388, P515; Ito Y, 2012, MOL BIOL CELL, V23, P3203, DOI 10.1091/mbc.E12-01-0034; Arikado H., 1990, B FAC BIORESOUR MIE, V3, P1; Bondili JS, 2006, PHYTOCHEMISTRY, V67, P2215, DOI 10.1016/j.phytochem.2006.07.007; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Christophe S., 2008, PLANT BIOTECHNOL J, V6, P702; Colmer TD, 2003, ANN BOT-LONDON, V91, P301, DOI 10.1093/aob/mcf114; Colmer TD, 2006, NEW PHYTOL, V170, P767, DOI 10.1111/j.1469-8137.2006.01725.x; DREW MC, 1979, PLANTA, V147, P83, DOI 10.1007/BF00384595; Fedoroff N.V., 2002, SCI STKE, V140, pre10; Funabiki A, 2013, PLANT SCI, V211, P70, DOI 10.1016/j.plantsci.2013.06.011; Furukawa J., 2008, ANAL CHEM, V80; He D., 2013, FRONT PLANT SCI, V4; He Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095246; Jain M., 2006, BMC PLANT BIOL, V6; Lafitte H.R., 2004, PROG FUT P 4 INT CRO; Linkemer G, 1998, CROP SCI, V38, P1576; Mano Y., 2007, Plant Root, V1, P17, DOI 10.3117/plantroot.1.17; Mizoi Junya, 2013, Methods Mol Biol, V956, P269, DOI 10.1007/978-1-62703-194-3_20; Pagny S, 2003, PLANT J, V33, P189, DOI 10.1046/j.0960-7412.2002.01604.x; Paulus K.E., 2011, FRONT PLANT SCI, V2; Salome PA, 2006, PLANT CELL, V18, P55, DOI 10.1105/tpc.105.037994; Sarkar N.K., 2012, CELL STRESS CHAPERON, V3, P427; Setter TL, 2009, ANN BOT-LONDON, V103, P221, DOI 10.1093/aob/mcn137; Shimamura S, 2003, PLANT SOIL, V251, P351, DOI 10.1023/A:1023036720537; Siyiannis VF, 2012, PROTOPLASMA, V249, P671, DOI 10.1007/s00709-011-0309-y; Steklov MY, 2013, PLANT CELL REP, V32, P781, DOI 10.1007/s00299-013-1408-3; Strasser R, 2000, FEBS LETT, V472, P105, DOI 10.1016/S0014-5793(00)01443-5; Urao T, 1998, FEBS LETT, V427, P175, DOI 10.1016/S0014-5793(98)00418-9	72	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-9452			PLANT SCI	Plant Sci.	JUL	2015	236						75	88		10.1016/j.plantsci.2015.03.022		14	Biochemistry & Molecular Biology; Plant Sciences	Biochemistry & Molecular Biology; Plant Sciences	CK9JO	WOS:000356556600007		
J	da Silva, JAT; Tsavkelova, EA; Zeng, SJ; Ng, TB; Parthibhan, S; Dobranszki, J; Cardoso, JC; Rao, MV				da Silva, Jaime A. Teixeira; Tsavkelova, Elena A.; Zeng, Songjun; Ng, Tzi Bun; Parthibhan, S.; Dobranszki, Judit; Cardoso, Jean Carlos; Rao, M. V.			Symbiotic in vitro seed propagation of Dendrobium: fungal and bacterial partners and their influence on plant growth and development	PLANTA			English	Review						Dendrobium germination and propagation; Mycorrhiza; Orchid-associated bacteria; Orchidaceae; Symbiotic seed germination	ORCHID-ASSOCIATED BACTERIA; MYCORRHIZAL-FUNGI; EPIPHYTIC ORCHIDS; TERRESTRIAL ORCHIDS; CANCER-CELLS; FUSARIUM-OXYSPORUM; AUSTRALIAN ORCHIDS; ESCHERICHIA-COLI; TROPICAL ORCHIDS; GOODYERA-REPENS	The genus Dendrobium is one of the largest genera of the Orchidaceae Juss. family, although some of its members are the most threatened today. The reason why many species face a vulnerable or endangered status is primarily because of anthropogenic interference in natural habitats and commercial overexploitation. The development and application of modern techniques and strategies directed towards in vitro propagation of orchids not only increases their number but also provides a viable means to conserve plants in an artificial environment, both in vitro and ex vitro, thus providing material for reintroduction. Dendrobium seed germination and propagation are challenging processes in vivo and in vitro, especially when the extreme specialization of these plants is considered: (1) their biotic relationships with pollinators and mycorrhizae; (2) adaptation to epiphytic or lithophytic life-styles; (3) fine-scale requirements for an optimal combination of nutrients, light, temperature, and pH. This review also aims to summarize the available data on symbiotic in vitro Dendrobium seed germination. The influence of abiotic factors as well as composition and amounts of different exogenous nutrient substances is examined. With a view to better understanding how to optimize and control in vitro symbiotic associations, a part of the review describes the strong biotic relations of Dendrobium with different associative microorganisms that form microbial communities with adult plants, and also influence symbiotic seed germination. The beneficial role of plant growth-promoting bacteria is also discussed.	[Tsavkelova, Elena A.] Moscow MV Lomonosov State Univ, Dept Microbiol, Fac Biol, Moscow 119234, Russia; [Zeng, Songjun] Chinese Acad Sci, Key Lab South China Agr Plant Mol Anal & Gene Imp, South China Bot Garden, Guangzhou 510650, Guangdong, Peoples R China; [Ng, Tzi Bun] Chinese Univ Hong Kong, Sch Biomed Sci, Fac Med, Hong Kong, Hong Kong, Peoples R China; [Ng, Tzi Bun] Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen, Peoples R China; [Parthibhan, S.; Rao, M. V.] Bharathidasan Univ, Dept Plant Sci, Tiruchchirappalli 620024, Tamil Nadu, India; [Dobranszki, Judit] Univ Debrecen, Res Inst Nyiregyhaza, H-4400 Nyiregyhaza, Hungary; [Cardoso, Jean Carlos] Univ Fed Sao Carlos, Ctr Ciencias Agr, Dept Rural Dev, BR-13600970 Araras, Brazil	da Silva, JAT (reprint author), POB 7,Miki Cho Post Off, Ikenobe, Kagawa 30112, Japan.	jaimetex@yahoo.com; tsavkelova@mail.ru; zengsongjun@scib.ac.cn; b021770@mailserv.cuhk.edu.hk; thibhan@gmail.com; dobranszki@freemail.hu; jeancardosoctv@gmail.com; mvrao_456@yahoo.co.in					Adams DG, 2008, J EXP BOT, V59, P1047, DOI 10.1093/jxb/ern005; Adams DG, 2000, ECOLOGY CYANOBACTERI, P523; Alabouvette C, 2009, NEW PHYTOL, V184, P529, DOI 10.1111/j.1469-8137.2009.03014.x; Yu J, 2013, APPL MICROBIOL BIOT, V97, P9825, DOI 10.1007/s00253-013-5294-y; Li GJ, 2014, EXP THER MED, V8, P1015, DOI 10.3892/etm.2014.1834; Liu HX, 2010, BOT REV, V76, P241, DOI 10.1007/s12229-010-9045-9; Nontachaiyapoom S, 2010, MYCORRHIZA, V20, P459, DOI 10.1007/s00572-010-0297-3; Zhang LC, 2012, MYCOL PROG, V11, P395, DOI 10.1007/s11557-011-0754-1; Tsavkelova E, 2012, FUNGAL GENET BIOL, V49, P48, DOI 10.1016/j.fgb.2011.10.005; Martos F, 2012, MOL ECOL, V21, P5098, DOI 10.1111/j.1365-294X.2012.05692.x; Waterman RJ, 2008, J EXP BOT, V59, P1085, DOI 10.1093/jxb/erm366; Dearnaley JDW, 2007, MYCORRHIZA, V17, P475, DOI 10.1007/s00572-007-0138-1; Olivain C, 1997, NEW PHYTOL, V137, P481, DOI 10.1046/j.1469-8137.1997.00855.x; Miyazawa M, 1999, J AGR FOOD CHEM, V47, P2163, DOI 10.1021/jf970930a; Lugtenberg B, 2009, ANNU REV MICROBIOL, V63, P541, DOI 10.1146/annurev.micro.62.081307.162918; Yang LC, 2014, CARBOHYD POLYM, V111, P856, DOI 10.1016/j.carbpol.2014.05.007; COCKBURN W, 1985, PLANT PHYSIOL, V77, P83, DOI 10.1104/pp.77.1.83; da Silva JAT, 2015, PLANT CELL REP, V34, P671, DOI 10.1007/s00299-015-1754-4; Vinale F, 2008, SOIL BIOL BIOCHEM, V40, P1, DOI 10.1016/j.soilbio.2007.07.002; Hossain MM, 2013, CRIT REV PLANT SCI, V32, P69, DOI 10.1080/07352689.2012.715984; Faria DC, 2013, WORLD J MICROB BIOT, V29, P217, DOI 10.1007/s11274-012-1173-4; Chen J, 2011, WORLD J MICROB BIOT, V27, P1009, DOI 10.1007/s11274-010-0544-y; Kamilova F, 2006, MOL PLANT MICROBE IN, V19, P250, DOI 10.1094/MPMI-19-0250; BeckerHapak M, 1997, BIOCHEM BIOPH RES CO, V239, P305, DOI 10.1006/bbrc.1997.7469; SANFORD WW, 1973, BOT J LINN SOC, V66, P307; Swarts ND, 2009, ANN BOT-LONDON, V104, P543, DOI 10.1093/aob/mcp025; Rikkinen J, 2013, MYCOKEYS, P3, DOI 10.3897/mycokeys.6.3869; Knudson L, 1925, BOT GAZ, V79, P345, DOI 10.1086/333488; Fay MF, 2009, ANN BOT-LONDON, V104, P359, DOI [10.1093/aob/mcp195, 10.1093/aob/mcp190]; Xiong L, 2013, MOLECULES, V18, P6153, DOI 10.3390/molecules18066153; Ng TB, 2012, APPL MICROBIOL BIOT, V93, P1795, DOI 10.1007/s00253-011-3829-7; Rasmussen HN, 2014, BOT J LINN SOC, V175, P313, DOI 10.1111/boj.12170; Bidartondo MI, 2004, P ROY SOC B-BIOL SCI, V271, P1799, DOI 10.1098/rspb.2004.2807; Zhu GS, 2008, FUNGAL DIVERS, V33, P123; Tsavkelova EA, 2008, FUNGAL GENET BIOL, V45, P1393, DOI 10.1016/j.fgb.2008.07.011; Zeng SJ, 2012, SCI HORTIC-AMSTERDAM, V138, P198, DOI 10.1016/j.scienta.2012.02.026; RASMUSSEN HN, 1993, AM J BOT, V80, P1374, DOI 10.2307/2445665; Bonnardeaux Y, 2007, MYCOL RES, V111, P51, DOI 10.1016/j.mycres.2006.11.006; Vujanovic V, 2000, ANN BOT-LONDON, V86, P79, DOI 10.1006/anbo.2000.1162; Mohanty P, 2012, PLANT CELL TISS ORG, V109, P297, DOI 10.1007/s11240-011-0095-4; Song JI, 2012, ONCOL REP, V27, P813, DOI 10.3892/or.2011.1551; WILKINSON KG, 1989, NEW PHYTOL, V112, P429, DOI 10.1111/j.1469-8137.1989.tb00334.x; Cameron DD, 2006, NEW PHYTOL, V171, P405, DOI 10.1111/j.1469-8137.2006.01767.x; Rasmussen HN, 2002, NEW PHYTOL, V154, P797, DOI 10.1046/j.1469-8137.2002.00422.x; Venkateswarlu S, 2002, BIOSCI BIOTECH BIOCH, V66, P2236, DOI 10.1271/bbb.66.2236; Xing YM, 2011, CURR MICROBIOL, V62, P1218, DOI 10.1007/s00284-010-9848-2; Otero JT, 2002, AM J BOT, V89, P1852; Spaepen S, 2007, FEMS MICROBIOL REV, V31, P425, DOI 10.1111/j.1574-6976.2007.00072.x; Zi XM, 2014, MYCORRHIZA, V24, P487, DOI 10.1007/s00572-014-0565-8; Stewart SL, 2002, AQUAT BOT, V72, P25, DOI 10.1016/S0304-3770(01)00214-5; Kavroulakis N, 2007, J EXP BOT, V58, P3853, DOI 10.1093/jxb/erm230; Pan LH, 2014, INT J BIOL MACROMOL, V64, P420, DOI 10.1016/j.ijbiomac.2013.12.024; Gebauer G, 2003, NEW PHYTOL, V160, P209, DOI 10.1046/j.1469-8137.2003.00872.x; Batty AL, 2001, AUST J BOT, V49, P619, DOI 10.1071/BT01029; Bernard N, 1900, REV GEN BOT, V12, P108; BEYRLE HF, 1995, CAN J BOT, V73, P1128; Bougoure J, 2014, PLANT CELL ENVIRON, V37, P1223, DOI 10.1111/pce.12230; BRUNDRETT M, 1991, ADV ECOL RES, V21, P171, DOI 10.1016/S0065-2504(08)60099-9; Burgeff H, 1959, ORCHIDS SCI SURVEY, P361; Chaotham C, 2014, ANTICANCER RES, V34, P1931; Chen CA, 2013, J MED FOOD, V16, P869, DOI 10.1089/jmf.2012.2617; Chen J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058268; Chen J, 2012, MYCORRHIZA, V22, P297, DOI 10.1007/s00572-011-0404-0; Chen Jian, 2014, Zhongguo Zhong Yao Za Zhi, V39, P291; [陈瑞蕊 Chen Ruirui], 2003, [应用与环境生物学报, Chinese Journal of Applied and Environmental Biology], V9, P97; Chen XM, 2010, J PLANT GROWTH REGUL, V29, P328, DOI 10.1007/s00344-010-9139-y; [陈晓梅 CHEN Xiaomei], 2008, [中草药, Chinese Traditional and Herbal Drugs], V39, P423; CLEMENTS M A, 1988, Lindleyana, V3, P73; Dan Y, 2012, AFR J MICROBIOL RES, V6, P34, DOI 10.5897/AJMR11.442; da Silva JAT, 2014, PLANT CELL TISS ORG, V119, P447, DOI 10.1007/s11240-014-0561-x; da Silva JAT, 2014, PLANT CELL REP, V33, P1413, DOI 10.1007/s00299-014-1631-6; Dressler R.L., 1993, PHYLOGENY CLASSIFICA; Dressler Robert L., 2005, Selbyana, V26, P155; DYCUS AUGUSTUS M., 1957, BOT GAZ, V119, P78, DOI 10.1086/335966; Ehling-Schulz M, 1997, J BACTERIOL, V179, P1940; FONNESBE.M, 1972, PHYSIOL PLANTARUM, V27, P310, DOI 10.1111/j.1399-3054.1972.tb03619.x; Forsyth LM, 2006, MYCOL RES, V110, P929, DOI 10.1016/j.mycres.2006.03.008; Galdiano RF, 2012, SCI HORTIC-AMSTERDAM, V148, P154, DOI 10.1016/j.scienta.2012.09.036; Galdiano RF, 2011, REV BRAS CIENC SOLO, V35, P729, DOI 10.1590/S0100-06832011000300008; Gong CY, 2014, VASC PHARMACOL, V62, P134, DOI 10.1016/j.vph.2014.04.007; Guo S, 1990, J CHIN MAT MED, V15, P445; He XH, 2010, SCI CHINA LIFE SCI, V53, P1374, DOI 10.1007/s11427-010-4096-z; Henskens FL, 2012, ANN BOT-LONDON, V110, P555, DOI 10.1093/aob/mcs108; Homolka L, 2013, LAB PROTOCOLS FUNGAL, P604; Hsu JL, 2014, J UROLOGY, V191, P1429, DOI 10.1016/j.juro.2013.11.102; Hynson NA, 2013, BIOL PLANTS LIVING F, P297; Jin Hui, 2009, Chinese Journal of Plant Ecology, V33, P433, DOI 10.3773/j.issn.1005-264x.2009.03.002; Kamemoto H, 1999, BREEDING DENDROBIUM, P166; Kang ZhiHua, 2007, Journal of Nanjing Forestry University (Natural Sciences Edition), V31, P49; Nogueira R. E., 2005, Acta Botanica Brasilica, V19, P417, DOI 10.1590/S0102-33062005000300001; Katiyar RS, 1986, J INDIAN BOT SOC, V65, P329; Kew (Royal Botanic Gardens), 2011, WORLD CHECKL SEL PLA; Kharitonova IP, 1999, PHYTONCIDAL ACTIVITY, P131; Kim JH, 2014, DOI ARCH PHARM RES, DOI [10.1007/s12272-014-0511-5, DOI 10.1007/S12272-014-0511-5]; Knudson L, 1922, BOT GAZ, V73, P1, DOI 10.1086/332956; Knudson L, 1921, B REAL SOC ESPANOLA, V21, P250; Knudson Lewis, 1946, AMER ORCHID SOC BULL, V15, P214; Kolomeitseva GL, 2002, B GBS RUSS ACAD SCI, V183, P117; Kolomeitseva GL, 2012, ORCHID SEEDS DEV STR, P352; Kowitdamrong A, 2013, BIOMED RES INT, V2013, P765; Kravchenko LV, 2004, MICROBIOLOGY+, V73, P156, DOI 10.1023/B:MICI.0000023982.76684.9d; Kuga Y, 2014, NEW PHYTOL, V202, P594, DOI 10.1111/nph.12700; Kumar Pankaj, 2011, Taiwania, V56, P23; Liebel HT, 2010, AM J BOT, V97, P903, DOI 10.3732/ajb.0900354; Lin JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094040; Lin X, 2015, PLANTA MED, V81, P130, DOI 10.1055/s-0034-1383411; Lin X, 2011, INT IMMUNOPHARMACOL, V11, P2025, DOI 10.1016/j.intimp.2011.08.014; Lindblad P, 2009, MICROBIOL MONOGR, V8, P225, DOI 10.1007/7171_2008_118; Liu XF, 2011, NAT PROD COMMUN, V6, P867; Lv Gui-Yuan, 2013, Zhongguo Zhong Yao Za Zhi, V38, P3560; Maor R, 2004, APPL ENVIRON MICROB, V70, P852; Merckx VSFT, 2012, MOL ECOL, V21, P1524, DOI 10.1111/j.1365-294X.2012.05472.x; Moghaddam MJM, 2012, J AGR SCI TECH-IRAN, V14, P985; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; NOEL ARA, 1974, ANN BOT-LONDON, V38, P495; Nontachaiyapoom S, 2011, SCI HORTIC-AMSTERDAM, V130, P303, DOI 10.1016/j.scienta.2011.06.040; Nurfadilah S, 2013, ANN BOT-LONDON, V111, P1233, DOI 10.1093/aob/mct064; Otero J. T., 2013, LANKESTERIANA, V13, P57; Pant B., 2013, African Journal of Plant Science, V7, P448; Parthibhan S, 2015, J NAT CONSERV, V24, P68, DOI 10.1016/j.jnc.2014.11.003; Pereira MC, 2009, REV BRAS CIENC SOLO, V33, P1187, DOI 10.1590/S0100-06832009000500012; PETERSON RL, 1990, CAN J BOT, V68, P1117; Pridgeon AM, 1986, LINDLEYANA, V1, P96; PRITCHARD HW, 1984, CRYO-LETT, V5, P295; Qian XP, 2014, CARBOHYD POLYM, V101, P982, DOI 10.1016/j.carbpol.2013.10.035; Rai Amar N., 2002, Biology and Environment, V102B, P65, DOI 10.3318/BIOE.2002.102.1.65; Rasmussen H. N., 1995, TERRESTRIAL ORCHIDS; Roberts DL, 2008, CURR BIOL, V18, pR325, DOI 10.1016/j.cub.2008.02.026; Roy A, 1998, CYANOBACTERIAL BIOTE, P439; Ryan Matthew J, 2007, Methods Mol Biol, V368, P127; Saharan BS, 2011, LIFE SCI MED RES, V2011, P1; Sandmann G, 1998, APPL ENVIRON MICROB, V64, P1972; Sattayasai N, 2009, PLANT CELL REP, V28, P1243, DOI 10.1007/s00299-009-0724-0; Selosse MA, 2011, SYMBIOSIS, V54, P61, DOI 10.1007/s13199-011-0131-5; Selosse Marc-André, 2010, Plant Signal Behav, V5, P349, DOI 10.4161/psb.5.4.10791; Singh A, 2009, ETHNOBOTANICAL LEAFL, V13, P351; Smith S. E., 1997, MYCORRHIZAL SYMBIOSI; Smith SE, 2008, MYCORRHIZAL SYMBIOSIS, 3RD EDITION, P1; Song JY, 2001, ACTA ACAD MED SINICA, V23, P547; Stockel M, 2014, NEW PHYTOL, V202, P606, DOI 10.1111/nph.12688; Stoessl A, 1984, ORCHID BIOL REV PERS, P151; Sukphan P, 2014, NAT PROD COMMUN, V9, P825; Sun J, 2014, NAT PROD RES, V28, P1900, DOI 10.1080/14786419.2014.955495; Sundin GW, 1999, MICROBIAL ECOL, V38, P27, DOI 10.1007/s002489900152; Swangmaneecharern P, 2012, SCI HORTIC-AMSTERDAM, V148, P55, DOI 10.1016/j.scienta.2012.09.013; Tan XM, 2014, SCI HORTIC-AMSTERDAM, V165, P62, DOI 10.1016/j.scienta.2013.10.031; da Silva JAT, 2014, CRIT REV BIOTECHNOL, V34, P56, DOI 10.3109/07388551.2013.807219; Tian CC, 2013, FITOTERAPIA, V91, P247, DOI 10.1016/j.fitote.2013.09.018; TOUCHELL DH, 1993, BIODIVERS CONSERV, V2, P594, DOI 10.1007/BF00051960; Tsai AC, 2010, CANCER LETT, V292, P163, DOI 10.1016/j.canlet.2009.11.020; Tsavkelova E, 2011, BACTERIA IN AGROBIOLOGY: PLANT GROWTH RESPONSES, P221, DOI 10.1007/978-3-642-20332-9_11; Tsavkelova EA, 2003, MIKOL FITOPATOL, V37, P57; Tsavkelova EA, 2007, ARCH MICROBIOL, V188, P655, DOI 10.1007/s00203-007-0286-x; Tsavkelova EA, 2003, MICROBIOLOGY, V86, P91; Tsavkelova EA, 2003, MICROBIOLOGY+, V72, P92, DOI 10.1023/A:1022238309083; Tsavkelova EA, 2006, APPL BIOCHEM MICROB, V42, P133; Tsavkelova EA, 2001, MICROBIOLOGY+, V70, P492, DOI 10.1023/A:1010402715376; Tsavkelova E. A., 2003, Mikologiya i Fitopatologiya, V37, P75; Tsavkelova EA, 2004, MICROBIOLOGY+, V73, P710, DOI 10.1007/s11021-005-0013-z; Tudzynski B., 2002, P183; VAKHRAMEEVA MG, 2008, ORCHIDS RUSSIA ADJAC; Vendrame WA, 2008, HORTSCIENCE, V43, P264; Wang H, 2011, WORLD J MICROB BIOT, V27, P2051, DOI 10.1007/s11274-011-0667-9; Wang JH, 1998, CRYO-LETT, V19, P123; Wang Q, 2014, ONCOL LETT, V7, P493, DOI 10.3892/ol.2013.1728; WARCUP JH, 1981, NEW PHYTOL, V87, P371, DOI 10.1111/j.1469-8137.1981.tb03208.x; WILKINSON KG, 1994, PLANT SOIL, V159, P291, DOI 10.1007/BF00009292; [吴慧凤 Wu Huifeng], 2012, [生态学报, Acta Ecologica Sinica], V32, P2491; Wu JP, 2002, CHINESE J APPL ECOLO, V13, P845; Yang H, 2012, PHYTOTHER RES, V26, P974, DOI 10.1002/ptr.3632; Yang S, 2014, PHYTOMEDICINE, V21, P712, DOI 10.1016/j.phymed.2013.10.026; Yang SJ, 2014, MICROB BIOTECHNOL, V7, P611, DOI 10.1111/1751-7915.12148; [杨友联 YANG YouLian], 2008, [微生物学通报, Microbiology], V35, P909; Yuan ZL, 2009, WORLD J MICROB BIOT, V25, P295, DOI 10.1007/s11274-008-9893-1; Yuan ZQ, 2009, BIOL PLANTARUM, V53, P155, DOI 10.1007/s10535-009-0024-0; Zainuddin M, 2011, AFR J BIOTECHNOL, V10, P11870; Zeng SJ, 2014, CRIT REV BIOTECHNOL, V34, P358, DOI 10.3109/07388551.2013.841117; Zhao MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072705; Zotz G, 2013, OECOLOGIA, V171, P733, DOI 10.1007/s00442-012-2575-6	179	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0032-0935	1432-2048		PLANTA	Planta	JUL	2015	242	1					1	22		10.1007/s00425-015-2301-9		22	Plant Sciences	Plant Sciences	CK8VG	WOS:000356516800001		
J	Yong, HY; Wang, CL; Bancroft, I; Li, F; Wu, XM; Kitashiba, H; Nishio, T				Yong, Hui-Yee; Wang, Chunlei; Bancroft, Ian; Li, Feng; Wu, Xiaoming; Kitashiba, Hiroyasu; Nishio, Takeshi			Identification of a gene controlling variation in the salt tolerance of rapeseed (Brassica napus L.)	PLANTA			English	Article						Rapeseed; Salt tolerance; Salt stress; Association mapping; TSN1	GENOME-WIDE ASSOCIATION; QUANTITATIVE TRAIT LOCUS; SALINITY TOLERANCE; STRESS TOLERANCE; POPULATION-STRUCTURE; NATURAL VARIATION; OXIDATIVE STRESS; ION HOMEOSTASIS; LOW-TEMPERATURE; CALCIUM SENSOR	By genome-wide association study, QTLs for salt tolerance in rapeseed were detected, and a TSN1 ortholog was identified as a candidate gene responsible for genetic variation in cultivars. Dissecting the genomic regions governing abiotic stress tolerance is necessary for marker-assisted breeding to produce elite breeding lines. In this study, a world-wide collection of rapeseed was evaluated for salt tolerance. These rapeseed accessions showed a large variation for salt tolerance index ranging from 0.311 to 0.999. Although no significant correlation between salt tolerance and Na+ content was observed, there was a significant negative correlation between shoot biomass production under a control condition and salt tolerance. These rapeseed accessions were genotyped by DArTseq for a total of 51,109 genetic markers, which were aligned with 'pseudomolecules' representative of the genome of rapeseed to locate their hypothetical order for association mapping. A total of 62 QTLs for salt tolerance, shoot biomass, and ion-homeostasis-related traits were identified by association mapping using both the P and Q+K models. Candidate genes located within the QTL regions were also shortlisted. Sequence analysis showed many polymorphisms for BnaaTSN1. Three of them in the coding region resulting in a premature stop codon or frameshift were found in most of the sensitive lines. Loss-of-function mutations showed a significant association with salt tolerance in B. napus.	[Yong, Hui-Yee; Wang, Chunlei; Kitashiba, Hiroyasu; Nishio, Takeshi] Tohoku Univ, Grad Sch Agr Sci, Aoba Ku, Sendai, Miyagi 9818555, Japan; [Li, Feng; Wu, Xiaoming] Chinese Acad Agr Sci, Oil Crop Res Inst, Wuhan 430062, Peoples R China; [Bancroft, Ian] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England	Nishio, T (reprint author), Tohoku Univ, Grad Sch Agr Sci, Aoba Ku, 1-1 Tsutsumidori Amamiyamachi, Sendai, Miyagi 9818555, Japan.	huiyee1@yahoo.com; chunleiwang@aliyun.com; ian.bancroft@york.ac.uk; lifengmail@hotmail.com; wuxm@oilcrops.cn; kite@bios.tohoku.ac.jp; nishio@bios.tohoku.ac.jp			Japan Science and Technology Agency [J120000331]; Rapeseed Project for Restoring Tsunami-Salt-Damaged Farmland; Ministry of Education, Culture, Sports, Science and Technology, Japan; UK Department for Environment, Food and Rural Affairs [Defra IF0144]	We are grateful to Dr. Tadashi Takahashi for his guidance about measurement of ion contents. This work was supported in part by the Japan China Joint Research Program of the Japan Science and Technology Agency (J120000331) and the Rapeseed Project for Restoring Tsunami-Salt-Damaged Farmland. Hui-Yee Yong is a recipient of a Japanese government (Monbukagakusho: MEXT) scholarship from the Ministry of Education, Culture, Sports, Science and Technology, Japan. Construction of the genome pseudomolecules was supported by UK Department for Environment, Food and Rural Affairs (Defra IF0144).	Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Batelli G, 2007, MOL CELL BIOL, V27, P7781, DOI 10.1128/MCB.00430-07; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.2307/3870648; Gaxiola RA, 2001, P NATL ACAD SCI USA, V98, P11444, DOI 10.1073/pnas.191389398; Ren ZH, 2005, NAT GENET, V37, P1141, DOI 10.1038/ng1643; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Cellier F, 2004, PLANT J, V39, P834, DOI 10.1111/j.1365-313X.2004.02177.x; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Munns R, 2012, NAT BIOTECHNOL, V30, P360, DOI 10.1038/nbt.2120; Zhao J, 2008, PLANT PHYSIOL, V148, P796, DOI 10.1104/pp.108.124248; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Quan RD, 2007, PLANT CELL, V19, P1415, DOI 10.1105/tpc.106.042291; Leshem Y, 2006, P NATL ACAD SCI USA, V103, P18008, DOI 10.1073/pnas.0604421103; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Pritchard JK, 2000, GENETICS, V155, P945; Ding GD, 2010, ANN BOT-LONDON, V105, P1221, DOI 10.1093/aob/mcq050; Tocquin Pierre, 2003, BMC Plant Biology, V3, P2, DOI 10.1186/1471-2229-3-2; Bose J, 2013, J EXP BOT, V64, P471, DOI 10.1093/jxb/ers343; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Katsuhara M, 1996, PLANT CELL PHYSIOL, V37, P169; Harper AL, 2012, NAT BIOTECHNOL, V30, P798, DOI 10.1038/nbt.2302; Long NV, 2013, THEOR APPL GENET, V126, P2335, DOI 10.1007/s00122-013-2139-0; Broadley MR, 2008, PLANT PHYSIOL, V146, P1707, DOI 10.1104/pp.107.114645; Mendez-Vigo B, 2011, PLANT PHYSIOL, V157, P1942, DOI 10.1104/pp.111.183426; Ren ZH, 2010, P NATL ACAD SCI USA, V107, P5669, DOI 10.1073/pnas.0910798107; Zhu JH, 2007, MOL CELL BIOL, V27, P5214, DOI 10.1128/MCB.01989-06; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lippuner V, 1996, J BIOL CHEM, V271, P12859; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Tripathi V, 2009, PLANT J, V58, P778, DOI 10.1111/j.1365-313X.2009.03812.x; Kim BG, 2007, PLANT J, V52, P473, DOI 10.1111/j.1365-313X.2007.03249.x; Munns R, 2003, PLANT SOIL, V253, P201, DOI 10.1023/A:1024553303144; Levine A, 1996, CURR BIOL, V6, P427, DOI 10.1016/S0960-9822(02)00510-9; Lin HX, 2004, THEOR APPL GENET, V108, P253, DOI 10.1007/s00122-003-1421-y; Byrt CS, 2007, PLANT PHYSIOL, V143, P1918, DOI 10.1104/pp.093476; Hirschi KD, 1996, P NATL ACAD SCI USA, V93, P8782, DOI 10.1073/pnas.93.16.8782; Ashraf M, 2004, CRIT REV PLANT SCI, V23, P157, DOI 10.1080/07352680490433286; Lata C, 2011, J EXP BOT, V62, P3387, DOI 10.1093/jxb/err016; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Katori T, 2010, J EXP BOT, V61, P1125, DOI 10.1093/jxb/erp376; Apse MP, 1999, SCIENCE, V285, P1256, DOI 10.1126/science.285.5431.1256; Yang M, 2011, PLANT SOIL, V339, P97, DOI 10.1007/s11104-010-0516-x; Ashraf M, 2008, ADV AGRON, V97, P45, DOI 10.1016/S0065-2113(07)00002-8; Yang YZ, 2010, MOL CELL, V40, P1016, DOI 10.1016/j.molcel.2010.11.024; Cui F, 2012, PLANT CELL, V24, P233, DOI 10.1105/tpc.111.093062; Basunanda P, 2010, THEOR APPL GENET, V120, P271, DOI 10.1007/s00122-009-1133-z; ASHRAF M, 1990, ENVIRON EXP BOT, V30, P475, DOI 10.1016/0098-8472(90)90028-3; Barboza L, 2013, P NATL ACAD SCI USA, V110, P15818, DOI 10.1073/pnas.1314979110; Cha-um S, 2012, PLANT CELL TISS ORG, V110, P23, DOI 10.1007/s11240-012-0126-9; Courtois B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078037; Frey N. F. dit, 2010, Plant Cell, V22, P1575; Epstein E, 1980, SCIENCE, V210, P99; Fang ZW, 1998, PLANT MOL BIOL, V37, P597, DOI 10.1023/A:1005913629485; FitzGerald JE, 2009, BIOCHEM SOC T, V37, P897, DOI 10.1042/BST0370897; Forster BP, 2001, EUPHYTICA, V120, P317, DOI 10.1023/A:1017592618298; Jha D, 2010, PLANT CELL ENVIRON, V33, P793, DOI 10.1111/j.1365-3040.2009.02105.x; Li F, 2014, DNA RES, V21, P355, DOI 10.1093/dnares/dsu002; Liu J, 2009, PLANT SOIL, V320, P255, DOI 10.1007/s11104-009-9891-6; Nasu S., 2012, J INTEGRATED FIELD S, V9, P33; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pokrovskii VB, 1990, SELEKTSIYA SEMENOVOD, V4, P24; Ruan CJ, 2012, CRITICAL REV PLANT S, V29, P329; Rus A, 2006, PLOS GENET, V2, P1964, DOI 10.1371/journal.pgen.0020210; Shinozaki K, 2000, CURR OPIN PLANT BIOL, V3, P217, DOI 10.1016/S1369-5266(00)00067-4; Shuuichi N, 2003, J EXP BOT, V54, P2231; Tang JC, 2013, PLANT CELL ENVIRON, V36, P2021, DOI 10.1111/pce.12112; Wang Y, 2010, CELL RES, V20, P826, DOI 10.1038/cr.2010.74; Zhu GY, 2001, EUPHYTICA, V121, P251, DOI 10.1023/A:1012016431577	70	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0032-0935	1432-2048		PLANTA	Planta	JUL	2015	242	1					313	326		10.1007/s00425-015-2310-8		14	Plant Sciences	Plant Sciences	CK8VG	WOS:000356516800022		
J	Matsuno, K; Yamaguchi, A; Hirawake, T; Nishino, S; Inoue, J; Kikuchi, T				Matsuno, Kohei; Yamaguchi, Atsushi; Hirawake, Toru; Nishino, Shigeto; Inoue, Jun; Kikuchi, Takashi			Reproductive success of Pacific copepods in the Arctic Ocean and the possibility of changes in the Arctic ecosystem	POLAR BIOLOGY			English	Article						Arctic Ocean; Pacific copepods; Neocalanus flemingeri; Reproduction	NORTHERN BERING SEA; PELAGIC FOOD WEBS; NEOCALANUS-FLEMINGERI; LIFE-HISTORIES; PLUMCHRUS; PARADOX	The species composition of Arctic zooplankton differs greatly from that of the zooplankton of the North Pacific and Bering Sea. Particularly with greater warming from sea-ice retreat, the reproduction of North Pacific species transported into the Chukchi Sea and beyond may lead to changes in the Arctic pelagic ecosystem. We report the egg production and hatching of the Pacific copepod Neocalanus flemingeri in the Chukchi Sea based on shipboard experiments performed in September 2013. The reproductive capability of N. flemingeri observed in the Chukchi Sea resembled that reported in the Pacific, with the exception of a lower hatching success. Only 7.5 % of N. flemingeri eggs hatched compared with 93 % in Pacific experiments. Low hatching success is considered to be caused by failures of fertilization. The potential recruitment number for N. flemingeri suggests that it is unlikely to establish expatriate Arctic populations in the near future.	[Matsuno, Kohei; Inoue, Jun] Natl Inst Polar Res, Arctic Environm Res Ctr, Tachikawa, Tokyo 1908518, Japan; [Yamaguchi, Atsushi; Hirawake, Toru] Hokkaido Univ, Grad Sch Fisheries Sci, Marine Biol Lab, Hakodate, Hokkaido 0418611, Japan; [Nishino, Shigeto; Kikuchi, Takashi] Japan Agcy Marine Earth Sci & Technol, Yokosuka, Kanagawa 2370061, Japan	Matsuno, K (reprint author), Natl Inst Polar Res, Arctic Environm Res Ctr, 10-3 Midori Cho, Tachikawa, Tokyo 1908518, Japan.	k.matsuno@fish.hokudai.ac.jp	Yamaguchi, Atsushi/A-8613-2012		Green Network of Excellence Program's (GRENE Program) Arctic Climate Change Research Project: 'Rapid Change of the Arctic Climate System and its Global Influences'; JSPS [24248032, 24110005]	We are grateful to the captain, officers and crew of the R.V. Mirai (JAMSTEC), operated by GODI, for their help in the sample collection. This study was supported by the Green Network of Excellence Program's (GRENE Program) Arctic Climate Change Research Project: 'Rapid Change of the Arctic Climate System and its Global Influences.' This study was partially supported by a Grant-in-Aid for Scientific Research (A) (24248032) and a Grant-in-Aid for Scientific Research on Innovative Areas (24110005) from the JSPS.	Kobari T, 2001, MAR ECOL PROG SER, V209, P243, DOI 10.3354/meps209243; Saito H, 2000, DEEP-SEA RES PT I, V47, P2141, DOI 10.1016/S0967-0637(00)00017-0; MILLER CB, 1988, PROG OCEANOGR, V20, P293, DOI 10.1016/0079-6611(88)90044-4; SPRINGER AM, 1989, CONT SHELF RES, V9, P359, DOI 10.1016/0278-4343(89)90039-3; Matsuno K, 2011, POLAR BIOL, V34, P1349, DOI 10.1007/s00300-011-0988-z; COACHMAN LK, 1966, LIMNOL OCEANOGR, V11, P44; Grebmeier JM, 2006, PROG OCEANOGR, V71, P331, DOI 10.1016/j.pocean.2006.10.001; Reid PC, 2007, GLOBAL CHANGE BIOL, V13, P1910, DOI 10.1111/j.1365-2486.2007.01413.x; Woodgate RA, 2005, DEEP-SEA RES PT II, V52, P3116, DOI 10.1016/j.dsr2.2005.10.016; CONOVER RJ, 1988, HYDROBIOLOGIA, V167, P127, DOI 10.1007/BF00026299; Ershova EA, 2012, BIOL BULL+, V39, P676, DOI 10.1134/S1062359012080043; Geinrikh AK, 2002, OCEANOLOGY+, V42, P77; Hunt GL, 2007, DEEP-SEA RES PT II, V54, P2453, DOI 10.1016/j.dsr2.2007.07.029; Longhurst A.R., 2006, ECOLOGICAL GEOGRAPHY; Matsuno K, 2012, POLAR SCI, V6, P105, DOI 10.1016/j.polar.2012.01.002; MILLER C B, 1989, Bulletin of Plankton Society of Japan, V36, P27; Nelson R.J., 2014, PACIFIC ARCTIC REGIO, P269; SPRINGER AM, 1993, CONT SHELF RES, V13, P575, DOI 10.1016/0278-4343(93)90095-F	18	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0722-4060	1432-2056		POLAR BIOL	Polar Biol.	JUL	2015	38	7					1075	1079		10.1007/s00300-015-1658-3		5	Biodiversity Conservation; Ecology	Biodiversity & Conservation; Environmental Sciences & Ecology	CK9BP	WOS:000356535300012		
J	Matsuzawa, T				Matsuzawa, Tetsuro			Sumatran orangutans and the World War II	PRIMATES			English	Editorial Material									[Matsuzawa, Tetsuro] Japan Monkey Ctr, Inuyama, Aichi, Japan; [Matsuzawa, Tetsuro] Kyoto Univ, Inuyama, Aichi, Japan	Matsuzawa, T (reprint author), Japan Monkey Ctr, Inuyama, Aichi, Japan.	matsuzawa.tetsuro.8w@kyoto-u.ac.jp						0	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0032-8332	1610-7365		PRIMATES	Primates	JUL	2015	56	3					207	209		10.1007/s10329-015-0474-2		3	Zoology	Zoology	CK9BU	WOS:000356536000001		
J	Takabayashi, S; Katoh, H				Takabayashi, Shuji; Katoh, Hideki			Noninvasive genotyping of common marmoset (Callithrix jacchus) by fingernail PCR	PRIMATES			English	Article						Common marmoset; Fingernail DNA; QF-PCR	CHIMERISM; MICE	The common marmoset (Callithrix jacchus) is a New World primate that is a useful model for medical studies. In this study, we report a convenient, reliable, and noninvasive procedure to genotype a living common marmoset by using fingernails. This method was used to successfully genotype DNA by restriction fragment length polymorphism (RFLP) PCR without prior purification, by using the KOD FX PCR enzyme kit. Additionally, there is no sample contamination from hematopoietic chimera derived from fused placenta in utero. We compared chimeric levels between various tissues in females with male littermates using quantitative fluorescent (QF)-PCR to prepare a reliable DNA source for genetic analyses, such as genotyping, gene mapping, or genomic sequencing. The chimerism detected appeared to be restricted to lymphatic tissues, such as bone marrow, thymus, spleen, lymph nodes and blood cells. As a result, DNA from fingernails with the quick is the best DNA source for genetic research in living marmosets.	[Takabayashi, Shuji; Katoh, Hideki] Hamamatsu Univ Sch Med, Expt Anim Inst, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan	Takabayashi, S (reprint author), Hamamatsu Univ Sch Med, Expt Anim Inst, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	shuji@hama-med.ac.jp					Hofstetter JR, 1997, BIOCHEM MOL MED, V62, P197, DOI 10.1006/bmme.1997.2637; Mansfield K, 2003, COMPARATIVE MED, V53, P383; BENIRSCHKE K, 1962, SCIENCE, V138, P513, DOI 10.1126/science.138.3539.513; Flicek P, 2010, NUCLEIC ACIDS RES, V38, pD557, DOI 10.1093/nar/gkp972; Arras M, 2007, LAB ANIM-UK, V41, P30, DOI 10.1258/002367707779399446; Gengozian N, 1964, CYTOGENETICS, V10, P384; Katoh H, 2009, AM J PRIMATOL, V71, P912, DOI 10.1002/ajp.20729; Ross CN, 2007, P NATL ACAD SCI USA, V104, P6278, DOI 10.1073/pnas.0607426104; Schneider MR, 2005, ANAL BIOCHEM, V344, P1, DOI 10.1016/j.ab.2005.03.035; Sweeney CG, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-98; Takabayashi S, 2011, EXP ANIM TOKYO, V60, P417; Tie J, 2014, ELECTROPHORESIS, V35, P3188, DOI 10.1002/elps.201400061; Tomioka I, 2010, GENES CELLS, V15, P959, DOI 10.1111/j.1365-2443.2010.01437.x; Worley CK, 2014, NAT GENET, V46, P850	14	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0032-8332	1610-7365		PRIMATES	Primates	JUL	2015	56	3					235	240		10.1007/s10329-015-0466-2		6	Zoology	Zoology	CK9BU	WOS:000356536000005		
J	Green, MA; Emery, K; Hishikawa, Y; Warta, W; Dunlop, ED				Green, Martin A.; Emery, Keith; Hishikawa, Yoshihiro; Warta, Wilhelm; Dunlop, Ewan D.			Solar cell efficiency tables (version 46)	PROGRESS IN PHOTOVOLTAICS			English	Article						solar cell efficiency; photovoltaic efficiency; energy conversion efficiency	CONVERSION EFFICIENCY; CONCENTRATOR; STABILITY	Consolidated tables showing an extensive listing of the highest independently confirmed efficiencies for solar cells and modules are presented. Guidelines for inclusion of results into these tables are outlined, and new entries since January 2015 are reviewed. Copyright (c) 2015 John Wiley & Sons, Ltd.	[Green, Martin A.] Univ New S Wales, Australian Ctr Adv Photovolta, Sydney, NSW 2052, Australia; [Emery, Keith] Natl Renewable Energy Lab, Golden, CO 80401 USA; [Hishikawa, Yoshihiro] Natl Inst Adv Ind Sci & Technol, Res Ctr Photovolta Technol RCPVT, Tsukuba, Ibaraki 3058568, Japan; [Warta, Wilhelm] Fraunhofer Inst Solar Energy Syst, Dept Solar Cells Mat & Technol, D-79110 Freiburg, Germany; [Dunlop, Ewan D.] Commiss European Communities, Joint Res Ctr, Inst Energy, Renewable Energy Unit, IT-21027 Ispra, VA, Italy	Green, MA (reprint author), Univ New S Wales, Sch Photovolta & Renewable Energy Engn, Sydney, NSW 2052, Australia.	m.green@unsw.edu.au			U.S. Department of Energy [DE-AC36-08-GO28308]; National Renewable Energy Laboratory	The Australian Centre for Advanced Photovoltaics commenced operation in February 2013 with support from the Australian Government through the Australian Renewable Energy Agency (ARENA). The Australian Government does not accept responsibility for the views, information, or advice expressed herein. The work by K. Emery was supported by the U.S. Department of Energy under contract no. DE-AC36-08-GO28308 with the National Renewable Energy Laboratory.	Noh JH, 2013, NANO LETT, V13, P1764, DOI 10.1021/nl400349b; Tanenbaum DM, 2012, RSC ADV, V2, P882, DOI 10.1039/c1ra00686j; Green MA, 2009, PROG PHOTOVOLTAICS, V17, P85, DOI 10.1002/pip.880; Masuko K, 2014, IEEE J PHOTOVOLT, V4, P1433, DOI 10.1109/JPHOTOV.2014.2352151; Krasovec UO, 2013, SOL ENERG MAT SOL C, V117, P67, DOI 10.1016/j.solmat.2013.05.029; [Anonymous], 2015, PV MAGAZINE     0206; [Anonymous], 1985, DOECE0128 SOL EN RES, P7; Jorgensen M, 2012, ADV MATER, V24, P580, DOI 10.1002/adma.201104187; Wang W, 2014, ADV ENERGY MATER, V4, DOI 10.1002/aenm.201301465; Geisz JF, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4816837; Green MA, 2015, PROG PHOTOVOLTAICS, V23, P1, DOI 10.1002/pip.2573; Green MA, 2015, PROG PHOTOVOLTAICS, V23, P685, DOI 10.1002/pip.2612; ZHANG FZ, 1995, IEEE T ELECTRON DEV, V42, P144; Service RF, 2011, SCIENCE, V332, P293, DOI 10.1126/science.332.6027.293; Gueymard CA, 2002, SOL ENERGY, V73, P443, DOI 10.1016/S0038-092X(03)00005-7; Green MA, 2012, PROG PHOTOVOLTAICS, V20, P12, DOI 10.1002/pip.2163; Zhao J, 1997, PROG PHOTOVOLTAICS, V5, P269, DOI 10.1002/(SICI)1099-159X(199707/08)5:4<269::AID-PIP174>3.0.CO;2-1; Zhao JH, 1998, APPL PHYS LETT, V73, P1991, DOI 10.1063/1.122345; Sai H, 2014, IEEE J PHOTOVOLT, V4, P1349, DOI 10.1109/JPHOTOV.2014.2355037; Ward JS, 2002, PROG PHOTOVOLTAICS, V10, P41, DOI 10.1002/pip.424; Chiang C. J., 1990, 21 IEEE PHOT SPEC C, P861; Chiu PT, 2014, P 40 IEEE PVSC; Cousins PJ, 2010, 35 IEEE PVSC HON HI; Fukano T, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.062301; Hosoya M, 2013, P 93 ANN M CHEM SOC, P21; Jager-Waldau A, 2004, PVNET EUROPEAN ROADM; Kaneko K, 2015, NIMS ACHIEVES 15 EFF; Kawai M, 2013, NIKKEI ELECT; Kayes B. M., 2011, P 37 IEEE PHOT SPEC; Keavney C. J., 1990, 21 IEEE PHOT SPEC C, V1, P141; Keevers MJ, 2007, 22 EUR PHOT SOL EN C; Komiya R., 2011, 21 INT PHOT SCI ENG; Matsui T., 2013, P 28 EUR PHOT SOL EN, P2213; Mattos LS, 2012, 38 IEEE PHOT SPEC C; Nakamura M, 2013, 39 IEEE PVSC TAMP US; Powalla M., 2014, 29 EUR PHOT SOL EN C; Sakata I, 2006, 2006 IEEE 4 WORLD C, V1, P1; Sasaki K., 2013, P 9 INT C CONC PHOT; Slade A, 2005, 15 INT PHOT SCI ENG, P701; Slooff LH, 2008, PHYS STATUS SOLIDI-R, V2, P257, DOI 10.1002/pssr.200802186; Steiner M, 2015, PROG PHOTOVOLTAICS, V23, P1323, DOI 10.1002/pip.2568; Sugimoto H, 2014, 40 IEEE PHOT SPEC C; Swanson R, 2012, CHALL PV SCI TECHN M; Venkatasubramanian R, 1997, 25 IEEE PHOT SPEC C, P31; Verlinden P., 2014, 6 WORLD C PV EN CONV; Wallin E, 2012, PROG PHOTOVOLTAICS, V20, P851, DOI 10.1002/pip.2246	46	30	30	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1062-7995	1099-159X		PROG PHOTOVOLTAICS	Prog. Photovoltaics	JUL	2015	23	7					805	812		10.1002/pip.2637		8	Energy & Fuels; Materials Science, Multidisciplinary; Physics, Applied	Energy & Fuels; Materials Science; Physics	CK6WM	WOS:000356369400001		
J	Galleano, R; Zaaiman, W; Strati, C; Bartocci, S; Pravettoni, M; Marzoli, M; Fucci, R; Leanza, G; Timo, G; Minuto, A; Catena, M; Aleo, F; Takagi, S; Akiyama, A; Nunez, R; Belluardo, G				Galleano, Roberto; Zaaiman, Willem; Strati, Cecilia; Bartocci, Simona; Pravettoni, Mauro; Marzoli, Matteo; Fucci, Raffaele; Leanza, Gianni; Timo, Gianluca; Minuto, Alessandro; Catena, Mario; Aleo, Francesco; Takagi, Shin; Akiyama, Akihito; Nunez, Ruben; Belluardo, Giorgio			Second international spectroradiometer intercomparison: results and impact on PV device calibration	PROGRESS IN PHOTOVOLTAICS			English	Article						solar radiation; solar cell; intercomparison; spectroradiometer; calibration	IRRADIANCE	This paper describes the results of an intercomparison of spectroradiometers for measuring global normal incidence and direct normal incidence spectral irradiance in the visible and in the near infrared, together with an assessment of the impact these results may have on the calibration of the short circuit current (I-sc) of triple-junction photovoltaic devices and on the relevant spectral mismatch calculation. The intercomparison was conducted by six European scientific laboratories and a Japanese industrial partner. Seven spectroradiometer systems, for a total of 13 different instruments/channels using two different technologies and made by four different manufacturers were involved. This group of systems represents a good cross section of the instrumentation for solar spectrum measurements available to date. The instruments were calibrated by each partner prior to the intercomparison following their usual procedure and traceability route in order to verify the entire measurement and traceability chain. The difference in measured spectral irradiance showed to have an impact on the calibration of a set of Iso-Type cells varying from +/- 2% to +/- 14% for middle and bottom cell, respectively. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Galleano, Roberto; Zaaiman, Willem] ESTI, Renewable Energy Unit, IET, EC,DG JRC, Ispra, Italy; [Strati, Cecilia; Bartocci, Simona] Univ Tor Vergata, Dept Enterprise Engn, FTA Lab Rome, Rome, Italy; [Pravettoni, Mauro; Marzoli, Matteo] SUPSI, CH-6952 Canobbio, Switzerland; [Fucci, Raffaele; Leanza, Gianni] ENEA, UTTP FOTO, Portici, Italy; [Timo, Gianluca; Minuto, Alessandro] RSE Spa, Milan, Italy; [Catena, Mario; Aleo, Francesco] Enel Ingn & Ric SpA, Catania, Italy; [Takagi, Shin; Akiyama, Akihito] EKO Instruments, Tokyo, Japan; [Nunez, Ruben] Univ Politecn Madrid, Inst Energia Solar, Madrid, Spain; [Belluardo, Giorgio] Inst Renewable Energy, EURAC Res, Bolzano, Italy	Galleano, R (reprint author), IET, DG JRC, EC, Renewable Energy Unit,ESTI, Ispra, Italy.	Roberto.GALLEANO@ec.europa.eu					[Anonymous], 609043 ISOIEC; Gueymard CA, 2001, SOL ENERGY, V71, P325, DOI 10.1016/S0038-092X(01)00054-8; [Anonymous], 2006, 91 IOM; Betts TR, 2006, 2006 IEEE 4 WORLD C, V2; Galleano R, 2014, PROG PHOTOVOLTAICS, V22, P1128, DOI 10.1002/pip.2361; Gueymard C, 1995, FSECPF27095 FLOR SOL; Krawczynski M, 2009, P 24 EUR PHOT SOL EN; Martinez-Lozano JA, 2003, J ATMOS OCEAN TECH, V20, P997, DOI 10.1175/1457.1; Muellejans H, 2005, MEASUREMENT SCI TECH, V16, P1250, DOI [10.1088/0957-0233/16/6/002, DOI 10.1088/0957-0233/16/6/002]; Rummel S, 2006, 2006 IEEE 4 WORLD C, V2; van der Heide A, 2005, 20 EUR PHOT SOL EN C; Winter S, 2005, 31 IEEE PHOT SPEC C, DOI [10.1109/PVSC.2005.1488304, DOI 10.1109/PVSC.2005.1488304]	12	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1062-7995	1099-159X		PROG PHOTOVOLTAICS	Prog. Photovoltaics	JUL	2015	23	7					929	938		10.1002/pip.2511		10	Energy & Fuels; Materials Science, Multidisciplinary; Physics, Applied	Energy & Fuels; Materials Science; Physics	CK6WM	WOS:000356369400014		
J	Saito, S; Haruta, H; Kobayashi, T; Kato, S				Saito, Shinnosuke; Haruta, Hidenori; Kobayashi, Toshiyuki; Kato, Satoshi			A Case of Anorexia Nervosa With Tracheoesophageal Fistula	PSYCHOSOMATICS			English	Article							COMPLICATION		[Saito, Shinnosuke; Kobayashi, Toshiyuki; Kato, Satoshi] Jichi Med Univ, Dept Psychiat, Shimotsuke, Tochigi 3290498, Japan; [Haruta, Hidenori] Jichi Med Univ, Clin Inst Digest Dis, Surg Branch, Shimotsuke, Tochigi 3290498, Japan	Saito, S (reprint author), Jichi Med Univ, Dept Psychiat, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	saitoshinnosuke@gmail.com					ABDU RA, 1987, ARCH SURG-CHICAGO, V122, P830; PAYNE DK, 1990, CHEST, V98, P161, DOI 10.1378/chest.98.1.161; Baisi A, 1999, DIS ESOPHAGUS, V12, P209; Diddee R, 2006, CONTIN ED ANAESTH CR, V6, P105, DOI 10.1093/bjaceaccp/mkl019; FERGUSSON RJ, 1985, POSTGRAD MED J, V61, P815; Hatzitolios AI, 1997, POSTGRAD MED J, V73, P662; Marzelle J, 1989, Eur J Cardiothorac Surg, V3, P499, DOI 10.1016/1010-7940(89)90108-5; Norrington A, 2012, ARCH DIS CHILDHOOD-E, V97, P48, DOI 10.1136/adc.2010.199885; Reed Michael F, 2003, Chest Surg Clin N Am, V13, P271, DOI 10.1016/S1052-3359(03)00030-9; Saito Shinnosuke, 2013, Seishin Shinkeigaku Zasshi, V115, P729; Takemura T, 1988, Nihon Shokakibyo Gakkai Zasshi, V85, P939	11	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0033-3182			PSYCHOSOMATICS	Psychosomatics	JUL-AUG	2015	56	4					419	422				4	Psychiatry; Psychology	Psychiatry; Psychology	CL0IR	WOS:000356626100014		
J	Hihara, T; Kubota, M; Okuro, A				Hihara, Tsutomu; Kubota, Masahisa; Okuro, Atsushi			Evaluation of sea surface temperature and wind speed observed by GCOM-W1/AMSR2 using in situ data and global products	REMOTE SENSING OF ENVIRONMENT			English	Article						AMSR2/GCOM-W1; Sea surface temperature; Sea surface wind speed; Marine meteorology; Microwave radiometer	SATELLITE; ALGORITHM	The Global Change Observation Mission (GCOM) 1st-Water (GCOM-W1) satellite, equipped with the Advanced Microwave Scanning Radiometer 2 (AMSR2), was launched on May 18, 2012, by the Japan Aerospace Exploration Agency (JAXA), and began observing on July 3, 2012. In this study, we evaluated the sea surface temperature (SST) and sea surface wind speed (SSW) data from the AMSR2 (ver. 1) standard product, provided by JAXA, by comparison with mooring buoy data or global products. From a comparison of the AMSR2 and Triangle Trans-Ocean Buoy Network (TRITON) data, mean differences of 0.21 degrees C and 030 m/s, and root mean square (RMS) differences of 0.49 degrees C and 125 m/s, were inferred for SST and SSW, respectively. During daytime low wind-speed conditions, SSTs from AMSR2 are significantly higher than from TRITON. This implies that SSTs from AMSR2 are strongly affected by diurnal heating. From an intercomparison of global products for the Southern Ocean, the annual-mean SSW from AMSR2 is as much as 1 m/s lower than values from other SSW products. Although the SSW data from AMSR2 have a similar accuracy to data from other products, the AMSR2 data have the advantage of fewer missing data compared with other products. Furthermore, we checked for significant differences in annual means by comparing data from WindSat, AMSR2, and AMSR for the Earth Observing System (AMSR-E) provided by JAXA. For the Southern Ocean, we found remarkable differences in the annual-mean values of SST and SSW. SSTs from AMSR2 are lower than from WindSat in regions of strong current in the Northern Hemisphere, and SSTs from AMSR-E JAXA are higher than from WindSat in the same regions. However, the results also suggest a risk of artificial trends in the satellite data if AMSR2, AMSR-E JAXA, and WindSat data are used continuously. (C) 2015 Elsevier Inc. All rights reserved.	[Hihara, Tsutomu; Kubota, Masahisa; Okuro, Atsushi] Tokai Univ, Sch Marine Sci & Technol, Shimizu, Shizuoka, Japan; [Okuro, Atsushi] Maritime Self Def Force, Oceanog Command, Yokosuka, Kanagawa, Japan	Hihara, T (reprint author), Tokai Univ, Sch Marine Sci & Technol, 3-20-1 Orido, Shimizu, Shizuoka, Japan.	tsutomu@mercury.oi.u-tokai.ac.jp			JAXA; Institute of Oceanic Research and Development, Tokai University; HyARC Collaborative Research Program, Nagoya University	This research was partly supported by JAXA and the Institute of Oceanic Research and Development, Tokai University. The data used in this study were provided by JAXA, IFREMER, RSS, and the TAO Project Office of the Pacific Marine Environmental Laboratory, National Oceanic and Atmospheric Administration. This study was supported by the HyARC Collaborative Research Program, Nagoya University.	Stuart-Menteth AC, 2003, J GEOPHYS RES-OCEANS, V108, DOI [10.1029/2002JC001534, 10.1029/2002jc001534]; Chen SS, 1997, Q J ROY METEOR SOC, V123, P357, DOI 10.1002/qj.49712353806; Reynolds RW, 2007, J CLIMATE, V20, P5473, DOI 10.1175/2007JCLI1824.1; Gentemann CL, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016291; Kawai Y, 2002, J OCEANOGR, V58, P805, DOI 10.1023/A:1022867028876; STRAMMA L, 1986, J PHYS OCEANOGR, V16, P827, DOI 10.1175/1520-0485(1986)016<0827:LDSSTV>2.0.CO;2; Donlon C, 2007, B AM METEOROL SOC, V88, P1197, DOI 10.1175/BAMS-88-8-1197; Fairall CW, 2003, J CLIMATE, V16, P571, DOI 10.1175/1520-0442(2003)016<0571:BPOASF>2.0.CO;2; Bentamy A, 2012, INT J REMOTE SENS, V33, P1729, DOI 10.1080/01431161.2011.600348; KASTEN F, 1980, SOL ENERGY, V24, P177, DOI 10.1016/0038-092X(80)90391-6; Donlon CJ, 2012, REMOTE SENS ENVIRON, V116, P140, DOI 10.1016/j.rse.2010.10.017; van den Dool HM, 2000, J CLIMATE, V13, P1421, DOI 10.1175/1520-0442(2000)013<1421:EOT>2.0.CO;2; JAXA, 2013, GCOM W1 SHIZUKU DAT; Kubota M, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004338; Okuro A, 2014, INT J REMOTE SENS, V35, P5394, DOI 10.1080/01431161.2014.926415; Price F.J., 1986, J GEOPHYS RES, V91, P8411; Shibata A, 2007, J OCEANOGR, V63, P863, DOI 10.1007/s10872-007-0073-y; Shibata A, 2006, J OCEANOGR, V62, P321, DOI 10.1007/s10872-006-0057-3; Shibata A., 2004, ITALIAN J REMOTE SEN, V30, P131; Wentz FJ, 1997, J GEOPHYS RES-OCEANS, V102, P8703, DOI 10.1029/96JC01751; Wentz F.J., 2000, ALGORITHM THEORETICA; Wentz F.J., 2007, SUPPLEMENT 1 ALGORIT	22	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0034-4257	1879-0704		REMOTE SENS ENVIRON	Remote Sens. Environ.	JUL	2015	164						170	178		10.1016/j.rse.2015.04.005		9	Environmental Sciences; Remote Sensing; Imaging Science & Photographic Technology	Environmental Sciences & Ecology; Remote Sensing; Imaging Science & Photographic Technology	CK9IU	WOS:000356554600015		
J	Inada, N; Ito, H; Yasunaga, K; Kuroda, M; Iwanaga, R; Hagiwara, T; Tani, I; Yukihiro, R; Uchiyama, T; Ogasahara, K; Hara, K; Inoue, M; Murakami, T; Someki, F; Nakamura, K; Sugiyama, T; Uchida, H; Ichikawa, H; Kawakubo, Y; Kano, Y; Tsujii, M				Inada, Naoko; Ito, Hiroyuki; Yasunaga, Kazuhiro; Kuroda, Miho; Iwanaga, Ryoichiro; Hagiwara, Taku; Tani, Iori; Yukihiro, Ryoji; Uchiyama, Tokio; Ogasahara, Kei; Hara, Koichi; Inoue, Masahiko; Murakami, Takashi; Someki, Fumio; Nakamura, Kazuhiko; Sugiyama, Toshiro; Uchida, Hiroyuki; Ichikawa, Hironobu; Kawakubo, Yuki; Kano, Yukiko; Tsujii, Masatsugu			Psychometric properties of the Repetitive Behavior Scale-Revised for individuals with autism spectrum disorder in Japan	RESEARCH IN AUTISM SPECTRUM DISORDERS			English	Article						Restricted and repetitive behaviors; Autism spectrum disorder; Repetitive Behavior Scale-Revised Japanese; Version; Reliability; Validity	PERVASIVE DEVELOPMENTAL DISORDERS; OBSESSIVE-COMPULSIVE SCALE; YOUNG-CHILDREN; RELIABILITY; ASSOCIATION; VALIDATION; VALIDITY; PLACEBO; ADULTS; TRIAL	Restricted and repetitive behaviors (RRBs) constitute a core symptom of autism spectrum disorder (ASD). The Repetitive Behavior Scale-Revised (RBS-R) is a widely used questionnaire administered by parents or caregivers to assess RRBs in individuals with ASD. This study evaluated the psychometric properties of the RBS-R Japanese Version (RBS-R-J). The ASD and non-ASD groups comprised 274 and 36 participants, respectively. We examined corrected item-total correlation, Cronbach's alpha, and RBS-R-J scores of different diagnostic groups, as well as correlations between RBS-R-J scores and intelligence quotient (IQ), autistic symptoms, adaptive/maladaptive functioning, aberrant behaviors, and sensory processing. All items showed moderate corrected item-total correlations. Cronbach's alpha coefficient was .93. We found significant differences in the mean RBS-R-J scores of the low-functioning ASD group and the intellectual disabilities group, and of low-functioning and high-functioning ASD groups. RBS-R-J scores negatively correlated with IQ and scores on the Sensory Profile (Japanese version) and Adaptive Behavior Composite of the Maladaptive Behavior Index of the Vineland Adaptive Behavior Scales-Second Edition (VABS-II; Japanese version), but positively correlated with scores on the peak and current symptoms subscales of the Pervasive Developmental Disorders Autism Society Japan Rating Scale, the VABS-II, and the Aberrant Behavior Checklist-Community (Japanese version). From these results, we conclude that RBS-R-J showed good reliability, diagnostic validity, and convergent validity, indicating that it is a reliable, valid instrument for use among ASD individuals in clinical and research settings. (c) 2015 Elsevier Ltd. All rights reserved.	[Inada, Naoko; Yasunaga, Kazuhiro] Univ Tokyo, Grad Sch Educ, Bunkyo Ku, Tokyo 1130033, Japan; [Ito, Hiroyuki] Hamamatsu Univ Sch Med, Res Ctr Child Mental Dev, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Kuroda, Miho; Uchiyama, Tokio] Tokaigakuen Univ, Fac Humanities, Tenpaku Ku, Nagoya, Aichi 4688514, Japan; [Iwanaga, Ryoichiro] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 8528520, Japan; [Hagiwara, Taku] Hokkaido Univ, Asahikawa, Hokkaido 0708621, Japan; [Tani, Iori] Kyoto Gakuen Univ, Fac Human & Cultural Studies, Sogabecho, Kameoka 6218555, Japan; [Yukihiro, Ryoji] Fukushima Univ, Fac Human Dev & Culture, Fukushima 9601296, Japan; [Ogasahara, Kei] Tokyo Gakugei Univ, Sch Educ, Koganei, Tokyo 1848501, Japan; [Hara, Koichi] Univ Tokushima, Fac Integrated Arts & Sci, Tokushima 7708501, Japan; [Inoue, Masahiko] Tottori Univ, Grad Sch Med Sci, Tottori 6808550, Japan; [Murakami, Takashi] Chukyo Univ, Sch Contemporary Sociol, Showa Ku, Nagoya, Aichi 4668666, Japan; [Someki, Fumio] CUNY Coll Staten Isl, Dept Educ, Staten Isl, NY 10314 USA; [Nakamura, Kazuhiko] Hirosaki Univ, Sch Med, Hirosaki, Aomori 0368560, Japan; [Sugiyama, Toshiro] Hamamatsu Univ Sch Med, Dept Child & Adolescent Psychiat, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Uchida, Hiroyuki] Osaka Univ, United Grad Sch Child Dev, Suita, Osaka 5650871, Japan; [Ichikawa, Hironobu] Japan Dev Disorders Network, Minato Ku, Tokyo 1050013, Japan; [Kawakubo, Yuki; Kano, Yukiko] Univ Tokyo, Grad Sch Med, Dept Child Neuropsychiat, Bunkyo Ku, Tokyo 1138655, Japan	Inada, N (reprint author), Univ Tokyo, Grad Sch Educ, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	nainada-tky@umin.ac.jp			Japanese Ministry of Health, Labour and Welfare for Neurological and Psychiatric Disorders from Chukyo University [H21-KOKORO-006]	This study was funded in part by the Japanese Ministry of Health, Labour and Welfare (H21-KOKORO-006) for Neurological and Psychiatric Disorders from Chukyo University.	Aman M, 1986, ABERRANT BEHAV CHECK; Aman M. G., 1994, ABERRANT BEHAV CHECK; American Psychiatric Association, 2013, DIAGN STAT MAN MENT; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Anagnostou E, 2012, MOL AUTISM, V3, DOI 10.1186/2040-2392-3-16; Kim YS, 2011, AM J PSYCHIAT, V168, P904, DOI 10.1176/appi.ajp.2011.10101532; Mirenda P, 2010, J AUTISM DEV DISORD, V40, P1521, DOI 10.1007/s10803-010-1012-0; Dawson G, 2010, PEDIATRICS, V125, pE17, DOI 10.1542/peds.2009-0958; Lam KSL, 2007, J AUTISM DEV DISORD, V37, P855, DOI 10.1007/s10803-006-0213-z; Bodfish JW, 2000, J AUTISM DEV DISORD, V30, P237, DOI 10.1023/A:1005596502855; Fombonne E, 2005, J CLIN PSYCHIAT, V66, P3; PRIOR M, 1973, J AUTISM CHILD SCHIZ, V3, P154, DOI 10.1007/BF01537990; Szatmari P, 2006, J CHILD PSYCHOL PSYC, V47, P582, DOI 10.1111/j.1469-7610.2005.01537.x; Bishop SL, 2006, CHILD NEUROPSYCHOL, V12, P247, DOI 10.1080/09297040600630288; Scahill L, 1997, J AM ACAD CHILD PSY, V36, P844, DOI 10.1097/00004583-199706000-00023; MCDOUGLE CJ, 1995, AM J PSYCHIAT, V152, P772; Hardan AY, 2012, BIOL PSYCHIAT, V71, P956, DOI 10.1016/j.biopsych.2012.01.014; Gabriels RL, 2005, RES DEV DISABIL, V26, P169, DOI 10.1016/j.ridd.2004.05.003; Lam KSL, 2008, J CHILD PSYCHOL PSYC, V49, P1193, DOI 10.1111/j.1469-7610.2008.01944.x; Baird G, 2006, LANCET, V368, P210, DOI 10.1016/S0140-6736(06)69041-7; Lewis MH, 1998, MENT RETARD DEV D R, V4, P80, DOI 10.1002/(SICI)1098-2779(1998)4:2<80::AID-MRDD4>3.0.CO;2-0; Baghdadli A, 2003, J INTELL DISABIL RES, V47, P622, DOI 10.1046/j.1365-2788.2003.00507.x; Bishop S. L., 2012, J AUTISM DEV DISORDE; Boyd B. A., 2000, RES AUTISM SPECT DIS, V3, P959; CAMPBELL M, 1990, PSYCHOPHARMACOL BULL, V26, P130; Dunn W, 1997, INFANT YOUNG CHILD, V9, P23; Dunn W., 1999, SENSORY PROFILE USER; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1006; Inada N., 2012, JAPANESE J DEV PSYCH, V23, P123; Ito H., 2012, SEISHINIGAKU, V54, P889; Ito H, 2012, RES AUTISM SPECT DIS, V6, P1265, DOI 10.1016/j.rasd.2012.04.002; Ito H., 2013, SEISHINIGAKU, V55, P537; Japanese WAIS-III Publication Committee, 2006, NIH WAISII CHIN KEN, V3rd; Japanese WISC-III Publication Committee, 1998, NIH WAISII CHIN KEN, V3rd; Liss M, 2001, J AUTISM DEV DISORD, V31, P219, DOI 10.1023/A:1010707417274; Pervasive Developmental Disorders Autism Society Japan Rating Scale (PARS) Committee, 2008, KOUH HATT SYOG NIH J; Rojahn J, 2013, RES DEV DISABIL, V34, P1804, DOI 10.1016/j.ridd.2013.02.024; Sparrow S, 2005, VINELAND ADAPTIVE BE; Tanaka Institute for Educational Research, 2003, TAN BIN CHIN KENS, V5th; Yukihiro R., 2013, SEISHINIGAKU, V55, P627	40	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1750-9467	1878-0237		RES AUTISM SPECT DIS	Res. Autism Spectr. Disord.	JUL	2015	15-16						60	68		10.1016/j.rasd.2015.01.002		9	Education, Special; Psychology, Developmental; Psychiatry; Rehabilitation	Education & Educational Research; Psychology; Psychiatry; Rehabilitation	CL1XM	WOS:000356738200007		
J	Yamasaki, K; Mukae, H; Kawanami, T; Fukuda, K; Noguchi, S; Akata, K; Naito, K; Oda, K; Ogoshi, T; Nishida, C; Orihashi, T; Kawanami, Y; Ishimoto, H; Taniguchi, H; Yatera, K				Yamasaki, Kei; Mukae, Hiroshi; Kawanami, Toshinori; Fukuda, Kazumasa; Noguchi, Shingo; Akata, Kentarou; Naito, Keisuke; Oda, Keishi; Ogoshi, Takaaki; Nishida, Chinatsu; Orihashi, Takeshi; Kawanami, Yukiko; Ishimoto, Hiroshi; Taniguchi, Hatsumi; Yatera, Kazuhiro			Possible role of anaerobes in the pathogenesis of nontuberculous mycobacterial infection	RESPIROLOGY			English	Article						16S ribosomal RNA gene; anaerobes; bronchiectasis; clone library method; pulmonary nontuberculous mycobacterial infection	THIN-SECTION CT; OBSTRUCTIVE PULMONARY-DISEASE; HIGH-RESOLUTION CT; CYSTIC-FIBROSIS; MOLECULAR-IDENTIFICATION; LUNG-DISEASE; DIAGNOSIS; MICROBIOME; BACTERIA	Background and objectiveRecent advances in cultivation-independent molecular biological modalities for detecting bacterial species have indicated that several bacterial species may play a role in the pathogenesis of certain infectious diseases. The aim of this study was to evaluate the role of bacterial flora in the pathogenesis of nontuberculous mycobacteriosis (NTM) using a bacterial floral analysis of bronchoalveolar lavage fluid (BALF) with 16S rRNA gene sequencing in patients with bronchiectasis. MethodsFifty-eight patients with bronchiectasis evaluated using chest computed tomography were enrolled. BALF obtained from the most affected lung lesions was evaluated using culture and culture-independent methodologies. Approximately 600 bp of the bacterial 16S rRNA gene (E341F-E907R) was amplified via polymerase chain reaction using universal primers, and clone libraries were constructed. Nucleotide sequences of 96 randomly chosen clones for each specimen were determined, and the homology was searched using a basic local alignment search tool to determine the bacterial phylotypes and their proportions (bacterial floral analysis) in each specimen. ResultsTwenty-nine patients with bronchiectasis were diagnosed with NTM based on culture-based methods using Ogawa medium. The molecular method showed a significantly high rate of anaerobes among the patients with NTM compared with that observed in the bronchiectasis patients without NTM. In addition, findings of collapse/consolidation were significantly related to the proportion of Prevotella species in the BALF samples determined using the molecular method (P<0.001). ConclusionGiven the results of the present study, anaerobes may play an important role in the pathogenesis of bronchiectasis in patients with NTM. We compared the lung microbiome in bronchiectasis patients with and without pulmonary NTM using a molecular method with bronchoscopic specimens. Consequently, findings of collapse/consolidation on chest CT were significantly related to the proportion of Prevotella species. Anaerobes may play an important role in the pathogenesis of pulmonary NTM.	[Yamasaki, Kei; Mukae, Hiroshi; Kawanami, Toshinori; Noguchi, Shingo; Akata, Kentarou; Naito, Keisuke; Oda, Keishi; Ogoshi, Takaaki; Nishida, Chinatsu; Orihashi, Takeshi; Kawanami, Yukiko; Ishimoto, Hiroshi; Taniguchi, Hatsumi; Yatera, Kazuhiro] Univ Occupat & Environm Hlth, Dept Resp Med, Kitakyushu, Fukuoka 807, Japan; [Fukuda, Kazumasa] Univ Occupat & Environm Hlth, Dept Microbiol, Kitakyushu, Fukuoka 807, Japan	Mukae, H (reprint author), Univ Occupat & Environm Hlth Japan, Dept Resp Med, Yahatanishi Ku, 1-1 Iseigaoka, Kitakyushu, Fukuoka 8078555, Japan.	hmukae@med.uoeh-u.ac.jp			University of Occupational and Environmental Health, Japan; Ministry of Education, Science, Sports and Culture [23591173, 24790828]	We thank Drs Chiharu Yoshii (Wakamatsu Hospital, Fukuoka, Japan), Takashi Kido (University of Occupational and Environmental Health, Japan, Fukuoka, Japan), Naoyuki Inoue (Kyushu Rosai Hospital, Fukuoka, Japan), Shuya Nagata (University of Occupational and Environmental Health, Japan, Fukuoka, Japan), Minako Hanaka (University of Occupational and Environmental Health, Japan, Fukuoka, Japan), Susumu Tokuyama (Kyushu Rosai Hospital, Fukuoka, Japan), Yasuo Chojin (University of Occupational and Environmental Health, Japan, Fukuoka, Japan), Yu Suzuki (Kokura Kinen Hospital, Fukuoka, Japan), Ikuko Shimabukuro (Wakamatsu Hospital, Fukuoka, Japan), Tomoko Shiraishi (University of Occupational and Environmental Health, Japan, Fukuoka, Japan), Kanako Hara (Kyushu Rosai Hospital, Fukuoka, Japan), Chiyo Ito (University of Occupational and Environmental Health, Japan, Fukuoka, Japan), Masanori Isa (University of Occupational and Environmental Health, Japan, Fukuoka, Japan), Kaori Kato (University of Occupational and Environmental Health, Japan, Fukuoka, Japan), Takashi Tachiwada (University of Occupational and Environmental Health, Japan, Fukuoka, Japan), Tetsuya Hanaka (University of Occupational and Environmental Health, Japan, Fukuoka, Japan), Tsutomu Takaki (University of Occupational and Environmental Health, Japan, Fukuoka, Japan), Keigo Uchimura (University of Occupational and Environmental Health, Japan, Fukuoka, Japan), Yousuke Sasahara (University of Occupational and Environmental Health, Japan, Fukuoka, Japan), Takanobu Johtatsu (University of Occupational and Environmental Health, Japan, Fukuoka, Japan), Ryosuke Hata (University of Occupational and Environmental Health, Japan, Fukuoka, Japan), Chisato Miyoshi (University of Occupational and Environmental Health, Japan, Fukuoka, Japan), Yasuhiro Kimura (University of Occupational and Environmental Health, Japan, Fukuoka, Japan), Ryo Torii (University of Occupational and Environmental Health, Japan, Fukuoka, Japan), Masahiro Tahara (University of Occupational and Environmental Health, Japan, Fukuoka, Japan), Kazuki Sakagami (University of Occupational and Environmental Health, Japan, Fukuoka, Japan), Hiroaki Ikegami (University of Occupational and Environmental Health, Japan, Fukuoka, Japan), Yoko Fukuda (University of Occupational and Environmental Health, Japan, Fukuoka, Japan) and Kazuhiro Uyama (University of Occupational and Environmental Health, Japan, Fukuoka, Japan) for collecting the samples, and Ms Yoshiko Yamazaki (University of Occupational and Environmental Health, Japan, Fukuoka, Japan) and Kumiko Matsuyama (University of Occupational and Environmental Health, Japan, Fukuoka, Japan) for their technical assistance. This study was partially supported by a High Altitude Research Grant from the University of Occupational and Environmental Health, Japan, Ministry of Education, Science, Sports and Culture Grant-in-Aid for Scientific Research (C), 23591173 (2011), and Ministry of Education, Science, Sports and Culture Grant-in-Aid for Young Scientists (B), 24790828 (2012).	Takaishi H, 2008, INT J MED MICROBIOL, V298, P463, DOI 10.1016/j.ijmm.2007.07.016; Sze MA, 2012, AM J RESP CRIT CARE, V185, P1073, DOI 10.1164/rccm.201111-2075OC; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; KOLENBRANDER PE, 1993, J BACTERIOL, V175, P3247; Judge EP, 2006, CHEST, V130, P1424, DOI 10.1378/chest.130.5.1424; Ohkusa T, 2003, GUT, V52, P79, DOI 10.1136/gut.52.1.79; Harris JK, 2007, P NATL ACAD SCI USA, V104, P20529, DOI 10.1073/pnas.0709804104; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; Han MK, 2012, THORAX, V67, P456, DOI 10.1136/thoraxjnl-2011-201183; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; van Ingen J, 2009, THORAX, V64, P502, DOI 10.1136/thx.2008.110957; Kawanami T, 2011, CHEST, V139, P600, DOI 10.1378/chest.10-0460; Huang YJ, 2010, OMICS, V14, P9, DOI 10.1089/omi.2009.0100; Garzoni C, 2013, THORAX, V68, P1150, DOI 10.1136/thoraxjnl-2012-202917; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; Koh WJ, 2005, RADIOLOGY, V235, P282, DOI 10.1148/radiol.2351040371; Kawanami T, 2011, TOHOKU J EXP MED, V225, P65, DOI 10.1620/tjem.225.65; Harris KA, 2003, J MED MICROBIOL, V52, P685, DOI 10.1099/jmm.0.05213-0; BHALLA M, 1991, RADIOLOGY, V179, P783; Bousbia S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032486; Gudbjartsson T, 2012, RESPIRATION, V84, P80, DOI 10.1159/000336238; Hauser PM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090934; Kim TS, 2005, AM J ROENTGENOL, V184, P1247; McEvoy S, 2012, EUR RADIOL, V22, P2736, DOI 10.1007/s00330-012-2558-3; Price KE, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-27; Quinn RA, 2014, MBIO, V5, DOI 10.1128/mBio.00956-13; Yamasaki K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063103	27	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	JUL	2015	20	5					758	765		10.1111/resp.12536		8	Respiratory System	Respiratory System	CK6XH	WOS:000356371600012		
J	Hasegawa, K; Sato, S; Tanimura, K; Fuseya, Y; Uemasu, K; Sato, A; Hirai, T; Mishima, M; Muro, S				Hasegawa, Koichi; Sato, Susumu; Tanimura, Kazuya; Fuseya, Yoshinori; Uemasu, Kiyoshi; Sato, Atsuyasu; Hirai, Toyohiro; Mishima, Michiaki; Muro, Shigeo			Emphysema and airway disease affect within-breath changes in respiratory resistance in COPD patients	RESPIROLOGY			English	Article						airway disease; chronic obstructive pulmonary disease; emphysema; respiratory resistance; within-breath analysis	OBSTRUCTIVE PULMONARY-DISEASE; FORCED OSCILLATION TECHNIQUE; DEEP INSPIRATION; INPUT IMPEDANCE; LUNG-INFLATION; CT-SCAN; ASSOCIATION; DIMENSIONS; MECHANICS; ASTHMA	Background and objectiveChronic obstructive pulmonary disease (COPD) is characterized by a mixture of emphysema and airway disease. The forced oscillation technique (FOT) has been applied to COPD patients to clarify changes in respiratory mechanics; dynamic changes in respiratory resistance (Rrs) during breathing (within-breath changes in Rrs, Rrs) are characteristic of COPD. However, the pathophysiological significance of these changes is unknown. The aim of this study was to assess how emphysema and airway disease influence Rrs in COPD patients. MethodsIn this cross-sectional study, stable COPD patients were recruited and underwent respiratory impedance measurements with a commercially available FOT device. Rrs was recorded during tidal breathing and then analyzed as whole-breath Rrs (Rrs at 5Hz, R5; Rrs at 20Hz, R20; and their difference, R5-R20) or as Rrs, the difference between the expiratory and inspiratory Rrs (R5, R20 and R5-R20). The percentage of the low attenuation area (LAA%) and airway wall area (WA%) was quantified by computed tomography analysis, and their contributions to Rrs were examined. ResultsSeventy-five COPD patients were recruited. LAA% was negatively correlated with R5 and R5-R20 (P=0.0002 and P=0.0033, respectively); meanwhile, WA% in B-10 was positively correlated with R5 and R5-R20 (P=0.0057 and P<0.0001, respectively). Multivariate analysis revealed that the contribution of both LAA% and WA% in B-10 to Rrs was independent of the severity of airflow limitations. ConclusionThis study shows that emphysema suppresses Rrs in COPD patients, while airway disease increases Rrs in these patients. Within-breath changes in respiratory resistance (Rrs) measured with the forced oscillation technique are characteristic findings in COPD. However, the pathophysiological significance of these changes is unknown. Using quantitative computed tomography analysis, we revealed that emphysema suppressed Rrs, while airway disease increases Rrs.	[Hasegawa, Koichi; Sato, Susumu; Tanimura, Kazuya; Fuseya, Yoshinori; Uemasu, Kiyoshi; Sato, Atsuyasu; Hirai, Toyohiro; Mishima, Michiaki; Muro, Shigeo] Kyoto Univ, Grad Sch Med, Dept Resp Med, Kyoto, Japan	Sato, S (reprint author), Kyoto Univ, Grad Sch Med, Dept Resp Med, Sakyo Ku, Kawahara 54, Shogoin, Kyoto 6068507, Japan.	ssato@kuhp.kyoto-u.ac.jp		Sato, Atsuyasu/0000-0001-8068-9984			Oostveen E, 2003, EUR RESPIR J, V22, P1026, DOI 10.1183/09031936.03.00089403; HANTOS Z, 1992, J APPL PHYSIOL, V72, P168; Nakano Y, 2000, AM J RESP CRIT CARE, V162, P1102; Di Mango AMGT, 2006, RESP MED, V100, P399, DOI 10.1016/j.rmed.2005.07.005; Ogawa E, 2009, THORAX, V64, P20, DOI 10.1136/thx.2008.097543; DUBOIS AB, 1956, J APPL PHYSIOL, V8, P587; Paredi P, 2010, THORAX, V65, P263, DOI 10.1136/thx.2009.120790; Mishima M, 1999, P NATL ACAD SCI USA, V96, P8829, DOI 10.1073/pnas.96.16.8829; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Baldi S, 2010, J APPL PHYSIOL, V109, P1019, DOI 10.1152/japplphysiol.00147.2010; CAUBERGHS M, 1992, J APPL PHYSIOL, V73, P2355; Crim C, 2011, RESP MED, V105, P1069, DOI 10.1016/j.rmed.2011.01.010; Diaz AA, 2012, CHEST, V141, P736, DOI 10.1378/chest.11-1026; Haruna A, 2010, CHEST, V138, P635, DOI 10.1378/chest.09-2836; Kurosawa H, 2004, NEW ENGL J MED, V350, P1036, DOI 10.1056/NEJMicm030626; Ohara T, 2006, RESPIROLOGY, V11, P579, DOI 10.1111/j.1400-1843.2006.00899.x; Ohishi J, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000184; Scichilone N, 2004, CHEST, V125, P2029, DOI 10.1378/chest.125.6.2029; Scichilone N, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-55; Tanabe N, 2011, AM J RESP CRIT CARE, V183, P1653, DOI 10.1164/rccm.201009-1535OC; Yamauchi Y, 2012, INT J CHRONIC OBSTR, V7, P259, DOI 10.2147/COPD.S30399; ZERAH F, 1995, CHEST, V108, P41, DOI 10.1378/chest.108.1.41	22	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	JUL	2015	20	5					775	781		10.1111/resp.12535		7	Respiratory System	Respiratory System	CK6XH	WOS:000356371600014		
J	Tanabe, N; Taniguchi, H; Tsujino, I; Sakamaki, F; Emoto, N; Kimura, H; Takamura, K; Hanaoka, M; Nishimura, M; Tatsumi, K				Tanabe, Nobuhiro; Taniguchi, Hiroyuki; Tsujino, Ichizo; Sakamaki, Fumio; Emoto, Noriaki; Kimura, Hiroshi; Takamura, Kei; Hanaoka, Masayuki; Nishimura, Masaharu; Tatsumi, Koichiro		JRS Lung Dis PH Study Grp	Multi-institutional retrospective cohort study of patients with severe pulmonary hypertension associated with respiratory diseases	RESPIROLOGY			English	Article						chronic obstructive pulmonary disease; clinical respiratory medicine; nitric oxide; pulmonary circulation and pulmonary hypertension; pulmonary fibrosis	VENTRICULAR DIASTOLIC DYSFUNCTION; INTERSTITIAL LUNG-DISEASE; CONTROLLED-TRIAL; ASPIRE REGISTRY; FIBROSIS; SILDENAFIL; COPD; EMPHYSEMA; SPECTRUM	Background and objectivePulmonary hypertension (PH) is often associated with respiratory diseases, but only a small number of patients present with severe PH defined as mean pulmonary arterial pressure35mmHg. We here conducted a multicenter, retrospective study of patients with severe PH associated with respiratory diseases (R-PH) to reveal their demographics, treatment, prognosis and determinants of prognosis. MethodsFrom 101 patients with severe R-PH collected by postal survey at the first stage, 70 patients with four major diseases (chronic obstructive pulmonary disease (COPD), combined pulmonary fibrosis with emphysema (CPFE), interstitial pneumonia associated with connective tissue disease (CTD-IP), interstitial pneumonia (IP)) and normal pulmonary arterial wedge pressure were studied for clinical characteristics, treatment and prognosis. ResultsThree-year survival rates were 50% for COPD (n=18), 35.7% for IP (n=19) and 68.1% for CTD-IP (n=20), and the 2-year survival rate for CPFE (n=13) was only 22.6%. Eighty-onepercent of patients had been treated with pharmacotherapy specific for pulmonary arterial hypertension. Those patients who had received phosphodiesterase-5 inhibitors (PDE-5I) displayed significantly better survival from the date of diagnosis than those who had not (3-year survival: 61.8% vs 20.0% P<0.0001), especially in the IP, CTD-IP and CPFE groups. Multivariate analysis also revealed that treatment with PDE-5I was a positive prognostic factor. ConclusionsWe here demonstrated the dismal prognosis of patients with severe R-PH. The remarkably better survival in those patients who had received PDE-5I warrants and facilitates future prospective randomized studies in this particular population.	[Tanabe, Nobuhiro; Tatsumi, Koichiro] Chiba Univ, Grad Sch Med, Dept Respirol, Chiba 2608670, Japan; [Tanabe, Nobuhiro] Chiba Univ, Grad Sch Med, Dept Adv Med Pulm Hypertens, Chiba 2608670, Japan; [Taniguchi, Hiroyuki] Tosei Gen Hosp, Dept Resp Med & Allergy, Seto, Aichi, Japan; [Tsujino, Ichizo; Nishimura, Masaharu] Hokkaido Univ Hosp, Dept Med 1, Sapporo, Hokkaido 060, Japan; [Sakamaki, Fumio] Tokyo Saiseikai Cent Hosp, Dept Med, Tokyo, Japan; [Emoto, Noriaki] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Cardiovasc Med, Kobe, Hyogo 657, Japan; [Kimura, Hiroshi] Nara Med Univ, Dept Internal Med 2, Kashihara, Nara 634, Japan; [Takamura, Kei] Obihiro Kosei Gen Hosp, Dept Med 1, Obihiro, Hokkaido, Japan; [Hanaoka, Masayuki] Shinshu Univ, Sch Med, Dept Med 1, Matsumoto, Nagano 390, Japan	Tanabe, N (reprint author), Chiba Univ, Grad Sch Med, Dept Respirol, Chuou Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	ntanabe@faculty.chiba-u.jp			Pulmonary Circulation/Lung Injury Assembly of the Japanese Respiratory Society; Respiratory Failure Research Group of the Ministry of Health, Labour and Welfare of Japan	We thank all doctors of the JRS Lung Disease PH Study group listed in Appendix S2 for their contribution to this study. This study was partly supported by a grant from the Pulmonary Circulation/Lung Injury Assembly of the Japanese Respiratory Society and by a grant from the Respiratory Failure Research Group of the Ministry of Health, Labour and Welfare of Japan.	Blanco I, 2010, AM J RESP CRIT CARE, V181, P270, DOI 10.1164/rccm.200907-0988OC; Hurdman J, 2013, EUR RESPIR J, V41, P1292, DOI 10.1183/09031936.00079512; Cottin V, 2010, EUR RESPIR J, V35, P105, DOI 10.1183/09031936.00038709; Hinchcliff M, 2012, CLIN EXP RHEUMATOL, V30, pS30; Han MLK, 2013, CHEST, V143, P1699, DOI 10.1378/chest.12-1594; Stolz D, 2008, EUR RESPIR J, V32, P619, DOI 10.1183/09031936.00011308; Chaouat A, 2008, EUR RESPIR J, V32, P1371, DOI 10.1183/09031936.00015608; Hurdman J, 2012, EUR RESPIR J, V39, P945, DOI 10.1183/09031936.00078411; Scharf SM, 2002, AM J RESP CRIT CARE, V166, P314, DOI 10.1164/rccm.2107027; Mathai SC, 2009, ARTHRITIS RHEUM, V60, P569, DOI 10.1002/art.24267; Hoeper MM, 2011, INT J CARDIOL, V154, pS45, DOI 10.1016/S0167-5273(11)70492-2; Lopez-Sanchez M, 2013, PLOS ONE, V8, pe6803; Mittoo S, 2010, CAN RESPIR J, V17, P282; Galie N, 2009, EUR RESPIR J, V34, P1219, DOI 10.1183/09031936.00139009; Papadopoulos CE, 2008, EUR RESPIR J, V31, P701, DOI 10.1183/09031936.00102107; Seeger W, 2013, J AM COLL CARDIOL, V62, pD109, DOI 10.1016/j.jacc.2013.10.036; Simonneau G, 2013, J AM COLL CARDIOL, V62, pD34, DOI 10.1016/j.jacc.2013.10.029; Tanabe Nobuhiro, 2014, Respir Investig, V52, P167, DOI 10.1016/j.resinv.2013.11.003; Zisman DA, 2010, NEW ENGL J MED, V363, P620, DOI 10.1056/NEJMoa1002110	19	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	JUL	2015	20	5					805	812		10.1111/resp.12530		8	Respiratory System	Respiratory System	CK6XH	WOS:000356371600018		
J	Suzuki, J; Tsukada, N; Goto, A				Suzuki, Jun; Tsukada, Naotoshi; Goto, Akira			Role of Public Research Institutes in Japan's National Innovation System: Case Study of AIST, RIKEN and JAXA	SCIENCE TECHNOLOGY AND SOCIETY			English	Article							ABSORPTIVE-CAPACITY; POLICY; PARTNERSHIPS; CONSORTIA; ALLIANCES; INDUSTRY	Among the actors in the National Innovation System, Public Research Institutes (PRIs) are probably the least studied. Historically, PRIs played an important role in conducting research related to the Japanese government's missions in defence, space exploration, health care, agriculture and industrial technology. PRIs that aimed to help industry played a significant role during the catch-up period before and after the second World War. However, throughout the 1970s and 1980s, as Japanese firms acquired new technological capabilities and crossed technological frontiers with increasing financial resources, the firms' reliance on PRIs as a source of advanced technology decreased. At present, discussions are underway regarding the role and rationale of PRIs in Japan's innovation system. In this article, we focus on three large PRIs in JapanAIST, RIKEN and JAXAand investigate their role in helping Japan's industry by examining their patents. We briefly describe their background and history of development, which clarifies their distinctive role in Japan's innovation systems. We use four measures drawn from patent data (technological value, exclusionary value, expected market value and knowledge spillover) to describe PRI performance. The difference between the PRIs' patents and those of universities and firms, as well as the impact of the PRIs' research collaboration with the private sector is analysed. We found that each of the three PRIs has its own identity and is fulfilling its specific role. In addition, we pinpoint problems concerning universities' patenting activity. Finally, we discuss factors that might affect the research outcome.	[Suzuki, Jun; Tsukada, Naotoshi; Goto, Akira] Natl Grad Inst Policy Studies GRIPS, Minato Ku, Tokyo 1068677, Japan; [Goto, Akira] RIETI, Chiyoda Ku, Tokyo 1008901, Japan	Suzuki, J (reprint author), Natl Grad Inst Policy Studies GRIPS, Minato Ku, 7-22-1 Roppongi, Tokyo 1068677, Japan.	jsuzuki@grips.ac.jp					Hagedoorn J, 2000, RES POLICY, V29, P567, DOI 10.1016/S0048-7333(99)00090-6; Cassiman B, 2002, AM ECON REV, V92, P1169, DOI 10.1257/00028280260344704; Mowery DC, 1996, STRATEGIC MANAGE J, V17, P77; [Anonymous], 2013, BAS POL REF IND ADM; Hagedoorn J, 2002, RES POLICY, V31, P477, DOI 10.1016/S0048-7333(01)00120-2; Woolthuis RK, 2005, TECHNOVATION, V25, P609, DOI 10.1016/j.technovation.2003.11.002; Sakakibara M, 1997, RES POLICY, V26, P447, DOI 10.1016/S0048-7333(97)00018-8; Woolgar L, 2007, RES POLICY, V36, P1261, DOI 10.1016/j.respol.2007.04.010; Branstetter L, 1998, J IND ECON, V46, P207; Cockburn IM, 1998, J IND ECON, V46, P157; Arnold E, 2004, RES EVALUAT, V13, P3, DOI 10.3152/147154404781776509; [Anonymous], 2014, REC STRENGTH NAT RES; Arnold E., 1997, DEV FIRMS TECHNOLOGI; Baba Y., 2008, DOES U REFORM PROMOT; COHEN WM, 1990, ADMIN SCI QUART, V35, P128, DOI 10.2307/2393553; Hall B. H., 2001, 8498 NBER; Hiroshige T., 1973, J IND ECON; Kneller R., 2008, J INTELLECTUAL PROPE, V5, P36; Lerner J, 1998, J IND ECON, V46, P125; MEXT, 2003, HIGH ED SUPP KNOWL B; MEXT, 2010, MAIN FIND PAN NAT RE; Odagiri Hiroyuki, 1996, TECHNOLOGY IND DEV J; OECD, 2011, PUBL RES I MAPP SECT; Richards D., 1994, IND ECOLOGY US JAPAN; RIKEN, 2013, RIKEN ANN REP 2012 2; RIKEN, 2005, RIKEN SPIR 88 YEARS; Rush Howard, 1996, TECHNOLOGY I STRATEG; Siegel Donald, 2002, P NSF WORKSH; Sutton George Paul, 2005, HIST LIQUID PROPELLA	29	0	0	SAGE PUBLICATIONS INDIA  PVT LTD	NEW DELHI	B-1-I-1 MOHAN CO-OPERATIVE INDUSTRIAL AREA, MATHURA RD, POST BAG NO 7, NEW DELHI 110 044, INDIA	0971-7218	0973-0796		SCI TECHNOL SOC	Sci. Technol. Soc.	JUL	2015	20	2					133	160		10.1177/0971721815579793		28	Management	Business & Economics	CL0KE	WOS:000356630800001		
J	Sutthijakra, S; Intarakumnerd, P				Sutthijakra, S.; Intarakumnerd, P.			Role and Capabilities of Intermediaries in University-Industry Linkages: A Case of Hard Disk Drive Industry in Thailand	SCIENCE TECHNOLOGY AND SOCIETY			English	Article							INNOVATION INTERMEDIATION; TECHNOLOGY; ORGANIZATIONS; COMMUNITY; SYSTEMS	The intermediaries are important organisations in mitigating systemic failures. Few of such failures are those of university-industry linkages (UILs). Although there are several previous studies, they did not pay adequate attention on how these intermediaries accumulate their capabilities that are necessary to perform their roles over time. This study will try to partially fill in such gap by investigating capabilities-building processes of intermediaries. The intermediaries in Hard Disk Drive (HDD) industry in Thailand was selected as a case study. Qualitative data was collected from 20 semi-structured and in-depth interviews of intermediaries' management, university researchers and industrial companies in the intermediaries' networks. The findings show that the intermediaries play consulting, brokering, mediating and resources providing roles. They assist to increase levels of interactions between university and industry, transform informal to formal relationships and nurture potential human resources for the industry. However, performing such activities depends on the intermediaries' capabilities. Four key capabilities encompass network capabilities, coordination capabilities, knowledge-building capabilities and management capabilities. Underneath them, strategic capabilities, depending on leadership, engender the intermediaries' visions and strategies. Human resources development is stimulated through individual and collective learning. These four capabilities are embedded into the existing organisational systems by using mentoring and on-the-job training for newcomers, building up the database system and arranging meetings for knowledge sharing on a regular basis. However, discontinuity of government supports leads to a decrease in network members, transformation of formal relationships back to informal ones and the close down of intermediary.	[Sutthijakra, S.] Dhurakij Pundit Univ, Fac Business Adm, Dept Management, Bangkok, Thailand; [Intarakumnerd, P.] Natl Grad Inst Policy Studies GRIPS, Tokyo, Japan	Sutthijakra, S (reprint author), Dhurakij Pundit Univ, Fac Business Adm, Dept Management, Bangkok, Thailand.	sawitree.sut@dpu.ac.th					Zollo M, 2002, ORGAN SCI, V13, P339, DOI 10.1287/orsc.13.3.339.2780; Howells J, 2006, RES POLICY, V35, P715, DOI 10.1016/j.respol.2006.03.005; Adler PS, 2002, ACAD MANAGE REV, V27, P17, DOI 10.2307/4134367; Westphal JD, 2001, STRATEGIC MANAGE J, V22, P1113, DOI 10.1002/smj.205; Boon WPC, 2008, TECHNOL FORECAST SOC, V75, P644, DOI 10.1016/j.techfore.2007.03.001; Perkmann M, 2007, INT J MANAG REV, V9, P259, DOI 10.1111/j.1468-2370.2007.00225.x; Owen-Smith J, 2004, ORGAN SCI, V15, P5, DOI 10.1287/orsc.1030.0054; Klerkx L, 2008, TECHNOVATION, V28, P364, DOI 10.1016/j.technovation.2007.05.005; Agrawal A, 2001, INT J MANAG REV, V3, P285, DOI 10.1111/1468-2370.00069; BESSANT J, 1995, RES POLICY, V24, P97, DOI 10.1016/0048-7333(93)00751-E; Lynn LH, 1996, RES POLICY, V25, P91, DOI 10.1016/0048-7333(94)00817-5; Malerba F, 2002, RES POLICY, V31, P247, DOI 10.1016/S0048-7333(01)00139-1; Carlsson B, 2002, RES POLICY, V31, P233, DOI 10.1016/S0048-7333(01)00138-X; Blomqvist K., 2006, International Journal of Management Concepts and Philosophy, V2; BOI, 2012, THAILAND INVESTMENT, V22; Callon M., 1994, TECHNOLOGY JUMAN VAL, V19, P395; COHEN WM, 1990, ADMIN SCI QUART, V35, P128, DOI 10.2307/2393553; Dodgson M., 1996, EFFECTIVE INNOVATION; Doner RF, 2013, SCI TECHNOL SOC, V18, P213, DOI 10.1177/0971721813489454; Hoppe H., 2005, 4891 CEPR, V4891, P1; Intarakumnerd P., 2010, 8 TRIPL HEL INT C U; Intarakumnerd P, 2011, ASIA PAC BUS REV, V17, P241, DOI 10.1080/13602381.2011.533504; Intarakumnerd Patarapong, 2009, Seoul Journal of Economics, V22, P551; Kolodny H, 2001, RES POLICY, V30, P201, DOI 10.1016/S0048-7333(99)00119-5; Nonaka I., 1995, KNOWLEDGE CREATING C; Partners H., 2007, STUDY ROLE INTERMEDI; Sander E., 2013, ERC BEST PRACTICES M; SCHOEMAKER PJH, 1992, SLOAN MANAGE REV, V34, P67; Sieg JH, 2010, R&D MANAGE, V40, P281, DOI 10.1111/j.1467-9310.2010.00596.x; Spencer JW, 2001, ACAD MANAGE J, V44, P432, DOI 10.2307/3069465; Stewart J., 2008, INT J INNOVATION MAN, V12, P295, DOI DOI 10.1142/S1363919608002035; Tran Y, 2011, R&D MANAGE, V41, P80, DOI 10.1111/j.1467-9310.2010.00628.x; Ye J., 2013, IIM BANGALORE MANAGE, V25, P69	33	0	0	SAGE PUBLICATIONS INDIA  PVT LTD	NEW DELHI	B-1-I-1 MOHAN CO-OPERATIVE INDUSTRIAL AREA, MATHURA RD, POST BAG NO 7, NEW DELHI 110 044, INDIA	0971-7218	0973-0796		SCI TECHNOL SOC	Sci. Technol. Soc.	JUL	2015	20	2					182	203		10.1177/0971721815579796		22	Management	Business & Economics	CL0KE	WOS:000356630800003		
J	Okazaki, H; Kwak, Y; Tamura, T				Okazaki, Hiroko; Kwak, Youngjoo; Tamura, Toru			Depositional and erosional architectures of gravelly braid bar formed by a flood in the Abe River, central Japan, inferred from a three-dimensional ground-penetrating radar analysis	SEDIMENTARY GEOLOGY			English	Article						Gravelly braid bars; GPR; Flood deposits; High sediment discharge; Japan	SOUTH SASKATCHEWAN RIVER; ALLUVIAL ARCHITECTURE; BRITISH-COLUMBIA; SEDIMENTARY ARCHITECTURE; BURDEKIN RIVER; JAMUNA RIVER; BED RIVERS; EVOLUTION; CANADA; FACIES	We conducted a ground-penetrating radar (GPR) survey of gravelly braid bars in the Abe River, central Japan, to clarify the three-dimensional (3D) variations in their depositional facies under various geomorphologic conditions. In September 2011, a ten-year return-period flood in the study area reworked and deposited braid bars. After the flood, we surveyed three bars with different geomorphologies using a GPR system with a 250-MHz antenna and identified seven fundamental radar depositional facies: Inclined reflections (fades Ia and Ib), horizontal to subhorizontal reflections (facies IIa and IIb), discontinuous reflections (facies IIIa and IIIb), and fades assemblage with a large-scale channel-shaped lower boundary (facies IV). Combinations of these fades in dicate bar formation processes: channel filling, lateral aggradation, and lateral and downstream accretion. In the Abe River, aerial photographs and airborne laser scanning data were obtained before and after the flood. The observed changes of the surface topography are consistent with the subsurface results seen in the GPR sections. This study demonstrated that the erosional and depositional architecture observed among bars with different channel styles was related to river width and represented depositional processes for high-sediment discharge. The quantitative characterizations of the sedimentary architecture will be useful for interpreting gravelly fluvial deposits in the rock record. (C) 2015 Elsevier B.V. All rights reserved.	[Okazaki, Hiroko] Nat Hist Museum & Inst, Dept Earth Sci, Chiba, Chiba 2608682, Japan; [Kwak, Youngjoo] UNESCO, Int Ctr Water Hazard & Risk Management, Publ Works Res Inst, Tsukuba, Ibaraki 3058516, Japan; [Tamura, Toru] Geol Survey Japan, AIST, Tsukuba, Ibaraki 3058567, Japan	Okazaki, H (reprint author), Nat Hist Museum & Inst, Dept Earth Sci, Chiba, Chiba 2608682, Japan.	kohiroko@chiba-muse.or.jp			JSPS KAKENHI [23540538]	We appreciate Shizuoka Office MLIT for giving topographical and hydrological data of the Abe River. JSPS KAKENHI Grant Number 23540538 supported this work. We thank Dr. Hiroshi Ikeda for helpful comments. Two anonymous reviewers and the Chief Editor, Jasper Knight, are thanked for thoughtful comments.	Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Peakall J, 2007, J SEDIMENT RES, V77, P197, DOI 10.2110/jsr.2007.017; Smith GHS, 2010, GEOLOGY, V38, P579, DOI 10.1130/G30861.1; Parker NO, 2013, SEDIMENTOLOGY, V60, P820, DOI 10.1111/j.1365-3091.2012.01364.x; Horn JD, 2012, J SEDIMENT RES, V82, P72, DOI 10.2110/jsr.2012.9; Fielding CR, 2006, SEDIMENT GEOL, V190, P227, DOI 10.1016/j.sedgeo.2006.05.009; Smith GHS, 2009, J SEDIMENT RES, V79, P629, DOI 10.2110/jsr.2009.066; SMITH ND, 1974, J GEOL, V82, P205; MIALL AD, 1985, EARTH-SCI REV, V22, P261, DOI 10.1016/0012-8252(85)90001-7; PARKER G, 1976, J FLUID MECH, V76, P457, DOI 10.1017/S0022112076000748; Rice SP, 2009, SEDIMENTOLOGY, V56, P709, DOI 10.1111/j.1365-3091.2008.00994.x; BRIDGE JS, 1995, SEDIMENTOLOGY, V42, P839, DOI 10.1111/j.1365-3091.1995.tb00413.x; Best JL, 2003, J SEDIMENT RES, V73, P516, DOI 10.1306/010603730516; Lunt IA, 2004, SEDIMENTOLOGY, V51, P377, DOI 10.1111/j.1365-3091.2004.00627.x; Alexander J, 1997, SEDIMENTOLOGY, V44, P327, DOI 10.1111/j.1365-3091.1997.tb01527.x; Dean DJ, 2013, GEOMORPHOLOGY, V201, P183, DOI 10.1016/j.geomorph.2013.06.020; Kostic B, 2007, SEDIMENTOLOGY, V54, P789, DOI 10.1111/j.1365-3091.2007.00860.x; Bristow CS, 1999, SEDIMENTOLOGY, V46, P1029; Bersezio R, 2007, SEDIMENT GEOL, V202, P230, DOI 10.1016/j.sedgeo.2007.05.002; Bristow C, 1996, SEDIMENTOLOGY, V43, P995, DOI 10.1111/j.1365-3091.1996.tb01515.x; FREDSOE J, 1978, J FLUID MECH, V84, P609, DOI 10.1017/S0022112078000373; Bristow CS, 2006, SEDIMENTOLOGY, V53, P769, DOI 10.1111/j.1365-3091.2006.00792.x; Fisher JA, 2007, SEDIMENT GEOL, V195, P55, DOI 10.1016/j.sedgeo.2006.07.005; Ashworth PJ, 2011, SEDIMENTOLOGY, V58, P1860, DOI 10.1111/j.1365-3091.2011.01242.x; CANT DJ, 1978, SEDIMENTOLOGY, V25, P625, DOI 10.1111/j.1365-3091.1978.tb00323.x; Ashworth PJ, 2000, SEDIMENTOLOGY, V47, P533, DOI 10.1046/j.1365-3091.2000.00305.x; ASHMORE PE, 1991, CAN J EARTH SCI, V28, P326, DOI 10.1139/e91-030; BANKS NL, 1973, J SEDIMENT PETROL, V43, P423; Best J. L., 2007, LARGE RIVERS GEOMORP, P395, DOI 10.1002/9780470723722.ch19; Blodgett K. H, 1980, J SEDIMENT PETROL, V50, P139; Bridge J.S, 2003, RIVERS FLOODPLAINS; Bridge JS, 1993, GEOLOGICAL SOC LONDO, V75, P13, DOI DOI 10.1144/GSL.SP.1993.075.01.02; Bristow C.S., 1987, SEPM SPECIAL PUBLICA, V39, P63; Carling PA, 1999, J SEDIMENT RES, V69, P534; Church M., 1983, INT ASS SEDIMENTOLOG, V6, P169; Collinson J. D., 1996, SEDIMENTARY ENV PROC, P37; CROWLEY KD, 1983, GEOL SOC AM BULL, V94, P117, DOI 10.1130/0016-7606(1983)94<117:LBCMPR>2.0.CO;2; Fielding CR, 1999, INT AS SED, V28, P347, DOI 10.1002/9781444304213.ch25; Franke D, 2015, SEDIMENTOLOGY, V62, P57, DOI 10.1111/sed.12139; Hickin AS, 2009, J SEDIMENT RES, V79, P457, DOI 10.2110/jsr.2009.044; Ikeda H., 1983, 2 U TSUK ENV RES CTR; ISEYA F, 1987, GEOGR ANN A, V69, P15, DOI 10.2307/521363; van de Lageweg WI, 2013, J SEDIMENT RES, V83, P1033, DOI 10.2110/jsr.2013.70; LEWIN J, 1976, GEOL SOC AM BULL, V87, P281, DOI 10.1130/0016-7606(1976)87<281:IOBFAM>2.0.CO;2; Miall A.D., 1996, GEOLOGY FLUVIAL DEPO; Miall A.D., 1992, FACIES MODELS RESPON, P119; Mosher S.-J., 2002, INT ASS SEDIMENTOLOG, V32, P213; REYNOLDS J. M., 1997, INTRO APPL ENV GEOPH; Smith GHS, 2006, SEDIMENTOLOGY, V53, P413, DOI [10.1111/j.1365-3091.2005.000769.x, 10.1111/j.1365-3091.2005.00769.x]; SCHUMM SA, 1972, GEOL SOC AM BULL, V83, P1755, DOI 10.1130/0016-7606(1972)83[1755:ESOCP]2.0.CO;2; Seminara G., 1989, WATER RESOUR MONOGR, V12, P267, DOI DOI 10.1029/WM012P0267; Shizuoka Office MLIT, 2012, SHIZ OFF MLIT ANN 2; Tamura T, 2010, QUATERNARY RES, V74, P227, DOI 10.1016/j.yqres.2010.07.009; Tamura T, 2011, GEOMORPHOLOGY, V132, P153, DOI 10.1016/j.geomorph.2011.05.005; Wooldridge CL, 2005, J SEDIMENT RES, V75, P844, DOI 10.2110/jsr.2005.066	55	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0037-0738	1879-0968		SEDIMENT GEOL	Sediment. Geol.	JUL 1	2015	324						32	46		10.1016/j.sedgeo.2015.04.008		15	Geology	Geology	CL1XA	WOS:000356737000003		
J	Yokozawa, H; Morita, T				Yokozawa, Hiroki; Morita, Takeshi			Wireguide driving actuator using resonant-type smooth impact drive mechanism	SENSORS AND ACTUATORS A-PHYSICAL			English	Article						Ultrasonic motor; Resonant-type smooth impact drive mechanism; R-SIDM; Wire-driving	ULTRASONIC MOTOR; SIDM ACTUATOR	This paper proposes a wireguide-driving piezoelectric actuator for narrow space driving such as in endoscopic devices. Conventional wireguide-driving actuators use torsional or bending vibration. We examined a resonant-type smooth impact drive mechanism (R-SIDM) utilizing longitudinal vibration as the driving principle. The longitudinal vibration is resistant to outside disturbances. Different to conventional smooth impact drive mechanism (SIDM) actuators, R-SIDM actuators use the resonant effect. The quasi-saw-shaped displacement is excited by combining two resonant vibrations with a frequency ratio of 1:2. This driving principle allows lower input voltage compared to that of the conventional SIDM. As the driving source, a step-shaped Langevin transducer was fabricated. With this step-shaped design, the longitudinal resonant frequency ratio f(3)/f(1) could be adjusted to 2. At the tip of this transducer, an aluminum wireguide was attached to excite a quasi-saw-shaped vibration at the end tip. The length of the wireguide was designed to match the resonant frequencies of the transducer. It was confirmed that a bearing rotor (diameter: 10 mm) could be rotated. As we expected, a quasi-saw-shaped vibration was excited, and we could measure a non-loaded driving speed of 176 mm/s and a maximum load of 0.47 N for a 100 Vp-p input voltage and a 6.0 N preload. (C) 2015 Elsevier B.V. All rights reserved.	[Yokozawa, Hiroki; Morita, Takeshi] Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba 2778563, Japan	Yokozawa, H (reprint author), Univ Tokyo, Grad Sch Frontier Sci, 5-1-5 Kashiwanoha, Kashiwa, Chiba 2778563, Japan.	yokozawa@ems.k.u-tokyo.ac.jp	MORITA, Takeshi/E-8484-2010				Watson B, 2009, SENSOR ACTUAT A-PHYS, V152, P219, DOI 10.1016/j.sna.2009.04.001; Morita T, 2003, SENSOR ACTUAT A-PHYS, V103, P291, DOI 10.1016/S0924-4247(02)00405-3; Nishimura T, 2012, ULTRASONICS, V52, P75, DOI 10.1016/j.ultras.2011.06.013; Carotenuto R, 2000, APPL PHYS LETT, V77, P1905, DOI 10.1063/1.1310636; Friend J, 2004, JPN J APPL PHYS 1, V43, P3040, DOI 10.1143/JJAP.43.3040; Kurosawa M, 1997, INT J JPN S PREC ENG, V31, P87; Morita T, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.07HE05; Okamoto Yasuhiro, 2004, DEV SMOOTH IMPACT DR, V1, P23; Philip E., 2002, IEEE T ULTRASON FERR, V49; Tamura H., 2010, AUT M JPN AC SOC, P1233; Tanabe M, 2008, JPN J APPL PHYS, V47, P4262, DOI 10.1143/JJAP.47.4262; Tanabe M, 2007, JPN J APPL PHYS 1, V46, P4805, DOI 10.1143/JJAP.46.4805; Yokose T, 2014, SENSOR ACTUAT A-PHYS, V214, P142, DOI 10.1016/j.sna.2014.04.012	13	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0924-4247			SENSOR ACTUAT A-PHYS	Sens. Actuator A-Phys.	JUL 1	2015	230						40	44		10.1016/j.sna.2015.04.012		5	Engineering, Electrical & Electronic; Instruments & Instrumentation	Engineering; Instruments & Instrumentation	CL1YI	WOS:000356740400006		
J	Kikuchi, H; Kamata, S; Nakai, T; Hashi, S; Ishiyama, K				Kikuchi, Hiroaki; Kamata, Shingo; Nakai, Tomoo; Hashi, Shuichiro; Ishiyama, Kazushi			Influence of demagnetizing field on thin-film GMI magnetic sensor elements with uniaxial magnetic anisotropy	SENSORS AND ACTUATORS A-PHYSICAL			English	Article						Giant magnetoimpedance; Demagnetizing field; Uniaxial anisotropy; Impedance change; Sensitivity; Discontinuous jump	STEPPED GIANT MAGNETOIMPEDANCE; IMPEDANCE; RIBBON; DOMAIN; SHAPE	We investigated the dependence of demagnetizing effect on the giant magnetoimpedance (GMI) properties of elements fabricated using a thin film with uniaxial magnetic anisotropy. Using photolithography techniques, we fabricated two types of sensor elements. One type has a typical GMI configuration, i.e., the easy axis is parallel to the width of the sensor element, whereas the other type has an inclined easy axis. In sensors with a typical GMI configuration, the impedance changes and sensitivity at the edges of the elements are reduced relative to the middle sections, whereas the discontinuous impedance jump is substantially reduced or modified in sensors with inclined easy-axis GM! elements. This divergence in behavior can be explained by the differences in the distribution of demagnetizing fields within the respective element types. Because the demagnetizing field has an increased gradient of growth at the edge of an element, rotation or movement of the magnetization moment becomes increasingly modified. We confirmed the changes in the distribution of the demagnetizing field within the element using magnetic-field analysis and confirmed by domain observation that nonuniform magnetic domain movement occurs at the edge of the element. The change in the direction-to-gain ratio associated with higher element sensitivity is also discussed, and a method to effectively utilize the discontinuous jump is introduced. Only the central part of the element should be used to eliminate the influence due to the distribution of the demagnetizing field. (C) 2015 Elsevier B.V. All rights reserved.	[Kikuchi, Hiroaki; Kamata, Shingo] Iwate Univ, Fac Engn, Morioka, Iwate 0208551, Japan; [Nakai, Tomoo] Miyagi Prefectural Govt, Ind Technol Inst, Sendai, Miyagi 9813206, Japan; [Hashi, Shuichiro; Ishiyama, Kazushi] Tohoku Univ, Elect Commun Res Inst, Sendai, Miyagi 9808577, Japan	Kikuchi, H (reprint author), Iwate Univ, Fac Engn, 4-3-5 Ueda, Morioka, Iwate 0208551, Japan.	hkiku@iwate-u.ac.jp		Kikuchi, Hiroaki/0000-0003-3636-8627	Cooperative Research Project of the Research Institute of Electrical Communication, Tohoku University; Japan Society for the Promotion of Science [23656259, 25289119]	This work was supported in part by the Cooperative Research Project of the Research Institute of Electrical Communication, Tohoku University, and in part by the Grant-in-Aid for Challenging Exploratory Research, Grant No. 23656259, and for Scientific Research (B), Grant No. 25289119, from the Japan Society for the Promotion of Science.	Uchiyama T, 2012, IEEE T MAGN, V48, P3833, DOI 10.1109/TMAG.2012.2198627; MOHRI K, 1995, IEEE T MAGN, V31, P2455, DOI 10.1109/20.390157; Kraus L, 2003, SENSOR ACTUAT A-PHYS, V106, P187, DOI 10.1016/S0924-4247(03)00164-X; Kikuchi H, 2013, IEEE T MAGN, V49, P4044, DOI 10.1109/TMAG.2013.2243130; Chen DX, 1998, PHYS REV B, V57, P10699, DOI 10.1103/PhysRevB.57.10699; STONER EC, 1948, PHILOS TR R SOC S-A, V240, P599, DOI 10.1098/rsta.1948.0007; Yabukami S, 2009, J MAGN MAGN MATER, V321, P675, DOI 10.1016/j.jmmm.2008.11.083; Phan MH, 2008, PROG MATER SCI, V53, P323, DOI 10.1016/j.pmatsci.2007.05.003; Cai C. M., 2005, INTERMAG Asia 2005: Digest of the IEEE International Magnetics Conference (IEEE Cat. No.05CH37655), DOI 10.1109/INTMAG.2005.1463632; Chikazumi S., 1997, PHYS FERROMAGNETISM, P509; Garcia-Arribas A, 2013, EUR PHYS J B, V86, DOI 10.1140/epjb/e2013-30933-6; Jang KJ, 1999, IEEE T MAGN, V35, P3889; Kikuchi H, 2014, J APPL PHYS, V115, DOI 10.1063/1.4859095; Kikuchi H., 1997, J MAGN SOC JPN, V21, P789, DOI 10.3379/jmsjmag.21.789; Matsuo T, 2011, J APPL PHYS, V109, DOI 10.1063/1.3556923; Nakai T, 2005, J MAGN MAGN MATER, V290, P1355, DOI 10.1016/j.jmmm.2004.11.436; Nakai T, 2009, IEEE T MAGN, V45, P3499, DOI 10.1109/TMAG.2009.2022416; Ota K., 1973, JIKIKOUGAKU NO KISO, P41; Ozawa T., 2013, J MAGN SOC JPN, V37, P1; Pirota KR, 1999, PHYS REV B, V60, P6685, DOI 10.1103/PhysRevB.60.6685; TAKAHASHI N, 1989, IEEE T MAGN, V25, P4144, DOI 10.1109/20.42549; Valenzuela R., 1995, J APPL PHYS, V78, P189; Zhukova V, 2003, J APPL PHYS, V94, P1115, DOI 10.1063/1.1585113; Zhukova V., 2002, PHYS REV B, V65	24	1	1	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0924-4247			SENSOR ACTUAT A-PHYS	Sens. Actuator A-Phys.	JUL 1	2015	230						142	149		10.1016/j.sna.2015.04.027		8	Engineering, Electrical & Electronic; Instruments & Instrumentation	Engineering; Instruments & Instrumentation	CL1YI	WOS:000356740400018		
J	Ijima, Y; Miyazaki, N; Mizuno, H; Sakauchi, S				Ijima, Yusuke; Miyazaki, Noboru; Mizuno, Hideyuki; Sakauchi, Sumitaka			Statistical model training technique based on speaker clustering approach for HMM-based speech synthesis	SPEECH COMMUNICATION			English	Article						HMM-based speech synthesis; Average voice model; Speaker adaptation; Speaker clustering	SYNTHESIS SYSTEM; ADAPTATION; ALGORITHMS; SELECTION; FEATURES; HSMM	This paper proposes an average voice model training technique based on a speaker clustering approach to generate synthetic speech with enhanced similarity to the target speakers' speech. A novel point of the proposed technique is the use of the speaker characteristics (called "speaker class"), which are obtained from unsupervised clustering, as the additional contextual factor for the average voice based speech synthesis. In the model training process, first, speaker clustering is performed for all speakers used for model training to obtain the speaker class for each speaker. The average voice model with multiple speaker characteristics is trained by using the obtained speaker class. For the speaker adaptation and speech parameter generation, the speaker class of the target speaker is estimated on the basis of the Euclidean distance between the centroids of each cluster and the target speaker's feature. The use of the estimated speaker class makes it possible to utilize the model parameters that have speaker characteristics similar to those of the target speaker for speaker adaptation and speech parameter generation. The results of objective and subjective experiments indicated the proposed technique can synthesize speech with improved similarity and naturalness. (C) 2015 Elsevier B.V. All rights reserved.	[Ijima, Yusuke; Miyazaki, Noboru; Mizuno, Hideyuki; Sakauchi, Sumitaka] NTT Corp, NTT Media Intelligence Labs, Yokosuka, Kanagawa 2390847, Japan	Ijima, Y (reprint author), NTT Corp, NTT Media Intelligence Labs, 1-1 Hikari No Oka, Yokosuka, Kanagawa 2390847, Japan.						Adachi Y, 2008, INT CONF ACOUST SPEE, P4861; Amino K., 2006, WESPAC 9; Hunt AJ, 1996, INT CONF ACOUST SPEE, P373, DOI 10.1109/ICASSP.1996.541110; Yamagishi J, 2009, IEEE T AUDIO SPEECH, V17, P66, DOI 10.1109/TASL.2008.2006647; Tokuda K, 2000, INT CONF ACOUST SPEE, P1315, DOI 10.1109/ICASSP.2000.861820; Campbell WM, 2006, IEEE SIGNAL PROC LET, V13, P308, DOI 10.1109/LSP.2006.870086; Toda T, 2007, IEICE T INF SYST, VE90D, P816, DOI 10.1093/ietisy/e90-d.5.816; Zen H, 2007, IEICE T INF SYST, VE90D, P825, DOI 10.1093/ietisy/e90-d.5.825; Anastasakos T, 1996, ICSLP 96 - FOURTH INTERNATIONAL CONFERENCE ON SPOKEN LANGUAGE PROCESSING, PROCEEDINGS, VOLS 1-4, P1137; Kawahara H, 1999, SPEECH COMMUN, V27, P187, DOI 10.1016/S0167-6393(98)00085-5; Yu K, 2010, INT CONF ACOUST SPEE, P4238, DOI 10.1109/ICASSP.2010.5495690; Dall R., 2012, INTERSPEECH 2012; Higuchi N., 1995, EUR 95, P435; HUANG C, 2002, ACOUST SPEECH SIG PR, P609; Ijima Y, 2015, IEICE T INF SYST, VE98D, P157, DOI 10.1587/transinf.2014EDP7183; Ijima Y., 2013, 8 ISCA WORKSH SPEECH, P161; Koriyama T., 2011, INTERSPEECH 2011, P2657; LEGGETTER CJ, 1995, COMPUT SPEECH LANG, V9, P171, DOI 10.1006/csla.1995.0010; Maeno Y., 2011, INTERSPEECH 2011, P1849; Markus T., 2013, 8 ISCA WORKSH SPEECH, P103; Shinoda K., 1997, EUROSPEECH 97, P99; Tachibana M, 2006, IEICE T INF SYST, VE89D, P1092, DOI 10.1093/ietisy/e89-d.3.1092; Yamagishi I., 2003, IEICE T INF SYST, VE86-D, P534; Yamagishi J, 2007, IEICE T INF SYST, VE90D, P533, DOI 10.1093/ietisy/e90-d.2.533; Yamagishi J, 2010, 11TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2010 (INTERSPEECH 2010), VOLS 1-2, P418; Yamagishi J, 2009, IEEE T AUDIO SPEECH, V17, P1208, DOI 10.1109/TASL.2009.2016394; Yamagishi J, 2005, IEICE T INF SYST, VE88D, P502, DOI 10.1093/ietisy/e88-d.3.502; Yokomizo S, 2010, 11TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2010 (INTERSPEECH 2010), VOLS 1-2, P430; YOSHIZAWA S, 2001, ACOUST SPEECH SIG PR, P341	29	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-6393	1872-7182		SPEECH COMMUN	Speech Commun.	JUL	2015	71						50	61		10.1016/j.specom.2015.04.003		12	Acoustics; Computer Science, Interdisciplinary Applications	Acoustics; Computer Science	CK3PU	WOS:000356128800003		
J	Sato, S; Yagi, M; Machida, M; Yasuda, A; Konomi, T; Miyake, A; Fujiyoshi, K; Kaneko, S; Takemitsu, M; Machida, M; Yato, Y; Asazuma, T				Sato, Shunsuke; Yagi, Mitsuru; Machida, Masayoshi; Yasuda, Akimasa; Konomi, Tsunehiko; Miyake, Atsushi; Fujiyoshi, Kanehiro; Kaneko, Shinjiro; Takemitsu, Masakazu; Machida, Masafumi; Yato, Yoshiyuki; Asazuma, Takashi			Reoperation rate and risk factors of elective spinal surgery for degenerative spondylolisthesis: minimum 5-year follow-up	SPINE JOURNAL			English	Article						Degenerative lumbar spondylolisthesis; Adjacent segmental disease; Deep wound infection; Re-operation; Laminotomy; Complication	ADJACENT SEGMENT DEGENERATION; LUMBAR SPINE; BILATERAL LAMINOTOMY; DISC DEGENERATION; CLINICAL ARTICLE; FACET JOINT; STENOSIS; FUSION; DECOMPRESSION; OUTCOMES	BACKGROUND CONTEXT: The favorable outcome of surgical treatment for degenerative lumbar spondylolisthesis (DS) is widely recognized, but some patients require reoperation because of complications, such as pseudoarthrosis, persistent pain, infection, and progressive degenerative changes. Among these changes, adjacent segmental disease (ASD) and same segmental disease (SSD) are common reasons for reoperation. However, the relative risks of the various factors and their interactions are unclear. PURPOSE: The purpose of this study was to determine the longitudinal reoperation rate after surgery for DS and to assess the incidence and independent risk factors for ASD and SSD. STUDY DESIGN: This study is a retrospective consecutive case series of patients with DS who were surgically treated. PATIENT SAMPLE: We assessed 163 consecutive patients who were surgically treated for DS between 2003 and 2008. Individual patients were followed for at least 5 years after the initial surgery. OUTCOME MEASURES: The primary end point was any type of second lumbar surgery. Radiographic measurements and demographic data were reviewed. We compared patients who underwent reoperation with those who did not. Logistic regression analysis was used to determine the relative risk of ASD and SSD in patients surgically treated for DS. METHODS: Radiographic measurements and demographic data were reviewed. We identified the incidence and risk factors for reoperation, and we performed univariate and multivariate analyses to determine the independent risk factors for revision surgery for SSD and for ASD as the two distinct reasons for the reoperation. Age, gender, etiology, body mass index (BMI), and other radiographic data were analyzed to determine the risk factors for developing SSD and ASD. RESULTS: The average patient age was 65.8 (50-81 years; 73 women and 90 men; mean followup, 5.961.6 years). Eighty-nine patients had posterior lumbar interbody fusion and 74 had laminotomies. Twenty-two patients had L3-L4 involvement and 141 had L4-L5 involvement. The cumulative reoperation rate was 6.1% at 1 year, 8.5% at 2 years, 15.2% at 3 years, 17.7% at 5 years, and 23.3% (38/163 patients) at the final follow-up. A significantly higher reoperation rate was observed for patients undergoing laminotomy than for patients undergoing posterior lumbar interbody fusion (33.8% vs. 14.4%, p=.01). Eighteen patients (11.0%) had SSD, and 13 patients (8.9%) developed ASD. Higher BMI (obesity) and greater disc height (greater than 10 mm) predicted the occurrence of SSD in the multivariate model (BMI=odds ratio 4.11 [95% confidence interval 1.29-13.11], p=.016; disc height=3.18 [1.03-9.82], p=.044), and gender (male) and facet degeneration (Fujiwara grade greater than 3) predicted the development of ASD in the multivariate model (gender=4.74 [1.09-20.45], p=.037; facet degeneration=6.31 [1.09-36.52], p=.039). CONCLUSIONS: The incidence of reoperation in patients surgically treated for DS was 23.2% at a mean time of 5.9 years. A significantly higher incidence of reoperation was observed in patients treated with decompression alone compared with those treated with decompression and fusion. Body mass index and disc height were identified as independent risk factors for SSD, whereas male gender and facet degeneration were identified as independent risk factors for ASD. The results of this comprehensive review will guide spine surgeons in their preoperative planning and in the surgical management of patients with DS, thereby reducing the reoperation rate. (C) 2015 Elsevier Inc. All rights reserved.	[Sato, Shunsuke; Yagi, Mitsuru; Machida, Masayoshi; Yasuda, Akimasa; Konomi, Tsunehiko; Miyake, Atsushi; Fujiyoshi, Kanehiro; Kaneko, Shinjiro; Takemitsu, Masakazu; Machida, Masafumi; Yato, Yoshiyuki; Asazuma, Takashi] Natl Hosp Org Murayama Med Ctr, Dept Orthoped Surg, Tokyo 2080011, Japan	Yagi, M (reprint author), Natl Hosp Org Murayama Med Ctr, Dept Orthoped Surg, 2-37-1 Musashimur Ayama City Gakuen, Tokyo 2080011, Japan.	yagiman@gmail.com					Anandjiwala J, 2011, EUR SPINE J, V20, P1951, DOI 10.1007/s00586-011-1917-0; Martin BI, 2007, SPINE, V32, P2119, DOI 10.1097/BRS.0b013e318145a56a; Kim CH, 2013, SPINE J, V13, P1230, DOI 10.1016/j.spinee.2013.06.069; Kim BD, 2014, J NEUROSURG-SPINE, V20, P606, DOI 10.3171/2014.3.SPINE13699; Deyo RA, 2011, J BONE JOINT SURG AM, V93A, P1979, DOI 10.2106/JBJS.J.01292; Lee CS, 2009, EUR SPINE J, V18, P1637, DOI 10.1007/s00586-009-1060-3; BRIDWELL KH, 1993, J SPINAL DISORD, V6, P461; Fujiwara A, 2000, SPINE, V25, P3036, DOI 10.1097/00007632-200012010-00011; Martin BI, 2007, SPINE, V32, P382, DOI 10.1097/01.brs.0000254104.55716.46; Thome C, 2005, J NEUROSURG-SPINE, V3, P129, DOI 10.3171/spi.2005.3.2.0129; Ghogawala Z, 2004, J NEUROSURG-SPINE, V1, P267, DOI 10.3171/spi.2004.1.3.0267; Yagi M, 2009, J NEUROSURG-SPINE, V10, P293, DOI 10.3171/2009.1.SPINE08288; Blumenthal C, 2013, J NEUROSURG-SPINE, V18, P340, DOI 10.3171/2013.1.SPINE12537; Okuda S, 2004, SPINE, V29, P1535, DOI 10.1097/01.BRS.0000131417.93637.9D; Martin BI, 2012, SPINE J, V12, P89, DOI 10.1016/j.spinee.2011.11.010; Pearson A, 2010, SPINE, V35, P298, DOI 10.1097/BRS.0b013e3181bdafd1; Okuda S, 2008, SPINE, V33, P2754, DOI 10.1097/BRS.0b013e31817bb9c2; Weinstein JN, 2008, NEW ENGL J MED, V358, P794, DOI 10.1056/NEJMoa0707136; Lee JC, 2014, SPINE, V39, pE339, DOI 10.1097/BRS.0000000000000164; LOMBARDI JS, 1985, SPINE, V10, P821, DOI 10.1097/00007632-198511000-00008; Fujiwara A, 2001, CLIN ORTHOP RELAT R, P88; Mannion AF, 2014, SPINE, V39, P1373, DOI 10.1097/BRS.0000000000000437; Sidhu GS, 2014, CLIN ORTHOP RELAT R, V472, P1792, DOI 10.1007/s11999-014-3619-5; Soh Jaewan, 2013, Asian Spine J, V7, P273, DOI 10.4184/asj.2013.7.4.273; Yang SM, 2013, J KOREAN NEUROSURG S, V54, P194, DOI 10.3340/jkns.2013.54.3.194	25	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1529-9430	1878-1632		SPINE J	Spine Journal	JUL 1	2015	15	7					1536	1544		10.1016/j.spinee.2015.02.009		9	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CK6BY	WOS:000356314000007		
J	Kato, S; Hozumi, T; Yamakawa, K; Saito, M; Goto, T; Kondo, T				Kato, So; Hozumi, Takahiro; Yamakawa, Kiyofumi; Saito, Makoto; Goto, Takahiro; Kondo, Taiji			META: an MRI-based scoring system differentiating metastatic from osteoporotic vertebral fractures	SPINE JOURNAL			English	Article						Metastatic vertebral fracture; Osteoporotic vertebral fracture; Compression fracture; Magnetic resonance imaging; Differential diagnosis; Discriminant analysis	PATHOLOGICAL COMPRESSION FRACTURES; MAGNETIC-RESONANCE; DISCRIMINANT-ANALYSIS; MALIGNANT CAUSES; CHEMICAL-SHIFT; BENIGN; PREDICTION; COLLAPSE; SPINE; BODY	BACKGROUND CONTEXT: Magnetic resonance imaging (MRI) is useful for the differential diagnosis of osteoporotic vertebral fractures (OVFs) and metastatic vertebral fractures (MVFs), but no single finding is absolutely conclusive. PURPOSE: The purpose of the present study was to create a scoring system to facilitate the correct diagnosis of MVFs by integrating several MRI findings. STUDY DESIGN: This is a retrospective and single-center observational study that attempts to create a diagnostic scoring system by discriminant analysis. PATIENTS SAMPLE: We included 100 OVFs and 100 MVFs in thoracolumbar vertebrae of which MR images were obtained within 60 days from the suspected time of fractures. OUTCOME MEASURES: The sensitivity and specificity of known important MRI findings were assessed, and the classification accuracy of the scoring system was investigated. METHODS: Seven MRI findings of these fractures were analyzed to evaluate their sensitivity and specificity. Using these findings as variables, discriminant analysis was performed in 140 fractures as a training set, and the classification accuracy was calculated in the remaining 60 fractures as a test set. Additionally, the images of these 60 fractures were reviewed by another blinded reviewer to investigate the interobserver reliability of each finding. RESULTS: All findings had high specificity with low-to-moderate sensitivity. Eight variables were selected in the final discriminant function. A simpler scoring system (MRI Evaluation Totalizing Assessment [META]) was created by approximating the coefficients and the constant term by integral numbers. The classification accuracy was calculated to be 96.6% in the test set. The interobserver reliability of the key findings varied, but the final discrimination conducted by META had the high agreement between the two reviewers (k=0.93). CONCLUSIONS: This novel scoring system, META, could prove to be a useful tool for the differential diagnosis of OVFs and MVFs. It is simple and physician friendly, yet highly accurate. (C) 2015 Elsevier Inc. All rights reserved.	[Kato, So] Univ Tokyo, Grad Sch Med, Dept Orthopaed Surg Sensory & Motor Syst Med Surg, Bunkyo Ku, Tokyo 1138655, Japan; [Kato, So; Hozumi, Takahiro; Yamakawa, Kiyofumi; Goto, Takahiro; Kondo, Taiji] Tokyo Metropolitan Komagome Hosp, Dept Orthopaed Surg & Musculoskeletal Oncol, Bunkyo Ku, Tokyo 1138677, Japan; [Saito, Makoto] Tokyo Metropolitan Komagome Hosp, Div Clin Res Support, Bunkyo Ku, Tokyo 1138677, Japan	Kato, S (reprint author), Univ Tokyo, Grad Sch Med, Dept Orthopaed Surg Sensory & Motor Syst Med Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	skatou-tky@umin.org					Abdel-Wanis M E, 2011, J Orthop Surg (Hong Kong), V19, P145; AN HS, 1995, SPINE, V20, P1776, DOI 10.1097/00007632-199508150-00005; Ragab Y, 2009, EUR J RADIOL, V72, P125, DOI 10.1016/j.ejrad.2008.06.019; Spuentrup E, 2001, AM J ROENTGENOL, V176, P351; Baur A, 1998, RADIOLOGY, V207, P349; Dolphens M, 2014, EUR SPINE J, V23, P530, DOI 10.1007/s00586-013-3058-0; Seltzer SE, 1997, RADIOLOGY, V202, P219; Chan JHM, 2002, BRIT J RADIOL, V75, P207; Moulopoulos LA, 1996, JMRI-J MAGN RESON IM, V6, P667, DOI 10.1002/jmri.1880060416; Thawait SK, 2013, AM J ROENTGENOL, V200, P493, DOI 10.2214/AJR.11.7192; BAKER LL, 1990, RADIOLOGY, V174, P495; Baur A, 2001, AM J NEURORADIOL, V22, P366; Baur A, 2002, RADIOLOGY, V225, P730, DOI 10.1148/radiol.2253011413; Cuenod CA, 1996, RADIOLOGY, V199, P541; Fu Tsai-Sheng, 2004, Chang Gung Med J, V27, P808; Hozumi T, 2011, J SPINE RES, V2, P548; Jung Hee-Sun, 2003, Radiographics, V23, P179, DOI 10.1148/rg.231025043; Kondo T, 2010, SEIKEIGEKA, V61, P1435; LACHENBR.PA, 1968, TECHNOMETRICS, V10, P1, DOI 10.2307/1266219; Langlois RE, 2008, MACHINE LEARNING BIO; Lin SP, 2012, BRIT J ANAESTH, V108, P302, DOI 10.1093/bja/aer369; McLachlan GJ, 2012, WIRES COMPUTATIONAL, V4, P421, DOI DOI 10.1002/WICS.1219; Pongpornsup Sopa, 2009, Journal of the Medical Association of Thailand, V92, P64; RUPP RE, 1995, SPINE, V20, P2499, DOI 10.1097/00007632-199512000-00007; Shih TTF, 1999, JMRI-J MAGN RESON IM, V9, P635, DOI 10.1002/(SICI)1522-2586(199905)9:5<635::AID-JMRI4>3.0.CO;2-E; Soman K. P., 2006, DATA MINING THEORY P; Tan DYL, 2002, ANN ACAD MED SINGAP, V31, P8; Uetani M, 2004, CLIN RADIOL, V59, P124, DOI 10.1016/j.crad.2003.07.005; Van Toen C, 2015, EUR SPINE J, V24, P136, DOI 10.1007/s00586-014-3612-4; YUH WTC, 1989, RADIOLOGY, V172, P215; Yuzawa Y, 2005, J ORTHOP SCI, V10, P345, DOI 10.1007/s00776-005-0910-z	31	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1529-9430	1878-1632		SPINE J	Spine Journal	JUL 1	2015	15	7					1563	1570		10.1016/j.spinee.2015.03.011		8	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CK6BY	WOS:000356314000010		
J	Ohya, J; Chikuda, H; Kato, S; Hayakawa, K; Oka, H; Takeshita, K; Tanaka, S; Ogata, T				Ohya, Junichi; Chikuda, Hirotaka; Kato, So; Hayakawa, Kentaro; Oka, Hiroyuki; Takeshita, Katsushi; Tanaka, Sakae; Ogata, Toru			Elevated levels of phosphorylated neurofilament heavy subunit in the cerebrospinal fluid of patients with lumbar spinal stenosis: preliminary findings	SPINE JOURNAL			English	Article						Phosphorylated neurofilament heavy subunit; Cerebrospinal fluid; Lumbar spinal stenosis; Outcome; Diagnosis; Biomarker	NF-H; AXONAL INJURY; BIOMARKER; SYMPTOMS; PHOSPHOFORMS; PREDICTORS; SEVERITY; BLOOD	BACKGROUND CONTEXT: The phosphorylated neurofilament heavy subunit (pNfH) is an axon fiber structural protein that is released into the cerebrospinal fluid (CSF) after nerve damage. Although the previous studies have reported elevated CSF levels of pNfHin various neurological diseases, including amyotrophic lateral sclerosis, these levels have not been examined in patients with spinal stenosis. PURPOSE: The purpose of this study was to investigate the CSF levels of pNfH in patients with lumbar spinal stenosis (LSS) and to examine the relationship between CSF levels of pNfH and the severity of LSS. STUDY DESIGN: This is a prospective observational study. PATIENT SAMPLE: We included consecutive patients with LSS who were undergoingmyelography for preoperative evaluation. The CSF samples from patients with idiopathic scoliosis were used as the controls. OUTCOME MEASURES: Physiological measures: CSF levels of pNfH were measured using an enzyme- linked immunosorbent assay. The Zurich Claudication Questionnaire (ZCQ) and the Numerical Rating Scale (NRS) for sciatic pain were used to assess the clinical severity of LSS, and patients were grouped into tertiles according to their symptom severity and pain grading. Axial magnetic resonance imaging was used to evaluate the morphological severity of LSS, and patients were classified into three groups based on their morphological grading (using the CSF/rootlet ratio). METHODS: Analysis of variance was used to examine the relationship between the CSF levels of pNfH and the severity of LSS. RESULTS: Thirty- three patients with LSS were included (13 men and 20 women and mean age 73.2 [range 58- 88] years). Most patients (n=32) were positive for pNfH in their CSF (mean 1,344 [149- 9,250] pg/mL), whereas all control subjects were negative for pNfH in their CSF. Regarding the association with clinical severity, patients in the third tertiles of ZCQ and NRS tended to have higher levels of pNfH compared with the other groups. There was no association between the CSF level of pNfH and the morphological severity of LSS. CONCLUSIONS: This study detected elevated pNfH levels in the CSF of patients with LSS. Patients with severe clinical symptoms were more likely to exhibit high levels of pNfH. Our results indicate the potential usefulness of pNfH as a biomarker for compressive spinal disorders. (C) 2015 Elsevier Inc. All rights reserved.	[Ohya, Junichi; Chikuda, Hirotaka; Kato, So; Hayakawa, Kentaro; Oka, Hiroyuki; Takeshita, Katsushi; Tanaka, Sakae] Univ Tokyo, Dept Orthopaed Surg, Tokyo 1138655, Japan; [Ogata, Toru] Natl Rehabil Ctr Persons Disabil, Res Inst, Dept Rehabil Movement Funct, Tokorozawa, Saitama, Japan	Chikuda, H (reprint author), Univ Tokyo, Grad Sch Med, Dept Orthopaed Surg Sensory & Motor Syst Med Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	chikuda-tky@umin.ac.jp			Japanese Ministry of Health, Labor and Welfare [H24: Shintai/Chiteki 005]	The authors declare that they have no competing interests. This study was funded by a grant from the Japanese Ministry of Health, Labor and Welfare (No. H24: Shintai/Chiteki 005), which played no role in the design, data collection, analysis, decision to publish, or preparation of the manuscript.	Petzold A, 2005, J NEUROL SCI, V233, P183, DOI 10.1016/j.jns.2005.03.015; Haig AJ, 2007, J BONE JOINT SURG AM, V89A, P358, DOI 10.2106/JBJS.E.00704; KATZ JN, 1995, SPINE, V20, P1155, DOI 10.1097/00007632-199505150-00008; Katz JN, 1999, SPINE, V24, P2229, DOI 10.1097/00007632-199911010-00010; Shaw G, 2005, BIOCHEM BIOPH RES CO, V336, P1268, DOI 10.1016/j.bbrc.2005.08.252; Lohman CM, 2006, SPINE, V31, P1834, DOI 10.1097/01.brs.0000227370.65573.ac; Boylan KB, 2013, J NEUROL NEUROSUR PS, V84, P467, DOI 10.1136/jnnp-2012-303768; Sirvanci M, 2008, EUR SPINE J, V17, P679, DOI 10.1007/s00586-008-0646-5; Petzold A, 2003, J IMMUNOL METHODS, V278, P179, DOI 10.1016/S0022-1759(03)00189-3; Schizas C, 2010, SPINE, V35, P1919, DOI 10.1097/BRS.0b013e3181d359bd; Yang YR, 2008, CELL MOL NEUROBIOL, V28, P737, DOI 10.1007/s10571-007-9257-7; Lewis SB, 2008, J CEREBR BLOOD F MET, V28, P1261, DOI 10.1038/jcbfm.2008.12; Hara N, 2010, EUR SPINE J, V19, P1849, DOI [10.1007/s00586-010-1374-1, 10.1007/s00586.010.1374.1]; Hayakawa K, 2012, SPINAL CORD, V50, P493, DOI 10.1038/sc.2011.184; Aono H, 2007, SPINE, V32, pE262, DOI 10.1097/01.brs.0000259922.82413.72; GOLDSTEIN ME, 1987, J NEUROIMMUNOL, V14, P149, DOI 10.1016/0165-5728(87)90049-X; Herkowitz HN, 2006, ROTHMAN SIMEONE SPIN; Kuhle J, 2011, NEUROLOGY, V76, P1206, DOI 10.1212/WNL.0b013e31821432ff; STUCKI G, 1995, J CLIN EPIDEMIOL, V48, P1369, DOI 10.1016/0895-4356(95)00054-2; Zeifang Felix, 2008, BMC Musculoskelet Disord, V9, P89, DOI 10.1186/1471-2474-9-89	20	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1529-9430	1878-1632		SPINE J	Spine Journal	JUL 1	2015	15	7					1587	1592		10.1016/j.spinee.2015.03.013		6	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CK6BY	WOS:000356314000013		
J	McGetrick, PJ; Kim, CW; Gonzalez, A; Brien, EJO				McGetrick, Patrick J.; Kim, Chul-Woo; Gonzalez, Arturo; Brien, Eugene J. O.			Experimental validation of a drive-by stiffness identification method for bridge monitoring	STRUCTURAL HEALTH MONITORING-AN INTERNATIONAL JOURNAL			English	Article						Acceleration; bridge; drive-by; monitoring; stiffness; vehicle-bridge interaction	PASSING VEHICLE; DYNAMIC-RESPONSE; DAMAGE IDENTIFICATION; MOVING VEHICLE; MODEL; VIBRATION; VARIABILITY; FREQUENCIES; TEMPERATURE	An experimental investigation is carried out to verify the feasibility of using an instrumented vehicle to detect and monitor bridge dynamic parameters. The low-cost method consists of the use of a moving vehicle fitted with accelerometers on its axles. In the laboratory experiment, the vehicle-bridge interaction model consists of a scaled two-axle vehicle model crossing a simply supported steel beam. The bridge model also includes a scaled road surface profile. The effects of varying the vehicle model configuration and speed are investigated. A finite element beam model is calibrated using the experimental results, and a novel algorithm for the identification of global bridge stiffness is validated. Using measured vehicle accelerations as input to the algorithm, the beam stiffness is identified with a reasonable degree of accuracy.	[McGetrick, Patrick J.] Queens Univ Belfast, Sch Planning Architecture & Civil Engn, Belfast BT9 5AG, Antrim, North Ireland; [Kim, Chul-Woo] Kyoto Univ, Dept Civil & Earth Resources Engn, Kyoto, Japan; [Gonzalez, Arturo; Brien, Eugene J. O.] Univ Coll Dublin, Sch Civil Struct & Environm Engn, Dublin 2, Ireland	McGetrick, PJ (reprint author), Queens Univ Belfast, Sch Planning Architecture & Civil Engn, David Keir Bldg, Belfast BT9 5AG, Antrim, North Ireland.	p.mcgetrick@qub.ac.uk			Japanese Society for the Promotion of Science [24360178]; 7th European Framework ASSET (Advanced Safety and Driver Support in Efficient Road Transport) project	This research was supported by the Japanese Society for the Promotion of Science Postdoctoral Fellowship for North American and European Researchers (short term), the 7th European Framework ASSET (Advanced Safety and Driver Support in Efficient Road Transport) project and the Japanese Society for the Promotion of Science Grant-in-Aid for Scientific Research (B) (project no. 24360178).	Bu JQ, 2006, J ENG MECH-ASCE, V132, P1372, DOI 10.1061/(ASCE)0733-9399(2006)132:12(1372); Liu CY, 2007, J STRUCT ENG-ASCE, V133, P1742, DOI 10.1061/(ASCE)0733-9445(2007)133:12(1742); Kim CW, 2008, STRUCT INFRASTRUCT E, V4, P371, DOI 10.1080/15732470701270082; [Anonymous], 86081995 ISO; Deng L, 2010, ENG STRUCT, V32, P21, DOI 10.1016/j.engstruct.2009.08.013; Farrar CR, 2007, PHILOS T R SOC A, V365, P303, DOI 10.1098/rsta.2006.1928; Brownjohn JMW, 2001, FINITE ELEM ANAL DES, V37, P761, DOI 10.1016/S0168-874X(00)00071-8; Gonzalez A, 2012, J SOUND VIB, V331, P4115, DOI 10.1016/j.jsv.2012.04.019; Peeters B, 2001, EARTHQUAKE ENG STRUC, V30, P149, DOI 10.1002/1096-9845(200102)30:2<149::AID-EQE1>3.0.CO;2-Z; Lin CW, 2005, ENG STRUCT, V27, P1865, DOI 10.1016/j.engstruct.2005.06.016; Kim CW, 2005, COMPUT STRUCT, V83, P1627, DOI 10.1016/j.compstruc.2004.12.004; Sohn H, 2007, PHILOS T R SOC A, V365, P539, DOI 10.1098/rsta.2006.1935; Teughels A, 2004, J SOUND VIB, V278, P589, DOI 10.1016/j.jsv.2003.10.041; Yang YB, 2009, J SOUND VIB, V322, P718, DOI 10.1016/j.jsv.2008.11.028; Yang YB, 2005, J SOUND VIB, V284, P205, DOI 10.1016/j.jsv.2004.06.032; Yang YB, 2004, J SOUND VIB, V272, P471, DOI 10.1016/S0022-460X(03)00378-X; McGetrick PJ, 2009, INSIGHT, V51, P433, DOI 10.1784/insi.2009.51.8.433; MOTTERSHEAD JE, 1993, J SOUND VIB, V167, P347, DOI 10.1006/jsvi.1993.1340; Xia Y, 2006, ENG STRUCT, V28, P441, DOI 10.1016/j.enqstruct.2005.09.001; Brownjohn JMW, 2005, STRUCT CONTROL HLTH, V12, P227, DOI 10.1002/stc.67; Bathe K. J., 1976, NUMERICAL METHODS FI; Belay A, 2008, J SOUND VIB, V311, P1161, DOI 10.1016/j.jsv.2007.10.019; Carden EP, 2004, STRUCT HEALTH MONIT, V3, P355, DOI 10.1177/1475921704047500; Cerda F, 2014, SMART STRUCT SYST, V13, P849; Chang KC, 2014, SMART STRUCT SYST, V13, P755; Clough RW, 1993, DYNAMICS STRUCTURES; Cunha A, 2013, STRUCT CONTROL HLTH, V20, P853, DOI 10.1002/stc.1516; De Roeck G, 2013, STRUCT HLTH MONIT, V13, P82; De Boer PT, 2005, ANN OPER RES, V134, P19, DOI 10.1007/s10479-005-5724-z; Doebling S. W., 1998, SHOCK VIBRATION DIGE, V30, P91, DOI DOI 10.1177/058310249803000201; Farrar C.R., 2013, STRUCTURAL HLTH MONI; Fiyba L., 1999, VIBRATION SOLIDS STR; Friswell MI, 1995, FINITE ELEMENT MODEL, P286; Gonzalez A., 2010, FINITE ELEMENT ANAL, P637; Gonzalez A, 2008, P 9 INT C COMP STRUC; Gonzalez A, 2010, P 5 WORLD C STRUCT C; Henchi K, 1998, J SOUND VIB, V212, P663, DOI 10.1006/jsvi.1997.1459; Kim CW, 2009, P 10 INT C STRUCT SA, P758; MATLAB, 2005, MATLAB VERS 7; McGetrick PJ, 2014, P 9 INT C STRUCT DYN; MEMORY TJ, 1995, ENG STRUCT, V17, P705, DOI 10.1016/0141-0296(95)00037-8; Oshima Y, 2008, P 4 INT C BRIDG MAIN, P3030; Rubinstein R.Y., 2004, CROSS ENTROPY METHOD; Sohn H., 2004, LA13976MS LOS AL NAT; Tedesco J. W., 1999, STRUCTURAL DYNAMICS; Toshinami T, 2010, P 5 INT C BRIDG MAIN, P317; Walsh BJ, 2009, KEY ENG MAT, V413-414, P269; Weaver Jr W., 1987, STRUCTURAL DYNAMICS; Xia PQ, 2003, EXP MECH, V43, P372; Yang YB, 2013, INT J STRUCT STAB DY, V13, DOI 10.1142/S0219455413500193; Yang YB, 2009, ENG STRUCT, V31, P2448, DOI 10.1016/j.engstruct.2009.06.001; Yau J. D., 2004, VEHICLE BRIDGE INTER	52	1	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1475-9217	1741-3168		STRUCT HEALTH MONIT	Struct. Health Monit.	JUL	2015	14	4					317	331		10.1177/1475921715578314		15	Engineering, Multidisciplinary; Instruments & Instrumentation	Engineering; Instruments & Instrumentation	CK7EI	WOS:000356393900001		
J	Amano, R; Kimura, K; Nakata, B; Yamazoe, S; Motomura, H; Yamamoto, A; Tanaka, S; Hirakawa, K				Amano, Ryosuke; Kimura, Kenjiro; Nakata, Bunzo; Yamazoe, Sadaaki; Motomura, Hisashi; Yamamoto, Akira; Tanaka, Sayaka; Hirakawa, Kosei			Pancreatectomy with major arterial resection after neoadjuvant chemoradiotherapy gemcitabine and S-1 and concurrent radiotherapy for locally advanced unresectable pancreatic cancer	SURGERY			English	Article							CELIAC AXIS RESECTION; DISTAL PANCREATECTOMY; PREOPERATIVE CHEMORADIATION; BODY CANCER; PHASE-II; THERAPY; ADENOCARCINOMA; RADIATION; CARCINOMA; JAPAN	Background. Pancreatic cancer (PC) with arterial invasion is currently a contraindication to resection and has a miserable prognosis. Methods. Seventeen patients with locally advanced PC involving the celiac axis and/or common hepatic artery (CHA) who received chemoradiotherapy (CRT) composed of gemcitabine, S-1, and external beam irradiation over the last 2 years were investigated. Thirteen patients underwent pancreatectomy with major arterial resection: 6 distal pancreatectomies with resection of the celiac axis, 4 total pancreatectomies with resection of both the celiac axis and the CHA, and 3 pancreatoduodenectomies with resection of the CHA. Preoperative arterial embolization and/or arterial reconstruction to prevent ischemic gastropathy and hepatopathy was performed in 7 of the 13 patients. Results. Distant metastases were found in 3 patients after CRT One patient did not consent to operation after CRT. The morbidity rate of the 13 patients who underwent surgery was 62% (8/13), but no deaths occurred. Although there were no responders on CT, >90% of tumor cells were necrotic on histopathology in 5 of 13 tumors after CRT. Invasion of the celiac axis remained in 5 tumors, and extrapancreatic plexus invasion remained in 8 tumors, but an RO resection was achieved in 12 of 13 tumors. Lymph node metastases were found in 3 of 13 cases. The overall 1-year survival rate from commencement of CRT and resection was 12 of 13 patients. Conclusion. Neoadjuvant CRT containing gemcitabine and S-1 and subsequent pancreatectomy with major arterial resection for patients with locally advanced PC with arterial invasion were carried out safely with an acceptable RO resection acceptable morbidity and mortality, and encouraging survival (12 of 13) at 1 year postoperatively.	[Amano, Ryosuke; Kimura, Kenjiro; Nakata, Bunzo; Yamazoe, Sadaaki; Hirakawa, Kosei] Osaka City Univ, Grad Sch Med, Dept Surg Oncol, Osaka 5458585, Japan; [Nakata, Bunzo] Kashiwara Municipal Hosp, Dept Surg, Osaka, Japan; [Motomura, Hisashi] Osaka City Univ, Grad Sch Med, Dept Plast & Reconstruct Surg, Osaka 558, Japan; [Yamamoto, Akira] Osaka City Univ, Grad Sch Med, Dept Radiol, Osaka 558, Japan; [Tanaka, Sayaka] Osaka City Univ, Grad Sch Med, Dept Diagnost Pathol, Osaka 558, Japan	Amano, R (reprint author), Osaka City Univ, Grad Sch Med, Dept Surg Oncol, Abeno Ku, 1-4-3 Asahimachi, Osaka 5458585, Japan.	ramano@med.osaka-cu.ac.jp					Ueno H, 2013, J CLIN ONCOL, V31, P1640, DOI 10.1200/JCO.2012.43.3680; Yamaguchi K, 2011, JPN J CLIN ONCOL, V41, P836, DOI 10.1093/jjco/hyr077; Wanebo HJ, 2000, ARCH SURG-CHICAGO, V135, P81, DOI 10.1001/archsurg.135.1.81; Okada K, 2013, SURGERY, V153, P365, DOI 10.1016/j.surg.2012.07.036; Satoi S, 2012, J GASTROINTEST SURG, V16, P784, DOI 10.1007/s11605-011-1795-0; Landry J, 2010, J SURG ONCOL, V101, P587, DOI 10.1002/jso.21527; Kim EJ, 2013, CANCER-AM CANCER SOC, V119, P2692, DOI 10.1002/cncr.28117; Allendorf JD, 2008, J GASTROINTEST SURG, V12, P91, DOI 10.1007/s11605-007-0296-7; Hirano S, 2007, ANN SURG, V246, P46, DOI 10.1097/01.sla.0000258608.52615.5a; Takahashi H, 2012, ANN SURG, V255, P95, DOI 10.1097/SLA.0b013e31823d813c; Stitzenberg KB, 2008, ANN SURG ONCOL, V15, P1399, DOI 10.1245/s10434-008-9844-y; Stokes JB, 2011, ANN SURG ONCOL, V18, P619, DOI 10.1245/s10434-010-1456-7; Pisters PWT, 2000, J CLIN ONCOL, V18, P860; Leone F, 2013, CANCER-AM CANCER SOC, V119, P277, DOI 10.1002/cncr.27736; Katz MHG, 2012, J GASTROINTEST SURG, V16, P68, DOI 10.1007/s11605-011-1748-7; Katz MHG, 2012, CANCER-AM CANCER SOC, V118, P5749, DOI 10.1002/cncr.27636; Baumgartner JM, 2012, J GASTROINTEST SURG, V16, P1152, DOI 10.1007/s11605-012-1839-0; Egawa S, 2012, PANCREAS, V41, P985, DOI 10.1097/MPA.0b013e318258055c; Yamamoto Y, 2012, SURGERY, V151, P61, DOI 10.1016/j.surg.2011.06.030; Konstantinidis IT, 2013, ANN SURG, V257, P731, DOI 10.1097/SLA.0b013e318263da2f; Matsuno S, 2004, PANCREAS, V28, P219, DOI 10.1097/00006676-200404000-00002; Wente MN, 2007, SURGERY, V142, P761, DOI 10.1016/j.surg.2007.05.005; Patel M, 2011, J SURG ONCOL, V104, P155, DOI 10.1002/jso.21954; Hayashibe A, 2007, J SURG ONCOL, V95, P106, DOI 10.1002/jso.20608; Talamonti MS, 2006, ANN SURG ONCOL, V13, P150, DOI 10.1245/ASO.2006.03.039; Bockhorn M, 2011, BRIT J SURG, V98, P86, DOI 10.1002/bjs.7270; Dudeja V, 2013, HPB, V15, P661, DOI 10.1111/hpb.12015; Eguchi H, 2014, CANCER CHEMOTH PHARM, V73, P309, DOI 10.1007/s00280-013-2357-9; EVANS DB, 1992, ARCH SURG-CHICAGO, V127, P1335; Ferrone CR, 2015, ANN SURG, V261, P12, DOI 10.1097/SLA.0000000000000867; Japan Pancreas Society, 2011, CLASS PANCR CARC; Kato K, 2009, PANCREAS, V38, P605, DOI 10.1097/MPA.0b013e3181a4891d; Lind PA, 2008, ACTA ONCOL, V47, P413, DOI 10.1080/02841860701592384; Nakata B, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-15; Papalezova KT, 2012, J SURG ONCOL, V106, P111, DOI 10.1002/jso.23044; Rau BM, 2012, SURGERY, V152, pS103, DOI 10.1016/j.surg.2012.05.015; Sho M, 2013, J HEPATO-BIL-PAN SCI, V20, P197, DOI 10.1007/s00534-012-0532-8; Strobel O, 2012, SURGERY, V152, pS33, DOI 10.1016/j.surg.2012.05.029; Tanaka M, 2007, SUIZO, V22, pe1	39	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0039-6060			SURGERY	Surgery	JUL	2015	158	1					191	200		10.1016/j.surg.2015.02.016		10	Surgery	Surgery	CK6ED	WOS:000356320400025		
J	Beppu, N; Matsubara, N; Noda, M; Yamano, T; Kakuno, A; Doi, H; Kamikonya, N; Kimura, F; Yamanaka, N; Yanagi, H; Tomita, N				Beppu, Naohito; Matsubara, Nagahide; Noda, Masashi; Yamano, Tomoki; Kakuno, Ayako; Doi, Hiroshi; Kamikonya, Norihiko; Kimura, Fumihiko; Yamanaka, Naoki; Yanagi, Hidenori; Tomita, Naohiro			Short-course radiotherapy with delayed surgery versus conventional chemoradiotherapy: A comparison of the short- and long-term outcomes in patients with T3 rectal cancer	SURGERY			English	Article							TOTAL MESORECTAL EXCISION; QUALITY-OF-LIFE; COURSE PREOPERATIVE RADIOTHERAPY; RANDOMIZED-TRIAL; COURSE CHEMORADIATION; RADIATION-THERAPY; BOWEL DYSFUNCTION; ERECTILE FUNCTION; LOCAL RECURRENCE; SEXUAL FUNCTION	Introduction. The aim of this study was to compare the short- and long-term outcomes between short-course radiotherapy with delayed surgery (SRT-delay) and a standard conventional chemoradiotherapy (CRT) regimen. Methods. Two collaborating institutions adopted different regimens; the SRT-delay regimen was selected by Meiwa Hospital and the CRT regimen was selected by Hyogo College of Medicine. The inclusion criteria were T3 middle and low rectal cancer patients treated with radical surgery after preoperative therapy. The median follow-up period was 44 months (range, 12-85). Results. From 2007 to 2013, 104 patients were treated using the SRT-delay regimen and 61 patients were treated using the CRT regimen. The pretreatment characteristics of the 2 groups were not significantly different. The sphincter-preserving rate (93.3%, 85.2%), T downstaging (37.5%, 37.7%), ypN(-) (74.0%, 67.2%), postoperative complications and the bowel, and urinary and sexual functioning of the SRT-delay regimen were noninferior to those of the CRT regimen. The 3-year local recurrence-free survival, recurrence-free survival, and overall survival in the SRT-delay and CRT groups were 90.6% and 90.6% (P = .764), 83.8% and 78.3% (P = .687) and 96.0% and 92.8% (P = .833), respectively. Conclusion. The SRT-delay regimen was noninferior in terms of the downstaging effect, and oncologic and functional outcomes compared with the CRT regimen for T3 middle and low rectal cancer.	[Beppu, Naohito; Matsubara, Nagahide; Noda, Masashi; Yamano, Tomoki; Tomita, Naohiro] Hyogo Coll Med, Dept Surg, Nishinomiya, Hyogo 6638501, Japan; [Kakuno, Ayako] Meiwa Hosp, Dept Pathol, Nishinomiya, Hyogo, Japan; [Doi, Hiroshi; Kamikonya, Norihiko] Hyogo Coll Med, Dept Radiol, Nishinomiya, Hyogo 6638501, Japan; [Kimura, Fumihiko; Yamanaka, Naoki; Yanagi, Hidenori] Meiwa Hosp, Dept Surg, Nishinomiya, Hyogo, Japan	Beppu, N (reprint author), Hyogo Coll Med, Dept Surg, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan.	beppu-n@hyo-rned.ac.jp					Akasu T, 2009, ANN SURG ONCOL, V16, P2779, DOI 10.1245/s10434-009-0546-x; Kim TH, 2008, ANN SURG ONCOL, V15, P729, DOI 10.1245/s10434-007-9696-x; Rogers RG, 2003, INT UROGYNECOL J PEL, V14, P164, DOI 10.1007/s00192-003-1063-2; Valentini V, 2009, RADIOTHER ONCOL, V92, P148, DOI 10.1016/j.radonc.2009.06.027; Pietrzak L, 2007, RADIOTHER ONCOL, V84, P217, DOI 10.1016/j.radonc.2007.07.007; Smith N, 2008, ACTA ONCOL, V47, P20, DOI 10.1080/02841860701697720; Pettersson D, 2010, BRIT J SURG, V97, P580, DOI 10.1002/bjs.6914; Marijnen CAM, 2005, J CLIN ONCOL, V23, P1847, DOI 10.1200/JCO.2005.05.256; Martling A, 2001, CANCER, V92, P896, DOI 10.1002/1097-0142(20010815)92:4<896::AID-CNCR1398>3.0.CO;2-R; Kapiteijn E, 2001, NEW ENGL J MED, V345, P638, DOI 10.1056/NEJMoa010580; Rosen RC, 1999, INT J IMPOT RES, V11, P319; Schmoll HJ, 2012, ANN ONCOL, V23, P2479, DOI 10.1093/annonc/mds236; [Anonymous], 2006, GEN RUL CLIN PATH ST; Folkesson J, 2005, J CLIN ONCOL, V23, P5644, DOI 10.1200/JCO.2005.08.144; Peeters KCMJ, 2005, J CLIN ONCOL, V23, P6199, DOI 10.1200/JCO.2005.14.779; Park SY, 2014, WORLD J SURG, V38, P1834, DOI 10.1007/s00268-013-2419-5; Bujko K, 2006, BRIT J SURG, V93, P1215, DOI 10.1002/bjs.5506; Sato T, 2007, INT J RADIAT ONCOL, V69, P1442, DOI 10.1016/j.ijrobp.2007.05.081; Minsky BD, 2012, J CLIN ONCOL, V30, P3777, DOI 10.1200/JCO.2012.45.0551; Sato T, 2011, INT J RADIAT ONCOL, V79, P677, DOI 10.1016/j.ijrobp.2009.11.007; Kim JY, 2012, ANN SURG ONCOL, V19, P2485, DOI 10.1245/s10434-012-2262-1; Hatfield P, 2009, RADIOTHER ONCOL, V92, P210, DOI 10.1016/j.radonc.2009.04.007; Contin P, 2014, INT J COLORECTAL DIS, V29, P165, DOI 10.1007/s00384-013-1780-z; Pettersson D, 2012, BRIT J SURG, V99, P577, DOI 10.1002/bjs.7796; Blomqvist L, 2008, ACTA ONCOL, V47, P5, DOI 10.1080/02841860701802585; Emmertsen KJ, 2012, ANN SURG, V255, P922, DOI 10.1097/SLA.0b013e31824f1c21; Ngan SY, 2012, J CLIN ONCOL, V30, P3827, DOI 10.1200/JCO.2012.42.9597; BARRY MJ, 1992, J UROLOGY, V148, P1549; Beppu N, 2014, INT J COLORECTAL DIS, V29, P1459, DOI 10.1007/s00384-014-1997-5; Beppu N, 2014, SURG TODAY; Birgisson H, 2005, J CLIN ONCOL, V23, P8697, DOI 10.1200/JCO-2005.02.9017; Emmertsen KJ, 2013, BRIT J SURG, V100, P1377, DOI 10.1002/bjs.9223; Faria S, 2014, COLORECTAL DIS, V16, P66; Fokstuen T, 2009, RADIOTHER ONCOL, V93, P293, DOI 10.1016/j.radonc.2009.08.034; Hartley A, 2002, BRIT J SURG, V89, P889, DOI 10.1046/j.1365-2168.2002.02136.x; MARCIO J, 1993, DIS COLON RECTUM, V36, P77; Lim RS, 2014, TECH COLOPROCTOL, V18, P993, DOI 10.1007/s10151-014-1189-x; Nishizawa Y, 2011, INT J COLORECTAL DIS, V26, P1541, DOI 10.1007/s00384-011-1247-z; Riachy E, 2014, J UROLOGY, V191, P186, DOI 10.1016/j.juro.2013.08.007	39	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0039-6060			SURGERY	Surgery	JUL	2015	158	1					225	235		10.1016/j.surg.2015.03.014		11	Surgery	Surgery	CK6ED	WOS:000356320400028		
J	Daruwalla, J; Greish, K; Malcontenti-Wilson, C; Muralidharan, V; Maeda, H; Christophi, C				Daruwalla, Jurstine; Greish, Khaled; Malcontenti-Wilson, Cathy; Muralidharan, Vijayaragavan; Maeda, Hiroshi; Christophi, Chris			Styrene maleic acid copolymer-pirarubicin induces tumor-selective oxidative stress and decreases tumor hypoxia as possible treatment of colorectal cancer liver metastases	SURGERY			English	Article							PEGYLATED-LIPOSOMAL DOXORUBICIN; HYPERBARIC-OXYGEN THERAPY; ENDOTHELIAL GROWTH-FACTOR; RECURRENT OVARIAN-CANCER; PHASE-II; SUPEROXIDE-DISMUTASE; DRUG-DELIVERY; BLOOD-VESSELS; BREAST-CANCER; SOLID TUMORS	Background. Pirarubicin, a derivative of doxorubicin, induces tumor destruction via the production of reactive oxygen species (ROS) but is associated with cardiotoxicity. As a macromolecule (conjugated to styrene-maleic acid [SMA]), SMA-pirarubicin is selective to tumors resulting in improved survival with decreased systemic toxicity. Tumor destruction is, however incomplete, and resistant cells at the periphery of the tumor contribute to recurrence. Tumor hypoxia is a major factor in tumor resistance. Understanding the effect of oxidative stress induced by SMA-pirarubicin on the tumor microenvironment may be key to overcoming resistance. This study investigated the pattern of ROS production and tumor hypoxia after treatment with SMA-pirarubicin in a murine model of colorectal liver metastases. Methods. Liver metastases were induced in male, CBA mice using a murine-derived colon cancer cell line. SMA-pirarubicin (maximum tolerated dose, 100 mg/kg) or pirarubicin, (maximum tolerated dose, 10 mg/kg) were administered intravenously 14 days after tumor induction. Systemic oxidative stress in serum, liver, and cardiac tissue was quantified using the thiobarbituric acid reactive substances assay. Flow cytometry and fluorescence microscopy were used to assess ROS production for 48 hours after treatment. Tumor hypoxia was quantified using immunohistochemistry for pimonidazole adducts. Results. SMA-pirarubicin (100 mg/kg) induced ROS exclusively in tumors with minimal levels in serum and cardiac tissue. ROS levels were induced in a time-dependent and dose-dependent manner optimal between 4 and 24 hours after drug administration. Although tumor hypoxia was decreased overall, residual tumor cells adjacent to patent vessels were hypoxic. Conclusion. This study provides insight into the tumor microenvironment after chemotherapy. SMA-pirarubicin inhibits the growth of colorectal liver metastases by inducing ROS, which seems to be largely tumor selective. The temporal pattern of ROS production can be used to improve future dosing regimens. Furthermore, the observation that residual tumor cells are hypoxic clarifies the need for a multimodal approach with agents that can alter the hypoxic state to effect complete tumor destruction.	[Daruwalla, Jurstine; Malcontenti-Wilson, Cathy; Muralidharan, Vijayaragavan; Christophi, Chris] Univ Melbourne, Austin Hlth, Dept Surg, Heidelberg, Vic 3084, Australia; [Greish, Khaled] Univ Otago, Dept Pharmacol & Toxicol, Dunedin, New Zealand; [Greish, Khaled] Suez Canal Univ, Dept Oncol, Ismailia, Egypt; [Maeda, Hiroshi] Sojo Univ, Inst Drug Delivery Sci, Kumamoto, Japan	Daruwalla, J (reprint author), Univ Melbourne, Austin Hosp, Dept Surg, Level 8,Lance Townsend Bldg,Studley Rd, Heidelberg, Vic 3084, Australia.	jurstinedaruwalla@gmail.com			National Health and Medical Research Council (NHMRC), Australia [400190]	Funded by a National Health and Medical Research Council (NHMRC; Grant ID 400190), Australia. Grant-in-Aid for Scientific Research on Priority Areas in Cancer, Ministry of Science and Technology, Japan (No. 20015045).	Morikawa S, 2002, AM J PATHOL, V160, P985, DOI 10.1016/S0002-9440(10)64920-6; Hockel M, 1999, CANCER RES, V59, P4525; Winquist E, 2003, EUR J CANCER, V39, P1866, DOI 10.1016/S0959-8049(03)00358-7; Mentha G, 2007, EJSO-EUR J SURG ONC, V33, pS76, DOI 10.1016/j.ejso.2007.09.016; Gackowski D, 2002, INT J CANCER, V101, P395, DOI 10.1002/ijc.10610; Zhou R, 2002, CANCER RES, V62, P2561; Brown NS, 2001, BREAST CANCER RES, V3, P323, DOI 10.1186/bcr315; Tomlinson JS, 2007, J CLIN ONCOL, V25, P4575, DOI 10.1200/JCO.2007.11.0833; Greish K, 2004, J CONTROL RELEASE, V97, P219, DOI 10.1016/j.conrel.2004.03.027; Sedlak TW, 2004, PEDIATRICS, V113, P1776, DOI 10.1542/peds.113.6.1776; Wang SW, 2004, J BIOL CHEM, V279, P25535, DOI 10.1074/jbc.M400944200; Tangpong J, 2007, J NEUROCHEM, V100, P191, DOI 10.1111/j.1471-4159.2006.04179.x; Markman M, 2000, GYNECOL ONCOL, V78, P369, DOI 10.1006/gyno.2000.5921; Au JLS, 2002, J CONTROL RELEASE, V78, P81, DOI 10.1016/S0168-3659(01)00488-6; Parker MA, 2001, BBA-BIOMEMBRANES, V1514, P206, DOI 10.1016/S0005-2736(01)00371-6; Daruwalla J, 2006, WORLD J SURG, V30, P2112, DOI 10.1007/s00268-006-0190-6; Kimura H, 1996, CANCER RES, V56, P5522; Brizel DM, 1997, INT J RADIAT ONCOL, V38, P285, DOI 10.1016/S0360-3016(97)00101-6; Hockel M, 1996, CANCER RES, V56, P4509; Maeda H, 2009, EUR J PHARM BIOPHARM, V71, P409, DOI 10.1016/j.ejpb.2008.11.010; Wang CC, 2012, WORLD J GASTROENTERO, V18, P25, DOI 10.3748/wjg.v18.i1.25; Shannon AM, 2003, CANCER TREAT REV, V29, P297, DOI 10.1016/S0305-7372(03)00003-3; KLEEBERG UR, 1990, ONKOLOGIE, V13, P175; Zhou SY, 2001, TOXICOL LETT, V121, P151, DOI 10.1016/S0378-4274(01)00329-0; Primeau AJ, 2005, CLIN CANCER RES, V11, P8782, DOI 10.1158/1078-0432.CCR-05-1664; Daruwalla J, 2010, CANCER SCI, V101, P1866, DOI 10.1111/j.1349-7006.2010.01619.x; Swain SM, 2003, CANCER, V97, P2869, DOI 10.1002/cncr.11407; CHAPLIN DJ, 1987, CANCER RES, V47, P597; Kong Q, 2000, MED HYPOTHESES, V55, P29, DOI 10.1054/mehy.1999.0982; ARMSTRONG D, 1994, ADV EXP MED BIOL, V366, P43; Stebbing J, 2002, CANCER TREAT REV, V28, P121, DOI 10.1054/ctrv.2002.0262; OBERLEY LW, 1979, CANCER RES, V39, P1141; Laurent A, 2005, CANCER RES, V65, P948; Brahimi-Horn C, 2001, TRENDS CELL BIOL, V11, pS32, DOI 10.1016/S0962-8924(01)02126-2; Coda N, 2003, MOL CELL BIOL, V23, P359; Cuisnier O, 2003, INT J ONCOL, V23, P1033; Cvetkovic D, 2001, UROLOGY, V57, P821, DOI 10.1016/S0090-4295(00)01044-X; Daruwalla J, 2005, J SURG ONCOL, V91, P134, DOI 10.1002/jso.20289; Daruwalla J, 2008, J VASC RES, V46, P218; Daruwalla J, 2006, EUR J CANCER, V42, P3304, DOI 10.1016/j.ejca.2006.08.004; Daruwalla J, 2007, J DRUG TARGET, V15, P487, DOI 10.1080/10611860701499839; DEWHIRST MW, 1992, RADIAT RES, V130, P171, DOI 10.2307/3578274; Di Bella NJ, 2003, CLIN LYMPHOMA, V3, P235, DOI 10.3816/CLM.2003.n.004; DUBOIS A, 1994, J CANCER RES CLIN, V120, P173; Dunst J, 2001, STRAHLENTHER ONKOL, V177, P469, DOI 10.1007/PL00002428; Giri SN, 2004, CANCER CHEMOTH PHARM, V53, P141, DOI 10.1007/s00280-003-0703-z; HIRANO S, 1994, DRUG EXP CLIN RES, V20, P153; Israel VP, 2000, GYNECOL ONCOL, V78, P143, DOI 10.1006/gyno.2000.5819; Karagoz B, 2008, BASIC CLIN PHARMACOL, V102, P287, DOI 10.1111/j.1742-7843.2007.00196.x; Kimura K, 1986, Gan To Kagaku Ryoho, V13, P368; Kuruppu D, 1996, J GASTROEN HEPATOL, V11, P26, DOI 10.1111/j.1440-1746.1996.tb00006.x; LAFRENIERE R, 1986, J NATL CANCER I, V76, P309; Menna P, 2007, J PHARMACOL EXP THER, V322, P408, DOI 10.1124/jpet.107.122820; MILNER LS, 1991, J LAB CLIN MED, V118, P427; Rockwell S, 2001, Novartis Found Symp, V240, P133; Sugiyama T, 1999, JPN J CANCER RES, V90, P775; TSURUO T, 1982, CANCER RES, V42, P1462; YAMAURA H, 1979, INT J RADIAT BIOL, V35, P201, DOI 10.1080/09553007914550241	58	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0039-6060			SURGERY	Surgery	JUL	2015	158	1					236	247		10.1016/j.surg.2015.03.019		12	Surgery	Surgery	CK6ED	WOS:000356320400029		
J	Takiguchi, S; Murakami, K; Yanagimoto, Y; Takata, A; Miyazaki, Y; Mori, M; Doki, Y				Takiguchi, Shuji; Murakami, Kohei; Yanagimoto, Yoshitomo; Takata, Akihiro; Miyazaki, Yasuhiro; Mori, Masaki; Doki, Yuichiro			Clinical application of ghrelin in the field of surgery	SURGERY TODAY			English	Review						Ghrelin; Gastrectomy; Esophagectomy; Chemotherapy; Cachexia	PLACEBO-CONTROLLED TRIAL; CISPLATIN-INDUCED ANOREXIA; ESOPHAGEAL CANCER-PATIENTS; CHRONIC HEART-FAILURE; DOUBLE-BLIND; FOOD-INTAKE; INTRAVENOUS GHRELIN; ACYLATED PEPTIDE; CHEMOTHERAPY; APPETITE	Ghrelin was discovered as an intrinsic ligand for the growth hormone (GH)-secretagogue receptor (GHS-R) in 1999. The endogenous production of ghrelin occurs mainly in the stomach. Ghrelin has multiple functions; it has orexigenic action, stimulates GH secretion, has anti-inflammatory activities, stimulates gastrointestinal activity, stabilizes heart function and has other metabolic roles. Moreover, ghrelin is the only gastrointestinal hormone known to stimulate appetite. In the past decade, clinical applications of ghrelin have been attempted for various pathologies, based on its anabolic function, including applications for patients with anorexia nervosa and cachexia due to chronic heart, renal or pulmonary diseases. In the field of surgery, we have conducted several clinical trials using exogenous ghrelin in patients undergoing total gastrectomy, esophagectomy and neoadjuvant chemotherapy, including cisplatin treatment, and consistently obtained unique and striking benefits in these patients. Ghrelin comprehensively improves the patients' general conditions and quality of life via its pleiotropic physiological functions. This characteristic is unique and different from the existing drugs; therefore, ghrelin may be an indispensable supplement to prevent surgical stress and postoperative sequelae. This review summarizes the recent advances toward the clinical application of ghrelin.	[Takiguchi, Shuji; Murakami, Kohei; Yanagimoto, Yoshitomo; Takata, Akihiro; Miyazaki, Yasuhiro; Mori, Masaki; Doki, Yuichiro] Osaka Univ, Grad Sch Med, Dept Surg Gastroenterol, Suita, Osaka 5650871, Japan	Takiguchi, S (reprint author), Osaka Univ, Grad Sch Med, Dept Surg Gastroenterol, 2-2,E-2 Yamadaoka, Suita, Osaka 5650871, Japan.	stakiguchi@gesurg.med.osaka-u.ac.jp					Akamizu T, 2011, PEPTIDES, V32, P2295, DOI 10.1016/j.peptides.2011.05.018; Andreis PG, 2003, FEBS LETT, V536, P173, DOI 10.1016/S0014-5793(03)00051-6; Strasser F, 2008, BRIT J CANCER, V98, P300, DOI 10.1038/sj.bjc.6604148; Date Y, 2002, GASTROENTEROLOGY, V123, P1120, DOI 10.1053/gast.2002.35954; Ando N, 2012, ANN SURG ONCOL, V19, P68, DOI 10.1245/s10434-011-2049-9; Takeda H, 2008, GASTROENTEROLOGY, V134, P2004, DOI 10.1053/j.gastro.2008.02.078; Akamizu T, 2012, EUR J INTERN MED, V23, P197, DOI 10.1016/j.ejim.2011.12.001; Nagaya N, 2004, CIRCULATION, V110, P3674, DOI 10.1161/01.CIR.0000149746.62908.BB; Yamamoto K, 2013, SURG TODAY, V43, P48, DOI 10.1007/s00595-012-0342-2; Tschop M, 2001, DIABETES, V50, P707, DOI 10.2337/diabetes.50.4.707; Chopin L, 2011, MOL CELL ENDOCRINOL, V340, P65, DOI 10.1016/j.mce.2011.04.013; Date Y, 2000, ENDOCRINOLOGY, V141, P4255, DOI 10.1210/en.141.11.4255; Yamamoto K, 2010, SURGERY, V148, P31, DOI 10.1016/j.surg.2009.11.026; Sato T, 2012, J BIOCHEM, V151, P119, DOI 10.1093/jb/mvr134; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Hesketh PJ, 2003, J CLIN ONCOL, V21, P4112, DOI 10.1200/JCO.2003.01.095; Doki Y, 2006, SURGERY, V139, P797, DOI 10.1016/j.surg.2005.11.015; Neary NM, 2004, J CLIN ENDOCR METAB, V89, P2832, DOI 10.1210/jc.2003-031768; Yang J, 2008, CELL, V132, P387, DOI 10.1016/j.cell.2008.01.017; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Cheyuo C, 2012, AM J PHYSIOL-ENDOC M, V302, pE265, DOI 10.1152/ajpendo.00508.2011; Adachi S, 2010, GASTROENTEROLOGY, V138, P1312, DOI 10.1053/j.gastro.2009.12.058; Li WG, 2004, CIRCULATION, V109, P2221, DOI 10.1161/01.CIR.0000127956.43874.F2; Lundholm K, 2010, CANCER-AM CANCER SOC, V116, P2044, DOI 10.1002/cncr.24917; Yakabi K, 2010, ENDOCRINOLOGY, V151, P3773, DOI 10.1210/en.2010-0061; Hiura Y, 2012, CANCER-AM CANCER SOC, V118, P4785, DOI 10.1002/cncr.27430; Hiura Y, 2012, INT J CLIN ONCOL, V17, P316, DOI 10.1007/s10147-011-0289-0; Nagaya N, 2005, CHEST, V128, P1187, DOI 10.1378/chest.128.3.1187; Kelsen DP, 1998, NEW ENGL J MED, V339, P1979, DOI 10.1056/NEJM199812313392704; Ueno H, 2005, REGUL PEPTIDES, V126, P11, DOI 10.1016/j.regpep.2004.08.007; Nishi Y, 2011, PEPTIDES, V32, P2175, DOI 10.1016/j.peptides.2011.07.024; Yoshida N, 2014, SURG TODAY, V44, P526, DOI 10.1007/s00595-013-0577-6; Hesketh PJ, 2003, EUR J CANCER, V39, P1074, DOI 10.1016/S0959-8049(02)00674-3; Ashby DR, 2009, KIDNEY INT, V76, P199, DOI 10.1038/ki.2009.114; BUTCHER ME, 1993, ONCOLOGY, V50, P191; CUBEDDU LX, 1993, J CLIN PHARMACOL, V33, P691; de Wit R, 2004, EUR J CANCER, V40, P403, DOI 10.1016/j.ejca.2003.08.028; Falken Y, 2013, NEUROGASTROENT MOTIL, V25, DOI 10.1111/nmo.12098; Fujimiya M, 2011, PEPTIDES, V32, P2348, DOI 10.1016/j.peptides.2011.07.020; Fujitsuka N, 2012, METHOD ENZYMOL, V514, P289, DOI 10.1016/B978-0-12-381272-8.00018-0; Hill NE, 2012, CURR OPIN CRIT CARE, V18, P199, DOI 10.1097/MCC.0b013e3283514b01; Hotta M, 2009, ENDOCR J, V56, P1119, DOI 10.1507/endocrj.K09E-168; Leite-Moreira AF, 2007, DRUG DISCOV TODAY, V12, P276, DOI 10.1016/j.drudis.2007.02.009; Miki K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035708; Nagaya N, 2001, J CLIN ENDOCR METAB, V86, P5854, DOI 10.1210/jc.86.12.5854; Nozoe T, 2012, SURG TODAY, V42, P945, DOI 10.1007/s00595-012-0183-z; Otto B, 2001, Eur J Endocrinol, V145, P669; Takiguchi S, 2012, METHOD ENZYMOL, V514, P409, DOI 10.1016/B978-0-12-381272-8.00026-X; Ueno H, 2010, ANN NY ACAD SCI, V1200, P120, DOI 10.1111/j.1749-6632.2010.05509.x; Wynne K, 2005, J AM SOC NEPHROL, V16, P2111, DOI 10.1681/ASN.2005010039	50	4	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	JUL	2015	45	7					801	807		10.1007/s00595-014-1040-z		7	Surgery	Surgery	CK2LB	WOS:000356040800001		
J	Kuroki, T; Eguchi, S				Kuroki, Tamotsu; Eguchi, Susumu			Laparoscopic distal pancreatosplenectomy for pancreatic ductal adenocarcinoma	SURGERY TODAY			English	Review						Laparoscopic; Distal pancreatosplenectomy; Pancreatic adenocarcinoma; Minimally invasive surgery	CELIAC AXIS RESECTION; PORT-SITE METASTASES; SINGLE-INSTITUTION; EXPERIENCE; PANCREATICODUODENECTOMY; OUTCOMES; FUTURE; CANCER	Laparoscopic distal pancreatectomy (LDP) including laparoscopic distal pancreatosplenectomy has rapidly developed as a minimally invasive surgery. LDP is mainly indicated for benign disease and low-grade malignancy during the initial period. In recent years, an increasing number of LDPs for pancreatic ductal adenocarcinoma (PDAC) have been reported. However, the benefits of LPD for PDAC, especially in view of the oncological benefits, are unclear and remain controversial. In this review of the literature, we note that LDP has been found to be a technically feasible and safe surgical procedure in selected patients and that LDP has the advantages expected of a minimally invasive surgery. In addition, LDP has oncological feasibility for PDAC in light of its favorable rate of R0 resection and lymph node harvest compared to conventional laparotomy. Large randomized and controlled prospective studies are needed to determine the clinical advantages of LDP for left-sided PDAC.	[Kuroki, Tamotsu; Eguchi, Susumu] Nagasaki Univ, Grad Sch Biomed Sci, Dept Surg, Nagasaki 8528501, Japan	Kuroki, T (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Surg, 1-7-1 Sakamoto, Nagasaki 8528501, Japan.	tkuroki-gi@umin.ac.jp					Ferrone CR, 2008, J GASTROINTEST SURG, V12, P1691, DOI 10.1007/s11605-008-0636-2; Mehta SS, 2012, SURG ENDOSC, V26, P402, DOI 10.1007/s00464-011-1887-7; Kang CM, 2014, WORLD J GASTROENTERO, V20, P2343, DOI 10.3748/wjg.v20.i9.2343; Ziprin P, 2002, J AM COLL SURGEONS, V195, P395, DOI 10.1016/S1072-7515(02)01249-8; Benson D, 2011, J SURG RES, V166, P275, DOI 10.1016/j.jss.2010.05.059; Baker MS, 2009, SURGERY, V146, P635, DOI 10.1016/j.surg.2009.06.045; Marangos IP, 2012, SURGERY, V151, P717, DOI 10.1016/j.surg.2011.12.016; Choi SH, 2011, SURG ENDOSC, V25, P2360, DOI 10.1007/s00464-010-1556-2; Kooby DA, 2008, ANN SURG, V248, P438, DOI 10.1097/SLA.0b013e318185a990; Hirano S, 2007, ANN SURG, V246, P46, DOI 10.1097/01.sla.0000258608.52615.5a; Lebedyev A, 2004, SURG ENDOSC, V18, P1427, DOI 10.1007/s00464-003-8221-y; Mabrut JY, 2005, SURGERY, V137, P597, DOI 10.1016/j.surg.2005.02.002; Fox AM, 2012, SURG ENDOSC, V26, P1220, DOI 10.1007/s00464-011-2061-y; Abu Hilal M, 2012, SURG ENDOSC, V26, P1670, DOI 10.1007/s00464-011-2090-6; Abu Hilal M, 2013, PANCREATOLOGY, V13, P443, DOI 10.1016/j.pan.2013.04.196; Nakamura M, 2013, J HEPATO-BIL-PAN SCI, V20, P421, DOI 10.1007/s00534-012-0578-7; Strasberg SM, 2003, SURGERY, V133, P521, DOI 10.1067/msy.2003.146; Kneuertz PJ, 2012, J AM COLL SURGEONS, V215, P167, DOI 10.1016/j.jamcollsurg.2012.03.023; Song KB, 2011, SURG ENDOSC, V25, P3364, DOI 10.1007/s00464-011-1727-9; Curet MJ, 2004, AM J SURG, V187, P705, DOI 10.1016/j.amjsurg.2003.10.015; Magge D, 2013, JAMA SURG, V148, P525, DOI 10.1001/jamasurg.2013.1673; Fernandez-Cruz L, 2007, J GASTROINTEST SURG, V11, P1607, DOI 10.1007/s11605-007-0266-0; Cuschieri A, 1996, ANN SURG, V223, P280, DOI 10.1097/00000658-199603000-00008; Yeh JJ, 2007, BRIT J SURG, V94, P466, DOI 10.1002/bjs.5488; Hu MG, 2014, SURG ENDOSC, V28, P2584, DOI 10.1007/s00464-014-3507-9; Cho A, 2011, J LAPAROENDOSC ADV S, V21, P957, DOI 10.1089/lap.2011.0300; Kooby DA, 2010, J AM COLL SURGEONS, V210, P779, DOI 10.1016/j.jamcollsurg.2009.12.033; Lee SH, 2014, SURG ENDOSC, DOI [10.1007/s00464-014-3537-3, DOI 10.1007/S00464-014-3537-3.]; Nakamura Y, 2009, J HEPATO-BILIARY-PAN, V16, P741, DOI 10.1007/s00534-009-0140-4; Palanivelu C, 2007, SURG ENDOSC, V21, P373, DOI 10.1007/s00464-006-9020-z; Rehman S, 2014, WORLD J SURG, V38, P476, DOI 10.1007/s00268-013-2268-2; Sahm M, 2009, SURG TODAY, V39, P1103, DOI 10.1007/s00595-008-3999-9; Sunagawa Hiroki, 2014, Asian J Endosc Surg, V7, P172, DOI 10.1111/ases.12085; Takaori K, 2007, SURG TODAY, V37, P535, DOI 10.1007/s00595-007-3472-1; Young S, 2012, J GASTROINTEST SURG, V16, P2294, DOI 10.1007/s11605-012-2050-z	35	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	JUL	2015	45	7					808	812		10.1007/s00595-014-1021-2		5	Surgery	Surgery	CK2LB	WOS:000356040800002		
J	Nio, M; Wada, M; Sasaki, H; Tanaka, H				Nio, Masaki; Wada, Motoshi; Sasaki, Hideyuki; Tanaka, Hiromu			Effects of age at Kasai portoenterostomy on the surgical outcome: a review of the literature	SURGERY TODAY			English	Review						Biliary atresia; Kasai portoenterostomy; Early diagnosis; Liver transplantation	BILIARY ATRESIA; EXPERIENCE; LIVER; OPERATION; MANAGEMENT; INFANTS; DISEASE; ACID	The efficacy of early Kasai portoenterostomy has been repeatedly reported. However, the optimal age for performing this procedure remains controversial. This article reviews the literature on the age of patients at the time of Kasai portoenterostomy and its utility as a prognostic indicator. The age at the time of surgery is a known predictor of outcome; however, its exact predictive value in this context is unclear. Multicenter studies involving large volumes of data have tended to show advantages of early Kasai portoenterostomy, and there is no clear evidence to recommend any delay in the timing of surgery. At present, a reasonable strategy would be to perform a Kasai portoenterostomy as early as possible. The stool color card system has recently been implemented in Japan as part of a nationwide screening program, and it is expected to work well based on the early reports. However, efforts to identify an optimal screening system for ensuring the earliest diagnosis of biliary atresia should continue. An early diagnosis of biliary atresia is difficult, and global efforts are required to improve the early diagnosis rates.	[Nio, Masaki; Wada, Motoshi; Sasaki, Hideyuki; Tanaka, Hiromu] Tohoku Univ, Dept Pediat Surg, Grad Sch Med, Aoba Ku, Sendai, Miyagi 9808574, Japan	Nio, M (reprint author), Tohoku Univ, Dept Pediat Surg, Grad Sch Med, Aoba Ku, 1-1 Seiryomachi, Sendai, Miyagi 9808574, Japan.	mnio@ped-surg.med.tohoku.ac.jp					McKiernan PJ, 2000, LANCET, V355, P25, DOI 10.1016/S0140-6736(99)03492-3; Lien TH, 2011, HEPATOLOGY, V53, P202, DOI 10.1002/hep.24023; Suzuki M, 2011, PEDIATR INT, V53, P497, DOI 10.1111/j.1442-200X.2010.03268.x; Wildhaber BE, 2011, HEPATOLOGY, V54, P367, DOI 10.1002/hep.24346; Chen G, 2012, J PEDIATR SURG, V47, P2184, DOI 10.1016/j.jpedsurg.2012.09.002; Hung PY, 2006, J PEDIATR GASTR NUTR, V42, P190, DOI 10.1097/01.mpg.0000189339.92891.64; Serinet MO, 2006, HEPATOLOGY, V44, P75, DOI 10.1002/hep.21219; Davenport M, 2004, LANCET, V363, P1354, DOI 10.1016/S0140-6736(04)16045-5; Davenport M, 1997, J PEDIATR SURG, V32, P479, DOI 10.1016/S0022-3468(97)90611-4; LALLY KP, 1989, PEDIATRICS, V83, P723; Powell JE, 2003, J MED SCREEN, V10, P112, DOI 10.1258/096914103769010996; Shinkai M, 2009, J PEDIATR GASTR NUTR, V48, P443; Lau TT, 2013, BIOMATERIALS, V34, P6659, DOI 10.1016/j.biomaterials.2013.05.034; Wildhaber BE, 2008, J PEDIATR GASTR NUTR, V46, P299, DOI 10.1097/MPG.0b013e3181633562; Lykavieris P, 2005, HEPATOLOGY, V41, P366, DOI 10.1002/hep.20547; Schreiber RA, 2007, J PEDIATR-US, V151, P659, DOI 10.1016/j.jpeds.2007.05.051; Shneider BL, 2006, J PEDIATR-US, V148, P467, DOI 10.1016/j.jpeds.2005; Wildhaber BE, 2003, J PEDIATR SURG, V38, P1480, DOI 10.1016/S0022-3468(03)00499-8; Nio M, 2010, J PEDIATR SURG, V45, P2361, DOI 10.1016/j.jpedsurg.2010.08.032; Sokol RJ, 2007, HEPATOLOGY, V46, P566, DOI 10.1002/hep.21790; Nio M, 2012, J PEDIATR SURG, V47, P2179, DOI 10.1016/j.jpedsurg.2012.09.003; Song Z, 2012, J PEDIATR GASTR NUTR, V55, P370, DOI 10.1097/MPG.0b013e31825bb01a; Carvalho Elisa de, 2010, J Pediatr (Rio J), V86, P473, DOI 10.2223/JPED.2054; Gustafsson J, 2006, UPSALA J MED SCI, V111, P131; Ibrahim M, 1991, BILIARY ATRESIA, P96; Japanese Biliary Atresia Society, 2013, J JPN SOC PEDIAT SUG, V49, P277; KARRER FM, 1990, J PEDIATR SURG, V25, P1076, DOI 10.1016/0022-3468(90)90222-U; KARRER FM, 1990, SURG CLIN N AM, V70, P1403; Kasai M, 1980, CHOLESTASIS INFANCY, P337; Leonhardt J, 2011, EUR J PEDIATR SURG, V21, P82, DOI 10.1055/s-0030-1268476; MATSUI A, 1995, LANCET, V345, P1181, DOI 10.1016/S0140-6736(95)91013-1; Mushtaq I, 1999, BRIT MED J, V319, P1253; Nio M, 2013, PEDIATR SURG INT, V29, P989, DOI 10.1007/s00383-013-3396-3; OH M, 1995, J PEDIATR SURG, V30, P1077, DOI 10.1016/0022-3468(95)90345-3; OHI R, 1985, WORLD J SURG, V9, P285; Ohi R, 1992, Semin Pediatr Surg, V1, P115; Raval MV, 2010, SURGERY, V148, P785, DOI 10.1016/j.surg.2010.07.028; Schoen BT, 2001, J PEDIATR SURG, V36, P97, DOI 10.1053/jpsu.2001.20020; STEWART BA, 1990, PEDIATR SURG INT, V5, P87	39	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	JUL	2015	45	7					813	818		10.1007/s00595-014-1024-z		6	Surgery	Surgery	CK2LB	WOS:000356040800003		
J	Tanaka, E; Okabe, H; Kinjo, Y; Tsunoda, S; Obama, K; Hisamori, S; Sakai, Y				Tanaka, Eiji; Okabe, Hiroshi; Kinjo, Yousuke; Tsunoda, Shigeru; Obama, Kazutaka; Hisamori, Shigeo; Sakai, Yoshiharu			Advantages of the prone position for minimally invasive esophagectomy in comparison to the left decubitus position: better oxygenation after minimally invasive esophagectomy	SURGERY TODAY			English	Article						Esophageal cancer; Minimally invasive surgery; Prone position	LYMPH-NODE DISSECTION; RESPIRATORY-DISTRESS-SYNDROME; THORACOSCOPIC ESOPHAGECTOMY; CANCER; ESOPHAGUS; MOBILIZATION; BENEFITS; OUTCOMES	The aim of this retrospective study was to evaluate whether minimally invasive esophagectomy (MIE) in the prone position has advantages over the left decubitus position. A total of 110 consecutive patients with esophageal cancer who had undergone MIE were included in the analysis. The clinical outcomes were compared between 51 patients treated in the prone position (prone group) and 59 patients treated in the left decubitus position (LD group). The main outcome was postoperative respiratory complications and postoperative oxygenation [arterial oxygen pressure/fraction of inspired oxygen (P/F ratio)]. The secondary outcomes included the length of the operation, blood loss, number of dissected lymph nodes, postoperative morbidities and mortality. The P/F ratio after the operation was significantly higher in the prone group (0 h: P = 0.01, 12 h: P < 0.001). No significant differences were observed in the frequency of respiratory complications (P = 0.89). The blood loss in the prone group was significantly lower (P < 0.001), and the number of dissected intrathoracic lymph nodes was significantly higher (P = 0.03) than in the LD group. No significant differences were observed in the frequencies of overall postoperative complications. MIE in the prone position preserves better oxygenation of patients during the early recovery period, and is associated with less blood loss and a larger number of dissected lymph nodes.	[Tanaka, Eiji; Okabe, Hiroshi; Kinjo, Yousuke; Tsunoda, Shigeru; Obama, Kazutaka; Hisamori, Shigeo; Sakai, Yoshiharu] Kyoto Univ, Grad Sch Med, Dept Surg, Sakyo Ku, Kyoto 6068507, Japan	Okabe, H (reprint author), Kyoto Univ, Grad Sch Med, Dept Surg, Sakyo Ku, 54 Kawahara Cho, Kyoto 6068507, Japan.	tanaei@kuhp.kyoto-u.ac.jp; hokabe@kuhp.kyoto-u.ac.jp					Akiyama H, 1994, ANN SURG, V220, P372; Altorki N, 2002, ANN SURG, V236, P177, DOI 10.1097/01.SLA.0000021583.51164.F4; Luketich JD, 2012, ANN SURG, V256, P95, DOI 10.1097/SLA.0b013e3182590603; Ando N, 2012, ANN SURG ONCOL, V19, P68, DOI 10.1245/s10434-011-2049-9; Biere SSAY, 2012, LANCET, V379, P1887, DOI 10.1016/S0140-6736(12)60516-9; Noshiro H, 2010, SURG ENDOSC, V24, P2965, DOI 10.1007/s00464-010-1072-4; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Okabe H, 2013, J GASTROINTEST SURG, V17, P397, DOI 10.1007/s11605-012-2009-0; Fridrich P, 1996, ANESTH ANALG, V83, P1206, DOI 10.1097/00000539-199612000-00013; Yatabe T, 2013, SURG TODAY, V43, P386, DOI 10.1007/s00595-012-0375-6; Pelosi P, 1996, ANESTH ANALG, V83, P578, DOI 10.1097/00000539-199609000-00025; Kinjo Y, 2012, SURG ENDOSC, V26, P381, DOI 10.1007/s00464-011-1883-y; Chatte G, 1997, AM J RESP CRIT CARE, V155, P473; Luketich JD, 2003, ANN SURG, V238, P486, DOI 10.1097/01.sla.0000089858.40725.68; Palanivelu C, 2006, J AM COLL SURGEONS, V203, P7, DOI 10.1016/j.jamcollsurg.2006.03.016; Jarral OA, 2012, SURG ENDOSC, V26, P2095, DOI 10.1007/s00464-012-2172-0; Fabian T, 2008, SURG ENDOSC, V22, P2485, DOI 10.1007/s00464-008-9799-x; Yatabe T, 2010, J ANESTH, V24, P803, DOI 10.1007/s00540-010-0968-4; AKIYAMA H, 1994, ANN SURG, V220, P364, DOI 10.1097/00000658-199409000-00012; Nguyen NT, 2008, ANN SURG, V248, P1081, DOI 10.1097/SLA.0b013e31818b72b5; Blanch L, 1997, INTENS CARE MED, V23, P1033, DOI 10.1007/s001340050453; Yoshida N, 2014, SURG TODAY, V44, P526, DOI 10.1007/s00595-013-0577-6; Watanabe M, 2013, SURG TODAY, V43, P237, DOI 10.1007/s00595-012-0300-z; Feng MX, 2012, J AM COLL SURGEONS, V214, P838, DOI 10.1016/j.jamcollsurg.2011.12.047; Itami A, 2008, SURG ENDOSC, V22, P2741, DOI 10.1007/s00464-008-0106-7; Iwahashi M, 2014, SURG TODAY, V44, P1708, DOI 10.1007/s00595-013-0782-3; Luketich JD, 2003, ANN SURG, V238, P485; PUTNAM JB, 1994, ANN THORAC SURG, V57, P319; Sato N, 2002, ANN SURG, V236, P184, DOI 10.1097/01.SLA.0000022025.67985.53; Tanaka E, 2012, Asian J Endosc Surg, V5, P111, DOI 10.1111/j.1758-5910.2012.00131.x	30	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	JUL	2015	45	7					819	825		10.1007/s00595-014-1061-7		7	Surgery	Surgery	CK2LB	WOS:000356040800004		
J	Morimoto, M; Miyakura, Y; Lefor, AT; Takahashi, K; Horie, H; Koinuma, K; Tanaka, H; Ito, H; Shimizu, T; Kono, Y; Sata, N; Fukushima, N; Sakatani, T; Yasuda, Y				Morimoto, Mitsuaki; Miyakura, Yasuyuki; Lefor, Alan T.; Takahashi, Kazuya; Horie, Hisanaga; Koinuma, Koji; Tanaka, Hiroyuki; Ito, Homare; Shimizu, Tetsuichiro; Kono, Yoshihiko; Sata, Naohiro; Fukushima, Noriyoshi; Sakatani, Takashi; Yasuda, Yoshikazu			Reduction in the size of enlarged pelvic lymph nodes after chemoradiation therapy is associated with fewer lymph node metastases in locally advanced rectal carcinoma	SURGERY TODAY			English	Article						Rectal cancer; CRT; Lateral lymph node; Lateral lymph node dissection	PATHOLOGICAL COMPLETE RESPONSE; COMBINED-MODALITY THERAPY; TOTAL MESORECTAL EXCISION; PREOPERATIVE CHEMORADIATION; NEOADJUVANT CHEMORADIATION; CANCER; SURVIVAL; CHEMORADIOTHERAPY; RECURRENCE; ADENOCARCINOMA	We hypothesized that a reduction in the size of the lymph nodes after neoadjuvant therapy for locally advanced rectal carcinoma would be associated with decreased lymph node metastases and/or a better prognosis. Between March 2006 and April 2012, 71 patients with primary rectal cancer received neoadjuvant chemoradiation therapy (CRT). For all lymph nodes 5 mm or larger in size, the major and minor axes were measured on CT scan images, and the product was calculated. The lymph node size was determined before and after CRT. The patients were divided into three groups based on the lymph node size before and after treatment. Group A exhibited a reduction in size of 60 % or more, Group B a reduction of less than 60 % and Group C had no lymph node enlargement before treatment. The incidence of lymph node metastases on pathological examination was 15 % in Group A and 50 % in Group B (p = 0.006). The five-year disease-free survival in Group A was 84 % compared with 78 % in Group B (log rank p = 0.34). The five-year overall survival in Group A was 92 % compared with 74 % in Group B (log rank p = 0.088). A reduction in the size of enlarged lymph nodes after neoadjuvant therapy may be a useful prognostic factor for recurrence and survival.	[Morimoto, Mitsuaki; Miyakura, Yasuyuki; Lefor, Alan T.; Takahashi, Kazuya; Horie, Hisanaga; Koinuma, Koji; Tanaka, Hiroyuki; Ito, Homare; Shimizu, Tetsuichiro; Kono, Yoshihiko; Sata, Naohiro; Yasuda, Yoshikazu] Jichi Med Univ, Dept Surg, Shimotsuke, Tochigi 3290498, Japan; [Fukushima, Noriyoshi; Sakatani, Takashi] Jichi Med Univ, Dept Pathol, Shimotsuke, Tochigi 3290498, Japan	Miyakura, Y (reprint author), Jichi Med Univ, Dept Surg, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	mittyone2000@yahoo.co.jp; miyakura@jichi.ac.jp		Lefor, Alan/0000-0001-6673-5630			Akiyoshi T, 2013, ANN SURG ONCOL, V21, P189; Huebner M, 2012, WORLD J SURG, V36, P675, DOI 10.1007/s00268-011-1409-8; CHARI RS, 1995, ANN SURG, V221, P778, DOI 10.1097/00000658-199506000-00016; Heald RJ, 1998, ARCH SURG-CHICAGO, V133, P894, DOI 10.1001/archsurg.133.8.894; Rodel C, 2005, J CLIN ONCOL, V23, P8688, DOI 10.1200/JCO.2005.02.1329; Sugihara K, 2006, DIS COLON RECTUM, V49, P1663, DOI 10.1007/s10350-006-0714-z; RICH TA, 1995, INT J RADIAT ONCOL, V32, P1025, DOI 10.1016/0360-3016(95)00020-Y; Kim NK, 2006, ANN SURG, V244, P1024, DOI 10.1097/01.sla.0000225360.99257.73; Theodoropoulos G, 2002, DIS COLON RECTUM, V45, P895, DOI 10.1097/01.DCR.000009491.47145.8F; de la Fuente SG, 2009, J GASTROINTEST SURG, V13, P269, DOI 10.1007/s11605-008-0717-2; Garcia-Aguilar J, 2003, DIS COLON RECTUM, V46, P298, DOI 10.1097/01.DCR.0000054637.75996.DF; Shia J, 2004, AM J SURG PATHOL, V28, P215, DOI 10.1097/00000478-200402000-00009; Sauer R, 2004, NEW ENGL J MED, V351, P1731, DOI 10.1056/NEJMoa040694; Kalady MF, 2009, ANN SURG, V250, P582, DOI 10.1097/SLA.0b013e3181b91e63; Onaitis MW, 2001, ANN SURG ONCOL, V8, P801, DOI 10.1245/aso.2001.8.10.801; Kuo LJ, 2007, ANN SURG ONCOL, V14, P2766, DOI 10.1245/s10434-007-9471-z; Stipa F, 2006, ANN SURG ONCOL, V13, P1047, DOI 10.1245/ASO.2006.03.053; Smith KD, 2010, ANN SURG, V251, P261, DOI 10.1097/SLA.0b013e3181bdfc27; Onaitis MW, 2001, ANN SURG, V233, P778, DOI 10.1097/00000658-200106000-00007; Bedrosian I, 2004, J GASTROINTEST SURG, V8, P56, DOI 10.1016/j.gassur.2003.09.019; Dworak O, 1997, INT J COLORECTAL DIS, V12, P19, DOI 10.1007/s003840050072; Guillem JG, 2005, ANN SURG, V241, P829, DOI 10.1097/01.sla.0000161980.46459.96; Japanese Society for Cancer of the Colon and Rectum, 2009, JAP CLASS COL CARC; Kaminsky-Forrett MC, 1998, INT J RADIAT ONCOL, V42, P935, DOI 10.1016/S0360-3016(98)00345-9; Morcos B, 2010, EJSO-EUR J SURG ONC, V36, P345, DOI 10.1016/j.ejso.2009.12.006; Sobin LH, 2009, COLON RECTUM UICC TN, V7th, P100; Takahashi T, 2000, DIS COLON RECTUM, V43, P59; Vauthey JN, 1999, ANN SURG, V229, P745, DOI 10.1097/00000658-199905000-00018	28	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	JUL	2015	45	7					834	840		10.1007/s00595-014-1007-0		7	Surgery	Surgery	CK2LB	WOS:000356040800006		
J	Ohira, G; Kawahira, H; Miyauchi, H; Suzuki, K; Nishimori, T; Hanari, N; Mori, M; Tohma, T; Gunji, H; Horibe, D; Narushima, K; Matsubara, H				Ohira, Gaku; Kawahira, Hiroshi; Miyauchi, Hideaki; Suzuki, Kazufumi; Nishimori, Takanori; Hanari, Naoyuki; Mori, Mikito; Tohma, Takayuki; Gunji, Hisashi; Horibe, Daisuke; Narushima, Kazuo; Matsubara, Hisahiro			Synthetic polyglycomer short-term absorbable sutures vs. polydioxanone long-term absorbable sutures for preventing incisional hernia and wound dehiscence after abdominal wall closure: a comparative randomized study of patients treated for gastric or colon cancer	SURGERY TODAY			English	Article						Suture material; Incisional hernia; Wound dehiscence; Randomized trial	MIDLINE LAPAROTOMY; METAANALYSIS; TRIAL	To compare the results of abdominal wall closure using interrupted synthetic short-term vs. long-term tensile strength-retaining absorbable sutures. The subjects were 55 patients undergoing elective laparotomy through a midline vertical incision for gastric or colon cancer surgery between November 2008 and August 2010, at our hospital. After providing informed consent, the patients were randomized for suturing with Polysorb(A (R)), which provides short-term tensile strength, or with (PDSII)-I-A (R), which provides long-term strength. The primary outcome analyzed was the incidence of incisional hernia or wound dehiscence. There were 28 patients allocated to the Polysorb group and 27 to the PDS II group. Postoperative wound dehiscence was noted in two patients (3.6 %). Five of 51 patients (9.8 %) suffered incisional hernia within 1 year after surgery, 6 of 41 patients (14.6 %) within 2 years, and 6 of 35 patients (17.1 %) within 3 years. There was no significant per year difference in the incidence of incisional hernia or wound dehiscence between the groups. Outcomes were favorable in both groups and not inferior to reported outcomes of larger-scale studies. Verification of the equivalence between the two types of suture material necessitates larger-scale studies that adopt the same suture methods.	[Ohira, Gaku; Miyauchi, Hideaki; Suzuki, Kazufumi; Nishimori, Takanori; Hanari, Naoyuki; Mori, Mikito; Tohma, Takayuki; Gunji, Hisashi; Horibe, Daisuke; Narushima, Kazuo; Matsubara, Hisahiro] Chiba Univ, Grad Sch Med, Dept Frontier Surg, Chiba 2638522, Japan; [Kawahira, Hiroshi] Chiba Univ, Ctr Frontier Med Engn, Inage Ku, Chiba 2638522, Japan	Kawahira, H (reprint author), Chiba Univ, Ctr Frontier Med Engn, Inage Ku, 1-33 Yayoi Chou, Chiba 2638522, Japan.	hk@faculty.chiba-u.jp					Justinger C, 2012, SURGERY, V151, P398, DOI 10.1016/j.surg.2011.08.004; Hsiao WC, 2000, WORLD J SURG, V24, P747; CORMAN ML, 1981, AM J SURG, V141, P510, DOI 10.1016/0002-9610(81)90150-1; Hodgson NCF, 2000, ANN SURG, V231, P436, DOI 10.1097/00000658-200003000-00018; Diener MK, 2010, ANN SURG, V251, P843, DOI 10.1097/SLA.0b013e3181d973e4; Rath AM, 1998, HERNIA, V2, P145, DOI 10.1007/BF01250034; van't Riet M, 2002, BRIT J SURG, V89, P1350, DOI 10.1046/j.1365-2168.2002.02258.x; WISSING J, 1987, BRIT J SURG, V74, P738, DOI 10.1002/bjs.1800740831	8	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	JUL	2015	45	7					841	845		10.1007/s00595-014-1103-1		5	Surgery	Surgery	CK2LB	WOS:000356040800007		
J	Nozawa, A; Kubo, S; Takemura, S; Sakata, C; Urata, Y; Nishioka, T; Kinoshita, M; Hamano, G; Uenishi, T; Suehiro, S				Nozawa, Akinori; Kubo, Shoji; Takemura, Shigekazu; Sakata, Chikaharu; Urata, Yorihisa; Nishioka, Takayoshi; Kinoshita, Masahiko; Hamano, Genya; Uenishi, Takahiro; Suehiro, Shigefumi			Hepatic resection for hepatocellular carcinoma in super-elderly patients aged 80 years and older in the first decade of the 21st century	SURGERY TODAY			English	Article						Hepatectomy; Super-elderly; Hepatocellular carcinoma; Delirium	LIVER RESECTION; HEPATECTOMY; SURGERY	We evaluated the preoperative and postoperative characteristics and prognosis of super-elderly patients with hepatocellular carcinoma (HCC). Four hundred and thirty-one patients who underwent hepatic resection for HCC were classified into three groups according to their age at the time of surgery: super-elderly (a parts per thousand yen80 years; n = 20), elderly (70-80 years; n = 172) and younger (< 70 years; n = 239). We compared the clinical characteristics, preoperative and postoperative factors and prognosis among the groups to evaluate whether liver resection is appropriate for super-elderly patients. The liver function was not significantly different among the groups. The proportion of patients with preoperative cardiovascular and respiratory disease and hypertension was higher in the super-elderly group compared to the other groups. The super-elderly group had shorter operations and reduced hemorrhage rates compared to the other groups. Postoperative cardiovascular complications and delirium were more frequently observed in the super-elderly group. The overall and tumor-free survival rates were not significantly different among the groups. Super-elderly patients had a lower rate of liver or HCC-related death and a higher rate of death due to other causes than the other groups. Super-elderly HCC patients who are appropriately evaluated and selected might have a favorable prognosis after undergoing hepatic resection.	[Nozawa, Akinori; Kubo, Shoji; Takemura, Shigekazu; Sakata, Chikaharu; Urata, Yorihisa; Nishioka, Takayoshi; Kinoshita, Masahiko; Hamano, Genya; Uenishi, Takahiro] Osaka City Univ, Grad Sch Med, Dept Hepatobiliary Pancreat Surg, Abeno Ku, Osaka 5458585, Japan; [Nozawa, Akinori; Suehiro, Shigefumi] Osaka City Univ, Grad Sch Med, Dept Cardiovasc Surg, Osaka 5458585, Japan	Nozawa, A (reprint author), Osaka City Univ, Grad Sch Med, Dept Hepatobiliary Pancreat Surg, Abeno Ku, 1-4-3 Asahimachi, Osaka 5458585, Japan.	m1166658@med.osaka-cu.ac.jp					Ferrero A, 2005, WORLD J SURG, V29, P1101, DOI 10.1007/s00268-005-7768-2; Hanazaki K, 2001, J AM COLL SURGEONS, V192, P38, DOI 10.1016/S1072-7515(00)00778-X; Koch M, 2011, SURGERY, V149, P680, DOI 10.1016/j.surg.2010.12.002; Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009; Poon RTP, 1999, AM J GASTROENTEROL, V94, P2460; Yamada S, 2012, HEPATOL RES, V42, P454, DOI 10.1111/j.1872-034X.2011.00952.x; Tsujita E, 2012, HEPATO-GASTROENTEROL, V59, P1553, DOI 10.5754/hge09485; Huang J, 2009, J GASTROINTEST SURG, V13, P1627, DOI 10.1007/s11605-009-0933-4; MAKUUCHI M, 1993, SEMIN SURG ONCOL, V9, P298, DOI 10.1002/ssu.2980090404; Kondo K, 2008, WORLD J SURG, V32, P2223, DOI 10.1007/s00268-008-9688-4; Yoshimura Y, 2004, WORLD J SURG, V28, P982, DOI 10.1007/s00268-004-7344-1; Kaibori M, 2009, J SURG ONCOL, V99, P154, DOI 10.1002/jso.21221; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; FONG Y, 1995, ANN SURG, V222, P426; Ikai I, 2007, HEPATOL RES, V37, P676, DOI 10.1111/j.1872-034X.2007.00119.x; Rahbari NN, 2011, SURGERY, V149, P713, DOI 10.1016/j.surg.2010.10.001; Yeh CN, 2004, HEPATO-GASTROENTEROL, V51, P219; Aldrighetti L, 2006, J SURG ONCOL, V93, P186, DOI 10.1002/jso.20342; Nanashima A, 2011, J SURG ONCOL, V104, P284, DOI 10.1002/jso.21932; Caratozzolo E, 2007, G Chir, V28, P419; Dingo D, 2004, ANN SURG, V240, P205; EZAKI T, 1987, BRIT J SURG, V74, P471, DOI 10.1002/bjs.1800740614; Fong Y, 1997, BRIT J SURG, V84, P1386; Fong Y, 1995, ANN SURG, V222, P434; FORTNER JG, 1990, ANN SURG, V211, P141, DOI 10.1097/00000658-199002000-00005; Ministry of Health Labour and Welfare, 2010, JAP SIMPL LIF TABL; NAGASUE N, 1993, SURGERY, V113, P148; Shirabe K, 2009, WORLD J SURG, V33, P1927, DOI 10.1007/s00268-009-0122-3; TAKENAKA K, 1994, ARCH SURG-CHICAGO, V129, P846; The Terminology Committee of the IHPBA, 2000, HPB, V2, P333; Tsujita E, 2010, SURGERY, V147, P696, DOI 10.1016/j.surg.2009.10.054; Wu CC, 1999, SURGERY, V125, P332, DOI 10.1016/S0039-6060(99)70245-X; Yamamoto K, 1997, HEPATO-GASTROENTEROL, V44, P514; YANAGA K, 1988, AM J SURG, V155, P238, DOI 10.1016/S0002-9610(88)80703-7	34	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	JUL	2015	45	7					851	857		10.1007/s00595-014-0994-1		7	Surgery	Surgery	CK2LB	WOS:000356040800009		
J	Okuda, K; Yano, M; Sasaki, H; Moriyama, S; Hikosaka, Y; Shitara, M; Tatematsu, T; Suzuki, A; Fujii, Y				Okuda, Katsuhiro; Yano, Motoki; Sasaki, Hidefumi; Moriyama, Satoru; Hikosaka, Yu; Shitara, Masayuki; Tatematsu, Tsutomu; Suzuki, Ayumi; Fujii, Yoshitaka			A safe method for marking small pulmonary nodules with crystal violet	SURGERY TODAY			English	Article						Co-morbidity; Lung cancer diagnosis; Lung cancer surgery	THORACOSCOPIC SURGERY; PREOPERATIVE MARKING; NEEDLE-BIOPSY; LUNG-CANCER; RESECTION; LOCALIZATION; LESIONS; CT; GUIDANCE; EMBOLISM	The number of cases of wedge resection of small-sized pulmonary nodules performed under video-assisted thoracoscopic surgery (VATS) is increasing. Computed tomography (CT)-guided marking with hook wires has been used to locate the nodules that are not identifiable under VATS. However, this method is invasive and is associated with a risk of complications. We evaluated the usefulness of marking the pleural surface above the nodule using crystal violet for 22 small-sized pulmonary nodules. Following the collapse of the lung, a long stick with a cotton tip dipped in crystal violet was inserted from the thoracic port or a small thoracotomy, and was placed against the inside of the chest wall right above the nodule with reference to the preoperative CT image. The lung was then expanded, and the crystal violet-infiltrated tip stained the visceral pleura. Regardless of the marking point, wedge resection of the lung was performed. To evaluate the accuracy of the marking, we measured the distance from the center of the marking to the point on the visceral pleural nearest to the nodule (DMN) in the resected lung specimen. This marking method caused no morbidity during or after the operation. The DMN ranged between 0 and 50 mm (mean +/- A SD 18.2 +/- A 12.6 mm). In 18 of 22 cases (81.8 %), the DMN was 20 mm or less. The intraoperative marking method using crystal violet was performed with reasonable accuracy. It also caused no morbidity. It was easy and non-invasive. This method can be used in the cases in which CT-guided percutaneous marking is not feasible due to the nodule's location.	[Okuda, Katsuhiro; Yano, Motoki; Sasaki, Hidefumi; Moriyama, Satoru; Hikosaka, Yu; Shitara, Masayuki; Tatematsu, Tsutomu; Suzuki, Ayumi; Fujii, Yoshitaka] Nagoya City Univ, Grad Sch Med Sci, Dept Oncol Immunol & Surg, Mizuho Ku, Nagoya, Aichi 4678601, Japan	Yano, M (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Oncol Immunol & Surg, Mizuho Ku, 1 Kawasumi,Mizuho Cho, Nagoya, Aichi 4678601, Japan.	motoki@med.nagoya-cu.ac.jp					Suzuki K, 1999, CHEST, V115, P563, DOI 10.1378/chest.115.2.563; Iwasaki Y, 2005, RESP MED, V99, P285, DOI 10.1016/j.rmed.2004.07.015; Tomiyama N, 2006, EUR J RADIOL, V59, P60, DOI 10.1016/j.ejrad.2006.02.001; Horan TA, 2002, ANN THORAC SURG, V73, P1647, DOI 10.1016/S0003-4975(01)03371-9; Sakiyama S, 2003, J THORAC CARDIOV SUR, V126, P1207, DOI 10.1016/S0022-5223(03)00821-3; Matsuguma H, 2005, ANN THORAC SURG, V80, P2026, DOI 10.1016/j.athoracsur.2005.06.074; Miyoshi T, 2006, J THORAC CARDIOV SUR, V131, P704, DOI 10.1016/j.jtcvs.2005.09.019; Endo M, 2004, CHEST, V125, P1747, DOI 10.1378/chest.125.5.1747; Ikeda K, 2007, CHEST, V131, P502, DOI 10.1378/chest.06-1882; MACK MJ, 1992, ANN THORAC SURG, V53, P1123; KERRIGAN DC, 1992, ANN THORAC SURG, V53, P163; Echfeld U, 2005, ANN THORAC SURG, V79, P313; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Mack MJ, 1993, ANN THORAC SURG, V56, P30; MACK MJ, 1993, ANN THORAC SURG, V56, P825; Munden RF, 1997, RADIOLOGY, V202, P105; Nishida T, 2013, EUR J CARDIO-THORAC, V44, P1131, DOI 10.1093/ejcts/ezt285; Santambrogio R, 1999, ANN THORAC SURG, V68, P218, DOI 10.1016/S0003-4975(99)00459-2; Sawabata N, 2000, CHEST, V118, P936, DOI 10.1378/chest.118.4.936; Watanabe K, 2006, J THORAC CARDIOVASC, V132, P210; Yoshida Y, 2011, INTERACT CARDIOV TH, V13, P25, DOI 10.1510/icvts.2011.266932	21	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	JUL	2015	45	7					871	875		10.1007/s00595-014-1048-4		5	Surgery	Surgery	CK2LB	WOS:000356040800012		
J	Kubota, A; Goda, T; Tsuru, T; Yonekura, T; Yagi, M; Kawahara, H; Yoneda, A; Tazuke, Y; Tani, G; Ishii, T; Umeda, S; Hirano, K				Kubota, Akio; Goda, Taro; Tsuru, Tomomitsu; Yonekura, Takeo; Yagi, Makoto; Kawahara, Hisayoshi; Yoneda, Akihiro; Tazuke, Yuko; Tani, Gakuto; Ishii, Tomohiro; Umeda, Satoshi; Hirano, Katsuhisa			Efficacy and safety of strong acid electrolyzed water for peritoneal lavage to prevent surgical site infection in patients with perforated appendicitis	SURGERY TODAY			English	Article						Strong acid electrolyzed water; Perforated peritonitis; Surgical site infection; Peritoneal lavage; Bactericidal activity; Hypochlorous acid; Perforated appendicitis	AQUEOUS-SOLUTION; SURGERY; PH	Our previous experimental study of perforated peritonitis in rats proved that peritoneal lavage with strong acid electrolyzed water (SAEW) has no adverse effects, reduces the bacteria count in the ascitic fluid more effectively than saline, and increases the survival rate significantly. Thus, we conducted a randomized controlled study, applying SAEW in the treatment of perforated appendicitis in children. Forty-four patients, aged 3-14 years, were randomly divided into two groups: Group S (n = 20), in which the peritoneal cavity was lavaged with 100 ml/kg saline and the wound was washed out with 200 ml saline; and Group E (n = 24), in which the peritoneal cavity was lavaged with 100 ml/kg SAEW and the wound was washed out with 200 ml SAEW. No adverse effect of SAEW was observed in Group E. There was no difference in the bacterial evanescence ratio of ascitic fluid after lavage between Groups S and E (11.1 and 15.8 %, respectively). A residual abscess developed in one patient from each group (5.0 and 4.2 %, respectively). The incidence of surgical site infection (SSI) was significantly lower in Group E than in Group S (0 and 20 %, respectively; P < 0.05). There was no difference in the duration of pyrexia, positive C-reactive protein, leukocytosis, or hospital stay between the groups. Peritoneal lavage and wound washing with SAEW have no adverse effects and are effective for preventing SSI.	[Kubota, Akio; Goda, Taro; Kawahara, Hisayoshi; Yoneda, Akihiro; Tazuke, Yuko; Tani, Gakuto; Ishii, Tomohiro; Umeda, Satoshi; Hirano, Katsuhisa] Osaka Med Ctr, Dept Pediat Surg, Izumi Ku, Osaka 5941101, Japan; [Kubota, Akio; Goda, Taro; Kawahara, Hisayoshi; Yoneda, Akihiro; Tazuke, Yuko; Tani, Gakuto; Ishii, Tomohiro; Umeda, Satoshi; Hirano, Katsuhisa] Res Ctr Maternal & Child Hlth, Osaka 5941101, Japan; [Tsuru, Tomomitsu] St Maria Hosp, Dept Pediat Surg, Kurume, Fukuoka, Japan; [Yonekura, Takeo] Kinki Univ, Nara Hosp, Dept Pediat Surg, Nara, Japan; [Yagi, Makoto] Kinki Univ, Sch Med, Div Pediat Surg, Osaka 589, Japan	Kubota, A (reprint author), Osaka Med Ctr, Dept Pediat Surg, Izumi Ku, 840 Murodo Cho, Osaka 5941101, Japan.	kubota@wakayama-med.ac.jp; tarorinahana@yahoo.co.jp; tsururin@st-mary-med.or.jp; yonera@nara.med.kindai.ac.jp; yagim@surg.med.kindai.ac.jp; kawaharahisayoshi@gmail.com; akihiroyo@gmail.com; tazuke@mch.pref.osaka.jp; tani@kuh.biglobe.ne.jp; t_ici0314@yahoo.co.jp; sumeda@pedsurg.med.osaka-u.ac.jp; hrnkths@med.u-toyama.ac.jp					Abe S, 1994, JAPAN J CONSERV DENT, V37, P1616; Owens CD, 2008, J HOSP INFECT, V70, P3, DOI 10.1016/S0195-6701(08)60017-1; Bratzler DW, 2006, CLIN INFECT DIS, V43, P322, DOI 10.1086/505220; Nichols RL, 2001, EMERG INFECT DIS, V7, P220; Tagawa M, 2000, J ANTIMICROB CHEMOTH, V46, P363, DOI 10.1093/jac/46.3.363; BECKING LGMB, 1960, J GEOL, V68, P243; Hayashi H, 1997, ARTIF ORGANS, V21, P39; Hotta K, 1994, ACTINOMYCETOLOGICA, V18, P51, DOI 10.3209/saj.8_51; Hotta K, 2000, J JPN SOC INTENSIVE, V7, P97; Kubota A, 1999, ASIAN J SURG, V22, P282; Kubota A, 2009, SURG TODAY, V39, P514, DOI 10.1007/s00595-008-3914-4; Morita C, 2000, J VIROL METHODS, V85, P163, DOI 10.1016/S0166-0934(99)00165-2; Nakagawara S, 1998, ANAL SCI, V14, P691, DOI 10.2116/analsci.14.691; Ohuchi Shingo, 2003, Jpn J Thorac Cardiovasc Surg, V51, P511, DOI 10.1007/s11748-003-0112-6; Sekiya S, 1997, ARTIF ORGANS, V21, P32; Selkon J B, 2006, J Wound Care, V15, P33; Takemura M, 1999, JPN J SURG, V61, P1303; Tanaka N, 1999, ARTIF ORGANS, V23, P303; Wang L., 2007, J BURNS WOUNDS, V6, P65	19	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	JUL	2015	45	7					876	879		10.1007/s00595-014-1050-x		4	Surgery	Surgery	CK2LB	WOS:000356040800013		
J	Matsumoto, T; Tanaka, S; Okadome, J; Kyuragi, R; Fukunaga, R; Kawakubo, E; Itoh, H; Okazaki, J; Shirabe, K; Fukuda, A; Maehara, Y				Matsumoto, Takuya; Tanaka, Shinichi; Okadome, Jun; Kyuragi, Ryoichi; Fukunaga, Ryota; Kawakubo, Eisuke; Itoh, Hiroyuki; Okazaki, Jin; Shirabe, Ken; Fukuda, Atsushi; Maehara, Yoshihiko			Midterm outcomes of endovascular repair for abdominal aortic aneurysms with the on-label use compared with the off-label use of an endoprosthesis	SURGERY TODAY			English	Article						Abdominal aortic aneurysm; Endovascular aneurysm repair; Endoprostheses; Instructions for use	HYPOGASTRIC ARTERY BYPASS; PELVIC CIRCULATION; ENDOLEAK; MULTICENTER	Endovascular repair of an abdominal aortic aneurysm (EVAR) is sometimes not performed in accordance with the instructions for use (IFU) of the endoprosthesis ("off-label use"). We investigated whether the off-label use of the endograft affected the outcomes of EVAR. Demographic, anatomical, intraoperative and follow-up data on 100 patients in whom the endograft was used on-label in EVAR were compared retrospectively with the corresponding data of 50 patients with off-label endograft use. The endograft IFU were most often not followed in patients with challenging aortic neck anatomy or iliac access or fixation, steep neck angulation or bilateral hypogastric artery embolization. Compared with patients in whom the device was used on-label, patients with off-label use had significantly higher rates of intraoperative type I or III endoleaks and proximal aortic cuff placement or other adjunctive procedures. However, there were no midterm differences between the two groups in the rates of type 1b or II endoleaks, sac enlargement, device-limb occlusion or patient survival. Most midterm outcomes of EVAR in which the endografts were used off-label were similar to those associated with on-label use of the devices. Off-label use of EVAR endoprostheses is feasible, but requires the use of special techniques in patients with challenging anatomical features.	[Matsumoto, Takuya; Tanaka, Shinichi; Okadome, Jun; Kyuragi, Ryoichi; Fukunaga, Ryota; Kawakubo, Eisuke; Itoh, Hiroyuki; Okazaki, Jin; Shirabe, Ken; Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Higashi Ku, Fukuoka 8128582, Japan; [Fukuda, Atsushi] Karatsu Saiseikai Hosp, Dept Surg, Saga 8470852, Japan	Matsumoto, T (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	tak@qa2.so-net.ne.jp			WL Gore and Associates	We thank Rie Nishikuma for editorial assistance, Junji Kishimoto for statistical advice, Nicholas Smith for language assistance, Renee J. Robillard for English-language editing and WL Gore and Associates for providing funding for the English-language editing.	Angiletta D, 2011, ANN VASC SURG, V25, pe15; Hoshina Katsuyuki, 2014, Ann Vasc Dis, V7, P34, DOI 10.3400/avd.oa.13-00073; Hogg ME, 2011, J VASC SURG, V53, P1178, DOI 10.1016/j.jvs.2010.11.045; Zarins CK, 2000, J VASC SURG, V32, P90, DOI 10.1067/mva.2000.108278; Naughton PA, 2012, J VASC SURG, V55, P956, DOI 10.1016/j.jvs.2011.10.121; Miller A, 2009, ARCH SURG-CHICAGO, V144, P900, DOI 10.1001/archsurg.2009.70; Carroccio A, 2002, J VASC SURG, V36, P679, DOI 10.1067/mva.2002.128309; Lee WA, 2006, J VASC SURG, V44, P1162, DOI 10.1016/j.jvs.2006.08.047; Unno N, 2006, J VASC SURG, V44, P1170, DOI 10.1016/j.jvs.2006.08.011; Hoshina K, 2011, INT ANGIOL, V30, P467; Gelfand DV, 2006, ANN VASC SURG, V20, P69, DOI 10.1007/s10016-005-9382-z; Arko FR, 2004, J VASC SURG, V39, P404, DOI 10.1016/j.jvs.2003.07.012; Broker HS, 2008, J VASC SURG, V47, P702, DOI 10.1016/j.jvs.2007.11.049; Buth J, 2000, J VASC SURG, V31, P134, DOI 10.1016/S0741-5214(00)70075-9; Eguchi D, 2010, JPN J VASC SURG, V19, P385; Greenberg R, 2000, CARDIOVASC SURG, V8, P350, DOI 10.1016/S0967-2109(00)00035-1; Matsumoto T, 2002, J CARDIOVASC SURG, V43, P403; Parodi J C, 1991, Ann Vasc Surg, V5, P491, DOI 10.1007/BF02015271; Yamasaki Ryo, 1999, Fukuoka Acta Medica, V90, P318	19	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	JUL	2015	45	7					880	885		10.1007/s00595-014-0978-1		6	Surgery	Surgery	CK2LB	WOS:000356040800014		
J	Izumi, D; Ishimoto, T; Yoshida, N; Nakamura, K; Kosumi, K; Tokunaga, R; Sugihara, H; Sawayama, H; Karashima, R; Imamura, Y; Ida, S; Hiyoshi, Y; Iwagami, S; Baba, Y; Sakamoto, Y; Miyamoto, Y; Watanabe, M; Baba, H				Izumi, Daisuke; Ishimoto, Takatsugu; Yoshida, Naoya; Nakamura, Kenichi; Kosumi, Keisuke; Tokunaga, Ryuma; Sugihara, Hidetaka; Sawayama, Hiroshi; Karashima, Ryuichi; Imamura, Yu; Ida, Satoshi; Hiyoshi, Yukiharu; Iwagami, Shiro; Baba, Yoshifumi; Sakamoto, Yasuo; Miyamoto, Yuji; Watanabe, Masayuki; Baba, Hideo			A clinicopathological analysis of primary mucosal malignant melanoma	SURGERY TODAY			English	Article						Primary mucosal malignant melanoma; CXCL12; CXCR4	CD44 SURFACE EXPRESSION; CUTANEOUS MELANOMA; PANCREATIC-CANCER; BREAST-CANCER; CXCR4; ESOPHAGUS; PROGNOSIS; MIGRATION; CELLS; PROLIFERATION	Primary mucosal malignant melanoma (PMMM) is a rare and highly lethal neoplasm associated with a poor prognosis. CXC chemokine receptor 4 (CXCR4) is expressed on various tumor cells, including malignant melanoma. Recent data indicate that CXCL12 and CXCR4 play a critical role in the behavior of cancer cells and in the survival of cancer patients. However, there has been no study that has addressed the expression and function of CXCR4/CXCL12 signaling in PMMM. Immunohistochemical staining for CXCL12 and Ki67 in biopsy tissues from 10 cases of PMMM was performed. We analyzed the correlations between the clinicopathological features and expression levels of CXCL12 and Ki67. Six cases showed a high level of CXCL12 expression, while four cases had a low level of expression. High expression of CXCL12 correlated with a poor prognosis, although statistical significance was not reached (p = 0.054). Ki67 was highly expressed in five cases, while the expression in the other five cases was low. There was no correlation between the Ki67 expression and prognosis. The findings of this study suggest that CXCL12 expression may play an important role in the biological behavior of PMMM and may be associated with a poor prognosis of PMMM patients.	[Izumi, Daisuke; Ishimoto, Takatsugu; Yoshida, Naoya; Nakamura, Kenichi; Kosumi, Keisuke; Tokunaga, Ryuma; Sugihara, Hidetaka; Sawayama, Hiroshi; Karashima, Ryuichi; Imamura, Yu; Hiyoshi, Yukiharu; Iwagami, Shiro; Baba, Yoshifumi; Sakamoto, Yasuo; Miyamoto, Yuji; Baba, Hideo] Kumamoto Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, Chuo Ku, Kumamoto 8608556, Japan; [Ida, Satoshi; Watanabe, Masayuki] Canc Inst Hosp JCFR, Gastroenterol Surg, Tokyo, Japan	Baba, H (reprint author), Kumamoto Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan.	hdobaba@kumamoto-u.ac.jp					Toyozawa S, 2012, ACTA HISTOCHEM CYTOC, V45, P293, DOI 10.1267/ahc.12004; Torres S, 2013, CLIN CANCER RES, V19, P6006, DOI 10.1158/1078-0432.CCR-13-1130; Iwanuma Y, 2012, J GASTROENTEROL, V47, P21, DOI 10.1007/s00535-011-0490-y; CHALKIADAKIS G, 1985, ANN THORAC SURG, V39, P472; Sahoo Manash Ranjan, 2013, Am J Case Rep, V14, P280, DOI 10.12659/AJCR.889089; Jamieson NB, 2011, CLIN CANCER RES, V17, P3316, DOI 10.1158/1078-0432.CCR-10-3284; Urruticoechea A, 2005, J CLIN ONCOL, V23, P7212, DOI 10.1200/JCO.2005.07.501; Li Z, 2013, MOL CELL BIOCHEM, V381, P233, DOI 10.1007/s11010-013-1707-6; Li BZ, 2007, MELANOMA RES, V17, P239, DOI 10.1097/CMR.0b013e3281c4a079; Yin M, 2012, AM J PATHOL, V181, P2202, DOI 10.1016/j.ajpath.2012.08.027; Zlotnik A, 2006, INT J CANCER, V119, P2026, DOI 10.1002/ijc.22024; Scala S, 2005, CLIN CANCER RES, V11, P1835, DOI 10.1158/1078-0432.CCR-04-1887; SABANATHAN S, 1989, AM J GASTROENTEROL, V84, P1475; Saur D, 2005, GASTROENTEROLOGY, V129, P1237, DOI 10.1053/j.gastro.2005.06.056; Scala S, 2006, CLIN CANCER RES, V12, P2427, DOI 10.1158/1078-0432.CCR-05-1940; Koshiba T, 2000, CLIN CANCER RES, V6, P3530; Pich A, 2004, ANN ONCOL, V15, P1319, DOI 10.1093/annonc/mdh299; Boni R, 1996, J AM ACAD DERMATOL, V35, P416, DOI 10.1016/S0190-9622(96)90607-6; Dietrich A, 1997, EUR J CANCER, V33, P926, DOI 10.1016/S0959-8049(96)00512-6; Gimotty PA, 2005, J CLIN ONCOL, V23, P8048, DOI 10.1200/JCO.2005.02.0735; Jo, 1992, INT J ONCOL; Kim J, 2005, CLIN CANCER RES, V23, P2744; Liu YX, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-16; Machado J, 2011, WORLD J GASTROENTERO, V17, P4734, DOI 10.3748/wjg.v17.i42.4734; Samanna V, 2006, EXP CELL RES, V312, P2214, DOI 10.1016/j.yexcr.2006.03.022; Yoshinari C, 1999, MELANOMA RES, V9, P223, DOI 10.1097/00008390-199906000-00003	26	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	JUL	2015	45	7					886	891		10.1007/s00595-014-1041-y		6	Surgery	Surgery	CK2LB	WOS:000356040800015		
J	Shimada, S; Fukai, M; Wakayama, K; Ishikawa, T; Kobayashi, N; Kimura, T; Yamashita, K; Kamiyama, T; Shimamura, T; Taketomi, A; Todo, S				Shimada, Shingo; Fukai, Moto; Wakayama, Kenji; Ishikawa, Takahisa; Kobayashi, Nozomi; Kimura, Taichi; Yamashita, Kenichiro; Kamiyama, Toshiya; Shimamura, Tsuyoshi; Taketomi, Akinobu; Todo, Satoru			Hydrogen sulfide augments survival signals in warm ischemia and reperfusion of the mouse liver	SURGERY TODAY			English	Article						Hydrogen sulfide; Liver; Ischemia; Reperfusion; Mouse	HEPATIC ISCHEMIA/REPERFUSION INJURY; RAT-LIVER; PROTECTS; TRANSPLANTATION; ACTIVATION; MODEL; CARDIOPROTECTION; PRESERVATION; H2S; ANTIOXIDANT	Hydrogen sulfide (H2S) ameliorates hepatic ischemia and reperfusion injury (IRI), but the precise mechanism remains elusive. We investigated whether sodium hydrogen sulfide (NaHS), a soluble derivative of H2S, would ameliorate hepatic IRI, and if so, via what mechanism. Mice were subjected to partial warm ischemia for 75 min followed by reperfusion. Either NaHS or saline was administered intravenously 10 min before reperfusion. The liver and serum were collected 3, 6, and 24 h after reperfusion. In the NaHS(-) group, severe IRI was apparent by the ALT leakage, tissue injury score, apoptosis, lipid peroxidation, and inflammation (higher plasma TNF-alpha, IL-6, IL-1 beta, IFN-gamma, IL-23, IL-17, and CD40L), whereas IRI was significantly ameliorated in the NaHS(+) group. These effects could be explained by the augmented nuclear translocation of Nrf2, and the resulting up-regulation of HO-1 and thioredoxin-1. Phosphorylation of the PDK-1/Akt/mTOR/p70S6k axis, which is known to mediate pro-survival and anti-apoptotic signals, was significantly augmented in the NaHS(+) group, with a higher rate of PCNA-positive cells thereafter. NaHS ameliorated hepatic IRI by direct and indirect anti-oxidant activities by augmenting pro-survival, anti-apoptotic, and anti-inflammatory signals via mechanisms involving Nrf-2, and by accelerating hepatic regeneration via mechanisms involving Akt-p70S6k.	[Shimada, Shingo; Wakayama, Kenji; Ishikawa, Takahisa; Kobayashi, Nozomi; Kamiyama, Toshiya; Taketomi, Akinobu] Hokkaido Univ, Grad Sch Med, Dept Gastroenterol Surg 1, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Fukai, Moto; Yamashita, Kenichiro] Hokkaido Univ, Grad Sch Med, Dept Transplant Surg, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Kimura, Taichi] Hokkaido Univ, Grad Sch Med, Dept Pathol, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Shimamura, Tsuyoshi] Hokkaido Univ Hosp, Cent Clin Facil, Dept Organ Transplantat, Kita Ku, Sapporo, Hokkaido 060, Japan; [Todo, Satoru] St Maria Hosp, Affiliated Lab, Kurume, Fukuoka, Japan	Fukai, M (reprint author), Hokkaido Univ, Grad Sch Med, Dept Transplant Surg, Kita Ku, N-15,W-7, Sapporo, Hokkaido 0608638, Japan.	db7m-fki@hotmail.co.jp			Public Trust Surgery Fund; Ministry of Education, Science, Sports, and Culture of Japan [25293272]	We thank Mr. Masatoshi Horigome and Ms. Sayaka Miyoshi for their excellent technical support. This work was supported in part by a Public Trust Surgery Fund (2012) and a grant-in-aid for Scientific Research from the Ministry of Education, Science, Sports, and Culture of Japan (No. 25293272).	Fukai M, 2005, FREE RADICAL BIO MED, V38, P1372, DOI 10.1016/j.freeradbiomed.2005.02.004; Elrod JW, 2007, P NATL ACAD SCI USA, V104, P15560, DOI 10.1073/pnas.0705891104; Noshita N, 2001, J CEREBR BLOOD F MET, V21, P1442; Johansen D, 2006, BASIC RES CARDIOL, V101, P53, DOI 10.1007/s00395-005-0569-9; Kang K, 2009, LIVER TRANSPLANT, V15, P1306, DOI [10.1002/lt.21810, 10.1002/It.21810]; Jha S, 2008, AM J PHYSIOL-HEART C, V295, pH801, DOI 10.1152/ajpheart.00377.2008; Lowicka E, 2007, PHARMACOL REP, V59, P4; Kimura Y, 2010, ANTIOXID REDOX SIGN, V12, P1, DOI 10.1089/ars.2008.2282; King AL, 2011, EXP PHYSIOL, V96, P840, DOI 10.1113/expphysiol.2011.059725; Paine A, 2010, BIOCHEM PHARMACOL, V80, P1895, DOI 10.1016/j.bcp.2010.07.014; Hu Y, 2008, PFLUG ARCH EUR J PHY, V455, P607, DOI 10.1007/s00424-007-0321-4; Yokota R, 2000, SURGERY, V127, P661, DOI 10.1067/msy.2000.105864; Fu ZF, 2008, LIFE SCI, V82, P1196, DOI 10.1016/j.lfs.2008.04.005; Akamatsu Y, 2004, FASEB J, V18, P771, DOI 10.1096/fj.03-0921fje; Kim YC, 2003, ONCOGENE, V22, P1860, DOI 10.1038/sj.onc.1206369; Calvert JW, 2009, CIRC RES, V105, P365, DOI 10.1161/CIRCRESAHA.109.199919; Vollmar B, 2009, PHYSIOL REV, V89, P1269, DOI 10.1152/physrev.00027.2008; Tsang A, 2004, CIRC RES, V95, P230, DOI 10.1161/01.RES.0000138303.76488.fe; Wang DW, 2012, AUTOPHAGY, V8, P954, DOI 10.4161/auto.19927; Schlegel A, 2013, J HEPATOL, V59, P984, DOI 10.1016/j.jhep.2013.06.022; Monbaliu D, 2012, J HEPATOL, V56, P474, DOI 10.1016/j.jhep.2011.07.004; Shen XD, 2009, HEPATOLOGY, V50, P1537, DOI 10.1002/hep.23153; Vitvitsky V, 2012, ANTIOXID REDOX SIGN, V17, P22, DOI 10.1089/ars.2011.4310; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Abu-Amara M, 2010, LIVER TRANSPLANT, V16, P1016, DOI 10.1002/lt.22117; Hunter JP, 2012, BRIT J SURG, V99, P1665, DOI 10.1002/bjs.8956; Zwacka RM, 1998, NAT MED, V4, P698, DOI 10.1038/nm0698-698; Watanabe R, 2010, PHARMACOL THERAPEUT, V127, P261, DOI 10.1016/j.pharmthera.2010.04.004; Bos EM, 2012, TRANSPL INT, V25, P897, DOI 10.1111/j.1432-2277.2012.01514.x; Balaban CL, 2011, ARTIF ORGANS, V35, P508, DOI 10.1111/j.1525-1594.2011.01256.x; Ban K, 2012, PLOS ONE, V7; Bhogal RH, 2012, PLOS ONE, V7; Chen Y, 2007, TRANSPLANTATION, V84, P1071, DOI 10.1097/01.tp.0000287126.12083.48; Debonera F, 2004, AM J TRANSPLANT, V4, P1964, DOI 10.1111/j.1600-6143.2004.00626.x; Henderson PW, 2010, J GASTROEN HEPATOL, V25, P1642, DOI 10.1111/j.1440-1746.2010.06380.x; Husted TL, 2006, INFLAMM RES, V55, P177, DOI 10.1007/s00011-006-0073-1; Ke B, 2011, J HEPATOL, V56, P359; Kis A, 2003, J MOL CELL CARDIOL, V35, P1063, DOI 10.1016/S0022-2828(03)00208-6; Klingerman CM, 2013, AM J PHYSIOL-REG I, V305, pR630, DOI 10.1152/ajpregu.00218.2013; Koh PO, 2011, J PINEAL RES, V51, P214, DOI 10.1111/j.1600-079X.2011.00879.x; Nakamitsu A, 2001, SURG TODAY, V31, P140; Ota T, 1997, SURG TODAY, V27, P313; Shao JL, 2011, J MOL NEUROSCI, V43, P453, DOI 10.1007/s12031-010-9464-4; Si R, 2011, J MOL CELL CARDIOL, V50, P16, DOI 10.1016/j.yjmcc.2010.08.017; SUZUKI S, 1991, Transplantation (Baltimore), V52, P979, DOI 10.1097/00007890-199112000-00008; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P917, DOI 10.1038/nrd2425; Wei Y, 2010, BMC GASTROENTEROL, V10, P42; Yadav SS, 1998, TRANSPLANTATION, V65, P1433, DOI 10.1097/00007890-199806150-00004; Zhang Q, 2013, PLOS ONE, V8	49	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	JUL	2015	45	7					892	903		10.1007/s00595-014-1064-4		12	Surgery	Surgery	CK2LB	WOS:000356040800016		
J	Eguchi, K; Sawafuji, M				Eguchi, Keisuke; Sawafuji, Makoto			Surgical management of a patient with bilateral multiple pulmonary epithelioid hemangioendothelioma: report of a case	SURGERY TODAY			English	Article						Lung wedge resection; Bilateral thoracotomy; VATS; Multiple lung nodules	INTRAVASCULAR BRONCHIOLOALVEOLAR TUMOR; THE-LITERATURE; LUNG	Pulmonary epithelioid hemangioendothelioma (PEH) is a rare lung disease. This report describes the case of a 54-year-old female who underwent radical resection for bilateral multiple PEH nodules. Bilateral multiple nodular shadows were seen on the patient's chest X-rays during an annual health check. PEH was diagnosed based on a video-assisted thoracoscopic biopsy specimen. Thirty-two pulmonary nodules were resected through the bilateral transverse thoracosternotomy. The patient's postoperative recovery was uneventful, and she remains free of PEH recurrence 11 years after the surgery.	[Eguchi, Keisuke; Sawafuji, Makoto] Kawasaki Municipal Hosp, Dept Gen Thorac Surg, Kawasaki, Kanagawa 2100013, Japan	Eguchi, K (reprint author), Kawasaki Municipal Hosp, Dept Gen Thorac Surg, 12-1 Shinkawa Tori, Kawasaki, Kanagawa 2100013, Japan.	keguchi2@mac.com					Schattenberg T, 2008, SURG TODAY, V38, P844, DOI 10.1007/s00595-007-3712-4; Chevreau C, 2013, CANCER-AM CANCER SOC, V119, P2639, DOI 10.1002/cncr.28109; Bagan P, 2006, ANN THORAC SURG, V82, P2010, DOI 10.1016/j.athoracsur.2006.06.068; DAIL DH, 1983, CANCER, V51, P452, DOI 10.1002/1097-0142(19830201)51:3<452::AID-CNCR2820510317>3.0.CO;2-M; Endo T, 2004, J NEURO-ONCOL, V67, P337, DOI 10.1023/B:NEON.0000024215.79178.27; MIETTINEN M, 1987, CANCER, V60, P2471, DOI 10.1002/1097-0142(19871115)60:10<2471::AID-CNCR2820601021>3.0.CO;2-8; ROUDIERPOUJOL C, 1994, ANN DERMATOL VENER, V121, P898; SWEENEY WB, 1986, ANN THORAC SURG, V42, P702; Ye B, 2013, ONCOL LETT, V5, P1491, DOI 10.3892/ol.2013.1217	9	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	JUL	2015	45	7					904	906		10.1007/s00595-014-0926-0		3	Surgery	Surgery	CK2LB	WOS:000356040800017		
J	Abe, H; Yamazaki, K; Mori, T; Kawai, Y; Kubota, Y; Umeda, T; Ishida, M; Tani, T				Abe, Hajime; Yamazaki, Keiichi; Mori, Tsuyoshi; Kawai, Yuki; Kubota, Yoshihiro; Umeda, Tomoko; Ishida, Mitsuaki; Tani, Tohru			Umbilical metastasis derived from breast cancer: report of a case	SURGERY TODAY			English	Article						Umbilical metastasis; Breast cancer; Immunohistochemical staining	FINE-NEEDLE ASPIRATION; MARY-JOSEPHS-NODULE; RECURRENCE; EXPRESSION; NEOPLASMS	Umbilical metastases mainly arise from malignancies of the digestive and gynecological systems, but rarely from breast cancer. A 64-year-old woman with a history of breast cancer was referred to us for investigation of a painful lesion in the umbilicus. Immunohistochemical staining of a specimen obtained by biopsy from the nodule showed umbilical metastasis of breast cancer. After a work up, she was successfully treated with a combination of surgery and endocrine therapy. We report this case to reinforce that not all periumbilical tumoral deposits are consistent.	[Abe, Hajime; Yamazaki, Keiichi] Bell Land Gen Hosp, Breast Ctr, Naka Ku, Sakai, Osaka 5998247, Japan; [Abe, Hajime; Mori, Tsuyoshi; Kawai, Yuki; Kubota, Yoshihiro; Umeda, Tomoko] Shiga Univ Med Sci Hosp, Div Breast & Gen Surg, Otsu, Shiga, Japan; [Ishida, Mitsuaki] Shiga Univ Med Sci, Dept Clin Lab Med, Otsu, Shiga 52021, Japan; [Ishida, Mitsuaki] Shiga Univ Med Sci, Div Diagnost Pathol, Otsu, Shiga 52021, Japan; [Tani, Tohru] Shiga Univ Med Sci, Dept Surg, Otsu, Shiga 52021, Japan	Abe, H (reprint author), Bell Land Gen Hosp, Breast Ctr, Naka Ku, 500-3 Higashiyama, Sakai, Osaka 5998247, Japan.	abe@belle.shiga-med.ac.jp					MAJMUDAR B, 1991, GYNECOL ONCOL, V40, P152, DOI 10.1016/0090-8258(91)90108-H; Ching ASC, 2002, ABDOM IMAGING, V27, P746, DOI 10.1007/s00261-002-0018-2; Galvan VG, 1998, ANN INTERN MED, V128, P410; Chu PG, 2000, MODERN PATHOL, V13, P962, DOI 10.1038/modpathol.3880175; Bailey H, 1949, DEMONSTRATIONS PHYS, P227; Esserman LJ, 2011, BREAST CANCER RES TR, V129, P607, DOI 10.1007/s10549-011-1564-5; Gabriele R., 2005, WORLD J SURG ONCOL, V3, P13, DOI DOI 10.1186/1477-7819-3-13; MAZOUJIAN G, 1989, CANCER, V63, P2156, DOI 10.1002/1097-0142(19890601)63:11<2156::AID-CNCR2820631115>3.0.CO;2-B; NCCN clinical Practice Guidelines in oncology. ver. 3, 2013, BREAST CANC; Nishimura R, 2013, ONCOLOGY-BASEL, V85, P100, DOI 10.1159/000353099; POWELL FC, 1984, J AM ACAD DERMATOL, V10, P610, DOI 10.1016/S0190-9622(84)80265-0; SCHNEIDER V, 1990, ACTA CYTOL, V34, P555; SHETTY MR, 1990, J SURG ONCOL, V45, P212, DOI 10.1002/jso.2930450316; SRINIVASAN R, 1993, ACTA CYTOL, V37, P894; WICK MR, 1989, HUM PATHOL, V20, P281, DOI 10.1016/0046-8177(89)90137-8	15	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	JUL	2015	45	7					907	910		10.1007/s00595-014-0991-4		4	Surgery	Surgery	CK2LB	WOS:000356040800018		
J	Kashiyama, N; Kuratani, T; Torikai, K; Maeda, K; Toda, K; Miyagawa, S; Nishi, H; Yoshikawa, Y; Fukushima, S; Yoshioka, D; Saito, T; Sawa, Y				Kashiyama, Noriyuki; Kuratani, Toru; Torikai, Kei; Maeda, Koichi; Toda, Koichi; Miyagawa, Shigeru; Nishi, Hiroyuki; Yoshikawa, Yasushi; Fukushima, Satsuki; Yoshioka, Daisuke; Saito, Tetsuya; Sawa, Yoshiki			Urgent transcatheter aortic valve replacement for severe aortic valve stenosis with acute decompensated heart failure: report of a case	SURGERY TODAY			English	Article						Aortic valve stenosis; Transcatheter aortic valve replacement; Acute decompensated heart failure	LEFT-VENTRICULAR FUNCTION; IMPLANTATION	Recent evidence suggests that transcatheter aortic valve replacement (TAVR) is feasible for treating severe aortic valve stenosis (AS) in patients who are considered high risk for elective surgery. However, it is still unclear whether TAVR is a better option than surgical aortic valve replacement for severe AS with acute decompensated heart failure. We report a case of severe AS with acute heart failure, which was treated successfully by urgent TAVR, with cardiopulmonary support.	[Kashiyama, Noriyuki; Torikai, Kei; Maeda, Koichi; Toda, Koichi; Miyagawa, Shigeru; Nishi, Hiroyuki; Yoshikawa, Yasushi; Fukushima, Satsuki; Yoshioka, Daisuke; Saito, Tetsuya; Sawa, Yoshiki] Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, Suita, Osaka 5650087, Japan; [Kuratani, Toru] Osaka Univ, Grad Sch Med, Dept Minimally Invas Cardiovasc Surg, Osaka, Japan	Sawa, Y (reprint author), Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, Yamadaoka 2-2, Suita, Osaka 5650087, Japan.	sawa-p@surg1.med.osaka-u.ac.jp					Bonow RO, 2006, CIRCULATION, V114, pE84, DOI 10.1161/CIRCULATIONAHA.106.176857; Doguet F, 2010, EUR J CARDIO-THORAC, V38, P394, DOI 10.1016/j.ejcts.2010.02.016; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; Maeda K, 2012, J CARDIAC SURG, V27, P686, DOI 10.1111/jocs.12013; MCHENRY MM, 1979, BRIT HEART J, V41, P463; Sharony R, 2003, ANN THORAC SURG, V75, P1808, DOI 10.1016/S0003-4975(03)00117-6; Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510; Unbehaun A, 2012, J THORAC CARDIOV SUR, V143, P1356, DOI 10.1016/j.jtcvs.2011.07.008	8	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	JUL	2015	45	7					911	914		10.1007/s00595-014-1059-1		4	Surgery	Surgery	CK2LB	WOS:000356040800019		
J	Homma, T; Yamamoto, Y; Doki, Y; Senda, K; Touge, M; Ojima, T; Shimada, Y; Yoshimura, N				Homma, Takahiro; Yamamoto, Yutaka; Doki, Yoshinori; Senda, Kazutaka; Touge, Masayoshi; Ojima, Toshihiro; Shimada, Yoshifumi; Yoshimura, Naoki			Complete thoracoscopic diaphragm plication using carbon dioxide insufflation: report of a case	SURGERY TODAY			English	Article						Diaphragm; Minimally invasive surgery; VATS; Diaphragm plication		Diaphragm plication has become the accepted treatment for major respiratory impairment caused by diaphragmatic eventration and paralysis. Various open and minimally invasive plication techniques have been described and while video-assisted thoracoscopic diaphragm plication appears to be a safe and effective alternative to open surgery, the workspace is limited. We describe how we performed complete thoracoscopic diaphragm plication using carbon dioxide (CO2) insufflation for a patient with unilateral diaphragmatic eventration. Using CO2 insufflation seems to dramatically improve the workspace.	[Homma, Takahiro; Yamamoto, Yutaka] Joetsu Gen Hosp, Div Thorac Surg, Niigata 9438507, Japan; [Doki, Yoshinori; Senda, Kazutaka; Touge, Masayoshi; Ojima, Toshihiro; Shimada, Yoshifumi; Yoshimura, Naoki] Toyama Univ, Dept Gen Thorac & Cardiovasc Surg, Toyama 9300194, Japan	Homma, T (reprint author), Joetsu Gen Hosp, Div Thorac Surg, 148-1 Daido Fukuda, Niigata 9438507, Japan.	hommat.tym@gmail.com					Bestall JC, 1999, THORAX, V54, P581; Huttl TP, 2004, SURG ENDOSC, V18, P547, DOI 10.1007/s00464-003-8127-8; Groth SS, 2010, ANN THORAC SURG, V89, pS2146, DOI 10.1016/j.athoracsur.2010.03.021; Kernstine KH, 2009, ADULT CHEST SURG, P1077; KIZILCAN F, 1993, J PEDIATR SURG, V28, P42, DOI 10.1016/S0022-3468(05)80351-3; Miller DL, 2007, ANN THORAC SURG, V83, P1850, DOI 10.1016/j.athoracsur.2006.11.030; Morrison JMW, 1923, ARCH RADIOL ELECTROT, V28, P72; Ohtsuka T, 1999, ANN THORAC SURG, V68, P29, DOI 10.1016/S0003-4975(99)00319-7	8	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	JUL	2015	45	7					915	918		10.1007/s00595-014-1008-z		4	Surgery	Surgery	CK2LB	WOS:000356040800020		
J	Katsuno, H; Maeda, K; Hanai, T; Mizuno, M; Kurashita, T; Tsukamoto, T				Katsuno, Hidetoshi; Maeda, Koutarou; Hanai, Tsunekazu; Mizuno, Masahiro; Kurashita, Takamitsu; Tsukamoto, Tetsuya			Gigantic lymphangioma with marked extraluminal progression of the ascending colon: report of a case	SURGERY TODAY			English	Article						Colon; Lymphangioma; Fertility	ADULT INTUSSUSCEPTION; CYSTIC LYMPHANGIOMA; LARGE-INTESTINE	We report a case of gigantic cystic lymphangioma of the ascending colon excised through an open laparotomy. A 34-year-old woman consulted a gynecologist for treatment of infertility. Transvaginal ultrasonography revealed a cystic mass in the pelvis, and she was transferred to our hospital for further investigation. Abdominal enhanced computed tomography (CT) showed a bulky cystic mass, 25 cm or larger, in the abdominal and pelvic cavity. Colonoscopy revealed a cystic submucosal tumor with a cushion sign. Cystic lymphangioma was diagnosed and excised via open surgery as we could not exclude its malignant potential. Pathological examination confirmed lymphangioma. To our knowledge, this is the most gigantic lymphangioma of the colon documented in the literature. About 3 months after surgery, the patient discovered that she was pregnant and her first baby was delivered at term, uneventfully.	[Katsuno, Hidetoshi; Maeda, Koutarou; Hanai, Tsunekazu; Mizuno, Masahiro; Kurashita, Takamitsu] Fujita Hlth Univ, Sch Med, Dept Surg, Toyoake, Aichi 4701192, Japan; [Tsukamoto, Tetsuya] Fujita Hlth Univ, Sch Med, Diagnost Pathol, Toyoake, Aichi 4701192, Japan	Katsuno, H (reprint author), Fujita Hlth Univ, Sch Med, Dept Surg, Dengakugakubo 1-98, Toyoake, Aichi 4701192, Japan.	katsuno@fujita-hu.ac.jp					Chung SH, 2009, WORLD J GASTROENTERO, V15, P5620, DOI 10.3748/wjg.15.5620; BERARDI RS, 1974, DIS COLON RECTUM, V17, P265, DOI 10.1007/BF02588115; Chang MS, 2008, J JPN SURG ASS, V69, P2114; Chisholm A, 1932, AM J SURG, V17, P281, DOI 10.1016/S0002-9610(32)90497-8; Huguet KL, 2007, AM SURGEON, V73, P414; Kim J, 2005, DIGEST DIS SCI, V50, P1747, DOI 10.1007/s10620-005-2929-6; Kim TO, 2006, WORLD J GASTROENTERO, V12, P2130; KURAMOTO S, 1988, DIS COLON RECTUM, V31, P900, DOI 10.1007/BF02554857; Matsuba Y, 2003, J GASTROENTEROL, V38, P181, DOI 10.1007/s005350300030; Matsuda Takeshi, 2001, Journal of Nippon Medical School, V68, P262, DOI 10.1272/jnms.68.262; Nagata H, 2013, SURG TODAY, V44, P1367; ROS PR, 1987, RADIOLOGY, V164, P327; Stout AP, 1969, DIS COLON ANORECTUM, P295; VaraThorbeck C, 1997, EUR J SURG, V163, P395; VARGASSERRANO B, 1995, EUR J RADIOL, V19, P183, DOI 10.1016/0720-048X(95)00604-O; Wegner G, 1877, ARCH KLIN CHIR, V20, P641; Yoshitoshi Y, 1965, Nihon Rinsho, V23, P2264	17	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	JUL	2015	45	7					919	923		10.1007/s00595-014-1055-5		5	Surgery	Surgery	CK2LB	WOS:000356040800021		
J	Kawashima, M; Sano, A; Tanaka, M				Kawashima, Mitsuaki; Sano, Atsushi; Tanaka, Makoto			Sternal closure with absorbable pins and cords in general thoracic surgery	SURGERY TODAY			English	Article						Sternum; Sternotomy; Thoracic surgery	STERNOTOMY; SUTURES	After median sternotomy, the sternum is commonly closed using metal wires, which sometimes cause complications because they are permanent foreign bodies. As an alternative, we used a combination of absorbable sutures and pins for full median sternotomy in 24 adult general thoracic surgery patients. There were three cases of sternal dehiscence detectable by computed tomography, none of which required re-operation. Two of these patients had diabetes mellitus (DM) and the third patient was on corticosteroid therapy. In an appropriately selected patient population that excludes patients with DM or who are undergoing corticosteroid therapy, we have not observed any sternal complications. We concluded that our technique is clinically feasible with appropriate patient selection.	[Kawashima, Mitsuaki; Sano, Atsushi; Tanaka, Makoto] Chigasaki Municipal Hosp, Dept Thorac Surg, Chigasaki, Kanagawa 2530042, Japan	Sano, A (reprint author), Chigasaki Municipal Hosp, Dept Thorac Surg, Honson 5-15-1, Chigasaki, Kanagawa 2530042, Japan.	sanoa-tky@umin.ac.jp					Hamaji Masatsugu, 2009, Interact Cardiovasc Thorac Surg, V9, P559, DOI 10.1510/icvts.2009.212506; Luciani N, 2006, J CARDIAC SURG, V21, P580, DOI 10.1111/j.1540-8191.2006.00302.x; MULCH J, 1986, THORAC CARDIOV SURG, V34, P191, DOI 10.1055/s-2007-1020407; Oiwa H, 2004, ANN THORAC SURG, V78, P358, DOI 10.1016/S0003-4975(03)01284-0; PASTORINO U, 1994, J THORAC CARDIOV SUR, V107, P596; SCHWAB RJ, 1994, THORAC CARDIOV SURG, V42, P185, DOI 10.1055/s-2007-1016484; Tsunekawa T, 2012, INTERACT CARDIOV TH, V15, P377, DOI 10.1093/icvts/ivs151; Usui A, 2006, J THORAC CARDIOV SUR, V131, P1174, DOI 10.1016/j.jtcvs.2005.12.043; Zor MH, 2014, SURG TODAY, V44, P1476, DOI 10.1007/s00595-013-0737-8	9	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	JUL	2015	45	7					929	931		10.1007/s00595-014-1092-0		3	Surgery	Surgery	CK2LB	WOS:000356040800023		
J	Yamaguchi, T; Kinugasa, Y; Shiomi, A; Sato, S; Yamakawa, Y; Kagawa, H; Tomioka, H; Mori, K				Yamaguchi, Tomohiro; Kinugasa, Yusuke; Shiomi, Akio; Sato, Sumito; Yamakawa, Yushi; Kagawa, Hiroyasu; Tomioka, Hiroyuki; Mori, Keita			Learning curve for robotic-assisted surgery for rectal cancer: use of the cumulative sum method	SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES			English	Article						Rectal cancer; Robotic-assisted surgery; Learning curve; CUSUM method; Total mesorectal excision; Lateral lymph node dissection	LAPAROSCOPIC COLORECTAL SURGERY; TOTAL MESORECTAL EXCISION; MULTIDIMENSIONAL-ANALYSIS; RESECTION; EXPERIENCE	Few data are available to assess the learning curve for robotic-assisted surgery for rectal cancer. The aim of the present study was to evaluate the learning curve for robotic-assisted surgery for rectal cancer by a surgeon at a single institute. From December 2011 to August 2013, a total of 80 consecutive patients who underwent robotic-assisted surgery for rectal cancer performed by the same surgeon were included in this study. The learning curve was analyzed using the cumulative sum method. This method was used for all 80 cases, taking into account operative time. Operative procedures included anterior resections in 6 patients, low anterior resections in 46 patients, intersphincteric resections in 22 patients, and abdominoperineal resections in 6 patients. Lateral lymph node dissection was performed in 28 patients. Median operative time was 280 min (range 135-683 min), and median blood loss was 17 mL (range 0-690 mL). No postoperative complications of Clavien-Dindo classification Grade III or IV were encountered. We arranged operative times and calculated cumulative sum values, allowing differentiation of three phases: phase I, Cases 1-25; phase II, Cases 26-50; and phase III, Cases 51-80. Our data suggested three phases of the learning curve in robotic-assisted surgery for rectal cancer. The first 25 cases formed the learning phase.	[Yamaguchi, Tomohiro; Kinugasa, Yusuke; Shiomi, Akio; Sato, Sumito; Yamakawa, Yushi; Kagawa, Hiroyasu; Tomioka, Hiroyuki] Shizuoka Canc Ctr Hosp, Div Colon & Rectal Surg, Nagaizumi, Shizuoka 4118777, Japan; [Mori, Keita] Shizuoka Canc Ctr Hosp, Clin Trial Coordinat Off, Nagaizumi, Shizuoka 4118777, Japan	Yamaguchi, T (reprint author), Shizuoka Canc Ctr Hosp, Div Colon & Rectal Surg, 1007 Shimonagakubo, Nagaizumi, Shizuoka 4118777, Japan.	t.yamaguchi@scchr.jp					Bokhari MB, 2011, SURG ENDOSC, V25, P855, DOI 10.1007/s00464-010-1281-x; Fujita S, 2012, LANCET ONCOL, V13, P616, DOI 10.1016/S1470-2045(12)70158-4; Kinugasa Y, 2007, BRIT J SURG, V94, P620, DOI 10.1002/bjs.5540; Bege T, 2010, ANN SURG, V251, P249, DOI 10.1097/SLA.0b013e3181b7fdb0; Pigazzi A, 2006, SURG ENDOSC, V20, P1521, DOI 10.1007/s00464-005-0855-5; Park JS, 2011, SURG ENDOSC, V25, P240, DOI 10.1007/s00464-010-1166-z; Corcione F, 2005, SURG ENDOSC, V19, P117, DOI 10.1007/s00464-004-9004-9; Kim YW, 2012, SURG LAPARO ENDO PER, V22, P400, DOI 10.1097/SLE.0b013e3182622c2d; Watanabe T, 2012, INT J CLIN ONCOL, V17, P1, DOI 10.1007/s10147-011-0315-2; Delaney CP, 2003, DIS COLON RECTUM, V46, P1633, DOI 10.1097/01.DCR.0000098941.42470.D9; Ito M, 2009, SURG ENDOSC, V23, P403, DOI 10.1007/s00464-008-9912-1; Son GM, 2010, J LAPAROENDOSC ADV S, V20, P609, DOI 10.1089/lap.2010.0007; Weber PA, 2002, DIS COLON RECTUM, V45, P1689, DOI 10.1097/01.DCR.0000037657.78153.A8; Guillou PJ, 2005, LANCET, V365, P1718, DOI 10.1016/S0140-6736(05)66545-2; Sng KK, 2013, SURG ENDOSC, V27, P3297, DOI 10.1007/s00464-013-2909-4; Akmal Y, 2012, SURG ENDOSC, V26, P2471, DOI 10.1007/s00464-012-2216-5; Kayano H, 2011, SURG ENDOSC, V25, P2972, DOI 10.1007/s00464-011-1655-8; Park IJ, 2009, J GASTROINTEST SURG, V13, P275, DOI 10.1007/s11605-008-0722-5; McCulloch P, 2002, BRIT MED J, V324, P1448, DOI 10.1136/bmj.324.7351.1448; de Chaput Saintonge DM, 1974, LANCET, V1, P120; Jimenez-Rodriguez RM, 2013, INT J COLORECTAL DIS, V28, P815, DOI 10.1007/s00384-012-1620-6; Liang JT, 2011, ANN SURG ONCOL, V18, P153, DOI 10.1245/s10434-010-1238-2; Miyajima N, 2009, SURG ENDOSC, V23, P113, DOI 10.1007/s00464-008-0078-7; Sobin LH, 2009, TNM CLASSIFICATION M; Staudacher Carlo, 2010, World J Gastrointest Surg, V2, P275, DOI 10.4240/wjgs.v2.i9.275; WOHL H, 1977, NEW ENGL J MED, V296, P1044, DOI 10.1056/NEJM197705052961806	26	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0930-2794	1432-2218		SURG ENDOSC	Surg. Endosc.	JUL	2015	29	7					1679	1685		10.1007/s00464-014-3855-5		7	Surgery	Surgery	CK8VM	WOS:000356517500002		
J	Suzuki, T; Egi, H; Hattori, M; Tokunaga, M; Sawada, H; Ohdan, H				Suzuki, Takahisa; Egi, Hiroyuki; Hattori, Minoru; Tokunaga, Masakazu; Sawada, Hiroyuki; Ohdan, Hideki			An evaluation of the endoscopic surgical skills assessment using a video analysis software program	SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES			English	Article						Endoscopic surgery; Objective skill assessment; HUESAD; Suturing movement; Motion analysis; Dartfish Software	CONSTRUCT-VALIDITY; LAPAROSCOPIC SIMULATOR; CONCURRENT VALIDITY; PSYCHOMOTOR TESTER; MOTION ANALYSIS; MIST-VR; PERFORMANCE; MODEL	Recently, the endoscopic surgical skills of surgeons have become a focus of many investigators and society as a whole. Hence, the importance of the training and education programs used to ensure safer endoscopic surgery has been gradually increasing. We developed our own motion analysis system called the HUESAD, and already demonstrated its construct validity. In this study, we verified that another motion analysis system (which uses the Dartfish Software program) could assess surgeons' endoscopic surgical skills. Experts (who had performed more than 100 laparoscopic surgeries) and novices (who had no experience performing laparoscopic surgery) were recruited for this study. The task was suturing in a dry box trainer. The time and the locus tracing of both sides' needle holders were analyzed using the new video analysis system (Dartfish Software). There were statistically significant differences between the experts and novices in all three variables assessed (task time: p = 0.0011, the locus tracing of the left sides' needle holders: p = 0.0011, the locus tracing of the right sides' needle holders: p = 0.0011). The results of this study demonstrated that the results of the motion analysis by the Dartfish Software were well correlated with the surgeon's skill level.	[Suzuki, Takahisa; Tokunaga, Masakazu; Sawada, Hiroyuki; Ohdan, Hideki] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Gastroenterol & Transplant Surg, Appl Life Sci,Minami Ku, Hiroshima 7348551, Japan; [Egi, Hiroyuki; Hattori, Minoru] Hiroshima Univ, Inst Biomed & Hlth Sci, Adv Med Skills Training Ctr, Hiroshima 7348551, Japan	Egi, H (reprint author), Hiroshima Univ, Inst Biomed & Hlth Sci, Adv Med Skills Training Ctr, Hiroshima 7348551, Japan.	hiroegi@yahoo.co.jp					[Anonymous], 1998, SURG ENDOSC, V12, P379; Moorthy K, 2004, SURG ENDOSC, V18, P1608, DOI 10.1007/s00464-003-9312-5; Pellen MGC, 2009, SURG ENDOSC, V23, P130, DOI 10.1007/s00464-008-0066-y; Mason JD, 2013, SURG ENDOSC, V27, P1468, DOI 10.1007/s00464-012-2631-7; Datta V, 2002, SURGERY, V131, P318, DOI 10.1067/msy.2002.120235; Egi H, 2008, SURG TODAY, V38, P705, DOI 10.1007/s00595-007-3696-0; Botden SMBI, 2007, WORLD J SURG, V31, P764, DOI 10.1007/s00268-006-0724-y; Maithel S, 2006, SURG ENDOSC, V20, P104, DOI 10.1007/s00464-005-0054-4; Woodrum DT, 2006, AM J SURG, V191, P28, DOI 10.1016/j.amjsurg.2005.10.018; Padulo J, 2012, J STRENGTH COND RES, V26, P1331, DOI 10.1519/JSC.0b013e318231aafa; Tokunaga M, 2012, MINIM INVASIV THER, V21, P142, DOI 10.3109/13645706.2011.596547; Anastakis DJ, 1999, AM J SURG, V177, P167, DOI 10.1016/S0002-9610(98)00327-4; Duffy AJ, 2005, SURG ENDOSC, V19, P401, DOI 10.1007/s00464-004-8202-9; Gallagher AG, 2004, SURG ENDOSC, V18, P660, DOI 10.1007/s00464-003-8176-z; Francis NK, 2002, ARCH SURG-CHICAGO, V137, P841, DOI 10.1001/archsurg.137.7.841; Bann SD, 2003, WORLD J SURG, V27, P390, DOI 10.1007/s00268-002-6769-7; Panait L, 2009, J SURG RES, V156, P312, DOI 10.1016/j.jss.2009.04.018; Macmillan AIM, 1999, AM J SURG, V177, P274, DOI 10.1016/S0002-9610(99)00016-1; EAES guidelines, 1994, SURG ENDOSC, V8, P721; Egi H, 2013, MINIM INVASIV THER, V22, P144, DOI 10.3109/13645706.2012.742113; Egi H, 2010, MINIM INVASIV THER, V19, P30, DOI 10.3109/13645700903493017; Litynski G S, 1999, JSLS, V3, P163; Martin JA, 1997, BRIT J SURG, V84, P273, DOI 10.1002/bjs.1800840237; Rucci JA, 2010, J STRENGTH COND RES, V24, P771, DOI 10.1519/JSC.0b013e3181cbab96; Tokunaga M, 2012, J SURG RES, V174, P90, DOI 10.1016/j.jss.2010.11.906; Xafis V, 2013, SURG ENDOSC, V27, P2606, DOI 10.1007/s00464-013-2798-6; Yamaguchi S, 2007, SURG ENDOSC, V21, P2253, DOI 10.1007/s00464-007-9362-1; Zhang AM, 2008, SURG ENDOSC, V22, P1440, DOI 10.1007/s00464-007-9625-x	28	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0930-2794	1432-2218		SURG ENDOSC	Surg. Endosc.	JUL	2015	29	7					1804	1808		10.1007/s00464-014-3863-5		5	Surgery	Surgery	CK8VM	WOS:000356517500020		
J	Nakata, K; Nagai, E; Ohuchida, K; Shimizu, S; Tanaka, M				Nakata, Kohei; Nagai, Eishi; Ohuchida, Kenoki; Shimizu, Shuji; Tanaka, Masao			Technical feasibility of laparoscopic total gastrectomy with splenectomy for gastric cancer: clinical short-term and long-term outcomes	SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES			English	Article						Laparoscopic total gastrectomy; Gastric cancer; Splenectomy; Prognosis	ASSISTED DISTAL GASTRECTOMY; POSTOPERATIVE PANCREATIC FISTULA; D2; LYMPHADENECTOMY; ADENOCARCINOMA; SURGERY	Since its widespread acceptance for the treatment of early gastric cancer, laparoscopic gastrectomy has been gaining popularity as a treatment option for advanced gastric cancer. However, laparoscopic total gastrectomy (LTG) with splenectomy is seldom performed, because of its difficulty of removal of station 10 lymph nodes; splenectomy is technically essential for complete removal of these lymph nodes. The purpose of this study was to describe the details of the LTG procedure and to evaluate the short- and long-term outcomes of LTG with splenectomy. Of 725 consecutive patients with gastric cancer who underwent laparoscopic gastrectomy with lymph node dissection in our institution from January 1996 to December 2012, 18 consecutive patients who underwent LTG with splenectomy were enrolled in this study. No operative mortality occurred, and the pathological margins were free from cancer cells in all patients. The mean operation time was 388 min (range 324-566 min). The mean volume of blood loss was 45 ml (range 5-347 ml), and the mean number of dissected lymph nodes was 51 (range 40-105). Postoperative morbidity occurred in six patients (33.3 %) (each with grade B postoperative pancreatic fistula, postoperative bleeding, chylous ascites, atelectasis, ileus, and intra-abdominal infection). Five patients (27.8 %) developed recurrence (four in the peritoneum and one in the liver), and the overall 3- and 5-year survival rates were 83.0 and 72.6 %, respectively. Considering the 0 % mortality rate and low rates of postoperative morbidity and locoregional recurrence, LTG with splenectomy is technically and oncologically acceptable. This procedure can be expanded to include advanced gastric cancer, which generally requires splenectomy for lymph node dissection.	[Nakata, Kohei; Nagai, Eishi; Ohuchida, Kenoki; Shimizu, Shuji; Tanaka, Masao] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Oncol, Fukuoka 8128582, Japan	Nagai, E (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Oncol, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	eishi@surg1.med.kyushu-u.ac.jp					Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Goto H, 2013, GASTRIC CANCER, V16, P590, DOI 10.1007/s10120-012-0214-x; Bassi C, 2005, SURGERY, V138, P8, DOI 10.1016/j.surg.2005.05.001; Hwang SI, 2009, SURG ENDOSC, V23, P1252, DOI 10.1007/s00464-008-0140-5; Noshiro H, 2003, ANN SURG, V238, P680, DOI 10.1097/01.sla.0000094302.51616.2a; Tokunaga M, 2009, J GASTROINTEST SURG, V13, P1058, DOI 10.1007/s11605-009-0840-8; Sano T, 2004, J CLIN ONCOL, V22, P2767, DOI 10.1200/JCO.2004.10.184; Shinohara T, 2009, ARCH SURG-CHICAGO, V144, P1138, DOI 10.1001/archsurg.2009.223; Shimizu S, 2000, SURG ENDOSC-ULTRAS, V14, P27, DOI 10.1007/s004649900005; Miki Y, 2011, J GASTROINTEST SURG, V15, P1969, DOI 10.1007/s11605-011-1628-1; Lee JH, 2012, WORLD J SURG, V36, P2394, DOI 10.1007/s00268-012-1669-y; Kanaya S, 2011, SURG ENDOSC, V25, P3928, DOI 10.1007/s00464-011-1792-0; Huscher CG, 2005, ANN SURG, V241, P7; Japanese Gastric Cancer Association, 2010, GASTRIC CANCER, V2011, P113; Kitano S, 1994, SURG LAPARO ENDO PER, V4, P8; Kitano S, 2007, ANN SURG, V245, P2; Kunisaki C, 2007, J GASTROINTEST SURG, V11, P1039, DOI 10.1007/s11605-007-0186-z; Nobuoka D, 2008, WORLD J SURG, V32, P2261, DOI 10.1007/s00268-008-9683-9; Obama K, 2011, SURGERY, V149, P1; Otsuji E, 1996, SURGERY, V120, P4; Sano T, 1997, BRIT J SURG, V84, P1310; Satoh Seiji, 2009, Surg Endosc, V23, P436, DOI 10.1007/s00464-008-9978-9	22	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0930-2794	1432-2218		SURG ENDOSC	Surg. Endosc.	JUL	2015	29	7					1817	1822		10.1007/s00464-014-3870-6		6	Surgery	Surgery	CK8VM	WOS:000356517500022		
J	Miura, S; Kanno, A; Masamune, A; Hamada, S; Takikawa, T; Nakano, E; Yoshida, N; Hongo, S; Kikuta, K; Kume, K; Hirota, M; Yoshida, H; Katayose, Y; Uuno, M; Shimosegawa, T				Miura, Shin; Kanno, Atsushi; Masamune, Atsushi; Hamada, Shin; Takikawa, Tetsuya; Nakano, Eriko; Yoshida, Naoki; Hongo, Seiji; Kikuta, Kazuhiro; Kume, Kiyoshi; Hirota, Morihisa; Yoshida, Hiroshi; Katayose, Yu; Uuno, Michiaki; Shimosegawa, Tooru			Bismuth classification is associated with the requirement for multiple biliary drainage in preoperative patients with malignant perihilar biliary stricture	SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES			English	Article						Cholangitis; Endoscopic naso-biliary drainage; Hepatic resection; Cholangiocarcinoma; Obstructive jaundice	PORTAL-VEIN EMBOLIZATION; POSTOPERATIVE INFECTIOUS COMPLICATIONS; ENDOSCOPIC NASOBILIARY DRAINAGE; MAJOR LIVER RESECTION; HILAR CHOLANGIOCARCINOMA; SURGICAL-TREATMENT; HEPATECTOMY; MANAGEMENT; CONSENSUS; CANCER	Single preoperative biliary drainage for malignant perihilar biliary stricture occasionally fails to control jaundice and cholangitis. Multiple biliary drainage is required in such cases, but their clinical background is unclear. We determined the clinical characteristics associated with the requirement for multiple biliary drainage. The consecutive 122 patients with malignant perihilar biliary stricture were enrolled in a single-center retrospective study. Preoperative biliary drainage was initially performed on the future remnant hepatic lobe. Additional drainage was performed if jaundice failed to improve or cholangitis developed in undrained hepatic lobes. Detailed clinical characteristics and the number of preoperative biliary drainage procedures required before operation were analyzed. Thirty-one patients (25.4 %) initially underwent multiple biliary drainage. However, 69 (56.7 %) required multiple biliary drainage by the time of the operation. In the univariate analysis, the initial serum bilirubin level, cholangitis, percutaneous portal vein embolization, history of inserted endoscopic biliary stenting, length of preoperative period, operative procedure, and Bismuth classification were significant factors. In the multivariate analysis using these factors, Bismuth classification was independently associated with the requirement for multiple biliary drainage. The number of patients who required multiple biliary drainage was higher in those with Bismuth-II (91.9 %), Bismuth-IIIa (65.7 %), and Bismuth-IV (92.9 %) than in those with Bismuth-I (22.2 %) and Bismuth-IIIb (18.2 %). Patients with Bismuth-II, Bismuth-IIIa, and Bismuth-IV are at higher risk for multiple biliary drainage. A strategy based on the Bismuth classification for performing preoperative biliary drainage is important for patients with malignant perihilar biliary stricture.	[Miura, Shin; Kanno, Atsushi; Masamune, Atsushi; Hamada, Shin; Takikawa, Tetsuya; Nakano, Eriko; Yoshida, Naoki; Hongo, Seiji; Kikuta, Kazuhiro; Kume, Kiyoshi; Hirota, Morihisa; Shimosegawa, Tooru] Tohoku Univ, Grad Sch Med, Div Gastroenterol, Aoba Ku, Sendai, Miyagi 980, Japan; [Yoshida, Hiroshi; Katayose, Yu; Uuno, Michiaki] Tohoku Univ, Grad Sch Med, Dept Hepatobiliary Pancreat Surg, Sendai, Miyagi 980, Japan	Kanno, A (reprint author), Tohoku Univ, Grad Sch Med, Div Gastroenterol, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 980, Japan.	atsushih@med.tohoku.ac.jp					COTTON PB, 1991, GASTROINTEST ENDOSC, V37, P383, DOI 10.1016/S0016-5107(91)70740-2; Rerknimitr R, 2013, J GASTROEN HEPATOL, V28, P593, DOI 10.1111/jgh.12128; Kubo S, 2002, J SURG RES, V107, P113, DOI 10.1006/jsre.2002.6503; Vienne A, 2010, GASTROINTEST ENDOSC, V72, P728, DOI 10.1016/j.gie.2010.06.040; Sano T, 2006, ANN SURG, V244, P240, DOI 10.1097/01.sla.0000217605.66519.38; Liu F, 2011, DIGEST DIS SCI, V56, P663, DOI 10.1007/s10620-010-1338-7; Nagino M, 2008, J HEPATO-BILIARY-PAN, V15, P25, DOI 10.1007/s00534-007-1277-7; Imamura H, 1999, HEPATOLOGY, V29, P1099, DOI 10.1002/hep.510290415; Kawakami H, 2011, J GASTROENTEROL, V46, P242, DOI 10.1007/s00535-010-0298-1; Sewnath ME, 2002, ANN SURG, V236, P17, DOI 10.1097/01.SLA.0000018565.87010.B8; Nagino M, 2006, ANN SURG, V243, P364, DOI 10.1097/01.sla.0000201482.11876.14; Hochwald SN, 1999, ARCH SURG-CHICAGO, V134, P261, DOI 10.1001/archsurg.134.3.261; Abulkhir A, 2008, ANN SURG, V247, P49, DOI 10.1097/SLA.0b013e31815f6e5b; BISMUTH H, 1988, WORLD J SURG, V12, P39; Cherqui D, 2000, ARCH SURG-CHICAGO, V135, P302, DOI 10.1001/archsurg.135.3.302; Sugawara G, 2006, ANN SURG, V244, P706, DOI 10.1097/01.sla.0000219039.20924.88; Kamiya S, 2004, ANN SURG, V239, P510, DOI 10.1097/01.sla.0000118594.23874.89; Kennedy TJ, 2009, HPB, V11, P445, DOI 10.1111/j.1477-2574.2009.00090.x; Ferrero A, 2009, WORLD J SURG, V33, P318, DOI 10.1007/s00268-008-9830-3; Nuzzo G, 2012, ARCH SURG-CHICAGO, V147, P26, DOI 10.1001/archsurg.2011.771; Kawashima H, 2013, ANN SURG, V257, P121, DOI 10.1097/SLA.0b013e318262b2e9; Natsume S, 2012, ANN SURG, V255, P754, DOI 10.1097/SLA.0b013e31824a8d82; Nimura Y, 2008, HPB, V10, P130, DOI 10.1080/13651820801992666; BRANDES JW, 1981, ENDOSCOPY, V13, P27, DOI 10.1055/s-2007-1021637; Khan SA, 2002, GUT, V51, P1; Nagino M, 2013, ANN SURG, V258, P129, DOI 10.1097/SLA.0b013e3182708b57; Nimura Y, 2000, J Hepatobiliary Pancreat Surg, V7, P155, DOI 10.1007/s005340050170; Rea DJ, 2005, ANN SURG, V242, P451, DOI 10.1097/01.sla.0000179678.13285.fa; Saxena A, 2011, AM J SURG, V202, P310, DOI 10.1016/j.amjsurg.2010.08.041	29	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0930-2794	1432-2218		SURG ENDOSC	Surg. Endosc.	JUL	2015	29	7					1862	1870		10.1007/s00464-014-3878-y		9	Surgery	Surgery	CK8VM	WOS:000356517500029		
J	Tsutsumi, K; Kato, H; Muro, S; Yamamoto, N; Noma, Y; Horiguchi, S; Harada, R; Okada, H; Yamamoto, K				Tsutsumi, Koichiro; Kato, Hironari; Muro, Shinichiro; Yamamoto, Naoki; Noma, Yasuhiro; Horiguchi, Shigeru; Harada, Ryo; Okada, Hiroyuki; Yamamoto, Kazuhide			ERCP using a short double-balloon enteroscope in patients with prior pancreatoduodenectomy: higher maneuverability supplied by the efferent-limb route	SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES			English	Article						Short double-balloon enteroscopy (DBE); Endoscopic retrograde cholangiopancreatography (ERCP); Pancreatoduodenectomy (PD); Braun anastomosis; Maneuverability	ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; BILLROTH II GASTRECTOMY; OBLIQUE-VIEWING ENDOSCOPE; GI TRACT SURGERY; EN-Y ANASTOMOSIS; RECONSTRUCTION; ANATOMY	In endoscopic retrograde cholangiopancreatography (ERCP) for patients who have undergone a pancreatoduodenectomy (PD) with a Braun anastomosis, two different approaches are available: the afferent-limb route and the efferent-limb route. This study was to clarify the usefulness of a short double-balloon enteroscope (DBE) in ERCP for prior-PD patients, and to reveal which route was optimal for ERCP. Seventy-two consecutive patients with a prior PD underwent diagnostic or therapeutic ERCP using the DBE. This retrospective study evaluated the outcome of the ERCP and assessed the shape of the DBE by fluoroscopic imaging to compare the maneuverability of the two routes. In 71 patients (99 %) the bilioenteric anastomosis was reached and cholangiography was performed. Treatment was required in 59 patients (83 %) and was performed successfully in all. Complications occurred in two patients (3 %) with cholangitis. In three patients, the afferent-limb route had to be changed to the efferent-limb route in the procedure. A gentler arc-shaped angulation of the DBE was induced using the efferent-limb route compared to the afferent-limb route (128A degrees (n = 42) vs. 113A degrees (n = 15); p = 0.037), and that was also revealed in 11 patients (15 %) who underwent repeated ERCP by each route (123A degrees vs. 96A degrees; p = 0.003). The short DBE facilitates ERCP in prior-PD patients. Particularly, ERCP using the efferent-limb route can achieve a maneuverable procedure without unnecessary stress, such as scope insertion to the sharp-angled afferent limb and the handling of various accessories through the narrow scope channel with a sense of resistance.	[Tsutsumi, Koichiro; Kato, Hironari; Muro, Shinichiro; Yamamoto, Naoki; Noma, Yasuhiro; Horiguchi, Shigeru; Harada, Ryo; Okada, Hiroyuki; Yamamoto, Kazuhide] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Gastroenterol & Hepatol, Kita Ku, Okayama 7008558, Japan	Tsutsumi, K (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Gastroenterol & Hepatol, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	ttmkuicru@yahoo.co.jp; drkatocha@yahoo.co.jp; shinm0416@yahoo.co.jp; naokihiko@gmail.com; kirio_03@yahoo.co.jp; horiguchis@gmail.com; rharada927@yahoo.co.jp; hiro@md.okayama-u.ac.jp; kazuhide@md.okayama-u.ac.jp					Chahal P, 2006, ENDOSCOPY, V38, P1241, DOI 10.1055/s-2006-945003; Cicek B, 2007, J GASTROEN HEPATOL, V22, P1210, DOI 10.1111/j.1440-1746.2006.04765.x; Kim MH, 1997, ENDOSCOPY, V29, P82, DOI 10.1055/s-2007-1004080; Aabakken L, 2007, ENDOSCOPY, V39, P1068, DOI 10.1055/s-2007-966841; Faylona JMV, 1999, ENDOSCOPY, V31, P546; Osoegawa T, 2012, WORLD J GASTROENTERO, V18, P6843, DOI 10.3748/wjg.v18.i46.6843; Lin LF, 1999, AM J GASTROENTEROL, V94, P144; Farrell J, 2006, ENDOSCOPY, V38, P1246, DOI 10.1055/s-2006-944970; Cho S, 2011, CAN J GASTROENTEROL, V25, P615; Feitoza AB, 2002, GASTROINTEST ENDOSC, V55, P75, DOI 10.1067/mge.2002.120385; Feitoza AB, 2001, GASTROINTEST ENDOSC, V54, P743, DOI 10.1067/mge.2001.120169; Haber Gregory B, 2008, Gastroenterol Hepatol (N Y), V4, P397; House MG, 2006, ANN SURG, V243, P571, DOI 10.1097/01.sla.0000216285.07069.fc; Itoi T, 2010, AM J GASTROENTEROL, V105, P93, DOI 10.1038/ajg.2009.559; Kikuyama M, 2009, DIGEST ENDOSC, V21, P180, DOI 10.1111/j.1443-1661.2009.00882.x; Kimura W, 2008, J HEPATO-BILIARY-PAN, V15, P270, DOI 10.1007/s00534-007-1305-7; Matsushita M, 2009, ENDOSCOPY, V41, P902, DOI 10.1055/s-0029-1215087; Nakahara K, 2009, J GASTROENTEROL, V44, P212, DOI 10.1007/s00535-008-2299-x; Trede M, 1997, SURG PANCREAS, P487	19	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0930-2794	1432-2218		SURG ENDOSC	Surg. Endosc.	JUL	2015	29	7					1944	1951		10.1007/s00464-014-3889-8		8	Surgery	Surgery	CK8VM	WOS:000356517500038		
J	Takada, J; Araki, H; Onogi, F; Nakanishi, T; Kubota, M; Ibuka, T; Shimizu, M; Moriwaki, H				Takada, Jun; Araki, Hiroshi; Onogi, Fumito; Nakanishi, Takayuki; Kubota, Masaya; Ibuka, Takashi; Shimizu, Masahito; Moriwaki, Hisataka			Safety of carbon dioxide insufflation during gastric endoscopic submucosal dissection in patients with pulmonary dysfunction under conscious sedation	SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES			English	Article						Carbon dioxide; Endoscopic submucosal dissection; Pulmonary dysfunction; Transcutaneous partial pressure of CO2; Gastric cancer	CEREBRAL AIR-EMBOLISM; CONTROLLED-TRIAL; RETROGRADE CHOLANGIOPANCREATOGRAPHY; GASTROINTESTINAL ENDOSCOPY; CO2 INSUFFLATION; DOUBLE-BLIND; CANCER; TENSION; EFFICACY; COLONOSCOPY	Carbon dioxide (CO2) insufflation is effective for gastric endoscopic submucosal dissection (ESD). However, its safety is unknown in patients with pulmonary dysfunction. This study aimed to investigate the safety of CO2 insufflation during gastric ESD in patients with pulmonary dysfunction under conscious sedation. We analyzed 322 consecutive patients undergoing ESD using CO2 insufflation (1.4 L/min) for gastric lesions. Pulmonary dysfunction was defined as a forced expiratory volume in 1.0 s/forced vital capacity (FEV1.0%) < 70 % or vital capacity < 80 %. Transcutaneous partial pressure of CO2 (PtcCO(2)) was recorded before, during, and after ESD. In total, 127 patients (39 %) had pulmonary dysfunction. There were no significant differences in baseline PtcCO(2) before ESD, peak PtcCO(2) during ESD, and median PtcCO(2) after ESD between the pulmonary dysfunction group and normal group. There was a significant correlation between PtcCO(2) elevation from baseline and ESD procedure time (r = 0.22, P < 0.05) only in the pulmonary dysfunction group. In patients with FEV1.0% < 60 %, the correlation was much stronger (r = 0.39, P < 0.05). Neither the complication incidences nor the hospital stay differed between the two groups. CO2 narcosis or gas embolism was not reported in either group. CO2 insufflation during gastric ESD in patients with pulmonary dysfunction under conscious sedation is safe with regard to complication risk and hospital stay. However, in patients with severe obstructive lung disease, especially in those with FEV1.0% < 60 %, longer procedure time may induce CO2 retention, thus requiring CO2 monitoring.	[Takada, Jun; Araki, Hiroshi; Onogi, Fumito; Nakanishi, Takayuki; Kubota, Masaya; Ibuka, Takashi; Shimizu, Masahito; Moriwaki, Hisataka] Gifu Univ, Grad Sch Med, Dept Gastroenterol Internal Med, Gifu 5011194, Japan	Araki, H (reprint author), Gifu Univ, Grad Sch Med, Dept Gastroenterol Internal Med, 1-1 Yanagido, Gifu 5011194, Japan.	jun_yuri1_1@yahoo.co.jp; araara@gifu-u.ac.jp					American Thoracic Society, 1991, AM REV RESPIR DIS, V144, P1202; Hirai F, 2011, GASTROINTEST ENDOSC, V73, P743, DOI 10.1016/j.gie.2010.10.003; Rai A, 1999, AM J GASTROENTEROL, V94, P845; Suzuki T, 2010, ENDOSCOPY, V42, P1021, DOI 10.1055/s-0030-1255969; Hirabayashi M, 2009, J ANESTH, V23, P198, DOI 10.1007/s00540-008-0734-z; Dellon ES, 2010, GASTROINTEST ENDOSC, V72, P68, DOI 10.1016/j.gie.2010.01.041; Oka S, 2006, GASTROINTEST ENDOSC, V64, P877, DOI 10.1016/j.gie.2006.03.932; Saito Y, 2007, GASTROINTEST ENDOSC, V65, P537, DOI 10.1016/j.gie.2006.11.002; Gotoda T, 2006, J GASTROENTEROL, V41, P929, DOI 10.1007/s00535-006-1954-3; Kikuchi T, 2010, SURG ENDOSC, V24, P2231, DOI 10.1007/s00464-010-0939-8; Church J, 2003, DIS COLON RECTUM, V46, P322, DOI 10.1097/01.DCR.0000054700.26909.46; Bhavani-Shankar K, 1998, CAN J ANAESTH, V45, P164; Nonaka S, 2010, SURG ENDOSC, V24, P1638, DOI 10.1007/s00464-009-0824-5; Watanabe K, 2006, GASTROINTEST ENDOSC, V63, P776, DOI 10.1016/j.gie.2005.08.049; Fujishiro M, 2006, WORLD J GASTROENTERO, V12, P5108; Bretthauer M, 2002, GUT, V50, P604, DOI 10.1136/gut.50.5.604; Sumanac K, 2002, GASTROINTEST ENDOSC, V56, P190, DOI 10.1067/mge.2002.126391; Gotoda T, 2006, CURR OPIN GASTROEN, V22, P561, DOI 10.1097/01.mog.0000239873.06243.00; Maeda Y, 2013, ENDOSCOPY, V45, P335, DOI 10.1055/s-0032-1326199; Green BT, 2005, GASTROINTEST ENDOSC, V61, P620, DOI 10.1016/S0016-5107(04)02788-9; Bisceglia M, 2009, ADV ANAT PATHOL, V16, P255, DOI 10.1097/PAP.0b013e3181aab793; Chhajed PN, 2005, CHEST, V127, P585, DOI 10.1378/chest.127.2.585; EPSTEIN MF, 1985, J PEDIATR-US, V106, P282, DOI 10.1016/S0022-3476(85)80306-1; FREEMAN ML, 1993, GASTROENTEROLOGY, V105, P331; GRAFF TD, 1959, AM J OBSTET GYNECOL, V78, P259; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Katzgraber F, 1998, INT J LEGAL MED, V111, P154, DOI 10.1007/s004140050137; Lenz P, 2014, ENDOSCOPY, V46, P53, DOI 10.1055/s-0033-1359041; Mayer KL, 1998, SURG ENDOSC-ULTRAS, V12, P1025, DOI 10.1007/s004649900773; Morley AP, 1997, ENDOSCOPY, V29, P332, DOI 10.1055/s-2007-1004205; Nagai A, 2009, NIHON KOKYUKI GAKK S, V30, P32; Nayagam J, 2004, ANAESTH INTENS CARE, V32, P260; Oda Ichiro, 2006, Gastric Cancer, V9, P262, DOI 10.1007/s10120-006-0389-0; Onozato Y, 2006, ENDOSCOPY, V38, P980, DOI 10.1055/s-2006-944809; Park EY, 2012, YONSEI MED J, V53, P459, DOI 10.3349/ymj.2012.53.3.459; Rohling R, 1999, J CLIN MONITOR COMP, V15, P23, DOI 10.1023/A:1009950425204; Stabile L, 2006, ACTA ANAESTH SCAND, V50, P648, DOI 10.1111/j.1399-6576.2006.00978.x; Yamamoto H, 2005, BEST PRACT RES CL GA, V19, P909, DOI 10.1016/j.bpg.2005.03.004; Yoshida M, 2014, INT J COLORECTAL DIS, V29, P365, DOI 10.1007/s00384-013-1806-6	39	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0930-2794	1432-2218		SURG ENDOSC	Surg. Endosc.	JUL	2015	29	7					1963	1969		10.1007/s00464-014-3892-0		7	Surgery	Surgery	CK8VM	WOS:000356517500040		
J	Kutsumura, N; Inagaki, M; Kiriseko, A; Saito, T				Kutsumura, Noriki; Inagaki, Mai; Kiriseko, Akito; Saito, Takao			Novel One-Pot Synthetic Method for Propargyl Alcohol Derivatives from Allyl Alcohol Derivatives	SYNTHESIS-STUTTGART			English	Article						elimination; one-pot synthesis; propargyl alcohol derivatives; allyl alcohol derivatives; neighboring-group effects	CLAISEN REARRANGEMENT; VICINAL DIBROMIDES; CARBONYL GROUPS; DBU CONDITIONS; ETHERS; ELIMINATION; ALDEHYDES; CYCLIZATION; CATALYSTS; ADDITIONS	An efficient one-pot procedure for the synthesis of propargyl alcohol derivatives from allyl alcohol derivatives has been developed. The key to this transformation from a C-C double bond to a C-C triple bond is that hydrogen bromide elimination from 1,2-dibromoalkanes that contain a neighboring oxygen functional group is promoted by the inductive electron-withdrawing effect of the oxygen functional group. In the one-pot reaction, tetrabutylammonium hydroxide was the best base, and the addition of molecular sieves 13X also promoted the reaction.	[Kutsumura, Noriki; Inagaki, Mai; Kiriseko, Akito; Saito, Takao] Tokyo Univ Sci, Dept Chem, Fac Sci, Shinjuku Ku, Tokyo 1628601, Japan; [Kutsumura, Noriki] Univ Tsukuba, Int Inst Integrat Sleep Med WPI IIIS, Tsukuba, Ibaraki 3058577, Japan	Kutsumura, N (reprint author), Tokyo Univ Sci, Dept Chem, Fac Sci, Shinjuku Ku, Tokyo 1628601, Japan.	kutsumura.noriki.gn@u.tsukuba.ac.jp; tsaito@rs.kagu.tus.ac.jp			Sasakawa Scientific Research Grant from The Japan Science Society; Central Glass Co. Ltd. Award in Synthetic Organic Chemistry, Japan; Tokyo Ohka Foundation for The Promotion of Science and Technology	This work was partly supported by the Sasakawa Scientific Research Grant from The Japan Science Society, the Central Glass Co. Ltd. Award in Synthetic Organic Chemistry, Japan, and the Tokyo Ohka Foundation for The Promotion of Science and Technology.	Xu HJ, 2011, J ORG CHEM, V76, P8036, DOI 10.1021/jo201196a; Magnus P, 2005, J AM CHEM SOC, V127, P12476, DOI 10.1021/ja0535817; Mori K, 2013, J AM CHEM SOC, V135, P3964, DOI 10.1021/ja311902f; WHITE WN, 1958, J AM CHEM SOC, V80, P3271, DOI 10.1021/ja01546a023; Lu G, 2005, COORDIN CHEM REV, V249, P1736, DOI 10.1016/j.ccr.2004.12.020; Trost BM, 2009, ADV SYNTH CATAL, V351, P963, DOI 10.1002/adsc.200800776; Pollex A, 2005, ORG LETT, V7, P5705, DOI 10.1021/ol052462t; Pu L, 2003, TETRAHEDRON, V59, P9873, DOI 10.1016/j.tet.2003.10.042; Chintareddy VR, 2011, J ORG CHEM, V76, P4482, DOI 10.1021/jo200314g; Moghaddam FM, 1997, SYNTHETIC COMMUN, V27, P4073, DOI 10.1080/00397919708005453; Anson CE, 2008, EUR J ORG CHEM, P196, DOI 10.1002/ejoc.200700919; Banfi L, 2000, EUR J ORG CHEM, P939; Bartz QR, 1935, J AM CHEM SOC, V57, P371, DOI 10.1021/ja01305a044; Bujok R, 2004, J ORG CHEM, V69, P6894, DOI 10.1021/jo049222w; Caldwell JJ, 2005, SYNTHESIS-STUTTGART, P3293, DOI 10.1055/s-2005-918459; Cozzi PG, 2004, EUR J ORG CHEM, P4095, DOI 10.1002/ejoc.200400246; Feng LP, 2004, ORG LETT, V6, P2059, DOI 10.1021/ol049266r; FU H, 1991, J AM CHEM SOC, V113, P5878, DOI 10.1021/ja00015a061; GOUX C, 1995, ORGANOMETALLICS, V14, P4585, DOI 10.1021/om00010a024; Guanti G, 2002, TETRAHEDRON-ASYMMETR, V13, P2703, DOI 10.1016/S0957-4166(02)00711-5; Ho IT, 2011, EUR J ORG CHEM, P1472, DOI 10.1002/ejoc.201001169; Kutsumura N, 2006, TETRAHEDRON LETT, V47, P4133, DOI 10.1016/j.tetlet.2006.04.075; Kutsumura N, 2010, SYNLETT, P2717, DOI 10.1055/s-0030-1258813; Kutsumura N, 2011, CHEM LETT, V40, P1231, DOI 10.1246/cl.2011.1231; Kutsumura N, 2011, SYNTHESIS-STUTTGART, P2377, DOI 10.1055/s-0030-1260089; Kutsumura N, 2014, TETRAHEDRON, V70, P8004, DOI 10.1016/j.tet.2014.08.041; Kutsumura N, 2010, ORG LETT, V12, P3316, DOI 10.1021/ol101110v; Kutsumura N, 2013, EUR J ORG CHEM, P3337, DOI 10.1002/ejoc.201300173; KWART H, 1973, J AM CHEM SOC, V95, P5234, DOI 10.1021/ja00797a023; LEMIEUX RU, 1975, J AM CHEM SOC, V97, P4069, DOI 10.1021/ja00847a034; Listunov D, 2015, NAT PROD REP, V32, P49, DOI 10.1039/c4np00043a; Marshall JA, 1998, J ORG CHEM, V63, P5962, DOI 10.1021/jo980603h; Montevecchi PC, 1998, J ORG CHEM, V63, P537, DOI 10.1021/jo971399l; Ohgiya T, 2008, SYNLETT, P3091, DOI 10.1055/s-0028-1087360; Ohkubo M, 2007, ORG LETT, V9, P773, DOI 10.1021/ol062963u; OLIVERO S, 1995, TETRAHEDRON LETT, V36, P4429, DOI 10.1016/0040-4039(95)00782-8; OVERMAN LE, 1993, J ORG CHEM, V58, P4662, DOI 10.1021/jo00069a032; Sreedhar E, 2011, EUR J ORG CHEM, P1078, DOI 10.1002/ejoc.201001378; TREILHOU M, 1992, J ORG CHEM, V57, P3203, DOI 10.1021/jo00037a044; Trost BM, 2014, J AM CHEM SOC, V136, P88, DOI 10.1021/ja411270d; Trost BM, 2003, ORG LETT, V5, P1467, DOI 10.1021/ol034241y; Tsuji J, 1995, ANGEW CHEM INT EDIT, V34, P2589; Turlington M, 2012, SYNLETT, P649, DOI 10.1055/s-0031-1290530; Wu XF, 2009, EUR J ORG CHEM, P1144, DOI 10.1002/ejoc.200801176; Yokoyarna T, 2007, B CHEM SOC JPN, V80, P578, DOI 10.1246/bcsj.80.578	45	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0039-7881	1437-210X		SYNTHESIS-STUTTGART	Synthesis	JUL	2015	47	13					1844	1850		10.1055/s-0034-1380499		7	Chemistry, Organic	Chemistry	CK8UF	WOS:000356513500004		
J	Tominaga, M; Iekushi, A; Katagiri, K; Ohara, K; Yamaguchi, K; Azumaya, I				Tominaga, Masahide; Iekushi, Akitaka; Katagiri, Kosuke; Ohara, Kazuaki; Yamaguchi, Kentaro; Azumaya, Isao			Channel-dependent conformations of single-strand polymers in organic networks composed of tetrapodal adamantanes with N-heterocyclic moieties (vol 55, pg 5789, 2014)	TETRAHEDRON LETTERS			English	Correction									[Tominaga, Masahide; Iekushi, Akitaka; Katagiri, Kosuke; Ohara, Kazuaki; Yamaguchi, Kentaro] Tokushima Bunri Univ, Fac Pharmaceut Sci, Sanuki, Kagawa 7692193, Japan; [Azumaya, Isao] Toho Univ, Fac Pharmaceut Sci, Funabashi, Chiba 2748510, Japan	Tominaga, M (reprint author), Tokushima Bunri Univ, Fac Pharmaceut Sci, Kagawa Campus,1314-1 Shido, Sanuki, Kagawa 7692193, Japan.	tominagam@kph.bunri-u.ac.jp; isao.azumaya@phar.toho-u.ac.jp					Tominaga M, 2014, TETRAHEDRON LETT, V55, P5789, DOI 10.1016/j.tetlet.2014.08.099	1	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0040-4039			TETRAHEDRON LETT	Tetrahedron Lett.	JUL 1	2015	56	27					4143	4144		10.1016/j.tetlet.2015.05.046		2	Chemistry, Organic	Chemistry	CL2CE	WOS:000356750400022		
J	Suzuki, Y; Miura, K; Shigemune, A; Sasahara, H; Ohta, H; Uehara, Y; Ishikawa, T; Hamada, S; Shirasawa, K				Suzuki, Yasuhiro; Miura, Kiyoyuki; Shigemune, Akiko; Sasahara, Hideki; Ohta, Hisatoshi; Uehara, Yasuki; Ishikawa, Tetsuya; Hamada, Shigeki; Shirasawa, Kenta			Marker-assisted breeding of a LOX-3-null rice line with improved storability and resistance to preharvest sprouting	THEORETICAL AND APPLIED GENETICS			English	Article							ORYZA-SATIVA L.; REGULATES ABSCISIC-ACID; SEED PHOSPHOLIPASE-D; LACKING LIPOXYGENASE-3; PRODUCT SPECIFICITY; STORED RICE; SNP MARKERS; NULL-ALLELE; GENE; DORMANCY	Breakage of the tight linkage between rice seed lipoxygenase - 3 and easy preharvest sprouting trait led to breeding of lines with few stale flavors after long storage and desirable preharvest sprouting resistance. Lipoxygenase-3 (LOX-3) is involved in the production of volatile constituents in stored rice, and the development of stale flavor is delayed in LOX-3 null rice. In the process of breeding new LOX-3-null lines with long storability, we found a close association between LOX-3 and preharvest sprouting resistance. To determine whether this relationship was due to the tight linkage of two genes or the pleiotropic effect of LOX-3, we performed marker-assisted selection using a BC3F3 population derived from crosses between LOX-3-present/preharvest sprouting-resistant lines and LOX-3-null/preharvest susceptible lines. In one individual, a recombination event occurred 13 kb downstream of LOX-3 (RM15750) and a significant quantitative trait locus, namely qPHS3, for easy preharvest sprouting trait (LOD = 10.4) was detected in an 842-kb region between RM15711 and RM15768. Using BC3F4 and BC3F5 populations, we succeeded in selecting LOX-3-absent and preharvest sprouting-resistant lines with only a 393-kb introgressed chromosome segment from the donor line for LOX-3-null at the LOX-3 locus on chromosome 3. This result indicated that the LOX-3 gene and the locus affecting preharvest sprouting are distinct. The selected line was named 'Hokuriku 244'. Sensory testing of rice grains with and without LOX-3 confirmed that stale flavor production in LOX-3-null rice during storage was lower than in normal LOX-3 rice. These results indicated that rice varieties with little stale flavor after long storage and preharvest sprouting resistance had been selected.	[Miura, Kiyoyuki; Shigemune, Akiko; Sasahara, Hideki; Ohta, Hisatoshi; Uehara, Yasuki] NARO, Agric Res Cent, Joetsu, Niigata 9430193, Japan	Suzuki, Y (reprint author), NARO, Inst Crop Sci, 2-1-18 Kannondai, Tsukuba, Ibaraki 3058518, Japan.	suzuyasu@affrc.go.jp			Ministry of Agriculture, Forestry and Fisheries of Japan	We thank Ms. Chika Hashimoto and Sumiko Sakurai for technical assistance, Dr. Tsuyu Ando of the STAFF Institute for genotyping and Dr. Ikuo Ashikawa (NARO Inst. Crop Sci.) for helpful discussions of an early version of this manuscript. This work was supported in part by a grant from the Ministry of Agriculture, Forestry and Fisheries of Japan (the research project; Development of New rice Varieties using Genomic Breeding Technology). We would like to thank Enago (www.enago.jp) for the English language review.	Suzuki Y, 1996, EUPHYTICA, V91, P99, DOI 10.1007/BF00035279; Sato Y, 2011, NUCLEIC ACIDS RES, V39, pD1141, DOI 10.1093/nar/gkq1085; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; IDA S, 1983, AGR BIOL CHEM TOKYO, V47, P637; Kawahara Y, 2013, RICE, V6, DOI 10.1186/1939-8433-6-4; Groos C, 2002, THEOR APPL GENET, V104, P39, DOI 10.1007/s001220200004; Suzuki Y, 1999, J AGR FOOD CHEM, V47, P1119, DOI 10.1021/jf980967a; Graeber K, 2012, PLANT CELL ENVIRON, V35, P1769, DOI 10.1111/j.1365-3040.2012.02542.x; Suzuki M, 2008, PLANT PHYSIOL, V146, P1193, DOI 10.1104/pp.107.114108; Gu XY, 2011, GENETICS, V189, P1515, DOI 10.1534/genetics.111.131169; Feussner I, 2002, ANNU REV PLANT BIOL, V53, P275, DOI 10.1146/annurev.arplant.53.100301.135248; Nakamura S, 2011, PLANT CELL, V23, P3215, DOI 10.1105/tpc.111.088492; Shirasawa K, 2008, BREEDING SCI, V58, P169, DOI 10.1270/jsbbs.58.169; McCouch SR, 2012, AM J BOT, V99, P407, DOI 10.3732/ajb.1100385; Zhou Z, 2002, J CEREAL SCI, V35, P65, DOI 10.1006/jcrs.2001.0418; Holdsworth MJ, 2008, NEW PHYTOL, V179, P33, DOI 10.1111/j.1469-8137.2008.02437.x; Sakai H, 2013, PLANT CELL PHYSIOL, V54, pE6, DOI 10.1093/pcp/pcs183; Sugimoto K, 2010, P NATL ACAD SCI USA, V107, P5792, DOI 10.1073/pnas.0911965107; McCouch SR, 2008, RICE, V1, P72, DOI 10.1007/s12284-008-9004-9; Dong YJ, 2003, FIELD CROP RES, V81, P133, DOI 10.1016/S0378-4290(02)00217-4; Frank G, 2005, CURR OPIN PLANT BIOL, V8, P183; Gardner H. W., 1988, Advances in Cereal Science and Technology, V9, P161; Horiuchi H, 1996, RICE BREEDING MANUAL, P147; Ideta O, 2012, BREED RES, V14, P106; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Lincoln SE, 1993, CONSTRUCTING GENETIC; Sugimoto K, 2009, GAMMA FIELD S, V48, P53; Suzuki Y, 1996, J AGR FOOD CHEM, V44, P3479, DOI 10.1021/jf9600465; SUZUKI Y, 1993, JPN J BREED, V43, P405; Suzuki Y, 2000, RICE GENET NEWSL, V17, P13; Suzuki Y, 2011, CROP SCI, V51, P567, DOI 10.2135/cropsci2010.08.0460; Suzuki Y, 2011, CROP SCI, V51, P2113, DOI 10.2135/cropsci2010.12.0716; Suzuki Y, 1995, GAMMA FIELD S, V33, P51; Takahashi N, 1997, SCI RICE PLANT, V3, P348; TAKANO K, 1993, CEREAL FOOD WORLD, V38, P695; TSUGITA T, 1983, AGR BIOL CHEM TOKYO, V47, P543; Wang S, 2007, WINDOWS QTL CARTOGRA; YAMAMOTO A, 1980, LIPIDS, V15, P1, DOI 10.1007/BF02534108; YASUMATSU K, 1964, AGR BIOL CHEM TOKYO, V28, P257	39	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0040-5752	1432-2242		THEOR APPL GENET	Theor. Appl. Genet.	JUL	2015	128	7					1421	1430		10.1007/s00122-015-2516-y		10	Agronomy; Plant Sciences; Genetics & Heredity; Horticulture	Agriculture; Plant Sciences; Genetics & Heredity	CK3WT	WOS:000356148000016		
J	Kudo, Y; Chiba, C; Konoki, K; Cho, Y; Yotsu-Yamashita, M				Kudo, Yuta; Chiba, Chikafumi; Konoki, Keiichi; Cho, Yuko; Yotsu-Yamashita, Mad			Confirmation of the absence of tetrodotoxin and its analogues in the juveniles of the Japanese fire-bellied newt, Cynops pyrrhogaster, captive-reared from eggs in the laboratory using HILIC-LC-MS	TOXICON			English	Article						Cynops pyrrhogaster; LC-MS; Newt; Tetrodotoxin; Toxicity analysis	FISH FUGU-NIPHOBLES; RED-SPOTTED NEWT; ROUGH-SKIN NEWT; PUFFER FISH; TARICHA-GRANULOSA; NOTOPHTHALMUS-VIRIDESCENS; EVOLUTIONARY RESPONSE; MARINE ANIMALS; DANGEROUS PREY; GARTER SNAKES	The tetrodotoxin (TTX) contents of the Japanese fire-bellied newt, Cynops pyrrhogaster, captive-reared from eggs to metamorphosed juveniles with a non-toxic diet for 70 weeks, as well as wild-caught juvenile newts, were investigated using a high-resolution hydrophilic interaction chromatography-LC-MS. TFX was detected in 0- to 22-week-old captive-reared juvenile newts but was not detected (<15 ng/g) in the 36- to 70-week-old newts, while significant levels of TTX (13-14 mu g/g) were detected in the wild-caught juveniles. (C) 2015 Elsevier Ltd. All rights reserved.	[Kudo, Yuta; Konoki, Keiichi; Cho, Yuko; Yotsu-Yamashita, Mad] Tohoku Univ, Grad Sch Agr Sci, Aoba Ku, Sendai, Miyagi 9818555, Japan; [Chiba, Chikafumi] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan	Yotsu-Yamashita, M (reprint author), Tohoku Univ, Grad Sch Agr Sci, Aoba Ku, 1-1 Tsutsumidori Amamiyamachi, Sendai, Miyagi 9818555, Japan.	myama@biochem.tohoku.ac.jp			Japan Society for the Promotion of Science (JSPS) [LS012]; KAKENHI [26292057]	The authors are grateful to Prof. Dr. Dietrich Mebs (Institute of Legal Medicine, University of Frankfurt, Germany) for valuable discussion. This work was funded by the Japan Society for the Promotion of Science (JSPS) through its Funding Program for the Next Generation World-Leading Researchers (LS012) and the KAKENHI Grant-in-Aid for Scientific Research (B) no. 26292057 to M.Y.Y.; Y.K. is a research fellow of JSPS (DC1) (no. 25-5534).	GOTO T, 1965, TETRAHEDRON, V21, P2059, DOI 10.1016/S0040-4020(01)98344-9; Noguchi T, 2008, MAR DRUGS, V6, P220, DOI 10.3390/md20080011; Brodie ED, 2002, EVOLUTION, V56, P2067; Geffeney S, 2002, SCIENCE, V297, P1336, DOI 10.1126/science.1074310; DALY JW, 1994, TOXICON, V32, P279, DOI 10.1016/0041-0101(94)90081-7; Chau R, 2013, MAR DRUGS, V11, P2695, DOI 10.3390/md11082695; Chau R, 2011, AQUAT TOXICOL, V104, P61, DOI 10.1016/j.aquatox.2011.04.001; Kudo Y, 2014, J NAT PROD, V77, P1000, DOI 10.1021/np401097n; Yotsu-Yamashita M, 2012, TOXICON, V59, P257, DOI 10.1016/j.toxicon.2011.12.004; BRODIE ED, 1974, COPEIA, P506; Wood SA, 2012, J CHEM ECOL, V38, P1342, DOI 10.1007/s10886-012-0212-9; Yotsu-Yamashita M, 2007, TOXICON, V50, P306, DOI 10.1016/j.toxicon.2007.03.019; YASUMOTO T, 1988, J AM CHEM SOC, V110, P2344, DOI 10.1021/ja00215a078; MATSUI T, 1982, B JPN SOC SCI FISH, V48, P253; Yotsu-Yamashita M, 2013, MAR DRUGS, V11, P2799, DOI 10.3390/md11082799; Salvitti L, 2015, TOXICON, V95, P23, DOI 10.1016/j.toxicon.2014.12.006; YotsuYamashita M, 1995, TETRAHEDRON LETT, V36, P9329, DOI 10.1016/0040-4039(95)02020-P; Yotsu-Yamashita M, 2011, FORENSIC TOXICOL, V29, P61, DOI 10.1007/s11419-010-0106-x; Kudo Y, 2012, MAR DRUGS, V10, P655, DOI 10.3390/md10030655; Jang JH, 2007, TOXICON, V50, P947, DOI 10.1016/j.toxicon.2007.06.026; MATSUI T, 1981, B JPN SOC SCI FISH, V47, P535; TSUDA K, 1964, CHEM PHARM BULL, V12, P1357; Jang JH, 2010, MAR DRUGS, V8, P1049, DOI 10.3390/md8041049; Yotsu-Yamashita M, 2001, J TOXICOL-TOXIN REV, V20, P51, DOI 10.1081/TXR-100102536; KIM YH, 1975, SCIENCE, V189, P151, DOI 10.1126/science.1138374; Cardall BL, 2004, TOXICON, V44, P933, DOI 10.1016/j.toxicon.2004.09.006; Lehman EM, 2004, TOXICON, V44, P243, DOI 10.1016/j.toxicon.2004.05.019; BRODIE ED, 1991, EVOLUTION, V45, P221, DOI 10.2307/2409496; Hanifin CT, 2010, MAR DRUGS, V8, P577, DOI 10.3390/md8030577; YASUMOTO T, 1986, AGR BIOL CHEM TOKYO, V50, P793; Nakagawa T, 2006, ANAL BIOCHEM, V352, P142, DOI 10.1016/j.ab.2006.02.010; Yotsu-Yamashita M, 2003, TOXICON, V41, P893, DOI 10.1016/S0041-0101(03)00068-0; Salvitti LR, 2015, TOXINS, V7, P255, DOI 10.3390/toxins7020255; Hanifin CT, 2003, J CHEM ECOL, V29, P1729, DOI 10.1023/A:1024885824823; Honda S, 2005, NIPPON SUISAN GAKK, V71, P815, DOI 10.2331/suisan.71.815; BUCHWALD HD, 1964, SCIENCE, V143, P474, DOI 10.1126/science.143.3605.474; Casco-Robles MM, 2011, NAT PROTOC, V6, P600, DOI 10.1038/nprot.2011.334; Daly JW, 1997, TOXICON, V35, P705, DOI 10.1016/S0041-0101(96)00165-1; Gall BG, 2011, TOXICON, V57, P978, DOI 10.1016/j.toxicon.2011.03.020; Gall BG, 2014, TOXICON, V90, P249, DOI 10.1016/j.toxicon.2014.08.060; Hanifin CT, 2008, PLOS BIOL, V6, P471, DOI 10.1371/journal.pbio.0060060; Kono M, 2008, TOXICON, V52, P714, DOI 10.1016/j.toxicon.2008.08.002; Kono M, 2008, TOXICON, V51, P1269, DOI 10.1016/j.toxicon.2008.02.017; Kudo Y., 2014, ANGEW CHEM, V126, P14774; Kudo Y, 2014, ANGEW CHEM INT EDIT, V53, P14546, DOI 10.1002/anie.201408913; NOGUCHI T, 1986, J BIOCHEM-TOKYO, V99, P311; SHIMIZU Y, 1983, CHEM PHARM BULL, V31, P3625; STOKES AN, 2012, BIOL PROCED ONLINE, V14, P1, DOI DOI 10.1186/1480-9222-14-3; Stokes AN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100718; Turner A.D., 2015, EURO SURVEILL, V20, P21011; Woodward R.B., 1964, PURE APPL CHEM, V9, P49, DOI 10.1351/pac196409010049; Yasumoto T, 1996, J TOXICOL-TOXIN REV, V15, P81; YASUMOTO T, 1986, ANN NY ACAD SCI, V479, P44, DOI 10.1111/j.1749-6632.1986.tb15560.x; YOTSU M, 1990, TOXICON, V28, P238, DOI 10.1016/0041-0101(90)90419-8; Yotsui-Yamashita M, 2010, TOXICON, V55, P153, DOI 10.1016/j.toxicon.2009.07.003	55	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0041-0101			TOXICON	Toxicon	JUL	2015	101						101	105		10.1016/j.toxicon.2015.05.008		5	Pharmacology & Pharmacy; Toxicology	Pharmacology & Pharmacy; Toxicology	CL1VX	WOS:000356734100015		
J	Ryosaka, M; Ishida, H; Takagi, T; Shimizu, T; Tanabe, K; Kondo, T				Ryosaka, Makoto; Ishida, Hideki; Takagi, Toshio; Shimizu, Tomokazu; Tanabe, Kazunari; Kondo, Tsunenori			Solid-type RCC originating from native kidneys in renal transplant recipients should be monitored cautiously	TRANSPLANT INTERNATIONAL			English	Article						end-stage renal disease; immunosuppressive therapy; kidney transplantation; renal cell carcinoma	CELL CARCINOMA; MALIGNANCY	Incidental hemodialysis-related renal cell carcinoma (id-RCC) has been reported to have a good prognosis. However, we have observed rapid progression of id-RCC in some renal transplant patients. Operative indications for id-RCC detected via computed tomography (CT) immediately before renal transplantation (RTx) remain unclear. The purpose of this study was to examine the effects of immunosuppression on the progression of solid-type RCC (s-RCC) and cystic-type RCC (c-RCC). We divided 202 patients with id-RCC into four groups as follows: Group 1, s-RCC with RTx (n=17); Group 2, c-RCC with RTx (n=27); Group 3, s-RCC without RTx (n=53); and Group 4, c-RCC without RTx (n=105). Five-year cancer specific survival (CSS) rates were significantly worse in Group 1 than Group 3 (79.6% and 100%, respectively, P=0.012), as were non-recurrence rates (NRRs) (59.2 and 100%, respectively, P<0.001). In contrast, 5-year CSS rates were similar in Group 2 and Group 4 (100% and 95.7%, respectively, P=0.295) as were NRR (100% and 98.7%, respectively, P=0.230). Solid-type RCC should be removed immediately after RTx, and more carefully monitored for recurrence during follow-up.	[Ryosaka, Makoto; Ishida, Hideki; Takagi, Toshio; Shimizu, Tomokazu; Tanabe, Kazunari; Kondo, Tsunenori] Tokyo Womens Med Univ, Dept Urol, Tokyo 1628666, Japan	Kondo, T (reprint author), Tokyo Womens Med Univ, Dept Urol, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	tkondo@kc.twmu.ac.jp					AGISHI T, 1980, T AM SOC ART INT ORG, V26, P406; Doublet JD, 1997, J UROLOGY, V158, P42, DOI 10.1097/00005392-199707000-00012; Gutierrez-Dalmau A, 2007, DRUGS, V67, P1167, DOI 10.2165/00003495-200767080-00006; Kalble T, 2005, EUR UROL, V47, P156, DOI 10.1016/j.eururo.2004.02.009; Geissler EK, 2010, KIDNEY INT, V78, P1075, DOI 10.1038/ki.2010.324; Breda A, 2015, WORLD J UROL, V33, P1, DOI 10.1007/s00345-014-1248-y; Kasiske BL, 2004, AM J TRANSPLANT, V4, P905, DOI 10.1111/j.1600-6143.2004.00450.x; Cairns Paul, 2010, Cancer Biomark, V9, P461, DOI 10.3233/CBM-2011-0176; Choyke PL, 2000, EUR RADIOL, V10, P1716, DOI 10.1007/s003300000601; Gigante M, 2012, BJU INT, V110, pE570, DOI 10.1111/j.1464-410X.2012.11273.x; Goh A, 2011, AM J TRANSPLANT, V11, P86, DOI 10.1111/j.1600-6143.2010.03303.x; Japan organ transplantation network, 2013, NEWS LETT, V17, P8; Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group, 2009, AM J TRANSPLANT S3, V9, pS1; Klatte T, 2010, BJU INT, V105, P1260, DOI 10.1111/j.1464-410X.2009.08941.x; Ramos E, 1998, PRIMER TRANSPLANTATI, V1st, P183; Setoguchi S, 2007, J JAP SOC DIAL THER, V40, P643; Sheashaa HA, 2011, TRANSPLANTATION, V92, P1123, DOI 10.1097/TP.0b013e3182339cdd; Tanabe K, 2004, TRANSPLANT P, V36, P2175, DOI 10.1016/j.transproceed.2004.08.142	18	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0934-0874	1432-2277		TRANSPL INT	Transpl. Int.	JUL	2015	28	7					813	819		10.1111/tri.12571		7	Surgery; Transplantation	Surgery; Transplantation	CK1YY	WOS:000356007100006		
J	Kimura, T; Sasaki, H; Akazawa, K; Egawa, S				Kimura, Takahiro; Sasaki, Hiroshi; Akazawa, Kouhei; Egawa, Shin			Gonadotropin-releasing hormone antagonist: A real advantage?	UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS			English	Review						Degarelix; Prostate cancer; GnRH antagonist; Oncological outcome; Cardiovascular disease	ANDROGEN DEPRIVATION THERAPY; GOSERELIN PLUS BICALUTAMIDE; PROSTATE VOLUME REDUCTION; TRACT SYMPTOM RELIEF; OF-LIFE IMPROVEMENT; TESTOSTERONE SURGE; SEX STEROIDS; OPEN-LABEL; PHASE-III; CANCER	Degarelix is a gonadotropin-releasing hormone (GnRH) antagonist that is approved for the treatment of prostate cancer. GnRH antagonists bind directly to and block GnRH receptors, without causing the initial testosterone surge associated with GnRH agonists. A pivotal phase El study indicated that degarelix induced significantly faster reduction of testosterone and prostate-specific antigen level than GnRH agonist does. In addition, its 5-year extension trial suggested that patients could be safely switched from GnRH agonist to degarelix treatment with sustained efficacy, as measured by biochemical markers. Possible benefits of GnRH antagonists over agonists were suggested especially in patients with advanced prostate cancer with metastatic and symptomatic disease. Moreover, the recent reports including pooled data analyses on degarelix suggest improved disease control, quality of life, and lower urinary tract symptoms and decreased risk of cardiovascular diseases when compared with GnRH agonists. However, interpretation of these reports should be conducted cautiously because of the potential biases involved. This article critically reviews the results of the clinical trials and subsequent analyses and evaluates the points and counterpoints of the conclusions. (C) 2015 Elsevier Inc. All rights reserved.	[Kimura, Takahiro; Sasaki, Hiroshi; Egawa, Shin] Jikei Univ Sch Med, Dept Urol, Minato Ku, Tokyo, Japan; [Akazawa, Kouhei] Niigata Univ Med & Dent Hosp, Dept Med Informat, Niigata, Japan	Egawa, S (reprint author), Jikei Univ Sch Med, Dept Urol, Minato Ku, Tokyo, Japan.	s-egpro@jikei.ac.jp					[Anonymous], 2015, NCCN GUIDELINES PROS; Engel JB, 2007, NAT CLIN PRACT ENDOC, V3, P157, DOI 10.1038/ncpendmet0399; Anderson J, 2013, UROL INT, V90, P321, DOI 10.1159/000345423; Van Poppel H, 2012, INT J UROL, V19, P594, DOI 10.1111/j.1442-2042.2012.02997.x; Chen HF, 1999, J CLIN ENDOCR METAB, V84, P743, DOI 10.1210/jc.84.2.743; Siraj A, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-246; van Poppel H, 2008, UROLOGY, V71, P1001, DOI 10.1016/j.urology.2007.12.070; Dong F, 2011, J NEUROENDOCRINOL, V23, P456, DOI 10.1111/j.1365-2826.2011.02119.x; Hussain M, 2013, NEW ENGL J MED, V368, P1314, DOI 10.1056/NEJMoa1212299; Lu LT, 2012, BJU INT, V109, P1183, DOI 10.1111/j.1464-410X.2011.10434.x; Tanriverdi F, 2005, CLIN EXP IMMUNOL, V142, P103, DOI 10.1111/j.1365-2249.2005.02904.X; Haring R, 2013, CLIN ENDOCRINOL, V78, P629, DOI 10.1111/cen.12013; Radu A, 2010, NEW ENGL J MED, V363, P1621, DOI 10.1056/NEJMoa1001283; Klotz L, 2008, BJU INT, V102, P1531, DOI 10.1111/j.1464-410X.2008.08183.x; Falk E, 2013, EUR HEART J, V34, P719, DOI 10.1093/eurheartj/ehs411; Albertsen PC, 2014, EUR UROL, V65, P565, DOI 10.1016/j.eururo.2013.10.032; Crawford ED, 2011, J UROLOGY, V186, P889, DOI 10.1016/j.juro.2011.04.083; Haring R, 2012, INT J ANDROL, V35, P775, DOI 10.1111/j.1365-2605.2012.01285.x; Mason M, 2013, CLIN ONCOL-UK, V25, P190, DOI 10.1016/j.clon.2012.09.010; Axcrona K, 2012, BJU INT, V110, P1721, DOI 10.1111/j.1464-410X.2012.11107.x; Blettner M, 1999, INT J EPIDEMIOL, V28, P1, DOI 10.1093/ije/28.1.1; Stangelberger A, 2008, EUR UROL, V53, P890, DOI 10.1016/j.eururo.2007.12.021; BHASIN S, 1994, J ANDROL, V15, P386; Blair HC, 2011, ANN NY ACAD SCI, V1240, P26, DOI 10.1111/j.1749-6632.2011.06287.x; Crook JM, 2012, NEW ENGL J MED, V367, P895, DOI 10.1056/NEJMoa1201546; Cui Y, 2014, UROL INT, V93, P152, DOI 10.1159/000356272; de la Rosette J, 2011, INT J CLIN PRACT, V65, P559, DOI 10.1111/j.1742-1241.2011.02637.x; Heidenreich A, 2014, EUR UROL, V65, P467, DOI 10.1016/j.eururo.2013.11.002; Jiang GC, 2001, J MED CHEM, V44, P453, DOI 10.1021/jm0003900; Klotz L, 2014, EUR UROL, V66, P1101, DOI 10.1016/j.eururo.2013.12.063; Lee Dawn, 2014, J Med Econ, V17, P233, DOI 10.3111/13696998.2014.893240; Namiki Shunichi, 2008, Nihon Hinyokika Gakkai Zasshi, V99, P631; Persson BE, 2009, NEUROENDOCRINOLOGY, V90, P235, DOI 10.1159/000228832; Shore N, 2012, EFFICACY SAFETY 3 MO; THOMPSON IM, 1990, J UROLOGY, V144, P1479; Zinner NR, 2004, UROLOGY, V64, P1177, DOI 10.1016/j.urology.2004.07.033	36	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1078-1439	1873-2496		UROL ONCOL-SEMIN ORI	Urol. Oncol.-Semin. Orig. Investig.	JUL	2015	33	7					322	328		10.1016/j.urolonc.2015.04.013		7	Oncology; Urology & Nephrology	Oncology; Urology & Nephrology	CL0MX	WOS:000356637900003		
J	Sakata, K; Kondo, T; Mizuno, N; Shoji, M; Yasui, H; Yamamori, T; Inanami, O; Yokoo, H; Yoshimura, N; Hattori, Y				Sakata, Kimimasa; Kondo, Takashi; Mizuno, Natsumi; Shoji, Miki; Yasui, Hironobu; Yamamori, Tohru; Inanami, Osamu; Yokoo, Hiroki; Yoshimura, Naoki; Hattori, Yuichi			Roles of ROS and PKC-beta II in ionizing radiation-induced eNOS activation in human vascular endothelial cells	VASCULAR PHARMACOLOGY			English	Article						X-ray radiation; Human endothelial cells; eNOS; Protein kinase C; Reactive oxygen species	NITRIC-OXIDE SYNTHASE; INTRACORONARY IRRADIATION; BALLOON ANGIOPLASTY; RESTENOSIS MODEL; MESANGIAL CELLS; APOPTOSIS; INHIBITION; MECHANISMS; OXYGEN; DAMAGE	Vascular endothelial cells can absorb higher radiation doses than any other tissue in the body, and post-radiation impaired endothelial nitric oxide synthase (eNOS) function may be developed as a potential contributor to the pathogenesis of vascular injury. In this study, we investigated early alterations of eNOS signaling in human umbilical venous endothelial cells (HUVECs) exposed to X-ray radiation. We found that ionizing radiation increased eNOS phosphorylation at Ser-1177 and dephosphorylation at Thr-495 in HUVECs in a dose-dependent (<= 20 Gy) and time-dependent (6-72 h) manner. The total expression levels of eNOS were unchanged by radiation. Although a transient but significant increase in extracellular signal-regulated protein kinase 1/2 (ERK1/2) phosphorylation and a biphasic decline in Akt phosphorylation were observed after irradiation, these inhibitors were without effect on the radiation-induced changes in eNOS phosphorylation. There was an increase in protein kinase C-beta II (PKC-beta II) expression and the ablation of PKC-beta II by small interfering RNA (siRNA) negated the radiation effect on the two eNOS phosphorylation events. Furthermore, when the radiation-induced increase in reactive oxygen species (ROS) generation was prevented by the anti-oxidant N-acetyl-L-cysteine, eNOS Ser-1177 phosphorylation and Thr-495 dephosphorylation in irradiated HUVECs were significantly reduced. However, transfection of PKC-beta siRNA did not alter ROS production after irradiation, and NAC failed to block the radiation-induced increase in PKC-beta II expression. Taken together, our results suggest that ionizing radiation-induced eNOS activation in human vascular endothelial cells is attributed to both the upregulation of PKC-beta II and the increase in ROS generation which were independent of each other. (C) 2015 Elsevier Inc. All rights reserved.	[Sakata, Kimimasa; Mizuno, Natsumi; Yokoo, Hiroki; Hattori, Yuichi] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Mol & Med Pharmacol, Toyama 9300194, Japan; [Sakata, Kimimasa; Yoshimura, Naoki] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Thorac & Cardiovasc Surg, Toyama 9300194, Japan; [Kondo, Takashi] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Radiol Sci, Toyama 9300194, Japan; [Shoji, Miki] Toyama Univ, Life Sci Res Ctr, Toyama 9300194, Japan; [Yasui, Hironobu; Yamamori, Tohru; Inanami, Osamu] Hokkaido Univ, Grad Sch Vet Med, Dept Environm Vet Sci, Radiat Biol Lab, Sapporo, Hokkaido 0600818, Japan	Hattori, Y (reprint author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Mol & Med Pharmacol, Toyama 9300194, Japan.	yhattori@med.u-toyama.ac.jp	Yamamori, Tohru/A-7285-2012		Funding Program for Study of the Health Effects of Radiation Organized by the Ministry of the Environment, Japan	This work was financially supported, in part, by the Funding Program for Study of the Health Effects of Radiation Organized by the Ministry of the Environment, Japan. The authors thank Toshio Fujimori for the technical assistance. Dr. Kumiko Taguchi participated in the planning of the initial experiments.	Mikkelsen RB, 2003, ONCOGENE, V22, P5734, DOI 10.1038/sj.onc.1206663; Taguchi K, 2014, J PHARMACOL EXP THER, V349, P199, DOI 10.1124/jpet.113.211854; Rose BA, 2010, PHYSIOL REV, V90, P1507, DOI 10.1152/physrev.00054.2009; FAJARDO LF, 1988, PATHOL ANNU, V23, P297; Diggelmann KV, 2010, BRIT J RADIOL, V83, P971, DOI 10.1259/bjr/62011713; Nishikawa T, 2000, NATURE, V404, P787; Fleming I, 2003, AM J PHYSIOL-REG I, V284, pR1, DOI 10.1152/ajpregu.00323.2002; Chen Q, 2003, CELL DEATH DIFFER, V10, P323, DOI 10.1038/sj.cdd.4401148; Borghini A, 2013, ATHEROSCLEROSIS, V230, P40, DOI 10.1016/j.atherosclerosis.2013.06.010; Sabate M, 1999, CIRCULATION, V100, P1623; Schultz-Hector S, 2007, INT J RADIAT ONCOL, V67, P10, DOI 10.1016/j.ijrobp.2006.08.071; Studer RK, 1997, METABOLISM, V46, P918, DOI 10.1016/S0026-0495(97)90080-9; Huang A, 2012, DIABETES, V61, P3181, DOI 10.2337/db12-0559; Garcia-Barros M, 2003, SCIENCE, V300, P1155, DOI 10.1126/science.1082504; Rask-Madsen C, 2008, ARTERIOSCL THROM VAS, V28, P919, DOI 10.1161/ATVBAHA.108.162842; Barcellos-Hoff MH, 2008, RADIAT ENVIRON BIOPH, V47, P33, DOI 10.1007/s00411-007-0141-0; Bejarano Jorge, 2004, J Interv Cardiol, V17, P203, DOI 10.1111/j.1540-8183.2004.00379.x; Chen F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099823; Grabham Peter, 2013, Vasc Cell, V5, P19, DOI 10.1186/2045-824X-5-19; Ha H, 1992, AM J PHYSIOL, V263, pF201; Hirakawa M, 2002, CANCER RES, V62, P1450; Hua H, 2003, J BIOL CHEM, V278, P33951, DOI 10.1074/jbc.M302823200; Lazo JS, 2013, J PHARMACOL EXP THER, V347, P669, DOI 10.1124/jpet.113.208421; Menendez JC, 1998, INT J RADIAT ONCOL, V41, P905, DOI 10.1016/S0360-3016(98)00112-6; Nakamura N, 2013, ANNU REV GENET, V47, P33, DOI 10.1146/annurev-genet-111212-133501; POLLOCK JS, 1991, P NATL ACAD SCI USA, V88, P10480, DOI 10.1073/pnas.88.23.10480; Qi FZ, 1998, BRIT J PHARMACOL, V123, P653, DOI 10.1038/sj.bjp.0701654; Sonveaux P, 2002, FASEB J, V16, P1979, DOI 10.1096/fj.02-0487fje; Sugihara T, 1999, CIRCULATION, V100, P635; Takatsuka H, 2002, CLIN TRANSPLANT, V16, P374, DOI 10.1034/j.1399-0012.2002.02035.x; VERIN V, 1995, CIRCULATION, V92, P2284; WAKSMAN R, 1995, CIRCULATION, V92, P3025; WIEDERMANN JG, 1994, J AM COLL CARDIOL, V23, P1491; Zhang XH, 2010, BRIT J PHARMACOL, V159, P928, DOI 10.1111/j.1476-5381.2009.00594.x	34	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1537-1891	1879-3649		VASC PHARMACOL	Vasc. Pharmacol.	JUL	2015	70						55	65		10.1016/j.vph.2015.03.016		11	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CK9ND	WOS:000356565900007		
J	Jung, J; Mori, T; Kobayashi, C; Matsunaga, Y; Yoda, T; Feig, M; Sugita, Y				Jung, Jaewoon; Mori, Takaharu; Kobayashi, Chigusa; Matsunaga, Yasuhiro; Yoda, Takao; Feig, Michael; Sugita, Yuji			GENESIS: a hybrid-parallel and multi-scale molecular dynamics simulator with enhanced sampling algorithms for biomolecular and cellular simulations	WILEY INTERDISCIPLINARY REVIEWS-COMPUTATIONAL MOLECULAR SCIENCE			English	Article							REPLICA-EXCHANGE METHOD; ROUGH ENERGY LANDSCAPE; PARTICLE MESH EWALD; MONTE-CARLO METHOD; FORCE-FIELD; COMPUTER-SIMULATION; MEMBRANE TENSION; LIPID-BILAYERS; PROTEIN; SYSTEMS	GENESIS (Generalized-Ensemble Simulation System) is a new software package for molecular dynamics (MD) simulations of macromolecules. It has two MD simulators, called ATDYN and SPDYN. ATDYN is parallelized based on an atomic decomposition algorithm for the simulations of all-atom force-field models as well as coarse-grained Go-like models. SPDYN is highly parallelized based on a domain decomposition scheme, allowing large-scale MD simulations on supercomputers. Hybrid schemes combining OpenMP and MPI are used in both simulators to target modern multicore computer architectures. Key advantages of GENESIS are (1) the highly parallel performance of SPDYN for very large biological systems consisting of more than one million atoms and (2) the availability of various REMD algorithms (T-REMD, REUS, multi-dimensional REMD for both all-atom and Go-like models under the NVT, NPT, NPAT, and NPT ensembles). The former is achieved by a combination of the midpoint cell method and the efficient three-dimensional Fast Fourier Transform algorithm, where the domain decomposition space is shared in real-space and reciprocal-space calculations. Other features in SPDYN, such as avoiding concurrent memory access, reducing communication times, and usage of parallel input/output files, also contribute to the performance. We show the REMD simulation results of a mixed (POPC/DMPC) lipid bilayer as a real application using GENESIS. GENESIS is released as free software under the GPLv2 licence and can be easily modified for the development of new algorithms and molecular models. (C) 2015 The Authors. WIREs Computational Molecular Science published by John Wiley & Sons, Ltd.	[Jung, Jaewoon; Kobayashi, Chigusa; Matsunaga, Yasuhiro; Sugita, Yuji] RIKEN Adv Inst Computat Sci, Computat Biophys Res Team, Kobe, Hyogo, Japan; [Mori, Takaharu; Sugita, Yuji] RIKEN, Theoret Mol Sci Lab, Wako, Saitama, Japan; [Yoda, Takao] Nagahama Inst Biosci & Technol, Nagahama, Japan; [Feig, Michael] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Feig, Michael] Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA; [Sugita, Yuji] RIKEN, Interdisciplinary Theoret Sci Res Grp, Wako, Saitama, Japan; [Sugita, Yuji] RIKEN, Quantitat Biol Ctr, Lab Biomol Funct Simulat, Kobe, Hyogo, Japan	Sugita, Y (reprint author), RIKEN Adv Inst Computat Sci, Computat Biophys Res Team, Kobe, Hyogo, Japan.	sugita@riken.jp	Sugita, Yuji/L-6726-2014	Sugita, Yuji/0000-0001-9738-9216	RIKEN Advanced Institute for Computational Science through the HPCI System Research project [ra000009, hp120060, hp120309, hp130003, hp140091, hp140169, hp140229]; High Performance Computing Infrastructure (HPCI) Strategic Program of the Ministry of Education, Culture, Sports, Science and Technology (MEXT);  [26119006]	We would like to thank Dr. Isseki Yu at RIKEN for valuable discussions about the cytoplasmic simulations. We also thank Drs. Takashi Imai, Raimondas Galvelis, Ryuhei Harada, Yasuaki Komuro, Wataru Nishima, Naoyuki Miyashita, Yasuhito Karino, Suyong Re, Yasumasa Joti at RIKEN, Hikaru Inoue and Tomoyuki Noda at Fujitsu Ltd., and Norio Takase at Isogo Soft for contributing to the development of GENESIS. This research used the computational resources of K computer provided by the RIKEN Advanced Institute for Computational Science through the HPCI System Research project (Project ID: ra000009, hp120060, hp120309, hp130003, hp140091, hp140169, and hp140229). We thank the RIKEN Integrated Cluster of Clusters (RICC) for additional computer resources used in the calculations. This research was supported in part by a Grant-in-Aid for Scientific Research on Innovative Areas (No. 26119006) and the Fund from the High Performance Computing Infrastructure (HPCI) Strategic Program of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) (to YS).	Akimov SA, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.011919; Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27; Ando T, 2010, P NATL ACAD SCI USA, V107, P18457, DOI 10.1073/pnas.1011354107; Feig M, 2015, J MOL GRAPH MODEL, V58, P1, DOI 10.1016/j.jmgm.2015.02.004; KITAO A, 1991, CHEM PHYS, V158, P447, DOI 10.1016/0301-0104(91)87082-7; Feig M, 2004, J MOL GRAPH MODEL, V22, P377, DOI 10.1016/j.jmgm.2003.12.005; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Vanommeslaeghe K, 2012, J CHEM INF MODEL, V52, P3155, DOI 10.1021/ci3003649; Tajkhorshid E, 2002, SCIENCE, V296, P525, DOI 10.1126/science.1067778; Clementi C, 2000, J MOL BIOL, V298, P937, DOI 10.1006/jmbi.2000.3693; Gumbart J, 2009, STRUCTURE, V17, P1453, DOI 10.1016/j.str.2009.09.010; Barducci A, 2011, WIRES COMPUT MOL SCI, V1, P826, DOI 10.1002/wcms.31; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Berneche S, 2001, NATURE, V414, P73, DOI 10.1038/35102067; Mori T, 2013, J CHEM THEORY COMPUT, V9, P5629, DOI 10.1021/ct400445k; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; GALLA HJ, 1979, J MEMBRANE BIOL, V48, P215, DOI 10.1007/BF01872892; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Hamelberg D, 2004, J CHEM PHYS, V120, P11919, DOI 10.1063/1.1755656; Kar P, 2013, J CHEM THEORY COMPUT, V9, P3769, DOI 10.1021/ct400230y; Liu P, 2005, P NATL ACAD SCI USA, V102, P13749, DOI 10.1073/pnas.0506346102; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Ingolfsson HI, 2014, WIRES COMPUT MOL SCI, V4, P225, DOI 10.1002/wcms.1169; Owens JD, 2008, P IEEE, V96, P879, DOI 10.1109/JPROC.2008.917757; TAKETOMI H, 1975, INT J PEPT PROT RES, V7, P445; Salomon-Ferrer R, 2013, WIRES COMPUT MOL SCI, V3, P198, DOI 10.1002/wcms.1121; Sutto L, 2012, WIRES COMPUT MOL SCI, V2, P771, DOI 10.1002/wcms.1103; Ayuyan AG, 2008, BIOPHYS J, V94, P2654, DOI 10.1529/biophysj.107.118596; Raman EP, 2010, J PHYS CHEM B, V114, P12981, DOI 10.1021/jp105758h; Whitford PC, 2009, PROTEINS, V75, P430, DOI 10.1002/prot.22253; Mukherjee S, 2004, ANNU REV CELL DEV BI, V20, P839, DOI 10.1146/annurev.cellbio.20.010403.095451; ZHANG YH, 1995, J CHEM PHYS, V103, P10252, DOI 10.1063/1.469927; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Huang XH, 2009, P NATL ACAD SCI USA, V106, P19765, DOI 10.1073/pnas.0909088106; MCCAMMON JA, 1977, NATURE, V267, P585, DOI 10.1038/267585a0; Kenzaki H, 2011, J CHEM THEORY COMPUT, V7, P1979, DOI 10.1021/ct2001045; Fukunishi H, 2002, J CHEM PHYS, V116, P9058, DOI 10.1063/1.1472510; Sugita Y, 2000, CHEM PHYS LETT, V329, P261, DOI 10.1016/S0009-2614(00)00999-4; Jung J, 2013, J COMPUT CHEM, V34, P2412, DOI 10.1002/jcc.23404; Sugita Y, 2000, J CHEM PHYS, V113, P6042, DOI 10.1063/1.1308516; Duan Y, 1998, SCIENCE, V282, P740, DOI 10.1126/science.282.5389.740; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Feig M, 2010, BIOPHYS J, V99, P2577, DOI 10.1016/j.bpj.2010.08.010; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Feig M, 2013, J MOL GRAPH MODEL, V45, P144, DOI 10.1016/j.jmgm.2013.08.017; Mitsutake A, 2001, BIOPOLYMERS, V60, P96, DOI 10.1002/1097-0282(2001)60:2<96::AID-BIP1007>3.0.CO;2-F; Karanicolas J, 2003, J MOL BIOL, V334, P309, DOI 10.1016/j.jmb.2003.09.047; Mori Y, 2010, J PHYS SOC JPN, V79, DOI 10.1143/JPSJ.79.074003; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137; de Groot BL, 2001, SCIENCE, V294, P2353, DOI 10.1126/science.1062459; Okabe T, 2001, CHEM PHYS LETT, V335, P435, DOI 10.1016/S0009-2614(01)00055-0; Lindahl E, 2001, J MOL MODEL, V7, P306; Takada S, 2012, CURR OPIN STRUC BIOL, V22, P130, DOI 10.1016/j.sbi.2012.01.010; Nilsson L, 2009, J COMPUT CHEM, V30, P1490, DOI 10.1002/jcc.21169; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct3004000x; Hamada T, 2011, SOFT MATTER, V7, P9061, DOI 10.1039/c1sm05948c; Portet T, 2012, BIOPHYS J, V103, pL35, DOI 10.1016/j.bpj.2012.08.061; Liwo A, 2008, CURR OPIN STRUC BIOL, V18, P134, DOI 10.1016/j.sbi.2007.12.001; LEVITT M, 1988, P NATL ACAD SCI USA, V85, P7557, DOI 10.1073/pnas.85.20.7557; Neria E, 1996, J CHEM PHYS, V105, P1902, DOI 10.1063/1.472061; Saunders MG, 2013, ANNU REV BIOPHYS, V42, P73, DOI 10.1146/annurev-biophys-083012-130348; Li L, 2006, BIOCHEMISTRY-US, V45, P11819, DOI 10.1021/bi060808h; Sugita Y, 1999, CHEM PHYS LETT, V314, P141, DOI 10.1016/S0009-2614(99)01123-9; PLIMPTON S, 1995, J COMPUT PHYS, V117, P1, DOI 10.1006/jcph.1995.1039; Andoh Y, 2013, J CHEM THEORY COMPUT, V9, P3201, DOI 10.1021/ct400203a; Aydin F, 2014, SOFT MATTER, V10, P6096, DOI 10.1039/c4sm00998c; Bowers KJ, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2191489; Bowers KJ, 2006, INT C HIGH PERF COMP; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Chen D, 2014, P NATL ACAD SCI USA, V111, P179, DOI 10.1073/pnas.1314993111; Crowley MF, 1997, J SUPERCOMPUT, V11, P255, DOI 10.1023/A:1007907925007; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Eleftheriou M, 2003, LECT NOTES COMPUT SC, V2913, P194; Hansmann UHE, 1997, PHYS REV E, V56, P2228, DOI 10.1103/PhysRevE.56.2228; Hynninen AP, 2014, J COMPUT CHEM, V35, P406, DOI 10.1002/jcc.23501; Ikeguchi M, 2004, J COMPUT CHEM, V25, P529, DOI 10.1002/jcc.10402; Itoh SG, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3372767; Itoh SG, 2013, J COMPUT CHEM, V34, P622, DOI 10.1002/jcc.23167; Jung J, 2014, J COMPUT CHEM, V35, P1064, DOI 10.1002/jcc.23591; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MacKerell Alexander D. Jr., 2000, Biopolymers, V56, P257, DOI 10.1002/1097-0282(2000)56:4<257::AID-BIP10029>3.0.CO;2-W; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; McGuffee SR, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000694; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Mori Y, 2010, J PHYS SOC JPN, V79, DOI 10.1143/JPSJ.79.074001; Narumi T, 2006, INT C HIGH PERF COMP; Ohmura I, 2014, PHILOS T R SOC A, V372, DOI 10.1098/rsta.2013.0387; Park S, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.108102; Paschek D, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.238105; Piana S, 2011, BIOPHYS J, V100, pL47, DOI 10.1016/j.bpj.2011.03.051; Sanbonmatsu KY, 2012, CURR OPIN STRUC BIOL, V22, P168, DOI 10.1016/j.sbi.2012.01.008; Service RF, 2013, SCIENCE, V339, P264, DOI 10.1126/science.339.6117.264; Shaw DE, 2010, SCIENCE, V330, P341, DOI 10.1126/science.1187409; Shaw DE, 2009, INT C HIGH PERF COMP; Shaw DE, 2005, J COMPUT CHEM, V26, P1803, DOI 10.1002/jcc.20331; Takahashi D, 2010, LECT NOTES COMPUT SC, V6067, P606; Uline MJ, 2012, BIOPHYS J, V102, P517, DOI 10.1016/j.bpj.2011.12.050; Zhu X, 2012, WIRES COMPUT MOL SCI, V2, P167, DOI 10.1002/wcms.74	99	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1759-0876	1759-0884		WIRES COMPUT MOL SCI	Wiley Interdiscip. Rev.-Comput. Mol. Sci.	JUL-AUG	2015	5	4					310	323		10.1002/wcms.1220		14	Chemistry, Multidisciplinary; Mathematical & Computational Biology	Chemistry; Mathematical & Computational Biology	CL0CF	WOS:000356605600002		
J	Ofuji, K				Ofuji, Kenta			Recent improvements and challenges in Fukushima: prefecture's economy and living environment	WILEY INTERDISCIPLINARY REVIEWS-ENERGY AND ENVIRONMENT			English	Article								Today as we approach the 3-year mark since the earthquake disaster and nuclear accident, Fukushima Prefecture's economy is gradually improving, albeit not yet completely, and the living environment in urban areas is showing signs of recovery. Yet much remains to be done to reassure people, who have still not returned home since evacuating, about their fears concerning radiation, and to dispel harmful rumors about the tourism and the farming and fishing industries. In this article, I raise three issues: (1) decontamination and target dose, (2) contaminated water and revival of the fishing industry, and (3) a vision for the industrialization of renewable energy; and present examples of the progress made in recent efforts in these three issues to close the gap between the ideal and reality. (C) 2014 John Wiley & Sons, Ltd.	Univ Aizu, Dept Comp Sci & Engn, Aizu Wakamatsu, Fukushima, Japan	Ofuji, K (reprint author), Univ Aizu, Dept Comp Sci & Engn, Aizu Wakamatsu, Fukushima, Japan.	o-fu@u-aizu.ac.jp					Tsumune D, 2013, BIOGEOSCIENCES, V10, P5601, DOI 10.5194/bg-10-5601-2013; Kusakabe M, 2013, BIOGEOSCIENCES, V10, P5019, DOI 10.5194/bg-10-5019-2013; Fukushima Medical University Hospital Radiation Exposure Medical Team (currently Radiation Disaster Medical Center), 2013, FAC RAD HAZ MESS MED; Fukushima Prefecture Energy Division, 2013, STAT INST REN EN FUK; Fukushima Prefecture Energy Division, 2013, FUK REN EN PION ACT; Fukushima Prefecture Government Department of Commerce Industry and Labor, 2013, STAT TOUR VIS FUK PR; Fukushima Prefecture Government Energy Division, 2012, FUK PREF REN EN PROM; Fukushima Prefecture Government Statistics Division, 2010, FUK PREF ANN EC REP; Fukushima Prefecture Government Statistics Division, FY2010 OV EC CALC CO; Ishikawa Y, 2012, 12P014 RIETI; Japanese Environment Management Bureau Ministry of the Environment, DEC PROGR; Japanese Ministry of the Environment, DEC INF; Japanese Nuclear Regulation Authority, 4 REV TEAM M SAF REA; Moritani M, 2012, SPELL ONE MILLI SIEV; Ofuji K, 2013, ENERG ENVIRON-UK, V24, P711; Seki M, 2012, E JAPAN GREAT DISAST	16	0	0	WILEY PERIODICALS, INC	SAN FRANCISCO	ONE MONTGOMERY ST, SUITE 1200, SAN FRANCISCO, CA 94104 USA	2041-8396	2041-840X		WIRES ENERGY ENVIRON	Wiley Interdiscip. Rev. Energy Environ.	JUL-AUG	2015	4	4					307	315		10.1002/wene.139		9	Energy & Fuels	Energy & Fuels	CK8MG	WOS:000356491600001		
J	Matsubara, S; Baba, Y				Matsubara, Shigeki; Baba, Yosuke			Uterine artery pseudoaneurysm after non-traumatic vaginal delivery as a cause of postpartum hemorrhage: determination of its mechanism is urgently needed	ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA			English	Letter							ABORTION		[Matsubara, Shigeki; Baba, Yosuke] Jichi Med Univ, Dept Obstet & Gynecol, Shimotsuke, Tochigi, Japan	Matsubara, S (reprint author), Jichi Med Univ, Dept Obstet & Gynecol, Shimotsuke, Tochigi, Japan.	matsushi@jichi.ac.jp					Baba Y, 2014, ARCH GYNECOL OBSTET, V290, P435, DOI 10.1007/s00404-014-3226-4; Gronvall M, 2014, ACTA OBSTET GYN SCAN, V93, P716, DOI 10.1111/aogs.12376; Kim JW, 2014, GYNECOL OBSTET INVES, V78, P136, DOI 10.1159/000363742; Cunningham FG, 2014, WILLIAMS OBSTET, V24th, P780; Matsubara S, 2014, ACTA OBSTET GYN SCAN, V93, P723, DOI 10.1111/aogs.12361; Matsubara S, 2014, INT J GYNECOL OBSTET, V125, P84, DOI 10.1016/j.ijgo.2013.10.013; Matsubara S, 2011, ARCH GYNECOL OBSTET, V283, P669, DOI 10.1007/s00404-010-1551-9	7	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-6349	1600-0412		ACTA OBSTET GYN SCAN	Acta Obstet. Gynecol. Scand.	JUL	2015	94	7					788	789		10.1111/aogs.12575		2	Obstetrics & Gynecology	Obstetrics & Gynecology	CK0BK	WOS:000355868600019		
J	Persson, P; Friederich-Persson, M; Fasching, A; Hansell, P; Inagi, R; Palm, F				Persson, P.; Friederich-Persson, M.; Fasching, A.; Hansell, P.; Inagi, R.; Palm, F.			Adenosine A(2)a receptor stimulation prevents proteinuria in diabetic rats by promoting an anti-inflammatory phenotype without affecting oxidative stress	ACTA PHYSIOLOGICA			English	Article						CGS21680; diabetes mellitus; diabetic nephropathy; kidney; macrophages; tumour necrosis factor-alpha	ISCHEMIA-REPERFUSION INJURY; CHRONIC KIDNEY-DISEASE; GLOMERULAR HYPERFILTRATION; RENAL-FAILURE; NEPHROPATHY; INFLAMMATION; INHIBITION; HYPOXIA; A(2A); ACTIVATION	AimDiabetic patients are at increased risk for kidney disease. There is presently no clinical treatment available that effectively protects kidney function in diabetics. This study investigates whether chronic stimulation of the adenosine A(2a) receptor (A(2a)AR) protects kidney function in insulinopenic diabetic rats. MethodsStreptozotocin-induced diabetic rats and corresponding controls were chronically treated with the adenosine A(2a)AR agonist CGS21680 throughout the four-week diabetes duration. Kidney function was thereafter investigated, and urine and plasma samples were collected for analysis of protein, oxidative stress and inflammatory markers. ResultsGlomerular filtration rate, renal blood flow, filtration fraction and diabetes-induced kidney hypoxia were all unaffected by chronic A(2a)AR stimulation. Furthermore, diabetic rats had increased oxidative stress, which was further increased by chronic A(2a)AR stimulation. However, the 10-fold increased urinary protein excretion observed in the diabetic rats was completely prevented by chronic A(2a)AR stimulation. These beneficial effects were accompanied by reduced levels of the pro-inflammatory TNF- and increased levels of the anti-inflammatory IL-10 as well as decreased infiltration of macrophages, glomerular damage and basement membrane thickness. ConclusionChronic A(2a)AR stimulation prevents proteinuria and glomerular damage in experimental diabetes via an anti-inflammatory mechanism independent of oxidative stress and kidney hypoxia.	[Persson, P.; Friederich-Persson, M.; Fasching, A.; Hansell, P.; Palm, F.] Uppsala Univ, Dept Med Cell Biol, Div Integrat Physiol, Uppsala, Sweden; [Inagi, R.] Univ Tokyo, Grad Sch Med, Div Chron Kidney Dis Pathophysiol, Tokyo, Japan; [Palm, F.] Linkoping Univ, Dept Med & Hlth Sci, Div Drug Res, Linkoping, Sweden; [Palm, F.] Linkoping Univ, Ctr Med Image Sci & Visualizat, Linkoping, Sweden	Persson, P (reprint author), Biomed Ctr, Dept Med Cell Biol, Husargatan 3,Box 571, S-75123 Uppsala, Sweden.	Patrik.Persson@mcb.uu.se		Persson, Patrik/0000-0003-4468-032X			Gupta S, 2013, J DIABETES COMPLICAT, V27, P548, DOI 10.1016/j.jdiacomp.2013.07.005; Persson P, 2012, AM J PHYSIOL-REG I, V302, pR1443, DOI 10.1152/ajpregu.00502.2011; Kinsey GR, 2009, J AM SOC NEPHROL, V20, P1744, DOI 10.1681/ASN.2008111160; BOHLE A, 1991, PATHOL RES PRACT, V187, P251; Matejka J, 2010, HEART VESSELS, V25, P536, DOI 10.1007/s00380-010-0004-5; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; Palm F, 2003, DIABETOLOGIA, V46, P1153, DOI 10.1007/s00125-003-1155-z; Stenvinkel P, 2002, KIDNEY INT, V62, P1791, DOI 10.1046/j.1523-1755.2002.00637.x; Kinsey GR, 2012, J AM SOC NEPHROL, V23, P1528, DOI 10.1681/ASN.2012010070; Parving HH, 2001, KIDNEY INT, V60, P228, DOI 10.1046/j.1523-1755.2001.00790.x; Kreckler LM, 2006, J PHARMACOL EXP THER, V317, P172, DOI 10.1124/jpet.105.096016; Gessi S, 2000, BRIT J PHARMACOL, V129, P2, DOI 10.1038/sj.bjp.0703045; Koscso B, 2013, J LEUKOCYTE BIOL, V94, P1309, DOI 10.1189/jlb.0113043; Omote K, 2014, AM J PHYSIOL-RENAL, V306, pF1335, DOI 10.1152/ajprenal.00509.2013; Mimura I, 2010, NAT REV NEPHROL, V6, P667, DOI 10.1038/nrneph.2010.124; Persson MF, 2012, DIABETOLOGIA, V55, P1535, DOI 10.1007/s00125-012-2469-5; Lewis A, 2008, HISTOL HISTOPATHOL, V23, P731; BJORCK S, 1992, BRIT MED J, V304, P339; Awad AS, 2006, AM J PHYSIOL-RENAL, V290, pF828, DOI 10.1152/ajprenal.00310.2005; SCHMIDT KN, 1995, CHEM BIOL, V2, P13, DOI 10.1016/1074-5521(95)90076-4; Kumagai T, 2009, AM J PHYSIOL-RENAL, V296, pF912, DOI 10.1152/ajprenal.90575.2008; Basile DP, 2003, AM J PHYSIOL-RENAL, V284, pF338, DOI 10.1152/ajprenal.00169.2002; Collins Allan J, 2014, Am J Kidney Dis, V63, pA7, DOI 10.1053/j.ajkd.2013.11.001; El-Awady MS, 2013, PHYSL REP, V1; Friederich-Persson M, 2013, HYPERTENSION, V62, P914, DOI 10.1161/HYPERTENSIONAHA.113.01425; Gill A, 2009, AM J NEPHROL, V30, P521, DOI 10.1159/000248762; MATHOT RAA, 1995, BRIT J PHARMACOL, V114, P761; Mora Carmen, 2006, Curr Diab Rep, V6, P463, DOI 10.1007/s11892-006-0080-1; Motonishi S, 2014, J AM SOC NEPHROL; Nagase R, 2012, CLIN EXP NEPHROL, V16, P739, DOI 10.1007/s10157-012-0625-3; Nordquist L, 2015, J AM SOC NEPHROL, V26, P328, DOI 10.1681/ASN.2013090990; Persson P, 2015, KIDNEY INT, V87, P109, DOI 10.1038/ki.2014.219; Ribe D, 2008, FREE RADICAL BIO MED, V44, P1433, DOI 10.1016/j.freeradbiomed.2007.12.035; Wang ZG, 2014, INFLAMMATION, V37, P2020, DOI 10.1007/s10753-014-9934-x; Xiao H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060173	35	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1748-1708	1748-1716		ACTA PHYSIOL	Acta Physiol.	JUL	2015	214	3					311	318		10.1111/apha.12511		8	Physiology	Physiology	CK5ZD	WOS:000356306300007		
J	Kunihiro, Y; Tanaka, N; Matsumoto, T; Yamamoto, N; Matsunaga, N				Kunihiro, Yoshie; Tanaka, Nobuyuki; Matsumoto, Tsuneo; Yamamoto, Norihide; Matsunaga, Naofumi			The usefulness of a diagnostic method combining high-resolution CT findings and serum markers for cytomegalovirus pneumonia and pneumocystis pneumonia in non-AIDS patients	ACTA RADIOLOGICA			English	Article						Cytomegalovirus; pneumocystis pneumonia; beta-D-glucan; antigenemia; HRCT	BONE-MARROW-TRANSPLANTATION; CARINII-PNEUMONIA; IMMUNOCOMPROMISED PATIENTS; INFECTION; ANTIGENEMIA	Background: The combination of high-resolution computed tomography (HRCT) findings and serum markers would be of great value in diagnosing cytomegalovirus pneumonia (CMVP) and pneumocystis pneumonia (PCP) considering low invasiveness. Purpose: To compare the HRCT findings of CMVP and PCP and to evaluate the differences in HRCT findings between patients diagnosed based on pathologic evidence and serum markers. Material and Methods: Two radiologists retrospectively evaluated the HRCT findings of 21 patients with CMVP and 70 patients with PCP. Eight patients with CMVP and 32 patients with PCP were diagnosed based on pathologic evidence ("Path'' group), while 13 patients with CMVP and 38 patients with PCP were diagnosed based on serum markers (CMV antigenemia, beta-D-glucan) ("Serum-Marker'' group). A total of 19 CT morphological criteria were evaluated, and the significance of the differences between the two diseases and between the "Path'' and "Serum-Marker'' groups with respect to each disease was calculated. Results: The presence of small nodules, the tree-in-bud pattern, and the halo sign was found more frequently in the CMVP group. Extensive ground-glass attenuation (GGA), a mosaic pattern, and a diffuse distribution were observed more frequently in the PCP group. There were significant differences between the "Path'' and "Serum-Marker'' groups in average extent of consolidation and distribution of consolidation in PCP, and the distribution of GGA in CMVP, respectively. Conclusion: The combined use of HRCT findings and serum markers is useful for the diagnosis of CMVP and PCP in non-AIDS patients. The typical HRCT findings for the differential diagnosis included extensive GGA with mosaic pattern in PCP and nodules, nodules with or without the tree-in-bud pattern, and the halo sign in CMVP.	[Kunihiro, Yoshie; Tanaka, Nobuyuki; Matsunaga, Naofumi] Yamaguchi Univ, Dept Radiol, Grad Sch Med, Yamaguchi, Japan; [Matsumoto, Tsuneo] Natl Hosp Org, Yamaguchi Ube Med Ctr, Dept Clin Res, Yamaguchi, Japan; [Yamamoto, Norihide] Yamaguchi Univ, Div Lab, Yamaguchi, Japan	Kunihiro, Y (reprint author), Yamaguchi Univ, Dept Radiol, Grad Sch Med, 1-1-1 Minamikogushi, Ube, Yamaguchi 7558505, Japan.	kyoshie@yamaguchi-u.ac.jp					AAFEDT BC, 1990, J CAN ASSOC RADIOL, V41, P276; Algin O, 2011, DIAGN INTERV RADIOL, V17, P18, DOI 10.4261/1305-3825.DIR.2901-09.1; Tasaka S, 2007, CHEST, V131, P1173, DOI 10.1378/chest.06-1467; Fujii Takeshi, 2007, Journal of Infection and Chemotherapy, V13, P1, DOI 10.1007/s10156-006-0484-5; Austin JHM, 1996, RADIOLOGY, V200, P327; KUHLMAN JE, 1990, RADIOLOGY, V175, P711; Boiselle PM, 1999, AM J ROENTGENOL, V172, P1301; Franquet T, 2003, AM J ROENTGENOL, V181, P1059; Gasparetto EL, 2004, BRIT J RADIOL, V77, P724, DOI 10.1259/bjr/70800575; Gruden JF, 1997, AM J ROENTGENOL, V169, P967; HARTMAN TE, 1994, AM J ROENTGENOL, V162, P547; Kang EY, 1996, J COMPUT ASSIST TOMO, V20, P295, DOI 10.1097/00004728-199603000-00024; Machida U, 1999, BONE MARROW TRANSPL, V24, P1153, DOI 10.1038/sj.bmt.1702031; MURCH CR, 1989, CLIN RADIOL, V40, P240, DOI 10.1016/S0009-9260(89)80180-1; Sakamaki H, 1997, BONE MARROW TRANSPL, V20, P143, DOI 10.1038/sj.bmt.1700856; Vogel MN, 2007, BRIT J RADIOL, V80, P516, DOI 10.1259/bjr/39696316	16	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0284-1851	1600-0455		ACTA RADIOL	Acta Radiol.	JUL	2015	56	7					806	813		10.1177/0284185114539320		8	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CK2PB	WOS:000356051900006		
J	Nakahara, M; Ito, M; Hattori, N; Magota, K; Takahata, M; Nagahama, K; Sudo, H; Kamishima, T; Tamaki, N; Iwasaki, N				Nakahara, Masayuki; Ito, Manabu; Hattori, Naoya; Magota, Keiichi; Takahata, Masahiko; Nagahama, Ken; Sudo, Hideki; Kamishima, Tamotsu; Tamaki, Nagara; Iwasaki, Norimasa			18F-FDG-PET/CT better localizes active spinal infection than MRI for successful minimally invasive surgery	ACTA RADIOLOGICA			English	Article						Fluorodeoxyglucose F18; positron emission tomography; spine; infection; magnetic resonance imaging; adult	POSITRON-EMISSION-TOMOGRAPHY; LUMBAR SPINE; PET; SPONDYLODISCITIS; DIFFERENTIATION; DIAGNOSIS; GLUCOSE	Background: Surgical debridement is often required to treat spinal infections. Successful surgery requires accurate localization of the active infections, however, current imaging technique still requires surgeons' experience to narrow the surgical fields to achieve less invasive procedures. Purpose: To investigate the use of F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) for successful surgical planning. Material and Methods: Nine patients with suspected spinal infection underwent magnetic resonance imaging (MRI) and FDG-PET/CT before surgery to locate active foci of infections. The spinal structures were divided into seven compartments at each intervertebral disc level for a total of 315 compartments investigated. The same classification system was used to design operating fields for histological correlation. Results: FDG-PET/CT diagnosed fewer compartments as active infection (34 compartments, 10.8%) than MRI (62 compartments, 19.7%, P = 0.002). Surgical exploration was performed in 49 compartments, and demonstrated active infection in 25 compartments. The sensitivity / specificity of FDG-PET/CT was 100% / 79%, respectively, which was superior to those of MRI, 76% / 42%. Foci of active infection showed hypermetabolic activity with a SUVmax of 7.1 +/- 2.6 (range, 3.0-12.7). Receiver operating characteristic (ROC) analysis indicated an optimal threshold for active spinal infection at a SUVmax of 4.2, corresponding to a sensitivity of 90.3% and specificity of 91.2%. Conclusion: FDG-PET/CT demonstrated limited areas of abnormality allowing accurate delineation, and is thus useful to narrow the surgical fields. Since overall diagnostic accuracy of FDG-PET/CT was superior to that of MRI, FDG-PET/CT is a useful technique to narrow the surgical field for successful less invasive surgery.	[Nakahara, Masayuki; Takahata, Masahiko; Nagahama, Ken; Iwasaki, Norimasa] Hokkaido Univ, Dept Orthoped Surg, Grad Sch Med, Sapporo, Hokkaido 0608638, Japan; [Ito, Manabu; Sudo, Hideki] Hokkaido Univ, Grad Sch Med, Dept Adv Med Spine & Spinal Cord Disorders, Sapporo, Hokkaido 0608638, Japan; [Hattori, Naoya; Magota, Keiichi; Tamaki, Nagara] Hokkaido Univ, Dept Nucl Med, Grad Sch Med, Sapporo, Hokkaido 0608638, Japan; [Kamishima, Tamotsu] Hokkaido Univ, Fac Hlth Sci, Sapporo, Hokkaido 0608638, Japan	Hattori, N (reprint author), Hokkaido Univ, Dept Nucl Med, Grad Sch Med, Kita Ku, N15 W7, Sapporo, Hokkaido 0608638, Japan.	nhattori@med.hokudai.ac.jp					De Winter F, 2003, SPINE, V28, P1314, DOI 10.1097/00007632-200306150-00017; Soret M, 2007, J NUCL MED, V48, P932, DOI 10.2967/jnumed.106.035774; Gaertner FC, 2013, CANCER IMAGING, V13, P36, DOI 10.1102/1470-7330.2013.0005; Zhuang HM, 2001, NUCL MED COMMUN, V22, P1123, DOI 10.1097/00006231-200110000-00011; Tins BJ, 2004, SEMIN MUSCULOSKEL R, V8, P215, DOI 10.1055/s-2004-835362; Butler JS, 2006, SPINE, V31, P2695, DOI 10.1097/01.brs.0000244662.78725.37; MODIC MT, 1988, RADIOLOGY, V166, P193; Ledermann HP, 2003, RADIOLOGY, V228, P506, DOI 10.1148/radiol.2282020752; Stumpe KDM, 2002, AM J ROENTGENOL, V179, P1151; Busing KA, 2013, NUCL MED BIOL, V40, P206, DOI 10.1016/j.nucmedbio.2012.10.014; Ito M, 2007, SPINE, V32, P200, DOI 10.1097/01.brs.0000251645.58076.96; Costello JE, 2013, AM J ROENTGENOL, V201, P1283, DOI 10.2214/AJR.12.9720; Grane P, 1998, ACTA RADIOL, V39, P108; Gratz S, 2002, EUR J NUCL MED MOL I, V29, P516, DOI 10.1007/s00259-001-0719-8; Guhlmann A, 1998, RADIOLOGY, V206, P749; Ichiya Y, 1996, Ann Nucl Med, V10, P185; Maus TP, 2002, PHYS MED REH CLIN N, V13, pvi; Maus Timothy P, 2002, Phys Med Rehabil Clin N Am, V13, P487, DOI 10.1016/S1047-9651(02)00009-8; Nanni C, 2012, EUR J NUCL MED MOL I, V39, P1538, DOI 10.1007/s00259-012-2179-8; Reller LB, 2001, CLIN INFECT DIS, V32, P1589, DOI 10.1086/320537; Rothman SLG, 1996, ORTHOP CLIN N AM, V27, P15; Schmitz A, 2001, EUR SPINE J, V10, P534, DOI 10.1007/s005860100339; Shin DS, 2008, SKELETAL RADIOL, V37, P415, DOI 10.1007/s00256-008-0462-3	23	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0284-1851	1600-0455		ACTA RADIOL	Acta Radiol.	JUL	2015	56	7					829	836		10.1177/0284185114541983		8	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CK2PB	WOS:000356051900009		
J	de Guglielmo, G; Martin-Fardon, R; Teshima, K; Ciccocioppo, R; Weiss, F				de Guglielmo, Giordano; Martin-Fardon, Remi; Teshima, Koji; Ciccocioppo, Roberto; Weiss, Friedbert			MT-7716, a potent NOP receptor agonist, preferentially reduces ethanol seeking and reinforcement in post-dependent rats	ADDICTION BIOLOGY			English	Article						Addiction; alcohol; MT-7716; nociceptin; orphanin FQ; reinstatement; self-administration; stress	CORTICOTROPIN-RELEASING-FACTOR; ALCOHOL-PREFERRING RATS; CENTRAL-NERVOUS-SYSTEM; ANXIETY-LIKE BEHAVIORS; NOCICEPTIN/ORPHANIN FQ; CENTRAL AMYGDALA; COCAINE-SEEKING; GENE-EXPRESSION; ANIMAL-MODEL; BED NUCLEUS	Dysregulation of the nociceptin (N/OFQ) system has been implicated in alcohol abuse and alcoholism, and growing evidence suggests that targeting this system may be beneficial for treating alcoholism. To further explore the treatment target potential of the N/OFQ system, the novel non-peptide, small-molecule N/OFQ (NOP) agonist MT-7716, (R)-2-{3-[1-(Acenaphthen-1-yl)piperidin-4-yl]-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl}-N-methylacetamide hydrochloride hydrate, was examined for its effects on ethanol self-administration and stress-induced reinstatement of alcohol seeking in non-dependent and post-dependent rats. Male Wistar rats were trained to self-administer ethanol and then made ethanol dependent via repeated intragastric ethanol intubation. The effects of MT-7716 (0.3 and 1mg/kg; PO) on alcohol self-administration were determined 2 weeks following dependence induction, when baseline self-administration was restored. Effects of MT-7716 on stress-induced reinstatement were tested in separate cohorts of rats, 1 and 3 weeks post-withdrawal. MT-7716 reduced alcohol self-administration and stress-induced reinstatement of alcohol seeking in post-dependent rats, but was ineffective in non-dependent animals. Moreover, the prevention of stress-induced reinstatement by MT-7716 was more pronounced at 3 weeks post-dependence. The results further confirm treatment target potential for the NOP receptor and identify non-peptide NOP agonists as promising potential treatment drugs for alcohol abuse and relapse prevention. The findings also support dysregulation of the N/OFQ system as a factor in alcohol seeking and reinforcement.	[de Guglielmo, Giordano; Martin-Fardon, Remi; Weiss, Friedbert] Scripps Res Inst, Mol & Cellular Neurosci Dept, La Jolla, CA 92037 USA; [de Guglielmo, Giordano; Ciccocioppo, Roberto] Univ Camerino, Sch Pharm, Pharmacol Unit, I-62032 Camerino, Italy; [Teshima, Koji] Mitsubishi Tanabe Pharma Corp, Div Res, Dept CNS 2, Pharmacol Res Labs 1, Mitsubishi, Japan	de Guglielmo, G (reprint author), Univ Camerino, Sch Pharm, Pharmacol Unit, Via Madonna della Carceri, I-62032 Camerino, Italy.	giordano.deguglielmo@unicam.it			NIH/NIAAA [AA014351]	This is publication number 24061 from The Scripps Research Institute. This study was supported by NIH/NIAAA AA014351 (F.W.). The authors thank Tony Kerr, Belinda Leos and Alfredo Fiorelli for expert technical assistance.	Neal CR, 1999, J COMP NEUROL, V412, P563; Wise RA, 1998, DRUG ALCOHOL DEPEN, V51, P13, DOI 10.1016/S0376-8716(98)00063-5; Roberts AJ, 2000, NEUROPSYCHOPHARMACOL, V22, P581, DOI 10.1016/S0893-133X(99)00167-0; Funk CK, 2007, BIOL PSYCHIAT, V61, P78, DOI 10.1016/j.biopsych.2006.03.063; Zhao Y, 2007, ALCOHOL CLIN EXP RES, V31, P1505, DOI 10.1111/j.1530-0277.2007.00456.x; Aujla H, 2013, ADDICT BIOL, V18, P467, DOI 10.1111/j.1369-1600.2012.00466.x; Everitt BJ, 2002, J NEUROSCI, V22, P3312; Roberto M, 2006, P NATL ACAD SCI USA, V103, P9715, DOI 10.1073/pnas.0601899103; Liu X, 2002, J NEUROSCI, V22, P7856; Hansson AC, 2006, P NATL ACAD SCI USA, V103, P15236, DOI 10.1073/pnas.0604419103; Le AD, 1999, NEUROPSYCHOPHARMACOL, V21, P435, DOI 10.1016/S0893-133X(99)00024-X; WEISS F, 1993, J PHARMACOL EXP THER, V267, P250; Rodd ZA, 2006, BEHAV BRAIN RES, V171, P207, DOI 10.1016/j.bbr.2006.03.032; Gozzi A, 2013, NEUROIMAGE, V69, P112, DOI 10.1016/j.neuroimage.2012.12.015; Cruz MT, 2012, BIOL PSYCHIAT, V71, P666, DOI 10.1016/j.biopsych.2011.10.032; Erb S, 1999, J NEUROSCI, V19, part. no.; Sommer WH, 2008, BIOL PSYCHIAT, V63, P139, DOI 10.1016/j.biopsych.2007.01.010; Hansson AC, 2007, ADDICT BIOL, V12, P30, DOI 10.1111/j.1369-1600.2007.00050.x; MOLLEREAU C, 1994, FEBS LETT, V341, P33, DOI 10.1016/0014-5793(94)80235-1; BUNZOW JR, 1994, FEBS LETT, V347, P284, DOI 10.1016/0014-5793(94)00561-3; Ciccocioppo R, 2006, ADDICT BIOL, V11, P339, DOI 10.1111/j.1369-1600.2006.00032.x; Zorrilla EP, 2001, PSYCHOPHARMACOLOGY, V158, P374, DOI 10.1007/s002130100773; Economidou D, 2008, BIOL PSYCHIAT, V64, P211, DOI 10.1016/j.biopsych.2008.02.004; Martin-Fardon R, 2010, BRAIN RES, V1314, P145, DOI 10.1016/j.brainres.2009.12.027; Eckardt MJ, 1998, ALCOHOL CLIN EXP RES, V22, P998, DOI 10.1111/j.1530-0277.1998.tb03695.x; Ayanwuyi Lydia O, 2013, Front Psychiatry, V4, P23, DOI 10.3389/fpsyt.2013.00023; Braconi S, 2010, ALCOHOL CLIN EXP RES, V34, P538, DOI 10.1111/j.1530-0277.2009.01119.x; Ciccocioppo R, 2004, PSYCHOPHARMACOLOGY, V172, P170, DOI 10.1007/s00213-003-1645-1; Ciccocioppo R, 2014, J NEUROSCI, V34, P363, DOI 10.1523/JNEUROSCI.2400-13.2014; Ciccocioppo R, 2003, J NEUROSCI, V23, P9445; Ciccocioppo R, 2001, NEUROREPORT, V12, P1145, DOI 10.1097/00001756-200105080-00019; Ciccocioppo R, 1999, PSYCHOPHARMACOLOGY, V141, P220, DOI 10.1007/s002130050828; Economidou D, 2011, ALCOHOL CLIN EXP RES, V35, P747, DOI 10.1111/j.1530-0277.2010.01392.x; Kallupi Marsida, 2014, Front Integr Neurosci, V8, P18, DOI 10.3389/fnint.2014.00018; Macey DJ, 1996, ALCOHOL, V13, P163, DOI 10.1016/0741-8329(95)02030-6; Martin-Fardon R, 2000, NEUROREPORT, V11, P1939, DOI 10.1097/00001756-200006260-00026; Silberman Yuval, 2013, Front Psychiatry, V4, P42, DOI 10.3389/fpsyt.2013.00042; Teshima K, 2005, BRIT J PHARMACOL, V146, P33, DOI 10.1038/sj.bjp.0706311; Valdez GR, 2002, ALCOHOL CLIN EXP RES, V26, P1494, DOI 10.1097/01.ALC.0000033120.51856.F0	39	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1355-6215	1369-1600		ADDICT BIOL	Addict. Biol.	JUL	2015	20	4					643	651		10.1111/adb.12157		9	Biochemistry & Molecular Biology; Substance Abuse	Biochemistry & Molecular Biology; Substance Abuse	CK1TG	WOS:000355989600002		
J	Mori, T; Itoh, T; Yoshizawa, K; Ise, Y; Mizuo, K; Saeki, T; Komiya, S; Masukawa, D; Shibasaki, M; Suzuki, T				Mori, Tomohisa; Itoh, Toshimasa; Yoshizawa, Kazumi; Ise, Yuya; Mizuo, Keisuke; Saeki, Tomoya; Komiya, Sachiko; Masukawa, Daiki; Shibasaki, Masahiro; Suzuki, Tsutomu			Involvement of - and -opioid receptor function in the rewarding effect of (+/-)-pentazocine	ADDICTION BIOLOGY			English	Article						Opioid receptor; pentazocine; rewarding effect	PAIN-LIKE STATE; SIGMA-1 RECEPTOR; MORPHINE REWARD; DOPAMINE; RATS; COCAINE; MICE; AGONISTS; MU; N,N-DIMETHYLTRYPTAMINE	Most opioid receptor agonists have abuse potential, and the rewarding effects of opioids can be reduced in the presence of pain. While each of the enantiomers of pentazocine has a differential pharmacologic profile, (+/-)-pentazocine has been used clinically for the treatment of pain. However, little information is available regarding which components of pentazocine are associated with its rewarding effects, and whether the (+/-)-pentazocine-induced rewarding effects can be suppressed under pain. Therefore, the present study was performed to investigate the effects of pain on the acquisition of the rewarding effects of (+/-)-pentazocine, and to examine the mechanism of the rewarding effects of (+/-)-pentazocine using the conditioned place preference paradigm. (+/-)-Pentazocine and (-)-pentazocine, but not (+)-pentazocine, produced significant rewarding effects. Even though the rewarding effects induced by (+/-)-pentazocine were significantly suppressed under pain induced by formalin, accompanied by increase of preprodynorphin mRNA levels in the nucleus accumbens, a high dose of (+/-)-pentazocine produced significant rewarding effects under pain. In the normal condition, (+/-)-pentazocine-induced rewarding effects were blocked by a low dose of naloxone, whereas the rewarding effects induced by high doses of pentazocine under pain were suppressed by naltrindole (a -opioid receptor antagonist). Interestingly, (+/-)-pentazocine did not significantly affect dopamine levels in the nucleus accumbens. These findings suggest that the rewarding effects of (-)-pentazocine may contribute to the abuse potential of (+/-)-pentazocine through - as well as -opioid receptors, without robust activation of the mesolimbic dopaminergic system. We also found that neural adaptations can reduce the abuse potential of (+/-)-pentazocine under pain.	[Mori, Tomohisa; Itoh, Toshimasa; Yoshizawa, Kazumi; Ise, Yuya; Mizuo, Keisuke; Saeki, Tomoya; Komiya, Sachiko; Masukawa, Daiki; Shibasaki, Masahiro; Suzuki, Tsutomu] Hoshi Univ, Dept Toxicol, Sch Pharm & Pharmaceut Sci, Tokyo 1428501, Japan	Suzuki, T (reprint author), Hoshi Univ, Dept Toxicol, Sch Pharm & Pharmaceut Sci, Shinagawa Ku, 2-4-41 Ebara, Tokyo 1428501, Japan.	suzuki@hoshi.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was supported by grants in part from Ministry of Education, Culture, Sports, Science and Technology of Japan.	DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274; Narita M, 2005, NEUROPSYCHOPHARMACOL, V30, P111, DOI 10.1038/sj.npp.1300527; Ranganathan M, 2012, BIOL PSYCHIAT, V72, P871, DOI 10.1016/j.biopsych.2012.06.012; Niikura K, 2010, TRENDS PHARMACOL SCI, V31, P299, DOI 10.1016/j.tips.2010.04.003; Martin TJ, 2007, ANESTHESIOLOGY, V106, P312, DOI 10.1097/00000542-200702000-00020; van der Kam EL, 2008, PAIN, V136, P373, DOI 10.1016/j.pain.2007.07.027; Hiranita T, 2010, J PHARMACOL EXP THER, V332, P515, DOI 10.1124/jpet.109.159236; Narita M, 2006, J NEUROSCI, V26, P398, DOI 10.1523/JNEUROSCI.2761-05.2006; Younger JW, 2011, PAIN, V152, P1803, DOI 10.1016/j.pain.2011.03.028; Sun SJ, 2004, AM J PHYSIOL-HEART C, V287, pH969, DOI 10.1152/ajpheart.01171.2003; Martin TJ, 2011, ANESTHESIOLOGY, V114, P633, DOI 10.1097/ALN.0b013e318209aba7; Suzuki T, 1996, LIFE SCI, V59, P1667, DOI 10.1016/0024-3205(96)00498-5; Narita M, 2008, NEUROPSYCHOPHARMACOL, V33, P1097, DOI 10.1038/sj.npp.1301471; Fontanilla D, 2009, SCIENCE, V323, P934, DOI 10.1126/science.1166127; Hnasko TS, 2005, NATURE, V438, P854, DOI 10.1038/nature04172; Hojsted J, 2007, EUR J PAIN, V11, P490, DOI 10.1016/j.ejpain.2006.08.004; Narita M, 2001, ADDICT BIOL, V6, P373, DOI 10.1080/13556210020077091; FUNADA M, 1993, NEUROPHARMACOLOGY, V32, P1315; Gudelsky GA, 1999, J NEURAL TRANSM, V106, P849, DOI 10.1007/s007020050205; Gutstein HB, 2001, OPIOID ANALGESICS, V10th; Hiranita T, 2013, NEUROPSYCHOPHARMACOL, V38, P605, DOI 10.1038/npp.2012.224; Ito S, 2006, BEHAV PHARMACOL, V17, P691, DOI 10.1097/FBP.0b013e32801155a1; Ito S, 2008, BEHAV PHARMACOL, V19, P113, DOI 10.1097/FBP.0b013e3282f62c1b; Kawamura K, 2003, SYNAPSE, V48, P80, DOI 10.1002/syn.10190; Martin TJ, 2008, NEUROPSYCHOPHARMACOL, V33, P1171, DOI 10.1038/sj.npp.1301490; Mori T, 2014, ADDICT BIOL, V19, P362, DOI 10.1111/j.1369-1600.2012.00488.x; Mori T, 2012, ADDICT BIOL, V17, P717, DOI 10.1111/j.1369-1600.2010.00306.x; Su TP, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.261pe12; SUZUKI T, 1991, PSYCHOPHARMACOLOGY, V105, P9, DOI 10.1007/BF02316857; Suzuki T, 1997, EUR J PHARMACOL, V324, P21, DOI 10.1016/S0014-2999(97)00062-9; Suzuki T., 1997, LIFE SCI, V60, P283; SUZUKI T, 1991, LIFE SCI, V48, P1827, DOI 10.1016/0024-3205(91)90238-7; Suzuki Tsutomu, 1999, Life Sciences, V64, pPL1; WADLEY C, 1980, INT J ADDICT, V15, P1285; WHO, 1996, CANC PAIN REL; Yoshizawa K, 2012, ADDICT BIOL, V17, P949, DOI 10.1111/j.1369-1600.2010.00257.x	36	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1355-6215	1369-1600		ADDICT BIOL	Addict. Biol.	JUL	2015	20	4					724	732		10.1111/adb.12169		9	Biochemistry & Molecular Biology; Substance Abuse	Biochemistry & Molecular Biology; Substance Abuse	CK1TG	WOS:000355989600009		
J	Boase, J; Kobayashi, T; Schrock, A; Suzuki, T; Suzuki, T				Boase, Jeffrey; Kobayashi, Tetsuro; Schrock, Andrew; Suzuki, Tsutomu; Suzuki, Takahisa			Reconnecting Here and There: The Reactivation of Dormant Ties in the United States and Japan	AMERICAN BEHAVIORAL SCIENTIST			English	Article						collectivism; personal networks; weak ties; reconnection; dormant ties	ET-AL. 2002; TRUST; INDIVIDUALISM; COLLECTIVISM; WEAK; COMMITMENT; SOLIDARITY; CULTURES; NETWORK; DECAY	This article examines the reactivation of dormant ties in Japan and the United States. Using the institutional approach to culture developed by Yamagishi et al., it is hypothesized that respondents living in Japan will be less likely to reconnect with dormant ties when prompted than respondents living in the United States. It is further hypothesized that interaction with kin and work ties will help to explain lower levels of reconnection in Japan than in the United States. To examine these hypotheses, we developed a field experiment in which 95 adults living in Japan and 68 adults living in the United States were prompted by a smartphone application to reconnect with dormant ties. The results of this study show strong support for the hypothesis that respondents living in Japan are less likely to reconnect with dormant ties than respondents living in the United States when prompted. There is also mixed support for the hypothesis that interaction with kin and work ties helps to explain lower levels of reconnection in Japan than in the United States.	[Boase, Jeffrey] Univ Toronto, Mississauga, ON L5L 1C6, Canada; [Kobayashi, Tetsuro; Suzuki, Takahisa] Natl Inst Informat, Tokyo, Japan; [Schrock, Andrew] Univ So Calif, Commun, Los Angeles, CA USA; [Suzuki, Tsutomu] Tohoku Gakuin Univ, Fac Liberal Arts, Sendai, Miyagi 980, Japan	Boase, J (reprint author), Univ Toronto, Inst Commun Culture Informat & Technol, 3359 Mississauga Rd, Mississauga, ON L5L 1C6, Canada.	j.boase@utoronto.ca			Research Organization of Information and Systems, Japan	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Financial support provided by the Research Organization of Information and Systems, Japan.	DINDIA K, 1993, J SOC PERS RELAT, V10, P163, DOI 10.1177/026540759301000201; Licoppe C, 2004, ENVIRON PLANN D, V22, P135, DOI 10.1068/d323t; Kiyonari T, 2006, SOC PSYCHOL QUART, V69, P270; Burt RS, 2000, SOC NETWORKS, V22, P1, DOI 10.1016/S0378-8733(99)00015-5; Oyserman D, 2002, PSYCHOL BULL, V128, P3, DOI 10.1037//0033-2909.128.1.3; Levin DZ, 2011, ORGAN SCI, V22, P923, DOI 10.1287/orsc.1100.0576; Fiske AP, 2002, PSYCHOL BULL, V128, P78, DOI 10.1037/0033-2909.128.1.78; Cook KS, 2005, SOC PSYCHOL QUART, V68, P121; Burt RS, 2002, SOC NETWORKS, V24, P333, DOI 10.1016/S0378-8733(02)00017-5; Boase J, 2006, CAMBRIDGE HANDBOOK OF PERSONAL RELATIONSHIPS, P709, DOI 10.1017/CBO9780511606632.039; Hidalgo CA, 2008, PHYSICA A, V387, P3017, DOI 10.1016/j.physa.2008.01.073; Yamagishi T, 2008, PSYCHOL SCI, V19, P579, DOI 10.1111/j.1467-9280.2008.02126.x; Boase J, 2012, HUM COMMUN RES, V38, P95, DOI 10.1111/j.1468-2958.2011.01416.x; Jack SL, 2005, J MANAGE STUD, V42, P1233, DOI 10.1111/j.1467-6486.2005.00540.x; Bond MH, 2002, PSYCHOL BULL, V128, P73, DOI 10.1037//0033-2909.128.1.73; Haythornthwaite C, 2002, INFORM SOC, V18, P385, DOI 10.1080/01972240290108195; Yamagishi T, 1998, AM J SOCIOL, V104, P165, DOI 10.1086/210005; Baxter L. A., 1984, J SOC PERS RELAT, V1, P29, DOI 10.1177/0265407584011003; BLUMSTEIN P, 1988, ANNU REV SOCIOL, V14, P467, DOI 10.1146/annurev.so.14.080188.002343; Boase J., 2006, STRENGTH INTERNET TI; Boase Jeffrey, 2008, Information Communication & Society, V11, DOI 10.1080/13691180801999001; Boase J, 2013, J COMPUT-MEDIAT COMM, V18, P508, DOI 10.1111/jcc4.12021; Duck S., 1982, PERSONAL RELATIONSHI; Earley PC, 1998, J MANAGE, V24, P265, DOI 10.1177/014920639802400302; Goffman E., 1986, STIGMA NOTES MANAGEM; GRANOVET.MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Granovetter M., 1983, SOCIAL STRUCTURE NET, P105; Granovetter M., 1995, GETTING JOB STUDY CO, P139; Hampton K. N., 2011, SOCIAL NETWORKING SI; HECHTER M, 1993, J THEOR POLIT, V5, P455, DOI 10.1177/0951692893005004002; HOFSTEDE G, 1983, J INT BUS STUD, V14, P75, DOI 10.1057/palgrave.jibs.8490867; Kobayashi T., 2012, COMMUNICATION METHOD, V6, P126; Ling R., 2008, NEW TECH NEW TIES MO; Ling R., 2012, MOBILE COMMUNICATION; Miller A. S., 2000, ORDER ACCIDENT ORIGI; Rollie S. S., 2005, HDB DIVORCE RELATION, P223; Simmel G., 1898, AM J SOCIOL, V3, P662, DOI 10.1086/ajs.1898.3.issue-5; Wilken R., 2009, MOB COMMUN INT, P127; YAMAGISHI T, 1986, J PERS SOC PSYCHOL, V51, P110, DOI 10.1037/0022-3514.51.1.110; YAMAGISHI T, 1994, MOTIV EMOTION, V18, P129, DOI 10.1007/BF02249397; Yamagishi T., 1998, ASIAN J SOC PSYCHOL, V1, P315, DOI 10.1111/1467-839X.00020	41	1	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0002-7642	1552-3381		AM BEHAV SCI	Am. Behav. Sci.	JUL	2015	59	8			SI		931	945		10.1177/0002764215580588		15	Psychology, Clinical; Social Sciences, Interdisciplinary	Psychology; Social Sciences - Other Topics	CK4YK	WOS:000356229100003		
J	Trampush, JW; Lencz, T; Knowles, E; Davies, G; Guha, S; Pe'er, I; Liewald, DC; Starr, JM; Djurovic, S; Melle, I; Sundet, K; Christoforou, A; Reinvang, I; Mukherjee, S; DeRosse, P; Lundervold, A; Steen, VM; John, M; Espeseth, T; Raikkonen, K; Widen, E; Palotie, A; Eriksson, JG; Giegling, I; Konte, B; Ikeda, M; Roussos, P; Giakoumaki, S; Burdick, KE; Payton, A; Ollier, W; Horan, M; Scult, M; Dickinson, D; Straub, RE; Donohoe, G; Morris, D; Corvin, A; Gill, M; Hariri, A; Weinberger, DR; Pendleton, N; Iwata, N; Darvasi, A; Bitsios, P; Rujescu, D; Lahti, J; Le Hellard, S; Keller, MC; Andreassen, OA; Deary, IJ; Glahn, DC; Malhotra, AK				Trampush, Joey W.; Lencz, Todd; Knowles, Emma; Davies, Gail; Guha, Saurav; Pe'er, Itsik; Liewald, David C.; Starr, John M.; Djurovic, Srdjan; Melle, Ingrid; Sundet, Kjetil; Christoforou, Andrea; Reinvang, Ivar; Mukherjee, Semanti; DeRosse, Pamela; Lundervold, Astri; Steen, Vidar M.; John, Majnu; Espeseth, Thomas; Raikkonen, Katri; Widen, Elisabeth; Palotie, Aarno; Eriksson, Johan G.; Giegling, Ina; Konte, Bettina; Ikeda, Masashi; Roussos, Panos; Giakoumaki, Stella; Burdick, Katherine E.; Payton, Antony; Ollier, William; Horan, Mike; Scult, Matthew; Dickinson, Dwight; Straub, Richard E.; Donohoe, Gary; Morris, Derek; Corvin, Aiden; Gill, Michael; Hariri, Ahmad; Weinberger, Daniel R.; Pendleton, Neil; Iwata, Nakao; Darvasi, Ariel; Bitsios, Panos; Rujescu, Dan; Lahti, Jari; Le Hellard, Stephanie; Keller, Matthew C.; Andreassen, Ole A.; Deary, Ian J.; Glahn, David C.; Malhotra, Anil K.			Independent evidence for an association between general cognitive ability and a genetic locus for educational attainment	AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS			English	Article						neurocognition; general cognitive ability; educational attainment; genetics; GWAS; proxy phenotype	GENOME-WIDE-ASSOCIATION; HUMAN INTELLIGENCE; VARIANTS; HEIGHT; RISK; METAANALYSIS; PERFORMANCE; POPULATION; CHILDHOOD; ADULT	Cognitive deficits and reduced educational achievement are common in psychiatric illness; understanding the genetic basis of cognitive and educational deficits may be informative about the etiology of psychiatric disorders. A recent, large genome-wide association study (GWAS) reported a genome-wide significant locus for years of education, which subsequently demonstrated association to general cognitive ability (g) in overlapping cohorts. The current study was designed to test whether GWAS hits for educational attainment are involved in general cognitive ability in an independent, large-scale collection of cohorts. Using cohorts in the Cognitive Genomics Consortium (COGENT; up to 20,495 healthy individuals), we examined the relationship between g and variants associated with educational attainment. We next conducted meta-analyses with 24,189 individuals with neurocognitive data from the educational attainment studies, and then with 53,188 largely independent individuals from a recent GWAS of cognition. A SNP (rs1906252) located at chromosome 6q16.1, previously associated with years of schooling, was significantly associated with g (P=1.47x10(-4)) in COGENT. The first joint analysis of 43,381 non-overlapping individuals for this a priori-designated locus was strongly significant (P=4.94x10(-7)), and the second joint analysis of 68,159 non-overlapping individuals was even more robust (P=1.65x10(-9)). These results provide independent replication, in a large-scale dataset, of a genetic locus associated with cognitive function and education. As sample sizes grow, cognitive GWAS will identify increasing numbers of associated loci, as has been accomplished in other polygenic quantitative traits, which may be relevant to psychiatric illness. (c) 2015 Wiley Periodicals, Inc.	[Trampush, Joey W.; Lencz, Todd; Guha, Saurav; Mukherjee, Semanti; DeRosse, Pamela; John, Majnu; Malhotra, Anil K.] Zucker Hillside Hosp, Div Psychiat Res, Glen Oaks, NY 11004 USA; [Trampush, Joey W.; Lencz, Todd; Mukherjee, Semanti; DeRosse, Pamela; John, Majnu; Malhotra, Anil K.] Feinstein Inst Med Res, Ctr Psychiat Neurosci, Manhasset, NY USA; [Trampush, Joey W.; Lencz, Todd; Malhotra, Anil K.] Hofstra North Shore LIJ Sch Med, Dept Psychiat, Hempstead, NY USA; [Knowles, Emma; Glahn, David C.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Davies, Gail; Liewald, David C.; Starr, John M.; Deary, Ian J.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Davies, Gail; Deary, Ian J.] Univ Edinburgh, Dept Psychol, Edinburgh, Midlothian, Scotland; [Pe'er, Itsik] Columbia Univ, Dept Comp Sci, New York, NY 10027 USA; [Pe'er, Itsik] Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY USA; [Starr, John M.] Univ Edinburgh, Alzheimer Scotland Dementia Res Ctr, Edinburgh, Midlothian, Scotland; [Djurovic, Srdjan; Melle, Ingrid; Sundet, Kjetil; Andreassen, Ole A.] NorMent, KG Jebsen Ctr, Oslo, Norway; [Djurovic, Srdjan; Melle, Ingrid; Andreassen, Ole A.] Oslo Univ Hosp, Oslo, Norway; [Melle, Ingrid; Sundet, Kjetil; Andreassen, Ole A.] Univ Oslo, Oslo, Norway; [Christoforou, Andrea; Steen, Vidar M.; Le Hellard, Stephanie] Univ Bergen, Dept Clin Med, Dr Einar Martens Res Grp Biol Psychiat, KG Jebsen Ctr Psychosis Res, Bergen, Norway; [Christoforou, Andrea; Steen, Vidar M.; Le Hellard, Stephanie] Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway; [Reinvang, Ivar; Espeseth, Thomas] Univ Oslo, Dept Psychol, Oslo, Norway; [Lundervold, Astri] Univ Bergen, KG Jebsen Ctr Res Neuropsychiat Disorders, Bergen, Norway; [Lundervold, Astri] Univ Bergen, Dept Biol & Med Psychol, Bergen, Norway; [Lundervold, Astri] Haraldsplass Deaconess Hosp, Kavli Res Ctr Aging & Dementia, Bergen, Norway; [Espeseth, Thomas] Oslo Univ Hosp, Div Mental Hlth & Addict, KG Jebsen Ctr Psychosis Res, Oslo, Norway; [Raikkonen, Katri; Lahti, Jari] Univ Helsinki, Inst Behav Sci, Helsinki, Finland; [Widen, Elisabeth; Palotie, Aarno] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland; [Palotie, Aarno] Wellcome Trust Sanger Inst, Cambridge, England; [Palotie, Aarno] Univ Helsinki, Dept Med Genet, Helsinki, Finland; [Palotie, Aarno] Univ Cent Hosp, Helsinki, Finland; [Eriksson, Johan G.] Natl Inst Hlth & Welf, Helsinki, Finland; [Eriksson, Johan G.] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland; [Eriksson, Johan G.] Univ Helsinki, Cent Hosp, Unit Gen Practice, Helsinki, Finland; [Eriksson, Johan G.] Folkhalsan Res Ctr, Helsinki, Finland; [Eriksson, Johan G.] Vasa Cent Hosp, Vaasa, Finland; [Giegling, Ina; Konte, Bettina; Rujescu, Dan] Univ Halle, Dept Psychiat, Halle, Germany; [Ikeda, Masashi; Iwata, Nakao] Fujita Hlth Univ, Sch Med, Dept Psychiat, Toyoake, Aichi 47011, Japan; [Roussos, Panos; Burdick, Katherine E.] Mt Sinai Sch Med, Dept Psychiat, New York, NY USA; [Giakoumaki, Stella] Univ Crete, Dept Psychol, Sch Social Sci, Iraklion, Greece; [Payton, Antony; Ollier, William] Univ Manchester, Ctr Integrated Genom Med Res, Manchester, Lancs, England; [Horan, Mike] Univ Manchester, Sch Community Based Med, Neurodegenerat Res Grp, Manchester, Lancs, England; [Scult, Matthew; Hariri, Ahmad] Duke Univ, Dept Psychol & Neurosci, Neurogenet Lab, Durham, NC USA; [Dickinson, Dwight; Straub, Richard E.; Weinberger, Daniel R.] NIMH, Clin Brain Disorders Brain & Genes Cognit & Psych, Intramural Res Program, NIH, Bethesda, MD 20892 USA; [Straub, Richard E.; Weinberger, Daniel R.] Johns Hopkins Univ Med Campus, Lieber Inst Brain Dev, Baltimore, MD USA; [Donohoe, Gary; Morris, Derek; Corvin, Aiden; Gill, Michael] Trinity Coll Dublin, Dept Psychiat, Neuropsychiat Genet Res Grp, Dublin, Ireland; [Donohoe, Gary; Morris, Derek; Corvin, Aiden; Gill, Michael] Trinity Coll Dublin, Trinity Coll Inst Neurosci, Dublin, Ireland; [Pendleton, Neil] Univ Manchester, Inst Brain Behav & Mental Hlth, Manchester, Lancs, England; [Darvasi, Ariel] Hebrew Univ Jerusalem, Inst Life Sci, Dept Genet, IL-91904 Jerusalem, Israel; [Bitsios, Panos] Univ Crete, Fac Med, Dept Psychiat & Behav Sci, Iraklion, Crete, Greece; [Lahti, Jari] Folkhalsan Res Ctr, Inst Genet, Helsinki, Finland; [Keller, Matthew C.] Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA	Trampush, JW (reprint author), Zucker Hillside Hosp, Div Psychiat Res, 75-59 263rd St, Glen Oaks, NY 11004 USA.	jtrampush@nshs.edu		Scult, Matthew/0000-0001-5554-8186	National Institutes of Health [R01 MH079800, P50 MH080173, RC2 MH089964, R01 MH080912, K23 MH077807, K01 MH085812]; Health Research Board (Ireland); Science Foundation Ireland; Research Council of Norway [154313/V50, 177458/V50]; Bergen Research Foundation; University of Bergen; Research Council of Norway (FUGE, Psykisk Helse); Helse Vest RHF; Dr. Einar Martens Fund; Academy of Finland; Finnish Diabetes Research Society; Folkhalsan Research Foundation; Novo Nordisk Foundation; Finska Lakaresallskapet; Signe and Ane Gyllenberg Foundation; University of Helsinki; Ministry of Education; Ahokas Foundation; Emil Aaltonen Foundation; UK Biotechnology and Biological Sciences Research Council (BBSRC); BBSRC; Medical Research Council (MRC); NSF Graduate Research Fellowship; NIDA [R01DA031579, R01DA033369]; NIH/NIMH Intramural Research Program; Lieber Institute for Brain Development; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; DOD ADNI (Department of Defense) [W81XWH-12-2-0012]; National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering; Canadian Institutes of Health Research	This work has been supported by grants from the National Institutes of Health (R01 MH079800 and P50 MH080173 to AKM; RC2 MH089964 to TL; R01 MH080912 to DCG; K23 MH077807 to KEB; K01 MH085812 to MCK). Dr. Donohoe is generously funded by the Health Research Board (Ireland) and Science Foundation Ireland. Data collection for the TOP cohort was supported by the Research Council of Norway, South-East Norway Health Authority. The NCNG study was supported by Research Council of Norway Grants 154313/V50 and 177458/V50. The NCNG GWAS was financed by grants from the Bergen Research Foundation, the University of Bergen, the Research Council of Norway (FUGE, Psykisk Helse), Helse Vest RHF and Dr. Einar Martens Fund. The Helsinki Birth Cohort Study has been supported by grants from the Academy of Finland, the Finnish Diabetes Research Society, Folkhalsan Research Foundation, Novo Nordisk Foundation, Finska Lakaresallskapet, Signe and Ane Gyllenberg Foundation, University of Helsinki, Ministry of Education, Ahokas Foundation, Emil Aaltonen Foundation. For the LBC1936 cohort we thank the cohort participants and team members who contributed to this study. Phenotype collection was supported by Age UK (The Disconnected Mind project). Genotyping was funded by the UK Biotechnology and Biological Sciences Research Council (BBSRC). The work was undertaken by The University of Edinburgh Centre for Cognitive Ageing and Cognitive Epidemiology, part of the cross council Lifelong Health and Wellbeing Initiative(MR/K026992/1). Funding from the BBSRC and Medical Research Council (MRC) is gratefully acknowledged. The Duke Neurogenetic Study was supported by an NSF Graduate Research Fellowship to MS, Duke University, and NIDA grants R01DA031579 & R01DA033369. The NIMH Genes, Cognition and Psychosis Study was funded by the NIH/NIMH Intramural Research Program and the Lieber Institute for Brain Development. Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: AbbVie, Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; and Transition Therapeutics. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for NeuroImaging at the University of Southern California.; Finally, several publicly available datasets were included; we kindly thank the investigative teams and staffs of the Pediatric Imaging, Neurocognition, and Genetics (PING) study, the Alzheimer's Disease Neuroimaging Initiative (ADNI) project, and the studies who made their data available in dbGaP.	Luciano M, 2011, BIOL PSYCHOL, V86, P193, DOI 10.1016/j.biopsycho.2010.11.008; Batty GD, 2008, HEART, V94, P1541, DOI 10.1136/hrt.2008.149567; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Rietveld CA, 2014, P NATL ACAD SCI USA, V111, P13790, DOI 10.1073/pnas.1404623111; Marioni RE, 2014, INTELLIGENCE, V44, P26, DOI 10.1016/j.intell.2014.02.006; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Deary IJ, 2012, NATURE, V482, P212, DOI 10.1038/nature10781; Deary IJ, 2009, HUM GENET, V126, P215, DOI 10.1007/s00439-009-0655-4; Halbritter F, 2012, NAT METHODS, V9, P7, DOI 10.1038/nmeth.1809; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Weedon MN, 2007, NAT GENET, V39, P1245, DOI 10.1038/ng2121; Johnson W, 2008, INTELLIGENCE, V36, P81, DOI 10.1016/j.intell.2007.06.001; Davies G, 2011, MOL PSYCHIATR, V16, P996, DOI 10.1038/mp.2011.85; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Donohoe G, 2013, PSYCHOL MED, V43, P2027, DOI 10.1017/S0033291712002656; Need AC, 2009, HUM MOL GENET, V18, P4650, DOI 10.1093/hmg/ddp413; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Deary I, 2008, NATURE, V456, P175, DOI 10.1038/456175a; Gottfredson LS, 1997, INTELLIGENCE, V24, P79, DOI 10.1016/S0160-2896(97)90014-3; Millan MJ, 2012, NAT REV DRUG DISCOV, V11, P141, DOI 10.1038/nrd3628; Johnson W, 2009, INTELLIGENCE, V37, P466, DOI 10.1016/j.intell.2009.05.006; Deary IJ, 2010, NAT REV NEUROSCI, V11, P201, DOI 10.1038/nrn2793; Han B, 2011, AM J HUM GENET, V88, P586, DOI 10.1016/j.ajhg.2011.04.014; Deary IJ, 2012, ANNU REV PSYCHOL, V63, P453, DOI 10.1146/annurev-psych-120710-100353; Zollner S, 2007, AM J HUM GENET, V80, P605, DOI 10.1086/512821; Yang J, 2014, NAT GENET, V46, P100, DOI 10.1038/ng.2876; Chabris CF, 2012, PSYCHOL SCI, V23, P1314, DOI 10.1177/0956797611435528; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Chen JS, 2004, AM J HUM GENET, V75, P807, DOI 10.1086/425589; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Benyamin B, 2014, MOL PSYCHIATR, V19, P253, DOI 10.1038/mp.2012.184; Carroll J. B., 1993, HUMAN COGNITIVE ABIL; Davies G, 2015, MOL PSYCHIATR, V20, P183, DOI 10.1038/mp.2014.188; Deary I.J., 2011, PSYCHOL SCI PUBL INT, V11, P53; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Lencz T, 2014, MOL PSYCHIATR, V19, P168, DOI 10.1038/mp.2013.166; Martin NW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020128; Muhleisen TW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4339; Panizzon MS, 2014, INTELLIGENCE, V43, P65, DOI 10.1016/j.intell.2014.01.008; Rietveld CA, 2014, PSYCHOL SCI, V25, P1975, DOI 10.1177/0956797614545132; Rietveld CA, 2013, SCIENCE, V340, P1467, DOI 10.1126/science.1235488; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917	42	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1552-4841	1552-485X		AM J MED GENET B	Am. J. Med. Genet. B	JUL	2015	168	5					363	373		10.1002/ajmg.b.32319		11	Genetics & Heredity; Psychiatry	Genetics & Heredity; Psychiatry	CK2XW	WOS:000356079700006		
J	Saito, E; Inoue, M; Sawada, N; Shimazu, T; Yamaji, T; Iwasaki, M; Sasazuki, S; Noda, M; Iso, H; Tsugane, S				Saito, Elko; Inoue, Manami; Sawada, Node; Shimazu, Taichi; Yamaji, Taiki; Iwasaki, Motoki; Sasazuki, Shizuka; Noda, Mitsuhiko; Iso, Hiroyasu; Tsugane, Shoichiro		JPHC Study Grp	Association of green tea consumption with mortality due to all causes and major causes of death in a Japanese population: the Japan Public Health Center-based Prospective Study (JPHC Study)	ANNALS OF EPIDEMIOLOGY			English	Article						Tea; Adult; Cardiovascular diseases/mortality; Respiratory diseases/mortality; Follow-up studies; Japan/epidemiology; Proportional hazards models	RANDOMIZED CONTROLLED-TRIALS; CARDIOVASCULAR-DISEASE; SUBSEQUENT RISK; CAFFEINE; CANCER; COHORT; METAANALYSIS; THEANINE; ADULTS; COFFEE	Purpose: We examined the association between green tea consumption and mortality due to all causes, cancer, heart disease, cerebrovascular disease, respiratory disease, injuries, and other causes of death in a large-scale population-based cohort study in Japan. Methods: We studied 90,914 Japanese (aged between 40 and 69 years) recruited between 1990 and 1994. After 18.7 years of follow-up, 12,874 deaths were reported. The association between green tea consumption and risk of all causes and major causes of mortality was assessed using the Cox proportional hazards regression model with adjustment for potential confounders. Results: Hazard ratios for all-cause mortality among men who consumed green tea compared with those who drank less than 1 cup/day were 0.96 (0.89-1.03) for 1-2 cups/day, 0.88 (0.82-0.95) for 3-4 cups/day, and 0.87 (0.81-0.94) for more than 5 cups/day (P for trend <.001). Corresponding hazard ratios for women were 0.90 (0.81-1.00), 0.87(0.79-0.96), and 0.83 (0.75-0.91; P for trend <.001). Green tea was inversely associated with mortality from heart disease in both men and women and mortality from cerebrovascular disease and respiratory disease in men. No association was found between green tea and total cancer mortality. Conclusions: This prospective study suggests that the consumption of green tea may reduce the risk of all-cause mortality and the three leading causes of death in Japan. (C) 2015 Elsevier Inc. All rights reserved.	[Saito, Elko; Inoue, Manami; Sawada, Node; Shimazu, Taichi; Yamaji, Taiki; Iwasaki, Motoki; Sasazuki, Shizuka; Tsugane, Shoichiro] Natl Canc Ctr, Res Ctr Canc Prevent & Screening, Epidemiol & Prevent Grp, Tokyo 104, Japan; [Saito, Elko; Inoue, Manami] Univ Tokyo, Grad Sch Med, Tokyo 1130033, Japan; [Noda, Mitsuhiko] Natl Ctr Global Hlth & Med, Diabet Res Ctr, Dept Diabet Res, Tokyo, Japan; [Iso, Hiroyasu] Osaka Univ, Grad Sch Med, Dept Social & Environm Med, Publ Hlth, Suita, Osaka, Japan	Inoue, M (reprint author), Univ Tokyo, Grad Sch Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	mnminoue@m.u-tokyo.ac.jp			National Cancer Center Research and Development Fund [23-A-31[toku], 26-A-2]; Ministry of Health, Labor and Welfare of Japan; Health and Labor Sciences Research Expenses for Commission (Comprehensive Research on Life-Style Related Diseases including Cardiovascular Diseases and Diabetes Mellitus) [H26-005]	This study was supported by the National Cancer Center Research and Development Fund (23-A-31[toku] and 26-A-2; since 2011), by a Grant-in-Aid for Cancer Research from the Ministry of Health, Labor and Welfare of Japan (from 1989 to 2010) and by Health and Labor Sciences Research Expenses for Commission (Comprehensive Research on Life-Style Related Diseases including Cardiovascular Diseases and Diabetes Mellitus H26-005). Members of the Japan Public Health Center-based Prospective Study (JPHC Study, principal investigator: S. Tsugane) Group are: S. Tsugane, N. Sawada, M. Iwasaki, S. Sasazuki, T. Yamaji, T. Shimazu, and T. Hanaoka, National Cancer Center, Tokyo; J. Ogata, S. Baba, T. Mannami, A. Okayama, and Y. Kokubo, National Cerebral and Cardiovascular Center, Osaka; K. Miyakawa, F. Saito, A. Koizumi, Y. Sano, I. Hashimoto, T. Ikuta, Y. Tanaba, H. Sato, Y. Roppongi, and T. Takashima, Iwate Prefectural Ninohe Public Health Center, Iwate; Y. Miyajima, N. Suzuki, S. Nagasawa, Y. Furusugi, N. Nagai, Y. Ito, S. Komatsu, and T. Minamizono, Akita Prefectural Yokote Public Health Center, Akita; H. Sanada, Y. Hatayama, F. Kobayashi, H. Uchino, Y. Shirai, T. Kondo, R. Sasaki, Y. Watanabe, Y. Miyagawa, Y. Kobayashi, M. Machida, K. Kobayashi, and M. Tsukada, Nagano Prefectural Saku Public Health Center, Nagano; Y. Kishimoto, E. Takara, T. Fukuyama, M. Kinjo, M. Irei, and H. Sakiyama, Okinawa Prefectural Chubu Public Health Center, Okinawa; K. Imoto, H. Yazawa, T. Seo, A. Seiko, F. Ito, F. Shoji, and R. Saito, Katsushika Public Health Center, Tokyo; A. Murata, K. Minato, K. Motegi, T. Fujieda, and S. Yamato, Ibaraki Prefectural Mito Public Health Center, Ibaraki; K. Matsui, T. Abe, M. Katagiri, and M. Suzuki, Niigata Prefectural Kashiwazaki and Nagaoka Public Health Center, Niigata; M. Doi, A. Terao, Y. Ishikawa, and T. Tagami, Kochi Prefectural Chuo-higashi Public Health Center, Kochi; H. Sueta, H. Doi, M. Urata, N. Okamoto, F. Ide, and H. Goto, Nagasaki Prefectural Kamigoto Public Health Center, Nagasaki; H. Sakiyama, N. Onga, H. Takaesu, M. Uehara, T. Nakasone, and M. Yamakawa, Okinawa Prefectural Miyako Public Health Center, Okinawa; F. Horii, I. Asano, H. Yamaguchi, K. Aoki, S. Maruyama, M. Ichii, and M. Takano, Osaka Prefectural Suita Public Health Center, Osaka; Y. Tsubono, Tohoku University, Miyagi; K. Suzuki, Research Institute for Brain and Blood Vessels Akita, Akita; Y. Honda, K. Yamagishi, S. Sakurai, and N. Tsuchiya, University of Tsukuba, Ibaraki; M. Kabuto, National Institute for Environmental Studies, Ibaraki; M. Yamaguchi, Y. Matsumura, S. Sasaki, and S. Watanabe, National Institute of Health and Nutrition, Tokyo; M. Akabane, Tokyo University of Agriculture, Tokyo; T. Kadowaki and M. Inoue, The University of Tokyo, Tokyo; M. Noda and T. Mizoue, National Center for Global Health and Medicine, Tokyo; Y. Kawaguchi, Tokyo Medical and Dental University, Tokyo; Y. Takashima and Y. Yoshida, Kyorin University, Tokyo; K. Nakamura and R. Takachi, Niigata University, Niigata; J. Ishihara, Sagami Women's University, Kanagawa; S. Matsushima and S. Natsukawa, Saku General Hospital, Nagano; H. Shimizu, Sakihae Institute, Gifu; H. Sugimura, Hamamatsu University School of Medicine, Shizuoka; S. Tominaga, Aichi Cancer Center, Aichi; N. Hamajima, Nagoya University, Aichi; H. Iso and T. Sobue, Osaka University, Osaka; M. Iida, W. Ajiki, and A. Ioka, Osaka Medical Center for Cancer and Cardiovascular Disease, Osaka; S. Sato, Chiba Prefectural Institute of Public Health, Chiba; E. Maruyama, Kobe University, Hyogo; M. Konishi, K. Okada, and I.; Saito, Ehime University, Ehime; N. Yasuda, Kochi University, Kochi; S. Kono, Kyushu University, Fukuoka; S. Akiba, Kagoshima University, Kagoshima.	Mineharu Y, 2011, J EPIDEMIOL COMMUN H, V65, P230, DOI 10.1136/jech.2009.097311; Sugiyama K, 2010, J NUTR, V140, P1007, DOI 10.3945/jn.109.109314; Shimazu T, 2007, INT J EPIDEMIOL, V36, P600, DOI 10.1093/ije/dym005; Einother SJL, 2013, PSYCHOPHARMACOLOGY, V225, P251, DOI 10.1007/s00213-012-2917-4; Suzuki E, 2009, ANN EPIDEMIOL, V19, P732, DOI 10.1016/j.annepidem.2009.06.003; Imai K, 1997, PREV MED, V26, P769, DOI 10.1006/pmed.1997.0242; Rogers PJ, 2008, PSYCHOPHARMACOLOGY, V195, P569, DOI 10.1007/s00213-007-0938-1; Wang Y, 2009, J AGR FOOD CHEM, V57, P8109, DOI 10.1021/jf804025c; Zheng XX, 2011, AM J CLIN NUTR, V94, P601, DOI 10.3945/ajcn.110.010926; Iso H, 2006, ANN INTERN MED, V144, P554; Brice C, 2001, HUM PSYCHOPHARM CLIN, V16, P523, DOI 10.1002/hup.327; Inoue M, 2009, CANCER EPIDEM BIOMAR, V18, P1746, DOI [10.1158/1055-9965.EPI-08-0923, 10.1158/1055-9965-EPI-08-0923]; [Anonymous], 2009, VIT STAT JAPAN LAT T; Camfield DA, 2014, NUTR REV, V72, P507, DOI 10.1111/nure.12120; Nieoullon A, 2002, PROG NEUROBIOL, V67, P53, DOI 10.1016/S0301-0082(02)00011-4; Kuriyama S, 2006, JAMA-J AM MED ASSOC, V296, P1255, DOI 10.1001/jama.296.10.1255; Yokogoshi H, 1998, NEUROCHEM RES, V23, P667, DOI 10.1023/A:1022490806093; Nagao T, 2007, OBESITY, V15, P1473, DOI 10.1038/oby.2007.176; Zucchi R, 1997, PHARMACOL REV, V49, P1; Hoshiyama Y, 2002, BRIT J CANCER, V87, P309, DOI 10.1038/sj.bjc.6600487; Iwasaki M, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2756; Kurahashi N, 2009, CANCER SCI, V100, P284, DOI 10.1111/j.1349-7006.2008.01027.x; Nathan Pradeep J., 2006, Journal of Herbal Pharmacotherapy, V6, P21, DOI 10.1300/J157v06n02_02; Nehlig A., 2010, JAD, Journal of Alzheimer's Disease, V20, P85; Schneider C, 2009, AM FAM PHYSICIAN, V79, P591; Science and Technology Agency, 2000, STAND TABL FOOD COMP; Spyridopoulos I, 2008, ARTERIOSCL THROM VAS, V28, P1967, DOI 10.1161/ATVBAHA.108.174060; Tsubono Y, 2003, J EPIDEMIOL, V13, pS125; Tsugane S, 2001, J Epidemiol, V11, pS24; Tsugane S, 2014, JPN J CLIN ONCOL, V44, P777, DOI 10.1093/jjco/hyu096; Tsugane S, 2001, J Epidemiol, V11, pS30; Watanabe I, 2009, AM J CLIN NUTR, V90, P672, DOI 10.3945/ajcn.2009.27599; Watanabe S, 2001, J Epidemiol, V11, pS3; Welsh EJ, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001112.pub2; World Health Organization, 1992, INT STAT CLASS DIS R; Zheng XX, 2013, AM J CLIN NUTR, V97, P750, DOI 10.3945/ajcn.111.032573	36	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1047-2797	1873-2585		ANN EPIDEMIOL	Ann. Epidemiol.	JUL	2015	25	7					512	518		10.1016/j.annepidem.2015.03.007		7	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CJ8SG	WOS:000355773200008		
J	Nishio, T; Hatano, E; Sakurai, T; Taura, K; Okuno, M; Kasai, Y; Seo, S; Yasuchika, K; Mori, A; Kaido, T; Uemoto, S				Nishio, Takahiro; Hatano, Etsuro; Sakurai, Takaki; Taura, Kojiro; Okuno, Masayuki; Kasai, Yosuke; Seo, Satoru; Yasuchika, Kentaro; Mori, Akira; Kaido, Toshimi; Uemoto, Shinji			Impact of Hepatic Steatosis on Disease-Free Survival in Patients with Non-B Non-C Hepatocellular Carcinoma Undergoing Hepatic Resection	ANNALS OF SURGICAL ONCOLOGY			English	Article							NONALCOHOLIC FATTY LIVER; GAMMA-CARBOXY PROTHROMBIN; METABOLIC SYNDROME; RISK-FACTORS; ALPHA-FETOPROTEIN; SURGICAL COMPLICATIONS; CLINICAL-FEATURES; CIRRHOSIS; ETIOLOGY; JAPAN	Although the prevalence of non-B non-C hepatocellular carcinoma (NBNC HCC) has increased, its clinicopathologic characteristics remain unclear. We retrospectively analyzed 518 HCC patients who underwent hepatic resection. Hepatitis B surface antigen- and hepatitis C antibody-negative patients were categorized into the NBNC HCC group (n = 145); others were categorized into the hepatitis B or C HCC (BC HCC) group (n = 373). We subdivided the etiologies of NBNC HCC according to alcohol intake and presence of steatosis. NBNC HCC was associated with nonalcoholic fatty liver disease (NAFLD) (13.1 %), fatty liver disease with moderate alcohol intake (9.0 %), alcoholic liver disease (ALD) (29.7 %), cryptogenic disease (44.1 %), and other known etiologies (4.1 %). The prevalence of obesity, diabetes mellitus, and hypertension was higher and hepatic function was better in the NBNC HCC group, which had significantly larger tumors than the BC HCC group. The entire NBNC HCC group displayed similar overall and disease-free survival as the BC HCC group. Among the subdivisions, NAFLD-associated HCC patients had significantly better disease-free survival than ALD-associated HCC and BC HCC patients. Microvascular invasion (hazard ratio [HR] 2.30; 95 % confidence interval [CI] 1.33-3.96) and steatosis area < 5 % of noncancerous region (HR 2.13; 95 % CI 1.21-3.93) were associated with disease-free survival in NBNC HCC patients. The prognosis of NBNC HCC was similar to that of BC HCC. Among NBNC HCC patients, NAFLD-associated HCC patients had a relatively low recurrence risk. Absence of steatosis in hepatic parenchyma had a significant impact on disease-free survival in NBNC HCC patients.	[Nishio, Takahiro; Hatano, Etsuro; Taura, Kojiro; Okuno, Masayuki; Kasai, Yosuke; Seo, Satoru; Yasuchika, Kentaro; Mori, Akira; Kaido, Toshimi; Uemoto, Shinji] Kyoto Univ, Dept Surg, Grad Sch Med, Kyoto, Japan; [Sakurai, Takaki] Kyoto Univ, Dept Diagnost Pathol, Grad Sch Med, Kyoto, Japan	Nishio, T (reprint author), Kyoto Univ, Dept Surg, Grad Sch Med, Kyoto, Japan.	etsu@kuhp.kyoto-u.ac.jp					Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; Marrero JA, 2009, GASTROENTEROLOGY, V137, P110, DOI 10.1053/j.gastro.2009.04.005; Bugianesi E, 2002, GASTROENTEROLOGY, V123, P134, DOI 10.1053/gast.2002.34168; Hamaguchi M, 2005, ANN INTERN MED, V143, P722; Tanaka H, 2008, ANN INTERN MED, V148, P820; Jemal A, 2010, CA-CANCER J CLIN, V60, P277, DOI [10.3322/caac.20073, 10.1002/caac.20073]; Nagaoki Y, 2012, HEPATOL RES, V42, P368, DOI 10.1111/j.1872-034X.2011.00929.x; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; Bedogni G, 2005, HEPATOLOGY, V42, P44, DOI 10.1002/hep.20734; Michitaka K, 2010, J GASTROENTEROL, V45, P86, DOI 10.1007/s00535-009-0128-5; Li CZ, 2014, HEPATOL RES, V44, pE11, DOI 10.1111/hepr.12201; Siegel AB, 2009, CANCER-AM CANCER SOC, V115, P5651, DOI 10.1002/cncr.24687; Clavien PA, 2009, ANN SURG, V250, P187, DOI 10.1097/SLA.0b013e3181b13ca2; IKEDA K, 1993, HEPATOLOGY, V18, P47, DOI 10.1016/0270-9139(93)90505-H; Eckel RH, 2010, LANCET, V375, P181, DOI 10.1016/S0140-6736(09)61794-3; Starley BQ, 2010, HEPATOLOGY, V51, P1820, DOI 10.1002/hep.23594; Nair S, 2002, HEPATOLOGY, V36, P150, DOI 10.1053/jhep.2002.33713; Lok AS, 2010, GASTROENTEROLOGY, V138, P493, DOI 10.1053/j.gastro.2009.10.031; Abe H, 2008, J GASTROENTEROL, V43, P967, DOI 10.1007/s00535-008-2264-8; [Anonymous], 1994, HEPATOLOGY 1, V20, P15; Cauchy F, 2013, BRIT J SURG, V100, P113, DOI 10.1002/bjs.8963; JOHNSON PJ, 1987, J HEPATOL, V4, P140, DOI 10.1016/S0168-8278(87)80021-1; Kondo R, 2014, HEPATOL RES, V44, P1039, DOI 10.1111/hepr.12219; Suzuki Y, 2013, HEPATOL RES, V43, P1020, DOI 10.1111/hepr.12056; Taura N, 2013, MED SCI MONITOR, V19, P742, DOI 10.12659/MSM.889361; TSUKUMA H, 1993, NEW ENGL J MED, V328, P1797, DOI 10.1056/NEJM199306243282501; Utsunomiya T, 2011, HEPATOL RES, V41, P711, DOI 10.1111/j.1872-034X.2011.00818.x; Yano Y, 2002, AM J GASTROENTEROL, V97, P156; ZAMAN SN, 1985, LANCET, V1, P1357	32	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9265	1534-4681		ANN SURG ONCOL	Ann. Surg. Oncol.	JUL	2015	22	7					2226	2234		10.1245/s10434-014-4181-9		9	Oncology; Surgery	Oncology; Surgery	CJ8KF	WOS:000355748300018		
J	Watanabe, H; Yokoyama, Y; Kokuryo, T; Ebata, T; Igami, T; Sugawara, G; Mizuno, T; Shimoyama, Y; Nagino, M				Watanabe, Hiroyuki; Yokoyama, Yukihiro; Kokuryo, Toshio; Ebata, Tomoki; Igami, Tsuyoshi; Sugawara, Gen; Mizuno, Takashi; Shimoyama, Yoshie; Nagino, Masato			Prognostic Value of Hepatocyte Growth Factor Receptor Expression in Patients with Perihilar Cholangiocarcinoma	ANNALS OF SURGICAL ONCOLOGY			English	Article							MACROPHAGE-STIMULATING PROTEIN; SMALL-MOLECULE INHIBITOR; MULTI-KINASE INHIBITOR; C-MET OVEREXPRESSION; TYROSINE KINASE; CELL CARCINOMA; TISSUE MICROARRAYS; GASTRIC CARCINOMAS; TUMOR PROGRESSION; GENE-PRODUCT	Although an aggressive surgical approach to perihilar cholangiocarcinoma (PHC) has improved survival, a prognosis of advanced PHC remains unsatisfactory. The overexpression of mesenchymal-epithelial transition factor (MET) and recepteur d'origine nantais (RON) has been shown to be associated with poor prognosis in some types of cancer. One hundred sixty-nine patients who underwent histologically curative resection for PHC were subjected to immunohistochemical analysis for MET and RON. The association between a positive expression of MET or RON and clinicopathologic features as well as the patients' prognosis were analyzed. There were 27 patients (16 %) who had a positive expression for both MET and RON. Although clinicopathologic features in the either MET- or RON-negative group were not significantly different compared to the both MET- and RON-positive group, the prognosis tended to be worse in the patients with both MET and RON positivity. When the analysis was limited to patients with advanced-stage disease (stage III and IVa), a multivariate analysis revealed that both MET and RON positivity and lymph node metastasis were identified as independent poor prognostic factors. The overall survival rate for patients with both MET and RON positivity was worse than that with either MET or RON negativity in patients with advanced PHC. The poor prognosis in these patients was not associated with unfavorable clinicopathologic features. The examination of MET and RON expression in PHC may enable a tailored method for patient classification that could not otherwise be achieved using the conventional pathologic classification system.	[Watanabe, Hiroyuki; Yokoyama, Yukihiro; Kokuryo, Toshio; Ebata, Tomoki; Igami, Tsuyoshi; Sugawara, Gen; Mizuno, Takashi; Nagino, Masato] Nagoya Univ, Grad Sch Med, Div Surg Oncol, Dept Surg, Nagoya, Aichi 4648601, Japan; [Shimoyama, Yoshie] Nagoya Univ, Grad Sch Med, Dept Pathol & Clin Labs, Nagoya, Aichi 4648601, Japan	Watanabe, H (reprint author), Nagoya Univ, Grad Sch Med, Div Surg Oncol, Dept Surg, Nagoya, Aichi 4648601, Japan.	kokuryoh@med.nagoya-u.ac.jp					Follenzi A, 2000, ONCOGENE, V19, P3041, DOI 10.1038/sj.onc.1203620; Christensen JG, 2003, CANCER RES, V63, P7345; Miyamoto M, 2011, BRIT J CANCER, V105, P131, DOI 10.1038/bjc.2011.199; ZARNEGAR R, 1995, J CELL BIOL, V129, P1177, DOI 10.1083/jcb.129.5.1177; Wang QR, 2013, CANCER LETT, V340, P43, DOI 10.1016/j.canlet.2013.06.022; Igami T, 2010, J HEPATO-BIL-PAN SCI, V17, P449, DOI 10.1007/s00534-009-0209-0; Kawada I, 2014, CANCER RES, V74, P884, DOI 10.1158/0008-5472.CAN-12-3583; Robles R, 2004, ANN SURG, V239, P265, DOI 10.1097/01.sla.0000108702.45715.81; HAN S, 1991, BIOCHEMISTRY-US, V30, P9768, DOI 10.1021/bi00104a029; Cheng HL, 2005, BRIT J CANCER, V92, P1906, DOI 10.1038/sj.bjc.6602593; Juntermanns B, 2013, ANN SURG ONCOL, V20, P277, DOI 10.1245/s10434-012-2486-0; Ha SY, 2013, MODERN PATHOL, V26, P1632, DOI 10.1038/modpathol.2013.108; Aoba T, 2013, ANN SURG, V257, P718, DOI 10.1097/SLA.0b013e3182822277; WANG MH, 1994, SCIENCE, V266, P117, DOI 10.1126/science.7939629; BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; Gray JK, 2012, CANCER LETT, V314, P92, DOI 10.1016/j.canlet.2011.09.021; Lee WY, 2005, CLIN CANCER RES, V11, P2222, DOI 10.1158/1078-0432.CCR-04-1761; Catenacci DVT, 2011, CANCER BIOL THER, V12, P9, DOI 10.4161/cbt.12.1.15747; NALDINI L, 1991, ONCOGENE, V6, P501; Yan SB, 2013, INVEST NEW DRUG, V31, P833, DOI 10.1007/s10637-012-9912-9; Choueiri TK, 2013, J CLIN ONCOL, V31, P181, DOI 10.1200/JCO.2012.43.3383; Zhang YW, 2003, P NATL ACAD SCI USA, V100, P12718, DOI 10.1073/pnas.2135113100; Matsumoto K, 1996, J BIOCHEM-TOKYO, V119, P591; Camp ER, 2005, ANN SURG ONCOL, V12, P273, DOI 10.1245/ASO.2005.08.013; Chen QY, 1997, HEPATOLOGY, V26, P59; Comperat E, 2008, J UROLOGY, V179, P868, DOI 10.1016/j.juro.2007.10.079; DEGEN SJF, 1991, BIOCHEMISTRY-US, V30, P9781, DOI 10.1021/bi00104a030; Dussault I, 2009, ANTI-CANCER AGENT ME, V9, P221; Garcia S, 2007, BRIT J CANCER, V96, P329, DOI 10.1038/sj.bjc.6603569; Herynk MH, 2000, IN VIVO, V14, P587; Kim SA, 2014, AURIS NASUS LARYNX, V41, P201, DOI 10.1016/j.anl.2013.10.014; Lee CT, 2008, DIS COLON RECTUM, V51, P1268, DOI 10.1007/s10350-008-9297-1; Leelawat K, 2006, J SURG RES, V136, P78, DOI 10.1016/j.jss.2006.05.031; Maggiora P, 2003, EXP CELL RES, V288, P382, DOI 10.1016/S0014-4827(03)00250-7; Nagino M, 2013, ANN SURG, V258, P129, DOI 10.1097/SLA.0b013e3182708b57; Sarmiento JM, 2002, SURG ONCOL CLIN N AM, V11, pviii; Sarmiento Juan M, 2002, Surg Oncol Clin N Am, V11, P893, DOI 10.1016/S1055-3207(02)00034-0; Shapiro GI, 2013, INVEST NEW DRUG, V31, P742, DOI 10.1007/s10637-012-9881-z; Sotoudeh K, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-57; Steinig AG, 2013, BIOORG MED CHEM LETT, V23, P4381, DOI 10.1016/j.bmcl.2013.05.074; WANG MH, 1995, P NATL ACAD SCI USA, V92, P3933, DOI 10.1073/pnas.92.9.3933; Young AL, 2011, HPB, V13, P483, DOI 10.1111/j.1477-2574.2011.00328.x; Zeng JY, 2014, MOL CANCER THER, V13, P37, DOI 10.1158/1535-7163.MCT-13-0242	43	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9265	1534-4681		ANN SURG ONCOL	Ann. Surg. Oncol.	JUL	2015	22	7					2235	2242		10.1245/s10434-014-4170-z		8	Oncology; Surgery	Oncology; Surgery	CJ8KF	WOS:000355748300019		
J	Marubashi, S; Gotoh, K; Akita, H; Takahashi, H; Sugimura, K; Miyoshi, N; Motoori, M; Kishi, K; Noura, S; Fujiwara, Y; Ohue, M; Nakazawa, T; Nakanishi, K; Ito, Y; Yano, M; Ishikawa, O; Sakon, M				Marubashi, Shigeru; Gotoh, Kunihito; Akita, Hirofumi; Takahashi, Hidenori; Sugimura, Keijiro; Miyoshi, Norikatsu; Motoori, Masaaki; Kishi, Kentaro; Noura, Shingo; Fujiwara, Yoshiyuki; Ohue, Masayuki; Nakazawa, Tetsuro; Nakanishi, Katsuyuki; Ito, Yuri; Yano, Masahiko; Ishikawa, Osamu; Sakon, Masato			Analysis of Recurrence Patterns After Anatomical or Non-anatomical Resection for Hepatocellular Carcinoma	ANNALS OF SURGICAL ONCOLOGY			English	Article							PRESERVED LIVER-FUNCTION; LONG-TERM SURVIVAL; HEPATIC RESECTION; INTRAHEPATIC RECURRENCE; TUMOR HEMODYNAMICS; SURGICAL COMPLICATIONS; HEPATECTOMY; CLASSIFICATION; NATIONWIDE; CIRRHOSIS	Recurrence patterns after hepatic resection has been poorly understood in view of tumor blood flow drainage (TBFD) area. Our goal was to clarify the recurrence patterns after anatomical versus nonanatomical hepatic resection for hepatocellular carcinoma (HCC). A total of 424 consecutive patients with HCC, who were treated by curative resection (R0) at our hospital from 2001 to 2012, were evaluated. Among these, we compared the outcomes of the anatomical resection group (AR group, n = 243) and the nonanatomical resection group (NR group, n = 181). We performed an analysis of the recurrence patterns of HCC based on the preoperative CT during hepatic arteriography in these 424 patients. Preoperative liver function was better in the AR group than the NR group (P < 0.001), and tumor size was larger in the AR group than the NR group (P < 0.001). HCC recurrence was recorded in 145 patients (59.7 %) of the AR group and 102 patients (56.4 %) of the NR group with no significant differences between the two groups (P = 0.590). The incidences of extrahepatic and intrahepatic recurrence (solitary/multiple) were similar between the two groups. In addition, the rate of recurrences by local dissemination, either recurrences in the same subsegment in the NR group or recurrences in the TBFD area in the AR group, was sufficiently low (1.4 %) as to be considered negligible. The incidence and patterns of HCC recurrence were similar between the anatomical and nonanatomical resection. Recurrence by local dissemination may be considered to be negligible in both surgical methods.	[Marubashi, Shigeru; Gotoh, Kunihito; Akita, Hirofumi; Takahashi, Hidenori; Sugimura, Keijiro; Miyoshi, Norikatsu; Motoori, Masaaki; Kishi, Kentaro; Noura, Shingo; Fujiwara, Yoshiyuki; Ohue, Masayuki; Yano, Masahiko; Ishikawa, Osamu; Sakon, Masato] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Surg, Osaka, Japan; [Nakazawa, Tetsuro; Nakanishi, Katsuyuki] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Radiol, Osaka, Japan; [Ito, Yuri] Osaka Med Ctr Canc & Cardiovasc Dis, Ctr Canc Control & Stat, Osaka, Japan	Marubashi, S (reprint author), Osaka Med Ctr Canc & Cardiovasc Dis, Dept Surg, Osaka, Japan.	s-marubashi@umin.ac.jp					BELGHITI J, 1991, ANN SURG, V214, P114, DOI 10.1097/00000658-199108000-00004; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Sasaki K, 2013, AM SURGEON, V79, P1163; MAKUUCHI M, 1985, SURG GYNECOL OBSTET, V161, P346; Utsunomiya T, 2014, ANN SURG, V259, P336, DOI 10.1097/SLA.0b013e31829291e9; Fujimoto A, 2012, NAT GENET, V44, P760, DOI 10.1038/ng.2291; Eguchi S, 2008, SURGERY, V143, P469, DOI 10.1016/j.surg.2007.12.003; [Anonymous], 1989, JPN J SURG, V19, P98; Yamada D, 2013, EUR J CANCER, V49, P1725, DOI 10.1016/j.ejca.2012.12.002; CHEN MF, 1994, ARCH SURG-CHICAGO, V129, P738; Ercolani G, 2003, ANN SURG, V237, P536, DOI 10.1097/00000658-200304000-00016; Hasegawa K, 2005, ANN SURG, V242, P252, DOI 10.1097/01.sla.0000171307.37401.db; Clavien PA, 2009, ANN SURG, V250, P187, DOI 10.1097/SLA.0b013e3181b13ca2; Poon RTP, 2002, ANN SURG, V235, P373, DOI 10.1097/00000658-200203000-00009; Ikai I, 2007, HEPATOL RES, V37, P676, DOI 10.1111/j.1872-034X.2007.00119.x; Ueno S, 2008, J HEPATO-BILIARY-PAN, V15, P493, DOI 10.1007/s00534-007-1312-8; Tiong L, 2011, BRIT J SURG, V98, P1210, DOI 10.1002/bjs.7669; Marubashi S, 2011, ANN SURG ONCOL, V18, P2200, DOI 10.1245/s10434-011-1577-7; Duffy JP, 2008, CANCER J, V14, P100, DOI 10.1097/PPO.0b013e31816a5c1f; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Imamurai H, 1999, BRIT J SURG, V86, P1032, DOI 10.1046/j.1365-2168.1999.01185.x; Kaibori M, 2006, SURGERY, V139, P385, DOI 10.1016/j.surg.2005.08.035; Kang CM, 2010, J SURG RES, V160, P81, DOI 10.1016/j.jss.2009.01.021; Marubashi S, 2007, TRANSPL INT, V20, P576, DOI 10.1111/j.1432-2277.2007.00480.x; NAGASUE N, 1993, GASTROENTEROLOGY, V105, P488; Ochiai T, 2013, ANTICANCER RES, V33, P1689; Sakon M, 2013, HEPATOL RES, V43, P155, DOI 10.1111/hepr.12001; Sakon M, 2002, ARCH SURG-CHICAGO, V137, P94, DOI 10.1001/archsurg.137.1.94; Sakon M, 2000, J SURG ONCOL, V73, P179, DOI 10.1002/(SICI)1096-9098(200003)73:3<179::AID-JSO13>3.0.CO;2-M; Tanaka K, 2008, SURGERY, V143, P607, DOI 10.1016/j.surg.2008.01.006; Tomimaru Y, 2012, DIGEST DIS SCI, V57, P1942, DOI 10.1007/s10620-012-2114-7; Wakai T, 2007, ANN SURG ONCOL, V14, P1356, DOI 10.1245/s10434-006-9318-z; Wu CC, 2005, BRIT J SURG, V92, P348, DOI 10.1002/bjs.4838; Yamamoto M, 2001, SURGERY, V130, P443, DOI 10.1067/msy.2001.116406	34	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9265	1534-4681		ANN SURG ONCOL	Ann. Surg. Oncol.	JUL	2015	22	7					2243	2252		10.1245/s10434-014-4214-4		10	Oncology; Surgery	Oncology; Surgery	CJ8KF	WOS:000355748300020		
J	Adachi, T; Eguchi, S; Beppu, T; Ueno, S; Shiraishi, M; Okuda, K; Yamashita, Y; Kondo, K; Nanashima, A; Ohta, M; Takami, Y; Noritomi, T; Kitahara, K; Fujioka, H				Adachi, Tomohiko; Eguchi, Susumu; Beppu, Toru; Ueno, Shinichi; Shiraishi, Masayuki; Okuda, Koji; Yamashita, Yo-ichi; Kondo, Kazuhiro; Nanashima, Atsushi; Ohta, Masayuki; Takami, Yuko; Noritomi, Tomoaki; Kitahara, Kenji; Fujioka, Hikaru			Prognostic Impact of Preoperative Lymph Node Enlargement in Intrahepatic Cholangiocarcinoma: A Multi-Institutional Study by the Kyushu Study Group of Liver Surgery	ANNALS OF SURGICAL ONCOLOGY			English	Article							POSITRON-EMISSION-TOMOGRAPHY; CANCER; RECURRENCE; RESECTION; METASTASIS; SURVIVAL; BILIARY	Although lymph node metastasis (LNM) has been considered an important prognostic factor for intrahepatic cholangiocarcinoma (ICC), the impact of lymph node enlargement on the prognosis of ICC, and the accuracy of diagnosis of LNM, have not been fully clarified. Using a chart review of 225 patients with ICC, we compared survival times between patients with and without lymph node enlargement, and we evaluated the accuracy of diagnosis of LNM. We also performed a multivariate analysis to determine the variables affecting overall survival in the study population. The survival time of patients without lymph node enlargement was significantly longer than that of patients with lymph node enlargement (median survival time [MST] 43.7 vs. 20.1 months; p = 0.007). However, in the group with enlarged lymph nodes, survival time was prolonged as a result of hepatectomy (MST 20.1 vs. 7.6 months; p < 0.01). The sensitivity of lymph node size and positron emission tomography-computed tomography findings for diagnosing LNM were 50.0 % (23/46) and 31.2 % (5/16), respectively, and were thus insufficient. Multivariate analysis identified the serum carcinoembryonic antigen (hazard ratio [HR] 1.830) and carbohydrate antigen 19-9 (HR 2.189) levels, blood transfusion (HR 1.792), intrahepatic metastasis (HR 1.988), and final stage (HR 8.684) as prognostic factors for overall survival, but lymph node enlargement was not identified as a prognostic factor. Preoperative evaluation of LNM proved to be difficult, and survival time in ICC patients with lymph node enlargement was prolonged as a result of hepatectomy. Thus, ICC patients with preoperative lymph node enlargement should not be prematurely deemed non-curative cases.	[Adachi, Tomohiko; Eguchi, Susumu; Beppu, Toru; Ueno, Shinichi; Shiraishi, Masayuki; Okuda, Koji; Yamashita, Yo-ichi; Kondo, Kazuhiro; Nanashima, Atsushi; Ohta, Masayuki; Takami, Yuko; Noritomi, Tomoaki; Kitahara, Kenji; Fujioka, Hikaru] Kyushu Study Grp Liver Surg, Omura, Nagasaki, Japan; [Adachi, Tomohiko; Eguchi, Susumu] Nagasaki Univ, Grad Sch Biomed Sci, Dept Surg, Nagasaki 852, Japan	Adachi, T (reprint author), Kyushu Study Grp Liver Surg, Omura, Nagasaki, Japan.	fujioka@nagasaki-mc.com					Grotenhuis BA, 2013, WORLD J SURG, V37, P147, DOI 10.1007/s00268-012-1804-9; Hyder O, 2013, SURGERY, V153, P811, DOI 10.1016/j.surg.2012.12.005; Adachi T, 2014, J HEPATO-BIL-PAN SCI, V21, P162, DOI 10.1002/jhbp.30; Ribero D, 2012, ARCH SURG-CHICAGO, V147, P1107, DOI 10.1001/archsurg.2012.1962; Endo I, 2008, ANN SURG, V248, P84, DOI 10.1097/SLA.0b013e318176c4d3; Pritchard KI, 2012, J CLIN ONCOL, V30, P1274, DOI 10.1200/JCO.2011.38.1103; Ikai I, 2004, HEPATOL RES, V28, P21, DOI 10.1016/j.hepres.2003.08.002; Ercolani G, 2010, ANN SURG, V252, P107, DOI 10.1097/SLA.0b013e3181e462e6; Knabe M, 2013, SURG ENDOSC, V27, P1196, DOI 10.1007/s00464-012-2575-y; Choi SB, 2009, ANN SURG ONCOL, V16, P3048, DOI 10.1245/s10434-009-0631-1; Shirabe K, 2010, ANN SURG ONCOL, V17, P1816, DOI 10.1245/s10434-010-0929-z; de Jong MC, 2011, J CLIN ONCOL, V29, P3140, DOI 10.1200/JCO.2011.35.6519; Bastiaannet E, 2009, J CLIN ONCOL, V27, P4774, DOI 10.1200/JCO.2008.20.1822; Kidd EA, 2010, J CLIN ONCOL, V28, P2108, DOI 10.1200/JCO.2009.25.4151; Chen YX, 2011, FRONT ONCOL, V42, P1; Grobmyer SR, 2006, ANN SURG, V244, P260, DOI 10.1097/01.sla.0000217606.59625.9d; Liver Cancer Study Group of Japan, 2010, GEN RUL CLIN PATH ST; Miwa S, 2006, J GASTROENTEROL, V41, P893, DOI 10.1007/s00535-006-1877-z; Nanashima A, 2010, DIGEST DIS SCI, V55, P3617, DOI 10.1007/s10620-010-1180-y; Noji T, 2008, BRIT J SURG, V95, P92, DOI 10.1002/bjs.5920; Sano T, 2008, ANN SURG ONCOL, V15, P590, DOI 10.1245/s10434-007-9687-y; Saxena A, 2010, J GASTROINTEST SURG, V14, P1128, DOI 10.1007/s11605-010-1203-1; Seo S, 2008, SURGERY, V143, P769, DOI 10.1016/j.surg.2008.01.010; Uchiyama K, 2011, J HEPATO-BIL-PAN SCI, V18, P443, DOI 10.1007/s00534-010-0349-2	24	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9265	1534-4681		ANN SURG ONCOL	Ann. Surg. Oncol.	JUL	2015	22	7					2269	2278		10.1245/s10434-014-4239-8		10	Oncology; Surgery	Oncology; Surgery	CJ8KF	WOS:000355748300023		
J	Yamashita, Y; Imai, D; Bekki, Y; Kimura, K; Matsumoto, Y; Nakagawara, H; Ikegami, T; Yoshizumi, T; Shirabe, K; Aishima, S; Maehara, Y				Yamashita, Yo-ichi; Imai, Daisuke; Bekki, Yuki; Kimura, Koichi; Matsumoto, Yoshiriro; Nakagawara, Hidekazu; Ikegami, Toru; Yoshizumi, Tomoharu; Shirabe, Ken; Aishima, Shinichi; Maehara, Yoshihiko			Surgical Outcomes of Hepatic Resection for Hepatitis B Virus Surface Antigen-Negative and Hepatitis C Virus Antibody-Negative Hepatocellular Carcinoma	ANNALS OF SURGICAL ONCOLOGY			English	Article							RISK-FACTORS; NONALCOHOLIC STEATOHEPATITIS; CLINICAL CHARACTERISTICS; LIVER-DISEASE; HEPATOCARCINOGENESIS; EXPERIENCE; MORTALITY; FEATURES; HEPATECTOMY; RECURRENCE	The incidence of hepatitis B virus surface antigen-negative and hepatitis C virus antibody-negative hepatocellular carcinoma (NBNC-HCC) is gradually increasing. A retrospective cohort study was performed in 694 patients who underwent curative hepatic resection for primary HCC from January 1990 to December 2011. In the NBNC-HCC group (n = 110), the complication rate of diabetic mellitus (38 %) was significantly higher than that of the B-HCC group (n = 110; 17 %), and their rate of alcohol abuse (38 %) was significantly higher than that of both the B-HCC (26 %) and C-HCC groups (n = 474; 22 %). In the NBNC-HCC group, the tumor diameter (4.5 +/- A 3.6 cm) was significantly larger than that of the C-HCC group (2.9 +/- A 1.8 cm), but the rate of histological cirrhosis (37 %) was significantly lower than those of both the B-HCC (67 %) and C-HCC (53 %) groups. There were no significant differences regarding overall and disease-free survival among the three groups. In the NBNC-HCC group, multiple intrahepatic or distant recurrences (25 %) were significantly higher than in the C-HCC group (17 %), and the rate of recurrence more than 2 years after hepatic resection (24 %) was significantly higher than that of the B-HCC group (12 %). The surgical outcomes of patients with NBNC-HCC were not significantly different compared with those of the patients with B-HCC or C-HCC. There was a substantial population with late recurrence among the patients with NBNC-HCC after curative hepatic resection, and thus not only long-term follow-up but also the early establishment of preventive methods for HCC recurrence from NBNC-hepatitis are necessary.	[Yamashita, Yo-ichi; Imai, Daisuke; Bekki, Yuki; Kimura, Koichi; Matsumoto, Yoshiriro; Nakagawara, Hidekazu; Ikegami, Toru; Yoshizumi, Tomoharu; Shirabe, Ken; Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 812, Japan; [Aishima, Shinichi] Saga Univ, Pathol & Microbiol, Saga 840, Japan	Yamashita, Y (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 812, Japan.	yamashi@surg2.med.kyushu-u.ac.jp			Ministry of Education, Science, and Culture in Japan [25462093]	This study was partly funded by a Grant-in-Aid (No. 25462093) from the Ministry of Education, Science, and Culture in Japan.	Toshikuni N, 2009, J GASTROEN HEPATOL, V24, P1276, DOI 10.1111/j.1440-1746.2009.05851.x; SAKAMOTO M, 1991, HUM PATHOL, V22, P172, DOI 10.1016/0046-8177(91)90039-R; Hassoun Z, 2003, CLIN GASTROENTEROL H, V1, P10, DOI 10.1053/jcgh.2003.50003; Bosetti C, 2008, HEPATOLOGY, V48, P137, DOI 10.1002/hep.22312; Welzel TM, 2013, AM J GASTROENTEROL, V108, P1314, DOI 10.1038/ajg.2013.160; Ohira H, 2013, J GASTROENTEROL, V48, P109, DOI 10.1007/s00535-012-0616-x; Kaibori M, 2012, AM J SURG, V204, P300, DOI 10.1016/j.amjsurg.2011.11.014; Taketomi A, 2007, J AM COLL SURGEONS, V204, P580, DOI 10.1016/j.jamcollsurg.2007.01.035; Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347; El-Serag HB, 2007, HEPATOL RES, V37, pS88, DOI 10.1111/j.1872-034X.2007.00168.x; Kaneda K, 2012, HEPATO-GASTROENTEROL, V59, P1889, DOI 10.5754/hge10778; Eun JR, 2010, J HEPATOL, V53, P118, DOI 10.1016/j.jhep.2010.02.026; Takaki A, 2013, INT J MOL SCI, V14, P20704, DOI 10.3390/ijms141020704; Sasaki Y, 2006, ANN SURG, V244, P771, DOI 10.1097/01.sla.0000225126.56483.b3; Yamashita Y, 2007, J AM COLL SURGEONS, V205, P19, DOI 10.1016/j.jamcollsurg.2007.01.069; Shimada M, 1998, BRIT J SURG, V85, P195; Clavien PA, 2009, ANN SURG, V250, P187, DOI 10.1097/SLA.0b013e3181b13ca2; Kawai D, 2012, HEPATOLOGY, V56, P912, DOI 10.1002/hep.25782; Kondo K, 2008, J GASTROINTEST SURG, V12, P468, DOI 10.1007/s11605-007-0402-x; Starley BQ, 2010, HEPATOLOGY, V51, P1820, DOI 10.1002/hep.23594; Yang JD, 2011, CLIN GASTROENTEROL H, V9, P617, DOI 10.1016/j.cgh.2011.03.027; Shirabe K, 2011, LIVER INT, V31, P1366, DOI 10.1111/j.1478-3231.2011.02572.x; MAKUUCHI M, 1987, SURG GYNECOL OBSTET, V164, P155; Kanwal F, 2011, GASTROENTEROLOGY, V140, P1182, DOI 10.1053/j.gastro.2010.12.032; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Moucari R, 2008, GUT, V57, P828, DOI 10.1136/gut.2007.139477; Caballeria L, 2001, AM J GASTROENTEROL, V96, P1160; Hatanaka K, 2007, INTERVIROLOGY, V50, P24, DOI 10.1159/000096309; KANEMATSU T, 1989, HEPATOLOGY, V10, P98, DOI 10.1002/hep.1840100119; Li T, 2013, CANCER-AM CANCER SOC, V119, P126, DOI 10.1002/cncr.27697; Noguchi K, 2000, INT J MOL MED, V6, P661; Shim J, 2005, J GASTROEN HEPATOL, V20, P746, DOI 10.1111/j.1400-1746.2005.03747.x; Stefanska J., 2008, MEDIAT INFLAMM, V2008, DOI [10.1155/2008/106507, DOI 10.1155/2008/106507]; Theise ND, 1996, LIVER, V16, P134; Yamashita Y, 2013, SURGERY, V154, P1038, DOI 10.1016/j.surg.2013.04.046	35	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9265	1534-4681		ANN SURG ONCOL	Ann. Surg. Oncol.	JUL	2015	22	7					2279	2285		10.1245/s10434-014-4261-x		7	Oncology; Surgery	Oncology; Surgery	CJ8KF	WOS:000355748300024		
J	Fujikawa, H; Sakamaki, K; Kawabe, T; Hayashi, T; Aoyama, T; Sato, T; Oshima, T; Rino, Y; Morita, S; Masuda, M; Ogata, T; Cho, H; Yoshikawa, T				Fujikawa, H.; Sakamaki, K.; Kawabe, T.; Hayashi, T.; Aoyama, T.; Sato, T.; Oshima, T.; Rino, Y.; Morita, S.; Masuda, M.; Ogata, T.; Cho, H.; Yoshikawa, T.			A New Statistical Model Identified Two-thirds of Clinical T1 Gastric Cancers as Possible Candidates for Endoscopic Treatment	ANNALS OF SURGICAL ONCOLOGY			English	Article							LYMPH-NODE METASTASIS; CARCINOMA; SURVIVAL	Clinical T1 gastric cancer has low metastatic potential to lymph nodes and is generally curable by local treatment. Endoscopic resection can preserve the whole stomach and does not impair the patient's quality of life; however, its indication is strictly limited to the subset of patients without nodal metastasis. The study was designed to predict reliably the patients without nodal metastasis based only on the clinical information. We examined patients with clinical T1 disease who were treated with surgery. The clinically available information was evaluated for its ability to predict nodal metastasis by logistic regression model. Then, the predictive ability of the logistic regression model using the risk factors for nodal metastasis was evaluated by a receiver operating characteristic curve. A total of 511 patients were entered into this study. The clinical depth (cT1a or cT1b), maximal tumor diameter, and pathological type were confirmed to be significantly different between patients with and without nodal metastasis. The cutoff value of the tumor diameter differed depending on the histology and clinical depth: 79 mm for differentiated type and 48 mm for undifferentiated type in cT1a tumors, and 43 mm for differentiated type and 11 mm for undifferentiated type in cT1b tumors. According to these criteria, 348 of the 511 patients (68.1 %) were classified to have predictive N0 status. The negative predictive value was 95.7 % (95 % confidence interval 94.0-97.5 %). The predictive criteria based on the multivariate logistic model identified that almost two-thirds of the patients with clinical T1 gastric cancer were possible candidates for endoscopic treatment.	[Fujikawa, H.; Kawabe, T.; Hayashi, T.; Aoyama, T.; Sato, T.; Ogata, T.; Cho, H.; Yoshikawa, T.] Kanagawa Canc Ctr KCCH, Dept Gastrointestinal Surg, Yokohama, Kanagawa, Japan; [Fujikawa, H.; Oshima, T.; Rino, Y.; Masuda, M.; Yoshikawa, T.] Yokohama City Univ, Dept Surg, Yokohama, Kanagawa 232, Japan; [Sakamaki, K.] Yokohama City Univ, Dept Biostat & Epidemiol, Grad Sch Med, Yokohama, Kanagawa 232, Japan; [Morita, S.] Kyoto Univ, Grad Sch Med, Dept Biomed Stat & Bioinformat, Kyoto, Japan	Fujikawa, H (reprint author), Kanagawa Canc Ctr KCCH, Dept Gastrointestinal Surg, Yokohama, Kanagawa, Japan.	yoshikawat@kcch.jp					Parkin DM, 2001, EUR J CANCER, V37, pS4; Hirasawa T, 2009, GASTRIC CANCER, V12, P148, DOI 10.1007/s10120-009-0515-x; Kitagawa Y, 2013, J CLIN ONCOL, V31, P3704, DOI 10.1200/JCO.2013.50.3789; Seto Y, 1997, WORLD J SURG, V21, P186; Kikuchi S, 2004, LANGENBECK ARCH SURG, V389, P69, DOI 10.1007/s00423-004-0462-2; Roviello F, 2006, J SURG ONCOL, V94, P275, DOI 10.1002/jso.20566; Gotoda T, 2006, J GASTROENTEROL, V41, P929, DOI 10.1007/s00535-006-1954-3; FOLLI S, 1995, BRIT J SURG, V82, P952, DOI 10.1002/bjs.1800820732; Nakamura K, 1999, CANCER, V85, P1500, DOI 10.1002/(SICI)1097-0142(19990401)85:7<1500::AID-CNCR10>3.0.CO;2-8; Fujikawa H, 2014, ANN SURG ONCOL, V21, P3002, DOI 10.1245/s10434-014-3667-9; Gotoda T, 2000, GASTRIC CANCER, V3, P219, DOI 10.1007/PL00011720; Hayashi K, 2006, GASTRIC CANC, V9, P51; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P113, DOI 10.1007/s10120-011-0042-4; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Katai H, 2000, CANCER, V88, P1796, DOI 10.1002/(SICI)1097-0142(20000415)88:8<1796::AID-CNCR6>3.0.CO;2-2; Nomura K, 2005, CANC STAT JAPAN 2005; Santoro R, 2007, BRIT J SURG, V94, P737, DOI 10.1002/bjs.5600; Yin Jin Xuan, 2009, Nihon Shokakibyo Gakkai Zasshi, V106, P1603	18	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9265	1534-4681		ANN SURG ONCOL	Ann. Surg. Oncol.	JUL	2015	22	7					2317	2322		10.1245/s10434-015-4474-7		6	Oncology; Surgery	Oncology; Surgery	CJ8KF	WOS:000355748300029		
J	Nakagawa, M; Inokuchi, M; Takagi, Y; Kato, K; Sugita, H; Otsuki, S; Kojima, K; Uetake, H; Sugihara, K				Nakagawa, Masatoshi; Inokuchi, Mikito; Takagi, Yoko; Kato, Keiji; Sugita, Hirofumi; Otsuki, Sho; Kojima, Kazuyuki; Uetake, Hiroyuki; Sugihara, Kenichi			Erythropoietin-Producing Hepatocellular A1 is an Independent Prognostic Factor for Gastric Cancer	ANNALS OF SURGICAL ONCOLOGY			English	Article							RECEPTOR TYROSINE KINASE; BREAST-CARCINOMA CELLS; COLORECTAL-CANCER; EPH RECEPTORS; EXPRESSION; METASTASIS; OVEREXPRESSION; IDENTIFICATION; INVASIVENESS; ANGIOGENESIS	Erythropoietin-producing hepatocellular (Eph) receptors are the largest subfamily of receptor tyrosine kinases that have been investigated as a possible target for molecular targeted therapy of various cancers. Patients (n = 222) who underwent gastrectomy for primary gastric cancer were enrolled in this study. Tumor protein expression of EphA1 and EphB6 in surgically resected specimen was investigated using immunohistochemistry. The associations between expression of EphA1 and EphB6 and clinicopathological factors and prognosis were analyzed. High expression of EphA1 was associated with undifferentiated histology (P = 0.002), depth of tumor (P < 0.001), lymph node metastasis (P = 0.001), venous invasion (P = 0.015), stage (P = 0.001), and remote metastasis or recurrence (P < 0.001). In univariate analysis, patients with high expression of EphA1 had significantly poorer overall survival and relapse-free survival compared with patients with low EphA1 expression. The expression level of EphB6 was not associated with any clinicopathological factors and patient survival. Multivariate analysis indicated that depth of tumor [hazard ratio (HR) 9.26, 95 % confidence interval (CI) 0.03-0.46, P = 0.003], lymph node metastasis (HR 9.26, 95 % CI 0.07-0.39, P < 0.001), and high expression of EphA1 (HR 1.86, 95 % CI 0.29-0.99, P = 0.048) are independent prognostic factors for relapse-free survival. EphA1 is a possible target of molecular targeted therapy of gastric cancer.	[Nakagawa, Masatoshi; Inokuchi, Mikito; Kato, Keiji; Sugita, Hirofumi; Otsuki, Sho; Sugihara, Kenichi] Tokyo Med & Dent Univ, Dept Surg Oncol, Grad Sch, Bunkyo Ku, Tokyo, Japan; [Kojima, Kazuyuki] Tokyo Med & Dent Univ, Ctr Minimally Invas Surg, Bunkyo Ku, Tokyo, Japan; [Takagi, Yoko; Uetake, Hiroyuki] Tokyo Med & Dent Univ, Grad Sch, Dept Translat Oncol, Bunkyo Ku, Tokyo, Japan	Nakagawa, M (reprint author), Tokyo Med & Dent Univ, Dept Surg Oncol, Grad Sch, Bunkyo Ku, Tokyo, Japan.	mnaksrg2@tmd.ac.jp					Park DI, 2006, DIGEST DIS SCI, V51, P1371, DOI 10.1007/s10620-005-9057-1; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74; Gravalos C, 2008, ANN ONCOL, V19, P1523, DOI 10.1093/annonc/mdn169; [Anonymous], 2010, MAGN FRING FIELDS; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Tang XX, 1999, CLIN CANCER RES, V5, P1491; Steinberg M, 2007, CLIN THER, V29, P2289, DOI 10.1016/j.clinthera.2007.11.005; Tredan O, 2015, TARGET ONCOL, V10, P189, DOI 10.1007/s11523-014-0334-9; Noberini R, 2008, J BIOL CHEM, V283, P29461, DOI 10.1074/jbc.M804103200; Gerety SS, 2002, DEVELOPMENT, V129, P1397; Ogawa K, 2000, ONCOGENE, V19, P6043, DOI 10.1038/sj.onc.1204004; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Cappuzzo F, 2005, J NATL CANCER I, V97, P643, DOI 10.1093/jnci/dji112; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Chen G, 2010, ONCOL REP, V23, P563, DOI 10.3892/or_00000670; Dong YC, 2009, MODERN PATHOL, V22, P151, DOI 10.1038/modpathol.2008.188; Flanagan JG, 1997, CELL, V90, P403; Fox BP, 2009, ONCOGENE, V28, P1706, DOI 10.1038/onc.2009.18; Fox BP, 2004, BIOCHEM BIOPH RES CO, V318, P882, DOI 10.1016/j.bbrc.2004.04.102; Hafner C, 2003, INT J ONCOL, V23, P1553; Inazawa J, 2004, CANCER SCI, V95, P559, DOI 10.1111/j.1349-7006.2004.tb02486.x; Kataoka H, 2004, CANCER SCI, V95, P136, DOI 10.1111/j.1349-7006.2004.tb03194.x; Kikuchi S, 2014, GASTRIC CANCER, DOI [10.1007/s10120-014-0390-y, DOI 10.1007/S10120-014-0390-Y]; Lai KO, 2004, J BIOL CHEM, V279, P13383, DOI 10.1074/jbc.M313356200; Martinez A, 2005, BRAIN RES REV, V49, P211, DOI 10.1016/j.brainresrev.2005.02.001; Miyazaki Kohji, 2013, BMC Clin Pathol, V13, P19, DOI 10.1186/1472-6890-13-19; Oshima T, 2008, INT J ONCOL, V33, P573, DOI 10.3892/ijo_00000042; Peng LB, 2013, INT J CLIN EXP PATHO, V6, P1854; Sugimura Haruhiko, 2010, World J Gastrointest Oncol, V2, P421, DOI 10.4251/wjgo.v2.i12.421; Wang JD, 2007, HUM PATHOL, V38, P1649, DOI 10.1016/j.humpath.2007.01.030; Wang JD, 2013, APMIS, V121, P30, DOI 10.1111/j.1600-0463.2012.02941.x; Yu GZ, 2011, J CANCER RES CLIN, V137, P73, DOI 10.1007/s00432-010-0861-4; Yuan WJ, 2009, DIGEST DIS SCI, V54, P2410, DOI 10.1007/s10620-008-0649-4; Zhang J, 2006, J PATHOL, V208, P453, DOI 10.1002/path.1937	34	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9265	1534-4681		ANN SURG ONCOL	Ann. Surg. Oncol.	JUL	2015	22	7					2329	2335		10.1245/s10434-014-4231-3		7	Oncology; Surgery	Oncology; Surgery	CJ8KF	WOS:000355748300031		
J	Kitayama, J; Emoto, S; Yamaguchi, H; Ishigami, H; Onoyama, H; Yamashita, H; Seto, Y; Matsuzaki, K; Watanabe, T				Kitayama, Joji; Emoto, Shigenobu; Yamaguchi, Hironori; Ishigami, Hironori; Onoyama, Haruna; Yamashita, Hiroharu; Seto, Yasuyuki; Matsuzaki, Keisuke; Watanabe, Toshiaki			Flow Cytometric Quantification of Intraperitoneal Free Tumor Cells is a Useful Biomarker in Gastric Cancer Patients with Peritoneal Metastasis	ANNALS OF SURGICAL ONCOLOGY			English	Article							PROGNOSTIC VALUE; MALIGNANT ASCITES; PANCREATIC-CANCER; CHAIN-REACTION; CYTOLOGY; CARCINOMA; GASTRECTOMY; WASHINGS; LAVAGE; S-1	The frequency of intraperitoneal free tumor cells (IPTC) is considered to reflect the severity of peritoneal metastasis (PM). We quantified the relative number of IPTC against leukocytes in peritoneal fluid and evaluated its clinical relevance in gastric cancer (GC) patients, particularly those with PM. Cells recovered from ascites or peritoneal lavage fluid were immunostained with monoclonal antibodies (mAb) to CD45 and CD326 (EpCAM). Using flow cytometry (FACS), CD326(+) and CD45(+) cells were classified as either tumor cells (T) or leukocytes (L) and the T/L ratio (TLR) was calculated in a total of 506 samples obtained from 300 patients with GC and 33 patients with liver cirrhosis (LC). Median (M) of the TLR of the initial samples obtained from 199 patients with PM(+) GC was 1.32 % (0-1,868.44 %), which was significantly higher than that in patients with PM(-) GC (M = 0 %, 0-0.35 %; n = 101) or LC (M = 0 %, 0-0.031 %; n = 33). In 104 PM(+) patients who received combination chemotherapy including intraperitoneal paclitaxel, the TLR was repeatedly measured in peritoneal fluid obtained from the port. In these patients, the TLR showed a strong correlation with clinical features as well as cytological findings and carcinoembryonic antigen messenger RNA status. Finally, the median survival time of the 11 patients with initial TLR > 10 % was significantly shorter than that of the 52 patients with TLR < 10 % (271 vs. 627 days; p = 0.0002). The TLR excellently reflected tumor burden in the peritoneal cavity, and could be a reliable biomarker to determine the outcome, as well as the effectiveness, of chemotherapy in patients with PM(+) GC.	[Kitayama, Joji; Emoto, Shigenobu; Yamaguchi, Hironori; Ishigami, Hironori; Watanabe, Toshiaki] Univ Tokyo, Dept Surg Oncol, Bunkyo Ku, Tokyo, Japan; [Onoyama, Haruna; Yamashita, Hiroharu; Seto, Yasuyuki] Univ Tokyo, Dept Gastrointestinal Surg, Bunkyo Ku, Tokyo, Japan; [Matsuzaki, Keisuke] Kanamecho Hosp, Tokyo, Japan	Kitayama, J (reprint author), Univ Tokyo, Dept Surg Oncol, Bunkyo Ku, Tokyo, Japan.	kitayama-1su@h.u-tokyo.ac.jp			Ministry of Health, Labor and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan; Public Trust Surgery Research Fund, Tokyo, Japan	We thank Ms. Chieko Uchikawa, Ikuko Nieda, and Yu Saito for their excellent technical and clerical support. This study was financially supported by the Ministry of Health, Labor and Welfare of Japan. This work was funded by the Ministry of Education, Culture, Sports, Science and Technology of Japan, and the Ministry of Health, Labor and Welfare of Japan, and by a Grant-in-aid of the Public Trust Surgery Research Fund, Tokyo, Japan.	Bonenkamp JJ, 1996, BRIT J SURG, V83, P672, DOI 10.1002/bjs.1800830526; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Vogel P, 1999, EUR J SURG ONCOL, V25, P515, DOI 10.1053/ejso.1999.0688; Patriarca C, 2012, CANCER TREAT REV, V38, P68, DOI 10.1016/j.ctrv.2011.04.002; Heiss MM, 2010, INT J CANCER, V127, P2209, DOI 10.1002/ijc.25423; Katsuragi K, 2007, BRIT J CANCER, V97, P550, DOI 10.1038/sj.bjc.6603909; ZISELMAN EM, 1984, ACTA CYTOL, V28, P105; Miyashiro I, 2005, WORLD J SURG, V29, P1131, DOI 10.1007/s00268-005-7703-6; Ishigami H, 2010, ANN ONCOL, V21, P67, DOI 10.1093/annonc/mdp260; Kitayama J, 2014, CYTOM PART B-CLIN CY, V86, P56, DOI 10.1002/cyto.b.21126; Bando E, 1999, AM J SURG, V178, P256, DOI 10.1016/S0002-9610(99)00162-2; Yamaguchi H, 2013, CANCER-AM CANCER SOC, V119, P3354, DOI 10.1002/cncr.28204; NAKAMURA K, 1992, CANCER, V70, P1030, DOI 10.1002/1097-0142(19920901)70:5<1030::AID-CNCR2820700504>3.0.CO;2-C; Went PT, 2004, HUM PATHOL, V35, P122, DOI 10.1016/S0046-8177(03)00502-1; Benevolo M, 1998, J CLIN ONCOL, V16, P3406; Hayes N, 1999, BRIT J CANCER, V79, P520, DOI 10.1038/sj.bjc.6690081; Kitayama J, 2014, ANN SURG ONCOL, V21, P539, DOI 10.1245/s10434-013-3208-y; Burges A, 2007, CLIN CANCER RES, V13, P3899, DOI 10.1158/1078-0432.CCR-06-2769; Lorenzen S, 2010, ANN SURG ONCOL, V17, P2733, DOI 10.1245/s10434-010-1090-4; Baeuerle PA, 2007, BRIT J CANCER, V96, P417, DOI 10.1038/sj.bjc.6603494; Isobe Y, 2011, GASTRIC CANCER, V14, P301, DOI 10.1007/s10120-011-0085-6; Dalal K, 2008, GASTRIC CANCER, V11, P206, DOI 10.1007/s10120-008-0483-6; Del Monte SR, 2012, J SURG ONCOL, V106, P17, DOI 10.1002/jso.23052; Horattas MC, 1997, AM J SURG, V174, P334, DOI 10.1016/S0002-9610(97)00111-6; Horattas MC, 1997, AM J SURG, V174, P337; IITSUKA Y, 1990, ACTA CYTOL, V34, P437; Kodera Y, 2002, ANN SURG, V235, P499, DOI 10.1097/00000658-200204000-00007; KOGA S, 1984, J CANCER RES CLIN, V108, P236, DOI 10.1007/BF00402474; Konishi M, 2002, ARCH SURG-CHICAGO, V137, P475, DOI 10.1001/archsurg.137.4.475; Kowalewska M, 2008, BRIT J CANCER, V98, P512, DOI 10.1038/sj.bjc.6604189; Leake PA, 2012, GASTRIC CANCER, V15, pS27, DOI 10.1007/s10120-011-0071-z; Sodek KL, 2012, CANCER METAST REV, V31, P397, DOI 10.1007/s10555-012-9351-2; Vogel P, 2000, DIS COLON RECTUM, V43, P92, DOI 10.1007/BF02237250; Warshaw AL, 1991, AM J SURG, V161, P29; WARSHAW AL, 1991, AM J SURG, V161, P26, DOI 10.1016/0002-9610(91)90356-I	35	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9265	1534-4681		ANN SURG ONCOL	Ann. Surg. Oncol.	JUL	2015	22	7					2336	2342		10.1245/s10434-014-4238-9		7	Oncology; Surgery	Oncology; Surgery	CJ8KF	WOS:000355748300032		
J	Shigematsu, H; Taguchi, K; Koui, H; Ohno, S				Shigematsu, Hideo; Taguchi, Kenichi; Koui, Hiroko; Ohno, Shinji			Clinical Significance of Extracapsular Invasion at Sentinel Lymph Nodes in Breast Cancer Patients with Sentinel Lymph Node Involvement	ANNALS OF SURGICAL ONCOLOGY			English	Article							COMPARING RADICAL-MASTECTOMY; AMERICAN SOCIETY; TRIAL; METASTASIS; DISSECTION; EXTENSION; PREDICTOR; PROGNOSIS; BIOPSY; NOMOGRAM	A certain number of patients have extracapsular invasion (ECI) at the sentinel lymph node (SLN), but only a few reports describe its clinical significance. This study aimed to determine the clinical significance of ECI at SLN in breast cancer patients with involved SLN. This study evaluated ECI at SLN in 131 consecutive SLN-positive patients who underwent axillary lymph node dissection between 2003 and 2008 at the National Kyushu Cancer Center with regard to their long-term prognosis and non-SLN metastasis. Of the 131 patients, 46 (35 %) tested positive for ECI at SLN. Of these 46 patients, 61 % (28/46) had non-SLN metastasis compared with 28 % (24/85) in ECI-negative group (chi (2) test; P < 0.001). Multivariate analysis showed that ECI at SLN is significantly predictive for non-SLN metastasis [hazard ratio (HR) 3.2; 95 % confidence interval (CI) 1.4-7.1; P = 0.005]. The 5-year recurrence-free survival (RFS) rates were 71.3 % in the ECI-positive group and 89.9 %in the ECI-negative group (P = 0.001, log-rank test). Cox-regression analysis showed that ECI at SLN independently predicts lower RFS (HR 4.5; 95 % CI 1.8-11.7; P = 0.002). The findings show that ECI at SLN is an independent predictor of both non-SLN metastasis and poor prognosis for breast cancer patients with involved SLN. The clinical significance of ECI at SLN in operable-stage breast cancer warrants further study.	[Shigematsu, Hideo] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Surg Oncol, Hiroshima, Japan; [Taguchi, Kenichi] Kyushu Natl Canc Ctr, Dept Pathol, Fukuoka, Japan; [Koui, Hiroko; Ohno, Shinji] Kyushu Natl Canc Ctr, Dept Breast Oncol, Fukuoka, Japan	Shigematsu, H (reprint author), Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Surg Oncol, Hiroshima, Japan.	shigematu1330@yahoo.co.jp					Chen AY, 2008, J NATL CANCER I, V100, P462, DOI 10.1093/jnci/djn057; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Mittendorf EA, 2012, ANN SURG, V255, P109, DOI 10.1097/SLA.0b013e318238f461; Weaver DL, 2011, NEW ENGL J MED, V364, P412, DOI 10.1056/NEJMoa1008108; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Lucci A, 2007, J CLIN ONCOL, V25, P3657, DOI 10.1200/JCO.2006.07.4062; Kadoya T, 2013, BREAST CANCER RES TR, V141, P269, DOI 10.1007/s10549-013-2687-7; Singletary SE, 2002, J CLIN ONCOL, V20, P3628, DOI 10.1200/JCO.2002.02.026; Krag DN, 2010, LANCET ONCOL, V11, P927, DOI 10.1016/S1470-2045(10)70207-2; Werkoff G, 2009, J CLIN ONCOL, V27, P5707, DOI 10.1200/JCO.2009.21.9139; FISHER B, 1985, NEW ENGL J MED, V312, P674, DOI 10.1056/NEJM198503143121102; Fisher B, 2002, NEW ENGL J MED, V347, P567, DOI 10.1056/NEJMoa020128; Kapoor NS, 2012, ARCH SURG-CHICAGO, V147, P1047, DOI 10.1001/archsurg.2012.1563; Giuliano AE, 2011, JAMA-J AM MED ASSOC, V305, P569, DOI 10.1001/jama.2011.90; Ohara M, 2013, BREAST, V22, P958, DOI 10.1016/j.breast.2013.05.003; Colzani E, 2011, J CLIN ONCOL, V29, P4014, DOI 10.1200/JCO.2010.32.6462; Degnim AC, 2005, AM J SURG, V190, P543, DOI 10.1016/j.amjsurg.2005.06.008; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Luporsi E, 2012, BREAST CANCER RES TR, V132, P895, DOI 10.1007/s10549-011-1837-z; Lyman GH, 2014, J CLIN ONCOL, V32, P1365, DOI 10.1200/JCO.2013.54.1177; Simon RM, 2009, J NATL CANCER I, V101, P1446, DOI 10.1093/jnci/djp335; DONEGAN WL, 1993, CANCER, V72, P778, DOI 10.1002/1097-0142(19930801)72:3<778::AID-CNCR2820720324>3.0.CO;2-J; Fujii T, 2010, WORLD J SURG, V34, P544, DOI 10.1007/s00268-009-0389-4; Gooch J, 2014, ANN SURG ONCOL, V21, P2897, DOI 10.1245/s10434-014-3752-0; Heneghan HM, 2009, BMC SURG, V9, DOI 10.1186/1471-2482-9-15; Hetelekidis S, 2000, INT J RADIAT ONCOL, V46, P31, DOI 10.1016/S0360-3016(99)00424-1; Ilknur GB, 2004, TUMORI, V90, P107; Sanghani M, 2009, CANCER, V115, P1613, DOI 10.1002/cncr.24174; Sargent DJ, 2005, J CLIN ONCOL, V23, P2020, DOI 10.1200/JCO.2005.01.112; Stitzenberg KB, 2003, ANN SURG, V237, P612; Stitzenberg KB, 2003, ANN SURG, V237, P607, DOI 10.1097/00000658-200305000-00002; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van la Parra RFD, 2014, WORLD J SURG, V38, P1070, DOI 10.1007/s00268-013-2387-9; Yajima R, 2014, ANN SURG ONCOL	34	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9265	1534-4681		ANN SURG ONCOL	Ann. Surg. Oncol.	JUL	2015	22	7					2365	2371		10.1245/s10434-014-4269-2		7	Oncology; Surgery	Oncology; Surgery	CJ8KF	WOS:000355748300037		
J	Matsumoto, I; Tanaka, M; Shirakawa, S; Shinzeki, M; Toyama, H; Asari, S; Goto, T; Yamashita, H; Ishida, J; Ajiki, T; Fukumoto, T; Shimokawa, M; Ku, YS				Matsumoto, Ippei; Tanaka, Masaki; Shirakawa, Sachiyo; Shinzeki, Makoto; Toyama, Hirochika; Asari, Sadaki; Goto, Tadahiro; Yamashita, Hironori; Ishida, Jun; Ajiki, Tetsuo; Fukumoto, Takumi; Shimokawa, Mototsugu; Ku, Yonson			Postoperative Serum Albumin Level is a Marker of Incomplete Adjuvant Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma	ANNALS OF SURGICAL ONCOLOGY			English	Article							RANDOMIZED CONTROLLED-TRIAL; INTERNATIONAL STUDY-GROUP; BREAST-CANCER; SURGERY; GEMCITABINE; SURVIVAL; NUTRITION; RESECTION; PANCREATICODUODENECTOMY; COMPLETION	Adjuvant chemotherapy (AC) is recommended as a standard treatment after curative resection in patients with pancreatic adenocarcinoma (PA). Although patients who failed to complete AC had significantly worse survival compared with those who completed AC for cancers in various organs, the effects of complete AC on survival in patients with PA have not been investigated. The purpose of this study was to clarify the impact of complete AC on PA patient survival and to identify independent risk factors for incomplete AC. Medical records of 236 consecutive PA patients who planned to undergo surgical resection with curative intent between January 2000 and September 2012 at Kobe University Hospital were retrospectively reviewed. Of these, the complete AC (n = 75) and the incomplete AC (n = 30) groups due to adverse events were compared. Patient survival was significantly better in the complete AC group than in the incomplete AC group (median survival time 48.9 vs. 17.9 months; 5-year survival rate 42.7 vs. 17.1 %; p < 0.0001). Preoperative white blood cell count and postoperative serum albumin level were identified as independent risk factors for incomplete AC. By receiver operating characteristic curve analysis, the cutoff value of postoperative serum albumin level was 3.1 mg/dL. PA patients who completed AC had significantly better survival than those who failed to complete AC. Postoperative serum albumin level is a marker for failure to complete AC. Further prospective studies are needed to determine whether perioperative nutritional intervention could increase AC completion rate and improve prognosis in PA patients.	[Matsumoto, Ippei; Tanaka, Masaki; Shirakawa, Sachiyo; Shinzeki, Makoto; Toyama, Hirochika; Asari, Sadaki; Goto, Tadahiro; Yamashita, Hironori; Ishida, Jun; Ajiki, Tetsuo; Fukumoto, Takumi; Ku, Yonson] Kobe Univ, Grad Sch Med, Div Hepatobiliary Pancreat Surg, Dept Surg, Kobe, Hyogo 657, Japan; [Matsumoto, Ippei] Kinki Univ, Fac Med, Dept Surg, Osaka, Japan; [Shimokawa, Mototsugu] Kyushu Natl Canc Ctr, Canc Biostat Lab, Clin Res Inst, Fukuoka, Japan	Matsumoto, I (reprint author), Kobe Univ, Grad Sch Med, Div Hepatobiliary Pancreat Surg, Dept Surg, Kobe, Hyogo 657, Japan.	ippeimm@gmail.com					Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Don BR, 2004, SEMIN DIALYSIS, V17, P432, DOI 10.1111/j.0894-0959.2004.17603.x; Oettle H, 2013, JAMA-J AM MED ASSOC, V310, P1473, DOI 10.1001/jama.2013.279201; Morris M, 2007, BRIT J CANCER, V96, P701, DOI 10.1038/sj.bjc.6603627; Aoyama T, 2013, ANN SURG ONCOL, V20, P2000, DOI 10.1245/s10434-012-2776-6; Bassi C, 2005, SURGERY, V138, P8, DOI 10.1016/j.surg.2005.05.001; Jamieson NB, 2011, ANN SURG ONCOL, V18, P2318, DOI 10.1245/s10434-011-1560-3; Ueno H, 2009, BRIT J CANCER, V101, P908, DOI 10.1038/sj.bjc.6605256; Englesbe MJ, 2010, J AM COLL SURGEONS, V211, P271, DOI 10.1016/j.jamcollsurg.2010.03.039; Yang H, 2009, ANN NY ACAD SCI, V1165, P338, DOI 10.1111/j.1749-6632.2009.04026.x; Lassen K, 2012, CLIN NUTR, V31, P817, DOI 10.1016/j.clnu.2012.08.011; Neoptolemos JP, 2010, JAMA-J AM MED ASSOC, V304, P1073, DOI 10.1001/jama.2010.1275; ROTHSCHILD MA, 1988, HEPATOLOGY, V8, P385, DOI 10.1002/hep.1840080234; Neoptolemos JP, 2004, NEW ENGL J MED, V350, P1200, DOI 10.1056/NEJMoa032295; Oettle H, 2007, JAMA-J AM MED ASSOC, V297, P267, DOI 10.1001/jama.297.3.267; Wente MN, 2007, SURGERY, V142, P761, DOI 10.1016/j.surg.2007.05.005; Makary MA, 2010, J AM COLL SURGEONS, V210, P901, DOI 10.1016/j.jamcollsurg.2010.01.028; Park JS, 2012, J KOREAN MED SCI, V27, P261, DOI 10.3346/jkms.2012.27.3.261; Lohrisch C, 2006, J CLIN ONCOL, V24, P4888, DOI 10.1200/JCO.2005.01.6089; Baradi H, 2004, J GASTROINTEST SURG, V8, P428, DOI 10.1016/j.gassur.2004.01.007; Dobrila-Dintinjana R, 2012, HEPATO-GASTROENTEROL, V60, P475; Fairfield KM, 2011, J CLIN ONCOL, V29, P3921, DOI 10.1200/JCO.2010.34.1552; La Torre M, 2012, ANN SURG ONCOL, V19, P2917, DOI 10.1245/s10434-012-2348-9; Nurgalieva ZZ, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0419-1; Sobin LH, 2010, TNM CLASSIFICATION M	25	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9265	1534-4681		ANN SURG ONCOL	Ann. Surg. Oncol.	JUL	2015	22	7					2408	2415		10.1245/s10434-014-4280-7		8	Oncology; Surgery	Oncology; Surgery	CJ8KF	WOS:000355748300043		
J	Hachiya, A; Ode, H; Matsuda, M; Kito, Y; Shigemi, U; Matsuoka, K; Imamura, J; Yokomaku, Y; Iwatani, Y; Sugiura, W				Hachiya, Atsuko; Ode, Hirotaka; Matsuda, Masakazu; Kito, Yumiko; Shigemi, Urara; Matsuoka, Kazuhiro; Imamura, Junji; Yokomaku, Yoshiyuki; Iwatani, Yasumasa; Sugiura, Wataru			Natural polymorphism S119R of HIV-1 integrase enhances primary INSTI resistance	ANTIVIRAL RESEARCH			English	Article						HIV-1; Integrase strand transfer inhibitor; Drug resistance; Polymorphism; Deep sequencing	ANTIRETROVIRAL-NAIVE ADULTS; ONCE-DAILY DOLUTEGRAVIR; DRUG-RESISTANCE; WILD-TYPE; INFECTION; INHIBITORS; S/GSK1349572; ELVITEGRAVIR; REPLICATION; RALTEGRAVIR	Integrase strand transfer inhibitors (INSTIs), which block proviral DNA integration into the host chromosome, are clinically effective against HIV-1 isolates exhibiting resistance to other classes of antiretroviral agents. Although naturally occurring amino acid variation has been less frequently observed in the integrase region, the functional constraints of this variation on primary INSTI resistance-associated mutations are not fully understood. In the present study, we focused on the S119G/R/P/T (S119X) polymorphisms, which are frequently observed in HIV-1 sequences derived from clinical specimens (naive, n = 458, 26%). The frequency of the S119X polymorphism together with Q148H/R (n = 8, 63%) or N155H (n = 12, 83%) was relatively high compared with that of naive group. Our in vitro assays revealed that S119G/P/T alone exerted no effect on the susceptibility to INSTIs, whereas S119R enhanced the level of INSTI resistance induced by well-known INSTI resistance-associated mutations (Y143C, Q148H or N155H). Notably, the S119R polymorphism contributed to a significant (5.9-fold) increase in dolutegravir resistance caused by G140S/Q148H. Analysis of two cases of virological failure during raltegravir-based therapy showed that the accumulation and the rapid evolution of primary INSTI resistance-associated mutations coincided with the S119R mutation. These data highlight the role of the S119X polymorphism in INSTI resistance, and this polymorphism might be linked to the potential treatment outcome with INSTI-based therapy. (C) 2015 Elsevier B.V. All rights reserved.	[Hachiya, Atsuko; Ode, Hirotaka; Matsuda, Masakazu; Kito, Yumiko; Shigemi, Urara; Matsuoka, Kazuhiro; Imamura, Junji; Yokomaku, Yoshiyuki; Iwatani, Yasumasa; Sugiura, Wataru] Natl Hosp Org Nagoya Med Ctr, Clin Res Ctr, Dept Infect Dis & Immunol, Nagoya, Aichi 4600001, Japan; [Iwatani, Yasumasa; Sugiura, Wataru] Nagoya Univ, Grad Sch Med, Dept AIDS Res, Nagoya, Aichi 4600001, Japan	Hachiya, A (reprint author), Natl Hosp Org Nagoya Med Ctr, Clin Res Ctr, Naka Ku, 4-1-1 San No Maru, Nagoya, Aichi 4600001, Japan.	hachiya@nnh.hosp.go.jp	Matsuoka, Kazuhiro/N-8419-2015		Ministry of Health, Labor and Welfare	This work was supported by a grant for the promotion of AIDS research from the Ministry of Health, Labor and Welfare (Y.Y., Y.I. and W.S.). We thank Dr. Eiichi Kodama for his generous gift of the plasmids used in this study, Ms. Reiko Okazaki and Masumi Hosaka for the sample preparation and the CARES staff for their dedicated assistance. We are indebted to the AIDS Research Reference and Reagent Program, NIAID, and NIH for the TZM-bl cells.	Shimura K, 2008, J VIROL, V82, P764, DOI 10.1128/JVI.01534-07; Hightower KE, 2011, ANTIMICROB AGENTS CH, V55, P4552, DOI 10.1128/AAC.00157-11; Raffi F, 2013, LANCET, V381, P735, DOI 10.1016/S0140-6736(12)61853-4; Maertens GN, 2010, NATURE, V468, P326, DOI 10.1038/nature09517; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Clotet B, 2014, LANCET, V383, P2222, DOI 10.1016/S0140-6736(14)60084-2; Brockman MA, 2012, J VIROL, V86, P6913, DOI 10.1128/JVI.07133-11; Hazuda DJ, 2000, SCIENCE, V287, P646, DOI 10.1126/science.287.5453.646; Kobayashi M, 2011, ANTIMICROB AGENTS CH, V55, P813, DOI 10.1128/AAC.01209-10; Yang X, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-475; Rhee SY, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-74; Harper AL, 2001, J VIROL, V75, P7756, DOI 10.1128/JVI.75.16.7756-7762.2001; Li XA, 2011, VIROLOGY, V411, P194, DOI 10.1016/j.virol.2010.12.008; Walmsley SL, 2013, NEW ENGL J MED, V369, P1807, DOI 10.1056/NEJMoa1215541; Hare S, 2010, P NATL ACAD SCI USA, V107, P20057, DOI 10.1073/pnas.1010246107; Menendez-Arias L, 2013, ANTIVIR RES, V98, P93, DOI 10.1016/j.antiviral.2013.01.007; Ceccherini-Silberstein F, 2010, J ANTIMICROB CHEMOTH, V65, P2305, DOI 10.1093/jac/dkq326; Demeulemeester J, 2014, CELL HOST MICROBE, V16, P651, DOI 10.1016/j.chom.2014.09.016; Hachiya A, 2013, ANTIMICROB AGENTS CH, V57, P4554, DOI 10.1128/AAC.00283-13; Messiaen P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052562; Ode H, 2014, ANTIVIR THER, V19, pA80; Vavro C, 2013, ANTIMICROB AGENTS CH, V57, P1379, DOI 10.1128/AAC.01791-12; Wensing Annemarie M, 2014, Top Antivir Med, V22, P642	23	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-3542	1872-9096		ANTIVIR RES	Antiviral Res.	JUL	2015	119						84	88		10.1016/j.antiviral.2015.04.014		5	Pharmacology & Pharmacy; Virology	Pharmacology & Pharmacy; Virology	CK3KA	WOS:000356113800011		
J	Lingner, J; Funahashi, R; Combe, E; Letz, M; Jakob, G				Lingner, Julian; Funahashi, Ryoji; Combe, Emmanuel; Letz, Martin; Jakob, Gerhard			Thermoelectric sintered glass-ceramics with a Bi2Sr2Co2O (x) phase	APPLIED PHYSICS A-MATERIALS SCIENCE & PROCESSING			English	Article							SYSTEM; FIGURE; MERIT	Glass-ceramic materials containing Bi2Sr2Co2O (x) crystals with plate-like structures are prepared by a melting process and a subsequent sintering step after manual quenching. The chemical starting compositions of the samples are Bi2Sr2Co2O (x) (BSC222), Bi1.8Sr2Co2O (x) (Bi1.8) and Bi2Sr2Co1.7O (x) (Co1.7). All three samples are p-type conductors. The electric properties of Seebeck coefficient S and electrical resistivity rho show only a slight dependence on chemical composition. The Seebeck values increase with increasing temperature, and at T = 873 K, they reach S = 180, 176 and 167 A mu V/K, respectively. The electrical resistivity slightly decreases with temperature for two samples and increases for the Co1.7 sample. The thermal conductivity for all measured samples at this temperature is around kappa = 0.8 W/(m K). The figure of merit ZT increases with temperature for all samples. The materials reach a ZT value of 0.03 at T = 873 K.	[Lingner, Julian; Jakob, Gerhard] Johannes Gutenberg Univ Mainz, Inst Phys, D-55128 Mainz, Germany; [Funahashi, Ryoji; Combe, Emmanuel] Natl Inst Adv Ind Sci & Technol, Ikeda, Osaka 5638577, Japan; [Lingner, Julian; Letz, Martin] SCHOTT AG, Mat Dev, D-55122 Mainz, Germany	Lingner, J (reprint author), Johannes Gutenberg Univ Mainz, Inst Phys, D-55128 Mainz, Germany.	julian.lingner@web.de	Funahashi, Ryoji/G-3039-2014	Funahashi, Ryoji/0000-0002-1004-0204			Xu GJ, 2002, J APPL PHYS, V91, P4344, DOI 10.1063/1.1455157; Funahashi R, 2002, APPL PHYS LETT, V81, P1459, DOI 10.1063/1.1502190; Riffat SB, 2003, APPL THERM ENG, V23, P913, DOI 10.1016/S1359-4311(03)00012-7; Sotelo A, 2012, J EUR CERAM SOC, V32, P3745, DOI 10.1016/j.jeurceramsoc.2012.05.035; CUSACK N, 1958, P PHYS SOC LOND, V72, P898, DOI 10.1088/0370-1328/72/5/429; Populoh S, 2012, SCRIPTA MATER, V66, P1073, DOI 10.1016/j.scriptamat.2012.03.002; Ohta H, 2008, INORG CHEM, V47, P8429, DOI 10.1021/ic800644x; Snyder GJ, 2008, NAT MATER, V7, P105, DOI 10.1038/nmat2090; Funahashi R, 2000, JPN J APPL PHYS 2, V39, pL1127, DOI 10.1143/JJAP.39.L1127; Funahashi R., 2014, UNPUB; Funahashi R, 2000, APPL PHYS LETT, V76, P2385, DOI 10.1063/1.126354; International Energy Outlook, 2013, DOEEIA0484; Jankovsky O, 2013, J EUR CERAM SOC, V33, P2699, DOI 10.1016/j.jeurceramsoc.2013.04.035; Klein Y, 2005, J APPL PHYS, V98, DOI 10.1063/1.1947894; Terasaki I., 1997, PHYS REV B, V56; Wang YY, 2003, NATURE, V423, P425, DOI 10.1038/nature01639	16	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0947-8396	1432-0630		APPL PHYS A-MATER	Appl. Phys. A-Mater. Sci. Process.	JUL	2015	120	1					59	66		10.1007/s00339-015-9169-1		8	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	CJ9YO	WOS:000355860400009		
J	Hidai, H; Matsusaka, S; Chiba, A; Morita, N				Hidai, Hirofumi; Matsusaka, Souta; Chiba, Akira; Morita, Noboru			Heat accumulation in microdrilled glass from ultraviolet laser ablation	APPLIED PHYSICS A-MATERIALS SCIENCE & PROCESSING			English	Article							HIGH-REPETITION-RATE; ASPECT-RATIO HOLES; FEMTOSECOND LASER; TRANSPARENT MATERIALS; PULSED-LASER; FIBER; RATES; MICROCHANNELS; PICOSECOND; RADIATION	We present numerical and experimental studies of heat accumulation during high-aspect-ratio ultraviolet laser microdrilling of glass. The dependence on pulse repetition rate of the ablation threshold was studied. The rate determines the amount of heat accumulation and temperature variation across the illuminated area. No change in the glass was observed for pulse energies below 1 A mu J at 1 kHz; melting occurred at 0.3 A mu J, with ablation at 0.7 A mu J at 20 kHz. Also, the hole depth doubled when the pulse repetition rate was increased from 1 to 20 kHz. Moreover, the fluence of 4 J/cm(2) that passed through drilled holes at 1 kHz decreased to 1 J/cm(2) at 20 kHz.	[Hidai, Hirofumi; Matsusaka, Souta; Chiba, Akira; Morita, Noboru] Chiba Univ, Dept Mech Engn, Inage Ku, Chiba 2638522, Japan	Hidai, H (reprint author), Chiba Univ, Dept Mech Engn, Inage Ku, I-33 Yayoi Cho, Chiba 2638522, Japan.	hidai@faculty.chiba-u.jp			Advanced Machining Technology and Development Association (AMTDA); Japan Science and Technology Agency (JST) under the Development of Innovative Seeds, Potentiality Verification Stage	The authors gratefully acknowledge the support of the Advanced Machining Technology and Development Association (AMTDA) and the Japan Science and Technology Agency (JST) under the Development of Innovative Seeds, Potentiality Verification Stage.	Weber R, 2014, OPT EXPRESS, V22, P11312, DOI 10.1364/OE.22.011312; Shah L, 2001, APPL SURF SCI, V183, P151, DOI 10.1016/S0169-4332(01)00468-8; Tamaki T, 2006, OPT EXPRESS, V14, P10460, DOI 10.1364/OE.14.010460; Ancona A, 2008, OPT EXPRESS, V16, P8958, DOI 10.1364/OE.16.008958; Esser D, 2011, OPT EXPRESS, V19, P25632, DOI 10.1364/OE.19.025632; Salleo A, 2000, APPL PHYS A-MATER, V71, P601, DOI 10.1007/s003390000546; Hnatovsky C, 2006, APPL PHYS A-MATER, V84, P47, DOI 10.1007/s00339-006-3590-4; Schaffer CB, 2003, APPL PHYS A-MATER, V76, P351, DOI 10.1007/s00339-002-1819-4; Eaton SM, 2005, OPT EXPRESS, V13, P4708, DOI 10.1364/OPEX.13.004708; Finger J, 2014, OPT EXPRESS, V22, P18790, DOI 10.1364/OE.22.018790; Doring S, 2012, OPT EXPRESS, V20, P27147, DOI 10.1364/OE.20.027147; Karimelahi S, 2014, APPL PHYS A-MATER, V114, P91, DOI 10.1007/s00339-013-8155-8; Weck A, 2008, APPL PHYS A-MATER, V90, P537, DOI 10.1007/s00339-007-4300-6; Richter S, 2011, APPL PHYS A-MATER, V103, P257, DOI 10.1007/s00339-011-6369-1; Baeuerle D., 2000, LASER PROCESSING CHE, V3rd; Breitling D., 2001, Proceedings of the SPIE - The International Society for Optical Engineering, V4184, DOI 10.1117/12.413994; Brygo F, 2006, APPL SURF SCI, V252, P8314, DOI 10.1016/j.apsusc.2005.11.036; Di Niso F, 2014, OPT EXPRESS, V22, P12200, DOI 10.1364/OE.22.012200; Doring S., 2013, PHYS PROCEDIA, V41, P431; Gattass RR, 2006, OPT EXPRESS, V14, P5279, DOI 10.1364/OE.14.005279; Golyatina RI, 2004, LASER PHYS, V14, P1429; Hiramoto S., 1993, Q J JPN WELD SOC, V11, P75; Hwang DJ, 2004, APPL PHYS A-MATER, V79, P605, DOI 10.1007/s00339-004-2547-8; Li ZL, 2005, APPL PHYS A-MATER, V81, P753, DOI 10.1007/s00339-004-3024-0; Nielsen CS, 2006, J APPL PHYS, V99, DOI 10.1063/1.2193648; Shelby JE, 2005, INTRODUCTION TO GLASS SCIENCE AND TECHNOLOGY, P1; Volf M. B., 1984, CHEM APPROACH GLASS; Yakovlenko SI, 2006, LASER PHYS, V16, P1273, DOI 10.1134/S1054660X06090015; Zhao X, 2011, APPL PHYS A-MATER, V104, P713, DOI 10.1007/s00339-011-6326-z	29	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0947-8396	1432-0630		APPL PHYS A-MATER	Appl. Phys. A-Mater. Sci. Process.	JUL	2015	120	1					357	367		10.1007/s00339-015-9196-y		11	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	CJ9YO	WOS:000355860400044		
J	Wostmann, M; Redkin, PV; Zheng, JA; Witte, H; Ganeev, RA; Zacharias, H				Woestmann, Michael; Redkin, Pavel V.; Zheng, Jiaan; Witte, Henrik; Ganeev, Rashid A.; Zacharias, Helmut			High-order harmonic generation in plasmas from nanoparticle and mixed metal targets at 1-kHz repetition rate	APPLIED PHYSICS B-LASERS AND OPTICS			English	Article							X-RAY PULSES; MOLECULAR-DYNAMICS; ATOMIC CLUSTERS; RARE-GASES; RADIATION; XENON	High-order harmonic generation in laser-produced plasmas from nanoparticle and mixed metal targets is studied using a femtosecond Ti:sapphire laser operating at 1-kHz repetition rate. Mixed plasmas from brass and plasmas from nanoparticles (Al, carbon) are investigated and compared to their monatomic counterparts of Zn, Cu, and Al. The dependence on the delay between the heating ablation pulse and the driving converting pulse is studied for a light (carbon) and a heavy atom (silver) target. Further, we report on a comparative measurement of the efficiencies and the photon flux from argon gas harmonics and carbon plasma harmonics. For our conditions, the 13th harmonic is generated in a carbon plasma with an efficiency of eta = 5.3 x 10(-7) and yields a flux of about 9.8 x 10(10) photons s(-1), about 40 % higher than the corresponding harmonic flux in Ar gas under otherwise identical conditions.	[Woestmann, Michael; Redkin, Pavel V.; Zheng, Jiaan; Witte, Henrik; Ganeev, Rashid A.; Zacharias, Helmut] Univ Munster, Inst Phys, D-48149 Munster, Germany; [Redkin, Pavel V.] Samarkand State Univ, Samarkand 140104, Uzbekistan; [Ganeev, Rashid A.] Inst Ion Plasma & Laser Technol, Tashkent 100125, Uzbekistan; [Ganeev, Rashid A.] Saitama Med Univ, Saitama 3500495, Japan	Wostmann, M (reprint author), Univ Munster, Inst Phys, D-48149 Munster, Germany.	michael.woestmann@wwu.de			Volkswagen Stiftung [85 124]	Financial support by the Volkswagen Stiftung (Grant No. 85 124) is gratefully acknowledged.	SCHRIVER KE, 1990, PHYS REV LETT, V64, P2539, DOI 10.1103/PhysRevLett.64.2539; Pai CH, 2006, OPT LETT, V31, P984, DOI 10.1364/OL.31.000984; Willner A, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.175002; Pertot Y, 2012, J PHYS B-AT MOL OPT, V45, DOI 10.1088/0953-4075/45/7/074017; Garcia CC, 2008, J ANAL ATOM SPECTROM, V23, P470, DOI 10.1039/b718845e; Ganeev RA, 2014, JETP LETT+, V99, P368, DOI 10.1134/S0021364014070078; HENKE BL, 1993, ATOM DATA NUCL DATA, V54, P181, DOI 10.1006/adnd.1993.1013; Kundu M, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.033201; Roth J, 2000, INT J MOD PHYS C, V11, P317, DOI 10.1142/S0129183100000298; Donnelly TD, 1996, PHYS REV LETT, V76, P2472, DOI 10.1103/PhysRevLett.76.2472; Hu SX, 1997, APPL PHYS LETT, V71, P2605, DOI 10.1063/1.119342; Vozzi C, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1888053; Tisch JWG, 1997, J PHYS B-AT MOL OPT, V30, pL709, DOI 10.1088/0953-4075/30/20/006; Seres J, 2007, NAT PHYS, V3, P878, DOI 10.1038/nphys775; Stadler J, 1997, INT J MOD PHYS C, V8, P1131, DOI 10.1142/S0129183197000990; Chowdhuri MB, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2437742; Ganeev RA, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.033821; Takahashi EJ, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.053904; Hutchison C, 2012, OPT LETT, V37, P2064, DOI 10.1364/OL.37.002064; Bom LBE, 2011, OPT EXPRESS, V19, P3077, DOI 10.1364/OE.19.003077; Kanai T, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.153904; FERRAY M, 1988, J PHYS B-AT MOL OPT, V21, pL31, DOI 10.1088/0953-4075/21/3/001; Ganeev RA, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.015807; Ganeev RA, 2005, J OPT SOC AM B, V22, P1927, DOI 10.1364/JOSAB.22.001927; de Aldana JRV, 2001, J OPT SOC AM B, V18, P325, DOI 10.1364/JOSAB.18.000325; Ganeev RA, 2013, HIGH-ORDER HARMONIC GENERATION IN LASER PLASMA PLUMES, P1; Ganeev RA, 2006, J MOD OPTIC, V53, P1451, DOI 10.1080/09500340600552265; Ganeev RA, 2014, EUR PHYS J D, V68, DOI 10.1140/epjd/e2014-50329-6; Ganeev RA, 2009, J APPL PHYS, V106, DOI 10.1063/1.3176493; Ganeev RA, 2011, APPL PHYS B-LASERS O, V103, P151, DOI 10.1007/s00340-010-4318-x; Ganeev RA, 2008, J PHYS B-AT MOL OPT, V41, DOI 10.1088/0953-4075/41/4/045603; Ganeev RA, 2009, J PHYS B-AT MOL OPT, V42, DOI 10.1088/0953-4075/42/5/055402; Huve J, 2006, OPT COMMUN, V266, P261, DOI 10.1016/j.optcom.2006.04.063; Kanai T, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.041402; LOMPRE LA, 1990, J OPT SOC AM B, V7, P754, DOI 10.1364/JOSAB.7.000754; MCPHERSON A, 1987, J OPT SOC AM B, V4, P595, DOI 10.1364/JOSAB.4.000595; Ozaki T, 2010, LASER PART BEAMS, V28, P69, DOI 10.1017/S0263034609990589; Papadogiannis NA, 2001, APPL PHYS B-LASERS O, V73, P687, DOI 10.1007/s003400100734; SALT FW, 1956, NATURE, V178, P434, DOI 10.1038/178434b0; Schnurer M, 1999, PHYS REV LETT, V83, P722, DOI 10.1103/PhysRevLett.83.722; Silies M, 2009, APPL PHYS A-MATER, V96, P59, DOI [10.1007/S00339-009-5172-8, 10.1007/s00339-009-5172-8]; Singhal H, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.043821; Singhal H, 2010, J PHYS B-AT MOL OPT, V43, DOI 10.1088/0953-4075/43/2/025603; Tsilimis G, 2003, J OPT SOC AM B, V20, P246, DOI 10.1364/JOSAB.20.000246; Veniard V., 2002, Physical Review A (Atomic, Molecular, and Optical Physics), V65, DOI 10.1103/PhysRevA.65.013202; Zastrau U, 2011, J INSTRUM, V6, DOI 10.1088/1748-0221/6/10/P10001	46	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0946-2171	1432-0649		APPL PHYS B-LASERS O	Appl. Phys. B-Lasers Opt.	JUL	2015	120	1					17	24		10.1007/s00340-015-6043-y		8	Optics; Physics, Applied	Optics; Physics	CJ9YY	WOS:000355861600003		
J	Kuroda, K; Shibata, K; Yoshikuni, Y				Kuroda, Keiji; Shibata, Keisuke; Yoshikuni, Yuzo			Wavelength-dependent transition time of gain saturation in an erbium-doped fiber amplifier	APPLIED PHYSICS B-LASERS AND OPTICS			English	Article							POPULATION-INVERSION; CROSS-SECTIONS; ABSORPTION; RECOVERY; GRATINGS; PROBE	We report a study of the wavelength dependence of the gain saturation transition time in an erbium-doped fiber amplifier. A self-probe method that enables us to probe the change of population in an amplifier by using a pulse to induce that change was used to evaluate the transition time over a wavelength range from 1528 to 1559 nm. It was found that the transition time changed from 400 ns to 1.65 mu s with increasing wavelength. The wavelength dependence of the transition time was then analyzed using a model to describe the temporal evolution of the erbium population at the input end of a fiber based on McCumber theory.	[Kuroda, Keiji; Shibata, Keisuke; Yoshikuni, Yuzo] Kitasato Univ, Sch Sci, Dept Phys, Sagamihara, Kanagawa 2520373, Japan	Kuroda, K (reprint author), Kitasato Univ, Sch Sci, Dept Phys, 1-15-1 Kitazato Minamiku, Sagamihara, Kanagawa 2520373, Japan.	kkuroda@kitasato-u.ac.jp					MINISCALCO WJ, 1991, OPT LETT, V16, P258, DOI 10.1364/OL.16.000258; Stepanov S, 2007, OPT COMMUN, V271, P91, DOI 10.1016/j.optcom.2006.09.044; Havstad SA, 1999, OPT LETT, V24, P1466, DOI 10.1364/OL.24.001466; DESURVIRE E, 1990, OPT LETT, V15, P547, DOI 10.1364/OL.15.000547; Desurvire E., 1989, IEEE Photonics Technology Letters, V1, DOI 10.1109/68.36040; Fan XY, 2005, OPT EXPRESS, V13, P5756, DOI 10.1364/OPEX.13.005756; Kuroda K, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.120201; Kuroda K, 2013, OPT COMMUN, V300, P96, DOI 10.1016/j.optcom.2013.02.069; Kuroda K, 2012, APPL OPTICS, V51, P3670, DOI 10.1364/AO.51.003670; Kuroda K, 2014, OPT FIBER TECHNOL, V20, P483, DOI 10.1016/j.yofte.2014.05.014; Poti L, 2008, IEEE J QUANTUM ELECT, V44, P473, DOI 10.1109/JQE.2007.914297; Quimby RS, 2002, J APPL PHYS, V92, P180, DOI 10.1063/1.1485112; Stepanov S., 2010, APPL PHYS B, V102, P601; Stepanov S., 2008, J PHYS D, V41, P22402; Wey J. S., 1997, OPT LETT, V23, P1757	15	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0946-2171	1432-0649		APPL PHYS B-LASERS O	Appl. Phys. B-Lasers Opt.	JUL	2015	120	1					111	115		10.1007/s00340-015-6109-x		5	Optics; Physics, Applied	Optics; Physics	CJ9YY	WOS:000355861600016		
J	Ibrahim, WS; Watanabe, K; Ibrahim, ME; Yonezu, K				Ibrahim, W. S.; Watanabe, K.; Ibrahim, M. E.; Yonezu, K.			Neoproterozoic Tectonic Evolution of Gabal Abu Houdied Area, South Eastern Desert, Egypt: As a Part of Arabian-Nubian Shield Tectonics	ARABIAN JOURNAL FOR SCIENCE AND ENGINEERING			English	Article						Gabal Abu Houdeid; Neoproterozoic; South Eastern Desert; Tectonics; Gondwana; Paleostress evolution	FAULT-SLIP DATA; ALLAQI-HEIANI-SUTURE; STRUCTURAL EVOLUTION; PALEOSTRESS FIELDS; NORTHEAST SUDAN; REGIONAL STRESS; INVERSE PROBLEM; AFRICAN OROGEN; SHEAR ZONE; DEFORMATION	The Neoproterozic-related structures have provided important insights into the tectonic history of the Egyptian Eastern Desert as well as the Arabian-Nubian Shield (ANS). The Gabal Abu Houdeid (GAH) area is in the extreme northern portion of the Hamisana shear zone (HSZ), one of the major high-strain zones in the ANS. The Neoproterozoic rocks exposed around GAH include ophiolitic ultramafic-mafic rocks, island-arc metasediments, metavolcanic rocks, intrusive syn-tectonic granodiorites, post-tectonic gabbros, and granites. The analysis of large-scale structures and fault kinematic data in terms of ductile and brittle deformation indicates that the sequence of folding and faulting events was constrained by available litho-tectonic units. Four deformational events are distinguished in the Neoproterozic rocks. Event D1 a pure compression stress regime with sigma 1 stress axis trending NNW-SSE to N-S represents an early shortening event associated with the Pan-African thrusting, during which intra-oceanic arcs and plateaus were accreted. Event D2 characterized by structures developed under ENE-WSW compressional regime (shortening event) and considered as the early stage of the second episode of collision within the Pan-African orogeny. Event D3 transpressional deformation associated with E-W contraction and N-S extension. It is the main event that controlled the deformation along the HSZ during the late stages of the collision between the East and West Gondwana in terms of escape tectonics. The D4 event is interpreted as a post-orogenic extensional event manifested by E-W dextral strike-slip and dip-slip normal faults striking NNW-SSE to N-S and E-W, which began to occur after the emplacement of post-tectonic granites.	[Ibrahim, W. S.; Watanabe, K.; Yonezu, K.] Kyushu Univ, Dept Earth Resources Engn, Fac Engn, Fukuoka 8190395, Japan; [Ibrahim, W. S.; Ibrahim, M. E.] Nucl Mat Author, Cairo, Egypt	Ibrahim, WS (reprint author), Kyushu Univ, Dept Earth Resources Engn, Fac Engn, Fukuoka 8190395, Japan.	W-Ibrahim@mine.kyushu-u.ac.jp			Japan MEXT Scholarship program; Global Centre of Excellence (GCOE) program of Kyushu University, Japan	This study was supported by the Japan MEXT Scholarship program (Ph. D. scholarship to the first author) and Egyptian Nuclear Materials Authority (fieldwork). This project was financially supported by the Global Centre of Excellence (GCOE) program of Kyushu University, Japan. We are grateful to all members of the Abu Rushied project of the Nuclear Materials Authority for their assistance in the fieldwork. Many thanks to Dr. Jillian Gabo, Kyushu University for improvement of English phrasing.	Abdeen M.M., 2007, EGU 2007 ASS VIENN A; Abdeena M.M., 2007, PRECAMBRIAN RES, V185, P95; ABDELSALAM MG, 1994, J GEOL SOC LONDON, V151, P767, DOI 10.1144/gsjgs.151.5.0767; Alexandrowski P., 1986, J STRUCTURAL GEOLOGY, V7, P73; ANGELIER J, 1990, GEOPHYS J INT, V103, P363, DOI 10.1111/j.1365-246X.1990.tb01777.x; Angelier J., 1979, TECTONOPHYSICS AMSTE, V56, P17, DOI DOI 10.1016/0040-1951; Angelier J., 1994, CONTINENTAL DEFORMAT, P101; KRANTZ RW, 1988, J STRUCT GEOL, V10, P225, DOI 10.1016/0191-8141(88)90056-9; ARMIJO R, 1982, TECTONOPHYSICS, V82, P145, DOI 10.1016/0040-1951(82)90092-0; Johnson PR, 2003, GEOL SOC SPEC PUBL, P289; AYALEW T, 1990, GEOL SOC AM BULL, V102, P1309, DOI 10.1130/0016-7606(1990)102<1309:UPARSG>2.3.CO;2; SHACKLETON RM, 1980, NATURE, V285, P472, DOI 10.1038/285472a0; Abdelsalam MG, 2003, PRECAMBRIAN RES, V123, P203, DOI 10.1016/S0301-9268(03)00068-8; STERN RJ, 1989, J GEOL SOC LONDON, V146, P1017, DOI 10.1144/gsjgs.146.6.1017; Stein M, 1996, NATURE, V382, P773, DOI 10.1038/382773a0; STERN RJ, 1990, GEOLOGY, V18, P1103, DOI 10.1130/0091-7613(1990)018<1103:OOLPSI>2.3.CO;2; KRONER A, 1992, PRECAMBRIAN RES, V59, P15, DOI 10.1016/0301-9268(92)90049-T; Abdelsalam MG, 2003, PRECAMBRIAN RES, V124, P87, DOI 10.1016/S0301-9268(03)00080-9; Yamaji A, 2000, J STRUCT GEOL, V22, P441, DOI 10.1016/S0191-8141(99)00163-7; ETCHECOPAR A, 1981, J STRUCT GEOL, V3, P51, DOI 10.1016/0191-8141(81)90056-0; Sperner B, 2010, TECTONOPHYSICS, V482, P29, DOI 10.1016/j.tecto.2009.07.019; Delvaux D, 2003, GEOL SOC SPEC PUBL, V212, P75, DOI 10.1144/GSL.SP.2003.212.01.06; Abdeen MM, 2005, GONDWANA RES, V8, P457, DOI 10.1016/S1342-937X(05)71148-5; Abdelsalam MG, 1996, J AFR EARTH SCI, V23, P289, DOI 10.1016/S0899-5362(97)00003-1; STOESER DB, 1985, GEOL SOC AM BULL, V96, P817, DOI 10.1130/0016-7606(1985)96<817:PMAOTA>2.0.CO;2; GEPHART JW, 1984, J GEOPHYS RES, V89, P9305, DOI 10.1029/JB089iB11p09305; BAKOR AR, 1976, EARTH PLANET SC LETT, V30, P1, DOI 10.1016/0012-821X(76)90002-9; Kusky TM, 2003, PRECAMBRIAN RES, V123, P81, DOI 10.1016/S0301-9268(03)00062-7; ANGELIER J, 1984, J GEOPHYS RES, V89, P5835, DOI 10.1029/JB089iB07p05835; MARRETT R, 1990, J STRUCT GEOL, V12, P973, DOI 10.1016/0191-8141(90)90093-E; SHACKLETON RM, 1994, GEOL RUNDSCH, V83, P537, DOI 10.1007/BF01083226; Fry N, 1999, J STRUCT GEOL, V21, P7, DOI 10.1016/S0191-8141(98)00099-6; Ghebreab W, 1998, EARTH-SCI REV, V45, P1, DOI 10.1016/S0012-8252(98)00036-1; Arthaud F., 1969, B SOC GEOL FR, V11, P729; BERHE SM, 1990, J GEOL SOC LONDON, V147, P41, DOI 10.1144/gsjgs.147.1.0041; Burke K., 1986, AM GEOPHYS UNION GEO, V14, P41; de Wall H, 2001, PRECAMBRIAN RES, V107, P179, DOI 10.1016/S0301-9268(00)00141-8; HARDCASTLE KC, 1991, COMPUT GEOSCI, V17, P23, DOI 10.1016/0098-3004(91)90078-R; HARRIS NBW, 1993, GEOLOGICAL SOC SPECI, P363; Ibrahim W.S., 2014, ARAB J GEOSCI, V151, P527; Kroner A., 1987, PROTEROZOIC LITHOSPH, V17, P235; MEANS WD, 1987, J STRUCT GEOL, V9, P585, DOI 10.1016/0191-8141(87)90143-X; MICHAEL AJ, 1984, J GEOPHYS RES, V89, P1517, DOI 10.1029/JB089iB13p11517; MILLER MM, 1992, J GEOL SOC LONDON, V149, P743, DOI 10.1144/gsjgs.149.5.0743; Pallister J.S., 1989, PRECAMBRIAN RES, V38, P60; PETIT JP, 1987, J STRUCT GEOL, V9, P597, DOI 10.1016/0191-8141(87)90145-3; Ramsay J.G., 1967, FOLDING FRACTURING R; Ren DW, 2006, J AFR EARTH SCI, V44, P181, DOI 10.1016/j.jafrearsci.2005.10.010; Saintrot A, 2002, TECTONOPHYSICS, V357, P1, DOI 10.1016/S0040-1951(02)00360-8; STERN RJ, 1994, ANNU REV EARTH PL SC, V22, P319, DOI 10.1146/annurev.ea.22.050194.001535; Unrug R., 1997, GSA TODAY, V7, P1; Vail J. R., 1983, Journal of African Earth Sciences, V1; WILL TM, 1991, J STRUCT GEOL, V13, P813, DOI 10.1016/0191-8141(91)90006-5; YIN ZM, 1993, J GEOPHYS RES-SOL EA, V98, P12165, DOI 10.1029/93JB00194; Zoheir BA, 2007, GONDWANA RES, V12, P289, DOI 10.1016/j.gr.2006.10.005	55	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1319-8025	2191-4281		ARAB J SCI ENG	Arab. J. Sci. Eng.	JUL	2015	40	7					1947	1966		10.1007/s13369-014-1521-9		20	Multidisciplinary Sciences	Science & Technology - Other Topics	CK1BM	WOS:000355940400015		
J	Nora, D; Kurashige, Y; Shudo, K; Takahashi, A; Abiko, Y; Saitoh, M				Nora, Daisuke; Kurashige, Yoshihito; Shudo, Kai; Takahashi, Ayumi; Abiko, Yoshihiro; Saitoh, Masato			Effect of epithelial cells derived from periodontal ligament on osteoblast-like cells in a Transwell membrane coculture system	ARCHIVES OF ORAL BIOLOGY			English	Article						ERM; Amelogenin; Calcification; MC3T3-E1	ROOT SHEATH; AMELOGENIN; MALASSEZ; RESTS; EXPRESSION; CEMENTUM; GENES	Background and objective: The epithelial rests of Malassez (ERM) are developmental residues of Hertwig's epithelial root sheath, and they are present throughout life in the periodontal ligament. Previous studies have shown that ERM induce cementogenesis or inhibit cementosteogenesis. This study investigated how ERM cells are involved in osteoblast mineralization in an in vitro coculture system. Materials and methods: ERM cells were isolated from porcine periodontal ligament by an outgrowth method. Osteoblast-like MC3T3-E1 cells were cocultured with ERM or gingival epithelium (GE) cells in six-well Transwell units. Mineralization of MC3T3-E1 cells was confirmed by Alizarin Red staining after 30 days of culture. Alkaline phosphatase (ALP) activity was measured in the culture media. To examine whether enamel matrix proteins are involved in the mineralization of MC3T3-E1 cells, an anti-amelogenin antibody was added to the culture media. Results: The staining by Alizarin Red of MC3T3-E1 cells cocultured with ERM cells was clearly weaker than that in the GE cell coculture. The ALP activity in the ERM cell coculture was significantly lower than that in the GE cell coculture (p < 0.05). Alizarin Red staining of MC3T3-E1 cells in the ERM cell coculture with anti-amelogenin antibody was clearly stronger than in those cocultures without the antibody at 30 days. The ALP activity in the ERM cell coculture with anti-amelogenin antibody was significantly higher than in those cultures without the antibody (p <0.05). Conclusion: This study demonstrated that ERM cells inhibit the calcification of osteoblast-like cells in a Transwell coculture system and that this inhibition is reversed with an antiamelogenin antibody. (c) 2015 Elsevier Ltd. All rights reserved.	[Nora, Daisuke; Kurashige, Yoshihito; Shudo, Kai; Takahashi, Ayumi; Saitoh, Masato] Hlth Sci Univ Hokkaido, Sch Dent, Div Pediat Dent, Ishikari, Hokkaido 0610293, Japan; [Abiko, Yoshihiro] Hlth Sci Univ Hokkaido, Sch Dent, Div Oral Med & Pathol, Ishikari, Hokkaido 0610293, Japan	Saitoh, M (reprint author), Hlth Sci Univ Hokkaido, Sch Dent, Div Pediat Dent, 1757 Kanazawa, Ishikari, Hokkaido 0610293, Japan.	noro@hoku-iryo-u.ac.jp; msaitoh@hoku-iryo-u.ac.jp			Health Sciences University of Hokkaido	This study was funded by Health Sciences University of Hokkaido.	Abiko Yoshihiro, 2001, Medical Electron Microscopy, V34, P185, DOI 10.1007/s007950100014; Abiko Yoshihiro, 1994, Bulletin of Tokyo Dental College, V35, P55; LINDSKOG S, 1988, J CLIN PERIODONTOL, V15, P371, DOI 10.1111/j.1600-051X.1988.tb01014.x; Shinmura Y, 2008, J CELL PHYSIOL, V217, P728, DOI 10.1002/jcp.21546; Keinan D, 2013, J ENDODONT, V39, P582, DOI 10.1016/j.joen.2013.01.004; Shimono M, 2003, MICROSC RES TECHNIQ, V60, P491, DOI 10.1002/jemt.10290; ARUNACHALAM B, 1990, J IMMUNOL METHODS, V135, P181, DOI 10.1016/0022-1759(90)90271-V; Brice G L, 1991, Aust Orthod J, V12, P90; BRUNETTE DM, 1976, ARCH ORAL BIOL, V21, P393, DOI 10.1016/0003-9969(76)90001-7; Fong CD, 2000, ORAL SURG ORAL MED O, V90, P218, DOI 10.1067/moe.2000.107052; Fujiyama K, 2004, J DENT RES, V83, P625; Giri D, 2001, AM J PATHOL, V159, P139, DOI 10.1016/S0002-9440(10)61681-1; Hamamoto Y, 1996, ORAL SURG ORAL MED O, V81, P703, DOI 10.1016/S1079-2104(96)80077-1; Hasegawa N, 2003, J PERIODONTAL RES, V38, P51; Izumikawa M, 2012, THESCIENTIFICWORLDJO, V2012; Jue SS, 2010, CLIN ORAL IMPLAN RES, V21, P741, DOI 10.1111/j.1600-0501.2009.01901.x; Kwak SY, 2010, INTERFACE ORAL HEALTH SCIENCE 2009, P418, DOI 10.1007/978-4-431-99644-6_120; Liu Fang, 2001, Medical Electron Microscopy, V34, P174, DOI 10.1007/s007950100012; Nishimura Michiko, 1999, Medical Electron Microscopy, V32, P127, DOI 10.1007/s007950050019; Shimonishi M, 2008, J PERIODONTAL RES, V43, P64, DOI 10.1111/j.1600-0765.2007.00995.x; SNEAD ML, 1983, P NATL ACAD SCI-BIOL, V80, P7254, DOI 10.1073/pnas.80.23.7254; Suzuki M, 2006, J PERIODONTAL RES, V41, P280, DOI 10.1111/j.1600-0765.2006.00871.x; Tokiyasu Y, 2000, J PERIODONTOL, V71, P1829, DOI 10.1902/jop.2000.71.12.1829; Viswanathan HL, 2003, J PERIODONTOL, V74, P1423, DOI 10.1902/jop.2003.74.10.1423; WESSELINK PR, 1993, ARCH ORAL BIOL, V38, P399, DOI 10.1016/0003-9969(93)90211-4; Young N, 2005, J IMMUNOL, V175, P8287	26	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0003-9969	1879-1506		ARCH ORAL BIOL	Arch. Oral Biol.	JUL	2015	60	7					1007	1012		10.1016/j.archoralbio.2015.02.016		6	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CK3KK	WOS:000356114800005		
J	Suzuki, T; Ryu, K; Kojima, K; Iriuchishima, T; Saito, S; Nagaoka, M; Tokuhashi, Y				Suzuki, Takashi; Ryu, Keinosuke; Kojima, Kei; Iriuchishima, Takanori; Saito, Shu; Nagaoka, Masahiro; Tokuhashi, Yasuaki			Evaluation of spacer block technique using tensor device in unicompartmental knee arthroplasty	ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY			English	Article						UKA; Gap; Soft tissue balance; Arthroplasty; Mobile-bearing	INTRAOPERATIVE JOINT GAP; SOFT-TISSUE IMBALANCE; SURVIVAL ANALYSIS; EXTENSION GAP; REPLACEMENT; FLEXION; TENSION; BALANCE; LAXITY	Mobile-bearing unicompartmental knee arthroplasty (UKA) was designed so that flexion and extension gap adjustments could achieve isometric function of the ligaments throughout ROM to prevent complications. However, achieving accurate knee balancing using a spacer block technique remains difficult since determination of the thickness of the spacer block is determined according to the feeling of the individual surgeon's hand. The objective of the study was to investigate flexion and extension medial unicompartmental knee gap kinematics in mobile-bearing UKA and to reveal the accuracy of spacer block measurement technique using a gap tensor device. Mobile-bearing UKA was performed in 40 knees of 31 subjects using generally accepted spacer block technique so that the extension gap was made equal to the flexion gap. The extension and flexion gaps of the medial knee compartment were measured using the tensor device with 25, 50, 75, 100, 125, and 150 N of joint distraction force. The interplay gap was calculated by subtracting the thickness of the tibial prosthesis and the thickness of the selected size of bearing from the measured extension and flexion gaps. Medial compartmental joint interplay gap differences were compared among flexion and extension gaps. The mean flexion interplay gap was 25 N: 0.5 mm, 50 N: 1.5 mm, 75 N: 2.4 mm, 100 N: 3.1 mm, 125 N: 3.6 mm, 150 N: 4.0 mm. The mean extension interplay gap was 25 N: -0.2 mm, 50 N: 0.81 mm, 75 N: 1.7 mm, 100 N: 2.5 mm, 125 N: 3.1 mm, 150 N: 3.5 mm. The measured extension gap was shown to be significantly smaller compared with the flexion gap at every joint distraction force (P < 0.01). These results suggest that gap measurement using a spacer block in UKA has the potential risk that the resulting extension gap may be smaller than the flexion gap. Surgeons should adjust the flexion and extension gaps with caution to achieve good ligament function when performing mobile-bearing UKA.	[Suzuki, Takashi; Ryu, Keinosuke; Kojima, Kei; Nagaoka, Masahiro] Nihon Univ Hosp, Dept Orthopaed Surg, Chiyoda Ku, Tokyo 1018309, Japan; [Iriuchishima, Takanori] Kamimoku Hot Springs Hosp, Tone, Gunma 3791311, Japan; [Saito, Shu; Tokuhashi, Yasuaki] Nihon Univ, Dept Orthopaed Surg, Sch Med, Itabashi Ku, Tokyo 1738610, Japan	Suzuki, T (reprint author), Nihon Univ Hosp, Dept Orthopaed Surg, Chiyoda Ku, 1-6 Kandasurugadai, Tokyo 1018309, Japan.	rastavibration2328@yahoo.co.jp					Whiteside LA, 2000, CLIN ORTHOP RELAT R, P45; Asano H, 2004, J ARTHROPLASTY, V19, P558, DOI 10.1016/j.arth.2004.01.003; O'Connor J J, 1996, Proc Inst Mech Eng H, V210, P217, DOI 10.1243/PIME_PROC_1996_210_415_02; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Unitt L, 2008, J BONE JOINT SURG BR, V90B, P159, DOI 10.1302/0301-620X.90B2.19327; Matsumoto T, 2007, KNEE SURG SPORT TR A, V15, P1013, DOI 10.1007/s00167-007-0331-y; Muratsu H, 2010, CLIN BIOMECH, V25, P926, DOI 10.1016/j.clinbiomech.2010.06.020; Price AJ, 2011, CLIN ORTHOP RELAT R, V469, P174, DOI 10.1007/s11999-010-1506-2; Watanabe T, 2013, CLIN ORTHOP RELAT R, V471, P1326, DOI 10.1007/s11999-012-2755-z; Svard UCG, 2001, J BONE JOINT SURG BR, V83B, P191, DOI 10.1302/0301-620X.83B2.10966; Parmaksizoglu AS, 2010, ACTA ORTHOP TRAUMATO, V44, P135, DOI 10.3944/AOTT.2010.2296; Pandit H, 2011, J BONE JOINT SURG BR, V93B, P198, DOI 10.1302/0301-620X.93B2.25767; Pang HN, 2011, KNEE SURG SPORT TR A, V19, P1496, DOI 10.1007/s00167-011-1483-3; Gleeson RE, 2004, KNEE, V11, P379, DOI 10.1016/j.knee.2004.06.006; ten Ham AM, 2013, KNEE SURG SPORT TR A, V21, P2447, DOI 10.1007/s00167-012-2021-7; Asano H, 2008, KNEE SURG SPORT TR A, V16, P999, DOI 10.1007/s00167-008-0591-1; ATTFIELD SF, 1994, MED ENG PHYS, V16, P501, DOI 10.1016/1350-4533(94)90076-0; DORR LD, 1986, CLIN ORTHOP RELAT R, P5; Hananouchi T, 2012, KNEE, V19, P601, DOI 10.1016/j.knee.2011.08.001; INSALL JN, 1985, CLIN ORTHOP RELAT R, P13; Krackow K A, 1999, Am J Knee Surg, V12, P222; Matsumoto T, 2012, J ARTHROPLASTY, V27, P1723, DOI 10.1016/j.arth.2012.02.020; Matsumoto T, 2013, CLIN BIOMECH, V28, P29, DOI 10.1016/j.clinbiomech.2012.09.002; O'Connor J. J, 1989, J ENG MED, V203, P223; Okamoto S, 2014, KNEE SURG SPORT TR A, V22, P3174, DOI 10.1007/s00167-014-2858-z; Price Andrew J, 2007, Orthopedics, V30, P7; SAMBATAKAKIS A, 1993, J BIOMED ENG, V15, P339, DOI 10.1016/0141-5425(93)90013-O; Winemaker MJ, 2002, J ARTHROPLASTY, V17, P2, DOI 10.1054/arth.2002.29321	28	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0936-8051	1434-3916		ARCH ORTHOP TRAUM SU	Arch. Orthop. Trauma Surg.	JUL	2015	135	7					1011	1016		10.1007/s00402-015-2231-9		6	Orthopedics; Surgery	Orthopedics; Surgery	CK5FC	WOS:000356246800015		
J	Kobayashi, K; Hashimoto, M; Honkakoski, P; Negishi, M				Kobayashi, Kaoru; Hashimoto, Mari; Honkakoski, Paavo; Negishi, Masahiko			Regulation of gene expression by CAR: an update	ARCHIVES OF TOXICOLOGY			English	Review						Constitutive androstane receptor; Cytochrome P450; Drug metabolism; Epidermal growth factor receptor; Liver injury; Glucose metabolism	CONSTITUTIVE ANDROSTANE RECEPTOR; PREGNANE-X-RECEPTOR; ORPHAN NUCLEAR RECEPTOR; RESPONSIVE ENHANCER MODULE; MOUSE PRIMARY HEPATOCYTES; INDUCED LIVER-INJURY; ACTIVE/ANDROSTANE RECEPTOR; GLUCOCORTICOID-RECEPTOR; CYP2B6 GENE; GAMMA COACTIVATOR-1-ALPHA	The constitutive androstane receptor (CAR), a member of the nuclear receptor superfamily, is a well-known xenosensor that regulates hepatic drug metabolism and detoxification. CAR activation can be elicited by a large variety of xenobiotics, including phenobarbital (PB) which is not a directly binding CAR ligand. The mechanism of CAR activation is complex and involves translocation from the cytoplasm into the nucleus, followed by further activation steps in the nucleus. Recently, epidermal growth factor receptor (EGFR) has been identified as a PB-responsive receptor, and PB activates CAR by inhibiting the EGFR signaling. In addition to regulation of drug metabolism, activation of CAR has multiple biological end points such as modulation of xenobiotic-elicited liver injury, and the role of CAR in endobiotic functions such as glucose metabolism and cholesterol homeostasis is increasingly recognized. Thus, investigations on the molecular mechanism of CAR activation are critical for the real understanding of CAR-mediated processes. Here, we summarize the current understanding of mechanisms by which CAR activators regulate gene expression through cellular signaling pathways and the roles of CAR on xenobiotic-elicited hepatocellular carcinoma, liver injury, glucose metabolism and cholesterol homeostasis.	[Kobayashi, Kaoru; Hashimoto, Mari] Chiba Univ, Grad Sch Pharmaceut Sci, Lab Pharmacol & Toxicol, Chiba, Japan; [Honkakoski, Paavo; Negishi, Masahiko] NIEHS, Pharmacogenet Sect, Reprod & Dev Biol Lab, NIH, Res Triangle Pk, NC 27709 USA; [Honkakoski, Paavo] Univ Eastern Finland, Fac Hlth Sci, Sch Pharm, Kuopio, Finland	Kobayashi, K (reprint author), Chiba Univ, Grad Sch Pharmaceut Sci, Lab Pharmacol & Toxicol, Chiba, Japan.	kaoruk@faculty.chiba-u.jp					Maglich JM, 2002, MOL PHARMACOL, V62, P638, DOI 10.1124/mol.62.3.638; Kobayashi K, 2005, DRUG METAB DISPOS, V33, P924, DOI 10.1124/dmd.104.002741; Burk O, 2005, MOL PHARMACOL, V67, P1954, DOI 10.1124/mol.104.009019; Lynch C, 2013, PHARM RES-DORDR, V30, P489, DOI 10.1007/s11095-012-0895-1; Kobayashi K, 2003, MOL PHARMACOL, V64, P1069, DOI 10.1124/mol.64.5.1069; Yoshida Y, 1996, BIOCHEM BIOPH RES CO, V229, P182, DOI 10.1006/bbrc.1996.1777; Braeuning A, 2014, TOXICOL SCI, V140, P259, DOI 10.1093/toxsci/kfu099; Miao J, 2006, J BIOL CHEM, V281, P14537, DOI 10.1074/jbc.M51713200; Shiraki T, 2003, J BIOL CHEM, V278, P11344, DOI 10.1074/jbc.M212859200; Zhang J, 2002, SCIENCE, V298, P422, DOI 10.1126/science.1073502; Ueda A, 2002, MOL PHARMACOL, V61, P1, DOI 10.1124/mol.61.1.1; Masson D, 2008, J LIPID RES, V49, P1682, DOI 10.1194/jlr.M700374-JLR200; Xu CS, 2009, DRUG METAB DISPOS, V37, P1539, DOI 10.1124/dmd.109.026989; Mutoh S, 2009, J BIOL CHEM, V284, P34785, DOI 10.1074/jbc.M109.048108; Kodama S, 2004, MOL CELL BIOL, V24, P7931, DOI 10.1128/MCB.24.18.7931.7940.2004; Rignall B, 2011, CARCINOGENESIS, V32, P52, DOI 10.1093/carcin/bgq226; Kast HR, 2002, J BIOL CHEM, V277, P2908, DOI 10.1074/jbc.M109326200; Dussault I, 2002, MOL CELL BIOL, V22, P5270, DOI 10.1128/MCB.22.15.5270-5280.2002; Maglich JM, 2003, J BIOL CHEM, V278, P17277, DOI 10.1074/jbc.M300138200; Honkakoski P, 1998, BIOCHEM J, V330, P889; Sueyoshi T, 1999, J BIOL CHEM, V274, P6043, DOI 10.1074/jbc.274.10.6043; Aleksunes LM, 2012, DRUG METAB DISPOS, V40, P1366, DOI 10.1124/dmd.112.045112; Sberna AL, 2011, ARTERIOSCL THROM VAS, V31, P2232, DOI 10.1161/ATVBAHA.110.222497; Tzameli I, 2000, MOL CELL BIOL, V20, P2951, DOI 10.1128/MCB.20.9.2951-2958.2000; Yamazaki Y, 2011, LAB INVEST, V91, P1624, DOI 10.1038/labinvest.2011.115; Muangmoonchai R, 2001, BIOCHEM J, V355, P71, DOI 10.1042/0264-6021:3550071; Ferguson SS, 2005, MOL PHARMACOL, V68, P747, DOI 10.1124/mol.105.013169; Tojima H, 2012, TOXICOL LETT, V212, P288, DOI 10.1016/j.toxlet.2012.06.001; Honkakoski P, 1998, MOL CELL BIOL, V18, P5652; Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100; Yamamoto Y, 2004, CANCER RES, V64, P7197, DOI 10.1158/0008-5472.CAN-04-1459; Goodwin B, 2002, MOL PHARMACOL, V62, P359, DOI 10.1124/mol.62.2.359; Kawamoto T, 1999, MOL CELL BIOL, V19, P6318; Harada N, 2002, CANCER RES, V62, P1971; Chen YP, 2003, MOL PHARMACOL, V64, P316, DOI 10.1124/mol.64.2.316; Forman BM, 1998, NATURE, V395, P612, DOI 10.1038/26996; Ding X, 2006, J BIOL CHEM, V281, P26540, DOI 10.1074/jbc.M600931200; Honkakoski P, 1998, MOL PHARMACOL, V53, P597; Huang WD, 2005, MOL ENDOCRINOL, V19, P1646, DOI 10.1210/me.2004-0520; BAES M, 1994, MOL CELL BIOL, V14, P1544; Lee SST, 1996, J BIOL CHEM, V271, P12063; Papa S, 2004, NAT CELL BIOL, V6, P146, DOI 10.1038/ncb1093; Sberna AL, 2011, J HEPATOL, V55, P154, DOI 10.1016/j.jhep.2010.10.029; Yamamoto Y, 2008, DRUG METAB DISPOS, V36, P1189, DOI 10.1124/dmd.108.020628; Slosky LM, 2013, MOL PHARMACOL, V84, P774, DOI 10.1124/mol.113.086298; Wei P, 2000, NATURE, V407, P920; Jitrapakdee S, 2012, INT J BIOCHEM CELL B, V44, P33, DOI 10.1016/j.biocel.2011.10.001; Sueyoshi T, 2008, MOL PHARMACOL, V73, P1113, DOI 10.1124/mol.107.042960; Bae YJ, 2004, DNA CELL BIOL, V23, P81, DOI 10.1089/104454904322759894; Benet M, 2010, J BIOL CHEM, V285, P28457, DOI 10.1074/jbc.M110.118364; Burk O, 2005, BIOL CHEM, V386, P503, DOI 10.1515/BC.2005.060; Chen TH, 2012, J HEPATOL, V56, P210, DOI 10.1016/j.jhep.2011.07.015; Chen XR, 2007, TOXICOLOGY, V231, P224, DOI 10.1016/j.tox.2006.12.019; Chen XS, 2011, LAB INVEST, V91, P1136, DOI 10.1038/labinvest.2011.68; Cheung C, 2005, DRUG METAB DISPOS, V33, P449, DOI 10.1124/dmd.104.002402; Choi HS, 1997, J BIOL CHEM, V272, P23565, DOI 10.1074/jbc.272.38.23565; CLEMMESEN J, 1978, ECOTOX ENVIRON SAFE, V1, P457, DOI 10.1016/0147-6513(78)90014-3; CONNEY AH, 1960, J PHARMACOL EXP THER, V130, P1; DeKeyser JG, 2009, MOL PHARMACOL, V75, P1005, DOI 10.1124/mol.108.053702; DIWAN BA, 1992, CARCINOGENESIS, V13, P1893, DOI 10.1093/carcin/13.10.1893; Dong BN, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6944; GOERDT C, 1995, J CLIN PHARMACOL, V35, P767; Hosseinpour F, 2006, MOL PHARMACOL, V69, P1095, DOI 10.1124/mol.105.019505; Huang WD, 2004, J CLIN INVEST, V113, P137, DOI 10.1172/JCI200418385; Imai J, 2013, DRUG METAB PHARMACOK, V28, P290, DOI 10.2133/dmpk.DMPK-12-RG-112; Inoue K, 2009, FEBS LETT, V583, P2126, DOI 10.1016/j.febslet.2009.05.031; Inoue K, 2008, J BIOL CHEM, V283, P10425, DOI 10.1074/jbc.M800729200; Kiyosawa N, 2004, ARCH TOXICOL, V78, P435, DOI 10.1007/s00204-004-0565-0; Koike C, 2005, FEBS LETT, V579, P6733, DOI 10.1016/j.febslet.2005.10.070; Koike C, 2007, MOL PHARMACOL, V71, P1217, DOI 10.1124/mol.107.034538; KORHONEN T, 1987, CLIN PHARMACOL THER, V41, P633; Kublbeck J, 2011, BIOCHEM PHARMACOL, V82, P1994, DOI 10.1016/j.bcp.2011.08.027; Lamminpaa A, 2002, EUR J CLIN PHARMACOL, V58, P137, DOI 10.1007/s00228-002-0429-6; Laurenzana EM, 2012, MOL PHARMACOL, V82, P918, DOI 10.1124/mol.112.080721; Lempiainen H, 2005, MOL ENDOCRINOL, V19, P2258, DOI 10.1012/me.2004-0534; Liu MJ, 2009, MOL PHARMACOL, V76, P604, DOI 10.1124/mol.109.057455; Makinen JM, 2002, MOL PHARMACOL, V62, P366, DOI 10.1124/mol.62.2.366; MILLER M, 1995, ARTERIOSCL THROM VAS, V15, P2151; Min GS, 2002, J BIOL CHEM, V277, P26356, DOI 10.1074/jbc.M200051200; Moennikes O, 2000, CANCER RES, V60, P5087; Mutoh S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003705; Ohno M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115663; Osabe M, 2011, J BIOL CHEM, V286, P35763, DOI 10.1074/jbc.M111.284596; Pellinen P, 1996, HEPATOLOGY, V23, P515; PELLINEN P, 1994, EUR J PHARM-ENVIRON, V270, P35, DOI 10.1016/0926-6917(94)90078-7; Rezen T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-384; Saito K, 2013, DRUG METAB DISPOS, V41, P1170, DOI 10.1124/dmd.113.051623; Sidhu JS, 1999, J BIOCHEM MOL TOXIC, V13, P1, DOI 10.1002/(SICI)1099-0461(1999)13:1<1::AID-JBT1>3.0.CO;2-2; Sueyoshi T, 2001, ANNU REV PHARMACOL, V41, P123, DOI 10.1146/annurev.pharmtox.41.1.123; Sugatani J, 2005, MOL PHARMACOL, V67, P845, DOI 10.1124/mol.104.007161; Swales K, 2005, J BIOL CHEM, V280, P3458, DOI 10.1074/jbc.M411318200; Timsit YE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096092; TSUDA H, 1995, CARCINOGENESIS, V16, P101, DOI 10.1093/carcin/16.1.101; Wang HB, 2004, J BIOL CHEM, V279, P29295, DOI 10.1074/jbc.M400580200; Yamamoto Y, 2003, ARCH BIOCHEM BIOPHYS, V409, P207, DOI 10.1016/S0003-9861(02)00456-3; Yamamoto Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010121; Yang H, 2014, MOL PHARMACOL, V85, P249, DOI 10.1124/mol.113.089763; Yoshinari K, 2003, FEBS LETT, V548, P17, DOI 10.1016/S0014-5793(03)00720-8; Yoshinari K, 2012, TOXICOL LETT, V208, P185, DOI 10.1016/j.toxlet.2011.11.003; Yoshinari K, 2010, BIOCHEM PHARMACOL, V79, P261, DOI 10.1016/j.bcp.2009.08.008; Zelko I, 2001, MOL CELL BIOL, V21, P2838, DOI 10.1128/MCB.21.8.2838-2846.2001	101	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-5761	1432-0738		ARCH TOXICOL	Arch. Toxicol.	JUL	2015	89	7					1045	1055		10.1007/s00204-015-1522-9		11	Toxicology	Toxicology	CK3EQ	WOS:000356099800005		
J	Rubiolo, JA; Vale, C; Martin, V; Fuwa, H; Sasaki, M; Botana, LM				Rubiolo, J. A.; Vale, C.; Martin, V.; Fuwa, H.; Sasaki, M.; Botana, L. M.			Potassium currents inhibition by gambierol analogs prevents human T lymphocyte activation	ARCHIVES OF TOXICOLOGY			English	Article						Gambierol; Heptacyclic analog of gambierol; Tetracyclic analog of gambierol; Voltage-gated potassium channels; Human T lymphocytes; Ciguatoxin; Autoimmune diseases	DINOFLAGELLATE GAMBIERDISCUS-TOXICUS; ION CHANNELS; BIOLOGICAL EVALUATION; AUTOIMMUNE-DISEASES; GENE-EXPRESSION; MESSENGER-RNA; UP-REGULATION; K+ CHANNELS; KV1.3; ASTHMA	Gambierol is a marine polycyclic ether toxin, produced along with ciguatoxin congeners by the dinoflagellate Gambierdiscus toxicus. We have recently reported that two truncated skeletal analogs of gambierol comprising the EFGH- and BCDEFGH-rings of the parent compound showed similar potency to gambierol on voltage-gated potassium channels (Kv) inhibition in neurons. Gambierol and its truncated analogs share the main crucial elements for biological activity, which are the C28=C29 double bond within the H-ring and the unsaturated side chain. Since Kv channels are critical for the regulation of calcium signaling, proliferation, secretion and migration in human T lymphocytes, we evaluated the activity of both the tetracyclic and heptacyclic analogs of gambierol on potassium currents in resting T lymphocyte and their effects on interleukin-2 (IL-2) release and gene expression in activated T lymphocytes. The results presented in this work clearly demonstrate that both truncated analogs of gambierol inhibit Kv channels present in resting T lymphocytes (Kv1.3) and prevented lymphocyte activation by concanavalin A. The main effects of the heptacyclic and tetracyclic analogs of gambierol in human T cells are: (1) inhibition of potassium channels in resting and concanavalin-activated T cells in the nanomolar range, (2) inhibition of IL-2 release from concanavalin-activated T cells and (3) negatively affect the expression of genes involved in cell proliferation and immune response observed in concanavalin-activated lymphocytes. These results together with the lack of toxicity in this cellular model, indicates that both analogs of gambierol have additional potential for the development of therapeutic tools in autoimmune diseases.	[Rubiolo, J. A.; Vale, C.; Martin, V.; Botana, L. M.] Univ Santiago de Compostela, Fac Vet, Dept Farmacol, Lugo 27003, Spain; [Fuwa, H.; Sasaki, M.] Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi 980, Japan	Vale, C (reprint author), Univ Santiago de Compostela, Fac Vet, Dept Farmacol, Lugo 27003, Spain.	mdelcarmen.vale@usc.es; Luis.Botana@usc.es	Fuwa, Haruhiko/D-1773-2010; Vale, Carmen/L-5287-2014; Rubiolo, Juan/A-8732-2014; 	Vale, Carmen/0000-0002-9842-6223; Botana, Luis M/0000-0003-2153-6608	FEDER; CDTI and Technological Funds; Ministerio de Economia y Competitividad [AGL2012-40185-CO2-01]; Conselleria de Cultura, Educacion e Ordenacion Universitaria [GRC2013-016]; Axencia Galega de Innovacion, Spain [ITC-20133020 SINTOX, IN852A 2013/16-3 MYTIGAL]; CDTI under ISIP Programme, Spain [IDI-20130304 APTAFOOD]; European Union [265409 muAQUA, 315285 CIGUATOOLS, 312184 PHARMASEA]; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [24102507, 23102016]	The research leading to these results has received funding from the following FEDER co-funded grants. From CDTI and Technological Funds, supported by Ministerio de Economia y Competitividad, AGL2012-40185-CO2-01 and Conselleria de Cultura, Educacion e Ordenacion Universitaria, GRC2013-016, and through Axencia Galega de Innovacion, Spain, ITC-20133020 SINTOX, IN852A 2013/16-3 MYTIGAL. From CDTI under ISIP Programme, Spain, IDI-20130304 APTAFOOD. From the European Union's Seventh Framework Programme managed by REA - Research Executive Agency (FP7/2007-2013) under grant agreement Nos. 265409 mu AQUA, 315285 CIGUATOOLS and 312184 PHARMASEA. Grants-in-Aid for Scientific Research on Priority Areas "Chemical Biology of Natural Products": (Nos. 24102507 and 23102016) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	Ghanshani S, 2000, J BIOL CHEM, V275, P37137, DOI 10.1074/jbc.M003941200; Bradding P, 2009, BRIT J PHARMACOL, V157, P1330, DOI 10.1111/j.1476-5381.2009.00362.x; Kopljar I, 2009, P NATL ACAD SCI USA, V106, P9896, DOI 10.1073/pnas.0812471106; Glimcher LH, 2000, GENE DEV, V14, P1693; Fuwa H, 2003, BIOORG MED CHEM LETT, V13, P2519, DOI 10.1016/S0960-894X(03)00467-0; Naseer T, 1997, AM J RESP CRIT CARE, V155, P845; Wulff H, 2000, P NATL ACAD SCI USA, V97, P8151, DOI 10.1073/pnas.97.14.8151; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Bodendiek SB, 2009, EUR J MED CHEM, V44, P1838, DOI 10.1016/j.ejmech.2008.10.033; O'Garra A, 1998, IMMUNITY, V8, P275, DOI 10.1016/S1074-7613(00)80533-6; JUNE CH, 1989, J AUTOIMMUN, V2, P55, DOI 10.1016/0896-8411(89)90117-0; Frazer KA, 1997, GENOME RES, V7, P495; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; SATAKE M, 1993, J AM CHEM SOC, V115, P361, DOI 10.1021/ja00054a061; Beeton C, 2006, P NATL ACAD SCI USA, V103, P17414, DOI 10.1073/pnas.0605136103; Cuypers E, 2008, TOXICON, V51, P974, DOI 10.1016/j.toxicon.2008.01.004; Wulff H, 2003, CURR OPIN DRUG DI DE, V6, P640; Kopljar I, 2013, J GEN PHYSIOL, V141, P359, DOI 10.1085/jgp.201210890; Alfonso A, 2005, BIOCHEM PHARMACOL, V69, P1627, DOI 10.1016/j.bcp.2005.03.022; Alonso E, 2012, J AM CHEM SOC, V134, P7467, DOI 10.1021/ja300565t; Lam J, 2011, DRUG DEVELOP RES, V72, P573, DOI 10.1002/ddr.20467; Fuwa H, 2002, J AM CHEM SOC, V124, P14983, DOI 10.1021/ja028167a; Chandy KG, 2004, TRENDS PHARMACOL SCI, V25, P280, DOI 10.1016/j.tips.2004.03.010; Wills-Karp M, 2004, IMMUNOL REV, V202, P175, DOI 10.1111/j.0105-2896.2004.00215.x; Cahalan MD, 2009, IMMUNOL REV, V231, P59, DOI 10.1111/j.1600-065X.2009.00816.x; Maes T, 2012, AM J RESP CELL MOL, V47, P261, DOI 10.1165/rcmb.2012-0080TR; Varga Z, 2010, IMMUNOL LETT, V130, P19, DOI 10.1016/j.imlet.2009.12.015; DECOURSEY TE, 1984, NATURE, V307, P465, DOI 10.1038/307465a0; Fuwa H, 2004, CHEM-EUR J, V10, P4894, DOI 10.1002/chem.200400355; Perez S, 2012, CHEM RES TOXICOL, V25, P1929, DOI 10.1021/tx300242m; Saeed AI, 2003, BIOTECHNIQUES, V34, P374; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Rudd CE, 1999, CELL, V96, P5, DOI 10.1016/S0092-8674(00)80953-8; Beeton C, 2003, J BIOL CHEM, V278, P9928, DOI 10.1074/jbc.M212868200; CAHALAN MD, 1985, J PHYSIOL-LONDON, V358, P197; Chandy KG, 2001, TOXICON, V39, P1269, DOI 10.1016/S0041-0101(01)00120-9; Fanger CM, 2001, J BIOL CHEM, V276, P12249, DOI 10.1074/jbc.M011342200; Hu LN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054267; Hu LN, 2012, J BIOL CHEM, V287, P1261, DOI 10.1074/jbc.M111.296798; Huang da W, 2009, CURR PROTOC BIOINFOR, P11; Huang da W., 2009, NAT PROTOC, V4, P44, DOI [DOI 10.1038/NPR0T.2008.211, 10.1038/nprot.2008.211]; HUANG SK, 1995, J IMMUNOL, V155, P2688; Nicolaou SA, 2009, J IMMUNOL, V183, P6296, DOI 10.4049/jimmunol.0900613; Panyi G, 2004, IMMUNOL LETT, V92, P55, DOI 10.1016/j.imlet.2003.11.020; Rael Efren L, 2011, World Allergy Organ J, V4, P54, DOI 10.1097/WOX.0b013e31821188e0; Ellisen LW, 2001, EUR J CELL BIOL, V80, P321, DOI 10.1078/0171-9335-00162; Varga Z, 2012, MOL PHARMACOL, V82, P372, DOI 10.1124/mol.112.078006; WISKOCIL R, 1985, J IMMUNOL, V134, P1599; Ying S, 1997, J IMMUNOL, V158, P5050	49	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-5761	1432-0738		ARCH TOXICOL	Arch. Toxicol.	JUL	2015	89	7					1119	1134		10.1007/s00204-014-1299-2		16	Toxicology	Toxicology	CK3EQ	WOS:000356099800011		
J	Hammad, S; Omar, MA; Abdallah, MF; Abdel-Wareth, AAA; Al-Aboody, MS; Ahmed, H				Hammad, Seddik; Omar, Mosaab A.; Abdallah, Mohammed F.; Abdel-Wareth, Ahmed A. A.; Al-Aboody, Mohammad S.; Ahmed, Hassan			Current research on experimental and applied animal sciences	ARCHIVES OF TOXICOLOGY			English	Letter							GENE-EXPRESSION ALTERATIONS; VITRO TEST SYSTEMS; OF-THE-ART; IN-VITRO; FUTURE PERSPECTIVES; PRIMARY HEPATOCYTES; LIVER-REGENERATION; CELL; HEPATOTOXICITY; NEPHROTOXICITY		[Hammad, Seddik] South Valley Univ, Dept Forens Med & Vet Toxicol, Fac Vet Med, Qena, Egypt; [Omar, Mosaab A.; Al-Aboody, Mohammad S.] Majmaah Univ, Dept Med Labs, Coll Sci, Alzulfi, Saudi Arabia; [Abdallah, Mohammed F.] Hacettepe Univ, Fac Pharm, Dept Pharmaceut Toxicol, Sihyyie Ankara, Turkey; [Abdel-Wareth, Ahmed A. A.] Univ Bonn, Inst Anim Sci, Anim Nutr Grp, Bonn, Germany; [Ahmed, Hassan] Natl Inst Physiol Sci, Div Cerebral Circuitry, Okazaki, Aichi 444, Japan	Hammad, S (reprint author), South Valley Univ, Dept Forens Med & Vet Toxicol, Fac Vet Med, Qena, Egypt.	seddik.hammad@vet.svu.edu.eg	Abdel-Wareth, Ahmed/I-8338-2015	Abdel-Wareth, Ahmed/0000-0001-5886-0415			Schug M, 2013, ARCH TOXICOL, V87, P337, DOI 10.1007/s00204-012-0999-8; Ramaiahgari SC, 2014, ARCH TOXICOL, V88, P1083, DOI 10.1007/s00204-014-1215-9; Godoy P, 2013, ARCH TOXICOL, V87, P1315, DOI 10.1007/s00204-013-1078-5; Tiong HY, 2014, MOL PHARMACEUT, V11, P1933, DOI 10.1021/mp400720w; Watzek N, 2013, ARCH TOXICOL, V87, P1545, DOI 10.1007/s00204-013-1054-0; Waldmann T, 2014, CHEM RES TOXICOL, V27, P408, DOI 10.1021/tx400402j; Zellmer S, 2010, HEPATOLOGY, V52, P2127, DOI 10.1002/hep.23930; Zimmer B, 2014, ARCH TOXICOL, V88, P1109, DOI 10.1007/s00204-014-1231-9; Heise T, 2012, CURR MED CHEM, V19, P1721; Leist M, 2013, ARCH TOXICOL, V87, P2037, DOI 10.1007/s00204-013-1154-x; Ghallab A, 2013, EXCLI J, V12, P1024; Lilienblum W, 2008, ARCH TOXICOL, V82, P211, DOI 10.1007/s00204-008-0279-9; Hohme S, 2007, CHEM-BIOL INTERACT, V168, P74, DOI 10.1016/j.cbi.2007.01.010; Drasdo D, 2014, J HEPATOL, V61, P951, DOI 10.1016/j.jhep.2014.06.013; Hoehme S, 2010, P NATL ACAD SCI USA, V107, P10371, DOI 10.1073/pnas.0909374107; Godoy P, 2009, HEPATOLOGY, V49, P2031, DOI 10.1002/hep.22880; Krug AK, 2013, ARCH TOXICOL, V87, P123, DOI 10.1007/s00204-012-0967-3; Hammad S, 2013, EXCLI J, V12, P993; Hammad S, 2014, ARCH TOXICOL, V88, P1161, DOI 10.1007/s00204-014-1243-5; Balmer NV, 2014, ARCH TOXICOL, V88, P1451, DOI 10.1007/s00204-014-1279-6; Godoy P, 2010, BIOL CHEM, V391, P73, DOI 10.1515/BC.2010.010; Deluzurieux M, 2013, JEAAS, V1, P10; Drasdo D, 2014, ARCH TOXICOL, V88, P2071, DOI 10.1007/s00204-014-1384-6; Gebel T, 2014, ARCH TOXICOL, V88, P2191, DOI 10.1007/s00204-014-1383-7; Ghallab A, 2014, ARCH TOXICOL, V88, P2085, DOI 10.1007/s00204-014-1404-6; Graham WA, 2014, JEAAS, V1, P182; Grinberg M, 2014, ARCH TOXICOL, V88, P2261, DOI 10.1007/s00204-014-1400-x; Hammad S, 2013, J EXP APPL ANIM SCI, V1, P1; Hengstler JG, 2014, ARCH TOXICOL, V88, P2083, DOI 10.1007/s00204-014-1398-0; Huang JX, 2014, EXPERT OPIN DRUG MET, V10, P1621, DOI 10.1517/17425255.2014.967681; Ikewuchi JC, 2013, JEAAS, V1, P56; Intzoglou KS, 2014, JEAAS, V1, P229; Mallaiah P, 2014, JEAAS, V1, P186; Marchan R, 2013, ARCH TOXICOL, V87, P2043, DOI 10.1007/s00204-013-1164-8; Mishra D, 2013, JEAAS, V1, P4; Musk GC, 2014, JEAAS, V1, P273; Pullanna K, 2014, JEAAS, V1, P253; Rezaei F, 2014, JEAAS, V1, P290; Schliess F, 2014, HEPATOLOGY, V60, P2040, DOI 10.1002/hep.27136; Soriano-Ubeda C, 2013, J EXP APPL ANIM SCI, V1, P67; Zarrindast MR, 2013, JEAAS, V1, P44	41	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-5761	1432-0738		ARCH TOXICOL	Arch. Toxicol.	JUL	2015	89	7					1149	1150		10.1007/s00204-015-1534-5		2	Toxicology	Toxicology	CK3EQ	WOS:000356099800013		
J	Kanehira, K; Uchida, Y; Takemae, N; Hikono, H; Tsunekuni, R; Saito, T				Kanehira, Katsushi; Uchida, Yuko; Takemae, Nobuhiro; Hikono, Hirokazu; Tsunekuni, Ryota; Saito, Takehiko			Characterization of an H5N8 influenza A virus isolated from chickens during an outbreak of severe avian influenza in Japan in April 2014	ARCHIVES OF VIROLOGY			English	Article							HONG-KONG; DOMESTIC DUCKS; VIRULENCE; POULTRY; PROTEIN; TRANSMISSION; PATHOLOGY; BINDING; CHINA; BIRDS	A highly pathogenic avian influenza virus (HPAIV) of subtype H5N8, A/chicken/Kumamoto/1-7/2014, was isolated from a Japanese chicken farm during an outbreak in April 2014. Phylogenetic analysis revealed that this virus belonged to HA clade 2.3.4.4. All eight genomic segments showed high sequence similarity to those of the H5N8 subtype HPAIVs A/broiler duck/Korea/Buan2/2014 and A/baikal teal/Korea/Donglim3/2014, which were isolated in Korea in January 2014. Intranasal experimental infection of chickens and ducks with A/chicken/Kumamoto/1-7/2014 was performed to assess the pathogenicity of the virus in chickens and the potential for waterfowl to act as a virus reservoir and carrier. A high-titer virus challenge (10(6) EID50 per animal) was lethal in chickens, but they were unaffected by lower virus doses (10(2) EID50 or 10(4) EID50 per animal). Virus challenge at all doses examined was found to result in asymptomatic infection of ducks. An HI assay revealed that A/chicken/Kumamoto/1-7/2014 possessed relatively low cross-reactivity with H5 viruses belonging to clades other than clade 2.3.4.4. These results suggest that waterfowl may be able to spread the virus even if they possess antibodies resulting from a previous infection with H5 HPAIV that was antigenically distinguishable from viruses belonging to clade 2.3.4.4.	[Kanehira, Katsushi; Uchida, Yuko; Takemae, Nobuhiro; Hikono, Hirokazu; Tsunekuni, Ryota; Saito, Takehiko] Natl Agr & Food Res Org NARO, Natl Inst Anim Hlth, Influenza & Prion Dis Res Ctr, Tsukuba, Ibaraki 3050856, Japan; [Saito, Takehiko] Gifu Univ, United Grad Sch Vet Sci, Gifu 5011193, Japan	Saito, T (reprint author), Natl Agr & Food Res Org NARO, Natl Inst Anim Hlth, Influenza & Prion Dis Res Ctr, 3-1-5 Kannondai, Tsukuba, Ibaraki 3050856, Japan.	taksaito@affrc.go.jp			Ministry of Agriculture, Forestry and Fisheries of Japan	We would like to thank Dr. Masaomi Mori, Kumamoto Prefectural Livestock Hygiene Center, Japan, and Dr. Youn-Jeong Lee of the Animal and Plant Quarantine Agency, Korea, for kindly providing us with viral samples. We would also like to thank Dr. Eri Nobusawa, National Institute of Infectious Diseases, Japan, for providing Anh05 antigen, and post-infection ferret serum against Anh05 and Kum14. This study was partially supported by a research project for improving food safety and animal health from the Ministry of Agriculture, Forestry and Fisheries of Japan.	Bridges CB, 2002, J INFECT DIS, V185, P1005, DOI 10.1086/340044; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Uchida Y, 2012, VIRUS RES, V170, P109, DOI 10.1016/j.virusres.2012.09.004; Fan SF, 2009, VIROLOGY, V384, P28, DOI 10.1016/j.virol.2008.11.044; PINTO LH, 1992, CELL, V69, P517, DOI 10.1016/0092-8674(92)90452-I; Mase M, 2005, VIROLOGY, V332, P167, DOI 10.1016/j.virol.2004.11.016; Jiao PR, 2008, J VIROL, V82, P1146, DOI 10.1128/JVI.01698-07; Nidom CA, 2010, EMERG INFECT DIS, V16, P1515, DOI 10.3201/eid1610.100508; de Vries RP, 2014, J VIROL, V88, P768, DOI 10.1128/JVI.02690-13; Uchida Y, 2008, VIRUS RES, V138, P70, DOI 10.1016/j.virusres.2008.08.007; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264; Lee YJ, 2014, EMERG INFECT DIS, V20, P1087, DOI 10.3201/eid2006.140233; Kanehira K, 2014, MICROBIOL IMMUNOL, V58, P327, DOI 10.1111/1348-0421.12152; KIDA H, 1980, INFECT IMMUN, V30, P547; Samson M, 2013, ANTIVIR RES, V98, P174, DOI 10.1016/j.antiviral.2013.03.014; Kilpatrick AM, 2006, P NATL ACAD SCI USA, V103, P19368, DOI 10.1073/pnas.0609227103; Liu QF, 2012, J VIROL, V86, P1233, DOI 10.1128/JVI.05699-11; Sakoda Y, 2012, J GEN VIROL, V93, P541, DOI 10.1099/vir.0.037572-0; Xu XY, 1999, VIROLOGY, V261, P15, DOI 10.1006/viro.1999.9820; Nakamura K, 2008, AVIAN DIS, V52, P8, DOI 10.1637/8027-060607-Reg; Wu HB, 2014, EMERG INFECT DIS, V20, P1315, DOI 10.3201/eid2008.140339; Gu M, 2013, EMERG INFECT DIS, V19, P2021, DOI 10.3201/eid1912.130340; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Kim Young-Il, 2014, Emerg Microbes Infect, V3, pe75, DOI 10.1038/emi.2014.75; Li QH, 2014, VET RES, V45, DOI 10.1186/s13567-014-0127-2; Linster M, 2014, CELL, V157, P329, DOI 10.1016/j.cell.2014.02.040; REED L. J., 1938, AMER JOUR HYG, V27, P493; Ramey AM, 2013, JPN J VET RES, V61, P117; Schmolke M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002186; Srinivasan K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049597; Steel J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000252; Watanabe Y, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002068; Smith GJD, 2014, INFLUENZA OTHER RESP, V8, P384, DOI 10.1111/irv.12230; World Organisation for Animal Health, 2014, AV INFL MAN DIAGN TE; World Organisation for Animal Health, 2014, UPD HIGHL PATH AV IN; World Organisation for Animal Health, 2015, UPD HIGHL PATH AV IN; Yamamoto Y, 2010, JARQ-JPN AGR RES Q, V44, P73; Yang H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001081	38	1	1	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0304-8608	1432-8798		ARCH VIROL	Arch. Virol.	JUL	2015	160	7					1629	1643		10.1007/s00705-015-2428-9		15	Virology	Virology	CK3FA	WOS:000356100800002		
J	Kitajima, M; Rachmadi, AT; Iker, BC; Haramoto, E; Pepper, IL; Gerba, CP				Kitajima, Masaaki; Rachmadi, Andri T.; Iker, Brandon C.; Haramoto, Eiji; Pepper, Ian L.; Gerba, Charles P.			Occurrence and genetic diversity of human cosavirus in influent and effluent of wastewater treatment plants in Arizona, United States	ARCHIVES OF VIROLOGY			English	Article						Cosavirus; qPCR; Wastewater; Nested PCR; Phylogenetic analysis	IDENTIFICATION; ENTEROVIRUS	Human cosavirus (HCoSV) is a novel member of the family Picornaviridae. We investigated the prevalence and genetic diversity of HCoSV in influent and effluent wastewater in Arizona over a 12-month period, from August 2011 to July 2012. HCoSV sequences were identified in six (25 %) influent samples and one (4 %) effluent sample, with the highest concentration of 3.24 x 10(5) and 1.54 x 10(3) copies/liter in influent and effluent, respectively. The strains were characterized based on their 5' untranslated region and classified into species A and D, demonstrating that genetically heterogeneous HCoSV were circulating with a clear temporal shift of predominant strains in the study area.	[Kitajima, Masaaki; Rachmadi, Andri T.; Iker, Brandon C.; Pepper, Ian L.; Gerba, Charles P.] Univ Arizona, Dept Soil Water & Environm Sci, Tucson, AZ 85721 USA; [Haramoto, Eiji] Univ Yamanashi, Int Res Ctr River Basin Environm, Kofu, Yamanashi 4008511, Japan	Kitajima, M (reprint author), Singapore MIT Alliance Res & Technol, Ctr Environm Sensing & Modeling, 1 CREATE Way,09-03 CREATE Tower, Singapore 138602, Singapore.	kitajima@smart.mit.edu	Haramoto, Eiji/D-2301-2013		National Science Foundation (NSF) Water and Environmental Technology (WET) Center, The University of Arizona; Japan Society for the Promotion of Science (JSPS) under JSPS Postdoctoral Fellowships for Research Abroad [517]; Fulbright Master of Science and Technology Scholarship	This study was partly supported by the National Science Foundation (NSF) Water and Environmental Technology (WET) Center, The University of Arizona.; We also wish to acknowledge the support of the Japan Society for the Promotion of Science (JSPS) to Masaaki Kitajima, under JSPS Postdoctoral Fellowships for Research Abroad (FY 2011 no. 517). Andri T. Rachmadi is a recipient of a 2012 Fulbright Master of Science and Technology Scholarship.	Katayama H, 2002, APPL ENVIRON MICROB, V68, P1033, DOI 10.1128/AEM.68.3.1033-1039.2002; Blinkova O, 2009, J CLIN MICROBIOL, V47, P3507, DOI 10.1128/JCM.01062-09; Haramoto E, 2014, FOOD ENVIRON VIROL, V6, P62, DOI 10.1007/s12560-013-9120-6; Gerba CP, 2013, WOODHEAD PUBL FOOD S, P293, DOI 10.1533/9780857098870.3.293; Sinclair RG, 2008, ADV APPL MICROBIOL, V65, P249, DOI 10.1016/S0065-2164(08)00609-6; Tapparel C, 2013, INFECT GENET EVOL, V14, P282, DOI 10.1016/j.meegid.2012.10.016; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Kitajima M, 2014, SCI TOTAL ENVIRON, V488, P290, DOI 10.1016/j.scitotenv.2014.04.087; Kapoor A, 2008, P NATL ACAD SCI USA, V105, P20482, DOI 10.1073/pnas.0807979105; Bibby K, 2013, ENVIRON SCI TECHNOL, V47, P1945, DOI 10.1021/es305181x; Kapusinszky B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036685; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kitajima M, 2014, FOOD ENVIRON VIROL, V6, P213, DOI 10.1007/s12560-014-9148-2; Ng Terry Fei Fan, 2012, J Virol, V86, P12161, DOI 10.1128/JVI.00869-12; Rezig D, 2014, J VIROL METHODS, V207, P12, DOI 10.1016/j.jviromet.2014.06.011; Stocker A, 2012, EMERG INFECT DIS, V18, P656, DOI 10.3201/eid1804.111415	16	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0304-8608	1432-8798		ARCH VIROL	Arch. Virol.	JUL	2015	160	7					1775	1779		10.1007/s00705-015-2435-x		5	Virology	Virology	CK3FA	WOS:000356100800016		
J	Sakamoto, SH; Eto, T; Okubo, Y; Shinohara, A; Morita, T; Koshimoto, C				Sakamoto, Shinsuke H.; Eto, Takeshi; Okubo, Yoshinobu; Shinohara, Akio; Morita, Tetsuo; Koshimoto, Chihiro			The effects of maternal presence on natal dispersal are seasonally flexible in an asocial rodent	BEHAVIORAL ECOLOGY AND SOCIOBIOLOGY			English	Article						Flexibility; Kin competition; Reproductive competition; Social thermoregulation; Solitary living	JAPANESE FIELD-MOUSE; SIBERIAN FLYING SQUIRREL; WHITE-FOOTED MICE; APODEMUS-SPECIOSUS; REPRODUCTIVE COMPETITION; SOCIAL THERMOREGULATION; RHABDOMYS PUMILIO; GROUND-SQUIRRELS; KIN RECOGNITION; MAMMALS	In mammals, social tolerance among females, the philopatric sex, is formed through continued physical proximity between kin after offspring are weaned. However, the benefits of continued close association may be outweighed by costs such as local resource competition and risk of inbreeding. We hypothesized that for 'philopatric females', a flexible tendency towards either natal dispersal or philopatry is an important behavioral response to changes in social conditions. We examined this using an asocial rodent, Apodemus speciosus, which exhibits two discrete breeding seasons, one in spring and the second in autumn. Daughters and mothers were shown to recognize each other as kin at the time of weaning in both seasons. In spring, some mothers reproduced twice, and some first-litter daughters matured and reproduced in the same season. In autumn, however, only mothers reproduced, and there were no second litters. In spring, the proportion of natal dispersers was higher among weaned offspring whose mother remained present than those whose mother was absent, while in autumn, natal dispersal was more frequent when the mother was absent than when she remained. Sons dispersed earlier than their female littermates. Population density alone is insufficient to explain these patterns. We suggest that variable levels of reproductive competition between female kin result in seasonal differences in female natal dispersal. Breeding condition can be modulated by environmental factors, and the promotion of reproductive activity of females in spring may cause natal dispersal of daughters, while the inhibition of reproductive activity in autumn may permit philopatry.	[Sakamoto, Shinsuke H.; Shinohara, Akio; Koshimoto, Chihiro] Miyazaki Univ, Div Bioresources, Frontier Sci Res Ctr, Kiyotake, Miyazaki 8891692, Japan; [Eto, Takeshi; Okubo, Yoshinobu] Miyazaki Univ, Interdisciplinary Grad Sch Agr & Engn, Miyazaki 8892192, Japan; [Morita, Tetsuo] Miyazaki Univ, Fac Agr, Miyazaki 8892192, Japan	Koshimoto, C (reprint author), Miyazaki Univ, Div Bioresources, Frontier Sci Res Ctr, Kiyotake, Miyazaki 8891692, Japan.	ckos@med.miyazaki-u.ac.jp			JSPS [24657018, 23650236]; University of Miyazaki	We are grateful to Takashi Saitou, Tadashi Suzuki, Tamotsu Kusano, and Fumio Hayashi for their advice on this study. We would like to thank Yusuke Sakai and Ryousuke Ozaki for help with animal maintenance. We thank the Agricultural and Forestry Research Center of the University of Tsukuba for permission to conduct the field study within the site. This study was supported by Grant-in-Aid for Challenging Exploratory Research from JSPS (Grant Numbers 24657018 to Shinsuke H. Sakamoto; 23650236 to Chihiro Koshimoto) and by grants from the University of Miyazaki (Support Program for Integrated Research Project for Human and Veterinary Medicine, and Athena research fellowships). This study was presented at the workshop "Dispersal male and Philopatric female" at the annual meeting of the Mammalogical Society, Japan, in 2012. We thank Takuya Shimada, Naoki Onishi, Yamato Tsuji, and Akihiro Yamane, the organizers of the workshop. We are grateful to the two reviewers who provided insightful comments on an earlier version of the text.	ADAMCZEWSKA KRYSTYNA A., 1961, ACTA THERIOL, V5, P1; WALDMAN B, 1988, ANNU REV ECOL SYST, V19, P543; Sinervo B, 2003, SCIENCE, V300, P1949, DOI 10.1126/science.1083109; Dingemanse NJ, 2003, P ROY SOC B-BIOL SCI, V270, P741, DOI 10.1098/rspb.2002.2300; Kokko H, 2006, AM NAT, V167, P901, DOI 10.1086/504604; Shintaku Y, 2010, J MAMMAL, V91, P1168, DOI 10.1644/09-MAMM-A-305.1; Clarke AL, 1997, OIKOS, V79, P429, DOI 10.2307/3546885; BRONSON FH, 1985, BIOL REPROD, V32, P1, DOI 10.1095/biolreprod32.1.1; Bronson FH, 2009, PHILOS T R SOC B, V364, P3331, DOI 10.1098/rstb.2009.0140; Schradin C, 2012, MOL ECOL, V21, P541, DOI 10.1111/j.1365-294X.2011.05256.x; Clutton-Brock TH, 2012, MOL ECOL, V21, P472, DOI 10.1111/j.1365-294X.2011.05232.x; Le Galliard JF, 2012, MOL ECOL, V21, P505, DOI 10.1111/j.1365-294X.2011.05410.x; Edelman AJ, 2007, ETHOLOGY, V113, P147, DOI 10.1111/j.1439-0310.2006.01310.x; Brostrom G, 2011, COMPUT STAT DATA AN, V55, P3123, DOI 10.1016/j.csda.2011.06.011; Le Galliard JF, 2006, BEHAV ECOL, V17, P733, DOI 10.1093/beheco/arl002; Schoepf I, 2012, J ANIM ECOL, V81, P649, DOI 10.1111/j.1365-2656.2011.01939.x; Le Galliard JF, 2005, AM NAT, V165, P206, DOI 10.1086/427090; Anderson DR, 2000, J WILDLIFE MANAGE, V64, P912, DOI 10.2307/3803199; DOBSON FS, 1982, ANIM BEHAV, V30, P1183; WASER PM, 1985, ECOLOGY, V66, P1170, DOI 10.2307/1939169; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Cote J, 2007, P R SOC B, V274, P383, DOI 10.1098/rspb.2006.3734; Gilbert C, 2010, BIOL REV, V85, P545, DOI 10.1111/j.1469-185X.2009.00115.x; Miller TEX, 2011, AM NAT, V177, P549, DOI 10.1086/659628; Kokko H, 2008, J EVOLUTION BIOL, V21, P919, DOI 10.1111/j.1420-9101.2008.01540.x; Schradin C, 2010, J ANIM ECOL, V79, P515, DOI 10.1111/j.1365-2656.2009.01651.x; Arnaud CM, 2012, MOL ECOL, V21, P493, DOI 10.1111/j.1365-294X.2011.05219.x; Beery AK, 2009, PHYSIOL BEHAV, V97, P52, DOI 10.1016/j.physbeh.2009.01.020; Burnham K. P., 2002, MODEL SELECTION MULT; Clobert Jean, 2008, P323; Clobert Jean, 2004, P307, DOI 10.1016/B978-012323448-3/50015-5; Corbet G.B., 1978, MAMMALS PALAEARCTIC; Eto T, 2014, PHYSIOL BEHAV, V133, P22, DOI 10.1016/j.physbeh.2014.04.051; Goldman B. D., 2003, SCI STKE, V192, ppe29; Hanski IK, 2009, BEHAV ECOL, V20, P60, DOI 10.1093/beheco/arn115; Harold JG, 1982, ANIM BEHAV, V30, P497; HOLMES WG, 1986, ANIM BEHAV, V34, P38, DOI 10.1016/0003-3472(86)90004-7; JACQUOT JJ, 1995, BEHAV ECOL SOCIOBIOL, V37, P407, DOI 10.1007/BF00170588; JANS JE, 1983, PHYSIOL BEHAV, V30, P959, DOI 10.1016/0031-9384(83)90261-5; Lacey Eileen A., 2007, P243; Lambin Xavier, 2001, P110; LAMBIN X, 1994, J ANIM ECOL, V63, P945, DOI 10.2307/5271; Le Galliard JF, 2007, BEHAV ECOL, V18, P665, DOI 10.1093/beheco/arm023; LEGAN SJ, 1980, BIOL REPROD, V23, P1061, DOI 10.1095/biolreprod23.5.1061; Lott DF, 1991, INTRASPECIFIC VARIAT; MALOIY GMO, 1988, COMP BIOCHEM PHYS A, V91, P1, DOI 10.1016/0300-9629(88)91583-6; Nakata K., 2009, WILD MAMMALS JAPAN, P169; Oh HS, 1998, J FAC AGR KYUSHU U, V42, P397; OKA T, 1992, ECOL RES, V7, P163, DOI 10.1007/BF02348495; Pinheiro J, 2012, NLME LINEAR NONLINEA; PORTER RH, 1981, DEV PSYCHOBIOL, V14, P375, DOI 10.1002/dev.420140410; PRYCHODKO W, 1958, ECOLOGY, V39, P500, DOI 10.2307/1931760; Quirici V, 2011, BEHAV ECOL SOCIOBIOL, V65, P787, DOI 10.1007/s00265-010-1082-1; R Development Core Team, 2012, R LANG ENV STAT COMP; Sakamoto SH, 2012, MAMM STUDY, V37, P261, DOI 10.3106/041.037.0401; Sekijima T, 1995, J MAMMALOGICAL SOC J, V20, P143; Selonen V, 2014, BEHAV ECOL SOCIOBIOL, V68, P971, DOI 10.1007/s00265-014-1709-8; Selonen V, 2010, BEHAV ECOL SOCIOBIOL, V64, P1019, DOI 10.1007/s00265-010-0917-0; Shields W.M., 1987, P3; Stamps Judy A., 2001, P230; Stenseth N.C., 1992, P5; Therneau T, 2011, COXME MIXED EFFECTS; VANAARDE RJ, 1985, J REPROD FERTIL, V75, P577; Williams CT, 2013, BEHAV ECOL SOCIOBIOL, V67, P757, DOI 10.1007/s00265-013-1499-4; WOLFF JO, 1992, NATURE, V359, P409, DOI 10.1038/359409a0	65	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0340-5443	1432-0762		BEHAV ECOL SOCIOBIOL	Behav. Ecol. Sociobiol.	JUL	2015	69	7					1075	1084		10.1007/s00265-015-1920-2		10	Behavioral Sciences; Ecology; Zoology	Behavioral Sciences; Environmental Sciences & Ecology; Zoology	CK2ML	WOS:000356044700002		
J	Ikegami, A; Ueshima, K; Saito, M; Ikoma, K; Fujioka, M; Hayashi, S; Ishida, M; Fujiwara, H; Mazda, O; Kubo, T				Ikegami, Akira; Ueshima, Keiichiro; Saito, Masazumi; Ikoma, Kazuya; Fujioka, Mikihiro; Hayashi, Shigeki; Ishida, Masashi; Fujiwara, Hiroyoshi; Mazda, Osam; Kubo, Toshikazu			Femoral perfusion after pulsed electromagnetic field stimulation in a steroid-induced osteonecrosis model	BIOELECTROMAGNETICS			English	Article						corticosteroid-induced osteonecrosis; femoral blood flow; dynamic contrast-enhanced MR	CORTICOSTEROID-INDUCED OSTEONECROSIS; UP-REGULATION; IN-VITRO; RABBITS; HEAD; ANGIOGENESIS; RATS	This study was designed to evaluate femoral perfusion after pulsed electromagnetic field (PEMF) stimulation in a steroid-induced osteonecrosis rabbit model by dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI). Steroid-induced osteonecrosis was produced by single intramuscular injection of methylprednisolone in 15 rabbits. Eight rabbits underwent PEMF stimulation (PEMF group) and seven did not (control group). DCE-MRI was performed before PEMF stimulation, immediately before steroid administration, and 1, 5, 10, and 14 days after steroid administration. Regions of interest were set in the bilateral proximal femora. Enhancement ratio (ER), initial slope (IS), and area under the curve (AUC) were analyzed. ER, IS, and AUC in the control group significantly decreased after steroid administration compared with before administration (P<0.05). In PEMF group, IS significantly decreased; however, ER and AUC showed no significant differences after steroid administration compared with before. ER and IS in PEMF group were higher than in control group until 10th day, and AUC was higher until 5th day after steroid administration (P<0.05). PEMF stimulation restrains the decrease in blood flow after steroid administration. Bioelectromagnetics. 36:349-357, 2015. (c) 2015 Wiley Periodicals, Inc.	[Ikegami, Akira; Ueshima, Keiichiro; Saito, Masazumi; Ikoma, Kazuya; Fujioka, Mikihiro; Hayashi, Shigeki; Ishida, Masashi; Fujiwara, Hiroyoshi; Kubo, Toshikazu] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Orthopaed, Kyoto 6028566, Japan; [Mazda, Osam] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Immunol, Kyoto 6028566, Japan	Saito, M (reprint author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Orthopaed, Kamigyo Ku, Kyoto 6028566, Japan.	masaito@koto.kpu-m.ac.jp			Research on Rare and Intractable Diseases, Health and Labour Sciences Research; Hip Joint Foundation of Japan [H24-nanchi-ippan-001]	Grant sponsor: Research on Rare and Intractable Diseases, Health and Labour Sciences Research (H24-nanchi-ippan-001); Hip Joint Foundation of Japan.	Aaron RK, 2002, J ORTHOPAED RES, V20, P233, DOI 10.1016/S0736-0266(01)00084-5; Motomura G, 2004, ARTHRITIS RHEUM, V50, P3387, DOI 10.1002/art.20517; Iuchi T, 2003, CIRC RES, V92, P81, DOI 10.1161/01.RES.0000050588.35034.3C; Weinstein RS, 2010, AGING CELL, V9, P147, DOI 10.1111/j.1474-9726.2009.00545.x; Kubo T, 1997, MAGN RESON IMAGING, V15, P1017, DOI 10.1016/S0730-725X(97)00159-8; YAMAMOTO T, 1995, CLIN ORTHOP RELAT R, P235; Kuribayashi M, 2010, ACTA ORTHOP, V81, P154, DOI [10.3109/17453671003628772, 10.3109/17453671003587101]; Chalidis B, 2011, INT J IMMUNOPATH PH, V24, P17; Miyanishi K, 2005, RHEUMATOLOGY, V44, P332, DOI 10.1093/rheumatology/keh505; Bodamyali T, 1998, BIOCHEM BIOPH RES CO, V250, P458, DOI 10.1006/bbrc.1998.9243; [Anonymous], 2004, CLIN ORTHOP RELAT R, DOI 10.1097/00003086-200402000-00005; Massari L, 2006, J BONE JOINT SURG AM, V88A, P56, DOI 10.2106/JBJS.F.00536; Tepper OM, 2004, FASEB J, V18, P1231, DOI 10.1096/fj.03-0847fje; Yang XY, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/732848; NAGAI M, 1994, J DENT RES, V73, P1601; ATSUMI T, 1992, CLIN ORTHOP RELAT R, P22; BASSETT CAL, 1982, JAMA-J AM MED ASSOC, V247, P623, DOI 10.1001/jama.247.5.623; Ding S, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-215; Goto T, 2010, J ORTHOP SCI, V15, P661, DOI 10.1007/s00776-010-1510-0; Hayashi S, 2014, J MAGN RESO IN PRESS; Ichiseki T, 2006, RHEUMATOLOGY, V45, P287, DOI 10.1093/rheumatology/kei149; Ishida M, 2008, CLIN ORTHOP RELAT R, V466, P1068, DOI 10.1007/s11999-008-0182-y; Kabata T, 2008, J RHEUMATOL, V35, P2383, DOI 10.3899/jrheum.070838; Kerachian MA, 2009, J STEROID BIOCHEM, V116, P127, DOI 10.1016/j.jsbmb.2009.05.001; Kerachian MA, 2006, ENDOTHELIUM-J ENDOTH, V13, P237, DOI 10.1080/10623320600904211; Miyanishi K, 2001, RHEUMATOLOGY, V40, P196, DOI 10.1093/rheumatology/40.2.196; Nelson Fred R T, 2003, J Am Acad Orthop Surg, V11, P344; Smith TL, 2004, J ORTHOPAED RES, V22, P80, DOI 10.1016/S0736-0266(03)00157-8	28	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0197-8462	1521-186X		BIOELECTROMAGNETICS	Bioelectromagnetics	JUL	2015	36	5					349	357		10.1002/bem.21910		9	Biology; Biophysics	Life Sciences & Biomedicine - Other Topics; Biophysics	CK2XQ	WOS:000356078700003		
J	Mahara, A; Somekawa, S; Kobayashi, N; Hirano, Y; Kimura, Y; Fujisato, T; Yamaoka, T				Mahara, Atsushi; Somekawa, Shota; Kobayashi, Naoki; Hirano, Yoshiaki; Kimura, Yoshiharu; Fujisato, Toshiya; Yamaoka, Tetsuji			Tissue-engineered acellular small diameter long-bypass grafts with neointima-inducing activity	BIOMATERIALS			English	Article						Small-diameter vascular graft; Long bypass; Acellular; Tissue engineering; Neointima	BLOOD-VESSELS; VASCULAR GRAFTS; CELLS; RECONSTRUCTION; REGENERATION; RECOVERY; ARTERIES; PEPTIDE	Researchers have attempted to develop efficient antithrombogenic surfaces, and yet small-caliber artificial vascular grafts are still unavailable. Here, we demonstrate the excellent patency of tissue-engineered small-caliber long-bypass grafts measuring 20-30 cm in length and having a 2-mm inner diameter. The inner surface of an acellular ostrich carotid artery was modified with a novel hetero-bifunctional peptide composed of a collagen-binding region and the integrin alpha 4 beta 1 ligand, REDV. Six grafts were transplanted in the femoral femoral artery crossover bypass method. Animals were observed for 20 days and received no anticoagulant medication. No thrombogenesis was observed on the luminal surface and five cases were patent. In contrast, all unmodified grafts became occluded, and severe thrombosis was observed. The vascular grafts reported here are the first successful demonstrations of short-term patency at clinically applicable sizes. (C) 2015 Elsevier Ltd. All rights reserved.	[Mahara, Atsushi; Somekawa, Shota; Kobayashi, Naoki; Yamaoka, Tetsuji] Natl Cerebral & Cardiovasc Ctr, Res Inst, Dept Biomed Engn, Suita, Osaka 5658565, Japan; [Somekawa, Shota; Kimura, Yoshiharu] Kyoto Inst Technol, Dept Biobased Mat Sci, Sakyo Ku, Kyoto 6068585, Japan; [Kobayashi, Naoki; Hirano, Yoshiaki] Kansai Univ, Fac Chem Mat & Bioengn, Suita, Osaka 5658680, Japan; [Fujisato, Toshiya] Osaka Inst Technol, Dept Biomed Engn, Asahi Ku, Osaka 5358585, Japan	Yamaoka, T (reprint author), Natl Cerebral & Cardiovasc Ctr, Res Inst, Dept Biomed Engn, Suita, Osaka 5658565, Japan.	yamtet@ncvc.go.jp			National Cerebral and Cardiovascular Center [22-2-4]; Japan Science and Technology Agent (JST)	T.Y. acknowledges financial support from the Intramural Research Fund of National Cerebral and Cardiovascular Center (22-2-4) and the S-Innovation Research Program for the "Development of the biofunctional materials for realization of innovative medicine", Japan Science and Technology Agent (JST).	Ahmed M, 2014, BIOMATERIALS, V35, P9033, DOI 10.1016/j.biomaterials.2014.07.008; L'Heureux N, 1998, FASEB J, V12, P47; Swartz DD, 2005, AM J PHYSIOL-HEART C, V288, pH1451, DOI 10.1152/ajpheart.00479.2004; BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699; Yokota T, 2008, J THORAC CARDIOV SUR, V136, P900, DOI 10.1016/j.jtcvs.2008.02.058; Ma HY, 2010, ADV FUNCT MATER, V20, P2833, DOI 10.1002/adfm.201000922; Hashi CK, 2007, P NATL ACAD SCI USA, V104, P11915, DOI 10.1073/pnas.0704581104; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Funamoto S, 2010, BIOMATERIALS, V31, P3590, DOI 10.1016/j.biomaterials.2010.01.073; Hashi CK, 2010, ARTERIOSCL THROM VAS, V30, P1621, DOI 10.1161/ATVBAHA.110.208348; Neff LP, 2011, J VASC SURG, V53, P426, DOI 10.1016/j.jvs.2010.07.054; Edelman ER, 1999, CIRC RES, V85, P1115; Enomoto S, 2010, J VASC SURG, V51, P155, DOI 10.1016/j.jvs.2009.09.005; Mo X, 2006, ANGEW CHEM INT EDIT, V45, P2267, DOI 10.1002/anie.200504529; Conte MS, 1998, FASEB J, V12, P43; Fuchs JR, 2001, ANN THORAC SURG, V72, P577, DOI 10.1016/S0003-4975(01)02820-X; Rayatpisheh S, 2014, BIOMATERIALS, V35, P2713, DOI 10.1016/j.biomaterials.2013.12.035; Noishiki Y, 1996, NAT MED, V2, P90, DOI 10.1038/nm0196-90; Hoenig MR, 2005, ARTERIOSCL THROM VAS, V25, P1128, DOI 10.1161/01.ATV.0000158996.03867.72; Isenberg BC, 2006, CIRC RES, V98, P25, DOI 10.1161/01.RES.0000196867.12470.84; Chioato T., 2014, BIOMED RES INT, V2014; Ehashi T, 2011, J BIOMAT SCI-POLYM E, V22, P627, DOI 10.1163/092050610X488250; Fujisato T, 2005, CARDIOVASCULAR REGENERATION THERAPIES USING TISSUE ENGINEERING APPROACHES, P83, DOI 10.1007/4-431-27378-6_7; Isayama N, 2014, BIOMATERIALS, V35, P3589, DOI 10.1016/j.biomaterials.2014.01.006; MacNeill BD, 2002, VASC MED, V7, P241, DOI 10.1191/1358863x02vm433ra; Mahara A., 2014, J ARTIF ORGANS; Mahara A, 2014, BIOMED RES INT; MIWA H, 1994, J VASC SURG, V19, P658; Rocco K. A., 2014, TISSUE ENG PART B-RE, V26, P628; Sakakibara S, 2014, J ARTIF ORGANS, V17, P169, DOI 10.1007/s10047-014-0760-6; Sreejalekshmi M. G., 2010, J BIOMED MATER RES A, V96, P477; Title J. C., 2011, BIOMATERIALS, V33, P38; Wolfe P. S., 2009, J BIOMED MATER RES A, V92, P1321	33	4	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0142-9612	1878-5905		BIOMATERIALS	Biomaterials	JUL	2015	58						54	62		10.1016/j.biomaterials.2015.04.031		9	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	CK3ND	WOS:000356121900006		
J	Toyama, H; Nakamura, M; Hashimoto, Y; Fujii, S				Toyama, Hirozumi; Nakamura, Masaharu; Hashimoto, Yuichi; Fujii, Shinya			Design and synthesis of novel ROR inverse agonists with a dibenzosilole scaffold as a hydrophobic core structure	BIOORGANIC & MEDICINAL CHEMISTRY			English	Article						Retinoic acid receptor-related orphan receptor; ROR; Dibenzosilole; Sila-substitution	RECEPTOR; MODULATORS; CANCER; LIGAND; TRIAL; GAMMA	Molecular structure calculations indicated that the dibenzosilole skeleton could be well superposed on phenanthridinone, which is a structural component of ligands of retinoic acid receptor-related orphan receptors (RORs). Therefore, we designed, synthesized and biologically evaluated a series of novel ROR ligands based on the dibenzosilole scaffold as a hydrophobic core structure. Dibenzosilole derivatives bearing a hexafluoro-2-hydroxypropyl group on the benzene ring exhibited significant ROR-inhibitory activity, comparable to that of the lead phenanthridinone derivative 5. Our results indicate that the dibenzosilole skeleton would be a useful scaffold for developing novel biologically active compounds, and that cis-amide structure can be replaced by an alkylsilyl functionality. (C) 2015 Elsevier Ltd. All rights reserved.	[Toyama, Hirozumi; Nakamura, Masaharu; Hashimoto, Yuichi; Fujii, Shinya] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan	Fujii, S (reprint author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.	fujiis@iam.u-tokyo.ac.jp			Ministry of Education Culture, Sports, Science and Technology, Japan; Japan Society for the Promotion of Science (KAKENHI) [26293025, 25460146]	The work partially supported by 'Platform for Drug Discovery, Informatics, and Structural Life Science', and 'Grants-in-Aid for Scientific Research from The Ministry of Education Culture, Sports, Science and Technology, Japan, and the Japan Society for the Promotion of Science (KAKENHI Grant No. 26293025 (YH) and No. 25460146 (SF))'.	ALFTHAN O, 1983, SCAND J UROL NEPHROL, V17, P37; Solt LA, 2011, NATURE, V472, P491, DOI 10.1038/nature10075; Franz AK, 2013, J MED CHEM, V56, P388, DOI 10.1021/jm3010114; Nakamura M, 2013, BIOORGAN MED CHEM, V21, P7381, DOI 10.1016/j.bmc.2013.09.046; Gately S, 2007, DRUG DEVELOP RES, V68, P156, DOI 10.1002/ddr.20177; Daud A, 2005, CLIN CANCER RES, V11, P3009, DOI 10.1158/1078-0432.CCR-04-1722; Fauber BP, 2013, BIOORG MED CHEM LETT, V23, P6604, DOI 10.1016/j.bmcl.2013.10.054; Fauber BP, 2014, J MED CHEM, V57, P5871, DOI 10.1021/jm401901d; Jetten Anton M, 2009, Nucl Recept Signal, V7, pe003, DOI 10.1621/nrs.07003; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Morris G. M., 2009, J COMPUT CHEM, V16, P2785, DOI DOI 10.1002/JCC.21256; Nishiyama Y, 2014, BIOORGAN MED CHEM, V22, P2799, DOI 10.1016/j.bmc.2014.03.007; Rizvi NA, 2002, J CLIN ONCOL, V20, P3522, DOI 10.1200/JCO.2002.02.090; Toyama H., 1948, BIOORGAN MED CHEM, V2014, P22	14	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-0896	1464-3391		BIOORGAN MED CHEM	Bioorg. Med. Chem.	JUL 1	2015	23	13					2982	2988		10.1016/j.bmc.2015.05.004		7	Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry, Organic	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	CJ9UO	WOS:000355848900003		
J	Cui, J; Matsuoka, S; Kinoshita, M; Matsumori, N; Sato, F; Murata, M; Ando, J; Yamakoshi, H; Dodo, K; Sodeoka, M				Cui, Jin; Matsuoka, Shigeru; Kinoshita, Masanao; Matsumori, Nobuaki; Sato, Fuminori; Murata, Michio; Ando, Jun; Yamakoshi, Hiroyuki; Dodo, Kosuke; Sodeoka, Mikiko			Novel Raman-tagged sphingomyelin that closely mimics original raft-forming behavior	BIOORGANIC & MEDICINAL CHEMISTRY			English	Article						Sphingomyelin; Lipid rafts; Raman imaging; Solid-state H-2 NMR; Phase distribution	SOLID-STATE NMR; LIPID RAFTS; COUPLING REACTIONS; LIVE CELLS; MEMBRANES; CHOLESTEROL; MICROSCOPY; PHASE; SPECTROSCOPY; RESONANCE	Three Raman probes of sphingomyelin (SM) were synthesized and evaluated for their applicability to imaging experiments. One probe containing a hydroxymethyl-1,3-butadiyne moiety in the polar head group showed strong scattering. The solid-state H-2 NMR spectra of this probe in oriented bilayer membrane revealed excellent compatibility with natural SM in phase behavior since the probe undergoes phase separation to form raft-like liquid ordered (L-o) domains in the raft-mimicking mixed bilayers. (C) 2015 Elsevier Ltd. All rights reserved.	[Cui, Jin; Matsuoka, Shigeru; Kinoshita, Masanao; Matsumori, Nobuaki; Murata, Michio] Osaka Univ, Dept Chem, Toyonaka, Osaka 5600043, Japan; [Cui, Jin; Matsuoka, Shigeru; Kinoshita, Masanao; Sato, Fuminori; Murata, Michio] Osaka Univ, Lipid Act Struct Project, JST, ERATO, Toyonaka, Osaka 5600043, Japan; [Cui, Jin; Matsuoka, Shigeru; Kinoshita, Masanao; Sato, Fuminori; Murata, Michio] Osaka Univ, Project Res Ctr Fundamental Sci, Toyonaka, Osaka 5600043, Japan; [Ando, Jun; Yamakoshi, Hiroyuki; Dodo, Kosuke; Sodeoka, Mikiko] Sodeoka Live Cell Chem Project, JST, ERATO, Wako, Saitama 3510198, Japan; [Ando, Jun; Yamakoshi, Hiroyuki; Dodo, Kosuke; Sodeoka, Mikiko] RIKEN, Synthet Organ Chem Lab, Wako, Saitama 3510198, Japan; [Ando, Jun; Dodo, Kosuke; Sodeoka, Mikiko] AMED CREST, Wako, Saitama 3510198, Japan; [Ando, Jun] Osaka Univ, Dept Appl Phys, Suita, Osaka 5650871, Japan	Murata, M (reprint author), Osaka Univ, Dept Chem, 1-1 Machikaneyama, Toyonaka, Osaka 5600043, Japan.	murata@chem.sci.osaka-u.ac.jp	Sodeoka, Mikiko/A-9952-2008; Dodo, Kosuke/G-2264-2012	Sodeoka, Mikiko/0000-0002-1344-364X; 	Japanese Society of Technology (JST) ERATO, Lipid Active Structure Project; AMED-CREST, Japan Agency for Medical Research and Development; MEXT, Japan [25242073]	We thank Mr. Tomokazu Yasuda for providing SM-d<INF>2</INF>, and Dr. Yuichi Umegawa for his kind support for <SUP>2</SUP>H NMR measurements. We also thank Dr. Sebastien Lethu for helpful discussions. This work was supported by Japanese Society of Technology (JST) ERATO, Lipid Active Structure Project, by AMED-CREST, Japan Agency for Medical Research and Development, and by Grant-In-Aids for Scientific Research (A) (No. 25242073) from MEXT, Japan.	Ando J, 2015, P NATL ACAD SCI USA, V112, P4558, DOI 10.1073/pnas.1418088112; Yamakoshi H, 2012, J AM CHEM SOC, V134, P20681, DOI 10.1021/ja308529n; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Yamamoto T, 2006, ORG LETT, V8, P5569, DOI 10.1021/ol0622581; OLDFIELD E, 1978, BIOCHEMISTRY-US, V17, P2727, DOI 10.1021/bi00607a006; Terao J, 2007, ANGEW CHEM INT EDIT, V46, P2086, DOI 10.1002/anie.200603451; Brzustowicz MR, 2002, BIOPHYS J, V82, P285; Palonpon AF, 2013, CURR OPIN CHEM BIOL, V17, P708, DOI 10.1016/j.cbpa.2013.05.021; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Matsumori N, 2012, BIOCHEMISTRY-US, V51, P8363, DOI 10.1021/bi3009399; Yamakoshi H, 2011, J AM CHEM SOC, V133, P6102, DOI 10.1021/ja108404p; Li L, 2005, BIOPHYS J, V89, P3480, DOI 10.1529/biophysj.105.065607; Mehnert T, 2006, BIOPHYS J, V90, P939, DOI 10.1529/biopyhsj.105.063271; Sezgin E, 2012, BBA-BIOMEMBRANES, V1818, P1777, DOI 10.1016/j.bbamem.2012.03.007; Yin WY, 2009, ORG LETT, V11, P709, DOI 10.1021/ol8027863; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Baumgart T, 2007, BBA-BIOMEMBRANES, V1768, P2182, DOI 10.1016/j.bbamem.2007.05.012; MURARI R, 1986, BIOCHEMISTRY-US, V25, P1062, DOI 10.1021/bi00353a017; DAVIS JH, 1976, CHEM PHYS LETT, V42, P390, DOI 10.1016/0009-2614(76)80392-2; Matsumori N, 2008, J AM CHEM SOC, V130, P4757, DOI 10.1021/ja077580l; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Opilik L, 2011, PHYS CHEM CHEM PHYS, V13, P9978, DOI 10.1039/c0cp02832k; Bartels T, 2008, J AM CHEM SOC, V130, P14521, DOI 10.1021/ja801789t; BUNOW MR, 1977, BIOCHIM BIOPHYS ACTA, V489, P191, DOI 10.1016/0005-2760(77)90138-2; Cadiot P., 1969, CHEM ACETYLENES, P597; CALHOUN WI, 1979, BIOCHIM BIOPHYS ACTA, V555, P436, DOI 10.1016/0005-2736(79)90397-3; Cruz A, 2005, LANGMUIR, V21, P5349, DOI 10.1021/la046759w; Cui J., 2015, BIOORG MED CHEM LETT, V2, P203; Goretta SA, 2012, BIOORGAN MED CHEM, V20, P4012, DOI 10.1016/j.bmc.2012.05.015; Guard-Friar D., 1810, J PHYS CHEM-US, V1985, P89; Guo W, 2002, BIOPHYS J, V83, P1465; JUNGALWALA FB, 1979, J LIPID RES, V20, P579; KABISCH G, 1982, SPECTROCHIM ACTA A, V38, P1195, DOI 10.1016/0584-8539(82)80162-1; Klymchenko AS, 2014, CHEM BIOL, V21, P97, DOI 10.1016/j.chembiol.2013.11.009; Lethu S, 2014, ORG LETT, V16, P844, DOI 10.1021/ol4036159; MENDELSOHN R, 1980, BIOCHIM BIOPHYS ACTA, V598, P260, DOI 10.1016/0005-2736(80)90004-8; Potma EO, 2005, CHEMPHYSCHEM, V6, P77, DOI 10.1002/cphc.200400390; Sandbhor MS, 2009, J ORG CHEM, V74, P8669, DOI 10.1021/jo901824h	38	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-0896	1464-3391		BIOORGAN MED CHEM	Bioorg. Med. Chem.	JUL 1	2015	23	13					2989	2994		10.1016/j.bmc.2015.05.014		6	Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry, Organic	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	CJ9UO	WOS:000355848900004		
J	Shoda, T; Kato, M; Harada, R; Fujisato, T; Okuhira, K; Demizu, Y; Inoue, H; Naito, M; Kurihara, M				Shoda, Takuji; Kato, Masashi; Harada, Rintaro; Fujisato, Takuma; Okuhira, Keiichiro; Demizu, Yosuke; Inoue, Hideshi; Naito, Mikihiko; Kurihara, Masaaki			Synthesis and evaluation of tamoxifen derivatives with a long alkyl side chain as selective estrogen receptor down-regulators	BIOORGANIC & MEDICINAL CHEMISTRY			English	Article						Breast cancer; Estrogen receptor; SERD; Tamoxifen	BREAST-CANCER; MULTIFUNCTIONAL MEDICINES; ANTIESTROGENS; MODULATORS; RECOGNITION; ANTAGONISM; MECHANISMS; DESIGN; SYSTEM; ROLES	Estrogen receptors (ERs) play a major role in the growth of human breast cancer cells. An antagonist that acts as not only an inhibitor of ligand binding but also an inducer of the down-regulation of ER would be useful for the treatment for ER-positive breast cancer. We previously reported the design and synthesis of a selective estrogen receptor down-regulator (SERD), (E/Z)-4-(1-{4-[2-(dodecylamino) ethoxy] phenyl}-2-phenylbut-1-en-1-yl) phenol (C12), which is a tamoxifen derivative having a long alkyl chain on the amine moiety. This compound induced degradation of ER alpha via a proteasome-dependent pathway and showed an antagonistic effect in MCF-7 cells. With the aim of increasing the potency of SERDs, we designed and synthesized various tamoxifen derivatives that have various lengths and terminal groups of the long alkyl side chain. During the course of our investigation, C10F having a 10-fluorodecyl group on the amine moiety of 4-OHT was shown to be the most potent compound among the tamoxifen derivatives. Moreover, computational docking analysis suggested that the long alkyl chain interacted with the hydrophobic region on the surface of the ER, which is a binding site of helix 12 and coactivator. These results provide useful information to develop promising candidates as SERDs. (C) 2015 Elsevier Ltd. All rights reserved.	[Shoda, Takuji; Kato, Masashi; Harada, Rintaro; Fujisato, Takuma; Demizu, Yosuke; Kurihara, Masaaki] Natl Inst Hlth Sci, Div Organ Chem, Setagaya Ku, Tokyo 1588501, Japan; [Kato, Masashi; Fujisato, Takuma; Inoue, Hideshi] Tokyo Univ Pharm & Life Sci, Sch Life Sci, Hachioji, Tokyo 1920392, Japan; [Okuhira, Keiichiro; Naito, Mikihiko] Natl Inst Hlth Sci, Div Biochem & Mol Biol, Setagaya Ku, Tokyo 1588501, Japan; [Kurihara, Masaaki] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa 2268501, Japan	Shoda, T (reprint author), Natl Inst Hlth Sci, Div Organ Chem, Setagaya Ku, 1-18-1 Kamiyoga, Tokyo 1588501, Japan.	tsho@nihs.go.jp; masaaki@nihs.go.jp			JSPS KAKENHI [26860085]	We thank Mariko Seki for technical advice regarding cell culture and the Western blotting analysis and Dr. Tomoko Nishimaki-Mogami for help to set up the fluorescent multiple plate reader. This work was supported, in part, by JSPS KAKENHI Grant Number 26860085 (TS).	Ali SM, 2010, BIOORG MED CHEM LETT, V20, P2665, DOI 10.1016/j.bmcl.2010.02.024; Brauch H, 2009, EUR J CANCER, V45, P2274, DOI 10.1016/j.ejca.2009.05.032; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Pike ACW, 2001, STRUCTURE, V9, P145, DOI 10.1016/S0969-2126(01)00568-8; Jozwik KM, 2012, NAT REV CANCER, V12, P381, DOI 10.1038/nrc3263; Jiang Q, 2012, ACS MED CHEM LETT, V3, P392, DOI 10.1021/ml3000287; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Laios I, 2003, J STEROID BIOCHEM, V87, P207, DOI 10.1016/j.jsbmb.2003.09.011; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Desta Z, 2004, J PHARMACOL EXP THER, V310, P1062, DOI 10.1124/jpet.104.065607; Thomas C, 2011, NAT REV CANCER, V11, P597, DOI 10.1038/nrc3093; DAUVOIS S, 1992, P NATL ACAD SCI USA, V89, P4037, DOI 10.1073/pnas.89.9.4037; Jordan VC, 2003, J MED CHEM, V46, P883, DOI 10.1021/jm020449y; Lewis-Wambi JS, 2011, MOL PHARMACOL, V80, P610, DOI 10.1124/mol.111.072249; Shoda T, 2014, BIOORG MED CHEM LETT, V24, P87, DOI 10.1016/j.bmcl.2013.11.078; Johnson MD, 2004, BREAST CANCER RES TR, V85, P151, DOI 10.1023/B:BREA.0000025406.31193.e8; Renoir JM, 2013, BIOCHEM PHARMACOL, V85, P449, DOI 10.1016/j.bcp.2012.10.018; Jordan VC, 2003, J MED CHEM, V46, P1081, DOI 10.1021/jmj020450x; MacGregor JI, 1998, PHARMACOL REV, V50, P151; Demizu Y, 2012, BIOORG MED CHEM LETT, V22, P1793, DOI 10.1016/j.bmcl.2011.11.086; Baumann CK, 2007, DRUGS, V67, P2335; Carlson Robert W, 2005, Clin Breast Cancer, V6 Suppl 1, pS5, DOI 10.3816/CBC.2005.s.008; Kojetin DJ, 2008, ENDOCR-RELAT CANCER, V15, P851, DOI 10.1677/ERC-07-0281; Teft WA, 2011, DRUG METAB DISPOS, V39, P558, DOI 10.1124/dmd.110.036160	24	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-0896	1464-3391		BIOORGAN MED CHEM	Bioorg. Med. Chem.	JUL 1	2015	23	13					3091	3096		10.1016/j.bmc.2015.05.002		6	Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry, Organic	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	CJ9UO	WOS:000355848900012		
J	Kunikawa, S; Tanaka, A; Mukoyoshi, K; Nagashima, S; Tominaga, H; Chida, N; Tasaki, M; Shirai, F				Kunikawa, Shigeki; Tanaka, Akira; Mukoyoshi, Koichiro; Nagashima, Shinya; Tominaga, Hiroaki; Chida, Noboru; Tasaki, Mamoru; Shirai, Fumiyuki			Optimization of 2,4-diamino-5-fluoropyrimidine derivatives as protein kinase C theta inhibitors with mitigated time-dependent drug-drug interactions and P-gp liability	BIOORGANIC & MEDICINAL CHEMISTRY			English	Article						Protein kinase C theta (PKC theta); CYP3A4 time-dependent inhibition (TDI); P-glycoprotein (P-gp)	PKC-THETA; SOTRASTAURIN; THERAPY; GLYCOPROTEIN; CYCLOSPORINE; ABSORPTION; DISEASES; DESIGN; AEB071	Protein kinase C theta (PKC theta) plays a critical role in T cell signaling and has therapeutic potential for T cell-mediated diseases such as transplant rejection and rheumatoid arthritis. Here, a series of 2,4-diamino-5-fluoropyrimidine derivatives were prepared and evaluated for their inhibition of PKC theta. Of these compounds, 14f was found to exhibit potent PKC theta inhibitory activity and significantly weak CYP3A4 time-dependent inhibition (TDI) and P-glycoprotein (P-gp) liability. (C) 2015 Elsevier Ltd. All rights reserved.	[Kunikawa, Shigeki; Tanaka, Akira; Mukoyoshi, Koichiro; Nagashima, Shinya; Tominaga, Hiroaki; Chida, Noboru; Tasaki, Mamoru; Shirai, Fumiyuki] Astellas Pharma Inc, Drug Discovery Res, Chem Res Labs, Tsukuba, Ibaraki 3058585, Japan	Kunikawa, S (reprint author), Astellas Pharma Inc, Drug Discovery Res, Chem Res Labs, 21 Miyukigaoka, Tsukuba, Ibaraki 3058585, Japan.	shigeki.kunikawa@astellas.com					Woltering TJ, 2013, BIOORG MED CHEM LETT, V23, P4239, DOI 10.1016/j.bmcl.2013.05.003; Gummert JF, 1999, J AM SOC NEPHROL, V10, P1366; Meller N, 1999, CELL IMMUNOL, V193, P185, DOI 10.1006/cimm.1999.1478; BELLAMY FD, 1984, TETRAHEDRON LETT, V25, P839, DOI 10.1016/S0040-4039(01)80041-1; Roberts LR, 2008, BIOORG MED CHEM LETT, V18, P6437, DOI 10.1016/j.bmcl.2008.10.066; Spitaler M, 2004, NAT IMMUNOL, V5, P785, DOI 10.1038/ni1097; KOCH U, 1995, J PHYS CHEM-US, V99, P9747, DOI 10.1021/j100024a016; Isakov N, 2002, ANNU REV IMMUNOL, V20, P761, DOI 10.1146/annurev.immunol.20.100301.064807; Chand S, 2012, CURR PHARM DESIGN, V18, P4725; Wagner J, 2011, J MED CHEM, V54, P6028, DOI 10.1021/jm200469u; Riley RJ, 2007, EXPERT OPIN DRUG MET, V3, P51, DOI 10.1517/17425255.3.1.51; Tumey LN, 2009, BIOORGAN MED CHEM, V17, P7933, DOI 10.1016/j.bmc.2009.10.020; Silakari O, 2012, MOL INFORM, V31, P659, DOI 10.1002/minf.201100123; Huang K, 2012, DRUG METAB PHARMACOK, V27, P486, DOI 10.2133/dmpk.DMPK-11-RG-142; Jimenez JM, 2013, J MED CHEM, V56, P1799, DOI 10.1021/jm301465a; Kovarik JM, 2010, BIOPHARM DRUG DISPOS, V31, P331, DOI 10.1002/bdd.715; Kovarik JM, 2010, J CLIN PHARMACOL, V50, P1260, DOI 10.1177/0091270009360534; Matz M, 2011, EXPERT OPIN DRUG MET, V7, P103, DOI 10.1517/17425255.2011.540238; Niu CS, 2009, BIOORG MED CHEM LETT, V19, P5829, DOI 10.1016/j.bmcl.2009.08.086; Probst GD, 2010, BIOORG MED CHEM LETT, V20, P6034, DOI 10.1016/j.bmcl.2010.08.070; Ramesh M, 2012, J MOL MODEL, V18, P709, DOI 10.1007/s00894-011-1105-5; Riley RJ, 2001, PHARMACEUT RES, V18, P652, DOI 10.1023/A:1011085411050; Romagnani S, 1996, CLIN IMMUNOL IMMUNOP, V80, P225, DOI 10.1006/clin.1996.0118; Singh R., WO, Patent No. [2,009,012,421, 2009012421]; Weckbecker G, 2010, TRANSPL INT, V23, P543, DOI 10.1111/j.1432-2277.2009.01015.x; Zakeri-Milani P, 2014, EXPERT OPIN DRUG MET, V10, P859, DOI 10.1517/17425255.2014.905543	26	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-0896	1464-3391		BIOORGAN MED CHEM	Bioorg. Med. Chem.	JUL 1	2015	23	13					3269	3277		10.1016/j.bmc.2015.04.050		9	Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry, Organic	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	CJ9UO	WOS:000355848900032		
J	Inami, K; Shiino, J; Hagiwara, S; Takeda, K; Mochizuki, M				Inami, Keiko; Shiino, Junko; Hagiwara, Shin; Takeda, Kei; Mochizuki, Masataka			Transnitrosation of non-mutagenic N-nitrosoproline forms mutagenic N-nitroso-N-methylurea	BIOORGANIC & MEDICINAL CHEMISTRY			English	Article						N-Nitrosoproline; N-Nitroso-N-methylurea; Transnitrosation; Thioureas	S-NITROSATION; NITRIC-OXIDE; NITROSAMINES; ACIDS; FISH; NITROSODIMETHYLAMINE; NITROSOSARCOSINE; NITROZATION; KINETICS; PROLINE	N-Nitroso-N-methylurea (NMU) is a potent carcinogen and suspected as a cause of human cancer. In this study, mutagenic NMU was detected by HPLC after the transnitrosation of non-mutagenic N-nitrosoproline (NP) to N-methylurea in the presence of thiourea (TU) under acidic conditions. The structure of NMU was confirmed by comparing H-1 NMR and IR spectra with that of authentic NMU after fractionation by column chromatography. Furthermore, a fraction containing NMU formed by transnitrosation was mutagenic in Salmonella typhimurium TA1535. NMU was formed in the reaction of NP and N-methylurea in the presence of 1,1,3,3-tetramethylthiourea (TTU) or 1,3-dimethylthiourea in place of TU as an accelerator. The reaction rate constants (k) for NMU formation were correlated with their nucleophilicity of sulfur atom in thioureas. The N-methylurea concentration did not affect the NMU formation, whereas the rate of NMU formation correlated linearly with concentrations of NP, TTU and oxonium ion. The observed kinetics suggests a mechanism by which the nitroso group was transferred directly from the protonated NP to the thiourea then to N-methylurea to form NMU. The rate-determining step was the formation of the complex with the protonated NP and thiourea. (C) 2015 Elsevier Ltd. All rights reserved.	[Inami, Keiko; Hagiwara, Shin; Mochizuki, Masataka] Tokyo Univ Sci, Fac Pharmaceut Sci, Noda, Chiba 2788510, Japan; [Inami, Keiko; Shiino, Junko; Takeda, Kei; Mochizuki, Masataka] Kyoritsu Univ Pharm, Tokyo 1058512, Japan	Inami, K (reprint author), Tokyo Univ Sci, Fac Pharmaceut Sci, Yamazaki 2641, Noda, Chiba 2788510, Japan.	inami@rs.noda.tus.ac.jp					ALKAABI SS, 1984, J CHEM SOC PERK T 2, P1803, DOI 10.1039/p29840001803; Al-Mustafa AH, 2001, TOXICOLOGY, V163, P127, DOI 10.1016/S0300-483X(01)00388-2; Lijinsky W, 1999, MUTAT RES-GEN TOX EN, V443, P129, DOI 10.1016/S1383-5742(99)00015-0; Yanagimoto T, 2007, J AM CHEM SOC, V129, P736, DOI 10.1021/ja0658259; Mortelmans K, 2000, MUTAT RES-FUND MOL M, V455, P29, DOI 10.1016/S0027-5107(00)00064-6; MARON DM, 1983, MUTAT RES, V113, P173, DOI 10.1016/0165-1161(83)90010-9; Inami K, 2013, BIOORGAN MED CHEM, V21, P7853, DOI 10.1016/j.bmc.2013.10.008; MIRVISH SS, 1980, J NATL CANCER I, V64, P1435; HALL KJ, 1976, J CHEM EDUC, V53, P493; CASADO J, 1986, J CHEM EDUC, V63, P450; KEEFER LK, 1988, J AM CHEM SOC, V110, P7459, DOI 10.1021/ja00230a029; Ghosh AK, 2015, J MED CHEM, V58, P2895, DOI 10.1021/jm501371s; Arndt F., 1943, ORG SYNTH, V2, P461; Challis B. C., 1973, J CHEM SOC P2, V11, P1526; Deng DJ, 1998, J AGR FOOD CHEM, V46, P202, DOI 10.1021/jf9706282; DIX LR, 1991, J CHEM SOC PERK T 2, P1099, DOI 10.1039/p29910001099; Engemann A, 2013, J AGR FOOD CHEM, V61, P998, DOI 10.1021/jf305040e; Hallett G., 1979, J CHEM SOC P2, P624; Haorah J, 2001, J AGR FOOD CHEM, V49, P6068, DOI 10.1021/jf010602h; ISHIBASHI T, 1981, J AGR FOOD CHEM, V29, P1098, DOI 10.1021/jf00107a054; Lijinsky W., 1992, CAMBRIDGE MONOGRAPHS; LIJINSKY W, 1970, TETRAHEDRON, V26, P5137, DOI 10.1016/S0040-4020(01)93166-7; MASUI M, 1979, CHEM PHARM BULL, V27, P1274; MIWA M, 1989, BIOCHEM BIOPH RES CO, V159, P373, DOI 10.1016/0006-291X(89)90001-6; Ohwada T, 2001, J AM CHEM SOC, V123, P10164, DOI 10.1021/ja010917d; Preussmann R., 1984, CHEM CARCINOGENS, V2nd; Rao T. K., 1981, MUTAT RES, V89, P34; SEN NP, 1983, J AGR FOOD CHEM, V31, P1033, DOI 10.1021/jf00119a028; Sen NP, 2001, J AGR FOOD CHEM, V49, P2096, DOI 10.1021/jf0011384; Sen NP, 2000, J AGR FOOD CHEM, V48, P5088, DOI 10.1021/jf990918d; SEN NP, 1990, J AGR FOOD CHEM, V38, P1007, DOI 10.1021/jf00094a020; SHAPIRO KB, 1991, FOOD CHEM TOXICOL, V29, P751, DOI 10.1016/0278-6915(91)90183-8; Singer S. S., 1980, IARC SCI PUBL, V31, P111; SINGER SS, 1977, TETRAHEDRON LETT, P1613; SINGER SS, 1981, J ORG CHEM, V46, P3461, DOI 10.1021/jo00330a016; SINGER SS, 1978, J ORG CHEM, V43, P4612, DOI 10.1021/jo00418a016; SINGER SS, 1980, J ORG CHEM, V45, P4931, DOI 10.1021/jo01312a022; Stuff JE, 2009, J FOOD COMPOS ANAL, V22, pS42, DOI 10.1016/j.jfca.2009.01.008; TANNO M, 1990, CHEM PHARM BULL, V38, P49; TANNO M, 1994, CHEM PHARM BULL, V42, P1760; Tsuda M., 1987, IARC SCI PUBL, V84, P446; WILLIAMS DLH, 1977, J CHEM SOC PERK T 2, P128, DOI 10.1039/p29770000128; Williams D. L. H., 1975, J CHEM SOC CHEM COMM, P373	43	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-0896	1464-3391		BIOORGAN MED CHEM	Bioorg. Med. Chem.	JUL 1	2015	23	13					3297	3302		10.1016/j.bmc.2015.04.058		6	Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry, Organic	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	CJ9UO	WOS:000355848900035		
J	Onoda, K; Sawada, H; Morita, D; Fujii, K; Tokiwa, H; Kuroda, T; Miyachi, H				Onoda, Kenji; Sawada, Hiromi; Morita, Daichi; Fujii, Kana; Tokiwa, Hiroaki; Kuroda, Teruo; Miyachi, Hiroyuki			Anti-MRSA activity of isoplagiochin-type macrocyclic bis(bibenzyl)s is mediated through cell membrane damage	BIOORGANIC & MEDICINAL CHEMISTRY			English	Article						Isoplagiochin; Methicillin resistance; Membrane; Cell membrane damage; Structure-activity relationship	RICCARDIN-C; BOAT CONFIGURATION; BLASIA-PUSILLA; CONSTITUENTS; DERIVATIVES; LIVERWORT; CAVICULARIN; HEPATICAE; EFFICIENT; DIMERS	We synthesized three geometrical isomers of a macrocyclic bis(bibenzyl) based on isoplagiochin, a natural product isolated from bryophytes, and evaluated their antibacterial activity towards methicillin-resistant Staphylococcus aureus (anti-MRSA activity). The isomer containing a 1,4-linked ring (5) showed only weak activity, whereas the isomers containing a 1,3-linked (6) or 1,2-linked (7) C ring showed potent anti-MRSA activity. Molecular dynamics calculations indicated that these differences are probably due to differences in the conformational flexibility of the macrocyclic ring; the active compounds 6 and 7 were more rigid than 5. In order to understand the action mechanism of anti-MRSA activity, we investigated the cellular flux of a fluorescent DNA-binder, ethidium bromide (EtBr), in the presence and absence of these macrocycles. The active compound 6 increased the levels of EtBr inflow and outflow in S. aureus cells, as did our potent anti-MRSA riccardin derivative (4), indicating that these compounds increased the permeability of the cytoplasmic membrane. Inactive 5 had no effect on EtBr inflow or outflow. Furthermore, compound 6 abrogated the normal intracellular concentration gradients of Na+ and K+ in S. aureus cells, increasing the intracellular Na+ concentration and decreasing the K+ concentration, while 5 had no such effect. These results indicate that anti-MRSA-active macrocyclic bis(bibenzyl) derivatives directly damage the gram-positive bacterial membrane, resulting in increased permeability. (C) 2015 Elsevier Ltd. All rights reserved.	[Onoda, Kenji; Sawada, Hiromi; Morita, Daichi; Fujii, Kana; Kuroda, Teruo; Miyachi, Hiroyuki] Okayama Univ, Div Pharmaceut Sci, Grad Sch Med Dent & Pharmaceut Sci, Kita Ku, Okayama 7008530, Japan; [Tokiwa, Hiroaki] Rikkyo Univ, Dept Chem, Toshima Ku, Tokyo 1718501, Japan	Miyachi, H (reprint author), Okayama Univ, Div Pharmaceut Sci, Grad Sch Med Dent & Pharmaceut Sci, Kita Ku, 1-1-1 Tsushima Naka, Okayama 7008530, Japan.	miyachi@pharm.okayama-u.ac.jp	KURODA, Teruo/B-2028-2011		Drug Discovery for Intractable Infectious Diseases Project; Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University; Grant for Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan; Terumo Foundation; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) [A26293027]	This work was supported in part by the Drug Discovery for Intractable Infectious Diseases Project, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, a Grant for Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan, Terumo Foundation and a Grant-in-aid for Scientific Research KAKENHI (B) (Grant number 26293027 to H.M.) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT). We also thank the SC-NMR Laboratory of Okayama University for NMR measurements.	Andrews JM, 2001, J ANTIMICROB CHEMOTH, V48, P5; Ito T, 1999, ANTIMICROB AGENTS CH, V43, P1449; Zheng GS, 2007, J CHEM THEORY COMPUT, V3, P1349, DOI 10.1021/ct600312f; ASAKAWA Y, 1982, PHYTOCHEMISTRY, V21, P2143, DOI 10.1016/0031-9422(82)83073-2; Yoshida T, 1996, TETRAHEDRON, V52, P14487, DOI 10.1016/0040-4020(96)00889-7; Sawada H, 2013, BIOORG MED CHEM LETT, V23, P6563, DOI 10.1016/j.bmcl.2013.10.069; Zhao P, 2013, ORG LETT, V15, P402, DOI 10.1021/ol303390a; Asakawa Y, 2004, PHYTOCHEMISTRY, V65, P623, DOI 10.1016/j.phytochem.2004.01.003; Gupta S, 2014, ENVIRON SCI POLLUT R, V21, P10186, DOI 10.1007/s11356-014-2951-3; Sawada H, 2012, BIOORG MED CHEM LETT, V22, P7444, DOI 10.1016/j.bmcl.2012.10.052; Asakawa Y., 2009, HETEROCYCLES, V2009, P99; Asakawa Y., 1995, PROGR CHEM ORGANIC N, P618; Asakawa Y, 2000, SPECTROSC-INT J, V14, P149; Dodo K, 2008, BIOORGAN MED CHEM, V16, P4272, DOI 10.1016/j.bmc.2008.02.078; Eicher T, 1998, EUR J ORG CHEM, P877; Esumi T, 2004, TETRAHEDRON LETT, V45, P6941, DOI 10.1016/j.tetlet.2004.07.068; Fukuyama Y, 2001, HETEROCYCLES, V54, P259; Geseru G. M., 1995, NAT PROD REP, P69; Harrowven DC, 2005, ANGEW CHEM INT EDIT, V44, P3899, DOI 10.1002/anie.200500466; Hashimoto T., 1993, J HATTORI BOT LAB, V74, P121; HASHIMOTO T, 1994, TETRAHEDRON LETT, V35, P909, DOI 10.1016/S0040-4039(00)75996-X; Iwai Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019825; Iwashita M, 2011, TETRAHEDRON, V67, P6073, DOI 10.1016/j.tet.2011.06.018; Kostiuk SL, 2011, CHEM-EUR J, V17, P10906, DOI 10.1002/chem.201101550; Kral T, 2002, BIOPHYS CHEM, V95, P135, DOI 10.1016/S0301-4622(01)00253-8; Kuroda M., 2001, LANCET, V357, P225; Mitchell BA, 1999, J BIOL CHEM, V274, P3541, DOI 10.1074/jbc.274.6.3541; Takiguchi H, 2011, CHEM LETT, V40, P1069, DOI 10.1246/cl.2011.1069; Toyota M, 1997, PHYTOCHEMISTRY, V44, P293, DOI 10.1016/S0031-9422(96)00479-7	29	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-0896	1464-3391		BIOORGAN MED CHEM	Bioorg. Med. Chem.	JUL 1	2015	23	13					3309	3316		10.1016/j.bmc.2015.04.047		8	Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry, Organic	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	CJ9UO	WOS:000355848900037		
J	Kato, E; Inagaki, Y; Kawabata, J				Kato, Eisuke; Inagaki, Yosuke; Kawabata, Jun			Higenamine 4 '-O-beta-D-glucoside in the lotus plumule induces glucose uptake of L6 cells through beta 2-adrenergic receptor	BIOORGANIC & MEDICINAL CHEMISTRY			English	Article						Nelumbo nucifera Gaertn.; Hypoglycemic effect; Glucose uptake; beta 2-Adrenergic receptor agonist; Diabetes mellitus	SKELETAL-MUSCLE CELLS; NELUMBO-NUCIFERA; COMPLICATIONS; FLAVONOIDS; ALKALOIDS; LEAVES; RATS	Hypoglycemic effect is an efficient means to modulate elevated blood glucose levels in patients with diabetes. We found that the extract of lotus plumule (the germ of Nelumbo nucifera Gaertn. seed) showed potent glucose uptake enhancement activity against L6 myotubes, which results in a hypoglycemic effect. This activity was further investigated, and an active constituent was identified as a single bioactive compound, higenamine 4'-O-beta-D-glucoside. Mechanistic studies employing phosphatidylinositol 3-kinase (PI3K) inhibitor, AMP-activated protein kinase (AMPK) inhibitor, or adrenergic receptor antagonist showed that the compound induced its activity through beta 2-adrenergic receptor. Patients with type II diabetes mellitus frequently develop insulin resistance. Owing to the differences between the mechanism of action of insulin and of the isolated compound, the compound or lotus plumule itself may have the possibility of modulating blood glucose levels in insulin-resistant patients effectively. (C) 2015 Elsevier Ltd. All rights reserved.	[Kato, Eisuke; Kawabata, Jun] Hokkaido Univ, Grad Sch Agr, Div Appl Biosci, Lab Food Biochem,Kita Ku, Sapporo, Hokkaido 0608589, Japan; [Inagaki, Yosuke] Nippon Supplement Inc, Kita Ku, Osaka 5300013, Japan	Kato, E (reprint author), Hokkaido Univ, Grad Sch Agr, Div Appl Biosci, Lab Food Biochem,Kita Ku, Sapporo, Hokkaido 0608589, Japan.	eikato@chem.agr.hokudai.ac.jp	Kawabata, Jun/A-4495-2012		JSPS KAKENHI [25750391]; Towa Foundation for Food Research	This work was supported by JSPS KAKENHI Grant number 25750391 and the Towa Foundation for Food Research.	Liu CM, 2014, MOLECULES, V19, P17829, DOI 10.3390/molecules191117829; Huang CF, 2011, J AGR FOOD CHEM, V59, P1087, DOI 10.1021/jf103382h; Kashiwada Y, 2005, BIOORGAN MED CHEM, V13, P443, DOI 10.1016/j.bmc.2004.10.020; Stratton IM, 2000, BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Retnakaran R, 2006, DIABETES, V55, P1832, DOI 10.2337/db05-1620; Mukherjee PK, 2009, J PHARM PHARMACOL, V61, P407, DOI 10.1211/jpp/61.04.0001; Mukherjee PK, 1997, J ETHNOPHARMACOL, V58, P207, DOI 10.1016/S0378-8741(97)00107-4; Yamamoto N, 2006, ANAL BIOCHEM, V351, P139, DOI 10.1016/j.ab.2005.12.011; Fox CS, 2004, JAMA-J AM MED ASSOC, V292, P2495, DOI 10.1001/jama.292.20.2495; Hegde VR, 1997, BIOORG MED CHEM LETT, V7, P1207, DOI 10.1016/S0960-894X(97)00194-7; KOSHIYAMA H, 1970, Chemical and Pharmaceutical Bulletin (Tokyo), V18, P2564; Mani SS, 2010, BIOL TRACE ELEM RES, V138, P226, DOI 10.1007/s12011-010-8614-4; Nevzorova J, 2002, BRIT J PHARMACOL, V137, P9, DOI 10.1038/sj.bjp.0704845; Nevzorova J, 2006, BRIT J PHARMACOL, V147, P446, DOI 10.1038/sj.bjp.0706626; Pesnot T., 2011, CHEM COMMUN, P3242; Sato M, 2014, DIABETES, V63, P4115, DOI 10.2337/db13-1860; Tilley AJ, 2012, BIOORGAN MED CHEM, V20, P2353, DOI 10.1016/j.bmc.2012.02.008; Wu HP, 2013, EUR J ORG CHEM, P2898, DOI 10.1002/ejoc.201300072; Zhou TY, 2009, J MED PLANTS RES, V3, P290	19	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-0896	1464-3391		BIOORGAN MED CHEM	Bioorg. Med. Chem.	JUL 1	2015	23	13					3317	3321		10.1016/j.bmc.2015.04.054		5	Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry, Organic	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	CJ9UO	WOS:000355848900038		
J	Hamaguchi, W; Masuda, N; Miyamoto, S; Kikuchi, S; Narazaki, F; Shiina, Y; Seo, R; Amano, Y; Mihara, T; Moriguchi, H; Hattori, K				Hamaguchi, Wataru; Masuda, Naoyuki; Miyamoto, Satoshi; Kikuchi, Shigetoshi; Narazaki, Fumie; Shiina, Yasuhiro; Seo, Ryushi; Amano, Yasushi; Mihara, Takuma; Moriguchi, Hiroyuki; Hattori, Kouji			Addressing phototoxicity observed in a novel series of biaryl derivatives: Discovery of potent, selective and orally active phosphodiesterase 10A inhibitor ASP9436	BIOORGANIC & MEDICINAL CHEMISTRY			English	Article						Schizophrenia; PDE10A inhibitor; Phototoxicity	PDE10A INHIBITORS; BIOLOGICAL EVALUATION; BENZIMIDAZOLE DERIVATIVES; QUINOLINE DERIVATIVES; IMPROVES COGNITION; SCHIZOPHRENIA; PYRAZOLOQUINOLINES; DESIGN; SAR; ANTIPSYCHOTICS	We synthesized several biaryl derivatives as PDE10A inhibitors to prevent phototoxicity of 2-[4-({[1-methyl-4-(pyridin-4-yl)-1H-pyrazol-3-yl] oxy} methyl) phenyl] quinoline (1) and found that the energy difference between the energy-minimized conformation and the coplanar conformation of the biaryl moiety helped facilitate prediction of the phototoxic potential of biaryl compounds. Replacement of the quinoline ring of 1 with N-methyl benzimidazole increased this energy difference and prevented phototoxicity in the 3T3 NRU test. Further optimization identified 1-methyl-5-(1-methyl-3-{[4-(1-methyl-1H-benzimidazol-4-yl) phenoxy] methyl}-1H-pyrazol-4-yl) pyridin-2(1H)-one (38b). Compound 38b exhibited good selectivity against other PDEs, and oral administration of 38b improved visual-recognition memory deficit in mice at doses of 0.001 and 0.003 mg/kg in the novel object recognition test. ASP9436 (sesquiphosphate of 38b) may therefore be used for the treatment of schizophrenia with a low risk of phototoxicity. (C) 2015 Elsevier Ltd. All rights reserved.	[Hamaguchi, Wataru; Masuda, Naoyuki; Miyamoto, Satoshi; Kikuchi, Shigetoshi; Narazaki, Fumie; Shiina, Yasuhiro; Seo, Ryushi; Amano, Yasushi; Mihara, Takuma; Moriguchi, Hiroyuki; Hattori, Kouji] Astellas Pharma Inc, Drug Discovery Res, Tsukuba, Ibaraki 3058585, Japan	Hamaguchi, W (reprint author), Astellas Pharma Inc, Drug Discovery Res, 21 Miyukigaoka, Tsukuba, Ibaraki 3058585, Japan.	wataru.hamaguchi@astellas.com			Astellas Pharma Inc.	The authors thank Dr. Susumu Wakanuki and Ms. Ayako Moritomo for their helpful support in preparing this manuscript. The authors also thank Dr. Takeshi Shimada and Ms. Junko Yarimizu for performing pharmacological evaluations, and the staff of Astellas Research Technologies Co., Ltd, for conducting CYP screening, elemental analysis, and spectral measurements. This study was sponsored by Astellas Pharma Inc.	Loughney K, 1999, GENE, V234, P109, DOI 10.1016/S0378-1119(99)00171-7; Rzasa RM, 2012, BIOORG MED CHEM LETT, V22, P7371, DOI 10.1016/j.bmcl.2012.10.078; Fujishige K, 1999, J BIOL CHEM, V274, P18438, DOI 10.1074/jbc.274.26.18438; Ceridono M, 2012, REGUL TOXICOL PHARM, V63, P480, DOI 10.1016/j.yrtph.2012.06.001; Asproni B, 2011, BIOORGAN MED CHEM, V19, P642, DOI 10.1016/j.bmc.2010.10.038; Kunitomo J, 2014, J MED CHEM, V57, P9627, DOI 10.1021/jm5013648; Ho GD, 2012, BIOORG MED CHEM LETT, V22, P2585, DOI 10.1016/j.bmcl.2012.01.113; Verhoest PR, 2009, J MED CHEM, V52, P5188, DOI [10.1021/jm900521k, 10.1021/jm9015334]; Rzasa RM, 2014, BIOORGAN MED CHEM, V22, P6570, DOI 10.1016/j.bmc.2014.10.013; Simpson EH, 2010, NEURON, V65, P585, DOI 10.1016/j.neuron.2010.02.014; Taylor DM, 2003, ACTA PSYCHIAT SCAND, V107, P85, DOI 10.1034/j.1600-0447.2003.02078.x; Soderling SH, 1999, P NATL ACAD SCI USA, V96, P7071, DOI 10.1073/pnas.96.12.7071; Hamaguchi W, 2013, BIOORGAN MED CHEM, V21, P7612, DOI 10.1016/j.bmc.2013.10.035; Smith SM, 2013, NEUROPHARMACOLOGY, V64, P215, DOI 10.1016/j.neuropharm.2012.06.013; Hu E, 2014, J MED CHEM, V57, P6632, DOI 10.1021/jm500713j; [Anonymous], MOE 2013 08; Yang SW, 2012, BIOORG MED CHEM LETT, V22, P235, DOI 10.1016/j.bmcl.2011.11.023; Xie Z, 2006, NEUROSCIENCE, V139, P597, DOI 10.1016/j.neuroscience.2005.12.042; Dayalu P, 2008, EXPERT OPIN PHARMACO, V9, P1451, DOI [10.1517/14656566.9.9.1451 , 10.1517/14656560802170573]; Ho GD, 2012, BIOORG MED CHEM LETT, V22, P1019, DOI 10.1016/j.bmcl.2011.11.127; Helal CJ, 2011, J MED CHEM, V54, P4536, DOI 10.1021/jm2001508; Hu E, 2013, J MED CHEM, V56, P8781, DOI 10.1021/jm401234w; Hu E, 2012, BIOORG MED CHEM LETT, V22, P2262, DOI 10.1016/j.bmcl.2012.01.086; Newcomer JW, 2005, CNS DRUGS, V19, P1; Harada K, 2012, EUR J PHARMACOL, V685, P59, DOI 10.1016/j.ejphar.2012.04.013; Chino A, 2014, BIOORGAN MED CHEM, V22, P3515, DOI 10.1016/j.bmc.2014.04.023; McElroy WT, 2012, BIOORG MED CHEM LETT, V22, P1335, DOI 10.1016/j.bmcl.2011.12.080; Bartolome-Nebreda JM, 2014, J MED CHEM, V57, P4196, DOI 10.1021/jm500073h; Bauer U., 1944, BIOORG MED CHEM LETT, V2012, P22; Boschi D, 2010, CHEM BIODIVERS, V7, P1173, DOI 10.1002/cbdv.200900421; BUUHOI NP, 1953, J CHEM SOC, P3768, DOI 10.1039/jr9530003768; Casey DE, 2005, AM J MED, V118, p15S, DOI 10.1016/j.amjmed.2005.01.046; Chappie TA, 2007, J MED CHEM, V50, P182, DOI 10.1021/jm060653b; Dore A, 2014, EUR J MED CHEM, V84, P181, DOI 10.1016/j.ejmech.2014.07.020; Gocke E, 2003, MUTAT RES-GEN TOX EN, V535, P43, DOI 10.1016/S1383-5718(02)00283-8; Hamaguchi W, 2015, BIOORGAN MED CHEM, V23, P297, DOI 10.1016/j.bmc.2014.11.039; Hamaguchi W, 2014, CHEM PHARM BULL, V62, P1200; Haranosono Y, 2014, J TOXICOL SCI, V39, P655; Kilburn JP, 2013, BIOORGAN MED CHEM, V21, P6053, DOI 10.1016/j.bmc.2013.07.030; Peters B, 2002, ATLA-ALTERN LAB ANIM, V30, P415; Saha S, 2005, PLOS MED, V2, P413, DOI 10.1371/journal.pmed.0020141	41	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-0896	1464-3391		BIOORGAN MED CHEM	Bioorg. Med. Chem.	JUL 1	2015	23	13					3351	3367		10.1016/j.bmc.2015.04.052		17	Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry, Organic	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	CJ9UO	WOS:000355848900041		
J	Arai, M; Kamiya, K; Pruksakorn, P; Sumii, Y; Kotoku, N; Joubert, JP; Moodley, P; Han, C; Shin, D; Kobayashi, M				Arai, Masayoshi; Kamiya, Kentaro; Pruksakorn, Patamaporn; Sumii, Yuji; Kotoku, Naoyuki; Joubert, Jean-Pierre; Moodley, Prashini; Han, Chisu; Shin, Dayoung; Kobayashi, Motomasa			Anti-dormant mycobacterial activity and target analysis of nybomycin produced by a marine-derived Streptomyces sp.	BIOORGANIC & MEDICINAL CHEMISTRY			English	Article						Nybomycin; Antibiotic; Tuberculosis; Dormant; Target identification	DEPLETION-INDUCED DORMANCY; NONREPLICATING PERSISTENCE; ACTION-MECHANISM; CELL-DIVISION; TUBERCULOSIS; SPONGE; SUBSTANCE; IDENTIFICATION; SMEGMATIS; PROTEIN	In the course of our search for anti-dormant Mycobacterial substances, nybomycin ( 1) was re-discovered from the culture broth of a marine-derived Streptomyces sp. on the bioassay-guided separation. Compound 1 showed anti-microbial activity against Mycobacterium smegmatis and Mycobacterium bovis BCG with the MIC of 1.0 mu g/mL under both actively growing aerobic conditions and dormancy inducing hypoxic conditions. Compound 1 is also effective to Mycobacterium tuberculosis including the clinically isolated strains. The mechanistic analysis indicated that 1 bound to DNA and induces a unique morphological change to mycobacterial bacilli leading the bacterial cell death. (C) 2015 Elsevier Ltd. All rights reserved.	[Arai, Masayoshi; Kamiya, Kentaro; Pruksakorn, Patamaporn; Sumii, Yuji; Kotoku, Naoyuki; Han, Chisu; Shin, Dayoung; Kobayashi, Motomasa] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan; [Joubert, Jean-Pierre; Moodley, Prashini] Univ KwaZulu Natal, Nelson R Mandela Sch Med, ZA-4013 Congella, Durban, South Africa	Arai, M (reprint author), Osaka Univ, Grad Sch Pharmaceut Sci, Yamada Oka 1-6, Suita, Osaka 5650871, Japan.	araim@phs.osaka-u.ac.jp; kobayasi@phs.osaka-u.ac.jp			Hoansha Foundation; JSPS (Japan) [22241053]; Platform for Drug Discovery, Informatics, and Structural Life Science from MEXT (Japan); Japan (JSPS)-South Africa (NRF) Joint Research Program; MEXT [23102005]	The authors are grateful to Drs. William R. Jacobs, Jr. and Catherine Vilcheze (Albert Einstein College of Medicine, New York, USA) for kindly providing the M. smegmatis mc<SUP>2</SUP>155 and M. bovis BCG Pasteur strains, the pMV206, pMV261 and pYUB415 vectors, and for their support concerning the genomic DNA library. The authors also thank to Drs. Osamu Muraoka and Junji Fujimori (Kinki University, Osaka, Japan) for supporting the analysis using a scanning electron microscopy. This study was financially supported by assistance from the Hoansha Foundation, and a Grant-in-Aid for Scientific Research B (22241053) from JSPS (Japan) to M. A., and by assistance from the Platform for Drug Discovery, Informatics, and Structural Life Science from MEXT (Japan), and Japan (JSPS)-South Africa (NRF) Joint Research Program to M.A. and M.K., and by a Grant-in-Aid for Scientific Research on Innovative Areas (23102005) from MEXT to M.K.	Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139; Lim A, 1999, J BACTERIOL, V181, P2252; Pruksakorn P, 2010, BIOORG MED CHEM LETT, V20, P3658, DOI 10.1016/j.bmcl.2010.04.100; Hiramatsu K, 2012, INT J ANTIMICROB AG, V39, P478, DOI 10.1016/j.ijantimicag.2012.02.007; Kang CM, 2005, GENE DEV, V19, P1692, DOI 10.1101/gad.1311105; Dick T, 1998, FEMS MICROBIOL LETT, V163, P159, DOI 10.1016/S0378-1097(98)00166-9; Abate G, 2004, J CLIN MICROBIOL, V42, P871, DOI 10.1128/JCM.42.2.871-873.2004; FORBIS RM, 1973, J AM CHEM SOC, V95, P5003, DOI 10.1021/ja00796a037; Nonejuie P, 2013, P NATL ACAD SCI USA, V110, P16169, DOI 10.1073/pnas.1311066110; STRELITZ F, 1955, P NATL ACAD SCI USA, V41, P620, DOI 10.1073/pnas.41.9.620; Dziadek J, 2003, MICROBIOL-SGM, V149, P1593, DOI 10.1099/mic.0.26023-0; Gomez JE, 2000, P NATL ACAD SCI USA, V97, P8554, DOI 10.1073/pnas.140225297; Wayne LG, 1996, INFECT IMMUN, V64, P2062; Idemyor V, 2007, J NATL MED ASSOC, V99, P1414; Arai M, 2014, J NAT MED-TOKYO, V68, P372, DOI 10.1007/s11418-013-0811-y; Arai M, 2014, CHEMBIOCHEM, V15, P117, DOI 10.1002/cbic.201300470; Arai M, 2011, MAR DRUGS, V9, P984, DOI 10.3390/md9060984; Balasubramanian V, 1996, J BACTERIOL, V178, P273; Connell ND, 1995, METHOD CELL BIOL, V45, P107, DOI 10.1016/S0091-679X(08)61848-8; Pruksakorn P, 2011, BIOL PHARM BULL, V34, P1287; RINEHART KL, 1970, J AM CHEM SOC, V92, P6994, DOI 10.1021/ja00726a060; Rustad TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001502; World Health Organisation, GLOB TUB REP 2014; Yamano Y, 2012, BIOORG MED CHEM LETT, V22, P4877, DOI 10.1016/j.bmcl.2012.05.071	24	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-0896	1464-3391		BIOORGAN MED CHEM	Bioorg. Med. Chem.	JUL 1	2015	23	13					3534	3541		10.1016/j.bmc.2015.04.033		8	Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry, Organic	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	CJ9UO	WOS:000355848900058		
J	Rixson, JE; Abraham, JR; Egoshi, Y; Skelton, BW; Young, K; Gilbert, J; Sakoff, JA; Gericke, KM; McCluskey, A; Stewart, SG				Rixson, James E.; Abraham, James R.; Egoshi, Yuki; Skelton, Brian W.; Young, Kelly; Gilbert, Jayne; Sakoff, Jennette A.; Gericke, Kersten M.; McCluskey, Adam; Stewart, Scott G.			The synthesis and biological activity of novel anthracenone-pyranones and anthracenone-furans	BIOORGANIC & MEDICINAL CHEMISTRY			English	Article						Anthrapyranones; Natural products; Growth inhibition; Human cancer cells; Castro-Stephens reaction	PROTEIN PHOSPHATASE 1; NORCANTHARIDIN ANALOGS; ANTICANCER ACTIVITY; ANTHRAPYRAN ANTIBIOTICS; MEDICINAL CHEMISTRY; GAMMA-INDOMYCINONE; CARBOXYLIC-ACIDS; DOMINO REACTIONS; 2A INHIBITION; PLURAMYCINS	An efficient and divergent methodology for the synthesis of new anthracenone-pyranones and anthracenone-furans is described. Key reactions discussed in these syntheses include an aldehyde promoted annulation with a beta-keto-sulfoxide, a domino alkyne insertion/carbonylation/Nu-acylation and a DMEDA promoted Castro-Stephens reaction. We also report the in vitro growth inhibition of these compounds in a range of human cancer cells. The natural product BE-26554A displayed good cell growth activity on BE2-C neuroblastoma and SMA glioblastoma cell lines at 0.17 and 0.16 mu M (GI(50)), respectively. Of note, were a CF3 functionalised anthracenone 4-pyranone (chromone) derivative 22, and an anthracenone-furan derivative 54 which displayed 0.20 mu M and 0.38 mu M growth inhibition, respectively, in the BE2-C neuroblastoma cell line. (C) 2015 Elsevier Ltd. All rights reserved.	[Rixson, James E.; Abraham, James R.; Egoshi, Yuki; Stewart, Scott G.] Univ Western Australia, Sch Chem & Biochem, Crawley, WA 6009, Australia; [Egoshi, Yuki] Sophia Univ, Fac Sci & Technol, Dept Mat & Life Sci, Chiyoda Ku, Tokyo 1028554, Japan; [Skelton, Brian W.] Univ Western Australia, Ctr Microscopy Characterisat & Anal, Crawley, WA 6009, Australia; [Young, Kelly; Gilbert, Jayne; Sakoff, Jennette A.] Calvary Mater Newcastle Hosp, Dept Med Oncol, Waratah, NSW 2298, Australia; [Gericke, Kersten M.] Bayer Pharma AG, Med Chem, D-42096 Wuppertal, Germany; [McCluskey, Adam] Univ Newcastle, Callaghan, NSW 2308, Australia	McCluskey, A (reprint author), Univ Newcastle, Chem Bldg,Univ Dr, Callaghan, NSW 2308, Australia.	Adam.McCluskey@newcastle.edu.au; scott.stewart@uwa.edu.au	Stewart, Scott/A-3822-2009		Hunter Medical Research Institute; Biotechnology Innovation Fund, AusIndustry, Australia	The authors would like to thank A/Prof Lindsay Byrne for NMR assistance and Dr. Tony Reader for mass spectrometry support. This work received financial support from the Hunter Medical Research Institute and the Biotechnology Innovation Fund, AusIndustry, Australia.	Kitamura K, 2014, ANGEW CHEM INT EDIT, V53, P1262, DOI 10.1002/anie.201308017; STEPHENS RD, 1963, J ORG CHEM, V28, P3313, DOI 10.1021/jo01047a008; Rixson JE, 2013, ORG LETT, V15, P4834, DOI 10.1021/ol402240v; Fei ZB, 2005, ORG LETT, V7, P3617, DOI 10.1021/ol0509742; Jacubert M, 2010, TETRAHEDRON, V66, P3775, DOI 10.1016/j.tet.2010.03.055; Bohm HJ, 2004, CHEMBIOCHEM, V5, P637, DOI 10.1002/cbic.200301023; Purser S, 2008, CHEM SOC REV, V37, P320, DOI 10.1039/b610213c; Woon ECY, 2006, TETRAHEDRON, V62, P4829, DOI 10.1016/j.tet.2006.03.005; Stewart SG, 2009, EUR J ORG CHEM, P1934, DOI 10.1002/ejoc.200900028; Augustine JK, 2007, J ORG CHEM, V72, P9854, DOI 10.1021/jo701888m; HAUSER FM, 1979, J AM CHEM SOC, V101, P1628, DOI 10.1021/ja00500a061; Kozlowski MC, 2007, ADV SYNTH CATAL, V349, P583, DOI 10.1002/adsc.200600570; CASTRO CE, 1966, J ORG CHEM, V31, P4071, DOI 10.1021/jo01350a045; Tietze LF, 2006, ANGEW CHEM INT EDIT, V45, P6990, DOI 10.1002/anie.200601992; Hill TA, 2008, CHEMMEDCHEM, V3, P1878, DOI 10.1002/cmdc.200800192; Bakunova SM, 2007, J MED CHEM, V50, P5807, DOI 10.1021/jm0708634; Narayan R, 2014, CHEM-EUR J, V20, P4568, DOI 10.1002/chem.201400186; O'Keefe BM, 2010, J AM CHEM SOC, V132, P15528, DOI 10.1021/ja107926f; Hill TA, 2007, BIOORG MED CHEM LETT, V17, P3392, DOI 10.1016/j.bmcl.2007.03.093; Hamilton PL, 2012, NAT PROD REP, V29, P134, DOI 10.1039/c1np00054c; Wright BJD, 2008, J AM CHEM SOC, V130, P16786, DOI 10.1021/ja805936v; Hsu DS, 2006, CHEM LETT, V35, P1016, DOI 10.1246/cl.2006.1016; Tietze LF, 2006, ORG LETT, V8, P5873, DOI 10.1021/ol062492b; Hill TA, 2007, BIOORGAN MED CHEM, V15, P6126, DOI 10.1016/j.bmc.2007.06.034; Priebbenow DL, 2011, ORG BIOMOL CHEM, V9, P1508, DOI 10.1039/c0ob00835d; BODDY IK, 1986, AUST J CHEM, V39, P2075; Boersch C, 2011, ANGEW CHEM INT EDIT, V50, P10448, DOI 10.1002/anie.201103296; BRANSOVA J, 1995, INT J BIOCHEM CELL B, V27, P701, DOI 10.1016/1357-2725(95)00031-J; Buccini M, 2014, ORG BIOMOL CHEM, V12, P1100, DOI 10.1039/c3ob42333f; CAMBIE RC, 1987, AUST J CHEM, V40, P215; Castro C. E., 1972, ORG SYNTH, V52, P128; Christopher Braddock D., 2013, CHEM COMMUN, P11176; Foulgoc L, 2012, SYNLETT, P768, DOI 10.1055/s-0031-1290529; Gramatica M. P. G. P., 1986, HETEROCYCLES, V24, P743; HAGLUND O, 1991, SYNLETT, P723; Hansen MR, 1996, ACCOUNTS CHEM RES, V29, P249, DOI 10.1021/ar950167a; Koeda T. H. A. T., 1971, J ANTIBIOT, P200; Krohn K, 2011, EUR J ORG CHEM, P2223, DOI 10.1002/ejoc.201100093; Krohn K, 2004, EUR J ORG CHEM, P209, DOI 10.1002/ejoc.200300451; Lee SJ, 1999, J AM CHEM SOC, V121, P8971, DOI 10.1021/ja991607m; Mzhelskaya I. D. I. M. A., 2004, RUSS CHEM B, V53, P2798; Nakatani K, 1996, TETRAHEDRON, V52, P9427, DOI 10.1016/0040-4020(96)00480-2; Ojiri K., 1994, JP, Patent No. 06228121; Priebbenow DL, 2010, J ORG CHEM, V75, P1787, DOI 10.1021/jo902652h; Rixson JE, 2012, EUR J ORG CHEM, P544, DOI 10.1002/ejoc.201101305; SCHUMACHER RW, 1995, J NAT PRODUCTS, V58, P613, DOI 10.1021/np50118a024; Stewart SG, 2010, ORG BIOMOL CHEM, V8, P3563, DOI 10.1039/c003742g; SUN DY, 1995, J AM CHEM SOC, V117, P2430, DOI 10.1021/ja00114a007; Tietze L. F., 2006, DOMINO REACTIONS ORG; Uno H, 1999, CHEM COMMUN, P1005, DOI 10.1039/a901602c; VONSTRAN.M, 1972, J HETEROCYCLIC CHEM, V9, P171; Wang X., 2014, CHEM COMMUN, P652	52	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-0896	1464-3391		BIOORGAN MED CHEM	Bioorg. Med. Chem.	JUL 1	2015	23	13					3552	3565		10.1016/j.bmc.2015.04.032		14	Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry, Organic	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	CJ9UO	WOS:000355848900060		
J	Teno, N; Gohda, K; Wanaka, K; Tsuda, Y; Akagawa, M; Akiduki, E; Araki, M; Masuda, A; Otsubo, T; Yamashita, Y				Teno, Naoki; Gohda, Keigo; Wanaka, Keiko; Tsuda, Yuko; Akagawa, Maiko; Akiduki, Eriko; Araki, Mitsuhito; Masuda, Arisa; Otsubo, Tadamune; Yamashita, Yukiko			Novel type of plasmin inhibitors: Providing insight into P4 moiety and alternative scaffold to pyrrolopyrimidine	BIOORGANIC & MEDICINAL CHEMISTRY			English	Article						Plasmin inhibitors; Benzimidazole; Scaffold; Pyrrolopyrimidine; P4 moiety; Structure-activity relationship	CATHEPSIN-K INHIBITORS; MATRIX METALLOPROTEINASES; CANCER-THERAPY; FORCE-FIELD; GROWTH; BENZIMIDAZOLE; MOLECULES; NITRILE; WARHEAD	Here we report a series of plasmin inhibitors which were originally derived from the parent structure of 1 and 2. Our efforts focused on the optimization of the P4 moiety of 2 and on the quest of alternative scaffold to pyrrolopyrimidine in the parent compounds. The results of the former gave us pivotal information on the further optimization of the P4 moiety in plasmin inhibitors and those of the latter revealed that appropriate moieties extending from the benzimidazole scaffold engaged with S4 pocket in the active site of plasmin. (C) 2015 Elsevier Ltd. All rights reserved.	[Teno, Naoki; Yamashita, Yukiko] Hiroshima Int Univ, Fac Clin Nutr, Kure, Hiroshima 7370112, Japan; [Gohda, Keigo] Kansai CAMM Kansai, Comp Aided Mol Modeling Res Ctr, Nishinomiya, Hyogo 6638241, Japan; [Wanaka, Keiko] Kobe Res Projects Thrombosis & Haemostasis, Tarumi Ku, Kobe, Hyogo 6550033, Japan; [Tsuda, Yuko] Kobe Gakuin Univ, Fac Pharmaceut Sci, Chuo Ku, Kobe, Hyogo 6508586, Japan; [Akagawa, Maiko; Akiduki, Eriko; Araki, Mitsuhito; Masuda, Arisa; Otsubo, Tadamune] Hiroshima Int Univ, Fac Pharmaceut Sci, Kure, Hiroshima 7370112, Japan	Teno, N (reprint author), Hiroshima Int Univ, Fac Clin Nutr, 5-1-1 Hirokoshingai, Kure, Hiroshima 7370112, Japan.	n-teno@ps.hirokoku-u.ac.jp			Ministry of Education, Science, Sports and Culture of Japan [24590154]	The work was supported by Grant-in-Aid for Scientific Research (C, 24590154) from the Ministry of Education, Science, Sports and Culture of Japan. We are grateful to Dr. Lawrence H. Lazarus for critically reading the manuscript.	Al-Horani RA, 2014, MED RES REV, V34, P1168, DOI 10.1002/med.21315; Almstetter M., [No title captured], Patent No. [WO 2012143143, 2012143143]; Gialeli C, 2011, FEBS J, V278, P16, DOI 10.1111/j.1742-4658.2010.07919.x; CHANG G, 1989, J AM CHEM SOC, V111, P4379, DOI 10.1021/ja00194a035; Lijnen HR, 2001, THROMB HAEMOSTASIS, V86, P324; Gaba M, 2014, EUR J MED CHEM, V76, P494, DOI 10.1016/j.ejmech.2014.01.030; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI 10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P; Okada Y, 2000, CHEM PHARM BULL, V48, P1964; Ishihara M, 2012, LEUKEMIA, V26, P332, DOI 10.1038/leu.2011.203; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; MOHAMADI F, 1990, J COMPUT CHEM, V11, P440, DOI 10.1002/jcc.540110405; Davis GE, 2001, J CELL SCI, V114, P917; Fei F, 2013, EXPERT OPIN THER PAT, V23, P1157, DOI 10.1517/13543776.2013.800857; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Xue MZ, 2012, CURR PHARM DESIGN, V18, P2901; Swedberg JE, 2011, BIOCHEMISTRY-US, V50, P8454, DOI 10.1021/bi201203y; Li YH, 2013, ANGEW CHEM INT EDIT, V52, P12156, DOI 10.1002/anie.201306850; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Farina Antonietta Rosella, 2014, Cancers (Basel), V6, P240, DOI 10.3390/cancers6010240; Gohda K, 2012, J ENZYM INHIB MED CH, V27, P571, DOI 10.3109/14756366.2011.603129; Kaur G, 2014, MINI-REV MED CHEM, V14, P747; Luo Y, 2010, BIOORGAN MED CHEM, V18, P5048, DOI 10.1016/j.bmc.2010.05.076; Nicholas S., [No title captured], Patent No. [WO 2009117421, 2009117421]; Szende B, 2002, IN VIVO, V16, P281; Teno N, 2011, BIOORG MED CHEM LETT, V21, P6305, DOI 10.1016/j.bmcl.2011.08.121; Teno N, 2008, BIOORG MED CHEM LETT, V18, P2599, DOI 10.1016/j.bmcl.2008.03.036; Teno N, 2010, CURR TOP MED CHEM, V10, P752; Teno N, 2007, BIOORG MED CHEM LETT, V17, P6096, DOI 10.1016/j.bmcl.2007.09.047; Teno N, 2012, J PEPT SCI, V18, P620, DOI 10.1002/psc.2442; Teno N, 2014, BIOORGAN MED CHEM, V22, P2339, DOI 10.1016/j.bmc.2014.02.002; Teno N, 2008, J MED CHEM, V51, P5459, DOI 10.1021/jm800626a	31	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-0896	1464-3391		BIOORGAN MED CHEM	Bioorg. Med. Chem.	JUL 1	2015	23	13					3696	3704		10.1016/j.bmc.2015.04.013		9	Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry, Organic	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	CJ9UO	WOS:000355848900074		
J	Tsutsui, N; Tanabe, G; Morita, N; Okayama, Y; Kita, A; Sugiura, R; Muraoka, O				Tsutsui, Nozomi; Tanabe, Genzoh; Morita, Nao; Okayama, Yoshitomo; Kita, Ayako; Sugiura, Reiko; Muraoka, Osamu			Structure-activity relationship studies on acremomannolipin A, the potent calcium signal modulator with a novel glycolipid structure 3: Role of the length of alditol side chain	BIOORGANIC & MEDICINAL CHEMISTRY			English	Article						Acremomannolipin A; Glycolipid; Calcium signal modulator; Acremonium strictum; SAR study	FUNGUS ACREMONIUM-STRICTUM; BETA-MANNOPYRANOSIDES; ANALOGS	Five homologs of a novel glycolipid acremomannolipin A (1a), the potential Ca2+ signal modulator isolated from Acremonium strictum, bearing alditols of different length (1g-1k) were synthesized by a stereoselective beta-mannosylation of appropriately protected mannosyl sulfoxide (2) with five alditols (1g: C2, 1h: C3, 1i: C4, 1j: C5 and 1k: C7 units), and their potential in modulating Ca2+ signaling were evaluated. Homologs with alditols of more than 4 carbons (1i, 1j and 1k) were equally or more potent than the parent compound (1a) regardless of the length of the alditol chain. Whereas activities of two homologs with shorter chains (1g and 1h) decreased to a considerable extent. The results indicated that the length of the alditol side chain was a crucial determinant for the potent calcium signal modulating activity. (C) 2015 Elsevier Ltd. All rights reserved.	[Tsutsui, Nozomi; Tanabe, Genzoh; Morita, Nao; Okayama, Yoshitomo; Muraoka, Osamu] Kinki Univ, Fac Pharm, Lab Pharmaceut Organ Chem, Higashiosaka, Osaka 5778502, Japan; [Kita, Ayako; Sugiura, Reiko] Kinki Univ, Fac Pharm, Lab Mol Pharmacogen, Higashiosaka, Osaka 5778502, Japan	Sugiura, R (reprint author), Kinki Univ, Fac Pharm, Lab Mol Pharmacogen, 3-4-1 Kowakae, Higashiosaka, Osaka 5778502, Japan.	sugiurar@phar.kindai.ac.jp; muraoka@phar.kindai.ac.jp			MEXT	This study was performed as a research program of the Project for Development of Innovative Research on Cancer Therapeutics (P-Direct), Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT). This study was supported by research grants from MEXT, and by the MEXT-Supported Program for the Strategic Research Foundation at Private Universities (2014-2018).	Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Crich D, 1996, J ORG CHEM, V61, P4506, DOI 10.1021/jo9606517; Crich D, 1998, TETRAHEDRON, V54, P8321, DOI 10.1016/S0040-4020(98)00426-8; Doboszewski B, 2008, TETRAHEDRON, V64, P5551, DOI 10.1016/j.tet.2008.03.088; Ishiwata S., 2008, SOURCE BOOK MODELS B, P439, DOI 10.1007/978-1-59745-285-4_46; Muraoka O, 2010, TETRAHEDRON, V66, P3717, DOI 10.1016/j.tet.2010.03.072; Sugiura R, 2012, BIOORG MED CHEM LETT, V22, P6735, DOI 10.1016/j.bmcl.2012.08.085; Tanabe G, 2007, BIOORGAN MED CHEM, V15, P3926, DOI 10.1016/j.bmc.2006.10.014; Tsutsui N, 2014, BIOORGAN MED CHEM, V22, P945, DOI 10.1016/j.bmc.2013.12.052; Tsutsui N, 2013, TETRAHEDRON, V69, P9917, DOI 10.1016/j.tet.2013.09.086; Tsutsui N, 2013, TETRAHEDRON LETT, V54, P451, DOI 10.1016/j.tetlet.2012.10.128; Woo YH, 2006, BIOORGAN MED CHEM, V14, P2375, DOI 10.1016/j.bmc.2005.11.012	12	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-0896	1464-3391		BIOORGAN MED CHEM	Bioorg. Med. Chem.	JUL 1	2015	23	13					3761	3773		10.1016/j.bmc.2015.03.079		13	Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry, Organic	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	CJ9UO	WOS:000355848900082		
J	Imai, M; Kumaoka, T; Hosaka, M; Sato, Y; Li, C; Sudoh, M; Tamada, Y; Yokoe, H; Saito, S; Tsubuki, M; Takahashi, N				Imai, Masahiko; Kumaoka, Takaya; Hosaka, Makiko; Sato, Yui; Li, Chuan; Sudoh, Masashi; Tamada, Yoshiko; Yokoe, Hiromasa; Saito, Setsu; Tsubuki, Masayoshi; Takahashi, Noriko			Inhibitory effects of hydroxylated cinnamoyl esters on lipid absorption and accumulation	BIOORGANIC & MEDICINAL CHEMISTRY			English	Article						Lipase; Lipid absorption; Lipid accumulation; Anti-obesity; Caffeic acid phenylethyl ester	ACID PHENETHYL ESTER; FACTOR-KAPPA-B; PANCREATIC LIPASE; ANTIOXIDANT PROPERTIES; METABOLIC SYNDROME; GENE-EXPRESSION; IN-VITRO; OBESITY; CELLS; ADIPOCYTES	Obesity is a risk factor associated with several lifestyle-related diseases, for example, diabetes, high blood pressure, hyperlipidemia and cancer. Caffeic acid 2-phenylethyl ester (CAPE, 1), a naturally-occurring compound found in various plants and propolis, which exhibits anti-inflammatory, immunomodulatory and cytotoxic activities and inhibits 3T3-L1 differentiation to adipocytes. As part of our efforts to moderate lifestyle-related diseases, we synthesized analogs of 1 and studied their effects on pancreatic lipase activities, lipid absorption, and 3T3-L1 differentiation. We found that catechols 1-4 show inhibitory activities against pancreatic lipase in a dose-dependent manner in vitro. Compounds 1-3 proved to be more potent inhibitors of pancreatic lipase than 5, 6, 8, and 9, which have one hydroxyl group, respectively. Compound 7 has three aromatic hydroxyl groups and restrains greater lipase inhibitory activity than the other compounds. In addition, 7 and 3 significantly suppress a rise in blood triglyceride (TG) levels in mice given corn oil orally. Furthermore, 2 and 3 are more potent at preventing 3T3-L1 differentiation (lipid accumulation) than 1, while 7 is more potent than 3, 8, and 9 in these assays. Compounds 2, 3, and 7 inhibit lipid absorption and accumulation, with new compound 7 being the most potent. These results indicate that 7 may have potential benefits as a health agent with anti-obesity properties. (C) 2015 Elsevier Ltd. All rights reserved.	[Imai, Masahiko; Kumaoka, Takaya; Hosaka, Makiko; Sato, Yui; Li, Chuan; Takahashi, Noriko] Hoshi Univ, Inst Med Chem, Physiol Chem Lab, Shinagawa, Tokyo 1428501, Japan; [Sudoh, Masashi; Tamada, Yoshiko; Yokoe, Hiromasa; Saito, Setsu; Tsubuki, Masayoshi] Hoshi Univ, Inst Med Chem, Bioorgan Chem Lab, Shinagawa, Tokyo 1428501, Japan	Takahashi, N (reprint author), Hoshi Univ, Inst Med Chem, Physiol Chem Lab, 2-4-41 Ebara, Shinagawa, Tokyo 1428501, Japan.	t-noriko@hoshi.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan; Promotion and Mutual Aid Corporation for Private Schools of Japan; JSPS Core-to-Core Program, A. Advanced Research Networks, Japan	We thank Dr. Terrence Burke, Jr. for helpful comments. We thank Dr. Shigeyuki Imamura and Dr. Kazunaga Yazawa for their expert technical assistance. This investigation was supported in part by 'the Ministry of Education, Culture, Sports, Science and Technology, Japan', 'the Promotion and Mutual Aid Corporation for Private Schools of Japan', and 'JSPS Core-to-Core Program, A. Advanced Research Networks, Japan'.	Etzenhouser B, 2001, BIOORGAN MED CHEM, V9, P199, DOI 10.1016/S0968-0896(00)00238-8; Nagaoka T, 2002, BIOORGAN MED CHEM, V10, P3351, DOI 10.1016/S0968-0896(02)00138-4; Matsuzawa Y, 2006, FEBS LETT, V580, P2917, DOI 10.1016/j.febslet.2006.04.028; FESEN MR, 1993, P NATL ACAD SCI USA, V90, P2399, DOI 10.1073/pnas.90.6.2399; KUJUMGIEV A, 1993, PHARMAZIE, V48, P785; Lei F, 2007, INT J OBESITY, V31, P1023, DOI 10.1038/sj.ijo.0803502; Toyoda T, 2009, INT J CANCER, V125, P1786, DOI 10.1002/ijc.24586; Liu W, 2008, PHYTOMEDICINE, V15, P1140, DOI 10.1016/j.phymed.2008.07.002; Kikuzaki H, 2002, J AGR FOOD CHEM, V50, P2161, DOI 10.1021/jf011348w; Lefkovits I, 1997, INT J ONCOL, V11, P59; Michaluart P, 1999, CANCER RES, V59, P2347; Uwai K, 2008, BIOORGAN MED CHEM, V16, P7795, DOI 10.1016/j.bmc.2008.07.006; SUDINA GF, 1993, FEBS LETT, V329, P21, DOI 10.1016/0014-5793(93)80184-V; Juman S, 2011, BIOL PHARM BULL, V34, P490, DOI 10.1248/bpb.34.490; SADOWSKI HB, 1992, J BIOL CHEM, V267, P4722; Ritchie SA, 2007, NUTR METAB CARDIOVAS, V17, P319, DOI 10.1016/j.numecd.2006.07.005; Nishimura K, 2009, CHEM PHARM BULL, V57, P476; GRUNBERGER D, 1988, EXPERIENTIA, V44, P230, DOI 10.1007/BF01941717; Chen YJ, 2001, ANTI-CANCER DRUG, V12, P143, DOI 10.1097/00001813-200102000-00008; Juman S, 2010, BIOL PHARM BULL, V33, P1484, DOI 10.1248/bpb.33.1484; Orban Z, 2000, NEUROIMMUNOMODULAT, V7, P99, DOI 10.1159/000026427; Tsujita T, 2006, J LIPID RES, V47, P1852, DOI 10.1194/jlr.M600168-JLR200; Karu N, 2007, J AGR FOOD CHEM, V55, P2824, DOI 10.1021/jf0628025; Chan Dick C, 2004, Am J Cardiovasc Drugs, V4, P227, DOI 10.2165/00129784-200404040-00004; Golay A, 2005, BEST PRACT RES CL EN, V19, P649, DOI 10.1016/j.beem.2005.07.010; Juman S, 2012, BIOL PHARM BULL, V35, P1941; Karamac M, 1996, Z NATURFORSCH C, V51, P903; Matsuzawa Y, 1995, OBES RES S2, V3, P187; Montani JP, 2002, INT J OBESITY, V26, pS28, DOI 10.1038/sj.ijo.0802125; Natarajan K, 1996, P NATL ACAD SCI USA, V93, P9090, DOI 10.1073/pnas.93.17.9090; Takahashi N, 2008, INT J CANCER, V122, P689, DOI 10.1002/ijc.23154; Weng YC, 2010, J AGR FOOD CHEM, V58, P10033, DOI 10.1021/jf1024246; Yasui N, 2013, J ASIAN NAT PROD RES, V15, P1189, DOI 10.1080/10286020.2013.825609; You TJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE741, DOI 10.1152/ajpendo.00419.2004; Zhang ZZ, 2010, J NAT PROD, V73, P252, DOI 10.1021/np900519d	35	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-0896	1464-3391		BIOORGAN MED CHEM	Bioorg. Med. Chem.	JUL 1	2015	23	13					3788	3795		10.1016/j.bmc.2015.03.086		8	Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry, Organic	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	CJ9UO	WOS:000355848900085		
J	Yoshida, Y; Terauchi, T; Naoe, Y; Kazuta, Y; Ozaki, F; Beuckmann, CT; Nakagawa, M; Suzuki, M; Kushida, I; Takenaka, O; Ueno, T; Yonaga, M				Yoshida, Yu; Terauchi, Taro; Naoe, Yoshimitsu; Kazuta, Yuji; Ozaki, Fumihiro; Beuckmann, Carsten T.; Nakagawa, Makoto; Suzuki, Michiyuki; Kushida, Ikuo; Takenaka, Osamu; Ueno, Takashi; Yonaga, Masahiro			Design, synthesis, and structure-activity relationships of a series of novel N-aryl-2-phenylcyclopropanecarboxamide that are potent and orally active orexin receptor antagonists (vol 22, pg 6071, 2014)	BIOORGANIC & MEDICINAL CHEMISTRY			English	Correction									[Yoshida, Yu; Terauchi, Taro; Naoe, Yoshimitsu; Kazuta, Yuji; Ozaki, Fumihiro; Yonaga, Masahiro] Eisai & Co Ltd, Eisai Prod Creat Syst, Med Chem, Tsukuba, Ibaraki 3002635, Japan; [Beuckmann, Carsten T.; Nakagawa, Makoto; Suzuki, Michiyuki] Eisai & Co Ltd, Eisai Prod Creat Syst, Biopharmacol, Tsukuba, Ibaraki 3002635, Japan; [Kushida, Ikuo] Eisai & Co Ltd, Eisai Prod Creat Syst, Phys Chem, Tsukuba, Ibaraki 3002635, Japan; [Takenaka, Osamu; Ueno, Takashi] Eisai & Co Ltd, Eisai Prod Creat Syst, Drug Metab & Pharmacokinet, Tsukuba, Ibaraki 3002635, Japan	Yoshida, Y (reprint author), Eisai & Co Ltd, Eisai Prod Creat Syst, Med Chem, 5-1-3 Tokodai, Tsukuba, Ibaraki 3002635, Japan.	y11-yoshida@hhc.eisai.co.jp					Yoshida Y, 2014, BIOORGAN MED CHEM, V22, P6071, DOI 10.1016/j.bmc.2014.08.034	1	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-0896	1464-3391		BIOORGAN MED CHEM	Bioorg. Med. Chem.	JUL 1	2015	23	13					3870	3870		10.1016/j.bmc.2015.04.042		1	Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry, Organic	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	CJ9UO	WOS:000355848900094		
J	Sakamoto, H; Uchii, T; Yamaguchi, K; Koto, A; Takamura, EI; Satomura, T; Sakuraba, H; Ohshima, T; Suye, S				Sakamoto, Hiroaki; Uchii, Toshiki; Yamaguchi, Kayo; Koto, Ayako; Takamura, Ei-ichiro; Satomura, Takenori; Sakuraba, Haruhiko; Ohshima, Toshihisa; Suye, Shin-ichiro			Construction of a biocathode using the multicopper oxidase from the hyperthermophilic archaeon, Pyrobaculum aerophilum: towards a long-life biobattery	BIOTECHNOLOGY LETTERS			English	Article						Bio-fuel cells; Carbon nanotube; Glucose dehydrogenase; Hyperthermophilic enzyme; Multicopper oxidase; Pyrroloquinoline quinone; Surface modification	MULTIWALLED CARBON NANOTUBES; ELECTRON-TRANSFER; BIOFUEL CELLS; REDUCTION; ORIENTATION; LACCASE; OXYGEN	The life of biobatteries remains an issue due to loss of enzyme activity over time. In this study, we sought to develop a biobattery with a long life using a hyperthermophilic enzyme. We hypothesized that use of such hyperthermophilic enzymes would allow for the biofuel cells to have a long battery life. Using pyrroloquinoline quinone-glucose dehydrogenase and the multicopper oxidase from Pyrobaculum aerophilum, we constructed an anode and cathode. The maximum output was 11 mu W at 0.2 V, and the stability of the both electrode was maintained at 70 % after 14 days. The biofuel cells that use hyperthermophilic enzymes may prolong their life.	[Sakamoto, Hiroaki] Univ Fukui, Tenure Track Program Innovat Res, Fukui 9108507, Japan; [Uchii, Toshiki; Yamaguchi, Kayo; Satomura, Takenori; Suye, Shin-ichiro] Univ Fukui, Grad Sch Engn, Dept Appl Chem & Biotechnol, Fukui 9108507, Japan; [Koto, Ayako; Takamura, Ei-ichiro; Suye, Shin-ichiro] Univ Fukui, Grad Sch Engn, Dept Frontier Fiber Technol & Sci, Fukui 9108507, Japan; [Sakuraba, Haruhiko] Kagawa Univ, Dept Appl Biol Sci, Fac Agr, Takamatsu, Kagawa 760, Japan; [Ohshima, Toshihisa] Osaka Inst Technol, Fac Engn, Dept Biomed Engn, Osaka 535, Japan	Suye, S (reprint author), Univ Fukui, Grad Sch Engn, Dept Appl Chem & Biotechnol, Bunkyo 3-9-1, Fukui 9108507, Japan.	suyeb10@u-fukui.ac.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI [23510127]	This work was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI (23510127) Grant-in-Aid for Scientific Research (C).	Karnicka K, 2008, ANAL CHEM, V80, P7643, DOI 10.1021/ac8011297; Sakuraba H, 2011, ACTA CRYSTALLOGR F, V67, P753, DOI 10.1107/S1744309111018173; Ramanavicius A, 2008, BIOSENS BIOELECTRON, V24, P761, DOI 10.1016/j.bios.2008.06.048; Kim J, 2006, BIOTECHNOL ADV, V24, P296, DOI 10.1016/j.biotechadv.2005.11.006; Olejnik P, 2012, J PHYS CHEM C, V116, P25911, DOI 10.1021/jp3098654; Osman MH, 2011, BIOSENS BIOELECTRON, V26, P3087, DOI 10.1016/j.bios.2011.01.004; Krzeminski L, 2011, J PHYS CHEM B, V115, P12607, DOI 10.1021/jp205852u; Lee JY, 2010, J POWER SOURCES, V195, P750, DOI 10.1016/j.jpowsour.2009.08.050; Palmore GTR, 1999, J ELECTROANAL CHEM, V464, P110, DOI 10.1016/S0022-0728(99)00008-X; Fenga PG, 2013, ELECTROCHIM ACTA, V106, P109, DOI 10.1016/j.electacta.2013.05.046; Fernandez-Sanchez C, 2002, BIOELECTROCHEMISTRY, V58, P149, DOI 10.1016/S1567-5394(02)00119-6; Koto A, 2014, J BIOSENS BIOELECTRO, V5; Ray S, 2013, ELECTROCHIM ACTA, V99, P85, DOI 10.1016/j.electacta.2013.03.080; Sakuraba H, 2010, ARCH BIOCHEM BIOPHYS, V502, P81, DOI 10.1016/j.abb.2010.08.002	14	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0141-5492	1573-6776		BIOTECHNOL LETT	Biotechnol. Lett.	JUL	2015	37	7					1399	1404		10.1007/s10529-015-1819-z		6	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CJ7OL	WOS:000355685800010		
J	Tomozawa, A; Ishikawa, S; Shiota, N; Cholvisudhi, P; Makita, K				Tomozawa, Arisa; Ishikawa, Seiji; Shiota, Nobuhiro; Cholvisudhi, Phantila; Makita, Koshi			Perioperative risk factors for acute kidney injury after liver resection surgery: an historical cohort study	CANADIAN JOURNAL OF ANESTHESIA-JOURNAL CANADIEN D ANESTHESIE			English	Article							ACUTE-RENAL-FAILURE; RED-CELL STORAGE; CARDIOTHORACIC SURGERY; SURGICAL-PATIENTS; CARDIAC-SURGERY; BYPASS-SURGERY; ANESTHESIA; OUTCOMES; TRANSFUSION; VALIDATION	This study aimed to identify the incidence and risk factors for acute kidney injury (AKI) after liver resection surgery and to clarify the relationship between postoperative AKI and outcome. We conducted a historical cohort study of patients who underwent liver resection surgery with sevoflurane anesthesia from January 2004 to October 2011. Acute kidney injury was diagnosed based on the Acute Kidney Injury Network classification within 72 hr after the surgery. Patient data, surgical and anesthetic data, and laboratory data were extracted manually from the patients' electronic charts. Multivariable logistic regression analysis was used to identify perioperative risk factors for postoperative AKI. Acute kidney injury was diagnosed in 78 of 642 patients (12.1%; 95% confidence interval [CI]: 9.7 to 14.9). Multivariable analysis showed an independent association between postoperative AKI and preoperative estimated glomerular filtration rate (adjusted odds ratio [aOR] 0.74; 95% CI: 0.64 to 0.85), preoperative hypertension (aOR 2.10; 95% CI: 1.11 to 3.97), and intraoperative red blood cell transfusion (aOR 1.04; 95% CI: 1.01 to 1.07). Development of AKI within 72 hr after liver resection surgery was associated with increased hospital mortality, prolonged length of stay, and increased rates of mechanical ventilation, reintubation, and renal replacement therapy. Perioperative risk factors for AKI after liver resection surgery are similar to those established for other surgical procedures. Further studies are needed to establish causality and to determine whether interventions on modifiable risk factors can reduce the incidence of postoperative AKI and improve patient outcome. This study was registered at the University Hospital Medical Information Network (UMIN) Center (UMIN 000008089).	[Tomozawa, Arisa; Ishikawa, Seiji; Makita, Koshi] Tokyo Med & Dent Univ, Dept Anesthesiol, Grad Sch Med & Dent Sci, Bunkyo Ku, Tokyo 1138519, Japan; [Shiota, Nobuhiro; Cholvisudhi, Phantila] Chulalongkorn Univ, Fac Med, Dept Anesthesiol, Bangkok 10330, Thailand	Ishikawa, S (reprint author), Tokyo Med & Dent Univ, Dept Anesthesiol, Grad Sch Med & Dent Sci, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	ishikawa.mane@tmd.ac.jp			Department of Anesthesiology, Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Japan; Ministry of Education, Culture, Sports, Science and Technology, Japan [25462426]	This work was funded by the Department of Anesthesiology, Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Japan. Dr. Ishikawa is supported through Grant-in-Aid for Scientific Research ((C) 25462426) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Abelha FJ, 2009, CRIT CARE, V13, DOI 10.1186/cc7894; Almac Emre, 2007, Best Pract Res Clin Anaesthesiol, V21, P195, DOI 10.1016/j.bpa.2007.01.004; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Bastin AJ, 2013, J CRIT CARE, V28, P389, DOI 10.1016/j.jcrc.2012.12.008; Weingarten TN, 2012, CAN J ANESTH, V59, P1111, DOI 10.1007/s12630-012-9797-2; Tinmouth A, 2006, TRANSFUSION, V46, P2014, DOI 10.1111/j.1537-2995.2006.01026.x; Licker M, 2011, ANN THORAC SURG, V91, P844, DOI 10.1016/j.athoracsur.2010.10.037; Bennett-Guerrero E, 2007, P NATL ACAD SCI USA, V104, P17063, DOI 10.1073/pnas.0708160104; MORAN SM, 1985, KIDNEY INT, V27, P928, DOI 10.1038/ki.1985.101; Karkouti K, 2009, CIRCULATION, V119, P495, DOI 10.1161/CIRCULATIONAHA.108.786913; Comporti M, 2002, FREE RADICAL BIO MED, V32, P568, DOI 10.1016/S0891-5849(02)00759-1; Bennet SJ, 2010, INJURY, V41, P335, DOI 10.1016/j.injury.2009.07.009; Endo A, 2012, ANESTH ANALG, V115, P1309, DOI 10.1213/ANE.0b013e31826ba8d7; Jafari SM, 2010, J ARTHROPLASTY, V25, P49, DOI 10.1016/j.arth.2010.04.008; van de Watering L, 2011, VOX SANG, V100, P36, DOI 10.1111/j.1423-0410.2010.01441.x; Ishikawa S, 2012, ANESTH ANALG, V114, P1256, DOI 10.1213/ANE.0b013e31824e2d20; Thakar CV, 2007, CLIN J AM SOC NEPHRO, V2, P426, DOI 10.2215/CJN.03961106; Joannidis M, 2009, INTENS CARE MED, V35, P1692, DOI 10.1007/s00134-009-1530-4; Melendez JA, 1998, J AM COLL SURGEONS, V187, P620, DOI 10.1016/S1072-7515(98)00240-3; Kheterpal S, 2009, ANESTHESIOLOGY, V110, P505, DOI 10.1097/ALN.0b013e3181979440; Bihorac A, 2009, ANN SURG, V249, P851, DOI 10.1097/SLA.0b013e3181a40a0b; Karkouti K, 2012, ANESTHESIOLOGY, V116, P613, DOI 10.1097/ALN.0b013e3182475e39; Hobson CE, 2009, CIRCULATION, V119, P2444, DOI 10.1161/CIRCULATIONAHA.108.800011; Carmichael P, 2003, ANZ J SURG, V73, P144, DOI 10.1046/j.1445-2197.2003.02640.x; Ricci Z, 2010, CURR OPIN CRIT CARE, V16, P13, DOI 10.1097/MCC.0b013e328334b13b; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Lassnigg A, 2008, CRIT CARE MED, V36, P1129, DOI 10.1097/CCM.0b013e318169181a; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Conzen PF, 2002, ANESTHESIOLOGY, V97, P578, DOI 10.1097/00000542-200209000-00010; HIGUCHI H, 1995, ANESTHESIOLOGY, V83, P449, DOI 10.1097/00000542-199509000-00003; Jones Dean R, 2008, Best Pract Res Clin Anaesthesiol, V22, P193, DOI 10.1016/j.bpa.2007.08.005; Kim MY, 2011, RENAL FAILURE, V33, P316, DOI 10.3109/0886022X.2011.560406; Masoomi H, 2012, AM SURGEON, V78, P1019; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Moore EM, 2010, ANAESTH INTENS CARE, V38, P113; Noor S, 2008, CLIN GERIATR MED, V24, P721, DOI 10.1016/j.cger.2008.07.004; Shirabe K, 2010, WORLD J SURG, V34, P1555, DOI 10.1007/s00268-010-0495-3; Slankamenac K, 2009, ANN SURG, V250, P720, DOI 10.1097/SLA.0b013e3181bdd840; Tang Ignatius Y, 2004, Best Pract Res Clin Anaesthesiol, V18, P91, DOI 10.1016/j.bpa.2003.09.006; Weingarten TN, 2013, OBES SURG, V23, P64, DOI 10.1007/s11695-012-0766-1	40	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0832-610X	1496-8975		CAN J ANESTH	Can. J. Anesth.	JUL	2015	62	7					753	761		10.1007/s12630-015-0397-9		9	Anesthesiology	Anesthesiology	CJ9NY	WOS:000355830500006		
J	Aoyama, K; Takenaka, I; Iwagaki, T; Sano, H				Aoyama, Kazuyoshi; Takenaka, Ichiro; Iwagaki, Tamao; Sano, Haruhiko			A simple maneuver for confirmation of the guidewire during ultrasound-guided internal jugular vein cannulation	CANADIAN JOURNAL OF ANESTHESIA-JOURNAL CANADIEN D ANESTHESIE			English	Letter							GUIDANCE		[Aoyama, Kazuyoshi; Takenaka, Ichiro; Iwagaki, Tamao; Sano, Haruhiko] Steel Mem Yawata Hosp, Dept Anesthesia, Kitakyushu, Fukuoka, Japan	Aoyama, K (reprint author), Steel Mem Yawata Hosp, Dept Anesthesia, Kitakyushu, Fukuoka, Japan.	aoyama.k@ns.yawata-mhp.or.jp					Blaivas M, 2009, CRIT CARE MED, V37, P2345, DOI 10.1097/CCM.0b013e3181a067d4; Moak JH, 2011, AM J EMERG MED, V29, P432, DOI 10.1016/j.ajem.2010.01.004; Ayoub C, 2010, CAN J ANAESTH, V57, P500, DOI 10.1007/s12630-010-9291-7; Movahed MR, 2010, NEW ENGL J MED, V363, P796	4	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0832-610X	1496-8975		CAN J ANESTH	Can. J. Anesth.	JUL	2015	62	7					839	840		10.1007/s12630-015-0346-7		2	Anesthesiology	Anesthesiology	CJ9NY	WOS:000355830500019		
J	Watanabe, K; Arumugam, S; Sreedhar, R; Thandavarayan, RA; Nakamura, T; Nakamura, M; Harima, M; Yoneyama, H; Suzuki, K				Watanabe, Kenichi; Arumugam, Somasundaram; Sreedhar, Remya; Thandavarayan, Rajarajan A.; Nakamura, Takashi; Nakamura, Masahiko; Harima, Meilei; Yoneyama, Hiroyuki; Suzuki, Kenji			Small interfering RNA therapy against carbohydrate sulfotransferase 15 inhibits cardiac remodeling in rats with dilated cardiomyopathy	CELLULAR SIGNALLING			English	Article						Experimental autoimmune myocarditis; Chronic heart failure; Cardiac remodeling; CHST15 siRNA	ACETYLGALACTOSAMINE 4-SULFATE 6-O-SULFOTRANSFERASE; GIANT-CELL MYOCARDITIS; CHONDROITIN SULFATE; HEART-FAILURE; MAST-CELLS; I COLLAGEN; SQUID CARTILAGE; PROTEOGLYCANS; DECORIN; GENE	Carbohydrate sulfotransferase 15 (CHST15) is a sulfotransferase responsible for biosynthesis of chondroitin sulfate E (CS-E), which plays important roles in numerous biological events such as biosynthesis of proinflammatory cytokines. However, the effects of CHST15 siRNA in rats with chronic heart failure (CHF) after experimental autoimmune myocarditis (EAM) have not yet been investigated. CHF was elicited in Lewis rats by immunization with cardiac myosin, and after immunization, the rats were divided into two groups and treated with either CHST15 siRNA (2 mu g/week) or vehicle. Age matched normal rats without immunizations were also included in this study. After 7 weeks of treatment, we investigated the effects of CHST15 siRNA on cardiac function, proinflammatory cytokines, and cardiac remodeling in RAM rats. Myocardial functional parameters measured by hemodynamic and echocardiographic studies were significantly improved by CHST15 siRNA treatment in rats with CHF compared with that of vehicle-treated CHF rats. CHST15 siRNA significantly reduced cardiac fibrosis, and hypertrophy and its marker molecules (left ventricular (LV) mRNA expressions of transforming growth factor betal, collagens land III, and atrial natriuretic peptide) compared with vehicle-treated CHF rats. CHF-induced increased myocardial mRNA expressions of proinflammatory cytokines [interleukin (IL)-6, IL-1 beta], monocyte chemoattractant protein-1, and matrix metalloproteinases (MMP-2 and -9), and CHST15 were also suppressed by the treatment with CHST15 siRNA. Western blotting study has confirmed the results obtained from mRNA analysis as CHST5 siRNA treated rats expressed reduced levels of inflammatory and cardiac remodeling marker proteins. Our results demonstrate for the first time, that CHST15 siRNA treatment significantly improved LV function and ameliorated the progression of cardiac remodeling in rats with CHF after EAM. (C) 2015 Elsevier Inc. All rights reserved.	[Watanabe, Kenichi; Arumugam, Somasundaram; Sreedhar, Remya; Nakamura, Takashi; Harima, Meilei] Niigata Univ Pharm & Appl Life Sci, Fac Pharmaceut Sci, Dept Clin Pharmacol, Niigata 9568603, Japan; [Thandavarayan, Rajarajan A.] Houston Methodist Res Inst, Dept Cardiovasc Sci, Houston, TX 77030 USA; [Nakamura, Masahiko] Yamanashi Prefectural Cent Hosp, Dept Cardiol, Kofu, Yamanashi, Japan; [Yoneyama, Hiroyuki] Stelic Inst & Co Inc, Minato City, Tokyo, Japan; [Suzuki, Kenji] Niigata Univ, Grad Sch Med & Dent Sci, Dept Gastroenterol & Hepatol, Niigata, Japan	Watanabe, K (reprint author), Niigata Univ Pharm & Appl Life Sci, Fac Pharmaceut Sci, Dept Clin Pharmacol, Akiha Ku, 265-1 Higashijima, Niigata 9568603, Japan.	watanabe@nupals.ac.jp			Yujin Memorial Grant, Ministry of Education, Culture, Sports, Science, and Technology, Japan [23602012]; promotion and Mutual Aid Corporation for Private Schools, Japan [26460239]; Japan Science and Technology Agency (JST), Japan [AS2117901G]	This research was supported by a Yujin Memorial Grant, Ministry of Education, Culture, Sports, Science, and Technology, Japan (23602012), and by a grant from the promotion and Mutual Aid Corporation for Private Schools, Japan (26460239), and by Japan Science and Technology Agency (JST, AS2117901G), Japan. We thank Wawaimuli Arozal, Flori Ratna Sari, Hiroko Shimazaki, Sayaka Egawa, Fuji Tomohiko, Kana Kawadura, Yoshiyasu Kobayashi, and Yuhki for their assistance in this research work. We also express our sincere gratitude to Dr. Masaki Nagata (Division of Oral and Maxillofacial Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan) for carrying out RT-PCR analysis to this study.	Al Haj Zen Ayman, 2003, Matrix Biol, V22, P251, DOI 10.1016/S0945-053X(03)00018-0; Sharp PA, 1999, GENE DEV, V13, P139, DOI 10.1101/gad.13.2.139; KLINGEL K, 1992, P NATL ACAD SCI USA, V89, P314, DOI 10.1073/pnas.89.1.314; WEBER KT, 1993, CARDIOVASC RES, V27, P341, DOI 10.1093/cvr/27.3.341; Douglas T, 2006, BIOMACROMOLECULES, V7, P2388, DOI 10.1021/bm0603746; Clement AM, 1999, NEUROSCI LETT, V269, P125, DOI 10.1016/S0304-3940(99)00432-2; Spinale FG, 1996, J MOL CELL CARDIOL, V28, P1591, DOI 10.1006/jmcc.1996.0150; Barth AS, 2006, J AM COLL CARDIOL, V48, P1610, DOI 10.1016/j.jacc.2006.07.026; Harborth J, 2001, J CELL SCI, V114, P4557; KODAMA M, 1990, CLIN IMMUNOL IMMUNOP, V57, P250, DOI 10.1016/0090-1229(90)90039-S; Keene DR, 2000, J BIOL CHEM, V275, P21801, DOI 10.1074/jbc.C000278200; Watanabe K, 2000, BRIT J PHARMACOL, V130, P1489, DOI 10.1038/sj.bjp.0703450; Ohtake S, 2001, J BIOL CHEM, V276, P43894, DOI 10.1074/jbc.M104922200; MATSUMORI A, 1994, BRIT HEART J, V72, P561; Honke K, 2002, MED RES REV, V22, P637, DOI 10.1002/med.10020; Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; Kusche-Gullberg M, 2003, CURR OPIN STRUC BIOL, V13, P605, DOI 10.1016/j.sbi.2003.08.002; KAWAI Y, 1966, J BIOCHEM-TOKYO, V60, P317; Kawashima H, 2002, J BIOL CHEM, V277, P12921, DOI 10.1074/jbc.M200396200; YAMAGUCHI Y, 1990, NATURE, V346, P281, DOI 10.1038/346281a0; BASHEY RI, 1993, MATRIX, V13, P363; Cooper Jr L.T., 2003, MYOCARDITIS BENCH BE, P358; DEC GW, 1985, NEW ENGL J MED, V312, P885, DOI 10.1056/NEJM198504043121404; ELIAKIM R, 1986, P NATL ACAD SCI USA, V83, P461, DOI 10.1073/pnas.83.2.461; Falcao L, 2004, J RENIN-ANGIO-ALDO S, V5, P121, DOI 10.3317/jraas.2004.028; Fechner H, 2007, GENE THER, V14, P960, DOI 10.1038/sj.gt.3302948; GARG AK, 1989, BIOMATERIALS, V10, P413, DOI 10.1016/0142-9612(89)90133-6; HEIMER R, 1995, J MOL CELL CARDIOL, V27, P2191, DOI 10.1016/S0022-2828(95)91479-X; Hinek A, 2005, AM J MED GENET A, V133A, P1, DOI 10.1002/ajmg.a.30495; Hwang JJ, 2002, PHYSIOL GENOMICS, V10, P31, DOI 10.1152/physiolgenomics.00122.2001.; Ito Y, 2000, J BIOL CHEM, V275, P34728, DOI 10.1074/jbc.M909633199; Kiryu H, 2011, BIOINFORMATICS, V27, P1788, DOI 10.1093/bioinformatics/btr276; KODAMA M, 1994, CIRC RES, V75, P278; Medeiros DM, 2002, CONNECT TISSUE RES, V43, P32, DOI 10.1080/713713431; Palaniyandi Selvaraj Suresh, 2005, Biol Pharm Bull, V28, P2128, DOI 10.1248/bpb.28.2128; Palaniyandi SS, 2004, EUR J IMMUNOL, V34, P3508, DOI 10.1002/eji.200425147; Prussin C, 2006, J ALLERGY CLIN IMMUN, V117, pS450, DOI 10.1016/j.jaci.2005.11.016; Rothermund L, 2002, AM J HYPERTENS, V15, P644, DOI 10.1016/S0895-7061(02)02956-4; SCHONHERR E, 1995, J BIOL CHEM, V270, P8877; Sreedhar R., 2015, CELL SIGNAL; TALIERCIO CP, 1985, J AM COLL CARDIOL, V6, P1126; Weber KT, 1991, CARDIOVASC REV REP, V12, P61	43	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0898-6568	1873-3913		CELL SIGNAL	Cell. Signal.	JUL	2015	27	7					1517	1524		10.1016/j.cellsig.2015.03.004		8	Cell Biology	Cell Biology	CK0HY	WOS:000355887500025		
J	Punkvang, A; Kamsri, P; Saparpakorn, P; Hannongbua, S; Wolschann, P; Irle, S; Pungpo, P				Punkvang, Auradee; Kamsri, Pharit; Saparpakorn, Patchreenart; Hannongbua, Supa; Wolschann, Peter; Irle, Stephan; Pungpo, Pornpan			Key Structures and Interactions for Binding of Mycobacterium tuberculosis Protein Kinase B Inhibitors from Molecular Dynamics Simulation	CHEMICAL BIOLOGY & DRUG DESIGN			English	Article						aminopyrimidine; M; tuberculosis; molecular dynamics simulation; protein kinase B; tuberculosis	FATTY-ACID BIOSYNTHESIS; AFFINITY INHA INHIBITORS; DRUG DISCOVERY; CRYSTAL-STRUCTURE; RESP METHODOLOGY; ISONIAZID TARGET; PKNB; REDUCTASE; GROWTH; AMBER	Substituted aminopyrimidine inhibitors have recently been introduced as antituberculosis agents. These inhibitors show impressive activity against protein kinase B, a Ser/Thr protein kinase that is essential for cell growth of M.tuberculosis. However, up to now, X-ray structures of the protein kinase B enzyme complexes with the substituted aminopyrimidine inhibitors are currently unavailable. Consequently, structural details of their binding modes are questionable, prohibiting the structural-based design of more potent protein kinase B inhibitors in the future. Here, molecular dynamics simulations, in conjunction with molecular mechanics/Poisson-Boltzmann surface area binding free-energy analysis, were employed to gain insight into the complex structures of the protein kinase B inhibitors and their binding energetics. The complex structures obtained by the molecular dynamics simulations show binding free energies in good agreement with experiment. The detailed analysis of molecular dynamics results shows that Glu93, Val95, and Leu17 are key residues responsible to the binding of the protein kinase B inhibitors. The aminopyrazole group and the pyrimidine core are the crucial moieties of substituted aminopyrimidine inhibitors for interaction with the key residues. Our results provide a structural concept that can be used as a guide for the future design of protein kinase B inhibitors with highly increased antagonistic activity.	[Punkvang, Auradee] Nakhon Phanom Univ, Fac Sci, Muang 48000, Nakhon Phanom, Thailand; [Kamsri, Pharit; Pungpo, Pornpan] Ubon Ratchathani Univ, Dept Chem, Warinchamrap 34190, Ubonratchathani, Thailand; [Saparpakorn, Patchreenart; Hannongbua, Supa] Kasetsart Univ, Dept Chem, Bangkok 10900, Thailand; [Wolschann, Peter] Univ Vienna, Inst Theoret Chem, A-1090 Vienna, Austria; [Wolschann, Peter] Univ Vienna, Fac Life Sci, Dept Pharmaceut Technol & Biopharmaceut, Vienna, Austria; [Irle, Stephan] Nagoya Univ, Inst Transformat Biomol WPI ITbM, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Irle, Stephan] Nagoya Univ, Grad Sch Sci, Dept Chem, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Punkvang, A (reprint author), Nakhon Phanom Univ, Fac Sci, Muang 48000, Nakhon Phanom, Thailand.	auradee.punkvang@npu.ac.th	Irle, Stephan/E-8984-2011; 	Irle, Stephan/0000-0003-4995-4991; Hannongbua, Supa/0000-0002-9901-4466	Thailand Research Fund [MRG5680169, DBG5680003]; National Research Council of Thailand; Higher Education Research Promotion; Royal Golden Jubilee Ph.D. Program [PHD/004/2554]; Nakhon Phanom University; Faculty of Science, Ubon Ratchathani University; ASEA-Uninet; University of Vienna; NECTEC	This research was supported by Thailand Research Fund (MRG5680169, DBG5680003), the National Research Council of Thailand and Higher Education Research Promotion. The financial support from Royal Golden Jubilee Ph.D. Program (PHD/004/2554) to P. Kamsri is gratefully acknowledged. Nakhon Phanom University, Faculty of Science, Ubon Ratchathani University, ASEA-Uninet, University of Vienna, and NECTEC are gratefully acknowledged for supporting this research.	am Ende Christopher W, 2008, Bioorg Med Chem Lett, V18, P3029, DOI 10.1016/j.bmcl.2008.04.038; CIEPLAK P, 1995, J COMPUT CHEM, V16, P1357, DOI 10.1002/jcc.540161106; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Wright HT, 2007, CURR OPIN MICROBIOL, V10, P447, DOI 10.1016/j.mib.2007.07.001; Lougheed KEA, 2011, TUBERCULOSIS, V91, P277, DOI 10.1016/j.tube.2011.03.005; Fernandez P, 2006, J BACTERIOL, V188, P7778, DOI 10.1128/JB.00963-06; Wehenkel A, 2006, FEBS LETT, V580, P3018, DOI 10.1016/j.febslet.2006.04.046; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Szekely R, 2008, IMMUNOL LETT, V116, P225, DOI 10.1016/j.imlet.2007.12.005; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Ortiz-Lombardia M, 2003, J BIOL CHEM, V278, P13094, DOI 10.1074/jbc.M300660200; Srinivasan J, 1998, J AM CHEM SOC, V120, P9401, DOI 10.1021/ja981844+; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Sullivan TJ, 2006, ACS CHEM BIOL, V1, P43, DOI 10.1021/cb0500042; Rozwarski DA, 1998, SCIENCE, V279, P98, DOI 10.1126/science.279.5347.98; Av-Gay Y, 1999, INFECT IMMUN, V67, P5676; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; Kang CM, 2005, GENE DEV, V19, P1692, DOI 10.1101/gad.1311105; Young TA, 2003, NAT STRUCT BIOL, V10, P168, DOI 10.1038/nsb897; DESSEN A, 1995, SCIENCE, V267, P1638, DOI 10.1126/science.7886450; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Vilcheze C, 2006, NAT MED, V12, P1027, DOI 10.1038/nm1466; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Chapman TM, 2012, BIOORG MED CHEM LETT, V22, P3349, DOI 10.1016/j.bmcl.2012.02.107; Chawla Y, 2014, J BIOL CHEM, V289, P13858, DOI 10.1074/jbc.M114.563536; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Fox T, 1998, J PHYS CHEM B, V102, P8070, DOI 10.1021/jp9717655; Kuo MR, 2003, J BIOL CHEM, V278, P20851, DOI 10.1074/jbc.M211968200; Magnet S, 2010, TUBERCULOSIS, V90, P354, DOI 10.1016/j.tube.2010.09.001; Freundlich JS, 2009, CHEMMEDCHEM, V4, P241, DOI 10.1002/cmdc.200800261; Campbell JW, 2001, ANNU REV MICROBIOL, V55, P305, DOI 10.1146/annurev.micro.55.1.305; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; He X, 2006, J MED CHEM, V49, P6308, DOI 10.1021/jm060715y; Boyne ME, 2007, ANTIMICROB AGENTS CH, V51, P3562, DOI 10.1128/AAC.00383-07; Case D., 2012, AMBER 12; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Drews SJ, 2001, FEMS MICROBIOL LETT, V205, P369, DOI 10.1111/j.1574-6968.2001.tb10974.x; He Xin, 2007, Bioorg Med Chem, V15, P6649, DOI 10.1016/j.bmc.2007.08.013; Heath Richard J, 2004, Curr Opin Investig Drugs, V5, P146; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Mdluli K, 2006, CURR OPIN PHARMACOL, V6, P459, DOI 10.1016/j.coph.2006.06.004; Zhang YM, 2004, LIPIDS, V39, P1055, DOI 10.1007/s11745-004-1330-3	42	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1747-0277	1747-0285		CHEM BIOL DRUG DES	Chem. Biol. Drug Des.	JUL	2015	86	1					871	881		10.1111/cbdd.12465		11	Biochemistry & Molecular Biology; Chemistry, Medicinal	Biochemistry & Molecular Biology; Pharmacology & Pharmacy	CK6TX	WOS:000356362300006		
J	Foote, CJ; Chaudhry, H; Bhandari, M; Thabane, L; Furukawa, TA; Petrisor, B; Guyatt, G				Foote, Clary J.; Chaudhry, Harman; Bhandari, Mohit; Thabane, Lehana; Furukawa, Toshi A.; Petrisor, Brad; Guyatt, Gordon			Network Meta-analysis: Users' Guide for Surgeons: Part I - Credibility	CLINICAL ORTHOPAEDICS AND RELATED RESEARCH			English	Article							QUALITY; TRIALS; FRACTURES	Conventional meta-analyses quantify the relative effectiveness of two interventions based on direct (that is, head-to-head) evidence typically derived from randomized controlled trials (RCTs). For many medical conditions, however, multiple treatment options exist and not all have been compared directly. This issue limits the utility of traditional synthetic techniques such as meta-analyses, since these approaches can only pool and compare evidence across interventions that have been compared directly by source studies. Network meta-analyses (NMA) use direct and indirect comparisons to quantify the relative effectiveness of three or more treatment options. Interpreting the methodologic quality and results of NMAs may be challenging, as they use complex methods that may be unfamiliar to surgeons; yet for these surgeons to use these studies in their practices, they need to be able to determine whether they can trust the results of NMAs. The first judgment of trust requires an assessment of the credibility of the NMA methodology; the second judgment of trust requires a determination of certainty in effect sizes and directions. In this Users' Guide for Surgeons, Part I, we show the application of evaluation criteria for determining the credibility of a NMA through an example pertinent to clinical orthopaedics. In the subsequent article (Part II), we help readers evaluate the level of certainty NMAs can provide in terms of treatment effect sizes and directions.	[Foote, Clary J.; Chaudhry, Harman; Bhandari, Mohit; Thabane, Lehana; Petrisor, Brad; Guyatt, Gordon] McMaster Univ, Div Orthopaed Surg, Hamilton, ON L8L 2X2, Canada; [Furukawa, Toshi A.] Kyoto Univ, Sch Publ Hlth, Grad Sch Med, Dept Hlth Promot & Human Behav, Kyoto, Japan; [Furukawa, Toshi A.] Kyoto Univ, Sch Publ Hlth, Grad Sch Med, Dept Clin Epidemiol, Kyoto, Japan	Chaudhry, H (reprint author), McMaster Univ, Div Orthopaed Surg, 293 Wellington St N,Suite 110, Hamilton, ON L8L 2X2, Canada.	harman.chaudhry@medportal.ca					Jansen JP, 2011, VALUE HEALTH, V14, P417, DOI 10.1016/j.jval.2011.04.002; Mills EJ, 2012, ANN MED, V44, P588, DOI 10.3109/07853890.2012.705016; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Lewis RA, 2015, SPINE J, V15, P1461, DOI 10.1016/j.spinee.2013.08.049; Ristevski B, 2014, J ORTHOP TRAUMA, V28, P307, DOI 10.1097/BOT.0000000000000002; Salanti G, 2012, RES SYNTH METHODS, V3, P80, DOI 10.1002/jrsm.1037; Guyatt G, 2011, J CLIN EPIDEMIOL, V64, P383, DOI 10.1016/j.jclinepi.2010.04.026; Chaudhry H, 2008, INDIAN J ORTHOP, V42, P144, DOI 10.4103/0019-5413.40250; Jansen JP, 2008, VALUE HEALTH, V11, P956, DOI 10.1111/j.1524-4733.2008.00347.x; Murad MH, 2014, JAMA-J AM MED ASSOC, V312, P171, DOI 10.1001/jama.2014.5559; Brand RA, 2012, CLIN ORTHOP RELAT R, V470, P3261, DOI 10.1007/s11999-012-2624-9; Chaudhry H, 2012, J ARTHROPLASTY, V27, P569, DOI 10.1016/j.arth.2011.06.025; DETSKY AS, 1992, J CLIN EPIDEMIOL, V45, P255, DOI 10.1016/0895-4356(92)90085-2; Ebrahim S, 2014, CAN J SURG, V57, pE105, DOI 10.1503/cjs.010113; Foote CJ, 2015, CLIN ORTHOP RELAT RE; Higgins J.P.T., COCHRANE HDB SYSTEMA; Jansen JP, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-152; Lee P, 2012, BAYESIAN STAT INTRO; Li TJ, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-79; Mills Edward J, 2011, Clin Epidemiol, V3, P107, DOI 10.2147/CLEP.S16235; Mills Edward J, 2011, Clin Epidemiol, V3, P193, DOI 10.2147/CLEP.S16526; Moher D, 2009, PLOS MED; Mundi S, 2014, CAN J SURG, V57, pE141, DOI 10.1503/cjs.023413; Norman G. R., 2008, BIOSTATISTICS BARE E; Puhan MA, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5630; Song FJ, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4909; Wright JG, 2012, J BONE JOINT SURG AM, V94A, P1537, DOI 10.2106/JBJS.9417edit	27	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0009-921X	1528-1132		CLIN ORTHOP RELAT R	Clin. Orthop. Rel. Res.	JUL	2015	473	7					2166	2171		10.1007/s11999-015-4286-x		6	Orthopedics; Surgery	Orthopedics; Surgery	CJ8LM	WOS:000355752200002		
J	Chaudhry, H; Foote, CJ; Guyatt, G; Thabane, L; Furukawa, TA; Petrisor, B; Bhandari, M				Chaudhry, Harman; Foote, Clary J.; Guyatt, Gordon; Thabane, Lehana; Furukawa, Toshi A.; Petrisor, Brad; Bhandari, Mohit			Network Meta-analysis: Users' Guide for Surgeons: Part II - Certainty	CLINICAL ORTHOPAEDICS AND RELATED RESEARCH			English	Article							BONE MORPHOGENETIC PROTEIN-2; OPEN TIBIAL FRACTURES; COMPARATIVE EFFICACY; QUALITY; GRADE; OUTCOMES; TRIALS; BIAS	In the previous article (Network Meta-analysis: Users' Guide for Surgeons-Part I, Credibility), we presented an approach to evaluating the credibility or methodologic rigor of network meta-analyses (NMA), an innovative approach to simultaneously addressing the relative effectiveness of three or more treatment options for a given medical condition or disease state. In the second part of the Users' Guide for Surgeons, we discuss and demonstrate the application of criteria for determining the certainty in effect sizes and directions associated with a given treatment option through an example pertinent to clinical orthopaedics.	[Chaudhry, Harman; Foote, Clary J.; Guyatt, Gordon; Petrisor, Brad; Bhandari, Mohit] McMaster Univ, Div Orthopaed Surg, Hamilton, ON L8L 2X2, Canada; [Chaudhry, Harman; Foote, Clary J.; Guyatt, Gordon; Thabane, Lehana; Bhandari, Mohit] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON L8L 2X2, Canada; [Furukawa, Toshi A.] Kyoto Univ, Sch Publ Hlth, Grad Sch Med, Dept Hlth Promot & Human Behav, Kyoto, Japan; [Furukawa, Toshi A.] Kyoto Univ, Grad Sch Med, Sch Publ Hlth, Dept Clin Epidemiol, Kyoto, Japan	Chaudhry, H (reprint author), McMaster Univ, Div Orthopaed Surg, 293 Wellington St N,Suite 110, Hamilton, ON L8L 2X2, Canada.	harman.chaudhry@medportal.ca					Mills EJ, 2012, JAMA-J AM MED ASSOC, V308, P1246, DOI 10.1001/2012.jama.11228; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1277, DOI 10.1016/j.jclinepi.2011.01.011; Jansen JP, 2011, VALUE HEALTH, V14, P417, DOI 10.1016/j.jval.2011.04.002; Leucht S, 2013, LANCET, V382, P951, DOI 10.1016/S0140-6736(13)60733-3; Lexchin J, 2003, BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Salanti G, 2011, J CLIN EPIDEMIOL, V64, P163, DOI 10.1016/j.jclinepi.2010.03.016; Moher D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000097; Thorlund K, 2013, ANN RHEUM DIS, V72, P1524, DOI 10.1136/annrheumdis-2012-201574; Sutton AJ, 2001, STAT METHODS MED RES, V10, P277, DOI 10.1191/096228001678227794; Cipriani A, 2013, ANN INTERN MED, V159, P130, DOI 10.7326/0003-4819-159-2-201307160-00008; Guyatt GH, 2012, J CLIN EPIDEMIOL, V65, P1243, DOI 10.1016/j.jclinepi.2012.07.013; Guyatt G, 2013, J CLIN EPIDEMIOL, V66, P151, DOI 10.1016/j.jclinepi.2012.01.006; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1283, DOI 10.1016/j.jclinepi.2011.01.012; Aro HT, 2011, J BONE JOINT SURG AM, V93A, P801, DOI 10.2106/JBJS.I.01763; Govender S, 2002, J BONE JOINT SURG AM, V84A, P2123; Bhandari M, 2001, CONTROL CLIN TRIALS, V22, P687, DOI 10.1016/S0197-2456(01)00147-7; Chess LE, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-76; Cope S, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-100; Druyts Eric, 2013, Clin Epidemiol, V5, P173, DOI 10.2147/CLEP.S44273; Foote CJ, 2015, CLIN ORTHOP RELAT RE; Guyatt G, TOOLS ASSESS RISK BI; Jansen JP, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-152; Jansen JP, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-159; Leopold SS, 2013, CLIN ORTHOP RELAT R, V471, P1403, DOI 10.1007/s11999-013-2886-x; Puhan MA, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5630	25	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0009-921X	1528-1132		CLIN ORTHOP RELAT R	Clin. Orthop. Rel. Res.	JUL	2015	473	7					2172	2178		10.1007/s11999-015-4287-9		7	Orthopedics; Surgery	Orthopedics; Surgery	CJ8LM	WOS:000355752200003		
J	Sekiya, I; Muneta, T; Horie, M; Koga, H				Sekiya, Ichiro; Muneta, Takeshi; Horie, Masafumi; Koga, Hideyuki			Arthroscopic Transplantation of Synovial Stem Cells Improves Clinical Outcomes in Knees With Cartilage Defects	CLINICAL ORTHOPAEDICS AND RELATED RESEARCH			English	Article							ANTERIOR CRUCIATE LIGAMENT; ARTICULAR-CARTILAGE; CHONDROCYTE IMPLANTATION; MESENCHYMAL TISSUES; FLUID INCREASE; REPAIR; REGENERATION; INJURY; OSTEOARTHRITIS; PROLIFERATION	Transplantation of mesenchymal stem cells (MSCs) is one possible strategy to achieve articular cartilage repair. We previously reported that synovial MSCs were highly proliferative and able to undergo chondrogenesis. We also found that placing a suspension of synovial MSCs on a cartilage defect for 10 minutes promoted cartilage repair in rabbit and pig models. However, the in vivo efficacy of this approach has not been tested clinically. We asked whether transplantation of synovial MSCs improves (1) MRI features, (2) histologic features, and (3) clinical evaluation scores in patients with cartilage defects in the knee? Patients with a symptomatic single cartilage lesion of the femoral condyle were indicated for inclusion in our study, and between April 2008 and April 2011, 10 patients were enrolled in this study. All patients completed followups of 3 years or more. The average followup period was 52 months (range, 37-80 months). Synovial MSCs were expanded with 10% autologous human serum for 14 days after digestion. For transplantation, the patient was positioned so that the cartilage defect was facing upward, and synovial MSC suspension was placed on the cartilage defect with a syringe under arthroscopic control. The defect with the applied suspension then was held in the upward position for 10 minutes. Five patients underwent concomitant ACL reconstructions, among whom two had meniscus suturing performed simultaneously. For MRI quantification, the cartilage defect was scored from 0 to 5. Second-look arthroscopy was performed for four patients and biopsy specimens were evaluated histologically. Clinical outcome was assessed using the Lysholm score and Tegner Activity Level Scale at final followup. Comparisons of MRI and Lysholm scores before and after treatment for each patient were analyzed using the Wilcoxon signed-rank test. MRI score (median +/- A 95% CI) was 1.0 +/- A 0.3 before and 5.0 +/- A 0.7 after, and increased after treatment in each patient (p = 0.005). Second-look arthroscopy in four patients showed that the cartilage defect appeared to be qualitatively better in all cases. Histologic analyses showed hyaline cartilage in three patients and fibrous cartilage in one at the deep zone. The Lysholm score (median +/- A 95% CI) was 76 +/- A 7 before and 95 +/- A 3 after, and increased after treatment in each patient (p = 0.005). The Tegner Activity Level Scale did not decrease after treatment in each patient. For this small initial case series, transplantation of synovial MSCs was effective in terms of MRI score, qualitative histology, and Lysholm score. The use of synovial MSCs has an advantage in that the cells can be prepared at passage 0 in only 14 days. Transplantation of synovial MSCs may be less invasive than mosaicplasty and autologous chondrocyte implantation. To conclusively show the effectiveness of this treatment requires comparative studies, especially with more established arthroscopic procedures, such as marrow stimulation techniques. Level IV, therapeutic study.	[Sekiya, Ichiro; Horie, Masafumi] Tokyo Med & Dent Univ, Ctr Stem Cell & Regenerat Med, Bunkyo Ku, Tokyo 1138519, Japan; [Muneta, Takeshi; Koga, Hideyuki] Tokyo Med & Dent Univ, Grad Sch, Dept Joint Surg & Sports Med, Tokyo, Japan	Sekiya, I (reprint author), Tokyo Med & Dent Univ, Ctr Stem Cell & Regenerat Med, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	sekiya.arm@tmd.ac.jp			Research on Regenerative Medicine for Clinical Application from the Ministry of Health, Labor and Welfare, Tokyo, Japan	The institution of one (IS) or more of the authors has received, during the study period, funding from the Research on Regenerative Medicine for Clinical Application from the Ministry of Health, Labor and Welfare, Tokyo, Japan.	Segawa Y, 2009, J ORTHOP RES, V27, P435, DOI 10.1002/jor.20786; Saris DBF, 2008, AM J SPORT MED, V36, P235, DOI 10.1177/0363546507311095; Sekiya I, 2012, J ORTHOP RES, V30, P943, DOI 10.1002/jor.22029; Koga H, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2460; WAKITANI S, 1994, J BONE JOINT SURG AM, V76A, P579; Wakitani S, 2007, J TISSUE ENG REGEN M, V1, P74, DOI 10.1002/term.8; Matsukura Y, 2014, CLIN ORTHOP RELAT R, V472, P1357, DOI 10.1007/s11999-013-3418-4; Mollon B, 2013, OSTEOARTHR CARTILAGE, V21, P1824, DOI 10.1016/j.joca.2013.08.024; Muneta T, 2007, ARTHROSCOPY, V23, P618, DOI 10.1016/j.arthro.2007.04.010; Wakitani S, 2011, J TISSUE ENG REGEN M, V5, P146, DOI 10.1002/term.299; Sakaguchi Y, 2005, ARTHRITIS RHEUM, V52, P2521, DOI 10.1002/art.21212; Morito T, 2008, RHEUMATOLOGY, V47, P1137, DOI 10.1093/rheumatology/ken114; Roos EM, 1998, J ORTHOP SPORT PHYS, V28, P88; Nejadnik H, 2010, AM J SPORT MED, V38, P1110, DOI 10.1177/0363546509359067; Koga H, 2008, CELL TISSUE RES, V333, P207, DOI 10.1007/s00441-008-0633-5; Wakitani S, 1998, TISSUE ENG, V4, P429, DOI 10.1089/ten.1998.4.429; Namdari S, 2013, CLIN ORTHOP RELAT R, V471, P2455, DOI 10.1007/s11999-013-2904-z; Nimura A, 2008, ARTHRITIS RHEUM, V58, P501, DOI 10.1002/art.23219; Wakitani S, 2002, OSTEOARTHR CARTILAGE, V10, P199, DOI 10.1053/joca.2001.0504; Marlovits S, 2004, EUR J RADIOL, V52, P310, DOI 10.1016/j.ejrad.2004.03.014; Archer Charles W., 2003, Birth Defects Research, V69, P144, DOI 10.1002/bdrc.10015; Arnold MP, 2012, KNEE SURG SPORT TR A, V20, P195, DOI 10.1007/s00167-011-1733-4; Atesok K, 2013, J AM ACAD ORTHOP SUR, V21, P258, DOI 10.5435/JAAOS-21-04-258; BENTLEY G, 1975, J BONE JOINT SURG BR, V57, P454; ERMIS A, 1995, HUM GENET, V96, P651, DOI 10.1007/BF00210293; Ito K, 2013, INTERNAL MED, V52, P201, DOI 10.2169/internalmedicine.52.8206; Koga H, 2007, STEM CELLS, V25, P689, DOI 10.1634/stemcells.2006-0281; LYSHOLM J, 1982, AM J SPORT MED, V10, P150, DOI 10.1177/036354658201000306; Nakamura T, 2012, CYTOTHERAPY, V14, P327, DOI 10.3109/14653249.2011.638912; Shimaya M, 2010, OSTEOARTHR CARTILAGE, V18, P1300, DOI 10.1016/j.joca.2010.06.005; TANAKA S, 1993, METHOD ENZYMOL, V223, P358; TEGNER Y, 1985, CLIN ORTHOP RELAT R, P43	32	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0009-921X	1528-1132		CLIN ORTHOP RELAT R	Clin. Orthop. Rel. Res.	JUL	2015	473	7					2316	2326		10.1007/s11999-015-4324-8		11	Orthopedics; Surgery	Orthopedics; Surgery	CJ8LM	WOS:000355752200028		
J	Yanagisawa, Y; Matsuura, N; Mukai, K; Nakajima, A; Motoyama, M; Yamanishi, K; Yamada, H; Hayashida, K; Matsunaga, H				Yanagisawa, Yoshinobu; Matsuura, Naomi; Mukai, Keiichiro; Nakajima, Akihiro; Motoyama, Mikuni; Yamanishi, Kyosuke; Yamada, Hisashi; Hayashida, Kazuhisa; Matsunaga, Hisato			Clinically related or predictive factors and impacts on long-term treatment outcomes of involvement behaviors in patients with obsessive-compulsive disorder	COMPREHENSIVE PSYCHIATRY			English	Article							FAMILY ACCOMMODATION; PERSONALITY-DISORDERS; GENDER-DIFFERENCES; SCALE; DEPRESSION; SYMPTOMS; FEATURES	Background: Patients with obsessive compulsive disorder (OCD) frequently exhibit involvement behaviors (IBs) in which they accommodate their caregivers to their OCD symptoms by 1) asking them for reassurance, 2) forcing them to participate in their rituals, or 3) forcing them to assist in avoidance according to the patients' rules or demands. Such behaviors correspond to those of their caregivers, and are referred to as family accommodation (FA). Methods: We performed multifactorial comparisons between 256 OCD patients with and without IBs in order to examine the clinical characteristics and long-term treatment outcomes of OCD patients with IBs. A multiple logistic regression analysis was also performed to identify the related and predictive factors of IBs. Results: A total of 108 out of the 256 OCD patients examined (42%) were determined to exhibit IBs. OCD patients with IBs were differentially characterized by demographic and phenomenological characteristics (e.g. female predominance and poorer insight), more severe psychopathological features (e.g. lower GAFS, higher anxiety, or a depressive status), and poorer treatment outcomes. Furthermore, the predictive factors of IBs such as being female, having a higher compulsive score, and lower GAFS were identified by logistic analyses and structural equation modeling. Conclusion: The presence of IBs correlated with the severe clinical features, treatment refractoriness, and poorer long-term outcome of OCD. The severity of compulsions, being female, and lower GAFS were identified as predictive factors for the presence of IBs. Similar to FA, these findings appear to support the effectiveness of early identification and family-focused intervention in the treatment of OCD patients with IBs. (C) 2015 Elsevier Inc. All rights reserved.	[Yanagisawa, Yoshinobu; Mukai, Keiichiro; Nakajima, Akihiro; Motoyama, Mikuni; Yamanishi, Kyosuke; Yamada, Hisashi; Hayashida, Kazuhisa; Matsunaga, Hisato] Hyogo Coll Med, Dept Neuropsychiat, Nishinomiya, Hyogo 6638501, Japan; [Matsuura, Naomi] Tokyo Univ Social Welf, Grad Sch Educ, Nagoya, Aichi, Japan	Matsunaga, H (reprint author), Hyogo Coll Med, Dept Neuropsychiat, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan.	hisa1311@hyo-med.ac.jp					Albert U, 2010, PSYCHIAT RES, V179, P204, DOI 10.1016/j.psychres.2009.06.008; American Psychiatric Association, 2013, DIAGN STAT MAN MENT; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63; Matsunaga H, 2005, COMPR PSYCHIAT, V46, P43, DOI 10.1016/j.comppsych.2004.07.001; Pallanti S, 2006, PROG NEURO-PSYCHOPH, V30, P400, DOI 10.1016/j.pnpbp.2005.11.028; STEKETEE G, 1993, BEHAV PSYCHOTHER, V21, P81; Koran LM, 2007, AM J PSYCHIAT, V164, P5; Amir N, 2000, J ANXIETY DISORD, V14, P209, DOI 10.1016/S0887-6185(99)00032-8; Calvocoressi L, 1999, J NERV MENT DIS, V187, P636, DOI 10.1097/00005053-199910000-00008; Vikas A, 2011, INT J SOC PSYCHIATR, V57, P45, DOI 10.1177/0020764010347333; Lebowitz ER, 2012, EXPERT REV NEUROTHER, V12, P229, DOI [10.1586/ern.11.200, 10.1586/ERN.11.200]; Storch EA, 2012, PSYCHIAT RES, V196, P83, DOI 10.1016/j.psychres.2011.10.013; Pinto A, 2013, J OBSESS-COMPULS REL, V2, P457, DOI 10.1016/j.jocrd.2012.06.001; Bipeta Rajshekhar, 2013, Child Adolesc Psychiatry Ment Health, V7, P20, DOI 10.1186/1753-2000-7-20; Cabinet Office, 2010, WAK IS TYOUS HIK NI; Cherian AV, 2014, PSYCHIAT RES, V215, P372, DOI 10.1016/j.psychres.2013.11.017; Ramos-Cerqueira Ana Teresa de Abreu, 2008, Depress Anxiety, V25, P1020, DOI 10.1002/da.20431; Doi T., 1973, ANATOMY DEPENDENCE; Ferrao YA, 2006, J AFFECT DISORDERS, V94, P199, DOI 10.1016/j.jad.2006.04.019; First MB, 1997, STRUCTURED CLIN INTE; GOLOMB M, 1995, AM J PSYCHIAT, V152, P579; Gomes JB, 2014, PSYCHIAT CLIN NEUROS, V68, P621, DOI 10.1111/pcn.12172; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1006; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1012; Jenike MA, 1990, OBSESSIVE COMPULSIVE, P325; Matsunaga H, 2000, COMPR PSYCHIAT, V41, P266, DOI 10.1053/comp.2000.7426; Matsunaga H, 2002, COMPR PSYCHIAT, V43, P150, DOI 10.1053/comp.2002.30798; Mito H, 2010, COMPR PSYCHIAT, V55, P1526; Narita Y, 1974, SEISHIN IGAKU, V16, P957; Pato MT, 1991, CURRENT TREATMENTS O, P115; Renshaw Keith D., 2005, Cognitive Behaviour Therapy, V34, P164, DOI 10.1080/16506070510043732; Saito K, 2007, UNDERSTANDING ACTUAL; Smith HW, 2000, ELECT J SOCIOL, V5; Spielberger CD, 1970, MANUAL STATE TRAIT A; Stewart SE, 2008, ANN CLIN PSYCHIATRY, V20, P65, DOI 10.1080/10401230802017043; Summerfeldt L.J., OBSESSIVE COMPULSIVE, P79; Thompson-Hollands J, 2014, J FAM PSYCHOL, V28, P287, DOI 10.1037/a0036709; Veale D, 2014, BRAZ J PSYCHIAT S1, V36, P14; VOGEL SH, 1996, CULT HUM D, P177; Von Noppen B, 2009, BEHAV RES THER, V47, P18; Watts J, 2002, LANCET, V359, P1131, DOI 10.1016/S0140-6736(02)08186-2	42	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0010-440X	1532-8384		COMPR PSYCHIAT	Compr. Psychiat.	JUL	2015	60						105	113		10.1016/j.comppsych.2015.03.002		9	Psychiatry	Psychiatry	CK3JO	WOS:000356112600016		
J	Mitsui, N; Asakura, S; Inoue, T; Shimizu, Y; Fujii, Y; Kako, Y; Tanaka, T; Kitagawa, N; Kusumi, I				Mitsui, Nobuyuki; Asakura, Satoshi; Inoue, Takeshi; Shimizu, Yusuke; Fujii, Yutaka; Kako, Yuki; Tanaka, Teruaki; Kitagawa, Nobuki; Kusumi, Ichiro			Temperament and character profiles of Japanese university student suicide completers (vol 54, pg 556, 2013)	COMPREHENSIVE PSYCHIATRY			English	Correction									[Mitsui, Nobuyuki; Asakura, Satoshi; Inoue, Takeshi; Shimizu, Yusuke; Fujii, Yutaka; Kako, Yuki; Tanaka, Teruaki; Kusumi, Ichiro] Hokkaido Univ, Grad Sch Med, Dept Psychiat, Sapporo, Hokkaido, Japan; [Asakura, Satoshi; Fujii, Yutaka] Hokkaido Univ, Hlth Care Ctr, Sapporo, Hokkaido, Japan; [Kitagawa, Nobuki] Hokudai Dori Mental Hlth Clin Liveforest Healthca, Sapporo, Hokkaido, Japan	Mitsui, N (reprint author), Hokkaido Univ, Grad Sch Med, Dept Psychiat, Sapporo, Hokkaido, Japan.						Mitsui N, 2013, COMPR PSYCHIAT, V54, P556, DOI 10.1016/j.comppsych.2012.11.002	1	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0010-440X	1532-8384		COMPR PSYCHIAT	Compr. Psychiat.	JUL	2015	60						168	169		10.1016/j.comppsych.2015.04.004		2	Psychiatry	Psychiatry	CK3JO	WOS:000356112600025		
J	Chai, JC; Shrestha, S; Hino, T; Ding, WQ; Kamo, Y; Carter, J				Chai, Jin-Chun; Shrestha, Sailesh; Hino, Takenori; Ding, Wen-Qi; Kamo, Yukihiko; Carter, John			2D and 3D analyses of an embankment on clay improved by soil-cement columns	COMPUTERS AND GEOTECHNICS			English	Article						Numerical analysis; Embankment; Deep mixing; Bending moment		The behaviour of a test embankment constructed on a soft clayey deposit in Saga, Japan, was simulated by both three-dimensional (3D) and two-dimensional (2D) finite element analyses (FEA). Floating soil-cement columns had been installed in the clay prior to construction of the embankment Comparing the results of 3D and 2D PEA indicates that 2D analysis predicts incorrect results in terms of the lateral displacement and bending moment in the columns under the toe of the embankment. In the 2D analysis, the rows of columns were modelled by continuous walls, which partially block the interaction between the soil layers and the columns and influence the simulated lateral displacement and bending moment in the column. It has been postulated that compaction of fill material during the construction process has a significant influence on both the magnitude and pattern of the lateral displacement of the column under the toe of the embankment. Pragmatically, this influence can be indirectly simulated by reducing the stiffness and increasing Poisson's ratio of the embankment fill material. Finally, both the measured and PEA results indicate that the columns not only reduced the total settlement but also accelerated the settlement rate of the deposit under the embankment loading, due to the much higher stiffness of the column material. (C) 2015 Elsevier Ltd. All rights reserved.	[Chai, Jin-Chun; Shrestha, Sailesh] Saga Univ, Grad Sch Sci & Technol, Saga 840, Japan; [Hino, Takenori] Saga Univ, Inst Lowland & Marine Res, Saga 840, Japan; [Ding, Wen-Qi] Tongji Univ, Shanghai 200092, Peoples R China; [Kamo, Yukihiko] JIP Techno Sci Corp, Tokyo, Japan; [Carter, John] Univ Newcastle, Fac Engn & Built Environm, Callaghan, NSW 2308, Australia	Chai, JC (reprint author), Saga Univ, Grad Sch Sci & Technol, Saga 840, Japan.	chai@cc.saga-u.ac.jp; shresthasailesh@gmail.com; hino@ilt.saga-u.ac.jp; dingwq2004@263.net; yukihiko_kamo@cm.jip-ts.co.jp; john.Carter@newcastle.edu.au					Oliveira PJV, 2011, COMPUT GEOTECH, V38, P566, DOI 10.1016/j.compgeo.2011.03.005; Chai JC, 1999, J GEOTECH GEOENVIRON, V125, P216, DOI 10.1061/(ASCE)1090-0241(1999)125:3(216); Huang J, 2010, COMPUT GEOTECH, V37, P638, DOI 10.1016/j.compgeo.2010.04.002; Ariake Sea Coastal Road Development Office (ASCRDO), 2009, RES REP TECHN BUILD; Bergado DT, 1994, IMPROVEMENT TECHNIQU, P222; Bjerrum L., 1973, P 8 INT C SOIL MECH, V3, P111; BROMS BB, 1979, J GEOTECH ENG-ASCE, V105, P539; Chai J. C., 2009, P ICE GROUND IMPROV, V163, P109; Chai J-C, 2011, DEFORMATION ANAL SOF, P247; Chai JC, 2014, COMPUT GEOTECH, V55, P482, DOI 10.1016/j.compgeo.2013.10.001; Chai J-C, 2012, COMPUT GEOTECH, V48, P116; CHAI JC, 1993, CAN GEOTECH J, V30, P710; Hino Takenori, 2012, [Frontiers of Structural and Civil Engineering, 结构与土木工程前沿], V6, P153; Igaya Y, 2012, P 8 INT S LOWL TECHN, P40; Igaya Y, 2011, LOWLAND TECHNOL INT, V13, P41; Japanese Society of Civil Engineer (JSCE), 1986, MAN STRUCT DES JAP R; Leroueil S., 2006, P 13 DAN EUR C GEOT, P55; Miura N., 1998, INDIAN GEOTECH J, V28, P121; Nguyen Duy Q, 2015, CAN GEOTECH J, V52, P1; Pongsivasathit S, 2012, GROUND IMPROVE P I C, V166, P44; Porbaha A., 2000, GROUND IMPROVEMENT, V4, P91; Roscoe K. H., 1968, ENG PLASTICITY, P535; Shen S-L, 2001, 1 AS PAC C COMP MECH, P485; Takakura A, 2001, SAGA U, V31, P17; Taylor D. W., 1948, FUNDAMENTALS SOIL ME	25	3	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0266-352X	1873-7633		COMPUT GEOTECH	Comput. Geotech.	JUL	2015	68						28	37		10.1016/j.compgeo.2015.03.014		10	Computer Science, Interdisciplinary Applications; Engineering, Geological; Geosciences, Multidisciplinary	Computer Science; Engineering; Geology	CK3MT	WOS:000356120900004		
J	Shen, SL; Wu, YX; Xu, YS; Hino, T; Wu, HN				Shen, Shui-Long; Wu, Yong-Xia; Xu, Ye-Shuang; Hino, Takenori; Wu, Huai-Na			Evaluation of hydraulic parameters from pumping tests in multi-aquifers with vertical leakage in Tianjin	COMPUTERS AND GEOTECHNICS			English	Article						Pumping test; Analytical method; Numerical method; Hydrogeological parameters	LAND SUBSIDENCE; NUMERICAL-SIMULATION; GROUNDWATER-FLOW; CONFINED AQUIFER; GRAVEL FORMATION; LARGE-DIAMETER; SHANGHAI; CONDUCTIVITY; SOILS; WELL	This paper presents a case history of behaviour during a series of pumping tests in an alternated multi-aquifer-aquitard system in a foundation pit in Tianjin, China. The test site is located at Tianjin Railway Station, which is in the downtown area and is surrounded by many buildings. The groundwater system at the test site is composed of a phreatic aquifer and three confined aquifers. Four groups of single well pumping tests were conducted in each aquifer to obtain the hydrogeological parameters of the aquifers and investigate the hydraulic connection among the aquifers. Test results show that there is hydraulic connection among the upper 3 aquifers. Moreover, both analytical and numerical methods were employed to analyse the hydrogeological parameters. The analytical solution was obtained for the phreatic aquifer using the Dupuit equation, and the Cooper-Jacob method was conducted for the confined aquifers. The numerical simulation was performed using a finite element method (FEM). The results illustrate that the numerical method gives more reliable results than the analytical method does. The numerical simulation considers the anisotropic characteristic of soils, and the hydrogeological parameters of all of the soils can be calculated. The analytical solution, however, may be influenced by wellbore storage or by the leakage effect of the aquitards, and it only gives the parameters of the aquifer where the pumping tests were performed. (C) 2015 Elsevier Ltd. All rights reserved.	[Shen, Shui-Long; Wu, Yong-Xia; Xu, Ye-Shuang; Wu, Huai-Na] Shanghai Jiao Tong Univ, Dept Civil Engn, State Key Lab Ocean Engn, Shanghai 200240, Peoples R China; [Hino, Takenori] Shanghai Jiao Tong Univ, Dept Civil Engn, Shanghai 200240, Peoples R China; [Hino, Takenori] Saga Univ, Inst Lowland & Marine Res, Saga, Japan	Shen, SL (reprint author), Shanghai Jiao Tong Univ, Dept Civil Engn, State Key Lab Ocean Engn, Shanghai 200240, Peoples R China.	slshen@sjtu.edu.cn; wxia2011@sjtu.edu.cn; xuyeshuang@sjtu.edu.cn; hino@ilt.saga-u.ac.jp; wu-hn@sjtu.edu.cn			National Nature Science Foundation of China (NSFC) [41472252]; National Basic Research Program of China (973 Program) [2015CB057806]	The research work described herein was funded by the National Nature Science Foundation of China (NSFC) (Grant No. 41472252) and also partially supported by the National Basic Research Program of China (973 Program: 2015CB057806). This financial support is gratefully acknowledged.	Chapuis RP, 2003, CAN GEOTECH J, V40, P1093, DOI 10.1139/T03-059; Chapuis RP, 2005, CAN GEOTECH J, V42, P1212, DOI 10.1139/T05-045; Ma L, 2014, HYDROGEOL J, V22, P371, DOI 10.1007/s10040-013-1068-y; Chai JC, 2014, GEOTEXT GEOMEMBRANES, V42, P437, DOI 10.1016/j.geotexmem.2014.07.001; Shen SL, 2006, MAR GEORESOUR GEOTEC, V24, P149, DOI 10.1080/10641190600704848; Zeng LL, 2011, APPL CLAY SCI, V51, P86, DOI 10.1016/j.clay.2010.11.005; Lin HT, 2010, J HYDROL, V389, P57, DOI 10.1016/j.jhydrol.2010.05.021; CHAPUIS RP, 1992, CAN GEOTECH J, V29, P711, DOI 10.1139/t92-078; Roy D, 2009, ENG GEOL, V107, P109, DOI 10.1016/j.enggeo.2009.05.006; Wang JX, 2009, ENVIRON GEOL, V57, P447, DOI 10.1007/s00254-008-1315-z; Yin JH, 1999, GEOTECHNIQUE, V49, P699; Xu YS, 2009, ENG GEOL, V109, P241, DOI 10.1016/j.enggeo.2009.08.009; Yin ZY, 2011, J GEOTECH GEOENVIRON, V137, P1103, DOI 10.1061/(ASCE)GT.1943-5606.0000527; Chai JC, 2004, GEOTECHNIQUE, V54, P143, DOI 10.1680/geot.54.2.143.36332; Cimen M, 2008, J HYDROL ENG, V13, P141, DOI 10.1061/(ASCE)1084-0699(2008)13:3(141); Jean JS, 1996, WATER RESOUR MANAG, V10, P81, DOI 10.1007/BF00429681; Johnson GS, 2002, HYDROGEOL J, V10, P428, DOI 10.1007/s10040-002-0201-0; Xu YS, 2012, NAT HAZARDS, V63, P1255, DOI 10.1007/s11069-012-0220-7; Chapuis RP, 2002, CAN GEOTECH J, V39, P14, DOI 10.1139/T01-070; Shen SL, 2003, MAR GEORESOUR GEOTEC, V21, P15, DOI 10.1080/010641190390213721; Shen SL, 2011, CAN GEOTECH J, V48, P1378, DOI [10.1139/T11-049, 10.1139/t11-049]; Chapuis RP, 2004, CAN GEOTECH J, V41, P787, DOI 10.1139/T04-022; Xu YS, 2012, HYDROGEOL J, V20, P1623, DOI 10.1007/s10040-012-0892-9; Tan Y, 2013, J GEOTECH GEOENVIRON, V139, P1875, DOI 10.1061/(ASCE)GT.1943-5606.0000928; Shen SL, 2014, TUNN UNDERGR SP TECH, V40, P309, DOI 10.1016/j.tust.2013.10.013; Sethi R, 2011, J HYDROL, V400, P187, DOI 10.1016/j.jhydrol.2011.01.043; Ni JC, 2011, ENG GEOL, V117, P17, DOI 10.1016/j.enggeo.2010.10.001; Vilarrasa V, 2011, ENG GEOL, V120, P68, DOI 10.1016/j.enggeo.2011.04.005; Shaqour FM, 2008, ENVIRON GEOL, V53, P1603, DOI 10.1007/s00254-007-0768-9; Majumdar PK, 2008, J IRRIG DRAIN E-ASCE, V134, P400, DOI 10.1061/(ASCE)0733-9437(2008)134:3(400); Ou CY, 2010, B ENG GEOL ENVIRON, V69, P1, DOI 10.1007/s10064-009-0218-x; Yin JH, 1999, CAN GEOTECH J, V36, P736; Chapuis RP, 2003, CAN GEOTECH J, V40, P616, DOI 10.1139/T03-013; Luo ZJ, 2008, J HYDRODYN, V20, P596, DOI 10.1016/S1001-6058(08)60100-6; Bear J., 1972, DYNAMICS FLUIDS PORO; Bear J, 1979, HYDRAULICS GROUNDWAT; Chai JC, 2014, COMPUT GEOTECH, V55, P482, DOI 10.1016/j.compgeo.2013.10.001; Chai JC, 2014, COMPUT GEOTECH, V57, P105, DOI 10.1016/j.compgeo.2014.01.008; Cooper HH, 1946, T AM GEOPHYS UNION, V27, P526; Dupuit J, 1863, ETUDES THEORIQUES PR, V2nd, P229; Jiao JJ, 1996, GROUND WATER, V34, P795, DOI 10.1111/j.1745-6584.1996.tb02073.x; JIAO JJ, 1995, GROUND WATER, V33, P794, DOI 10.1111/j.1745-6584.1995.tb00026.x; Jiao JJ, 1997, GROUND WATER, V35, P25, DOI 10.1111/j.1745-6584.1997.tb00056.x; Kruseman GP, 1994, ANAL EVALUATION PUMP; Kuang XX, 2014, HYDROL PROCESS, V28, P5450, DOI 10.1002/hyp.10058; Masrouri F., 2009, LAB FIELD TESTING UN, P79, DOI 10.1007/978-1-4020-8819-3_7; Mbonimpa M., 2002, GEOTECHNICAL GEOLOGI, V20, P235, DOI [10.1023/A:1016046214724, DOI 10.1023/A:1016046214724]; Ministry of Construction of the People's Republic of China (MCPRC), 1999, 5029699 MCPRC GB; Ministry of Construction of the People's Republic of China (MCPRC), 2001, 500272001 MCPRC GB; PAPADOPU.IS, 1967, WATER RESOUR RES, V3, P241, DOI 10.1029/WR003i001p00241; Pickles AR, 2003, P I CIVIL ENG-GEOTEC, V156, P147; Schafer DC, 1978, JOHNSON DRILLERS J; Theis CV, 1935, EOS T AM GEOPHYS UN, V16, P519; Xu YS, 2014, ENG GEOL, V183, P254, DOI 10.1016/j.enggeo.2014.08.023; [杨建民 Yang Jianmin], 2008, [土木工程学报, China Civil Engineering Journal], V41, P67; Yin ZY, 2013, INT J NUMER ANAL MET, V37, P855, DOI 10.1002/nag.1125	56	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0266-352X	1873-7633		COMPUT GEOTECH	Comput. Geotech.	JUL	2015	68						196	207		10.1016/j.compgeo.2015.03.011		12	Computer Science, Interdisciplinary Applications; Engineering, Geological; Geosciences, Multidisciplinary	Computer Science; Engineering; Geology	CK3MT	WOS:000356120900018		
J	Niu, LB; Nakada, K				Niu, Li-Bin; Nakada, Kensuke			Effect of chloride and sulfate ions in simulated boiler water on pitting corrosion behavior of 13Cr steel	CORROSION SCIENCE			English	Article						Stainless steel; Polarization; SEM; Pitting corrosion	STAINLESS-STEEL; POWER-PLANTS; GROWTH; PITS; FOILS	The pitting corrosion behavior of 13Cr steel was investigated in simulated boiler waters containing chloride ions (Cl-) and sulfate ions (SO42-) using potentiodynamic and potentiostatic polarization tests in addition to pit morphology analysis. The presence of 100 ppm cl(-) in the water caused pitting corrosion of the steel. Pit initiation was inhibited by the addition of 50 ppm or 100 ppm SO42- into the water containing 100 ppm Cl-. Pit growth was also suppressed by the presence of 50 ppm SO42- in the water with 100 ppm Cl-; however, it was conversely promoted in the presence of 100 ppm SO42-. (C) 2015 Elsevier Ltd. All rights reserved.	[Niu, Li-Bin] Shinshu Univ, Acad Assembly, Inst Engn, Nagano 3808553, Japan; [Nakada, Kensuke] Shinshu Univ, Matsumoto, Nagano, Japan	Niu, LB (reprint author), Shinshu Univ, Acad Assembly, Inst Engn, 4-17-1 Wakasato, Nagano 3808553, Japan.	niulibn@shinshu-u.ac.jp					LECKIE HP, 1966, J ELECTROCHEM SOC, V113, P1262, DOI 10.1149/1.2423801; Zuo Y, 2002, CORROS SCI, V44, P13, DOI 10.1016/S0010-938X(01)00031-2; [Anonymous], 1998, T97801 CENTR RES I E, P29; FRANKEL GS, 1987, CORROSION, V43, P429; Tang YM, 2014, CORROS SCI, V80, P111, DOI 10.1016/j.corsci.2013.11.015; PISTORIUS PC, 1992, CORROS SCI, V33, P1885, DOI 10.1016/0010-938X(92)90191-5; Ernst P, 1997, CORROS SCI, V39, P1133, DOI 10.1016/S0010-938X(97)00043-7; Ernst P, 2002, CORROS SCI, V44, P943, DOI 10.1016/S0010-938X(01)00134-2; Ernst P, 2002, CORROS SCI, V44, P927, DOI 10.1016/S0010-938X(01)00133-0; MANKOWSKI J, 1975, CORROS SCI, V15, P493, DOI 10.1016/0010-938X(75)90015-3; ALKIRE RC, 1988, CORROS SCI, V28, P411, DOI 10.1016/0010-938X(88)90060-1; Bellows JC., 1999, POWER PLANT CHEM, V1, P26; BURSTEIN GT, 1993, CORROS SCI, V35, P57, DOI 10.1016/0010-938X(93)90133-2; Dooley B., 2000, POWERPLANT CHEM, V2, P709; Hirano M., 2004, ZAIRYO TO KANKYO, V53, P568; Hirano M, 2005, ISIJ INT, V45, P373, DOI 10.2355/isijinternational.45.373; Japan Society of Corrosion Engineering, 2000, CORR HDB, P573; Japanese Standards Association, 2006, B8223 JIS JAP STAND; JONAS O, 1985, MATER PERFORMANCE, V24, P9; Jonas O., 2008, P 37 TURB S HOUST TE, P211; Niu LB, 2013, MATER TRANS, V54, P2225, DOI 10.2320/matertrans.M2013202; Niu LB, 2010, J JPN I MET, V74, P635; Sakai Y., 2000, GEOTHERMAL COUNCIL T, V24, P521; Turnbull A, 2004, CORROS SCI, V46, P1239, DOI 10.1016/j.corsci.2003.09.017	24	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0010-938X	1879-0496		CORROS SCI	Corrosion Sci.	JUL	2015	96						171	177		10.1016/j.corsci.2015.04.005		7	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CK3MZ	WOS:000356121500018		
J	Qin, HJ; Wang, JQ; Liu, P; Wang, Y; Chen, MW				Qin, H-J; Wang, J. Q.; Liu, P.; Wang, Y.; Chen, M. W.			Hierarchical nanoporous metal/metal-oxide composite by dealloying metallic glass for high-performance energy storage	CORROSION SCIENCE			English	Article						Glass; SEM; De-alloying; Oxidation	PSEUDOCAPACITIVE PERFORMANCE; ELECTRODE MATERIALS; SUPERCAPACITORS; ARRAYS; ALLOY; CU; TEMPERATURE; FABRICATION; NANOSHEETS; NANOWIRES	A free-standing nanoporous YNiCo metal/metal-oxide composite with hierarchical porosity is fabricated by chemically dealloying Al85Y6Ni6Co3 metallic glass in alkaline solutions. The mixed core-shell-like metal/metal-oxide structure formed during dealloying due to the active properties of these metals. Time-dependent etching experiments suggest that the formation of large and small pores occur simultaneously, which may be related to the different dissolution rate of Al at different sites. The nanoporous composite with a highly conductive metal core exhibits a high areal capacitance. Moreover, this strategy can be extended to fabricate other nanoporous composites considering that the composition of metallic glass can be easily tuned. (C) 2015 Elsevier Ltd. All rights reserved.	[Qin, H-J; Wang, Y.] Chongqing Univ, Sch Chem & Chem Engn, State Key Lab Mech Transmiss, Chongqing 400044, Peoples R China; [Wang, J. Q.] Chinese Acad Sci, Ningbo Inst Mat Technol & Engn, Ningbo 315201, Zhejiang, Peoples R China; [Liu, P.; Chen, M. W.] Tohoku Univ, WPI Adv Inst Mat Res, Sendai, Miyagi 9808577, Japan	Qin, HJ (reprint author), Chongqing Univ, Sch Chem & Chem Engn, State Key Lab Mech Transmiss, Chongqing 400044, Peoples R China.	hjqiu@cqu.edu.cn; jqwang@nimte.ac.cn; wangy@cqu.edu.cn; mwchen@wpi-aimr.tohoku.ac.jp	Chen, Mingwei/A-4855-2010; Liu, Pan/H-5469-2012	Chen, Mingwei/0000-0002-2850-8872; 	Thousand Young Talents Program of the Chinese Central Government [0220002102003]; National Natural Science Foundation of China (NSFC) [21373280]; Beijing National Laboratory for Molecular Sciences (BNLMS); Hundred Talents Program at Chongqing University [0903005203205]; JST-CREST "Interface Science for Highly Efficient Energy Utilization", JST; "World Premier International Research Center (WPI) Initiative" by MEXT, Japan	This work was supported by the Thousand Young Talents Program of the Chinese Central Government (No. 0220002102003), National Natural Science Foundation of China (NSFC, No. 21373280), Beijing National Laboratory for Molecular Sciences (BNLMS) and Hundred Talents Program at Chongqing University (No. 0903005203205); JST-CREST "Interface Science for Highly Efficient Energy Utilization", JST; and "World Premier International Research Center (WPI) Initiative" by MEXT, Japan.	Jiang H, 2012, CHEM COMMUN, V48, P4465, DOI 10.1039/c2cc31418e; Liu JP, 2012, J MATER CHEM, V22, P2419, DOI 10.1039/c1jm14804d; Erlebacher J, 2009, MRS BULL, V34, P561, DOI 10.1557/mrs2009.155; Lang XY, 2010, J PHYS CHEM C, V114, P2600, DOI 10.1021/jp907682x; Xia XH, 2012, ACS NANO, V6, P5531, DOI 10.1021/nn301454q; Zhang GQ, 2012, ENERG ENVIRON SCI, V5, P9453, DOI 10.1039/c2ee22572g; Ding Y, 2009, MRS BULL, V34, P569, DOI 10.1557/mrs2009.156; Mihaylov L, 2015, CORROS SCI, V94, P350, DOI 10.1016/j.corsci.2015.02.031; Kim JH, 2011, CHEM COMMUN, V47, P5214, DOI 10.1039/c0cc05191h; Kang JL, 2014, ADV MATER, V26, P269, DOI 10.1002/adma.201302975; Luo XK, 2013, CORROS SCI, V67, P100, DOI 10.1016/j.corsci.2012.10.010; Qi Z, 2009, J ALLOY COMPD, V472, P71, DOI 10.1016/j.jallcom.2008.04.017; Jiang J, 2011, ENERG ENVIRON SCI, V4, P5000, DOI 10.1039/c1ee02293h; Zhang JT, 2012, CHEM SOC REV, V41, P7016, DOI 10.1039/c2cs35210a; Lu XF, 2014, J MATER CHEM A, V2, P4706, DOI 10.1039/c3ta14930g; Tuan NT, 2014, CORROS SCI, V80, P7, DOI 10.1016/j.corsci.2013.11.043; Yu JS, 2008, CHEM MATER, V20, P4548, DOI 10.1021/cm8009644; Wittstock A, 2010, SCIENCE, V327, P319, DOI 10.1126/science.1183591; Wei YY, 2014, J MATER CHEM A, V2, P8103, DOI 10.1039/c3ta15423h; Dan ZH, 2013, ELECTROCHIM ACTA, V108, P512, DOI 10.1016/j.electacta.2013.07.047; Wu CM, 2011, J POWER SOURCES, V196, P7828, DOI 10.1016/j.jpowsour.2011.03.083; Cai F, 2014, J MATER CHEM A, V2, P11509, DOI 10.1039/c4ta01235f; Inoue A, 2011, ACTA MATER, V59, P2243, DOI 10.1016/j.actamat.2010.11.027; Zhang L, 2011, J PHYS CHEM C, V115, P19583, DOI 10.1021/jp205892n; Weissmuller J, 2009, MRS BULL, V34, P577, DOI 10.1557/mrs2009.157; Hakamada M, 2009, J ALLOY COMPD, V485, P583, DOI 10.1016/j.jallcom.2009.06.031; Wang HW, 2013, ACS APPL MATER INTER, V5, P6255, DOI 10.1021/am4012484; Zhang ZH, 2009, J PHYS CHEM C, V113, P12629, DOI 10.1021/jp811445a; Wang JQ, 2012, INTERMETALLICS, V29, P35, DOI 10.1016/j.intermet.2012.04.009; Liu JP, 2011, ADV MATER, V23, P2076, DOI 10.1002/adma.201100058; Wu ZB, 2014, J MATER CHEM A, V2, P14759, DOI 10.1039/c4ta02390k; Qiu HJ, 2014, J POWER SOURCES, V247, P896, DOI 10.1016/j.jpowsour.2013.08.070; Li J, 2015, CORROS SCI, V91, P95, DOI 10.1016/j.corsci.2014.11.002; Liu WB, 2015, CORROS SCI, V94, P114, DOI 10.1016/j.corsci.2015.01.043; Liu YH, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.125504; Qiu H.-J, 2015, Corrosion Science, V92, DOI 10.1016/j.corsci.2014.12.017; Qiu H.J., 2014, SCRIPTA MATER, V89, P69	37	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0010-938X	1879-0496		CORROS SCI	Corrosion Sci.	JUL	2015	96						196	202		10.1016/j.corsci.2015.04.003		7	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CK3MZ	WOS:000356121500021		
J	Tagawa, H; Irie, J; Itoh, A; Kusumoto, Y; Kato, M; Kobayashi, N; Tanaka, K; Morinaga, R; Fujita, M; Nakajima, Y; Morimoto, K; Sugizaki, T; Kawano, Y; Yamada, S; Kawai, T; Watanabe, M; Itoh, H				Tagawa, Hirotsune; Irie, Junichiro; Itoh, Arata; Kusumoto, Yukie; Kato, Mari; Kobayashi, Nana; Tanaka, Kumiko; Morinaga, Rieko; Fujita, Masataka; Nakajima, Yuya; Morimoto, Kohkichi; Sugizaki, Taichi; Kawano, Yoshinaga; Yamada, Satoru; Kawai, Toshihide; Watanabe, Mitsuhiro; Itoh, Hiroshi			Bile acid binding resin improves hepatic insulin sensitivity by reducing cholesterol but not triglyceride levels in the liver	DIABETES RESEARCH AND CLINICAL PRACTICE			English	Article						Bile acid binding resin; Hepatic insulin resistance; Non-alcoholic fatty liver disease	TYPE-2 DIABETES-MELLITUS; NONALCOHOLIC STEATOHEPATITIS; ALANINE AMINOTRANSFERASE; FATTY LIVER; MOUSE; COLESTIMIDE; PREVENTION; RECEPTORS; THERAPY; DISEASE	Aims: Bile acid binding resin (BAR) improves glycaemic control in patients with type 2 diabetes. Although the mechanism is hypothesised to involve the clearance of excess hepatic triglyceride, this hypothesis has not been examined in appropriately designed studies. Therefore, we investigated whether reduced hepatic triglyceride deposition is involved in BAR-mediated improvements in glycaemic control in spontaneous fatty liver diabetic mice without dietary interventions. Methods: Male 6-week-old fatty liver Shionogi (FLS) mice were fed a standard diet without or with 1.5% BAR (colestilan) for 6 weeks. Glucose tolerance, insulin sensitivity, hepatic lipid content, and gene expression were assessed. A liver X receptor (LXR) agonist was also administered to activate the LXR pathway. We also retrospectively analysed the medical records of 21 outpatients with type 2 diabetes who were treated with colestilan for >= 6 months. Results: BAR enhanced glucose tolerance and insulin sensitivity in FLS mice without altering fat mass. BAR improved hepatic insulin sensitivity, increased IRS2 expression, and decreased SREBP expression. BAR reduced hepatic cholesterol levels but not hepatic triglyceride levels. BAR also reduced the expression of LXR target genes, and LXR activation abolished the BAR-mediated improvements in glycaemic control. Colestilan significantly lowered serum cholesterol levels and improved glycaemic control in patients with type 2 diabetes. Conclusions: BAR improved hepatic insulin resistance in FLS mice by reducing hepatic cholesterol without affecting hepatic triglyceride levels or body fat distribution. Our study revealed that BAR improves glycaemic control at least in part by downregulating the hepatic cholesterol-LXR-IRS2 pathway. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Tagawa, Hirotsune; Irie, Junichiro; Itoh, Arata; Kusumoto, Yukie; Kato, Mari; Kobayashi, Nana; Tanaka, Kumiko; Morinaga, Rieko; Fujita, Masataka; Nakajima, Yuya; Morimoto, Kohkichi; Sugizaki, Taichi; Kawano, Yoshinaga; Kawai, Toshihide; Watanabe, Mitsuhiro; Itoh, Hiroshi] Keio Univ, Sch Med, Dept Internal Med, Div Endocrinol Metab & Nephrol, Tokyo 1608582, Japan; [Yamada, Satoru] Kitasato Inst Hosp, Ctr Diabet, Tokyo 1088642, Japan	Irie, J (reprint author), Keio Univ, Sch Med, Dept Internal Med, Div Endocrinol Metab & Nephrol, Tokyo 1608582, Japan.	j-irie@z8.keio.jp			Kanae Foundation for the Promotion of Medical Science; Daiwa Securities Health Foundation; Keio University School of Medicine; Keio University	FLS mice were kindly provided by Shionogi & Co., Ltd. This study was supported by Kanae Foundation for the Promotion of Medical Science, Daiwa Securities Health Foundation, a research fellowship from Keio University School of Medicine, and a Grant-in-Aid for the Encouragement of Young Medical Scientists from Keio University.	Kobayashi M, 2007, DIABETES, V56, P239, DOI 10.2337/db06-0353; Staels B, 2009, DIABETES CARE, V32, pS237, DOI 10.2337/dc09-S355; Le TA, 2012, HEPATOLOGY, V56, P922, DOI 10.1002/hep.25731; Psichas A, 2012, NEUROGASTROENT MOTIL, V24, P1095, DOI 10.1111/j.1365-2982.2012.01988.x; Soga M, 1999, LAB ANIM SCI, V49, P269; Meng ZX, 2012, DIABETOLOGIA, V55, P1733, DOI 10.1007/s00125-012-2516-2; Yamakawa T, 2007, ENDOCR J, V54, P53, DOI 10.1507/endocrj.K05-098; Handelsman Y, 2011, DIABETES CARE, V34, pS244, DOI 10.2337/dc11-s237; Fraser A, 2009, DIABETES CARE, V32, P741, DOI 10.2337/dc08-1870; Calkin AC, 2012, NAT REV MOL CELL BIO, V13, P213, DOI 10.1038/nrm3312; Chisholm JW, 2003, J LIPID RES, V44, P2039, DOI 10.1194/jlr.M300135-JLR200; Ide T, 2004, NAT CELL BIOL, V6, P351, DOI 10.1038/ncb1111; Kalaany NY, 2005, CELL METAB, V1, P231, DOI 10.1016/j.cmet.2005.03.001; Potthoff MJ, 2013, AM J PHYSIOL-GASTR L, V304, pG371, DOI 10.1152/ajpgi.00400.2012; Kodama K, 2012, P NATL ACAD SCI USA, V109, P7049, DOI 10.1073/pnas.1114513109; Bays HE, 2008, ARCH INTERN MED, V168, P1975, DOI 10.1001/archinte.168.18.1975; Beysen C, 2012, DIABETOLOGIA, V55, P432, DOI 10.1007/s00125-011-2382-3; Porez G, 2012, J LIPID RES, V53, P1723, DOI 10.1194/jlr.R024794; Suzuki Tatsuya, 2006, Journal of Nippon Medical School, V73, P277, DOI 10.1272/jnms.73.277; Min HK, 2012, CELL METAB, V15, P665, DOI 10.1016/j.cmet.2012.04.004; Chen LH, 2010, J PHARMACOL EXP THER, V334, P164, DOI 10.1124/jpet.110.166892; Basciano H, 2009, AM J PHYSIOL-ENDOC M, V297, pE462, DOI 10.1152/ajpendo.90764.2008; Cao GQ, 2003, J BIOL CHEM, V278, P1131, DOI 10.1074/jbc.M210208200; FOLCH J, 1957, J BIOL CHEM, V226, P497; GARG A, 1994, ANN INTERN MED, V121, P416; Harach T, 2012, SCI REP-UK, V2, DOI 10.1038/srep00430; Irie J, 2007, DIABETES, V56, P186, DOI 10.2337/db06-0793; RIFKIND BM, 1984, JAMA-J AM MED ASSOC, V251, P351; Sattar N, 2007, DIABETES, V56, P984, DOI 10.2337/db06-1256; Shindo N, 2010, J HEPATOL, V52, P903, DOI 10.1016/j.jhep.2009.12.033; Taniai M, 2009, HEPATOL RES, V39, P685, DOI 10.1111/j.1872-034X.2009.00507.x; Watanabe M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038286	32	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-8227	1872-8227		DIABETES RES CLIN PR	Diabetes Res. Clin. Pract.	JUL	2015	109	1					85	94		10.1016/j.diabres.2015.04.025		10	Endocrinology & Metabolism	Endocrinology & Metabolism	CK4YA	WOS:000356228100012		
J	Kato, H; Nagai, Y; Ohta, A; Tenjin, A; Nakamura, Y; Tsukiyama, H; Sasaki, Y; Fukuda, H; Ohshige, T; Terashima, Y; Sada, Y; Kondo, A; Sasaoka, T; Tanaka, Y				Kato, Hiroyuki; Nagai, Yoshio; Ohta, Akio; Tenjin, Ayumi; Nakamura, Yuta; Tsukiyama, Hidekazu; Sasaki, Yosuke; Fukuda, Hisashi; Ohshige, Toshihiko; Terashima, Yuko; Sada, Yukiyoshi; Kondo, Akihiko; Sasaoka, Toshiyasu; Tanaka, Yasushi			Effect of sitagliptin on intrahepatic lipid content and body fat in patients with type 2 diabetes	DIABETES RESEARCH AND CLINICAL PRACTICE			English	Article						Type 2 diabetes; DPP-4 inhibitor; Sitagliptin; Fatty liver; Body fat	DIPEPTIDYL PEPTIDASE-4 INHIBITORS; ACTIVATED PROTEIN-KINASE; INSULIN SENSITIVITY; HUMAN HEPATOCYTES; ADIPOSE-TISSUE; OBESE SUBJECTS; METFORMIN; EFFICACY; LIVER; GLP-1	Aims: To evaluate the effect of the DPP-4 inhibitor sitagliptin on intrahepatic lipid (IHL) content and body fat in overweight Japanese patients with type 2 diabetes. Methods: A prospective, 24-week, single-center, open-label comparative study enrolled 20 Japanese patients with type 2 diabetes (male: 11, female: 9) with a BMI >= 25 kg/m(2) or fatty liver. Subjects were randomly assigned to receive treatment with sitagliptin (25 mg titrated up to 50 mg: S) or glimepiride (0.5 mg titrated up to 1 mg: G). After starting each treatment, IHL and total fat mass were evaluated by H-1-magnetic resonance spectroscopy (H-1-MRS) and dual energy X-ray absorptiometry (DEXA), respectively at baseline and at 12 weeks and 24 weeks. Results: After 24 weeks, HbA1c levels showed a similar significant decrease in both groups from 7.2 (7.0, 7.5) to 6.6 (6.4, 6.8)%, (54 (53, 56) to 48(47, 49) mmol/mol) with S and 7.3(6.8, 7.4) to 6.6 (6.3, 6.7)%, (55 (51, 56) to 48 (46, 49) mmol/mol) with G, median (interquartile range), p < 0.05 vs. baseline, with no significant differences between the two groups. The IHL and total body fat mass were decreased in S group from 24.5(18.9, 36.6) to 20.5 (14.6, 28.5)% (p = 0.009) and 22.5 (20.6, 33.7) to 21.6 (19.7, 32.4) kg (p = 0.028), respectively, but not in G group. Conclusions: Our findings indicate that sitagliptin and glimepiride achieved similar glycemic control, but only sitagliptin reduced IHL and total body fat (UMIN: 000013356). (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Kato, Hiroyuki; Nagai, Yoshio; Ohta, Akio; Tenjin, Ayumi; Nakamura, Yuta; Tsukiyama, Hidekazu; Sasaki, Yosuke; Fukuda, Hisashi; Ohshige, Toshihiko; Terashima, Yuko; Sada, Yukiyoshi; Kondo, Akihiko; Tanaka, Yasushi] St Marianna Univ, Sch Med, Dept Internal Med, Div Endocrinol & Metab, Kawasaki, Kanagawa 2168511, Japan; [Sasaoka, Toshiyasu] Univ Sch Toyama, Dept Clin Pharmacol, Sugitani, Toyama 9300194, Japan	Nagai, Y (reprint author), St Marianna Univ, Sch Med, Dept Internal Med, Div Endocrinol & Metab, Kawasaki, Kanagawa 2168511, Japan.	ynagai@marianna-u.ac.jp					Sato F, 2007, J CLIN ENDOCR METAB, V92, P3326, DOI 10.1210/jc.2006-2384; Kirk E, 2009, GASTROENTEROLOGY, V136, P1552, DOI 10.1053/j.gastro.2009.01.048; Viollet B, 2012, CLIN SCI, V122, P253, DOI 10.1042/CS20110386; Amori RE, 2007, JAMA-J AM MED ASSOC, V298, P194, DOI 10.1001/jama.298.2.194; Kim YG, 2013, DIABETOLOGIA, V56, P696, DOI 10.1007/s00125-012-2827-3; Jung YA, 2014, DIABETES RES CLIN PR, V105, P47, DOI 10.1016/j.diabres.2014.04.028; Vendrell J, 2011, ENDOCRINOLOGY, V152, P4072, DOI 10.1210/en.2011-1070; Svegliati-Baroni G, 2011, LIVER INT, V31, P1285, DOI 10.1111/j.1478-3231.2011.02462.x; Gupta NA, 2010, HEPATOLOGY, V51, P1584, DOI 10.1002/hep.23569; Tamura Y, 2005, J CLIN ENDOCR METAB, V90, P3191, DOI 10.1210/jc.2004-1959; Agerso H, 2002, DIABETOLOGIA, V45, P195, DOI 10.1007/s00125-001-0719-z; Inzucchi SE, 2012, DIABETOLOGIA, V55, P1577, DOI 10.1007/s00125-012-2534-0; Getty-Kaushik L, 2006, OBESITY, V14, P1124, DOI 10.1038/oby.2006.129; Osawa H, 1996, J CLIN ULTRASOUND, V24, P25, DOI 10.1002/(SICI)1097-0096(199601)24:1<25::AID-JCU4>3.0.CO;2-N; Ben-Shlomo S, 2011, J HEPATOL, V54, P1214, DOI 10.1016/j.jhep.2010.09.032; Neumiller JJ, 2010, PHARMACOTHERAPY, V30, P463, DOI 10.1592/phco.30.5.463; Viollet B, 2009, ACTA PHYSIOL, V196, P81, DOI 10.1111/j.1748-1716.2009.01970.x; Aso Y, 2012, TRANSL RES, V159, P25, DOI 10.1016/j.trsl.2011.09.005; Kern M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038744; Aoki K, 2012, ACTA DIABETOL, V49, P225, DOI 10.1007/s00592-011-0322-9; Ceperuelo-Mallafre V, 2014, J CLIN ENDOCR METAB, V99, pE908, DOI 10.1210/jc.2013-3350; Cuthbertson DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050117; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI [10.2337/dc12-0413, 10.2337/dc12-041.3]; Iwamoto Y, 2010, ENDOCR J, V57, P383; Rosskamp R., 1996, Diabetes Research and Clinical Practice, V31, pS33; Sada Yukiyoshi, 2011, Obes Res Clin Pract, V5, pe79, DOI 10.1016/j.orcp.2010.12.007; Sancho V, 2006, INT J MOL MED, V17, P1133; Stephenne X, 2011, DIABETOLOGIA, V54, P3101, DOI 10.1007/s00125-011-2311-5; Tamura Y, 2008, DIABETES OBES METAB, V10, P733, DOI 10.1111/j.1463-1326.2007.00801.x	29	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-8227	1872-8227		DIABETES RES CLIN PR	Diabetes Res. Clin. Pract.	JUL	2015	109	1					199	205		10.1016/j.diabres.2015.04.008		7	Endocrinology & Metabolism	Endocrinology & Metabolism	CK4YA	WOS:000356228100028		
J	Nakao, A				Nakao, Atsuhito			IL-7: AhR We Ready for a New Cytokine to Fight Colitis?	DIGESTIVE DISEASES AND SCIENCES			English	Editorial Material							ARYL-HYDROCARBON RECEPTOR; INFLAMMATORY-BOWEL-DISEASE; IMMUNITY; CELLS		[Nakao, Atsuhito] Univ Yamanashi, Fac Med, Dept Immunol, Chuo Ku, Kofu, Yamanashi 4093898, Japan; [Nakao, Atsuhito] Juntendo Univ, Sch Med, Atopy Res Ctr, Tokyo 113, Japan	Nakao, A (reprint author), Univ Yamanashi, Fac Med, Dept Immunol, Chuo Ku, 1110 Shimokato, Kofu, Yamanashi 4093898, Japan.	anakao@yamanashi.ac.jp					Takamura T, 2010, IMMUNOL CELL BIOL, V88, P685, DOI 10.1038/icb.2010.35; Qiu J, 2012, IMMUNITY, V36, P92, DOI 10.1016/j.immuni.2011.11.011; HANKINSON O, 1995, ANNU REV PHARMACOL, V35, P307, DOI 10.1146/annurev.pharmtox.35.1.307; Monteleone I, 2011, GASTROENTEROLOGY, V141, P237, DOI 10.1053/j.gastro.2011.04.007; Yang H, 2008, AM J PHYSIOL-GASTR L, V294, pG1421, DOI 10.1152/ajpgi.00060.2008; Barouki R, 2007, FEBS LETT, V581, P3608, DOI 10.1016/j.febslet.2007.03.046; Esser C, 2009, TRENDS IMMUNOL, V30, P447, DOI 10.1016/j.it.2009.06.005; Monteleone I, 2012, CURR OPIN GASTROEN, V28, P310, DOI 10.1097/MOG.0b013e328352ad69; Boyman O, 2012, CELL MOL LIFE SCI, V69, P1597, DOI 10.1007/s00018-012-0968-7; Ji T, DIGEST DIS SCI, DOI [10.1007/s10620-015-3632-x, DOI 10.1007/S10620-015-3632-X]; Kanai T, 2009, CURR OPIN GASTROEN, V25, P306, DOI 10.1097/MOG.0b013e32832bc627; Li Ying, 2011, Cell, V147, P629, DOI 10.1016/j.cell.2011.09.025	12	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0163-2116	1573-2568		DIGEST DIS SCI	Dig. Dis. Sci.	JUL	2015	60	7					1876	1877		10.1007/s10620-015-3721-x		2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CK2DT	WOS:000356021500003		
J	Mizuno, S; Matsui, D; Watanabe, I; Ozaki, E; Kuriyama, N; Watanabe, Y				Mizuno, Shigeto; Matsui, Daisuke; Watanabe, Isao; Ozaki, Etsuko; Kuriyama, Nagato; Watanabe, Yoshiyuki			Serologically Determined Gastric Mucosal Condition Is a Predictive Factor for Osteoporosis in Japanese Men	DIGESTIVE DISEASES AND SCIENCES			English	Article						Helicobacter pylori; Atrophic gastritis; Osteoporosis; Cohort study	HELICOBACTER-PYLORI INFECTION; CALCIUM HOMEOSTASIS; ATROPHIC GASTRITIS; BONE; CANCER; RISK; ERADICATION; ANTIBODY; COHORT	There are few reports about the influence of Helicobacter pylori infection and/or atrophic gastritis on bone conditions in Japan. To assess whether the combination of serologically determined Helicobacter pylori infection and atrophic gastritis is available as a biomarker for bone conditions. We studied 230 men in their 50s and 60s. Helicobacter pylori infection was determined using serum antibody to this bacterium. Atrophic gastritis was diagnosed on the basis of the serum pepsinogen I and II criteria. The characteristics of the participants' bone were measured at the radius using an ultrasonic bone densitometry system. The risks of low trabecular bone density, low elastic modulus of trabecular bone, and low cortical thickness among subjects who were positive for Helicobacter pylori infection and/or atrophic gastritis relative to those who were not were calculated. Helicobacter pylori infection significantly increased the risk of low trabecular bone density (odds ratio 1.83, 95 % confidence interval 1.04-3.21, P = 0.03). Atrophic gastritis significantly increased the risk of low trabecular bone density (2.22, 1.17-4.22, 0.01). Compared with anti-Helicobacter pylori antibody (-) and atrophic gastritis (-) subjects, anti-Helicobacter pylori antibody (+) and atrophic gastritis (+) subjects were a significant high-risk group for low trabecular bone density (2.65, 1.27-5.55, 0.01). A serological diagnosis of Helicobacter pylori infection and atrophic gastritis, which is utilized for risk assessment of gastric cancer, was suggested to be useful for risk assessment of osteoporosis.	[Mizuno, Shigeto] Kobe Pharmaceut Univ, Dept Med Pharmaceut, Higashinada Ku, Kobe, Hyogo 6588558, Japan; [Matsui, Daisuke; Watanabe, Isao; Ozaki, Etsuko; Kuriyama, Nagato; Watanabe, Yoshiyuki] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Epidemiol Community Hlth & Med, Kamigyo Ku, Kyoto 6028566, Japan	Mizuno, S (reprint author), Kobe Pharmaceut Univ, Dept Med Pharmaceut, Higashinada Ku, 4-19-1 Motoyama Kita, Kobe, Hyogo 6588558, Japan.	mizuno@kobepharma-u.ac.jp; d-matsui@koto.kpu-m.ac.jp; ricky@koto.kpu-m.ac.jp; ozaki@koto.kpu-m.ac.jp; nkuriyam@koto.kpu-m.ac.jp; watanabe@koto.kpu-m.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [17015018, 221S0001, 25460233]	This study was supported in part by Grant-in-Aid for Scientific Research on Priority Areas of Cancer (No. 17015018), Grant-in-Aid for Scientific Research on Innovative Areas (No. 221S0001), and Grant-in-Aid for Scientific Research (C) (No. 25460233) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Watabe H, 2005, GUT, V54, P764, DOI 10.1136/gut.2004.055400; Ohata H, 2004, INT J CANCER, V109, P138, DOI 10.1002/ijc.11680; Wakai K, 2011, J EPIDEMIOL, V21, P223, DOI 10.2188/jea.JE20100139; Yu EW, 2011, AM J MED, V124, P519, DOI 10.1016/j.amjmed.2011.01.007; Yamaoka Y, 1997, GUT, V41, P442; Buzas GM, 2014, WORLD J GASTROENTERO, V20, P5226, DOI 10.3748/wjg.v20.i18.5226; Mizuno S, 2010, DIGEST DIS SCI, V55, P3132, DOI 10.1007/s10620-010-1154-0; Miki K, 2011, P JPN ACAD B-PHYS, V87, P405, DOI 10.2183/pjab.87.405; Schinke T, 2009, NAT MED, V15, P674, DOI 10.1038/nm.1963; Soen S, 2013, J BONE MINER METAB, V31, P247, DOI 10.1007/s00774-013-0447-8; Keller J, 2013, OSTEOPOROSIS INT, V24, P2737, DOI 10.1007/s00198-013-2335-4; Sipponen P, 2010, SCAND J GASTROENTERO, V45, P133, DOI 10.3109/00365520903434117; Figura N, 2014, J CLIN PATHOL, V67, DOI 10.1136/jclinpath-2013-201743; Figura N, 2005, DIGEST DIS SCI, V50, P847, DOI 10.1007/s10620-005-2651-4; Hernlund E, 2013, Arch Osteoporos, V8, P136, DOI 10.1007/s11657-013-0136-1; Kakehasi AM, 2009, DIGEST DIS SCI, V54, P819, DOI 10.1007/s10620-008-0417-5; Kawai T, 2002, INTERNAL MED, V41, P780, DOI 10.2169/internalmedicine.41.780; Kim HW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101852; Kinoshita Y, 1997, GUT, V41, P452; MIKI K, 1987, Gastroenterologia Japonica, V22, P133; Nakagawa H, 2013, MEDIAT INFLAMM, V2013; Ozdem S, 2007, DIGEST DIS SCI, V52, P967, DOI 10.1007/s10620-006-9292-0; Sai H, 2010, OSTEOPOROSIS INT, V21, P1781, DOI 10.1007/s00198-010-1217-2; Shiota S, 2013, EXPERT REV GASTROENT, V7, P35, DOI [10.1586/egh.12.67, 10.1586/EGH.12.67]; Watanabe Y, 1997, J CLIN GASTROENTEROL, V25, P391, DOI 10.1097/00004836-199707000-00024; Yamamoto T, 2009, OSTEOPOROSIS INT, V20, P1215, DOI 10.1007/s00198-008-0774-0	26	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0163-2116	1573-2568		DIGEST DIS SCI	Dig. Dis. Sci.	JUL	2015	60	7					2063	2069		10.1007/s10620-015-3576-1		7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CK2DT	WOS:000356021500026		
J	Aoki, T; Nagata, N; Sakamoto, K; Arai, T; Niikura, R; Shimbo, T; Shinozaki, M; Sekine, K; Okubo, H; Watanabe, K; Sakurai, T; Yokoi, C; Akiyama, J; Yanase, M; Mizokami, M; Noda, M; Uemura, N				Aoki, Tomonori; Nagata, Naoyoshi; Sakamoto, Kayo; Arai, Tomohiro; Niikura, Ryota; Shimbo, Takuro; Shinozaki, Masafumi; Sekine, Katsunori; Okubo, Hidetaka; Watanabe, Kazuhiro; Sakurai, Toshiyuki; Yokoi, Chizu; Akiyama, Junichi; Yanase, Mikio; Mizokami, Masashi; Noda, Mitsuhiko; Uemura, Naomi			Abdominal Fat Accumulation, as Measured by Computed Tomography, Increases the Risk of Ischemic Colitis: A Retrospective Case-Control Study	DIGESTIVE DISEASES AND SCIENCES			English	Article						Abdominal visceral fat; Metabolic syndrome; Acute large bowel ischemia; Computed tomography; Body mass index	ADIPOSE-TISSUE; CROHNS-DISEASE; ATHEROSCLEROSIS; STRATEGIES; MORTALITY; AREA	Visceral fat contributes to insulin resistance and atherosclerosis. We retrospectively investigated whether abdominal fat accumulation, as measured by computed tomography, is a risk of ischemic colitis and related clinical outcomes. Outpatient-onset ischemic colitis patients (n = 58) and age- and sex-matched controls (n = 58) underwent colonoscopy and computed tomography. Associations between body mass index, visceral adipose tissue area, subcutaneous adipose tissue area, and ischemic colitis were estimated using odds ratios adjusted for hypertension, diabetes mellitus, and dyslipidemia. In multivariate analysis, ischemic colitis was significantly associated with subcutaneous adipose tissue area (P for trend 0.030) and marginally associated with visceral adipose tissue area (P for trend 0.094), but was not associated with body mass index (P for trend 0.460). The adjusted odds ratios for the highest quartile of subcutaneous and visceral adipose tissue in ischemic colitis were 3.48 (1.06-11.4) and 2.43 (0.74-8.00), respectively, compared with the lowest quartile. When body mass index was considered simultaneously, ischemic colitis remained associated with subcutaneous adipose tissue (P for trend 0.016) and visceral adipose tissue (P for trend 0.077). No significant differences were noted between any of the obesity indices and the distribution type of colitis, blood transfusion requirement, or length of hospital stay. Abdominal fat accumulation measured by computed tomography, but not body mass index, was associated with outpatient-onset ischemic colitis. Ischemic colitis remained associated with abdominal fat, even when body mass index was simultaneously considered. However, clinical outcomes of ischemic colitis were not associated with abdominal fat accumulation.	[Aoki, Tomonori; Nagata, Naoyoshi; Niikura, Ryota; Sekine, Katsunori; Okubo, Hidetaka; Watanabe, Kazuhiro; Sakurai, Toshiyuki; Yokoi, Chizu; Akiyama, Junichi; Yanase, Mikio] Natl Ctr Global Hlth & Med, Dept Gastroenterol & Hepatol, Shinjuku Ku, Tokyo 1628655, Japan; [Sakamoto, Kayo; Arai, Tomohiro; Shinozaki, Masafumi] Natl Ctr Global Hlth & Med, Dept Diagnost Radiol, Shinjuku Ku, Tokyo 1628655, Japan; [Shimbo, Takuro] Natl Ctr Global Hlth & Med, Dept Clin Res & Informat, Int Clin Res Ctr,Res Inst, Shinjuku Ku, Tokyo 1628655, Japan; [Mizokami, Masashi] Kohnodai Hosp, Res Ctr Hepatitis & Immunol, Natl Ctr Global Hlth & Med, Ichikawa, Chiba 2728516, Japan; [Noda, Mitsuhiko] Natl Ctr Global Hlth & Med, Dept Diabet Res, Diabet Res Ctr, Shinjuku Ku, Tokyo 1628655, Japan; [Uemura, Naomi] Kohnodai Hosp, Dept Gastroenterol & Hepatol, Natl Ctr Global Hlth & Med, Ichikawa, Chiba 2728516, Japan	Nagata, N (reprint author), Natl Ctr Global Hlth & Med, Dept Gastroenterol & Hepatol, Shinjuku Ku, 1-21-1 Toyama, Tokyo 1628655, Japan.	iitomo_1020@yahoo.co.jp; nnagata_ncgm@yahoo.co.jp; ksakamo@hosp.ncgm.go.jp; depository.of.mail@gmail.com; rniikura@triton.ocn.ne.jp; tshimbo@ohta-hp.or.jp; shmasafu@hosp.ncgm.go.jp; hawaiiantuberider@gmail.com; h.okubo.john@gmail.com; c12pagani@yahoo.co.jp; tsakurai@hosp.ncgm.go.jp; chizzzucchi@gmail.com; akiyama@fc4.so-net.ne.jp; myanase@hosp.ncgm.go.jp; mizokami0810@gmail.com; mnoda@hosp.ncgm.go.jp; nuemura@hospk.ncgm.go.jp			Medicine for Ministry of Health, Labour and Welfare; Health and Labour Sciences Research Grants; grant for Comprehensive Research on Life-Style Related Diseases including Cardiovascular Diseases and Diabetes Mellitus from the Ministry of Health, Labour and Welfare of Japan [H25-016]; grants for research and development from the National Center for Global Health and Medicine	This study was partly supported by the Medicine for Ministry of Health, Labour and Welfare; Health and Labour Sciences Research Grants; a grant for Comprehensive Research on Life-Style Related Diseases including Cardiovascular Diseases and Diabetes Mellitus (H25-016) from the Ministry of Health, Labour and Welfare of Japan; and grants for research and development from the National Center for Global Health and Medicine. We thank Hisae Kawashiro, Sawako Iijima, Yoko Tanigawa, Aiko Gotanda, and Yaeko Sawada for help with data collection.	Longstreth GF, 2010, CLIN GASTROENTEROL H, V8, P49, DOI 10.1016/j.cgh.2009.09.006; Willett WC, 1999, NEW ENGL J MED, V341, P427, DOI 10.1056/NEJM199908053410607; Fantuzzi G, 2007, ARTERIOSCL THROM VAS, V27, P996, DOI 10.1161/ATVBAHA.106.131755; Erhayiem B, 2011, CLIN GASTROENTEROL H, V9, P684, DOI 10.1016/j.cgh.2011.05.005; Goodpaster BH, 2002, CURR OPIN CLIN NUTR, V5, P481, DOI 10.1097/00075197-200209000-00005; Villanueva C, 2013, NEW ENGL J MED, V368, P11, DOI 10.1056/NEJMoa1211801; Paterno F, 2008, RADIOL CLIN N AM, V46, P877, DOI 10.1016/j.rcl.2008.06.005; Pou KM, 2007, CIRCULATION, V116, P1234, DOI 10.1161/CIRCULATIONAHA.107.710509; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; Higgins PDR, 2004, ALIMENT PHARM THERAP, V19, P729, DOI 10.1111/j.1365-2036.2004.01903.x; Mosele M, 2010, SCAND J GASTROENTERO, V45, P428, DOI 10.3109/00365520903513225; Nagata N, 2014, GASTROINTEST ENDOSC, V80, P1124, DOI 10.1016/j.gie.2014.06.039; Nagata N, 2013, CLIN GASTROENTEROL H, V11, P673, DOI 10.1016/j.cgh.2012.12.034; Desreumaux P, 1999, GASTROENTEROLOGY, V117, P73, DOI 10.1016/S0016-5085(99)70552-4; THAETE FL, 1995, INT J OBESITY, V19, P464; Barba C, 2004, LANCET, V363, P157; Chavalitdhamrong D, 2011, GASTROINTEST ENDOSC, V74, P852, DOI 10.1016/j.gie.2011.05.039; Fernandez JC, 2010, WORLD J GASTROENTERO, V16, P4564, DOI 10.3748/wjg.v16.i36.4564; Hozawa A, 2008, OBESITY, V16, P1714, DOI 10.1038/oby.2008.237; Huerta C, 2011, ALIMENT PHARM THER, V33, P969, DOI 10.1111/j.1365-2036.2011.04614.x; Kimura T, 2012, DIGEST DIS SCI, V57, P1652, DOI 10.1007/s10620-012-2088-5; Koutroubakis IE, 2001, GASTROENTEROLOGY, V121, P561, DOI 10.1053/gast.2001.27227; Longo WE, 2003, SURGERY, V134, P629; Scharff JR, 2003, SURGERY, V134, P624, DOI 10.1016/S0039-6060(03)00308-8; Longstreth GF, 2009, CLIN GASTROENTEROL H, V7, P1075, DOI 10.1016/j.cgh.2009.05.026; Nagata N, 2014, INT J CANCER, V135, P2273, DOI 10.1002/ijc.28872; Nagata N, 2014, J CLIN GASTROENTEROL, DOI [10.1097/MCG.0000000000000267, DOI 10.1097/MCG.0000000000000267]; Park CJ, 2007, DIS COLON RECTUM, V50, P232, DOI 10.1007/s10350-006-0753-5; Patel P, 2013, J OBES, V2013, DOI DOI 10.1155/2013/489187; Tordjman J, 2012, J HEPATOL, V56, P1152, DOI 10.1016/j.jhep.2011.12.015; Wang Wei, 2012, Zhonghua Nei Ke Za Zhi, V51, P769; Webber BJ, 2012, JAMA-J AM MED ASSOC, V308, P2577, DOI 10.1001/jama.2012.70830	32	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0163-2116	1573-2568		DIGEST DIS SCI	Dig. Dis. Sci.	JUL	2015	60	7					2104	2111		10.1007/s10620-015-3555-6		8	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CK2DT	WOS:000356021500031		
J	Fukuyama, T; Takahashi, Y; Kubota, Y; Mogami, Y; Imai, K; Kondo, Y; Sakuma, H; Tominaga, K; Oguni, H; Nishimura, S				Fukuyama, Tetsuhiro; Takahashi, Yukitoshi; Kubota, Yuko; Mogami, Yukiko; Imai, Katsumi; Kondo, Yoshiyuki; Sakuma, Hiroshi; Tominaga, Koji; Oguni, Hirokazu; Nishimura, Shigeko			Semi-quantitative analyses of antibodies to N-methyl-D-aspartate type glutamate receptor subunits (GluN2B & GluN1) in the clinical course of Rasmussen syndrome	EPILEPSY RESEARCH			English	Article						Rasmussen syndrome; Antibodies; Cerebrospinal fluid; NMDA type glutamate receptor; ELISA	EPILEPSIA PARTIALIS CONTINUA; NMDA-RECEPTOR; CHRONIC ENCEPHALITIS; GRANZYME-B; T-CELLS; AUTOANTIBODIES; GLUR3; GLUR-EPSILON-2; AUTOIMMUNITY; DIAGNOSIS	Objective: In Rasmussen syndrome (RS), in addition to the predominant involvement of cytotoxic T cells, heterogeneous autoantibodies against neural molecules are also found, but their function has not been elucidated. We examined antibodies to N-methyl-D-aspartate (NMDA) type glutamate receptor (GluR) subunits (GluN2B & GluN1) semi-quantitatively in cerebrospinal fluid (CSF) samples from RS patients, and evaluated their changes over time and their roles in immunopathogenesis. Methods: Autoantibodies against N-terminal and C-terminal of GluN2B and GluN1 were examined in 40 CSF samples collected from 18 RS patients 5 to 180 months after the onset of RS. Epileptic patients without infectious etiology or progressive clinical course served as disease controls (n= 23). Synthesized peptides encoding the extracellular and intracellular domains of human GluN2B and GluN1 subunits were used as antigens in ELISA. We defined the cut-off for these antibodies as mean +2 standard deviations (optimal density) of the disease controls. MRI were evaluated according to the MRI staging proposed by Bien et al. (2002b, Neurology 58, 250). Results: CSF levels of antibodies against N-terminal and C-terminal of GluN2B were higher in RS patients than in disease controls (p< 0.01). Likewise, CSF levels of antibodies against N-terminal and C-terminal of GluN1 were also higher in RS patients than in disease controls (p< 0.01). All four antibodies tested were below cut-off levels in almost all CSF samples collected within one year from epilepsy onset. The proportions of CSF samples with these antibodies above cut-off levels were highest from 12 to 23 months after epilepsy onset, and declined after 24 months. CSF levels of these antibodies were higher when seizure occurred daily than when seizure occurred less frequently (p< 0.01), and were higher at MRI stage 3 than at MRI stages 0, 2 and 4 (p< 0.05), except for anti-GluN1-CT antibody at stage 2. Conclusions: Broad epitope recognition spectrum and delayed production of autoantibodies to NMDA type GluR in CSF of RS patients suggest that the autoantibodies are produced against NMDA type GluR antigens derived from cytotoxic T cell-mediated neuronal damages. These antibodies may impact the pathophysiology of RS in the most active stage, and could be a marker for active inflammation in the clinical course of RS. Further studies including passive transfer of the antibodies to mice may reveal the pivotal roles of the antibodies in RS. (C) 2015 Elsevier B.V. All rights reserved.	[Fukuyama, Tetsuhiro; Takahashi, Yukitoshi; Kubota, Yuko; Mogami, Yukiko; Imai, Katsumi; Nishimura, Shigeko] Shizuoka Inst Epilepsy & Neurol Disorders, Natl Epilepsy Ctr, Shizuoka, Japan; [Takahashi, Yukitoshi] Gifu Univ, Sch Med, Dept Pediat, Gifu 500, Japan; [Takahashi, Yukitoshi] Univ Shizuoka, Sch Pharmaceut Sci, Shizuoka 4228526, Japan; [Kondo, Yoshiyuki; Sakuma, Hiroshi] Natl Ctr Hosp, Natl Ctr Neurol & Psychiat, Dept Child Neurol, Kodaira, Tokyo, Japan; [Tominaga, Koji] Osaka Univ, Grad Sch Med, Dept Pediat, Suita, Osaka, Japan; [Oguni, Hirokazu] Tokyo Womens Med Univ, Dept Pediat, Shinjuku Ku, Tokyo, Japan	Fukuyama, T (reprint author), Nagano Childrens Hosp, Div Neurol, 3100 Toyoshina, Azumino 3998288, Japan.	fukusukemyelin@gmail.com			Health and Labour Sciences Research Grants for Comprehensive Research on Disability Health and Welfare [21591342, 23591238, 24591537, H24-002]; Research on rare and intractable diseases; Japan Epilepsy Research Foundation	This study was funded in part by grants-in-aid for Scientific Research vertical bar no. 21591342, 23591238 and 24591537, Health and Labour Sciences Research Grants for Comprehensive Research on Disability Health and Welfare (H24-002); Research on rare and intractable diseases; and grants from The Japan Epilepsy Research Foundation.	Anderman F., 1991, CHRONIC ENCEPHALITIS, P283; Bien CG, 2002, NEUROLOGY, V58, P250; Dalmau J, 2011, LANCET NEUROL, V10, P63, DOI 10.1016/S1474-4422(10)70253-2; Bauer J, 2007, ANN NEUROL, V62, P67, DOI 10.1002/ana.21148; Hughes EG, 2010, J NEUROSCI, V30, P5866, DOI 10.1523/JNEUROSCI.0167-10.2010; RASMUSSEN T, 1958, NEUROLOGY, V8, P435; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; ROGERS SW, 1994, SCIENCE, V265, P648, DOI 10.1126/science.8036512; Niehusmann P, 2009, ARCH NEUROL-CHICAGO, V66, P458, DOI 10.1001/archneurol.2009.5; Irani SR, 2010, BRAIN, V133, P1655, DOI 10.1093/brain/awq113; Florance NR, 2009, ANN NEUROL, V66, P11, DOI 10.1002/ana.21756; Fujita K, 2012, J NEUROIMMUNOL, V251, P90, DOI 10.1016/j.jneuroim.2012.06.010; Dalmau J, 2008, LANCET NEUROL, V7, P1091, DOI 10.1016/S1474-4422(08)70224-2; Oguni H, 1992, Adv Neurol, V57, P419; Suleiman J, 2013, EPILEPSIA, V54, P2091, DOI 10.1111/epi.12405; Dalmau J, 2007, ANN NEUROL, V61, P25, DOI 10.1002/ana.21050; Takahashi Y, 2009, EPILEPSIA, V50, P1419, DOI 10.1111/j.1528-1167.2008.01977.x; Bien CG, 2002, ANN NEUROL, V51, P311, DOI 10.1002/ana.10100; Mori H, 1998, NEURON, V21, P571, DOI 10.1016/S0896-6273(00)80567-X; Bien CG, 2005, BRAIN, V128, P454, DOI 10.1093/brain/awh415; FARRELL MA, 1995, ACTA NEUROPATHOL, V89, P313; Gahring LC, 2001, J IMMUNOL, V166, P1433; Ganor Y, 2005, EPILEPSY RES, V65, P11, DOI 10.1016/j.eplepsyres.2005.03.011; RASMUSSEN T, 1978, APPL NEUROPHYSIOL, V41, P1; Takahashi Y, 2008, ANN NEUROL, V64, P110, DOI 10.1002/ana.21362; Takahashi Y, 2003, NEUROLOGY, V61, P891; Takahashi Y, 2013, BRAIN DEV-JPN, V35, P778, DOI 10.1016/j.braindev.2013.01.010; Takahashi Y, 2005, EPILEPSIA, V46, P152, DOI 10.1111/j.1528-1167.2005.01024.x; Takano S, 2011, NEUROSCI RES, V71, P294, DOI 10.1016/j.neures.2011.07.1834; Watson R, 2005, NEUROLOGY, V65, P1802, DOI 10.1212/01.wnl.0000191566.86977.04; Watson R, 2004, NEUROLOGY, V63, P43; Wiendl H, 2001, NEUROLOGY, V57, P1511; Yang R, 2000, NEURON, V28, P375, DOI 10.1016/S0896-6273(00)00118-5	33	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-1211	1872-6844		EPILEPSY RES	Epilepsy Res.	JUL	2015	113						34	43		10.1016/j.eplepsyres.2015.03.004		10	Clinical Neurology	Neurosciences & Neurology	CK3JZ	WOS:000356113700006		
J	Inoue, Y; Ohtsuka, Y				Inoue, Yushi; Ohtsuka, Yoko		STP-1 Study Grp	Long-term safety and efficacy of stiripentol for the treatment of Dravet syndrome: A multicenter, open-label study in Japan	EPILEPSY RESEARCH			English	Article						Dravet syndrome; Severe myoclonic epilepsy in infancy; Stiripentol; Long-term administration; Tolerability; Efficacy	SEVERE MYOCLONIC EPILEPSY; IN-VITRO; INFANCY; TOPIRAMATE; TRIAL; CHILDHOOD; CLOBAZAM	Background: We have previously shown the benefits of short-term add-on stiripentol therapy for Dravet syndrome inadequately controlled by clobazam and valproate in Japanese patients. We report here the outcomes of long-term stiripentol use. Methods: Patients with Dravet syndrome having >= 4 clonic/tonic-clonic seizures per 30 days while on clobazam and valproate (with or without bromide) received add-on stiripentol for 16 weeks. Those benefiting from stiripentol (50 mg/kg/day; up to 2500 mg/day) continued the therapy for additional up to 40 weeks. Responders were defined as those whose clonic/tonic-clonic seizures became <= 50% frequent as compared to baseline. Results: Of 24 patients starting stiripentol, 21 received the drug for >16 weeks and 19 completed the study. At the endpoint, the responder rate was 54%, with 2 patients remaining clonic/tonic-clonic seizure-free. Twenty-two patients experienced stiripentol-related adverse events, with two having severe ones. They included somnolence (79%), loss of appetite (67%), ataxia (58%), and elevated gamma-glutamyltransferase (38%). No adverse events led to study discontinuation, but 19 patients required dose reduction for stiripentol and/or either antiepileptic drug combined. Stiripentol dose reduction was done in 9 patients, mostly due to somnolence or loss of appetite. Conclusions: During adjunctive stiripentol use with clobazam and valproate, careful monitoring for adverse events such as somnolence and loss of appetite is recommended, and dose reduction may become needed for any of the antiepileptics. Despite the need for safety precautions, the durable responses to stiripentol for up to 56 weeks suggest that the drug is effective as an adjunct to clobazam and valproate for the treatment of Dravet syndrome. (C) 2015 Elsevier B.V. All rights reserved.	[Inoue, Yushi] Natl Epilepsy Ctr, Shizuoka Inst Epilepsy & Neurol Disorders, Aoi Ku, Shizuoka 4208688, Japan; [Ohtsuka, Yoko] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Child Neurol, Kita Ku, Okayama 7008558, Japan	Inoue, Y (reprint author), Natl Epilepsy Ctr, Shizuoka Inst Epilepsy & Neurol Disorders, Aoi Ku, Urushiyama 886, Shizuoka 4208688, Japan.	yinoue-jes@umin.net; ohtsuka@okayama-u.ac.jp			Meiji Seika Pharma Co., Ltd.; Japanese Government	This study was sponsored by Meiji Seika Pharma Co., Ltd., which controlled the whole process of the study, including the design, monitoring, collection, management and analysis of the data. These activities were supported by grant from Japanese Government, which was specifically aimed to resolve "Drug Lag" problem in Japan. We thank the Contract Research Organization (CRO) ACRONET, which helped accomplish the study.	Giraud C, 2006, DRUG METAB DISPOS, V34, P608, DOI 10.1124/dmd.105.007237; Kassai B, 2008, EPILEPSIA, V49, P343, DOI 10.1111/j.1528-1167.2007.01423x; HURST DL, 1990, EPILEPSIA, V31, P397, DOI 10.1111/j.1528-1157.1990.tb05494.x; Brunklaus A, 2012, BRAIN, V135, P2329, DOI 10.1093/brain/aws151; Thanh TN, 2002, ARCH PEDIATRIE, V9, P1120; Wirrell EC, 2013, EPILEPSIA, V54, P1595, DOI 10.1111/epi.12303; Kroll-Seger J, 2006, NEUROPEDIATRICS, V37, P325, DOI 10.1055/s-2007-964867; Chiron C, 2000, LANCET, V356, P1638, DOI 10.1016/S0140-6736(00)03157-3; Inoue Y, 2014, EPILEPSY RES, V108, P725, DOI 10.1016/j.eplepsyres.2014.02.008; Striano P, 2007, NEUROLOGY, V69, P250, DOI 10.1212/01.wnl.0000265222.24102.db; Oka E, 2006, EPILEPSIA, V47, P626, DOI 10.1111/j.1528-1167.2006.00477.x; YAKOUB M, 1992, BRAIN DEV-JPN, V14, P299; Nieto-Barrera M, 2000, SEIZURE-EUR J EPILEP, V9, P590, DOI 10.1053/seiz.2000.0466; Coppola G, 2002, EPILEPSY RES, V49, P45, DOI 10.1016/S0920-1211(02)00010-4; DIAVEY, 2014, DIAVEY POSTM SURV TR; ERNST JP, 1988, BRAIN DEV-JPN, V10, P385; Inoue Y, 2009, EPILEPSIA, V50, P2362, DOI 10.1111/j.1528-1167.2009.02179.x; OGUNI H, 1994, EPILEPSIA, V35, P1140, DOI 10.1111/j.1528-1157.1994.tb01780.x; Tran A, 1997, CLIN PHARMACOL THER, V62, P490, DOI 10.1016/S0009-9236(97)90044-8	19	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-1211	1872-6844		EPILEPSY RES	Epilepsy Res.	JUL	2015	113						90	97		10.1016/j.eplepsyres.2015.03.012		8	Clinical Neurology	Neurosciences & Neurology	CK3JZ	WOS:000356113700011		
J	Rodiek, B; Takagi, S; Ueda, T; Hauser, MJB				Rodiek, Beatrice; Takagi, Seiji; Ueda, Tetsuo; Hauser, Marcus J. B.			Patterns of cell thickness oscillations during directional migration of Physarum polycephalum	EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS			English	Article						Cell locomotion; Cell motility; Spatio-temporal patterns; Physarum polycephalum; Self-organisation; Rhythmic contraction	SLIME-MOLD; PLASMODIUM; CONTRACTION; ORGANIZATION; SHAPE; EXTENSION; MOVEMENT; DYNAMICS; NETWORK; ABSENCE	The functional relationship between the velocity of cell locomotion and intracellular spatial patterns of thickness oscillations in the acellular slime mould Physarum polycephalum was studied. The freely migrating plasmodial cells of 300-800 A mu m length were tadpole-shaped and displayed thickness oscillations along their longitudinal (body) axis. Two distinct patterns of intracellular thickness oscillations were observed in dependence on the locomotive velocity. The first mode consisted of a single travelling wave that propagated from the rear to the front of the cell. This pattern occurred when the plasmodium migrated slowly. The second mode was a multinodal standing wave that was found during events of fast propagation. Transitions between these two types of cell thickness oscillation patterns took place in narrow propagation velocity intervals. We discuss the possible mechanism leading to these patterns, which are conjectured to modulate both the intracellular pressure and the velocity of free locomotion of the cell.	[Rodiek, Beatrice; Hauser, Marcus J. B.] Univ Magdeburg, Inst Expt Phys, Abt Biophys, D-39106 Magdeburg, Germany; [Takagi, Seiji; Ueda, Tetsuo] Hokkaido Univ, Res Inst Elect Sci, Kita Ku, Sapporo, Hokkaido 0600806, Japan; [Takagi, Seiji] Future Univ Hakodate, Sch Syst Informat Sci, Hakodate, Hokkaido 0418655, Japan	Hauser, MJB (reprint author), Univ Magdeburg, Inst Expt Phys, Abt Biophys, Univ Pl 2, D-39106 Magdeburg, Germany.	marcus.hauser@ovgu.de			Alexander von Humboldt Foundation, Germany; Network Joint Research Centre for Materials and Devices, RIES, Japan	We thank Prof. Wolfgang Marwan (Institute of Biology, Otto-von-Guericke-Universitat Magdeburg) for providing plasmodia of wild-type WT31 and for fruitful discussions. We also thank Ms. Frederike Euchner for help with experiments. Financial support by the Alexander von Humboldt Foundation, Germany, and the Network Joint Research Centre for Materials and Devices, RIES, Japan is gratefully acknowledged.	Alexopoulos CA, 1996, INTRO MYCOLOGY, P145; Ueda K, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.021916; Matsumoto K, 2008, BIOPHYS J, V94, P2492, DOI 10.1529/biophysj.107.113050; Nakagaki T, 2000, BIOPHYS CHEM, V84, P195, DOI 10.1016/S0301-4622(00)00108-3; Codling EA, 2008, J R SOC INTERFACE, V5, P813, DOI 10.1098/rsif.2008.0014; MORI Y, 1986, PROTOPLASMA, V135, P31, DOI 10.1007/BF01277050; Tero A, 2010, SCIENCE, V327, P439, DOI 10.1126/science.1177894; Takagi S, 2008, PHYSICA D, V237, P420, DOI 10.1016/j.physd.2007.09.012; Baumgarten W, 2013, PHYS BIOL, V10, DOI 10.1088/1478-3975/10/2/026003; Baumgarten W, 2014, EPL-EUROPHYS LETT, V108, DOI 10.1209/0295-5075/108/50010; Baumgarten W, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.046113; Bernitt E, 2010, IFMBE PROC, V31, P1133; Bosgraaf L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005253; Driscoll MK, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/5/055001; Furth R, 1920, Z PHYS, V2, P244, DOI 10.1007/BF01328731; Guy RD, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.016310; HADER DP, 1984, PLANT CELL PHYSIOL, V25, P55; HALL RL, 1977, J MATH BIOL, V4, P327, DOI 10.1007/BF00275081; ISENBERG G, 1976, CELL TISSUE RES, V173, P495; Ito M, 2011, J PHYS SOC JPN, V80, DOI 10.1143/JPSJ.80.074801; Jeon K. W., 1973, BIOL AMOEBA; Kakiuchi Y, 2006, BIOL RHYTHM RES, V37, P137, DOI 10.1080/09291010500386618; KAMIYA N, 1988, CELL MOTIL CYTOSKEL, V10, P107, DOI 10.1002/cm.970100115; Kamiya N., 1959, PROTOPLASMIC STRE 3A, V8, P1; Kessler D, 1982, CELL BIOL PHYSARUM D, V1, P145; KOHAMA K, 1988, J BIOCHEM-TOKYO, V104, P995; Li L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002093; Li L, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/4/046006; Marwan W, 2002, PROTIST, V153, P391, DOI 10.1078/14344610260450127; MATSUMOTO K, 1988, J THEOR BIOL, V131, P175, DOI 10.1016/S0022-5193(88)80235-2; MATSUMOTO K, 1986, J THEOR BIOL, V122, P339, DOI 10.1016/S0022-5193(86)80125-4; Nakagaki T, 1996, J THEOR BIOL, V179, P261, DOI 10.1006/jtbi.1996.0065; Radszuweit M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099220; Radszuweit M, 2010, EUR PHYS J-SPEC TOP, V191, P159, DOI 10.1140/epjst/e2010-01348-2; Romanovskii Yu. M., 1995, Physics-Uspekhi, V38, DOI 10.1070/PU1995v038n05ABEH000086; SATOH H, 1985, EXP CELL RES, V156, P79, DOI 10.1016/0014-4827(85)90263-0; Takagi S, 2010, PHYSICA D, V239, P873, DOI 10.1016/j.physd.2009.06.011; TEPLOV VA, 1991, BIOSYSTEMS, V24, P269, DOI 10.1016/0303-2647(91)90046-N; Tsuda S, 2011, BIOSYSTEMS, V103, P331, DOI 10.1016/j.biosystems.2010.11.001; Ueda T., 2005, NETWORKS INTERACTING, P221; UEDA T, 1988, Protoplasma Supplementum, V1, P51; UEDA T, 1983, J GEN MICROBIOL, V129, P2475; WOHLFARTHBOTTERMANN KE, 1962, PROTOPLASMA, V54, P514, DOI 10.1007/BF01252640; WOHLFARTHBOTTERMANN KE, 1979, J EXP BIOL, V81, P15	44	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0175-7571	1432-1017		EUR BIOPHYS J BIOPHY	Eur. Biophys. J. Biophys. Lett.	JUL	2015	44	5					349	358		10.1007/s00249-015-1028-7		10	Biophysics	Biophysics	CK3VA	WOS:000356143100007		
J	Yamamoto-Ibusuki, M; Yamamoto, Y; Fujiwara, S; Sueta, A; Yamamoto, S; Hayashi, M; Tomiguchi, M; Takeshita, T; Iwase, H				Yamamoto-Ibusuki, Mutsuko; Yamamoto, Yutaka; Fujiwara, Saori; Sueta, Aiko; Yamamoto, Satoko; Hayashi, Mitsuhiro; Tomiguchi, Mai; Takeshita, Takashi; Iwase, Hirotaka			C6ORF97-ESR1 breast cancer susceptibility locus: influence on progression and survival in breast cancer patients	EUROPEAN JOURNAL OF HUMAN GENETICS			English	Article							INTERNATIONAL EXPERT CONSENSUS; GENOME-WIDE ASSOCIATION; PRIMARY THERAPY; HIGHLIGHTS; WOMEN; RISK; JAPANESE; 6Q25.1; GENES	Genome-wide association studies have identified a single-nucleotide polymorphism (SNP) to be associated with an increased risk of breast cancer. The biology of one of the susceptibility locus C6ORF-ESR1 and whether it also contributes to progression of established disease has not yet been ascertained. We examined the association of rs2046210 and its six linkage disequilibrium SNPs with clinicopathological characteristics, prognosis, and gene expression levels of ESR1 and the C6ORFs (C6ORF97: CCDC170, C6ORF211, C6ORF96: RMND1) in 344 breast cancer tissue samples and 253 corresponding samples of adjacent normal tissue. Tumor genotypes with homozygous risk alleles were more frequent than normal tissues. The tumor genotypes of rs2046210 and rs6929137 with homozygous risk alleles showed worse relapse-free survival (RFS, P = 0.038 and P = 0.031, respectively), whereas no notable associations were observed with either clinicopathological characteristics or expression of the peripheral genes. Higher C6ORF97 expression correlated with ER negativity (P < 0.0001), highly proliferative characteristics (P = 0.0005 for Ki67, P < 0.0001 for nuclear grade) and worse RFS in the ER+/HER2- cohort (P = 0.013), whereas the other two C6ORFs showed the inverse associations. Furthermore, C6ORF97 showed significant worse prognostic values especially in luminal B subtype in the publically available data sets. rs2046210 and the upstream gene C6ORF97 might have substantial roles not only in carcinogenesis but also in progression toward a more aggressive phenotype in breast cancer patients, which suggests that functional studies of this locus are imperative.	[Yamamoto-Ibusuki, Mutsuko; Yamamoto, Yutaka; Fujiwara, Saori; Sueta, Aiko; Yamamoto, Satoko; Hayashi, Mitsuhiro; Tomiguchi, Mai; Takeshita, Takashi; Iwase, Hirotaka] Kumamoto Univ, Grad Sch Med Sci, Dept Breast & Endocrine Surg, Kumamoto, Kumamoto 8608556, Japan; [Yamamoto, Yutaka; Sueta, Aiko] Kumamoto Univ, Grad Sch Med Sci, Dept Mol Targeting Therapy Breast Canc, Chuo Ku, Kumamoto, Kumamoto 8608556, Japan	Iwase, H (reprint author), Kumamoto Univ, Grad Sch Med Sci, Dept Breast & Endocrine Surg, 1-1-1 Honjo, Kumamoto, Kumamoto 8608556, Japan.	hiwase@kumamoto-u.ac.jp					Goldhirsch A, 2007, ANN ONCOL, V18, P1133, DOI 10.1093/annonc/mdm271; Sueta A, 2012, BREAST CANCER RES TR, V132, P711, DOI 10.1007/s10549-011-1904-5; Germain D, 2011, ENDOCRIN METAB CLIN, V40, P473, DOI 10.1016/j.ecl.2011.05.009; Fasching PA, 2012, HUM MOL GENET, V21, P3926, DOI 10.1093/hmg/dds159; Turnbull C, 2010, NAT GENET, V42, P504, DOI 10.1038/ng.586; Goldhirsch A, 2003, J CLIN ONCOL, V21, P3357, DOI 10.1200/JCO.2003.04.576; McShane LM, 2005, EUR J CANCER, V41, P1690, DOI 10.1016/j.ejca.2005.03.032; Horne HN, 2014, BREAST CANCER RES TR, V143, P181, DOI 10.1007/s10549-013-2771-z; Zheng W, 2013, HUM MOL GENET, V22, P2539, DOI 10.1093/hmg/ddt089; Zheng W, 2009, NAT GENET, V41, P324, DOI 10.1038/ng.318; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Goldhirsch A, 2005, ANN ONCOL, V16, P1569, DOI 10.1093/annonc/mdi326; Cai QY, 2011, CANCER RES, V71, P1344, DOI 10.1158/0008-5472.CAN-10-2733; Drury S, 2011, PLOS GENET, V7; Dunbier AK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001382; Ibusuki M, 2013, BREAST CANCER-TOKYO, V20, P159, DOI 10.1007/s12282-011-0318-x; Mizoo T, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-565; Riaz M, 2012, BREAST CANCER RES TR, V133, P843, DOI 10.1007/s10549-011-1663-3; Stacey SN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001029; Tapper W, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2213; Yang Z, 2013, BREAST CANCER RES TR, V139, P267, DOI 10.1007/s10549-013-2494-1	21	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1018-4813	1476-5438		EUR J HUM GENET	Eur. J. Hum. Genet.	JUL	2015	23	7					949	956		10.1038/ejhg.2014.219		8	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	CK4DJ	WOS:000356170700009		
J	Sakamoto, Y; Sato, S; Hama, Y; Nagatsuka, K; Minematsu, K; Toyoda, K				Sakamoto, Y.; Sato, S.; Hama, Y.; Nagatsuka, K.; Minematsu, K.; Toyoda, K.			The relationship between the pre-admission CHA(2)DS(2)-VASc score and proximal artery occlusion in patients with acute stroke and atrial fibrillation	EUROPEAN JOURNAL OF NEUROLOGY			English	Article						acute ischaemic stroke; atrial fibrillation; magnetic resonance angiography; vessel occlusion	ACUTE ISCHEMIC-STROKE; CARDIOEMBOLIC STROKE; RISK; THROMBOEMBOLISM; CHADS(2); OUTCOMES; THROMBUS; PLAQUES	Background and purposeThe CHA(2)DS(2)-VASc score is associated with severity and outcome of ischaemic stroke in patients with atrial fibrillation (AF). It was hypothesized that a high CHA(2)DS(2)-VASc score was related to severity and outcome because of its association with proximal artery occlusion (PAO). This study aimed to elucidate the relationship between the CHA(2)DS(2)-VASc score and PAO and to determine whether the effect of the CHA(2)DS(2)-VASc score on severity or outcome is independent of PAO. MethodsAcute stroke patients with AF were retrospectively enrolled. PAO was defined as occlusion at the internal carotid artery or proximal middle cerebral artery on admission magnetic resonance angiography. Multivariable analyses were performed to identify independent factors associated with PAO and determine the associations of the CHA(2)DS(2)-VASc score with the initial National Institutes of Health Stroke Scale (NIHSS) score and poor functional outcome (discharge modified Rankin scale score 4-6). ResultsIn all, 213 patients [102 women; median age 80 (interquartile range 71-86)years; NIHSS score 16 (9-22)] were enrolled. On multivariable analysis, the CHA(2)DS(2)-VASc score (odds ratio 1.40, 95% confidence interval 1.12-1.76 per 1 point) was independently associated with PAO and correlated with the initial NIHSS score (standardized coefficient 0.198, P=0.017). This association was not significant after further adjustment for PAO (0.080, P=0.241). The CHA(2)DS(2)-VASc score was independently related to poor outcome even adjusted for PAO (odds ratio 1.39, 95% confidence interval 1.03-1.88). ConclusionThe CHA(2)DS(2)-VASc score was associated with PAO in acute ischaemic stroke patients with AF. The CHA(2)DS(2)-VASc score may be correlated with the NIHSS score through the presence of PAO and with poor functional outcome independently of PAO.	[Sakamoto, Y.; Sato, S.; Hama, Y.; Minematsu, K.; Toyoda, K.] Natl Cerebral & Cardiovasc Ctr, Dept Cerebrovasc Med, Suita, Osaka 5658565, Japan; [Nagatsuka, K.] Natl Cerebral & Cardiovasc Ctr, Dept Neurol, Suita, Osaka 5658565, Japan	Toyoda, K (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Cerebrovasc Med, 5-7-1 Fujishirodai, Suita, Osaka 5658565, Japan.	toyoda@ncvc.go.jp	Toyoda, Kazunori/J-3828-2015	Toyoda, Kazunori/0000-0002-8346-9845	Intramural Research Fund for Cardiovascular Diseases of the National Cerebral and Cardiovascular Center [H24-6-30]; Ministry of Health, Labour and Welfare, Japan [H23-Junkanki-Ippan-010, H24-Junkanki-Ippan-011]	This study was supported in part by an Intramural Research Fund (H24-6-30) for Cardiovascular Diseases of the National Cerebral and Cardiovascular Center and Grants-in-Aid (H23-Junkanki-Ippan-010 and H24-Junkanki-Ippan-011) from the Ministry of Health, Labour and Welfare, Japan.	Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; VANSWIETEN JC, 1988, STROKE, V19, P604; Ntaios G, 2013, NEUROLOGY, V80, P1009, DOI 10.1212/WNL.0b013e318287281b; Dorenkamp M, 2013, INT J CARDIOL, V163, P26, DOI 10.1016/j.ijcard.2011.06.124; Tomii Y, 2011, STROKE, V42, P3511, DOI 10.1161/STROKEAHA.111.628586; Fischer U, 2005, STROKE, V36, P2121, DOI 10.1161/01.STR.0000182099.04994.fc; Smith WS, 2009, STROKE, V40, P3834, DOI 10.1161/STROKEAHA.109.561787; Camm AJ, 2010, EUR HEART J, V31, P2369, DOI 10.1093/eurheartj/ehq278; Sato S, 2011, J NEUROL SCI, V307, P149, DOI 10.1016/j.jns.2011.04.018; Providencia R, 2012, EUROPACE, V14, P36, DOI 10.1093/europace/eur272; Hirano T, 2010, STROKE, V41, P2828, DOI 10.1161/STROKEAHA.110.594333; Starr ME, 2010, BLOOD, V115, P4886, DOI 10.1182/blood-2009-10-246678; Hong HJ, 2012, EUR J NEUROL, V19, P284, DOI 10.1111/j.1468-1331.2011.03518.x; Ren JF, 2005, J CARDIOVASC ELECTR, V16, P474, DOI 10.1111/j.1540-8167.2005.40465.x; Zabalgoitia M, 1998, ANN INTERN MED, V128, P639; Doust JA, 2004, ARCH INTERN MED, V164, P1978, DOI 10.1001/archinte.164.18.1978; Park JH, 2011, EUROPACE, V13, P1541, DOI 10.1093/europace/eur135; Molina CA, 2001, STROKE, V32, P1079; Deguchi I, 2013, J STROKE CEREBROVASC, V22, pE343, DOI 10.1016/j.jstrokecerebrovasdis.2013.02.018; Feinberg WM, 1999, THROMB HAEMOSTASIS, V82, P100; Giralt-Steinhauer E, 2012, J NEUROL, V259, P745, DOI 10.1007/s00415-011-6259-7; Kuwashiro T, 2010, CEREBROVASC DIS, V29, P290, DOI 10.1159/000275506; Sakamoto Y, 2014, J STROKE CEREBROVASC, V23, P799, DOI 10.1016/j.jstrokecerebrovasdis.2013.07.002; Tu HTH, 2013, CEREBROVASC DIS, V36, P273, DOI 10.1159/000353670; Yoshimura S, 2010, J NEUROL NEUROSUR PS, V81, P1306, DOI 10.1136/jnnp.2009.198606	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1351-5101	1468-1331		EUR J NEUROL	Eur. J. Neurol.	JUL	2015	22	7					1081	1087		10.1111/ene.12711		7	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CK3BP	WOS:000356090800011		
J	Sakaguchi, M; Kitagawa, K; Okazaki, S; Yoshioka, D; Sakata, Y; Mochizuki, H; Sawa, Y; Yoshimine, T				Sakaguchi, M.; Kitagawa, K.; Okazaki, S.; Yoshioka, D.; Sakata, Y.; Mochizuki, H.; Sawa, Y.; Yoshimine, T.			Sulcus subarachnoid hemorrhage is a common stroke subtype in patients with implanted left ventricular assist devices	EUROPEAN JOURNAL OF NEUROLOGY			English	Article						computed tomography; infarction; left ventricular assist devices; sulcus subarachnoid hemorrhage	HEART-FAILURE; CONVEXITY; SUPPORT	Background and purposeStroke is one of the major complications observed in patients with an implanted left ventricular assist device (LVAD). The purpose of this study was to clarify the types and characteristics of acute stroke in patients after LVAD implantation by using brain computed tomography (CT) findings. MethodsBetween 2005 and 2012, 110 consecutive patients who underwent LVAD implantation were reviewed. The most commonly used device was the pulsatile extracorporeal LVAD. Amongst them, 49 patients suffered from acute stroke at least once with a total of 115 stroke events. The clinical categories, lesion sites, laboratory data and CT findings of each acute stroke event were analyzed. ResultsCerebral infarction (35 patients, 72 events), cerebral hemorrhage (25 patients, 31 events) and subarachnoid hemorrhage (SAH) (23 patients, 33 events) were identified. A mean of 2.3 stroke events occurred per person. Of the 72 infarction events, multiple infarctions were observed in 29 events. Of the cerebral hemorrhage events (n=31), almost all were subcortical lesions (n=27) and none were observed in the basal ganglia. Of the 23 patients with SAH events (n=33), SAH localized within a single sulcus, sulcus SAH, was observed in 25 events. ConclusionsComputed tomography findings of acute stroke after implantation of an LVAD are characteristically multifocal cortical lesions, regardless of brain infarction and hemorrhage. Unexpectedly, sulcus SAH was a common stroke subtype in patients with implanted LVADs. Sulcus SAH should be carefully examined in patients after LVAD implantation, when they complain of non-specific neurological complaints.	[Sakaguchi, M.; Okazaki, S.; Mochizuki, H.; Yoshimine, T.] Osaka Univ, Grad Sch Med, Stroke Ctr, Suita, Osaka 5650871, Japan; [Sakaguchi, M.; Okazaki, S.; Mochizuki, H.] Osaka Univ, Grad Sch Med, Dept Neurol, Suita, Osaka 5650871, Japan; [Kitagawa, K.] Tokyo Womens Med Univ, Dept Neurol, Tokyo 1628666, Japan; [Yoshioka, D.; Sawa, Y.] Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, Suita, Osaka 5650871, Japan; [Sakata, Y.] Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Suita, Osaka 5650871, Japan; [Yoshimine, T.] Osaka Univ, Grad Sch Med, Dept Neurosurg, Suita, Osaka 5650871, Japan	Sakaguchi, M (reprint author), Osaka Univ, Grad Sch Med, Dept Neurol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	sakaguti@neurol.med.osaka-u.ac.jp; kkitagawa@nij.twmu.ac.jp					Rose EA, 2001, NEW ENGL J MED, V345, P1435, DOI 10.1056/NEJMoa012175; Khurram A, 2014, STROKE, V45, P1151, DOI 10.1161/STROKEAHA.113.004298; Nakajima I, 2011, CIRC J, V75, P1138, DOI 10.1253/circj.CJ-10-0986; Cuvinciuc V, 2010, AM J NEURORADIOL, V31, P1355, DOI 10.3174/ajnr.A1986; Martini SR, 2012, NEUROLOGY, V79, P2275, DOI 10.1212/WNL.0b013e318276896f; Saito S, 2010, CIRC J, V74, P715, DOI 10.1253/circj.CJ-09-0747; Stehlik J, 2011, J HEART LUNG TRANSPL, V30, P1078, DOI 10.1016/j.healun.2011.08.003; Kumar S, 2010, NEUROLOGY, V74, P893, DOI 10.1212/WNL.0b013e3181d55efa; Backes D, 2012, EUR J CARDIO-THORAC, V42, P612, DOI 10.1093/ejcts/ezs320; Bruno VA, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0338-3; Geraldes R, 2013, J STROKE CEREBROVASC, V23, pe23; Izenberg A, 2009, STROKE, V40, P3725, DOI 10.1161/STROKEAHA.109.557009; Kato TS, 2012, STROKE, V43, P872, DOI 10.1161/STROKEAHA.111.639682; Lazar RM, 2004, CIRCULATION, V109, P2423, DOI 10.1161/01.CIR.0000129414.95137.CD; Renou P, 2012, CEREBROVASC DIS, V34, P147, DOI 10.1159/000339685; Sayer G, 2009, CARDIOVASC THER, V27, P140, DOI 10.1111/j.1755-5922.2009.00081.x; Slaughter MS, 2009, NEW ENGL J MED, V361, P2241, DOI 10.1056/NEJMoa0909938; Tsukui H, 2007, J THORAC CARDIOV SUR, V134, P114, DOI 10.1016/j.jtcvs.2007.02.044; WHISNANT J P, 1990, Stroke, V21, P637; Yoon CW, 2012, J THROMB HAEMOST, V10, P2394, DOI 10.1111/j.1538-7836.2012.04909.x	20	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1351-5101	1468-1331		EUR J NEUROL	Eur. J. Neurol.	JUL	2015	22	7					1088	1093		10.1111/ene.12712		6	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CK3BP	WOS:000356090800012		
J	Watts, GF; Gidding, S; Wierzbicki, AS; Toth, PP; Alonso, R; Brown, WV; Bruckert, E; Defesche, J; Lin, KK; Livingston, M; Mata, P; Parhofer, KG; Raal, FJ; Santos, RD; Sijbrands, EJG; Simpson, WG; Sullivan, DR; Susekov, AV; Tomlinson, B; Wiegman, A; Yamashita, S; Kastelein, JJP				Watts, Gerald F.; Gidding, Samuel; Wierzbicki, Anthony S.; Toth, Peter P.; Alonso, Rodrigo; Brown, W. Virgil; Bruckert, Eric; Defesche, Joep; Lin, Khoo Kah; Livingston, Michael; Mata, Pedro; Parhofer, Klaus G.; Raal, Frederick J.; Santos, Raul D.; Sijbrands, Eric J. G.; Simpson, William G.; Sullivan, David R.; Susekov, Andrey V.; Tomlinson, Brian; Wiegman, Albert; Yamashita, Shizuya; Kastelein, John J. P.			Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation	EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY			English	Article						Familial hypercholesterolaemia; international guidance; adults; children; screening; diagnosis; assessment; treatment; models of care	ASSOCIATION EXPERT PANEL; MANAGEMENT; GUIDELINES; RECOMMENDATIONS; DIAGNOSIS	Familial hypercholesterolaemia (FH) is a dominantly inherited disorder present from birth that markedly elevates plasma low-density lipoprotein (LDL) cholesterol and causes premature coronary heart disease. There are at least 20 million people with FH worldwide, but the majority remains undetected and current treatment is often suboptimal. To address this major gap in coronary prevention we present, from an international perspective, consensus-based guidance on the care of FH. The guidance was generated from seminars and workshops held at an international symposium. The recommendations focus on the detection, diagnosis, assessment and management of FH in adults and children, and set guidelines for clinical purposes. They also refer to best practice for cascade screening and risk notifying and testing families for FH, including use of genetic testing. Guidance on treatment is based on risk stratification, management of non-cholesterol risk factors and safe and effective use of LDL lowering therapies. Recommendations are given on lipoprotein apheresis. The use of emerging therapies for FH is also foreshadowed. This international guidance acknowledges evidence gaps, but aims to make the best use of contemporary practice and technology to achieve the best outcomes for the care of FH. It should accordingly be employed to inform clinical judgment and be adjusted for country-specific and local healthcare needs and resources.	[Watts, Gerald F.] Univ Western Australia, Sch Med & Pharmacol, Royal Perth Hosp, Cardiometab Serv, Perth, WA 6847, Australia; [Gidding, Samuel] Alfred I DuPont Hosp Children, Nemours Cardiac Nemours Cardiac Ctr, Div Cardiol, Wilmington, DE 19803 USA; [Gidding, Samuel] Thomas Jefferson Univ, Jefferson Med Coll, Philadelphia, PA 19107 USA; [Wierzbicki, Anthony S.] NHS Fdn Trust, Guys & St Thomas Hosp, London, England; [Toth, Peter P.] Univ Illinois, Coll Med, CGH Med Ctr, Peoria, IL 61656 USA; [Toth, Peter P.] Illinois Michigan State Univ, Coll Osteopath Med, E Lansing, MI USA; [Alonso, Rodrigo] Fdn Jimenez Diaz, Lipid Clin, E-28040 Madrid, Spain; [Brown, W. Virgil] Emory Univ, Sch Med, Atlanta, GA USA; [Bruckert, Eric] Univ Paris 06, Hop La Pitie Salpetriere, F-75252 Paris 05, France; [Defesche, Joep] Univ Amsterdam, Acad Med Ctr, Lab Expt Vasc Med, Sect Mol Diagnost, NL-1012 WX Amsterdam, Netherlands; [Lin, Khoo Kah] Heart Fdn Malaysia, Pontai Med Ctr, Kuala Lumpur, Malaysia; [Livingston, Michael] Int FH Fdn, St Andrews Court, Thame, England; [Mata, Pedro] Fdn Hipercolesterolemia Familiar, Madrid, Spain; [Parhofer, Klaus G.] Univ Munich, Div Endocrinol & Metab, Munich, Germany; [Raal, Frederick J.] Univ Witwatersrand, Fac Hlth Sci, Carbohydrate & Lipid Metab Res Unit, Johannesburg, South Africa; [Santos, Raul D.] Univ Sao Paulo, Sch Med, Lipid Clin Heart Inst InCor, BR-05508 Sao Paulo, Brazil; [Sijbrands, Eric J. G.] Erasmus Univ, Erasmus Med Ctr, Sect Pharmacol Vasc & Metab Dis, Rotterdam, Netherlands; [Simpson, William G.] Univ Aberdeen, Aberdeen Royal Infirm, Aberdeen AB9 1FX, Scotland; [Sullivan, David R.] Univ Sydney, Royal Prince Alfred Hosp, Lipid Clin, Sydney, NSW 2006, Australia; [Susekov, Andrey V.] Minist Hlth Russian Federat, Lab Clin Lipidol, Moscow, Russia; [Tomlinson, Brian] Chinese Univ Hong Kong, Prince Wales Hosp, Div Clin Pharmacol, Hong Kong, Hong Kong, Peoples R China; [Wiegman, Albert; Kastelein, John J. P.] Univ Amsterdam, Acad Med Ctr, NL-1012 WX Amsterdam, Netherlands; [Yamashita, Shizuya] Osaka Univ, Grad Sch Med, Suita, Osaka 565, Japan	Watts, GF (reprint author), Univ Western Australia, Sch Med & Pharmacol, Royal Perth Hosp, Cardiometab Serv,Dept Internal Med, GPO Box X2213, Perth, WA 6847, Australia.	gerald.watts@uwa.edu.au	Santos, Raul/A-1170-2010; Tomlinson, Brian/P-5365-2015	Santos, Raul/0000-0002-9860-6582; 	Abbrie; Abbott; Aegerion; Alnylam Pharma; Atherotech; Amarin Pharma; Amgen; AMT; Astra Zeneca; Astellas; AtheroNova Inc.; Bayer Yakuhin; Biolab; Boehringer Ingelheim; Bristol-Myers Squibb; Catabasis Pharma; Cedus; Cerenis Therapeutics SA; CSL Behring LLC; Danone; Dezima; Eli Lilly; Forbion Capital Partners Inc.; Gedeon-Richter; Genentech; Genfit; Genzyme; Glaxo-Wellcome; GlaxoSmithKline; Hoffman-La Roche; Isis Pharma; INC Research LLC; Janssen; Kaken Pharma; Kinemed; Kissei Pharma; Kowa; Kyowa Medex; Lilly; Liposcience; LPS Advisor Inc.; Medpace Inc.; Menarini; Merck Seron; Merck Sharp Dohme; Mochida Pharma; Novartis; Omthera Pharma; Ono Pharma; Otsuka; Pfizer; Pronova Biopharma Norge A.S.; Ranbaxy; Randox; Regeneron Pharma; Resverlogix; Roche; Sanofi; Servier; Siemens; Shionogi; Sticares Cardiovascular Research Foundation; Synexus Ltd; Takeda; Teijin; Vascular Research Network; Medicines Company; UniQure Inc.; Vascular BioGenics Ltd; Xenon Pharma	Some members of the Group have received lecture honoraria, consultancy fees, and/or research funding from: Abbrie (PPT); Abbott (GFW, KKL, KGP, RDS, AVS, BT); Aegerion (WVB, EB, ML, PM, KGP, RDS, JK); Alnylam Pharma (JK); Atherotech (PPT); Amarin Pharma (GFW, PPT, AVS, JK); Amgen (GFW, PPT, WVB, EB, KGP, FJR, RDS, DRS, AVS, BT, JK); AMT (EB); Astra Zeneca (GFW, PPT, WVB, EB, JD, KKL, FJR, RDS, WGS, DRS, AVS, BT, SY, EJGS; JK); Astellas (SY); AtheroNova Inc. (JK); Bayer Yakuhin (SY); Biolab (RDS); Boehringer Ingelheim (KGP, EJGS, BT, SY, JK); Bristol-Myers Squibb (WVB, KGP, RDS, BT, JK); Catabasis Pharma (WVB, JK); Cedus (EB); Cerenis Therapeutics SA (WVB, JK); CSL Behring LLC (JK); Danone (EB); Dezima (JK); Eli Lilly (JK); Forbion Capital Partners Inc. (JK); Gedeon-Richter (AVS); Genentech (JK); Genfit (GFW, EB); Genzyme (GFW, PPT, RA, WVB, EB, ML, KGP, FJR, RDS, EJGS, WGS, AVS, BT, JK); Glaxo-Wellcome (WVB); GlaxoSmithKline (SG, EB, BT); Hoffman-La Roche (AW, JK); Isis Pharma (FJR, RDS, JK); INC Research LLC (JK); Janssen (BT); Kaken Pharma (SY); Kinemed (JK); Kissei Pharma (SY); Kowa (GFW, KGP, PPT, SY); Kyowa Medex (SY); Lilly (RDS); Liposcience (PPT, WVB); LPS Advisor Inc. (JK); Medpace Inc. (JK); Menarini (WGS); Merck Seron (BT); Merck Sharp & Dohme (GFW, SG, RA, WVB, KKL, KGP, FJR, RDS, EJGS, WGS, DRS, AVS, BT, SY, JK); Mochida Pharma (SY); Novartis (GFW, EB, KKL, KGP, AVS, BT, JK); Omthera Pharma (AVS, JK); Ono Pharma (SY); Otsuka (SY); Pfizer (WVB, KKL, KGP, FJR, RDS, EJGS, DRS, AVS, SY, JK); Pronova Biopharma Norge A.S. (JK); Ranbaxy (BT); Randox (WGS); Regeneron Pharma (ML, JD, JK); Resverlogix (JK); Roche (GFW, EB, KGP, WGS, DRS, BT); Sanofi (GFW, RA, WVB, EB, KKL, ML, PM, KGP, FJR, RDS, DRS, AVS, JK); Servier (BT); Siemens (WGS); Shionogi (SY); Sticares Cardiovascular Research Foundation (JK); Synexus Ltd (JK); Takeda (BT, SY); Teijin (SY); Vascular Research Network (JD); The Medicines Company (JK); UniQure Inc. (JK); Vascular BioGenics Ltd (JK); Xenon Pharma (JK).	Nordestgaard BG, 2013, EUR HEART J, V34, P3478, DOI 10.1093/eurheartj/eht273; Kusters DM, 2012, ARCH DIS CHILD, V97, P272, DOI 10.1136/archdischild-2011-300081; Civeira F, 2004, ATHEROSCLEROSIS, V173, P55, DOI 10.1016/j.atherosclerosis.2003.11.010; Goldberg AC, 2011, J CLIN LIPIDOL, V5, P133, DOI 10.1016/j.jacl.2011.03.001; Descamps OS, 2011, ATHEROSCLEROSIS, V218, P272, DOI 10.1016/j.atherosclerosis.2011.06.016; Reiner Z, 2011, EUR HEART J, V32, P1769, DOI 10.1093/eurheartj/ehr158; Daniels SR, 2011, J CLIN LIPIDOL, V5, pS30, DOI 10.1016/j.jacl.2011.03.453; Watts GF, 2011, ATHEROSCLEROSIS SUPP, V12, P221, DOI 10.1016/j.atherosclerosissup.2011.06.001; Harada-Shiba M, 2012, J ATHEROSCLER THROMB, V19, P1043; Grundy SM, 2013, J CLIN LIPIDOL, V7, P561, DOI 10.1016/j.jacl.2013.10.001; Grundy SM, 2002, CIRCULATION, V106, P3143; Santos RD, 2012, ARQ BRAS CARDIOL, V99, P1, DOI 10.5935/abc.20120202; Stone NJ, 2013, CIRCULATION, V129, pS1, DOI DOI 10.1161/01.CIR.0000437738.63853.7A	13	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	2047-4873	2047-4881		EUR J PREV CARDIOL	Eur. J. Prev. Cardiol.	JUL	2015	22	7					849	854		10.1177/2047487314533218		6	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CJ8PE	WOS:000355764600004		
J	Deng, N; Kuwabara, T; Korkolis, YP				Deng, N.; Kuwabara, T.; Korkolis, Y. P.			Cruciform Specimen Design and Verification for Constitutive Identification of Anisotropic Sheets	EXPERIMENTAL MECHANICS			English	Article						Anisotropy; Sheet metal; Multiaxial testing; Cruciform specimen	BIAXIAL TENSILE TEST; HIGH-STRENGTH STEEL; SUBSEQUENT YIELD SURFACE; SHAPED SPECIMENS; METAL SHEETS; BEHAVIOR; TUBES; DEFORMATION; TEMPERATURE; PRESSURE	A novel cruciform specimen design is proposed, which is a composite of existing specimens. The typical shortcomings of many existing designs are that the strains achievable in the test-section before failure are very limited and the stresses in the test-section cannot be easily determined from experimental measurements, or without the use of an inverse finite element analysis. The proposed specimen overcomes both of these difficulties. The proposed geometry features slotted arms; very tight corner radii; a test-section of reduced thickness; and a sharp transition between the arms and the test-section. This new geometry is investigated numerically, at first. It is shown that the stress and strain distributions in the test-section are very uniform, with the exception of a thin outer boundary-layer. This implies that the strains can be measured anywhere in the test-section (except at the boundary-layer) without significant impact on the results. Subsequently, a virtual biaxial experiment is described. Two materials (steel 1018 and aluminum Al-2090-T3) are considered, each with an appropriate material model (Hill 1948 and Yld2004-3D, respectively). In both cases, the proposed specimen identifies the material model very accurately, using only the load cell readings and strains measured within the test-section. Finally, the proposed specimen is used in biaxial experiments to identify an appropriate material model for the dual-phase steel DP 590. It is shown that the Yld2004-3D model captures the material behavior up to almost 10 % strain; however the coefficients of this model should evolve with plastic deformation, for best fitting performance. During the course of the experimental study, the uniformity of the strain fields is assessed using the Digital Image Correlation method.	[Deng, N.; Korkolis, Y. P.] Univ New Hampshire, Dept Mech Engn, Durham, NH 03824 USA; [Kuwabara, T.] Tokyo Univ Agr & Technol, Dept Mech Syst Engn, Koganei, Tokyo, Japan	Korkolis, YP (reprint author), Univ New Hampshire, Dept Mech Engn, 33 Acad Way, Durham, NH 03824 USA.	yannis.korkolis@unh.edu	Kuwabara, Toshihiko/K-7175-2012	Kuwabara, Toshihiko/0000-0002-9550-6762	U.S. National Science Foundation [CMMI-1031169]; U.S. National Science Foundation (Office of International Science and Engineering)	The support of the U.S. National Science Foundation (Grant CMMI-1031169 and the Office of International Science and Engineering) is acknowledged with thanks. We also thank Stephen Racca and Vojtech Kubec (University of New Hampshire) for their help in machining the specimens and Tomoyuki Hakoyama and Junpei Kawaguchi (Tokyo University of Agriculture and Technology) for their help with the biaxial experiments and the Digital Image Correlation. Thanks are also due to Dr. Ming Shi of U.S. Steel for providing the DP590 sheets.	Abu-Farha F, 2009, JOM-US, V61, P48, DOI 10.1007/s11837-009-0121-8; Andar MO, 2010, ISIJ INT, V50, P613, DOI 10.2355/isijinternational.50.613; [Anonymous], 2014, 16842 ISO; Naka T, 2003, J MATER PROCESS TECH, V140, P494, DOI 10.1016/S0924-0136(03)00780-5; Kuwabara T, 1998, J MATER PROCESS TECH, V80-1, P517, DOI 10.1016/S0924-0136(98)00155-1; Kuwabara T, 2007, INT J PLASTICITY, V23, P385, DOI 10.1016/j.ijplas.2006.06.003; Barlat F, 2005, INT J PLASTICITY, V21, P1009, DOI 10.1016/j.ijplas.2004.06.004; Yoon JW, 2006, INT J PLASTICITY, V22, P174, DOI 10.1016/j.ijplas.2005.03.013; Haltom SS, 2013, INT J SOLIDS STRUCT, V50, P1507, DOI 10.1016/j.ijsolstr.2012.12.009; Hannon A, 2008, J MATER PROCESS TECH, V198, P1, DOI 10.1016/j.jmatprotec.2007.10.015; Hanabusa Y, 2013, J MATER PROCESS TECH, V213, P961, DOI 10.1016/j.jmatprotec.2012.12.007; Hanabusa Y, 2010, STEEL RES INT, V81, P1376; ARCAN M, 1978, EXP MECH, V18, P141, DOI 10.1007/BF02324146; HILL R, 1994, INT J SOLIDS STRUCT, V31, P2999, DOI 10.1016/0020-7683(94)90065-5; Yu Y, 2002, J MATER PROCESS TECH, V123, P67, DOI 10.1016/S0924-0136(02)00062-6; MAKINDE A, 1992, EXP MECH, V32, P138, DOI 10.1007/BF02324725; Kulawinski D, 2011, ENG FRACT MECH, V78, P1684, DOI 10.1016/j.engfracmech.2011.02.021; Kuwabara T, 2000, ACTA MATER, V48, P2071, DOI 10.1016/S1359-6454(00)00048-3; Korkolis YP, 2009, INT J PLASTICITY, V25, P2059, DOI 10.1016/j.ijplas.2008.12.016; Korkolis YP, 2008, INT J PLASTICITY, V24, P509, DOI 10.1016/j.ijplas.2007.07.010; Muller W, 1996, J MATER PROCESS TECH, V60, P643, DOI 10.1016/0924-0136(96)02399-0; Kuwabara T, 2005, INT J PLASTICITY, V21, P101, DOI 10.1016/j.ijplas.2004.04.006; Kuwabara T, 2002, ACTA MATER, V50, P3717, DOI 10.1016/S1359-6454(02)00184-2; Green DE, 2004, INT J PLASTICITY, V20, P1677, DOI 10.1016/j.ijplas.2003.11.012; Kuwabara T, 2013, INT J PLASTICITY, V45, P103, DOI 10.1016/j.ijplas.2012.12.003; Banabic D, 2010, SHEET METAL FORMING PROCESSES: CONSTITUTIVE MODELLING AND NUMERICAL SIMULATION, P1, DOI 10.1007/978-3-540-88113-1; BOEHLER JP, 1994, EXP MECH, V34, P1, DOI 10.1007/BF02328435; Borsutzki M, 2002, WERKST 2002 P DVM C, P186; Cakmak UD, 2014, EXP MECH, V54, P653, DOI 10.1007/s11340-013-9820-8; DEMMERLE S, 1993, J MECH PHYS SOLIDS, V41, P143, DOI 10.1016/0022-5096(93)90067-P; FERRON G, 1988, J TEST EVAL, V16, P253; Gozzi J, 2005, EXP MECH, V45, P533, DOI [10.1177/0014485105059554, 10.1007/BF02427907]; Guelon T, 2009, POLYM TEST, V28, P715, DOI 10.1016/j.polymertesting.2009.06.001; Hill R, 1992, J APPL MECH ASME, V59, P1; Hoferlin E, 2000, MODEL SIMUL MATER SC, V8, P423, DOI 10.1088/0965-0393/8/4/302; Korkolis YP, 2010, ASME J APPL MECH, V77, P64501; Korkolis YP, NONLINEAR UNLOADING; Kressig R., 1986, ACTA MECH, V65, P169; Kuwabara T, 2014, COMPREHENSIVE MAT PR, V1, P95; Kuwabara T, 2002, TETSU TO HAGANE, V88, P334; LIN SB, 1995, INT J PLASTICITY, V11, P583, DOI 10.1016/S0749-6419(94)00024-7; Merklein M, 2013, J MATER PROCESS TECH, V213, P939, DOI 10.1016/j.jmatprotec.2012.12.005; Mohr D, 2008, EXP MECH, V48, P65, DOI 10.1007/s11340-007-9053-9; Moondra S, 2004, TRANSACTIONS OF THE NORTH AMERICAN MANUFACTURING RESEARCH INSTITUTION OF SME, VOL 32, 2004, P247; Rousselier G, 2009, INT J MATER FORM, V2, P367, DOI 10.1007/s12289-009-0423-y; SHIRATOR.E, 1968, J MECH PHYS SOLIDS, V16, P373, DOI 10.1016/0022-5096(68)90002-1; Tasan CC, 2008, P 2008 SEM 11 INT C, P2; Walters CL, 2013, EXP MECH, V53, P1647, DOI 10.1007/s11340-013-9754-1; Wilson JF, 2013, SME J MANUF PROCESS, V15, P580; Zhao X, 2014, EXP MECH, V54, P343, DOI 10.1007/s11340-013-9808-4	50	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0014-4851	1741-2765		EXP MECH	Exp. Mech.	JUL	2015	55	6					1005	1022		10.1007/s11340-015-9999-y		18	Materials Science, Multidisciplinary; Mechanics; Materials Science, Characterization & Testing	Materials Science; Mechanics	CJ6RT	WOS:000355622000001		
J	Takahashi, Y; Arai, S; Yamamoto, Y; Higuchi, K; Kondo, H; Kitagawa, Y; Muto, S; Tanaka, N				Takahashi, Y.; Arai, S.; Yamamoto, Y.; Higuchi, K.; Kondo, H.; Kitagawa, Y.; Muto, S.; Tanaka, N.			Evaluation of Interfacial Fracture Strength in Micro-Scale Components Combined with High-Voltage Environmental Electron Microscopy	EXPERIMENTAL MECHANICS			English	Article						Interface; Micro-components; Strength evaluation; Environmental cell; HVEM	THIN-FILMS; HYDROGEN; TENSILE; PLASTICITY; SENSORS; STRESS; COPPER; TEM; CRACKING; EDGE	A novel experimental method that enables evaluation of interfacial strength of micro-components subjected to well-controlled various environments is proposed. The method combines a high-voltage transmission electron microscope (HVEM) equipped with an open type environmental cell (EC) and a quantitative nano-mechanical holder. The experiments were conducted by using focused-ion-beam-processed micro-cantilever specimens containing interfaces of dissimilar materials (silicon (Si) and copper (Cu)). The in situ observation of fracture phenomenon along a target interface (Si/Cu) and the simultaneous measurement of fracture load were successfully implemented under vacuum and gaseous environments (N-2 gas and N-2/H-2 mixed gas) whose maximum pressure was controlled at 5 x 10(3) Pa. The stress distribution at the onset of fracture was calculated in detail by finite element analysis. The strength against interfacial debonding was then evaluated by the local normal stress value at the interface free-edge. The proposed technique, which can also be combined with simultaneous electron probe analyses, is highly versatile when compared to the conventional nano-mechanical strength evaluations under limited environments.	[Takahashi, Y.; Kondo, H.; Kitagawa, Y.] Kansai Univ, Dept Mech Engn, Suita, Osaka 5648680, Japan; [Arai, S.; Yamamoto, Y.; Higuchi, K.; Muto, S.; Tanaka, N.] Nagoya Univ, EcoTopia Sci Inst, Chikusa Ku, Nagoya, Aichi 4648603, Japan	Takahashi, Y (reprint author), Kansai Univ, Dept Mech Engn, 3-3-35 Yamate Cho, Suita, Osaka 5648680, Japan.	yoshim-t@kansai-u.ac.jp			Reaction science/Nanomaterials science Research support base of Microstructure Analysis Platform in 'Nanotechnology Platform Project' by MEXT, Japan; JSPS KAKENHI [23234567, 25709003, 25000012]; Kansai University	The present study was performed under the auspices of Reaction science/Nanomaterials science Research support base of Microstructure Analysis Platform in 'Nanotechnology Platform Project' by MEXT, Japan. Y. T. of the authors is also grateful to financial support by: JSPS KAKENHI Nos. 23234567 (Research Activity Start-up), 25709003 (Grant-in-Aid for Young Scientists A), 25000012 (Specially Promoted Research); the Kansai University Grant-in-Aid for progress of research in graduate course (2012).	Alam MO, 2006, IEEE T DEVICE MAT RE, V6, P421, DOI 10.1109/TDMR.2006.881451; Wang XG, 2005, PHYS REV LETT, V95, DOI 10.1143/PhysRevLett.95.156102; RUUD JA, 1993, J MATER RES, V8, P112, DOI 10.1557/JMR.1993.0112; Keller RR, 1996, MAT SCI ENG A-STRUCT, V214, P42, DOI 10.1016/0921-5093(96)10253-7; REEDY ED, 1995, J ADHES SCI TECHNOL, V9, P237, DOI 10.1163/156856195X01148; ORIANI RA, 1974, ACTA METALL MATER, V22, P1065, DOI 10.1016/0001-6160(74)90061-3; Tan CKC, 2009, APPL CATAL B-ENVIRON, V93, P66, DOI 10.1016/j.apcatb.2009.09.013; Haque MA, 2002, EXP MECH, V42, P123, DOI 10.1177/0018512002042001797; LEE TC, 1991, REV SCI INSTRUM, V62, P1438, DOI 10.1063/1.1142464; Robertson IM, 2001, ENG FRACT MECH, V68, P671, DOI 10.1016/S0013-7944(01)00011-X; GERBERICH WW, 1991, PHILOS MAG A, V63, P363; Kitamura T, 2003, ENG FRACT MECH, V70, P2089, DOI 10.1016/S0013-7944(02)00254-0; Haque MA, 2002, SENSOR ACTUAT A-PHYS, V97-8, P239, DOI 10.1016/S0924-4247(01)00861-5; Espinosa HD, 2004, J MECH PHYS SOLIDS, V52, P667, DOI 10.1016/j.jmps.2003.07.001; Bogy DB, 1968, J APPL MECH, V35, P146; BOND GM, 1986, SCRIPTA METALL MATER, V20, P653, DOI 10.1016/0036-9748(86)90484-9; Butler EP, 1981, PRACTICAL METHODS EL, V9, P239; Cao J, 2008, J ALLOY COMPD, V466, P363, DOI 10.1016/j.jallcom.2007.11.033; Courtney T. H., 2000, MECH BEHAV MAT; Freund L. B., 2003, THIN FILM MAT; Gall K, 2004, METALL MATER TRANS A, V35A, P321, DOI 10.1007/s11661-004-0133-5; Getino J, 1996, SENSOR ACTUAT B-CHEM, V33, P128, DOI 10.1016/0925-4005(96)01840-0; Hirakata H, 2006, ENG FRACT MECH, V73, P2698, DOI 10.1016/j.engfracmech.2006.04.019; Huang BQ, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2767198; Jang HJ, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.165329; Kamiya S, 2013, SURF COAT TECH, V215, P280, DOI 10.1016/j.surfcoat.2012.07.100; Kim BJ, 2013, MATER CHEM PHYS, V138, P366, DOI 10.1016/j.matchemphys.2012.12.002; Kim SH, 2006, J ELECTROCERAM, V17, P995, DOI 10.1007/s10832-006-9385-3; Koiwa K, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.04CB05; Monet J.G., 1958, J IRON STEEL I, V189, P37; Nafari A, 2005, SENSOR ACTUAT A-PHYS, V123-24, P44, DOI 10.1016/j.sna.2005.03.068; Sanz-Velasco A, 2006, SOLID STATE ELECTRON, V50, P865, DOI 10.1016/j.sse.2006.04.026; Sumigawa T, 2013, THIN SOLID FILMS, V531, P362, DOI 10.1016/j.tsf.2013.01.019; Takahashi Y, 2008, THIN SOLID FILMS, V516, P1925, DOI 10.1016/j.tsf.2007.08.062; Takahashi Y, 2010, ULTRAMICROSCOPY, V110, P1420, DOI 10.1016/j.ultramic.2010.07.011; Tanaka N, 2013, MICROSCOPY-JPN, V62, P205, DOI 10.1093/jmicro/dfs095; Troiano A, 1960, T AM SOC MET, V52, P54; VEHOFF H, 1983, ACTA METALL MATER, V31, P1781, DOI 10.1016/0001-6160(83)90125-6; Yan YB, 2014, ENG FRACT MECH, V116, P204, DOI 10.1016/j.engfracmech.2013.12.014; Zhu XW, 2014, J MATER SCI-MATER EL, V25, P742, DOI 10.1007/s10854-013-1639-7	40	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0014-4851	1741-2765		EXP MECH	Exp. Mech.	JUL	2015	55	6					1047	1056		10.1007/s11340-015-0008-2		10	Materials Science, Multidisciplinary; Mechanics; Materials Science, Characterization & Testing	Materials Science; Mechanics	CJ6RT	WOS:000355622000004		
J	Takita, A; Sasaki, K; Ohguchi, K; Takeda, R				Takita, A.; Sasaki, K.; Ohguchi, K.; Takeda, R.			An Effective Area Considering the Principal Stress to Evaluate Creep Strain Measured by Indentation Test	EXPERIMENTAL MECHANICS			English	Article						Solder joints; Indentation method; FEM analysis; Creep deformation	INSTRUMENTED INDENTATION; FRACTURE TEST; LEAD-FREE; ALLOY; SOLDER; HARDNESS; MODULUS; PHASE; SN	A method to estimate the creep properties by measuring the micro size deformation is required for the FEM analysis considering the creep deformation of the solder joint in-situ. An indentation creep test is one of the effective methods to directly evaluate the creep deformation of solder joint. However, the indentation test does not give the same creep properties as those obtained by the uniaxial creep tests using a bulk specimen. The authors have proposed an indentation test conducted under the constant depth to determine a suitable reference area, which leads to the same creep characteristics as those obtained by the uniaxial creep test. One of the remaining problems of the indentation test is that the reference area cannot be determined without the creep data obtained by the uniaxial creep test using bulk specimens. In this paper, a series of numerical indentation tests under a constant depth were conducted to construct a method to determine a new reference area without creep data obtained from the uniaxial creep test using bulk specimens. The numerical tests were conducted using finite element method (FEM). The numerical tests showed that the distribution of the principal stress plays an important role to determine the reference area of the indentation tests. Finally, it was found that the reference area obtained considering the distribution of the principal stress gives almost the same creep characteristic as those obtained by the uniaxial creep using bulk specimens.	[Takita, A.] Hokkaido Univ, Grad Sch Engn, Kita Ku, Sapporo, Hokkaido 0608628, Japan; [Sasaki, K.; Takeda, R.] Hokkaido Univ, Fac Engn, Kita Ku, Sapporo, Hokkaido 0608628, Japan; [Ohguchi, K.] Akita Univ, Dept Mat Sci & Engn, Akita 0108502, Japan	Sasaki, K (reprint author), Hokkaido Univ, Fac Engn, Kita Ku, N13,W8, Sapporo, Hokkaido 0608628, Japan.	katsu@eng.hokudai.ac.jp					ROEBUCK B, 1982, J MATER SCI LETT, V1, P519, DOI 10.1007/BF00724735; ATKINS AG, 1966, J I MET, V94, P369; Dorner D, 2003, MAT SCI ENG A-STRUCT, V357, P346, DOI 10.1016/S0921-5093(03)00205-3; Takita A, 2014, J ELECTRON MATER, V43, P2530, DOI 10.1007/s11664-014-3196-0; Zhao L, 2013, MATER DESIGN, V47, P677, DOI 10.1016/j.matdes.2012.12.032; Gogotsi GA, 2009, CERAM INT, V35, P1871, DOI 10.1016/j.ceramint.2008.10.026; Zhang N, 2011, ACTA MATER, V59, P3156, DOI 10.1016/j.actamat.2011.01.055; Ohguchi KI, 2006, J ELECTRON MATER, V35, P132, DOI 10.1007/s11664-006-0195-9; Abell KCR, 2002, ACTA MATER, V50, P3191; Doerner MF, 1986, J MATER RES, V1, P601, DOI 10.1557/JMR.1986.0601; Fujiwara M, 2001, MAT SCI ENG A-STRUCT, V319, P929, DOI 10.1016/S0921-5093(01)01079-6; Basaran C, 2004, MECH MATER, V36, P1111, DOI 10.1016/j.mechmat.2003.10.002; Takagi H, 2005, J JPN I MET, V69, P348, DOI 10.2320/jinstmet.69.348; Su CJ, 2013, J MECH PHYS SOLIDS, V61, P517, DOI 10.1016/j.jmps.2012.09.009; ANSTIS GR, 1981, J AM CERAM SOC, V64, P533, DOI 10.1111/j.1151-2916.1981.tb10320.x; Islam RA, 2005, J ALLOY COMPD, V392, P149, DOI 10.1016/j.jallcom.2004.08.079; Johson KL, 1985, CONTACT MECH; Kenichi K, 1997, J SOC MECH A, V63, P567; Kobayashi K, 2009, JPN SOC MECH ENG A, V75, P669; Komazaki S, 2012, J SOC MATER SCI JPN, V61, P980; Matsumura T, 2005, FUJITSU, V56; Miyamoto A., 2002, Journal of the Society of Materials Science, Japan, V51; Nishioka T., 2011, JAP J SOC MAT SCI, V60, P146, DOI 10.2472/jsms.60.146; Ochiai S, 2008, J EUR CERAM SOC, V28, P2309, DOI 10.1016/j.jeurceramsoc.2008.01.013; Ogawa T, 2007, J SOLID MECH MAT ENG, V1, P254; OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564; Pearce SP, 2011, INT J NONLIN MECH, V46, P1128, DOI 10.1016/j.ijnonlinmec.2011.04.030; SARGENT PM, 1992, MATER SCI TECH SER, V8, P594; Seddon I, 1965, INT J ENG SCI, V3, P47; Shibutani T, 2005, JPN SOC MECH ENG A, V71, P1285; Solder Strength Working Group, 2000, FACT DAT TENS LOW CY; Solder Strength Working Group, 2004, FACT DAT CREEP CREEP; Takagi H, 2004, MAT SCI ENG A-STRUCT, V387, P348, DOI 10.1016/j.msea.2004.01.061	33	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0014-4851	1741-2765		EXP MECH	Exp. Mech.	JUL	2015	55	6					1081	1091		10.1007/s11340-015-0005-5		11	Materials Science, Multidisciplinary; Mechanics; Materials Science, Characterization & Testing	Materials Science; Mechanics	CJ6RT	WOS:000355622000007		
J	Dawood, MAO; Koshio, S; Ishikawa, M; Yokoyama, S				Dawood, Mahmoud A. O.; Koshio, Shunsuke; Ishikawa, Manabu; Yokoyama, Saichiro			Interaction effects of dietary supplementation of heat-killed Lactobacillus plantarum and beta-glucan on growth performance, digestibility and immune response of juvenile red sea bream, Pagrus major	FISH & SHELLFISH IMMUNOLOGY			English	Article						Red sea bream; Heat-killed Lactobacillus plantarum; beta-glucan; Growth; Immunity	SALMON SALMO-SALAR; TILAPIA OREOCHROMIS-NILOTICUS; GROUPER EPINEPHELUS-COIOIDES; ONCORHYNCHUS-MYKISS WALBAUM; ENZYME-PRODUCING BACTERIA; DEAD PROBIOTIC CELLS; LACTIC-ACID BACTERIA; CYPRINUS-CARPIO-KOI; RAINBOW-TROUT; DISEASE RESISTANCE	Both heat-killed Lactobacillus plantarum (HK-LP) and beta-glucan (BG) play important roles in growth performance, feed utilization and health status of fish. Therefore, a feeding trial was conducted to determine the interactive effects of dietary HK-LP and BG on growth performance, digestibility, oxidative status and immune response of red sea bream for 56 days. A significant interaction was found between HK-LP and BG on final body weight, total plasma protein, glucose, serum bactericidal activity (BA), total serum protein, serum alternative complement pathway (ACP) activity, protein and dry matter digestibility coefficients (P < 0.05). In addition, body weight gain, specific growth rate, feed intake, protein efficiency ratio as well as serum lysozyme activity, ACP activity and mucus secretion were significantly affected by either HK-LP or BG (P < 0.05). Further, feeding 0.025% HK-LP combined with 0.1% BG significantly increased serum peroxidase activity compared with the other groups (P < 0.05). However, protein body content, somatic parameters, total bilirubin, blood urea nitrogen, glutamyl oxaloacetic transaminase (GOT), glutamic-pyruvate transaminase (GPT), triglycerides and mucus BA were not significantly altered by supplementations (P > 0.05). Interestingly, fish fed with both HK-LP at (0.025 and 0.1%) in combination with BG at (0 and 0.1%) showed higher oxidative stress resistance. Under the experimental conditions, dietary HK-LP and BG had a significant interaction on enhancing the growth, digestibility and immune responses of red sea bream. (C) 2015 Elsevier Ltd. All rights reserved.	[Dawood, Mahmoud A. O.] Kagoshima Univ, United Grad Sch Agr Sci, Kagoshima 8900056, Japan; [Koshio, Shunsuke; Ishikawa, Manabu; Yokoyama, Saichiro] Kagoshima Univ, Fac Fisheries, Lab Aquat Anim Nutr, Kagoshima 8900056, Japan; [Dawood, Mahmoud A. O.] Kafrelsheikh Univ, Fac Aquat & Fisheries Sci, Dept Aquaculture, Kafrelsheikh 33516, Egypt	Dawood, MAO (reprint author), Kagoshima Univ, United Grad Sch Agr Sci, 1-21-24 Korimoto, Kagoshima 8900056, Japan.	mahmouddawood55@gmail.com			Egyptian Government; Management Expenses Grants of the United Graduate School of Agriculture Sciences, Kagoshima University	The first author would like to thank Egyptian Government for financial support. This research was partially funded by the Management Expenses Grants of the United Graduate School of Agriculture Sciences, Kagoshima University provided to Dr. Shunsuke Koshio.	Kumari J, 2006, AQUACULTURE, V255, P133, DOI 10.1016/j.aquaculture.2005.12.012; Taoka Y, 2006, FISHERIES SCI, V72, P755, DOI 10.1111/j.1444-2906.2006.01215.x; Fast MD, 2002, COMP BIOCHEM PHYS A, V132, P645, DOI 10.1016/S1095-6433(02)00109-5; Hirose Y, 2006, J NUTR, V136, P3069; Sorensen M, 2011, AQUACULTURE, V314, P145, DOI 10.1016/j.aquaculture.2011.02.013; Ren TJ, 2008, J WORLD AQUACULT SOC, V39, P797, DOI 10.1111/j.1749-7345.2008.00216.x; Gao J, 2012, AQUACULTURE, V356, P73, DOI 10.1016/j.aquaculture.2012.05.034; Shida K, 2008, TRENDS IMMUNOL, V29, P565, DOI 10.1016/j.it.2008.07.011; Bachere E, 2003, AQUACULTURE, V227, P427, DOI 10.1016/S0044-8486(03)00521-0; JORGENSEN JB, 1995, DEV COMP IMMUNOL, V19, P43, DOI 10.1016/0145-305X(94)00045-H; Ortuno J, 2001, FISH SHELLFISH IMMUN, V11, P187, DOI 10.1006/fsim.2000.0304; Ray AK, 2012, AQUACULT NUTR, V18, P465, DOI 10.1111/j.1365-2095.2012.00943.x; Murosaki S, 1998, J ALLERGY CLIN IMMUN, V102, P57, DOI 10.1016/S0091-6749(98)70055-7; Misra CK, 2006, AQUACULTURE, V255, P82, DOI 10.1016/j.aquaculture.2005.12.009; Merrifield DL, 2010, AQUACULTURE, V302, P1, DOI 10.1016/j.aquaculture.2010.02.007; Irianto A, 2003, J FISH DIS, V26, P59, DOI 10.1046/j.1365-2761.2003.00414.x; Secombes CJ, 2001, DEV COMP IMMUNOL, V25, P713, DOI 10.1016/S0145-305X(01)00032-5; Lygren B, 1999, FISH SHELLFISH IMMUN, V9, P95, DOI 10.1006/fsim.1998.0179; Suzer C, 2008, AQUACULTURE, V280, P140, DOI 10.1016/j.aquaculture.2008.04.020; Eslamloo K, 2012, FISH SHELLFISH IMMUN, V32, P976, DOI 10.1016/j.fsi.2012.02.007; Dalmo RA, 2008, FISH SHELLFISH IMMUN, V25, P384, DOI 10.1016/j.fsi.2008.04.008; Welker TL, 2007, J WORLD AQUACULT SOC, V38, P24, DOI 10.1111/j.1749-7345.2006.00070.x; Diaz-Rosales P, 2006, FISH SHELLFISH IMMUN, V20, P482, DOI 10.1016/j.fsi.2005.06.007; Gibson G. R., 2004, Clinical Nutrition Supplements, V1, P25, DOI 10.1016/j.clnu.2004.09.005; Ji SC, 2007, FISHERIES SCI, V73, P63, DOI 10.1111/j.1444-2906.2007.01302.x; Ringo E, 1998, AQUACULTURE, V160, P177, DOI 10.1016/S0044-8486(97)00299-8; Lin SM, 2011, FISH SHELLFISH IMMUN, V31, P788, DOI 10.1016/j.fsi.2011.07.013; Salminen S, 1999, TRENDS FOOD SCI TECH, V10, P107, DOI 10.1016/S0924-2244(99)00027-8; Son VM, 2009, FISH SHELLFISH IMMUN, V26, P691, DOI 10.1016/j.fsi.2009.02.018; Lara-Flores M, 2003, AQUACULTURE, V216, P193, DOI 10.1016/S0044-8486(02)00277-6; Miranda CD, 2002, AQUACULTURE, V212, P31, DOI 10.1016/S0044-8486(02)00124-2; Paulsen SM, 2001, FISH SHELLFISH IMMUN, V11, P23, DOI 10.1006/fsim.2000.0291; Biswas G, 2013, FISH SHELLFISH IMMUN, V34, P1170, DOI 10.1016/j.fsi.2013.01.024; [Anonymous], 2012, AQUACULT NUTR, DOI DOI 10.1111/J.1365-2095.2011.00866.X; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Salinas I, 2008, FISH SHELLFISH IMMUN, V25, P114, DOI 10.1016/j.fsi.2008.03.011; Panigrahi A, 2010, FISH PHYSIOL BIOCHEM, V36, P969, DOI 10.1007/s10695-009-9375-x; Gatesoupe FJ, 1999, AQUACULTURE, V180, P147, DOI 10.1016/S0044-8486(99)00187-8; Liu WS, 2013, FISH SHELLFISH IMMUN, V35, P54, DOI 10.1016/j.fsi.2013.04.010; Nayak SK, 2010, FISH SHELLFISH IMMUN, V29, P2, DOI 10.1016/j.fsi.2010.02.017; CooK MT, 2003, FISH SHELLFISH IMMUN, V14, P333, DOI 10.1006/fsim.2002.0441; Kader MA, 2012, AQUACULTURE, V350, P109, DOI 10.1016/j.aquaculture.2012.04.009; Lin SM, 2012, AQUACULTURE, V342, P36, DOI 10.1016/j.aquaculture.2012.02.009; Naidu AS, 1999, CRIT REV FOOD SCI, V39, P13, DOI 10.1080/10408699991279187; AOAC, 1990, OFFICIAL METHODS ANA; Butprom S, 2013, SCI WORLD J; Choi Sanghoon, 2008, Immune Network, V8, P67; Das P, 2014, TURK J ZOOL, V38, P79, DOI 10.3906/zoo-1205-3; Furukawa A, 1966, NIPPON SUISAN GAKK, V32, P502; Giri SS, 2014, AQUACULT NUTR, V20, P163, DOI 10.1111/anu.12062; Han YZ, 2014, AQUACULTURE, V432, P130, DOI 10.1016/j.aquaculture.2014.05.004; Hirose Y, 2009, REGUL TOXICOL PHARM, V54, P214, DOI 10.1016/j.yrtph.2009.03.007; HJELMELAND K, 1983, J FISH BIOL, V23, P13, DOI 10.1111/j.1095-8649.1983.tb02878.x; IIDA T, 1989, NIPPON SUISAN GAKK, V55, P463; Kakuta I., 1996, SUISANZOSHOKU, V44, P427; Khonyoung D, 2012, J APPL ANIM RES, V40, P140, DOI 10.1080/09712119.2011.640208; Kiihlwein H, 2013, J ANIM PHYSIOL AN N, V98, P279; Lauridsen JH, 2010, ACTA ICHTHYOL PISCAT, V40, P61, DOI 10.3750/AIP2010.40.1.08; Li P, 2009, AQUAC RES, V40, P1578, DOI 10.1111/j.1365-2109.2009.02257.x; Morganti P, 2002, Int J Cosmet Sci, V24, P331, DOI 10.1046/j.1467-2494.2002.00159.x; Rahimnejad S, 2013, AQUACULTURE, V416, P212, DOI 10.1016/j.aquaculture.2013.09.026; Ren TongJun, 2007, Aquaculture, V267, P31, DOI 10.1016/j.aquaculture.2007.03.033; Rodriguez-Estrada U, 2013, N AM J AQUACULT, V75, P416, DOI 10.1080/15222055.2013.799620; Shelby Richard A., 2009, Journal of Applied Aquaculture, V21, P61, DOI 10.1080/10454430802694728; Song Seong Kyu, 2014, Fish Shellfish Immunol, V40, P40, DOI 10.1016/j.fsi.2014.06.016; Tatsumi N., 2000, J CLIN LAB INSTRUMEN, V23, P427; Thomas CM, 2010, GUT MICROBES, V1, P1, DOI DOI 10.4161/GMIC.1.3.11712; Tung H.T., 2009, AQUACULT SCI, V57, P175; Tung HT, 2010, J WORLD AQUACULT SOC, V41, P16; Wells JM, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S17; Yano T., 1992, TECHNIQUES FISH IMMU, V2, P131; Yokoyama S, 2006, AQUACULTURE, V255, P507, DOI 10.1016/j.aquaculture.2005.12.001; Zhang Q, 2014, FISH SHELLFISH IMMUN, V29, P1	73	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1050-4648	1095-9947		FISH SHELLFISH IMMUN	Fish Shellfish Immunol.	JUL	2015	45	1					33	42		10.1016/j.fsi.2015.01.033		10	Fisheries; Immunology; Marine & Freshwater Biology; Veterinary Sciences	Fisheries; Immunology; Marine & Freshwater Biology; Veterinary Sciences	CK3JR	WOS:000356112900006		
J	Tame, A; Yoshida, T; Ohishi, K; Maruyama, T				Tame, Akihiro; Yoshida, Takao; Ohishi, Kazue; Maruyama, Tadashi			Phagocytic activities of hemocytes from the deep-sea symbiotic mussels Bathymodiolus japonicus, B. platifrons, and B. septemdierum	FISH & SHELLFISH IMMUNOLOGY			English	Article						Hemocyte; Bathymodiolus; Deep-sea; Symbiotic mussel; Phagocytosis; Lysosome; Lectin; Ultrastructure	CLAM TAPES-PHILIPPINARUM; MYTILUS-EDULIS; MARINE MUSSEL; PINCTADA-FUCATA; GALLOPROVINCIALIS; BIVALVE; SUBPOPULATIONS; CYTOCHEMISTRY; AMEBOCYTES; SEPARATION	Deep-sea mytilid mussels harbor symbiotic bacteria in their gill epithelial cells that are horizontally or environmentally transmitted to the next generation of hosts. To understand the immune defense system in deep-sea symbiotic mussels, we examined the hemocyte populations of the symbiotic Bathymodiolus mussel species Bathymodiolus japonicus, Bathymodiolus platifrons, and Bathymodiolus septemdierum, and characterized three types of hemocytes: agranulocytes (AGs), basophilic granulocytes (BGs), and eosinophilic granulocytes (EGs). Of these, the EG cells were the largest (diameter, 8.4-10.0 mu m) and had eosinophilic cytoplasm with numerous eosinophilic granules (diameter, 0.8-1.2 mu m). Meanwhile, the BGs were of medium size (diameter, 6.7-8.0 mu m) and contained small basophilic granules (diameter, 03-0.4 mu m) in basophilic cytoplasm, and the AGs, the smallest of the hemocytes (diameter, 4.8-6.0 mu m), had basophilic cytoplasm lacking granules. A lectin binding assay revealed that concanavalin A bound to all three hemocyte types, while wheat germ agglutinin bound exclusively to EGs and BGs. The total hemocyte population densities within the hemolymph of all three Bathymodiolus mussel species were similar (8.4-13.3 x 10(5) cells/mL), and the percentages of circulating AGs, BGs, and EGs in the hemolymph of these organisms were 44.7-48.5%, 14.3-17.6%, and 34.3-41.0%, respectively. To analyze the functional differences between these hemocytes, the phagocytic activity and post-phagocytic phagosome lysosome fusion events were analyzed in each cell type using a fluorescent Alexa Fluor (R) 488-conjugated Escherichia coli bioparticle and a LysoTracker (R) lysosomal marker, respectively. While the AGs exhibited no phagocytic activity, both types of granulocytes were phagocytic. Of the three hemocyte types, the EGs exhibited the highest level of phagocytic activity as well as rapid phagosome lysosome fusion, which occurred within 2 h of incubation. Meanwhile, the BGs showed lower phagocytic activity and lower rates of phagosome lysosome fusion than the EGs. These findings indicate that the two types of granulocyte play distinct roles in the defense system. (C) 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).	[Tame, Akihiro] Marine Works Japan Ltd, Dept Tech Serv, Yokosuka, Kanagawa 2370063, Japan; [Tame, Akihiro; Yoshida, Takao; Maruyama, Tadashi] Kitasato Univ, Sch Marine Biosci, Minami Ku, Sagamihara, Kanagawa 2520373, Japan; [Tame, Akihiro; Yoshida, Takao; Ohishi, Kazue; Maruyama, Tadashi] Japan Agcy Marine Earth Sci & Technol, Yokosuka, Kanagawa 2370061, Japan	Maruyama, T (reprint author), Japan Agcy Marine Earth Sci & Technol, Res & Dev Ctr Marine Biosci, 2-15 Natsushima Cho, Yokosuka, Kanagawa 2370061, Japan.	tadashim@jamstec.go.jb					Parisi MG, 2008, FISH SHELLFISH IMMUN, V25, P834, DOI 10.1016/j.fsi.2008.09.005; Wootton EC, 2003, FISH SHELLFISH IMMUN, V15, P195, DOI 10.1016/S1050-4648(02)00161-4; Duperron S, 2009, CR BIOL, V332, P298, DOI 10.1016/j.crvi.2008.08.003; WAN CP, 1993, J IMMUNOL METHODS, V162, P1, DOI 10.1016/0022-1759(93)90400-2; Fujiwara Y, 2000, MAR ECOL PROG SER, V208, P147, DOI 10.3354/meps208147; Carballal MJ, 1997, J INVERTEBR PATHOL, V70, P96, DOI 10.1006/jipa.1997.4670; Carballal MJ, 1998, J INVERTEBR PATHOL, V72, P304, DOI 10.1006/jipa.1998.4779; Travers MA, 2008, FISH SHELLFISH IMMUN, V24, P400, DOI 10.1016/j.fsi.2007.10.001; Carballal MJ, 1997, DIS AQUAT ORGAN, V29, P127, DOI 10.3354/dao029127; Matozzo V, 2008, CELL BIOL INT, V32, P865, DOI 10.1016/j.cellbi.2008.03.008; Cima F, 2000, FISH SHELLFISH IMMUN, V10, P677, DOI 10.1006/fsim.2000.0282; Dubilier N, 2008, NAT REV MICROBIOL, V6, P725, DOI 10.1038/nrmicro1992; Bettencourt R, 2009, COMP BIOCHEM PHYS A, V152, P278, DOI 10.1016/j.cbpa.2008.10.022; Lorion J, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1243; Pipe RK, 1997, CELL TISSUE RES, V289, P537, DOI 10.1007/s004410050899; CAJARAVILLE MP, 1995, CELL STRUCT FUNCT, V20, P355; Hine PM, 1999, FISH SHELLFISH IMMUN, V9, P367, DOI 10.1006/fsim.1998.0205; Canesi L, 2002, MICROSC RES TECHNIQ, V57, P469, DOI 10.1002/jemt.10100; PIPE RK, 1990, HISTOCHEM J, V22, P595, DOI 10.1007/BF01072941; Kadar E, 2005, J EXP MAR BIOL ECOL, V318, P99, DOI 10.1016/j.jembe.2004.12.025; Wentrup C, 2013, ISME J, V7, P1244, DOI 10.1038/ismej.2013.5; BAYNE CJ, 1990, BIOSCIENCE, V40, P723, DOI 10.2307/1311504; BAYNE CJ, 1979, J INVERTEBR PATHOL, V34, P1, DOI 10.1016/0022-2011(79)90048-X; Bayne C.J., 1983, MOLLUSCAN IMMUNOLOGY; Carballal MJ, 1997, FISH SHELLFISH IMMUN, V7, P403, DOI 10.1006/fsim.1997.0094; Cheng T. C., 1981, BIVALVES; Cooper EL, 2006, INTEGR ZOOL, V1, P32, DOI 10.1111/j.1749-4877.2006.00010.x; DeChaine Eric G., 2006, V41, P227; Donaghy L, 2010, FISH SHELLFISH IMMUN, V28, P87, DOI 10.1016/j.fsi.2009.10.006; Donaghy L, 2009, AQUACULTURE, V297, P10, DOI 10.1016/j.aquaculture.2009.09.003; FRIEBEL B, 1995, COMP BIOCHEM PHYS A, V112, P81, DOI 10.1016/0300-9629(95)00086-M; Gorbushin AM, 2006, J MAR BIOL ASSOC UK, V86, P1175, DOI 10.1017/S0025315406014160; Mateo DR, 2009, DIS AQUAT ORGAN, V86, P253, DOI 10.3354/dao02121; Miyazaki JI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010363; MOORE MN, 1977, J INVERTEBR PATHOL, V29, P18, DOI 10.1016/0022-2011(77)90167-7; Nakayama K, 1998, ZOOL SCI, V15, P339, DOI 10.2108/zsj.15.339; NOEL D, 1994, MAR BIOL, V119, P549, DOI 10.1007/BF00354317; Ottaviani E., 2006, ISJ, V3, P50; PIPE RK, 1990, CELL TISSUE RES, V261, P261, DOI 10.1007/BF00318667; RASMUSSEN LPD, 1985, J INVERTEBR PATHOL, V45, P158, DOI 10.1016/0022-2011(85)90005-9; Rebelo MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057384; SAHLIN S, 1983, J IMMUNOL METHODS, V60, P115, DOI 10.1016/0022-1759(83)90340-X; Schmitz A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042114; SUZUKI T, 1992, ZOOL SCI, V9, P541; SUZUKI T, 1991, CELL TISSUE RES, V266, P75, DOI 10.1007/BF00678713; Takahashi K.G., 2000, TOHOKU J AGR RES, V51, P13; Wang YJ, 2012, FISH SHELLFISH IMMUN, V32, P381, DOI 10.1016/j.fsi.2011.08.024	47	1	1	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1050-4648	1095-9947		FISH SHELLFISH IMMUN	Fish Shellfish Immunol.	JUL	2015	45	1					146	156		10.1016/j.fsi.2015.03.020		11	Fisheries; Immunology; Marine & Freshwater Biology; Veterinary Sciences	Fisheries; Immunology; Marine & Freshwater Biology; Veterinary Sciences	CK3JR	WOS:000356112900019		
J	Horii, Y; Maeda, K; Shen, J; Fujisaki, Y; Nagai, K				Horii, Yuko; Maeda, Keiko; Shen, Jiao; Fujisaki, Yoshiyuki; Nagai, Katsuya			Effect of grapefruit and lavender essential oil scents on pancreatic sympathetic nerve activity and plasma glucose in rats	FLAVOUR AND FRAGRANCE JOURNAL			English	Article						pancreatic sympathetic nerve activity; hyperglycemia; hypoglycemia; essential oils; olfactory stimulation	AFFECTS AUTONOMIC NEUROTRANSMISSION; OLFACTORY STIMULATION; BLOOD-PRESSURE; METABOLISM; SYSTEM; LIVER; ACTIVATION; LIPOLYSIS; MECHANISM; APPETITE	We previously found that olfactory stimulation of rats with the scent of grapefruit oil (SGFO) elevated the activity of the sympathetic nerves innervating the adrenal glands, kidneys and white adipose tissue, blood pressure and the plasma glycerol level, whereas olfactory stimulation with the scent of lavender oil (SLVO) suppressed these same physiological values. In this study, we examined the effects of olfactory stimulation with SGFO and SLVO on the efferent pancreatic sympathetic nerve activity (pancreatic-SNA) in urethane-anaesthetized rats, hyperglycemia induced by intracranial injection of 2-deoxy-D-glucose (2DG) in rats and hyperglycemia in streptozotocin (STZ) diabetic rats which had been administered oral glucose. Olfactory stimulation with SGFO markedly elevated pancreatic-SNA and significantly increased the plasma glucose level after the 2DG injection, whereas olfactory stimulation with SLVO markedly inhibited pancreatic-SNA and significantly reduced the plasma glucose level after the 2DG injection. Furthermore, olfactory stimulation with SLVO suppressed the increase in the plasma glucose level after oral glucose loading in STZ-diabetic rats. These findings suggest that scent stimulation with SGFO and SLVO may affect the plasma glucose level via changes in the autonomic nervous system in rats. Copyright (c) 2015 John Wiley & Sons, Ltd.	[Horii, Yuko; Maeda, Keiko; Shen, Jiao; Nagai, Katsuya] Osaka Univ, Inst Prot Res, Div Prot Metab, Suita, Osaka 5650871, Japan; [Horii, Yuko; Shen, Jiao; Fujisaki, Yoshiyuki; Nagai, Katsuya] ANBAS Corp, Kita Ku, Osaka 5310072, Japan	Horii, Y (reprint author), ANBAS Corp, Kita Ku, 4-12-10 Toyosaki, Osaka 5310072, Japan.	yhorii@anbas.co.jp					SHIMAZU T, 1971, BIOCHIM BIOPHYS ACTA, V252, P28, DOI 10.1016/0304-4165(71)90089-4; Shen J, 2005, NEUROSCI LETT, V380, P289, DOI 10.1016/j.neulet.2005.01.058; Tanida M, 2005, BRAIN RES, V1058, P44, DOI 10.1016/j.brainres.2005.07.048; Nagai K, 1996, PROG BRAIN RES, V111, P253, DOI 10.1016/S0079-6123(08)60413-6; Tanida M, 2006, NEUROSCI LETT, V398, P155, DOI 10.1016/j.neulet.2005.12.076; Ganong W. F., 2005, REV MED PHYSL, P346; Nagai K, 2014, AUTON NEUROSCI-BASIC, V185, P29, DOI 10.1016/j.autneu.2014.06.005; NISHIKAWA Y, 1995, BRAIN RES, V695, P158, DOI 10.1016/0006-8993(95)00717-5; Shen J, 2007, NEUROSCI LETT, V416, P241, DOI 10.1016/j.neulet.2006.12.063; Shen J, 2005, NEUROSCI LETT, V383, P188, DOI 10.1016/j.neulet.2005.04.010; SHIMAZU T, 1981, DIABETOLOGIA, V20, P343, DOI 10.1007/BF00254502; SHIMAZU T, 1975, BIOCHIM BIOPHYS ACTA, V385, P242, DOI 10.1016/0304-4165(75)90352-9; Tanida M, 2007, NEUROSCI LETT, V413, P177, DOI 10.1016/j.neulet.2006.11.050; Tanida M, 2005, AM J PHYSIOL-REG I, V288, pR447, DOI 10.1152/ajpregu.00275.2004; Tanida M., 2008, NEUROSCI LETT, V439, P102	15	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0882-5734	1099-1026		FLAVOUR FRAG J	Flavour Frag. J.	JUL	2015	30	4					282	287		10.1002/ffj.3243		6	Chemistry, Applied; Food Science & Technology	Chemistry; Food Science & Technology	CK1ZH	WOS:000356008100004		
J	Torimitsu, S; Nishida, Y; Takano, T; Yajima, D; Inokuchi, G; Makino, Y; Motomura, A; Chiba, F; Yamaguchi, R; Hashimoto, M; Hoshioka, Y; Iwase, H				Torimitsu, Suguru; Nishida, Yoshifumi; Takano, Tachio; Yajima, Daisuke; Inokuchi, Go; Makino, Yohsuke; Motomura, Ayumi; Chiba, Fumiko; Yamaguchi, Rutsuko; Hashimoto, Mari; Hoshioka, Yumi; Iwase, Hirotaro			Differences in biomechanical properties and thickness among frontal and parietal bones in a Japanese sample	FORENSIC SCIENCE INTERNATIONAL			English	Article						Forensic Anthropology Population Data; Flexural strength; Thickness; Fracture load; Adult skull; Japanese	HUMAN CRANIAL BONE; INFANT SKULL; HEAD; BEHAVIOR; FLEXURE; SUTURE	The aim of this study was to assess the mechanical properties and thickness of adult frontal and parietal bones. The heads of 114 Japanese cadavers (78 male cadavers and 36 female cadavers) of known age and sex were used. A total of 912 cranial samples, 8 from each skull, were collected. Samples were imaged using multidetector computed tomography to measure sample thickness. The fracture load of each sample was measured using a bending test with calculation of flexural strength. Statistical analyses demonstrated no significant bilateral difference in either the mechanical properties or thickness of frontal or parietal bones. The mechanical properties and thicknesses of frontal bones were significantly greater than those of parietal bones regardless of sex. Therefore, the skull may have a great ability to resist frontal impacts compared with parietal impacts. In female samples, parietal bones were found to have a more uniform structure when compared with male samples. Male parietal bones were found to be thicker at medial sites than at lateral sites. This study also revealed parietal bones at lateral sites in female samples were thicker than in male samples. No strong association was observed between age and flexural strength of frontal or parietal bones. However, the fracture load was negatively correlated with age most likely due to the reduction of thickness. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Torimitsu, Suguru; Yajima, Daisuke; Inokuchi, Go; Makino, Yohsuke; Motomura, Ayumi; Chiba, Fumiko; Hoshioka, Yumi; Iwase, Hirotaro] Chiba Univ, Grad Sch Med, Dept Legal Med, Chuo Ku, Chiba 2608670, Japan; [Nishida, Yoshifumi; Takano, Tachio] Natl Inst Adv Ind Sci & Technol, Digital Human Res Ctr, Designing Everyday Life Funct & Social Syst Team, Koto Ku, Tokyo 1350064, Japan; [Makino, Yohsuke; Chiba, Fumiko; Yamaguchi, Rutsuko; Hashimoto, Mari; Iwase, Hirotaro] Univ Tokyo, Grad Sch Med, Dept Forens Med, Bunkyo Ku, Tokyo 1130033, Japan	Torimitsu, S (reprint author), Chiba Univ, Grad Sch Med, Dept Legal Med, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	number60188@chiba-u.jp			Designing Everyday Life Function and Social System Team; Digital Human Research Center; National Institute of Advanced Industrial Science and Technology (AIST); JSPS KAKENHI [26860462]	This work was supported by Designing Everyday Life Function and Social System Team, Digital Human Research Center, National Institute of Advanced Industrial Science and Technology (AIST), and JSPS KAKENHI, Grant Number 26860462.	Agur A.M.R., 1991, GRANTS ATLAS ANATOMY, P650; Rosas A, 2002, AM J PHYS ANTHROPOL, V117, P236, DOI 10.1002/ajpa.10023; Motherway JA, 2009, J BIOMECH, V42, P2129, DOI 10.1016/j.jbiomech.2009.05.030; Margulies SS, 2000, J BIOMECH ENG-T ASME, V122, P364, DOI 10.1115/1.1287160; MCPHERSON GK, 1980, J BIOMECH, V13, P9, DOI 10.1016/0021-9290(80)90003-2; Raul JS, 2008, INT J LEGAL MED, V122, P359, DOI 10.1007/s00414-008-0248-0; HUBBARD RP, 1971, J BIOMECH, V4, P491, DOI 10.1016/0021-9290(71)90039-X; Malli N, 2013, INT J LEGAL MED, V127, P195, DOI 10.1007/s00414-012-0690-x; Lynnerup N, 2001, FORENSIC SCI INT, V117, P45, DOI 10.1016/S0379-0738(00)00447-3; Coats B, 2006, J NEUROTRAUM, V23, P1222, DOI 10.1089/neu.2006.23.1222; WOOD JL, 1971, J BIOMECH, V4, P1, DOI 10.1016/0021-9290(71)90010-8; Arroyo M, 2010, NUTR HOSP, V25, P1053, DOI 10.3305/nh.2010.25.6.4854; Auperrin A, 2014, J BIOMECH, V47, P1180, DOI 10.1016/j.jbiomech.2013.10.060; Chaari F., 2009, EUR J COMPUTAT MECH, V18, P67; Delannoy Y, 2012, LEGAL MED-TOKYO, V14, P258, DOI 10.1016/j.legalmed.2012.04.006; Delille C., 2003, MEC IND, V4, P119, DOI DOI 10.1016/S1296-2139(03)00029-0; Delille R, 2007, INT J CRASHWORTHINES, V12, P101, DOI 10.1080/13588260701433081; EVANS FG, 1957, J APPL PHYSIOL, V10, P493; HUBBARD RP, 1971, J BIOMECH, V4, P251, DOI 10.1016/0021-9290(71)90031-5; Jamaiyah H, 2010, Med J Malaysia, V65 Suppl A, P131; Kikugawa H, 2004, MATER TRANS, V45, P3060, DOI 10.2320/matertrans.45.3060; MCELHANE.JH, 1970, J BIOMECH, V3, P495, DOI 10.1016/0021-9290(70)90059-X; Nishimoto T., 1995, T JPN SOC MECH ENG, V61, P2386; Pickering R.B., 1997, USE FORENSIC ANTHR, P84; Rahmoun J, 2014, MECH RES COMMUN, V60, P7, DOI 10.1016/j.mechrescom.2014.04.001; Ross AH, 1998, J FORENSIC SCI, V43, P267; Todd TW, 1924, ANAT REC, V27, P245, DOI 10.1002/ar.1090270504; Torimitsu S, 2014, LEGAL MED-TOKYO, V16, P102, DOI 10.1016/j.legalmed.2013.11.005; Torimitsu S., 2014, FORENSIC SCI INT, V234; Torimitsu S., 2015, FORENSIC SCI INT; Yamada H., 1970, STRENGTH BIOL MAT	31	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0379-0738	1872-6283		FORENSIC SCI INT	Forensic Sci.Int.	JUL	2015	252								190.e1	10.1016/j.forsciint.2015.04.029		6	Medicine, Legal	Legal Medicine	CJ9IQ	WOS:000355816200028		
J	Vaduganathan, M; Butler, J; Roessig, L; Fonarow, GC; Greene, SJ; Metra, M; Cotter, G; Kupfer, S; Zalewski, A; Sato, N; Filippatos, G; Gheorghiade, M				Vaduganathan, Muthiah; Butler, Javed; Roessig, Lothar; Fonarow, Gregg C.; Greene, Stephen J.; Metra, Marco; Cotter, Gadi; Kupfer, Stuart; Zalewski, Andrew; Sato, Naoki; Filippatos, Gerasimos; Gheorghiade, Mihai			Clinical trials in hospitalized heart failure patients: targeting interventions to optimal phenotypic subpopulations	HEART FAILURE REVIEWS			English	Article						Clinical trials; Heart failure; Outcomes; Patient selection	RELAX-AHF; EJECTION FRACTION; DRUG DEVELOPMENT; END-POINTS; STRATEGIES; GUIDELINES; REGISTRIES; SERELAXIN; TOLVAPTAN; ADMISSION	With one possible exception, the last decade of clinical trials in hospitalized heart failure (HHF) patients has failed to demonstrate improvement in long-term clinical outcomes. This trend necessitates a need to evaluate optimal drug development strategies and standards of trial conduct. It has become increasingly important to recognize the heterogeneity among HHF patients and the differential characterization of novel drug candidates. Targeting these agents to specific subpopulations may afford optimal net response related to the particular mode of action of the drug. Analyses of previous trials demonstrate profound differences in the baseline characteristics of patients enrolled across global regions and participating sites. Such differences may influence risks for events and interpretation of results. Therefore, the actual execution of trials and the epidemiology of HHF populations at the investigative sites must be taken into consideration. Collaboration among participating sites including the provision of registry data tailored to the planned development program will optimize trial conduct. Observational data prior to study initiation may enable sites to feedback and engage in protocol development to allow for feasible and valid clinical trial conduct. This site-centered, epidemiology-based network environment may facilitate studies in specific patient populations and promote optimal data collection and clear interpretation of drug safety and efficacy. This review summarizes the roundtable discussion held by a multidisciplinary team of representatives from academia, National Institutes of Health, industry, regulatory agencies, payers, and contract and academic research organizations to answer the question: Who should be targeted for novel therapies in HHF?.	[Vaduganathan, Muthiah] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med, Boston, MA USA; [Butler, Javed] Emory Univ Hosp, Div Cardiol, Atlanta, GA 30322 USA; [Roessig, Lothar] Novartis Pharmaceut, E Hanover, NJ USA; [Fonarow, Gregg C.] Ronald Reagan UCLA Med Ctr, Ahmanson UCLA Cardiomyopathy Ctr, Los Angeles, CA USA; [Greene, Stephen J.; Gheorghiade, Mihai] Northwestern Univ, Ctr Cardiovasc Innovat, Feinberg Sch Med, Chicago, IL 60611 USA; [Metra, Marco] Univ Brescia, Div Cardiol, Brescia, Italy; [Cotter, Gadi] Momentum Res Inc, Durham, NC USA; [Kupfer, Stuart] Takeda Global Res & Dev Ctr Inc, Deerfield, IL USA; [Zalewski, Andrew] Bayer Pharma AG, Berlin, Germany; [Sato, Naoki] Musashi Kosugi Hosp, Dept Internal Med & Cardiol, Nippon Med Sch, Kawasaki, Kanagawa, Japan; [Filippatos, Gerasimos] Attikon Univ Hosp, Athens, Greece	Gheorghiade, M (reprint author), Northwestern Univ, Ctr Cardiovasc Innovat, Feinberg Sch Med, 201 East Huron St,Galter 3-150, Chicago, IL 60611 USA.	m-gheorghiade@northwestern.edu		Metra, Marco/0000-0001-6691-8568	National Institutes of Health; European Union; Health Resource Services Administration; Food and Drug Administration; Agency for Healthcare Research and Quality	Javed Butler: Research Support: National Institutes of Health, European Union, Health Resource Services Administration, Food and Drug Administration; Consultant: Amgen, Bayer, Celladon, Gambro, GE Healthcare, Janssen, Medtronic, Novartis, Ono, Relypsa, Trevena; Stock Options: Stemedica. Lothar Roessig: Employee of Bayer Pharma AG. Gregg C Fonarow: Research support: Agency for Healthcare Research and Quality (significant), Consultant: Medtronic (modest), Gambro (significant), and Novartis (significant). Marco Metra: Received honoraria from Bayer, Corthera, Novartis, and Servier for speeches or participation in advisory boards/steering committees. Gadi Cotter: Employee of Momentum-Research, Inc. Stuart Kupfer: Employee of Takeda Global Research and Development Center, Inc. Andrew Zalewski: Employee of Novartis Pharmaceutical Corporation. Naoki Sato: Consultant to Chugai Pharmaceutical Company and honoraria from Daiichi-Sankyo, Otsuka, Philips Respironics, Astellas, Ono, Eisai, Chugai, Mitsubishi-Tanabe, Sanofi-Aventis, and Novartis pharmaceuticals. Mihai Gheorghiade: Consultant for Abbott Laboratories, Astellas, AstraZeneca, Bayer HealthCare AG, CorThera, Cytokinetics, DebioPharm S.A., Errekappa Terapeutici, GlaxoSmithKline, Ikaria, Johnson & Johnson, Medtronic, Merck, Novartis Pharma AG, Otsuka Pharmaceuticals, Palatin Technologies, Pericor Therapeutics, Protein Design Laboratories, Sanofi-Aventis, Sigma Tau, Solvay Pharmaceuticals, Takeda Pharmaceutical and Trevena Therapeutics. Muthiah Vaduganathan, Stephen J Greene, and Gerasimos Filippatos have no conflicts of interest or financial ties to disclose.	Ahmad T, 2014, JACC-HEART FAIL, V2, P260, DOI 10.1016/j.jchf.2013.12.004; Ambrosy AP, 2014, J AM COLL CARDIOL, V63, P1123, DOI 10.1016/j.jacc.2013.11.053; Ambrosy Andrew P, 2014, Curr Heart Fail Rep, V11, P416, DOI 10.1007/s11897-014-0221-9; Gheorghiade M, 2011, AM HEART J, V161, P224, DOI 10.1016/j.ahj.2010.10.023; Collins SP, 2012, AM HEART J, V164, P138, DOI 10.1016/j.ahj.2011.11.023; Vaduganathan M, 2013, NAT REV CARDIOL, V10, P85, DOI 10.1038/nrcardio.2012.181; Gheorghiade M, 2006, JAMA-J AM MED ASSOC, V296, P2217, DOI 10.1001/jama.296.18.2217; O'Connor CM, 2011, NEW ENGL J MED, V365, P32, DOI 10.1056/NEJMoa1100171; Hunt SA, 2009, J AM COLL CARDIOL, V53, pE1, DOI 10.1016/j.jacc.2008.11.013; Teerlink JR, 2009, LANCET, V373, P1429, DOI 10.1016/S0140-6736(09)60622-X; Butler J, 2013, J AM COLL CARDIOL, V61, P571, DOI 10.1016/j.jacc.2012.10.025; Greene SJ, 2014, AM HEART J, V168, P142, DOI 10.1016/j.ahj.2014.05.009; Felker GM, 2010, CIRC-HEART FAIL, V3, P643, DOI 10.1161/CIRCHEARTFAILURE.109.926030; Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309; Bayeva M, 2013, J AM COLL CARDIOL, V61, P599, DOI 10.1016/j.jacc.2012.08.1021; Schelbert EB, 2014, J AM COLL CARDIOL, V63, P2188, DOI 10.1016/j.jacc.2014.01.068; Butler J, 2013, JAMA-J AM MED ASSOC, V309, P1593, DOI 10.1001/jama.2013.1063; Teerlink JR, 2013, LANCET, V381, P29, DOI 10.1016/S0140-6736(12)61855-8; Collins SP, 2013, J AM COLL CARDIOL, V61, P121, DOI 10.1016/j.jacc.2012.08.1022; Konstam MA, 2007, JAMA-J AM MED ASSOC, V297, P1319, DOI 10.1001/jama.297.12.1319; Gheorghiade M, 2009, AM HEART J, V157, P957, DOI 10.1016/j.ahj.2009.04.010; Davison BA, 2011, CLIN RES CARDIOL, V100, P745, DOI 10.1007/s00392-011-0304-5; Felker GM, 2014, J AM COLL CARDIOL, V64, P1591, DOI 10.1016/j.jacc.2014.05.071; Fleming LM, 2014, AM J CARDIOL, V114, P1379, DOI 10.1016/j.amjcard.2014.07.071; Greenberg B, 2010, EUR SOC CARD HEART F; Greene SJ, 2014, J AM COLL CARDIOL, V64, P1599, DOI 10.1016/j.jacc.2014.06.1199; Hall MJ, 2012, NCHS DATA BRIEF, V108, p[2000, 1]; Lindenfeld J, 2010, J CARD FAIL, V16, pe1, DOI DOI 10.1016/J.CARDFAIL.2010.04.004; Senni M, 2014, EUR HEART J, V35, P2797, DOI 10.1093/eurheartj/ehu204; Shah SJ, 2015, CIRCULATION, V131, P269, DOI 10.1161/CIRCULATIONAHA.114.010637; Wang NC, 2010, AM J THER, V17, pE78, DOI 10.1097/MJT.0b013e3181e70a65; Wong TC, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000416	32	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1382-4147	1573-7322		HEART FAIL REV	Heart Fail. Rev.	JUL	2015	20	4					393	400		10.1007/s10741-015-9485-8		8	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CK2KK	WOS:000356039000003		
J	Fukushima, S; Miyagawa, S; Sakai, Y; Sawa, Y				Fukushima, Satsuki; Miyagawa, Shigeru; Sakai, Yoshiki; Sawa, Yoshiki			A sustained-release drug-delivery system of synthetic prostacyclin agonist, ONO-1301SR: a new reagent to enhance cardiac tissue salvage and/or regeneration in the damaged heart	HEART FAILURE REVIEWS			English	Article						Prostacyclin agonist; Surgical regeneration therapy; Drug delivery system; Translational research; Preclinical studies	PULMONARY ARTERIAL-HYPERTENSION; ELEVATION MYOCARDIAL-INFARCTION; SYNTHASE INHIBITORY-ACTIVITY; PERCUTANEOUS CORONARY INTERVENTION; ADHESION MOLECULE EXPRESSION; BONE MORPHOGENETIC PROTEIN-2; GROWTH-FACTOR EXPRESSION; RECEPTOR EP4 AGONIST; REPERFUSION INJURY; SELECTIVE AGONIST	Cardiac failure is a major cause of mortality and morbidity worldwide, since the standard treatment for cardiac failure in the clinical practice is chiefly to focus on removal of insults against the heart or minimisation of additional factors to exacerbate cardiac failure, but not on regeneration of the damaged cardiac tissue. A synthetic prostacyclin agonist, ONO-1301, has been developed as a long-acting drug for acute and chronic pathologies related to regional ischaemia, inflammation and/or interstitial fibrosis by pre-clinical studies. In addition, poly-lactic co-glycolic acid-polymerised form of ONO-1301, ONO-1301SR, was generated to achieve a further sustained release of this drug into the targeted region. This unique reagent has been shown to act on fibroblasts, vascular smooth muscle cells and endothelial cells in the tissue via the prostaglandin IP receptor to exert paracrinal release of multiple protective factors, such as hepatocyte growth factor, vascular endothelial growth factor or stromal cell-derived factor-1, into the adjacent damaged tissue, which is salvaged and/or regenerated as a result. Our laboratory developed a new surgical approach to treat acute and chronic cardiac failure using a variety of animal models, in which ONO-1301SR is directly placed over the cardiac surface to maximise the therapeutic effects and minimise the systemic complications. This review summarises basic and pre-clinical information of ONO-1301 and ONO-1301SR as a new reagent to enhance tissue salvage and/or regeneration, with a particular focus on the therapeutic effects on acute and chronic cardiac failure and underlying mechanisms, to explore a potential in launching the clinical study.	[Fukushima, Satsuki; Miyagawa, Shigeru; Sakai, Yoshiki; Sawa, Yoshiki] Osaka Univ, Dept Cardiovasc Surg, Grad Sch Med, Suita, Osaka 5650871, Japan	Sawa, Y (reprint author), Osaka Univ, Dept Cardiovasc Surg, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	fukushima.satsuki@hotmail.co.jp; sawa-p@surg1.med.osaka-u.ac.jp					Agarwal S, 2015, HEART, V101, P169, DOI 10.1136/heartjnl-2014-306254; Felker GM, 2002, J AM COLL CARDIOL, V39, P210, DOI 10.1016/S0735-1097(01)01738-7; Nakagawa N, 2012, KIDNEY INT, V82, P158, DOI 10.1038/ki.2012.115; Lederle FA, 2012, NEW ENGL J MED, V367, P1988, DOI 10.1056/NEJMoa1207481; Abraham WT, 2013, NAT REV CARDIOL, V10, P98, DOI 10.1038/nrcardio.2012.178; Chawengsub Y, 2009, AM J PHYSIOL-HEART C, V297, pH495, DOI 10.1152/ajpheart.00349.2009; Wolfram JA, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000119; Zucker IH, 2014, CLIN SCI, V126, P695, DOI 10.1042/CS20130294; Menasche P, 2011, J MOL CELL CARDIOL, V50, P258, DOI 10.1016/j.yjmcc.2010.06.010; Frangogiannis NG, 2014, NAT REV CARDIOL, V11, P255, DOI 10.1038/nrcardio.2014.28; Fukushima S, 2007, CIRCULATION, V115, P2254, DOI 10.1161/CIRCULATIONAHA.106.662577; Nakase H, 2010, INFLAMM BOWEL DIS, V16, P731, DOI 10.1002/ibd.21080; Xiao CY, 2004, CIRCULATION, V109, P2462, DOI 10.1161/01.CIR.0000128046.54681.97; Garcia C, 2005, BRIT J ANAESTH, V94, P159, DOI 10.1093/bja/aei026; Lonborg J, 2012, EUR HEART J, V33, P1491, DOI 10.1093/eurheartj/ehr309; Kim JS, 2010, JACC-CARDIOVASC INTE, V3, P332, DOI 10.1016/j.jcin.2009.11.021; Lang CC, 2013, NAT REV CARDIOL, V10, P125, DOI 10.1038/nrcardio.2012.196; O'Farrell FM, 2014, NAT REV CARDIOL, V11, P427, DOI 10.1038/nrcardio.2014.58; Piot C, 2008, NEW ENGL J MED, V359, P473, DOI 10.1056/NEJMoa071142; Takahashi HK, 2003, J PHARMACOL EXP THER, V307, P1188, DOI 10.1124/jpet.103.056432; Sivaraman V, 2014, J CARDIOVASC PHARM T, V19, P83, DOI 10.1177/1074248413499973; Mann DL, 2012, J THORAC CARDIOV SUR, V143, P1036, DOI 10.1016/j.jtcvs.2011.06.014; Sasaoka R, 2004, BIOCHEM BIOPH RES CO, V318, P704, DOI 10.1016/j.bbrc.2004.04.080; Wong GTC, 2010, J CARDIOTHOR VASC AN, V24, P790, DOI 10.1053/j.jvca.2009.09.012; Koitabashi N, 2012, NAT REV CARDIOL, V9, P147, DOI 10.1038/nrcardio.2011.172; Giblett JP, 2014, INT J CARDIOL, V177, P786, DOI 10.1016/j.ijcard.2014.10.041; Tous E, 2011, J CARDIOVASC TRANSL, V4, P528, DOI 10.1007/s12265-011-9291-1; Miyagawa S, 2010, TRANSPLANTATION, V90, P364, DOI 10.1097/TP.0b013e3181e6f201; Ruan CH, 2010, TEX HEART I J, V37, P391; Najjar SS, 2011, JAMA-J AM MED ASSOC, V305, P1863, DOI 10.1001/jama.2011.592; Kitakaze M, 2007, LANCET, V370, P1483, DOI 10.1016/S0140-6736(07)61634-1; Hishikari K, 2009, CARDIOVASC RES, V81, P123, DOI 10.1093/cvr/cvn254; Tanaka M, 2004, BONE, V34, P940, DOI 10.1016/j.bone.2004.01.002; Diaz R, 2007, JAMA-J AM MED ASSOC, V298, P2399, DOI 10.1001/jama.298.20.2399; Sanganalmath SK, 2013, CIRC RES, V113, P810, DOI 10.1161/CIRCRESAHA.113.300219; Mochly-Rosen D, 2012, NAT REV DRUG DISCOV, V11, P937, DOI 10.1038/nrd3871; Fukushima S, 2006, CIRCULATION, V114, pI251, DOI 10.1161/CIRCULATIONAHA.105.000794; Zamanian RT, 2014, CIRC RES, V115, P131, DOI 10.1161/CIRCRESAHA.115.303827; Murakami S, 2006, AM J PHYSIOL-LUNG C, V290, pL59, DOI 10.1152/ajplung.00042.2005; Schwartz BG, 2012, J AM COLL CARDIOL, V59, P9, DOI 10.1016/j.jacc.2011.07.051; Jiang F, 2014, NAT REV CARDIOL, V11, P413, DOI 10.1038/nrcardio.2014.59; Kloner RA, 2006, EUR HEART J, V27, P2400, DOI 10.1093/eurheartj/ehl094; Shudo Y, 2011, J THORAC CARDIOV SUR, V142, P1188, DOI 10.1016/j.jtcvs.2011.07.002; Antoniu SA, 2006, EXPERT OPIN INV DRUG, V15, P327, DOI 10.1517/113543784.15.3.327; Behfar A, 2014, NAT REV CARDIOL, V11, P232, DOI 10.1038/nrcardio.2014.9; Camici PG, 2015, NAT REV CARDIOL, V12, P48, DOI 10.1038/nrcardio.2014.160; Chang F, 2007, J ORTHOP RES, V25, P221, DOI 10.1002/jor.20327; Cohn JN, 2014, NAT REV CARDIOL, V11, P69, DOI 10.1038/nrcardio.2013.212; Dominguez-Rodriguez Alberto, 2014, World J Cardiol, V6, P100, DOI 10.4330/wjc.v6.i3.100; Dorris SL, 2012, MEDIAT INFLAMM, V2012; Fukushima S, 2006, CARDIOVASC RES, V69, P459, DOI 10.1016/j.cardiores.2005.10.008; Fukushima S, 2011, J HEART LUNG TRANSPL, V30, P227, DOI 10.1016/j.healun.2010.09.002; Fukushima Satsuki, 2013, Future Cardiol, V9, P215, DOI 10.2217/fca.12.85; Hagino H, 2005, BONE, V36, P444, DOI 10.1016/j.bone.2004/12.013; Hayashi K, 2005, J BONE JOINT SURG BR, V87B, P1150, DOI 10.1302/0301-620X.87B8.15886; Hayashi K, 1997, JPN J PHARMACOL, V73, P73, DOI 10.1254/jjp.73.73; Hayashi M, 2010, CLIN EXP ALLERGY, V40, P317, DOI 10.1111/j.1365-2222.2009.03418.x; Hazekawa M, 2012, J MICROENCAPSUL, V29, P211, DOI 10.3109/02652048.2011.622054; Hazekawa M, 2012, J PHARM PHARMACOL, V64, P353, DOI 10.1111/j.2042-7158.2011.01416.x; Hirata Y, 2013, EUR J PHARMACOL, V699, P81, DOI 10.1016/j.ejphar.2012.11.045; Hirata Y, 2009, BIOMED PHARMACOTHER, V63, P781, DOI 10.1016/j.biopha.2009.09.003; Hirata Y, 2012, EUR J PHARMACOL, V674, P352, DOI 10.1016/j.ejphar.2011.10.038; Honma Y, 2005, EUR J PHARMACOL, V518, P56, DOI 10.1016/j.ejphar.2005.06.006; Imanishi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069302; Imawaka H, 1998, J PHARMACOL EXP THER, V284, P949; Ishimaru K, 2013, J THORAC CARDIOV SUR, V146, P1516, DOI 10.1016/j.jtcvs.2013.02.045; Ito M, 2006, BONE, V39, P453, DOI 10.1016/j.bone.2006.02.054; Iwata H, 2009, LIFE SCI, V85, P255, DOI 10.1016/j.lfs.2009.06.002; Kainuma S, 2015, MOL THER, V23, P374, DOI 10.1038/mt.2014.225; Kasai K, 2001, HEPATOL RES, V21, P252, DOI 10.1016/S1386-6346(01)00103-6; Kataoka M, 2005, AM J RESP CRIT CARE, V172, P1575, DOI 10.1164/rccm.200501-1020C; Kimura Y, 2013, EUR J PHARMACOL, V721, P80, DOI 10.1016/j.ejphar.2013.09.051; Kubota Y, 2014, J THORAC CARDIOV SUR, V147, P1081, DOI 10.1016/j.jtcvs.2013.05.035; Malina M, 2000, EUR J VASC ENDOVASC, V19, P5, DOI 10.1053/ejvs.1999.0867; Marui A, 2006, J THORAC CARDIOV SUR, V131, P587, DOI 10.1016/j.jtcvs.2005.10.026; Moukarbel GV, 2004, CURR OPIN PHARMACOL, V4, P147, DOI 10.1016/j.coph.2003.10.012; Nakagawa K, 2007, BONE, V41, P543, DOI 10.1016/j.bone.2007.06.013; Nakamura A, 2013, CIRC J, V77, P2127, DOI 10.1253/circj.CJ-13-0107; Nakamura K, 2007, CLIN SCI, V112, P607, DOI 10.1042/CS20060301; Namikawa T, 2007, SPINE, V32, P2294; Ngoc PB, 2011, J CARDIOVASC PHARM, V57, P365, DOI 10.1097/FJC.0b013e31820b7be1; Niina Y, 2014, PANCREATOLOGY, V14, P201, DOI 10.1016/j.pan.2014.02.009; Ninomiya T, 2011, EUR J PHARMACOL, V650, P396, DOI 10.1016/j.ejphar.2010.10.021; Obata H, 2008, AM J RESP CRIT CARE, V177, P195, DOI 10.1164/rccm.200703-349OC; Ogawa M, 2009, TRANSPLANTATION, V87, P1645, DOI 10.1097/TP.0b013e3181a5c84c; Pagkalos Joseph, 2012, Curr Mol Pharmacol, V5, P174; Sekiguchi M, 2006, SPINE, V31, P869, DOI 10.1097/01.brs.0000209256.96186.a7; Shirasaka T, 2013, J THORAC CARDIOV SUR, V146, P413, DOI 10.1016/j.jtcvs.2012.10.003; Suzuki J, 2012, INT HEART J, V53, P64; Takahashi HK, 2005, EUR J PHARMACOL, V517, P252, DOI 10.1016/j.ejphar.2005.05.020; Takahashi HK, 2005, EUR J PHARMACOL, V512, P223, DOI 10.1016/j.ejphar.2005.01.046; Tsai MK, 2014, J INVEST MED, V62, P332, DOI 10.231/JIM.0000000000000042; Uchida T, 2013, J PHARMACOL SCI, V123, P392, DOI 10.1254/jphs.13073FP; Uchida T, 2013, J MICROENCAPSUL, V30, P245, DOI 10.3109/02652048.2012.720721; Wang X, 2009, SCAND CARDIOVASC J, V43, P72, DOI 10.1080/14017430802180449; Watanabe Y, 2014, J THORAC CARDIOVASC, V148, pe1; Xu Q, 2013, BIOMED RES-TOKYO, V34, P241; Xu Q, 2012, AM J PHYSIOL-GASTR L, V302, pG420, DOI 10.1152/ajpgi.00216.2011; Yamasaki H, 2011, AM J PHYSIOL-RENAL, V302, pF1616; Yusuf S, 1998, LANCET, V331, P1088	100	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1382-4147	1573-7322		HEART FAIL REV	Heart Fail. Rev.	JUL	2015	20	4					401	413		10.1007/s10741-015-9477-8		13	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CK2KK	WOS:000356039000004		
J	Yamada, K; Oshiro, Y; Okamura, S; Fujisaki, T; Kondo, S; Nakayama, Y; Suematsu, E; Tamura, K; Takeshita, M				Yamada, Kozue; Oshiro, Yumi; Okamura, Seiichi; Fujisaki, Tomoaki; Kondo, Seiji; Nakayama, Yoshifuku; Suematsu, Eiichi; Tamura, Kazuo; Takeshita, Morishige			Clinicopathological characteristics and rituximab addition to cytotoxic therapies in patients with rheumatoid arthritis and methotrexate-associated large B lymphoproliferative disorders	HISTOPATHOLOGY			English	Article						B lymphoproliferative disorders; BCL2; Epstein-Barr virus; methotrexate; rheumatoid arthritis; rituximab; sIL2R	EPSTEIN-BARR-VIRUS; POSITIVE MUCOCUTANEOUS ULCER; CELL LYMPHOMA; DISEASE; REMISSION; INFECTION	AimsTo analyse the clinicopathological characteristics and prognosis of 40 rheumatoid arthritis (RA) patients with methotrexate (MTX)-associated large B cell lymphoproliferative disorders (MTX-BLPD). Methods and resultsSoluble interleukin 2 receptor titres (median 1500U/ml) in 40 patients with MTX-BLPD were lower than those of 24 RA patients with non-MTX- associated (non-MTX) BLPD (5731U/ml) and 15 with control diffuse large B cell lymphoma (DLBCL, 5918U/ml) (P<0.01). Using in-situ hybridization, Epstein-Barr virus (EBV) was detected in tumour cells of 25 of 40 RA patients with MTX-BLPD (63%). Immunohistologically, BCL2 expression was detected in 35% of patients with MTX-BLPD, which was lower than 93% of control DLBCL patients (P<0.01). Eleven patients with EBV+ MTX-BLPD (44%) showed remission after MTX withdrawal. In RA patients with clinical stage III/IV BLPD, 15 with rituximab (R)+ cytotoxic therapies pursued better prognosis than 10 with R- cytotoxic therapies (P<0.05). Among the 15 patients, seven with MTX-BLPD showed better overall survival than nine control DLBCL patients (P<0.01). ConclusionsIn RA patients with MTX-BLPD, immunosuppression by MTX, EBV infection and low BCL2 expression in tumour cells may play roles in tumorigenesis and tumour regression. R+ cytotoxic therapies as well as MTX withdrawal were highly effective in these patients.	[Yamada, Kozue; Takeshita, Morishige] Fukuoka Univ, Dept Pathol, Fac Med, Fukuoka 8140180, Japan; [Oshiro, Yumi] Matsuyama Red Cross Hosp, Dept Pathol, Matsuyama, Ehime, Japan; [Okamura, Seiichi; Kondo, Seiji; Suematsu, Eiichi] Natl Hosp Org, Kyushu Med Ctr, Clin Res Ctr, Dept Internal Med, Fukuoka, Japan; [Fujisaki, Tomoaki] Matsuyama Red Cross Hosp, Dept Hematol, Matsuyama, Ehime, Japan; [Nakayama, Yoshifuku] Natl Hosp Org, Kyushu Med Ctr, Clin Res Ctr, Dept Pathol, Fukuoka, Japan; [Tamura, Kazuo] Fukuoka Univ, Fac Med, Dept Internal Med, Div Med Oncol Hematol & Infect Dis, Fukuoka 8140180, Japan	Takeshita, M (reprint author), Fukuoka Univ, Dept Pathol, Fac Med, Johnan Ku, 7-45-1 Nanakuma, Fukuoka 8140180, Japan.	m-take@adm.fukuoka-u.ac.jp			Ministry of Education, Science and Culture of Japan [25460444]	We wish to thank Professor Masaru Kojima MD, Department of Pathology, School of Medicine, Dokkyo University for providing special advice. We are grateful to Tomoko Fukushige, Masako Ishiguro, Tomomi Okabe and Kaori Saga for excellent technical assistance of IHC staining and PCR analysis. This study was supported in part by a Grant-in-Aid for Scientific Research (no. 25460444) from the Ministry of Education, Science and Culture of Japan.	Niitsu N, 2010, CANCER SCI, V101, P1309, DOI 10.1111/j.1349-7006.2010.01517.x; Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; KAMEL OW, 1993, NEW ENGL J MED, V328, P1317, DOI 10.1056/NEJM199305063281806; Johnson LR, 2006, AM J SURG PATHOL, V30, P1604, DOI 10.1097/01.pas.0000213317.59176.d2; Rizzi R, 2009, MED ONCOL, V26, P1, DOI 10.1007/s12032-008-9069-8; Gonzalez-Barca E, 2007, HAEMATOL-HEMATOL J, V92, P1489, DOI 10.3324/haematol.11360; Hoshida Y, 2007, J RHEUMATOL, V34, P322; Dojcinov SD, 2010, AM J SURG PATHOL, V34, P405, DOI 10.1097/PAS.0b013e3181cf8622; Feng WH, 2004, J NATL CANCER I, V96, P1691, DOI 10.1093/jnci/djh313; Montes-Moreno S, 2012, MODERN PATHOL, V25, P968, DOI 10.1038/modpathol.2012.52; Baecklund E, 2006, ARTHRITIS RHEUM, V54, P692, DOI 10.1002/art.21675; Mariette X, 2002, BLOOD, V99, P3909, DOI 10.1182/blood.V99.11.3909; Oyama T, 2003, AM J SURG PATHOL, V27, P16, DOI 10.1097/00000478-200301000-00003; Ichikawa A, 2013, EUR J HAEMATOL, V91, P20, DOI 10.1111/ejh.12116; Kikuma K, 2014, HUM PATHOL, V45, P1276, DOI 10.1016/j.humpath.2013.10.038; Craig FE, 2007, DIAGN MOL PATHOL, V16, P158, DOI 10.1097/PDM.0b013e31804f54a9; Kondo S, 2013, VIRCHOWS ARCH, V462, P399, DOI 10.1007/s00428-013-1389-1; Miyazaki T, 2007, AM J HEMATOL, V82, P1106, DOI 10.1002/ajh.21003; Bellas C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098169; Chadburn A, 2009, J CLIN ONCOL, V27, P5039, DOI 10.1200/JCO.2008.20.5450; Gaulard P, 2008, WHO CLASSIFICATION T, P350; Hart M, 2014, AM J SURG PATHOL, V38, P1522, DOI 10.1097/PAS.0000000000000282; Malaviya AN, 2010, INT J RHEUM DIS, V13, P288, DOI 10.1111/j.1756-185X.2010.01564.x; SALAFFI F, 1995, CLIN RHEUMATOL, V14, P458, DOI 10.1007/BF02207682; Smitten AL, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2404; vansDongen JJ, 2003, LEUKEMIA, V17, P2257; Wendler J, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4521	27	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0309-0167	1365-2559		HISTOPATHOLOGY	Histopathology	JUL	2015	67	1					70	80		10.1111/his.12627		11	Cell Biology; Pathology	Cell Biology; Pathology	CK3CH	WOS:000356092900006		
J	Emura, I; Usuda, H; Togashi, K; Satou, K				Emura, Iwao; Usuda, Hiroyuki; Togashi, Kenichi; Satou, Kazuhiro			Minute lesions of alveolar damage in lungs of patients with stable idiopathic pulmonary fibrosis	HISTOPATHOLOGY			English	Article						acute exacerbation; hypoxia-inducible factor-2; idiopathic pulmonary fibrosis; macrophage; minute lesion of alveolar damage; neutrophil; tumour necrosis factor-	ACUTE EXACERBATION; INTERSTITIAL PNEUMONIAS; HYPOXIA; MACROPHAGES; EXPRESSION; FEATURES; DISEASE	AimsTo investigate the mechanisms underlying the acute exacerbation of idiopathic pulmonary fibrosis, and in particular the role of minute lesions of alveolar damage. Methods and resultsWe examined surgical lung biopsy samples from 38 patients with stable idiopathic pulmonary fibrosis, and evaluated the association between the foci and development of acute exacerbation. Mild extravasation, probably resulting from lung injury and intra-alveolar oedema fluid, were observed in narrow areas of architecturally intact lung tissue. Minute lesions of alveolar damage were detected in these areas. Alveolar epithelial cells in these lesions were injured. Hypoxia-inducible factor-2-positive macrophages, tumour necrosis factor--positive macrophages and neutrophils had accumulated in alveolar spaces in and around these lesions. Cases were classified into patients without (17) and with (21) minute lesions of alveolar damage. Development to acute exacerbation (five cases) occurred only in patients with minute lesions of alveolar damage (P=0.03). ConclusionsThe formation of minute lesions of alveolar damage may be initiated by hypoxia, and such lesions play important roles in the development of acute exacerbation.	[Emura, Iwao; Usuda, Hiroyuki] Japanese Red Cross Nagaoka Hosp, Dept Surg Pathol, Nagaoka, Niigata 9402085, Japan; [Togashi, Kenichi] Japanese Red Cross Nagaoka Hosp, Dept Gen Thorac Surg, Nagaoka, Niigata 9402085, Japan; [Satou, Kazuhiro] Japanese Red Cross Nagaoka Hosp, Dept Internal Med, Nagaoka, Niigata 9402085, Japan	Emura, I (reprint author), Japanese Red Cross Nagaoka Hosp, Dept Surg Pathol, 2-297-1 Senshyuu, Nagaoka, Niigata 9402085, Japan.	emura@nagaoka.jrc.or.jp					[American Thoracic Society International Consensus Statement American Thoracic Society (ATS) and the European Respiratory Society (ERS)], 2000, AM J RESP CRIT CARE, V161, P646; American Thoracic Society/European Respiratory Society, 2002, AM J RESP CRIT CARE, V165, P277; Kim DS, 2006, EUR RESPIR J, V27, P143, DOI 10.1183/00936.06.00114004; Burke B, 2002, J PATHOL, V196, P204, DOI 10.1002/path.1029; Katzenstein ALA, 1998, AM J RESP CRIT CARE, V157, P1301; Churg A, 2007, AM J SURG PATHOL, V31, P277, DOI 10.1097/01.pas.0000213341.70852.9d; Talks KL, 2000, AM J PATHOL, V157, P411, DOI 10.1016/S0002-9440(10)64554-3; KONDOH Y, 1993, CHEST, V103, P1808, DOI 10.1378/chest.103.6.1808; Collard HR, 2007, AM J RESP CRIT CARE, V176, P636, DOI 10.1164/rccm.200703-463PP; Selman Moisés, 2006, Proc Am Thorac Soc, V3, P364, DOI 10.1513/pats.200601-003TK; Nizet V, 2009, NAT REV IMMUNOL, V9, P609, DOI 10.1038/nri2607; Parambil JG, 2005, CHEST, V128, P3310, DOI 10.1378/chest.128.5.3310; Rice AJ, 2003, AM J CLIN PATHOL, V119, P709, DOI 10.1309/UVARMDY8FE9FJDKU; Ambrosini V, 2003, EUR RESPIR J, V22, P821, DOI 10.1183/09031936.03.00022703; Churg A, 2011, HISTOPATHOLOGY, V58, P525, DOI 10.1111/j.1365-2559.2010.03650.x; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Husain AN, 2010, PATHOLOGIC BASIS DIS, V8th, P680; MYERS JL, 1988, CHEST, V94, P1309, DOI 10.1378/chest.94.6.1309; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806	19	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0309-0167	1365-2559		HISTOPATHOLOGY	Histopathology	JUL	2015	67	1					90	95		10.1111/his.12631		6	Cell Biology; Pathology	Cell Biology; Pathology	CK3CH	WOS:000356092900008		
J	Kuroda, N; Moritani, S; Ichihara, S				Kuroda, Naoto; Moritani, Suzuko; Ichihara, Shu			Combined hepatoid and serous carcinoma of the uterine corpus: an undescribed phenomenon	HISTOPATHOLOGY			English	Letter							YOLK-SAC TUMOR; ALPHA-FETOPROTEIN PRODUCTION; OF-THE-LITERATURE; ENDOMETRIAL ADENOCARCINOMA; UTERUS; CARCINOSARCOMA; COMPONENT		[Kuroda, Naoto] Kochi Red Cross Hosp, Dept Diagnost Pathol, Kochi, Japan; [Moritani, Suzuko; Ichihara, Shu] Nagoya Med Ctr, Dept Adv Diag, Div Pathol, Nagoya, Aichi, Japan	Kuroda, N (reprint author), Kochi Red Cross Hosp, Dept Diagnost Pathol, Kochi, Japan.						Adams SF, 2001, GYNECOL ONCOL, V83, P418, DOI 10.1006/gyno.2001.6383; Akhavan A, 2012, BMJ CASE REP, DOI [10.1136/bcr.02.2012.5830, DOI 10.1136/BCR.02.2012.5830]; Takano M, 2003, GYNECOL ONCOL, V91, P444, DOI 10.1016/S0090-8258(03)00512-2; Takahashi Y, 2003, PATHOL INT, V53, P323, DOI 10.1046/j.1440-1827.2003.01467.x; Fadare O, 2006, AM J SURG PATHOL, V30, P1519, DOI 10.1097/01.pas.0000213296.88778.db; Hoshida Y, 1996, INT J GYNECOL PATHOL, V15, P266, DOI 10.1097/00004347-199607000-00012; Hwang JH, 2011, SCOT MED J, V56, P1; Ishibashi K, 2011, PATHOL RES PRACT, V207, P332, DOI 10.1016/j.prp.2011.02.010; Kato K, 2007, INT J GYNECOL CANCER, V17, P1131; Kawaguchi Ryuji, 2011, Case Rep Oncol, V4, P358, DOI 10.1159/000330239; Kodama J, 2010, ONCOL LETT, V1, P243, DOI 10.3892/ol_00000043; KUBO K, 1991, ACTA PATHOL JAPON, V41, P399; Oguri H, 2006, GYNECOL ONCOL, V103, P368, DOI 10.1016/j.ygyno.2006.04.024; Patsner B, 2001, GYNECOL ONCOL, V80, P93, DOI 10.1006/gyno.2000.6011; Spatz A, 1998, GYNECOL ONCOL, V70, P285, DOI 10.1006/gyno.1998.5036; Takeuchi K, 2006, INT J GYNECOL CANCER, V16, P1439; Toyoda H, 2000, PATHOL INT, V50, P847, DOI 10.1046/j.1440-1827.2000.01124.x; Tran TAN, 2007, INT J GYNECOL PATHOL, V26, P66, DOI 10.1097/01.pgp.0000225843.21503.30; Yamamoto R, 1996, J CLIN PATHOL, V49, P420, DOI 10.1136/jcp.49.5.420	19	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0309-0167	1365-2559		HISTOPATHOLOGY	Histopathology	JUL	2015	67	1					135	137		10.1111/his.12614		3	Cell Biology; Pathology	Cell Biology; Pathology	CK3CH	WOS:000356092900014		
J	Budde, BS; Mizumoto, S; Kogawa, R; Becker, C; Altmuller, J; Thiele, H; Ruschendorf, F; Toliat, MR; Kaleschke, G; Haemmerle, JM; Hoehne, W; Sugahara, K; Nurnberg, P; Kennerknecht, I				Budde, Birgit S.; Mizumoto, Shuji; Kogawa, Ryo; Becker, Christian; Altmueller, Janine; Thiele, Holger; Rueschendorf, Franz; Toliat, Mohammad R.; Kaleschke, Gerrit; Haemmerle, Johannes M.; Hoaehne, Wolfgang; Sugahara, Kazuyuki; Nuernberg, Peter; Kennerknecht, Ingo			Skeletal dysplasia in a consanguineous clan from the island of Nias/Indonesia is caused by a novel mutation in B3GAT3	HUMAN GENETICS			English	Article							PROTEIN LINKAGE REGION; HUMAN GLUCURONOSYLTRANSFERASE I; PROTEOGLYCAN CORE PROTEIN; SULFATED GLYCOSAMINOGLYCANS; CHONDROITIN SULFATE; MOLECULAR-CLONING; HEPARAN-SULFATE; BIOSYNTHESIS; EXPRESSION; FAMILY	We describe a large family with disproportionate short stature and bone dysplasia from Nias in which we observed differences in severity when comparing the phenotypes of affected individuals from two remote branches. We conducted a linkage scan in the more severely affected family branch and determined a critical interval of 4.7 cM on chromosome 11. Sequencing of the primary candidate gene TBX10 did not reveal a disease-causing variant. When performing whole exome sequencing we noticed a homozygous missense variant in B3GAT3, c.419C > T [p.(Pro140Leu)]. B3GAT3 encodes beta-1,3-glucuronyltransferase-I (GlcAT-I). GlcAT-I catalyzes an initial step of proteoglycan synthesis and the mutation p. (Pro140Leu) lies within the donor substrate-binding subdomain of the catalytic domain. In contrast to the previously published mutation in B3GAT3, c.830G > A [p.(Arg277Gln)], no heart phenotype could be detected in our family. Functional studies revealed a markedly reduced GlcAT-I activity in lymphoblastoid cells from patients when compared to matched controls. Moreover, relative numbers of glycosaminoglycan (GAG) side chains were decreased in patient cells. We found that Pro140Leu-mutant GlcAT-I cannot efficiently transfer GlcA to the linker region trisaccharide. This failure results in a partial deficiency of both chondroitin sulfate and heparan sulfate chains. Since the phenotype of the Nias patients differs from the Larsen-like syndrome described for patients with mutation p.(Arg277Gln), we suggest mutation B3GAT3:p.(Pro140Leu) to cause a different type of GAG linkeropathy showing no involvement of the heart.	[Budde, Birgit S.; Becker, Christian; Altmueller, Janine; Thiele, Holger; Toliat, Mohammad R.; Hoaehne, Wolfgang; Nuernberg, Peter] Univ Cologne, CCG, D-50931 Cologne, Germany; [Mizumoto, Shuji; Kogawa, Ryo; Sugahara, Kazuyuki] Hokkaido Univ, Grad Sch Life Sci, Fac Adv Life Sci, Lab Proteoglycan Signaling & Therapeut, Sapporo, Hokkaido, Japan; [Altmueller, Janine] Univ Cologne, Inst Human Genet, D-50931 Cologne, Germany; [Rueschendorf, Franz] Max Delbrck Ctr Mol Med, Berlin, Germany; [Kaleschke, Gerrit] Univ Hosp Munster, Dept Cardiovasc Med, Div Adult Congenital & Valvular Heart Dis, Munster, Germany; [Haemmerle, Johannes M.] Yayasan Pusaka Nias, Nias, Sumatra Utara, Indonesia; [Nuernberg, Peter] Univ Cologne, Cologne Cluster Excellence Cellular Stress Respon, D-50931 Cologne, Germany; [Nuernberg, Peter] Univ Cologne, CMMC, D-50931 Cologne, Germany; [Kennerknecht, Ingo] Univ Munster, Inst Human Genet, D-48149 Munster, Germany; [Mizumoto, Shuji; Sugahara, Kazuyuki] Meijo Univ, Fac Pharm, Dept Pathobiochem, Nagoya, Aichi 468, Japan	Nurnberg, P (reprint author), Univ Cologne, CCG, D-50931 Cologne, Germany.	nuernberg@uni-koeln.de; ingo.kennerknecht@uni-muenster.de			Japan Society for the Promotion of Science, Japan [25670018, 25860037]; Japan Heart Foundation; Research Institute of Meijo University (Tenkai)	We want to thank Sr. Klara Duha OSF, Asrama Fa'omasi, Laverna, Gunungsitoli for their assistance when performing clinical examinations. The help of the family Gaho from Hilinamoza'ua and the family Duha from Bawodobara with sampling and Gert W. Widmann from Kempten with transporting the probes is highly appreciated. Nata'alui Duha, Fabius Ndruru, Hatima Farasi, Oktoberlina Telaumbanua and Arozanolo Gulo from the staff of the Museum Pusaka Nias did a great job in their administrative and secretarial support of the field research. We thank Elisabeth Kirst and Nina Dalibor for their technical assistance in the genetic analyses, and Takako Hayashi for her technical assistance in the quantitative analysis of GAGs. This work was supported in part by a Grant-in-aid for Challenging Exploratory Research 25670018 (to K. S.); by a Grant-in-aid for Young Scientists (B) 25860037 (to S. M.) from the Japan Society for the Promotion of Science, Japan; by the Drs. Hiroshi Irisawa and Aya Irisawa Memorial Research Grant from the Japan Heart Foundation (to S. M.); by the Research Institute of Meijo University (Tenkai) (to S. M.).	Mizumoto S, 2012, METHODS MOL BIOL, V836, P99, DOI 10.1007/978-1-61779-498-8_7; Nakajima M, 2013, AM J HUM GENET, V92, P927, DOI 10.1016/j.ajhg.2013.04.003; Oota H, 2002, AM J PHYS ANTHROPOL, V118, P146, DOI 10.1002/ajpa.10056; Sugahara K, 2000, CURR OPIN STRUC BIOL, V10, P518, DOI 10.1016/S0959-440X(00)00125-1; Vorster AA, 2015, CLIN GENET, V87, P492, DOI 10.1111/cge.12413; Holmborn K, 2012, J BIOL CHEM, V287, P33905, DOI 10.1074/jbc.M112.401646; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Baasanjav S, 2011, AM J HUM GENET, V89, P15, DOI 10.1016/j.ajhg.2011.05.021; Hill C, 2007, AM J HUM GENET, V80, P29, DOI 10.1086/510412; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; von Oettingen JE, 2014, AM J MED GENET A, V164, P1580, DOI 10.1002/ajmg.a.36487; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; KRESSE H, 1987, AM J HUM GENET, V41, P436; Kitagawa H, 1998, J BIOL CHEM, V273, P6615, DOI 10.1074/jbc.273.12.6615; Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609; Okajima T, 1999, J BIOL CHEM, V274, P22915, DOI 10.1074/jbc.274.33.22915; Bai XM, 2001, J BIOL CHEM, V276, P48189, DOI 10.1074/jbc.M107339200; Ouzzine M, 2002, J BIOL CHEM, V277, P25439, DOI 10.1074/jbc.M201912200; Malfait F, 2013, AM J HUM GENET, V92, P935, DOI 10.1016/j.ajhg.2013.04.016; Mizumoto S, 2013, J BIOL CHEM, V288, P10953, DOI 10.1074/jbc.R112.437038; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Mukhopadhyay N, 2005, BIOINFORMATICS, V21, P2556, DOI 10.1093/bioinformatics/bti364; Almeida R, 1999, J BIOL CHEM, V274, P26165, DOI 10.1074/jbc.274.37.26165; Ruschendorf F, 2005, BIOINFORMATICS, V21, P2123, DOI 10.1093/bioinformatics/bti264; Tone Y, 1999, FEBS LETT, V459, P415, DOI 10.1016/S0014-5793(99)01287-9; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418; Pedersen LC, 2000, J BIOL CHEM, V275, P34580, DOI 10.1074/jbc.M007399200; Bui C, 2014, AM J HUM GENET, V94, P405, DOI 10.1016/j.ajhg.2014.01.020; Faiyaz-Ul-Haque M, 2004, AM J MED GENET A, V128A, P39, DOI 10.1002/ajmg.a.30005; Strauch K, 2000, AM J HUM GENET, V66, P1945, DOI 10.1086/302911; Cartault F, 2015, EUR J HUM GENET, V23, P49, DOI 10.1038/ejhg.2014.60; Dick G, 2012, J HISTOCHEM CYTOCHEM, V60, P926, DOI 10.1369/0022155412461256; Gotting C, 2000, J MOL BIOL, V304, P517, DOI 10.1006/jmbi.2000.4261; Guo MH, 2013, AM J MED GENET A, V161, P2519, DOI 10.1002/ajmg.a.36128; Hayes AJ, 2013, DEV DYNAM, V242, P778, DOI 10.1002/dvdy.23970; Kennerknecht I, 2012, CROSSING BORDERS, V2, P3; McCoy Jr JP, 2001, CURR PROTOC CYTOM, DOI 10.1002/0471142956.cy0501s00; NEITZEL H, 1986, HUM GENET, V73, P320, DOI 10.1007/BF00279094; Pedersen LC, 2002, J BIOL CHEM, V277, P21869, DOI 10.1074/jbc.M112343200; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Ponighaus C, 2007, J BIOL CHEM, V282, P5201, DOI 10.1074/jbc.M611665200; QUENTIN E, 1990, P NATL ACAD SCI USA, V87, P1342, DOI 10.1073/pnas.87.4.1342; Sobel E, 1996, AM J HUM GENET, V58, P1323; Thiele H, 2005, BIOINFORMATICS, V21, P1730, DOI 10.1093/bioinformatics/bth488; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; van Oven M, 2011, MOL BIOL EVOL, V28, P1349, DOI 10.1093/molbev/msq300	47	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0340-6717	1432-1203		HUM GENET	Hum. Genet.	JUL	2015	134	7					691	704		10.1007/s00439-015-1549-2		14	Genetics & Heredity	Genetics & Heredity	CK0YD	WOS:000355930700002		
J	Agrawal, SA; Anand, D; Siddam, AD; Kakrana, A; Dash, S; Scheiblin, DA; Dang, CA; Terrell, AM; Waters, SM; Singh, A; Motohashi, H; Yamamoto, M; Lachke, SA				Agrawal, Smriti A.; Anand, Deepti; Siddam, Archana D.; Kakrana, Atul; Dash, Soma; Scheiblin, David A.; Dang, Christine A.; Terrell, Anne M.; Waters, Stephanie M.; Singh, Abhyudai; Motohashi, Hozumi; Yamamoto, Masayuki; Lachke, Salil A.			Compound mouse mutants of bZIP transcription factors Mafg and Mafk reveal a regulatory network of non-crystallin genes associated with cataract	HUMAN GENETICS			English	Article							FIBER CELL-DIFFERENTIATION; PROTEIN-DNA INTERACTIONS; BINDING MICROARRAY DATA; ALPHA-B-CRYSTALLIN; LENS DEVELOPMENT; MICE LACKING; C-MAF; ENVIRONMENTAL-FACTORS; VERTEBRATE LENS; ONLINE DATABASE	Although majority of the genes linked to early-onset cataract exhibit lens fiber cell-enriched expression, our understanding of gene regulation in these cells is limited to function of just eight transcription factors and largely in the context of crystallins. We report on small Maf transcription factors Mafg and Mafk as regulators of several non-crystallin human cataract-associated genes in fiber cells and establish their significance to this disease. We applied a bioinformatics tool for cataract gene discovery iSyTE to identify Mafg and its co-regulators in the lens, and generated various null-allelic combinations of Mafg:Mafk mouse mutants for phenotypic and molecular analysis. By age 4 months, Mafg-/-:Mafk+/- mutants exhibit lens defects that progressively develop into cataract. High-resolution phenotypic characterization of Mafg-/-:Mafk+/- mouse lens reveals severely disorganized fiber cells, while microarray-based expression profiling identifies 97 differentially regulated genes (DRGs). Integrative analysis of Mafg-/-:Mafk+/- lens-DRGs with (1) binding motifs and genomic targets of small Mafs and their regulatory partners, (2) iSyTE lens expression data, and (3) interactions between DRGs in the String database, unravel a detailed small Maf regulatory network in the lens, several nodes of which are linked to cataract. This approach identifies 36 high-priority candidates from the original 97 DRGs. Significantly, 8/36 (22 %) DRGs are associated with cataracts in human (GSTO1, MGST1, SC4MOL, UCHL1) or mouse (Aldh3a1, Crygf, Hspb1, Pcbd1), suggesting a multifactorial etiology that includes oxidative stress and misregulation of sterol synthesis. These data identify Mafg and Mafk as new cataract-associated candidates and define their function in regulating largely non-crystallin genes linked to human cataract.	[Agrawal, Smriti A.; Anand, Deepti; Siddam, Archana D.; Dash, Soma; Scheiblin, David A.; Dang, Christine A.; Terrell, Anne M.; Waters, Stephanie M.; Lachke, Salil A.] Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA; [Kakrana, Atul; Singh, Abhyudai; Lachke, Salil A.] Univ Delaware, Ctr Bioinformat & Computat Biol, Newark, DE 19716 USA; [Kakrana, Atul] Univ Delaware, Delaware Biotechnol Inst, Newark, DE 19716 USA; [Singh, Abhyudai] Univ Delaware, Dept Elect Engn, Newark, DE 19716 USA; [Motohashi, Hozumi] Tohoku Univ, Inst Dev Aging & Canc, Dept Gene Express Regulat, Sendai, Miyagi 980, Japan; [Yamamoto, Masayuki] Tohoku Univ, Grad Sch Med, Dept Med Biochem, Sendai, Miyagi 980, Japan	Lachke, SA (reprint author), Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA.	salil@udel.edu			National Institutes of Health [R01 EY021505]; Fight for Sight	We thank Drs. Melinda Duncan and Irfan Saadi for helpful comments and discussions. This work was supported by National Institutes of Health [R01 EY021505 to S.L.]; and Fight for Sight Grant-in-Aid award to S.L. S.L. is a Pew Scholar in Biomedical Sciences.	Alizadeh A, 2004, INVEST OPHTH VIS SCI, V45, P884, DOI 10.1167/iovs.03-0677; Hammond CJ, 2000, NEW ENGL J MED, V342, P1786, DOI 10.1056/NEJM200006153422404; Wigle JT, 1999, NAT GENET, V21, P318; Kataoka K, 2007, J BIOCHEM, V141, P775, DOI 10.1093/jb/mvm105; Kawauchi S, 1999, J BIOL CHEM, V274, P19254, DOI 10.1074/jbc.274.27.19254; Shiels A, 2010, MOL VIS, V16, P2007; Shiels A, 2013, CLIN GENET, V84, P120, DOI 10.1111/cge.12182; Lachke SA, 2010, WIRES SYST BIOL MED, V2, P305, DOI 10.1002/wsbm.59; Tanaka T, 1998, GENES CELLS, V3, P801, DOI 10.1046/j.1365-2443.1998.00230.x; Katsuoka F, 2003, MOL CELL BIOL, V23, P1163, DOI 10.1128/MCB.23.4.1163-1174.2003; Litt M, 1998, HUM MOL GENET, V7, P471, DOI 10.1093/hmg/7.3.471; Vanita V, 2006, AM J MED GENET A, V140A, P558, DOI 10.1002/ajmg.a.31126; Lachke SA, 2012, HUM GENET, V131, P235, DOI 10.1007/s00439-011-1064-z; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Bassnett S, 2011, PHILOS T R SOC B, V366, P1250, DOI 10.1098/rstb.2010.0302; Maeda A, 2009, DEV DYNAM, V238, P2280, DOI 10.1002/dvdy.22035; Scheiblin DA, 2014, INT J BIOCHEM CELL B, V50, P132, DOI 10.1016/j.biocel.2014.02.021; Shaham O, 2009, DEVELOPMENT, V136, P2567, DOI 10.1242/dev.032888; Chorley BN, 2012, NUCLEIC ACIDS RES, V40, P7416, DOI 10.1093/nar/gks409; Yang Y, 2004, J MOL BIOL, V344, P351, DOI 10.1016/j.jmb.2004.07.102; CVEKL A, 1994, MOL CELL BIOL, V14, P7363; Robasky K, 2011, NUCLEIC ACIDS RES, V39, pD124, DOI 10.1093/nar/gkq992; Yahyavi M, 2013, HUM MOL GENET, V22, P3250, DOI 10.1093/hmg/ddt179; Kasaikina MV, 2011, J BIOL CHEM, V286, P33203, DOI 10.1074/jbc.M111.259218; Cvekl A, 2007, PROG RETIN EYE RES, V26, P555, DOI 10.1016/j.preteyeres.2007.07.002; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Li W, 2008, BBA-MOL CELL RES, V1783, P1847, DOI 10.1016/j.bbamcr.2008.05.024; Newburger DE, 2009, NUCLEIC ACIDS RES, V37, pD77, DOI 10.1093/nar/gkn660; Lachke SA, 2012, INVEST OPHTH VIS SCI, V53, P1617, DOI 10.1167/iovs.11-8839; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Berthoud VM, 2009, ANTIOXID REDOX SIGN, V11, P339, DOI 10.1089/ars.2008.2119; Toki T, 1997, ONCOGENE, V14, P1901, DOI 10.1038/sj.onc.1201024; Hirotsu Y, 2012, NUCLEIC ACIDS RES, V40, P10228, DOI 10.1093/nar/gks827; Nishiguchi S, 1998, GENE DEV, V12, P776, DOI 10.1101/gad.12.6.776; Fares-Taie L, 2013, AM J HUM GENET, V92, P265, DOI 10.1016/j.ajhg.2012.12.003; Long Y, 2011, COMP BIOCHEM PHYS B, V158, P46, DOI 10.1016/j.cbpb.2010.09.005; Mori M, 2006, J CLIN INVEST, V116, P395, DOI 10.1172/JCI20797; Berry V, 2001, AM J HUM GENET, V69, P1141, DOI 10.1086/324158; Rao GN, 2011, CURR OPIN OPHTHALMOL, V22, P4, DOI 10.1097/ICU.0b013e3283414fc8; Motohashi H, 2002, GENE, V294, P1, DOI 10.1016/S0378-1119(02)00788-6; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Jamieson RV, 2002, HUM MOL GENET, V11, P33, DOI 10.1093/hmg/11.1.33; Churchill A, 2011, PHILOS T R SOC B, V366, P1234, DOI 10.1098/rstb.2010.0227; Fujimoto M, 2004, EMBO J, V23, P4297, DOI 10.1038/sj.emboj.7600435; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Ogino H, 1998, SCIENCE, V280, P115, DOI 10.1126/science.280.5360.115; Motohashi H, 2004, P NATL ACAD SCI USA, V101, P6379, DOI 10.1073/pnas.0305902101; Lachke SA, 2011, SCIENCE, V331, P1571, DOI 10.1126/science.1195970; Min JN, 2004, GENESIS, V40, P205, DOI 10.1002/gene.20087; Yamazaki H, 2012, MOL CELL BIOL, V32, P808, DOI 10.1128/MCB.06543-11; Ring BZ, 2000, DEVELOPMENT, V127, P307; Cheng C, 2013, DEVELOPMENT, V140, P4237, DOI 10.1242/dev.100727; Bu L, 2002, NAT GENET, V31, P276, DOI 10.1038/ng921; Hammond CJ, 2001, INVEST OPHTH VIS SCI, V42, P601; Fu L, 2002, J BIOL CHEM, V277, P4255, DOI 10.1074/jbc.M110027200; Donner AL, 2007, DEV BIOL, V303, P784, DOI 10.1016/j.ydbio.2006.10.047; Kannan MB, 2012, BBA-MOL CELL RES, V1823, P1841, DOI 10.1016/j.bbamcr.2012.06.012; Kim JI, 1999, P NATL ACAD SCI USA, V96, P3781, DOI 10.1073/pnas.96.7.3781; Malhotra D, 2010, NUCLEIC ACIDS RES, V38, P5718, DOI 10.1093/nar/gkq212; He MA, 2011, J CLIN INVEST, V121, P976, DOI 10.1172/JCI42650; Bayle JH, 2002, J BIOL CHEM, V277, P28884, DOI 10.1074/jbc.M201983200; Congdon N, 2005, OPHTHALMOLOGY, V112, P73, DOI 10.1016/j.ophtha.2004.07.012; Cvekl A, 2014, DEVELOPMENT, V141, P4432, DOI 10.1242/dev.107953; Graw J, 2002, INVEST OPHTH VIS SCI, V43, P2998; Huang BY, 2010, EUR J MED GENET, V53, P347, DOI 10.1016/j.ejmg.2010.07.001; Huang D. W., 2009, CURR PROTOC BIOINFOR, DOI [10.1002/0471250953.bi1311s27, DOI 10.1002/0471250953.BI1311S27]; Lassen N, 2007, J BIOL CHEM, V282, P25668, DOI 10.1074/jbc.M702076200; Liu YZ, 2007, MOL VIS, V13, P31; Nongpiur ME, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004089; Onodera K, 2000, EMBO J, V19, P1335, DOI 10.1093/emboj/19.6.1335; Reed NA, 2001, J IMMUNOL METHODS, V253, P243, DOI 10.1016/S0022-1759(01)00374-X; Rudolph T, 2011, OPHTHALMIC GENET, V32, P75, DOI 10.3109/13816810.2010.544360; Shavit JA, 1998, GENE DEV, V12, P2164, DOI 10.1101/gad.12.14.2164; Shiels A, 2007, INVEST OPHTH VIS SCI, V48, P500, DOI 10.1167/iovs.06-0947; Sorokina EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021122; Stamenkovic M, 2014, CLIN EXP OPHTHALMOL, V42, P277, DOI 10.1111/ceo.12180; Strzalka-Mrozik B, 2013, MOL VIS, V19, P1341; Yoshida T, 2002, GENES CELLS, V7, P693, DOI 10.1046/j.1365-2443.2002.00548.x; Zenkel M, 2007, INVEST OPHTH VIS SCI, V48, P5558, DOI 10.1167/iovs.07-0750	79	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0340-6717	1432-1203		HUM GENET	Hum. Genet.	JUL	2015	134	7					717	735		10.1007/s00439-015-1554-5		19	Genetics & Heredity	Genetics & Heredity	CK0YD	WOS:000355930700004		
J	Hitomi, Y; Kawashima, M; Aiba, Y; Nishida, N; Matsuhashi, M; Okazaki, H; Nakamura, M; Tokunaga, K				Hitomi, Yuki; Kawashima, Minae; Aiba, Yoshihiro; Nishida, Nao; Matsuhashi, Mika; Okazaki, Hitoshi; Nakamura, Minoru; Tokunaga, Katsushi			Human primary biliary cirrhosis-susceptible allele of rs4979462 enhances TNFSF15 expression by binding NF-1	HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; INFLAMMATORY-BOWEL-DISEASE; CYTOKINE 1A TL1A; TNF-LIKE LIGAND; RHEUMATOID-ARTHRITIS; CROHNS-DISEASE; JAPANESE POPULATION; DECOY RECEPTOR-3; LOCI; CELLS	A genome-wide association study (GWAS) identified tumor necrosis factor superfamily member 15 (TNFSF15) as the strongest associated gene with susceptibility to primary biliary cirrhosis (PBC) outside the HLA loci in the Japanese population. However, causal functional variants of the TNFSF15 locus and the molecular mechanism underlying disease susceptibility have not been clarified. Here, to identify the functional causal variants of the TNFSF15 locus, integrated analysis comprising in silico analysis, a case-control association study and in vitro functional analysis was performed. Initially, 32 functional candidate single-nucleotide polymorphisms (SNPs) in the expression regulatory motifs, the coding region, or the untranslated regions (UTRs) of the TNFSF15 locus were selected by in silico analysis. By the case-control association studies using PBC patients (n = 1279) and healthy controls (n = 1091) in the Japanese population, rs4979462 [P = 1.85 x 10(-14) (our previous study)], rs56211063 (P = 2.21 x 10(-14)), and rs55768522 (r (2) = 1 with rs4979462) were likely candidates for causal variants. Among these SNPs, rs4979462 was identified as the causal variant by in vitro functional analysis using luciferase assay and electrophoretic mobility shift assay (EMSA). Super-shift assay clarified that PBC-susceptible allele of rs4979462 generated a novel NF-1 binding site. Moreover, higher endogenous TNFSF15 protein and mRNA expression levels were observed in individuals with the PBC-susceptible allele of rs4979462. This study identified the causal variant for PBC susceptibility in the TNFSF15 locus and clarified its underlying molecular mechanism. TNFSF15 and NF-1 are considered to be potential targets for the treatment of PBC.	[Hitomi, Yuki; Kawashima, Minae; Nishida, Nao; Tokunaga, Katsushi] Univ Tokyo, Grad Sch Med, Dept Human Genet, Bunkyo Ku, Tokyo 1130033, Japan; [Kawashima, Minae] Japan Sci & Technol Agcy JST, Tokyo, Japan; [Aiba, Yoshihiro; Nakamura, Minoru] Nagasaki Med Ctr, Natl Hosp Org, Clin Res Ctr, Omura, Nagasaki, Japan; [Nishida, Nao] Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol, Ichikawa, Chiba, Japan; [Matsuhashi, Mika; Okazaki, Hitoshi] Univ Tokyo, Grad Sch Med, Dept Transfus Med, Tokyo 1130033, Japan; [Nakamura, Minoru] Nagasaki Univ, Grad Sch Biomed Sci, Dept Hepatol, Omura, Nagasaki, Japan; [Nakamura, Minoru] Nagasaki Med Ctr, Natl Hosp Org, Clin Res Ctr, Headquarters PBC Res NHOSLJ, Omura, Nagasaki, Japan	Hitomi, Y (reprint author), Univ Tokyo, Grad Sch Med, Dept Human Genet, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	yhitomi-tky@umin.ac.jp			Japan Society for the Promotion of Science [23591006, 2629318]; NHO; Research Program of Intractable Disease provided by the Ministry of Health, Labor, and Welfare of Japan; Japan Society for the Promotion of Science; Uehara Memorial Foundation; Takeda Foundation	We would like to thank all the patients and volunteers who enrolled in the study. We also thank Ms. Megumi Sageshima, Ms. Yuko Hirano, Ms. Natsumi Baba, Ms. Rieko Shirahashi, Ms. Ayumi Nakayama (The University of Tokyo), and Ms. Hitomi Nakamura (National Hospital Organization Nagasaki Medical Center) for technical and administrative assistance. This work was supported by Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (#23591006, #2629318) to M.N., Grant-in-Aid for Clinical Research from the NHO to M.N., Grant from the Research Program of Intractable Disease provided by the Ministry of Health, Labor, and Welfare of Japan to M.N., Grant from Core-to-Core program (Asia-Africa Science Platforms) from the Japan Society for the Promotion of Science to K.T., Uehara Memorial Foundation to Y.H., and Takeda Foundation to Y.H.	Bamias G, 2011, EXP DERMATOL, V20, P725, DOI 10.1111/j.1600-0625.2011.01304.x; Shih DQ, 2009, EUR J IMMUNOL, V39, P3239, DOI 10.1002/eji.200839087; Aiba Y, 2014, LIVER INT, V34, P679, DOI 10.1111/liv.12296; Liu XD, 2010, NAT GENET, V42, P658, DOI 10.1038/ng.627; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Yamazaki K, 2013, GASTROENTEROLOGY, V144, P781, DOI 10.1053/j.gastro.2012.12.021; Cassatella MA, 2007, J IMMUNOL, V178, P7325; Bayry J, 2010, NAT REV RHEUMATOL, V6, P67, DOI 10.1038/nrrheum.2009.263; Selmi C, 2004, GASTROENTEROLOGY, V127, P485, DOI 10.1053/S0016-5085(04)00841-8; Hirschfield GM, 2010, NAT GENET, V42, P655, DOI 10.1038/ng.631; Bamias G, 2008, CLIN IMMUNOL, V129, P249, DOI 10.1016/j.clim.2008.07.014; Bamias G, 2003, J IMMUNOL, V171, P4868; Kakuta Y, 2009, HUM MOL GENET, V18, P1089, DOI 10.1093/hmg/ddp005; Nagase T, 2000, DNA RES, V7, P65, DOI 10.1093/dnares/7.1.65; Mells GF, 2011, NAT GENET, V43, P329, DOI 10.1038/ng.789; Hirschfield GM, 2009, NEW ENGL J MED, V360, P2544, DOI 10.1056/NEJMoa0810440; Jones DEJ, 1999, J HEPATOL, V30, P402, DOI 10.1016/S0168-8278(99)80097-X; Migone TS, 2002, IMMUNITY, V16, P479, DOI 10.1016/S1074-7613(02)00283-2; Zhou M, 2014, CYTOKINE, V69, P125, DOI 10.1016/j.cyto.2014.04.007; Nakamura M, 2012, AM J HUM GENET, V91, P721, DOI 10.1016/j.ajhg.2012.08.010; Bamias G, 2010, CLIN IMMUNOL, V137, P242, DOI 10.1016/j.clim.2010.07.001; Bull MJ, 2008, J EXP MED, V205, P2457, DOI 10.1084/jem.20072378; Haridas V, 1999, ONCOGENE, V18, P6496, DOI 10.1038/sj.onc.1203059; Kaplan MM, 2005, NEW ENGL J MED, V353, P1261, DOI 10.1056/NEJMra043898; Nishida N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029967; Stranger BE, 2012, PLOS GENET, V8, P272, DOI 10.1371/journal.pgen.1002639; Yue TL, 1999, J BIOL CHEM, V274, P1479, DOI 10.1074/jbc.274.3.1479; Zhang FR, 2009, NEW ENGL J MED, V361, P2609, DOI 10.1056/NEJMoa0903753; Zinovieva E, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000528	29	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0340-6717	1432-1203		HUM GENET	Hum. Genet.	JUL	2015	134	7					737	747		10.1007/s00439-015-1556-3		11	Genetics & Heredity	Genetics & Heredity	CK0YD	WOS:000355930700005		
J	McVicar, M; Fukayama, S; Goto, M				McVicar, Matt; Fukayama, Satoru; Goto, Masataka			AutoGuitarTab: Computer-Aided Composition of Rhythm and Lead Guitar Parts in the Tablature Space	IEEE-ACM TRANSACTIONS ON AUDIO SPEECH AND LANGUAGE PROCESSING			English	Article						Algorithmic composition; computer-aided composition (CAC); symbolic music processing		We present AutoGuitarTab, a system for generating realistic guitar tablature given an input symbolic chord and key sequence. Our system consists of two modules: AutoRhythmGuitar and AutoLeadGuitar. The first of these generates rhythm guitar tablatures which outline the input chord sequence in a particular style (using Markov chains to ensure playability) and performs a structural analysis to produce a structurally consistent composition. AutoLeadGuitar generates lead guitar parts in distinct musical phrases, guiding the pitch classes towards chord tones and steering the evolution of the rhythmic and melodic intensity according to user preference. Experimentally, we uncover musician-specific trends in guitar playing style, and demonstrate our system's ability to produce playable, realistic and style-specific tablature using a combination of algorithmic, user-surveyed and expert evaluation techniques.	[McVicar, Matt; Fukayama, Satoru; Goto, Masataka] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058568, Japan	McVicar, M (reprint author), Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058568, Japan.	mattjamesmcvicar@gmail.com; s.fukayama@aist.go.jp; m.goto@aist.go.jp			OngaCREST, CREST, JST	This work was supported by OngaCREST, CREST, JST. The this manuscript and approving it for publication was Prof. Woon-Seng Gan.	ABESSER J, 2013, P 10 INT S COMP MUS, V7900, P333; Addessi A., 2005, BRIT J MUSIC EDUC, V22, P21, DOI DOI 10.1017/S0265051704005972; AMES C, 1989, LEONARDO, V22, P175, DOI 10.2307/1575226; Pachet F, 2003, J NEW MUSIC RES, V32, P333, DOI 10.1076/jnmr.32.3.333.16861; Nan Y, 2008, HUM BRAIN MAPP, V29, P312, DOI 10.1002/hbm.20390; Barbancho AM, 2012, IEEE T AUDIO SPEECH, V20, P915, DOI 10.1109/TASL.2011.2174227; Benadon F., 2003, P 5 TRIENN ESCOM C, P246; Burns A., 2006, P INT C NEW INT MUS, P196; Chomsky N., 2002, SYNTACTIC STRUCTURES; Conklin D., 2003, P AISB 2003 S ART IN, P30; CONKLIN D, 1995, J NEW MUSIC RES, V24, P51, DOI 10.1080/09298219508570672; FOOTE J, 2000, P IEEE INT C MULT EX, V1, P452; Goto M., 2002, P ISMIR, V2, P287; Goto M., 2011, P ISMIR 2011, P311; Hiller L., 1964, PERSPECT NEW MUSIC, P62; Hiller L., 1957, AUD ENG SOC CONV NEW; Hogg R., 1978, INTRO MATH STAT; Hori G., 2013, J INFORM PROCESSING, V21, P264; Humphrey E., 2014, P INT C AC SPEECH SI, P7024; Jensen K, 2009, LECT NOTES COMPUT SC, V5460, P1, DOI 10.1007/978-3-642-00899-3; Lukashevich H., 2008, P 9 INT C MUS INF RE, P375; McVicar M., 2014, P JOINT INT COMP MUS, P293; McVicar M., 2014, P INT C SIGN PROC, P599; Nierhaus S., 2009, ALGORITHMIC COMPOSIT; Nieto O., 2014, MIREX SUBMISSION 2D; Olson H., 1967, MUSIC PHYS ENG, V1769; Pachet F., 2001, P 22 INT JOINT C ART, P635; Pachet F., 2004, COMPUT ENTERTAIN CIE, V2, P14, DOI 10.1145/973801.973824; Papadopoulos A., 2014, P 28 AAAI C ART INT, P2731; Papadopoulos G., 1999, P AISB 99 S MUS CREA, P110; Ponsford D, 1999, J NEW MUSIC RES, V28, P150, DOI 10.1076/jnmr.28.2.150.3115; Radicioni D., 2004, P C INT MUS; Radisavljevic A., 2004, P INT COMP MUS C, V28; Rafael B, 2012, LECT NOTES COMPUT SC, V6927, P240; Raffel C., 2014, P 15 INT SOC MUS INF, P367; SAYEGH SI, 1989, COMPUT MUSIC J, V13, P76, DOI 10.2307/3680014; Schluter J., 2014, MIREX SUBMISSION STR; Shepared J., 2003, CONTINUUM ENCY POPUL, P9; Tuohy D., 2006, P C EV COMP, P1065; Xenakis I., 1992, FORMALIZED MUSIC THO; Yazawa Y., 2013, P INT C AC SPEECH SI, P196; Yazawa Y., 2014, P INT C AC SPEECH SI, P3122; Zaripov R., 1969, PERSPECT NEW MUSIC, P115	43	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2329-9290			IEEE-ACM T AUDIO SPE	IEEE-ACM Trans. Audio Speech Lang.	JUL	2015	23	7					1105	1117		10.1109/TASLP.2015.2419976		13	Acoustics; Engineering, Electrical & Electronic	Acoustics; Engineering	CK1YE	WOS:000356004800001		
J	Wang, R; Zhao, H; Lu, BL; Utiyama, M; Sumita, E				Wang, Rui; Zhao, Hai; Lu, Bao-Liang; Utiyama, Masao; Sumita, Eiichiro			Bilingual Continuous-Space Language Model Growing for Statistical Machine Translation	IEEE-ACM TRANSACTIONS ON AUDIO SPEECH AND LANGUAGE PROCESSING			English	Article						Continuous-space language model; language model growing (LMG); neural network language model; statistical machine translation (SMT)		Larger-gram language models (LMs) perform better in statistical machine translation (SMT). However, the existing approaches have two main drawbacks for constructing larger LMs: 1) it is not convenient to obtain larger corpora in the same domain as the bilingual parallel corpora in SMT; 2) most of the previous studies focus on monolingual information from the target corpora only, and redundant-grams have not been fully utilized in SMT. Nowadays, continuous-space language model (CSLM), especially neural network language model (NNLM), has been shown great improvement in the estimation accuracies of the probabilities for predicting the target words. However, most of these CSLM and NNLM approaches still consider monolingual information only or require additional corpus. In this paper, we propose a novel neural network based bilingual LM growing method. Compared to the existing approaches, the proposed method enables us to use bilingual parallel corpus for LM growing in SMT. The results show that our new method outperforms the existing approaches on both SMT performance and computational efficiency significantly.	[Wang, Rui; Zhao, Hai; Lu, Bao-Liang] Shanghai Jiao Tong Univ, Dept Comp Sci & Engn, Shanghai 200240, Peoples R China; [Wang, Rui; Zhao, Hai; Lu, Bao-Liang] Shanghai Jiao Tong Univ, Key Lab Shanghai Educ Commiss Intelligent Interac, Shanghai 200240, Peoples R China; [Utiyama, Masao; Sumita, Eiichiro] Natl Inst Informat & Commun Technol, Multilingual Translat Lab, Kyoto 6190289, Japan	Wang, R (reprint author), Shanghai Jiao Tong Univ, Dept Comp Sci & Engn, Shanghai 200240, Peoples R China.	wangrui.nlp@gmail.com; zhaohai@cs.sjtu.edu.cn; bllu@sjtu.edu.cn; mutiyama@nict.go.jp; eiichiro.sumita@nict.go.jp			National Natural Science Foundation of China [60903119, 61170114, 61272248]; National Basic Research Program of China [2013CB329401]; Science and Technology Commission of Shanghai Municipality [13511500200]; European Union Seventh Framework Program [247619]; Cai Yuanpei Program (CSC fund) [201304490199, 201304490171]; art and science interdiscipline funds of Shanghai Jiao Tong University [14X190040031(14JCRZ04)]	The work of R. Wang, H. Zhao, and B. L. Lu was supported in part by the National Natural Science Foundation of China under Grants 60903119, 61170114, and 61272248, the National Basic Research Program of China under Grant 2013CB329401, the Science and Technology Commission of Shanghai Municipality under Grant 13511500200, the European Union Seventh Framework Program under Grant 247619, the Cai Yuanpei Program (CSC fund 201304490199, 201304490171, and the art and science interdiscipline funds of Shanghai Jiao Tong University (a study on mobilization mechanism and alerting threshold setting for online community, and media image and psychology evaluation: a computational intelligence approach under Grant 14X190040031(14JCRZ04). associate editor coordinating the review of this manuscript and approving it for publication was Dr. Xiaodong He.	Chen SF, 1999, COMPUT SPEECH LANG, V13, P359, DOI 10.1006/csla.1999.0128; Mikolov T, 2010, 11TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2010 (INTERSPEECH 2010), VOLS 1-2, P1045; Siivola V, 2007, IEEE T AUDIO SPEECH, V15, P1617, DOI 10.1109/TASL.2007.896666; Bengio Y, 2003, J MACH LEARN RES, V3, P1137, DOI 10.1162/153244303322533223; [Anonymous], 2003, P 41 ANN M ASS COMP, DOI DOI 10.3115/1075096.1075117; Schwenk H, 2007, COMPUT SPEECH LANG, V21, P492, DOI 10.1016/j.csl.2006.09.003; Niesler TR, 1996, INT CONF ACOUST SPEE, P164, DOI 10.1109/ICASSP.1996.540316; Arsoy E., 2013, P INT C AC SPEECH SI, P8242; Arsoy E., 2014, IEEE-ACM T AUDIO SPE, V22, P184; Auli M., 2013, P EMNLP2013, p[1044, 18]; Axelrod A., 2011, P C EMP METH NAT LAN, P355; Bellegarda JR, 2004, SPEECH COMMUN, V42, P93, DOI 10.1016/j.specom.2003.08.002; Brants T., 2007, P 2007 JOINT C EMP M, P858; Cettolo M., 2012, P 16 C EUR ASS MACH, P261; Cho K., 2014, P C EMP METH NAT LAN, P1724; Devlin J., 2014, P 52 ANN M ASS COMP, P1370; Duh K., 2013, P 51 ANN M ASS COMP, P678; Fujii A., 2010, P 8 NTCIR WORKSH M E, P293; Gao J., 2014, P 52 ANN M ASS COMP, V1, P699; Goto Isao, 2011, PROCEEDINGS OF NTCIR, P559; Heafield K., 2013, P 51 ANN M ASS COMP, V2, P690; Jia Z., 2014, P 52 ANN M ASS COMP, P1512; Johnson H., 2007, P 2007 JOINT C EMP M, P967; Jonson R., 2006, P 11 C EUR ASS COMP, P57; Kalchbrenner N., 2013, P 2013 C EMP METH NA, P1700; Koehn P., 2007, P 45 ANN M ASS COMP, P177, DOI 10.3115/1557769.1557821; Koehn P., 2007, P 2 WORKSH STAT MACH, P224, DOI 10.3115/1626355.1626388; Koehn P, 2004, P EMNLP, V4, P388; Lauly S., 2014, ADV NEURAL INF PROCE, P1853; Le HS, 2011, INT CONF ACOUST SPEE, P5524; Liu L., 2013, P 51 ANN M ASS COMP, P791; Liu S., 2014, P 52 ANN M ASS COMP, P1491; Ma XH, 2012, PROCEEDINGS OF THE ASME INTERNATIONAL MECHANICAL ENGINEERING CONGRESS AND EXPOSITION, 2011, VOL 1, P785; Nakazawa T., 2014, PLATELETS, P1, DOI DOI 10.3109/09537104.2014.920081; Niehues J., 2012, P INT WORKSH SPOK LA, P311; Och F. J., 2003, Computational Linguistics, V29, DOI 10.1162/089120103321337421; Papineni K., 2002, P 40 ANN M ASS COMP, P311, DOI DOI 10.3115/1073083.1073135; Ristad E. S., 1995, P 33 ANN M ASS COMP, P220; Schwenk H., 2012, P NAACL HLT 2012 WOR, P11; Schwenk H., 2012, P COLING 2012, P1071; Schwenk H., 2006, P COLING ACL 2006 MA, P723, DOI 10.3115/1273073.1273166; Schwenk Holger, 2010, Prague Bulletin of Mathematical Linguistics, DOI 10.2478/v10108-010-0014-6; Siu MH, 2000, IEEE T SPEECH AUDI P, V8, P63; Son L. H., 2010, P 2010 C EMP METH NA, P778; Son L. H., 2012, P HLT NAACL 2012, P39; Stolcke A., 2011, P IEEE AUT SPEECH RE; Stolcke A., 2002, P INT C SPOK LANG PR, P257; Stolcke Andreas, 1998, P DARPA BROADC NEWS, P270; Sundermeyer M., 2014, P EMNLP, P14; Vaswani A., 2013, P EMP MOD NAT LANG P, P1387; Wang R., 2013, P C EMP METH NAT LAN, P845; Wang R., 2014, P C EMP METH NAT LAN, P189; Wang X., 2014, P 52 ANN M ASS COMP, P752; Wang XL, 2014, IEEE T KNOWL DATA EN, V26, P500, DOI 10.1109/TKDE.2013.30; Xu Q., 2012, P COLING 2012 COLING, P1341; Zaidan O.F., 2009, PRAGUE B MATH LINGUI, V91, P79; Zhang J., 2013, P 23 INT JOINT C ART, P2211; Zhang J., 2013, P 51 ANN M ASS COMP, P1425; Zhang J., 2014, P C EMP METH NAT LAN, P183; Zhang X., 2012, P 24 INT C COMP LING, P535; Zhao H., 2013, LECT NOTES COMPUTER, V7817, P248; Zhao Hongzhong, 2009, Proceedings of the 2009 2nd Asian-Pacific Conference on Synthetic Aperture Radar (APSAR 2009), DOI 10.1109/APSAR.2009.5374342; Zhao H., 2009, P C EMP METH NAT LAN, P30; Zhao H., 2009, P 12 C EUR CHAPT ACL, P879, DOI 10.3115/1609067.1609165; Zou W.Y., 2013, P C EMP METH NAT LAN, P1393	65	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2329-9290			IEEE-ACM T AUDIO SPE	IEEE-ACM Trans. Audio Speech Lang.	JUL	2015	23	7					1209	1220		10.1109/TASLP.2015.2425220		12	Acoustics; Engineering, Electrical & Electronic	Acoustics; Engineering	CK1YE	WOS:000356004800009		
J	Zeng, DZ; Guo, S; Barnawi, A; Yu, S; Stojmenovic, I				Zeng, Deze; Guo, Song; Barnawi, Ahmed; Yu, Shui; Stojmenovic, Ivan			An Improved Stochastic Modeling of Opportunistic Routing in Vehicular CPS	IEEE TRANSACTIONS ON COMPUTERS			English	Article						Vehicular cyber-physical system; epidemic routing; random linear network coding; stochastic analysis	DELAY TOLERANT NETWORKS; PERFORMANCE; ALLOCATION	Vehicular Cyber-Physical System (VCPS) provides CPS services via exploring the sensing, computing and communication capabilities on vehicles. VCPS is deeply influenced by the performance of the underlying vehicular network with intermittent connections, which make existing routing solutions hardly to be applied directly. Epidemic routing, especially the one using random linear network coding, has been studied and proved as an efficient way in the consideration of delivery performance. Much pioneering work has tried to figure out how epidemic routing using network coding (ERNC) performs in VCPS, either by simulation or by analysis. However, none of them has been able to expose the potential of ERNC accurately. In this paper, we present a stochastic analytical framework to study the performance of ERNC in VCPS with intermittent connections. By novelly modeling ERNC in VCPS using a token-bucket model, our framework can provide a much more accurate results than any existing work on the unicast delivery performance analysis of ERNC in VCPS. The correctness of our analytical results has also been confirmed by our extensive simulations.	[Zeng, Deze] China Univ Geosci, Sch Comp Sci, Wuhan 430074, Peoples R China; [Guo, Song] Univ Aizu, Sch Comp Sci & Engn, Fukushima, Japan; [Barnawi, Ahmed] King Abdulaziz Univ, Fac Comp & IT, Jeddah 21413, Saudi Arabia; [Yu, Shui] Deakin Univ, Sch Informat Technol, Geelong, Vic 3217, Australia; [Stojmenovic, Ivan] Deakin Univ, SIT, Melbourne, Vic, Australia; [Stojmenovic, Ivan] King Abdulaziz Univ, Jeddah 21413, Saudi Arabia; [Stojmenovic, Ivan] Univ Ottawa, SEECS, Ottawa, ON K1N 6N5, Canada	Zeng, DZ (reprint author), China Univ Geosci, Sch Comp Sci, Wuhan 430074, Peoples R China.	dazzae@gmail.com; sguo@u-aizu.ac.jp; ambarnawi@kau.edu.sa; syu@deakin.edu.au; Stojmenovic@gmail.com			Fundamental Research Funds for the Central Universities, China University of Geosciences (Wuhan) [CUG140615]; NSERC Discovery grant (Canada); Serbian Ministry of Science and Education [TR32016]; Singidunum University, Serbia	This research was supported by the Fundamental Research Funds for the Central Universities, China University of Geosciences (Wuhan) (Grant No. CUG140615). This research of Ivan Stojmenovic is partially supported by NSERC Discovery grant (Canada), and TR32016, Serbian Ministry of Science and Education (associated with Singidunum University, Serbia).	Ali A, 2013, AD HOC NETW, V11, P2567, DOI 10.1016/j.adhoc.2013.07.004; Altman E, 2013, IEEE T WIREL COMMUN, V12, P725, DOI 10.1109/TWC.2012.122212.120196; Altman E., 2010, P IEEE INFOCOM, P1; Li X, 2011, IEEE INFOCOM SER, P2174; Lin YF, 2008, IEEE J SEL AREA COMM, V26, P794, DOI 10.1109/JSAC.2008.080606; Altman E, 2009, IEEE INFOCOM SER, P1899, DOI 10.1109/INFCOM.2009.5062111; Altman E, 2011, IEEE ACM T NETWORK, V19, P1, DOI 10.1109/TNET.2010.2091968; Miloslavov A, 2012, IEEE T PARALL DISTR, V23, P1762, DOI 10.1109/TPDS.2012.107; Lee U, 2009, IEEE T VEH TECHNOL, V58, P882, DOI 10.1109/TVT.2008.928899; Abdrabou A, 2013, IEEE T WIREL COMMUN, V12, P4402, DOI 10.1109/TW.2013.072313.121397; Zhang XL, 2013, IEEE ACM T NETWORK, V21, P1407, DOI 10.1109/TNET.2012.2224369; Balasubramanian A, 2007, ACM SIGCOMM COMP COM, V37, P373, DOI 10.1145/1282427.1282422; Zhang XL, 2007, COMPUT NETW, V51, P2867, DOI 10.1016/j.comnet.2006.11.028; Cellucci CJ, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.066208; Burgess J., 2006, P IEEE INFOCOM, V6, P1; Gunasekaran R., 2012, P INT S WORLD WIR MO, P1; Hui P., 2005, P 2005 ACM SIGCOMM W, P244, DOI DOI 10.1145/1080139.1080142; Jia D., 2013, TRANSPORT RES C-EMER, V40, P215; Jones E. P., 2005, P ACM SIGCOMM WORKSH, P237, DOI 10.1145/1080139.1080141; Joy J., 2013, P 19 ANN INT C MOB C, P123; Khouzani MHR., 2012, P 13 ACM INT S MOB A, P175; Kim M., 2010, P IEEE IFIP INT C EM, P144; Kim M., 2013, P 28 ANN ACM S APPL, P447; Leeand U., 2010, COMPUT NETW, V54, P527; Li X, 2013, IEEE INFOCOM SER, P2571; Lindgren A., 2003, ACM SIGMOBILE MOBILE, V7, P19, DOI DOI 10.1145/961268.961272; Mahendran V, 2014, IEEE T MOBILE COMPUT, V13, P1816, DOI 10.1109/TMC.2013.25; Ni D., 2012, ADV RES APPL ARTIF I, V7345, P88; Rajkumar R. R., 2010, P DES AUT C JUN, P731; Saha A K, 2004, P 1 ACM INT WORKSH V, P91, DOI 10.1145/1023875.1023892; Sassatelli L., 2012, P 10 IEEE INT S MOD, P103; Subramanian R., 2012, P IEEE ICC, P487; Vahdat A., 2000, CS200006 DUK U DEP C; Widmer Jorg, 2005, P 2005 ACM SIGCOMM W, P284, DOI 10.1145/1080139.1080147; Zhu H., 2010, P IEEE INFOCOM, P101	35	0	0	IEEE COMPUTER SOC	LOS ALAMITOS	10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1314 USA	0018-9340	1557-9956		IEEE T COMPUT	IEEE Trans. Comput.	JUL	2015	64	7					1819	1829		10.1109/TC.2014.2349509		11	Computer Science, Hardware & Architecture; Engineering, Electrical & Electronic	Computer Science; Engineering	CK1TJ	WOS:000355989900002		
J	Gu, L; Zeng, DZ; Barnawi, A; Guo, S; Stojmenovic, I				Gu, Lin; Zeng, Deze; Barnawi, Ahmed; Guo, Song; Stojmenovic, Ivan			Optimal Task Placement with QoS Constraints in Geo-Distributed Data Centers Using DVFS	IEEE TRANSACTIONS ON COMPUTERS			English	Article						Data center; cost minimization; request mapping; dynamic voltage frequency scaling	POWER; PERFORMANCE	With the rising demands on cloud services, the electricity consumption has been increasing drastically as the main operational expenditure (OPEX) to data center providers. The geographical heterogeneity of electricity prices motivates us to study the task placement problem over geo-distributed data centers. We exploit the dynamic frequency scaling technique and formulate an optimization problem that minimizes OPEX while guaranteeing the quality-of-service, i.e., the expected response time of tasks. Furthermore, an optimal solution is discovered for this formulated problem. The experimental results show that our proposal achieves much higher cost-efficiency than the traditional resizing scheme, i.e., by activating/deactivating certain servers in data centers.	[Gu, Lin; Guo, Song] Univ Aizu, Sch Comp Sci & Engn, Fukushima, Japan; [Zeng, Deze] China Univ Geosci, Sch Comp Sci, Wuhan 430074, Peoples R China; [Barnawi, Ahmed] King Abdulaziz Univ, Fac Comp & IT, Jeddah 21413, Mekkah, Saudi Arabia; [Stojmenovic, Ivan] Deakin Univ, Dept SIT, Melbourne, Vic, Australia; [Stojmenovic, Ivan] King Abdulaziz Univ, Jeddah 21413, Mekkah, Saudi Arabia; [Stojmenovic, Ivan] Univ Ottawa, SEECS, Ottawa, ON K1N 6N5, Canada	Gu, L (reprint author), Univ Aizu, Sch Comp Sci & Engn, Fukushima, Japan.	linny.gu@gmail.com; dazzae@gmail.com; ambarnawi@kau.edu.sa; sguo@uizu.ac.jp; Stojmenovic@gmail.com			Fundamental Research Funds for the Central Universities, China University of Geosciences (Wuhan) [CUG140615]; NSERC Discovery grant (Canada); Serbian Ministry of Science and Education [TR32016]; Singidunum University, Serbia	This research was supported by the Fundamental Research Funds for the Central Universities, China University of Geosciences (Wuhan) (Grant No. CUG140615). This research of Ivan Stojmenovic is partially supported by NSERC Discovery grant (Canada), and TR32016, Serbian Ministry of Science and Education (associated with Singidunum University, Serbia).	Andrews M., 2010, P IEEE INFOCOM, P1, DOI 10.1109/ITAB.2010.5687800; Liu S, 2013, INT PARALL DISTRIB P, P611, DOI 10.1109/IPDPS.2013.60; Xu H, 2013, IEEE INFOCOM SER, P854; Leverich J, 2009, IEEE COMP ARCHIT L, V8, P48, DOI 10.1109/L-CA.2009.46; Govindan S, 2011, ISCA 2011: PROCEEDINGS OF THE 38TH ANNUAL INTERNATIONAL SYMPOSIUM ON COMPUTER ARCHITECTURE, P341; Qureshi A, 2009, ACM SIGCOMM COMP COM, V39, P123; Hanumaiah V, 2012, IEEE T COMPUT, V61, P1484, DOI 10.1109/TC.2011.156; Gao PX, 2012, ACM SIGCOMM COMP COM, V42, P211, DOI 10.1145/2377677.2377719; Meisner D, 2009, ACM SIGPLAN NOTICES, V44, P205; Fan XB, 2007, CONF PROC INT SYMP C, P13; Lin MH, 2011, IEEE INFOCOM SER, P1098; Kim NS, 2003, COMPUTER, V36, P68, DOI 10.1109/MC.2003.1250885; Howard J, 2011, IEEE J SOLID-ST CIRC, V46, P173, DOI 10.1109/JSSC.2010.2079450; Raghavendra R, 2008, ACM SIGPLAN NOTICES, V43, P48, DOI 10.1145/1353536.1346289; Meisner D, 2011, ISCA 2011: PROCEEDINGS OF THE 38TH ANNUAL INTERNATIONAL SYMPOSIUM ON COMPUTER ARCHITECTURE, P319; Bilgir O., 2011, P 3 WORKSH EN EFF DE, P1; Boyd S, 2004, CONVEX OPTIMIZATION; Chen G., 2008, P 5 USENIX S NETW SY, V8, P337; David H., 2011, P 8 ACM INT C AUT CO, P31; Delimitrou C, 2013, ACM SIGPLAN NOTICES, V48, P77; Etinski M, 2012, J PARALLEL DISTR COM, V72, P579, DOI 10.1016/j.jpdc.2012.01.006; Fu W., 2012, P ACM IEEE S ARCH NE, P139; Gunduz S, 2003, LECT NOTES COMPUT SC, V2869, P332; Hu Zhingang, 2004, P INT S LOW POW EL D, P32, DOI 10.1145/1013235.1013249; Jiang CF, 2009, 2009 ISECS INTERNATIONAL COLLOQUIUM ON COMPUTING, COMMUNICATION, CONTROL, AND MANAGEMENT, VOL IV, P428, DOI 10.1109/CCCM.2009.5267619; Le Sueur Etienne, 2010, P 2010 INT C POW AW, P1; Li B., 2013, P 6 INT C ADV COMP I, P33; Li D., 2012, P 41 INT C PAR PROC, P430; Liu Z., 2011, P ACM SIGMETRICS JOI, P233, DOI DOI 10.1145/1993744.1993767.URL; Liu Zhenhua, 2012, PERFORM EVALUATION, V40, P175; Ma K., 2012, P INT C PAR ARCH COM, P13; Marshall I, 1998, COMPUT NETWORKS ISDN, V30, P2123, DOI 10.1016/S0169-7552(98)00244-X; Rao L., 2010, P IEEE INFOCOM, P1, DOI DOI 10.1109/INFCOM.2010.5461933; Rountree B, 2012, IEEE SYM PARA DISTR, P947, DOI 10.1109/IPDPSW.2012.116; Urgaonkar R., 2011, P ACM SIGMETRICS JOI, P221	35	0	0	IEEE COMPUTER SOC	LOS ALAMITOS	10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1314 USA	0018-9340	1557-9956		IEEE T COMPUT	IEEE Trans. Comput.	JUL	2015	64	7					2049	2059		10.1109/TC.2014.2349510		11	Computer Science, Hardware & Architecture; Engineering, Electrical & Electronic	Computer Science; Engineering	CK1TJ	WOS:000355989900019		
J	Namba, K; Lombardi, F				Namba, Kazuteru; Lombardi, Fabrizio			Non-Binary Orthogonal Latin Square Codes for a Multilevel Phase Charge Memory (PCM)	IEEE TRANSACTIONS ON COMPUTERS			English	Article						Error correcting code (ECC); phase change memory (PCM); orthogonal Latin square (OLS) codes; multi-symbol error correcting code; parallel decoder	RESISTANCE; HSPICE; DRIFT	This manuscript proposes non-binary orthogonal Latin square (OLS) codes that are amenable to a multilevel phase change memory (PCM). This is based on the property that the proposed (n symbols, k symbols) t-symbol error correcting code uses the same H matrix as an (n bits, k bits) binary t-bit error correcting OLS code. The new codes are shown to have a shorter check bit length and better probability in encoding/decoding than conventional binary OLS codes. Extensive results are provided for assessment and comparison. The proposed codes are also shown to be always better than the matrix codes, i.e. independently of the metric and the parameters employed in the comparison.	[Namba, Kazuteru] Chiba Univ, Grad Sch Adv Integrat Sci, Chiba, Japan; [Lombardi, Fabrizio] Northeastern Univ, Dept Elect & Comp Engn, Boston, MA 02115 USA	Namba, K (reprint author), Chiba Univ, Grad Sch Adv Integrat Sci, Chiba, Japan.	namba@ieee.org; lombardi@ece.neu.edu					Xu W, 2011, IEEE T VLSI SYST, V19, P1357, DOI 10.1109/TVLSI.2010.2052640; Ielmini D, 2007, IEEE T ELECTRON DEV, V54, P308, DOI 10.1109/TED.2006.888752; Kim S, 2011, IEEE T ELECTRON DEV, V58, P584, DOI 10.1109/TED.2010.2095502; Karpov IV, 2007, J APPL PHYS, V102, DOI 10.1063/1.2825650; Argyrides C, 2011, IEEE T VLSI SYST, V19, P420, DOI 10.1109/TVLSI.2009.2036362; Boniardi M, 2009, 2009 IEEE INTERNATIONAL RELIABILITY PHYSICS SYMPOSIUM, VOLS 1 AND 2, P122, DOI 10.1109/IRPS.2009.5173236; Chen CY, 2010, IEEE T COMMUN, V58, P3140, DOI 10.1109/TCOMM.2010.091310.090327; Chishti Zeshan, 2009, Proceedings of the 2009 42nd Annual IEEE/ACM International Symposium on Microarchitecture (MICRO 2009), DOI 10.1145/1669112.1669126; Cobley RA, 2006, IEEE T ELECTRON DEV, V53, P112, DOI 10.1109/TED.2005.860642; Colbourn C.J., 1996, CRC HDB COMBINATORIA; Costello Jr D.J., 2004, ERROR CONTROL CODING; Datta R, 2011, IEEE VLSI TEST SYMP, P134, DOI 10.1109/VTS.2011.5783773; Fujiwara E., 2006, CODE DESIGN DEPENDAB; Fujiwara E., 2002, Proceedings 2002 IEEE International Symposium on Information Theory (Cat. No.02CH37371), DOI 10.1109/ISIT.2002.1023701; Hsiao H. Y., 1970, IBM J RES DEV, V14, P390; Junsangsri P, 2012, IEEE INT SYMP NANO, P77; Papandreou N, 2010, Proceedings of the 2010 17th IEEE International Conference on Electronics, Circuits and Systems (ICECS 2010), DOI 10.1109/ICECS.2010.5724687; Rajendran B., 2011, P IEEE INT MEM WORKS, P1; Reviriego P, 2011, IEEE T NUCL SCI, V58, P981, DOI 10.1109/TNS.2011.2109965; Wei XQ, 2006, IEEE T ELECTRON DEV, V53, P56, DOI 10.1109/TED.2005.860645	20	1	1	IEEE COMPUTER SOC	LOS ALAMITOS	10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1314 USA	0018-9340	1557-9956		IEEE T COMPUT	IEEE Trans. Comput.	JUL	2015	64	7					2092	2097		10.1109/TC.2014.2346182		6	Computer Science, Hardware & Architecture; Engineering, Electrical & Electronic	Computer Science; Engineering	CK1TJ	WOS:000355989900023		
J	Kurihara, J; Matsumoto, R; Uyematsu, T				Kurihara, Jun; Matsumoto, Ryutaroh; Uyematsu, Tomohiko			Relative Generalized Rank Weight of Linear Codes and Its Applications to Network Coding	IEEE TRANSACTIONS ON INFORMATION THEORY			English	Article						Network error correction; rank distance; relative dimension/intersection profile; relative generalized Hamming weight; relative generalized rank weight; secure network coding	SECURE NETWORK; HAMMING WEIGHT; MULTICAST; DIMENSION; SECRET	By extending the notion of minimum rank distance, this paper introduces two new relative code parameters of a linear code C-1 of length n over a field extension F(q)m and its subcode C-2 (sic) C-1. One is called the relative dimension/intersection profile (RDIP), and the other is called the relative generalized rank weight (RGRW). We clarify their basic properties and the relation between the RGRW and the minimum rank distance. As applications of the RDIP and the RGRW, the security performance and the error correction capability of secure network coding, guaranteed independently of the underlying network code, are analyzed and clarified. We propose a construction of secure network coding scheme, and analyze its security performance and error correction capability as an example of applications of the RDIP and the RGRW. Silva and Kschischang showed the existence of a secure network coding in which no part of the secret message is revealed to the adversary even if any dimC(1)-1 links are wiretapped, which is guaranteed over any underlying network code. However, the explicit construction of such a scheme remained an open problem. Our new construction is just one instance of secure network coding that solves this open problem.	[Kurihara, Jun] KDDI Res & Dev Labs Inc, Saitama 3568502, Japan; [Matsumoto, Ryutaroh; Uyematsu, Tomohiko] Tokyo Inst Technol, Dept Commun & Integrated Syst, Meguro Ku, Tokyo 1528550, Japan; [Matsumoto, Ryutaroh] Aalborg Univ, Dept Math Sci, DK-9220 Aalborg, Denmark	Kurihara, J (reprint author), KDDI Res & Dev Labs Inc, Saitama 3568502, Japan.	kurihara@ieee.org; ryutaroh@rmatsumoto.org; uyematsu@ieee.org		Matsumoto, Ryutaroh/0000-0002-5085-8879	Japan Society for the Promotion of Science [23246071, 26289116]; Villum Foundation through the VELUX Visiting Professor Programme	This work was supported in part by the Japan Society for the Promotion of Science under Grant 23246071 and Grant 26289116 and in part by the Villum Foundation through the VELUX Visiting Professor Programme. This paper was presented at the 2012 IEEE International Symposium on Information Theory [21] and at the 50th Annual Allerton Conference on Communication, Control, and Computing in 2012 [22].	Cai N, 2011, IEEE T INFORM THEORY, V57, P424, DOI 10.1109/TIT.2010.2090197; Chen H, 2007, LECT NOTES COMPUT SC, V4515, P291; Luo Y, 2005, IEEE T INFORM THEORY, V51, P1222, DOI 10.1109/TIT.2004.842763; SHAMIR A, 1979, COMMUN ACM, V22, P612, DOI 10.1145/359168.359176; Silva D, 2011, IEEE T INFORM THEORY, V57, P1124, DOI 10.1109/TIT.2010.2090212; FORNEY GD, 1994, IEEE T INFORM THEORY, V40, P1741, DOI 10.1109/18.340452; Silva D, 2008, IEEE T INFORM THEORY, V54, P3951, DOI 10.1109/TIT.2008.928291; Ho T, 2006, IEEE T INFORM THEORY, V52, P4413, DOI 10.1109/TIT.2006.881746; Zamir R, 2002, IEEE T INFORM THEORY, V48, P1250, DOI 10.1109/TIT.2002.1003821; Koetter R, 2003, IEEE ACM T NETWORK, V11, P782, DOI 10.1109/TNET.2003.818197; Ahlswede R, 2000, IEEE T INFORM THEORY, V46, P1204, DOI 10.1109/18.850663; Cai N, 2011, P IEEE, V99, P421, DOI 10.1109/JPROC.2010.2094592; Silva D, 2009, IEEE T INFORM THEORY, V55, P5479, DOI 10.1109/TIT.2009.2032817; Duursma IM, 2010, FINITE FIELDS TH APP, V16, P36, DOI 10.1016/j.ffa.2009.11.006; Silva D, 2009, ITW: 2009 IEEE INFORMATION THEORY WORKSHOP ON NETWORKING AND INFORMATION THEORY, P281; WEI VK, 1991, IEEE T INFORM THEORY, V37, P1412, DOI 10.1109/18.133259; Li SYR, 2003, IEEE T INFORM THEORY, V49, P371, DOI 10.1109/TIT.2002.807285; Blakley G. R., 1979, P AFIPS 1979 NAT COM, V48, P313; Cai N, 2009, 2009 IEEE INTERNATIONAL SYMPOSIUM ON INFORMATION THEORY, VOLS 1- 4, P413; Cai N, 2007, 2007 IEEE INTERNATIONAL SYMPOSIUM ON INFORMATION THEORY PROCEEDINGS, VOLS 1-7, P561, DOI 10.1109/ISIT.2007.4557284; Cover T. M., 2006, ELEMENTS INFORM THEO; Ducoat J., 2013, 11 INT C FIN FIELDS; El Rouayheb S, 2012, IEEE T INFORM THEORY, V58, P1361, DOI 10.1109/TIT.2011.2173631; Feldman J., 2004, P 42 ANN ALL C COMM, P1; Fragouli C., 2007, NETWORK CODING FUNDA; Gabidulin E. M., 1985, Problems of Information Transmission, V21; Gadouleau M., 2007, PROPERTIES RANK METR; Harada K, 2008, IEICE T FUND ELECTR, VE91A, P2720, DOI 10.1093/ietfec/e91-a.10.2720; Kurihara J., 2012, Proceedings of the 2012 IEEE International Symposium on Information Theory - ISIT, DOI 10.1109/ISIT.2012.6283510; Kurihara J, 2012, IEICE T FUND ELECTR, VE95A, P2067, DOI 10.1587/transfun.E95.A.2067; Kurihara J., 2012, P 50 ANN ALL C COMM, P533; Loidreau P., 2006, PROPERTIES CODES RAN; MacWilliams F. J., 1977, THEORY ERROR CORRECT; Matsumoto R., 2011, P NETCOD 2011 BEIJ C, P1; Meyer C. D., 2001, MATRIX ANAL APPL LIN; Ngai CK, 2011, IEEE T INFORM THEORY, V57, P1136, DOI 10.1109/TIT.2010.2095233; Nishiara Mikihiko, 2009, IEICE Transactions on Fundamentals of Electronics, Communications and Computer Sciences, VJ92-A; Oggier F, 2012, 2012 INTERNATIONAL SYMPOSIUM ON INFORMATION THEORY AND ITS APPLICATIONS (ISITA 2012), P406; Ozarow L. H., 1984, BELL SYST TECH J, V63, P2135; Shioji E, 2010, IEICE T FUND ELECTR, VE93A, P2026, DOI 10.1587/transfun.E93.A.2026; Stevens W. R., 1994, TCP IP ILLUSTRATED P, V1; STICHTENOTH H, 1990, IEEE T INFORM THEORY, V36, P90, DOI 10.1109/18.50376; Subramaman A., 2009, MDS CODES ERASURE ER; Yamamoto H., 1986, Electronics and Communications in Japan, Part 1 (Communications), V69, DOI 10.1002/ecja.4410690906; Zhang ZX, 2009, 2009 IEEE INFORMATION THEORY WORKSHOP (ITW 2009), P70; Zhang ZX, 2009, 2009 IEEE INTERNATIONAL SYMPOSIUM ON INFORMATION THEORY, VOLS 1- 4, P1155, DOI 10.1109/ISIT.2009.5206009; Zhu Y, 2004, IEEE J SEL AREA COMM, V22, P107, DOI 10.1109/JSAC.2003.818801	47	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9448	1557-9654		IEEE T INFORM THEORY	IEEE Trans. Inf. Theory	JUL	2015	61	7					3912	3936		10.1109/TIT.2015.2429713		25	Computer Science, Information Systems; Engineering, Electrical & Electronic	Computer Science; Engineering	CK5XP	WOS:000356301600017		
J	Takahashi, T; Kurita, T				Takahashi, Takashi; Kurita, Takio			Mixture of Subspaces Image Representation and Compact Coding for Large-Scale Image Retrieval	IEEE TRANSACTIONS ON PATTERN ANALYSIS AND MACHINE INTELLIGENCE			English	Article						Image retrieval; image search; likelihood function; principal component analysis	PRINCIPAL COMPONENT ANALYSIS; NEAREST-NEIGHBOR	There are two major approaches to content-based image retrieval using local image descriptors. One is descriptor-by-descriptor matching and the other is based on comparison of global image representation that describes the set of local descriptors of each image. In large-scale problems, the latter is preferred due to its smaller memory requirements; however, it tends to be inferior to the former in terms of retrieval accuracy. To achieve both low memory cost and high accuracy, we investigate an asymmetric approach in which the probability distribution of local descriptors is modeled for each individual database image while the local descriptors of a query are used as is. We adopt a mixture model of probabilistic principal component analysis. The model parameters constitute a global image representation to be stored in database. Then the likelihood function is employed to compute a matching score between each database image and a query. We also propose an algorithm to encode our image representation into more compact codes. Experimental results demonstrate that our method can represent each database image in less than several hundred bytes achieving higher retrieval accuracy than the state-of-the-art method using Fisher vectors.	[Takahashi, Takashi] Ryukoku Univ, Dept Appl Math & Informat, Otsu, Shiga 5202194, Japan; [Kurita, Takio] Hiroshima Univ, Dept Informat Engn, Higashihiroshima 7398527, Japan	Takahashi, T (reprint author), Ryukoku Univ, Dept Appl Math & Informat, Otsu, Shiga 5202194, Japan.	takataka@math.ryukoku.ac.jp; tkurita@hiroshima-u.ac.jp	Kurita, Takio/D-8674-2012	Kurita, Takio/0000-0003-3982-6750			Jegou H, 2010, INT J COMPUT VISION, V87, P316, DOI 10.1007/s11263-009-0285-2; Tipping ME, 1999, J ROY STAT SOC B, V61, P611, DOI 10.1111/1467-9868.00196; Andoni A, 2008, COMMUN ACM, V51, P117, DOI 10.1145/1327452.1327494; Jegou H, 2012, IEEE T PATTERN ANAL, V34, P1704, DOI 10.1109/TPAMI.2011.235; Kambhatla N, 1997, NEURAL COMPUT, V9, P1493, DOI 10.1162/neco.1997.9.7.1493; Mikolajczyk K, 2004, INT J COMPUT VISION, V60, P63, DOI 10.1023/B:VISI.0000027790.02288.f2; MALLAT SG, 1993, IEEE T SIGNAL PROCES, V41, P3397, DOI 10.1109/78.258082; Jegou H, 2010, PROC CVPR IEEE, P3304, DOI 10.1109/CVPR.2010.5540039; Jegou H, 2011, IEEE T PATTERN ANAL, V33, P117, DOI 10.1109/TPAMI.2010.57; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Vidal R, 2011, IEEE SIGNAL PROC MAG, V28, P52, DOI 10.1109/MSP.2010.939739; Tuytelaars T, 2011, 2011 IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION (ICCV), P1824, DOI 10.1109/ICCV.2011.6126449; Bishop C. M., 2006, PATTERN RECOGNITION; Boiman O., 2008, P IEEE C COMP VIS PA, P1; Gionis A, 1999, PROCEEDINGS OF THE TWENTY-FIFTH INTERNATIONAL CONFERENCE ON VERY LARGE DATA BASES, P518; Ho J., 2008, P IEEE C COMP VIS PA, P11; Jain M., 2012, P 2 ACM ICMR JUN, DOI 10.1145/2324796.2324820; JEGOU H, 2008, P EUR C COMP VIS, V5302, P304; Negrel R, 2012, IEEE IMAGE PROC, P2425, DOI 10.1109/ICIP.2012.6467387; Nister D., 2006, P IEEE C COMP VIS PA, P2161; Perronnin F, 2010, LECT NOTES COMPUT SC, V6314, P143, DOI 10.1007/978-3-642-15561-1_11; Perronnin F., 2007, P IEEE C COMP VIS PA, P1, DOI DOI 10.1109/CVPR.2007.383266]; Picard D, 2011, IEEE IMAGE PROC, P669, DOI 10.1109/ICIP.2011.6116641; Sivic J., 2003, P 9 IEEE C COMP VIS, V2, P1470, DOI DOI 10.1109/ICCV.2003.1238663; Weiss Y., 2008, P NEUR INF PROC SYST, P1753	25	0	0	IEEE COMPUTER SOC	LOS ALAMITOS	10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1314 USA	0162-8828	1939-3539		IEEE T PATTERN ANAL	IEEE Trans. Pattern Anal. Mach. Intell.	JUL	2015	37	7					1469	1479		10.1109/TPAMI.2014.2382092		11	Computer Science, Artificial Intelligence; Engineering, Electrical & Electronic	Computer Science; Engineering	CK0YG	WOS:000355931100013		
J	Morikawa, M				Morikawa, Masayuki			Postgraduate Education and Labor Market Outcomes: An Empirical Analysis Using Micro Data from Japan	INDUSTRIAL RELATIONS			English	Article							UNITED-STATES; RETURNS; SKILLS	Using a large micro dataset from Japan, this paper provides evidence on the relationship between postgraduate education and labor-market outcomes. According to the analysis, the key findings include: (1) The employment-to-population rates of females and elderly people with postgraduate educations are higher than those with undergraduate educations. (2) The postgraduate wage premium relative to undergraduates is approximately 30-40 percent, which is similar in magnitude for male and female workers. (3) The wage reduction after age 60 is less for workers with a postgraduate education. (4) The private rate of return to postgraduate education exceeds 10 percent.	Res Inst Econ Trade & Ind RIETI, Tokyo, Japan	Morikawa, M (reprint author), Res Inst Econ Trade & Ind RIETI, Tokyo, Japan.	morikawa-masayuki@rieti.go.jp					Abe Y, 2000, JPN ECON REV, V51, P252, DOI 10.1111/1468-5876.00150; Akabayashi H, 2011, J JPN INT ECON, V25, P183, DOI 10.1016/j.jjie.2011.07.003; Moretti E, 2004, AM ECON REV, V94, P656, DOI 10.1257/0002828041464623; Meghir C, 2011, HBK ECON, V3, P1, DOI 10.1016/S0169-7218(11)03001-2; Lefgren L, 2006, J LABOR ECON, V24, P787, DOI 10.1086/506486; Card D, 2001, ECONOMETRICA, V69, P1127, DOI 10.1111/1468-0262.00237; Jones BF, 2010, REV ECON STAT, V92, P1, DOI 10.1162/rest.2009.11724; Walker I, 2011, ECON EDUC REV, V30, P1177, DOI 10.1016/j.econedurev.2011.01.002; Jaeger DA, 1996, REV ECON STAT, V78, P733, DOI 10.2307/2109960; Jones BF, 2009, REV ECON STUD, V76, P283, DOI 10.1111/j.1467-937X.2008.00531.x; HASHIMOTO M, 1985, AM ECON REV, V75, P721; Altonji JG, 2012, ANNU REV ECON, V4, P185, DOI 10.1146/annurev-economics-080511-110908; Carneiro P, 2011, AM ECON REV, V101, P2309, DOI 10.1257/aer.101.6.2309; Falck O, 2011, LABOUR ECON, V18, P755, DOI 10.1016/j.labeco.2011.06.004; Card D., 1999, HDB LABOR EC, V3A, P1801, DOI DOI 10.1016/S1573-4463(99)03011-4; Cutler D.M., 2012, 17738 NAT BUR EC RES; Deere Donald R., 2006, HDB EC ED, V1, P255, DOI 10.1016/S1574-0692(06)01006-3; Eide ER, 2011, ECON EDUC REV, V30, P778, DOI 10.1016/j.econedurev.2011.03.009; Heckman James J., 2006, HDB EC ED, V1, P307, DOI 10.1016/S1574-0692(06)01007-5; MINCER J, 1988, J JAPANESE INT EC, V0002; Higuchi Yoshio, 2008, FINANCIAL REV, V92, P93; Hussey A, 2012, ECON EDUC REV, V31, P442, DOI 10.1016/j.econedurev.2011.12.004; Ichimura Hidehiko, 2009, 09E047 RES I EC TRAD; Kawaguchi Daiji, 2014, 14E017 RES I EC TRAD; Kawaguchi Daiji, 2011, 11J026 RES I EC TRAD; Lemieux T., 2006, J MINCER PIONEER MOD, P127, DOI 10.1007/0-387-29175-X_11; Lindley J., 2011, 5981 IZA; Lochner L, 2012, ANNU REV ECON, V4, P225, DOI 10.1146/annurev-economics-080511-110920; Ministry of Education Culture Sports Science and Technology, 2012, SCH BAS SURV; Ministry of health labour and welfare, 2011, SUMM REP BAS SURV WA; Ministry of Internal Affairs and Communication, 2007, EMPL STAT SURV; Montgomery M, 2003, IND RELAT, V42, P396, DOI 10.1111/1468-232X.00297; Mulligan CB, 2008, Q J ECON, V123, P1061, DOI 10.1162/qjec.2008.123.3.1061; Nagaoka Sadao, 2010, 10P013 RES I EC TRAD; Oreopoulos Philip, 2013, 19053 NAT BUR EC RES; Peracchi F., 2006, HDB EC ED, V1, P189, DOI 10.1016/S1574-0692(06)01005-1; Shimizutani S, 2010, IND RELAT, V49, P248; Sianesi B., 1999, FISCAL STUDIES, V20, P1, DOI DOI 10.1111/J.1475-5890.1999.TB00001.X; Song M, 2008, ECON EDUC REV, V27, P664, DOI 10.1016/j.econedurev.2007.09.008; TEULINGS CN, 1995, J POLIT ECON, V103, P280, DOI 10.1086/261984; Tsukada Naotoshi, 2007, 07J046 RES I EC TRAD	41	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0019-8676	1468-232X		IND RELAT	Ind. Relat.	JUL	2015	54	3					499	520		10.1111/irel.12100		22	Industrial Relations & Labor	Business & Economics	CJ9PX	WOS:000355835800006		
J	Matsuo, J; Nakamura, S; Takeda, S; Ishida, K; Yamazaki, T; Yoshida, M; Chiba, H; Hui, SP; Yamaguchi, H				Matsuo, Junji; Nakamura, Shinji; Takeda, Seiji; Ishida, Kasumi; Yamazaki, Tomohiro; Yoshida, Mitsutaka; Chiba, Hitoshi; Hui, Shu-Ping; Yamaguchi, Hiroyuki			Synergistic Costimulatory Effect of Chlamydia pneumoniae with Carbon Nanoparticles on NLRP3 Inflammasome-Mediated Interleukin-1 beta Secretion in Macrophages	INFECTION AND IMMUNITY			English	Article							BLOOD MONONUCLEAR-CELLS; CHLAMYDOPHILA-PNEUMONIAE; CYTOKINE PRODUCTION; ACTIVATION; PYROPTOSIS; IL-1-BETA; INFECTION; IDENTIFICATION; TRACHOMATIS; EXPRESSION	The obligate intracellular bacterium Chlamydia pneumoniae is not only a causative agent of community-acquired pneumonia but is also associated with a more serious chronic disease, asthma, which might be exacerbated by air pollution containing carbon nanoparticles. Although a detailed mechanism of exacerbation remains unknown, the proinflammatory cytokine interleukin- 1 beta (IL-1 beta) is a critical player in the pathogenesis of asthma. C. pneumoniae induces IL-1 beta in macrophages via NACHT, LRR, and PYD domain-containing protein 3 (NLRP3) inflammasome activation and Toll-like receptor 2/4 (TLR2/4) stimulation. Carbon nanoparticles, such as carbon nanotubes (CNTs), can also evoke the NLRP3 inflammasome to trigger IL-1 beta secretion from lipopolysaccharide-primed macrophages. This study assessed whether costimulation of C. pneumoniae with CNTs synergistically enhanced IL-1 beta secretion from macrophages, and determined the molecular mechanism involved. Enhanced IL-1 beta secretion from C. pneumoniae-infected macrophages by CNTs was dose and time dependent. Transmission electron microscopy revealed that C. pneumoniae and CNTs were engulfed concurrently by macrophages. Inhibitors of actin polymerization or caspase-1, a component of the inflammasome, significantly blocked IL-1 beta secretion. Gene silencing using small interfering RNA (siRNA) targeting the NLRP3 gene also abolished IL-1 beta secretion. Other inhibitors (K+ efflux inhibitor, cathepsin B inhibitor, and reactive oxygen species-generating inhibitor) also blocked IL-1 beta secretion. Taken together, these findings demonstrated that CNTs synergistically enhanced IL-1 beta secretion from C. pneumoniae-infected macrophages via the NLRP3 inflammasome and caspase-1 activation, providing novel insight into our understanding of how C. pneumoniae infection can exacerbate asthma.	[Matsuo, Junji; Ishida, Kasumi; Yamazaki, Tomohiro; Hui, Shu-Ping; Yamaguchi, Hiroyuki] Hokkaido Univ, Fac Hlth Sci, Dept Med Lab Sci, Sapporo, Hokkaido, Japan; [Takeda, Seiji; Chiba, Hitoshi; Hui, Shu-Ping] Hokkaido Univ, Fac Hlth Sci, Hlth Innovat & Technol Ctr, Sapporo, Hokkaido, Japan; [Chiba, Hitoshi] Hokkaido Univ, Fac Hlth Sci, Dept Hlth Sci Technol, Sapporo, Hokkaido, Japan; [Nakamura, Shinji] Juntendo Univ, Grad Sch Med, Div Biomed Imaging Res, Tokyo, Japan; [Yoshida, Mitsutaka] Juntendo Univ, Grad Sch Med, Div Ultrastruct Res, Tokyo, Japan; [Ishida, Kasumi; Yamazaki, Tomohiro] Japan Soc Promot Sci, Tokyo, Japan	Yamaguchi, H (reprint author), Hokkaido Univ, Fac Hlth Sci, Dept Med Lab Sci, Sapporo, Hokkaido, Japan.	hiroyuki@med.hokudai.ac.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI [25860824, 21590474, 24659194, 24117501]	This study was supported by grants-in-aid for the Japan Society for the Promotion of Science (JSPS) KAKENHI, grant no. 25860824, 21590474, 24659194, and 24117501 "Innovation Areas (Matryoshka-Type Evolution)." K. Ishida is a Research Fellow of the Japan Society for the Promotion of Science.	Duprez L, 2009, MICROBES INFECT, V11, P1050, DOI 10.1016/j.micinf.2009.08.013; Silveira TN, 2010, INFECT IMMUN, V78, P1403, DOI 10.1128/IAI.00905-09; He XB, 2010, J IMMUNOL, V184, P5743, DOI 10.4049/jimmunol.0903937; Broz P, 2010, CELL HOST MICROBE, V8, P471, DOI 10.1016/j.chom.2010.11.007; Meunier E, 2012, NANOMED-NANOTECHNOL, V8, P987, DOI 10.1016/j.nano.2011.11.004; Shimada K, 2012, MICROBES INFECT, V14, P1301, DOI 10.1016/j.micinf.2012.08.004; Prebeck S, 2001, J IMMUNOL, V167, P3316; Blasi F, 2009, CLIN MICROBIOL INFEC, V15, P29, DOI 10.1111/j.1469-0691.2008.02130.x; Horvath GL, 2011, IMMUNOL REV, V243, P119, DOI 10.1111/j.1600-065X.2011.01050.x; Miura K, 2011, INFECT IMMUN, V79, P4947, DOI 10.1128/IAI.05640-11; Meixenberger K, 2010, J IMMUNOL, V184, P922, DOI 10.4049/jimmunol.0901346; Takeda S, 2013, J BIOMED NANOTECHNOL, V9, P303, DOI 10.1166/jbn.2013.1518; Reisetter AC, 2011, J BIOL CHEM, V286, P21844, DOI 10.1074/jbc.M111.238519; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Hornung V, 2010, EUR J IMMUNOL, V40, P620, DOI 10.1002/eji.200940185; Abdul-Sater AA, 2010, MICROBES INFECT, V12, P652, DOI 10.1016/j.micinf.2010.04.008; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; KUO CC, 1995, CLIN MICROBIOL REV, V8, P451; Madico G, 2000, J CLIN MICROBIOL, V38, P1085; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; SABET SF, 1984, J CLIN MICROBIOL, V20, P217; Gross O, 2011, IMMUNOL REV, V243, P136, DOI 10.1111/j.1600-065X.2011.01046.x; Palomaki J, 2011, ACS NANO, V5, P6861, DOI 10.1021/nn200595c; Abdul-Sater AA, 2009, J BIOL CHEM, V284, P26789, DOI 10.1074/jbc.M109.026823; Brown JS, 2012, CLIN MED, V12, P538; Delzell John E Jr, 2013, FP Essent, V409, P32; Eitel J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030379; Ganguly K, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-94; Gnoatto N, 2007, J PERIODONTAL RES, V42, P553, DOI 10.1111/j.1600-0765.2007.00981.x; GRAYSTON JT, 1992, ANNU REV MED, V43, P317, DOI 10.1146/annurev.med.43.1.317; Heinemann M, 1996, INFECT IMMUN, V64, P4872; Ishida K, 2013, MICROBES INFECT, V15, P192, DOI 10.1016/j.micinf.2012.11.006; Jiang SJ, 2008, INFECT IMMUN, V76, P1558, DOI 10.1128/IAI.01331-07; KaukorantaTolvanen SSE, 1996, MICROB PATHOGENESIS, V21, P215, DOI 10.1006/mpat.1996.0056; Lage SL, 2013, METHODS, V61, P110, DOI 10.1016/j.ymeth.2013.02.010; Murr L E, 2005, Int J Environ Res Public Health, V2, P31, DOI 10.3390/ijerph2005010031; Netea MG, 2000, EUR J IMMUNOL, V30, P541, DOI 10.1002/1521-4141(200002)30:2<541::AID-IMMU541>3.0.CO;2-X; Roulis E, 2013, TRENDS MICROBIOL, V21, P120, DOI 10.1016/j.tim.2012.10.009; Saïd-Sadier Najwane, 2012, Biomed J, V35, P437, DOI 10.4103/2319-4170.104408; YING S, 2007, CURR IMMUNOL REV, V3, P31, DOI 10.2174/157339507779802179	41	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0019-9567	1098-5522		INFECT IMMUN	Infect. Immun.	JUL	2015	83	7					2917	2925		10.1128/IAI.02968-14		9	Immunology; Infectious Diseases	Immunology; Infectious Diseases	CK5EB	WOS:000356244000032		
J	Tanuma, K; Man, CS; Chen, Y				Tanuma, Kazumi; Man, Chi-Sing; Chen, Yue			Dispersion of Rayleigh waves in weakly anisotropic media with vertically-inhomogeneous initial stress	INTERNATIONAL JOURNAL OF ENGINEERING SCIENCE			English	Article						Rayleigh waves; Vertical inhomogeneity; Dispersion; Initial stress; Weakly anisotropic media; Surface impedance	ORDER ELASTIC-CONSTANTS; PERTURBATION FORMULAS; RESIDUAL-STRESS; SURFACE; ACOUSTOELASTICITY; ALUMINUM; VELOCITY; TEXTURE	Herein we present a procedure by which a high-frequency asymptotic formula can be derived for dispersion relations of Rayleigh waves that propagate in various directions along the free surface of a vertically-inhomogeneous, prestressed, and generally anisotropic half-space. The procedure is based on three assumptions, namely: (i) the incremental elasticity tensor of the material half-space can be written as the sum of a homogeneous isotropic part C-lso and a depth-dependent perturbative part A; (ii) at the free surface both the initial stress and A are small as compared with C-lso; (iii) the mass density, the initial stress, and A are smooth functions of depth from the free surface. We derive formulas and Lyapunov-type equations that can iteratively deliver each term of an asymptotic expansion of the surface impedance matrix, which leads to the aforementioned high-frequency asymptotic formula for Rayleigh-wave dispersion. As illustration we consider a thick-plate sample of AA 7075-T651 aluminum alloy, which has one face treated by low plasticity burnishing that induced a (depth-dependent) prestress at and immediately beneath the treated surface. We model the sample as a prestressed, weakly-textured orthorhombic aggregate of cubic crystallites and work out explicitly, up to the third order, the dispersion relations that pertain to Rayleigh waves propagating in several directions along the treated face of the sample. (C) 2015 Elsevier Ltd. All rights reserved.	[Tanuma, Kazumi] Gunma Univ, Fac Sci & Technol, Dept Math, Kiryu, Gumma 3768515, Japan; [Man, Chi-Sing; Chen, Yue] Univ Kentucky, Dept Math, Lexington, KY 40506 USA	Tanuma, K (reprint author), Gunma Univ, Fac Sci & Technol, Dept Math, Kiryu, Gumma 3768515, Japan.	tanuma@gunma-u.ac.jp; cman@uky.edu; chenyue0715@uky.edu	Man, Chi-Sing/E-4794-2011	Man, Chi-Sing/0000-0001-9166-2832	Society for the Promotion of Science, Japan [26400157]	The work of Tanuma was partially supported by Grant-in-Aid for Scientific Research (C), Society for the Promotion of Science, Japan (No. 26400157).	Man CS, 1996, J ELASTICITY, V45, P91, DOI 10.1007/BF00042485; THOMAS JF, 1968, PHYS REV, V175, P955, DOI 10.1103/PhysRev.175.955; Radovic M, 2004, MAT SCI ENG A-STRUCT, V368, P56, DOI 10.1016/j.msea.2003.09.080; [Anonymous], 2006, REV PROGR QUANTITATI; LOTHE J, 1976, J APPL PHYS, V47, P428, DOI 10.1063/1.322665; SARMA VPN, 1972, PHYS STATUS SOLIDI A, V10, P563, DOI 10.1002/pssa.2210100226; [Anonymous], 2000, AL STAND DAT 2000; Bellman R, 1997, INTRO MATRIX ANAL, V2nd; Biot M.A., 1965, MECH INCREMENTAL DEF; CHADWICK P, 1977, ADV APPL MECH, V17, P303, DOI 10.1016/S0065-2156(08)70223-0; Gantmacher F. R., 1960, THEORY MATRICES; HOGER A, 1986, J ELASTICITY, V16, P303, DOI 10.1007/BF00040818; Horgan C, 1996, ANISOTROPIC ELASTICI; Katchalov A. P., 2012, J MATH SCI, V185, P581; Man C.S, 1999, J ELASTICITY, V15, P191; Man CS, 2015, IMA J APPL MATH, V80, P47, DOI 10.1093/imamat/hxt025; MAN CS, 1987, J ELASTICITY, V17, P159, DOI 10.1007/BF00043022; Man C.S, 1994, J ELASTICITY, V128, P223; Man C.-S., 1999, REV PROGR QUANTITATI, V18, P1879; Paroni R, 2000, J ELASTICITY, V59, P145, DOI 10.1023/A:1011057315459; Song YQ, 2007, J ELASTICITY, V88, P187, DOI 10.1007/s10659-007-9130-4; Tanuma K, 2002, J ELASTICITY, V69, P181, DOI 10.1023/A:1027303515886; Tanuma K, 2008, J ELASTICITY, V92, P1, DOI 10.1007/s10659-007-9147-8; Tanuma K, 2013, MATH MECH SOLIDS, V18, P301, DOI 10.1177/1081286512438882	24	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0020-7225	1879-2197		INT J ENG SCI	Int. J. Eng. Sci.	JUL	2015	92						63	82		10.1016/j.ijengsci.2015.03.001		20	Engineering, Multidisciplinary	Engineering	CK3OC	WOS:000356124400005		
J	Tamura, M; Nemoto, K; Kawaguchi, A; Kato, M; Arai, T; Kakuma, T; Mizukami, K; Matsuda, H; Soya, H; Asada, T				Tamura, Masashi; Nemoto, Kiyotaka; Kawaguchi, Atsushi; Kato, Morimasa; Arai, Tetsuaki; Kakuma, Tatsuyuki; Mizukami, Katsuyoshi; Matsuda, Hiroshi; Soya, Hideaki; Asada, Takashi			Long-term mild-intensity exercise regimen preserves prefrontal cortical volume against aging	INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY			English	Article						aging; brain; exercise; cognition; voxel-based morphometry; longitudinal study	CEREBRAL BLOOD-VOLUME; PROPENSITY SCORE; AEROBIC EXERCISE; MEMORY; BRAIN; MRI; IMPAIRMENT; METABOLISM; DEMENTIA; DECLINE	ObjectivesIt has been suggested that exercise improves cognitive function and increases cerebral volume even in older people. However, the relation between cognitive function and brain volume is unclear. We evaluated the longitudinal change of cognitive function and gray matter volume due to mild-intensity exercise over 2 years, and the residual effects 6months post-exercise. MethodsSubjects were 110 healthy older individuals over 65years old in Tone town, Ibaraki prefecture. Seventy-five participants were voluntarily enrolled in the exercise group. A mild-intensity calisthenics regimen, which consisted of home-based and club-based programs for as long as 2 years, was employed as the intervention for the exercise group. ResultsThe exercise group showed significant improvement in attentional shift over the course of the observation period including a 6-month follow-up. Neuroimaging analysis revealed the significant preservation of bilateral prefrontal volume in the exercise group with small-volume corrections, although this effect faded after intervention. Furthermore, the longitudinal changes in attentional shift and memory were positively correlated with the prefrontal volumetric changes. ConclusionOur results suggest that mild-intensity exercise could prevent prefrontal volume reduction due to aging and impede cognitive decline. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Tamura, Masashi] Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Neuropsychiat, Tsukuba, Ibaraki, Japan; [Tamura, Masashi] Ibaraki Prefectural Med Ctr Psychiat, Kasama, Ibaraki, Japan; [Nemoto, Kiyotaka; Arai, Tetsuaki; Asada, Takashi] Univ Tsukuba, Dept Psychiat, Div Clin Med, Fac Med, Tsukuba, Ibaraki, Japan; [Kawaguchi, Atsushi] Kyoto Univ, Dept Biomed Stat & Bioinformat, Grad Sch Med, Kyoto, Japan; [Kato, Morimasa] Yonezawa Womens Jr Coll Yamagata Prefecture, Dept Hlth & Nutr, Yonezawa, Yamagata, Japan; [Kakuma, Tatsuyuki] Kurume Univ, Biostat Ctr, Kurume, Fukuoka 830, Japan; [Mizukami, Katsuyoshi] Univ Tsukuba, Fac Hlth & Sports Sci, Grad Sch Comprehens Human Sci, Tokyo, Japan; [Matsuda, Hiroshi] Natl Ctr Neurol & Psychiat, Integrat Brain Image Ctr, Tokyo, Japan; [Soya, Hideaki] Univ Tsukuba, Fac Hlth & Sports Sci, Lab Exercise Biochem & Neuroendocrinol, Tsukuba, Ibaraki, Japan	Nemoto, K (reprint author), Univ Tsukuba, Dept Psychiat, Div Clin Med, Fac Med, Tsukuba, Ibaraki, Japan.	kiyotaka@nemotos.net			Ministry of Health, Labour, and Welfare of Japan [H13-dementia, fracture-003]	This research was funded by the Ministry of Health, Labour, and Welfare of Japan (H13-dementia and fracture-003).	Angevaren M, 2008, COCHRANE DATABASE SY; Timinkul A, 2008, NEUROSCI RES, V61, P242, DOI 10.1016/j.neures.2008.03.012; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Smith PJ, 2010, PSYCHOSOM MED, V72, P239, DOI 10.1097/PSY.0b013e3181d14633; Fletcher PC, 2001, BRAIN, V124, P849, DOI 10.1093/brain/124.5.849; Anderson BJ, 2011, DEV PSYCHOBIOL, V53, P456, DOI 10.1002/dev.20563; Volkow ND, 2000, AM J PSYCHIAT, V157, P75; GROBER E, 1988, NEUROLOGY, V38, P900; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Swain RA, 2003, NEUROSCIENCE, V117, P1037, DOI 10.1016/S0306-4522(02)00664-4; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Herting MM, 2012, BEHAV BRAIN RES, V233, P517, DOI 10.1016/j.bbr.2012.05.012; MIRSKY AF, 1987, ENVIRON HEALTH PERSP, V74, P191, DOI 10.2307/3430449; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P399, DOI 10.1080/00273171.2011.568786; Bentourkia M, 2000, J NEUROL SCI, V181, P19, DOI 10.1016/S0022-510X(00)00396-8; Woolrich Mark W, 2009, Neuroimage, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; FAZEKAS F, 1993, NEUROLOGY, V43, P1683; McDonald BC, 2010, BREAST CANCER RES TR, V123, P819, DOI 10.1007/s10549-010-1088-4; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Colcombe SJ, 2006, J GERONTOL A-BIOL, V61, P1166; Ruscheweyh R, 2011, NEUROBIOL AGING, V32, P1304, DOI 10.1016/j.neurobiolaging.2009.08.001; Floel A, 2010, NEUROIMAGE, V49, P2756, DOI 10.1016/j.neuroimage.2009.10.043; Freedmans M, 1994, CLOCK DRAWING NEUROP; Gows AJ, 2012, NEUROLOGY, V79, P1802; Irwin ML, 2004, PREV MED, V39, P1080, DOI 10.1016/j.ypmed.2004.04.017; Miyamoto M, 2009, J CLIN NEUROSCI, V16, P270, DOI 10.1016/j.jocn.2008.03.007; Nemoto K, 2011, BMC MED IMAGING, V11, DOI 10.1186/1471-2342-11-3; Nicholas J, 2008, BRIT J GEN PRACT, V58, P687, DOI 10.3399/bjgp08X342471; Razs N, 2004, NEUROBIOL AGING, V25, P377; Sohlbergs MM, 1986, ATTENTION PROCESS TR; Solomon P R, 1998, Fam Med, V30, P265; VANSUFFELEN JGZ, 2008, CLIN J SPORT MED, V18, P486; Wechslers D, 1981, WAIS R MANUAL WECHSL; Yasuno F, 2012, NEUROBIOL AGING, V33, P2633, DOI 10.1016/j.neurobiolaging.2011.12.028	37	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0885-6230	1099-1166		INT J GERIATR PSYCH	Int. J. Geriatr. Psychiatr.	JUL	2015	30	7					686	694		10.1002/gps.4205		9	Geriatrics & Gerontology; Gerontology; Psychiatry	Geriatrics & Gerontology; Psychiatry	CK1RQ	WOS:000355985300003		
J	Tateno, A; Sakayori, T; Higuchi, M; Suhara, T; Ishihara, K; Kumita, S; Suzuki, H; Okubo, Y				Tateno, Amane; Sakayori, Takeshi; Higuchi, Makoto; Suhara, Tetsuya; Ishihara, Keiichi; Kumita, Shinichiro; Suzuki, Hidenori; Okubo, Yoshiro			Amyloid imaging with [F-18]florbetapir in geriatric depression: early-onset versus late-onset	INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY			English	Article						geriatric depression; beta-amyloid; Alzheimer's disease; positron emission tomography	MILD COGNITIVE IMPAIRMENT; LATE-LIFE DEPRESSION; FLORBETAPIR F 18; ALZHEIMERS-DISEASE; DEMENTIA; BRAIN; RISK; PET; MRI	BackgroundWe examined patients with mild cognitive impairment (MCI) with a history of geriatric depression (GD) and healthy controls (HC) to evaluate the effect of beta-amyloid (A) pathology on the pathology of GD by using [F-18]florbetapir PET. MethodsThirty-three elderly patients (76.74.2years) and 22 healthy controls (HC; 72.04.5years, average +/- SD) were examined by [F-18]florbetapir positron emission tomography (PET) to quantify the standard uptake value ratio (SUVR) as the degree of amyloid accumulation, by MRI to determine the degree of atrophy, by Mini-Mental State Examination for cognitive functions, and by Geriatric Depression Scale for the severity of depression, and by Clinical Dementia Rating for activity of daily living (ADL). The cut-off value of 1.08 for SUVR was defined as A-positive. ResultsOf the patients and HC, 39.4% and 27.3%, respectively, were beta-amyloid-positive. The onset age of GD was significantly correlated with SUVR (r=0.44, p<0.01). Compared to patients without A (GD-A), patients with A (GD+A) did not differ in terms of age, cognitive function, severity of depression and ADL, and brain atrophy. GD+A had significantly older average +/- SD age at onset of GD (73.6 +/- 7.1 versus 58.7 +/- 17.8, p<0.01) and significantly shorter average +/- SD time between onset of GD and PET scan day (3.1 +/- 5.2years versus 18.1 +/- 18.6years, p<0.001) than GD-A. ConclusionsOur results showed that the rate of A positivity was higher in late-onset GD and that onset-age was associated with SUVR, suggesting that the later the onset of GD, the more A pathology affected its onset. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Tateno, Amane; Sakayori, Takeshi; Okubo, Yoshiro] Nippon Med Sch, Dept Neuropsychiat, Bunkyo Ku, Tokyo 113, Japan; [Higuchi, Makoto; Suhara, Tetsuya] Natl Inst Radiol Sci, Mol Imaging Ctr, Chiba 260, Japan; [Ishihara, Keiichi] Nippon Med Sch, Clin Imaging Ctr Healthcare, Bunkyo Ku, Tokyo 113, Japan; [Kumita, Shinichiro] Nippon Med Sch, Dept Radiol, Bunkyo Ku, Tokyo 113, Japan; [Suzuki, Hidenori] Nippon Med Sch, Dept Pharmacol, Bunkyo Ku, Tokyo 113, Japan	Okubo, Y (reprint author), Nippon Med Sch, Dept Neuropsychiat, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 113, Japan.	okubo-y@nms.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japanese government; Ministry of Education, Culture, Sport, Science, and Technology, Japan (MEXT); Health and Labor Sciences Research Grant for Research on Psychiatric and Neurological Diseases and Mental Health from the Ministry of Health, Labor, and Welfare, Japanese government	This study was partly supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japanese government, by a grant of Strategic Research Foundation Grant-aided Project for Private Universities from the Ministry of Education, Culture, Sport, Science, and Technology, Japan (MEXT), and by a Health and Labor Sciences Research Grant for Research on Psychiatric and Neurological Diseases and Mental Health from the Ministry of Health, Labor, and Welfare, Japanese government. The radiotracer was provided at no cost to the study by Avid Radio-pharmaceuticals Inc.	Jack CR, 2009, BRAIN, V132, P1355, DOI 10.1093/brain/awp062; Ownby RL, 2006, ARCH GEN PSYCHIAT, V63, P530, DOI 10.1001/archpsyc.63.5.530; Chen KH, 2011, J ALZHEIMERS DIS, V26, P755, DOI 10.3233/JAD-2011-110002; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; MORRIS JC, 1993, NEUROLOGY, V43, P2412; Geerlings MI, 2008, NEUROLOGY, V70, P1258, DOI 10.1212/01.wnl.0000308937.30473.d1; Fleisher AS, 2011, ARCH NEUROL-CHICAGO, V68, P1404, DOI 10.1001/archneurol.2011.150; Rapp MA, 2008, AM J GERIAT PSYCHIAT, V16, P168, DOI 10.1097/JGP.0b013e31816029ec; Caraci F, 2010, EUR J PHARMACOL, V626, P64, DOI 10.1016/j.ejphar.2009.10.022; Byers AL, 2011, NAT REV NEUROL, V7, P323, DOI 10.1038/nrneurol.2011.60; Zarow C, 2003, ARCH NEUROL-CHICAGO, V60, P337, DOI 10.1001/archneur.60.3.337; Pomara N, 2012, AM J PSYCHIAT, V169, P523, DOI 10.1176/appi.ajp.2011.11081153; FAZEKAS F, 1991, AM J NEURORADIOL, V12, P915; Doraiswamy PM, 2012, NEUROLOGY, V79, P1636, DOI 10.1212/WNL.0b013e3182661f74; Camus V, 2012, EUR J NUCL MED MOL I, V39, P621, DOI 10.1007/s00259-011-2021-8; Hirata Y, 2005, NEUROSCI LETT, V382, P269, DOI 10.1016/j.neulet.2005.03.038; Borroni B, 2009, NEUROBIOL AGING, V30, P1406, DOI 10.1016/j.neurobiolaging.2007.11.023; Butters MA, 2008, ALZ DIS ASSOC DIS, V22, P261, DOI 10.1097/WAD.0b013e31816c92bf; Belanoff JK, 2001, J PSYCHIAT RES, V35, P127, DOI 10.1016/S0022-3956(01)00018-8; Elobeid A, 2012, ACTA NEUROPATHOL, V123, P97, DOI 10.1007/s00401-011-0906-z; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Hochstrasser T, 2013, J NEUROSCI RES, V91, P83, DOI 10.1002/jnr.23126; Johnson Keith A, 2013, Alzheimers Dement, V9, pS72, DOI 10.1016/j.jalz.2012.10.007; Kramberger Milica Gregoric, 2012, Dement Geriatr Cogn Dis Extra, V2, P48, DOI 10.1159/000334644; Kumar A, 2011, ARCH GEN PSYCHIAT, V68, P1143, DOI 10.1001/archgenpsychiatry.2011.122; Ledos JH, 2012, MOL PSYCHIATR, V18, P1053; Madsens K, 2008, NEUROBIOL AGING, V33, P2334; Petersen RC, 2005, ARCH NEUROL-CHICAGO, V62, P1160, DOI 10.1001/archneur.62.7.1160; Sierksma ASR, 2010, EUR J PHARMACOL, V626, P72, DOI 10.1016/j.ejphar.2009.10.021; Starkstein SE, 2011, AM J GERIAT PSYCHIAT, V19, P551, DOI 10.1097/JGP.0b013e3181ec897f; Suns X, 2008, ARCH GEN PSYCHIAT, V65, P542; Tateno A, 2015, INT J GERIATR PSYCH, V30, P505, DOI 10.1002/gps.4173; Wus KY, 2014, EUR J NUCL MED MOL I, V41, P714; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165	34	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0885-6230	1099-1166		INT J GERIATR PSYCH	Int. J. Geriatr. Psychiatr.	JUL	2015	30	7					720	728		10.1002/gps.4215		9	Geriatrics & Gerontology; Gerontology; Psychiatry	Geriatrics & Gerontology; Psychiatry	CK1RQ	WOS:000355985300007		
J	Guo, LC; Kitamura, T; Yan, YB; Sumigawa, T; Huang, K				Guo, Licheng; Kitamura, Takayuki; Yan, Yabin; Sumigawa, Takashi; Huang, Kai			Fracture mechanics investigation on crack propagation in the nano-multilayered materials	INTERNATIONAL JOURNAL OF SOLIDS AND STRUCTURES			English	Article						Nano-multilayered materials; Experiments and analyses; Crack propagation; Crossing-interface crack; Kinetic energy	FUNCTIONALLY GRADED MATERIALS; CU/SI INTERFACE; NANOSCALE COMPONENTS; FATIGUE-STRENGTH; THIN-FILMS; INITIATION; SCALE; DEFORMATION; PLASTICITY; STRESS	A set of new investigation method is proposed for the fracture mechanics experiments and analyses of nano-multilayered materials. The crack propagation behavior in a SiN/Cu nano-cantilever is investigated by fabricating a crack-like notch in the SiN layer. Two types of crack propagation behaviors are observed, including crack propagation in SiN layer and crossing-interface crack propagation through SiN/Cu interface. The interaction integral method combined with energy analyses is adopted for numerical simulation of the crack propagation behavior. The kinetic energy of the crack propagation is discussed. It is found that for the present brittle fracture process, the traditional Griffith criterion is not suitable and a new hypothesis based on the kinetic energy of the crack propagation is proposed that the crack will keep propagating until the accumulated kinetic energy is consumed totally to form new crack surface. Moreover, the hypothesis is consistent with the experimental results. It provides a significant thought for the analysis and prediction of nanoscale crack propagation behavior. (C) 2015 Elsevier Ltd. All rights reserved.	[Guo, Licheng; Huang, Kai] Harbin Inst Technol, Dept Astronaut Sci & Mech, Harbin 150001, Peoples R China; [Kitamura, Takayuki; Yan, Yabin; Sumigawa, Takashi] Kyoto Univ, Dept Mech Engn & Sci, Kyoto 6158540, Japan; [Yan, Yabin] China Acad Engn Phys, Inst Struct Mech, Mianyang 621900, Peoples R China	Guo, LC (reprint author), Harbin Inst Technol, Dept Astronaut Sci & Mech, Harbin 150001, Peoples R China.	guolc@hit.edu.cn			Japan Society for the Promotion of Science [25000012]; National Natural Science Foundation of China [11322217]; Science and Technology Development Fund of CAEP [2013B0302043]	This work is supported by a Grant-in-Aid for Specially Promoted (No. 25000012) from the Japan Society for the Promotion of Science, the National Natural Science Foundation of China (No. 11322217) and the Science and Technology Development Fund of CAEP (No. 2013B0302043).	Adnan A, 2010, J MECH PHYS SOLIDS, V58, P983, DOI 10.1016/j.jmps.2010.04.012; Belytschko T, 1999, INT J NUMER METH ENG, V45, P601, DOI 10.1002/(SICI)1097-0207(19990620)45:5<601::AID-NME598>3.0.CO;2-S; Abraham FF, 2000, PHYS REV LETT, V84, P3113, DOI 10.1103/PhysRevLett.84.3113; Gao HJ, 1996, J MECH PHYS SOLIDS, V44, P1453, DOI 10.1016/0022-5096(96)00038-5; Yu HJ, 2009, INT J SOLIDS STRUCT, V46, P3710, DOI 10.1016/j.ijsolstr.2009.06.019; Sumigawa T, 2010, MAT SCI ENG A-STRUCT, V527, P4796, DOI 10.1016/j.msea.2010.04.002; Hirakata H, 2007, INT J FRACTURE, V145, P261, DOI 10.1007/s10704-007-9079-0; EVANS AG, 1995, ACTA METALL MATER, V43, P2507, DOI 10.1016/0956-7151(94)00444-M; Rosakis AJ, 1999, SCIENCE, V284, P1337, DOI 10.1126/science.284.5418.1337; Arai M, 2007, ENG FRACT MECH, V74, P2055, DOI 10.1016/j.engfracmech.2006.10.021; Guozden T, 2010, INT J FRACTURE, V162, P107, DOI 10.1007/s10704-009-9426-4; Kim SW, 2012, ACTA MATER, V60, P2959, DOI 10.1016/j.actamat.2012.02.002; HUTCHINSON JW, 1992, ADV APPL MECH, V29, P63; Chowdhury PB, 2013, ACTA MATER, V61, P2531, DOI 10.1016/j.actamat.2013.01.030; Kim JH, 2003, COMPUT METHOD APPL M, V192, P1463, DOI 10.1016/S0045-7825(02)00652-7; Broberg K.B., 1989, STRUCTURAL INTEGRITY, P1; FREUND LB, 1979, J GEOPHYS RES, V84, P2199, DOI 10.1029/JB084iB05p02199; Gao HJ, 2001, J MECH PHYS SOLIDS, V49, P2113, DOI 10.1016/S0022-5096(01)00032-1; Guo LC, 2012, P ROY SOC A-MATH PHY, V468, P2939, DOI 10.1098/rspa.2012.0156; Huang GY, 2004, INT J SOLIDS STRUCT, V41, P731, DOI 10.1016/j.ijsolstr.2003.08.007; Jia YJ, 2012, J MECH PHYS SOLIDS, V60, P1447, DOI 10.1016/j.jmps.2012.04.008; Kalthoff J.F., 1977, ASTM STP, P161; RICE JR, 1988, J APPL MECH-T ASME, V55, P98; Sumigawa T, 2010, THIN SOLID FILMS, V518, P6040, DOI 10.1016/j.tsf.2010.06.039; Sumigawa T, 2011, MAT SCI ENG A-STRUCT, V528, P5158, DOI 10.1016/j.msea.2011.03.023; Sumigawa T, 2010, MAT SCI ENG A-STRUCT, V527, P6518, DOI 10.1016/j.msea.2010.07.002; Takahashi Y, 2008, THIN SOLID FILMS, V516, P1925, DOI 10.1016/j.tsf.2007.08.062; Wang HT, 2011, SCRIPTA MATER, V65, P377, DOI 10.1016/j.scriptamat.2011.05.009; Yan YB, 2011, ENG FRACT MECH, V78, P2935, DOI 10.1016/j.engfracmech.2011.08.010; Yan YB, 2012, MAT SCI ENG A-STRUCT, V556, P147, DOI 10.1016/j.msea.2012.06.070; Yu HJ, 2012, INT J FRACTURE, V177, P25, DOI 10.1007/s10704-012-9747-6; Zhang Y, 2011, COMP MATER SCI, V50, P1754, DOI 10.1016/j.commatsci.2011.01.007	32	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0020-7683	1879-2146		INT J SOLIDS STRUCT	Int. J. Solids Struct.	JUL	2015	64-65						208	220		10.1016/j.ijsolstr.2015.03.025		13	Mechanics	Mechanics	CK3JQ	WOS:000356112800018		
J	Kamoto, S				Kamoto, Shinsuke			Strategic capacity expansion under a potential entry threat	INTERNATIONAL REVIEW OF ECONOMICS & FINANCE			English	Article						Real options; Strategic incentive; Capacity expansion	RESEARCH-AND-DEVELOPMENT; REAL OPTIONS; INVESTMENT; EXIT; COMPETITION; DUOPOLY; UNCERTAINTY; DETERRENCE; PREEMPTION; CONTRACTS	This paper examines strategic investment decisions on capacity expansion in the presence of a potential entry threat. The model derives an equilibrium investment strategy on expansion thresholds and scales and evaluates the strategic value of the capacity expansion. It demonstrates that an incumbent firm expands its production capacity by strategic incentive to deter a potential competitor's market entry and prolong its period of monopoly. The results suggest that the strategic value of the expansion is high enough to induce the incumbent firm to undertake the capacity expansion that generates negative cash flows in the future as a stand-alone project. (C) 2015 Elsevier Inc. All rights reserved.	Kagawa Univ, Fac Econ, Takamatsu, Kagawa 7608523, Japan	Kamoto, S (reprint author), Kagawa Univ, Fac Econ, 2-1 Saiwaicho, Takamatsu, Kagawa 7608523, Japan.	kamoto@ec.kagawa-u.ac.jp			JSPS [23730353]	The author would like to thank Hamid Beladi (the editor), two anonymous referees, Jorge Cruz Lopez, Gregory Zunic, and participants at the 2011 World Business and Economics Research Conference (Auckland) for their useful comments and suggestions. The financial support from JSPS Grant-in-Aid for Scientific Research (No.23730353) is gratefully acknowledged.	AGHION P, 1987, AM ECON REV, V77, P388; Pawlina G, 2006, J ECON MANAGE STRAT, V15, P1, DOI 10.1111/j.1530-9134.2006.00090.x; Garlappi L, 2004, J FINANC QUANT ANAL, V39, P843; Weeds H, 2002, REV ECON STUD, V69, P729, DOI 10.1111/1467-937X.t01-1-00029; Nielsen MJ, 2002, INT J IND ORGAN, V20, P731, DOI 10.1016/S0167-7187(01)00057-1; GHEMAWAT P, 1985, RAND J ECON, V16, P184, DOI 10.2307/2555409; DIXIT A, 1980, ECON J, V90, P95, DOI 10.2307/2231658; Bar-Ilan A, 1999, J MACROECON, V21, P57, DOI 10.1016/S0164-0704(99)00090-7; Kulatilaka N, 1998, MANAGE SCI, V44, P1021, DOI 10.1287/mnsc.44.8.1021; Lambrecht B, 2003, J ECON DYN CONTROL, V27, P619, DOI 10.1016/S0165-1889(01)00064-1; LIEBERMAN MB, 1988, STRATEGIC MANAGE J, V9, P41, DOI 10.1002/smj.4250090706; Bayer C, 2007, J ECON DYN CONTROL, V31, P3069, DOI 10.1016/j.jedc.2006.10.006; Dixit A. K., 2000, PROJECT FLEXIBILITY, P50; Grenadier S. R., 2000, J APPL CORPORATE FIN, V13, P99, DOI 10.1111/j.1745-6622.2000.tb00057.x; Joaquin D. C, 2001, Q REV EC FINANCE, V41, P1, DOI 10.1016/S1062-9769(00)00058-2; Joaquin D. C., 2000, PROJECT FLEXIBILITY, P324; Kristiansen EG, 2006, J IND ECON, V54, P31, DOI 10.1111/j.1467-6427.2006.00274.x; Lambrecht BM, 2001, REV FINANC STUD, V14, P765, DOI 10.1093/rfs/14.3.765; MCDONALD R, 1986, Q J ECON, V101, P707, DOI 10.2307/1884175; Mukherjee A, 2013, INT REV ECON FINANC, V25, P108, DOI 10.1016/j.iref.2012.04.003; Murto P, 2004, RAND J ECON, V35, P111, DOI 10.2307/1593732; Pennings E, 2004, J IND ECON, V52, P569, DOI 10.1111/j.0022-1821.2004.00241.x; Pindyck R. S., 1994, INVESTMENT UNCERTAIN; PINDYCK RS, 1991, J ECON LIT, V29, P1110; PINDYCK RS, 1988, AM ECON REV, V78, P969; Sarkar S., 2009, MANAG DECIS EC, V30, P119, DOI 10.1002/mde.1446; Shackleton MB, 2004, J BANK FINANC, V28, P179, DOI 10.1016/S0378-4266(02)00403-X; Spence M, 1979, BELL J ECON, V10, P1; Wong KP, 2010, ECON MODEL, V27, P97, DOI 10.1016/j.econmod.2009.07.028; Yong JS, 1999, J BUS, V72, P385, DOI 10.1086/209619	30	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1059-0560	1873-8036		INT REV ECON FINANC	Int. Rev. Econ. Financ.	JUL	2015	38						157	177		10.1016/j.iref.2015.01.006		21	Business, Finance; Economics	Business & Economics	CK3OY	WOS:000356126600012		
J	Ko, HH; Ogaki, M				Ko, Hsiu-Hsin; Ogaki, Masao			Granger causality from exchange rates to fundamentals: What does the bootstrap test show us?	INTERNATIONAL REVIEW OF ECONOMICS & FINANCE			English	Article						Exchange rates; Fundamentals; Granger causality; Bootstrap test	MONETARY FUNDAMENTALS; RATE MODELS; PANEL; FIT	We use a residual-based bootstrap method to re-examine the finding of the Granger causality relation from exchange rates to fundamentals in Engel and West (2005), in which the relation is taken as evidence for their explanation for the present-value model for exchange rates. Our test results are against the previous findings. The Monte Carlo experiment results suggest that the previous evidence for the causality relation from exchange rates to fundamentals is very likely caused by the size distortion. Hence, the existing Granger causality evidence is not strong enough to validate the new explanation for the present-value model. (C) 2015 Elsevier Inc. All rights reserved.	[Ko, Hsiu-Hsin] Natl Univ Kaohsiung, Dept Appl Econ, Kaohsiung 811, Taiwan; [Ogaki, Masao] Keio Univ, Dept Econ, Tokyo 1088345, Japan	Ko, HH (reprint author), Natl Univ Kaohsiung, Dept Appl Econ, Kaohsiung 811, Taiwan.	hhko@nuk.edu.tw			JSPS KAKENHI [25285063]	The authors thank Carl R. Chen (the editor), the referees, the Ohio State University, and in particular, Paul Evans, Pok-Sang Lam for useful comments and suggestions. Ogaki's research was partially supported by JSPS KAKENHI 25285063.	Molodtsova T, 2009, J INT ECON, V77, P167, DOI 10.1016/j.jinteco.2008.11.001; Hacker RS, 2006, APPL ECON, V38, P1489, DOI 10.1080/00036840500405763; Cheung YW, 2005, J INT MONEY FINANC, V24, P1150, DOI 10.1016/j.jimonfin.2005.08.002; Mark NC, 2001, J INT ECON, V53, P29, DOI 10.1016/S0022-1996(00)00052-0; Kilian L, 1999, J APPL ECONOM, V14, P491, DOI 10.1002/(SICI)1099-1255(199909/10)14:5<491::AID-JAE527>3.0.CO;2-D; Engel C, 2005, J POLIT ECON, V113, P485, DOI 10.1086/429137; CAMPBELL JY, 1987, J POLIT ECON, V95, P1062, DOI 10.1086/261502; Rapach DE, 2004, J INT MONEY FINANC, V23, P867, DOI 10.1016/j.jimonfin.2004.05.002; Davidson R, 2000, ECONOMET REV, V19, P55, DOI DOI 10.1080/07474930008800459; Hatemi J.A., 2002, J APPL STAT, V29, P817; Ko H.-H., 2013, 577 RCER; MARK NC, 1995, AM ECON REV, V85, P201; MEESE RA, 1983, J INT ECON, V14, P3, DOI 10.1016/0022-1996(83)90017-X; Obstfeld M., 2000, NBER MACROECON ANNU, V2000, P339; Rogoff K., 2008, 14071 NBER; SIMS CA, 1980, ECONOMETRICA, V48, P1, DOI 10.2307/1912017; Xie ZX, 2014, INT REV ECON FINANC, V31, P95, DOI 10.1016/j.iref.2014.01.014	17	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1059-0560	1873-8036		INT REV ECON FINANC	Int. Rev. Econ. Financ.	JUL	2015	38						198	206		10.1016/j.iref.2015.02.016		9	Business, Finance; Economics	Business & Economics	CK3OY	WOS:000356126600014		
J	Jeon, H; Nishihara, M				Jeon, Haejun; Nishihara, Michi			The effects of business cycle and debt maturity on a firm's investment and default decisions	INTERNATIONAL REVIEW OF ECONOMICS & FINANCE			English	Article						Optimal switching; Markov chain; Real options; Debt maturity; Business cycle	OPTIMAL CAPITAL STRUCTURE; MACROECONOMIC CONDITIONS; CORPORATE-DEBT; CREDIT SPREADS; GROWTH OPPORTUNITIES; AGENCY CONFLICTS; LIQUIDITY RISK; LEVERAGE; DETERMINANTS; COVENANTS	We propose a model that jointly determines the capital structure and investment decisions taking business cycle and debt maturity into account. It endogenously determines the triggers of investment/disinvestment and default, which depend on the state of the economy. The investment triggers can be unimodal or bimodal with respect to debt maturity depending on the volatility of the growth opportunities. The optimal leverage ratio tends to increase as recession shortens, which induces higher yield spreads for short-term debt; but long-term debt is more affected by increase of expected cash flow, and thus the yield spreads decrease. (C) 2015 Elsevier Inc. All rights reserved.	[Jeon, Haejun] Osaka Univ, Grad Sch Econ, Ohnishi Lab, Toyonaka, Osaka 5600043, Japan; [Nishihara, Michi] Osaka Univ, Grad Sch Econ, Toyonaka, Osaka 5600043, Japan; [Nishihara, Michi] Ecole Polytech Fed Lausanne, Swiss Finance Inst, CH-1015 Lausanne, Switzerland	Jeon, H (reprint author), Osaka Univ, Grad Sch Econ, Ohnishi Lab, 1-7 Machikaneyama Cho, Toyonaka, Osaka 5600043, Japan.	haejun.jeon@gmail.com; nishihara@econ.osaka-u.ac.jp			KAKENHI [23310103, 26350424, 26285071]; Ishii Memorial Securities Research Promotion Foundation; JSPS	This version: February 11th, 2015. This work was supported by KAKENHI 23310103, 26350424, 26285071, the Ishii Memorial Securities Research Promotion Foundation, and the JSPS Postdoctoral Fellowships for Research Abroad. This paper was written when Michi Nishihara was a JSPS Postdoctoral Fellow for Research Abroad (visiting researcher at the Swiss Finance Institute, Ecole Polytechnique Federale de Lausanne). The authors would like to thank the Swiss Finance Institute and the JSPS Postdoctoral Fellowships for the research abroad.	Abel A., 2002, WORKING PAPER; Aivazian VA, 2005, FINANC MANAGE, V34, P107, DOI 10.1111/j.1755-053X.2005.tb00120.x; Chen H, 2010, J FINANC, V65, P2171, DOI 10.1111/j.1540-6261.2010.01613.x; Stohs MH, 1996, J BUS, V69, P279, DOI 10.1086/209692; Johnson SA, 2003, REV FINANC STUD, V16, P209, DOI 10.1093/rfs/16.1.209; Dang VA, 2011, J BUS FINAN ACCOUNT, V38, P225, DOI 10.1111/j.1468-5957.2010.02215.x; Billett MT, 2007, J FINANC, V62, P697, DOI 10.1111/j.1540-6261.2007.01221.x; Shibata T, 2012, INT REV ECON FINANC, V22, P141, DOI 10.1016/j.iref.2011.09.007; Hackbarth D, 2006, J FINANC ECON, V82, P519, DOI 10.1016/j.jfineco.2005.10.003; BARCLAY MJ, 1995, J FINANC, V50, P609, DOI 10.2307/2329421; BRENNAN MJ, 1978, J BUS, V51, P103, DOI 10.1086/295987; Vath VL, 2007, SIAM J CONTROL OPTIM, V46, P395, DOI 10.1137/050638783; Leland HE, 1998, J FINANC, V53, P1213, DOI 10.1111/0022-1082.00051; MYERS SC, 1977, J FINANC ECON, V5, P147, DOI 10.1016/0304-405X(77)90015-0; Leland HE, 1996, J FINANC, V51, P987, DOI 10.2307/2329229; BRICK IE, 1985, J FINANC, V40, P1423, DOI 10.2307/2328122; Arnold M, 2013, J FINANC ECON, V107, P350, DOI 10.1016/j.jfineco.2012.08.017; Bhamra HS, 2010, REV FINANC STUD, V23, P645, DOI 10.1093/rfs/hhp082; BRENNAN MJ, 1985, J BUS, V58, P135, DOI 10.1086/296288; Chen H, 2010, WORKING PAPER; Childs PD, 2005, J FINANC ECON, V76, P667, DOI 10.1016/j.jfineco.2004.06.012; DIAMOND DW, 1991, Q J ECON, V106, P709, DOI 10.2307/2937924; Diamond DW, 2014, J FINANC, V69, P719, DOI 10.1111/jofi.12118; Du D., 2010, WORKING PAPER; Elliott Robert J, 2009, International Journal of Theoretical and Applied Finance, V12, DOI 10.1142/S0219024909005361; Guo X, 2005, J ECON THEORY, V122, P37, DOI 10.1016/j.jet.2004.04.005; Huang J.-Z., 2012, REV ASSET PRICING ST, V2, P153, DOI DOI 10.1093/RAPSTU/RAS011; JENSEN MC, 1976, J FINANC ECON, V3, P305, DOI 10.1016/0304-405X(76)90026-X; Jeon H., 2014, WORKING PAPER; Jeon H, 2014, FINANC RES LETT, V11, P398, DOI 10.1016/j.frl.2014.08.002; LELAND HE, 1994, J FINANC, V49, P1213, DOI 10.2307/2329184; Mauer DC, 2005, J BANK FINANC, V29, P1405, DOI 10.1016/j.jbankfin.2004.05.036; MCDONALD R, 1986, Q J ECON, V101, P707, DOI 10.2307/1884175; MellaBarral P, 1997, J FINANC, V52, P531, DOI 10.1111/j.1540-6261.1997.tb04812.x; Moyen N, 2007, J ECON DYN CONTROL, V31, P433, DOI 10.1016/j.jedc.2005.10.008; Pham H, 2009, STOCH MOD APPL PROBA, V61, P1, DOI 10.1007/978-3-540-89500-8_1; Sarkar S, 2015, INT REV ECON FINANC, V37, P240, DOI 10.1016/j.iref.2014.11.026; Titman S, 2007, REV FINANC, V11, P401, DOI 10.1093/rof/rfm017	38	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1059-0560	1873-8036		INT REV ECON FINANC	Int. Rev. Econ. Financ.	JUL	2015	38						326	351		10.1016/j.iref.2015.02.031		26	Business, Finance; Economics	Business & Economics	CK3OY	WOS:000356126600023		
J	Ji, SP; Shi, Y; Shan, J; Shao, XW; Shi, ZC; Yuan, XX; Yang, P; Wu, WB; Tang, HJ; Shibasaki, R				Ji, Shunping; Shi, Yun; Shan, Jie; Shao, Xiaowei; Shi, Zhongchao; Yuan, Xiuxiao; Yang, Peng; Wu, Wenbin; Tang, Huajun; Shibasaki, Ryosuke			Particle filtering methods for georeferencing panoramic image sequence in complex urban scenes	ISPRS JOURNAL OF PHOTOGRAMMETRY AND REMOTE SENSING			English	Article						Mobile mapping; Particle filtering; Monte Carlo; Kalman filtering; Image matching; Gross errors	VISUAL SLAM; PROBABILISTIC LOCALIZATION; ENVIRONMENTS; APPEARANCE; MODEL; MAPS; GPS	Georeferencing image sequences is critical for mobile mapping systems. Traditional methods such as bundle adjustment need adequate and well-distributed ground control points (GCP) when accurate GPS data are not available in complex urban scenes. For applications of large areas, automatic extraction of GCPs by matching vehicle-born image sequences with geo-referenced ortho-images will be a better choice than intensive GCP collection with field surveying. However, such image matching generated GCP's are highly noisy, especially in complex urban street environments due to shadows, occlusions and moving objects in the ortho images. This study presents a probabilistic solution that integrates matching and localization under one framework. First, a probabilistic and global localization model is formulated based on the Bayes' rules and Markov chain. Unlike many conventional methods, our model can accommodate non-Gaussian observation. In the next step, a particle filtering method is applied to determine this model under highly noisy GCP's. Owing to the multiple hypotheses tracking represented by diverse particles, the method can balance the strength of geometric and radiometric constraints, i.e., drifted motion models and noisy GCP's, and guarantee an approximately optimal trajectory. Carried out tests are with thousands of mobile panoramic images and aerial ortho-images. Comparing with the conventional extended Kalman filtering and a global registration method, the proposed approach can succeed even under more than 80% gross errors in GCP's and reach a good accuracy equivalent to the traditional bundle adjustment with dense and precise control. (C) 2015 International Society for Photogrammetry and Remote Sensing, Inc. (ISPRS). Published by Elsevier B.V. All rights reserved.	[Ji, Shunping; Yuan, Xiuxiao] Wuhan Univ, Sch Remote Sensing & Informat Engn, Wuhan 430079, Peoples R China; [Shi, Yun; Shao, Xiaowei; Yang, Peng; Wu, Wenbin; Tang, Huajun] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Minist Agr, Key Lab Agriinformat, Beijing 10008, Peoples R China; [Shi, Yun; Shibasaki, Ryosuke] Univ Tokyo, Ctr Spatial Informat Sci, Kashiwa, Chiba 2778568, Japan; [Shan, Jie] Purdue Univ, Lyles Sch Civil Engn, W Lafayette, IN 47907 USA; [Shao, Xiaowei] Univ Tokyo, Earth Observat Data Integrat & Fus Res Initiat, Tokyo 1538505, Japan; [Shi, Zhongchao] Tokyo City Univ, Fac Environm Studies, Dept Restorat Ecol & Built Environm, Tuzuki Ku, Yokohama, Kanagawa 2248551, Japan	Shi, Y (reprint author), Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Minist Agr, Key Lab Agriinformat, 12 Southern St Zhongguanchun, Beijing 10008, Peoples R China.	jishunping@whu.edu.cn; shiyun@caas.cn; jshan@ecn.purdue.edu; shaozw@iis.u-tokyo.ac.jp; shizc@tcu.ac.jp; yuanxx@whu.edu.cn; yangpeng@caas.cn; wuwenbin@caas.cn; tanghuajun@caas.cn; shiba@csis.u-tokyo.ac.jp			National Key Basic Research Program of China [2012CB719902]; National Natural Science Foundation of China [41301365, 41471288, 61403285]; GRENE project of MEXT Japan	This work was jointly supported by the National Key Basic Research Program of China (2012CB719902), the National Natural Science Foundation of China (41301365, 41471288, 61403285), and the GRENE project of MEXT Japan. The authors thank the Associate Editor, Prof. Konrad Schindler and the two anonymous reviewers for their valuable suggestions and constructive comments.	Cui YJ, 2003, IEEE T ROBOTIC AUTOM, V19, P15, DOI 10.1109/TRA.2002.807557; Williams B, 2009, ROBOT AUTON SYST, V57, P1188, DOI 10.1016/j.robot.2009.06.010; Barrios C, 2011, IEEE T INSTRUM MEAS, V60, P3747, DOI 10.1109/TIM.2011.2147670; Brubaker MA, 2013, PROC CVPR IEEE, P3057, DOI 10.1109/CVPR.2013.393; Strasdat H, 2012, IMAGE VISION COMPUT, V30, P65, DOI 10.1016/j.imavis.2012.02.009; Bosse M, 2004, INT J ROBOT RES, V23, P1113, DOI 10.1177/0278364904049393; FISCHLER MA, 1981, COMMUN ACM, V24, P381, DOI 10.1145/358669.358692; Meer P, 2001, IEEE T PATTERN ANAL, V23, P1351, DOI 10.1109/34.977560; Cummins M, 2008, INT J ROBOT RES, V27, P647, DOI 10.1177/0278364908090961; Sibley G, 2010, INT J ROBOT RES, V29, P958, DOI 10.1177/0278364910369268; Thrun S, 2001, ARTIF INTELL, V128, P99, DOI 10.1016/S0004-3702(01)00069-8; Alonso IP, 2012, IEEE T INTELL TRANSP, V13, P1535, DOI 10.1109/TITS.2012.2193569; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Kummerle R., 2010, AUTONOMOUS ROBOTICS, V30, P25; Maddern W, 2012, INT J ROBOT RES, V31, P429, DOI 10.1177/0278364912438273; Marks TK, 2009, J FIELD ROBOT, V26, P26, DOI 10.1002/rob.20273; Montemerlo M., 2003, INT JOINT C ART INT, V18, P1151; Montemerlo M., 2003, CMURITR0328; Najjar M., 2005, AUTON ROBOT, V19, P173; Shi Y, 2013, SENSORS-BASEL, V13, P119, DOI 10.3390/s130100119; Shipboard Scientific Party, 2004, P OCEAN DRILLING PRO, V207, P1; Sibley D., 2009, ROBOT SCI SYST, V220, P1; Silpa-Anan C., 2005, VISUAL LOCALIZATION; Sim R., 2005, IJCAI WORKSH REAS UN, V14, P9; Sola J., 2011, INT J COMPUT VISION, V97, P339, DOI DOI 10.1007/S11263-011-0492-5	25	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0924-2716	1872-8235		ISPRS J PHOTOGRAMM	ISPRS-J. Photogramm. Remote Sens.	JUL	2015	105						1	12		10.1016/j.isprsjprs.2015.03.005		12	Geography, Physical; Geosciences, Multidisciplinary; Remote Sensing; Imaging Science & Photographic Technology	Physical Geography; Geology; Remote Sensing; Imaging Science & Photographic Technology	CK0KU	WOS:000355894900001		
J	Kimura, R; Yoshizaki, K; Osumi, N				Kimura, Ryuichi; Yoshizaki, Kaichi; Osumi, Noriko			Dynamic expression patterns of Pax6 during spermatogenesis in the mouse	JOURNAL OF ANATOMY			English	Article						meiosis; Pax6; spermatocytes; testis; XY body	SEX-CHROMOSOME INACTIVATION; SPERMATOGONIAL STEM-CELLS; MEIOTIC PROPHASE; PROGENITOR CELLS; NEURONAL FATE; TRANSCRIPTION; SPECIFICATION; NEUROGENESIS; IDENTIFICATION; SPERMATOCYTES	Spermatogenesis is a series of complex processes to generate mature sperm, and various molecules play crucial roles in regulating these processes. Previous studies imply a possibility that a transcriptional factor Pax6, a key player of brain and sensory organ development, could be involved in spermatogenesis, but neither expression nor function of Pax6 in the adult testis has been examined yet. In the present study, we described for the first time Pax6 expression dynamics in the adult mouse testis. Using cell-type-specific markers, the expression of Pax6 was detected in 67.0% of promyelocytic leukemia zinc finger (Plzf)-positive type A spermatogonia. The expression of Pax6 was also observed in p63-positive spermatocytes and round spermatids. We did not detect any expression of Pax6 in Sox9-positive Sertoli cells or in elongated spermatids and mature sperm. High-resolution analyses revealed that Pax6 formed a single dot-like structure during mid-phase of the pachytene spermatocyte. This dot-like structure co-localized with H2A.X demarcating XY body, a domain in which X and Y chromosomes are silenced and compartmentalized. These results may suggest a novel role of Pax6 in spermatogenesis.	[Kimura, Ryuichi; Yoshizaki, Kaichi; Osumi, Noriko] Tohoku Univ, Sch Med, Dept Dev Neurosci, Ctr Neurosci, Sendai, Miyagi 9808575, Japan	Osumi, N (reprint author), Tohoku Univ, Sch Med, Div Dev Neurosci, United Cts Adv Res & Translat Med ART,Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	osumi@med.tohoku.ac.jp			KAKENHI [256400002]; Core Research for Evolutional Science and Technology (CREST) from Ministry of Education, Culture, Sports, Science and Technology of Japan	The authors thank Dr Yasuhisa Matsui and Dr Kentaro Mochizuki for providing insightful comments and assistance, Dr Kentaro Tanemura and Mr Yoshiki Shirakata for critical reading of the manuscript and for advice on seminiferous tubule classification, Dr Keiko Nakayama for providing anti-cH2A. X antibody, and Ms Sayaka Makino for animal care. The authors are also grateful to all members of their laboratory for fruitful discussions. This work was supported by KAKENHI (256400002) and Core Research for Evolutional Science and Technology (CREST) from Ministry of Education, Culture, Sports, Science and Technology of Japan.	Mahadevaiah SK, 2001, NAT GENET, V27, P271, DOI 10.1038/85830; Jan SZ, 2012, BBA-MOL BASIS DIS, V1822, P1838, DOI 10.1016/j.bbadis.2012.02.008; Handel MA, 2004, EXP CELL RES, V296, P57, DOI 10.1016/j.yexcr.2004.03.008; Hack MA, 2005, NAT NEUROSCI, V8, P865, DOI 10.1038/nn1479; Takahashi M, 2002, DEVELOPMENT, V129, P1327; Inoue T, 2000, DEV BIOL, V219, P373, DOI 10.1006/dbio.2000.9616; Ji ZL, 2014, NUCLEIC ACIDS RES, V42, P6232, DOI 10.1093/nar/gku274; Stoykova A, 1997, DEVELOPMENT, V124, P3765; Tuoc TC, 2013, DEV CELL, V25, P256, DOI 10.1016/j.devcel.2013.04.005; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; MCKEE BD, 1993, CHROMOSOMA, V102, P71, DOI 10.1007/BF00356023; Maekawa M, 2005, GENES CELLS, V10, P1001, DOI 10.1111/j.1365-2443.2005.00893.x; Izadyar F, 2011, HUM REPROD, V26, P1296, DOI 10.1093/humrep/der026; Liu ZL, 2010, J BIOL CHEM, V285, P2758, DOI 10.1074/jbc.M109.066845; MCCARREY JR, 1992, DEV BIOL, V154, P160, DOI 10.1016/0012-1606(92)90056-M; Turner JMA, 2007, DEVELOPMENT, V134, P1823, DOI 10.1242/dev.000018; Seki T, 1995, NEUROREPORT, V6, P2479, DOI 10.1097/00001756-199512150-00010; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; Hack MA, 2004, MOL CELL NEUROSCI, V25, P664, DOI 10.1016/j.mcn.2003.12.012; Phillips BT, 2010, PHILOS T R SOC B, V365, P1663, DOI 10.1098/rstb.2010.0026; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; Ninkovic J, 2013, CELL STEM CELL, V13, P403, DOI 10.1016/j.stem.2013.07.002; Okada Y, 2010, J ANDROL, V31, P75, DOI 10.2164/jandrol.109.008052; Osumi N, 2008, STEM CELLS, V26, P1663, DOI 10.1634/stemcells.2007-0884; Bellani MA, 2005, J CELL SCI, V118, P3233, DOI 10.1242/jcs.02466; Hemendinger RA, 2002, CELL TRANSPLANT, V11, P499; Osumi N, 1997, DEVELOPMENT, V124, P2961; Bibel M, 2004, NAT NEUROSCI, V7, P1003, DOI 10.1038/nn1301; Baarends WM, 2003, CYTOGENET GENOME RES, V103, P225, DOI 10.1159/000076808; Rezai-Zadeh N, 2003, GENE DEV, V17, P1019, DOI 10.1101/gad.1068003; van der Heijden GW, 2007, NAT GENET, V39, P251, DOI 10.1038/ng1949; SOLARI AJ, 1974, INT REV CYTOL, V38, P273, DOI 10.1016/S0074-7696(08)60928-6; Thomson S, 2004, MOL CELL, V15, P585, DOI 10.1016/j.molcel.2004.08.002; Simpson TI, 2002, BIOESSAYS, V24, P1041, DOI 10.1002/bies.10174; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; Hayashi T, 2004, J ANDROL, V25, P692; Baarends WM, 1999, DEV BIOL, V207, P322, DOI 10.1006/dbio.1998.9155; Cvekl A, 2014, DEVELOPMENT, V141, P4432, DOI 10.1242/dev.107953; desVries FAT, 2005, GENE DEV, V19, P1376; Dora N, 2008, DEV DYNAM, V237, P1295, DOI 10.1002/dvdy.21528; Fernandez-Capetillo O, 2003, DEV CELL, V4, P497, DOI 10.1016/S1534-5807(03)00093-5; Gao J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020954; Haba H, 2009, NEUROSCI RES, V65, P116, DOI 10.1016/j.neures.2009.05.011; Hess RA, 2008, ADV EXP MED BIOL, V636, P1, DOI 10.1007/978-0-387-09597-4_1; Khalil AM, 2004, P NATL ACAD SCI USA, V101; Kim J, 2015, NATURE, V517, P466, DOI 10.1038/nature14097; Ontoso D, 2014, CHROMOSOMA, V123, P147, DOI 10.1007/s00412-013-0438-5; Osumi N, 2001, TOHOKU J EXP MED, V193, P163, DOI 10.1620/tjem.193.163; Russell LD, 1993, HISTOLOGICAL HISTOPA; Sansom SN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000511; Suzuki J, 2015, STEM CELLS DEV; Tripathi R, 2012, CELL MOL NEUROBIOL, V32, P209, DOI 10.1007/s10571-011-9749-3; Wolgemuth DJ, 2002, RECENT PROG HORM RES, V57, P75, DOI 10.1210/rp.57.1.75; Xie Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054507	54	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-8782	1469-7580		J ANAT	J. Anat.	JUL	2015	227	1					1	9		10.1111/joa.12318		9	Anatomy & Morphology	Anatomy & Morphology	CK7FD	WOS:000356396100001		
J	Tanaka, M; Yu, RK; Kurokawa, D				Tanaka, Mikiko; Yu, Reiko; Kurokawa, Daisuke			Anterior migration of lateral plate mesodermal cells during embryogenesis of the pufferfish Takifugu niphobles: insight into the rostral positioning of pelvic fins	JOURNAL OF ANATOMY			English	Article						evolution; lateral plate mesoderm; pelvic fin; pufferfish	PAIRED FINS; SPINAL-CORD; EVOLUTION	In vertebrates, paired appendages (limbs and fins) are derived from the somatic mesoderm subsequent to the separation of the lateral plate mesoderm into somatic and splanchnic layers. This is less clear for teleosts, however, because the developmental processes of separation into two layers and of extension over the yolk have rarely been studied. During teleost evolution, the position of pelvic fins has generally shifted rostrally (Rosen; Nelson, 1982, 1994), although at the early embryonic stage the presumptive pelvic fin cells are initially located near the future anus region - the anterior border of hoxc10a expression in the spinal cord - regardless of their final destination. Our previous studies in zebrafish (abdominal pelvic fins) and Nile tilapia (thoracic pelvic fins) showed that the presumptive pelvic fin cells shift their position with respect to the body trunk after its protrusion from the yolk surface. Furthermore, in Nile tilapia, presumptive pelvic fin cells migrate anteriorly on the yolk surface. Here, we examined the embryonic development of the lateral plate mesoderm at histological levels in the pufferfish Takifugu niphobles, which belongs to the highly derived teleost order Tetraodontiformes, and lacks pelvic fins. Our results show that, in T.niphobles, the lateral plate mesoderm bulges out as two separate layers of cells alongside the body trunk prior to its further extension to cover the yolk sphere. Once the lateral plate mesoderm extends laterally, it rapidly covers the surface of the yolk. Furthermore, cells located near the anterior border of hoxc10a expression in the spinal cord reach the anterior-most region of the yolk surface. In light of our previous and current studies, we propose that anterior migration of presumptive pelvic fin cells might be required for them to reach the thoracic or more anterior positions as is seen in other highly derived teleost groups.	[Tanaka, Mikiko; Yu, Reiko] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa 2268501, Japan; [Kurokawa, Daisuke] Univ Tokyo, Grad Sch Sci, Misaki Marine Biol Stn, Miura, Kanagawa, Japan	Tanaka, M (reprint author), Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, B-17,4259 Nagatsuta Cho, Yokohama, Kanagawa 2268501, Japan.	mitanaka@bio.titech.ac.jp			Toray Science Foundation; Nakajima Foundation; Narishige Zoological Science Award;  [25291086]	The authors thank Yumie Murata for critical suggestions. This work was supported in part by a Grant-in-Aid for Scientific Research (B) (25291086) to MT and DK, the Toray Science Foundation, the Nakajima Foundation, and the Narishige Zoological Science Award to MT. The authors also thank reviewers whose comments greatly improved the manuscript.	Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Yamanoue Y, 2009, MOL BIOL EVOL, V26, P623, DOI 10.1093/molbev/msn283; Fujimura K, 2007, DEV GROWTH DIFFER, V49, P301, DOI 10.1111/j.1440-169x.2007.00926.x; Tanaka M, 2011, EVOL DEV, V13, P382, DOI 10.1111/j.1525-142X.2011.00493.x; Grandel H, 1998, MECH DEVELOP, V79, P99, DOI 10.1016/S0925-4773(98)00176-2; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Murata Y, 2010, DEV BIOL, V347, P236, DOI 10.1016/j.ydbio.2010.07.034; McDonald LA, 2010, J ANAT, V216, P683, DOI 10.1111/j.1469-7580.2010.01233.x; Choe A, 2006, GENE EXPR PATTERNS, V6, P730, DOI 10.1016/j.modgep.2005.12.004; de la Rosa LN, 2014, EVOL DEV, V16, P38, DOI 10.1111/ede.12061; Funayama N, 1999, DEVELOPMENT, V126, P4129; Gosline W.A., 1971, FUNCTIONAL MORPHOLOG; Greenwood P. H., 1966, Bulletin of the American Museum of Natural History, V131, P339; Kaneko H, 2014, J ANAT, V225, P659, DOI 10.1111/joa.12244; Lance-Jones C, 2001, DEVELOPMENT, V128, P2255; Nelson JS, 1994, FISHES WORLD; Onimaru K, 2011, DEV BIOL, V359, P124, DOI 10.1016/j.ydbio.2011.08.003; ROSEN DE, 1982, AM ZOOL, V22, P261; Tanaka M, 2005, DEV BIOL, V281, P227, DOI 10.1016/j.ydbio.2005.02.016; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE	20	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-8782	1469-7580		J ANAT	J. Anat.	JUL	2015	227	1					81	88		10.1111/joa.12324		8	Anatomy & Morphology	Anatomy & Morphology	CK7FD	WOS:000356396100008		
J	Zhang, ML; Guo, ZF; Sano, YJ; Cheng, ZH; Zhang, LH				Zhang, Maoliang; Guo, Zhengfu; Sano, Yuji; Cheng, Zhihui; Zhang, Lihong			Stagnant subducted Pacific slab-derived CO2 emissions: Insights into magma degassing at Changbaishan volcano, NE China	JOURNAL OF ASIAN EARTH SCIENCES			English	Article						CO2 emissions; Stagnant subducted Pacific slab; C-He isotope coupling model; Deep carbon cycle; Changbaishan volcano	MANTLE TRANSITION ZONE; LARGE IGNEOUS PROVINCES; HELIUM ISOTOPIC-RATIOS; MIDOCEAN RIDGE BASALTS; NORTHEASTERN CHINA; MILLENNIUM ERUPTION; GEOTHERMAL FLUIDS; TIANCHI VOLCANO; GAS-COMPOSITION; EASTERN CHINA	Changbaishan volcano, similar to 1400 km away from Pacific subduction zone, has long been regarded as significant source of carbon released by episodic eruptions since Quaternary and magma-related geothermal activities at present (e.g. hot springs and soil microseepage). Soil CO2 flux measurements following accumulation chamber method indicate that average soil CO2 flux of western flank of the Changbaishan volcano is similar to 19.4 g m(-2) d(-1), which suggests relatively quiescent status of diffuse soil microseepage and might be informative for volcanic monitoring. Bubble gases from hot springs close to crater are characterized by arc-like He-3/He-4 ratios (2.7-6.33 R-A) and delta C-13(co2) values (-3.5 parts per thousand, to -7.5 parts per thousand, whereas the sample far away from crater has lower He-3/He-4 ratio (0.85 R-A) and delta C-13(co2) value (-12.3 parts per thousand). Three-component C-He isotope coupling model reveals that, upper mantle (MORB), slab carbonate (CAR) and organic metasediments (ORG) from both subducted Pacific slab and overriding continental crust are involved in origin and evolution of the Changbaishan volcanic gases. Combined with evidences from geochemical and geophysical studies, we propose that CO2-rich volcanic gases released by Changbaishan volcano might originate from stagnant subducted Pacific slab in the mantle transition zone (MTZ). The MTZ-derived volatiles mixed by components from upper mantle, slab carbonate and subducted organic metasediments underwent variable degrees of contamination by organic metasediments in continental crust during transportation from magma chamber to the surface. Subducted Pacific slab-derived materials contribute over half of the total carbon inventory at Changbaishan volcano, which could shed light on the significance of carbonatitic and carbonated silicate melts on liberating carbon from Earth's interior to the exosphere. (C) 2015 Elsevier Ltd. All rights reserved.	[Zhang, Maoliang; Guo, Zhengfu; Cheng, Zhihui; Zhang, Lihong] Chinese Acad Sci, Inst Geol & Geophys, Key Lab Cenozo Geol & Environm, Beijing 100029, Peoples R China; [Zhang, Maoliang; Cheng, Zhihui; Zhang, Lihong] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Sano, Yuji] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba 2778564, Japan	Guo, ZF (reprint author), 19 Beitucheng Western Rd, Beijing 100029, Peoples R China.	zfguo@mail.iggcas.ac.cn	Zhang, Maoliang/H-2419-2012	Zhang, Maoliang/0000-0002-5232-562X	Strategic Priority Research Program (B) of the Chinese Academy of Sciences [XDB03010600]; National Natural Science Foundation of China [41020124002, 41130314]	This paper is dedicated to the late Prof. Tsanyao Frank Yang, whose sincere and invaluable help greatly improved the research on volcanic gases of our group. The authors are grateful to Prof. David Hilton and an anonymous reviewer for constructive reviews which helped improve the manuscript. We also thank the Associate Editor, Prof. Yukio Isozaki, for his support. Prof. Guodong Zheng is acknowledged for careful and constructive revision of earlier version of the manuscript. Chunqing Sun, Xiangxian Ma, Hsin-yi Wen, Ai-Ti Chen, Ching-Chou Fu, Wenfeng Guo and Guoming Liu are thanked for their kind help in fieldwork and experiments. Special thanks go to Ting Li for providing unpublished data (samples JJ 1# and JJ 2#) based on fieldwork carried out by Ting Li, Zhihui Cheng and Wenfeng Guo. This study was financially supported by the Strategic Priority Research Program (B) of the Chinese Academy of Sciences (Grant No. XDB03010600) and the National Natural Science Foundation of China (Grants Nos. 41020124002 and 41130314).	Aiuppa A., 2006, J GEOPHYS RES, V111; van Keken PE, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000256; Maruyama S, 2007, GONDWANA RES, V11, P148, DOI 10.1016/j.gr.2006.06.001; Xu JD, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052600; Halmer MM, 2002, J VOLCANOL GEOTH RES, V115, P511, DOI 10.1016/S0377-0273(01)00318-3; Chen Y, 2007, LITHOS, V96, P108, DOI 10.1016/j.lithos.2006.09.015; CLARKE WB, 1976, INT J APPL RADIAT IS, V27, P515, DOI 10.1016/0020-708X(76)90082-X; Shaw AM, 2003, EARTH PLANET SC LETT, V214, P499, DOI 10.1016/S0012-821X(03)00401-1; Karato S, 2011, EARTH PLANET SC LETT, V301, P413, DOI 10.1016/j.epsl.2010.11.038; Marty B, 1999, GEOCHIM COSMOCHIM AC, V63, P3619, DOI 10.1016/S0016-7037(99)00169-6; EGGLER DH, 1976, GEOLOGY, V4, P69, DOI 10.1130/0091-7613(1976)4<69:DCCPMI>2.0.CO;2; Choi SH, 2006, CHEM GEOL, V232, P134, DOI 10.1016/j.chemgeo.2006.02.014; Sobolev SV, 2011, NATURE, V477, P312, DOI 10.1038/nature10385; Yin JH, 2012, QUATERNARY SCI REV, V47, P150, DOI 10.1016/j.quascirev.2012.05.015; Burton M, 2007, SCIENCE, V317, P227, DOI 10.1126/science.1141900; WEISS RF, 1971, J CHEM ENG DATA, V16, P235, DOI 10.1021/je60049a019; HIROSE K, 1995, EARTH PLANET SC LETT, V133, P463, DOI 10.1016/0012-821X(95)00096-U; Chiodini G, 2004, J VOLCANOL GEOTH RES, V133, P291, DOI 10.1016/S0377-0273(03)00403-7; Jahn BM, 2000, EPISODES, V23, P82; MARTY B, 1987, EARTH PLANET SC LETT, V83, P16, DOI 10.1016/0012-821X(87)90047-1; Sorey ML, 1998, J GEOPHYS RES-SOL EA, V103, P15303, DOI 10.1029/98JB01389; Tang YC, 2014, NAT GEOSCI, V7, P470, DOI 10.1038/NGEO2166; Dasgupta R, 2004, EARTH PLANET SC LETT, V227, P73, DOI 10.1016/j.epsl.2004.08.004; STAUDACHER T, 1988, EARTH PLANET SC LETT, V89, P173, DOI 10.1016/0012-821X(88)90170-7; Carapezza ML, 2004, APPL GEOCHEM, V19, P73, DOI 10.1016/S0883-2927(03)00111-2; Kuritani T, 2009, LITHOS, V112, P247, DOI 10.1016/j.lithos.2009.02.007; Penning H, 2007, ANAL CHEM, V79, P8399, DOI 10.1021/ac071420a; Hamme RC, 2004, DEEP-SEA RES PT I, V51, P1517, DOI 10.1016/j.dsr.2004.06.009; Lan TF, 2007, J VOLCANOL GEOTH RES, V165, P32, DOI 10.1016/j.jvolgeores.2007.04.015; Sano Y, 1996, GEOPHYS RES LETT, V23, P2749, DOI 10.1029/96GL02260; Stone R, 2011, SCIENCE, V334, P584, DOI 10.1126/science.334.6056.584; Stone R, 2010, SCIENCE, V329, P498, DOI 10.1126/science.329.5991.498-a; SANO Y, 1984, SCIENCE, V224, P150, DOI 10.1126/science.224.4645.150; Kuritani T, 2011, NAT GEOSCI, V4, P713, DOI [10.1038/ngeo1250, 10.1038/NGEO1250]; Taran YA, 2009, GEOCHIM COSMOCHIM AC, V73, P1067, DOI 10.1016/j.gca.2008.11.020; Xu YG, 2012, CHEM GEOL, V328, P168, DOI 10.1016/j.chemgeo.2012.01.027; MARTY B, 1991, CHEM GEOL, V91, P207, DOI 10.1016/0009-2541(91)90001-8; Wignall PB, 2001, EARTH-SCI REV, V53, P1, DOI 10.1016/S0012-8252(00)00037-4; Deng JF, 2004, EARTH-SCI REV, V65, P223, DOI 10.1016/j.earscirev.2003.08.001; Zou HB, 2010, LITHOS, V119, P289, DOI 10.1016/j.lithos.2010.07.006; Xu JD, 2013, GEOPHYS RES LETT, V40, P54, DOI 10.1029/2012GL054246; MARTY B, 1989, CHEM GEOL, V76, P25, DOI 10.1016/0009-2541(89)90125-3; Zhao DP, 2009, PHYS EARTH PLANET IN, V173, P197, DOI 10.1016/j.pepi.2008.11.009; Ray MC, 2009, CHEM GEOL, V266, P38, DOI 10.1016/j.chemgeo.2008.12.026; Sano Y, 2006, PURE APPL GEOPHYS, V163, P745, DOI 10.1007/s00024-006-0035-0; Yang W, 2012, CHEM GEOL, V328, P185, DOI 10.1016/j.chemgeo.2012.05.018; Chiodini G, 1998, APPL GEOCHEM, V13, P543, DOI 10.1016/S0883-2927(97)00076-0; Presnall DC, 2002, GEOCHIM COSMOCHIM AC, V66, P2073, DOI 10.1016/S0016-7037(02)00890-6; Tang YJ, 2012, LITHOS, V149, P79, DOI 10.1016/j.lithos.2011.12.001; Sparks RSJ, 2003, EARTH PLANET SC LETT, V210, P1, DOI 10.1016/S0012-821X(03)00124-9; Dasgupta R, 2010, EARTH PLANET SC LETT, V298, P1, DOI 10.1016/j.epsl.2010.06.039; MAMYRIN BA, 1970, GEOCHEM INT, V7, P498; TATSUMOTO M, 1992, EARTH PLANET SC LETT, V113, P107, DOI 10.1016/0012-821X(92)90214-G; Shangguan ZG, 1997, SCI CHINA SER D, V40, P390, DOI 10.1007/BF02877570; Robock A, 2000, REV GEOPHYS, V38, P191, DOI 10.1029/1998RG000054; Kelbert A, 2009, NATURE, V460, P1003, DOI 10.1038/nature08257; Zou HB, 2000, CHEM GEOL, V171, P33, DOI 10.1016/S0009-2541(00)00243-6; Yang TF, 2005, GEOCHEM J, V39, P469, DOI 10.2343/geochemj.39.469; Li SL, 2006, TECTONOPHYSICS, V420, P239, DOI 10.1016/j.tecto.2006.01.026; Fan WM, 2000, J PETROL, V41, P933, DOI 10.1093/petrology/41.7.933; Chiodini G, 1996, B VOLCANOL, V58, P41, DOI 10.1007/s004450050124; Guo ZF, 2002, SCI CHINA SER D, V45, P530, DOI 10.1360/02yd9055; Wei HQ, 2007, LITHOS, V96, P315, DOI 10.1016/j.lithos.2006.10.004; REVENAUGH J, 1994, NATURE, V369, P474, DOI 10.1038/369474a0; Marty B, 1998, CHEM GEOL, V145, P233, DOI 10.1016/S0009-2541(97)00145-9; Miller CF, 2008, ELEMENTS, V4, P11, DOI 10.2113/GSELEMENTS.4.1.11; Lei JS, 2005, TECTONOPHYSICS, V397, P281, DOI 10.1016/j.tecto.2004.12.009; Gudmundsson O, 1998, J GEOPHYS RES-SOL EA, V103, P7121, DOI 10.1029/97JB02488; ANDREWS JN, 1985, CHEM GEOL, V49, P339, DOI 10.1016/0009-2541(85)90166-4; Wu FY, 2002, CHEM GEOL, V187, P143, DOI 10.1016/S0009-2541(02)00018-9; Sano Y, 1998, J GEOPHYS RES-SOL EA, V103, P23863, DOI 10.1029/98JB01666; ALLARD P, 1991, NATURE, V351, P387, DOI 10.1038/351387a0; Huppert HE, 2002, NATURE, V420, P493, DOI 10.1038/nature01211; BASU AR, 1991, EARTH PLANET SC LETT, V105, P149, DOI 10.1016/0012-821X(91)90127-4; Horn S, 2000, B VOLCANOL, V61, P537; Syracuse EM, 2010, PHYS EARTH PLANET IN, V183, P73, DOI 10.1016/j.pepi.2010.02.004; Dodson A, 1998, GEOCHIM COSMOCHIM AC, V62, P3775, DOI 10.1016/S0016-7037(98)00267-1; BAUBRON JC, 1991, J GEOL SOC LONDON, V148, P571, DOI 10.1144/gsjgs.148.3.0571; Hernandez PA, 2001, SCIENCE, V292, P83, DOI 10.1126/science.1058450; Sparks RSJ, 2003, GEOL SOC SPEC PUBL, V213, P5, DOI 10.1144/GSL.SP.2003.213.01.02; SANO Y, 1995, CHEM GEOL, V119, P265, DOI 10.1016/0009-2541(94)00097-R; Favara R, 2001, APPL GEOCHEM, V16, P883, DOI 10.1016/S0883-2927(00)00055-X; Sakuyama T, 2013, CHEM GEOL, V359, P32, DOI 10.1016/j.chemgeo.2013.09.012; Fan WM, 2003, J VOLCANOL GEOTH RES, V121, P115, DOI 10.1016/S0377-0273(02)00415-8; HILTON DR, 1992, GEOCHIM COSMOCHIM AC, V56, P851, DOI 10.1016/0016-7037(92)90105-R; Ohtani E, 2005, ELEMENTS, V1, P25, DOI 10.2113/gselements.1.1.25; Gautheron C, 2002, EARTH PLANET SC LETT, V199, P39, DOI 10.1016/S0012-821X(02)00563-0; Sparks RSJ, 2012, SCIENCE, V335, P1310, DOI 10.1126/science.1219485; Wang Y, 2003, J ASIAN EARTH SCI, V21, P1159, DOI 10.1016/S1367-9120(03)00019-1; Ballentine CJ, 1997, EARTH PLANET SC LETT, V152, P233, DOI 10.1016/S0012-821X(97)00142-8; Carapezza ML, 2000, J VOLCANOL GEOTH RES, V95, P227, DOI 10.1016/S0377-0273(99)00128-6; Choi SH, 2005, CHEM GEOL, V221, P40, DOI 10.1016/j.chemgeo.2005.04.008; COOKKOLLARS J, 2014, ITALIAN ALPS CHEM GE, V386, P31; de Leeuw GAM, 2007, EARTH PLANET SC LETT, V258, P132, DOI 10.1016/j.epsl.2007.03.028; Deng J. F., 1998, GEODYNAMICS SERIES, V27, P59; Deng J F, 1994, GEOSCIENCE, V8, P349; Deng J. F., 1996, GEOSCIENCE, V10, P137; Deng J.F., 1992, GEOSCIENCE, V6, P267; De Vivo B, 2005, ELEMENTS, V1, P19, DOI 10.2113/gselements.1.1.19; Engebretson D. C., 1985, SPEC PAP GEOL SOC AM, V206, P1, DOI 10.1130/SPE206-p1; [樊祺诚 FAN Qicheng], 2007, [高校地质学报, Geological Journal of China Universities], V13, P175; Fischer TP, 1996, GEOLOGY, V24, P531, DOI 10.1130/0091-7613(1996)024<0531:TRBFGC>2.3.CO;2; Fu CC, 2005, GEOCHEM J, V39, P427, DOI 10.2343/geochemj.39.427; Gao Ling, 2010, Bulletin of Mineralogy, Petrology and Geochemistry, V29; [高玲 GAO Ling], 2006, [地震地质, Seismology and Geology], V28, P358; GERLACH T, 1991, NATURE, V351, P352, DOI 10.1038/351352a0; Giggenbach W. F., 1996, MONITORING MITIGATIO, P221, DOI DOI 10.1007/978-3-642-80087-0_7; Gill JB, 1981, OROGENIC ANDESITES P; [郭正府 Guo Zhengfu], 2010, [第四纪研究, Quaternary Sciences], V30, P497; Guo ZF, 2006, SCI CHINA SER D, V49, P304, DOI 10.1007/s11430-006-0304-x; Hahm D, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035955; HARDING JP, 1949, J MAR BIOL ASSOC UK, V28, P141; HART SR, 1984, EARTH PLANET SC LETT, V70, P297, DOI 10.1016/0012-821X(84)90014-1; Hernández Perez P., 2003, Journal of Geophysical Research, V108, P2210, DOI 10.1029/2002JB001847; Hilton DR, 2002, REV MINERAL GEOCHEM, V47, P319, DOI 10.2138/rmg.2002.47.9; Hiyagon H., 1994, NOBLE GAS GEOCHEMIST, P67; Hoefs J., 2009, STABLE ISOTOPE GEOCH; HOEFS J, 1976, GEOCHIM COSMOCHIM AC, V40, P945, DOI 10.1016/0016-7037(76)90143-5; Ichiki M, 2001, GEOPHYS RES LETT, V28, P3773, DOI 10.1029/2001GL012983; Jin DC, 1999, GEOLOGICAL REV S, V45, P304; Kerrick DM, 2001, REV GEOPHYS, V39, P565, DOI 10.1029/2001RG000105; Kim KH, 2005, GEOCHEM J, V39, P341, DOI 10.2343/geochemj.39.341; Liu GM, 2011, ACTA PETROL SIN, V27, P2905; Liu J. Q, 1999, VOLCANOES CHINA, P219; [刘明军 Liu Mingjun], 2004, [中国地震, Earthquake Research in China], V20, P64; Machida H, 1990, GEOGRAPHICAL REPORTS, V25, P1; Menzies MA, 1993, GEOL SOC SPEC PUBL, V76, P71, DOI 10.1144/GSL.SP.1993.076.01.04; Morikawa N, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021501; Nakajima J, 2007, EARTH PLANET SC LETT, V254, P90, DOI 10.1016/j.epsl.2006.11.024; Notsu K, 2005, J VOLCANOL GEOTH RES, V139, P147, DOI 10.1016/j.jvolgeores.2004.08.003; ONIONS RK, 1988, EARTH PLANET SC LETT, V90, P331, DOI 10.1016/0012-821X(88)90134-3; O'Reilly S., 2013, METASOMATISM CHEM TR, P471; PINEAU F, 1983, EARTH PLANET SC LETT, V62, P239, DOI 10.1016/0012-821X(83)90087-0; Rampino MR, 2010, P NATL ACAD SCI USA, V107, P6555, DOI 10.1073/pnas.1002478107; Ripepe M, 2005, GEOLOGY, V33, P341, DOI 10.1130/G21173.1; Sano Y, 1997, J VOLCANOL GEOTH RES, V77, P255, DOI 10.1016/S0377-0273(96)00098-4; SANO Y, 1990, J VOLCANOL GEOTH RES, V42, P41, DOI 10.1016/0377-0273(90)90068-Q; Sano Y., 1994, JAPAN APPL GEOCHEM, V9, P371; Sano Y., 2013, NOBLE GASES GEOCHEMI, P249, DOI DOI 10.1007/978-3-642-28836-4_10; Sano Y, 2008, GEOCHEM J, V42, P51; Shangguan Z.G., 1996, SCI GEOL SINICA, V31, P54; Sinclair A., 1974, J GEOCHEM EXPLOR, V3, P129, DOI DOI 10.1016/0375-6742(74)90030-2; TORGERSEN T, 1982, GEOCHIM COSMOCHIM AC, V46, P739, DOI 10.1016/0016-7037(82)90025-4; Van Soest MC, 1998, GEOCHIM COSMOCHIM AC, V62, P3323, DOI 10.1016/S0016-7037(98)00241-5; VAREKAMP JC, 1992, TERRA NOVA, V4, P363, DOI 10.1111/j.1365-3121.1992.tb00825.x; Wei H, 2013, B VOLCANOL, V75, P1; Wen H. Y., 2011, AGU FALL M, P2484; Xu S, 2013, J ASIAN EARTH SCI, V62, P526, DOI 10.1016/j.jseaes.2012.11.001; Zhang CK, 2002, CHIN J GEOPHYS, V45, P862; Zhang J. G., 1999, GEOL REV S, V45, P231; Zhang ML, 2011, ACTA PETROL SIN, V27, P2898; Zhou X. H., 1982, EARTH PLANET SC LETT, V59, P301	152	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1367-9120	1878-5786		J ASIAN EARTH SCI	J. Asian Earth Sci.	JUL 1	2015	106						49	63		10.1016/j.jseaes.2015.01.029		15	Geosciences, Multidisciplinary	Geology	CK3MB	WOS:000356119100004		
J	Nunome, S; Kanetaka, H; Kudo, T; Endoh, K; Hosoda, H; Igarashi, K				Nunome, Shoko; Kanetaka, Hiroyasu; Kudo, Tada-aki; Endoh, Kazuki; Hosoda, Hideki; Igarashi, Kaoru			Invitro evaluation of biocompatibility of Ti-Mo-Sn-Zr superelastic alloy	JOURNAL OF BIOMATERIALS APPLICATIONS			English	Article						Biocompatibility; Ti-Mo-Sn-Zr alloy; shape memory alloy; superelasticity; invitro evaluation	SHAPE-MEMORY ALLOY; BIOMEDICAL APPLICATIONS; MECHANICAL-PROPERTIES; ORTHODONTIC WIRES; STAINLESS-STEEL; ACTIVE CATHETER; TITANIUM-ALLOYS; NICKEL-TITANIUM; CELLS; BEHAVIOR	Shape memory alloys (SMAs) including superelastic alloys have unique properties such as shape memory and superelasticity, thus they are recognized as very useful biomaterials. These properties are very advantageous for medical use, and actually the SMA wires have been widely used in medical field. However, biocompatibility of nickel-titanium (Ni-Ti) alloy, which is the only practical SMA at present, has been questioned because of its high nickel content. The aim of this study was to evaluate the biocompatibility of a newly developed Ni-free Ti-based SMA for medical use. The newly developed SMA made of Ti-Mo-Sn-Zr system was processed into a disk of 15.1mm in diameter. Pure titanium of the same shape was prepared as control. All the disk surfaces were polished using emery papers, #120, #400, and #600. Scanning electron microscopy and a 3D optics profiler were used to evaluate the surface of the materials. Invitro evaluations included colony examination for evaluation of the cell cytotoxicity, DNA quantification for the cell proliferation, Alamar blue assay for metabolic activity, FDA staining for the live cell imaging, and cell cycle analysis, using Chinese hamster fibroblastic V-79 cells and mouse osteoblastic MC3T3-E1 cells. In colony examination and DNA quantification, there was no significant difference between the Ti-Mo-Sn-Zr and the pure titanium. In FDA staining, cultured cells on the Ti-Mo-Sn-Zr alloy showed the same biocompatibility as those on the pure titanium. The present results suggest that the newly developed Ti-Mo-Sn-Zr alloy showed the high biocompatibility comparable to pure titanium and can be used as efficient biomaterial for medical use.	[Nunome, Shoko; Igarashi, Kaoru] Tohoku Univ, Grad Sch Dens, Div Oral Dysfunct Sci, Sendai, Miyagi 9808575, Japan; [Kanetaka, Hiroyasu] Tohoku Univ, Grad Sch Dens, Liaison Ctr Innovat Dent, Sendai, Miyagi 9808575, Japan; [Kanetaka, Hiroyasu] Tohoku Univ, Grad Sch Biomed Engn, Div Biomed Engn Diag & Treatment, Sendai, Miyagi 9808575, Japan; [Kudo, Tada-aki] Tohoku Univ, Grad Sch Dens, Div Oral Physiol, Sendai, Miyagi 9808575, Japan; [Endoh, Kazuki; Hosoda, Hideki] Tokyo Inst Technol, Precis & Intelligence Lab, Yokohama, Kanagawa 227, Japan	Kanetaka, H (reprint author), Tohoku Univ, Grad Sch Dens, Liaison Ctr Innovat Dent, Aoba Ku, 4-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	kanetaka@dent.tohoku.ac.jp			Funding Program for Next Generation World-Leading Researchers [LR015]; Japan Society for the Promotion of Science [26220907]	Authors would like to thank the financial support for the material development by Funding Program for Next Generation World-Leading Researchers (No. LR015) and Grant-in-Aid for Scientific Research (S) (No.26220907) from Japan Society for the Promotion of Science.	Abou Neel EA, 2010, J TISSUE ENG, V1, P1; Acerbi Francesco, 2010, Neurosurgery, V67, P448, DOI 10.1227/NEU.0b013e3181faaa86; Inamura T, 2004, MATER TRANS, V45, P1083, DOI 10.2320/matertrans.45.1083; Verstrynge A, 2006, AM J ORTHOD DENTOFAC, V130, P460, DOI 10.1016/j.ajodo.2004.12.030; Franklin NM, 2001, ENVIRON TOXICOL CHEM, V20, P160, DOI 10.1897/1551-5028(2001)020<0160:DOFCBA>2.0.CO;2; Iijima M, 2010, DENT MATER J, V29, P53; Kasprzak KS, 2003, MUTAT RES-FUND MOL M, V533, P67, DOI 10.1016/j.mrfmmm.2003.08.021; Sargeant TD, 2008, BIOMATERIALS, V29, P1085, DOI 10.1016/j.biomaterials.2007.11.002; Niinomi M, 2008, J MECH BEHAV BIOMED, V1, P30, DOI 10.1016/j.jmbbm.2007.07.001; Maeshima T, 2006, MAT SCI ENG A-STRUCT, V438, P844, DOI 10.1016/j.msea.2006.05.092; Prigent H, 1998, J BIOMED MATER RES, V39, P200, DOI 10.1002/(SICI)1097-4636(199802)39:2<200::AID-JBM5>3.0.CO;2-T; Maeshima T, 2004, MATER TRANS, V45, P1096, DOI 10.2320/matertrans.45.1096; Rack HJ, 2006, MAT SCI ENG C-BIO S, V26, P1269, DOI 10.1016/j.msec.2005.08.032; Coen N, 2003, BRIT J CANCER, V88, P548, DOI 10.1038/sj.bjc.6600758; Shabalovskaya S, 2008, ACTA BIOMATER, V4, P447, DOI 10.1016/j.actbio.2008.01.013; Mineta T, 2001, SENSOR ACTUAT A-PHYS, V88, P112, DOI 10.1016/S0924-4247(00)00510-0; Michiardi A, 2006, J BIOMED MATER RES B, V77B, P249, DOI 10.1002/jbm.b.30441; Gonzalez M, 2014, MAT SCI ENG C-MATER, V42, P691, DOI 10.1016/j.msec.2014.06.010; Aravind S, 2013, J INT ORAL HLTH, V5, P1; Arciniegas M, 2008, PHILOS MAG, V88, P2529, DOI 10.1080/14786430802375667; Arciniegas M, 2013, J BIOMED MATER RES B, V101B, P709, DOI 10.1002/jbm.b.32873; BAGOT M, 1995, EUR J DERMATOL, V5, P614; Camelia S, 2010, WSEAS T BIOL BIOMED, V3, P277; Darel EH, 1990, ASM HDB, P897; Diego M, 2010, JOM, V52, P36; Endoh K, 2014, MAT RES, V922, P137; Espinar E, 2011, J MATER SCI-MATER M, V22, P1119, DOI 10.1007/s10856-011-4292-9; Espinar E, 2013, MED ORAL PATOL ORAL, V18, P721; Gonzalez M, 2009, J MATER ENG PERFORM, V18, P506, DOI 10.1007/s11665-009-9393-y; Gonzalez M, 2011, J MATER ENG PERFORM, V20, P653, DOI 10.1007/s11665-011-9917-0; Haga Y, 2001, INTERV NEURORADIOL, V7, P125; Hera K, 1999, ANGLE ORTHOD, V69, P39; Hosoda H, 2010, MATER SCI FORUM, V654-656, P2150, DOI 10.4028/www.scientific.net/MSF.654-656.2150; Hosoda H, 2001, T MRS J, V26, P235; Hosoda H, 2001, T MRS J, V26, P243; Hosoda N, 2001, 4 PAC RIM INT C ADV, P1623; Isama K, 2002, MATER TRANS, V43, P3155, DOI 10.2320/matertrans.43.3155; Ishigaki T, 2007, INT C SHAP MEM SUP T, P559; Jia-can S, 2009, INT ORTHOP, V34, P369; John O, 2000, EUR J BIOCHEM, V267, P5421; Kanetaka H, 2010, MATER TRANS, V51, P1944, DOI 10.2320/matertrans.M2010038; Kassab EJ, 2013, ANGLE ORTHOD, V83, P864, DOI 10.2319/091712-740.1; Kawakita Eiji, 2012, Open Orthop J, V6, P239, DOI 10.2174/1874325001206010239; Kawashita M, 2014, J BIOMED MATER RES A, V102, P1880, DOI 10.1002/jbm.a.34861; Kim HY, 2004, MATER TRANS, V45, P1090, DOI 10.2320/matertrans.45.1090; Kodama C, 1998, B RES I MINERAL DRES, V43, P179; Li HF, 2014, J MATER SCI-MATER M, V25, P1249, DOI 10.1007/s10856-014-5158-8; Limor H, 2011, TOXICOL SCI, V122, P489; Maeshima T, 2004, MATER TRANS, V45, P1101, DOI 10.2320/matertrans.45.1101; Marcin M, 2010, BIOL TRACE ELEM RES, V146, P272; Miaolei Z., 2013, APPL MATH, V2013, P1; Moharamzadeh K, 2009, MATERIALS, V2, P514, DOI 10.3390/ma2020514; Nakagawa M, 2001, Dent Mater J, V20, P305; Ohmatsu Y, 2001, 4 PAC RIM INT C ADV, P1627; Robin KP, 2005, ANTIMICROB AGENTS CH, V49, P2612; Robin KP, 2009, ANN CLIN MICROB ANTI, V8, P1; Rodolfo V, 2002, MAT T, V43, P2991; Saito H, 2007, INT C SHAP MEM SUP T, P565; Sasano H, 1984, 5 INT C TIT FRANKF G, P1667; Schiff N, 2006, EUR J ORTHODONT, V28, P298, DOI 10.1093/ejo/cji102; Sephra NR., 2012, SENSORS, V12, P12347; Sfondrini MF, 2010, AM J ORTHOD DENTOFAC, V137, P809, DOI 10.1016/j.ajodo.2008.07.021; Taniguchi M, 2014, FEBS OPEN BIO, V4, P328, DOI 10.1016/j.fob.2014.03.004; Tripuraneni SC, 2011, TRENDS BIOMATER, V25, P51; Xiaohua Y, 2013, BIOMED RES INT, V2013, P1; Xinwei L, 2013, INT ORTHOP, V34, P1033; Yan C, 2012, J NANOMATER, V2012, P1; Yingxun Liu, 2011, Journal of Nanoparticle Research, V13, DOI 10.1007/s11051-010-0019-y; Zhang YM, 2009, BIOMED MATER, V4, P1	69	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0885-3282	1530-8022		J BIOMATER APPL	J. Biomater. Appl.	JUL	2015	30	1					119	130		10.1177/0885328215569892		12	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	CK5CL	WOS:000356239600011		
J	Kondo, N; Saito, M; Hikichi, H; Aida, J; Ojima, T; Kondo, K; Kawachi, I				Kondo, Naoki; Saito, Masashige; Hikichi, Hiroyuki; Aida, Jun; Ojima, Toshiyuki; Kondo, Katsunori; Kawachi, Ichiro			Relative deprivation in income and mortality by leading causes among older Japanese men and women: AGES cohort study	JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH			English	Article							HEALTH; POPULATION; INEQUALITY; INDEX	Background Relative deprivation of income is hypothesised to generate frustration and stress through upward social comparison with one's peers. If psychosocial stress is the mechanism, relative deprivation should be more strongly associated with specific health outcomes, such as cardiovascular disease (compared with other health outcomes, eg, non-tobacco-related cancer). Methods We evaluated the association between relative income deprivation and mortality by leading causes, using a cohort of 21 031 community-dwelling adults aged 65 years or older. A baseline mail-in survey was conducted in 2003. Information on cause-specific mortality was obtained from death certificates. Our relative deprivation measure was the Yitzhaki Index, derived from the aggregate income shortfall for each person, relative to individuals with higher incomes in that person's reference group. Reference groups were defined according to gender, age group and same municipality of residence. Results We identified 1682 deaths during the 4.5 years of follow-up. A Cox regression demonstrated that, after controlling for demographic, health and socioeconomic factors including income, the HR for death from cardiovascular diseases per SD increase in relative deprivation was 1.50 (95% CI 1.09 to 2.08) in men, whereas HRs for mortality by cancer and other diseases were close to the null value. Additional adjustment for depressive symptoms and health behaviours (eg, smoking and preventive care utilisation) attenuated the excess risks for mortality from cardiovascular disease by 9%. Relative deprivation was not associated with mortality for women. Conclusions The results partially support our hypothesised mechanism: relative deprivation increases health risks via psychosocial stress among men.	[Kondo, Naoki] Univ Tokyo, Sch Publ Hlth, Tokyo 1130033, Japan; [Saito, Masashige; Kondo, Katsunori] Nihon Fukushi Univ, Nagoya, Aichi, Japan; [Hikichi, Hiroyuki; Kondo, Katsunori] Chiba Univ, Chiba, Japan; [Aida, Jun] Tohoku Univ, Sendai, Miyagi 980, Japan; [Ojima, Toshiyuki] Hamamatsu Univ, Sch Med, Hamamatsu, Shizuoka 4312102, Japan; [Kawachi, Ichiro] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Kondo, N (reprint author), Univ Tokyo, Sch Publ Hlth, Bunkyo Ku, Floor 3,Med Bldg 3,7-3-1 Hongo, Tokyo 1130033, Japan.	naoki-kondo@umin.ac.jp			MEXT; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [21119002, 25253052]; Ministry of Health, Labour and Welfare, Japan [H26-chouju-ippan-006];  [23243070]	This study used data from the Aichi Gerontological Evaluation Study (AGES), conducted by the Center for Well-being and Society, Nihon Fukushi University as one of its research projects. This study was supported in part by the MEXT-Supported Program for the Strategic Research Foundation at Private Universities, 2009-2013 and Grant-in-Aid for Scientific Research (23243070). NK was supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan (Nos. 21119002, 25253052) and the Ministry of Health, Labour and Welfare, Japan (H26-chouju-ippan-006).	Yngwe MA, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-664; Wilkinson RG, 2006, SOC SCI MED, V62, P1768, DOI 10.1016/j.socscimed.2005.08.036; Kondo N, 2008, SOC SCI MED, V67, P982, DOI 10.1016/j.socscimed.2008.06.002; Adjaye-Gbewonyo K, 2012, SOC SCI MED, V75, P129, DOI 10.1016/j.socscimed.2012.03.004; Subramanian SV, 2004, EPIDEMIOL REV, V26, P78, DOI 10.1093/epirev/mxh003; Smith HJ, 2012, PERS SOC PSYCHOL REV, V16, P203, DOI 10.1177/1088868311430825; Eibner C, 2005, J HUM RESOUR, V40, P591; Kawachi I, 2010, ANN NY ACAD SCI, V1186, P56, DOI 10.1111/j.1749-6632.2009.05340.x; Kagamimori S, 2009, SOC SCI MED, V68, P2152, DOI 10.1016/j.socscimed.2009.03.030; Subramanyam M, 2009, SOC SCI MED, V69, P327, DOI 10.1016/j.socscimed.2009.06.008; Festinger L, 1954, HUM RELAT, V7, P117, DOI 10.1177/001872675400700202; Gravelle H, 2009, HEALTH ECON, V18, P125, DOI 10.1002/hec.1354; Eibner Christine, 2004, J Ment Health Policy Econ, V7, P167; Ishida A, 2011, SOCIOL THEOR METHOD, V26, P371; Kalbfleisch J.D., 1980, STAT ANAL FAILURE TI; Kondo K., 2010, HLTH INEQUALITIES JA; Kondo N, 2008, 41 ANN M SOC EP RES; Kondo N, 2009, J EPIDEMIOL COMMUN H, V63, P461, DOI 10.1136/jech.2008.078642; Kondo N, 2011, J EPIDEMIOL COMMUNIT, V66, pe11; Kondo Naoki, 2009, META ANAL MULTILEVEL, V339, pb4471, DOI DOI 10.1136/BMJ.B4471; Nishi A, 2011, J EPIDEMIOL, V21, P151, DOI 10.2188/jea.JE20100135; OECD, 2013, CRIS SQUEEZ INC PUTS; Runciman W. G., 1966, RELATIVE DEPRIVATION; Saito M, 2012, SOC SCI MED, V75, P940, DOI 10.1016/j.socscimed.2012.04.006; Salti N, 2010, SOC SCI MED, V70, P720, DOI 10.1016/j.socscimed.2009.11.008; Sugishita M, 2009, JPN J COGN NEUROSCI, V11, P87; Wada K, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e1191; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; YITZHAKI S, 1979, Q J ECON, V93, P321, DOI 10.2307/1883197; Yngwe MA, 2003, SOC SCI MED, V57, P1463, DOI 10.1016/S0277-9536(02)00541-5	30	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0143-005X	1470-2738		J EPIDEMIOL COMMUN H	J. Epidemiol. Community Health	JUL	2015	69	7					680	685		10.1136/jech-2014-205103		6	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CK4BS	WOS:000356164200013		
J	Sciortino, A; Leij, FJ; Caputo, MC; Toride, N				Sciortino, Antonella; Leij, Feike J.; Caputo, Maria Clementina; Toride, Nobuo			Modeling Transport in Dual-Permeability Media with Unequal Dispersivity and Velocity	JOURNAL OF HYDROLOGIC ENGINEERING			English	Article						Dual porosity; Solute transport; Mathematical solutions	SOLUTE TRANSPORT; POROUS-MEDIA; STRATIFIED AQUIFERS; MATRIX DIFFUSION; MASS-TRANSFER; SOIL COLUMNS; ROCK; FLOW; SET	Porous media such as fractured rock and aggregated soils consist of two pore domains with distinct transport properties. A numerical code was developed to simulate solute concentrations in the two domains using a partitioned solution procedure to efficiently model transport in dual-permeability media. Furthermore, an approximate analytical solution was obtained that allows for different advective and dispersive terms in both flow domains, for a first-type or a third-type inlet condition. Solutions were obtained for local concentrations in both domains as well as effluent concentration and the concentration per medium volume. The problem was solved by decoupling the transport equations using diagonalization. This involves an error for the dispersivity matrix that is related to the difference in dispersivity of both domains. The correctness of the solution was assessed by comparison with numerical results. For low Damkohler numbers the solution was accurate even for a dispersivity ratio of 10. The need for a dual-dispersivity instead of a single-dispersivity model was illustrated with sample breakthrough curves and the solution was applied to optimize experimental breakthrough curves for an Andisol with a distinct intraaggregate and interaggregate porosity.	[Sciortino, Antonella; Leij, Feike J.] Calif State Univ Long Beach, Dept Civil Engn & Construct Engn, Long Beach, CA 90840 USA; [Caputo, Maria Clementina] CNR, Ist Ric Acque, I-70132 Bari, Italy; [Toride, Nobuo] Mie Univ, Lab Soil Phys & Hydrol, Fac Bioresources, Tsu, Mie 5148507, Japan	Sciortino, A (reprint author), Calif State Univ Long Beach, Dept Civil Engn & Construct Engn, 1250 Bellflower Blvd, Long Beach, CA 90840 USA.	antonella.sciortino@csulb.edu					Bolster D, 2011, J CONTAM HYDROL, V120-21, P198, DOI 10.1016/j.jconhyd.2010.02.003; Ronayne MJ, 2010, WATER RESOUR RES, V46, DOI 10.1029/2010WR009348; LEIJ FJ, 1991, WATER RESOUR RES, V27, P2719, DOI 10.1029/91WR01912; HAGGERTY R, 1995, WATER RESOUR RES, V31, P2383, DOI 10.1029/95WR01583; Vanderborght J, 2005, VADOSE ZONE J, V4, P206; RASMUSON A, 1986, WATER RESOUR RES, V22, P1247, DOI 10.1029/WR022i008p01247; de Anna P, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.184502; Baratelli F, 2011, TRANSPORT POROUS MED, V87, P465, DOI 10.1007/s11242-010-9695-4; COATS KH, 1964, SOC PETROL ENG J, V4, P73; VANGENUCHTEN MT, 1976, SOIL SCI SOC AM J, V40, P473; Dentz M, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.244301; SELIM HM, 1989, SOIL SCI SOC AM J, V53, P996; Carrera J, 1998, HYDROGEOL J, V6, P178, DOI 10.1007/s100400050143; VANGENUCHTEN MT, 1986, GEODERMA, V38, P165, DOI 10.1016/0016-7061(86)90013-3; Bedrikovetskii P. G., 1989, IZVESTIYA AKAD NAUK, V6, P100; Bedrikovetskii P. G., 1992, IZVESTIYA ROSSIISKOI, V3, P87; Esfandiari R. S., 2008, APPL MATH ENG; Fernandez-Garcia D, 2008, ADV WATER RESOUR, V31, P1364, DOI 10.1016/j.advwatres.2008.07.001; Javandel I., 1984, WATER RESOURCE MONOG, V10; LAPIDUS L, 1952, J PHYS CHEM-US, V56, P984, DOI 10.1021/j150500a014; Leij FJ, 2012, WATER RESOUR RES, V48, DOI 10.1029/2011WR011502; Leij F.J., 2012, HDB SOIL SCI; MALOSZEWSKI P, 1993, WATER RESOUR RES, V29, P2723, DOI 10.1029/93WR00608; NOVAKOWSKI KS, 1994, WATER RESOUR RES, V30, P37, DOI 10.1029/93WR02401; Roberts P. V., 1987, J CONTAM HYDROL, V1, P375, DOI 10.1016/0169-7722(87)90015-5; Selim H. M., 1998, PHYS NONEQUILIBRIUM; Sun N-Z, 1996, MATH MODELING GROUND; Toride N., 1995, 137 US SAL LAB; TORIDE N, 1993, WATER RESOUR RES, V29, P2167, DOI 10.1029/93WR00496; TSENG PH, 1995, ADV WATER RESOUR, V18, P335, DOI 10.1016/0309-1708(95)00022-B; van Genuchten M. Th., 2012, T ASABE, V55, P1355, DOI 10.13031/2013.42247; VANGENUCHTEN MT, 1984, SOIL SCI SOC AM J, V48, P703; VANDUIJN CJ, 1986, WATER RESOUR RES, V22, P1779, DOI 10.1029/WR022i013p01779; VELING EJM, 1989, WATER RESOUR RES, V25, P2081, DOI 10.1029/WR025i009p02081	34	0	0	ASCE-AMER SOC CIVIL ENGINEERS	RESTON	1801 ALEXANDER BELL DR, RESTON, VA 20191-4400 USA	1084-0699	1943-5584		J HYDROL ENG	J. Hydrol. Eng.	JUL	2015	20	7							04014075	10.1061/(ASCE)HE.1943-5584.0001073		9	Engineering, Civil; Environmental Sciences; Water Resources	Engineering; Environmental Sciences & Ecology; Water Resources	CK5CB	WOS:000356238600005		
J	Aoki, H; Tomita, H; Hara, A; Kunisada, T				Aoki, Hitomi; Tomita, Hiroyuki; Hara, Akira; Kunisada, Takahiro			Conditional Deletion of Kit in Melanocytes: White Spotting Phenotype Is Cell Autonomous	JOURNAL OF INVESTIGATIVE DERMATOLOGY			English	Article							NEURAL CREST CELLS; C-KIT; W-LOCUS; KERATINOCYTE EXPRESSION; GROWTH-FACTOR; STEEL FACTOR; MOUSE; DIFFERENTIATION; MAINTENANCE; SURVIVAL	It is well established that cell-intrinsic signaling through the receptor tyrosine kinase KIT is critical for the development of neural crest-derived melanocytes. Nevertheless, it is not entirely clear whether Kit acts exclusively in a melanocyte-autonomous manner or in addition indirectly through other cell types. To address this question in vivo, we generated a targeted allele of Kit that allowed for CRE recombinase-mediated deletion of the transmembrane domain of KIT. Mice carrying one copy of the targeted allele and expressing CRE under the melanoblast/melanocyte-specific tyrosinase promoter exhibited a white spotting phenotype that was even more extensive compared with that found in mice heterozygous for a Kit-null allele. This phenotype is unlikely the result of sequestration of KIT ligand by neighboring cells or by potentially secreted forms of KIT because the spotting phenotype could not be rescued by overexpression of KITL. Likewise, overexpression of endothelin-3 or hepatocyte growth factor was unable to rescue melanocytes in these mice. Although the severity of the observed phenotype remains to be explained, the findings indicate that melanocyte-selective impairment of Kit is sufficient to interfere with normal melanocyte development.	[Aoki, Hitomi; Kunisada, Takahiro] Gifu Univ Grad Sch Med, Dept Tissue & Organ Dev, Gifu 5011194, Japan; [Tomita, Hiroyuki; Hara, Akira] Gifu Univ Grad Sch Med, Dept Tumor Pathol Regenerat & Adv Med Sci, Gifu 5011194, Japan	Aoki, H (reprint author), Gifu Univ Grad Sch Med, Dept Tissue & Organ Dev, Gifu 5011194, Japan.	tkunisad@gifu-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Gifu University	We thank Caroline Beard for a Col1a-tetOP-Cre allele. We thank Dr Ian J Jackson for Dct-lacZ mice, Dr Frank Constantini for ROSAR26R-EYFP mice, and Dr Lionel Larue for Tyr-CreA mice. We also thank Dr Heinz Arnheiter for the critical reading of the manuscript. This study was supported in part by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and from Gifu University.	ANDERSON DM, 1990, CELL, V63, P235, DOI 10.1016/0092-8674(90)90304-W; MacKenzie MAF, 1997, DEV BIOL, V192, P99, DOI 10.1006/dbio.1997.8738; Aoki H, 2009, DEVELOPMENT, V136, P2511, DOI 10.1242/dev.037168; CABLE J, 1995, MECH DEVELOP, V50, P139, DOI 10.1016/0925-4773(94)00331-G; DUTTLINGER R, 1993, DEVELOPMENT, V118, P705; GEISSLER EN, 1988, CELL, V55, P185, DOI 10.1016/0092-8674(88)90020-7; Puig I, 2009, PIGM CELL MELANOMA R, V22, P331, DOI 10.1111/j.1755-148X.2009.00546.x; Kunisada T, 1998, J EXP MED, V187, P1565, DOI 10.1084/jem.187.10.1565; WEHRLEHALLER B, 1995, DEVELOPMENT, V121, P731; Kunisada T, 1998, DEVELOPMENT, V125, P2915; Valluet A, 2012, CELL REP, V2, P774, DOI 10.1016/j.celrep.2012.08.020; Hou L, 2000, DEVELOPMENT, V127, P5379; Yamada Y, 2010, CELL STEM CELL, V6, P10, DOI 10.1016/j.stem.2009.12.003; Delmas V, 2003, GENESIS, V36, P73, DOI 10.1002/gene.10197; Kunisada T, 2000, MECH DEVELOP, V94, P67, DOI 10.1016/S0925-4773(00)00308-7; ORRURTREGER A, 1990, DEVELOPMENT, V109, P911; Aoki H, 2011, PIGM CELL MELANOMA R, V24, P125, DOI 10.1111/j.1755-148X.2010.00801.x; Aoki H, 2012, DEVELOPMENT, V139, P667, DOI 10.1242/dev.072272; Dupin E, 2014, BIRTH DEFECTS RES C, V102, P187, DOI 10.1002/bdrc.21080; GALLI SJ, 1992, ANN NY ACAD SCI, V664, P69, DOI 10.1111/j.1749-6632.1992.tb39750.x; GEISSLER EN, 1981, GENETICS, V97, P337; Hall B. K., 1999, NEURAL CREST DEV EVO, V1; Hayashi S, 1995, DNA Res, V2, P211, DOI 10.1093/dnares/2.5.211; Hearing Vincent J, 2011, J Invest Dermatol, V131, pE8, DOI 10.1038/skinbio.2011.4; Hou L, 2004, DEVELOPMENT, V131, P3239, DOI 10.1242/dev.01193; Kunisada T, 2014, BIRTH DEFECTS RES C, V102, P251, DOI 10.1002/bdrc.21079; Le Douarin NM, 2009, NEURAL CREST; Monsel G, 2010, ONCOGENE, V29, P227, DOI 10.1038/onc.2009.320; Motohashi Tsutomu, 2015, Curr Top Dev Biol, V111, P69, DOI 10.1016/bs.ctdb.2014.11.003; MOTRO B, 1991, DEVELOPMENT, V113, P1207; O'Reilly-Pol T, 2012, DEVELOPMENT, V140, P996; RUSSELL ES, 1966, GENETICS, V53, P949; Silvers WK, 1979, COAT COLORS MICE MOD; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tosaki H, 2006, J INVEST DERMATOL, V126, P1111, DOI 10.1038/sj.jid.5700173; WehrleHaller B, 1996, DEV BIOL, V177, P463, DOI 10.1006/dbio.1996.0178; Yamazaki H, 2005, INT IMMUNOL, V17, P549, DOI 10.1093/intimm/dxh237	37	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0022-202X	1523-1747		J INVEST DERMATOL	J. Invest. Dermatol.	JUL	2015	135	7					1829	1838		10.1038/jid.2015.83		10	Dermatology	Dermatology	CK4GB	WOS:000356180100022		
J	Larroque-Cardoso, P; Camare, C; Nadal-Wollbold, F; Grazide, MH; Pucelle, M; Garoby-Salom, S; Bogdanowicz, P; Josse, G; Schmitt, AM; Uchida, K; Zarkovic, K; Salvayre, R; Negre-Salvayre, A				Larroque-Cardoso, Pauline; Camare, Caroline; Nadal-Wollbold, Florence; Grazide, Marie-Helene; Pucelle, Melanie; Garoby-Salom, Sandra; Bogdanowicz, Patrick; Josse, Gwendal; Schmitt, Anne-Marie; Uchida, Koji; Zarkovic, Kamelija; Salvayre, Robert; Negre-Salvayre, Anne			Elastin Modification by 4-Hydroxynonenal in Hairless Mice Exposed to UV-A. Role in Photoaging and Actinic Elastosis	JOURNAL OF INVESTIGATIVE DERMATOLOGY			English	Article							LIPID-PEROXIDATION PRODUCTS; SUN-DAMAGED SKIN; STRATUM-CORNEUM; PHOTODAMAGED SKIN; SOLAR ELASTOSIS; END-PRODUCTS; INFLAMMATION; PROTEIN; DEGRADATION; MECHANISMS	Chronic exposure to ultraviolet (UV) radiation causes oxidative stress, which is involved in photoaging and actinic elastosis. UV and reactive oxygen species generate lipid peroxidation products, including the alpha, beta-unsaturated carbonyl compounds such as acrolein or 4-hydroxynonenal (4-HNE). These aldehydes can modify proteins of the extracellular matrix, but their role in the pathogenesis of photoaging is not clarified. The aim of this study was to investigate whether these aldehydes contribute to alter elastin metabolism and whether topical carbonyl scavengers delay UV-induced skin photoaging. Hairless mice (4-6-week old) daily exposed to UV-A (20 J cm(-2) per day, up to 600 J cm(-2)) exhibited the typical features of photoaging, associated with a significant increase in 4-HNE- and acrolein-adduct content, and elastotic material deposition. Immunofluorescence studies showed the accumulation of 4-HNE adducts on elastin in the dermis of UV-A-exposed mice. This was mimicked in vitro by incubating orceinelastin with 4-HNE or acrolein, which altered its digestion by leukocyte-elastase, a feature possibly involved in the accumulation of elastotic material. A daily topical application of carnosine completely reversed the development of photoaging alterations and 4-HNE-adduct formation on elastin. These data emphasize the role of 4-HNE and acrolein in the mechanism of photoaging, and the preventive effect of carbonyl scavengers.	[Larroque-Cardoso, Pauline; Camare, Caroline; Pucelle, Melanie; Garoby-Salom, Sandra; Salvayre, Robert; Negre-Salvayre, Anne] Inserm UMR 1048, Toulouse, France; [Larroque-Cardoso, Pauline; Camare, Caroline; Grazide, Marie-Helene; Pucelle, Melanie; Garoby-Salom, Sandra; Salvayre, Robert; Negre-Salvayre, Anne] Univ Toulouse, Toulouse, France; [Nadal-Wollbold, Florence; Bogdanowicz, Patrick; Josse, Gwendal; Schmitt, Anne-Marie] Pierre Fabre Co, Ctr Europeen Rech Peau, Toulouse, France; [Uchida, Koji] Nagoya Univ, Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Zarkovic, Kamelija] Clin Hosp Ctr, Div Pathol, Zagreb, Croatia	Negre-Salvayre, A (reprint author), CHU Rangueil, INSERM UMR 1048, 1,Ave Jean Poulhes,BP 84225, F-31432 Toulouse, France.	anne.negre-salvayre@inserm.fr			INSERM (Institut National de la Sante et de la Recherche Medicale), University Paul Sabatier Toulouse; CERPER (Centre europeen de recherche sur la peau); ANR-Carina [ANR-12-BSV1-0016-01]	We thank C Bernis, E. Mucher, and C. Santiago for their excellent technical assistance. This work is supported by INSERM (Institut National de la Sante et de la Recherche Medicale), University Paul Sabatier Toulouse, CERPER (Centre europeen de recherche sur la peau), and ANR-Carina (ANR-12-BSV1-0016-01).	Aldini G, 2014, FREE RADICAL BIO MED, V69, P145, DOI 10.1016/j.freeradbiomed.2014.01.017; Aldini G, 2007, CHEM RES TOXICOL, V20, P416, DOI 10.1021/tx0601657; Negre-Salvayre A, 2008, BRIT J PHARMACOL, V153, P6, DOI 10.1038/sj.bjp.0707395; Tsukahara K, 2001, J INVEST DERMATOL, V117, P671, DOI 10.1046/j.0022-202x.2001.01450.x; LoPachin RM, 2009, CHEM RES TOXICOL, V22, P1499, DOI 10.1021/tx900147g; Fujita H, 2007, SKIN RES TECHNOL, V13, P84, DOI 10.1111/j.1600-0846.2007.00195.x; STARCHER B, 1995, CONNECT TISSUE RES, V31, P133, DOI 10.3109/03008209509028401; Aldini G, 2002, J MASS SPECTROM, V37, P1219, DOI 10.1002/jms.381; Kwon MJ, 2012, J DERMATOL SCI, V67, P81, DOI 10.1016/j.jdermsci.2012.06.003; Wlaschek M, 2001, J PHOTOCH PHOTOBIO B, V63, P41, DOI 10.1016/S1011-1344(01)00201-9; Uchida K, 1999, TRENDS CARDIOVAS MED, V9, P109, DOI 10.1016/S1050-1738(99)00016-X; Aldini G, 2005, BIOFACTORS, V24, P77; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Chen CH, 2014, PHYSIOL REV, V94, P1, DOI 10.1152/physrev.00017.2013; Gueraud F, 2010, FREE RADICAL RES, V44, P1098, DOI 10.3109/10715762.2010.498477; Berneburg M, 2000, PHOTODERMATOL PHOTO, V16, P239, DOI 10.1034/j.1600-0781.2000.160601.x; Zarkovic N, 2013, J PROTEOMICS, V92, P239, DOI 10.1016/j.jprot.2013.02.004; Nicolaou A, 2011, CHEM PHYS LIPIDS, V164, P535, DOI 10.1016/j.chemphyslip.2011.04.005; Yoshinaga E, 2012, J INVEST DERMATOL, V132, P315, DOI 10.1038/jid.2011.298; Larroque-Cardoso P, 2014, FREE RADICAL BIO MED, V71, P427, DOI 10.1016/j.freeradbiomed.2014.02.015; Kang SW, 2001, CLIN GERIATR MED, V17, P643, DOI 10.1016/S0749-0690(05)70091-4; Poli G, 2008, MED RES REV, V28, P569, DOI 10.1002/med.20117; Cho JL, 2012, PHOTOCH PHOTOBIO SCI, V11, P309, DOI 10.1039/c1pp05265a; Fisher GJ, 2002, ARCH DERMATOL, V138, P1462, DOI 10.1001/archderm.138.11.1462; Negre-Salvayre A, 2010, FREE RADICAL RES, V44, P1125, DOI 10.3109/10715762.2010.498478; Sproul EP, 2013, MATRIX BIOL, V32, P86, DOI 10.1016/j.matbio.2012.11.004; Vistoli G, 2013, FREE RADICAL RES, V47, P3, DOI 10.3109/10715762.2013.815348; Bernstein EF, 1996, CLIN DERMATOL, V14, P143, DOI 10.1016/0738-081X(95)00149-A; Burke KE, 2010, GIORN ITAL DERMAT V, V145, P445; Carlsen H, 2004, MUTAT RES-FUND MOL M, V551, P199, DOI 10.1016/j.mrfmmm.2004.02.024; Cavarra E, 2002, BIOL CHEM, V383, P199, DOI 10.1515/BC.2002.020; Gilchrest Barbara A, 2013, J Invest Dermatol, V133, pE2, DOI 10.1038/skinbio.2013.176; HAWK JLM, 1988, BRIT J DERMATOL, V118, P27, DOI 10.1111/j.1365-2133.1988.tb01746.x; Hirao T, 2005, FEBS LETT, V579, P6870, DOI 10.1016/j.febslet.2005.11.032; Ichihashi M., 2009, J ANTI-AGING MED, V6, P46; Iwai I, 2008, SKIN PHARMACOL PHYS, V21, P269, DOI 10.1159/000148042; Kligman LH, 1996, CLIN DERMATOL, V14, P183, DOI 10.1016/0738-081X(95)00154-8; Lewis KG, 2004, J AM ACAD DERMATOL, V5, P1; Menter JM, 1996, PHOTODERMATOL PHOTO, V12, P7; Muto J, 2007, J INVEST DERMATOL, V127, P1358, DOI 10.1038/sj.jid.5700647; Schalkwijk J, 2007, J INVEST DERMATOL, V127, P1286, DOI 10.1038/sj.jid.5700691; Scharffetter-Kochanek K, 2000, EXP GERONTOL, V35, P307, DOI 10.1016/S0531-5565(00)00098-X; Sellheyer K, 2003, J CUTAN PATHOL, V30, P123, DOI 10.1034/j.1600-0560.2003.00018.x; Tanaka N, 2001, ARCH DERMATOL RES, V293, P363, DOI 10.1007/s004030100239; Wingens M, 1998, J INVEST DERMATOL, V111, P996, DOI 10.1046/j.1523-1747.1998.00425.x; Yaar M, 1998, J Investig Dermatol Symp Proc, V3, P47	46	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0022-202X	1523-1747		J INVEST DERMATOL	J. Invest. Dermatol.	JUL	2015	135	7					1873	1881		10.1038/jid.2015.84		9	Dermatology	Dermatology	CK4GB	WOS:000356180100026		
J	Chiang, YZ; Zhao, CY; Melbourne, W; Wijayanti, A; Tran, K; Kim, J; Legaspi, K; Ishii, N; Koga, H; Schmidt, E; Zillikens, D; Hashimoto, T; Murrell, D				Chiang, Y. Z.; Zhao, C. Y.; Melbourne, W.; Wijayanti, A.; Tran, K.; Kim, J.; Legaspi, K.; Ishii, N.; Koga, H.; Schmidt, E.; Zillikens, D.; Hashimoto, T.; Murrell, D.			Biochip immunofluorescence microscopy as a new diagnostic tool for autoimmune blistering skin diseases in Australia	JOURNAL OF INVESTIGATIVE DERMATOLOGY			English	Meeting Abstract	Annual Meeting of the Medical-Dermatology-Society	MAR 19, 2015	San Francisco, CA	Med Dermatol Soc					[Chiang, Y. Z.; Wijayanti, A.; Tran, K.; Kim, J.; Legaspi, K.; Murrell, D.] St George Hosp, Sydney, NSW, Australia; [Zhao, C. Y.; Melbourne, W.] Univ New S Wales, Sydney, NSW, Australia; [Ishii, N.; Koga, H.; Hashimoto, T.] Kurume Univ, Kurume, Fukuoka 830, Japan; [Schmidt, E.; Zillikens, D.] Univ Lubeck, Lubeck, Germany								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0022-202X	1523-1747		J INVEST DERMATOL	J. Invest. Dermatol.	JUL	2015	135	7				4	1926	1926				1	Dermatology	Dermatology	CK4GB	WOS:000356180100040		
J	Itoh, H; Matsuo, H; Kitamura, N; Yamamoto, S; Higuchi, T; Takematsu, H; Kamikubo, Y; Kondo, T; Yamashita, K; Sasada, M; Takaori-Kondo, A; Adachi, S				Itoh, Hiroshi; Matsuo, Hidemasa; Kitamura, Naoko; Yamamoto, Sho; Higuchi, Takeshi; Takematsu, Hiromu; Kamikubo, Yasuhiko; Kondo, Tadakazu; Yamashita, Kouhei; Sasada, Masataka; Takaori-Kondo, Akifumi; Adachi, Souichi			Enhancement of neutrophil autophagy by an IVIG preparation against multidrug-resistant bacteria as well as drug-sensitive strains	JOURNAL OF LEUKOCYTE BIOLOGY			English	Article						xenophagy; bactericidal activity; phagocytosis; NETs	SEPTIC SHOCK; IMMUNOGLOBULIN; MACROPHAGES; MECHANISMS; LEUKOCYTES; PATHWAYS; OXIDASES; IMMUNITY; DEFENSE; SEPSIS	Autophagy occurs in human neutrophils after the phagocytosis of multidrug-resistant bacteria and drug-sensitive strains, including Escherichia coli and Pseudomonas aeruginosa. The present study detected autophagy by immunoblot analysis of LC3B conversion, by confocal scanning microscopic examination of LC3B aggregate formation and by transmission electron microscopic examination of bacteria-containing autophagosomes. Patients with severe bacterial infections are often treated with IVIG alongside antimicrobial agents. Here, we showed that IVIG induced neutrophil-mediated phagocytosis of multidrug-resistant strains. Compared with untreated neutrophils, neutrophils exposed to IVIG showed increased levels of bacterial cell killing, phagocytosis, O-2(-) release, MPO release, and NET formation. IVIG also increased autophagy in these cells. Inhibiting the late phase of autophagy (fusion of lysosomes with autophagosomes) with bafilomycin A1-reduced, neutrophil-mediated bactericidal activity. These findings indicate that autophagy plays a critical role in the bactericidal activity mediated by human neutrophils. Furthermore, the autophagosomes within the neutrophils contained bacteria only and their organelles only, or both bacteria and their organelles, a previously undocumented observation. Taken together, these results suggest that the contents of neutrophil autophagosomes may be derived from specific autophagic systems, which provide the neutrophil with an advantage. Thus, IVIG promotes the neutrophil-mediated killing of multidrug-resistant bacteria as well as drug-sensitive strains.	[Itoh, Hiroshi; Matsuo, Hidemasa; Kitamura, Naoko; Yamamoto, Sho; Takematsu, Hiromu; Kamikubo, Yasuhiko; Adachi, Souichi] Kyoto Univ, Grad Sch Med, Dept Human Hlth Sci, Kyoto 6068507, Japan; [Kondo, Tadakazu; Yamashita, Kouhei; Takaori-Kondo, Akifumi] Kyoto Univ, Grad Sch Med, Dept Hematol & Oncol, Kyoto 6068507, Japan; [Matsuo, Hidemasa; Higuchi, Takeshi] Kyoto Univ Hosp, Dept Clin Lab, Kyoto 606, Japan; [Sasada, Masataka] Shiga Med Ctr Adults, Dept Hematol & Oncol, Moriyama, Shiga, Japan	Adachi, S (reprint author), Kyoto Univ, Grad Sch Med, Dept Human Hlth Sci, Sakyo Ku, 53 Kawahara Cho, Kyoto 6068507, Japan.	adachiso@kuhp.kyoto-u.ac.jp			Ministry of Education, Science, Technology Sports, and Culture of Japan	This work was supported by a Grant-in-Aid from the Ministry of Education, Science, Technology Sports, and Culture of Japan. The authors thank Asami Shindome-Matsumura and Sachio Okuda, Kaketsuken, for preparation and analysis of the IgG-free serum; Shigeomi Shimizu, Tokyo Medical and Dental University, for help in identifying autophagosomes on TEM analysis; and Asuka Hori, Yuki Totsuka, and Shiori Tanimura for technical assistance.	Levine B, 2005, CELL, V120, P159, DOI 10.1016/j.cell.2005.01.005; BODEY GP, 1966, ANN INTERN MED, V64, P328; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Mitroulis I, 2010, EUR J IMMUNOL, V40, P1461, DOI 10.1002/eji.200940025; Remijsen Q, 2011, CELL RES, V21, P290, DOI 10.1038/cr.2010.150; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Sanjuan MA, 2009, IMMUNOL REV, V227, P203, DOI 10.1111/j.1600-065X.2008.00732.x; Yuan KF, 2012, J CELL SCI, V125, P507, DOI 10.1242/jcs.094573; TOMLINSON S, 1993, CURR OPIN IMMUNOL, V5, P83, DOI 10.1016/0952-7915(93)90085-7; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Laupland KB, 2007, CRIT CARE MED, V35, P2686, DOI 10.1097/01.CCM.0000295312.13466.1C; Huang J, 2009, P NATL ACAD SCI USA, V106, P6226, DOI 10.1073/pnas.0811045106; Casulli S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026469; DeLeo FR, 1996, J LEUKOCYTE BIOL, V60, P677; Kyrmizi I, 2013, J IMMUNOL, V191, P1287, DOI 10.4049/jimmunol.1300132; Masaoka T, 2000, JPN J CHEMOTHER, V48, P199; Mehta P, 2014, CURR OPIN IMMUNOL, V26, P69, DOI 10.1016/j.coi.2013.10.012; Quinn MT, 2004, J LEUKOCYTE BIOL, V76, P760, DOI 10.1189/jlb.0404216; SCHEDEL I, 1991, CRIT CARE MED, V19, P1104, DOI 10.1097/00003246-199109000-00003; Segal BH, 2000, PEDIATR CLIN N AM, V47, P1311, DOI 10.1016/S0031-3955(05)70273-X; TAKAHASHI A, 1992, EUR J HAEMATOL, V48, P196; Werdan K, 1996, CLIN EXP IMMUNOL, V104, P83; Yamashita K, 2008, P NATL ACAD SCI USA, V105, P16912, DOI 10.1073/pnas.0807952105	26	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0741-5400	1938-3673		J LEUKOCYTE BIOL	J. Leukoc. Biol.	JUL	2015	98	1					107	117		10.1189/jlb.4A0813-422RRR		11	Cell Biology; Hematology; Immunology	Cell Biology; Hematology; Immunology	CK5FJ	WOS:000356247700011		
J	Yamada, T; Himeno, T				Yamada, Takayuki; Himeno, Tetsuto			Testing homogeneity of mean vectors under heteroscedasticity in high-dimension	JOURNAL OF MULTIVARIATE ANALYSIS			English	Article						Testing homogeneity of mean vectors; High-dimension; Non-normal case		This paper is concerned with the problem of testing the homogeneity of mean vectors. The testing problem is without assuming common covariance matrix. We proposed a testing statistic based on the variation matrix due to the hypothesis and the unbiased estimator of the covariance matrix. The limiting null and non-null distributions are derived as each sample size and the dimensionality go to infinity together under a general population distribution, which includes elliptical distribution with finite fourth moments or distribution assumed in Chen and Qin (2010). In two-sample case, our proposed test has the same asymptotic power as Chen and Qin (2010)'s test. In addition, it is found that our proposed test has the same asymptotic power as the one of Dempster's trace statistic for MANOVA proposed in Fujikoshi et al. (2004) for the case that the population distributions are multivariate normal with common covariance matrix for all groups. A small scale simulation study is performed to compare the actual error probability of the first kind with the nominal. (C) 2015 Elsevier Inc. All rights reserved.	[Yamada, Takayuki] Nihon Univ, Coll Engn, Gen Studies, Koriyama, Fukushima 9638642, Japan; [Himeno, Tetsuto] Seikei Univ, Fac Sci & Technol, Dept Comp & Informat Sci, Musashino, Tokyo 1808633, Japan	Yamada, T (reprint author), Nihon Univ, Coll Engn, Gen Studies, 1 Nakagawara, Koriyama, Fukushima 9638642, Japan.	yma@ge.ce.nihon-u.ac.jp; t-himeno@st.seikei.ac.jp			Japan Society for the Promotion of Science (JSPS) [23740085]	The first author is supported by grants from Japan Society for the Promotion of Science (JSPS), Grant-in-Aid for Scientific Research, Young Scientists (B), #23740085, 2011-2013.	Anderson T. W., 2003, INTRO MULTIVARIATE S; Himeno T, 2014, J MULTIVARIATE ANAL, V130, P27, DOI 10.1016/j.jmva.2014.04.020; Chen SX, 2010, ANN STAT, V38, P808, DOI 10.1214/09-AOS716; DEMPSTER AP, 1958, ANN MATH STAT, V29, P995, DOI 10.1214/aoms/1177706437; KAC M, 1953, J RATION MECH ANAL, V2, P767; DEMPSTER AP, 1960, BIOMETRICS, V16, P41, DOI 10.2307/2527954; Bai X., 1996, STAT SINICA, V6, P311; Fujikoshi Y., 2004, J JAPAN STAT SOC, V34, P19; Rao C. R., 1973, LINEAR STAT INFERENC; Shiryayev A. N., 1984, PROBABILITY; Srivastava MS, 2006, J MULTIVARIATE ANAL, V97, P1927, DOI 10.1016/j.jmva.2005.08.010	11	0	0	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	0047-259X			J MULTIVARIATE ANAL	J. Multivar. Anal.	JUL	2015	139						7	27		10.1016/j.jmva.2015.02.005		21	Statistics & Probability	Mathematics	CK0JJ	WOS:000355891200002		
J	Sugasawa, S; Kubokawa, T				Sugasawa, Shonosuke; Kubokawa, Tatsuya			Parametric transformed Fay-Herriot model for small area estimation	JOURNAL OF MULTIVARIATE ANALYSIS			English	Article						Asymptotically unbiased estimator; Box-Cox transformation; Dual power transformation; Fay-Herriot model; Linear mixed model; Mean squared error; Parametric bootstrap; Small area estimation	MEAN-SQUARED ERROR; CONFIDENCE-INTERVAL; PREDICTION; LIKELIHOOD; REGRESSION	Motivated from analysis of positive data such as income, revenue, harvests and production, the paper suggests the parametric transformed Fay-Herriot model in small-area estimation. When the dual power transformation is used as the parametric transformation, we provide consistent estimators of the transformation parameter, the regression coefficients and the variance component. The empirical best linear unbiased predictors which plug in those consistent estimators are suggested, and their mean squared errors (MSE) are asymptotically evaluated. A second-order unbiased estimator of the MSE is also given through the parametric bootstrap. Finally, performances of the suggested procedures are investigated through simulation and empirical studies. (C) 2015 Elsevier Inc. All rights reserved.	[Sugasawa, Shonosuke] Univ Tokyo, Grad Sch Econ, Bunkyo Ku, Tokyo 1130033, Japan; [Kubokawa, Tatsuya] Univ Tokyo, Fac Econ, Bunkyo Ku, Tokyo 1130033, Japan	Sugasawa, S (reprint author), Univ Tokyo, Grad Sch Econ, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	shonosuke622@gmail.com; tatsuya@e.u-tokyo.ac.jp			Japan Society for the Promotion of Science [21540114, 23243039, 26330036]	The authors would like to thank the associate editor and the reviewer for many valuable comments and helpful suggestions which led to an improved version of this paper. Research of the second author was supported in part by Grant-in-Aid for Scientific Research (21540114, 23243039 and 26330036) from Japan Society for the Promotion of Science.	Opsomer JD, 2008, J ROY STAT SOC B, V70, P265; BATTESE GE, 1988, J AM STAT ASSOC, V83, P28, DOI 10.2307/2288915; Chatterjee S, 2008, ANN STAT, V36, P1221, DOI 10.1214/07-AOS512; GHOSH M, 1994, STAT SCI, V9, P55, DOI 10.1214/ss/1177010647; Yoshimori M, 2014, J MULTIVARIATE ANAL, V124, P281; Pfeffermann D, 2013, STAT SCI, V28, P40, DOI 10.1214/12-STS395; Li HL, 2010, J MULTIVARIATE ANAL, V101, P882, DOI 10.1016/j.jmva.2009.10.009; Das K, 2004, ANN STAT, V32, P818; Hall P, 2006, ANN STAT, V34, P1733, DOI 10.1214/009053606000000579; BOX GEP, 1964, J ROY STAT SOC B, V26, P211; Chambers R, 2014, J R STAT SOC B, V76, P47, DOI 10.1111/rssb.12019; Chaudhuri S, 2011, BIOMETRIKA, V98, P473, DOI 10.1093/biomet/asr004; Datta GS, 2005, BIOMETRIKA, V92, P183, DOI 10.1093/biomet/92.1.183; Diao LX, 2014, SCAND J STAT, V41, P497, DOI 10.1111/sjos.12045; Fay R., 1979, J AM STAT ASSOC, V74, P341; Hall P, 2006, J ROY STAT SOC B, V68, P221, DOI 10.1111/j.1467-9868.2006.00541.x; Hawala S., 2010, P AM STAT ASS SECT B; LAHIRI P, 1995, J AM STAT ASSOC, V90, P758, DOI 10.2307/2291089; Prasad N., 1990, J AM STAT ASSOC, V90, P758; Rao J.N.K., 2003, SMALL AREA ESTIMATIO; Slud EV, 2006, J ROY STAT SOC B, V68, P239, DOI 10.1111/j.1467-9868.2006.00542.x; Sugasawa S., 2014, ARXIV14104778; Yang ZL, 2006, ECON LETT, V92, P14, DOI 10.1016/j.econlet.2006.01.011; Yoshimori M, 2014, ANN STAT, V42, P1233, DOI 10.1214/14-AOS1219	24	0	0	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	0047-259X			J MULTIVARIATE ANAL	J. Multivar. Anal.	JUL	2015	139						295	311		10.1016/j.jmva.2015.04.001		17	Statistics & Probability	Mathematics	CK0JJ	WOS:000355891200019		
J	Tsukuma, H; Kubokawa, T				Tsukuma, Hisayuki; Kubokawa, Tatsuya			A unified approach to estimating a normal mean matrix in high and low dimensions	JOURNAL OF MULTIVARIATE ANALYSIS			English	Article						Efron-Morris estimator; Empirical Bayes procedure; High dimension; Invariant loss; Matrix mean; Moore-Penrose inverse; Shrinkage estimator; Statistical decision theory	MULTIVARIATE BETA-DISTRIBUTIONS; UNKNOWN COVARIANCE; SINGULAR WISHART; IMPROVEMENT	This paper addresses the problem of estimating the normal mean matrix with an unknown covariance matrix. Motivated by an empirical Bayes method, we suggest a unified form of the Efron-Morris type estimators based on the Moore-Penrose inverse. This form not only can be defined for any dimension and any sample size, but also can contain the Efron-Morris type or Baranchik type estimators suggested so far in the literature. Also, the unified form suggests a general class of shrinkage estimators. For shrinkage estimators within the general class, a unified expression of unbiased estimators of the risk functions is derived regardless of the dimension of covariance matrix and the size of the mean matrix. An analytical dominance result is provided for a positive-part rule of the shrinkage estimators. (C) 2015 Elsevier Inc. All rights reserved.	[Tsukuma, Hisayuki] Toho Univ, Fac Med, Ota Ku, Tokyo 1438540, Japan; [Kubokawa, Tatsuya] Univ Tokyo, Fac Econ, Bunkyo Ku, Tokyo 1130033, Japan	Tsukuma, H (reprint author), Toho Univ, Fac Med, Ota Ku, 5-21-16 Omori Nishi, Tokyo 1438540, Japan.	tsukuma@med.toho-u.ac.jp; tatsuya@e.u-tokyo.ac.jp			 [23500361];  [15K00055];  [21540114];  [23243039];  [26330036]	The authors are deeply grateful to two anonymous reviewers and an associate editor for their helpful suggestions. The first author acknowledges support from Grant-in-Aid for Scientific Research (23500361 and 15K00055), Japan. The second author acknowledges support from Grant-in-Aid for Scientific Research (21540114, 23243039 and 26330036), Japan.	Srivastava MS, 2003, ANN STAT, V31, P1537, DOI 10.1214/aos/1065705118; EFRON B, 1972, BIOMETRIKA, V59, P335, DOI 10.2307/2334578; Konno Y, 2009, J MULTIVARIATE ANAL, V100, P2237, DOI 10.1016/j.jmva.2009.05.002; Chetelat D, 2012, ANN STAT, V40, P3137, DOI 10.1214/12-AOS1067; BARANCHI.AJ, 1970, ANN MATH STAT, V41, P642, DOI 10.1214/aoms/1177697104; Konno Y., 1990, J JAPAN STAT SOC, V20, P191; KONNO Y, 1991, J MULTIVARIATE ANAL, V36, P44, DOI 10.1016/0047-259X(91)90090-O; Konno Y., 1992, THESIS U TSUKUBA; Kubokawa T, 2001, J MULTIVARIATE ANAL, V76, P138, DOI 10.1006/jmva.2000.1915; Muirhead R.J., 1982, ASPECTS MULTIVARIATE; NISHII R, 1988, SANKHYA SER A, V50, P137; Stein C., 1973, P PRAG S AS STAT, P345; Tsukuma H, 2007, J MULTIVARIATE ANAL, V98, P1592, DOI 10.1016/j.jmva.2007.04.009; Tsukuma H, 2010, STAT PROBABIL LETT, V80, P215, DOI 10.1016/j.spl.2009.10.009; UHLIG H, 1994, ANN STAT, V22, P395, DOI 10.1214/aos/1176325375	15	1	1	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	0047-259X			J MULTIVARIATE ANAL	J. Multivar. Anal.	JUL	2015	139						312	328		10.1016/j.jmva.2015.04.003		17	Statistics & Probability	Mathematics	CK0JJ	WOS:000355891200020		
J	Watanabe, A; Katori, N; Selva, D; Hayashi, K; Kinoshita, S				Watanabe, Akihide; Katori, Nobutada; Selva, Dinesh; Hayashi, Kengo; Kinoshita, Shigeru			Modified auricular cartilage sling for paralytic ectropion	JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY			English	Article						Paralytic ectropion; Auricular cartilage; Margin reflex distance; Lagophthalmos; Lower eyelid retractors	LOWER-LID RETRACTION; CONCHAL CARTILAGE; INVOLUTIONAL ENTROPION; EYELID RETRACTION; GRAFT; MANAGEMENT; SUSPENSION; RECONSTRUCTION; SUPPORT; REPAIR	Objective: To evaluate the outcomes of a modified auricular cartilage sling for paralytic ectropion. Methods: We treated 17 eyelids of 17 patients (average 67 years old) with an auricular cartilage sling between 2004 and 2012. All patients had paralytic ectropion with lower eyelid ptosis. Cartilage was harvested via an incision just inside the anterior rim of the helix. Skin incisions were made at the subciliary, medial and lateral canthal regions. The auricular cartilage graft was sutured to the medial canthal tendon medially, lateral orbital rim laterally, inferior tarsus superiorly, and lower eyelid retractors inferiorly. Average follow-up period was 40 months (range 16-60 months). Results: The median L-MRD (mm) was improved from 8.4 preoperatively (interquartile range 7.5-8.9) to 5.2 postoperatively (4.8-5.3). The median lagophthalmos (mm) was improved from 5.8 preoperatively (4.7-7.0) to 2.2 postoperatively (1.6-2.6). 16 patients had corneal exposure preoperatively and this resolved completely in 12 patients. All patients experienced good anatomical and functional results with relief of their preoperative pain/discomfort symptoms without complications. No patients required reoperation and none experienced infection, exposure of the cartilage graft, or recurrence of lower eyelid malpositions. Postoperatively, all lower eyelids moved downward with down-gaze. The auricular scar left no significant cosmetic deformity. Conclusions: The modified auricular cartilage sling with 4 point fixation for paralytic ectropion appears to maintain normal eyelid mobility with down-gaze and avoids the problem of lower eyelid fixation. (C) 2015 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.	[Watanabe, Akihide; Kinoshita, Shigeru] Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto 6020841, Japan; [Katori, Nobutada] Seirei Hamamatsu Gen Hosp, Dept Oculoplast & Orbital Surg, Shizuoka, Japan; [Selva, Dinesh] South Australian Inst Ophthalmol, Discipline Ophthalmol & Visual Sci, Adelaide, SA, Australia; [Selva, Dinesh] Royal Adelaide Hosp, Adelaide, SA 5000, Australia; [Hayashi, Kengo] Tokyo Med & Dent Univ, Dept Ophthalmol, Tokyo, Japan	Watanabe, A (reprint author), Kyoto Prefectural Univ Med, Dept Ophthalmol, Kamigyo Ku, 465 Kajii Cho, Kyoto 6020841, Japan.	awatanab@mx5.canvas.ne.jp					KERSTEN RC, 1990, ARCH OPHTHALMOL-CHIC, V108, P1339; FOX SA, 1966, AM J OPHTHALMOL, V62, P533; ANDERSON RL, 1979, ARCH OPHTHALMOL-CHIC, V97, P2192; MATSUO K, 1987, PLAST RECONSTR SURG, V80, P547, DOI 10.1097/00006534-198710000-00012; Arion H G, 1972, Int Surg, V57, P48; Baylis H I, 1985, Ophthal Plast Reconstr Surg, V1, P23, DOI 10.1097/00002341-198501000-00004; BAYLIS HI, 1982, AM J OPHTHALMOL, V93, P709; BLOMQVIST G, 1991, SCAND J PLAST RECONS, V25, P57; Chang L, 2006, OPHTHALMOLOGY, V113, P84, DOI 10.1016/j.ophtha.2005.06.038; Custer Philip L, 2004, Semin Plast Surg, V18, P31, DOI 10.1055/s-2004-823121; DOXANAS MT, 1981, OPHTHALMOLOGY, V88, P887; FLOWERS RS, 1994, PLAST RECONSTR SURG, V94, P544, DOI 10.1097/00006534-199409000-00022; Goel R, 2013, J CRANIO MAXILL SURG, V41, pE111, DOI 10.1016/j.jcms.2012.11.036; Hashikawa K, 2005, PLAST RECONSTR SURG, V115, P880, DOI 10.1097/01.PRS.000015233.87258.5D; HEYWOOD AJ, 1991, BRIT J PLAST SURG, V44, P183, DOI 10.1016/0007-1226(91)90123-2; Hontanilla B, 2013, J PLAST RECONSTR AES, V66, P518, DOI 10.1016/j.bjps.2012.12.022; JACKSON IT, 1989, PLAST RECONSTR SURG, V83, P636, DOI 10.1097/00006534-198904000-00007; Kakizaki H, 2007, OPHTHAL PLAST RECONS, V23, P292, DOI 10.1097/IOP.0b013e3180986778; KARESH JW, 1989, OPHTHALMOLOGY, V96, P419; MARKS MW, 1989, PLAST RECONSTR SURG, V83, P629, DOI 10.1097/00006534-198904000-00006; MAY M, 1990, ARCH OTOLARYNGOL, V116, P786; ROBBINS TH, 1981, BRIT J PLAST SURG, V34, P140, DOI 10.1016/S0007-1226(81)80080-X; Shaw GY, 1996, ARCH OTOLARYNGOL, V122, P51; SIEGEL RJ, 1988, PLAST RECONSTR SURG, V82, P42, DOI 10.1097/00006534-198882010-00008; Smith RJ, 2008, OPHTHAL PLAST RECONS, V24, P13, DOI 10.1097/IOP.0b013e31815efe35; Tan J, 2004, BRIT J OPHTHALMOL, V88, P1197, DOI 10.1136/bjo.2003.029397; Terzis JK, 2008, PLAST RECONSTR SURG, V121, P1206, DOI 10.1097/01.prs.0000305520.07311.fb; VASCONEZ LO, 1994, ANN PLAS SURG, V33, P557, DOI 10.1097/00000637-199411000-00016; ZBYLSKI JR, 1978, PLAST RECONSTR SURG, V61, P220, DOI 10.1097/00006534-197802000-00010	29	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1748-6815	1878-0539		J PLAST RECONSTR AES	J. Plast. Reconstr. Aesthet. Surg.	JUL	2015	68	7					902	906		10.1016/j.bjps.2015.03.019		5	Surgery	Surgery	CK4ZO	WOS:000356232100005		
J	Shimizu, F; Oatari, M; Uehara, M				Shimizu, Fumiaki; Oatari, Miwako; Uehara, Miyuki			Choice of recipient vessels for nasal ala reconstruction using a free auricular flap	JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY			English	Article						Nasal ala reconstruction; Free auricular flap; Recipient vessels; Angular vein	NASOLABIAL FLAP; MICROVASCULAR RECONSTRUCTION; COMPOSITE; DEFECTS; GRAFT; NOSE	Starting in 2010, we experienced seven cases of full-thickness nasal ala defects reconstructed with free auricular flaps. We modified previous methods using retrograde free auricular flaps by including both retrograde and antegrade superficial temporal vessels to enhance the venous drainage of the flap. Based on our experience and the findings of previous reports, we developed an algorithm to insert free auricular flaps for use in nasal ala reconstruction, and to select the recipient vessels. Eight free auricular flaps were transferred in seven cases. In all cases, one artery anastomosis and two venous anastomoses were performed. The facial artery was used as the recipient artery at the nasolabial fold in five cases, and the proximal stump of the superficial temporal artery was used as the recipient vessel via a vein graft in two cases. The facial vein at the nasolabial fold was used in six cases, and the facial vein at the mandible via a vein graft was used in one case. In all cases, the angular vein at the medial canthus was available and used as the second recipient vein. The key to success with free auricular flap transfer for nasal ala reconstruction is to select the proper recipient vessel. We believe that our algorithm and procedure will increase the rate of successful operations. (C) 2015 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.	[Shimizu, Fumiaki; Oatari, Miwako; Uehara, Miyuki] Oita Univ, Fac Med, Dept Plast Surg, Yufu, Oita 8795593, Japan	Shimizu, F (reprint author), Oita Univ, Fac Med, Dept Plast Surg, 1-1 Idaigaoka Hasama Machi, Yufu, Oita 8795593, Japan.	fumi@oita-u.ac.jp					Adams C, 2005, DERMATOL CLIN, V23, P129, DOI 10.1016/j.det.2004.08.005; Li SL, 2006, J PLAST RECONSTR AES, V59, P1300, DOI 10.1016/j.bjps.2006.03.050; BURGET GC, 1985, PLAST RECONSTR SURG, V76, P239, DOI 10.1097/00006534-198508000-00010; Cian C, 2012, DERMATOL SURG, V38, P1639; Cook JL, 2014, BRIT J DERMATOL, V171, P29, DOI 10.1111/bjd.13206; D'Aepa S, 2009, PLAST RECONSTR SURG, V123, p65e; Driscoll B P, 2001, Arch Facial Plast Surg, V3, P91, DOI 10.1001/archfaci.3.2.91; Friedman HI, 2003, ANN PLAS SURG, V50, P275, DOI 10.1097/01.SAP.0000046782.74684.4B; Heessam S, 2014, J DTSCH DERMATOL GES, P169; Iwao F, 2005, DERMATOL SURG, V31, P1351; Jin HR, 2009, AURIS NASUS LARYNX, V36, P560, DOI 10.1016/j.anl.2009.01.007; Kannan R, 2011, J Maxillofac Oral Surg, V10, P57, DOI 10.1007/s12663-010-0102-z; Kearney C, 2010, DERMATOL SURG, V36, P1319, DOI 10.1111/j.1524-4725.2010.01631.x; Kobayashi S, 1996, ANN PLAS SURG, V37, P490, DOI 10.1097/00000637-199611000-00006; Konofaos P, 2015, AESTH PLAST SURG; Lee HJ, 2014, J CRANIOFAC SURG, V25, P633, DOI 10.1097/SCS.0000000000000649; Li SD, 1984, PLAST RECONSTR SURG, V73, P827; Manafi Ali, 2013, World J Plast Surg, V2, P33; PARKHOUSE N, 1985, BRIT J PLAST SURG, V38, P306, DOI 10.1016/0007-1226(85)90233-4; PRIBAZ JJ, 1993, ANN PLAS SURG, V31, P289, DOI 10.1097/00000637-199310000-00001; Pribaz JJP, 1998, GRABBS ENCY FLAPS, P247; SHENAQ S M, 1989, Journal of Reconstructive Microsurgery, V5, P63, DOI 10.1055/s-2007-1006852; Shim HC, 2014, ANN DERMATOL, V26, P377, DOI 10.5021/ad.2014.26.3.377; Son Daegu, 2012, Arch Plast Surg, V39, P323, DOI 10.5999/aps.2012.39.4.323; TANAKA Y, 1993, ANN PLAS SURG, V31, P298, DOI 10.1097/00000637-199310000-00002; Teitzrow T, 2011, FACIAL PLAST SURG, V27, P243; Zhang YX, 2008, PLAST RECONSTR SURG, V121, P1589, DOI 10.1097/PRS.0b013e31816a8d83; Zilinsky I, 1999, PLAST RECONSTR SURG, V103, P192, DOI 10.1097/00006534-199901000-00031	28	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1748-6815	1878-0539		J PLAST RECONSTR AES	J. Plast. Reconstr. Aesthet. Surg.	JUL	2015	68	7					907	913		10.1016/j.bjps.2015.03.006		7	Surgery	Surgery	CK4ZO	WOS:000356232100006		
J	Matsuda, K; Kubo, T; Fukai, M; Kikuchi, M; Hikasa, H; Nakajima, Y; Tomita, K; Shibata, M; Hosokawa, K				Matsuda, Ken; Kubo, Tateki; Fukai, Megumi; Kikuchi, Mamoru; Hikasa, Hisashi; Nakajima, Yoriko; Tomita, Koichi; Shibata, Minoru; Hosokawa, Ko			Free perivascular tissue flap transfer	JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY			English	Article						Soft tissue defect; Free flap; Fascial flap; Anterolateral thigh flap; Perifascial areolar tissue	TEMPOROPARIETAL FASCIAL FLAP; RECONSTRUCTION; REVASCULARIZATION; COVERAGE	Local flaps and composite grafting are the procedures of choice for reconstructing relatively small soft tissue defects. However, despite their limited conveyable volume, local flaps sometimes require a wide dissection area and long new incisions. Composite grafts also have serious limitations and require a well-vascularized recipient bed. To overcome these limitations, we used a free vascularized perivascular tissue flap based on the descending branch of the lateral femoral circumflex artery. Using this method, we performed reconstructions for seven patients (four cases in head and neck region and three cases in lower limb) with various soft tissue defects (ranged from 4.0 cm(3) to 40.0 cm(3)). This flap was easily elevated, without the need for precise preoperative flap design, and the flap volume was adjustable regardless of whether deep fascia and muscle were included. The flap has a rich vascular supply, which allows bone and cartilage tissue to be combined with the transfer of soft tissue, and satisfactorily treats chronic wounds with poor blood supply. (C) 2015 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.	[Matsuda, Ken; Shibata, Minoru] Niigata Univ, Grad Sch Med, Dept Plast & Reconstruct Surg, Niigata 9518510, Japan; [Kubo, Tateki; Fukai, Megumi; Tomita, Koichi; Hosokawa, Ko] Osaka Univ, Grad Sch Med, Dept Plast & Reconstruct Surg, Osaka, Japan; [Kikuchi, Mamoru] Saga Univ Hosp, Dept Plast & Reconstruct Surg, Saga, Japan; [Hikasa, Hisashi] Osaka Police Hosp, Dept Plast & Reconstruct Surg, Osaka, Japan	Matsuda, K (reprint author), Niigata Univ, Grad Sch Med, Dept Plast & Reconstruct Surg, Chuo Ku, 1-757 Asahimachi Dori, Niigata 9518510, Japan.	matsuken@med.niigata-u.ac.jp					Acikel C, 2002, AESTHET PLAST SURG, V26, P416, DOI 10.1007/s00266-002-1509-9; YOUSIF NJ, 1990, PLAST RECONSTR SURG, V86, P1138, DOI 10.1097/00006534-199012000-00016; ROSE EH, 1990, PLAST RECONSTR SURG, V85, P224, DOI 10.1097/00006534-199002000-00010; Hsieh CH, 2003, PLAST RECONSTR SURG, V112, P976, DOI 10.1097/01.PRS.0000076221.25738.66; BRENT B, 1985, PLAST RECONSTR SURG, V76, P177, DOI 10.1097/00006534-198508000-00001; MIMOUN M, 1989, PLAST RECONSTR SURG, V84, P458; DATIASHVILI RO, 1992, PLAST RECONSTR SURG, V90, P687, DOI 10.1097/00006534-199210000-00023; Demirdover C, 2011, INT J MED SCI, V8, P362; Fukai M, 2013, J JPN PLAST RECONSTR, V33, P740; Ghods M, 2012, ANN PLAS SURG, V68, P599, DOI 10.1097/SAP.0b013e31821ee359; ISMAIL TIA, 1989, MICROSURG, V10, P155; Koizumi T, 2010, PLAST RECONSTR SURG, V126, p182E, DOI 10.1097/PRS.0b013e3181ea91e3; Mahabir RC, 2001, ANN PLAS SURG, V47, P148, DOI 10.1097/00000637-200108000-00007; MORRISON WA, 1993, ANN PLAS SURG, V31, P467, DOI 10.1097/00000637-199311000-00016; Ozkan O, 2005, MICROSURG, V25, P107, DOI 10.1002/micr.20094; Ulrich D, 2010, ARCH ORTHOP TRAUM SU, V130, P217, DOI 10.1007/s00402-009-0845-5; VanLanduyt K, 1996, MICROSURG, V17, P417, DOI 10.1002/(SICI)1098-2752(1996)17:7<417::AID-MICR13>3.0.CO;2-2; Watanabe T, 1996, ANN PLAS SURG, V37, P469, DOI 10.1097/00000637-199611000-00003; WINTSCH K, 1986, Journal of Reconstructive Microsurgery, V2, P143, DOI 10.1055/s-2007-1007014; YANO H, 1995, PLAST RECONSTR SURG, V95, P452, DOI 10.1097/00006534-199503000-00003; Yousif NJ, 1990, PLAST RECONSTR SURG, V86, P46	21	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1748-6815	1878-0539		J PLAST RECONSTR AES	J. Plast. Reconstr. Aesthet. Surg.	JUL	2015	68	7					973	978		10.1016/j.bjps.2015.03.005		6	Surgery	Surgery	CK4ZO	WOS:000356232100015		
J	Tashiro, K; Harima, M; Kato, M; Yamamoto, T; Yamashita, S; Narushima, M; Iida, T; Koshima, I				Tashiro, Kensuke; Harima, Mitsunobu; Kato, Motoi; Yamamoto, Takumi; Yamashita, Shuji; Narushima, Mitsunaga; Iida, Takuya; Koshima, Isao			Preoperative color Doppler ultrasound assessment in planning of SCIP flaps	JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY			English	Article						Microsurgery; Supermicrosurgery; SCIP flap; Color Doppler ultrasound; Preoperative imaging; Perforator flap	ARTERY PERFORATOR FLAP; LOWER-EXTREMITY RECONSTRUCTION; SUPERMICROSURGERY; DEFECTS	Introduction: Superficial circumflex iliac artery perforator (SCIP) flap is based on the perforator of superficial circumflex iliac artery (SCIA) system, and is a highly useful surgical tool with a wide variety of clinical applications. The SCIA system is associated with considerable anatomical variation, however, rendering transfer of a SCIP flap technically difficult. Patients and methods: Using preoperative color Doppler ultrasound (US), we examined a total of 11 flaps of 11 patients who had undergone reconstruction with SCIP flap from April to August of 2014. The origin of SCIA from femoral artery and the bifurcation of its superficial branch and deep branch were easily identifiable in all patients. Perforator courses and their penetration points were marked to guide dissection. Results: Although one patient required secondary revision and skin grafting because of partial necrosis, there were no serious postoperative complications such as total necrosis or resulting absorption of the transferred adiposal flap. In all cases, findings from the preoperative color Doppler US were useful in delineating the dominant vessel within the groin lesion. Conclusion: Using the technique described above, difficulties arising from the anatomical variation within the SCIA system are easily overcome, simplifying SCIP flap harvest. In addition to being relatively easy, the technique is also quick to administer and safe. (C) 2015 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.	[Tashiro, Kensuke; Harima, Mitsunobu; Kato, Motoi; Yamamoto, Takumi; Yamashita, Shuji; Narushima, Mitsunaga; Iida, Takuya; Koshima, Isao] Tokyo Univ Hosp, Dept Plast & Reconstruct Surg, Tokyo, Japan	Tashiro, K (reprint author), Univ Tokyo, Dept Plast & Reconstruct Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	tashirox@gmail.com					Cina A, 2010, RADIOLOGY, V255, P979, DOI 10.1148/radiol.10091166; Koshima I, 2004, PLAST RECONSTR SURG, V113, P233, DOI 10.1097/01.PRS.0000095948.03605.20; Ensat F, 2012, MICROSURG, V32, P605, DOI 10.1002/micr.20835; Narushima M, 2011, J PLAST RECONSTR AES, V64, P1580, DOI 10.1016/j.bjps.2011.07.005; Masia J, 2008, ANN PLAS SURG, V60, P29, DOI 10.1097/SAP.0b013e31805003c2; Hong JP, 2009, PLAST RECONSTR SURG, V123, P230, DOI 10.1097/PRS.0b013e3181904dc4; Hong JP, 2013, ANN PLAS SURG, V71, P380, DOI 10.1097/SAP.0b013e3182503ac5; Blondeel PN, 1998, BRIT J PLAST SURG, V51, P202, DOI 10.1016/S0007-1226(98)80010-6; Iida T, 2014, ANN PLAS SURG, V72, P332, DOI 10.1097/SAP.0b013e318260a3ad; Isken T, 2009, ANN PLAS SURG, V62, P158, DOI 10.1097/SAP.0b013e31817e9cbd; Koshima I, 2006, J RECONSTR MICROSURG, V22, P137, DOI 10.1055/s-2006-939957; Kosutic D, 2012, J PLAST RECONSTR AES, V65, P1530, DOI 10.1016/j.bjps.2012.04.045; Sinna Raphael, 2010, Eplasty, V10, pe11; Yu P, 2006, PLAST RECONSTR SURG, V118, P928	14	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1748-6815	1878-0539		J PLAST RECONSTR AES	J. Plast. Reconstr. Aesthet. Surg.	JUL	2015	68	7					979	983		10.1016/j.bjps.2015.03.004		5	Surgery	Surgery	CK4ZO	WOS:000356232100016		
J	Khater, AME; Doi, K; Hattori, Y; Sakamoto, S; Yonemura, H; Kumar, K				Khater, Amr M. E.; Doi, Kazuteru; Hattori, Yasunori; Sakamoto, Soutetsu; Yonemura, Hiroshi; Kumar, Kannan			The use of compound muscle action potentials (CMAP) for postoperative monitoring of free functioning gracilis muscle transfer: A preliminary report	JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY			English	Article						CMAP; Gracilis; DFMT; Brachial plexus; Wallerian degeneration	WALLERIAN DEGENERATION; BRACHIAL-PLEXUS; SKELETAL-MUSCLE; FREE FLAPS; ISCHEMIA; REPERFUSION; NERVE; VIABILITY; DOPPLER; MODEL	Background and purposes: The use of skin flap as a monitoring tool cannot sensitively reflect the vascularity of a functioning free muscle transfer (FFMT), and it may result in delayed detection of vascular compromise. We report the use of compound muscle action potentials (CMAPs) as a supplemental method in the monitoring of free gracilis transfers. Subjects and methods: In 46 successful free gracilis transfers in 23 patients following total brachial plexus injury (BPI), CMAPs were measured every hour for 75 h postoperatively. We analyzed the amplitude, latency, and duration to understand the Wallerian degeneration effect and thresholds to warn vascular compromise clinically. After the primary study, we applied CMAP monitoring for 23 clinical cases. Main findings: Three basic wave patterns of the CMAPs with or without dispersion were recognized. Forty-two CMAPs were successfully traced and 27 CMAPs with one constant wave pattern showed two types of amplitude and latency changes; positive and negative Wallerian degeneration. The mean 1-h maximal decreases of amplitudes and elongation of latency were 36% and 77%, respectively; however, they returned to the original pattern within 1 h. There were no significant differences of reinnervation time and final strength of elbow flexion between these 46 muscle transfers. In the clinical series, we experienced two cases of vascular compromise that showed CMAP critical alterations without skin flap changes. Conclusions: Our preliminary results show that the measurement of CMAPs has great potential for the sensitive and reliable monitoring of muscle circulation after FFMT. The clinical critical values of CMAP amplitude changes for vascular compromise are >40% sudden decrease, and they continued to decrease further. This technique is most useful for postoperative vascular monitoring of a buried muscle flap, and it is proven to be of clinical significance in current vascular compromised cases. (C) 2015 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.	[Khater, Amr M. E.; Doi, Kazuteru; Hattori, Yasunori; Sakamoto, Soutetsu; Yonemura, Hiroshi; Kumar, Kannan] Ogori Daiichi Gen Hosp, Dept Orthoped, Yamaguchi 7540002, Japan	Doi, K (reprint author), Ogori Daiichi Gen Hosp, Dept Orthoped Surg, 862-3 Shimogo Ogori, Yamaguchi 7540002, Japan.	doimicro@saikyo.or.jp					Addosooki Ahmad I, 2006, Tech Hand Up Extrem Surg, V10, P245, DOI 10.1097/01.bth.0000236986.43170.66; CHAUDHRY V, 1992, MUSCLE NERVE, V15, P687, DOI 10.1002/mus.880150610; Tan SH, 2012, J RECONSTR MICROSURG, V28, P387, DOI 10.1055/s-0032-1315761; Chuang DCC, 1996, PLAST RECONSTR SURG, V98, P1023, DOI 10.1097/00006534-199611000-00015; Chuang DCC, 1999, HAND CLIN, V15, P737; BATCHELOR A, 1982, BRIT J PLAST SURG, V35, P343, DOI 10.1016/S0007-1226(82)90124-2; DESMEDT JE, 1977, ANN NEUROL, V1, P55, DOI 10.1002/ana.410010105; Dodakundi Chaitanya, 2012, Tech Hand Up Extrem Surg, V16, P48, DOI 10.1097/BTH.0b013e31823b5669; Dodakundi C, 2012, J RECONSTR MICROSURG, V28, P267, DOI 10.1055/s-0032-1311681; Dodakundi C, 2013, J BONE JOINT SURG AM, V95A, P1505, DOI 10.2106/JBJS.K.01279; Doi K, 2000, J BONE JOINT SURG AM, V82A, P652; FASCHING MC, 1985, PLAST RECONSTR SURG, V75, P217, DOI 10.1097/00006534-198502000-00013; GILLIATT RW, 1972, J NEUROL NEUROSUR PS, V35, P335, DOI 10.1136/jnnp.35.3.335; Hattori Y, 2002, J HAND SURG-AM, V27A, P534, DOI 10.1053/jhsu.2002.32962; HICKEY MJ, 1992, J SURG RES, V53, P369, DOI 10.1016/0022-4804(92)90063-6; HOVIUS SER, 1995, J HAND SURG-AM, V20A, P88, DOI 10.1016/S0363-5023(05)80065-6; KHOURI RK, 1992, PLAST RECONSTR SURG, V89, P495, DOI 10.1097/00006534-199203000-00017; KUZON WM, 1986, J SURG RES, V41, P24, DOI 10.1016/0022-4804(86)90004-1; LEVENSON D, 1990, BRAIN RES, V523, P230, DOI 10.1016/0006-8993(90)91491-X; LINDSAY TF, 1990, J VASC SURG, V12, P8, DOI 10.1067/mva.1990.19946; MORRIS SF, 1993, PLAST RECONSTR SURG, V92, P1162, DOI 10.1097/00006534-199311000-00026; Rosenberg JJ, 2006, PLAST RECONSTR SURG, V118, P109, DOI 10.1097/01.prs.0000221113.78244.8c; Smit JM, 2008, J PLAST RECONSTR AES, V31, P1	23	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1748-6815	1878-0539		J PLAST RECONSTR AES	J. Plast. Reconstr. Aesthet. Surg.	JUL	2015	68	7					E137	E146		10.1016/j.bjps.2015.02.006		10	Surgery	Surgery	CK4ZO	WOS:000356232100001		
J	Saito, N; Itoga, M; Tamaki, M; Yamamoto, A; Kayaba, H				Saito, Norihiro; Itoga, Masamichi; Tamaki, Mami; Yamamoto, Ayako; Kayaba, Hiroyuki			Cough variant asthma patients are more depressed and anxious than classic asthma patients	JOURNAL OF PSYCHOSOMATIC RESEARCH			English	Article						Anxiety; Comprehensive Asthma Inventory (CAI); Cough variant asthma; Depression; Self-rating Depression Scale (SDS); State-Trait Anxiety Inventory (STAI)	QUALITY-OF-LIFE; NEGATIVE AFFECTIVITY; PSYCHIATRIC-DISORDERS; ATOPIC COUGH; DSM-IV; SYMPTOMS; ANXIETY; HEALTH; PREVALENCE; COMMUNITY	Objective: Many recent studies have indicated that depression and anxiety are more common in asthmatic patients than in the general population and psychological stress can lead to asthma exacerbations, but no study specifically targets cough variant asthma (CVA) patients. The purpose of this study was to evaluate depression and anxiety levels in CVA patients compared with classic asthma patients and to identify the psychological features of CVA patients. Methods: Fifty-nine outpatients with CVA and 128 outpatients with classic asthma were interviewed about psychosomatic and psychiatric symptoms, and they underwent three psychological tests: Self-rating Depression Scale (SDS), State-Trait Anxiety Inventory (STAI), and Comprehensive Asthma Inventory (CAI). They were ultimately screened for major and minor depression, dysthymia, panic disorder, generalized anxiety disorder, social anxiety disorder, and other anxiety disorders. Results: CVA patients showed higher SDS and STAI scores than classic asthma patients, and mood disorders and anxiety disorders were more common than in classic asthma outpatients. The psychological factors 'frustration', 'fright into illness', and 'distorted lifestyle' were more prominent in CVA patients than in classic asthma patients. Conclusion: OJA patients are on average more depressed and anxious than classic asthma outpatients. Though CVA appears pathologically to be just an early stage of typical asthma, the psychological stress may often be more serious than in asthma controlled by medication, which may explain why CVA cannot be controlled by a bronchodilator alone and patients often require no less intense therapy than for severe asthma. (C) 2015 Elsevier Inc. All rights reserved.	[Saito, Norihiro; Itoga, Masamichi; Yamamoto, Ayako; Kayaba, Hiroyuki] Hirosaki Univ, Grad Sch Med, Dept Clin Lab Med, Hirosaki, Aomori 0368562, Japan; [Saito, Norihiro; Tamaki, Mami] Yokote Municipal Hosp, Dept Allergy & Resp Med, Akita, Japan	Saito, N (reprint author), Hirosaki Univ, Grad Sch Med, Dept Clin Lab Med, 5 Zaifu Cho, Hirosaki, Aomori 0368562, Japan.	ningendamono0324@gmail.com					American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Katon WJ, 2004, PSYCHOSOM MED, V66, P349, DOI 10.1097/01.psy.0000126202.89941.ea; WATSON D, 1989, PSYCHOL REV, V96, P234, DOI 10.1037//0033-295X.96.2.234; Di Marco F, 2010, RESP MED, V104, P22, DOI 10.1016/j.rmed.2009.08.005; Niimi A, 2009, PULM PHARMACOL THER, V22, P114, DOI 10.1016/j.pupt.2008.12.001; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Niimi A, 1998, EUR RESPIR J, V11, P1064, DOI 10.1183/09031936.98.11051064; Okun A, 1996, PSYCHOL REP, V79, P1059; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V13, P508; Niimi A, 2000, LANCET, V356, P564, DOI 10.1016/S0140-6736(00)02584-8; Brightling CE, 1999, AM J RESP CRIT CARE, V160, P406; IRWIN RS, 1990, AM REV RESPIR DIS, V141, P640; Janssens T, 2013, CLIN EXP ALLERGY, V43, P1000, DOI 10.1111/cea.12138; Hasler G, 2005, AM J RESP CRIT CARE, V171, P1224, DOI 10.1164/rccm.200412-1669OC; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Manfreda J, 2001, CAN MED ASSOC J, V164, P995; Demura Shinichi, 2006, Environmental Health and Preventive Medicine, V11, P177, DOI 10.1007/BF02905276; Van Diest I, 2005, SOC SCI MED, V61, P1835, DOI 10.1016/j.socscimed.2005.03.031; Rank MA, 2014, J ALLER CL IMM-PRACT, V2, P518, DOI 10.1016/j.jaip.2014.06.020; McGarvey LPA, 1998, THORAX, V53, P738; CORRAO WM, 1979, NEW ENGL J MED, V300, P633, DOI 10.1056/NEJM197903223001201; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Birring SS, 2003, THORAX, V58, P339, DOI 10.1136/thorax.58.4.339; French CL, 1998, ARCH INTERN MED, V158, P1657, DOI 10.1001/archinte.158.15.1657; Lavoie KL, 2005, RESP MED, V99, P1249, DOI 10.1016/j.rmed.2005.03.003; Put C, 1999, EUR RESPIR J, V13, P751, DOI 10.1034/j.1399-3003.1999.13d09.x; [Anonymous], 2011, POCK GUID ASTHM MAN; BRAMAN SS, 1985, PRIMARY CARE, V12, P217; Centanni S, 2000, RESP MED, V94, P742, DOI 10.1053/rmed.1999.0766; Chung KF, 2008, LANCET, V371, P1364, DOI 10.1016/S0140-6736(08)60595-4; De Peuter S, 2007, PSYCHOL HEALTH, V22, P737, DOI 10.1080/14768320601151702; Ebana S, 1987, SHINSHIN IGAKU, V27, P449; Fritz GK, 2010, AM J RESP CRIT CARE, V182, P12, DOI [10.1164/rccm.200906-0836OC, 10.1164/rccm.200906-08360C]; Fujimura M, 2003, THORAX, V58, P14, DOI 10.1136/thorax.58.1.14; Global Initiative for Asthma (GINA), 2011, GLOB STRAT ASTHM MAN; Janssens T, 2009, CLIN PSYCHOL REV, V29, P317, DOI 10.1016/j.cpr.2009.02.006; Kastelik JA, 2005, EUR RESPIR J, V25, P235, DOI 10.1183/09031936.05.00140803; Katsura T, 1984, Arerugi, V33, P231; KOH YY, 1993, CLIN EXP ALLERGY, V23, P696, DOI 10.1111/j.1365-2222.1993.tb01796.x; Liu SG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103014; Magni C, 2010, MULTIDISCIP RESP MED, V5, P99, DOI 10.1186/2049-6958-5-2-99; MAGRUDER KM, 1995, AM J PSYCHIAT, V152, P1615; Millar MM, 1998, ANN ALLERG ASTHMA IM, V80, P345; Nakajima T, 2005, RESPIRATION, V72, P606, DOI 10.1159/000087459; Niimi A, 2013, J ASTHMA, V50, P932, DOI 10.3109/02770903.2013.823444; Niimi A, 2011, CURR RESP MED REV, V7, P47, DOI 10.2174/157339811794109327; OEI TPS, 1990, BRIT J CLIN PSYCHOL, V29, P429; Ono Y, 1995, Nihon Kyobu Shikkan Gakkai Zasshi, V33, P293; Put C, 2004, J PSYCHOSOM RES, V57, P249, DOI 10.1016/S0022-3999(03)00541-5; Ritz T, 2011, PSYCHOSOM MED, V73, P514, DOI 10.1097/PSY.0b013e318222050d; Ritz T, 2000, PSYCHOSOM MED, V62, P808; Ritz T, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00343; Ritz T, 2010, J APPL PHYSIOL, V108, P1542, DOI 10.1152/japplphysiol.00818.2009; Sawa M, 2013, NEUROPSYCHOBIOLOGY, V67, P103, DOI 10.1159/000345161; Spielberg C, 1970, MANUAL STATE TRAIT A; Takemura M, 2007, CLIN EXP ALLERGY, V37, P1833, DOI 10.1111/j.1365-2222.2007.02848.x; Tokuyama K, 1998, J ASTHMA, V35, P225, DOI 10.3109/02770909809068211; Trojan TD, 2014, ANN ALLERG ASTHMA IM, V112, P432, DOI 10.1016/j.anai.2014.02.015; Yamada T, 2000, JPN J PRIM CARE, V23, P80; Yin WY, 2015, ADDICTION, V110, P51, DOI 10.1111/add.12780; Yokota S, 1997, Arerugi, V46, P511	61	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-3999	1879-1360		J PSYCHOSOM RES	J. Psychosomat. Res.	JUL	2015	79	1					18	26		10.1016/j.jpsychores.2015.03.011		9	Psychiatry	Psychiatry	CK3JK	WOS:000356112200003		
J	Suetsugu, Y; Honjo, S; Ikeda, M; Kamibeppu, K				Suetsugu, Yoshiko; Honjo, Shuji; Ikeda, Mari; Kamibeppu, Kiyoko			The Japanese version of the Postpartum Bonding Questionnaire: Examination of the reliability, validity, and scale structure	JOURNAL OF PSYCHOSOMATIC RESEARCH			English	Article						Attachment; Bonding; Japanese maternal bonding; Mother-infant relationship; Postpartum Bonding Questionnaire	POSTNATAL DEPRESSION; PSYCHOMETRIC PROPERTIES; MATERNAL MOOD; MOTHER; ATTACHMENT; IMPAIRMENT; VALIDATION; INSTRUMENT; DISORDERS; PREGNANCY	Objective: The purpose of this study was to develop the Japanese version of the Postpartum Bonding Questionnaire (PBQ) to gather data on Japanese mothers for comparison with other cultures and to examine the scale structure of the PBQ among Japanese mothers. Methods: We administered the PBQ to a cross-section of 244 mothers 4 weeks after delivery and again 2 weeks later to 199 mothers as a retest to examine reliability. We used exploratory factor analysis to evaluate the factor structure of the PBQ. Correlations with the Mother-to-Infant Bonding Scale (MIBS), the Maternal Attachment Inventory (MAI), Edinburgh Postnatal Depression Scale (EPDS), and sociodemographic variables were calculated for validation. Results: The 14-item version of the PBQ extracted by exploratory analysis consisted of four factors: 'impaired bonding', 'rejection and anger', 'anxiety about care', and 'lack of affection'. We found significant correlations of the total scores of the PBQ and the 14-item version of the PBQ positively with the MIBS and negatively with the MA!. Moderate significant correlations with total scores were also found with the EPDS. Total scores for primiparous and depressed mothers were higher than those for multiparous mothers and mothers without depression. Conclusion: The results of this study demonstrated the reliability and validity of the PBQ and the 14-item version of the PBQ in Japanese mothers 4 weeks after delivery. (C) 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).	[Suetsugu, Yoshiko; Ikeda, Mari; Kamibeppu, Kiyoko] Univ Tokyo, Sch Hlth Sci & Nursing, Dept Family Nursing, Grad Sch Med,Fac Med, Tokyo 1138654, Japan; [Suetsugu, Yoshiko] Kyushu Univ, Grad Sch Med Sci, Dept Hlth Sci, Fukuoka 812, Japan; [Honjo, Shuji] Nagoya Univ, Sch Educ, Grad Sch Educ & Human Dev, Nagoya, Aichi 4648601, Japan	Kamibeppu, K (reprint author), Univ Tokyo, Sch Hlth Sci & Nursing, Dept Family Nursing, Grad Sch Med,Fac Med,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138654, Japan.	kkamibeppu-tky@umin.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology	We are very grateful to the mothers who participated in this study. We are also deeply grateful to I.F. Brockington for his support in developing the Japanese version of the PBQ This study was supported by the Japanese Ministry of Education, Culture, Sports, Science and Technology. The sponsors had no involvement in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication.	AINSWORT.MD, 1970, CHILD DEV, V41, P49, DOI 10.1111/j.1467-8624.1970.tb00975.x; Yamashita H, 2000, J AFFECT DISORDERS, V58, P145, DOI 10.1016/S0165-0327(99)00108-1; CRANLEY MS, 1981, NURS RES, V30, P281; Taylor A, 2005, ARCH WOMEN MENT HLTH, V8, P45, DOI 10.1007/s00737-005-0074-z; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Brockington IF, 2006, ARCH WOMEN MENT HLTH, V9, P233, DOI 10.1007/s00737-006-0132-1; Wittkowski A, 2010, BRIT J CLIN PSYCHOL, V49, P163, DOI 10.1348/014466509X445589; Klier CM, 2006, ARCH WOMEN MENT HLTH, V9, P289, DOI 10.1007/s00737-006-0150-z; Brockington IF, 2006, ARCH WOMEN MENT HLTH, V9, P253, DOI 10.1007/s00737-006-0134-z; Bowlby J., 1982, ATTACHMENT; BOWLBY J, 1958, INT J PSYCHOANAL, V39, P350; Brockington IF, 2001, ARCH WOMEN MENT HLTH, V3, P133, DOI DOI 10.1007/S007370170010; Cohen J., 1988, STAT POWER ANAL BEHA; CONDON JT, 1993, BRIT J MED PSYCHOL, V66, P167; Galton F, 1886, J ANTHR I, V15, P246, DOI 10.2307/2841583; Honjo S, 2003, PSYCHOPATHOLOGY, V36, P304; Ikeda M, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-112; Ishikawa N, 2011, J PSYCHOSOM RES, V71, P264, DOI 10.1016/j.jpsychores.2011.02.001; Kamibeppu Kiyoko, 2005, Am J Psychoanal, V65, P13, DOI 10.1007/s11231-004-1815-x; Kumar RC, 1997, BRIT J PSYCHIAT, V171, P175, DOI 10.1192/bjp.171.2.175; Maternal and Child Health Foundation, 2012, MAT CHILD HLTH STAT, P127; Moehler E, 2006, ARCH WOMEN MENT HLTH, V9, P273, DOI 10.1007/s00737-006-0149-5; Müller M E, 1994, J Nurs Meas, V2, P129; Muller M E, 1993, West J Nurs Res, V15, P199, DOI 10.1177/019394599301500205; Muller ME, 1993, WESTERN J NURS RES, P211; Nagata M, 2000, ACTA PSYCHIAT SCAND, V101, P209, DOI 10.1034/j.1600-0447.2000.101003209.x; Nakajima T, 2001, NIHON KANGO KAGAKKAI, V21, P1; Nishioka E, 2011, J AFFECT DISORDERS, V133, P553, DOI 10.1016/j.jad.2011.04.027; Okano T MM, 1996, ARCH PSYCHIAT DIAGN, V7, P525; Reck C, 2006, ARCH WOMEN MENT HLTH, V9, P265, DOI 10.1007/s00737-006-0144-x; Siu BWM, 2010, J NERV MENT DIS, V198, P174, DOI 10.1097/NMD.0b013e3181d14154; Sugishita K., 2013, Health, V5, P735; UNICEF, 2013, STAT WORLDS CHILDR 2; van Bussel JCH, 2010, ARCH WOMEN MENT HLTH, V13, P373, DOI 10.1007/s00737-009-0140-z; Wittkowski A, 2007, ARCH WOMEN MENT HLTH, V10, P171, DOI 10.1007/s00737-007-0191-y; Yoshida K, 2012, ARCH WOMEN MENT HLTH, V15, P343, DOI 10.1007/s00737-012-0291-1	36	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-3999	1879-1360		J PSYCHOSOM RES	J. Psychosomat. Res.	JUL	2015	79	1					55	61		10.1016/j.jpsychores.2015.02.008		7	Psychiatry	Psychiatry	CK3JK	WOS:000356112200009		
J	Sekiguchi, Y; Maeda, Y; Azekoshi, Y; Kinjo, M; Fujisaki, A; Nakamura, R; Yao, M				Sekiguchi, Y.; Maeda, Y.; Azekoshi, Y.; Kinjo, M.; Fujisaki, A.; Nakamura, R.; Yao, M.			PREVALENCE OF DYSPAREUNIA IN FEMALE UROLOGY CLINIC-CHARACTERISTICS OF DYSPAREUNIA PATIENTS	JOURNAL OF SEXUAL MEDICINE			English	Meeting Abstract									[Sekiguchi, Y.; Maeda, Y.; Azekoshi, Y.; Kinjo, M.; Fujisaki, A.; Nakamura, R.] LUNA Pelv Floor Total Support Clin, Womens Clin LUNA Grp, Yokohama, Kanagawa, Japan; [Yao, M.] Yokohama City Univ, Grad Sch Med, Dept Urol, Yokohama, Kanagawa, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1743-6095	1743-6109		J SEX MED	J. Sex. Med.	JUL	2015	12			4	SI	053	289	289				1	Urology & Nephrology	Urology & Nephrology	CK2VJ	WOS:000356071800047		
J	Walker, D; Matsuki, K; Struk, AM; Wright, TW; Banks, SA				Walker, David; Matsuki, Keisuke; Struk, Aimee M.; Wright, Thomas W.; Banks, Scott A.			Scapulohumeral rhythm in shoulders with reverse shoulder arthroplasty	JOURNAL OF SHOULDER AND ELBOW SURGERY			English	Article						Reverse total shoulder arthroplasty; rehabilitation; implant design; surgical technique; shoulder motion; scapulohumeral rhythm	CUFF TEAR ARTHROPATHY; IMPINGEMENT; PROSTHESIS; ARTHRITIS; DESIGN; MOTION; REPLACEMENT; KINEMATICS; ELEVATION; SENSORS	Background: Little is known about kinematic function of reverse total shoulder arthroplasty (RTSA). Scapulohumeral rhythm (SHR) is a common metric for assessing muscle function and shoulder joint motion. The purpose of this study was to compare SHR in shoulders with RTSA to normal shoulders. Methods: Twenty-eight subjects, more than 12 months after unilateral RTSA, were recruited for an Institutional Review Board-approved study. Subjects performed arm abduction in the coronal plane with and without a 1.4-kg hand-held weight. Three-dimensional model-image registration techniques were used to measure orientation and position for the humerus and scapula from fluoroscopic images. Analysis of variance and Tukey tests were used to assess groupwise and pairwise differences. Results: SHR in RTSA shoulders (1.3: 1) was significantly lower than in normal shoulders (3: 1). Below 30 degrees abduction, RTSA and normal shoulders show a wide range of SHR (1.3: 1 to 17: 1). Above 30 degrees abduction, SHR in RTSA shoulders was 1.3: 1 for unweighted abduction and 1.3: 1 for weighted abduction. Maximum RTSA shoulder abduction in weighted trials was lower than in unweighted trials. SHR variability in RTSA shoulders decreased with increasing arm elevation. Conclusion: RTSA shoulders show kinematics that are significantly different from normal shoulders. SHR in RTSA shoulders was significantly lower than in normal shoulders, indicating that RTSA shoulders use more scapulothoracic motion and less glenohumeral motion to elevate the arm. With these observations, it may be possible to improve rehabilitation protocols, with particular attention to the periscapular muscles, and implant design or placement to optimize functional outcomes in shoulders with RTSA. Level of evidence: Basic Science, Kinesiology. (C) 2015 Journal of Shoulder and Elbow Surgery Board of Trustees.	[Walker, David; Banks, Scott A.] Univ Florida, Dept Mech Engn, Gainesville, FL 32611 USA; [Matsuki, Keisuke] Teikyo Univ, Chiba Med Ctr, Dept Orthopaed Surg, Ichihara, Chiba, Japan; [Struk, Aimee M.; Wright, Thomas W.] Univ Florida, Dept Orthopaed & Rehabil, Gainesville, FL USA	Wright, TW (reprint author), 3450 Hull Rd,3rd Floor, Gainesville, FL 32608 USA.	wrightw@ortho.ufl.edu	Banks, Scott/B-6345-2008	Banks, Scott/0000-0003-0404-6826	American Shoulder and Elbow Surgeons	A research grant from the American Shoulder and Elbow Surgeons was received in partial support of this work.	Rittmeister M, 2001, J SHOULDER ELB SURG, V10, P17, DOI 10.1067/mse.2001.110515; Mulieri P, 2010, J BONE JOINT SURG AM, V92A, P2544, DOI 10.2106/JBJS.I.00912; Matsuki K, 2011, J SHOULDER ELB SURG, V20, P659, DOI 10.1016/j.jse.2010.09.012; Gutierrez S, 2008, J BONE JOINT SURG AM, V90A, P2606, DOI 10.2106/JBJS.H.00012; Scarlat MM, 2013, INT ORTHOP, V37, P843, DOI 10.1007/s00264-013-1832-6; Naveed MA, 2011, J BONE JOINT SURG BR, V93B, P57, DOI 10.1302/0301-620X.93B1.24218; Kwon YW, 2012, J SHOULDER ELB SURG, V21, P1184, DOI 10.1016/j.jse.2011.07.031; Inman VT, 1944, J BONE JOINT SURG, V26, P1; de Toledo JM, 2012, CLIN BIOMECH, V27, P793, DOI 10.1016/j.clinbiomech.2012.04.009; Parel I, 2012, GAIT POSTURE, V35, P636, DOI 10.1016/j.gaitpost.2011.12.015; Banks SA, 1996, IEEE T BIO-MED ENG, V43, P638, DOI 10.1109/10.495283; Harman M, 2005, J SHOULDER ELB SURG, V14, p162S, DOI 10.1016/j.jse.2004.09.030; Roche C, 2009, J SHOULDER ELB SURG, V18, P734, DOI 10.1016/j.jse.2008.12.008; De Wilde LF, 2004, J ORTHOP RES, V22, P1222, DOI 10.1016/j.orthres.2004.03.010; Kon Y, 2008, J SHOULDER ELB SURG, V17, P943, DOI 10.1016/j.jse.2008.05.047; Boileau P, 2006, J SHOULDER ELB SURG, V15, P527, DOI 10.1016/j.jse.2006.01.003; Phadke V, 2009, REV BRAS FISIOTER, V13, P1, DOI 10.1590/S1413-35552009005000012; Boileau P, 2005, J SHOULDER ELB SURG, V14, p147S, DOI 10.1016/j.jse.2004.10.006; Cordasco Frank A, 2010, HSS J, V6, P30, DOI 10.1007/s11420-009-9127-6; Kim MS, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-210; Lam F, 2007, CURR ORTHOPAED, V21, P40, DOI 10.1016/j.cuor.2006.10.004; Lin YL, 2013, J APPL BIOMECH, V29, P496; Linge BV, 1963, J BONE JOINT SURG BR, V45, P750; Madeleine P, 2002, EUR J APPL PHYSIOL, V87, P327, DOI 10.1007/s00421-002-0655-8; SHARKEY NA, 1994, J ORTHOPAED RES, V12, P699, DOI 10.1002/jor.1100120513; Walker D, 2014, J SHOULDER ELB SURG, V23, P166, DOI 10.1016/j.jse.2013.05.005	26	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	1058-2746			J SHOULDER ELB SURG	J. Shoulder Elbow Surg.	JUL	2015	24	7					1129	1134		10.1016/j.jse.2014.11.043		6	Orthopedics; Sport Sciences; Surgery	Orthopedics; Sport Sciences; Surgery	CK2OZ	WOS:000356051700024		
J	Itoigawa, Y; Suzuki, O; Sano, H; Anada, T; Handa, T; Hatta, T; Kuwahara, Y; Takahashi, A; Ezoe, Y; Kaneko, K; Itoi, E				Itoigawa, Yoshiaki; Suzuki, Osamu; Sano, Hirotaka; Anada, Takahisa; Handa, Takuto; Hatta, Taku; Kuwahara, Yoshiyuki; Takahashi, Atsushi; Ezoe, Yushi; Kaneko, Kazuo; Itoi, Eiji			The role of an octacalcium phosphate in the re-formation of infraspinatus tendon insertion	JOURNAL OF SHOULDER AND ELBOW SURGERY			English	Article						Rotator cuff repair; enthesis; octacalcium phosphate (OCP); collagen fibers; Sharpey fibers; tendon-to-bone healing; shoulder	ROTATOR CUFF REPAIR; MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS; TO-BONE INSERTION; SUPRASPINATUS TENDON; HYDROXYAPATITE; MODEL; RECONSTRUCTION; REGENERATION; OSTEOBLASTS	Background: To improve the success rate of rotator cuff repair, we investigated whether octacalcium phosphate (OCP) with gelatin (Gel) vehicle had a positive effect on tendon-to-bone healing. Methods: We assessed the histologic characteristics of the tendon-to-bone healing using the rabbit rotator cuff repair model. We divided the shoulders into 3 groups: control (without OCP/Gel composite), OCP/Gel composite (OCP_group), and Gel alone without OCP (Gel group) to evaluate the effectiveness of gelatin. Results: Both the number of newly formed tendon fibers and the Sharpey fibers at the repair site increased in the OCP_group compared with those in the other 2 groups on hematoxylin-eosin staining (P <. 05). On immunohistochemical evaluation, both the bone and the fibers in the OCP_group demonstrated that type I collagen was picked up, whereas the newly formed tendon fibers and Sharpey fibers revealed type III collagen. Conclusion: Treatment with OCP made collagen fibers and the Sharpey fibers, constituted by type I and type III collagens, increase at the tendon-to-bone insertion. It might be beneficial for the healing of rotator cuff tendon to bone. Level of evidence: Basic Science Study, Histology. (C) 2015 Journal of Shoulder and Elbow Surgery Board of Trustees.	[Itoigawa, Yoshiaki; Sano, Hirotaka; Hatta, Taku; Kuwahara, Yoshiyuki; Takahashi, Atsushi; Itoi, Eiji] Tohoku Univ, Sch Med, Dept Orthopaed Surg, Sendai, Miyagi 980, Japan; [Itoigawa, Yoshiaki; Kaneko, Kazuo] Juntendo Univ, Sch Med, Dept Orthopaed Surg, Tokyo 113, Japan; [Suzuki, Osamu; Anada, Takahisa; Ezoe, Yushi] Tohoku Univ, Grad Sch Dent, Div Craniofacial Funct Engn, Sendai, Miyagi 980, Japan; [Handa, Takuto] Yokushukai Dent Clin, Nishi Murayama, Japan; [Ezoe, Yushi] Tohoku Univ, Grad Sch Dent, Div Oral & Maxillofacial Surg, Sendai, Miyagi 980, Japan	Suzuki, O (reprint author), 4-1 Seiryo Machi,Aoba Ku, Sendai, Miyagi 9808575, Japan.	suzuki-o@m.tohoku.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology in Japan [23390450, 23659909, 23106010]; Iketani Science and Technology Foundation	This study was supported in part by grants-in-aid (23390450, 23659909, and 23106010) from the Ministry of Education, Culture, Sports, Science, and Technology in Japan and Iketani Science and Technology Foundation.	Omae H, 2009, J ORTHOP RES, V27, P937, DOI 10.1002/jor.20823; WULKER N, 1991, ACTA ORTHOP SCAND, V62, P142; Thomopoulos S, 2010, J MUSCULOSKEL NEURON, V10, P35; Seeherman HJ, 2008, J BONE JOINT SURG AM, V90A, P2206, DOI [10.2106/JBJS.G.00742, 10.2106/0S.G.00742]; LIU SH, 1994, ARTHROSCOPY, V10, P54, DOI 10.1016/S0749-8063(05)80293-2; Zhao S, 2014, AM J SPORT MED, V42, P1920, DOI 10.1177/0363546514532781; Koike Y, 2005, J ORTHOP RES, V23, P1433, DOI 10.1016/j.orthres.2005.02.015; SUZUKI O, 1991, TOHOKU J EXP MED, V164, P37, DOI 10.1620/tjem.164.37; Imaizumi H, 2006, CALCIFIED TISSUE INT, V78, P45, DOI 10.1007/s00223-005-0170-0; Anada T, 2008, TISSUE ENG PT A, V14, P965, DOI 10.1089/tea.2007.0339; Chen CH, 2011, KNEE SURG SPORT TR A, V19, P1597, DOI 10.1007/s00167-010-1373-0; Suzuki O, 2006, BIOMATERIALS, V27, P2671, DOI 10.1016/j.boimaterials.2005.12.004; GAZIELLY DF, 1994, CLIN ORTHOP RELAT R, P43; Gulotta LV, 2011, AM J SPORT MED, V39, P1282, DOI 10.1177/0363546510395485; Yamamoto Atsushi, 2010, J Shoulder Elbow Surg, V19, P116, DOI 10.1016/j.jse.2009.04.006; WHITTAKER P, 1991, MATRIX, V11, P56; Takami M, 2009, TISSUE ENG PT A, V15, P3991, DOI 10.1089/ten.TEA.2009.0065; Rodeo SA, 2007, J BONE JOINT SURG AM, V89A, P2485, DOI 10.2106/JBJS.C.01627; BROWN WALTER E., 1966, CLIN ORTHO RELAT RES, V44, P205; Caldwell GL, 1997, J BONE JOINT SURG AM, V79A, P1064; Cooper JO, 2014, J TISSUE ENG, V5, P1; COOPER RR, 1970, J BONE JOINT SURG AM, VA 52, P1; Francois RJ, 2001, CURR OPIN RHEUMATOL, V13, P255, DOI 10.1097/00002281-200107000-00003; Funakoshi T, 2005, AM J SPORT MED, V33, P1193, DOI 10.1177/036354650427689; Gulotta LV, 2009, AM J SPORT MED, V37, P2126, DOI 10.1177/0363546509339582; Gulotta LV, 2010, AM J SPORT MED, V38, P1429, DOI 10.1177/0363546510361235; Gulotta LV, 2011, CLIN ORTHOP RELAT R, V469, P2977, DOI 10.1007/s11999-010-1727-4; Handa T, 2012, ACTA BIOMATER, V8, P1190, DOI 10.1016/j.actbio.2011.12.002; HARRYMAN DT, 1991, J BONE JOINT SURG AM, V73A, P982; Kanazawa Tomonoshin, 2014, Muscles Ligaments Tendons J, V4, P201; Knudsen HB, 1999, J SHOULDER ELB SURG, V8, P242, DOI 10.1016/S1058-2746(99)90136-2; Miyatake N, 2009, BIOMATERIALS, V30, P1005, DOI 10.1016/j.biomaterials.2008.10.058; Mutsuzaki H, 2005, BIOMATERIALS, V26, P1027, DOI 10.1016/j.biomaterials.2004.03.039; Pelinkovic D, 2003, TISSUE ENG, V9, P143, DOI 10.1089/107632703762687627; Sano H, 2002, J SHOULDER ELB SURG, V11, P166, DOI 10.1067/mse.2002.120808; Shibuya I, 2013, CELL TISSUE RES, V352, P401, DOI 10.1007/s00441-012-1548-8; Soda Y, 2003, ACTA ORTHOP SCAND, V74, P322, DOI 10.1080/00016470308540847; SUZUKI O, 1993, BONE MINER, V20, P151, DOI 10.1016/S0169-6009(08)80024-4; WEISCHER CH, 1986, HISTOL HISTOPATHOL, V1, P303; Wolfman NM, 1997, J CLIN INVEST, V100, P321, DOI 10.1172/JCI119537; Zhao S, 2014, J SURG RES, V193, P33	41	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	1058-2746			J SHOULDER ELB SURG	J. Shoulder Elbow Surg.	JUL	2015	24	7					E175	E184		10.1016/j.jse.2015.01.011		10	Orthopedics; Sport Sciences; Surgery	Orthopedics; Sport Sciences; Surgery	CK2OZ	WOS:000356051700001		
J	Tada, Y; Yagi, K; Uno, M; Matsushita, N; Kanematsu, Y; Kuwayama, K; Shimada, K; Nishi, K; Hirasawa, M; Satomi, J; Kitazato, KT; Kageji, T; Matsuura, E; Nagahiro, S				Tada, Yoshiteru; Yagi, Kenji; Uno, Masaaki; Matsushita, Nobuhisa; Kanematsu, Yasuhisa; Kuwayama, Kazuyuki; Shimada, Kenji; Nishi, Kyoko; Hirasawa, Motohiro; Satomi, Junichiro; Kitazato, Keiko T.; Kageji, Teruyoshi; Matsuura, Eiji; Nagahiro, Shinji			Improvement of Plasma Biomarkers after Switching Stroke Patients from Other Angiotensin II Type I Receptor Blockers to Olmesartan	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Adiponectin; angiotensin-(1-7); hypertension; LDL/beta-2-glycoprotein I complex; olmesartan; peroxiredoxin	AMBULATORY BLOOD-PRESSURE; CONVERTING ENZYME 2; HYPERTENSIVE PATIENTS; OOPHORECTOMIZED RATS; ALDOSTERONE SYSTEM; TELMISARTAN; ADIPONECTIN; MEDOXOMIL; BRAIN; ACTIVATION	Background: Managing hypertension is crucial for preventing stroke recurrence. Some stroke patients experience resistant hypertension. In our experimental stroke model, olmesartan increased the expression of angiotensin (Ang) II converting enzyme-2. We hypothesized that switching to olmesartan affects biomarkers and the blood pressure (BP) in stroke patients whose BP is insufficiently controlled by standard doses of Ang II type I receptor blockers (ARBs) other than olmesartan. Methods: We recruited 25 patients to study our hypothesis. All had a history of stroke or silent cerebral infarction. We switched them to olmesartan (10-40 mg per day) for 12 weeks and determined their plasma level of Ang-(1-7), peroxiredoxin, oxidized low-density lipoprotein (oxLDL)/beta-2-glycoprotein I (beta 2GPI) complex, adiponectin, high mobility group box 1 (HMGB1), and tumor necrosis factor-alpha (TNF alpha) and recorded their BP before and after olmesartan treatment. Results: After switching the patients to olmesartan, their plasma level of Ang-(1-7) as a vasoprotective indicator and adiponectin regulating metabolic syndrome was increased, and peroxiredoxin and the oxLDL/beta 2GPI complex indicating its antioxidative stress and its proatherogenicity were lower than their baseline. This suggests that olmesartan may be more effective than other ARBs to improve these conditions. Neither HMGB1 nor TNF alpha reflecting an inflammatory response was affected, suggesting that the anti-inflammatory effects of olmesartan are similar to those of other ARBs. The recommended BP (<140/90) was obtained in 10 of the 25 patients after switching to olmesartan. No adverse events occurred. Conclusions: Switching from other ARBs to olmesartan may be a promising therapeutic option in patients with resistant hypertension.	[Tada, Yoshiteru; Yagi, Kenji; Kanematsu, Yasuhisa; Kuwayama, Kazuyuki; Shimada, Kenji; Nishi, Kyoko; Hirasawa, Motohiro; Satomi, Junichiro; Kitazato, Keiko T.; Kageji, Teruyoshi; Nagahiro, Shinji] Univ Tokushima, Inst Hlth Biosci, Dept Neurosurg, Tokushima, Tokushima 7708503, Japan; [Uno, Masaaki; Matsushita, Nobuhisa] Kawasaki Med Univ, Dept Neurosurg, Kurashiki, Okayama, Japan; [Matsuura, Eiji] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cell Chem, Okayama, Japan	Tada, Y (reprint author), Univ Tokushima, Inst Hlth Biosci, Dept Neurosurg, 3-18-15 Kuramoto Cho, Tokushima, Tokushima 7708503, Japan.	yoshiteru.tada@hotmail.co.jp					Furukawa T, 2009, CLIN DRUG INVEST, V29, P257, DOI 10.2165/00044011-200929040-00004; Feng YM, 2010, CIRC RES, V106, P373, DOI 10.1161/CIRCRESAHA.109.208645; Fliser D, 2004, CIRCULATION, V110, P1103, DOI 10.1161/01.CIR.0000140265.21608.8E; Shichita T, 2012, NAT MED, V18, P911, DOI 10.1038/nm.2749; Clement DL, 2003, NEW ENGL J MED, V348, P2407, DOI 10.1056/NEJMoa022273; Hara K, 2006, DIABETES CARE, V29, P1357, DOI 10.2337/dc05-1801; Passos-Silva DG, 2013, CLIN SCI, V124, P443, DOI 10.1042/CS20120461; Schrader J, 2005, STROKE, V36, P1218, DOI 10.1161/01.STR.0000166048.35740.a9; Greco TP, 2010, AM J CLIN PATHOL, V133, P737, DOI 10.1309/AJCP88WVRDRDFBAS; Ohshima K, 2014, HYPERTENSION, V63, pE53, DOI 10.1161/HYPERTENSIONAHA.113.02426; Abassi Z, 2009, BIOCHEM PHARMACOL, V78, P933, DOI 10.1016/j.bcp.2009.05.018; Miura S, 2006, J BIOL CHEM, V281, P19288, DOI 10.1074/jbc.M602144200; Aoki A, 2010, HEART VESSELS, V25, P195, DOI 10.1007/s00380-009-1186-6; Kiya Y, 2010, CLIN EXP HYPERTENS, V32, P129, DOI 10.3109/10641960903254430; Arao T, 2013, ENDOCR J, V60, P563; Calo LA, 2014, J HYPERTENS, V32, P193, DOI 10.1097/HJH.0b013e32836522c3; Cushman WC, 2012, HYPERTENSION, V60, P310, DOI 10.1161/HYPERTENSIONAHA.111.188284; de la Sierra A, 2013, J HYPERTENS, V31, pS13, DOI 10.1097/HJH.0b013e32835d2b05; Giles Thomas D, 2007, J Clin Hypertens (Greenwich), V9, P187, DOI 10.1111/j.1524-6175.2007.06395.x; Igase M, 2005, AM J PHYSIOL-HEART C, V289, pH1013, DOI 10.1152/ajpheart.00068.2005; Ikeda H, 2009, DIABETES RES CLIN PR, V83, P117, DOI 10.1016/j.diabres.2008.10.013; Karthikeyan VJ, 2007, J HUM HYPERTENS, V21, P8, DOI 10.1038/sj.jhh.1002113; Makita S, 2007, CARDIOVASC DRUG THER, V21, P317, DOI 10.1007/s10557-007-6039-x; Matsushita N, 2012, HYPERTENSION, V60, P1309, DOI 10.1161/HYPERTENSIONAHA.112.198762; Nakayama S, 2008, HYPERTENS RES, V31, P7, DOI 10.1291/hypres.31.7; Oparil S, 2001, J CLIN HYPERTENS, V3, P318; Oparil S, 2001, J Clin Hypertens (Greenwich), V3, P283, DOI 10.1111/j.1524-6175.2001.01136.x; Sezai A, 2011, ANN THORAC CARDIOVAS, V17, P487, DOI 10.5761/atcs.oa.11.01691; Shimada K, 2011, HYPERTENSION, V57, P1161, DOI 10.1161/HYPERTENSIONAHA.110.167650; Tsutamoto T, 2010, HYPERTENS RES, V33, P118, DOI 10.1038/hr.2009.192	30	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	JUL	2015	24	7					1487	1492		10.1016/j.jstrokecerebrovasdis.2015.03.015		6	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CK2OA	WOS:000356049000012		
J	Sueda, Y; Hosomi, N; Tsunematsu, M; Takamatsu, K; Nomura, E; Torii, T; Ohtsuki, T; Aoki, S; Mukai, T; Nezu, T; Kakehashi, M; Matsumoto, M				Sueda, Yoshimasa; Hosomi, Naohisa; Tsunematsu, Miwako; Takamatsu, Kazuhiro; Nomura, Eiichi; Torii, Tsuyoshi; Ohtsuki, Toshiho; Aoki, Shiro; Mukai, Tomoya; Nezu, Tomohisa; Kakehashi, Masayuki; Matsumoto, Masayasu		HEWS-tPA Collaborators	Effects of Meteorological Conditions on the Risk of Ischemic Stroke Events in Patients Treated with Alteplase-HEWS-tPA	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Meteorological conditions; ischemic stroke; stroke; prediction	HOSPITAL ADMISSIONS; WEATHER PARAMETERS; CORONARY; ASSOCIATIONS; MORTALITY; SEASON; WINTER	Background: Predicting a day that presents a high risk for the occurrence of ischemic stroke events may enable health professionals to prepare for emergency stroke therapy more properly. We evaluated the association between meteorological conditions and the frequency of ischemic stroke events in Japanese patients. Methods: Ischemic stroke patients (n = 299) who were treated with alteplase at 9 stroke hospitals in 3 restricted areas were examined. The daily rates of ischemic stroke events were compared with the daily mean thermo-hydrological index (THI), the atmospheric pressure, and the daily changes of these variables for the 6 days preceding an ischemic stroke event using Poisson regression analysis. Results: We trisected onset days based on the THI (low-temperature, intermediate-temperature, and high-temperature), atmospheric pressure (low-pressure, intermediate-pressure, and high-pressure), changes in THI for preceding 6 days from the previous day (cooler, unchanged-temperature, and warmer), and changes in atmospheric pressure (decreased-pressure, unchanged-pressure, and increased-pressure). The frequency of ischemic stroke was significantly higher on low-temperature or high-pressure days (risk ratio, 1.398, P = .022; risk ratio, 1.374, P = .039), on warmer-temperature days, and when atmospheric pressure varied from the day before (P < .05). There were significantly lower risks for ischemic stroke events on cooler-temperature days, and higher risks were associated with a variation in atmospheric pressure 3 days before the onset from 4 days before (P < .05). Conclusions: There were higher risks for ischemic stroke events associated with low ambient temperature, high atmospheric pressure, increased temperature, and varied atmospheric pressure. Also, atmospheric pressure variation 3 days before may be associated.	[Sueda, Yoshimasa; Torii, Tsuyoshi] Natl Hosp Organiza, Kure Med Ctr, Dept Neurol, Kure, Japan; [Hosomi, Naohisa; Ohtsuki, Toshiho; Aoki, Shiro; Mukai, Tomoya; Nezu, Tomohisa; Matsumoto, Masayasu] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Clin Neurosci & Therapeut, Hiroshima, Japan; [Tsunematsu, Miwako; Kakehashi, Masayuki] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Hlth Informat, Hiroshima, Japan; [Takamatsu, Kazuhiro] Brain Attack Ctr Ota Mem Hosp, Dept Neurol, Fukuyama, Hiroshima, Japan; [Nomura, Eiichi] Suiseikai Kajikawa Hosp, Dept Neurol, Hiroshima, Japan	Hosomi, N (reprint author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Clin Neurosci & Therapeut, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	nhosomi@hiroshima-u.ac.jp			Ministry of Health, Labour and Welfare, Japan [23590598]; Japan Science and Technology Agency [AS242Z02592P]; Smoking Research Foundation; Tsuchiya Foundation; Japan Heart Foundation	This study was supported in part by research grants from the Ministry of Health, Labour and Welfare, Japan (23590598), the Japan Science and Technology Agency (AS242Z02592P), the Smoking Research Foundation, the Tsuchiya Foundation, and the Japan Heart Foundation.	Magalhaes R, 2011, CEREBROVASC DIS, V32, P542, DOI 10.1159/000331473; BERGINER VM, 1989, STROKE, V20, P65; WOODHOUSE PR, 1994, LANCET, V343, P435, DOI 10.1016/S0140-6736(94)92689-1; Hori A, 2012, INT J ENVIRON HEAL R, V22, P416, DOI 10.1080/09603123.2011.650155; Goggins WB, 2012, INT J BIOMETEOROL, V56, P865, DOI 10.1007/s00484-011-0491-9; Analitis A, 2008, AM J EPIDEMIOL, V168, P1397, DOI 10.1093/aje/kwn266; Turin TC, 2008, STROKE, V39, P745, DOI 10.1161/STROKEAHA.107.495929; [Anonymous], 1990, STROKE, V21, P637; Hong YC, 2003, EPIDEMIOLOGY, V14, P473, DOI 10.1097/01.ede.0000078420.82023.e3; Panagiotakos DB, 2004, INT J CARDIOL, V94, P229, DOI 10.1016/j.ijcard.2003.04.050; Dawson J, 2008, ACTA NEUROL SCAND, V117, P85, DOI 10.1111/j.1600-0404.2007.00916.x; Feigin VL, 2000, EUR J NEUROL, V7, P171, DOI 10.1046/j.1468-1331.2000.00016.x; GORDON DJ, 1988, J CLIN EPIDEMIOL, V41, P679, DOI 10.1016/0895-4356(88)90120-5; Jimenez-Conde J, 2008, CEREBROVASC DIS, V26, P348, DOI 10.1159/000151637; KEATINGE WR, 1984, BRIT MED J, V289, P1405; Lin HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066403	16	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	JUL	2015	24	7					1500	1505		10.1016/j.jstrokecerebrovasdis.2015.03.013		6	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CK2OA	WOS:000356049000014		
J	Asai, K; Imamura, H; Mineharu, Y; Tani, S; Adachi, H; Narumi, O; Sato, S; Sakai, C; Sakai, N				Asai, Katsunori; Imamura, Hirotoshi; Mineharu, Yohei; Tani, Shoichi; Adachi, Hidemitsu; Narumi, Osamu; Sato, Shinsuke; Sakai, Chiaki; Sakai, Nobuyuki			X-ray Angiography Perfusion Analysis for the Balloon Occlusion Test of the Internal Carotid Artery	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Balloon occlusion test; X-ray angiography perfusion; 2D perfusion; internal carotid artery	THERAPEUTIC OCCLUSION; STUMP PRESSURE; TOLERANCE; SACRIFICE	Background: A perfusion study should be performed during the balloon occlusion test (BOT) to prevent ischemic events after therapeutic carotid occlusion. We evaluated the efficacy of X-ray angiography perfusion analysis during the BOT. Methods: Twenty-one consecutive patients who underwent the BOT of the internal carotid artery were included. Patients who had a venous phase delay of less than .5 seconds and a mean stump pressure of more than 50 mm Hg without any neurologic symptoms were considered tolerant, and other patients were considered intolerant. A time-density curve was constructed for each hemisphere using X-ray angiography perfusion software (2D-Perfusion). The mean transit time and area under the curve, which correspond to cerebral blood volume, were calculated from the curve. Differences in these parameters between the occluded and nonoccluded hemispheres and the perfusion index were compared between the tolerant and intolerant groups. Results: In the intolerant group, the mean transit time was significantly longer (1.31 +/- .72 seconds versus .44 +/- .21 seconds, P = .001) and the perfusion index was significantly lower (.72 +/- .16 versus .94 +/- .08, P = .001) compared with those in the tolerant group. The area under the curve was not different between the groups. Conclusions: Parameters obtained by X-ray angiography perfusion analysis were significantly different between the tolerant and intolerant groups. The X-ray angiography perfusion analysis could be a safe and effective method for assessing ischemic tolerance before therapeutic carotid occlusion. (C) 2015 by National Stroke Association	[Asai, Katsunori; Imamura, Hirotoshi; Mineharu, Yohei; Tani, Shoichi; Adachi, Hidemitsu; Narumi, Osamu; Sato, Shinsuke; Sakai, Nobuyuki] Gen Hosp, Kobe City Med Ctr, Dept Neurosurg, Kobe, Hyogo, Japan; [Asai, Katsunori; Mineharu, Yohei; Sakai, Chiaki; Sakai, Nobuyuki] Inst Biomed Res & Innovat, Div Neuroendovasc Therapy, Kobe, Hyogo, Japan	Asai, K (reprint author), Osaka Univ, Sch Med, Dept Neurosurg, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	asai-osk@umin.ac.jp					Gevers S, 2012, AM J NEURORADIOL, V33, P329, DOI 10.3174/ajnr.A2776; Abud DG, 2005, AM J NEURORADIOL, V26, P2602; Lin MD, 2012, RADIAT RES, V177, P387, DOI 10.1667/RR2696.1; van Rooij WJ, 2005, AM J NEURORADIOL, V26, P175; Latchaw RE, 2003, STROKE, V34, P1084, DOI 10.1161/01.STR.0000064840.99271.9E; Sugawara Y, 2002, J NUCL MED, V43, P1616; Struffert T, 2013, CLIN NEURORADIOL, V23, P285, DOI 10.1007/s00062-013-0208-z; Bogunovic H, 2005, ISPA 2005: Proceedings of the 4th International Symposium on Image and Signal Processing and Analysis, P147, DOI 10.1109/ISPA.2005.195400; Kawai N, 2012, INTERV NEURORADIOL, V18, P264; Kurata A, 1996, ACTA NEUROCHIR, V138, P549, DOI 10.1007/BF01411175; Levitt MR, 2014, J NEUROIMAGING, V24, P387, DOI 10.1111/jon.12046; LINSKEY ME, 1994, AM J NEURORADIOL, V15, P829; Lorberboym M, 1996, J NUCL MED, V37, P415; MATHIS JM, 1995, AM J NEURORADIOL, V16, P749; Michel E, 2001, AM J NEURORADIOL, V22, P1590; Torigai T, 2013, J STROKE CEREBROVASC, V22, P197, DOI 10.1016/j.jstrokecerebrovasdis.2011.07.015; Wang AYC, 2013, J STROKE CEREBROVASC, V22, pE533, DOI 10.1016/j.jstrokecerebrovasdis.2013.05.036	17	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	JUL	2015	24	7					1506	1512		10.1016/j.jstrokecerebrovasdis.2015.03.012		7	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CK2OA	WOS:000356049000015		
J	Matsumoto, Y; Iko, M; Tsutsumi, M; Mitsutake, T; Eto, A; Nii, K; Nakai, K; Oishi, H; Aikawa, H; Kazekawa, K				Matsumoto, Yoshihisa; Iko, Minoru; Tsutsumi, Masanori; Mitsutake, Takahumi; Eto, Ayumu; Nii, Kouhei; Nakai, Kanji; Oishi, Hiromichi; Aikawa, Hiroshi; Kazekawa, Kiyoshi			The Safety and Efficacy of Triple Antiplatelet Therapy after Intracranial Stent-Assisted Coil Embolization	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Intracranial aneurysm; stent-assisted coil embolization; ischemic event; antiplatelet therapy	PERCUTANEOUS CORONARY INTERVENTION; ENDOVASCULAR TREATMENT; ASPIRIN RESISTANCE; ISCHEMIC EVENTS; DOUBLE-BLIND; CLOPIDOGREL; ANEURYSMS; CILOSTAZOL; MULTICENTER; STROKE	Background: Stent-assisted coil embolization is effective for intracranial aneurysms, especially for wide-necked aneurysms; however, the optimal antiplatelet regimens for postoperative ischemic events have not yet been established. We aimed at determining the efficacy and safety of a triple antiplatelet therapy regimen after intracranial stent-assisted coil embolization. Methods: We retrospectively evaluated patients who underwent stent-assisted coil embolization for unruptured intracranial aneurysms or during the chronic phase of a ruptured intracranial aneurysm (>= 4 weeks after subarachnoid hemorrhage onset). We recorded the incidence of ischemic and bleeding events 140 days postoperatively. Results: We assessed 79 cases in patients who received either dual (n = 51) or triple (n = 28) antiplatelet therapy. The duration of triple antiplatelet therapy was 49 +/- 29 days. Seven patients in the dual group experienced postoperative ischemic events. Compared to the dual group, the triple group had a similar incidence of postoperative bleeding events but a significantly lower incidence of postoperative ischemic events (P < .05). Conclusions: Triple antiplatelet therapy had a significantly lower incidence of postoperative ischemic events and a similar incidence of postoperative bleeding events 140 days postoperatively. (C) 2015 by National Stroke Association	[Matsumoto, Yoshihisa; Oishi, Hiromichi] Tanushimaru Cent Hosp, Dept Neurosurg, Kurume, Fukuoka 8391213, Japan; [Iko, Minoru; Tsutsumi, Masanori; Mitsutake, Takahumi; Eto, Ayumu; Nii, Kouhei; Nakai, Kanji; Aikawa, Hiroshi; Kazekawa, Kiyoshi] Fukuoka Univ, Chikushi Hosp, Dept Neurosurg, Chikushino, Japan	Matsumoto, Y (reprint author), Tanushimaru Cent Hosp, Dept Neurosurg, 892 Masuoda, Kurume, Fukuoka 8391213, Japan.	fwip4873@mb.infoweb.ne.jp					Ahn Jeong Cheon, 2004, Korean Journal of Internal Medicine, V19, P230; Akpek S, 2005, AM J NEURORADIOL, V26, P1223; Chen KY, 2009, CIRCULATION, V119, P3207, DOI 10.1161/CIRCULATIONAHA.108.822791; Han YL, 2009, AM HEART J, V157, P733, DOI 10.1016/j.ahj.2009.01.006; Henkes H, 2002, INTERV NEURORADIOL, V8, P107; Asakura M, 1998, CIRCULATION, V97, P2003; Diener HC, 2004, LANCET, V364, P331; Kono K, 2013, ACTA NEUROCHIR, V155, P1549, DOI 10.1007/s00701-013-1771-4; Toyoda K, 2008, STROKE, V39, P1740, DOI 10.1161/STROKEAHA.107.504993; Lau WC, 2004, CIRCULATION, V109, P166, DOI 10.1161/01.CIR.0000112378.09325.F9; Mocco J, 2011, NEUROSURGERY, V69, P908, DOI 10.1227/NEU.0b013e318228490c; Wiebers D, 2003, LANCET, V362, P103, DOI 10.1016/S0140-6736(03)13860-3; Lee SW, 2011, J AM COLL CARDIOL, V57, P1264, DOI 10.1016/j.jacc.2010.10.035; Bendok BR, 2007, NEUROSURGERY, V61, P840; Bendok BR, 2007, NEUROSURGERY, V61, P835, DOI 10.1227/01.NEU.0000280076.82080.73; Kanaan H, 2010, NEUROSURGERY, V67, P1523, DOI 10.1227/NEU.0b013e3181f8d194; Kanaan H, 2010, NEUROSURGERY, V67, P1532; Kim JS, 2004, J CLIN NEUROSCI, V11, P600, DOI 10.1016/j.jocn.2003.10.022; Lopes D, 2005, J TRANSL MED, V56, pE416; Macchi L, 2006, CURR PHARM DESIGN, V12, P251, DOI 10.2174/138161206775193064; Matsumoto Y, 2014, J STROKE CEREBROVASC, V23, P771, DOI 10.1016/j.jstrokecerebrovasdis.2013.07.008; Mordasini P, 2008, SWISS MED WKLY, V138, P646, DOI 2008/43/smw-12396; Neubauer H, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-3; Rossen JD, 2012, J NEUROSURG, V117, P929, DOI 10.3171/2012.8.JNS12185; Sani Sepehr, 2005, Neurosurg Focus, V18, pE4; SCHATZ RA, 1987, CIRCULATION, V76, P450; Sheu JJ, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-164	27	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	JUL	2015	24	7					1513	1519		10.1016/j.jstrokecerebrovasdis.2015.03.010		7	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CK2OA	WOS:000356049000016		
J	Nakano, Y; Deguchi, K; Yamashita, T; Morihara, R; Matsuzono, K; Kawahara, Y; Sato, K; Kono, S; Hishikawa, N; Ohta, Y; Higashi, Y; Takao, Y; Abe, K				Nakano, Yumiko; Deguchi, Kentaro; Yamashita, Toru; Morihara, Ryuta; Matsuzono, Kosuke; Kawahara, Yuko; Sato, Kota; Kono, Syoichiro; Hishikawa, Nozomi; Ohta, Yasuyuki; Higashi, Yasuto; Takao, Yoshiki; Abe, Koji			High Incidence of Dementia Conversion than Stroke Recurrence in Poststroke Patients of Late Elder Society	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Poststroke dementia; stroke recurrence; vascular risk factors; secondary prevention; late elder society	COGNITIVE IMPAIRMENT; CEREBRAL MICROBLEEDS; ISCHEMIC-STROKE; RISK-FACTORS; DISEASE; PREVALENCE; TELMISARTAN; PREDICTORS; SURVIVORS; DECLINE	Background: This study investigated the incidence of current poststroke dementia (PSD), the annual conversion ratio into PSD, and the risk factors for conversion. Methods: In a 4.8-year follow-up period, 112 poststroke patients (ischemic stroke and intracerebral hemorrhage) were retrospectively investigated in cognitive examinations. They were categorized into 3 subgroups: converters into PSD, nonconverters who maintained their normal cognitive functions, and reverters who recovered to the normal mentality range. The clinical and demographic characteristics of these 3 subgroups were analyzed. Results: Among all 112 poststroke patients (61.6% male, 73.6 +/- 10.4 years old), 16.1% had PSD. During the follow-up period, a part of the normal baseline mentality group (83.9% of 112 original patients) newly developed PSD (subdivided into converters) with an annual conversion rate of 7.6%. The reversion rate from the baseline PSD group was 11.3%. There were significant differences in age (P < .05), baseline mini-mental state examination scores (P < .05), body mass index (P < .05), and periventricular and deep white matter hyperintensity grades (P < .05 and P - .01, respectively) between converters and nonconverters. The annual rate of stroke recurrence was only 2.2% in all stroke subtypes. Conclusions: In comparison with stroke recurrence (2.2%), 7.6% of the annual PSD conversion rate was very high. Therefore, prevention of direct conversion into PSD without stroke recurrence may be another important aspect of poststroke clinics, especially in late elder society. (C) 2015 by National Stroke Association	[Nakano, Yumiko; Deguchi, Kentaro; Yamashita, Toru; Morihara, Ryuta; Matsuzono, Kosuke; Kawahara, Yuko; Sato, Kota; Kono, Syoichiro; Hishikawa, Nozomi; Ohta, Yasuyuki; Abe, Koji] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Neurol, Okayama 7008558, Japan; [Higashi, Yasuto] Himeji Cent Hosp, Dept Neurol, Himeji, Hyogo, Japan; [Takao, Yoshiki] Kurashiki Heisei Hosp, Dept Neurol, Kurashiki, Okayama, Japan	Abe, K (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Neurol, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	yumikonakano@okayama-u.ac.jp			Ministry of Education, Science, Culture, and Sports of Japan [21390267]; Research Committee of CNS Degenerative Diseases; Ministry of Health, Labour and Welfare of Japan	This work was partly supported by a grant-in-aid for Scientific Research (B) from the Ministry of Education, Science, Culture, and Sports of Japan (21390267); grants-in aid from the Research Committee of CNS Degenerative Diseases (I. Nakano); and grants from the Ministry of Health, Labour and Welfare of Japan (H. Mizusawa, M. Nishizawa, H. Sasaki, and G. Sobue).	Allan LM, 2013, BRIT J PSYCHIAT, V203, P453, DOI 10.1192/bjp.bp.113.128355; Allan Louise M, 2011, Brain, V134, P3716, DOI 10.1093/brain/awr273; Altieri M, 2004, NEUROLOGY, V62, P2193; Hankey GJ, 2014, LANCET NEUROL, V13, P178, DOI 10.1016/S1474-4422(13)70255-2; Douiri A, 2013, STROKE, V44, P138, DOI 10.1161/STROKEAHA.112.670844; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; Elbaz A, 2013, NEUROLOGY, V81, P417, DOI 10.1212/WNL.0b013e31829d8761; Percy M, 2014, J ALZHEIMERS DIS, V38, P907, DOI 10.3233/JAD-131409; Pantoni L, 2010, LANCET NEUROL, V9, P689, DOI 10.1016/S1474-4422(10)70104-6; Sato K, 2014, J STROKE CEREBROVASC, V23, P2511, DOI 10.1016/j.jstrokecerebrovasdis.2014.02.019; Zekry D, 2003, NEUROBIOL AGING, V24, P213, DOI 10.1016/S0197-4580(02)00066-0; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351; Fazekas F, 1999, AM J NEURORADIOL, V20, P637; Jellinger KA, 2002, J NEURAL TRANSM, V109, P813, DOI 10.1007/s007020200068; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; Sahathevan R, 2012, INT J STROKE, V7, P61, DOI 10.1111/j.1747-4949.2011.00731.x; ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Jokinen H, 2009, CEREBROVASC DIS, V27, P384, DOI 10.1159/000207442; Ballard C, 2003, STROKE, V34, P2440, DOI 10.1161/01.STR.0000089923.29724.CE; Qiu C, 2010, NEUROLOGY, V75, P2221, DOI 10.1212/WNL.0b013e3182020349; Narasimhalu K, 2009, NEUROLOGY, V73, P1866, DOI 10.1212/WNL.0b013e3181c3fcb7; Shinohara Y, 2010, LANCET NEUROL, V9, P959, DOI 10.1016/S1474-4422(10)70198-8; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; Viswanathan A, 2011, ANN NEUROL, V70, P871, DOI 10.1002/ana.22516; Easton JD, 2012, LANCET NEUROL, V11, P503, DOI 10.1016/S1474-4422(12)70092-3; Pendlebury ST, 2009, LANCET NEUROL, V8, P1006, DOI 10.1016/S1474-4422(09)70236-4; Fukuuchi Y, 2008, CEREBROVASC DIS, V25, P40, DOI 10.1159/000111498; Werring DJ, 2004, BRAIN, V127, P2265, DOI 10.1093/brain/awh253; Jellinger KA, 2010, ACTA NEUROPATHOL, V119, P421, DOI 10.1007/s00401-010-0654-5; Brodaty H, 2013, J NEUROPSYCH CLIN N, V25, P283, DOI 10.1176/appi.neuropsych.12040080; Kliper E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105461; Kurata T, 2014, TRANSL STROKE RES, V6, P107; Moerland M, 2012, INT J VASC MED, V2012; Tokuchi R, 2014, J NEUROL SCI, V346, P288, DOI 10.1016/j.jns.2014.09.012; Yamashita T, 2014, J STROKE CEREBROVASC, V23, P2240, DOI 10.1016/j.jstrokecerebrovasdis.2014.04.010	35	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	JUL	2015	24	7					1621	1628		10.1016/j.jstrokecerebrovasdis.2015.03.037		8	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CK2OA	WOS:000356049000030		
J	Tanaka, K; Yamada, T; Torii, T; Furuta, K; Matsumoto, S; Yoshimura, T; Takase, KI; Wakata, Y; Nakashima, N; Kira, JI; Murai, H				Tanaka, Koji; Yamada, Takeshi; Torii, Takako; Furuta, Konosuke; Matsumoto, Shoji; Yoshimura, Takeo; Takase, Kei-Ichiro; Wakata, Yoshifumi; Nakashima, Naoki; Kira, Jun-Ichi; Murai, Hiroyuki			Pre-admission CHADS(2), CHA(2)DS(2)-VASc, and R(2)CHADS(2) Scores on Severity and Functional Outcome in Acute Ischemic Stroke with Atrial Fibrillation	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Ischemic stroke; risk score; atrial fibrillation; outcome; severity	HOSPITAL-BASED REGISTRY; CLINICAL-OUTCOMES; RENAL DYSFUNCTION; PREDICTING STROKE; COCKCROFT-GAULT; KIDNEY-FUNCTION; SEX-DIFFERENCES; ASSOCIATION; VALIDATION; PREVENTION	Background: We examined the association between pre-admission risk scores and severity on admission and functional outcome in acute ischemic stroke with atrial fibrillation (AF). Methods: Between September 2011 and April 2014, we retrospectively extracted consecutive ischemic stroke patients with AF whose pre-admission modified Rankin Scale (mRS) score was 2 or less from our prospective database. Pre-admission CHADS(2), CHA(2)DS2-VASc, and R(2)CHADS(2) scores were calculated in each patient, and their association with the National Institutes of Health Stroke Scale (NIHSS) score on admission or unfavorable outcome (mRS >= 3 at 3 months from the onset) was assessed. Results: A total of 344 patients (189 were men; age, 77.7 +/- 10.0 years) were included in the analysis. The median pre-admission CHADS(2), CHA(2)DS(2)-VASc, and R(2)CHADS(2) scores were 2, 4, and 4, respectively. NIHSS score on admission was positively correlated with pre-admission CHADS(2) (rho = .116, P = .031), CHA(2)DS(2)-VASc (rho = .166, P = .020), and R(2)CHADS(2) scores (rho = .106, P = .049). Receiver operating characteristic (ROC) curve analysis revealed that pre-admission CHADS(2) score of 2 or more (sensitivity, 80%; specificity, 45%; area under the ROC curve [AUC], .654), CHA(2)DS(2)-VASc score of 3 or more (sensitivity, 86%; specificity, 44%; AUC, .683), and R(2)CHADS(2) score of 4 or more (sensitivity, 61%; specificity, 62%; AUC, .657) were associated with unfavorable outcome. The pre-admission CHA(2)DS(2)-VASc score was better than the pre-admission CHADS(2) score in estimating unfavorable outcome (P = .017). In multivariate analysis, cutoffs of these scores, female sex, higher NIHSS score, and internal carotid artery occlusion were associated with unfavorable outcome. Conclusions: Pre-admission CHADS(2), CHA(2)DS(2)-VASc, and R(2)CHADS(2) scores were associated with onset severity and functional outcome in acute ischemic stroke with AF. (C) 2015 by National Stroke Association	[Tanaka, Koji; Torii, Takako; Furuta, Konosuke; Kira, Jun-Ichi; Murai, Hiroyuki] Kyushu Univ, Grad Sch Med Sci, Dept Neurol, Neurol Inst, Fukuoka 8128582, Japan; [Yamada, Takeshi] Saiseikai Fukuoka Gen Hosp, Dept Neurol, Fukuoka, Japan; [Furuta, Konosuke] Kokura Mem Hosp, Dept Neurol, Kitakyushu, Fukuoka, Japan; [Matsumoto, Shoji] Kokura Mem Hosp, Dept Neurosurg, Kitakyushu, Fukuoka, Japan; [Yoshimura, Takeo] Fukuoka City Hosp, Dept Neurol, Fukuoka, Japan; [Takase, Kei-Ichiro] Iizuka Hosp, Dept Neurol, Iizuka, Fukuoka, Japan; [Wakata, Yoshifumi; Nakashima, Naoki] Kyushu Univ Hosp, Med Informat Ctr, Fukuoka 812, Japan	Murai, H (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Neurol, Neurol Inst,Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	hmurai@neuro.med.kyushu-ac.jp					Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Poggio ED, 2005, AM J KIDNEY DIS, V46, P242, DOI 10.1053/j.ajkd.2005.04.023; Cirillo M, 2005, NEPHROL DIAL TRANSPL, V20, P1791, DOI 10.1093/ndt/gfh962; Yoo AJ, 2010, STROKE, V41, P1728, DOI 10.1161/STROKEAHA.110.582874; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Shinohara Y, 2011, J STROKE CEREBROVASC, V20, pS31, DOI 10.1016/j.jstrokecerebrovasdis.2011.05.004; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; MacWalter RS, 2002, STROKE, V33, P1630, DOI 10.1161/01.STR.0000016344.49819.F7; Kwakkel G, 2010, J NEUROL SCI, V294, P57, DOI 10.1016/j.jns.2010.04.004; Sato S, 2011, J NEUROL SCI, V307, P149, DOI 10.1016/j.jns.2011.04.018; Inoue H, 2013, CIRC J, V77, P2264, DOI 10.1253/circj.CJ-13-0290; Hong HJ, 2012, EUR J NEUROL, V19, P284, DOI 10.1111/j.1468-1331.2011.03518.x; Furie KL, 2012, STROKE, V43, P3442, DOI 10.1161/STR.0b013e318266722a; Wang D, 2014, EUR J NEUROL, V21, P160, DOI 10.1111/ene.12293; Henriksson KM, 2010, INT J CARDIOL, V141, P18, DOI 10.1016/j.ijcard.2008.11.122; Shinohara Y, 2011, J STROKE CEREBROVASC, V20, pS7, DOI 10.1016/j.jstrokecerebrovasdis.2011.05.003; Piccini JP, 2013, CIRCULATION, V127, P224, DOI 10.1161/CIRCULATIONAHA.112.107128; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Petty GW, 2000, STROKE, V31, P1062; Reeves MJ, 2008, LANCET NEUROL, V7, P915, DOI 10.1016/S1474-4422(08)70193-5; Arboix A, 2014, CLIN NEUROL NEUROSUR, V127, P19, DOI 10.1016/j.clineuro.2014.09.024; Deguchi I, 2013, J STROKE CEREBROVASC, V22, pE343, DOI 10.1016/j.jstrokecerebrovasdis.2013.02.018; Giralt-Steinhauer E, 2012, J NEUROL, V259, P745, DOI 10.1007/s00415-011-6259-7; Helou R, 2010, NEPHRON CLIN PRACT, V116, pC172, DOI 10.1159/000317197; Hoshino H, 2012, J STROKE CEREBROVASC, V21, P343, DOI 10.1016/j.jstrokecerebrovasdis.2010.08.011; Hoshino T, 2014, CIRC J, V78, P1481, DOI 10.1253/circj.CJ-14-0038; Inoue H, 2014, CIRC J, V78, P1997, DOI 10.1253/circj.CJ-66-0092; Koga M, 2011, J NEUROL SCI, V306, P49, DOI 10.1016/j.jns.2011.03.046; Lansberg MG, 2012, CHEST, V141, pe601S, DOI DOI 10.1378/CHEST.11-2302; National Kidney Foundation, 2002, AM J KIDNEY DIS S, V39, pS1, DOI DOI 10.1053/AJKD.2002.30571.PUBMED:11904577; Ottosen TP, 2014, DAN MED J, V61; Santalucia P, 2013, EUR J INTERN MED, V24, P167, DOI 10.1016/j.ejim.2012.10.004; Tu HTH, 2013, CEREBROVASC DIS, V36, P273, DOI 10.1159/000353670	33	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	JUL	2015	24	7					1629	1635		10.1016/j.jstrokecerebrovasdis.2015.03.036		7	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CK2OA	WOS:000356049000031		
J	Ohara, T; Uehara, T; Toyoda, K; Suzuki, R; Sato, S; Nagatsuka, K; Minematsu, K				Ohara, Tomoyuki; Uehara, Toshiyuki; Toyoda, Kazunori; Suzuki, Rieko; Sato, Shoichiro; Nagatsuka, Kazuyuki; Minematsu, Kazuo			Early Stroke Risk after Transient Ischemic Attack in Patients without Large-Artery Disease or Atrial Fibrillation	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Transient ischemic attack; stroke risk; small vessel disease; capsular warning syndrome; lacunar TIA	CAPSULAR WARNING SYNDROME; ABCD(2) SCORE; MINOR STROKE; RECURRENCE; ASSOCIATION; PREDICTORS; DIAGNOSIS; FEATURES; SUBTYPE; TIME	Background: Patients with transient ischemic attack (TIA) without large-artery disease (LAD) or atrial fibrillation (AF) on admission may be at higher risk of stroke than previously thought. The aim of this study was to investigate early stroke risk and its predictors in such patients. Methods: We studied 410 TIA patients admitted to our institute within 48 hours of onset. Urgent etiological workup revealed that 210 patients had neither symptomatic LAD nor AF. The outcome measure was the stroke occurrence within 7 days after admission. Results: Stroke occurred within 7 days in 15 patients, 7.1% of patients without LAD or AF and 6.5% of those with LAD or AF, showing no statistical difference between the 2 groups. Twelve of the 15 patients were diagnosed with small-vessel disease as the stroke etiology. In multivariable regression analysis, motor lacunar symptoms (odds ratio [OR], 5.7; 95% confidence interval [CI], 1.4-41.1), high systolic blood pressure on admission of 183 mm Hg or greater (OR, 15.3; 95% CI, 3.8-80.2), and positive diffusion-weighted imaging findings (OR, 6.1; 95% CI, 1.6-28.1) were independent predictors for the stroke occurrence within 7 days in patients without LAD or AF. Conclusions: TIA patients should be cautiously managed, even when neither LAD nor AF are identified by urgent workup. Clinical findings as motor lacunar symptom or high admission blood pressure, besides diffusion-weighted imaging findings, may be helpful to predict early stroke in such patients. (C) 2015 by National Stroke Association	[Ohara, Tomoyuki; Uehara, Toshiyuki; Toyoda, Kazunori; Suzuki, Rieko; Sato, Shoichiro; Minematsu, Kazuo] Natl Cerebral & Cardiovasc Ctr, Dept Cerebrovasc Med, Suita, Osaka 5658565, Japan; [Nagatsuka, Kazuyuki] Natl Cerebral & Cardiovasc Ctr, Dept Neurol, Suita, Osaka 5658565, Japan	Ohara, T (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Cerebrovasc Med, 5-7-1 Fujishirodai, Suita, Osaka 5658565, Japan.	ohar21@gmail.com	Toyoda, Kazunori/J-3828-2015	Toyoda, Kazunori/0000-0002-8346-9845	Intramural Research Fund for Cardiovascular Diseases of National Cerebral and Cardiovascular Center [H24-6-1]; Ministry of Health, Labor and Welfare, Japan [H24-Junkanki-Ippan-011]	This study was supported in part by an Intramural Research Fund (H24-6-1) for Cardiovascular Diseases of National Cerebral and Cardiovascular Center and Grants-in-Aid (H24-Junkanki-Ippan-011) from the Ministry of Health, Labor and Welfare, Japan.	Amarenco P, 2012, STROKE, V43, P863, DOI 10.1161/STROKEAHA.111.636506; Amarenco P, 2009, STROKE, V40, P3091, DOI 10.1161/STROKEAHA.109.552042; Lavallee PC, 2007, LANCET NEUROL, V6, P953, DOI 10.1016/S1474-4422(07)70248-X; Wang YJ, 2013, NEW ENGL J MED, V369, P11, DOI 10.1056/NEJMoa1215340; Lovett JK, 2004, NEUROLOGY, V62, P569; Johnston SC, 2007, LANCET, V369, P283, DOI 10.1016/S0140-6736(07)60150-0; Del Bene A, 2012, INT J STROKE, V7, P321, DOI 10.1111/j.1747-4949.2012.00789.x; Purroy F, 2007, STROKE, V38, P3225, DOI 10.1161/STROKEAHA.107.488833; Yamamoto Y, 2011, J NEUROL SCI, V304, P78, DOI 10.1016/j.jns.2011.02.006; Easton JD, 2009, STROKE, V40, P2276, DOI 10.1161/STROKEAHA.108.192218; UEHARA T, 1994, CEREBROVASC DIS, V4, P365, DOI 10.1159/000108509; Ois A, 2008, STROKE, V39, P1717, DOI 10.1161/STROKEAHA.107.505438; Merwick A, 2010, LANCET NEUROL, V9, P1060, DOI 10.1016/S1474-4422(10)70240-4; [Anonymous], 1990, STROKE, V21, P637; Kiyohara T, 2014, STROKE, V45, P418, DOI 10.1161/STROKEAHA.113.003077; Grant EG, 2003, RADIOLOGY, V229, P340, DOI 10.1148/radiol.2292030516; DONNAN GA, 1993, NEUROLOGY, V43, P957; Fujinami J, 2014, CEREBROVASC DIS, V37, P330, DOI 10.1159/000360757; HANKEY GJ, 1991, LANCET, V337, P335, DOI 10.1016/0140-6736(91)90953-M; Horer S, 2011, CEREBROVASC DIS, V32, P504, DOI 10.1159/000331919; Ohara Tomoyuki, 2011, Rinsho Shinkeigaku, V51, P406; Paul NLM, 2012, NEUROLOGY, V79, P1356, DOI 10.1212/WNL.0b013e31826c1af8; Poppe AY, 2008, STROKE, V39, pE108, DOI 10.1161/STROKEAHA.108.514034; Purroy F, 2012, CEREBROVASC DIS, V33, P182, DOI 10.1159/000334771; Sanders LM, 2011, MED J AUSTRALIA, V194, P135; Sanders LM, 2012, STROKE, V43, P2936, DOI 10.1161/STROKEAHA.112.664060	26	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	JUL	2015	24	7					1656	1661		10.1016/j.jstrokecerebrovasdis.2015.03.039		6	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CK2OA	WOS:000356049000035		
J	Anan, C; Oomura, M; Saeki, T; Ikeda, T; Sato, C; Yamada, K				Anan, Chise; Oomura, Masahiro; Saeki, Tomoaki; Ikeda, Toshimasa; Sato, Chikako; Yamada, Kentaro			Fatal Intraperitoneal Bleeding after Intravenous Administration of Tissue Plasminogen Activator	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Cerebral infarction; intraperitoneal hemorrhage; rt-PA; thrombolytic therapy	ISCHEMIC-STROKE; ALTEPLASE	We report a case of acute ischemic stroke, which developed fatal intraperitoneal bleeding after intravenous administration of alteplase. An 86-year-old woman developed acute infarction of the right middle cerebral artery during admission for chronic heart failure. Two days before the stroke, liver biopsy was performed; the result was benign. Although rivaroxaban was prescribed for atrial fibrillation, the rivaroxaban had been discontinued for liver biopsy until the time when she developed the stroke. A condition of recent biopsy required careful determination of eligibility of intravenous alteplase; however, we considered that the benefit of intravenous alteplase outweighed the hemorrhagic adverse effects. Alteplase (0.6 mg/kg) was started 2 hours after the stroke onset, however, no clinical improvement was obtained. One hour after the completion of alteplase, she suddenly developed a shock state. Emergent computed tomography disclosed massive intraperitoneal hemorrhage. She died 8 hours after the completion of alteplase. In the present case, mechanical thrombectomy without intravenous alteplase can be an alternative therapeutic option. (C) 2015 by National Stroke Association	[Anan, Chise; Oomura, Masahiro; Ikeda, Toshimasa; Sato, Chikako; Yamada, Kentaro] Nagoya City East Med Ctr, Dept Neurol, Nagoya, Aichi 4648547, Japan; [Saeki, Tomoaki] Nagoya City East Med Ctr, Dept Cardiol, Nagoya, Aichi 4648547, Japan	Anan, C (reprint author), Nagoya City East Med Ctr, Dept Neurol, Chikusa Ku, 1-2-23 Wakamizu, Nagoya, Aichi 4648547, Japan.	thingswillgomyway@yahoo.co.jp					Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Minematsu K, 2013, J STROKE CEREBROVASC, V22, P571, DOI 10.1016/j.jstrokecerebrovasdis.2013.04.001; Ismail A, 2000, Heart Dis, V2, P13; Nakashima T, 2009, INT J STROKE, V4, P425, DOI 10.1111/j.1747-4949.2009.00347.x; ROONGSRITONG C, 1994, INT J CARDIOL, V46, P182, DOI 10.1016/0167-5273(94)90042-6; Tandberg Askevold E, 2007, J STROKE CEREBROVASC, V16, P21	7	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	JUL	2015	24	7					E177	E178		10.1016/j.jstrokecerebrovasdis.2015.03.025		2	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CK2OA	WOS:000356049000004		
J	Kurokawa, T; Baba, Y; Fujino, K; Kuroiwa, Y; Tomita, Y; Nakane, M; Yamada, SM; Tanaka, F				Kurokawa, Takashi; Baba, Yasuhisa; Fujino, Kimihiro; Kuroiwa, Yoshiyuki; Tomita, Yusuke; Nakane, Makoto; Yamada, Shoko Merrit; Tanaka, Fumiaki			Vertebral Artery Dissection Leading to Fornix Infarction: A Case Report	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Vertebral artery dissection; fornix infarction; lateral posterior choroidal artery; cerebral embolism; posterior circulation; amnesia		Background: The subcallosal artery is a proximal branch of the anterior communicating artery and has been recognized as the vessel responsible for fornix infarction. Fornix infarction caused by vascular damage to the posterior circulation has not been reported previously. Results: A 26-year-old woman suffered from fornix infarction due to artery-to-artery embolism after vertebral artery dissection. Cerebral infarctions were also found in the left thalamus, body of the left caudate nucleus, and the left occipital lobe other than the fornix. Conclusions: Occlusion of the subcallosal artery results in cerebral infarction of fornix, anterior cingulate cortex, and genu of the corpus callosum. However, in our case, lesions were restricted to the territory of posterior circulation. In addition to subcallosal artery, lateral posterior choroidal artery, a perforating branch of the posterior cerebral artery, has been described to send branches to the fornix, so we speculated that the left lateral posterior choroidal artery was actually responsible for fornix infarction. (C) 2015 by National Stroke Association	[Kurokawa, Takashi; Baba, Yasuhisa; Fujino, Kimihiro; Kuroiwa, Yoshiyuki] Teikyo Univ, Univ Hosp Mizonokuchi, Sch Med, Dept Neurol, Kawasaki, Kanagawa 2138507, Japan; [Kuroiwa, Yoshiyuki] Minist Finance, Med Off, Tokyo, Japan; [Kuroiwa, Yoshiyuki] Tokyo Metropolitan Inst Med Sci, Tokyo 113, Japan; [Tomita, Yusuke; Nakane, Makoto; Yamada, Shoko Merrit] Teikyo Univ, Univ Hosp Mizonokuchi, Sch Med, Dept Neurosurg, Kawasaki, Kanagawa 2138507, Japan; [Tanaka, Fumiaki] Yokohama City Univ, Grad Sch Med, Dept Neurol & Stroke Med, Yokohama, Kanagawa 232, Japan	Kurokawa, T (reprint author), Teikyo Univ, Univ Hosp Mizonokuchi, Sch Med, Dept Neurol,Takatsu Ku, 3-8-3 Mizonokuchi, Kawasaki, Kanagawa 2138507, Japan.	tkurokawa2006@yahoo.co.jp					Moudgil SS, 2000, STROKE, V31, P1418; Ture U, 1996, NEUROSURGERY, V39, P1075; Margolis MT, 1974, RADIOLOGY SKULL BRAI, VII, P1551; Renou P, 2008, ARCH NEUROL-CHICAGO, V65, P1252, DOI 10.1001/archneur.65.9.1252; ROTHER J, 1993, STROKE, V24, P1310; Saito Yuko, 2006, J Stroke Cerebrovasc Dis, V15, P176, DOI 10.1016/j.jstrokecerebrovasdis.2006.04.004; Stephens RB, 1969, ARTERIES VEINS HUMAN, P96; TAKAHASHI S, 1985, RADIOLOGY, V155, P119; Tay KY, 2005, EUR RADIOL, V15, P1329, DOI 10.1007/s00330-005-2679-z	9	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	JUL	2015	24	7					E169	E172		10.1016/j.jstrokecerebrovasdis.2015.03.030		4	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CK2OA	WOS:000356049000002		
J	Sakata, H; Fujimura, M; Mugikura, S; Sato, K; Tominaga, T				Sakata, Hiroyuki; Fujimura, Miki; Mugikura, Shunji; Sato, Kenichi; Tominaga, Teiji			Local Vasogenic Edema without Cerebral Hyperperfusion after Direct Revascularization Surgery for Moyamoya Disease	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Moyamoya disease; vasogenic edema; reperfusion; cerebral hyperperfusion; extracranial-intracranial bypass	SUPERFICIAL TEMPORAL ARTERY; EXTRACRANIAL-INTRACRANIAL BYPASS; NEUROLOGICAL DETERIORATION; BRAIN; ANASTOMOSIS; MINOCYCLINE; HEMORRHAGE	Superficial temporal artery-middle cerebral artery anastomosis is generally used as the standard surgical treatment for moyamoya disease to prevent cerebral ischemic attacks. Although the main potential complications associated with this treatment are cerebral hyperperfusion and ischemia, the adverse impacts of revascularization surgery remain unclear. Of the 142 consecutive surgeries for moyamoya disease at our hospital from 2008, we herein presented 2 cases of adult-onset moyamoya disease that manifested local vasogenic edema at the site of anastomosis without cerebral hyperperfusion; 1 in a 31-year-old woman presented with transient ischemic attack and the other in a 22-year-old man manifested as minor completed stroke. Both patients underwent superficial temporal artery-middle cerebral artery anastomosis, resulting in the formation of a reversible high-signal-intensity lesion at the site of anastomosis on T2-weighted images along with an increase in apparent diffusion coefficient values, whereas diffusion-weighted images showed no changes. Neither hyperperfusion nor hypoperfusion, as assessed by single-photon emission computed tomography with N-isopropyl[123I]-p-iodoamphetamine, was observed postoperatively. In light of the increased risk of the further progression of vasogenic edema to intracerebral hemorrhage, these patients were treated with prophylactic blood pressure lowering and the intravenous infusion of a free radical scavenger. They did not have any further cerebrovascular events during the follow-up period. Regional vasogenic edema without cerebral hyperperfusion, possibly due to cerebral ischemia/reperfusion injury, may be another novel entity that needs to be considered as a potential complication after extracranial-intracranial bypass for moyamoya disease. Strict postoperative management should be used to avoid hemorrhagic transformation. (C) 2015 by National Stroke Association	[Sakata, Hiroyuki; Fujimura, Miki; Sato, Kenichi; Tominaga, Teiji] Tohoku Univ, Grad Sch Med, Dept Neurosurg, Sendai, Miyagi 9808574, Japan; [Mugikura, Shunji] Tohoku Univ, Grad Sch Med, Dept Radiol, Sendai, Miyagi 9808574, Japan	Fujimura, M (reprint author), Tohoku Univ, Grad Sch Med, Dept Neurosurg, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	fujimur@nsg.med.tohoku.ac.jp					SUZUKI J, 1969, ARCH NEUROL-CHICAGO, V20, P288; Kang HS, 2010, J NEUROL NEUROSUR PS, V81, P673, DOI 10.1136/jnnp.2009.191817; Maier CM, 2006, ANN NEUROL, V59, P929, DOI 10.1002/ana.20850; Kuroda S, 2008, LANCET NEUROL, V7, P1056, DOI 10.1016/S1474-4422(08)70240-0; Chan PH, 1996, STROKE, V27, P1124; Fujimura M, 2007, SURG NEUROL, V67, P273, DOI 10.1016/j.surneu.2006.07.017; Fujimura M, 2012, CEREBROVASC DIS, V33, P436, DOI 10.1159/000336765; Yong VW, 2004, LANCET NEUROL, V3, P744, DOI 10.1016/S1474-4422(04)00937-8; Takagi Y, 2007, NEUROL MED-CHIR, V47, P1, DOI 10.2176/nmc.47.1; Nag S, 2009, ACTA NEUROPATHOL, V118, P197, DOI 10.1007/s00401-009-0541-0; Otomo E, 2003, CEREBROVASC DIS, V15, P222, DOI 10.1159/000069318; Fujimura M, 2011, NEUROSURGERY, V68, P957, DOI 10.1227/NEU.0b013e318208f1da; Fujimura M, 2014, NEUROSURGERY, V74, P163, DOI 10.1227/NEU.0000000000000238; Fujimura M, 2009, SURG NEUROL, V71, P223, DOI 10.1016/j.surneu.2007.07.077; Hayashi T, 2010, J NEUROSURG-PEDIATR, V6, P73, DOI 10.3171/2010.4.PEDS09478; Hong KS, 2004, SEIZURE-EUR J EPILEP, V13, P317, DOI 10.1016/j.seizure.2003.08.004; Kai Y, 2003, AM J NEURORADIOL, V24, P619; Karapanayiotides T, 2005, STROKE, V36, P21, DOI 10.1161/01.STR.0000149946.86087.e5; Kokuzawa J, 2010, NEUROL MED-CHIR, V50, P250; Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis, 2012, NEUROL MED CHIR TOKY, V52, P245	20	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	JUL	2015	24	7					E179	E184		10.1016/j.jstrokecerebrovasdis.2015.03.050		6	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CK2OA	WOS:000356049000005		
J	Seki, M; Shibata, M; Itoh, Y; Suzuki, N				Seki, Morinobu; Shibata, Mamoru; Itoh, Yoshiaki; Suzuki, Norihiro			Intracerebral Hemorrhage due to Venous Thrombosis of Developmental Venous Anomaly during Pregnancy	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Developmental venous anomaly; venous thrombosis; pregnancy; hemorrhage	MALFORMATIONS	Background: Nowadays, developmental venous anomaly (DVA) is recognized as the most common cerebral vascular malformation. Most DVAs are diagnosed incidentally on routine brain imaging, but they are occasionally symptomatic. We report the case of a 26-year-old Japanese woman with intracerebral hemorrhage due to venous thrombosis of DVA. Methods: We examined her neurologic examinations carefully. We also observed her laboratory data, brain computed tomography (CT), and magnetic resonance imaging (MRI) findings. Results: She was 8 weeks pregnant and suffered from nausea, vomiturition, and appetite loss because of hyperemesis gravidarum. She presented with a sudden generalized seizure and was referred to our hospital. Brain CT showed a small hemorrhage and a tubular high-density structure compatible with an acutely thrombosed collecting vein in the right frontal lobe. T2*-weighted MRI also revealed a thrombosed collecting vein along with multiple medullary veins, which looked like caput medusa. She was diagnosed with an intracerebral hemorrhage and symptomatic epilepsy secondary to thrombosis of the DVA. After the acute phase of the disease, systemic anticoagulation therapy was administered to the patient to prevent the recurrence of venous thrombosis. We suspected that hyperemesis gravidarum with intravascular dehydration might have increased the risk of thrombosis in this patient. Conclusions: Thrombosis of the collecting vein of DVA is extremely rare. This is the first report regarding DVA thrombosis during pregnancy, to our knowledge. (C) 2015 by National Stroke Association	[Seki, Morinobu; Shibata, Mamoru; Itoh, Yoshiaki; Suzuki, Norihiro] Keio Univ, Sch Med, Dept Neurol, Tokyo 1608582, Japan	Seki, M (reprint author), Keio Univ, Sch Med, Dept Neurol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	sekimori709@gmail.com	Shibata, Mamoru/L-8537-2013; Suzuki, Norihiro/J-5125-2013	Shibata, Mamoru/0000-0002-2416-4259; 			Abarca-Olivas J, 2009, NEUROCIRUGIA, V20, P265; Ruiz DS, 2009, ANN NEUROL, V66, P271, DOI 10.1002/ana.21754; Huber G, 1996, EUR RADIOL, V6, P30, DOI 10.1007/BF00619949; McLaughlin MR, 1998, NEUROSURGERY, V43, P195, DOI 10.1097/00006123-199808000-00001; Hammoud D, 2002, J COMPUT ASSIST TOMO, V26, P633, DOI 10.1097/01.RCT.0000028230.30636.33; SARWAR M, 1978, ARCH NEUROL-CHICAGO, V35, P323; Sepelyak K, 2010, ARCH NEUROL-CHICAGO, V67, P1028, DOI 10.1001/archneurol.2010.176; Thobois S, 1999, REV NEUROL, V155, P48; Yamamoto M, 1989, Neurol Med Chir (Tokyo), V29, P1044, DOI 10.2176/nmc.29.1044	9	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	JUL	2015	24	7					E185	E187		10.1016/j.jstrokecerebrovasdis.2015.03.035		3	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CK2OA	WOS:000356049000006		
J	Kawase, T; Kagawa-Ohara, M; Aisaka, T; Oida, T				Kawase, Tokuzo; Kagawa-Ohara, Maiko; Aisaka, Tsunetomo; Oida, Tatsuo			Synthesis of Succinic Gemini Surfactants and the Effect of Stereochemistry on Their Monolayer Behaviors	JOURNAL OF SURFACTANTS AND DETERGENTS			English	Article						Succinic Gemini; Stereochemistry; Monolayer; Surface pressure-area isotherm; Brewster angle microscope; Compression modulus of monolayer; Jumping-up phenomena	AIR-WATER-INTERFACE; DIASTEREOMERIC 2-CHAIN SURFACTANTS; SPACER STEREOCHEMISTRY; AGGREGATION PROPERTIES; ACID; VESICLES	In this work, succinic gemini surfactants, dl- and meso-2,3-bis(alkyl)succinic acids (alkyl: C6H13-C13H27), were successfully synthesized by oxidative coupling of enolates of fatty acid tert-butyl esters with copper(II) bromide followed by treatment with CF3COOH. Focusing on the influence of stereochemistry (dl- and meso-) of succinic geminis, their monolayer behaviors at the air-water interface were explored using surface pressure-area (I -A) isotherms, the compression modulus of monolayers (epsilon (s)), and Brewster angle microscope (BAM) analysis. meso-2,3-Bis(undecyl)succinic acid showed a unique isotherm where the surface pressure drastically decreased at A = similar to 0.56 nm(2) (I = 21.9 mN m(-1)) regardless of compression rates and subphase temperatures, while dl-isomer showed the common isotherm of gas -> liquid-expanded -> liquid-condensed phase transitions. BAM analysis on meso-2,3-bis(undecyl)succinic acid films at the air-water interface showed that small islands of aggregates appear just after the maximum pressure (A = similar to 0.56 nm(2)), and on further compression needle-shaped assemblies appear that can grow in size. It was reasonably concluded that hydrophobic interactions can operate more effectively in meso-isomers than in dl-isomers, and that meso-molecules can "jump up" to cause a transition from monolayer to bilayer. This is the first finding of the "jumping-up" phenomenon of gemini surfactants having meso-stereochemistry.	[Kawase, Tokuzo; Kagawa-Ohara, Maiko; Aisaka, Tsunetomo; Oida, Tatsuo] Kyoto Inst Technol, Dept Chem & Mat Technol, Sakyo Ku, Kyoto 6068585, Japan	Kawase, T (reprint author), Kyoto Inst Technol, Dept Chem & Mat Technol, Sakyo Ku, Hashigamicho 1, Kyoto 6068585, Japan.	kawase@kit.ac.jp; m-kagawa@iml.chem.kit.ac.jp; t-aisaka@iml.chem.kit.ac.jp; t-oida@iml.chem.kit.ac.jp					Aisaka Tsunetomo, 2007, J Oleo Sci, V56, P633; Andres JM, 2001, TETRAHEDRON, V57, P8521, DOI 10.1016/S0040-4020(01)00804-3; KAJIYAMA T, 1989, CHEM LETT, P1047, DOI 10.1246/cl.1989.1047; Shankar BV, 2007, J PHYS CHEM B, V111, P11419, DOI 10.1021/jp074279i; Shankar BV, 2007, J PHYS CHEM B, V111, P9294, DOI 10.1021/jp073275a; Hait SK, 2002, CURR SCI INDIA, V82, P1101; Menger FM, 2001, J AM CHEM SOC, V123, P875, DOI 10.1021/ja0033178; Kumar N, 2014, J DISPER SCI TECHNOL, V35, P205, DOI 10.1080/01932691.2013.780243; Kawase T, 2011, J OLEO SCI, V60, P61, DOI 10.5650/jos.60.61; Zana R, 2002, ADV COLLOID INTERFAC, V97, P205, DOI 10.1016/S0001-8686(01)00069-0; Bello C, 2006, LANGMUIR, V22, P9333, DOI 10.1021/la061230f; MENGER FM, 1991, J AM CHEM SOC, V113, P1451, DOI 10.1021/ja00004a077; Pinazo A, 2011, IND ENG CHEM RES, V50, P4805, DOI 10.1021/ie1014348; Shankar BV, 2008, SOFT MATTER, V4, P1713, DOI 10.1039/b802425a; Buijnsters PJJA, 2002, EUR J ORG CHEM, P1397; Caracciolo G, 2007, LANGMUIR, V23, P10040, DOI 10.1021/la7014995; Franses E. I., 2004, GEMINI SURFACTANTS S, V117, P65, DOI DOI 10.1201/9780203913093; Hana Y, 2011, PHYS CHEM CHEM PHYS, V13, P1939, DOI [10.1039/c0cp01196g, DOI 10.1039/C0CP01196G]; HARVEY N, 1988, J AM CHEM SOC, V110, P4395, DOI 10.1021/ja00221a046; KAJIYAMA T, 1992, B CHEM SOC JPN, V65, P864, DOI 10.1246/bcsj.65.864; Kawase T, 2013, J OLEO SCI, V62, P371, DOI 10.5650/jos.62.371; Liang YQ, 2014, J SURFACTANTS DETERG, V17, P693, DOI 10.1007/s11743-013-1541-6; Luchetti L, 2000, LANGMUIR, V16, P161, DOI 10.1021/la990713z; Menger F. M., 2000, ANGEW CHEM INT EDIT, V39, P1906, DOI DOI 10.1002/1521-3773; Moran C, 2010, SURFACTANTS RENEWABL, DOI 10.1002/9780470686607.ch5; Nakanishi F, 1990, SEN IGAKKAISHI, V46, P409, DOI 10.2115/fiber.46.9_409; Neimert-Andersson K, 2004, J ORG CHEM, V69, P3746, DOI 10.1021/jo0357566; Pestman JM, 1997, LANGMUIR, V13, P6857, DOI 10.1021/la970681k; PORTER NA, 1988, J AM CHEM SOC, V110, P1896, DOI 10.1021/ja00214a038; Quermann R, 1993, LIEBIGS ANN CHEM, V1993, P1219, DOI [10.1002/jlac.19931991011977, DOI 10.1002/JLAC.19931991011977]; Ryhanen SJ, 2002, J PHYS CHEM B, V106, P11694, DOI 10.1021/jp015623t; Silva SG, 2012, EUR J ORG CHEM, P345, DOI 10.1002/ejoc.201101118; Sommerdijk NAJM, 1997, J AM CHEM SOC, V119, P4338, DOI 10.1021/ja962303s; Sugiyasu K, 2002, CHEM COMMUN, P1212, DOI 10.1039/b202799m; Tyagi P, 2009, TENSIDE SURFACT DET, V46, P373; Zana R, 2004, SURFACTANT SCI SERIE, V117, DOI [10.1201/9780203913093, DOI 10.1201/9780203913093]; Zhu Y-P, 2004, SURFACTANT SCI SERIE, V117, P281, DOI [10.1201/9780203913093, DOI 10.1201/9780203913093]; Zoubir E-H, 2010, NEW J CHEM, V34, P260, DOI [10.1039/B9NJ00282K, DOI 10.1039/B9NJ00282K]	38	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1097-3958	1558-9293		J SURFACTANTS DETERG	J. Surfactants Deterg.	JUL	2015	18	4					615	627		10.1007/s11743-015-1682-x		13	Chemistry, Applied; Chemistry, Physical; Engineering, Chemical	Chemistry; Engineering	CK4BR	WOS:000356164100007		
J	Mrowietz, U; Leonardi, CL; Girolomoni, G; Toth, D; Morita, A; Balki, SA; Szepietowski, JC; Regnault, P; Thurston, H; Papavassilis, C				Mrowietz, Ulrich; Leonardi, Craig L.; Girolomoni, Giampiero; Toth, Darryl; Morita, Akimichi; Balki, Shyamal A.; Szepietowski, Jacek C.; Regnault, Pascaline; Thurston, Helen; Papavassilis, Charis		SCULPTURE Study Grp	Secukinumab retreatment-as-needed versus fixed-interval maintenance regimen for moderate to severe plaque psoriasis: A randomized, double-blind, noninferiority trial (SCULPTURE)	JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY			English	Article						clinical trial; dosing; immunogenicity; noninferiority; psoriasis; retreatment as needed; secukinumab	THERAPY; EFFICACY; SAFETY; IMMUNOGENICITY; ADALIMUMAB	Background: Secukinumab has demonstrated high, sustained efficacy in psoriasis to 52 weeks on a fixed-interval regimen. Objective: We sought to compare a retreatment-as-needed versus a fixed-interval regimen. Methods: In this double-blind study, adults with moderate to severe plaque psoriasis were randomized 1: 1 to subcutaneous secukinumab at 300 mg (n = 484) or 150 mg (n = 482) weekly from baseline until week 4, and at week 8. At week 12, patients achieving 75% or more improvement from baseline Psoriasis Area and Severity Index score (PASI 75) were rerandomized to 2 dose levels of secukinumab retreatment as needed (n = 217, 300 mg; n = 206, 150 mg) or fixed interval (n = 217; n = 203). Primary end point was noninferiority of retreatment as needed versus fixed interval for maintaining PASI 75 to week 52. Results: Secukinumab induced high responses by week 12 (84.4%-91.1% PASI 75 responders). From week 12 to week 52, more patients on fixed interval (78.2%, 300 mg; 62.1%, 150 mg) maintained PASI 75 versus retreatment as needed (67.7%; 52.4%); statistical noninferiority of retreatment as needed was not established. Overall safety, including very low incidences of treatment-emergent anti-drug antibodies (<0.5%), was similar between regimens. Limitations: The primary end point was developed without any known precedent. Conclusion: Secukinumab fixed interval showed clear benefit versus the study-specified retreatment-as-needed regimen for maintaining efficacy. Both regimens exhibited safety consistent with previous trials. The potential of retreatment as needed with secukinumab warrants further investigation.	[Mrowietz, Ulrich] Univ Med Ctr Schleswig Holstein, Psoriasis Ctr, Dept Dermatol, D-24105 Kiel, Germany; [Leonardi, Craig L.] St Louis Univ, Sch Med, St Louis, MO USA; [Girolomoni, Giampiero] Univ Verona, Dept Med, Sect Dermatol & Venereol, I-37100 Verona, Italy; [Toth, Darryl] XLR8 Med Res, Windsor, ON, Canada; [Morita, Akimichi] Nagoya City Univ, Grad Sch Med Sci, Dept Geriatr & Environm Dermatol, Nagoya, Aichi, Japan; [Balki, Shyamal A.] Shree Hosp & Crit Care Ctr, Nagpur, Maharashtra, India; [Szepietowski, Jacek C.] Wroclaw Med Univ, Dept Dermatol Venereol & Allergol, Wroclaw, Poland; [Regnault, Pascaline; Thurston, Helen; Papavassilis, Charis] Novartis Pharma AG, Basel, Switzerland	Mrowietz, U (reprint author), Univ Med Ctr Schleswig Holstein, Psoriasis Ctr, Dept Dermatol, Campus Kiel,Schittenhelmstr 7, D-24105 Kiel, Germany.	umrowietz@dermatology.uni-kiel.de			Novartis Pharmaceuticals	Study funded by Novartis Pharmaceuticals. It was designed by the scientific steering committee and Novartis personnel. Investigators collected data, Novartis conducted data analyses, and all authors had access to data. The initial draft of the manuscript was written by a medical writer compensated by Novartis. All authors had final responsibility for the decision to submit for publication.	Garces S, 2013, ANN RHEUM DIS, V72, P1947, DOI 10.1136/annrheumdis-2012-202220; Menting SP, 2014, JAMA DERMATOL, V150, P130, DOI 10.1001/jamadermatol.2013.8347; Rich P, 2013, BRIT J DERMATOL, V168, P402, DOI 10.1111/bjd.12112; Moore A, 2007, J AM ACAD DERMATOL, V56, P598, DOI 10.1016/j.jaad.2006.09.002; Langley RG, 2014, NEW ENGL J MED, V371, P326, DOI 10.1056/NEJMoa1314258; Langley RGB, 2015, J DERMATOL TREAT, V26, P23, DOI 10.3109/09546634.2013.865009; FINLAY AY, 1994, CLIN EXP DERMATOL, V19, P210, DOI 10.1111/j.1365-2230.1994.tb01167.x; Papp K, 2011, BRIT J DERMATOL, V164, P434, DOI 10.1111/j.1365-2133.2010.10139.x; Papp KA, 2013, BRIT J DERMATOL, V168, P412, DOI 10.1111/bjd.12110; Reich K, 2013, BRIT J DERMATOL, V168, P1325, DOI 10.1111/bjd.12404; Hueber W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001107; Klein U, 2013, J INVEST DERMATOL, V133, pS172; Menter A, 2007, J AM ACAD DERMATOL, V56; Senn S, 2008, SAS METAANALYSIS MAC; Thaci D, 2015, BRIT J DERMATOL, DOI [10.1111/bjd.13814, DOI 10.1111/BJD.13814]	15	3	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0190-9622			J AM ACAD DERMATOL	J. Am. Acad. Dermatol.	JUL	2015	73	1					27	U109		10.1016/j.jaad.2015.04.011		11	Dermatology	Dermatology	CK6BZ	WOS:000356314100021		
J	Ohata, C; Ishii, N; Koga, H; Fukuda, S; Tateishi, C; Tsuruta, D; Furumura, M; Hashimoto, T				Ohata, Chika; Ishii, Norito; Koga, Hiroshi; Fukuda, Shunpei; Tateishi, Chiharu; Tsuruta, Daisuke; Furumura, Minao; Hashimoto, Takashi			Coexistence of autoimmune bullous diseases (AIBDs) and psoriasis: A series of 145 cases	JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY			English	Article						anti-laminin gamma 1 (p200) pemphigoid; autoimmune bullous disease; bullous pemphigoid; psoriasis; psoriasis vulgaris; pustular psoriasis	SUBEPIDERMAL BLISTERING DISEASE; LASER-SCANNING MICROSCOPY; SKIN; AUTOANTIBODIES	Background: Many case reports have described the coexistence of autoimmune bullous diseases (AIBDs) and psoriasis. Among them, anti-laminin gamma 1 (p200) pemphigoid is the best known. Objectives: We sought to characterize patients with AIBDs and psoriasis and to investigate common AIBDs occurring in these patients. Methods: This retrospective study included 145 patients with coexisting AIBD and psoriasis given a diagnosis from January 1, 1996, to July 31, 2013, at an academic dermatology department. Of these, 134 were consultation cases regarding AIBD diagnosis. Results: Ratio of male to female patients was 5.7:1. Psoriasis onset preceded AIBD onset in most patients. Mean age at AIBD onset was 65.4 years, and mean duration between psoriasis and AIBD onset was 14.6 years. Most cases had single AIBD, whereas 16 cases had combined AIBDs. Bullous pemphigoid was the most prevalent (63.4%) followed by anti-laminin gamma 1 pemphigoid (37.2%). Limitations: Consultation cases may not have included mild AIBD cases. Conclusion: This study confirmed the association of psoriasis and anti-laminin g1 pemphigoid. However, because bullous pemphigoid is a much more common disease, it is seen more frequently in patients with psoriasis than anti-laminin gamma 1 pemphigoid.	[Ohata, Chika; Ishii, Norito; Koga, Hiroshi; Fukuda, Shunpei; Furumura, Minao; Hashimoto, Takashi] Kurume Univ, Sch Med, Dept Dermatol, Kurume, Fukuoka 8300011, Japan; [Ohata, Chika; Ishii, Norito; Koga, Hiroshi; Fukuda, Shunpei; Furumura, Minao; Hashimoto, Takashi] Kurume Univ, Inst Cutaneous Cell Biol, Kurume, Fukuoka 8300011, Japan; [Tateishi, Chiharu; Tsuruta, Daisuke] Osaka City Univ, Grad Sch Medicine, Osaka 558, Japan	Hashimoto, T (reprint author), Kurume Univ, Sch Med, Dept Dermatol, 67 Asahimachi, Kurume, Fukuoka 8300011, Japan.	hashimot@med.kurume-u.ac.jp	Ohata, Chika/F-3277-2015	Ohata, Chika/0000-0001-8341-7300	Supported Program for the Strategic Research Foundation at Private Universities from the Ministry of Education, Culture, Sports, Science, and Technology; Ministry of Health, Labor, and Welfare [H23-028, H24-038]; Kaibara Morikazu Medical Science Promotion Foundation; Ishibashi Foundation; Kanae Foundation for the Promotion of Medical Science; Takeda Science Foundation; Chuo Mitsui Trust and Banking Company Ltd; Nakatomi Foundation;  [20390308];  [20591331];  [21659271];  [23591634];  [23791298];  [23791299];  [23791300];  [23791301];  [24659534];  [24591672];  [24591640];  [24791185]	Supported by Grants-in-Aid for Scientific Research (No. 20390308, 20591331, 21659271, 23591634, 23791298, 23791299, 23791300, 23791301, 24659534, 24591672, 24591640, 24791185), and Supported Program for the Strategic Research Foundation at Private Universities 2011-2015 from the Ministry of Education, Culture, Sports, Science, and Technology; and by Research on Measures for Intractable Diseases Project: matching fund subsidy (H23-028 to K. Iwatsuki, and H24-038 to T. Hashimoto) from the Ministry of Health, Labor, and Welfare. The study was also supported by grants from the Kaibara Morikazu Medical Science Promotion Foundation, Ishibashi Foundation, Kanae Foundation for the Promotion of Medical Science, Takeda Science Foundation, Chuo Mitsui Trust and Banking Company Ltd, and Nakatomi Foundation.	Dainichi T, 2009, P NATL ACAD SCI USA, V106, P2800, DOI 10.1073/pnas.0809230106; Ameglio F, 1998, BRIT J DERMATOL, V138, P611; Mondello MR, 1996, ARCH DERMATOL RES, V288, P527; Bickle KM, 2002, AM FAM PHYSICIAN, V65, P1861; Nevitt GJ, 1996, BRIT J DERMATOL, V135, P533, DOI 10.1111/j.1365-2133.1996.tb03826.x; Chen YJ, 2011, BRIT J DERMATOL, V165, P593, DOI 10.1111/j.1365-2133.2011.10386.x; Goletz S, 2014, J AM ACAD DERMATOL, V71, P185, DOI 10.1016/j.jaad.2014.02.036; Dilling A, 2007, J DERMATOL, V34, P1, DOI 10.1111/j.1346-8138.2007.00208.x; Parisi R, 2013, J INVEST DERMATOL, V133, P377, DOI 10.1038/jid.2012.339; Vaccaro M, 2002, BRIT J DERMATOL, V146, P392, DOI 10.1046/j.1365-2133.2002.04637.x; Bloom D, 1929, MED J REC, V130, P246; Bloom D, 1929, ARCH DERMATOL, V20, P254; GRATTAN CEH, 1985, BRIT J DERMATOL, V113, P281, DOI 10.1111/j.1365-2133.1985.tb02079.x; Iino Y, 2014, J EUR ACAD DERMATOL, DOI [10.1111/jdv.12521, DOI 10.1111/JDV.12521]; Kawahara Y, 2000, J DERMATOL SCI, V23, P93, DOI 10.1016/S0923-1811(99)00093-6; McFadden JP, 2013, BRIT J DERMATOL, V169, P718, DOI 10.1111/bjd.12400; MURAMATSU T, 1994, ARCH DERMATOL RES, V286, P142, DOI 10.1007/BF00374209; Ohata C, 2013, EUR J DERMATOL, V23, P715, DOI 10.1684/ejd.2013.2138; Ohata C, 2012, EUR J DERMATOL, V22, P812, DOI 10.1684/ejd.2012.1858; Takahashi H, 2011, J DERMATOL, V38, P1125, DOI 10.1111/j.1346-8138.2010.01145.x; Washio H, 2005, ACTA DERM-VENEREOL, V85, P561, DOI 10.1080/00015550510035677; Wilczek A, 2006, INT J DERMATOL, V45, P1353, DOI 10.1111/j.1365-4632.2006.02861.x; Yano S, 2008, J CELL PHYSIOL, V214, P1, DOI 10.1002/jcp.21300; Zhang LM, 2013, EUR J DERMATOL, V23, P94, DOI 10.1684/ejd.2012.1906	24	2	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0190-9622			J AM ACAD DERMATOL	J. Am. Acad. Dermatol.	JUL	2015	73	1					50	55		10.1016/j.jaad.2015.03.016		6	Dermatology	Dermatology	CK6BZ	WOS:000356314100023		
J	Nakamura, K; Harada, A; Kanno, T; Inagaki, R; Niwano, Y; Milleding, P; Ortengren, U				Nakamura, K.; Harada, A.; Kanno, T.; Inagaki, R.; Niwano, Y.; Milleding, P.; Ortengren, U.			The influence of low-temperature degradation and cyclic loading on the fracture resistance of monolithic zirconia molar crowns	JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS			English	Article						Fracture resistance; Zirconia; Monolithic crowns; Low-temperature degradation; Cyclic loading; Monoclinic phase; Phase transformation	ALL-CERAMIC CROWNS; Y-TZP; LITHIUM DISILICATE; STRENGTH; FATIGUE; TRANSFORMATION; MASTICATION; SYSTEMS; FUTURE; FORCE	The present study analyzed the kinetics of low-temperature degradation (LTD) in zirconia, and evaluated the influence of LTD and cyclic loading on the fracture resistance of monolithic zirconia molar crowns. Bar-shaped zirconia specimens were divided into nine groups and autoclaved at 134 degrees C for 0-200 h to induce LTD. The surface fraction and penetration depth of the monoclinic phase were examined using X-ray diffraction and scanning electron microscopy. Monolithic zirconia molar crowns were prepared for crown fracture testing. The crowns were autoclaved for 0-100 h (n=6) and cemented to dies. Six crown-die samples that were not autoclaved and six samples that were autoclaved for 100 h were subjected to cyclic loading with a load of 300 N for 240,000 cycles. All samples were tested in a load-to-failure test. The monoclinic fraction on the surface increased with autoclaving time and reached a plateau after 50 h. The depth of the monoclinic phase increased without reaching a plateau. The fracture load of the crowns significantly decreased from 5683 N (SD: 342) to 3975 N (SD: 194) after 100 h of autoclaving. Cyclic loading did not significantly affect the fracture resistance of the crowns in all cases. Kinetic analysis showed no linear correlation between the surface fraction and depth of the monoclinic phase after 50 h of autoclaving. Even though LTD increased the monoclinic phase, resulting in lower strength, the fracture resistance of the monolithic zirconia crowns was still sufficient to withstand the loading conditions in the molar regions. (C) 2015 Elsevier Ltd. All rights reserved.	[Nakamura, K.; Milleding, P.; Ortengren, U.] Gothenburg Univ, Dept Prosthet Dent Dental Mat Sci, Fac Odontol, S-40530 Gothenburg, Sweden; [Nakamura, K.; Niwano, Y.] Tohoku Univ, Grad Sch Dent, Lab Redox Regulat, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Harada, A.; Kanno, T.] Tohoku Univ, Grad Sch Dent, Div Mol & Regenerat Prosthodont, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Inagaki, R.] Tohoku Univ, Sch Dent Lab Technicians, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Ortengren, U.] Arctic Univ Norway, Fac Hlth Sci, Dept Clin Dent, N-9037 Tromso, Norway	Nakamura, K (reprint author), Tohoku Univ, Grad Sch Dent, Lab Redox Regulat, Aoba Ku, 4-1 Seiryo, Sendai, Miyagi 9808575, Japan.	keisuke@m.tohoku.ac.jp			JSPS KAKENHI [25462981]	The authors would like to acknowledge 3W/ESPE for generously supplying the zirconia blocks and die materials. This research was supported by JSPS KAKENHI Grant-in-Aid for Scientific Research (C), 25462981, 2014. The authors declare no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.	Curtis AR, 2006, J DENT, V34, P195, DOI 10.1016/j.jdent.2005.06.006; Oilo M, 2013, DENT MATER, V29, P815, DOI 10.1016/j.dental.2013.04.026; Keuper M, 2013, ACTA BIOMATER, V9, P4826, DOI 10.1016/j.actbio.2012.08.032; Kohyama K, 2004, ARCH ORAL BIOL, V49, P805, DOI 10.1016/j.archoralbio.2004.04.006; Haraguchi K, 2001, J BONE JOINT SURG BR, V83B, P996, DOI 10.1302/0301-620X.83B7.12122; Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034; [Anonymous], 2013, E11213 ASTM INT; SCOTT HG, 1975, J MATER SCI, V10, P1527, DOI 10.1007/BF01031853; KELLY PM, 1986, J AM CERAM SOC, V69, P259, DOI 10.1111/j.1151-2916.1986.tb07421.x; Attia A, 2004, J PROSTHET DENT, V92, P551, DOI 10.1016/j.prosdent.2004.09.002; Chevalier J, 1999, J AM CERAM SOC, V82, P2150; Schindler HJ, 1998, J PROSTHET DENT, V80, P330, DOI 10.1016/S0022-3913(98)70134-9; GARVIE RC, 1975, NATURE, V258, P703, DOI 10.1038/258703a0; Denry I, 2008, DENT MATER, V24, P299, DOI 10.1016/j.dental.2007.05.007; Bindl A, 2006, DENT MATER, V22, P29, DOI 10.1016/j.dental.2005.02.007; Lorente MC, 2010, DENT MATER, V26, P1035, DOI 10.1016/j.dental.2010.06.005; Chevalier J, 2009, J AM CERAM SOC, V92, P1901, DOI 10.1111/j.1551-2916.2009.03278.x; Chevalier J, 2007, ANNU REV MATER RES, V37, P1, DOI 10.1146/annurev.matsci.37.052506.084250; Johansson C, 2014, ACTA ODONTOL SCAND, V72, P145, DOI 10.3109/00016357.2013.822098; [Anonymous], 2008, ISO13356; Lughi V, 2010, DENT MATER, V26, P807, DOI 10.1016/j.dental.2010.04.006; Stober T, 2014, J ORAL REHABIL, V41, P314, DOI 10.1111/joor.12139; van der Bilt A, 2011, J ORAL REHABIL, V38, P754, DOI 10.1111/j.1365-2842.2010.02197.x; GARVIE RC, 1972, J AM CERAM SOC, V55, P303, DOI 10.1111/j.1151-2916.1972.tb11290.x; Rosentritt M, 2000, INT J PROSTHODONT, V13, P387; Dehestani M, 2013, INT J APPL CERAM TEC, V10, P129, DOI 10.1111/j.1744-7402.2011.02717.x; Elshazly ES, 2011, J MATER SCI TECHNOL, V27, P332; Guess PC, 2010, INT J PROSTHODONT, V23, P434; Flinn BD, 2012, J PROSTHET DENT, V108, P223, DOI 10.1016/S0022-3913(12)60166-8; Pittayachawan P, 2007, DENT MATER, V23, P1018, DOI 10.1016/j.dental.2006.09.003; Cotes C., 2014, DENT MAT; Deville S., 2005, APPL BIOMATER B, V72B, P239; Kohorst P, 2008, ACTA BIOMATER, V4, P1440, DOI 10.1016/j.actbio.2008.04.012; Nakamura K., 2015, ACTA ODONTOL SCAND	34	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1751-6161	1878-0180		J MECH BEHAV BIOMED	J. Mech. Behav. Biomed. Mater.	JUL	2015	47						49	56		10.1016/j.jmbbm.2015.03.007		8	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	CK0IB	WOS:000355887800006		
J	Bae, J; Ida, Y; Sekine, K; Kawano, F; Hamada, K				Bae, Jiyoung; Ida, Yumika; Sekine, Kazumitsu; Kawano, Fumiaki; Hamada, Kenichi			Effects of high-energy ball-milling on injectability and strength of beta-tricalcium-phosphate cement	JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS			English	Article						beta-TCP; Self-setting; Hydroxyapatite; Compressive strength; Diametral tensile strength; Injectability; Planetary ball-milling	LIMITED INJECTABILITY; HYPODERMIC INJECTION; CALCIUM PHOSPHATES; IONIC MODIFICATION; SETTING REACTION; BONE CEMENTS; PART II; HYDROXYAPATITE; BIOCOMPATIBILITY; VISCOSITY	Calcium phosphate cement (CPC) offers many advantages as a bone-substitution material. The objective of this study is to develop a new CPC that simultaneously exhibits fine injectability, a short setting time, and high strength. beta-tricalcium phosphate (beta-TCP, control) powder was ball-milled for 24 h to produce a new cement powder. The modified beta-TCP after 24 h milling (m beta-TCP-24 h) exhibited excellent injectability even 1 h after mixing. The mechanical properties of the set cement (compact) were evaluated using compressive strength (CS) and diametral tensile strength (DTS) testing. The CS and DTS values of the mp-TCP-24 h compacts were 8.02 MPa and 2.62 MPa, respectively, at 5 h after mixing, and were 49.6 MPa and 7.9 MPa, respectively, at 2 weeks after mixing. All the CS and DTS values of the m beta-TCP-24 h compacts were significantly higher than those of the control for the same duration after mixing. These results suggest that the mechanochemically modified beta-TCP powder dissolves rapidly and accelerates hydroxyapatite precipitation, which successfully shortens the cement setting time and enhances the strength. This study supports that m beta-TCP-24 h is a promising candidate for use in injectable CPCs with improved strength. (C) 2015 Elsevier Ltd. All rights reserved.	[Bae, Jiyoung; Ida, Yumika; Sekine, Kazumitsu; Hamada, Kenichi] Univ Tokushima, Grad Sch, Inst Biomed Sci, Dept Biomat & Bioengn, Kuramoto, Tokushima 7708504, Japan; [Kawano, Fumiaki] Univ Tokushima, Grad Sch, Inst Biomed Sci, Dept Comprehens Dent, Kuramoto, Tokushima 7708504, Japan	Hamada, K (reprint author), Univ Tokushima, Grad Sch, Inst Biomed Sci, Dept Biomat & Bioengn, 3-18-15 Kuramoto, Kuramoto, Tokushima 7708504, Japan.	enchantee23@naver.com; c301251008@tokushima-u.ac.jp; ksekine@tokushima-u.ac.jp; fumiaki@tokushima-u.ac.jp; hamada.dent@tokushima-u.ac.jp			Japan Society for the Promotion of Science (JSPS, KAKENHI) [24592957]	This work was partially supported by the Japan Society for the Promotion of Science (JSPS, KAKENHI Grant number 24592957).	Alizadeh M, 2013, CERAM INT, V39, P3307, DOI 10.1016/j.ceramint.2012.10.019; Alshaaer M, 2013, ADV MATER SCI ENG, DOI 10.1155/2013/149261; Cardoso DA, 2012, J BIOMED MATER RES B, V100B, P2316, DOI 10.1002/jbm.b.32794; Baroud G, 2005, ACTA BIOMATER, V1, P357, DOI 10.1016/j.actbio.2005.01.003; Dorozhkin SV, 2010, BIOMATERIALS, V31, P1465, DOI 10.1016/j.biomaterials.2009.11.050; BROWN WE, 1983, J DENT RES, V62, P672; Habib M, 2010, ACTA BIOMATER, V6, P250, DOI 10.1016/j.actbio.2009.06.012; Bachari EM, 1999, THIN SOLID FILMS, V348, P165, DOI 10.1016/S0040-6090(99)00060-7; Dorozhkin SV, 2010, ACTA BIOMATER, V6, P4457, DOI 10.1016/j.actbio.2010.06.031; Zhang JT, 2014, ACTA BIOMATER, V10, P1035, DOI 10.1016/j.actbio.2013.11.001; Prudhommeaux F, 1996, ARTHRITIS RHEUM, V39, P1319, DOI 10.1002/art.1780390809; Ginebra MP, 2010, ACTA BIOMATER, V6, P2863, DOI 10.1016/j.actbio.2010.01.036; Barinov SM, 2011, INORG MATER+, V47, P1470, DOI 10.1134/S0020168511130024; Gbureck U, 2003, BIOMATERIALS, V24, P4123, DOI 10.1016/S0142-9612(03)00283-7; Guo H, 2009, ACTA BIOMATER, V5, P268, DOI 10.1016/j.actbio.2008.07.018; Barralet JE, 2004, BIOMATERIALS, V25, P2197, DOI 10.1016/j.biomaterials.2003.09.085; Theiss F, 2005, BIOMATERIALS, V26, P4383, DOI 10.1016/j.biomaterials.2004.11.056; Bohner M, 2005, BIOMATERIALS, V26, P6423, DOI 10.1016/j.biomaterials.2005.03.049; Bohner M, 2005, BIOMATERIALS, V26, P1553, DOI 10.1016/j.biomaterials.2004.05.010; BERMUDEZ O, 1994, J MATER SCI-MATER M, V5, P144, DOI 10.1007/BF00053334; BERMUDEZ O, 1994, J MATER SCI-MATER M, V5, P67, DOI 10.1007/BF00121693; Bigi A, 2004, BIOMATERIALS, V25, P2893, DOI 10.1016/j.biomaterials.2003.09.059; Bohner M, 2001, EUR SPINE J, V10, pS114, DOI 10.1007/s005860100276; Cheng H.C., 2013, INT J APPL CERAM TEC, V11, P364; Dorozhkin Sergey V, 2013, J Funct Biomater, V4, P209, DOI 10.3390/jfb4040209; Driessens FCM, 2002, BIOMATERIALS, V23, P4011, DOI 10.1016/S0142-9612(02)00151-5; Ehrlich H, 2005, Z ANORG ALLG CHEM, V631, P1825, DOI 10.1002/zaac.200500195; Fatimi A, 2012, J MATER SCI-MATER M, V23, P1593, DOI 10.1007/s10856-012-4640-4; Gbureck U, 2004, BIOMATERIALS, V25, P2187, DOI 10.1016/j.biomaterials.2003.08.066; Gbureck U, 2004, J AM CERAM SOC, V87, P1126; Grover LM, 2013, BIOMATERIALS, V34, P6631, DOI 10.1016/j.biomaterials.2013.05.001; GRUNINGER SE, 1984, J DENT RES, V63, P200; Habib M, 2008, ACTA BIOMATER, V4, P1465, DOI 10.1016/j.actbio.2008.03.004; Habib M, 2012, ACTA BIOMATER, V8, P1164, DOI 10.1016/j.actbio.2011.10.032; Kim YB, 2013, MACROMOL RES, V21, P892, DOI 10.1007/s13233-013-1109-3; Kon M, 1998, Dent Mater J, V17, P223; Matassi Fabrizio, 2011, Clin Cases Miner Bone Metab, V8, P21; Matthews S, 2013, POWDER TECHNOL, V237, P221, DOI 10.1016/j.powtec.2013.01.028; Montufar EB, 2013, ACTA BIOMATER, V9, P6188, DOI 10.1016/j.actbio.2012.11.028; Nakano T, 2002, METALL MATER TRANS A, V33, P521, DOI 10.1007/s11661-002-0114-5; SADLER LY, 1991, CHEM ENG PROG, V87, P68; Sariibrahimoglu K., 2013, J BIOMED MATER RES B, V102, P415; Sobhana SSL, 2009, J NANOPART RES, V11, P333, DOI 10.1007/s11051-008-9385-0; Zamora V, 2011, J EUR CERAM SOC, V31, P2407, DOI 10.1016/j.jeurceramsoc.2011.05.035	44	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1751-6161	1878-0180		J MECH BEHAV BIOMED	J. Mech. Behav. Biomed. Mater.	JUL	2015	47						77	86		10.1016/j.jmbbm.2015.03.005		10	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	CK0IB	WOS:000355887800009		
J	Aryal, S; Matsunaga, K; Ching, WY				Aryal, Sitaram; Matsunaga, Katsuyuki; Ching, Wai-Yim			Ab initio simulation of elastic and mechanical properties of Zn- and Mg-doped hydroxyapatite (HAP)	JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS			English	Article						Nanoscale hydroxyapatite; Zn-Mg doping; Mechanical properties; Site-preference; Ab initio calculations; Hydroxyapatite (HAP); HA; Elastic properties	MAGNESIUM-SUBSTITUTED HYDROXYAPATITE; TOTAL-ENERGY CALCULATIONS; AUGMENTED-WAVE METHOD; CALCIUM HYDROXYAPATITE; ELECTRONIC-PROPERTIES; BASIS-SET; ZINC; CERAMICS; BONE; CRYSTALLIZATION	Hydroxyapatite (HAP) is an important bioceramic which constitutes the mineral components of bones and hard tissues in mammals. It is bioactive and used as bioceramic coatings for metallic implants and bone fillers. HAP readily absorbs a large amount of impurities. Knowledge on the elastic and mechanical properties of impurity-doped HAP is a subject of great importance to its potential for biomedical applications. Zn and Mg are the most common divalent cations HAP absorbs. Using density function theory based ab initio methods, we have carried out a large number of ab initio calculations to obtain the bulk elastic and mechanical properties of HAP with Zn or Mg doped in different concentration at the Ca1 and Ca2 sites using large 352-atom supercells. Detailed information on their dependece on the concetraion of the substitued impurity is obtained. Our results show that Mg enhances overall elastic and bulk mechanical properties whereas Zn tends to degrade except at low concentrations. At a higher concentration, the mechanical properties of Zn and Mg doped HAP also depend significantly on impurity distribution between the Ca1 and Ca2 sites. There is a strong evidence that Zn prefers Ca2 site for substituion whereas Mg has no such preference. These results imply that proper control of dopant concentration and their site preference must carefully considered in using doped HAP for specific biomedical applications. (C) 2015 Elsevier Ltd. All rights reserved.	[Aryal, Sitaram; Ching, Wai-Yim] Univ Missouri, Dept Phys, Kansas City, MO 64110 USA; [Matsunaga, Katsuyuki] Nagoya Univ, Dept Mat Sci & Engn, Nagoya, Aichi 4648603, Japan	Ching, WY (reprint author), Univ Missouri, Dept Phys, Kansas City, MO 64110 USA.	Chingw@umkc.edu			DOE [DE-FG-0284DR45170]; DOE-Office of BES, Division of Materials Science and Engineering [DE-SC008176]; Office of Science of DOE [DE-AC03-76SF00098]	This research was supported initially by DOE under DE-FG-0284DR45170 in the early phase of the work and more recently and partially by DOE-Office of BES, Division of Materials Science and Engineering under the grant DE-SC008176. This research used the resources of NERSC supported by the Office of Science of DOE under contract no. DE-AC03-76SF00098.	Kalita SJ, 2007, MAT SCI ENG C-BIO S, V27, P837, DOI 10.1016/j.msec.2006.09.036; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Landi E, 2008, J MATER SCI-MATER M, V19, P239, DOI 10.1007/s10856-006-0032-y; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; BIGI A, 1993, J INORG BIOCHEM, V49, P69, DOI 10.1016/0162-0134(93)80049-F; CHING WY, 1990, J AM CERAM SOC, V73, P3135, DOI 10.1111/j.1151-2916.1990.tb06430.x; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Dorozhkin SV, 2007, J MATER SCI, V42, P1061, DOI 10.1007/s10853-006-1467-8; Shepherd JH, 2012, J MATER SCI-MATER M, V23, P2335, DOI 10.1007/s10856-012-4598-2; Aryal S, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.184112; Ren FZ, 2009, ACTA BIOMATER, V5, P3141, DOI 10.1016/j.actbio.2009.04.014; Kresse G, 1996, COMP MATER SCI, V6, P15, DOI 10.1016/0927-0256(96)00008-0; Liang L, 2010, ACTA BIOMATER, V6, P3763, DOI 10.1016/j.actbio.2010.03.033; Ren F, 2010, ACTA BIOMATER, V6, P2787, DOI 10.1016/j.actbio.2009.12.044; Mano JF, 2004, COMPOS SCI TECHNOL, V64, P789, DOI 10.1016/j.compscitech.2003.09.001; Dorozhkin SV, 2009, J MATER SCI, V44, P2343, DOI 10.1007/s10853-008-3124-x; Webster TJ, 2004, BIOMATERIALS, V25, P2111, DOI 10.1016/j.biomaterials.2003.09.001; Li N, 2014, PHYS CHEM CHEM PHYS, V16, P1500, DOI 10.1039/c3cp53192a; Dorozhkin SV, 2002, ANGEW CHEM INT EDIT, V41, P3130, DOI 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1; Aryal S, 2012, J AM CERAM SOC, V95, P2075, DOI 10.1111/j.1551-2916.2012.05172.x; Tamm T, 2006, J SOLID STATE CHEM, V179, P1581, DOI 10.1016/j.jssc.2006.02.012; Rude RK, 2003, CALCIFIED TISSUE INT, V72, P32, DOI 10.1007/s00223-001-1091-1; Ellis DE, 2006, PHYS CHEM CHEM PHYS, V8, P967, DOI 10.1039/b509254j; NIELSEN OH, 1983, PHYS REV LETT, V50, P697, DOI 10.1103/PhysRevLett.50.697; Aryal S, 2013, INTERMETALLICS, V38, P116, DOI 10.1016/j.intermet.2013.03.002; Aryal S, 2014, PHYS STATUS SOLIDI B, V251, P1480, DOI 10.1002/pssb.201451226; Bodhak S, 2011, J AM CERAM SOC, V94, P1281, DOI 10.1111/j.1551-2916.2010.04228.x; Ching Wai-Yim, 2012, ELELCT STRUCTURE MET; Ching W.Y., 2009, ACTA BIOMATER, V5, P3065; Ching WY, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.214120; Ching WY, 2013, J AM CERAM SOC, V96, P2292, DOI 10.1111/jace.12376; DeGroot K., 1981, SCI CERAM, V11, P433; Dharmawardhana C.C., 2013, APL MAT, V1; Elliot J., 1994, STRUCTURE CHEM APPET; ELLIOTT JC, 1973, SCIENCE, V180, P1055, DOI 10.1126/science.180.4090.1055; Guo K.Xu, 2005, BIOMATERIALS, V26, P4073; Hayakawa S, 2007, J AM CERAM SOC, V90, P565, DOI 10.1111/j.1551-2916.2006.01396.x; HILL R, 1952, P PHYS SOC LOND A, V65, P349, DOI 10.1088/0370-1298/65/5/307; Yao HZ, 2007, J AM CERAM SOC, V90, P3194, DOI 10.1111/j.1551-2916.2007.01931.x; Kanzaki N, 2000, J PHYS CHEM B, V104, P4189, DOI 10.1021/jp9939726; Kawamura H, 2000, J BIOMED MATER RES, V50, P184, DOI 10.1002/(SICI)1097-4636(200005)50:2<184::AID-JBM13>3.0.CO;2-3; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; KRESSE G, 1993, PHYS REV B, V47, P558, DOI 10.1103/PhysRevB.47.558; Liang L, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.024201; Matsunaga K, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2940337; Matsunaga K, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.094101; Matsunaga K, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.014102; Miyaji F, 2005, MATER RES BULL, V40, P209, DOI 10.1016/j.materresbull.2004.10.020; Reuss, 1929, Z ANGEW MATH MECH, V9, P55; Rulis P, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.155104; Snyders R., 2007, APPL PHYS LETT, V90; SUDARSAN.K, 1969, ACTA CRYSTALL B-STRU, VB 25, P1534, DOI 10.1107/S0567740869004298; Tan CY, 2008, IFMBE PROC, V21, P326; Voigt W, 1928, LEHRBUCH KRISTALLPHY; Wateri F., 2004, COMPOS SCI TECHNOL, V64, P893; Zyman Z, 2006, MATERIALWISS WERKST, V37, P474, DOI 10.1002/mawe.200600022	56	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1751-6161	1878-0180		J MECH BEHAV BIOMED	J. Mech. Behav. Biomed. Mater.	JUL	2015	47						135	146		10.1016/j.jmbbm.2015.03.018		12	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	CK0IB	WOS:000355887800015		
J	Tanaka, KD; Denda, T; Ueda, K; Emura, N				Tanaka, Keita D.; Denda, Tetsuo; Ueda, Keisuke; Emura, Naoko			Fruit colour conceals endocarp dimorphism from avian seed dispersers in a tropical beach plant, Scaevola taccada (Goodeniaceae), found in Okinawa	JOURNAL OF TROPICAL ECOLOGY			English	Article						avian seed dispersal; avian visual model; cryptic dimorphism; deception; interspecific communication	LINEAR MIXED MODELS; EGG DISCRIMINATION; VISUAL ECOLOGY; PLUMAGE COLOR; OIL DROPLETS; EVOLUTION; PATTERNS; SIGNALS; BIRDS; POLYMORPHISM	Theory predicts that honest signalling strategies will not always be evolutionarily stable in interspecific communication, yet to demonstrate such a transition of signalling modality between honesty and dishonesty in the wild would be difficult. An endocarp dimorphism has been found in Scaevola taccada fruits: a morph with a cork substrate that facilitates ocean current seed dispersal and a morph without the cork. Both types of fruit are covered with sugar-containing flesh, and are similar in size and colour to one another (at least from a human perspective). The apparent lack of external differences between morphotypes could potentially degrade mutualistic relations between the plant and seed-dispersing birds because the presence of a cork could lower the fruit's nutritional value. Thus, unless seed dispersers can discriminate between the different types of fruit, this system may provide an example of a transition between honest and dishonest signalling. We examined S. taccada fruit and leaf colours from an avian visual perspective. Even though the fruits and leaves were different in colour from one another to birds, there was no perceivable difference in the colours between fruit morphotypes. Therefore, fruit colour is not an honest indicator of reward to seed dispersers. Further, we propose an adoption of a statistical method in avian visual modelling studies that avoids the common statistical errors, such as violation of the congruence principle.	[Tanaka, Keita D.; Ueda, Keisuke; Emura, Naoko] Rikkyo Univ, Sch Sci, Toshima Ku, Tokyo 1718501, Japan; [Denda, Tetsuo] Univ Ryukyus, Dept Marine & Nat Sci, Nishihara, Okinawa 9030213, Japan; [Emura, Naoko] Kyoto Univ, Ctr Ecol Res, Otsu, Shiga 5202113, Japan	Tanaka, KD (reprint author), Rikkyo Univ, Sch Sci, Toshima Ku, Room 4213,3-34-1 Nishi Ikebukuro, Tokyo 1718501, Japan.	keita.d.tanaka@gmail.com			Japan Society for the Promotion of Science [24770028, 23255004]; Japan Science Society: Sasakawa Scientific Research Grant [26-445]	We thank W. Kitamura for comments on statistics and W. Feeney for his helpful comments and suggestions. This study was financially aided by Grants-in-aid from the Japan Society for the Promotion of Science: Young Scientists B: 24770028 (K.D.T.); Basic A: 23255004 (K.U.); by the Japan Science Society: Sasakawa Scientific Research Grant: 26-445 (N.E.).	Vorobyev M, 1998, P ROY SOC B-BIOL SCI, V265, P351; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Stoddard MC, 2011, EVOLUTION, V65, P2004, DOI 10.1111/j.1558-5646.2011.01262.x; Siddiqi A, 2004, J EXP BIOL, V207, P2471, DOI 10.1242/jeb.01047; Cassey P, 2009, IBIS, V151, P689; Howarth DG, 2003, AM J BOT, V90, P915, DOI 10.3732/ajb.90.6.915; Raufaste N, 2001, EVOLUTION, V55, P1703, DOI 10.1111/j.0014-3820.2001.tb00689.x; Endler JA, 2005, EVOLUTION, V59, P1795; Langmore NE, 2011, P ROY SOC B-BIOL SCI, V278, P2455, DOI 10.1098/rspb.2010.2391; Osorio D, 1999, EVOL ECOL, V13, P673, DOI 10.1023/A:1011059715610; Gray SM, 2007, TRENDS ECOL EVOL, V22, P71, DOI 10.1016/j.tree.2006.10.005; Forsman A, 2008, ECOLOGY, V89, P34, DOI 10.1890/07-0572.1; Gigord LDB, 2001, P NATL ACAD SCI USA, V98, P6253, DOI 10.1073/pnas.111162598; Maia R, 2013, METHODS ECOL EVOL, V4, P906, DOI 10.1111/2041-210X.12069; Vorobyev M, 1998, J COMP PHYSIOL A, V183, P621, DOI 10.1007/s003590050286; Foster MS, 1998, J TROP ECOL, V14, P389, DOI 10.1017/S0266467498000303; Endler JA, 2005, BIOL J LINN SOC, V86, P405, DOI 10.1111/j.1095-8312.2005.00540.x; Stoddard MC, 2011, BEHAV ECOL, V22, P1042, DOI 10.1093/beheco/arr088; Hart NS, 2000, J COMP PHYSIOL A, V186, P375, DOI 10.1007/s003590050437; Gillespie RG, 2012, TRENDS ECOL EVOL, V27, P47, DOI 10.1016/j.tree.2011.08.009; Osorio D, 1996, P ROY SOC B-BIOL SCI, V263, P593, DOI 10.1098/rspb.1996.0089; Stoddard MC, 2008, AM NAT, V171, P755, DOI 10.1086/587526; Hart NS, 2001, J COMP PHYSIOL A, V187, P685, DOI 10.1007/s00359-001-0240-3; Hadfield JD, 2010, J STAT SOFTW, V33, P1; Antonov A, 2011, ETHOLOGY, V117, P1128, DOI 10.1111/j.1439-0310.2011.01969.x; Aviles JM, 2011, BEHAV ECOL SOCIOBIOL, V65, P1721, DOI 10.1007/s00265-011-1180-8; AVILES J. M., 2012, P ROY SOC LOND B BIO, V297, P1967; Aviles JM, 2008, P ROY SOC B-BIOL SCI, V275, P2345, DOI 10.1098/rspb.2008.0720; BACKHAUS W, 1987, BIOL CYBERN, V56, P293, DOI 10.1007/BF00319510; Barton NH, 2000, PHILOS T ROY SOC B, V355, P1553, DOI 10.1098/rstb.2000.0716; BIONDINI M. E., 1991, COMPUTER ASSISTED VE, P221; deen A., 2011, BMC EVOLUTIONARY BIO, V11, P313; Edwards DP, 2007, BEHAV ECOL SOCIOBIOL, V61, P1321, DOI 10.1007/s00265-007-0369-3; Emura N, 2012, J FOREST RES-JPN, V17, P352, DOI 10.1007/s10310-011-0300-7; Emura N, 2014, ECOL RES, V29, P733, DOI 10.1007/s11284-014-1164-z; Fadzly Nik, 2013, Trop Life Sci Res, V24, P31; Feeney WE, 2014, BEHAV ECOL, V25, P1365, DOI 10.1093/beheco/aru133; Freckleton RP, 2003, P ROY SOC B-BIOL SCI, V270, P299, DOI 10.1098/rspb.2002.2232; Galetti Mauro, 2002, P177, DOI 10.1079/9780851995250.0177; Kawakami K, 2009, ECOL RES, V24, P741, DOI 10.1007/s11284-008-0543-8; Koshitaka H, 2008, P R SOC B, V275, P947, DOI 10.1098/rspb.2007.1614; Legendre P., 1998, DEV ENV MODELLING, V20, P853; Sarkar D, 2008, USE R, P1; Stuart-Fox D, 2005, TRENDS ECOL EVOL, V20, P521, DOI 10.1016/j.tree.2005.08.004; TANAKA K. D., J ORNITHOLO IN PRESS; Tanaka KD, 2011, BEHAV ECOL, V22, P1012, DOI 10.1093/beheco/arr084	46	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0266-4674	1469-7831		J TROP ECOL	J. Trop. Ecol.	JUL	2015	31		4				335	344		10.1017/S0266467415000218		10	Ecology	Environmental Sciences & Ecology	CK3YY	WOS:000356154100005		
J	Kim, WJ; Shiroyanagi, Y; Yamazaki, Y				Kim, Woo Jin; Shiroyanagi, Yoshiyuki; Yamazaki, Yuichiro			Can Bladder Wall Thickness Predict Videourodynamic Findings in Children with Spina Bifida?	JOURNAL OF UROLOGY			English	Article						child; spinal dysraphism; ultrasonography; urinary bladder; urodynamics	LOWER URINARY-TRACT; DETRUSOR THICKNESS; HEALTHY-CHILDREN; MYELOMENINGOCELE; MYELODYSPLASIA	Purpose: We investigated whether bladder wall thickness measured at specifically defined bladder volumes could predict videourodynamic findings in children with spina bifida. Materials and Methods: We prospectively investigated patients with spina bifida on intermittent catheterization who underwent ultrasound examination simultaneously with videourodynamics. We evaluated the association between bladder wall thickness measured at maximum cystometric capacity and parameters including age, maximum detrusor pressure during filling or at leak and bladder compliance. Differences in bladder wall thickness measured at each percent maximum cystometric capacity were compared between patients with and without unfavorable videourodynamic findings. Maximum detrusor pressure 40 cm H2O or greater during filling or at leak, bladder compliance less than 10 ml/cm H2O, detrusor overactivity, bladder trabeculation and vesicoureteral reflux were defined as unfavorable videourodynamic findings. Results: A total of 23 males and 30 females with spina bifida (median age 7.8 years) underwent measurement of bladder wall thickness at maximum cystometric capacity. Mean +/- SD bladder wall thickness measured at maximum cystometric capacity was 1.7 +/- 0.5 mm. Only age had a weak correlation with bladder wall thickness measured at maximum cystometric capacity (p <0.05). In 31 patients bladder wall thickness was measured at each percent maximum cystometric capacity. Regarding unfavorable videourodynamic findings, there were no significant differences in bladder wall thickness measured at each percent maximum cystometric capacity, except for bladder trabeculation. Conclusions: Even if bladder wall thickness is measured at specifically defined bladder volumes, it cannot predict videourodynamic findings other than bladder trabeculation in children with spina bifida.	[Kim, Woo Jin; Shiroyanagi, Yoshiyuki; Yamazaki, Yuichiro] Kanagawa Childrens Med Ctr, Dept Urol, Yokohama, Kanagawa 2328555, Japan	Yamazaki, Y (reprint author), Kanagawa Childrens Med Ctr, Dept Urol, Minami Ku, 2-138-4 Mutsukawa, Yokohama, Kanagawa 2328555, Japan.	yuichiroy@gmail.com					Tanaka H, 2008, J UROLOGY, V180, P312, DOI 10.1016/j.juro.2008.03.062; Bright E, 2010, J UROLOGY, V184, P1847, DOI 10.1016/j.juro.2010.06.006; Neveus T, 2006, J UROLOGY, V176, P314, DOI 10.1016/S0022-5347(06)00305-3; Kuzmic AC, 2001, PEDIATR NEPHROL, V16, P1122; Drzewiecki BA, 2006, J UROLOGY, V186, P1190; Muller L, 2001, J UROLOGY, V166, P2364, DOI 10.1016/S0022-5347(05)65590-5; Muller L, 2006, J UROLOGY, V175, P704, DOI 10.1016/S0022-5347(05)00182-5; Palmer LS, 1997, J UROLOGY, V158, P1261, DOI 10.1016/S0022-5347(01)64448-3; Sekerci CA, 2014, J UROLOGY, V191, P199, DOI 10.1016/j.juro.2013.08.025; SHAPIRO E, 1991, J UROLOGY, V145, P1024	10	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0022-5347	1527-3792		J UROLOGY	J. Urol.	JUL	2015	194	1					180	183		10.1016/j.juro.2015.03.002		4	Urology & Nephrology	Urology & Nephrology	CK2AQ	WOS:000356012100062		
J	Kataoka, M; Ishibashi, K; Kumagai, S; Yanagida, T; Aikawa, K; Chiba, H; Kojima, Y				Kataoka, Masao; Ishibashi, Kei; Kumagai, Shin; Yanagida, Tomohiko; Aikawa, Ken; Chiba, Hideki; Kojima, Yoshiyuki			Expression and Function of LPA1 in Bladder Cancer	JOURNAL OF UROLOGY			English	Article						urinary bladder neoplasms; neoplasm invasiveness; lysophosphatidic acid; receptors, G-protein-coupled; rho-associated kinases	LYSOPHOSPHATIDIC ACID RECEPTOR; PROTEIN-COUPLED RECEPTOR; UROTHELIAL CARCINOMA; MALIGNANT ASCITES; PHASE-2 TRIAL; CELLS; INVASION; MIGRATION; IDENTIFICATION; METHOTREXATE	Purpose: LPA is one of several physiologically active lipid mediators that promote cell proliferation and invasion, and are present in serum, ascites and urine. LPA receptor is a G-protein coupled receptor that is considered a potential therapeutic target for some malignant cancers. We evaluated the expression of LPA receptors in bladder cancer and the effect of LPA in bladder cancer invasion. Materials and Methods: Using real-time polymerase chain reaction and immunohistochemical staining we determined LPA receptor expression in bladder cancer specimens from patients with bladder cancer, including 12 with Ta or T1 and 15 with T2-T4 disease. ROCK expression, myosin light chain phosphorylation and Matrigel (TM) invasion assays were done and morphological observations were made to assess LPA effects in T24 cells, which were derived from bladder cancer. Results: Notably LPA1 mRNA expression was significantly higher in muscle invasive bladder cancer specimens than in nonmuscle invasive specimens. Strong LPA1 expression was evident on cell membranes in muscle invasive specimens. T24 cell invasion was increased by LPA treatment and invasiveness was decreased by LPA1 siRNA or LPA1 inhibitor. LPA treatment increased ROCK1 expression and myosin light chain phosphorylation, and induced morphological changes, including lamellipodia formation and cell rounding. Conclusions: Results indicate that LPA signaling via LPA1 activation promoted bladder cancer invasion. LPA1 might be useful to detect bladder cancer with highly invasive potential and become a new therapeutic target for invasive bladder cancer treatment.	[Kataoka, Masao; Chiba, Hideki] Fukushima Med Univ, Dept Urol, Fukushima 9601295, Japan; [Chiba, Hideki] Fukushima Med Univ, Dept Pathol, Fukushima 9601295, Japan	Kataoka, M (reprint author), Fukushima Med Univ, Dept Urol, 1 Hikarigaoka, Fukushima 9601295, Japan.	masaoka@fmu.ac.jp					Kamai T, 2003, CLIN CANCER RES, V9, P2632; Ogata S, 2009, INT J GYNECOL CANCER, V19, P1473, DOI 10.1111/IGC.0b013e3181c03909; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Lee SJ, 2010, INT J BIOCHEM CELL B, V42, P1907, DOI 10.1016/j.biocel.2010.09.021; An SZ, 1998, J BIOL CHEM, V273, P7906, DOI 10.1074/jbc.273.14.7906; Lee CW, 2006, J BIOL CHEM, V281, P23589, DOI 10.1074/jbc.M603670200; von der Maase H, 2000, J CLIN ONCOL, V18, P3068; Saxman SB, 1997, J CLIN ONCOL, V15, P2564; Ren J, 2006, CANCER RES, V66, P3006, DOI 10.1158/0008-5472.CAN-05-1292; Yu SX, 2008, J NATL CANCER I, V100, P1630, DOI 10.1093/jnci/djn378; Bandoh K, 1999, J BIOL CHEM, V274, P27776, DOI 10.1074/jbc.274.39.27776; Grivas PD, 2014, CANCER-AM CANCER SOC, V120, P692, DOI 10.1002/cncr.28477; Boucharaba A, 2006, P NATL ACAD SCI USA, V103, P9643, DOI 10.1073/pnas.0600979103; Dreicer R, 2009, CANCER, V115, P4090, DOI 10.1002/cncr.24467; Hecht JH, 1996, J CELL BIOL, V135, P1071, DOI 10.1083/jcb.135.4.1071; Yamada T, 2004, J BIOL CHEM, V279, P6595, DOI 10.1074/jbc.M308133200; Baba K, 2001, J UROLOGY, V165, P259, DOI 10.1097/00005392-200101000-00075; Kim JH, 2011, J CELL PHYSIOL, V226, P2881, DOI 10.1002/jcp.22631; Komachi M, 2012, CANCER SCI, V103, P1099, DOI 10.1111/j.1349-7006.2012.02246.x; Komachi M, 2009, CARCINOGENESIS, V30, P457, DOI 10.1093/carcin/bgp011; Kotarsky K, 2006, J PHARMACOL EXP THER, V318, P619, DOI 10.1124/jpet.105.098848; MOOLENAAR WH, 1995, CURR OPIN CELL BIOL, V7, P203, DOI 10.1016/0955-0674(95)80029-8; Noguchi K, 2003, J BIOL CHEM, V278, P25600, DOI 10.1074/jbc.M302648200; Ohkawa R, 2006, NEPHROL DIAL TRANSPL, V21, P3612, DOI 10.1093/ndt/gfl437; vom Dorp F, 2011, UROL INT, V86, P220, DOI 10.1159/000321271; Yanagida K, 2009, J BIOL CHEM, V284, P17731, DOI 10.1074/jbc.M808506200	26	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0022-5347	1527-3792		J UROLOGY	J. Urol.	JUL	2015	194	1					238	244		10.1016/j.juro.2014.12.028		7	Urology & Nephrology	Urology & Nephrology	CK2AQ	WOS:000356012100080		
J	Funayama, M; Hattori, N				Funayama, Manabu; Hattori, Nobutaka			CHCHD2 and Parkinson's disease Reply	LANCET NEUROLOGY			English	Letter							MUTATIONS		[Funayama, Manabu; Hattori, Nobutaka] Juntendo Univ, Grad Sch Med, Ctr Genom & Regenerat Med, Res Inst Dis Old Age, Tokyo, Japan; [Funayama, Manabu; Hattori, Nobutaka] Juntendo Univ, Sch Med, Dept Neurol, Bunkyo Ku, Tokyo 1138421, Japan	Funayama, M (reprint author), Juntendo Univ, Grad Sch Med, Ctr Genom & Regenerat Med, Res Inst Dis Old Age, Tokyo, Japan.	nhattori@juntendo.ac.jp	Funayama, Manabu/E-6485-2013				Singleton AB, 2013, MOVEMENT DISORD, V28, P14, DOI 10.1002/mds.25249; Feyeux M, 2012, HUM MOL GENET, V21, P3883, DOI 10.1093/hmg/dds216; Kumari U, 2009, FEBS J, V276, P6455, DOI 10.1111/j.1742-4658.2009.07344.x; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Funayama M, 2015, LANCET NEUROL, V14, P274, DOI 10.1016/S1474-4422(14)70266-2; Song R, 2015, MOL MED REP, V11, P4053, DOI 10.3892/mmr.2015.3256	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUL	2015	14	7					682	683				2	Clinical Neurology	Neurosciences & Neurology	CK4LS	WOS:000356195900013		
J	Takeda, M; Takahashi, D; Shobayashi, M				Takeda, Mari; Takahashi, Daisuke; Shobayashi, Mikitaro			Collective action vs. conservation auction: Lessons from a social experiment of a collective auction of water conservation contracts in Japan	LAND USE POLICY			English	Article						Conservation auction; Collective action; Fairness; Transaction cost; Social experiment; Irrigation	INSIGHTS; PAYMENTS; DESIGN	In this study, we explore the possibility of "collective auction" of conservation contracts, and related issues, through a social experiment. We then propose an alternative policy to achieve both collective action in irrigation management and cost-effective water environment conservation. In a "collective auction", individual farmers as well as farmers' groups are allowed to participate. Communication and coordination among farmers and farmers' groups are allowed. Based on our participant survey and comparison with environmental payments for similar, previous conservation activities, the auction result shows that contract prices could be, at the very least, cost-effective. Moreover, collective irrigation management is not negatively affected owing to the auction. We find evidence of group participation and price coordination, which result in saving auction transaction costs, among local communities active in collective action in local resource management. Conversely, we find that bidding occurred at the individual farmer level as well. This difference in approach depends on the extent of the auction coordinators' commitment to the auction, reflected by their risk evaluation of unsuccessful bids. In either case, the auction coordinators could manage to minimize the likely unfairness arising from the auction. Although establishing a competitive environment to prevent possible collusion in such auctions is challenging, this study provides empirical evidence that collective action in pre-existing local resource management can reduce auction transaction costs. Utilizing local communities' abilities to organize collective action can reduce these costs and minimize the possible unfairness arising from the auction, thus facilitating compatibility between cost-effective conservation owing to the auction and local resource conservation by collective action. Finally, we suggest that (1) the transaction cost of such an auction could be reduced by allotting adequate time for collective decision making, and (2) conservation programs should be designed to minimize their impact on production bases. (C) 2015 Published by Elsevier Ltd.	[Takeda, Mari] Univ Tokyo, Dept Agr & Resource Econ, Bunkyo Ku, Tokyo 1138657, Japan; [Takahashi, Daisuke] Waseda Univ, Shinjuku Ku, Tokyo 1698050, Japan; [Shobayashi, Mikitaro] Gakusyuin Womens Coll, Shinjuku Ku, Tokyo 1628650, Japan	Takeda, M (reprint author), Univ Tokyo, Dept Agr & Resource Econ, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	atakeda@ecc.u-tokyo.ac.jp; d-takahashi@aoni.waseda.jp; 20070095@gakushuin.ac.jp			Policy Research Institute of the Ministry of Agriculture, Forestry, and Fisheries (PRIMAFF), Japan;  [2]	This paper is part of the requirement for the fulfillment of Grant #2 titled "Analysis on the Applicability of Rights Trading in Agriculture, Forestry, and Fisheries from the Perspective of Law and Economics." Payments for the collective auction of conservation contracts were funded by the Policy Research Institute of the Ministry of Agriculture, Forestry, and Fisheries (PRIMAFF), Japan. We would like to express our deepest appreciation to the LIDs of Anegawa-Sagan, Biwako-Yousui, Inukamigawa-Engan, Kamogawa-Ryuiki, and Shin-Asahi, and the officials at the Department of Agriculture and Fisheries, Shiga Prefectural Government.	Amdur L, 2011, ENVIRON MANAGE, V47, P859, DOI 10.1007/s00267-011-9655-y; Stoneham G, 2003, AUST J AGR RESOUR EC, V47, P477, DOI 10.1111/j.1467-8489.2003.t01-1-00224.x; Brown LK, 2011, ENVIRON RESOUR ECON, V50, P49, DOI 10.1007/s10640-011-9461-2; Narloch U, 2013, LAND USE POLICY, V35, P107, DOI 10.1016/j.landusepol.2013.05.002; Claassen R, 2008, ECOL ECON, V65, P737, DOI 10.1016/j.ecolecon.2007.07.032; Jack BK, 2009, CONSERV BIOL, V23, P359, DOI 10.1111/j.1523-1739.2008.01086.x; Narloch U, 2012, WORLD DEV, V40, P2096, DOI 10.1016/j.worlddev.2012.03.014; Association of Agriculture and Forestry Statistics, 2005, RUR COMM CARDS BAS 2; Hayashi K., 2004, DEP AGR RESOURCE EC, V04-E-01, P1; Hayashi K., 2008, Journal of Rural Planning, V26, P416, DOI 10.2750/arp.26.416; Kamogawa LID, 2008, PROJECT REPORT WATER; Kobayashi H., 2006, OECD WORKSH AGR WAT; Kollmuss A., 2010, HDB CARBON OFFSET PR, P256; Kono S., 2012, PADDY WATER ENVIRON, V10, P75; Milgrom P. R., 2004, PUTTING AUCTION THEO, P368; MLIT - Ministry of Land Infrastructure Transport and Tourism, 2012, WHIT PAP WAT RES; Nagata K., 1994, EVOLUTION LAND IMPRO; Nakashima Y., 2010, NOSAI, V62, P8; OECD, 2005, EV AGR ENV POL DES P, P400; Ostrom E., 1990, GOVERNING COMMONS EV, P298; Sarker A, 2001, AGR WATER MANAGE, V48, P89, DOI 10.1016/S0378-3774(00)00125-6; Schilizzi S., 2005, REPORT SCOTTISH EXEC; Shiga Prefecture, 2011, FISH FRIENDLY AGR PR; Shiga Prefecture, 2013, STAT YB SHIGA PREFEC; Shiga Prefecture, 2008, ENV SHIGA PREFECTURE; Shiga Prefecture, 2011, LIST LAND IMPROVEMEN; Shiga Prefecture Agricultural Technology Promotion Center, 2005, EFF WAT SAV POLL LOA; Shobayashi M., 2012, AGR ENV POLICY POLIC, P236; Shobayashi M, 2010, INT J WATER RESOUR D, V26, P351, DOI 10.1080/07900627.2010.492609	29	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0264-8377	1873-5754		LAND USE POLICY	Land Use Pol.	JUL	2015	46						189	200		10.1016/j.landusepol.2014.06.010		12	Environmental Studies	Environmental Sciences & Ecology	CK3IT	WOS:000356110500016		
J	Emura, T; Konno, Y; Michimae, H				Emura, Takeshi; Konno, Yoshihiko; Michimae, Hirofumi			Statistical inference based on the nonparametric maximum likelihood estimator under double-truncation	LIFETIME DATA ANALYSIS			English	Article						Asymptotic variance; Bootstrap; Confidence band; Goodness-of-fit test; Survival analysis	CENSORED-DATA; MODELS	Doubly truncated data consist of samples whose observed values fall between the right- and left- truncation limits. With such samples, the distribution function of interest is estimated using the nonparametric maximum likelihood estimator (NPMLE) that is obtained through a self-consistency algorithm. Owing to the complicated asymptotic distribution of the NPMLE, the bootstrap method has been suggested for statistical inference. This paper proposes a closed-form estimator for the asymptotic covariance function of the NPMLE, which is computationally attractive alternative to bootstrapping. Furthermore, we develop various statistical inference procedures, such as confidence interval, goodness-of-fit tests, and confidence bands to demonstrate the usefulness of the proposed covariance estimator. Simulations are performed to compare the proposed method with both the bootstrap and jackknife methods. The methods are illustrated using the childhood cancer dataset.	[Emura, Takeshi] Natl Cent Univ, Grad Inst Stat, Zhongli, Taiwan; [Konno, Yoshihiko] Japan Womens Univ, Dept Math & Phys Sci, Tokyo 112, Japan; [Michimae, Hirofumi] Kitasato Univ, Sch Pharm, Dept Clin Med Biostat, Tokyo, Japan	Emura, T (reprint author), Natl Cent Univ, Grad Inst Stat, Zhongli, Taiwan.	emura@stat.ncu.edu.tw; konno@fc.jwu.ac.jp; michimaeh@pharm.kitasato-u.ac.jp			National Science Council of Taiwan [NSC101-2118-M008-002-MY2]; Japan Society for the Promotion of Science [23570036];  [25330043];  [21500283]	We would like to thank the editor, the associate editor and the two reviewers for their helpful comments and corrections that greatly improved the manuscript. This work was financially supported by the National Science Council of Taiwan (NSC101-2118-M008-002-MY2) to T. Emura, and a Grant-in-Aid for a Research Fellow of the Japan Society for the Promotion of Science to H. Michimae (No. 23570036). The work of Y. Konno was partially supported by Grant-in-Aid for Scientific Research(C) (No. 25330043 and 21500283).	MURPHY SA, 1995, ANN STAT, V23, P182, DOI 10.1214/aos/1176324462; Chen YH, 2010, J ROY STAT SOC B, V72, P235; Shen PS, 2010, ANN I STAT MATH, V62, P835, DOI 10.1007/s10463-008-0192-2; Commenges D, 2002, STAT METHODS MED RES, V11, P167, DOI 10.1191/0962280202sm279ra; Emura T, 2012, STAT PAP, V53, P133, DOI 10.1007/s00362-010-0321-x; NAIR VN, 1984, TECHNOMETRICS, V26, P265, DOI 10.2307/1267553; Zeng DL, 2006, BIOMETRIKA, V93, P627, DOI 10.1093/biomet/93.3.627; Moreira C, 2013, COMPUT STAT DATA AN, V61, P107, DOI 10.1016/j.csda.2012.11.017; Moreira C, 2010, J NONPARAMETR STAT, V22, P567, DOI 10.1080/10485250903556102; Moreira C, 2012, ELECTRON J STAT, V6, P501, DOI 10.1214/12-EJS683; Zhu H, 2012, BIOMETRIKA, V99, P345, DOI 10.1093/biomet/ass009; Emura T, 2012, J MULTIVARIATE ANAL, V110, P171, DOI 10.1016/j.jmva.2012.03.012; Efron B, 1999, J AM STAT ASSOC, V94, P824, DOI 10.2307/2669997; Austin D, 2013, LIFETIME DATA ANAL, DOI [10.1007/s10985-013-9287-z, DOI 10.1007/S10985-013-9287-Z]; Moeschberger M. L., 2003, SURVIVAL ANAL TECHNI; Moreira C, 2016, COMPUT STAT DATA AN, V93, P294, DOI 10.1016/j.csda.2014.03.017; Shen PS, 2011, J NONPARAMETR STAT, V23, P1; Shen PS, 2012, J APPL STAT, V38, P2345; Stovring H, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-53; van der Vaart A. W., 1996, WEAK CONVERGENCE EMP	20	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1380-7870	1572-9249		LIFETIME DATA ANAL	Lifetime Data Anal.	JUL	2015	21	3					397	418		10.1007/s10985-014-9297-5		22	Mathematics, Interdisciplinary Applications; Statistics & Probability	Mathematics	CK4BY	WOS:000356165100004		
J	Kato, R; Sumitomo, S; Kawahata, K; Fujio, K; Yamamoto, K				Kato, R.; Sumitomo, S.; Kawahata, K.; Fujio, K.; Yamamoto, K.			Successful treatment of cerebral large vessel vasculitis in systemic lupus erythematosus with intravenous pulse cyclophosphamide	LUPUS			English	Article						NPSLE; cerebral large vessel vasculitis; cyclophosphamide	CENTRAL-NERVOUS-SYSTEM; MANIFESTATIONS	A 39-year-old woman with a six-year history of systemic lupus erythematosus (SLE) was admitted because of a prolonged high fever, discoid rash, and multiple lymphadenopathies. She also developed pericarditis, and was treated with intravenous methylprednisolone pulse therapy followed by prednisolone 50mg daily and cyclosporine 100mg daily. Meanwhile, she had a progressive headache, and a brain MRI revealed right pons infarction, although she did not have any abnormal neurological findings. An MRA revealed obvious irregular narrowing in the basilar, right vertebral and right posterior cerebral artery. There was no evidence of antiphospholipid syndrome. We concluded that the cause of the asymptomatic brain infarction was cerebral large vessel vasculitis associated with neuropsychiatric SLE. Intravenous cyclophosphamide pulse therapy was started, and two months later, we confirmed that the irregular arterial narrowing had markedly ameliorated. Cerebral large vessel vasculitis in neuropsychiatric SLE is very rare, and a marked amelioration has not been reported to date. Here, we present a rare case of cerebral large vessel vasculitis treated successfully with a clear visual presentation.	[Kato, R.; Sumitomo, S.; Fujio, K.; Yamamoto, K.] Univ Tokyo, Grad Sch Med, Dept Allergy & Rheumatol, Tokyo 1138655, Japan; [Kawahata, K.] Tokyo Med & Dent Univ, Grad Sch Med, Dept Med & Rheumatol, Tokyo, Japan	Sumitomo, S (reprint author), Univ Tokyo, Grad Sch Med, Dept Allergy & Rheumatol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	sumitos-tky@umin.ac.jp					Calabrese LH, 2007, ANN INTERN MED, V146, P34; ELLIS SG, 1979, SEMIN ARTHRITIS RHEU, V8, P212, DOI 10.1016/S0049-0172(79)80009-8; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Hirohata S, 2009, CLIN RHEUMATOL, V28, P1319, DOI 10.1007/s10067-009-1226-8; GREENAN TJ, 1992, RADIOLOGY, V182, P65; Demaerel P, 2004, EUR RADIOL, V14, P1005, DOI 10.1007/s00330-004-2239-y; Salvarani C, 2012, LANCET, V380, P767, DOI 10.1016/S0140-6736(12)60069-5; Bertsias GK, 2010, ANN RHEUM DIS, V69, P2074, DOI 10.1136/ard.2010.130476; Hajj-Ali RA, 2002, ARTHRIT RHEUM-ARTHR, V47, P662, DOI 10.1002/art.10797; Barile-Fabris L, 2005, ANN RHEUM DIS, V64, P620, DOI 10.1136/ard.2004.025528; Bertsias GK, 2010, NAT REV RHEUMATOL, V6, P358, DOI 10.1038/nrrheum.2010.62; Bockle BC, 2014, LUPUS, V23, P1417, DOI 10.1177/0961203314541689; Kizu H, 2011, CLIN RHEUMATOL, V30, P715, DOI 10.1007/s10067-010-1591-3; WEINER DK, 1991, J RHEUMATOL, V18, P748	14	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0961-2033	1477-0962		LUPUS	Lupus	JUL	2015	24	8					880	884		10.1177/0961203315570163		5	Rheumatology	Rheumatology	CK5AG	WOS:000356233900014		
J	Takao, H; Hayashi, N; Ohtomo, K				Takao, Hidemasa; Hayashi, Naoto; Ohtomo, Kuni			Brain morphology is individual-specific information	MAGNETIC RESONANCE IMAGING			English	Article						Biometrics; Brain morphology; Eigenbrain; Magnetic resonance imaging; Recognition; Voxel-based morphometry	VOXEL-BASED MORPHOMETRY; GRADIENT NONLINEARITY CORRECTION; DEMENTED OLDER-ADULTS; OPEN ACCESS SERIES; MRI DATA; INTENSITY NONUNIFORMITY; CORTICAL THICKNESS; ALZHEIMERS-DISEASE; MULTIPLE SCANNERS; MATTER DENSITY	The identification of individual differences in brain morphology is important to understand the background of individual differences in brain functions. In the present study, we investigated whether brain morphology is discernibly different among individuals and is personally identifiable information. Using structural magnetic resonance imaging data from 215 healthy subjects scanned twice (scan interval = 1.0 +/- 0.1 years), we performed brain recognition by image normalization using a voxel-based morphometry approach, feature extraction based on principal component analysis, and calculating the Euclidean distances between image pairs projected into the subspace. Even with only 32 dimensions used for projection, the rank-one identification rate was 99.5%. With >= 112 dimensions used, the rank-one identification rate was 100%. At a false accept rate of 0.01%, the genuine accept rates were 95.8% and 100% with 32 and 128 dimensions used for projection, respectively. There was little difference in the Euclidean distances among different combinations of scanners used or between probe gallery image pairs with and without scanner upgrade. These results indicate that brain morphology can identify a specific individual; i.e., brain morphology is personally identifiable information. Individually different brain morphology may occur as a collection of differences in brain structures that reflect individual differences in a variety of performances and various psychological characteristics and behavior patterns, and may provide the background of individual differences in personality and brain function. (C) 2015 Elsevier Inc. All rights reserved.	[Takao, Hidemasa; Ohtomo, Kuni] Univ Tokyo, Dept Radiol, Grad Sch Med, Bunkyo Ku, Tokyo 1138655, Japan; [Hayashi, Naoto] Univ Tokyo, Grad Sch Med, Dept Computat Diagnost Radiol & Prevent Med, Bunkyo Ku, Tokyo 1138655, Japan	Takao, H (reprint author), Univ Tokyo, Dept Radiol, Grad Sch Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	takaoh-tky@umin.ac.jp			Japan Society for the Promotion of Science [24689047, 221S0003]	We wish to thank Dr. Eriko Maeda and Dr. Takeharu Yoshikawa for their help in collecting data. This work was supported by a Grant-in-Aid for Young Scientists (A) 24689047 and a Grant-in-Aid for Scientific Research on Innovative Areas 221S0003 (Comprehensive Brain Science Network) from the Japan Society for the Promotion of Science.	Aloui K, 2011, VIS INF PROC EUVIP 2, P258; Aloui K, 2011, COMP INT BIOM ID MAN, P91; Pardoe H, 2008, NEUROIMAGE, V42, P611, DOI 10.1016/j.neuroimage.2008.05.007; SCHLAUG G, 1995, SCIENCE, V267, P699, DOI 10.1126/science.7839149; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Han X, 2006, NEUROIMAGE, V32, P180, DOI 10.1016/j.neuroimage.2006.02.051; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Fjell AM, 2009, J NEUROSCI, V29, P15223, DOI 10.1523/JNEUROSCI.3252-09.2009; Jovicich J, 2006, NEUROIMAGE, V30, P436, DOI 10.1016/j.neuroimage.2005.09.046; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351; Takao H, 2012, EUR J RADIOL, V81, P2801, DOI 10.1016/j.ejrad.2011.10.011; Kruggel F, 2010, NEUROIMAGE, V49, P2123, DOI 10.1016/j.neuroimage.2009.11.006; Jack CR, 2010, ALZHEIMERS DEMENT, V6, P212, DOI 10.1016/j.jalz.2010.03.004; Stonnington CM, 2008, NEUROIMAGE, V39, P1180, DOI 10.1016/j.neuroimage.2007.09.066; Van Essen DC, 2013, NEUROIMAGE, V80, P62, DOI 10.1016/j.neuroimage.2013.05.041; Huppertz HJ, 2010, NEUROIMAGE, V49, P2216, DOI 10.1016/j.neuroimage.2009.10.066; Takao H, 2011, J MAGN RESON IMAGING, V34, P438, DOI 10.1002/jmri.22636; Dickerson BC, 2008, NEUROIMAGE, V39, P10, DOI 10.1016/j.neuroimage.2007.08.042; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Marcus DS, 2010, J COGNITIVE NEUROSCI, V22, P2677, DOI 10.1162/jocn.2009.21407; Vovk U, 2007, IEEE T MED IMAGING, V26, P405, DOI 10.1109/TMI.2006.891486; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Suckling J, 2010, HUM BRAIN MAPP, V31, P1183, DOI 10.1002/hbm.20927; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Munte TF, 2002, NAT REV NEUROSCI, V3, P473, DOI 10.1038/nrn843; Jovicich J, 2009, NEUROIMAGE, V46, P177, DOI 10.1016/j.neuroimage.2009.02.010; Marcus DS, 2007, J COGNITIVE NEUROSCI, V19, P1498, DOI 10.1162/jocn.2007.19.9.1498; Schnack HG, 2004, HUM BRAIN MAPP, V22, P312, DOI 10.1002/hbm.20040; Aydin K, 2007, AM J NEURORADIOL, V28, P1859, DOI 10.3174/ajnr.A0696; Chen FL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054328; Ewers M, 2006, NEUROBIOL AGING, V27, P1051, DOI 10.1016/j.neurobiolaging.2005.05.032; Focke NK, 2011, NEUROIMAGE, V56, P1164, DOI 10.1016/j.neuroimage.2011.02.029; Mechelli A, 2004, NATURE, V431, P757, DOI 10.1038/431757a; Shuter B, 2008, NEUROIMAGE, V41, P371, DOI 10.1016/j.neuroimage.2008.02.003; Takao H, 2014, NEUROIMAGE, V84, P133, DOI 10.1016/j.neuroimage.2013.08.046; Takao H, 2010, NEURORADIOLOGY, V52, P691, DOI 10.1007/s00234-010-0715-4; Takao H, 2010, J MAGN RESON IMAGING, V32, P489, DOI 10.1002/jmri.22237; Takao H, 2013, J MAGN RESON IMAGING, V38, P1283, DOI 10.1002/jmri.24038	39	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0730-725X	1873-5894		MAGN RESON IMAGING	Magn. Reson. Imaging	JUL	2015	33	6					816	821		10.1016/j.mri.2015.03.010		6	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CK3MX	WOS:000356121300012		
J	Kawasaki, M; Hsiao, CN; Yang, JR; Shiojiri, M				Kawasaki, M.; Hsiao, C. N.; Yang, J. R.; Shiojiri, M.			Structural investigation of Ru/Pt nanocomposite films prepared by plasma-enhanced atomic layer depositions	MICRON			English	Article						Ru and Pt nanocomposite film; Atomic layer deposition; Analytical scanning transmission electron microscopy; Fuel cell catalyst	RUTHENIUM THIN-FILMS; CORE-SHELL NANOPARTICLES; OXYGEN	We have fabricated Ru and Pt nanocomposite films using plasma-enhanced atomic layer deposition (PE-ALD), and characterized their structure by means of analytical electron microscopy. Pt and Ru were deposited in Ar/O-2 plasma using trimethyl(methylcyclopentadienyl) platinum(IV) and bis(cyclopentadienyl)Ru(II) or bis(ethylcyclopentadienyl)Ru(II) as precursors, respectively. The resistivity of a Pt film deposited on a Si substrate at 300 degrees C was 16.2 mu Omega cm, and that of a Ru film was as low as 11 mu Omega cm, showing the film to be metallic and not oxidized. It was revealed that the film prepared by successive PE-ALDs of Pt and Ru on a thin amorphous carbon substrate for electron microscopy analysis is a nanocomposite of Ru ribbons and PtRu (7:3) alloy ribbons with 2-3 nm in width. The Ru ribbon comprised small particles with poor crystallinity of the hcp A3 structure and the PtRu ribbon comprised crystallites with good crystallinity of the fcc Al structure. The atomic layer deposition would be one of potential techniques to produce Ru/Pt nanocomposites for fuel cell catalysts. (C) 2015 Elsevier Ltd. All rights reserved.	[Kawasaki, M.] JEOL USA Inc, Peabody, MA 01960 USA; [Hsiao, C. N.] Instrument Technol Res Ctr, Natl Appl Res Labs, Hsinchu 30076, Taiwan; [Yang, J. R.] Natl Taiwan Univ, Dept Mat Sci & Engn, Taipei 10677, Taiwan; [Shiojiri, M.] Kyoto Inst Technol, Kyoto 6068585, Japan	Kawasaki, M (reprint author), JEOL USA Inc, 11 Dearborn Rd, Peabody, MA 01960 USA.	kawasaki@jeol.com; shiojiri@pc4.so-net.ne.jp					Aaltonen T, 2004, CHEM VAPOR DEPOS, V10, P215, DOI 10.1002/cvde.200306288; Muthuswamy N, 2013, INT J HYDROGEN ENERG, V38, P16631, DOI 10.1016/j.ijhydene.2013.02.056; Chen MJ, 2012, SEMICOND SCI TECH, V27, DOI 10.1088/0268-1242/27/7/074005; Aaltonen T, 2003, CHEM VAPOR DEPOS, V9, P45, DOI 10.1002/cvde.200290007; Niinisto L, 2004, PHYS STATUS SOLIDI A, V201, P1443, DOI 10.1002/pssa.200406798; Alayoglu S, 2009, ACS NANO, V3, P3127, DOI 10.1021/nn900242v; Ritala M, 1999, NANOTECHNOLOGY, V10, P19, DOI 10.1088/0957-4484/10/1/005; Park SJ, 2008, THIN SOLID FILMS, V516, P7345, DOI 10.1016/j.tsf.2008.02.011; Chen YY, 2013, THIN SOLID FILMS, V545, P183, DOI 10.1016/j.tsf.2013.07.079; Ochal P, 2011, J ELECTROANAL CHEM, V655, P140, DOI 10.1016/j.jelechem.2011.02.027; Kim SK, 2009, J PHYS CHEM C, V113, P11329, DOI 10.1021/jp9021882; Yim SS, 2008, J APPL PHYS, V103, DOI 10.1063/1.2938052; Alayoglu S, 2008, NAT MATER, V7, P333, DOI 10.1038/nmat2156; Yeo S, 2013, THIN SOLID FILMS, V546, P2, DOI 10.1016/j.tsf.2013.03.074; Park SJ, 2008, MICROELECTRON ENG, V85, P39, DOI 10.1016/j.mee.2007.01.239; Brankovic SR, 2001, ELECTROCHEM SOLID ST, V4, pA217, DOI 10.1149/1.1414943; Kwon OK, 2004, J ELECTROCHEM SOC, V151, pG109, DOI 10.1149/1.1640633; McCarthy J.J., 1980, SCANNING ELECT MICRO, V11, P259; Rakhtsaum G., 2013, PLATIN MET REV, V57, P202	19	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-4328			MICRON	Micron	JUL	2015	74						8	14		10.1016/j.micron.2015.03.012		7	Microscopy	Microscopy	CK4HU	WOS:000356185700003		
J	Tokunaga, T; Hayashi, Y; Iijima, T; Uesugi, Y; Unten, M; Sasaki, K; Yamamoto, T				Tokunaga, Tomoharu; Hayashi, Yasuhiko; Iijima, Toru; Uesugi, Yuki; Unten, Masaki; Sasaki, Katsuhiro; Yamamoto, Takahisa			In situ observation of carbon nanotube yarn during voltage application	MICRON			English	Article						Nanotube; Yarn; In situ TEM; Current; Voltage	ELECTRICAL-CONDUCTIVITY	Carbon nanotube (CNT) yarns are fabricated by drawing (combined with spinning) from CNT forests and grown on a substrate. Three types of phenomena occur in these CNT yarns with increasing amounts of current: yarn rotation, catalyst evaporation, and breakage of the yarn. These phenomena result from the resistive heating occurring during the current flow, and have been observed in situ under vacuum by transmission electron microscopy. If these CNT yarns are applied to electronic circuits, the rotation and breakage may lead to circuit failure. However, catalyst evaporation is a useful method for purifying CNT yarns without additional treatments prior to yarn fabrication. (C) 2015 Elsevier Ltd. All rights reserved.	[Tokunaga, Tomoharu; Sasaki, Katsuhiro; Yamamoto, Takahisa] Nagoya Univ, Dept Quantum Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Hayashi, Yasuhiko; Uesugi, Yuki; Unten, Masaki] Okayama Univ, Dept Elect Engn, Kita Ku, Okayama 7008530, Japan; [Iijima, Toru] Environm Energy Nanotechnol Res Inst Co Ltd, Ikeda, Nagano 3998602, Japan	Tokunaga, T (reprint author), Nagoya Univ, Dept Quantum Engn, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648603, Japan.	t.tokunaga@numse.nagoya-u.ac.jp	HAYASHI, Yasuhiko/B-9165-2013	HAYASHI, Yasuhiko/0000-0002-4113-5548	Advanced Characterization Nanotechnology Platform of the National Institute for Materials Science; High Voltage Electron Microscopy Laboratory of Nagoya University	This work was supported by the Advanced Characterization Nanotechnology Platform of the National Institute for Materials Science and the High Voltage Electron Microscopy Laboratory of Nagoya University.	SPARROW TG, 1984, CHEM PHYS LETT, V108, P547, DOI 10.1016/0009-2614(84)85051-4; Dresselhaus MS, 2005, PHYS REP, V409, P47, DOI 10.1016/j.physrep.2004.10.006; Miao MH, 2011, CARBON, V49, P3755, DOI 10.1016/j.carbon.2011.05.008; Miyagawa S, 2006, NUCL INSTRUM METH B, V242, P346, DOI 10.1016/j.nimb.2005.08.051; Meo M, 2006, ENG FRACT MECH, V73, P2589, DOI 10.1016/j.engfracmech.2006.05.005; Zhang M, 2004, SCIENCE, V306, P1358, DOI 10.1126/science.1104276; Huang W, 2003, CARBON, V41, P2585, DOI 10.1016/S0008-6223(03)00330-0; Jiang KL, 2002, NATURE, V419, P801, DOI 10.1038/419801a; Ci LJ, 2001, J CRYST GROWTH, V233, P823, DOI 10.1016/S0022-0248(01)01606-2; Datsyuk V, 2008, CARBON, V46, P833, DOI 10.1016/j.carbon.2008.02.012; Iijima T., 2011, PHYS STATUS SOLIDI A, V10, P2332; Jinag H., 2004, J ENG MAT TECH, V126, P265; Robert C., 1973, CRC HDB CHEM PHYS; Bachtold A, 1999, NATURE, V397, P673; Tran D.C., 2009, CARBON, V47, P2662; Wong W.E., 1997, SCIENCE, V277, P1971, DOI DOI 10.1126/SCIENCE.277.5334.1971; Zou P.X., 2004, PHYSICA E, V24, P14	17	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-4328			MICRON	Micron	JUL	2015	74						30	34		10.1016/j.micron.2015.04.004		5	Microscopy	Microscopy	CK4HU	WOS:000356185700006		
J	Koganezawa, S				Koganezawa, Shinji			Analytical parametric study of head-mounting block for reduction in spring-back deformation after ball swaging in hard disk drives	MICROSYSTEM TECHNOLOGIES-MICRO-AND NANOSYSTEMS-INFORMATION STORAGE AND PROCESSING SYSTEMS			English	Article								As part of the author's effort to optimize the design of the head-mounting blocks (HMBs) used in the head suspensions of hard disk drives, a parametric study was undertaken. First, the author derived a theoretical retention torque equation in preparation for this study. Then, eight design parameters, which are empirically believed to be important for controlling HMB deformation, were selected for the parametric analysis. Subsequently, the HMB deformation and retention torque after ball swaging were calculated using an analytical solution for HMB deformation, previously presented by the author, and the retention torque equation. As a result of this study, an optimal design for the HMB and its analysis results are presented, together with design guidelines for the HMB.	Kansai Univ, Dept Mech Engn, Suita, Osaka, Japan	Koganezawa, S (reprint author), Kansai Univ, Dept Mech Engn, 3-3-35 Yamate Cho, Suita, Osaka, Japan.	skoga@kansai-u.ac.jp					Aoki K, 2007, MICROSYST TECHNOL, V13, P943, DOI 10.1007/s00542-006-0299-4; Ee KC, 2010, J ADV MECH DES SYST, V4, P88, DOI 10.1299/jamdsm.4.88; Khenukhieo P, 2010, KKU RES J, V15, P581; Koganezawa S, 2013, SPRINGER MICROSYST T, DOI [10.1007/s00542-013-2047-x, DOI 10.1007/S00542-013-2047-X]	4	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0946-7076	1432-1858		MICROSYST TECHNOL	Microsyst. Technol.	JUL	2015	21	7					1523	1532		10.1007/s00542-014-2365-7		10	Engineering, Electrical & Electronic; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Engineering; Science & Technology - Other Topics; Materials Science; Physics	CK0ZB	WOS:000355933300020		
J	Hirayama, J; Ogawa, T; Hyvarinen, A				Hirayama, Jun-ichiro; Ogawa, Takeshi; Hyvaerinen, Aapo			Unifying Blind Separation and Clustering for Resting-State EEG/MEG Functional Connectivity Analysis	NEURAL COMPUTATION			English	Article							INDEPENDENT COMPONENT ANALYSIS; BRAIN CONNECTIVITY; NETWORKS; DYNAMICS; EEG; DEPENDENCIES; MODELS; AREA	Unsupervised analysis of the dynamics (nonstationarity) of functional brain connectivity during rest has recently received a lot of attention in the neuroimaging and neuroengineering communities. Most studies have used functional magnetic resonance imaging, but electroencephalography (EEG) and magnetoencephalography (MEG) also hold great promise for analyzing nonstationary functional connectivity with high temporal resolution. Previous EEG/MEG analyses divided the problem into two consecutive stages: the separation of neural sources and then the connectivity analysis of the separated sources. Such nonoptimal division into two stages may bias the result because of the different prior assumptions made about the data in the two stages. We propose a unified method for separating EEG/MEG sources and learning their functional connectivity (coactivation) patterns. We combine blind source separation (BSS) with unsupervised clustering of the activity levels of the sources in a single probabilistic model. A BSS is performed on the Hilbert transforms of band-limited EEG/MEG signals, and coactivation patterns are learned by a mixture model of source envelopes. Simulation studies show that the unified approach often outperforms conventional two-stage methods, indicating further the benefit of using Hilbert transforms to deal with oscillatory sources. Experiments on resting-state EEG data, acquired in conjunction with a cued motor imagery or nonimagery task, also show that the states (clusters) obtained by the proposed method often correlate better with physiologically meaningful quantities than those obtained by a two-stage method.	[Hirayama, Jun-ichiro; Ogawa, Takeshi; Hyvaerinen, Aapo] Adv Telecommun Res Inst Int ATR, Kyoto 6190288, Japan; [Hyvaerinen, Aapo] Univ Helsinki, Dept Comp Sci, Helsinki 00560, Finland; [Hyvaerinen, Aapo] Univ Helsinki, HIIT, Helsinki 00560, Finland	Hirayama, J (reprint author), Adv Telecommun Res Inst Int ATR, Kyoto 6190288, Japan.	hirayama@atr.jp; t.ogawa@atr.jp; aapo.hyvarinen@helsinki.fi					Amari S, 1996, ADV NEUR IN, V8, P757; Gomez-Herrero G, 2008, NEUROIMAGE, V43, P497, DOI 10.1016/j.neuroimage.2008.07.032; Osindero S, 2006, NEURAL COMPUT, V18, P381, DOI 10.1162/089976606775093936; Valpola H, 2004, SIGNAL PROCESS, V84, P267, DOI 10.1016/j.sigpro.2003.10.014; Shi LC, 2008, IEEE ENG MED BIO, P54, DOI 10.1109/IEMBS.2008.4649089; Ramkumar P, 2014, NEUROIMAGE, V86, P480, DOI 10.1016/j.neuroimage.2013.10.032; Hyvarinen A, 2000, NEURAL COMPUT, V12, P1705, DOI 10.1162/089976600300015312; Hirayama J, 2014, IEEE ENG MED BIO, P4932, DOI 10.1109/EMBC.2014.6944730; Kawanabe M, 2005, J MACH LEARN RES, V6, P453; Hyvarinen A, 2010, NEUROIMAGE, V49, P257, DOI 10.1016/j.neuroimage.2009.08.028; Makeig S, 2012, P IEEE, V100, P1567, DOI 10.1109/JPROC.2012.2185009; [Anonymous], 2009, SPR S COMPUTAT NEURO; Vinh NX, 2010, J MACH LEARN RES, V11, P2837; de Pasquale F, 2010, P NATL ACAD SCI USA, V107, P6040, DOI 10.1073/pnas.0913863107; Allen EA, 2014, CEREB CORTEX, V24, P663, DOI 10.1093/cercor/bhs352; Britz J, 2010, NEUROIMAGE, V52, P1162, DOI 10.1016/j.neuroimage.2010.02.052; Brookes MJ, 2011, P NATL ACAD SCI USA, V108, P16783, DOI 10.1073/pnas.1112685108; Leonardi N, 2013, NEUROIMAGE, V83, P937, DOI 10.1016/j.neuroimage.2013.07.019; Hyvarinen A, 2010, J MACH LEARN RES, V11, P1709; Haufe S, 2010, IEEE T BIO-MED ENG, V57, P1954, DOI 10.1109/TBME.2010.2046325; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; Hyvarinen A, 2001, NEURAL COMPUT, V13, P1527, DOI 10.1162/089976601750264992; Hironaga N, 2007, NEUROIMAGE, V34, P1519, DOI 10.1016/j.neuroimage.2006.10.030; Lance BJ, 2012, P IEEE, V100, P1585, DOI 10.1109/JPROC.2012.2184830; Smith SM, 2012, P NATL ACAD SCI USA, V109, P3131, DOI 10.1073/pnas.1121329109; Pfurtscheller G, 1997, NEUROSCI LETT, V239, P65, DOI 10.1016/S0304-3940(97)00889-6; Bingham E, 2000, Int J Neural Syst, V10, P1, DOI 10.1142/S0129065700000028; Bishop C. M., 2006, PATTERN RECOGNITION; Cadieu CF, 2012, NEURAL COMPUT, V24, P827, DOI 10.1162/NECO_a_00247; Dahne S, 2014, NEUROIMAGE, V96, P334, DOI 10.1016/j.neuroimage.2014.03.075; Friston Karl J., 1994, Human Brain Mapping, V2, P56, DOI 10.1002/hbm.460020107; Fukushima M, 2015, NEUROIMAGE, V105, P408, DOI 10.1016/j.neuroimage.2014.09.066; Grosse-Wentrup M., 2011, INT J BIOELECTROMAGN, V13, P115; Grosse-Wentrup M., 2009, ADV NEURAL INFORM PR, V21, P561; Hirayama J., 2012, ADV NEURAL INFORM PR, V24, P1872; Hyvarinen A., 2001, INDEPENDENT COMPONEN; Karklin Yan, 2005, Neural Comput, V17, P397, DOI 10.1162/0899766053011474; Keribin C., 2000, SANKHYA A, V62, P49, DOI [10.2307/25051289, DOI 10.2307/25051289]; Koster U, 2010, NEURAL COMPUT, V22, P2308, DOI 10.1162/NECO_a_00010; Liu Xiao, 2013, Front Syst Neurosci, V7, P101, DOI 10.3389/fnsys.2013.00101; Mahot M, 2013, IEEE T SIGNAL PROCES, V61, P3348, DOI 10.1109/TSP.2013.2259823; Ollila E., 2003, P 14 IEEE INT S PERS, P7; Onton J., 2009, FRONTIERS NEUROSCIEN, V159, P99; Ramkumar P, 2012, HUM BRAIN MAPP, V33, P1648, DOI 10.1002/hbm.21303; Salakhutdinov R., 2003, P INT C MACH LEARN, V20, P672; Schreier P J, 2010, STAT SIGNAL PROCESSI; Steele R. J., 2010, FRONTIERS STAT DECIS, P113; Zander TO, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025005; Zhang K., 2010, P 26 C UNC ART INT, P709	49	0	0	MIT PRESS	CAMBRIDGE	ONE ROGERS ST, CAMBRIDGE, MA 02142-1209 USA	0899-7667	1530-888X		NEURAL COMPUT	Neural Comput.	JUL	2015	27	7					1373	1404		10.1162/NECO_a_00747		32	Computer Science, Artificial Intelligence; Neurosciences	Computer Science; Neurosciences & Neurology	CK5FP	WOS:000356248500001		
J	Koyama, S				Koyama, Shinsuke			On the Spike Train Variability Characterized by Variance-to-Mean Power Relationship	NEURAL COMPUTATION			English	Article							DISPERSION MODEL DENSITIES; CORTICAL-NEURONS; POISSON; STATISTICS; PRECISION; CAT	We propose a statistical method for modeling the non-Poisson variability of spike trains observed in a wide range of brain regions. Central to our approach is the assumption that the variance and the mean of interspike intervals are related by a power function characterized by two parameters: the scale factor and exponent. It is shown that this single assumption allows the variability of spike trains to have an arbitrary scale and various dependencies on the firing rate in the spike count statistics, as well as in the interval statistics, depending on the two parameters of the power function. We also propose a statistical model for spike trains that exhibits the variance-to-mean power relationship. Based on this, a maximum likelihood method is developed for inferring the parameters from rate-modulated spike trains. The proposed method is illustrated on simulated and experimental spike trains.	[Koyama, Shinsuke] Inst Stat Math, Dept Stat Modeling, Tokyo 1908562, Japan; [Koyama, Shinsuke] Japan Sci & Technol Agcy, ERATO Sato Live Bioforecasting Project, Kyoto 6190237, Japan; [Koyama, Shinsuke] Adv Telecommun Res Inst Int, Kyoto 6190237, Japan	Koyama, S (reprint author), Inst Stat Math, Dept Stat Modeling, Tokyo 1908562, Japan.	skoyama@ism.ac.jp					Shadlen MN, 1998, J NEUROSCI, V18, P3870; Shimazaki H, 2010, J COMPUT NEUROSCI, V29, P171, DOI 10.1007/s10827-009-0180-4; Lu WL, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/6/063012; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; BERMAN M, 1981, BIOMETRIKA, V68, P143, DOI 10.1093/biomet/68.1.143; Kara P, 2000, NEURON, V27, P635, DOI 10.1016/S0896-6273(00)00072-6; Koyama S, 2014, MATH BIOSCI ENG, V11, P63, DOI 10.3934/mbe.2014.11.63; Nawrot MP, 2008, J NEUROSCI METH, V169, P374, DOI 10.1016/j.jneumeth.2007.10.013; Barbieri R, 2001, J NEUROSCI METH, V105, P25, DOI 10.1016/S0165-0270(00)00344-7; Koyama S, 2008, NEURAL COMPUT, V20, P1776, DOI 10.1162/neco.2008.06-07-540; Rokem A, 2006, J NEUROPHYSIOL, V95, P2541, DOI 10.1152/jn.00891.2005; Berry MJ, 1998, J NEUROSCI, V18, P2200; Reich DS, 1998, J NEUROSCI, V18, P10090; Koyama S, 2013, NEURAL COMPUT, V25, P854, DOI 10.1162/NECO_a_00420; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Kass RE, 2003, NETWORK-COMP NEURAL, V14, P5, DOI 10.1088/0954-898X/14/1/301; Maimon G, 2009, NEURON, V62, P426, DOI 10.1016/j.neuron.2009.03.021; Dunn PK, 2005, STAT COMPUT, V15, P267, DOI 10.1007/s11222-005-4070-y; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; JORGENSEN B, 1987, J ROY STAT SOC B MET, V49, P127; Dunn PK, 2008, STAT COMPUT, V18, P73, DOI 10.1007/s11222-007-9039-6; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; Averbeck BB, 2009, NEURON, V62, P310, DOI 10.1016/j.neuron.2009.04.021; Britten K. H., 2004, NEURAL SIGNAL ARCH, P1; Casella G., 2002, STAT INFERENCE; Cox D. R., 1962, RENEWAL THEORY; Cunningham J.P., 2008, NEURAL INFORM PROCES, V20, P329; deRuytervan Steveninck R. R., 1997, SCIENCE, V275, P1805; Jorgensen B., 1997, THEORY DISPERSION MO; Kass RE, 2001, NEURAL COMPUT, V13, P1713, DOI 10.1162/08997660152469314; Koyama S, 2014, ARXIVORG14096800PHYS; Koyama S, 2005, J PHYS A-MATH GEN, V38, pL531, DOI 10.1088/0305-4470/38/29/L04; Nelder J., 1989, GEN LINEAR MODELS; Pillow J. W., 2008, NEURAL INFORM PROCES, V22, P1473; Rokem A., 2009, RECORDING GRASSHOPPE; Shinomoto S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000433; Shinomoto S, 2003, NEURAL COMPUT, V15, P2823, DOI 10.1162/089976603322518759; Teich MC, 1997, J OPT SOC AM A, V14, P529, DOI 10.1364/JOSAA.14.000529; TROY JB, 1992, VISUAL NEUROSCI, V9, P535; Vere-Jones D., 2003, INTRO THEORY POINT P	40	0	0	MIT PRESS	CAMBRIDGE	ONE ROGERS ST, CAMBRIDGE, MA 02142-1209 USA	0899-7667	1530-888X		NEURAL COMPUT	Neural Comput.	JUL	2015	27	7					1530	1548		10.1162/NECO_a_00748		19	Computer Science, Artificial Intelligence; Neurosciences	Computer Science; Neurosciences & Neurology	CK5FP	WOS:000356248500006		
J	Sakaguchi, Y; Tanaka, M; Inoue, Y				Sakaguchi, Yutaka; Tanaka, Masato; Inoue, Yasuyuki			Adaptive intermittent control: A computational model explaining motor intermittency observed in human behavior	NEURAL NETWORKS			English	Article						Sensorimotor system; Feedback delay; Motor intermittency; Target tracking; Computational cost; Reliability	ELBOW TRACKING MOVEMENT; HUMAN MANUAL TRACKING; ACT-AND-WAIT; INVERTED PENDULUM; VISUAL FEEDBACK; INTERNAL-MODELS; CONTROL-SYSTEMS; SMITH PREDICTOR; BALANCE CONTROL; HUMAN OPERATOR	It is a fundamental question how our brain performs a given motor task in a real-time fashion with the slow sensorimotor system. Computational theory proposed an influential idea of feed-forward control, but it has mainly treated the case that the movement is ballistic (such as reaching) because the motor commands should be calculated in advance of movement execution. As a possible mechanism for operating feed-forward control in continuous motor tasks (such as target tracking), we propose a control model called "adaptive intermittent control" or "segmented control," that brain adaptively divides the continuous time axis into discrete segments and executes feed-forward control in each segment. The idea of intermittent control has been proposed in the fields of control theory, biological modeling and nonlinear dynamical system. Compared with these previous models, the key of the proposed model is that the system speculatively determines the segmentation based on the future prediction and its uncertainty. The result of computer simulation showed that the proposed model realized faithful visuo-manual tracking with realistic sensorimotor delays and with less computational costs (i.e., with fewer number of segments). Furthermore, it replicated "motor intermittency", that is, intermittent discontinuities commonly observed in human movement trajectories. We discuss that the temporally segmented control is an inevitable strategy for brain which has to achieve a given task with small computational (or cognitive) cost, using a slow control system in an uncertain variable environment, and the motor intermittency is the side-effect of this strategy. (C) 2015 Elsevier Ltd. All rights reserved.	[Sakaguchi, Yutaka; Tanaka, Masato; Inoue, Yasuyuki] Univ Electrocommun, Human Informat Lab, Grad Sch Informat Syst, Chofu, Tokyo 1828585, Japan	Sakaguchi, Y (reprint author), Univ Electrocommun, Human Informat Lab, Grad Sch Informat Syst, 1-5-1 Chofugaoka, Chofu, Tokyo 1828585, Japan.	sakaguchi@is.uec.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan [21120012]; Japan Society for the Promotion of Science (JSPS) [26280101]	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas "The study on the neural dynamics for understanding communication in terms of complex hetero systems (No. 4103)" (#21120012) of The Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan and Grant-in-Aid for Scientific Research (B) (#26280101) of Japan Society for the Promotion of Science (JSPS). We thank Prof. Shunji Sato, Prof. Yoshiyuki Sato and Prof. Jun Izawa for their helpful comments on the present study, and Ms. Yoko Tsuda and Ms. Akiyo Hotchi for their meticulous support during this study.	Saunders JA, 2003, EXP BRAIN RES, V152, P341, DOI 10.1007/s00221-003-1525-2; de Xivry JJO, 2013, J NEUROSCI, V33, P17301, DOI 10.1523/JNEUROSCI.2321-13.2013; Vince MA, 1948, B J PSYCHOL-GEN SECT, V38, P149; Milton J, 2009, CHAOS, V19, DOI 10.1063/1.3141429; Miall RC, 1996, J MOTOR BEHAV, V28, P125; Insperger T, 2014, BIOL CYBERN, V108, P85, DOI 10.1007/s00422-013-0582-2; Gawthrop P, 2011, BIOL CYBERN, V104, P31, DOI 10.1007/s00422-010-0416-4; Cabrera JL, 2004, CHAOS, V14, P691, DOI 10.1063/1.1785453; Novak KE, 2000, EXP BRAIN RES, V132, P419, DOI 10.1007/s002210000366; Kawato M, 1998, NOVART FDN SYMP, V218, P291; Milton J, 2009, PHILOS T R SOC A, V367, P1181, DOI 10.1098/rsta.2008.0257; NAVAS F, 1968, BIOPHYS J, V8, P252; Wolpert DM, 1998, TRENDS COGN SCI, V2, P338, DOI 10.1016/S1364-6613(98)01221-2; Loram ID, 2011, J PHYSIOL-LONDON, V589, P307, DOI 10.1113/jphysiol.2010.194712; Loram ID, 2012, J R SOC INTERFACE, V9, P2070, DOI 10.1098/rsif.2012.0142; Vieira TMM, 2012, J NEUROPHYSIOL, V107, P666, DOI 10.1152/jn.00659.2011; Lakie M, 2006, J PHYSIOL-LONDON, V577, P403, DOI 10.1113/jphysiol.2006.116772; Bottaro A, 2008, HUM MOVEMENT SCI, V27, P473, DOI 10.1016/j.humov.2007.11.005; Suzuki Y, 2012, J THEOR BIOL, V310, P55, DOI 10.1016/j.jtbi.2012.06.019; Roitman AV, 2004, J NEUROPHYSIOL, V91, P901, DOI 10.1152/jn.00261.2003; KEELE SW, 1968, J EXP PSYCHOL, V77, P155, DOI 10.1037/h0025754; KEELE SW, 1968, PSYCHOL BULL, V70, P387, DOI 10.1037/h0026739; Kawato M, 1999, CURR OPIN NEUROBIOL, V9, P718, DOI 10.1016/S0959-4388(99)00028-8; MIALL RC, 1993, J MOTOR BEHAV, V25, P53; Insperger T, 2011, COMMUN NONLINEAR SCI, V16, P2160, DOI 10.1016/j.cnsns.2010.07.025; Asai Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006169; BEPPU H, 1984, BRAIN, V107, P787, DOI 10.1093/brain/107.3.787; BEPPU H, 1987, BRAIN, V110, P1, DOI 10.1093/brain/110.1.1; Cabrera J., 2002, PHYS REV LETT, V89; Craik KJW, 1947, B J PSYCHOL-GEN SECT, V38, P56; Craik KJW, 1948, B J PSYCHOL-GEN SECT, V38, P142; Engel KC, 2000, J NEUROPHYSIOL, V83, P3483; Gawthrop P, 2014, BIOL CYBERN, V108, P159, DOI 10.1007/s00422-014-0587-5; Gawthrop P, 2010, IEEE T CONTR SYST T, V18, P1195, DOI 10.1109/TCST.2009.2034403; Gawthrop P, 2011, INT J CONTROL, V84, P1965, DOI 10.1080/00207179.2011.630759; Gawthrop PJ, 2009, INT J CONTROL, V82, P2235, DOI 10.1080/00207170902978115; Gawthrop PJ, 2010, INT J CONTROL, V83, P1581, DOI 10.1080/00207179.2010.483691; Gawthrop PJ, 2006, CONTROL ENG PRACT, V14, P1347, DOI 10.1016/j.conengprac.2005.09.002; Gollee H, 2012, BIOL CYBERN, V106, P359, DOI 10.1007/s00422-012-0503-9; HOSAKA T, 2006, PROG THEOR PHYS, V161, P314, DOI 10.1143/PTPS.161.314; Inoue Y, 2014, HUM MOVEMENT SCI, V33, P211, DOI 10.1016/j.humov.2013.10.002; Inoue Y, 2015, NEURAL NETWORKS, V62, P91, DOI 10.1016/j.neunet.2014.05.004; Insperger T, 2006, IEEE T CONTR SYST T, V14, P974, DOI 10.1109/TCST.2006.876938; Ishida F., 2004, PHYS REV LETT, V93; Karniel Amir, 2013, Front Comput Neurosci, V7, P12, DOI 10.3389/fncom.2013.00012; Kawato M., 1998, NOVART FDN SYMP, V218, P304; Loram ID, 2006, J PHYSIOL-LONDON, V577, P417, DOI 10.1113/jphysiol.2006.118786; Maciejowski J. M., 2002, PREDICTIVE CONTROL C; MIALL RC, 1993, J MOTOR BEHAV, V25, P203; MIALL RC, 1986, BEHAV BRAIN RES, V20, P185, DOI 10.1016/0166-4328(86)90003-3; Miall RC, 2006, EXP BRAIN RES, V172, P77, DOI 10.1007/s00221-005-0306-5; Milton J., 2008, EUROPHYSICS LETT EPL, V83; Milton JG, 2013, NONLINEAR THEORY ITS, V4, P129; Milton JG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007427; Pasalar S, 2005, EXP BRAIN RES, V163, P214, DOI 10.1007/s00221-004-2169-6; Paul R. P., 1981, ROBOT MANIPULATORS M; PEW RW, 1966, J EXP PSYCHOL, V71, P764, DOI 10.1037/h0023100; Ronco E, 1999, IEE P-CONTR THEOR AP, V146, P426, DOI 10.1049/ip-cta:19990504; Sakaguchi Y, 2004, NEURAL NETWORKS, V17, P935, DOI 10.1016/j.neunet.2004.05.004; Sakaguchi Y, 2008, LECT NOTES COMPUT SC, V4984, P1120; Sakaguchi Y, 2013, ADV COGNITIVE NEUROD, VIII, P461, DOI DOI 10.1007/978-94-007-4792-0_62; van de Kamp C, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002843; Vince MA, 1948, Q J EXP PSYCHOL, V1, P85, DOI 10.1080/17470214808416749; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; WOLPERT DM, 1992, J MOTOR BEHAV, V24, P299	65	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0893-6080	1879-2782		NEURAL NETWORKS	Neural Netw.	JUL	2015	67						92	109		10.1016/j.neunet.2015.03.012		18	Computer Science, Artificial Intelligence; Neurosciences	Computer Science; Neurosciences & Neurology	CK4MR	WOS:000356198400008		
J	Vaikath, NN; Majbour, NK; Paleologou, KE; Ardah, MT; van Dam, E; van de Berg, WDJ; Forrest, SL; Parkkinen, L; Gai, WP; Hattori, N; Takanashi, M; Lee, SJ; Mann, DMA; Imai, Y; Halliday, GM; Li, JY; El-Agnaf, OMA				Vaikath, Nishant N.; Majbour, Nour K.; Paleologou, Katerina E.; Ardah, Mustafa T.; van Dam, Esther; van de Berg, Wilma D. J.; Forrest, Shelley L.; Parkkinen, Laura; Gai, Wei-Ping; Hattori, Nobutaka; Takanashi, Masashi; Lee, Seung-Jae; Mann, David M. A.; Imai, Yuzuru; Halliday, Glenda M.; Li, Jia-Yi; El-Agnaf, Omar M. A.			Generation and characterization of novel conformation-specific monoclonal antibodies for alpha-synuclein pathology	NEUROBIOLOGY OF DISEASE			English	Article						alpha-Synuclein; Conformation-specific monoclonal antibodies; Parkinson's disease; Dementia with Lewy bodies	MULTIPLE SYSTEM ATROPHY; PARKINSONS-DISEASE; LEWY BODIES; ALZHEIMERS-DISEASE; ELEVATED LEVELS; NEURODEGENERATIVE DISORDERS; SOLUBLE OLIGOMERS; MEMBRANE-BINDING; VESICLE DOCKING; BRAIN PATHOLOGY	alpha-Synuclein (alpha-syn), a small protein that has the intrinsic propensity to aggregate, is implicated in several neurodegenerative diseases including Parkinson's disease (PD), dementia with Lewy bodies (DLB), and multiple system atrophy (MSA), which are collectively known as synudeinopathies. Genetic, pathological, biochemical, and animal modeling studies provided compelling evidence that alpha-syn aggregation plays a key role in the pathogenesis of PD and related synudeinopathies. It is therefore of utmost importance to develop reliable tools that can detect the aggregated forms of alpha-syn. We describe here the generation and characterization of six novel conformation-specific monoclonal antibodies that recognize specifically alpha-syn aggregates but not the soluble, monomeric form of the protein. The antibodies described herein did not recognize monomers or fibrils generated from other amyloidogenic proteins including beta-syn, gamma-syn, beta-amyloid, tau protein, islet amyloid polypeptide and ABri. Interestingly, the antibodies did not react to overlapping linear peptides spanning the entire sequence of alpha-syn, confirming further that they only detect alpha-syn aggregates. In immunohistochemical studies, the new conformation-specific monoclonal antibodies showed underappreciated small micro-aggregates and very thin neurites in PD and DLB cases that were not observed with generic pan antibodies that recognize linear epitope. Furthermore, employing one of our conformation-specific antibodies in a sandwich based ELISA, we observed an increase in levels of alpha-syn oligomers in brain lysates from DLB compared to Alzheimer's disease and control samples. Therefore, the conformation-specific antibodies portrayed herein represent useful tools for research, biomarkers development diagnosis and even immunotherapy for PD and related pathologies. (C) 2015 Elsevier Inc All rights reserved.	[Vaikath, Nishant N.; Majbour, Nour K.; Ardah, Mustafa T.; El-Agnaf, Omar M. A.] United Arab Emirates Univ, Coll Med & Hlth Sci, Dept Biochem, Al Ain, U Arab Emirates; [Vaikath, Nishant N.; Li, Jia-Yi] Lund Univ, Dept Expt Med Sci, Neural Plast & Repair Unit, Wallenberg Neurosci Ctr, Lund, Sweden; [Majbour, Nour K.; van Dam, Esther; van de Berg, Wilma D. J.] Vrije Univ Amsterdam Med Ctr, Neurosci Campus Amsterdam, Dept Anat & Neurosci, Amsterdam, Netherlands; [Paleologou, Katerina E.] Democritus Univ Thrace, Dept Mol Biol & Genet, Alexandroupolis, Greece; [Forrest, Shelley L.] Univ Sydney, Discipline Pathol, Charles Perkin Ctr, Sydney, NSW 2006, Australia; [Parkkinen, Laura] Univ Oxford, Dept Clin Neurol, Oxford, England; [Gai, Wei-Ping] Flinders Univ S Australia, Sch Med, Dept Human Physiol, Bedford Pk, SA, Australia; [Hattori, Nobutaka; Imai, Yuzuru] Juntendo Univ, Grad Sch Med, Dept Res Parkinsons Dis, Tokyo, Japan; [Hattori, Nobutaka; Takanashi, Masashi] Juntendo Univ, Grad Sch Med, Dept Neurol, Tokyo, Japan; [Lee, Seung-Jae] Seoul Natl Univ, Coll Med, Dept Med, Neurosci Res Inst, Seoul 110799, South Korea; [Mann, David M. A.] Univ Manchester, Salford Royal Fdn NHS Tmst, Clin & Cognit Neurosci Res Grp, Salford M6 BHD, Lancs, England; [Halliday, Glenda M.] Univ New S Wales, Fac Med, Sydney, NSW, Australia; [Halliday, Glenda M.] Neurosci Res Australia, Sydney, NSW, Australia; [El-Agnaf, Omar M. A.] Qatar Fdn, HBKU, Coll Sci Engn & Technol, Doha, Qatar	El-Agnaf, OMA (reprint author), Qatar Fdn, HBKU, Coll Sci Engn & Technol, Life Sci Sect, Doha, Qatar.	oelagnaf@qf.org.qa	Halliday, Glenda/E-8555-2011; 	Halliday, Glenda/0000-0003-0422-8398; Li, Jia-Yi/0000-0002-7770-7376	UAE University (UPAR grant) [31M127]; Alzheimer Brian Bank UK; Medical Research Council; NIHR Oxford Biomedical Research Centre; Stichting Parkinson Fonds (SPF; The Netherlands); Neuroscience Campus Amsterdam, VUmc; Alzheimer's Research UK; Alzheimer's Society through Manchester brain bank under the Brian for Dementia Research (BDR) initiative; Netherlands Brain Bank (Amsterdam, the Netherlands)	The laboratory of O.M.E. is supported by UAE University (UPAR grant, Grant No. 31M127). GMH is a National Health and Medical Research Council (NHMRC) Senior Principal Research Fellow (630434). Human brain tissue samples were received from the Sydney Brain Bank, which is supported by Neuroscience Research Australia, the University of New South Wales and the NHMRC. The Oxford Brain Bank is supported by Alzheimer Brian Bank UK, the Medical Research Council and the NIHR Oxford Biomedical Research Centre. The laboratory of WvdB is supported by the Stichting Parkinson Fonds (SPF; The Netherlands) and Neuroscience Campus Amsterdam, VUmc. We are grateful to all patients and controls for donating their brains. We acknowledge the support of Alzheimer's Research UK and Alzheimer's Society through their funding of the Manchester brain bank under the Brian for Dementia Research (BDR) initiative. We thank the Netherlands Brain Bank (Amsterdam, the Netherlands), especially Michiel Kooreman (technical coordinator) and Annemieke J.M. Rozemuller (neuropathologist, VUmc), for providing support. We would also like to acknowledge the valuable work of Angela Ingrassia (senior research technician; VUmc), who provided technical support. We also thank Masako Itaya (Jutendo University Graduate School of Medicine, Japan) and Hasegawa Kazuko (National Hospital Organization, Sagamihara National Hospital, Japan) for their support.	Aasly JO, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00248; Games D, 2014, J NEUROSCI, V34, P9441, DOI 10.1523/JNEUROSCI.5314-13.2014; Parnetti L, 2013, NAT REV NEUROL, V9, P131, DOI [10.1038/nrneurol.2013.10, 10.1038/nmeurol.2013.10]; Dickson DW, 1999, AM J PATHOL, V155, P1241, DOI 10.1016/S0002-9440(10)65226-1; Wang LN, 2014, CURR BIOL, V24, P2319, DOI 10.1016/j.cub.2014.08.027; Masliah E, 2005, NEURON, V46, P857, DOI 10.1016/j.neuron.2005.05.010; Mougenot ALJ, 2010, J NEUROSCI METH, V192, P268, DOI 10.1016/j.jneumeth.2010.08.010; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Ross OA, 2008, ANN NEUROL, V63, P743, DOI 10.1002/ana.21380; Tokuda T, 2010, NEUROLOGY, V75, P1766, DOI 10.1212/WNL.0b013e3181fd613b; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Kahle PJ, 2000, J NEUROSCI, V20, P6365; O'Dowd ST, 2013, J ALZHEIMERS DIS, V33, P923, DOI 10.3233/JAD-2012-121393; Baba M, 1998, AM J PATHOL, V152, P879; Bae EJ, 2012, J NEUROSCI, V32, P13454, DOI 10.1523/JNEUROSCI.1292-12.2012; Rockenstein E, 2014, BRAIN, V137, P1496, DOI 10.1093/brain/awu057; El-Agnaf OMA, 2003, LANCET NEUROL, V2, P461, DOI 10.1016/S1474-4422(03)00481-2; Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Lesage S, 2013, ANN NEUROL, V73, P459, DOI 10.1002/ana.23894; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Luk KC, 2012, J EXP MED, V209, P975, DOI 10.1084/jem.20112457; Giasson BI, 2000, J NEUROSCI RES, V59, P528, DOI 10.1002/(SICI)1097-4547(20000215)59:4<528::AID-JNR8>3.0.CO;2-0; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Burre J, 2014, P NATL ACAD SCI USA, V111, pE4274, DOI 10.1073/pnas.1416598111; Spillantini MG, 1998, NEUROSCI LETT, V251, P205; Sharon R, 2003, NEURON, V37, P583, DOI 10.1016/S0896-6273(03)00024-2; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Sacino AN, 2014, P NATL ACAD SCI USA, V111, P10732, DOI 10.1073/pnas.1321785111; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; Choi BK, 2013, P NATL ACAD SCI USA, V110, P4087, DOI 10.1073/pnas.1218424110; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509; Lai Y, 2014, BIOCHEMISTRY-US, V53, P3889, DOI 10.1021/bi5002536; Gai WP, 2000, EXP NEUROL, V166, P324, DOI 10.1006/exnr.2000.7527; Tran HT, 2014, CELL REP, V7, P2054, DOI 10.1016/j.celrep.2014.05.033; Paleologou KE, 2009, BRAIN, V132, P1093, DOI 10.1093/brain/awn349; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Appel-Cresswell S, 2013, MOVEMENT DISORD, V28, P811, DOI 10.1002/mds.25421; Lindersson E, 2004, J BIOL CHEM, V279, P12924, DOI 10.1074/jbc.M306390200; Fagerqvist T, 2013, J NEUROCHEM, V126, P131, DOI 10.1111/jnc.12175; Cremades N, 2012, CELL, V149, P1048, DOI 10.1016/j.cell.2012.03.037; Perrin RJ, 2003, NEUROSCI LETT, V349, P133, DOI 10.1016/S0304-3940(03)00781-X; O'Nuallain B, 2002, P NATL ACAD SCI USA, V99, P1485, DOI 10.1073/pnas.022662599; Croisier E, 2006, NEUROPATH APPL NEURO, V32, P351, DOI 10.1111/j.1365-2990.2006.00722.x; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Yu S, 2007, NEUROSCIENCE, V145, P539, DOI 10.1016/j.neuroscience.2006.12.028; Kovacs GG, 2012, ACTA NEUROPATHOL, V124, P37, DOI 10.1007/s00401-012-0964-x; El-Agnaf OMA, 2006, FASEB J, V20, P419, DOI 10.1096/fj.03-1449com; Ardah MT, 2015, NEUROBIOL DIS, V74, P89, DOI 10.1016/j.nbd.2014.11.007; Ardah MT, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00197; Culvenor JG, 1999, AM J PATHOL, V155, P1173, DOI 10.1016/S0002-9440(10)65220-0; Duda JE, 2002, ANN NEUROL, V52, P205, DOI 10.1002/ana.10279; El-Agnaf O.M., 1998, FEBS LETT, V440, P71; El-Agnaf O.M., 2000, IMPROVED SOLID PHASE, V1st; ElAgnaf OMA, 1997, J NEUROCHEM, V68, P437; El-Agnaf OMA, 2001, BIOCHEMISTRY-US, V40, P3449, DOI 10.1021/bi002278i; Gal W.P., 1999, J NEUROCHEM, V73, P2093; Hansson O, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt255; Martin FL, 2004, PROTEIN PEPTIDE LETT, V11, P229, DOI 10.2174/0929866043407138; Masliah E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019338; Paleologou KE, 2005, BIOCHEM SOC T, V33, P1106; Pametti L, 2014, FRONT AGING NEUROSCI, V6, P53; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Waxman EA, 2008, ACTA NEUROPATHOL, V116, P37, DOI 10.1007/s00401-008-0375-1; Zhang HY, 2013, BIOPHYS J, V104, P2706, DOI 10.1016/j.bpj.2013.04.050	70	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0969-9961	1095-953X		NEUROBIOL DIS	Neurobiol. Dis.	JUL	2015	79						81	99		10.1016/j.nbd.2015.04.009		19	Neurosciences	Neurosciences & Neurology	CK3IV	WOS:000356110700008		
J	Tokizawa, K; Sawada, S; Tai, T; Lu, J; Oka, T; Yasuda, A; Takahashi, M				Tokizawa, Ken; Sawada, Shin-ichi; Tai, Tetsuo; Lu, Jian; Oka, Tatsuo; Yasuda, Akinori; Takahashi, Masaya			Effects of partial sleep restriction and subsequent daytime napping on prolonged exertional heat strain	OCCUPATIONAL AND ENVIRONMENTAL MEDICINE			English	Article							PSYCHOMOTOR VIGILANCE TASK; BODY-TEMPERATURE; CIRCADIAN RHYTHMICITY; ENERGY-BALANCE; DEPRIVATION; EXERCISE; PERFORMANCE; SECRETION; FATIGUE; INTERLEUKIN-6	Objectives It is considered that sleep restriction is one of the risk factors for the development of exertional heat stroke and illness. However, how sleep restriction affects exertional heat strain and the nature of the coping strategy involved in this phenomenon remain unclear. Methods Fourteen healthy subjects were studied on four occasions: after a night of normal sleep (NS, 7-8 h) and after a night of partial sleep restriction (PSR, 4 h), each with or without taking a daytime nap during the subsequent experimental day. The laboratory test consisted of two 40 min periods of moderate walking in a hot room in the morning and the afternoon. Results The increase in rectal temperature during walking was significantly greater in PSR than in NS in the afternoon. The rating scores for physical and psychological fatigue and sleepiness were significantly greater in PSR than in NS, both in the morning and in the afternoon. The reaction times and lapses in the psychomotor vigilance task (PVT) after walking were significantly worse in PSR than in NS in the morning and after lunch. The nap intervention attenuated significantly the scores for fatigue and sleepiness in PSR. Furthermore, the decreased PVT response in PSR was significantly reversed by the nap. Conclusions These results suggest that PSR augments physiological and psychological strain and reduces vigilance in the heat. Taking a nap seemed to be effective in reducing psychological strain and inhibiting the decrease in vigilance.	[Tokizawa, Ken; Sawada, Shin-ichi; Tai, Tetsuo; Lu, Jian; Oka, Tatsuo; Yasuda, Akinori; Takahashi, Masaya] Natl Inst Occupat Safety & Hlth, Kawasaki, Kanagawa 2148585, Japan	Tokizawa, K (reprint author), Natl Inst Occupat Safety & Hlth, Tama Ku, Nagao 6-21-1, Kawasaki, Kanagawa 2148585, Japan.	tokizawa@h.jniosh.go.jp					Shechter A, 2013, AM J CLIN NUTR, V98, P1433, DOI 10.3945/ajcn.113.069427; Takahashi M, 2003, SLEEP MED REV, V7, P227, DOI 10.1053/smrv.2002.0241; CABANAC M, 1979, Q REV BIOL, V54, P1, DOI 10.1086/410981; Rav-Acha M, 2004, AM J MED SCI, V328, P84, DOI 10.1097/00000441-200408000-00003; VANCAUTER E, 1991, J CLIN INVEST, V88, P934, DOI 10.1172/JCI115396; Loh S, 2004, BEHAV RES METH INS C, V36, P339, DOI 10.3758/BF03195580; Hipolide DC, 2006, J NEUROENDOCRINOL, V18, P231, DOI 10.1111/j.1365-2826.2006.01412.x; Epstein Y, 2011, SCAND J MED SCI SPOR, V21, P742, DOI 10.1111/j.1600-0838.2011.01333.x; Casa DJ, 2012, CURR SPORT MED REP, V11, P115, DOI 10.1249/JSR.0b013e31825615cc; Okamoto-Mizuno K, 1999, SLEEP, V22, P767; Hardy JD, 1938, J NUTR, V15, P461; Wright KP, 2002, AM J PHYSIOL-REG I, V283, pR1370, DOI 10.1152/ajpregu.00205.2002; Rogers NL, 2003, FRONT BIOSCI-LANDMRK, V8, pS1056, DOI 10.2741/1174; Vgontzas AN, 1999, J CLIN ENDOCR METAB, V84, P2603, DOI 10.1210/jc.84.8.2603; Armstrong LE, 2007, MED SCI SPORT EXER, V39, P556, DOI 10.1249/MSS.0b013e31802fa199; Lamond N, 2005, AVIAT SPACE ENVIR MD, V76, P486; Lamond N, 2008, BEHAV RES METHODS, V40, P347, DOI 10.3758/BRM.40.1.347; Roach GD, 2006, CHRONOBIOL INT, V23, P1379, DOI 10.1080/07420520601067931; Bosy-Westphal A, 2008, OBESITY FACTS, V1, P266, DOI 10.1159/000158874; Reihmane D, 2013, EUR J APPL PHYSIOL, V113, P851, DOI 10.1007/s00421-012-2491-9; Faraut B, 2011, BRAIN BEHAV IMMUN, V25, P16, DOI 10.1016/j.bbi.2010.08.001; DINARELLO CA, 1991, BRAIN RES, V562, P199, DOI 10.1016/0006-8993(91)90622-3; Temesi J, 2013, MED SCI SPORT EXER, V45, P2243, DOI 10.1249/MSS.0b013e31829ce379; Yamada M, 2002, J APPL PHYSIOL, V92, P1789, DOI 10.1152/japplphysiol.00629.2001; Vgontzas AN, 2004, J CLIN ENDOCR METAB, V89, P2119, DOI 10.1210/jc.2003-031562; Koban M, 2005, AM J PHYSIOL-ENDOC M, V289, pE68, DOI 10.1152/ajpendo.00543.2004; ARMSTRONG LE, 1990, MED SCI SPORT EXER, V22, P36; BABKOFF H, 1991, SLEEP, V14, P534; DEWASMES G, 1993, EUR J APPL PHYSIOL O, V66, P542, DOI 10.1007/BF00634307; Dinges DF, 1989, SLEEP ALERTNESS CHRO, P171; DINGES DF, 1988, WORK STRESS, V2, P139, DOI 10.1080/02678378808259158; Fortes MB, 2013, MED SCI SPORT EXER, V45, P1915, DOI 10.1249/MSS.0b013e318294b0f8; HASKELL EH, 1981, ELECTROEN CLIN NEURO, V51, P494, DOI 10.1016/0013-4694(81)90226-1; HORNE JA, 1984, SLEEP, V7, P168; Johnson M P, 1992, J Sleep Res, V1, P24; KOLKA MA, 1988, J APPL PHYSIOL, V64, P1575; Lee IS, 2010, J CLIN SLEEP MED, V6, P163; LEMAY LG, 1990, AM J PHYSIOL, V258, pR798; Lucas Rebekah A I, 2014, Extrem Physiol Med, V3, P14, DOI 10.1186/2046-7648-3-14; MARTIN BJ, 1981, EUR J APPL PHYSIOL O, V47, P345, DOI 10.1007/BF02332962; MARTIN BJ, 1981, MED SCI SPORT EXER, V13, P220, DOI 10.1249/00005768-198104000-00002; Ministry of Health L and M, 2013, HEAT STROK INC WORKP; Moore JP, 2013, EUR J APPL PHYSIOL, V113, P2353, DOI 10.1007/s00421-013-2671-2; MYLES WS, 1985, MED SCI SPORT EXER, V17, P580; Oakley NR, 1997, VALIDATION POLYSOMNO; Okamoto-Mizuno K, 2012, J PHYSIOL ANTHROPOL, V31, DOI 10.1186/1880-6805-31-14; PIETROWSKY R, 1994, J CLIN ENDOCR METAB, V78, P683, DOI 10.1210/jc.78.3.683; PLYLEY MJ, 1987, EUR J APPL PHYSIOL O, V56, P338, DOI 10.1007/BF00690902; SAWKA MN, 1984, AM J PHYSIOL, V246, pR72; Vgontzas AN, 2007, AM J PHYSIOL-ENDOC M, V292, P253; WEIBEL L, 1995, SLEEP, V18, P549; WEITZMAN ED, 1983, J CLIN ENDOCR METAB, V56, P352	52	4	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1351-0711	1470-7926		OCCUP ENVIRON MED	Occup. Environ. Med.	JUL	2015	72	7					521	528		10.1136/oemed-2014-102548		8	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CK5WR	WOS:000356298200010		
J	El-Morsey, A; El-Seify, M; Desouky, AY; Abdel-Aziz, MM; Sakai, H; Yanai, T				El-Morsey, A.; El-Seify, M.; Desouky, A. Y.; Abdel-Aziz, M. M.; Sakai, H.; Yanai, T.			Sarcocystis chloropusae (protozoa: Sarcocystidae) n. sp from the common moorhen (Gallinula chloropus) from Egypt	PARASITOLOGY			English	Article						common moorhen (Gallinula chloropus); Sarcocystis chloropusae; Sarcocyst; Phylogeny; ITS-1	ANAS-PLATYRHYNCHOS; CYST MORPHOLOGY	A new name Sarcocystis chloropusae is proposed for a parasite previously found in two of 25 common moorhen (Gallinula chloropus) from Brolos Lake, Egypt. Sarcocysts were microscopic, up to 650 mu m long, the cyst wall was up to 4.5 mu m thick, and contained villar protrusions that were up to 4 mu m long and up to 2 mu m wide. The villar protrusions were crowded, contained vesicles but lacked microtubules. The ground substance layer was smooth. The bradyzoites were up to 12 mu m long and up to 2 mu m wide. Molecular characterization and phylogenetic analysis of the (ITS-1) supported the conclusion that the Sarcocystis in G. chloropus is a distinct species.	[El-Morsey, A.; Abdel-Aziz, M. M.] Natl Res Ctr, Vet Res Div, Parasitol & Anim Dis Dept, Giza, Egypt; [El-Seify, M.; Desouky, A. Y.] KafrElsheikh Univ, Fac Vet Med, Dept Parasitol, Kafrelsheikh, Egypt; [El-Morsey, A.; Sakai, H.; Yanai, T.] Gifu Univ, Fac Appl Biol Sci, Lab Vet Pathol, Gifu 5011193, Japan	Yanai, T (reprint author), Gifu Univ, Fac Appl Biol Sci, Lab Vet Pathol, 1-1 Yanagido, Gifu 5011193, Japan.	yanai@gifu-u.ac.jp			Missions Department of the Ministry of Higher Education and Scientific Research, Egypt [MIS]	Ahmed El-Morsey is a PhD researcher funded by the Missions Department of the Ministry of Higher Education and Scientific Research, Egypt (Grant No. MIS; 2007-2012).	El-Morsey A, 2014, PARASITOL RES, V113, P391, DOI 10.1007/s00436-013-3667-x; Kutkiene L, 2010, PARASITOL RES, V107, P879, DOI 10.1007/s00436-010-1945-4; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Kutkiene L, 2012, PARASITOL RES, V110, P1043, DOI 10.1007/s00436-011-2588-9; Dubey J. P, 1989, SARCOCYSTOSIS ANIMAL; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kutkiene L, 2008, PARASITOL RES, V102, P691, DOI 10.1007/s00436-007-0813-3; Kutkiene L, 2006, PARASITOL RES, V99, P562, DOI 10.1007/s00436-006-0196-x; Nei M., 1987, BIOL EVOL, V4, P406; Dubey Jitender P., 2001, P478, DOI 10.1002/9780470377000.ch17d	11	1	1	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0031-1820	1469-8161		PARASITOLOGY	Parasitology	JUL	2015	142	8					1063	1065		10.1017/S0031182015000293		3	Parasitology	Parasitology	CK2NZ	WOS:000356048900007		
J	Suda, K; Sueyoshi, R; Okawada, M; Koga, H; Lane, GJ; Yamataka, A; Doi, T				Suda, Kazuto; Sueyoshi, Ryo; Okawada, Manabu; Koga, Hiroyuki; Lane, Geoffrey J.; Yamataka, Atsuyuki; Doi, Takashi			Completely intramural bronchogenic cyst of the cervical esophagus in a neonate	PEDIATRIC SURGERY INTERNATIONAL			English	Article						Bronchogenic cyst; Neonate; Intramural; Esophagus; Cervix	OF-THE-LITERATURE; THORACOSCOPIC EXCISION; NECK; DIAGNOSIS	Bronchogenic cysts are congenital cystic lesions of foregut origin, usually intrapulmonary or mediastinal, while esophageal cysts generally originate within the esophagus. To the best of our knowledge, this is the first report of a case of a completely intramural bronchogenic cyst of the cervical esophagus in a neonate.	[Suda, Kazuto; Sueyoshi, Ryo; Okawada, Manabu; Koga, Hiroyuki; Lane, Geoffrey J.; Yamataka, Atsuyuki; Doi, Takashi] Juntendo Univ, Dept Pediat Gen & Urogenital Surg, Sch Med, Bunkyo Ku, Tokyo 1138421, Japan	Doi, T (reprint author), Juntendo Univ, Dept Pediat Gen & Urogenital Surg, Sch Med, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	yama@juntendo.ac.jp; doi@juntendo.ac.jp					Akutsu Y, 2006, DIGEST SURG, V23, P209, DOI 10.1159/000094751; Hallani H, 2004, LANCET, V363, P452, DOI 10.1016/S0140-6736(04)15492-5; Nobuhara KK, 1997, J PEDIATR SURG, V32, P1408, DOI 10.1016/S0022-3468(97)90550-9; Ko SF, 2006, CLIN IMAG, V30, P309, DOI 10.1016/j.clinimag.2006.02.003; Turkyilmaz A, 2007, DIS ESOPHAGUS, V20, P461, DOI 10.1111/j.1442-2050.2007.00729.x; Westerterp M, 2004, ENDOSCOPY, V36, P1119, DOI 10.1055/s-2004-826042; Sashiyama H, 2002, GASTROINTEST ENDOSC, V56, P141, DOI 10.1067/mge.2002.125231; Chafik Aziz, 2011, Asian Cardiovasc Thorac Ann, V19, P69, DOI 10.1177/0218492310394465; COHEN SR, 1982, ANN OTO RHINOL LARYN, V91, P622; Guillem P, 1997, EUR J CARDIO-THORAC, V12, P925, DOI 10.1016/S1010-7940(97)00260-1; HARMAND D, 1981, AM J GASTROENTEROL, V75, P321; Koizumi K, 1998, SURG TODAY, V28, P446; Kollias VD, 1998, RESPIRATION, V65, P208, DOI 10.1159/000029263; Mehta RP, 2004, INT J PEDIATR OTORHI, V68, P563, DOI 10.1016/j.ijporl.2003.12.015; Moz U, 2009, ACTA OTORHINOLARYNGO, V29, P36; Ott K, 1998, Dis Esophagus, V11, P130; Porte HL, 2001, ANN THORAC SURG, V71, P1703, DOI 10.1016/S0003-4975(00)02299-2; Pujary K, 2001, INT J PEDIATR OTORHI, V57, P145, DOI 10.1016/S0165-5876(00)00412-2; Rapado F, 1998, J LARYNGOL OTOL, V112, P893; Sasajima K, 1999, HEPATO-GASTROENTEROL, V46, P1785; Ustundag E, 2005, J LARYNGOL OTOL, V119, P419; WATSON DI, 1995, SURG ENDOSC-ULTRAS, V9, P824	22	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0179-0358	1437-9813		PEDIATR SURG INT	Pediatr. Surg. Int.	JUL	2015	31	7					683	687		10.1007/s00383-015-3720-1		5	Pediatrics; Surgery	Pediatrics; Surgery	CK0ZI	WOS:000355934000013		
J	Toyoda, H; Saito, M; Sato, H; Kawano, T; Kawakami, S; Yatani, H; Kanematsu, T; Hirata, M; Kang, Y				Toyoda, Hiroki; Saito, Mitsuru; Sato, Hajime; Kawano, Tsutomu; Kawakami, Shinpei; Yatani, Hirofumi; Kanematsu, Takashi; Hirata, Masato; Kang, Youngnam			Enhanced lateral inhibition in the barrel cortex by deletion of phospholipase C-related catalytically inactive protein-1/2 in mice	PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY			English	Article						PRIP; GABA(A) receptor; IPSP; Lateral inhibition; Barrel cortex	RECEPTIVE-FIELDS; SOMATOSENSORY CORTEX; GABA; INDEPENDENCE; HIPPOCAMPUS; NEURONS; SYNAPSE; REAL	We previously demonstrated that the deletion of phospholipase C-related catalytically inactive protein-1/2 (PRIP-1/2) enhances the desensitization of GABA(A) receptors (GABA(A)Rs), while it facilitates their resensitization at the offset of GABA puff, causing a hump-like tail current (tail-I) in layer 3 (L3) pyramidal cells (PCs) of the barrel cortex. In the present study, we investigated whether inhibitory synaptic transmission in L3 PCs in the barrel cortex is altered in the PRIP-1/2 double-knockout (PRIP-DKO) mice, and if so, how the interaction between excitation and inhibition is subsequently modified. PRIP-1/2 deletion resulted in the prolongation of the decay phase of inhibitory postsynaptic currents/potentials (IPSCs/IPSPs) in L3 PCs evoked by stimulation of L3, leaving the overall features of miniature IPSCs unchanged. An optical imaging revealed that the spatiotemporal profile of a horizontal excitation spread across columns in L2/3 caused by L4 stimulation in the barrel cortex was more restricted in PRIP-DKO mice compared to the wild type, while those obtained in the presence of bicuculline were almost identical between the two genotypes. These findings suggest that PRIP-1/2 deletion enhances the lateral inhibition by prolonging inhibitory synaptic actions to limit the intercolumnar integration in the barrel cortex. Considering the present findings together with our previous study including a mathematical simulation, the prolongation of inhibitory synaptic actions is likely to result from an enhancement of desensitization followed by an enhanced resensitization in GABA(A)Rs.	[Toyoda, Hiroki; Saito, Mitsuru; Sato, Hajime; Kawano, Tsutomu; Kawakami, Shinpei; Kang, Youngnam] Osaka Univ, Dept Neurosci & Oral Physiol, Grad Sch Dent, Suita, Osaka 5650871, Japan; [Kawakami, Shinpei] Morinaga & Co Ltd, Div Hlth Care, Nourishment Funct Lab, Yokohama, Kanagawa 2308504, Japan; [Yatani, Hirofumi] Osaka Univ, Dept Fixed Prosthodont, Grad Sch Dent, Suita, Osaka 5650871, Japan; [Kanematsu, Takashi] Hiroshima Univ, Grad Sch Biomed Sci, Div Integrated Med Sci, Dept Dent Pharmacol, Hiroshima 7348553, Japan; [Hirata, Masato] Kyushu Univ, Fac Dent Sci, Lab Mol & Cellular Biochem, Fukuoka 8128582, Japan	Kang, Y (reprint author), Osaka Univ, Dept Neurosci & Oral Physiol, Grad Sch Dent, 1-8 Yamadaoka, Suita, Osaka 5650871, Japan.	kang@dent.osaka-u.ac.jp			Japan Ministry of Education, Culture, Sports, Science and Technology [24229009];  [26290006]	This study was supported by a Grant-in-Aid for Scientific Research to Y.K. (B; 26290006) and by the Japan Ministry of Education, Culture, Sports, Science and Technology to M.H. (S; 24229009).	Wu X, 2012, J BIOL CHEM, V287, P27417, DOI 10.1074/jbc.M112.360461; Kyriazi HT, 1996, J NEUROPHYSIOL, V75, P547; GRINVALD A, 1984, NATURE, V308, P848, DOI 10.1038/308848a0; Mizokami A, 2007, J NEUROSCI, V27, P1692, DOI 10.1523/JNEUROSCI.3155-06.2007; Laaris N, 2000, J NEUROSCI, V20, P1529; Overstreet LS, 2003, J NEUROSCI, V23, P2618; Zarnowska ED, 2009, J NEUROPHYSIOL, V101, P1179, DOI 10.1152/jn.91203.2008; Petersen CCH, 2001, J NEUROSCI, V21, P8435; ARMSTRONGJAMES M, 1992, J NEUROPHYSIOL, V68, P1345; Mizokami A, 2010, J NEUROCHEM, V114, P302, DOI 10.1111/j.1471-4159.2010.06754.x; Kanematsu T, 2002, EMBO J, V21, P1004, DOI 10.1093/emboj/21.5.1004; TRAYNELIS SF, 1993, NEURON, V11, P279, DOI 10.1016/0896-6273(93)90184-S; Anstrom KK, 2007, BEHAV BRAIN RES, V179, P183, DOI 10.1016/j.bbr.2007.01.028; SIGWORTH FJ, 1980, J PHYSIOL-LONDON, V307, P97; Sato H, 2008, J NEUROSCI, V28, P3076, DOI 10.1523/JNEUROSCI.0172-08.2008; Keros S, 2005, J NEUROPHYSIOL, V94, P2073, DOI 10.1152/jn.00520.2005; DYKES RW, 1984, J NEUROPHYSIOL, V52, P1066; Foeller E, 2005, J NEUROPHYSIOL, V94, P4387, DOI 10.1152/jn.00553.2005; Fox K, 2003, J NEUROSCI, V23, P8380; Kitayama T, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-23; Laaris N, 2002, J NEUROPHYSIOL, V87, P1028, DOI 10.1152/jn.00512.2001; Nusser Z, 1997, NEURON, V19, P697, DOI 10.1016/S0896-6273(00)80382-7; THOMPSON SM, 1993, TRENDS NEUROSCI, V16, P222, DOI 10.1016/0166-2236(93)90160-N; Toyoda H, 2014, PFLUGERS ARCH	24	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0031-6768	1432-2013		PFLUG ARCH EUR J PHY	Pflugers Arch.	JUL	2015	467	7					1445	1456		10.1007/s00424-014-1592-1		12	Physiology	Physiology	CK2OK	WOS:000356050100005		
J	Yoshida, T; Nin, F; Ogata, G; Uetsuka, S; Kitahara, T; Inohara, H; Akazawa, K; Komune, S; Kurachi, Y; Hibino, H				Yoshida, Takamasa; Nin, Fumiaki; Ogata, Genki; Uetsuka, Satoru; Kitahara, Tadashi; Inohara, Hidenori; Akazawa, Kohei; Komune, Shizuo; Kurachi, Yoshihisa; Hibino, Hiroshi			NKCCs in the fibrocytes of the spiral ligament are silent on the unidirectional K+ transport that controls the electrochemical properties in the mammalian cochlea	PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY			English	Article						Endocochlear potential; Inner ear; Ion-selective electrodes; K+ transport; Na+,K+,2Cl(-)-cotransporter	STRIA-VASCULARIS; INNER-EAR; INTERMEDIATE CELLS; MARGINAL CELLS; COTRANSPORTER NKCC1; CHLORIDE CHANNELS; CL COTRANSPORTER; FINE-STRUCTURE; RAT COCHLEA; LOCALIZATION	Unidirectional K+ transport across the lateral cochlear wall contributes to the endocochlear potential (EP) of +80 mV in the endolymph, a property essential for hearing. The wall comprises two epithelial layers, the syncytium and the marginal cells. The basolateral surface of the former and the apical membranes of the latter face the perilymph and the endolymph, respectively. Intrastrial space (IS), an extracellular compartment between the two layers, exhibits low [K+] and a potential similar to the EP. This IS potential (ISP) dominates the EP and represents a K+ diffusion potential elicited by a large K+ gradient across the syncytial apical surface. The K+ gradient depends on the unidirectional K+ transport driven by Na+,K+-ATPases on the basolateral surface of each layer and the concomitant Na+,K+,2Cl(-)-cotransporters (NKCCs) in the marginal cell layer. The NKCCs coexpressed with the Na+,K+-ATPases in the syncytial layer also seem to participate in the K+ transport. To test this hypothesis, we examined the electrochemical properties of the lateral wall with electrodes measuring [K+] and potential. Blocking NKCCs by perilymphatic perfusion of bumetanide suppressed the ISP. Unexpectedly and unlike the inhibition of the syncytial Na+,K+-ATPases, the perfusion barely altered the electrochemical properties of the syncytium but markedly augmented [K+] of the IS. Consequently, the K+ gradient decreased and the ISP declined. These observations resembled those when the marginal cells' Na+,K+-ATPases or NKCCs were blocked with vascularly applied inhibitors. It is plausible that NKCCs in the marginal cells are affected by the perilymphatically perfused bumetanide, and these transporters, but not those in the syncytium, mediate the unidirectional K+ transport.	[Yoshida, Takamasa; Nin, Fumiaki; Ogata, Genki; Uetsuka, Satoru; Hibino, Hiroshi] Niigata Univ, Sch Med, Dept Mol Physiol, Chuo Ku, Niigata, Niigata 9518510, Japan; [Yoshida, Takamasa; Nin, Fumiaki; Ogata, Genki; Uetsuka, Satoru; Hibino, Hiroshi] Niigata Univ, Ctr Transdisciplinary Res, Niigata, Niigata 9518510, Japan; [Yoshida, Takamasa; Komune, Shizuo] Kyushu Univ, Grad Sch Med Sci, Dept Otorhinolaryngol, Fukuoka 812, Japan; [Uetsuka, Satoru; Kitahara, Tadashi; Inohara, Hidenori] Osaka Univ, Grad Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Suita, Osaka, Japan; [Kitahara, Tadashi] Nara Med Univ, Dept Otorhinolaryngol Head & Neck Surg, Kashihara, Nara 634, Japan; [Akazawa, Kohei] Niigata Univ, Med & Dent Hosp, Dept Med Informat, Niigata, Niigata 9518510, Japan; [Kurachi, Yoshihisa] Osaka Univ, Grad Sch Med, Dept Pharmacol, Div Mol & Cellular Pharmacol, Suita, Osaka, Japan; [Kurachi, Yoshihisa] Osaka Univ, Ctr Adv Med Engn & Informat, Suita, Osaka, Japan	Hibino, H (reprint author), Niigata Univ, Sch Med, Dept Mol Physiol, Chuo Ku, 1-757 Asahimachi Dori, Niigata, Niigata 9518510, Japan.	hibinoh@med.niigata-u.ac.jp			Global COE Program "in silico medicine" at Osaka University; Ministry of Education, Culture, Sport, Science and Technology of Japan; Senri Life Science Foundation; Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care; Mochida Memorial Foundation for Medical and Pharmaceutical Research; NOVARTIS Foundation (Japan) for the Promotion of Science; Takeda Science Foundation; Naito Foundation; Yujin Memorial Grant; Salt Science Research Foundation; Niigata University [24A006];  [25293058];  [22136002];  [25136704];  [25870248];  [25893075]	We thank Dr. Samuel Lagier (University of Geneva) and Dr. Adria LeBoeuf (University of Lausanne) for their critical reading of the text. This work is supported by following research grants and funds: Grant-in-Aid for Scientific Research B 25293058 (to HH), Grant-in-Aid for Scientific Research on Innovative Areas 22136002 (to YK) and 25136704 (to FN), Grant-in-Aid for Young Scientists B 25870248(to FN), Grant-in-Aid for Research Activity Start-up Research Project 25893075 (to GO), the Global COE Program "in silico medicine" at Osaka University (to YK), and a grant for "Research and Development of Next-Generation Integrated Life Simulation Software" (to YK) from the Ministry of Education, Culture, Sport, Science and Technology of Japan, the Senri Life Science Foundation (to HH), the Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care (to HH), the Mochida Memorial Foundation for Medical and Pharmaceutical Research (to HH), the NOVARTIS Foundation (Japan) for the Promotion of Science (to HH), the Takeda Science Foundation (to HH and FN), the Naito Foundation (to HH), Yujin Memorial Grant (to HH), the Salt Science Research Foundation (to FN), and Grant for Promotion of Niigata University Research Projects (24A006) (to HH).	Adachi N, 2013, J PHYSIOL-LONDON, V591, P4459, DOI 10.1113/jphysiol.2013.258046; HUDSPETH AJ, 1989, NATURE, V341, P397, DOI 10.1038/341397a0; Flagella M, 1999, J BIOL CHEM, V274, P26946, DOI 10.1074/jbc.274.38.26946; Hibino H, 2010, PFLUG ARCH EUR J PHY, V459, P521, DOI 10.1007/s00424-009-0754-z; Spicer SS, 1996, HEARING RES, V100, P80, DOI 10.1016/0378-5955(96)00106-2; WANGEMANN P, 1995, HEARING RES, V84, P19, DOI 10.1016/0378-5955(95)00009-S; Hibino H, 2006, PHYSIOLOGY, V21, P336, DOI 10.1152/physiol.00023.2006; Rickheit G, 2008, EMBO J, V27, P2907, DOI 10.1038/emboj.2008.203; Kennedy HJ, 2003, NAT NEUROSCI, V6, P832, DOI 10.1038/nn1089; Sekine T, 2006, AM J PHYSIOL-RENAL, V290, pF251, DOI 10.1152/ajprenal.00439.2004; KIKUCHI T, 1995, ANAT EMBRYOL, V191, P101, DOI 10.1007/BF00186783; Spicer SS, 2005, HEARING RES, V200, P87, DOI 10.1016/j.heares.2004.09.006; Weber PC, 2001, LARYNGOSCOPE, V111, P1156, DOI 10.1097/00005537-200107000-00006; Zdebik AA, 2009, PHYSIOLOGY, V24, P307, DOI 10.1152/physiol.00018.2009; Ando M, 1999, CELL TISSUE RES, V298, P179, DOI 10.1007/s004419900066; Takeuchi S, 2000, BIOPHYS J, V79, P2572; Wangemann P, 2006, J PHYSIOL-LONDON, V576, P11, DOI 10.1113/jphysiol.2006.112888; Sage CL, 2001, HEARING RES, V160, P1, DOI 10.1016/S0378-5955(01)00308-2; Kelly JJ, 2012, JARO-J ASSOC RES OTO, V13, P473, DOI 10.1007/s10162-012-0322-7; Estevez R, 2001, NATURE, V414, P558, DOI 10.1038/35107099; BEKESY GEORG v., 1952, JOUR ACOUSTICAL SOC AMER, V24, P72; BROWN KT, 1967, VISION RES, V7, P149, DOI 10.1016/0042-6989(67)90080-6; Crouch JJ, 1997, J HISTOCHEM CYTOCHEM, V45, P773; Damkier HH, 2010, PHYSIOLOGY, V25, P239, DOI 10.1152/physiol.00011.2010; DAVIS H, 1961, PHYSIOL REV, V41, P391; Higashiyama K, 2003, HEARING RES, V186, P1, DOI 10.1016/S0378-5955(03)00226-0; HINOJOSA R, 1966, AM J ANAT, V118, P631, DOI 10.1002/aja.1001180218; IKEDA K, 1989, HEARING RES, V39, P279, DOI 10.1016/0378-5955(89)90047-6; Kikuchi Toshihiko, 2000, Medical Electron Microscopy, V33, P51, DOI 10.1007/s007950070001; KONISHI T, 1983, HEARING RES, V11, P219, DOI 10.1016/0378-5955(83)90080-1; KONISHI T, 1961, J ACOUST SOC AM, V33, P349, DOI 10.1121/1.1908659; KUIJPERS W, 1970, PFLUG ARCH EUR J PHY, V320, P359, DOI 10.1007/BF00588214; KUSAKARI J, 1978, ACTA OTO-LARYNGOL, V86, P336, DOI 10.3109/00016487809107512; KUSAKARI J, 1978, LARYNGOSCOPE, V88, P12; Marcus DC, 2010, OXFORD HDB AUDITORY, P213; Mizuta K, 1997, HEARING RES, V106, P154, DOI 10.1016/S0378-5955(97)00010-5; Nin F, 2012, P NATL ACAD SCI USA, V109, P9191, DOI 10.1073/pnas.1120067109; Pace AJ, 2001, HEARING RES, V156, P17, DOI 10.1016/S0378-5955(01)00263-5; Qu CY, 2006, HEARING RES, V213, P79, DOI 10.1016/j.heares.2005.12.012; Qu CY, 2007, JARO-J ASSOC RES OTO, V8, P205, DOI 10.1007/s10162-007-0072-0; SAKAGAMI M, 1991, HEARING RES, V56, P168, DOI 10.1016/0378-5955(91)90166-7; SALT AN, 1987, LARYNGOSCOPE, V97, P984; SANTI PA, 1979, ACTA OTO-LARYNGOL, V88, P1, DOI 10.3109/00016487909137133; Shen W, 2013, J PHYSIOL-LONDON, V591, P133, DOI 10.1113/jphysiol.2012.241042; Slepecky NB, 1996, COCHLEA, P44; SUNOSE H, 1994, HEARING RES, V80, P86, DOI 10.1016/0378-5955(94)90012-4; Takeuchi S, 1999, AM J PHYSIOL-CELL PH, V277, pC91; Takeuchi S, 1998, NEUROSCI LETT, V247, P175, DOI 10.1016/S0304-3940(98)00318-8; WADA J, 1979, LARYNGOSCOPE, V89, P1457; Wu MF, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-23; Wu Q, 1998, AM J PHYSIOL-CELL PH, V275, pC1565	51	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0031-6768	1432-2013		PFLUG ARCH EUR J PHY	Pflugers Arch.	JUL	2015	467	7					1577	1589		10.1007/s00424-014-1597-9		13	Physiology	Physiology	CK2OK	WOS:000356050100015		
J	Fonseca, JD; Grause, G; Kameda, T; Yoshioka, T				Fonseca, Juan Diego; Grause, Guido; Kameda, Tomohito; Yoshioka, Toshiaki			Effects of steam on the thermal dehydrochlorination of poly(vinyl chloride) resin and flexible poly(vinyl chloride) under atmospheric pressure	POLYMER DEGRADATION AND STABILITY			English	Article						Dehydrochlorination; PVC resin; Flexible PVC; Medical waste; Reaction kinetics; Plasticizer	MECHANOCHEMICAL DECHLORINATION RATE; POLYVINYL-CHLORIDE; NAOH/ETHYLENE GLYCOL; WASTE; PVC; TEMPERATURE; DEGRADATION; NAOH; BEHAVIOR; PLASTICIZER	A steam-based treatment for the dehydrochlorination of poly(vinyl chloride) (PVC) at atmospheric pressure was evaluated. Temperatures ranging from 170 to 250 degrees C and steam concentrations of up to 75 vol% were applied to PVC resin and flexible PVC. Overall, the addition of steam increased the dehydrochlorination ratios for both sample types, regardless of temperature. PVC resin reached a maximum dehydrochlorination ratio of 76% after 1 h of treating at 250 degrees C and at a steam concentration of 50 vol%; this compares favorably to the 61% achieved under nitrogen. Higher steam concentrations reduced the maximum dehydrochlorination ratio for PVC resin; this was shown to be the result of a shielding effect due to rapid, superficial dehydrochlorination. This effect was not observed for flexible PVC, which reached a maximum dehydrochlorination ratio of 69% after 1 h of treating at 250 degrees C and at a steam concentration of 75 vol%; again, this is a significant improvement over the 51% value obtained under nitrogen. Moreover, the loss of plasticizer was shown to account for the majority of the flexible PVC weight loss. The reaction kinetics was also investigated. The proposed treatment is of special interest for the treatment of PVC medical equipment, since it could fulfill the needs for both sterilization and dehydrochlorination which the disposal of this waste requires. (c) 2015 Elsevier Ltd. All rights reserved.	[Fonseca, Juan Diego; Grause, Guido; Kameda, Tomohito; Yoshioka, Toshiaki] Tohoku Univ, Grad Sch Environm Studies, Aoba Ku, Sendai, Miyagi 9808579, Japan	Yoshioka, T (reprint author), Tohoku Univ, Grad Sch Environm Studies, Aoba Ku, 6-6-07 Aoba, Sendai, Miyagi 9808579, Japan.	grause@env.che.tohoku.ac.jp; yoshioka@env.che.tohoku.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [25241022]	This work was partially supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan, Grant-in-Aid for Scientific Research (A), 25241022. This research was partly conducted by the Division of Multidisciplinary Research on the Circulation of Waste Resources endowed by the Sendai Environmental Development Co., Ltd.	Kameda T, 2009, CHEMOSPHERE, V74, P287, DOI 10.1016/j.chemosphere.2008.09.009; Yoshioka T, 2005, CHEM LETT, V34, P70, DOI 10.1246/cl.2005.70; Marongiu A, 2003, J ANAL APPL PYROL, V70, P519, DOI 10.1016/S0165-2370(03)00024-X; [Anonymous], 2010, PVC MARK EUR S E AS; Shin SM, 2002, POLYM DEGRAD STABIL, V78, P511, DOI 10.1016/S0141-3910(02)00198-2; Takeshita Y, 2004, J SUPERCRIT FLUID, V31, P185, DOI 10.1016/j.supflu.2003.10.006; [Anonymous], 28553120 CAS; Starnes WH, 2004, MACROMOLECULES, V37, P352, DOI 10.1021/ma0352835; Grause G, 2011, J MATER CYCLES WASTE, V13, P265, DOI 10.1007/s10163-011-0031-z; Starnes WH, 2002, PROG POLYM SCI, V27, P2133, DOI 10.1016/S0079-6700(02)00063-1; Oh SC, 2009, J IND ENG CHEM, V15, P438, DOI 10.1016/j.jiec.2008.11.010; Sadat-Shojai M, 2011, POLYM DEGRAD STABIL, V96, P404, DOI 10.1016/j.polymdegradstab.2010.12.001; Kameda T, 2013, J MATER CYCLES WASTE, V15, P111, DOI 10.1007/s10163-012-0098-1; Blazevska-Gilev J., 2007, J U CHEM TECHNOL MET, V42, P29; Buekens A, 2011, J MATER CYCLES WASTE, V13, P190, DOI 10.1007/s10163-011-0018-9; CUI X, 2010, P AIP C, V1251, P256; Fukushima M, 2009, J MATER CYCLES WASTE, V11, P11, DOI 10.1007/s10163-008-0212-6; Guo L, 2001, POLYMER, V42, P5581, DOI 10.1016/S0032-3861(01)00037-4; Hashimoto K, 2008, J MATER SCI, V43, P2457, DOI 10.1007/s10853-007-2015-x; HOLLANDER A, 1991, EUR POLYM J, V27, P959, DOI 10.1016/0014-3057(91)90040-U; Kakuta N, 2009, J MATER CYCLES WASTE, V11, P23, DOI 10.1007/s10163-008-0214-4; Kameda T, 2009, POLYM DEGRAD STABIL, V94, P1595, DOI 10.1016/j.polymdegradstab.2009.05.006; Kameda T, 2009, POLYM DEGRAD STABIL, V94, P107, DOI 10.1016/j.polymdegradstab.2008.10.006; Kato K, 2006, NIPPON STEEL TECH RE, V94, P75; Koch HM, 2003, INT J HYG ENVIR HEAL, V206, P77, DOI 10.1078/1438-4639-00205; Mio H, 2002, ENVIRON SCI TECHNOL, V36, P1344, DOI 10.1021/es0106220; Osada F, 2010, J MATER CYCLES WASTE, V12, P245, DOI 10.1007/s10163-010-0294-9; Shin SM, 1997, CHEM SOC JPN, V1, P64; Shin SM, 1998, POLYM DEGRAD STABIL, V61, P349, DOI 10.1016/S0141-3910(97)00221-8; Slapak MJP, 2000, COMPUT THEOR POLYM S, V10, P481, DOI 10.1016/S1089-3156(99)00055-0; Starnes WH, 2012, J VINYL ADDIT TECHN, V18, P71, DOI 10.1002/vnl.20281; Tongamp W, 2009, J MATER CYCLES WASTE, V11, P32, DOI 10.1007/s10163-008-0216-2; Yoshihara M, 2010, J MATER CYCLES WASTE, V12, P264, DOI 10.1007/s10163-010-0275-z; Yoshinaga T, 2004, POLYM DEGRAD STABIL, V86, P541, DOI 10.1016/j.polymdegradstab.2004.06.008; Yoshioka T, 2002, P 2 INT S FEEDST REC; Yoshioka T, 2008, POLYM DEGRAD STABIL, V93, P1979, DOI 10.1016/j.polymdegradstab.2008.06.008; Yoshioka T, 2008, POLYM DEGRAD STABIL, V93, P1822, DOI 10.1016/j.polymdegradstab.2008.07.009; Yoshioka T, 2010, J POLYM RES, V17, P489, DOI 10.1007/s10965-009-9335-2	38	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0141-3910	1873-2321		POLYM DEGRAD STABIL	Polym. Degrad. Stabil.	JUL	2015	117						8	15		10.1016/j.polymdegradstab.2015.03.011		8	Polymer Science	Polymer Science	CK3LK	WOS:000356117400002		
J	Mizuno, S; Maeda, T; Kanemura, C; Hotta, A				Mizuno, Sawako; Maeda, Tomoki; Kanemura, Chiharu; Hotta, Atsushi			Biodegradability, reprocessability, and mechanical properties of polybutylene succinate (PBS) photografted by hydrophilic or hydrophobic membranes	POLYMER DEGRADATION AND STABILITY			English	Article						Polybutylene succinate; Biodegradability; Photografting polymerization; Reprocessability; Surface modification; Composite	POLY(BUTYLENE SUCCINATE); ALIPHATIC POLYESTERS; GRAFT-POLYMERIZATION; DEGRADATION RATE; NANOCOMPOSITES; BEHAVIOR; FILMS; ACID; POLY(L-LACTIDE); WETTABILITY	The biodegradability and the reprocessability of surface-modified polybutylene succinate (PBS) covalently grafted by hydrophilic or hydrophobic membrane were investigated. The original ungrafted PBS already possesses desirable mechanical and thermal properties, which are very close to those of widely used polyolefins such as polyethylene and polypropylene, but the intrinsic inflexible biodegradability of PBS is still limiting its practical use. Controlling the biodegradability and the reprocessability of PBS, therefore, is necessary to extend the usage of PBS. In this research, the surface of PBS was modified by the photografting polymerization of hydrophilic acrylic acid (AA) and hydrophobic styrene (St) monomers. The surface of PBS became more hydrophilic by increasing the reaction time of the photografting polymerization of AA (or hydrophobic when St was used). Additionally, to estimate the reprocessability of the photografted PBS, the surface-modified PBS was carefully remolded and hence the grafted-membrane was evenly dispersed in the reprocessed and recycled PBS. The structural and mechanical analyses of the modified PBS revealed that the biodegradability and the reprocessability of PBS were effectively controlled by the surface modification via the photografting polymerization and the successive internal dispersion of the grafted membrane. These experimental results may highly provide a new possibility of the extensive use of PBS as an alternative material for polyolefins. (c) 2015 Elsevier Ltd. All rights reserved.	[Mizuno, Sawako; Maeda, Tomoki; Kanemura, Chiharu; Hotta, Atsushi] Keio Univ, Dept Mech Engn, Yokohama, Kanagawa 2238522, Japan	Hotta, A (reprint author), Keio Univ, Dept Mech Engn, Yokohama, Kanagawa 2238522, Japan.	hotta@mech.keio.ac.jp		Hotta, Atsushi/0000-0001-9516-2739	Japan Society for the Promotion of Science (JSPS: "KAKENHI") [23360294];  [24656395]	This work was supported in part by a Grant-in-Aid for Scientific Research (B) from the Japan Society for the Promotion of Science (JSPS: "KAKENHI") (No. 23360294 to A.H.) and a Grant-in-Aid for Scientific Research for Challenging Exploratory Research (No. 24656395 to A.H.).	Ma HM, 2000, MACROMOLECULES, V33, P331, DOI 10.1021/ma990821s; Neppalli R, 2011, POLYMER, V52, P4054, DOI 10.1016/j.polymer.2011.06.039; Phua YJ, 2011, POLYM DEGRAD STABIL, V96, P1194, DOI 10.1016/j.polymdegradstab.2011.04.017; Kim HS, 2006, POLYM DEGRAD STABIL, V91, P1117, DOI 10.1016/j.polymdegradstab.2005.07.002; Nikolic MS, 2001, POLYM DEGRAD STABIL, V74, P263, DOI 10.1016/S0141-3910(01)00156-2; Kanemura C, 2012, POLYM DEGRAD STABIL, V97, P972, DOI 10.1016/j.polymdegradstab.2012.03.015; Cho K, 2001, J APPL POLYM SCI, V79, P1025; Kallrot M, 2007, BIOMACROMOLECULES, V8, P2492, DOI 10.1021/bm700442j; Kim MC, 2009, REACT FUNCT POLYM, V69, P287, DOI 10.1016/j.reactfunctpolym.2009.01.013; Sun J, 2010, SURF COAT TECH, V204, P4101, DOI 10.1016/j.surfcoat.2010.05.038; Janorkar AV, 2004, MACROMOLECULES, V37, P9151, DOI 10.1021/ma049056u; CHA Y, 1990, BIOMATERIALS, V11, P108, DOI 10.1016/0142-9612(90)90124-9; Fujimaki T, 1998, POLYM DEGRAD STABIL, V59, P209, DOI 10.1016/S0141-3910(97)00220-6; Hirotsu T, 2000, J APPL POLYM SCI, V78, P1121, DOI 10.1002/1097-4628(20001031)78:5<1121::AID-APP210>3.0.CO;2-H; Ray SS, 2003, MACROMOL MATER ENG, V288, P203, DOI 10.1002/mame.200390013; Tserki V, 2006, POLYM DEGRAD STABIL, V91, P367, DOI 10.1016/j.polymdegradstab.2005.04.035; Ahn BD, 2001, J APPL POLYM SCI, V82, P2808; Yoo ES, 1999, J POLYM SCI POL PHYS, V37, P1357, DOI 10.1002/(SICI)1099-0488(19990701)37:13<1357::AID-POLB2>3.0.CO;2-Q; Zhao JH, 2005, J APPL POLYM SCI, V97, P2273, DOI 10.1002/app.22009; Liu LF, 2009, POLYM DEGRAD STABIL, V94, P90, DOI 10.1016/j.polymdegradstab.2008.10.013; Kim HS, 2005, J APPL POLYM SCI, V97, P1513, DOI 10.1002/app.21905; Morent R, 2011, PLASMA PROCESS POLYM, V8, P171, DOI 10.1002/ppap.201000153; Hirotsu T, 1997, J PHOTOPOLYM SCI TEC, V10, P123, DOI 10.2494/photopolymer.10.123; Hoglund A, 2010, LANGMUIR, V26, P378, DOI 10.1021/la902166j; IHN KJ, 1995, MACROMOLECULES, V28, P2460, DOI 10.1021/ma00111a045; Janorkar AV, 2006, J POLYM SCI POL CHEM, V44, P6534, DOI 10.1002/pola.21700; Jin HJ, 2000, J POLYM SCI POL PHYS, V38, P1504, DOI 10.1002/(SICI)1099-0488(20000601)38:11<1504::AID-POLB100>3.0.CO;2-4; Kuan CF, 2006, COMPOS SCI TECHNOL, V66, P2231, DOI 10.1016/j.compscitech.2005.12.011; Nakagawa M, 2011, J APPL POLYM SCI, V119, P2031, DOI 10.1002/app.32931; Okamoto K, 2003, J POLYM SCI POL PHYS, V41, P3160, DOI 10.1002/polb.10708; Tachibana Y, 2010, POLYM DEGRAD STABIL, V95, P1406, DOI 10.1016/j.polymdegradstab.2010.01.006; Takahashi J, 2013, J APPL POLYM SCI, V129, P2591, DOI 10.1002/app.38974; Zhou WD, 2013, J APPL POLYM SCI, V127, P733, DOI 10.1002/app.37724	33	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0141-3910	1873-2321		POLYM DEGRAD STABIL	Polym. Degrad. Stabil.	JUL	2015	117						58	65		10.1016/j.polymdegradstab.2015.03.015		8	Polymer Science	Polymer Science	CK3LK	WOS:000356117400008		
J	Hyakutake, M; Tomizawa, S; Sugahara, I; Murata, E; Mizuno, K; Abe, H; Tsuge, T				Hyakutake, Manami; Tomizawa, Satoshi; Sugahara, Imari; Murata, Erni; Mizuno, Kouhei; Abe, Hideki; Tsuge, Takeharu			Carboxy-terminal modification of polyhydroxyalkanoate (PHA) via alcoholysis reaction catalyzed by Class IV PHA synthase	POLYMER DEGRADATION AND STABILITY			English	Article						Alcoholytic cleavage; Polyhydroxyalkanoate synthase; Bacillus; Carboxy-terminal modification; Functionalization	RECOMBINANT ESCHERICHIA-COLI; CHAIN TRANSFER AGENTS; BACILLUS-CEREUS YB-4; MOLECULAR-WEIGHT; RALSTONIA-EUTROPHA; BIOSYNTHESIS; GLYCEROL; ETHANOL; BLENDS; STRAIN	Polyhydroxyalkanoate (PHA) synthase from the bacterium Bacillus cereus YB-4 (PhaRC(YB4)), a class IV PHA synthase, shows both PHA polymerization and alcoholysis activities. In PhaRC(YB4)-expressing Escherichia coli in the presence of ethanol, biosynthesized PHA is subjected to an ethyl-esterification at the carboxy terminus as a result of alcoholytic cleavage of the PHA chain by PhaRC(YB4). In this study, we investigated the range of alcohol species available for alcoholysis by PhaRC(YB4) using E. coli JM109 as an assay host by monitoring the molecular weight of PHA during the second step of a two-step cultivation. PhaRC(YB4) utilized various alcohols other than ethanol for alcoholysis. Through the use of bifunctional compounds for alcoholysis, the PHA carboxy terminus could be modified with thiol, alkynyl, hydroxy, and benzyl groups, resulting in the functionalization of the PHA carboxy terminus. Furthermore, one-step production of carboxy-terminal functionalized PHA was developed using E. coli XL1-Blue as a production host. (c) 2015 Elsevier Ltd. All rights reserved.	[Hyakutake, Manami; Sugahara, Imari; Murata, Erni; Abe, Hideki; Tsuge, Takeharu] Tokyo Inst Technol, Dept Innovat & Engn Mat, Midori Ku, Yokohama, Kanagawa 2268502, Japan; [Hyakutake, Manami; Abe, Hideki] RIKEN, Ctr Sustainable Resource Sci, Biomass Engn Res Div, Wako, Saitama 3510198, Japan; [Tomizawa, Satoshi] Kumamoto Natl Coll Technol, Dept Biol & Chem Syst Engn, Yatsushiro, Kumamoto 8668501, Japan; [Mizuno, Kouhei] Kitakyushu Natl Coll Technol, Dept Mat Sci & Chem Engn, Kokuraminami Ku, Kitakyushu, Fukuoka 8020985, Japan	Hyakutake, M (reprint author), Tokyo Inst Technol, Dept Innovat & Engn Mat, Midori Ku, 4259 Nagatsuta, Yokohama, Kanagawa 2268502, Japan.	manami.hyakutake@riken.jp; tsuge.t.aa@m.titech.ac.jp	Tsuge, Takeharu/F-6618-2011	Tsuge, Takeharu/0000-0002-6296-6500	JSPS Young Scientist Fellowship [12J07940];  [KAKENHI 23310060]	We thank Dr. Y. Nakamura (Tokyo Institute of Technology) for the NMR analysis. This work was supported by a Grant-in-Aid for Scientific Research (KAKENHI 23310060) to T. Tsuge. M. Hyakutake is a recipient of a JSPS Young Scientist Fellowship (12J07940).	Agus J, 2010, POLYM DEGRAD STABIL, V95, P2250, DOI 10.1016/j.polymdegradstab.2010.09.009; Kusaka S, 1998, J MACROMOL SCI PURE, VA35, P319, DOI 10.1080/10601329808001980; PIZZOLI M, 1994, MACROMOLECULES, V27, P4755, DOI 10.1021/ma00095a016; McCool GJ, 2001, J BACTERIOL, V183, P4235, DOI 10.1128/JB.183.14.4235-4243.2001; Tomizawa S, 2011, BIOMACROMOLECULES, V12, P2660, DOI 10.1021/bm2004687; Kato M, 1996, APPL MICROBIOL BIOT, V45, P363; Mizuno K, 2010, POLYM DEGRAD STABIL, V95, P1335, DOI 10.1016/j.polymdegradstab.2010.01.033; Chen GQ, 2009, CHEM SOC REV, V38, P2434, DOI 10.1039/b812677c; Madden LA, 1999, INT J BIOL MACROMOL, V25, P43, DOI 10.1016/S0141-8130(99)00014-8; Rehm BHA, 2003, BIOCHEM J, V376, P15, DOI 10.1042/BJ20031254; Tsuge T, 2005, MACROMOL BIOSCI, V5, P112, DOI 10.1002/mabi.200400152; Hiroe A, 2013, ACS CHEM BIOL, V8, P2568, DOI 10.1021/cb400465p; Tomizawa S, 2010, APPL MICROBIOL BIOT, V87, P1427, DOI 10.1007/s00253-010-2601-8; Sudesh K, 2000, PROG POLYM SCI, V25, P1503, DOI 10.1016/S0079-6700(00)00035-6; Leong YK, 2014, J BIOTECHNOL, V180, P52, DOI 10.1016/j.jbiotec.2014.03.020; Hyakutake M, 2011, BIOSCI BIOTECH BIOCH, V75, P1615, DOI 10.1271/bbb.110229; Ashby RD, 2005, BIOMACROMOLECULES, V6, P2106, DOI 10.1021/bm058005h; Babinot J, 2011, MACROMOL CHEM PHYS, V212, P278, DOI 10.1002/macp.201000562; Hyakutake M, 2014, APPL MICROBIOL BIOTE; Hyakutake M, 2014, APPL ENVIRON MICROB, V80, P1421, DOI 10.1128/AEM.03576-13; Opsteen JA, 2005, CHEM COMMUN, P57, DOI 10.1039/b412930j; SLATER SC, 1988, J BACTERIOL, V170, P4431; Stubbe J, 2003, NAT PROD REP, V20, P445, DOI 10.1039/b209687k; Tomizawa S, 2013, APPL MICROBIOL BIOT, V97, P4821, DOI 10.1007/s00253-013-4798-9; Tsuge T, 2013, POLYM DEGRAD STABIL, V98, P1586, DOI 10.1016/j.polymdegradstab.2013.06.026	25	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0141-3910	1873-2321		POLYM DEGRAD STABIL	Polym. Degrad. Stabil.	JUL	2015	117						90	96		10.1016/j.polymdegradstab.2015.04.002		7	Polymer Science	Polymer Science	CK3LK	WOS:000356117400012		
J	Imamura, K; Kawakami, N; Furukawa, TA; Matsuyama, Y; Shimazu, A; Umanodan, R; Kawakami, S; Kasai, K				Imamura, K.; Kawakami, N.; Furukawa, T. A.; Matsuyama, Y.; Shimazu, A.; Umanodan, R.; Kawakami, S.; Kasai, K.			Does Internet-based cognitive behavioral therapy (iCBT) prevent major depressive episode for workers? A 12-month follow-up of a randomized controlled trial	PSYCHOLOGICAL MEDICINE			English	Article						Depression; internet cognitive behavioral therapy; prevention; workers	SELF-HELP; DISORDERS; ANXIETY; INTERVENTIONS; SEVERITY; SYMPTOMS; VERSION; JAPAN; CIDI	Background. In this study we investigated whether an Internet-based computerized cognitive behavioral therapy (iCBT) program can decrease the risk of DSM-IV-TR major depressive episodes (MDE) during a 12-month follow-up of a randomized controlled trial of Japanese workers. Method. Participants were recruited from one company and three departments of another company. Those participants who did not experience MDE in the past month were randomly allocated to intervention or control groups (n = 381 for each). A 6-week, six-lesson iCBT program was provided to the intervention group. While the control group only received the usual preventive mental health service for the first 6 months, the control group was given a chance to undertake the iCBT program after a 6-month follow-up. The primary outcome was a new onset of DSM-IV-TR MDE during the 12-month follow-up, as assessed by means of the web version of the WHO Composite International Diagnostic Interview (CIDI), version 3.0 depression section. Results. The intervention group had a significantly lower incidence of MDE at the 12-month follow-up than the control group (Log-rank chi(2) = 7.04, p < 0.01). The hazard ratio for the intervention group was 0.22 (95% confidence interval 0.06-0.75), when estimated by the Cox proportional hazard model. Conclusions. The present study demonstrates that an iCBT program is effective in preventing MDE in the working population. However, it should be noted that MDE was measured by self-report, while the CIDI can measure the episodes more strictly following DSM-IV criteria.	[Imamura, K.; Kawakami, N.; Shimazu, A.] Univ Tokyo, Grad Sch Med, Dept Mental Hlth, Tokyo 1130033, Japan; [Furukawa, T. A.] Kyoto Univ, Sch Publ Hlth, Grad Sch Med, Dept Hlth Promot & Human Behav, Kyoto, Japan; [Furukawa, T. A.] Kyoto Univ, Sch Publ Hlth, Grad Sch Med, Dept Clin Epidemiol, Kyoto, Japan; [Matsuyama, Y.] Univ Tokyo, Grad Sch Med, Dept Biostat, Tokyo 1130033, Japan; [Umanodan, R.] Hlth Wave Co Ltd, Kyoto Off, Kyoto, Japan; [Kawakami, S.] Nippon Univ Coll Arts, Tokyo, Japan; [Kasai, K.] Univ Tokyo, Grad Sch Med, Dept Neuropsychiat, Tokyo 1130033, Japan	Kawakami, N (reprint author), Univ Tokyo, Grad Sch Med, Dept Mental Hlth, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	nkawakami@m.u-tokyo.ac.jp			Japan Society for the Promotion of Science [20240062, 26860433]	The present study was supported by the Grant-in-Aid for Scientific Research (A) 2009 and 2010 (No. 20240062) and the Grant-in-Aid for Young Scientists (B) 2014 (No. 26860433) from the Japan Society for the Promotion of Science. The sponsor of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The authors had access to the data in the study and the final responsibility to submit the paper. We appreciate the help of the following persons in completing this project: Takayuki Narumi, Jun Naoi, Keisuke Kito, Chinatsu Narumi, Fukiko Ueda, and Mizuho Yamagishi.	American Psychiatric Association [APA], 2000, DIAGN STAT MAN MENT; Cuijpers P, 2009, CLIN PSYCHOL REV, V29, P449, DOI 10.1016/j.cpr.2009.04.005; Inoue A, 2013, J OCCUP HEALTH, V55, P47; Lintvedt OK, 2013, CLIN PSYCHOL PSYCHOT, V20, P10, DOI 10.1002/cpp.770; Spek V, 2007, PSYCHOL MED, V37, P319, DOI 10.1017/S0033291706008944; Christensen H, 2004, BRIT MED J, V328, P265, DOI 10.1136/bmj.37945.566632.EE; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Robins JM, 2000, BIOMETRICS, V56, P779, DOI 10.1111/j.0006-341X.2000.00779.x; Furukawa TA, 2008, INT J METH PSYCH RES, V17, P152, DOI 10.1002/mpr.257; Cuijpers P, 2008, AM J PSYCHIAT, V165, P1272, DOI 10.1176/appi.ajp.2008.07091422; Calear AL, 2009, J CONSULT CLIN PSYCH, V77, P1021, DOI 10.1037/a0017391; Kawakami N, 2005, PSYCHIAT CLIN NEUROS, V59, P441, DOI 10.1111/j.1440-1819.2005.01397.x; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; Kessler RC, 2012, PSYCHIAT CLIN N AM, V35, P1, DOI 10.1016/j.psc.2011.11.005; Hiroe T, 2005, PSYCHIAT RES, V135, P229, DOI 10.1016/j.psychres.2004.03.014; Beck AT, 1996, BDI 2 BECK DEPRESSIO; Christensen H, 2002, J MED INTERNET RES, V4, DOI 10.2196/jmir.4.1.e3; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Gega L, 2004, J CLIN PSYCHOL, V60, P147, DOI 10.1002/jclp.10241; Hosman C, 2004, PREVENTION MENTAL DI; Imamura K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097167; Lewinsohn PM, 1984, COPING DEPRESSION CO; Patten SB, 2003, PSYCHIAT SERV, V54, P396, DOI 10.1176/appi.ps.54.3.396; Peters L, 1998, PSYCHOL MED, V28, P893, DOI 10.1017/S0033291798006655; Rowe MM, 1999, J BEHAV MED, V22, P511, DOI 10.1023/A:1018661508593; Ruwaard Jeroen, 2007, Cognitive Behaviour Therapy, V36, P179, DOI 10.1080/16506070701381863; Saarni SI, 2007, BRIT J PSYCHIAT, V190, P326, DOI 10.1192/bjp.bp.106.025106; Shimoda H, 2014, INT J METH PSYCH RES, DOI [10.1002/mpr.1437, DOI 10.1002/MPR.1437]; Titov N, 2010, F1000 MED REPORTS, V2, P49, DOI DOI 10.3410/M2; WHO Department of Mental Health and Substance Abuse, 2001, ATL MENT HLTH RES WO; World Health Organisation, 2011, MENT HLTH ATL 2011; World Health Organization, 2005, MENT HLTH ATL 2005	32	1	1	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0033-2917	1469-8978		PSYCHOL MED	Psychol. Med.	JUL	2015	45	9					1907	1917		10.1017/S0033291714003006		11	Psychology, Clinical; Psychiatry; Psychology	Psychology; Psychiatry	CJ8ME	WOS:000355754800011		
J	Sato, S; Kawahara, JI				Sato, Shiori; Kawahara, Jun I.			Attentional capture by completely task-irrelevant faces	PSYCHOLOGICAL RESEARCH-PSYCHOLOGISCHE FORSCHUNG			English	Article							TOP-DOWN CONTROL; CONTROL SETTINGS; CONTINGENT CAPTURE; BLINK; DISTRACTION; SPEED; ONSET; LOAD	The present study investigated whether faces capture attention regardless of attentional set. The presentation of a face as a distractor during a visual search has been shown to impair performance relative to when the face was absent, implying that faces automatically attract attention. If attentional control is contingent on the observer's current goal, faces should not capture attention when they are irrelevant to the observer's attentional set. Previous studies demonstrating face-induced attentional capture used faces that were relevant to the task. Thus, a task in which faces were completely irrelevant to the observer's set was created. Participants identified a target letter among heterogeneously colored non-targets while ignoring a peripheral facial image that appeared as a brief distractor. No face-specific capture was observed when the target-distractor stimulus onset asynchrony (SOA) was long (Experiment 1). When the SOA was shortened, attentional capture by irrelevant faces was observed (Experiment 2). Experiment 3 extended this finding to all conditions, regardless of the attractiveness of faces. No such capture effect was found in Experiment 4 with inverted-face distractors. These results indicate that completely task-irrelevant faces break through top-down attentional set given a brief distractor-target SOA.	[Sato, Shiori; Kawahara, Jun I.] Chukyo Univ, Dept Psychol, Showa Ku, Nagoya, Aichi 4668666, Japan; [Kawahara, Jun I.] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki, Japan	Kawahara, JI (reprint author), Chukyo Univ, Dept Psychol, Showa Ku, 101-2 Yagoto, Nagoya, Aichi 4668666, Japan.	jkawa@lets.chukyo-u.ac.jp		Kawahara, Jun/0000-0002-4096-3923	MEXT KAKENHI [23119731]	This study was supported by Grant-in-Aid for Scientific Research on Innovative Areas, "Face perception and recognition" from MEXT KAKENHI 23119731 to JK. We thank Shoko Kanaya for her helpful comments on this work.	Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Langton SRH, 2008, COGNITION, V107, P330, DOI 10.1016/j.cognition.2007.07.012; Leber AB, 2006, PSYCHON B REV, V13, P132, DOI 10.3758/BF03193824; Maner JK, 2007, EVOL HUM BEHAV, V28, P28, DOI 10.1016/j.evolhumbehav.2006.05.006; Franconeri SL, 2005, PSYCHOL SCI, V16, P275, DOI 10.1111/j.0956-7976.2005.01528.x; BACON WF, 1994, PERCEPT PSYCHOPHYS, V55, P485, DOI 10.3758/BF03205306; Kirchner H, 2006, VISION RES, V46, P1762, DOI 10.1016/j.visres.2005.10.002; Bindemann M, 2005, PSYCHON B REV, V12, P1048, DOI 10.3758/BF03206442; Li FF, 2002, P NATL ACAD SCI USA, V99, P9596, DOI 10.1073/pnas.092277599; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Van der Stigchel S, 2009, ACTA PSYCHOL, V132, P201, DOI 10.1016/j.actpsy.2009.07.001; Eastwood JD, 2001, PERCEPT PSYCHOPHYS, V63, P1004, DOI 10.3758/BF03194519; Shapiro KL, 1997, TRENDS COGN SCI, V1, P291, DOI 10.1016/S1364-6613(97)01094-2; Lien MC, 2008, J EXP PSYCHOL HUMAN, V34, P509, DOI 10.1037/0096-1523.34.3.509; Ro T, 2001, PSYCHOL SCI, V12, P94, DOI 10.1111/1467-9280.00317; FOLK CL, 1992, J EXP PSYCHOL HUMAN, V18, P1030, DOI 10.1037//0096-1523.18.4.1030; Wyble B, 2013, J EXP PSYCHOL HUMAN, V39, P861, DOI 10.1037/a0030517; KAHNEMAN D, 1983, J EXP PSYCHOL HUMAN, V9, P510, DOI 10.1037//0096-1523.9.4.510; Theeuwes J, 2006, VIS COGN, V13, P657, DOI 10.1080/13506280500410949; Theeuwes J, 2010, ACTA PSYCHOL, V135, P77, DOI 10.1016/j.actpsy.2010.02.006; Folk CL, 2002, PERCEPT PSYCHOPHYS, V64, P741, DOI 10.3758/BF03194741; Forster S, 2008, J EXP PSYCHOL-APPL, V14, P73, DOI 10.1037/1076-898X.14.1.73; Lavie N, 2003, PSYCHOL SCI, V14, P510, DOI 10.1111/1467-9280.03453; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Folk CL, 1998, J EXP PSYCHOL HUMAN, V24, P847, DOI 10.1037/0096-1523.24.3.847; Ansorge U, 2003, J EXP PSYCHOL HUMAN, V29, P937, DOI 10.1037/0096-1523.29.5.937; Bindemann M, 2007, J VISION, V7, DOI 10.1167/7.10.15; Cerf M., 2008, ADV NEURAL INFORM PR, V20, P241; Chen P, 2007, VIS COGN, V15, P637, DOI 10.1080/13506280701317968; Christ SE, 2006, PSYCHON B REV, V13, P875, DOI 10.3758/BF03194012; Einhauser W., 2008, J VISION, V8, P1, DOI [10.1167/8.14.18, DOI 10.1167/8.14.18]; Folk CL, 2008, VIS COGN, V16, P616, DOI 10.1080/13506280601134018; Ghorashi SMS, 2003, J EXP PSYCHOL HUMAN, V29, P78, DOI 10.1037/0096-1523.29.1.78; Halit H, 2004, J CHILD PSYCHOL PSYC, V45, P1228, DOI 10.1111/j.1469-7610.2004.00321.x; Inukai T, 2010, ATTEN PERCEPT PSYCHO, V72, P658, DOI 10.3758/APP.72.3.658; Jenkins R, 2003, PERCEPT PSYCHOPHYS, V65, P298, DOI 10.3758/BF03194801; JONIDES J, 1988, PERCEPT PSYCHOPHYS, V43, P346, DOI 10.3758/BF03208805; Kawahara J., 2012, J VISION, V12, P1; Pratt J, 2002, PERCEPT PSYCHOPHYS, V64, P1361, DOI 10.3758/BF03194778; Rousselet GA, 2003, J VISION, V3, P440, DOI 10.1167/3.6.5; Schreij D, 2008, PERCEPT PSYCHOPHYS, V70, P208, DOI 10.3758/PP.70.2.208; von Muhlenen A, 2007, J EXP PSYCHOL HUMAN, V33, P1297, DOI 10.1037/0096-1523.33.6.1297; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474	43	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-0727	1430-2772		PSYCHOL RES-PSYCH FO	Psychol. Res.-Psychol. Forsch.	JUL	2015	79	4					523	533		10.1007/s00426-014-0599-8		11	Psychology, Experimental	Psychology	CK3WJ	WOS:000356146900002		
J	Yamakawa, M; Yorifuji, T; Kato, T; Yamauchi, Y; Doi, H				Yamakawa, Michiyo; Yorifuji, Takashi; Kato, Tsuguhiko; Yamauchi, Yoshitada; Doi, Hiroyuki			Breast-feeding and hospitalization for asthma in early childhood: a nationwide longitudinal survey in Japan	PUBLIC HEALTH NUTRITION			English	Article						Breast-feeding; Asthma; Child	BIRTH COHORT; CHILDREN; RISK; PREVALENCE; ALLERGY; ATOPY	Objective: Whether or not breast-feeding is protective against asthma among children is still controversial. Therefore, we examined the effects of breast-feeding on hospitalization for asthma in early childhood. Design: Secondary data analyses of a nationwide longitudinal survey of children in Japan ongoing since 2001, with results collected from 2001 to 2004. We used logistic regression models to evaluate the associations of breast-feeding with hospitalization for asthma in children between the ages of 6 and 42 months, adjusting for children's factors (sex, day-care attendance and presence of older siblings) and maternal factors (educational attainment and smoking habit). Setting: All over Japan. Subjects: Term singleton children with information on feeding practices during infancy (n 43 367). Results: After adjusting for maternal factors and children's factors, exclusive breast-feeding at 6-7 months of age was associated with decreased risk of hospitalization for asthma in children. The adjusted odds ratio was 0.77 (95 % CI 0.56, 1.06). One-month longer duration of breast-feeding was associated with a 4 % decreased risk of hospitalization for asthma (OR= 0.96; 95 % CI 0.92, 0.99). Conclusions: The protective effects of breast-feeding on hospitalization for asthma were observed in children between the ages of 6 and 42 months.	[Yamakawa, Michiyo] Okayama Univ, Ctr Reg Res, Kita Ku, Okayama 7008530, Japan; [Yorifuji, Takashi] Okayama Univ, Grad Sch Environm & Life Sci, Dept Human Ecol, Okayama, Japan; [Kato, Tsuguhiko] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Publ Hlth & Publ Policy, Hiroshima, Japan; [Yamauchi, Yoshitada] Kibi Int Univ, Sch Hlth Sci & Social Welf, Dept Nursing, Okayama, Japan; [Doi, Hiroyuki] Okayama Univ, Grad Sch Med, Dept Epidemiol Dent & Pharmaceut Sci, Okayama, Japan	Yamakawa, M (reprint author), Okayama Univ, Ctr Reg Res, Kita Ku, 3-1-1 Tsushima Naka, Okayama 7008530, Japan.	michi.yamak@cc.okayama-u.ac.jp			Health and Labour Sciences Research Grants on Health Research on Children, Youth and Families [H24-Jisedai-Ippan-004]	This work was funded by Health and Labour Sciences Research Grants on Health Research on Children, Youth and Families (number H24-Jisedai-Ippan-004). The funder had no role in the design, analysis or writing of this article.	Sears MR, 2002, LANCET, V360, P901, DOI 10.1016/S0140-6736(02)11025-7; Burgess SW, 2006, PEDIATRICS, V117, pE787, DOI 10.1542/peds.2005-1753; Quigley MA, 2007, PEDIATRICS, V119, pE837, DOI 10.1542/peds.2006-2256; Wilson AC, 1998, BRIT MED J, V316, P21; Oddy WH, 1999, BRIT MED J, V319, P815; Gdalevich M, 2001, J PEDIATR-US, V139, P261, DOI 10.1067/mpd.2001.117006; Kull I, 2004, J ALLERGY CLIN IMMUN, V114, P755, DOI 10.1016/j.jaci.2004.07.036; Miyake Y, 2003, CLIN EXP ALLERGY, V33, P312, DOI 10.1046/j.1365-2222.2003.t01-1-01607.x; Kramer MS, 2007, BRIT MED J, V335, P815, DOI 10.1136/bmj.39304.464016.AE; Friedman NJ, 2005, J ALLERGY CLIN IMMUN, V115, P1238, DOI 10.1016/j.jaci.2005.01.069; Yamakawa M, 2013, JAMA PEDIATR, V167, P919, DOI 10.1001/jamapediatrics.2013.2230; Scholtens S, 2009, THORAX, V64, P604, DOI 10.1136/thx.2007.094938; Lowe AJ, 2006, J ALLERGY CLIN IMMUN, V117, P682, DOI 10.1016/j.jaci.2005.10.027; Oddy WH, 2003, ARCH DIS CHILD, V88, P224, DOI 10.1136/adc.88.3.224; Department of Statistics and Information Ministry of Health Labour and Welfare, 2001, 1 LONG SURV BAB 21 C; Ip S., 2007, BREASTFEEDING MATERN; Japanese Society of Pediatric Allergy and Clinical Immunology, 2012, INCIDENCE PREDICTION, P101; Liu A. H., 2011, NELSON TXB PEDIAT, P780; Ministry of Health Labour and Welfare, 2007, GUID SUPP BREASTF WE; Oddy WH, 2004, J ASTHMA, V41, P605, DOI 10.1081/JAS-200026402; Silvers KM, 2012, J PEDIATR-US, V160, DOI 10.1016/j.jpeds.2011.11.055; Takemura Y, 2001, AM J EPIDEMIOL, V154, P115, DOI 10.1093/aje/154.2.115; World Health Organization, 2013, EXCL BREASTF; Yngve A, 2001, Public Health Nutr, V4, P729	24	1	1	CAMBRIDGE UNIV PRESS	CAMBRIDGE	EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND	1368-9800	1475-2727		PUBLIC HEALTH NUTR	Public Health Nutr.	JUL	2015	18	10					1756	1761		10.1017/S1368980014002407		6	Public, Environmental & Occupational Health; Nutrition & Dietetics	Public, Environmental & Occupational Health; Nutrition & Dietetics	CJ8MM	WOS:000355755900006		
J	Hartwig, M; Kobashi, Y; Okura, S; Tkach-Kawasaki, L				Hartwig, Manuela; Kobashi, Yohei; Okura, Sae; Tkach-Kawasaki, Leslie			Energy policy participation through networks transcending cleavage: an analysis of Japanese and German renewable energy promotion policies	QUALITY & QUANTITY			English	Article						Renewable energy policy; Feed-in tariff; Policy networks; Network analysis; Hyperlink networks	COLLECTIVE ACTION; ISSUE NETWORK; HYPERLINK; WEB	Developed countries with minimal energy self-sufficiency struggle with lowering their dependence on oil and coal. Security guarantees countermeasures against global warming, and ensuring new energy sources are issues that have driven their choices between nuclear power generation and promotion of renewable energy resources in recent years. Individual nations such as Japan and Germany have been implementing various policies according to their own political and social circumstances, and often these circumstances include discussions and negotiations among diverse actors with different viewpoints and objectives. The networks formed by overcoming the cleavage between the electric power industry and the community consisting mainly of environmental organizations and left-wing political forces could also function as an additional means for environmental actors to break through the impasse formed by the political structure. However, in assessing the effectiveness of the ties that overcome this confrontation, in addition to the existence of ties that connect such communities, it is also necessary to consider whether the influence of environmental actors through intermediary networks extends to the policy formation process. This paper describes the networks involved in the renewable energy feed-in tariff system enacted in Japan after March 2011 and in Germany in the early 2000s and 2012 to investigate such influences. When comparing the energy policies of Japan and Germany, corresponding networks unifying the two communities in both countries were observed in an analysis that emphasizes the existence of ties. However, an in-depth analysis of attitude-based networks and hyperlink networks focusing on policy reveals the predominance of economic and industrial interests in Japan, as well as functional differences even within the same corresponding networks.	[Hartwig, Manuela] Free Univ Berlin, Berlin, Germany; [Kobashi, Yohei; Okura, Sae; Tkach-Kawasaki, Leslie] Univ Tsukuba, Tsukuba, Ibaraki, Japan	Hartwig, M (reprint author), Free Univ Berlin, Berlin, Germany.	manuela.g.hartwig@gmail.com; yohei.kobashi@gmail.com; okura.sae.xp@alumni.tsukuba.ac.jp; tkach@japan.email.ne.jp					Huenteler J, 2012, ENERG POLICY, V45, P6, DOI 10.1016/j.enpol.2012.02.041; Jacobsson S, 2006, ENERG POLICY, V34, P256, DOI 10.1016/j.enpol.2004.08.029; Carlsson L, 2000, POLICY STUD J, V28, P502, DOI 10.1111/j.1541-0072.2000.tb02045.x; DOWDING K, 1995, POLIT STUD-LONDON, V43, P136, DOI 10.1111/j.1467-9248.1995.tb01705.x; Bardt H., 2012, FORDERUNG ERNEUERBAR; Bulkeley H, 2000, ENVIRON PLANN C, V18, P727, DOI 10.1068/c9905j; Federal Office of Economics and Export Control (BAFA), 2012, BES AUSGL; Fulton M, 2012, GERMAN FEED IN TARIF; Gautam P., 2014, J CONT E ASIA, V13, P19; Growitsch C., 2005, PRIVATKUNDEN SIND VE; Growitsch C., 2005, WIRTSCHAFT WANDEL, V12, P383; Hagenaars J. A., 2002, APPL LATENT CLASS AN; Honda H., 2005, DATSU GENSHI RYOKU N; Ikeda K, 2009, BRIT J POLIT SCI, V39, P655, DOI 10.1017/S0007123408000574; Jiang K., 2013, J CONT E ASIA, V13, P83; Kim JH, 2010, J AM SOC INF SCI TEC, V61, P1598, DOI 10.1002/asi.21357; McCutcheon AL, 1987, LATENT CLASS ANAL; Murai K., 2001, KOKUSAI SEIJI KEIZAI, V7, P133; Park H. W., 2003, CONNECTIONS, V25, P49; Park H. W., 2002, NETCOM NETWORKS COMM, V16, P155; Park H. W., 2003, J COMPUT MED COMMUN, V8; Park HW, 2012, QUAL QUANT, V46, P679, DOI 10.1007/s11135-010-9421-x; Park HW, 2008, QUAL QUANT, V42, P687, DOI 10.1007/s11135-007-9109-z; Phillips F, 2014, J CONT E ASIA, V13, P57; Rhodes R., 2006, OXFORD HDB PUBLIC PO, P425; Rhodes R. A. W., 1992, POLICY NETWORKS BRIT, P249; Sabatier P. A., 1988, POLICY SCI, V21, P129; Schreurs Miranda A., 2002, ENV POLITICS JAPAN G; Shumate M, 2008, J COMPUT-MEDIAT COMM, V14, P178, DOI 10.1111/j.1083-6101.2008.01436.x; Tsujinaka Y., 1999, SENKYO, V52, P13; Tsujinaka Y, 2007, PAC AFF, V80, P419; Yoshioka H., 2011, SHINPAN GENSHIRYOKU	32	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0033-5177	1573-7845		QUAL QUANT	Qual. Quant.	JUL	2015	49	4					1485	1512		10.1007/s11135-014-0093-9		28	Social Sciences, Interdisciplinary; Statistics & Probability	Social Sciences - Other Topics; Mathematics	CK0VB	WOS:000355922200010		
J	Park, DK; Feng, GR; Rahimi, R; Labruyere, S; Shibata, T; Nakazawa, S; Sato, K; Takui, T; Laflamme, R; Baugh, J				Park, Daniel K.; Feng, Guanru; Rahimi, Robabeh; Labruyere, Stephane; Shibata, Taiki; Nakazawa, Shigeaki; Sato, Kazunobu; Takui, Takeji; Laflamme, Raymond; Baugh, Jonathan			Hyperfine spin qubits in irradiated malonic acid: heat-bath algorithmic cooling	QUANTUM INFORMATION PROCESSING			English	Article						Quantum information; Quantum error correction; Algorithmic cooling; Electron spin resonance; Electron nuclear double resonance	QUANTUM DYNAMICAL SEMIGROUPS; CRYSTAL-STRUCTURE; RESONANCE; ENDOR; COMPUTATION; COMPUTERS; RADICALS; DIAMOND	The ability to perform quantum error correction is a significant hurdle for scalable quantum information processing. A key requirement for multiple-round quantum error correction is the ability to dynamically extract entropy from ancilla qubits. Heat-bath algorithmic cooling is a method that uses quantum logic operations to move entropy from one subsystem to another and permits cooling of a spin qubit below the closed system (Shannon) bound. Gamma-irradiated, C-13-labeled malonic acid provides up to five spin qubits: one spin-half electron and four spin-half nuclei. The nuclei are strongly hyperfine-coupled to the electron and can be controlled either by exploiting the anisotropic part of the hyperfine interaction or by using pulsed electron nuclear double resonance techniques. The electron connects the nuclei to a heat-bath with a much colder effective temperature determined by the electron's thermal spin polarization. By accurately determining the full spin Hamiltonian and performing realistic algorithmic simulations, we show that an experimental demonstration of heat-bath algorithmic cooling beyond the Shannon bound is feasible in both three-qubit and five-qubit variants of this spin system. Similar techniques could be useful for polarizing nuclei in molecular or crystalline systems that allow for non-equilibrium optical polarization of the electron spin.	[Park, Daniel K.; Feng, Guanru; Rahimi, Robabeh; Labruyere, Stephane; Laflamme, Raymond; Baugh, Jonathan] Univ Waterloo, Inst Quantum Comp, Waterloo, ON N2L 3G1, Canada; [Park, Daniel K.; Feng, Guanru; Rahimi, Robabeh; Laflamme, Raymond; Baugh, Jonathan] Univ Waterloo, Dept Phys & Astron, Waterloo, ON N2L 3G1, Canada; [Shibata, Taiki; Nakazawa, Shigeaki; Sato, Kazunobu; Takui, Takeji] Osaka City Univ, Grad Sch Sci, Dept Chem & Mol Mat Sci, Sumiyoshi Ku, Osaka 5588585, Japan; [Laflamme, Raymond] Perimeter Inst Theoret Phys, Waterloo, ON N2J 2W9, Canada; [Laflamme, Raymond] Canadian Inst Adv Res, Toronto, ON M5G 1Z8, Canada; [Baugh, Jonathan] Univ Waterloo, Dept Chem, Waterloo, ON N2L 3G1, Canada	Baugh, J (reprint author), Univ Waterloo, Inst Quantum Comp, Waterloo, ON N2L 3G1, Canada.	baugh@uwaterloo.ca	Sato, Kazunobu/B-2603-2010		NSERC; Canada Foundation for Innovation; CIFAR; province of Ontario; Industry Canada; MEXT, Japan; JSPS, Japan; AOARD project on "Quantum Properties of Molecular Nanomagnets" [FA2386-13-1-4030]	This research was supported by NSERC, the Canada Foundation for Innovation, CIFAR, the province of Ontario and Industry Canada. T. Takui would like to thank the support via Grants-in-Aid for Scientific Research on Innovative Areas "Quantum Cybernetics" and Scientific Research (B) from MEXT, Japan. The support for the present work by the FIRST project on "Quantum Information Processing" from JSPS, Japan, and by the AOARD project on "Quantum Properties of Molecular Nanomagnets" (Award No. FA2386-13-1-4030) is also acknowledged. We acknowledge David Cory and Richard Oakley for access to CW ESR spectrometers, Aaron Mailman for help with CW ESR, Jalil Assoud for assistance with X-ray spectroscopy, and Robert Pasuta for help with gamma-irradiation of samples. We thank Dawei Lu, Tal Mor and Yossi Weinstein for helpful discussions.	Akhtar W, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.097601; Khaneja N, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.032326; LOUBSER J, 1978, REP PROG PHYS, V41, P1201, DOI 10.1088/0034-4885/41/8/002; Ryan CA, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/1/013034; Boykin PO, 2002, P NATL ACAD SCI USA, V99, P3388, DOI 10.1073/pnas.241641898; Negrevergne C, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.170501; Sagstuen E, 2000, J PHYS CHEM A, V104, P6362, DOI 10.1021/jp000282p; Taminiau TH, 2014, NAT NANOTECHNOL, V9, P171, DOI [10.1038/nnano.2014.2, 10.1038/NNANO.2014.2]; Kelly J, 2015, NATURE, V519, P66, DOI 10.1038/nature14270; Knill E, 1997, PHYS REV A, V55, P900, DOI 10.1103/PhysRevA.55.900; Ryan CA, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.140501; Schulman LJ, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.120501; Doherty MW, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.205203; MCCALLEY RC, 1993, J PHYS CHEM-US, V97, P2888, DOI 10.1021/j100114a011; Knill E, 2000, NATURE, V404, P368, DOI 10.1038/35006012; Aliferis P, 2008, QUANTUM INF COMPUT, V8, P181; Hodges JS, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.010303; LINDBLAD G, 1976, COMMUN MATH PHYS, V48, P119, DOI 10.1007/BF01608499; Zhang YJ, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.170503; Knill E, 2005, NATURE, V434, P39, DOI 10.1038/nature03350; Khaneja N, 2005, J MAGN RESON, V172, P296, DOI 10.1016/j.jmr.2004.11.004; Emerson J, 2007, SCIENCE, V317, P1893, DOI 10.1126/science.1145699; Baugh J, 2005, NATURE, V438, P470, DOI 10.1038/nature04272; Havel TF, 2003, J MATH PHYS, V44, P534, DOI 10.1063/1.1518555; Rempp F, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.032325; Knill E, 1998, SCIENCE, V279, P342, DOI 10.1126/science.279.5349.342; Atherton NM, 1993, PRINCIPLES ELECT SPI; COLE T, 1961, J CHEM PHYS, V34, P1085, DOI 10.1063/1.1731663; Cole T, 1959, Proc Natl Acad Sci U S A, V45, P525, DOI 10.1073/pnas.45.4.525; Criger B, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.044302; Doherty MW, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/2/025019; Fernandez JM, 2004, INT J QUANTUM INF, V2, P461, DOI 10.1142/S0219749904000419; FUKAI M, 1991, THERMOCHIM ACTA, V183, P215, DOI 10.1016/0040-6031(91)80461-Q; GOEDKOOP JA, 1957, ACTA CRYSTALLOGR, V10, P125, DOI 10.1107/S0365110X57000353; Gottesman D., 1997, QUANTPH9705052 EPR; HORSFIELD A, 1961, MOL PHYS, V4, P327, DOI 10.1080/00268976100100481; JAGANNATHAN NR, 1994, J CHEM CRYSTALLOGR, V24, P75, DOI 10.1007/BF01665349; Kang J, 2003, J MAGN RESON, V165, P128, DOI 10.1016/S1090-7807(03)00256-8; Kaye P, 2007, QUANTUM INF PROCESS, V6, P295, DOI 10.1007/s11128-007-0059-0; Kaye Phillip, 2007, INTRO QUANTUM COMPUT; KRZYSTEK J, 1995, J PHYS CHEM-US, V99, P402, DOI 10.1021/j100001a060; MCCONNELL HM, 1960, J AM CHEM SOC, V82, P766, DOI 10.1021/ja01489a002; MORTON JR, 1964, CHEM REV, V64, P453, DOI 10.1021/cr60230a005; Moussa O., 2005, THESIS U WATERLOO; Preskill J, 1998, P ROY SOC A-MATH PHY, V454, P385, DOI 10.1098/rspa.1998.0167	45	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1570-0755	1573-1332		QUANTUM INF PROCESS	Quantum Inf. Process.	JUL	2015	14	7					2435	2461		10.1007/s11128-015-0985-1		27	Physics, Multidisciplinary; Physics, Mathematical	Physics	CK1PL	WOS:000355979200009		
J	Ishida, M; Gonoi, W; Hagiwara, K; Okuma, H; Shirota, G; Shintani, Y; Abe, H; Takazawa, Y; Fukayama, M; Ohtomo, K				Ishida, Masanori; Gonoi, Wataru; Hagiwara, Kazuchika; Okuma, Hidemi; Shirota, Go; Shintani, Yukako; Abe, Hiroyuki; Takazawa, Yutaka; Fukayama, Masashi; Ohtomo, Kuni			Early postmortem volume reduction of adrenal gland: initial longitudinal computed tomographic study	RADIOLOGIA MEDICA			English	Article						Postmortem imaging; Forensic radiology; Autopsy imaging; Adrenal gland; Volume	CLINICAL-EXPERIENCE; AUTOPSY; CT; HYPOSTASIS; MRI	We aimed to confirm whether postmortem adrenal volumetric changes occur by measuring adrenal volumes on computed tomography (CT). Fifty-five adrenal glands from 28 subjects who died were included. All subjects underwent antemortem CT (AMCT) and postmortem CT (PMCT) within 94-1,191 min after death, followed by conventional autopsy. CT volumetry was performed using freely-available software. Differences between AMCT and PMCT adrenal volumes were evaluated statistically along with differences in the degree of volume change, elapsed time to PMCT, and presence of underlying malignant disease. The mean volume of the right adrenal gland decreased from 3.8 cm(3) on AMCT to 2.6 cm(3) on PMCT (P < 0.001); the left adrenal gland decreased from 4.2 cm(3) on AMCT to 3.1 cm(3) on PMCT (P < 0.001). Conventional autopsy revealed decreased intracellular lipid components in portions of the adrenal glands. No correlation between the adrenal gland reduction rate and the elapsed time from AMCT to death or from death to PMCT was observed (P = 0.99 and 0.79; P = 0.28 and 0.59 for the right and left adrenal glands, respectively). Significant differences in both the bilateral adrenal gland reduction rates and underlying malignant disease were found for the left adrenal gland (P = 0.015), but not for the right (P = 0.74). Adrenal volume reduction was observed on PMCT compared to AMCT. This highlights the need to further elucidate the mechanism of adrenal shrinkage during the agonal stage and after death. This may be explained by pathological findings of intracellular lipid depletion.	[Ishida, Masanori; Gonoi, Wataru; Hagiwara, Kazuchika; Okuma, Hidemi; Shirota, Go; Ohtomo, Kuni] Univ Tokyo, Grad Sch Med, Dept Radiol, Bunkyo Ku, Tokyo 1138655, Japan; [Ishida, Masanori] Sanraku Hosp, Dept Radiol, Mutual Aid Assoc Tokyo Metropolitan Teachers & Of, Chiyoda Ku, Tokyo 1018326, Japan; [Shintani, Yukako; Abe, Hiroyuki; Takazawa, Yutaka; Fukayama, Masashi] Univ Tokyo, Grad Sch Med, Dept Pathol, Bunkyo Ku, Tokyo 1138655, Japan	Ishida, M (reprint author), Sanraku Hosp, Dept Radiol, Mutual Aid Assoc Tokyo Metropolitan Teachers & Of, Chiyoda Ku, 2-5 Kandasurugadai, Tokyo 1018326, Japan.	masanoriishida@hotmail.com			Japanese Ministry of Health, Labor and Welfare	This work was supported in part by a grant from the Japanese Ministry of Health, Labor and Welfare, for research into "Usefulness of postmortem images as an ancillary method for autopsy in evaluation of death associated with medical practice (2008-2009).	ALEJANDRO VSJ, 1984, AVIAN DIS, V28, P374, DOI 10.2307/1590344; Geraghty EM, 2004, ABDOM IMAGING, V29, P482, DOI 10.1007/s00261-003-0139-2; Ishida M, 2011, LEGAL MED-TOKYO, V13, P174, DOI 10.1016/j.legalmed.2011.03.002; Sawabe M, 2006, PATHOL INT, V56, P315, DOI 10.1111/j.1440-1827.2006.01966.x; Thali MJ, 2003, J FORENSIC SCI, V48, P386; Egger C, 2012, INT J LEGAL MED, V126, P3, DOI 10.1007/s00414-010-0542-5; Ishida M, 2011, LEGAL MED-TOKYO, V13, P280, DOI 10.1016/j.legalmed.2011.09.004; Ishida M, 2011, LEGAL MED-TOKYO, V13, P318, DOI 10.1016/j.legalmed.2011.08.003; Levy AD, 2010, AM J FOREN MED PATH, V31, P12, DOI 10.1097/PAF.0b013e3181c65e1a; Bernard K, 1997, SIMPSONS FORENSIC ME, V11th; DiMaio V.J., 2001, FORENSIC PATHOLOGY; Ezawa H, 2003, PATHOL INT, V53, P865, DOI 10.1046/j.1440-1827.2003.01573.x; Gonoi W, 2013, AM J ROENTGENOL, V201, P133, DOI 10.2214/AJR.12.8928; Hyodoh H, 2012, JPN J RADIOL, V30, P840, DOI 10.1007/s11604-012-0134-z; Kumar V., 2004, ROBBINS COTRAN PATHO; Kurtulus A, 2012, LEGAL MED-TOKYO, V14, P214, DOI 10.1016/j.legalmed.2012.03.002; Lam KY, 2001, ENDOCR PATHOL, V12, P33, DOI 10.1385/EP:12:1:33; Okuma H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076026; Patriquin L, 2001, J MAGN RESON IMAGING, V13, P277, DOI 10.1002/1522-2586(200102)13:2<277::AID-JMRI1040>3.0.CO;2-W; Prionas Nicolas D, 2010, J Med Phys, V35, P174, DOI 10.4103/0971-6203.62130; Reinhard BD, 2012, FORENSIC HISTOPATHOL, V1st; Shiotani S, 2004, FORENSIC SCI INT, V139, P39, DOI 10.1016/j.forsciint.2003.09.016; Takahashi N, 2013, FORENSIC SCI INT, V225, P27, DOI 10.1016/j.forsciint.2012.04.037; Takahashi N, 2010, AM J ROENTGENOL, V195, pW388, DOI 10.2214/AJR.10.4442; Wang Xuan, 2013, Chin Med Sci J, V27, P220; Yang KM, 2011, LEGAL MED-TOKYO, V13, P233, DOI 10.1016/j.legalmed.2011.05.004	26	1	1	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	0033-8362	1826-6983		RADIOL MED	Radiol. Med.	JUL	2015	120	7					662	669		10.1007/s11547-014-0449-1		8	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CK5WP	WOS:000356297800010		
J	Nishida, C; Yatera, K; Yamasaki, K; Torii, R; Kawanami, Y; Kawanami, T; Ishimoto, H; Shibuya, R; Takenaka, M; Yamada, S; Kasai, T; Tanaka, F; Mukae, H				Nishida, Chinatsu; Yatera, Kazuhiro; Yamasaki, Kei; Torii, Ryo; Kawanami, Yukiko; Kawanami, Toshinori; Ishimoto, Hiroshi; Shibuya, Ryo; Takenaka, Masaru; Yamada, Sohusuke; Kasai, Takahiko; Tanaka, Fumihiro; Mukae, Hiroshi			Possible familial case of Birt-Hogg-Dube syndrome complicated with lung cancer: A possible link between these two disease entities	RESPIRATORY MEDICINE			English	Article						Birt-Hogg-Dube syndrome; Lung cancer; Folliculin; Carcinogenesis; Pulmonary cyst	POLYCYSTIC KIDNEYS; GENE; NEOPLASIA; FLCN	A 65-year-old Japanese woman was introduced to our hospital for an examination of multiple pulmonary cystic lesions and a pulmonary nodule in the left lower lobe. She had a smoking history of 25 pack-years, and her two younger brothers had suffered from pneumothorax; one of them additionally had lung cancer with pulmonary multiple cystic lesions. A surgical biopsy specimen obtained from her left lower lobe revealed adenocarcinoma surrounded by a single epithelial layer that was covered with collagen fibers. The pathological features were compatible with the findings of the cystic lesions in the patients with Birt-Hogg-Dube syndrome (BHDS). A diagnosis of BHDS was eventually made according to the detection of a folliculin gene mutation. This is the first report of a possible familial case of BHDS complicated with primary lung cancer. We herein reviewed the previously reported cases of BHDS with lung cancer and other tumors and discussed a potential mechanism of tumorigenesis and carcinogenesis in the lung in the patients with BHDS. (C) 2015 Elsevier Ltd. All rights reserved.	[Nishida, Chinatsu; Yatera, Kazuhiro; Yamasaki, Kei; Torii, Ryo; Kawanami, Yukiko; Kawanami, Toshinori; Ishimoto, Hiroshi; Mukae, Hiroshi] Univ Occupat & Environm Hlth, Dept Resp Med, Kitakyushu, Fukuoka 8078555, Japan; [Shibuya, Ryo] Univ Occupat & Environm Hlth, Dept Pathol & Oncol, Kitakyushu, Fukuoka 8078555, Japan; [Takenaka, Masaru; Tanaka, Fumihiro] Univ Occupat & Environm Hlth, Dept Surg 2, Kitakyushu, Fukuoka 8078555, Japan; [Yamada, Sohusuke] Univ Occupat & Environm Hlth, Dept Pathol & Cell Biol, Kitakyushu, Fukuoka 8078555, Japan; [Kasai, Takahiko] Kinki Chuo Med Ctr, Natl Hosp Org, Dept Lab Med & Pathol, Sakai, Osaka, Japan	Yatera, K (reprint author), Univ Occupat & Environm Hlth, Dept Resp Med, Yahatanishi Ku, 1-1 Iseigaoka, Kitakyushu, Fukuoka 8078555, Japan.	yatera@med.uoeh-u.ac.jp					Cash TP, 2011, ONCOGENE, V30, P2534, DOI 10.1038/onc.2010.628; Nickerson ML, 2002, CANCER CELL, V2, P157, DOI 10.1016/S1535-6108(02)00104-6; Furuya M, 2012, AM J SURG PATHOL, V36, P589, DOI 10.1097/PAS.0b013e3182475240; BIRT AR, 1977, ARCH DERMATOL, V113, P1674, DOI 10.1001/archderm.113.12.1674; Nahorski MS, 2010, J MED GENET, V47, P385, DOI 10.1136/jmg.2009.073304; Baba M, 2008, J NATL CANCER I, V100, P140, DOI 10.1093/jnci/djm288; Khoo SK, 2001, ONCOGENE, V20, P5239, DOI 10.1038/sj.onc.1204703; Baba M, 2006, P NATL ACAD SCI USA, V103, P15552, DOI 10.1073/pnas.0603781103; Schmidt LS, 2005, AM J HUM GENET, V76, P1023, DOI 10.1086/430842; Furuya M, 2013, J CLIN PATHOL, V66, P178, DOI 10.1136/jclinpath-2012-201200; Lim DHK, 2010, HUM MUTAT, V31, pE1043, DOI 10.1002/humu.21130; Schmidt LS, 2001, AM J HUM GENET, V69, P876, DOI 10.1086/323744; Chen JD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003581; Hong SB, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-160; Khoo SK, 2003, J MED GENET, V39, P876	15	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0954-6111	1532-3064		RESP MED	Respir. Med.	JUL	2015	109	7					923	925		10.1016/j.rmed.2015.05.005		3	Cardiac & Cardiovascular Systems; Respiratory System	Cardiovascular System & Cardiology; Respiratory System	CK2QN	WOS:000356056200016		
J	Ogura, K; Morioka, K; Tsujii, Y; Hsu, SY; Wagner, MH				Ogura, Koji; Morioka, Kohei; Tsujii, Yoshinobu; Hsu, Shu-Yao; Wagner, Manfred H.			Uniaxial extensional flow behavior of comb-shaped poly(methyl methacrylate)	RHEOLOGICA ACTA			English	Article						Long-chain branched PMMA; Rheology; MSF model; Uniaxial extension; Strain hardening; Poly(methyl methacrylate)	TRANSFER RADICAL POLYMERIZATION; STRESS FUNCTION MODEL; ELONGATIONAL VISCOSITY; MOLECULAR-STRUCTURE; IMMISCIBLE POLYMER; MSF MODEL; MELTS; POLYSTYRENE; RHEOLOGY; DYNAMICS	Comb-shaped poly(methyl methacrylate)s (PMMAs) with various mass fractions and various molecular weights of the side chains were prepared by free-radical polymerization followed by atom transfer radical polymerization (ATRP). The rheological properties were characterized in linear-viscoelasticity and in uniaxial extensional flow. Due to branching and thereby slow relaxation of the backbone, significant strain hardening was observed and well analyzed by the molecular stress function (MSF) model. The model parameter f (max) (2) increased with increasing M (n,bb) at almost constant M (n,br) and , and with increasing at almost constant I broken vertical bar (n,br), where M (n,bb) and M (n,br) are the number-average molecular weights of the backbone and the branched chains, and and I broken vertical bar (n,br) are the average number per backbone and the number-average mass fraction of the branched chains, respectively. These results provide guidelines for the polymer design with the aim of enhancing strain hardening in elongational flow.	[Ogura, Koji; Morioka, Kohei] Sumitomo Chem Co Ltd, Basic Chem Res Lab, Niihama City, Ehime 7928521, Japan; [Tsujii, Yoshinobu; Hsu, Shu-Yao] Kyoto Univ, Inst Chem Res, Uji, Kyoto 6110011, Japan; [Wagner, Manfred H.] Berlin Inst Technol TU Berlin, Polymer Engn Polymer Phys, D-10623 Berlin, Germany	Ogura, K (reprint author), Sumitomo Chem Co Ltd, Basic Chem Res Lab, 5-1 Sobiraki Cho, Niihama City, Ehime 7928521, Japan.	ogurak2@sc.sumitomo-chem.co.jp					Rolon-Garrido VH, 2007, RHEOL ACTA, V46, P583, DOI 10.1007/s00397-006-0136-9; Matyjaszewski K, 1997, MACROMOLECULES, V30, P5192, DOI 10.1021/ma970359g; Nielsen JK, 2006, MACROMOLECULES, V39, P8844, DOI 10.1021/ma061476r; Liu QC, 2007, J POLYM SCI POL CHEM, V45, P3330, DOI 10.1002/pola.22082; MARRUCCI G, 1980, MACROMOLECULES, V13, P380, DOI 10.1021/ma60074a034; Wagner MH, 2001, J RHEOL, V45, P1387, DOI 10.1122/1.1413503; DOI M, 1978, J CHEM SOC FARAD T 2, V74, P1802, DOI 10.1039/f29787401802; Rolon-Garrido VH, 2011, RHEOL ACTA, V50, P519, DOI 10.1007/s00397-011-0559-9; Wagner MH, 2003, J RHEOL, V47, P779, DOI 10.1122/1.1562155; Wagner MH, 2008, J RHEOL, V52, P1049, DOI 10.1122/1.2957699; Neugebauer D, 2004, POLYMER, V45, P8173, DOI 10.1016/j.polymer.2004.09.069; Wagner MH, 2004, J RHEOL, V48, P489, DOI 10.1122/1.1687786; DOI M, 1979, J CHEM SOC FARAD T 2, V75, P38, DOI 10.1039/f29797500038; ROOVERS J, 1984, MACROMOLECULES, V17, P1196, DOI 10.1021/ma00136a016; Fuchs K, 1996, MACROMOLECULES, V29, P5893, DOI 10.1021/ma951385m; Rolon-Garrido VH, 2014, RHEOL ACTA, V53, P663, DOI 10.1007/s00397-014-0787-x; Ferry JD, 1980, VISCOELASTIC PROPERT; Kakuda M, 2006, NIHON REOROJI GAKK, V34, P181, DOI 10.1678/rheology.34.181; LINSTER JJ, 1989, MAKROMOL CHEM, V190, P599; Ogura K, 2000, NIHON REOROJI GAKK, V28, P99, DOI 10.1678/rheology.28.99; Ogura K, 2013, RHEOL ACTA, V52, P753, DOI 10.1007/s00397-013-0714-6; Ruymbeke E, 2010, J RHEOL, V54, P643; Takahashi T, 1999, J APPL POLYM SCI, V73, P757, DOI 10.1002/(SICI)1097-4628(19990801)73:5<757::AID-APP16>3.0.CO;2-O; Takahashi T, 1999, J APPL POLYM SCI, V72, P961, DOI 10.1002/(SICI)1097-4628(19990516)72:7<961::AID-APP12>3.0.CO;2-T; Winter HH, 2007, IRIS DEV; WU S, 1989, J POLYM SCI POL PHYS, V27, P723, DOI 10.1002/polb.1989.090270401; WU S, 1970, J PHYS CHEM-US, V74, P632, DOI 10.1021/j100698a026	27	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0035-4511	1435-1528		RHEOL ACTA	Rheol. Acta	JUL	2015	54	7					637	645		10.1007/s00397-015-0848-9		9	Mechanics	Mechanics	CK6GE	WOS:000356325700004		
J	Takahashi, M; Ikeda, J; Tomida, T; Hirata, K; Hattori, N; Inoue, Y				Takahashi, Masayoshi; Ikeda, Junji; Tomida, Takayuki; Hirata, Koichi; Hattori, Nobutaka; Inoue, Yuichi			Daytime symptoms of restless legs syndrome - clinical characteristics and rotigotine effectiveness	SLEEP MEDICINE			English	Article						Restless legs syndrome; Daytime; Rotigotine; Dopamine agonist; Patch	EPWORTH SLEEPINESS SCALE; PLACEBO-CONTROLLED TRIAL; JAPANESE VERSION; DOUBLE-BLIND; SENSORY SYMPTOMS; CIRCADIAN-RHYTHM; QUALITY INDEX; EKBOM DISEASE; DIAGNOSIS; EFFICACY	Objective: To elucidate the prevalence and clinical characteristics of daytime restless legs syndrome (RLS) among patients with idiopathic RLS and investigate the effectiveness of rotigotine for daytime RLS. Methods: In 256 enrolled RLS patients, we investigated factors associated with the presence of RLS symptoms throughout the day. We also assessed the duration of daytime RLS symptoms at hourly intervals, time of initial symptom onset during the day, and associations between duration of daytime and nighttime RLS symptoms. In addition, we compared changes in duration and frequency of RLS symptoms during daytime and nighttime after randomly assigning patients to a 13-week treatment with rotigotine, a dopamine agonist patch with 24-hour action, or placebo. Results: Eighty-one (31.6%) patients had daytime RLS symptoms. Only the International Restless Legs Syndrome Study Group rating scale total score was significantly associated with the presence of daytime RLS symptoms (p < 0.01) on multiple logistic regression analysis. Daytime RLS symptom onset was at 6 a.m. in 44.4% of patients; symptom duration increased significantly toward nighttime. There was a significant positive association between duration of daytime and nighttime RLS symptoms (p < 0.0001) and a greater statistically significant reduction of daytime RLS symptom duration with rotigotine treatment than with placebo (p = 0.03). Conclusions: Daytime symptoms are frequent in patients with RLS and may be associated with increased severity of the disorder and prolonged nighttime RLS symptoms. Rotigotine could become an important treatment choice for daytime symptoms. (C) 2015 Elsevier B.V. All rights reserved.	[Takahashi, Masayoshi; Inoue, Yuichi] Tokyo Med Univ, Dept Somnol, Shinjuku Ku, Tokyo 1608402, Japan; [Takahashi, Masayoshi; Ikeda, Junji; Tomida, Takayuki] Otsuka Pharmaceut Co Ltd, Chiyoda Ku, Tokyo 1018535, Japan; [Hirata, Koichi] Dokkyo Med Univ, Dept Neurol, Mibumachi, Tochigi 3210207, Japan; [Hattori, Nobutaka] Juntendo Univ Hosp, Dept Neurol, Bunkyo Ku, Tokyo 1130033, Japan	Inoue, Y (reprint author), Tokyo Med Univ, Dept Somnol, Shinjuku Ku, 6-1-1 Shinjuku, Tokyo 1608402, Japan.	inoue@somnology.com			Otsuka Pharmaceutical Co., Ltd., Japan; Otsuka Pharmaceutical Co., Ltd.	This study was financially supported by Otsuka Pharmaceutical Co., Ltd., Japan. The authors would like to thank Dr Keyra Martinez Dunn and Dr Stacey Tobin for providing editorial support, which was funded by Otsuka Pharmaceutical Co., Ltd.	Allen RP, 2007, SLEEP MED, V8, pS13, DOI 10.1016/j.sleep.2007.04.011; Tzonova D, 2012, SLEEP MED, V13, P151, DOI 10.1016/j.sleep.2011.09.015; Michaud M, 2005, SLEEP, V28, P843; Takegami M, 2009, SLEEP MED, V10, P556, DOI 10.1016/j.sleep.2008.04.015; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Tison F, 2005, NEUROLOGY, V65, P239, DOI 10.1212/01.wnl.0000168910.48309.4a; Allen RP, 2011, SLEEP MED, V12, P431, DOI 10.1016/j.sleep.2011.03.003; Allen RP, 2003, SLEEP MED, V4, P101, DOI 10.1016/S1389-9457(03)00010-8; Trenkwalder C, 2008, LANCET NEUROL, V7, P595, DOI 10.1016/S1474-4422(08)70112-1; Hening WA, 1999, SLEEP, V22, P901; Aurora RN, 2012, SLEEP, V35, P1039, DOI 10.5665/sleep.1988; Allen RP, 2005, ARCH INTERN MED, V165, P1286, DOI 10.1001/archinte.165.11.1286; Doi Y, 2000, PSYCHIAT RES, V97, P165, DOI 10.1016/S0165-1781(00)00232-8; WALTERS AS, 1995, MOVEMENT DISORD, V10, P634, DOI 10.1002/mds.870100517; Oertel W, 2011, LANCET NEUROL, V10, P710, DOI 10.1016/S1474-4422(11)70127-2; Hening WA, 2010, MOVEMENT DISORD, V25, P1675, DOI 10.1002/mds.23157; Winkelman JW, 2006, SLEEP MED, V7, P545, DOI 10.1016/j.sleep.2006.01.004; Garcia-Borreguero D, 2013, SLEEP MED, V14, P675, DOI 10.1016/j.sleep.2013.05.016; Garcia-Borreguero D, 2012, EUR J NEUROL, V19, P1385, DOI 10.1111/j.1468-1331.2012.03853.x; Garcia-Borreguero D, 2007, SLEEP MED, V8, P520, DOI 10.1016/j.sleep.2007.03.022; Garcia-Borreguero D, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-28; Hening WA, 2007, MOVEMENT DISORD, V22, pS395, DOI 10.1002/mds.21665; Inoue Y, 2013, PSYCHIAT CLIN NEUROS, V67, P412, DOI 10.1111/pcn.12074; Inoue Y, 2013, SLEEP MED, V14, P1085, DOI 10.1016/j.sleep.2013.07.007; JOHNS MW, 1991, SLEEP, V14, P540; Kohnen R, 2004, SLEEP, V27, P304; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Shima S, 1985, CLIN PSYCHIATR, V27, P717; Trenkwalder C, 1999, MOVEMENT DISORD, V14, P102, DOI 10.1002/1531-8257(199901)14:1<102::AID-MDS1017>3.0.CO;2-E	29	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1389-9457	1878-5506		SLEEP MED	Sleep Med.	JUL	2015	16	7					871	876		10.1016/j.sleep.2015.03.006		6	Clinical Neurology	Neurosciences & Neurology	CK2PF	WOS:000356052300011		
J	Mihara, I; Nakagawa, K; Kudo, M; Aoyagi, S				Mihara, Ichiro; Nakagawa, Keizo; Kudo, Masahiro; Aoyagi, Satoka			Evaluation and comparison of layered titanate nanosheets using TOF-SIMS and g-ogram analysis	SURFACE AND INTERFACE ANALYSIS			English	Article						nanomaterial; layered titanate nanosheets; metal oxide nanosheets; TOF-SIMS; G-SIMS; g-ogram	ION MASS-SPECTROMETRY; SEPARATION; TEMPLATE; NIOBATE	The evaluation of nanostructure is important to develop the highly controlled nanomaterials. In this study, two kinds of layered titanate nanosheets, which were produced by using hexylamine and laurylamine, respectively, as surfactants were investigated by Gentle Secondary Ion Mass Spectrometry Gentle-SIMS (G-SIMS) and g-ogram, which is the latest Time-of-Flight Secondary Ion Mass Spectrometry (TOF-SIMS) data analysis method for detecting more intact ions and obtaining the information on original chemical structures of samples precisely from complicated TOF-SIMS spectra. As a result, molecular related ions of the surfactants were detected from each sample, and the structural information of samples was obtained. From both samples, surfactant molecular ions connected with hydrocarbon were detected as more intact ions rather than molecular ions of themselves. It was suggested that hydrophobic domains of their lamellar mesostructure are formed robustly by more than two surfactant molecules connected with each other linearly. After all, important information on the chemical structure of the layered titanate nanosheets, which would be difficult to be found by using typical structural analysis methods such as X-ray diffraction and transmission electron microscopy, were obtained using G-SIMS and g-ogram. Therefore, it was shown that g-ogram and G-SIMS are helpful to evaluate the nanostructured materials. And it was also shown that g-ogram is applicable to organic-inorganic materials which contain long hydrocarbon structures. Copyright (c) 2015 John Wiley & Sons, Ltd.	[Mihara, Ichiro] Kuraray Co Ltd, Kurashiki Res Ctr, Kurashiki, Okayama, Japan; [Nakagawa, Keizo] Univ Tokushima, Dept Chem Sci & Technol, Tokushima 770, Japan; [Kudo, Masahiro; Aoyagi, Satoka] Seikei Univ, Dept Mat & Life Sci, Tokyo, Japan	Aoyagi, S (reprint author), Seikei Univ, Dept Mat & Life Sci, Tokyo, Japan.	aoyagi@st.seikei.ac.jp					Compton OC, 2007, J PHYS CHEM C, V111, P14589, DOI 10.1021/jp0751155; Sasaki T, 1997, J PHYS CHEM B, V101, P10159, DOI 10.1021/jp9727658; Takagaki A, 2003, J AM CHEM SOC, V125, P5479, DOI 10.1021/ja034085q; Sasaki T, 1997, CHEM MATER, V9, P602, DOI 10.1021/cm9604322; Aoyagi S, 2012, RAPID COMMUN MASS SP, V26, P2815, DOI 10.1002/rcm.6409; Fang MM, 1999, CHEM MATER, V11, P1526, DOI 10.1021/cm981066k; Gilmore IS, 2000, APPL SURF SCI, V161, P465, DOI 10.1016/S0169-4332(00)00317-2; Mihara I, 2013, SURF INTERFACE ANAL, V45, P453, DOI 10.1002/sia.5002; Nakagawa K, 2012, EUR J INORG CHEM, P2741, DOI 10.1002/ejic.201101136; Nakagawa K, 2011, CHEM LETT, V40, P687, DOI 10.1246/cl.2011.687; Ogaki R, 2011, ANAL CHEM, V83, P3627, DOI 10.1021/ac200347a; Saida T., 2010, J PHYS CHEM C, V14, P13390	12	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0142-2421	1096-9918		SURF INTERFACE ANAL	Surf. Interface Anal.	JUL	2015	47	7					764	770		10.1002/sia.5772		7	Chemistry, Physical	Chemistry	CK6RG	WOS:000356354700003		
J	Uchihashi, T; Nakayama, T				Uchihashi, Takashi; Nakayama, Tomonobu			Locality and lateral modulations of quantum well states in Ag(100) thin films studied using a scanning tunneling microscope	SURFACE SCIENCE			English	Article						Quantum well states; Silver; Thin film; Scanning tunneling microscopy; Diffraction	METAL; ISLANDS; SUPERCONDUCTIVITY; INTERFACE; SURFACES	We investigate Ag(100) thin films epitaxially grown on a Fe(100) substrate using a low-temperature scanning tunneling microscope. Fabrication of a wedge structure by evaporating Ag through a shadow mask allows us to observe a systematic evolution of quantum well (QW) states for layer thicknesses varying from 3 to 16 monolayers (ML). Close inspection of differential conductance spectra and images reveals significant modulations of QW states in the lateral directions, presumably due to the local defects at the Ag/Fe interface. The area where QW states are modulated extends over similar to 5 nm. In clear contrast, near a surface atomic step, QW states exhibit negligible changes at least up to 1 nm away from the step, leaving unmixed the two sets of neighboring QW states belonging to different thicknesses. The results are discussed in terms of a simple electron wave diffraction model. (C) 2015 Elsevier B.V. All rights reserved.	[Uchihashi, Takashi; Nakayama, Tomonobu] Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton MANA, Tsukuba, Ibaraki 3050044, Japan	Uchihashi, T (reprint author), Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton MANA, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan.	UCHIHASHI.Takashi@nims.go.jp			JSPS under the KAKENHI [25247053/25286055/25400385]; World Premier International Research Center (WPI) Initiative on Materials Nanoarchitectonics, MEXT, Japan	This work was financially supported by JSPS under the KAKENHI Grants No. 25247053/25286055/25400385 and by World Premier International Research Center (WPI) Initiative on Materials Nanoarchitectonics, MEXT, Japan. T. U. thanks R. Berndt for his fruitful discussions.	Altfeder IB, 1998, PHYS REV LETT, V80, P4895, DOI 10.1103/PhysRevLett.80.4895; ORTEGA JE, 1993, PHYS REV B, V47, P1540, DOI 10.1103/PhysRevB.47.1540; Ozer MM, 2006, NAT PHYS, V2, P173, DOI 10.1038/nphys244; ORTEGA JE, 1992, PHYS REV LETT, V69, P844, DOI 10.1103/PhysRevLett.69.844; Guo Y, 2004, SCIENCE, V306, P1915, DOI 10.1126/science.1105130; Su WB, 2001, PHYS REV LETT, V86, P5116, DOI 10.1103/PhysRevLett.86.5116; Chiang TC, 2000, SURF SCI REP, V39, P181, DOI 10.1016/S0167-5729(00)00006-6; Yeh V, 2000, PHYS REV LETT, V85, P5158, DOI 10.1103/PhysRevLett.85.5158; Sperl A, 2011, J PHYS CHEM A, V115, P6973, DOI 10.1021/jp112169s; Schmid M, 1996, PHYS REV LETT, V76, P2298, DOI 10.1103/PhysRevLett.76.2298; Milun M, 2002, REP PROG PHYS, V65, P99, DOI 10.1088/0034-4885/65/2/201; Upton MH, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.026802; Kawakami RK, 1999, PHYS REV LETT, V82, P4098, DOI 10.1103/PhysRevLett.82.4098; SMITH NV, 1985, PHYS REV B, V32, P3549, DOI 10.1103/PhysRevB.32.3549; Paggel JJ, 1999, SCIENCE, V283, P1709, DOI 10.1126/science.283.5408.1709; ARAKAWA Y, 1982, APPL PHYS LETT, V40, P939, DOI 10.1063/1.92959; Bischoff MMJ, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.045422; Bouhassoune M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6558; Bruno P, 1999, J PHYS-CONDENS MAT, V11, P9403, DOI 10.1088/0953-8984/11/48/305; Jalochowski M, 1996, PHYS REV LETT, V76, P4227, DOI 10.1103/PhysRevLett.76.4227; JEPSEN O, 1981, PHYS REV B, V23, P2684, DOI 10.1103/PhysRevB.23.2684; Kliewer J., 2002, Physical Review B (Condensed Matter and Materials Physics), V65, DOI 10.1103/PhysRevB.65.035412; KUBBY JA, 1992, PHYS REV LETT, V68, P329, DOI 10.1103/PhysRevLett.68.329; Li JT, 1998, PHYS REV LETT, V80, P3332, DOI 10.1103/PhysRevLett.80.3332; Matsuda I, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.125325; Nagamura N, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.256801; Qiu ZQ, 2002, J PHYS-CONDENS MAT, V14, pR169, DOI 10.1088/0953-8984/14/8/201; Stroscio J.A., 1993, SCANNING TUNNELING M, P77; Uchihashi T, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.033402; Ukraintsev VA, 1996, PHYS REV B, V53, P11176, DOI 10.1103/PhysRevB.53.11176; Yamada TK, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.056803	31	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0039-6028	1879-2758		SURF SCI	Surf. Sci.	JUL-AUG	2015	637						58	62		10.1016/j.susc.2015.03.009		5	Chemistry, Physical; Physics, Condensed Matter	Chemistry; Physics	CK3MI	WOS:000356119800010		
J	Teraoka, Y; Yoshigoe, A				Teraoka, Yuden; Yoshigoe, Akitaka			Photoemission spectroscopic study on influence of O-2 translational kinetic energy for Si(001) initial oxidation (vol 507, pg 797, 2002)	SURFACE SCIENCE			English	Correction									[Teraoka, Yuden; Yoshigoe, Akitaka] Japan Atom Energy Res Inst, Synchrotron Radiat Res Ctr, Mikazuki, Hyogo 6795148, Japan	Teraoka, Y (reprint author), Japan Atom Energy Res Inst, Synchrotron Radiat Res Ctr, 1-1-1 Kouto, Mikazuki, Hyogo 6795148, Japan.	yteraoka@spring8.or.jp					Teraoka Y, 2002, SURF SCI, V507, P797, DOI 10.1016/S0039-6028(02)01354-7	1	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0039-6028	1879-2758		SURF SCI	Surf. Sci.	JUL-AUG	2015	637						156	156		10.1016/j.susc.2015.04.024		1	Chemistry, Physical; Physics, Condensed Matter	Chemistry; Physics	CK3MI	WOS:000356119800023		
J	Teraoka, Y; Yoshigoe, A				Teraoka, Yuden; Yoshigoe, Akitaka			Initial oxidation states on Si(001) surface induced by translational kinetic energy of O-2 at room temperature studied by Si-2p core-level spectroscopy using synchrotron radiation (vol 482, pg 189, 2001)	SURFACE SCIENCE			English	Correction									[Teraoka, Yuden; Yoshigoe, Akitaka] Japan Atom Energy Res Inst, Synchrotron Radiat Res Ctr, Mikazuki, Hyogo 6795148, Japan	Yoshigoe, A (reprint author), Japan Atom Energy Res Inst, Synchrotron Radiat Res Ctr, 1-1-1 Kouto, Mikazuki, Hyogo 6795148, Japan.	yoshigoe@spring8.or.jp					TERAOKA Y, 2001, SURF SCI, V482, P189, DOI DOI 10.1016/S0039-6028(01)00749-X	1	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0039-6028	1879-2758		SURF SCI	Surf. Sci.	JUL-AUG	2015	637						157	157		10.1016/j.susc.2015.05.002		1	Chemistry, Physical; Physics, Condensed Matter	Chemistry; Physics	CK3MI	WOS:000356119800024		
J	Teraoka, Y; Yoshigoe, A				Teraoka, Yuden; Yoshigoe, Akitaka			Time resolved photoemission spectroscopy on Si(001)-2 x 1 surface during oxidation controlled by translational kinetic energy of O2 at room temperature (vol 532, pg 690, 2003)	SURFACE SCIENCE			English	Correction									[Teraoka, Yuden; Yoshigoe, Akitaka] Japan Atom Energy Res Inst, Synchrotron Radiat Res Ctr, Mikazuki, Hyogo 6795148, Japan	Yoshigoe, A (reprint author), Japan Atom Energy Res Inst, Synchrotron Radiat Res Ctr, 1-1-1 Kouto, Mikazuki, Hyogo 6795148, Japan.	yoshigoe@spring8.or.jp					Yoshigoe A, 2003, SURF SCI, V532, P690, DOI 10.1016/S0039-6028(03)00412-6	1	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0039-6028	1879-2758		SURF SCI	Surf. Sci.	JUL-AUG	2015	637						158	158		10.1016/j.susc.2015.05.003		1	Chemistry, Physical; Physics, Condensed Matter	Chemistry; Physics	CK3MI	WOS:000356119800025		
J	Yamada, Y; Ebata, S; Hiyama, T; Nakao, Y				Yamada, Yuuya; Ebata, Shiro; Hiyama, Tamejiro; Nakao, Yoshiaki			Synthesis of rhazinilam through intramolecular arylcyanation of alkenes catalyzed cooperatively by nickel/aluminum	TETRAHEDRON			English	Article						Rhazinilam; Nickel; Aluminum; Carbocyanation; C-C bond activation	CARBON-CARBON BONDS; ORGANIC-MOLECULES; CONCISE SYNTHESIS; NATURAL-PRODUCTS; ACTIVATION; (-)-RHAZINILAM; FUNCTIONALIZATION; ALKALOIDS; (+/-)-RHAZINILAM; CARBOCYANATION	Intramolecular arylcyanation across a tri-substituted double bond proceeds to give a primary alkyl cyanide product through functionalization of C-CN and allylic C-H bonds and double C-C bond formation in a 1,3-manner by cooperative nickel/AlMe2Cl catalysis. The transformation is applied to the synthesis of rhazinilam, a tubulin-binding alkaloid containing unique structural motifs such as axially chiral biaryl and strained nine-membered lactam as well as quaternary carbon. (C) 2015 Elsevier Ltd. All rights reserved.	[Yamada, Yuuya; Ebata, Shiro; Hiyama, Tamejiro; Nakao, Yoshiaki] Kyoto Univ, Grad Sch Engn, Dept Chem Mat, Nishikyo Ku, Kyoto 6158510, Japan; [Hiyama, Tamejiro] Chuo Univ, Res & Dev Initiat, Bunkyo Ku, Tokyo 1128551, Japan	Nakao, Y (reprint author), Kyoto Univ, Grad Sch Engn, Dept Chem Mat, Nishikyo Ku, Kyoto 6158510, Japan.	nakao.yoshiaki.8n@kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology [22105003]; Asahi Glass Foundation	This work has been supported financially by Grant-in-Aid for Scientific Research on Innovative Areas 'Molecular Activation Directed toward Straightforward Synthesis' (no. 22105003) from Ministry of Education, Culture, Sports, Science, and Technology and The Asahi Glass Foundation.	ABRAHAM DJ, 1972, TETRAHEDRON LETT, P909; Kondo T, 2005, CHEM LETT, V34, P1462, DOI 10.1246/cl.2005.1462; Watson MP, 2008, J AM CHEM SOC, V130, P12594, DOI 10.1021/ja805094j; Bowie AL, 2009, J ORG CHEM, V74, P1581, DOI 10.1021/jo801791j; Nakao Y, 2012, B CHEM SOC JPN, V85, P731, DOI 10.1246/bcsj.20120081; Beck EM, 2008, ANGEW CHEM INT EDIT, V47, P3004, DOI 10.1002/anie.200705005; Hirata Y, 2009, J AM CHEM SOC, V131, P10964, DOI 10.1021/ja901374v; Bowie AL, 2005, ORG LETT, V7, P5207, DOI 10.1021/ol052033v; Jun CH, 2004, CHEM SOC REV, V33, P610, DOI 10.1039/b308864m; LINDE HHA, 1965, HELV CHIM ACTA, V48, P1822, DOI 10.1002/hlca.19650480803; Liu ZS, 2006, J AM CHEM SOC, V128, P10352, DOI 10.1021/ja0629110; Chen F, 2014, CHEM REV, V114, P8613, DOI 10.1021/cr400628s; Pangborn AB, 1996, ORGANOMETALLICS, V15, P1518, DOI 10.1021/om9503712; Gutekunst WR, 2011, CHEM SOC REV, V40, P1976, DOI 10.1039/c0cs00182a; McMurray L, 2012, ANGEW CHEM INT EDIT, V51, P9288, DOI 10.1002/anie.201204151; Sugimoto K, 2013, ANGEW CHEM INT EDIT, V52, P7168, DOI 10.1002/anie.201303067; Nakao Y, 2008, J AM CHEM SOC, V130, P12874, DOI 10.1021/ja805088r; Magnus P, 2001, TETRAHEDRON, V57, P8647, DOI 10.1016/S0040-4020(01)00859-6; Nakao Y, 2014, TOP CURR CHEM, V346, P33, DOI 10.1007/128_2013_494; Gu ZH, 2010, ORG LETT, V12, P4224, DOI 10.1021/ol101523z; Yamaguchi J, 2012, ANGEW CHEM INT EDIT, V51, P8960, DOI 10.1002/anie.201201666; McMurray L, 2011, CHEM SOC REV, V40, P1885, DOI 10.1039/c1cs15013h; Sui XW, 2013, J AM CHEM SOC, V135, P9318, DOI 10.1021/ja404494u; Johnson JA, 2000, J AM CHEM SOC, V122, P6321, DOI 10.1021/ja0003223; Johnson JA, 2002, J AM CHEM SOC, V124, P6900, DOI 10.1021/ja026130k; Banwell MG, 2006, ARKIVOC, P163; Banwell MG, 2003, ORG BIOMOL CHEM, V1, P296, DOI 10.1039/b209992f; Baoudoin O., 2004, MINI-REV ORG CHEM, V1, P333; Development and Management of Human Resources, 2008, DEV MANAGEMENT HUMAN, V10, P4; Dong G, 2014, TOP CURR CHEM, V346, P1, DOI 10.1007/978-3-642-55055-3; Hsieh JC, 2010, SYNLETT, P1709, DOI 10.1055/s-0029-1219964; Murakami M., 2011, CHEM COMMUN, P1100; RATCLIFF.AH, 1973, TETRAHEDRON LETT, P5179; Schmuck C, 2008, EUR J ORG CHEM, P324, DOI 10.1002/ejoc.200700756; Xu T, 2014, ANGEW CHEM INT EDIT, V53, P10733, DOI 10.1002/anie.201404802	35	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0040-4020			TETRAHEDRON	Tetrahedron	JUL 1	2015	71	26-27					4413	4417		10.1016/j.tet.2015.03.012		5	Chemistry, Organic	Chemistry	CK4QG	WOS:000356207700001		
J	Murai, M; Okamoto, K; Miki, K; Ohe, K				Murai, Masahito; Okamoto, Kazuhiro; Miki, Koji; Ohe, Kouichi			Palladium-catalyzed three-component coupling reactions of 2-(cyanomethyl)phenol, aryl halides, and carbon monoxide	TETRAHEDRON			English	Article						Tandem catalysis; Carbonylation; Cycloisomerization; 3-Acyl-2-aminobenzofuran	TANDEM CATALYSIS; CYCLIZATION; NITRILES; CARBOPALLADATION; COMPLEXES; ALKYNES; IDENTIFICATION; CARBONYLATION; CONSTRUCTION; ANNULATION	Three-component coupling reactions of 2-(cyanomethyl)phenol, aryl halides, and carbon monoxide (CO) in orthogonal-tandem catalysis were investigated. In the reactions, 2-(cyanomethyl)phenyl esters, which are produced through Pd(PPh3)(4)-catalyzed alkoxycarbonylation of aryl halides with 2-(cyano-methyl)phenol, undergo cycloisomerization in situ catalyzed by Pd(PCy3)(2) as a co-catalyst to give 3-acyl-2-aminobenzofurans. Palladium species with homoleptic tertiary phosphines, such as Pd(PPh3)(4) and Pd(PCy3)(2), can catalyze the mechanistically distinct reactions in an orthogonal tandem manner without interference. By switching the base used in this reaction, 3-acyl-2-(N-acylamino)benzofurans were obtained as major products instead of 3-acyl-2-aminobenzofurans. Given that 2-(cyanomethyl)phenols can be synthesized from commercially available salicylic acid derivatives in two steps, the present method thus provides facile access to synthetically useful 3-acyl-2-aminobenzofurans. (C) 2015 Elsevier Ltd. All rights reserved.	[Murai, Masahito; Okamoto, Kazuhiro; Miki, Koji; Ohe, Kouichi] Kyoto Univ, Grad Sch Engn, Dept Energy & Hydrocarbon Chem, Nishikyo Ku, Kyoto 6158510, Japan	Ohe, K (reprint author), Kyoto Univ, Grad Sch Engn, Dept Energy & Hydrocarbon Chem, Nishikyo Ku, Kyoto 6158510, Japan.	ohe@scl.kyoto-u.ac.jp	Murai, Masahito/H-7402-2012		Nissan Chemical Industries, Ltd.; Ministry of Education, Culture, Sports, Science and Technology, Japan	This work was financially supported by Nissan Chemical Industries, Ltd. and Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Ambrosini LM, 2010, CHEMCATCHEM, V2, P1373, DOI 10.1002/cctc.200900323; SATOH T, 1994, ORGANOMETALLICS, V13, P4431, DOI 10.1021/om00023a052; Pellissier H, 2013, CHEM REV, V113, P442, DOI 10.1021/cr300271k; Wang CY, 2007, CHEM SOC REV, V36, P1395, DOI 10.1039/b608694m; Voigt B, 2005, BIOORG MED CHEM LETT, V15, P823, DOI 10.1016/j.bmcl.2004.10.091; Lu LQ, 2012, ACCOUNTS CHEM RES, V45, P1278, DOI 10.1021/ar200338s; Luo FH, 1998, ORGANOMETALLICS, V17, P1025, DOI 10.1021/om970842f; Ju Y, 2009, ORG LETT, V11, P3582, DOI 10.1021/ol901305q; Pletnev AA, 2002, J ORG CHEM, V67, P9428, DOI 10.1021/jo0262006; Mitchell EA, 2007, ORGANOMETALLICS, V26, P5230, DOI 10.1021/om700580d; Shindoh N, 2009, CHEM-EUR J, V15, P12168, DOI 10.1002/chem.200901486; Zhao L, 2002, ANGEW CHEM INT EDIT, V41, P4343, DOI 10.1002/1521-3773(20021115)41:22<4343::AID-ANIE4343>3.0.CO;2-5; Zhao BW, 2006, ORG LETT, V8, P5987, DOI 10.1021/ol062438v; Wasilke JC, 2005, CHEM REV, V105, P1001, DOI 10.1021/cr020018n; Lee JM, 2004, CHEM SOC REV, V33, P302, DOI 10.1039/b309033g; Tkach VS, 2008, J ORGANOMET CHEM, V693, P2069, DOI 10.1016/j.jorganchem.2007.12.019; Tsui GC, 2011, ORG LETT, V13, P208, DOI 10.1021/ol102598p; Murata T, 2012, ORG LETT, V14, P2296, DOI 10.1021/ol300718x; Ashikari Y, 2014, CHEM LETT, V43, P210, DOI 10.1246/cl.130947; Colquhoun H. M., 1991, CARBONYLATION DIRECT; KONG KC, 1991, J AM CHEM SOC, V113, P6313, DOI 10.1021/ja00016a082; Larock RC, 1999, J AM CHEM SOC, V121, P3238, DOI 10.1021/ja984086w; Miura T, 2007, ORG LETT, V9, P741, DOI 10.1021/ol062882y; Miura T, 2005, ORG LETT, V7, P3339, DOI 10.1021/ol051249u; Miura T, 2005, CHEM COMMUN, P2855, DOI 10.1039/b503686k; Murai M, 2009, CHEM COMMUN, P3466, DOI 10.1039/b904127c; Mural M., 2012, CHEM COMMUN, P7622; Nikitin K. V., 1991, MENDELEEV COMMUN, V1, P129, DOI 10.1070/MC1991v001n04ABEH000080; Tan T.-S., 2014, J MED IMAGING HLTH I, V4; Tian QP, 2003, J ORG CHEM, V68, P339, DOI 10.1021/jo026229; Tripathy R, 2012, BIOORG MED CHEM LETT, V22, P1421, DOI 10.1016/j.bmcl.2011.12.026; VERSTUYFT AW, 1976, INORG CHEM, V15, P1128, DOI 10.1021/ic50159a030; Wads M., 1983, J CHEM SOC DA, P1841; Wu XF, 2010, CHEMCATCHEM, V2, P509, DOI 10.1002/cctc.201000016; Xia G., 2012, ADV SYNTH CATAL, V354, P2701; Xia GQ, 2014, ORG LETT, V16, P2058, DOI 10.1021/ol500662f; Yang CC, 1997, J CHEM SOC PERK T 1, P2843, DOI 10.1039/a702710i; Yoshida J, 2011, SYNLETT, P1189, DOI 10.1055/s-0030-1259946; Zhang Y., 2009, J MED CHEM, V14, P2462; Zili X., 2001, BIOORG MED CHEM LETT, V11, P2875	40	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0040-4020			TETRAHEDRON	Tetrahedron	JUL 1	2015	71	26-27					4432	4437		10.1016/j.tet.2015.04.049		6	Chemistry, Organic	Chemistry	CK4QG	WOS:000356207700004		
J	Miyake, Y; Kimura, Y; Orito, N; Imai, H; Matsuda, T; Toshimitsu, A; Kondo, T				Miyake, Yuka; Kimura, Yu; Orito, Naomi; Imai, Hirohiko; Matsuda, Tetsuya; Toshimitsu, Akio; Kondo, Teruyuki			Synthesis and functional evaluation of chiral dendrimer-triamine-coordinated Gd complexes with polyaminoalcohol end groups as highly sensitive MRI contrast agents	TETRAHEDRON			English	Article						Chiral dendrimer; MRI contrast agent; Gadolinium; Polyethylene glycol; Molecular imaging	KIDNEY-DISEASE; PHARMACOKINETICS; RELAXIVITY; NANOMATERIALS; DYNAMICS; DESIGN; CANCER; CORES; SIZE	Novel chiral dendrimer-triamine-coordinated Gd complexes with polyaminoalcohol end groups were synthesized and shown to have longitudinal relaxivity (r(1)) values 5 times higher than that of clinically used Gd-DTPA. The affinities of Gd-4a and Gd-4b for bovine serum albumin (BSA), respectively, were estimated by a quartz crystal microbalance (QCM) measurement. The amino groups of the dendrimer were then conjugated with PEG. This conjugation with PEG strongly affected its ability to attenuate signals in T-1-weighted MRI. (C) 2015 Elsevier Ltd. All rights reserved.	[Miyake, Yuka; Kimura, Yu; Orito, Naomi; Toshimitsu, Akio; Kondo, Teruyuki] Kyoto Univ, Grad Sch Engn, Dept Energy & Hydrocarbon Chem, Nishikyo Ku, Kyoto 6158510, Japan; [Kimura, Yu] Kyoto Univ, Ctr Promot Interdisciplinary Educ & Res, Res & Educ Unit Leaders Integrated Med Syst, Kyoto 6158510, Japan; [Imai, Hirohiko; Matsuda, Tetsuya] Kyoto Univ, Grad Sch Informat, Sakyo Ku, Kyoto 6068501, Japan; [Toshimitsu, Akio] Kyoto Univ, Inst Chem Res, Div Multidisciplinary Chem, Uji, Kyoto 6110011, Japan; [Kondo, Teruyuki] Kyoto Univ, Ctr Promot Interdisciplinary Educ & Res, Adv Biomed Engn Res Unit, Kyoto 6158510, Japan	Kondo, T (reprint author), Kyoto Univ, Grad Sch Engn, Dept Energy & Hydrocarbon Chem, Nishikyo Ku, Kyoto 6158510, Japan.	teruyuki@scl.kyoto-u.ac.jp			Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program 'Innovative Techno-Hub for Integrated Medical Bio-imaging' from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan; Japan Society for the Promotion of Science (JSPS); JSPS KAKENHI [25870359, 15K01819, 15H01403]; Princess Takamatsu Cancer Research Fund; Magnetic Health Science Foundation; SEI Group CSR Foundation;  [255096]	This work was partly supported by the lCreation of Innovation Centers for Advanced Interdisciplinary Research Areas Program 'Innovative Techno-Hub for Integrated Medical Bio-imaging' from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan. YM acknowledges a fellowship from the Japan Society for the Promotion of Science (JSPS) and financial support from Grant-in-Aid for JSPS Fellows Number 255096. YK acknowledges financial support from JSPS KAKENHI Grant Number 25870359. TK acknowledges financial support from JSPS KAKENHI Grant Number 151(01819, 15H01403, the Princess Takamatsu Cancer Research Fund, Magnetic Health Science Foundation, and SEI Group CSR Foundation.	Bottrill M, 2006, CHEM SOC REV, V35, P557, DOI 10.1039/b516376p; Chen F, 2014, SMALL, V10, P1887, DOI 10.1002/smll.201303627; Kobayashi H, 2003, BIOCONJUGATE CHEM, V14, P388, DOI 10.1021/bc025633c; Boros E, 2015, DALTON T, V44, P4804, DOI 10.1039/c4dt02958e; Cyran CC, 2008, J MAGN RESON IMAGING, V27, P581, DOI 10.1002/jmri.21245; Caravan P, 2006, CHEM SOC REV, V35, P512, DOI 10.1039/b510982p; Perazella MA, 2008, CLIN J AM SOC NEPHRO, V3, P649, DOI 10.2215/CJN.00670208; Labieniec M, 2009, CENT EUR J BIOL, V4, P434, DOI 10.2478/s11535-009-0056-7; Kukowska-Latallo JF, 2005, CANCER RES, V65, P5317, DOI 10.1158/0008-5472.CAN-04-3921; Longmire MR, 2014, WIRES NANOMED NANOBI, V6, P155, DOI 10.1002/wnan.1250; Bryant LH, 1999, JMRI-J MAGN RESON IM, V9, P348, DOI 10.1002/(SICI)1522-2586(199902)9:2<348::AID-JMRI30>3.0.CO;2-J; Villaraza AJL, 2010, CHEM REV, V110, P2921, DOI 10.1021/cr900232t; Astruc D, 2010, CHEM REV, V110, P1857, DOI 10.1021/cr900327d; Werner EJ, 2008, ANGEW CHEM INT EDIT, V47, P8568, DOI 10.1002/anie.200800212; Zhu DR, 2013, INT J MOL SCI, V14, P10591, DOI 10.3390/ijms140510591; Kobayashi H, 2005, ADV DRUG DELIVER REV, V57, P2271, DOI 10.1016/j.addr.2005.09.016; Perazella MA, 2009, CLIN J AM SOC NEPHRO, V4, P461, DOI 10.2215/CJN.06011108; Kimura Y, 2012, ADV HEALTHC MATER, V1, P657, DOI 10.1002/adhm.201200103; Malik N, 2000, J CONTROL RELEASE, V65, P133, DOI 10.1016/S0168-3659(99)00246-1; Tang JB, 2013, PROG POLYM SCI, V38, P462, DOI 10.1016/j.progpolymsci.2012.07.001; Langereis S, 2007, NEW J CHEM, V31, P1152, DOI 10.1039/b616960k; Misselwitz B, 2001, MAGN RESON MATER PHY, V12, P128, DOI 10.1016/S1352-8661(01)00109-0; Caravan P, 1999, CHEM REV, V99, P2293, DOI 10.1021/cr980440x; Cheng YY, 2011, CHEM SOC REV, V40, P2673, DOI 10.1039/c0cs00097c; Botta M, 2012, EUR J INORG CHEM, P1945, DOI 10.1002/ejic.201101305; Bunb A., 2010, ACTA RADIOL, V51, P751; Campagna S., 2012, DESIGNING DENDRIMERS; Goenka AH, 2014, TEX HEART I J, V41, P7, DOI 10.14503/THIJ-13-3920; Hermann P, 2008, DALTON T, P3027, DOI 10.1039/b719704g; Kojima C, 2011, NANOMED-NANOTECHNOL, V7, P1001, DOI 10.1016/j.nano.2011.03.007; KOLB HC, 1992, TETRAHEDRON, V48, P10515, DOI 10.1016/S0040-4020(01)88349-6; Kondo T., 2009, PCT Int. Appl, Patent No. [WO 2009069833 A1, 2009069833]; Langereis S, 2004, MACROMOLECULES, V37, P3084, DOI 10.1021/ma035983+; Miyake Y, 2012, TETRAHEDRON LETT, V53, P4580, DOI 10.1016/j.tetlet.2012.06.072; Skendzel J. G., 2011, AJR, V196, P942; Turrin C.-O., 2012, DEDNDRIMER, P437; Vogtle F., 2009, DENDRIMER CHEM; WIENER EC, 1994, MAGNET RESON MED, V31, P1, DOI 10.1002/mrm.1910310102; Wiener EC, 1996, J AM CHEM SOC, V118, P7774, DOI 10.1021/ja9536126	39	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0040-4020			TETRAHEDRON	Tetrahedron	JUL 1	2015	71	26-27					4438	4444		10.1016/j.tet.2015.04.050		7	Chemistry, Organic	Chemistry	CK4QG	WOS:000356207700005		
J	Nakamura, K; Yasui, K; Tobisu, M; Chatani, N				Nakamura, Keisuke; Yasui, Kosuke; Tobisu, Mamoru; Chatani, Naoto			Rhodium-catalyzed cross-coupling of aryl carbamates with arylboron reagents	TETRAHEDRON			English	Article						Rhodium catalyst; C-O bond activation; Suzuki-Miyaura reaction; Cross-coupling; Carbamate	C-O BOND; CARBON-OXYGEN BONDS; ORGANOBORON COMPOUNDS; PHENOL DERIVATIVES; GRIGNARD-REAGENTS; VINYL-ACETATE; BORONIC ACIDS; ACTIVATION; ETHERS; CLEAVAGE	A new method has been developed for the rhodium-catalyzed cross-coupling of aryl carbamates with organoboron reagents. The use of an NHC ligand bearing a 2-adamantyl group, i.e., I(2-Ad), is essential to the success of the reaction. The reaction involves the rhodium-mediated activation of the relatively inert C(aryl)-O bond of aryl carbamates. (C) 2015 Elsevier Ltd. All rights reserved.	[Nakamura, Keisuke; Yasui, Kosuke; Tobisu, Mamoru; Chatani, Naoto] Osaka Univ, Fac Engn, Dept Appl Chem, Suita, Osaka 5650871, Japan; [Tobisu, Mamoru] Osaka Univ, Grad Sch Engn, Ctr Atom & Mol Technol, Suita, Osaka 5650871, Japan	Tobisu, M (reprint author), Osaka Univ, Fac Engn, Dept Appl Chem, Suita, Osaka 5650871, Japan.	tobisu@chem.eng.osaka-u.ac.jp; chatani@chem.eng.osaka-u.ac.jp			MEXT, Japan; ACT-C from JST, Japan	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas "Molecular Activation Directed toward Straightforward Synthesis" from MEXT, Japan and ACT-C from JST, Japan. We also thank the Instrumental Analysis Center, Faculty of Engineering, Osaka University, and Professors Mitsuhiro Arisawa, Tetsuya Satoh and Hayato Tsurugi (Osaka University) for assistance with HRMS.	Ackermann L, 2014, J ORG CHEM, V79, P8948, DOI 10.1021/jo501361k; MIYAURA N, 1995, CHEM REV, V95, P2457, DOI 10.1021/cr00039a007; Iwasaki T, 2014, J AM CHEM SOC, V136, P9260, DOI 10.1021/ja5043534; Mesganaw T, 2013, ORG PROCESS RES DEV, V17, P29, DOI 10.1021/op300236f; [Anonymous], 2008, RMCH, VLXII, P5; Sergeev AG, 2011, SCIENCE, V332, P439, DOI 10.1126/science.1200437; Zhang L, 2008, ADV SYNTH CATAL, V350, P2409, DOI 10.1002/adsc.200800414; Kuhl N, 2014, ADV SYNTH CATAL, V356, P1443, DOI 10.1002/adsc.201400197; Wang C, 2012, CHEM-EUR J, V18, P3482, DOI 10.1002/chem.201103784; Iglesias MJ, 2012, ORG LETT, V14, P4318, DOI 10.1021/ol302112q; Zhao YG, 2014, ORG LETT, V16, P3200, DOI 10.1021/ol501180q; Li BJ, 2008, ANGEW CHEM INT EDIT, V47, P10124, DOI 10.1002/anie.200803814; Yang MY, 2012, ORG LETT, V14, P816, DOI 10.1021/ol2033465; Tobisu M, 2013, TOP ORGANOMETAL CHEM, V44, P35, DOI 10.1007/3418_2012_42; WENKERT E, 1979, J AM CHEM SOC, V101, P2246, DOI 10.1021/ja00502a074; Takeda M, 2014, J ORG CHEM, V79, P2354, DOI 10.1021/jo500068p; Kinuta H, 2015, J AM CHEM SOC, V137, P1593, DOI 10.1021/ja511622e; Quasdorf KW, 2009, J AM CHEM SOC, V131, P17748, DOI 10.1021/ja906477r; Han FS, 2013, CHEM SOC REV, V42, P5270, DOI 10.1039/c3cs35521g; Quasdorf KW, 2011, J AM CHEM SOC, V133, P6352, DOI 10.1021/ja200398c; Silberstein AL, 2012, ORG LETT, V14, P3796, DOI 10.1021/ol301681z; Tobisu M, 2014, ORG LETT, V16, P5572, DOI 10.1021/ol502583h; Suzuki A, 2011, ANGEW CHEM INT EDIT, V50, P6722, DOI 10.1002/anie.201101379; Partyka DV, 2011, CHEM REV, V111, P1529, DOI 10.1021/cr1002276; Miyaura N, 2008, B CHEM SOC JPN, V81, P1535, DOI 10.1246/bcsj.81.1535; Molander GA, 2010, ORG LETT, V12, P4022, DOI 10.1021/ol101592r; Kakiuchi F, 2004, J AM CHEM SOC, V126, P2706, DOI 10.1021/ja0393170; Tobisu M, 2015, ORG LETT, V17, P680, DOI 10.1021/ol503707m; HANSCH C, 1991, CHEM REV, V91, P165, DOI 10.1021/cr00002a004; Yu DG, 2011, ANGEW CHEM INT EDIT, V50, P7097, DOI 10.1002/anie.201101461; Yu JY, 2010, ANGEW CHEM INT EDIT, V49, P6396, DOI 10.1002/anie.201002745; Tasker SZ, 2014, NATURE, V509, P299, DOI 10.1038/nature13274; Li BJ, 2009, J AM CHEM SOC, V131, P14656, DOI 10.1021/ja907281f; Antoft-Finch A, 2009, J AM CHEM SOC, V131, P17750, DOI 10.1021/ja907700e; Yu DG, 2010, ANGEW CHEM INT EDIT, V49, P4566, DOI 10.1002/anie.200907359; Tobisu M, 2012, TETRAHEDRON, V68, P5157, DOI 10.1016/j.tet.2012.04.005; [Anonymous], 2011, CHEM LETT, V40, P894; Yu DG, 2010, ACCOUNTS CHEM RES, V43, P1486, DOI 10.1021/ar100082d; Tobisu M, 2009, CHEM LETT, V38, P710, DOI 10.1246/cl.2009.710; Yu JY, 2009, ANGEW CHEM INT EDIT, V48, P7217, DOI 10.1002/anie.200903146; Mesganaw T, 2011, CHEM SCI, V2, P1766, DOI 10.1039/c1sc00230a; Grushin VV, 2004, J AM CHEM SOC, V126, P3068, DOI 10.1021/ja049844z; Rosen BM, 2011, CHEM REV, V111, P1346, DOI 10.1021/cr100259t; Alvarez-Bercedo P, 2010, J AM CHEM SOC, V132, P17352, DOI 10.1021/ja106943q; Zhao XD, 2010, J AM CHEM SOC, V132, P5837, DOI 10.1021/ja100783c; Baghbanzadeh M, 2011, J ORG CHEM, V76, P1507, DOI 10.1021/jo1024464; Ehle AR, 2012, ORG LETT, V14, P1202, DOI 10.1021/ol203322v; Zhao YG, 2014, J AM CHEM SOC, V136, P11224, DOI 10.1021/ja503819x; Colby DA, 2010, CHEM REV, V110, P624, DOI 10.1021/cr900005n; Shimasaki T, 2010, ANGEW CHEM INT EDIT, V49, P2929, DOI 10.1002/anie.200907287; Ueno S, 2006, J AM CHEM SOC, V128, P16516, DOI 10.1021/ja067612p; Ueura K, 2005, ORG LETT, V7, P2229, DOI 10.1021/ol050590b; [Anonymous], 2009, JEA, V95, P17; Satoh T, 2010, CHEM-EUR J, V16, P11212, DOI 10.1002/chem.201001363; Li BJ, 2011, CHEM-EUR J, V17, P1728, DOI 10.1002/chem.201002273; MIYAURA N, 1979, TETRAHEDRON LETT, V20, P3437, DOI 10.1016/S0040-4039(01)95429-2; Song WF, 2012, ANGEW CHEM INT EDIT, V51, P8251, DOI 10.1002/anie.201202466; Cornella J, 2013, ORG LETT, V15, P6298, DOI 10.1021/ol4031815; Cornella J, 2014, CHEM SOC REV, V43, P8081, DOI 10.1039/c4cs00206g; CORREA A, 2014, AM CHEM SOC, V136, P1062; de Meijere A., 2004, METAL CATALYZED CROS; Guan BT, 2008, CHEM COMMUN, P1437, DOI 10.1039/b718998b; Guan BT, 2008, J AM CHEM SOC, V130, P14468, DOI 10.1021/ja8056503; Hall DG, 2005, BORONIC ACIDS: PREPARATION AND APPLICATIONS IN ORGANIC SYNTHESIS AND MEDICINE, P1, DOI 10.1002/3527606548; Kinuta H, 2015, CHEM LETT, V44, P366, DOI 10.1246/cl.141084; Koch E., 2015, CHEM COMMUN, P855; Kuwano R, 2011, CHEM LETT, V40, P913, DOI 10.1246/cl.2011.913; Lee HW, 2009, SYNLETT, P3151, DOI 10.1055/s-0029-1218283; Leowanawat P, 2012, J ORG CHEM, V77, P1018, DOI 10.1021/jo2022982; Li WJ, 2011, ADV SYNTH CATAL, V353, P1671, DOI 10.1002/adsc.201100141; Miller RE, 2010, ORG LETT, V12, P2198, DOI 10.1021/ol100493v; MIYAURA N, 1979, J CHEM SOC CHEM COMM, P866, DOI 10.1039/c39790000866; Miyaura N., 2002, CROSS COUPLING REACT; MUTO K, 2012, AM CHEM SOC, V134, P169; Quasdorf KW, 2008, J AM CHEM SOC, V130, P14422, DOI 10.1021/ja806244b; Seganish WM, 2004, J ORG CHEM, V69, P6790, DOI 10.1021/jo0492057; Suzuki A., 2003, ORGANIC SYNTHESIS VI; Tobisu M., 2011, CHEM COMMUN, P2946; [徐连勇 XU Lianyong], 2010, [焊接学报, Transactions of the China Welding Institution], V31, P12; Xu M., 2013, CHEM COMMUN, P11539; Yamaguchi J, 2013, EUR J ORG CHEM, P19, DOI 10.1002/ejoc.201200914; Zhu Y., 2012, CHEM COMMUN, P218	82	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0040-4020			TETRAHEDRON	Tetrahedron	JUL 1	2015	71	26-27					4484	4489		10.1016/j.tet.2015.02.088		6	Chemistry, Organic	Chemistry	CK4QG	WOS:000356207700012		
J	Shibata, M; Fuchigami, R; Kotaka, R; Namba, K; Tanino, K				Shibata, Miki; Fuchigami, Ryuichi; Kotaka, Ryota; Namba, Kosuke; Tanino, Keiji			Acid-catalyzed [4+3] cycloaddition reaction of N-nosyl pyrroles	TETRAHEDRON			English	Article						Tropane alkaloid; Tropinone; [4+3] Cycloaddition reaction; N-Nosyl pyrroles	STABILIZED OXYALLYL CATIONS; INDUCED TANDEM; SCAFFOLDS; CHEMISTRY; FURAN	An acid-catalyzed [4+3] cycloaddition reaction of N-nosyl pyrroles with 2-(tert-butyldimethylsilyloxy) acrolein has been developed. The reaction of 2-(silyloxy)acrolein with N-nosyl pyrrole was catalyzed by Tf2NH, and a regio- and stereoselective reaction with 2-substituted N-nosyl pyrroles leading to tropinone derivatives possessing tetra-substituted carbon centers was also achieved. High regioselectivities were obtained by using Cu(OTf)(2) or Sc(OTf)(3) as a catalyst in nitromethane, and the reaction was applicable to various 2-substituted N-nosyl pyrroles in good yields and with high regioselectivities. (C) 2015 Elsevier Ltd. All rights reserved.	[Shibata, Miki; Kotaka, Ryota; Namba, Kosuke] Univ Tokushima, Pharmaceut Sci, Tokushima 7708505, Japan; [Fuchigami, Ryuichi] Hokkaido Univ, Grad Sch Chem Sci & Engn, Sapporo, Hokkaido 0600810, Japan; [Tanino, Keiji] Hokkaido Univ, Fac Sci, Dept Chem, Kita Ku, Sapporo, Hokkaido 0600810, Japan	Namba, K (reprint author), Univ Tokushima, Pharmaceut Sci, 1-78 Shomachi, Tokushima 7708505, Japan.	namba@tokush-ima-u.ac.jp; ktanino@sci.hokudai.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan [24310162, 26560449, 2301]; Naito Foundation; Yamada Foundation	This work was partially supported by Grant-in-Aid for Scientific Research (Grant Nos. 24310162 and 26560449), and Grant-in-Aid for Scientific Research on Innovative Areas (Project No. 2301: Chemical Biology of Natural Products) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. K. N. is grateful to the Naito Foundation and Yamada Foundation for support through a Research Fund for Recently Independent Professor.	Krenske EH, 2010, ORG LETT, V12, P444, DOI 10.1021/ol902591k; Kurdyumov AV, 2006, ORG LETT, V8, P191, DOI 10.1021/ol0523042; Nilson MG, 2011, J AM CHEM SOC, V133, P12451, DOI 10.1021/ja206138d; Singh S, 2000, CHEM REV, V100, P925, DOI 10.1021/cr9700538; He SZ, 2014, ORG LETT, V16, P2180, DOI 10.1021/ol5006455; [Anonymous], 2006, BOSPHORUS, V42, p[155, 156]; Antoline JE, 2007, ORG LETT, V9, P1275, DOI 10.1021/ol070103n; Harmata M, 2006, ADV SYNTH CATAL, V348, P2297, DOI 10.1002/adsc.200600294; Aungst RA, 2001, ORG LETT, V3, P3553, DOI 10.1021/ol016668f; Davies HML, 2004, J AM CHEM SOC, V126, P2692, DOI 10.1021/ja039908q; Fuchigami R, 2012, TETRAHEDRON LETT, V53, P5725, DOI 10.1016/j.tetlet.2012.07.130; HAKIMELAHI GH, 1982, CAN J CHEM, V60, P1106, DOI 10.1139/v82-165; Harmata M, 2000, ORG LETT, V2, P2703, DOI 10.1021/ol006281x; Harmata M., 2010, CHEM COMMUN, P8904; Harmata M, 2009, TETRAHEDRON LETT, V50, P5701, DOI 10.1016/j.tetlet.2009.07.111; Hodgson DM, 2010, ORG LETT, V12, P2834, DOI 10.1021/ol100943j; Kulkarni K, 2008, SYNLETT, P2209, DOI 10.1055/s-2008-1078255; Magee DI, 2006, EUR J ORG CHEM, P3667, DOI 10.1002/ejoc.200600226; Montana AM, 2001, TETRAHEDRON LETT, V42, P7809, DOI 10.1016/S0040-4039(01)01671-9; NOYORI R, 1983, ORG REACTIONS, V29, P163; Paparin JL, 2000, TETRAHEDRON LETT, V41, P2343, DOI 10.1016/S0040-4039(00)00198-2; Paparin JL, 2000, EUR J ORG CHEM, P3909; Rigby J. H., 1997, ORG REACTIONS, V51, P351; SASAKI T, 1982, TETRAHEDRON LETT, V23, P1693, DOI 10.1016/S0040-4039(00)87192-0; Smits R, 2014, BIOORGAN MED CHEM, V22, P804, DOI 10.1016/j.bmc.2013.12.011	25	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0040-4020			TETRAHEDRON	Tetrahedron	JUL 1	2015	71	26-27					4495	4499		10.1016/j.tet.2015.02.071		5	Chemistry, Organic	Chemistry	CK4QG	WOS:000356207700014		
J	Segawa, Y; Kuwabara, T; Matsui, K; Kawai, S; Itami, K				Segawa, Yasutomo; Kuwabara, Takuya; Matsui, Katsuma; Kawai, Satoru; Itami, Kenichiro			Palladium-free synthesis of [10]cycloparaphenylene	TETRAHEDRON			English	Article						Cycloparaphenylene; Homocoupling; Macrocyclization; Selective synthesis	BOTTOM-UP SYNTHESIS; PI-CONJUGATED MOLECULES; WALL CARBON NANOTUBES; CRYSTAL-STRUCTURE; SELECTIVE SYNTHESIS; PHOTOPHYSICAL PROPERTIES; ELECTRONIC-PROPERTIES; MEDIATED SYNTHESIS; CONCISE SYNTHESIS; SHAPE-PERSISTENT	A palladium-free, short-step synthesis of [101cycloparaphenylene ([101CPP) has been developed. The key macrocyclization step was performed by a nickel-mediated homocoupling of a newly designed U-shaped unit 2. Surprisingly, the rectangular macrocycle 3 was obtained in high yield compared with previous macrocyclization reactions in CPP syntheses. X-ray crystallography as well as DFT calculation revealed unstrained structure of the macrocycle 3. (C) 2015 Published by Elsevier Ltd.	[Segawa, Yasutomo; Kuwabara, Takuya; Kawai, Satoru; Itami, Kenichiro] JST, ERATO, Itami Mol Nanocarbon Project, Nagoya, Aichi 4648602, Japan; [Segawa, Yasutomo; Kuwabara, Takuya; Matsui, Katsuma; Kawai, Satoru; Itami, Kenichiro] Nagoya Univ, Grad Sch Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Itami, Kenichiro] Nagoya Univ, Inst Transformat Biomol WPI ITbM, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Itami, K (reprint author), JST, ERATO, Itami Mol Nanocarbon Project, Nagoya, Aichi 4648602, Japan.	itami@chem.nagoya.ac.jp	Segawa, Yasutomo/F-4889-2010; Itami, Kenichiro/B-5110-2011; Kuwabara, Takuya/A-2132-2015		ERATO program from JST; JSPS fellowship for young scientists; World Premier International Research Center Initiative (WPI), Japan	This work was supported by the ERATO program from JST (K.I.). K.M. is a recipient of JSPS fellowship for young scientists. Calculations were carried out using resources of the Research Center for Computational Science, Okazaki, Japan. ITbM is supported by the World Premier International Research Center Initiative (WPI), Japan.	Nishihara T, 2014, CHEM SCI, V5, P2293, DOI 10.1039/c3sc53462f; Sisto TJ, 2012, J ORG CHEM, V77, P5857, DOI 10.1021/jo301024g; Omachi H, 2012, ACCOUNTS CHEM RES, V45, P1378, DOI 10.1021/ar300055x; Yagi A, 2012, J AM CHEM SOC, V134, P2962, DOI 10.1021/ja300001g; Nishihara T, 2012, J PHYS CHEM LETT, V3, P3125, DOI 10.1021/jz3014826; Iwamoto T, 2013, CHEM-EUR J, V19, P14061, DOI 10.1002/chem.201302694; Evans PJ, 2014, NAT CHEM, V6, P404, DOI [10.1038/nchem.1888, 10.1038/NCHEM.1888]; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; [Anonymous], 2011, LANCET, V378, P50; Segawa Y, 2011, ANGEW CHEM INT EDIT, V50, P3244, DOI 10.1002/anie.201007232; Kayahara E, 2012, ORG LETT, V14, P3284, DOI 10.1021/ol301242t; Takaba H, 2009, ANGEW CHEM INT EDIT, V48, P6112, DOI 10.1002/anie.200902617; Omachi H, 2010, ANGEW CHEM INT EDIT, V49, P10202, DOI 10.1002/anie.201005734; Matsui K, 2014, J AM CHEM SOC, V136, P16452, DOI 10.1021/ja509880v; Darzi ER, 2012, J ORG CHEM, V77, P6624, DOI 10.1021/jo3011667; Camacho C, 2013, CHEM SCI, V4, P187, DOI 10.1039/c2sc20878d; Iwamoto T, 2014, CHEM-EUR J, V20, P14403, DOI 10.1002/chem.201403879; Segawa Y, 2012, ORG BIOMOL CHEM, V10, P5979, DOI 10.1039/c2ob25199j; Xia JL, 2012, CHEM SCI, V3, P3018, DOI 10.1039/c2sc20719b; Kubota N, 2015, J AM CHEM SOC, V137, P1356, DOI 10.1021/ja512271p; Fujitsuka M, 2012, PHYS CHEM CHEM PHYS, V14, P14585, DOI 10.1039/c2cp42712e; Kayahara E, 2013, CHEM LETT, V42, P621, DOI 10.1246/cl.130188; Segawa Y, 2011, CHEM LETT, V40, P423, DOI 10.1246/cl.2011.423; Omachi H, 2011, ORG LETT, V13, P2480, DOI 10.1021/ol200730m; Ito H, 2015, ANGEW CHEM INT EDIT, V54, P159, DOI 10.1002/anie.201409389; Ishii Y, 2014, ORG LETT, V16, P2174, DOI 10.1021/ol500643c; Golling FE, 2014, ANGEW CHEM INT EDIT, V53, P1525, DOI 10.1002/anie.201309104; Hitosugi S, 2012, J AM CHEM SOC, V134, P12442, DOI 10.1021/ja305723j; Xia JL, 2012, ANGEW CHEM INT EDIT, V51, P2474, DOI 10.1002/anie.201108167; Nakanishi Y, 2014, ANGEW CHEM INT EDIT, V53, P3102, DOI 10.1002/anie.201311268; Segawa Y, 2010, ORG LETT, V12, P2262, DOI 10.1021/ol1006168; Fujitsuka M, 2014, J PHYS CHEM A, V118, P4527, DOI 10.1021/jp504689q; Altomare A, 1999, J APPL CRYSTALLOGR, V32, P115, DOI 10.1107/S0021889898007717; Yamago S, 2010, ANGEW CHEM INT EDIT, V49, P757, DOI 10.1002/anie.200905659; Jasti R, 2008, J AM CHEM SOC, V130, P17646, DOI 10.1021/ja807126u; Alvarez MP, 2014, ANGEW CHEM INT EDIT, V53, P7033, DOI 10.1002/anie.201400719; Iwamoto T, 2011, J AM CHEM SOC, V133, P8354, DOI 10.1021/ja2020668; Tran-Van AF, 2014, ORG LETT, V16, P1594, DOI 10.1021/ol500194s; Adamska L, 2014, NANO LETT, V14, P6539, DOI 10.1021/nl503133e; Omachi H, 2013, NAT CHEM, V5, P572, DOI [10.1038/nchem.1655, 10.1038/NCHEM.1655]; Ishii Y, 2012, CHEM SCI, V3, P2340, DOI 10.1039/c2sc20343j; Yamago S, 2014, CHEM REC, V14, P84, DOI 10.1002/tcr.201300035; Xia JL, 2012, J AM CHEM SOC, V134, P19709, DOI 10.1021/ja307373r; Iwamoto T, 2014, ANGEW CHEM INT EDIT, V53, P6430, DOI 10.1002/anie.201403624; Hirst ES, 2012, J ORG CHEM, V77, P10473, DOI 10.1021/jo302186h; Sisto TJ, 2011, J AM CHEM SOC, V133, P15800, DOI 10.1021/ja205606p; Matsui K, 2012, ORG LETT, V14, P1888, DOI 10.1021/ol3005112; Huang CF, 2014, ORG LETT, V16, P2672, DOI 10.1021/ol500904x; Mysliwiec D, 2015, J AM CHEM SOC, V137, P1643, DOI 10.1021/ja511951x; Nishiuchi T, 2012, CHEM-EUR J, V18, P16621, DOI 10.1002/chem.201203227; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Matsui K, 2013, CHEM SCI, V4, P84, DOI 10.1039/c2sc21322b; Batson J. M., 2013, SYNLETT, P2545; Frisch M.J., 2013, GAUSSIAN 09 REVISION; Grave C, 2002, EUR J ORG CHEM, P3075; Hager S. J., 1999, POLY SCI A, V37, P2685; Hitosugi S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1505; Itami K, 2012, PURE APPL CHEM, V84, P907, DOI 10.1351/PAC-CON-11-11-15; Kayahara K., 2014, J AM CHEM SOC, V136, P2284; Matsuno S., 2013, CHEM SCI, V4, P3179; Peña Alvarez Miriam, 2014, Faraday Discuss, V173, P157, DOI 10.1039/c4fd00103f; NEWKOME GR, 1977, CHEM REV, V77, P513, DOI 10.1021/cr60308a003; Sibbel F., 2014, CHEM COMMUN, P954; Ueno H., 2015, ANGEW CHEM INT ED; Yagi A., 2013, CHEM COMMUN, P957; Zhao DH, 2003, CHEM COMMUN, P807, DOI 10.1039/b207442g	66	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0040-4020			TETRAHEDRON	Tetrahedron	JUL 1	2015	71	26-27					4500	4503		10.1016/j.tet.2015.02.066		4	Chemistry, Organic	Chemistry	CK4QG	WOS:000356207700015		
J	Nakai, K; Kurahashi, T; Matsubara, S				Nakai, Kenichiro; Kurahashi, Takuya; Matsubara, Seijiro			Nickel-catalyzed dual C-C sigma bond activation to construct carbocyclic skeletons	TETRAHEDRON			English	Article						C-C bond activation; Nickel catalyst; Heterocyclic compound; Carbocyclic compound	INTERMOLECULAR ALKYNE INSERTION; BETA-CARBON ELIMINATION; ACID CATALYSIS; DECARBONYLATIVE ADDITION; SELECTIVE ALKENYLATION; CYCLOADDITION; KETONES; CYCLIZATION; ANHYDRIDES; FRAMEWORKS	A nickel/Lewis acid catalyzed intermolecular cycloaddition reaction of o-cyanobenzylarylketones with allcynes to form naphthalenones is developed. This reaction is promoted by the nickel/Lewis Acid catalyst pair and involves the cleavage of two C-C sigma bonds to eliminate arylcyanide and the formation of different two C-C sigma bonds with alkyne insertion. (C) 2015 Elsevier Ltd. All rights reserved.	[Nakai, Kenichiro; Kurahashi, Takuya; Matsubara, Seijiro] Kyoto Univ, Grad Sch Engn, Dept Chem Mat, Nishikyo Ku, Kyoto 6158510, Japan; [Kurahashi, Takuya] ACT C, JST, Kawaguchi, Saitama 3320012, Japan	Kurahashi, T (reprint author), Kyoto Univ, Grad Sch Engn, Dept Chem Mat, Nishikyo Ku, Kyoto 6158510, Japan.	kurahashi.takuya.2c@kyoto-u.acjp; matsubara.seijiro.2e@kyoto-u.ac.jp			JST; ACT-C; Ministry of Education, Culture, Sports, Science and Technology, Japan; Japan Society for the Promotion of Science for Young Scientists	This work was supported by JST, ACT-C and Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology, Japan. T.K. acknowledges the Asahi Glass Foundation, The Sumitomo Foundation, Tokuyama Science Foundation, and Kansai Research Foundation. K.N. also acknowledges the Japan Society for the Promotion of Science for Young Scientists for fellowship support.	Kondo T, 2005, CHEM LETT, V34, P1462, DOI 10.1246/cl.2005.1462; Murakami M, 2010, CHEM REC, V10, P326, DOI 10.1002/tcr.201000023; Miura T, 2009, CHEM COMMUN, P1470, DOI 10.1039/b819162j; Nakao Y, 2007, J AM CHEM SOC, V129, P2428, DOI 10.1021/ja067364x; Nakao Y, 2009, J AM CHEM SOC, V131, P5070, DOI 10.1021/ja901153s; Nakao Y, 2010, J AM CHEM SOC, V132, P13666, DOI 10.1021/ja106514b; Kajita Y, 2008, J AM CHEM SOC, V130, P17226, DOI 10.1021/ja806569h; Nakamura I, 2009, ORG LETT, V11, P1055, DOI 10.1021/ol900113f; Jun CH, 2004, CHEM SOC REV, V33, P610, DOI 10.1039/b308864m; Nakao Y, 2011, J AM CHEM SOC, V133, P3264, DOI 10.1021/ja1102037; Jafarpour F, 2013, ORG LETT, V15, P3816, DOI 10.1021/ol401318v; Kotha S, 2006, CHEM-EUR J, V12, P8024, DOI 10.1002/chem.200600540; Murakami M, 2006, B CHEM SOC JPN, V79, P1315, DOI 10.1246/bcsj.79.1315; Nakai K, 2011, J AM CHEM SOC, V133, P11066, DOI 10.1021/ja203829j; Pletnev AA, 2002, J ORG CHEM, V67, P9276, DOI 10.1021/jo026178g; Yoshino Y, 2009, J AM CHEM SOC, V131, P7494, DOI 10.1021/ja900805y; Murakami M, 2005, J AM CHEM SOC, V127, P6932, DOI 10.1021/ja050674f; Murakami M, 2006, J AM CHEM SOC, V128, P2166, DOI 10.1021/ja0552895; Wang DH, 2008, J AM CHEM SOC, V130, P17676, DOI 10.1021/ja806681z; Oguma T, 2012, J AM CHEM SOC, V134, P20017, DOI 10.1021/ja310203c; Tsai CC, 2010, J AM CHEM SOC, V132, P11887, DOI 10.1021/ja1061246; Miura T, 2008, ORG LETT, V10, P3085, DOI 10.1021/ol8010826; Nakao Y, 2008, J AM CHEM SOC, V130, P2448, DOI 10.1021/ja710766j; Du L, 2011, CHEM-EUR J, V17, P1319, DOI [10.1002/chem.201001547, 10.1002/chem201001547]; Klumpp DA, 1997, J ORG CHEM, V62, P6666, DOI 10.1021/jo970293n; Shintani R, 2007, J AM CHEM SOC, V129, P14866, DOI 10.1021/ja077236o; Hu XJ, 2009, TETRAHEDRON LETT, V50, P2917, DOI 10.1016/j.tetlet.2009.03.186; Gandeepan P, 2010, J AM CHEM SOC, V132, P8569, DOI 10.1021/ja1026248; Tang GH, 2012, J NAT PROD, V75, P1962, DOI 10.1021/np3006315; Kajita Y, 2008, J AM CHEM SOC, V130, P6058, DOI 10.1021/ja7114426; Ashida S, 2008, B CHEM SOC JPN, V81, P885, DOI 10.1246/bcsj.81.885; BALOGHHERGOVICH E, 1982, SYNTHESIS-STUTTGART, P731; Edelbach BL, 1999, ORGANOMETALLICS, V18, P4040, DOI 10.1021/om990387i; HART H, 1967, J ORG CHEM, V32, P2448, DOI 10.1021/jo01283a020; Hutchinson D.K., 2005, U.S. Patent, Patent No. 0107364; Ikeda S, 1997, J AM CHEM SOC, V119, P4779, DOI 10.1021/ja9704491; Inami T, 2011, ORG LETT, V13, P1912, DOI 10.1021/ol200336c; KASTURI TR, 1990, TETRAHEDRON, V46, P7047, DOI 10.1016/S0040-4020(01)87889-3; Koizumi T, 2005, J ORG CHEM, V70, P8364, DOI 10.1021/jo050992x; Kuninobu Y, 2009, CHEM-ASIAN J, V4, P1424, DOI 10.1002/asia.200900137; Larock RC, 1999, J AM CHEM SOC, V121, P3238, DOI 10.1021/ja984086w; Maizuru N, 2011, CHEM LETT, V40, P375, DOI 10.1246/cl.2011.375; Matsuda T, 2013, EUR J ORG CHEM, V2013, P4219, DOI 10.1002/ejoc.201300220; MILLER B, 1976, J AM CHEM SOC, V98, P2227, DOI 10.1021/ja00424a036; MILLER B, 1987, J AM CHEM SOC, V109, P578, DOI 10.1021/ja00236a043; Murakami M, 2006, TETRAHEDRON, V62, P7540, DOI 10.1016/j.tet.2006.03.118; Murakami M., 2011, CHEM COMMUN, P1100; Nakai K, 2013, ORG LETT, V15, P856, DOI 10.1021/ol303546p; NOYORI R, 1978, TETRAHEDRON LETT, P4823; NOYORI R, 1972, J AM CHEM SOC, V94, P4018, DOI 10.1021/ja00766a065; Ooguri A, 2009, J AM CHEM SOC, V131, P13194, DOI 10.1021/ja904068p; PETERSON TH, 1993, TETRAHEDRON LETT, V34, P3219, DOI 10.1016/S0040-4039(00)73665-3; ROGGO BE, 1994, J ANTIBIOT, V47, P136; Ruhland K, 2012, EUR J ORG CHEM, P2683, DOI 10.1002/ejoc.201101616; SARD H, 1994, J HETEROCYCLIC CHEM, V31, P1085; Shintani R, 2009, ORG LETT, V11, P5642, DOI 10.1021/ol902326s; Tamaki T, 2011, ANGEW CHEM INT EDIT, V50, P12067, DOI 10.1002/anie.201106174	57	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0040-4020			TETRAHEDRON	Tetrahedron	JUL 1	2015	71	26-27					4512	4517		10.1016/j.tet.2015.02.064		6	Chemistry, Organic	Chemistry	CK4QG	WOS:000356207700017		
J	Ogura, A; Tanaka, K				Ogura, Akihiro; Tanaka, Katsunori			Azaelectrocyclization on cell surface: convenient and general approach to chemical biology research	TETRAHEDRON			English	Article						Azaelectrocyclization; Fluorescence; Labeling; Live cell; Lysine	FREE CLICK CHEMISTRY; STEREOSELECTIVE ASYMMETRIC 6-PI-AZAELECTROCYCLIZATION; COPPER(I)-CATALYZED AZIDE-ALKYNE; SUBSTITUTED PYRIDINE SYNTHESIS; SELECTIVE PROTEIN MODIFICATION; AGE PIGMENT A2-E; IN-VIVO DYNAMICS; FORMAL SYNTHESIS; LIVE CELLS; INHIBITORY MECHANISM	Convenient and general method for live cell surface labeling was established. Azide-containing fluorescences were initially conjugated with the unsaturated ester aldehyde containing the dibenzocyclooctyne (DIBO), by the strain-promoted click reaction. The resulting probes were then treated with the live cells in one-pot process, efficiently labeling the surface lysines by azaelectrocyclization under the mild conditions. (C) 2015 Elsevier Ltd. All rights reserved.	[Ogura, Akihiro; Tanaka, Katsunori] RIKEN, Biofunct Synthet Chem Lab, Wako, Saitama 3510198, Japan; [Tanaka, Katsunori] Kazan Fed Univ, A Butlerov Inst Chem, Biofunct Chem Lab, Kazan 420008, Russia; [Tanaka, Katsunori] JST, PRESTO, Wako, Saitama 3510198, Japan	Tanaka, K (reprint author), RIKEN, Biofunct Synthet Chem Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.				Japan Society for the Promotion of Science [23681047, 25560410, 26560438]; Mizutani Foundation for Glycoscience; MEXT [26102743]; AstraZeneca RD Grant; Russian Government Program for Competitive Growth	The authors thank Dr. Misako Taichi, Dr. Shinobu Kitazume, Ms. Rie Imamaki, and Dr. Naoyuki Taniguchi at RIKEN, for assistance with the cell-based experiments. The authors gratefully acknowledge support from Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science, No. 23681047, 25560410, and 26560438. Additional research support was provided by the Mizutani Foundation for Glycoscience, by a MEXT Grant-in-Aid for Scientific Research on Innovative Areas 'Chemical Biology of Natural Products: Target ID and Regulation of Bioactivity' (No. 26102743), and by an AstraZeneca R&D Grant. This work was performed under the support of the Russian Government Program for Competitive Growth, granted to the Kazan Federal University.	Almaraz RT, 2012, BIOTECHNOL BIOENG, V109, P992, DOI 10.1002/bit.24363; Sanders BC, 2011, J AM CHEM SOC, V133, P949, DOI 10.1021/ja1081519; Vocadlo DJ, 2003, P NATL ACAD SCI USA, V100, P9116, DOI 10.1073/pnas.1632821100; Codelli JA, 2008, J AM CHEM SOC, V130, P11486, DOI 10.1021/ja803086r; Link AJ, 2006, P NATL ACAD SCI USA, V103, P10180, DOI 10.1073/pnas.0601167103; Laughlin ST, 2008, SCIENCE, V320, P664, DOI 10.1126/science.1155106; Li J, 2013, J AM CHEM SOC, V135, P7330, DOI 10.1021/ja402424j; Tanaka K, 2008, CHEMBIOCHEM, V9, P2392, DOI 10.1002/cbic.200800336; Prescher JA, 2006, CELL, V126, P851, DOI 10.1016/j.cell.2006.08.017; Luchansky SJ, 2004, CHEMBIOCHEM, V5, P1706, DOI 10.1002/cbic.200400148; Fernandez-Suarez M, 2007, NAT BIOTECHNOL, V25, P1483, DOI 10.1038/nbt1355; Hangauer MJ, 2008, ANGEW CHEM INT EDIT, V47, P2394, DOI 10.1002/anie.200704847; Chang PV, 2009, ANGEW CHEM INT EDIT, V48, P4030, DOI 10.1002/anie.200806319; Tanaka K, 2008, ORG BIOMOL CHEM, V6, P815, DOI 10.1039/b718157b; Chin JW, 2003, SCIENCE, V301, P964, DOI 10.1126/science.1084772; Yang YY, 2010, CHEM BIOL, V17, P1212, DOI 10.1016/j.chembiol.2010.09.012; Link AJ, 2003, J AM CHEM SOC, V125, P11164, DOI 10.1021/ja036765z; Chang PV, 2010, P NATL ACAD SCI USA, V107, P1821, DOI 10.1073/pnas.0911116107; Becker CFW, 2008, ANGEW CHEM INT EDIT, V47, P8215, DOI 10.1002/anie.200802161; Niederwieser A, 2013, ANGEW CHEM INT EDIT, V52, P4265, DOI 10.1002/anie.201208991; [Anonymous], 2008, TDR DRAMA REV, V52, P10; Lin YA, 2008, J AM CHEM SOC, V130, P9642, DOI 10.1021/ja8026168; Tanaka K, 2010, ANGEW CHEM INT EDIT, V49, P8195, DOI 10.1002/anie.201000892; Hanson SR, 2007, J AM CHEM SOC, V129, P7266, DOI 10.1021/ja0724083; Kiick KL, 2002, P NATL ACAD SCI USA, V99, P19, DOI 10.1073/pnas.012583299; Liu DS, 2012, J AM CHEM SOC, V134, P792, DOI 10.1021/ja209325n; Laughlin ST, 2009, ACS CHEM BIOL, V4, P1068, DOI 10.1021/cb900254y; Wang Q, 2003, J AM CHEM SOC, V125, P3192, DOI 10.1021/ja021381e; van Berkel SS, 2007, CHEMBIOCHEM, V8, P1504, DOI 10.1002/cbic.200700278; Kho Y, 2004, P NATL ACAD SCI USA, V101, P12479, DOI 10.1073/pnas.0403413101; Tanaka K, 2001, J ORG CHEM, V66, P3099, DOI 10.1021/jo005779+; Tanaka Y, 2008, J AM CHEM SOC, V130, P3278, DOI 10.1021/ja7109772; Speers AE, 2004, CHEM BIOL, V11, P535, DOI 10.1016/j.chembiol.2004.03.012; van Kasteren SI, 2007, NATURE, V446, P1105, DOI 10.1038/nature05757; Tanaka K, 2010, CHEM REC, V10, P119, DOI 10.1002/tcr.200900026; Saxon E, 2000, SCIENCE, V287, P2007, DOI 10.1126/science.287.5460.2007; Prescher JA, 2005, NAT CHEM BIOL, V1, P13, DOI 10.1038/nchembio0605-13; Kobayashi T, 2006, ORG LETT, V8, P3813, DOI 10.1021/ol0614065; Agard NJ, 2006, ACS CHEM BIOL, V1, P644, DOI 10.1021/cb6003228; Song W, 2008, J AM CHEM SOC, V130, P9654, DOI 10.1021/ja803598e; Speers AE, 2003, J AM CHEM SOC, V125, P4686, DOI 10.1021/ja034490h; Tanaka K, 2012, BIOORGAN MED CHEM, V20, P1865, DOI 10.1016/j.bmc.2011.12.043; Deiters A, 2003, J AM CHEM SOC, V125, P11782, DOI 10.1021/ja0370037; Tanaka K, 2004, J ORG CHEM, V69, P5906, DOI 10.1021/jo049381f; Kobayashi T, 2006, ORG LETT, V8, P3809, DOI 10.1021/ol061405c; Tanaka K, 2002, J AM CHEM SOC, V124, P9660, DOI 10.1021/ja026464+; Chang PV, 2007, J AM CHEM SOC, V129, P8400, DOI 10.1021/ja070238o; Chen I, 2005, CURR OPIN BIOTECH, V16, P35, DOI 10.1016/j.copbio.2004.12.003; Baskin JM, 2007, P NATL ACAD SCI USA, V104, P16793, DOI 10.1073/pnas.0707090104; Miller LW, 2005, CURR OPIN CHEM BIOL, V9, P56, DOI 10.1016/j.cbpa.2004.12.007; Antos JM, 2006, CURR OPIN CHEM BIOL, V10, P253, DOI 10.1016/j.cbpa.2006.04.609; Lin PC, 2007, ORG LETT, V9, P2131, DOI 10.1021/ol070588f; [Anonymous], 2008, TUBERCULOSIS; Gierlich J, 2006, ORG LETT, V8, P3639, DOI 10.1021/ol0610946; Agard NJ, 2004, J AM CHEM SOC, V126, P15046, DOI 10.1021/ja0449981; Sletten EM, 2008, ORG LETT, V10, P3097, DOI 10.1021/ol801141k; Artner L M., 2012, CHEM COMMUN, P522; Lee Y.-J., 2014, CHEM COMMUN, P13085; Lutz JF, 2008, ANGEW CHEM INT EDIT, V47, P2182, DOI 10.1002/anie.200705365; Mbua NE, 2011, CHEMBIOCHEM, V12, P1911, DOI 10.1002/cbic.201100117; Paulick MG, 2007, P NATL ACAD SCI USA, V104, P20332, DOI 10.1073/pnas.0710139104; Reddington S. C., 2012, CHEM COMMUN, P8419; Sieber SA, 2006, CHEM COMMUN, P2311, DOI 10.1039/b600653c; Tanaka K, 1999, TETRAHEDRON, V55, P1657, DOI 10.1016/S0040-4020(98)01197-1; Tanaka K, 2010, CHEMMEDCHEM, V5, P841, DOI 10.1002/cmdc.201000027; Tanaka K, 2014, ORG BIOMOL CHEM, V12, P1412, DOI 10.1039/c3ob42267d; Tanaka K, 2011, SYNLETT, P2115, DOI 10.1055/s-0030-1261192; Tanaka K., 2007, PEPT SCI, P91, DOI DOI 10.2174/157019308785161684; Tanaka K, 2008, MINI-REV ORG CHEM, V5, P153, DOI 10.2174/157019308785161684; Tanaka K, 2010, J CARBOHYD CHEM, V29, P118, DOI 10.1080/07328303.2010.483042; Tanaka K, 2013, ORG BIOMOL CHEM, V11, P7326, DOI 10.1039/c3ob41507d; Tanaka K, 1998, TETRAHEDRON LETT, V39, P1185, DOI 10.1016/S0040-4039(97)10805-X; Tanaka K, 2000, ORG LETT, V2, P373, DOI 10.1021/ol991320u; Yamaguchi M, 2006, TETRAHEDRON LETT, V47, P7455, DOI 10.1016/j.tetlet.2006.08.041; Zhan WH, 2005, TETRAHEDRON LETT, V46, P1691, DOI 10.1016/j.tetlet.2005.01.066	75	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0040-4020			TETRAHEDRON	Tetrahedron	JUL 1	2015	71	26-27					4518	4521		10.1016/j.tet.2015.02.063		4	Chemistry, Organic	Chemistry	CK4QG	WOS:000356207700018		
J	Minami, Y; Kanda, M; Sakai, M; Hiyama, T				Minami, Yasunori; Kanda, Mayuko; Sakai, Megumi; Hiyama, Tamejiro			Palladium-catalyzed annulation of alkynyl aryl ethers with isocyanates through o-C-H cleavage. Synthesis of solid-state emissive 2-methylidene-2H-1,4-benzoxazin-3(4H)-ones	TETRAHEDRON			English	Article						Isocyanates; Alkynes; Annulation; Insertion; Fluorescence; Palladium	AGGREGATION-INDUCED EMISSION; TETRANUCLEAR ZINC CLUSTER; BOND ACTIVATION; PHOTOPHYSICAL PROPERTIES; ETHYNYL ETHERS; YNOL ETHERS; 3-COMPONENT REACTION; MOLECULAR-OXYGEN; CARBOXYLIC-ACIDS; INTERNAL ALKYNES	The title transformation can be achieved by the o-C-H cleavage of allcynyl aryl ethers, which is easily derived from phenols, followed by the insertion/annulation with isocyanates in the presence of a palladium catalyst. Various alkynyl aryl ethers and arylisocyanates are applied to this transformation to give the corresponding cyclic products. Mechanistic study indicates that the C-H cleavage is effected reversibly by the concerted metalation-deprotonation pathway. The products exhibit solid-state luminescence upon irradiation of UV light. Fluorescent maxima and quantum yields can be controlled by the substituents at appropriate sites in the products. (C) 2015 Elsevier Ltd. All rights reserved.	[Minami, Yasunori; Hiyama, Tamejiro] Chuo Univ, Res & Dev Initiat, Bunkyo Ku, Tokyo 1128551, Japan; [Minami, Yasunori; Hiyama, Tamejiro] JST, ACT C, Bunkyo Ku, Tokyo 1128551, Japan; [Kanda, Mayuko; Sakai, Megumi] Chuo Univ, Dept Appl Chem, Bunkyo Ku, Tokyo 1128551, Japan	Minami, Y (reprint author), Chuo Univ, Res & Dev Initiat, Bunkyo Ku, 1-13-27 Kasuga, Tokyo 1128551, Japan.	yminami@kc.chuo-u.ac.jp; thiyama@kc.chuo-u.ac.jp			JSPS [21225005, 25870747]	This work has been supported financially by a Grant in-Aids for Scientific Research (S) (21225005 to T.H.) and Young Scientists (B) (25870747 to Y.M.) from JSPS. Y.M. also acknowledges Asahi Glass Foundation. The authors would like to thank Dr. Makoto Yamashita, Dr. Katsunori Suzuki, Prof. Masaaki Haga, Dr. Hiroaki Ozawa, and their members for their kind assistance in the X-ray crystallographic and photophysical analyses.	Chernyak N, 2009, ADV SYNTH CATAL, V351, P1101, DOI 10.1002/adsc.200800765; Chiusoli GP, 2010, COORDIN CHEM REV, V254, P456, DOI 10.1016/j.ccr.2009.07.023; Itami K, 2005, J ORG CHEM, V70, P2778, DOI 10.1021/jo0477401; Liu Q, 2012, ANGEW CHEM INT EDIT, V51, P4666, DOI 10.1002/anie.201200750; Jazzar R, 2010, CHEM-EUR J, V16, P2654, DOI 10.1002/chem.200902374; Murakami M, 2002, J AM CHEM SOC, V124, P13976, DOI 10.1021/ja021062n; Dong YQ, 2007, CHEM COMMUN, P3255, DOI 10.1039/b704794k; Chernyak N, 2008, J AM CHEM SOC, V130, P5636, DOI 10.1021/ja8006534; Ohshima T, 2008, J AM CHEM SOC, V130, P2944, DOI 10.1021/ja711349r; Macias FA, 2009, NAT PROD REP, V26, P478, DOI 10.1039/b700682a; TAKEUCHI R, 1993, J ORG CHEM, V58, P5386, DOI 10.1021/jo00072a020; Hashmi ASK, 2009, ANGEW CHEM INT EDIT, V48, P5848, DOI 10.1002/anie.200900887; Iitsuka T, 2014, CHEM-EUR J, V20, P385, DOI 10.1002/chem.201303847; Muschelknautz C, 2011, ORG LETT, V13, P2556, DOI 10.1021/ol200655s; Minami Y, 2014, CHEM LETT, V43, P1791, DOI 10.1246/cl.140725; Wencel-Delord J, 2011, CHEM SOC REV, V40, P4740, DOI 10.1039/c1cs15083a; Xu T, 2012, ANGEW CHEM INT EDIT, V51, P7567, DOI 10.1002/anie.201202771; Komine Y, 2009, ORG LETT, V11, P2361, DOI 10.1021/ol900802d; Shimizu M, 2009, CHEM-ASIAN J, V4, P1289, DOI 10.1002/asia.200900110; Tanaka K, 2002, ORG LETT, V4, P933, DOI 10.1021/ol017308v; Ning ZJ, 2007, ADV FUNCT MATER, V17, P3799, DOI 10.1002/adfm.200700649; Shimizu M, 2009, ANGEW CHEM INT EDIT, V48, P3653, DOI 10.1002/anie.200900963; Minami Y, 2014, CHEM LETT, V43, P181, DOI 10.1246/cl.130894; Minami Y, 2013, ANGEW CHEM INT EDIT, V52, P10611, DOI 10.1002/anie.201304893; Ohkubo K, 2013, J AM CHEM SOC, V135, P5368, DOI 10.1021/ja402303k; Yan GB, 2013, ORG BIOMOL CHEM, V11, P5558, DOI 10.1039/c3ob40652k; Bertini F, 2012, J AM CHEM SOC, V134, P201, DOI 10.1021/ja210214r; Shimizu M, 2012, ANGEW CHEM INT EDIT, V51, P4095, DOI 10.1002/anie.201108943; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Lyons TW, 2010, CHEM REV, V110, P1147, DOI 10.1021/cr900184e; Shimizu M, 2010, CHEM-ASIAN J, V5, P1516, DOI 10.1002/asia.200900727; Miyauchi Y, 2012, ORG LETT, V14, P5856, DOI 10.1021/ol3027158; Zhang LM, 2004, J AM CHEM SOC, V126, P11806, DOI 10.1021/ja046112y; Gandeepan P, 2012, J AM CHEM SOC, V134, P5738, DOI 10.1021/ja300168m; Zhang YH, 2009, J AM CHEM SOC, V131, P14654, DOI 10.1021/ja907198n; Pangborn AB, 1996, ORGANOMETALLICS, V15, P1518, DOI 10.1021/om9503712; Hashmi ASK, 2008, CHEM-EUR J, V14, P6672, DOI 10.1002/chem.200800210; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Minami Y, 2012, J AM CHEM SOC, V134, P6124, DOI 10.1021/ja301588z; Parker E, 2014, ORGANOMETALLICS, V33, P780, DOI 10.1021/om4011627; Verrier C, 2012, ORG LETT, V14, P5122, DOI 10.1021/ol302392k; Ilas J, 2005, TETRAHEDRON, V61, P7325, DOI 10.1016/j.tet.2005.05.037; Hong YN, 2011, CHEM SOC REV, V40, P5361, DOI 10.1039/c1cs15113d; Shoji O, 2013, ANGEW CHEM INT EDIT, V52, P6606, DOI 10.1002/anie.201300282; Kim S, 2006, ADV FUNCT MATER, V16, P2317, DOI 10.1002/adfm.200500928; Shimizu M, 2010, J PHYS CHEM C, V114, P10004, DOI 10.1021/jp103410x; Shimizu M, 2008, ANGEW CHEM INT EDIT, V47, P9760, DOI 10.1002/anie.200804146; Mejuch T, 2011, ORG LETT, V13, P3604, DOI 10.1021/ol201221d; Kawasumi K, 2013, TETRAHEDRON, V69, P4371, DOI 10.1016/j.tet.2013.01.037; Novikov AS, 2013, CHEM-EUR J, V19, P2874, DOI 10.1002/chem.201203098; Xu T, 2012, J AM CHEM SOC, V134, P20005, DOI 10.1021/ja309978c; [Anonymous], 2000, CRYSTALSTRUCTURE 4 0; Gandeepan P, 2013, ORG LETT, V15, P2084, DOI 10.1021/ol400792y; Ilas J, 2008, J MED CHEM, V51, P2863, DOI 10.1021/jm701622y; Ohshima T, 2006, CHEM COMMUN, P2711, DOI 10.1039/b605066b; Komine Y, 2010, ORG LETT, V12, P1312, DOI 10.1021/ol100182u; Chakar FS, 2004, IND CROP PROD, V20, P131, DOI 10.1016/j.indcrop.2004.04.016; Bal R, 2006, ANGEW CHEM INT EDIT, V45, P448, DOI 10.1002/anie.200502940; Alford JS, 2014, J AM CHEM SOC, V136, P10266, DOI 10.1021/ja5058967; Lapointe D, 2010, CHEM LETT, V39, P1119, DOI 10.1246/cl.2010.1118; Colby DA, 2010, CHEM REV, V110, P624, DOI 10.1021/cr900005n; Sun CL, 2011, CHEM REV, V111, P1293, DOI 10.1021/cr100198w; Cui WJ, 2014, J ORG CHEM, V79, P3487, DOI 10.1021/jo5002356; Miyauchi Y, 2011, ANGEW CHEM INT EDIT, V50, P10922, DOI 10.1002/anie.201105519; Takeishi K, 2004, CHEM-EUR J, V10, P5681, DOI 10.1002/chem.200400679; Shindo M, 2007, TETRAHEDRON, V63, P10, DOI 10.1016/j.tet.2006.09.013; Kumar P, 2011, J AM CHEM SOC, V133, P7719, DOI 10.1021/ja2007627; Babu SS, 2010, J PHYS CHEM LETT, V1, P3413, DOI 10.1021/jz101219y; Auger V, 1924, CR HEBD ACAD SCI, V178, P1546; Azuma K, 2003, PHOTOCH PHOTOBIO SCI, V2, P443, DOI 10.1039/b300196b; Bai Y., 2011, CHEM COMMUN, P7650; BESSON J, 1954, Z ANORG ALLG CHEM, V277, P188, DOI 10.1002/zaac.19542770310; Cai H., 2011, CHEM COMMUN, P8682; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Geng G., 2012, SYNLETT, P601; Goll JM, 2008, ORGANOMETALLICS, V27, P3622, DOI 10.1021/om800390w; Graf K, 2013, ANGEW CHEM INT EDIT, V52, P12727, DOI 10.1002/anie.201304813; Grotjahn DB, 2000, J AM CHEM SOC, V122, P5222, DOI 10.1021/ja000243r; Horder J. R., 1968, J CHEM SOC A, P2004; Hu QX, 2012, ARKIVOC, P129; JINTOKU T, 1990, CHEM LETT, P1687, DOI 10.1246/cl.1990.1687; Kasha M., 1965, Eighth European Congress on Molecular Spectroscopy, DOI 10.1351/pac196511030371; Komine Y., 2010, SYNLETT, P3092; Kondo T, 2010, MOLECULES, V15, P4189, DOI 10.3390/molecules15064189; Kondo T., 2009, CHEMCATCHEM, V122, P5222; Koyama H., 1954, B CHEM SOC JPN, V27, P112, DOI 10.1246/bcsj.27.112; Lempa E., 2008, J PHOTOCH PHOTOBIO A, V99, P345; Li W., 2013, ORG LETT, V15, P3484; Love B., 1985, J MED CHEM, V28, P24; Luo JD, 2001, CHEM COMMUN, P1740, DOI 10.1039/b105159h; Minami Y, 2014, CHEM LETT, V43, P1408, DOI 10.1246/cl.140452; Miyasaka M, 2009, CHEM-EUR J, V15, P3674, DOI 10.1002/chem.200900098; Newman M. S., 1995, J AM CHEM SOC, V117, P946; Ogata K, 2012, ORG LETT, V14, P4214, DOI 10.1021/ol301897h; PESTEMER M, 1960, ANGEW CHEM INT EDIT, V72, P612, DOI 10.1002/ange.19600721703; Rouquet R., 2013, ANGEW CHEM INT EDIT, V52, P11726; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shimizu M, 2011, J PHYS CHEM C, V115, P11265, DOI 10.1021/jp201168x; Shimizu M, 2012, SYNLETT, P973, DOI 10.1055/s-0031-1290566; Sosa JR, 2008, ORG LETT, V10, P5091, DOI 10.1021/ol802147h; Sun JL, 2004, J PHYS CHEM A, V108, P3947, DOI 10.1021/jp0380529; Sun Y, 2012, J POLYM SCI POL CHEM, V50, P3788, DOI 10.1002/pola.26167; Tobisu M, 2008, CHEM COMMUN, P6013, DOI 10.1039/b806285d; Tong H, 2006, CHEM COMMUN, P3705, DOI 10.1039/b608425g; Urtel H, 2001, ORGANOMETALLICS, V20, P3938, DOI 10.1021/om010503t; Wiirthner F, 2011, ANGEW CHEM INT EDIT, V50, P3376; Yin FL, 2012, J CHEM RES, P41, DOI 10.3184/174751912X13263685422317; Yin J, 2014, J ORG CHEM, V79, P9179, DOI 10.1021/jo501615a; Ylijoki K. E., 2011, CHEM COMMUN, P10608	109	3	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0040-4020			TETRAHEDRON	Tetrahedron	JUL 1	2015	71	26-27					4522	4534		10.1016/j.tet.2015.02.062		13	Chemistry, Organic	Chemistry	CK4QG	WOS:000356207700019		
J	Suzuki, Y; Sun, B; Yoshino, T; Kanai, M; Matsunaga, S				Suzuki, Yudai; Sun, Bo; Yoshino, Tatsuhiko; Kanai, Motomu; Matsunaga, Shigeki			Cp*Co(III)-catalyzed oxidative C-H alkenylation of benzamides with ethyl acrylate	TETRAHEDRON			English	Article						Cobalt; Oxidation; Alkenylation; Catalysis; C-H activation	N BOND FORMATION; MILD CONDITIONS; ACTIVATION; OLEFINATION; FUNCTIONALIZATION; ALKYNES; INDOLES; ALKENES; CATALYSIS; COMPLEX	The utility of Cp-Co(III)-catalysts was expanded to oxidative C-C bond-forming reaction. In situ-generated Cp*Co(III)-catalyst, rather than a preformed cationic Cp*Co(III)-complex, was effective. Oxidative alkenylation of benzamides and acetanilide with ethyl acrylate proceeded with silver acetate as a stoichiometric oxidant, giving products in up to 93% yield. (C) 2015 Elsevier Ltd. All rights reserved.	[Suzuki, Yudai; Sun, Bo; Yoshino, Tatsuhiko; Kanai, Motomu; Matsunaga, Shigeki] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Yoshino, Tatsuhiko; Matsunaga, Shigeki] Japan Sci & Technol Agcy JST, ACT C, Bunkyo Ku, Tokyo 1130033, Japan; [Matsunaga, Shigeki] Hokkaido Univ, Fac Pharmaceut Sci, Sapporo, Hokkaido 0600812, Japan	Kanai, M (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	kanai@mol.f.u-tokyo.ac.jp; smatsuna@mol.f.u-tokyo.ac.jp			ACT-C from Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science, and Technology; Naito Foundation; Japan Society for the Promotion of Science	This work was supported by ACT-C from Japan Science and Technology Agency, Grant-in-Aid for Scientific Research on Innovative Areas from Ministry of Education, Culture, Sports, Science, and Technology and the Naito Foundation. Y.S. thanks Japan Society for the Promotion of Science fellowship.	Wang F, 2010, ORG LETT, V12, P5430, DOI 10.1021/ol102241f; Yamamoto S, 2014, ADV SYNTH CATAL, V356, P401, DOI 10.1002/adsc.201300991; Patel P, 2015, ACS CATAL, V5, P853, DOI 10.1021/cs501860b; Cui SL, 2013, CHEM SCI, V4, P3421, DOI 10.1039/c3sc51424b; Wencel-Delord J, 2013, NAT CHEM, V5, P369, DOI 10.1038/nchem.1607; Ikemoto H, 2014, J AM CHEM SOC, V136, P5424, DOI 10.1021/ja5008432; Gao K, 2010, J AM CHEM SOC, V132, P12249, DOI 10.1021/ja106814p; Patureau FW, 2012, ALDRICHIM ACTA, V45, P31; Grigorjeva L, 2014, ORG LETT, V16, P4684, DOI 10.1021/ol502005g; Hummel JR, 2015, J AM CHEM SOC, V137, P490, DOI 10.1021/ja5116452; Kuhl N, 2014, ADV SYNTH CATAL, V356, P1443, DOI 10.1002/adsc.201400197; Wencel-Delord J, 2011, CHEM SOC REV, V40, P4740, DOI 10.1039/c1cs15083a; Rakshit S, 2011, J AM CHEM SOC, V133, P2350, DOI 10.1021/ja109676d; Chen QA, 2011, J AM CHEM SOC, V133, P428, DOI 10.1021/ja1099853; Shen YY, 2013, ORG LETT, V15, P3366, DOI 10.1021/ol4014188; Ackermann L, 2011, CHEM REV, V111, P1315, DOI 10.1021/cr100412j; Cho SH, 2011, CHEM SOC REV, V40, P5068, DOI 10.1039/c1cs15082k; Tsai AS, 2011, ORG LETT, V13, P540, DOI 10.1021/ol102890k; Ding ZH, 2012, ANGEW CHEM INT EDIT, V51, P4698, DOI 10.1002/anie.201200019; Li GF, 2012, ORG LETT, V14, P5338, DOI 10.1021/ol302522n; Wender PA, 2009, NATURE, V460, P197, DOI 10.1038/460197a; Engle KM, 2013, J ORG CHEM, V78, P8927, DOI 10.1021/jo400159y; Lyons TW, 2010, CHEM REV, V110, P1147, DOI 10.1021/cr900184e; Li B, 2011, ANGEW CHEM INT EDIT, V50, P1109, DOI 10.1002/anie.201005394; Liu BQ, 2013, J AM CHEM SOC, V135, P468, DOI 10.1021/ja3099245; Patureau FW, 2011, ANGEW CHEM INT EDIT, V50, P1064, DOI 10.1002/anie.201006222; Zhu C, 2012, CHEM-ASIAN J, V7, P1502, DOI 10.1002/asia.201200035; TROST BM, 1991, SCIENCE, V254, P1471, DOI 10.1126/science.1962206; Park SH, 2011, ORG LETT, V13, P2372, DOI 10.1021/ol200600p; Chiba S, 2012, CHEM LETT, V41, P1554, DOI 10.1246/cl.2012.1554; Yu DG, 2014, J AM CHEM SOC, V136, P17722, DOI 10.1021/ja511011m; Gao K, 2011, J AM CHEM SOC, V133, P400, DOI 10.1021/ja108809u; Ye BH, 2012, SCIENCE, V338, P504, DOI 10.1126/science.1226938; Hyster TK, 2012, SCIENCE, V338, P500, DOI 10.1126/science.1226132; Presset M, 2013, ORG LETT, V15, P1528, DOI 10.1021/ol400307d; Yoshino T, 2013, CHEM-EUR J, V19, P9142, DOI 10.1002/chem.201301505; Engle KM, 2012, ACCOUNTS CHEM RES, V45, P788, DOI 10.1021/ar200185g; Arockiam PB, 2012, CHEM REV, V112, P5879, DOI [10.1021/cr300153j, 10.1021/cr300153J]; Beccalli EM, 2007, CHEM REV, V107, P5318, DOI 10.1021/cr068006f; Mkhalid IAI, 2010, CHEM REV, V110, P890, DOI 10.1021/cr900206p; Patureau FW, 2010, J AM CHEM SOC, V132, P9982, DOI 10.1021/ja103834b; Li B, 2013, CHEM-EUR J, V19, P11863, DOI 10.1002/chem.201301987; Jia CG, 2001, ACCOUNTS CHEM RES, V34, P633, DOI 10.1021/ar000209h; Lapointe D, 2010, CHEM LETT, V39, P1119, DOI 10.1246/cl.2010.1118; Ueura K, 2007, ORG LETT, V9, P1407, DOI 10.1021/ol070406h; Wang NJ, 2014, ORG LETT, V16, P3040, DOI 10.1021/ol501152a; Colby DA, 2010, CHEM REV, V110, P624, DOI 10.1021/cr900005n; Andou T, 2013, ANGEW CHEM INT EDIT, V52, P3213, DOI 10.1002/anie.201208666; Chen X, 2009, ANGEW CHEM INT EDIT, V48, P5094, DOI 10.1002/anie.200806273; Yoshino T, 2013, ANGEW CHEM INT EDIT, V52, P2207, DOI 10.1002/anie.201209226; Li BJ, 2012, CHEM SOC REV, V41, P5588, DOI 10.1039/c2cs35096c; Kuhl N, 2012, ANGEW CHEM INT EDIT, V51, P10236, DOI 10.1002/anie.201203269; Satoh T, 2010, CHEM-EUR J, V16, P11212, DOI 10.1002/chem.201001363; Rouquet G, 2013, ANGEW CHEM INT EDIT, V52, P11726, DOI 10.1002/anie.201301451; Zhou J, 2013, ORG LETT, V15, P3460, DOI 10.1021/ol401540k; Song WF, 2012, ANGEW CHEM INT EDIT, V51, P8251, DOI 10.1002/anie.201202466; Sun B, 2014, ADV SYNTH CATAL, V356, P1491, DOI 10.1002/adsc.201301110; Yamaguchi J, 2012, ANGEW CHEM INT EDIT, V51, P8960, DOI 10.1002/anie.201201666; Song GY, 2012, CHEM SOC REV, V41, P3651, DOI 10.1039/c2cs15281a; Ritleng V, 2002, CHEM REV, V102, P1731, DOI 10.1021/cr0104330; Zhang XS, 2013, CHEM-EUR J, V19, P11898, DOI 10.1002/chem.201300829; Grigorjeva L, 2014, ANGEW CHEM INT EDIT, V53, P10209, DOI 10.1002/anie.201404579; Karimi B, 2010, SYNTHESIS-STUTTGART, P1399, DOI 10.1055/s-0029-1218748; Kulkarni AA, 2009, SYNTHESIS-STUTTGART, P4087, DOI 10.1055/s-0029-1217131; Li J., 2015, ANGEW CHEM INT ED; Lu Y, 2015, CHEM SCI, V6, P1923, DOI 10.1039/c4sc03350g; Mishra N. K., 2014, CHEM COMMUN, P2350; MORITANI I, 1973, SYNTHESIS-STUTTGART, P524; Yoshikai N, 2011, SYNLETT, P1047, DOI 10.1055/s-0030-1259928; Yoshikai N., 2014, B CHEM SOC JPN, V87, P1047; Yu JQ, 2010, TOP CURR CHEM, V292, P1, DOI 10.1007/978-3-642-12356-6; Zhu C., 2012, CHEM COMMUN, P1674	72	8	8	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0040-4020			TETRAHEDRON	Tetrahedron	JUL 1	2015	71	26-27					4552	4556		10.1016/j.tet.2015.02.032		5	Chemistry, Organic	Chemistry	CK4QG	WOS:000356207700022		
J	Fujihara, T; Hosomi, T; Cong, C; Hosoki, T; Terao, J; Tsuji, Y				Fujihara, Tetsuaki; Hosomi, Takuro; Cong, Cong; Hosoki, Tomoya; Terao, Jun; Tsuji, Yasushi			Palladium-catalyzed formal hydroacylation of allenes employing carboxylic anhydrides and hydrosilanes	TETRAHEDRON			English	Article						Allene; Carboxylic anhydride; Hydroacylation; Hydrosilane; Palladium	ALDEHYDE OXIDATION LEVEL; FORMING TRANSFER HYDROGENATION; S-SUBSTITUTED ALDEHYDES; ALLYL METAL REAGENTS; O-P LIGAND; C-H BOND; INTERMOLECULAR HYDROACYLATION; REVERSE PRENYLATION; COUPLING REACTION; ALKYNE HYDROACYLATION	The formal hydroacylation reaction of allenes has been developed employing carboxylic anhydrides as acyl sources and hydrosilanes as reducing reagents in the presence of a commercially available palladium complex as a catalyst. The reaction affords alpha,beta-unsaturated ketones regio- and stereoselectively. The similar catalyst system is also effective for the reduction of carboxylic anhydrides to the corresponding aldehydes employing hydrosilanes. (C) 2015 Elsevier Ltd. All rights reserved.	[Fujihara, Tetsuaki; Hosomi, Takuro; Cong, Cong; Hosoki, Tomoya; Terao, Jun; Tsuji, Yasushi] Kyoto Univ, Grad Sch Engn, Dept Energy & Hydrocarbon Chem, Kyoto 6158510, Japan	Fujihara, T (reprint author), Kyoto Univ, Grad Sch Engn, Dept Energy & Hydrocarbon Chem, Kyoto 6158510, Japan.	tfuji@scl.kyoto-u.ac.jp; ytsuji@scl.kyoto-u.ac.jp	Terao, Jun/D-4562-2014	Terao, Jun/0000-0001-7180-3036	MEXT, Japan	This work was supported by Grant-in-Aid for Scientific Research (A) and also by Grant-in-Aid for Scientific Research on Innovative Areas ("Molecular activation directed toward straightforward synthesis") from MEXT, Japan.	Annarego W. L. F., 2003, PURIFICATION LAB CHE; Kakino R, 2002, B CHEM SOC JPN, V75, P137, DOI 10.1246/bcsj.75.137; Park YJ, 2008, ACCOUNTS CHEM RES, V41, P222, DOI 10.1021/ar700133y; LAROCK RC, 1980, J AM CHEM SOC, V102, P190, DOI 10.1021/ja00521a031; Chaplin AB, 2012, J AM CHEM SOC, V134, P4885, DOI 10.1021/ja211649a; Nagayama K, 2001, B CHEM SOC JPN, V74, P1803, DOI 10.1246/bcsj.74.1803; Willis MC, 2010, CHEM REV, V110, P725, DOI 10.1021/cr900096x; Moxham GL, 2008, CHEM-EUR J, V14, P8383, DOI 10.1002/chem.200800738; Coulter MM, 2010, J AM CHEM SOC, V132, P16330, DOI 10.1021/ja107198e; Kokubo K, 1999, B CHEM SOC JPN, V72, P303, DOI 10.1246/bcsj.72.303; KONDO T, 1990, J ORG CHEM, V55, P1286, DOI 10.1021/jo00291a035; Sato Y, 2002, ANGEW CHEM INT EDIT, V41, P1218, DOI 10.1002/1521-3773(20020402)41:7<1218::AID-ANIE1218>3.0.CO;2-D; Jun CH, 1997, J ORG CHEM, V62, P1200, DOI 10.1021/jo961887d; Murphy SK, 2011, ORG LETT, V13, P6216, DOI 10.1021/ol202663p; Wang DH, 2003, ORG LETT, V5, P4645, DOI 10.1021/ol035801w; Tanaka K, 2003, J AM CHEM SOC, V125, P8078, DOI 10.1021/ja035489l; Kundu K, 2005, J AM CHEM SOC, V127, P16042, DOI 10.1021/ja0564416; Osborne JD, 2008, J AM CHEM SOC, V130, P17232, DOI 10.1021/ja8069133; Han SB, 2009, J AM CHEM SOC, V131, P6916, DOI 10.1021/ja902437k; Tanaka K, 2001, J AM CHEM SOC, V123, P11492, DOI 10.1021/ja011907f; Leung JC, 2012, CHEM SCI, V3, P2202, DOI 10.1039/c2sc20350b; Hoshimoto Y, 2012, ANGEW CHEM INT EDIT, V51, P10812, DOI 10.1002/anie.201206186; Patman RL, 2009, J AM CHEM SOC, V131, P2066, DOI 10.1021/ja809456u; von Delius M, 2012, J AM CHEM SOC, V134, P15022, DOI 10.1021/ja305593y; Moxham GL, 2006, ANGEW CHEM INT EDIT, V45, P7618, DOI 10.1002/anie.200603133; Skucas E, 2007, J AM CHEM SOC, V129, P12678, DOI 10.1021/ja075971u; Coulter MM, 2009, J AM CHEM SOC, V131, P6932, DOI 10.1021/ja901915u; Kokubo K, 1997, J ORG CHEM, V62, P4564, DOI 10.1021/jo9709458; Shibahara F, 2008, J AM CHEM SOC, V130, P6338, DOI 10.1021/ja801213x; Bower JF, 2007, J AM CHEM SOC, V129, P15134, DOI 10.1021/ja077389b; Bercot EA, 2004, J AM CHEM SOC, V126, P10248, DOI 10.1021/ja046528b; Fu GC, 2005, MODERN RHODIUM-CATALYZED ORGANIC REACTIONS, P79, DOI 10.1002/3527604693.ch4; Fujihara T, 2012, SYNLETT, P2389, DOI 10.1055/s-0032-1317155; Fujihara T, 2013, ORG LETT, V15, P2286, DOI 10.1021/ol400862k; Fujihara T, 2013, ADV SYNTH CATAL, V355, P3420, DOI 10.1002/adsc.201300451; Goossen LJ, 2001, CHEM COMMUN, P2084; Goossen LJ, 2002, EUR J ORG CHEM, P3254; Goossen LJ, 2008, ANGEW CHEM INT EDIT, V47, P3100, DOI 10.1002/anie.200704782; Hatanaka S, 2010, CHEM-EUR J, V16, P1883, DOI 10.1002/chem.200902646; Hong YT, 2006, ANGEW CHEM INT EDIT, V45, P6885, DOI 10.1002/anie.200602377; Jun CH, 2007, EUR J ORG CHEM, P1869, DOI 10.1002/ejoc.200600846; Kokubo K., 1995, ORGANOMETALLICS, V14, P4524; KONDO T, 1987, TETRAHEDRON LETT, V28, P6229, DOI 10.1016/S0040-4039(00)61854-3; Murphy SK, 2014, ANGEW CHEM INT EDIT, V53, P2455, DOI 10.1002/anie.201309987; NAGAYAMA K, 1995, CHEM LETT, P367, DOI 10.1246/cl.1995.367; Nagayama K, 1999, B CHEM SOC JPN, V72, P573, DOI 10.1246/bcsj.72.573; Omura S, 2008, J AM CHEM SOC, V130, P14094, DOI 10.1021/ja806929y; Osborne JD, 2008, CHEM COMMUN, P5025, DOI 10.1039/b810935d; Shibahara E, 2008, J AM CHEM SOC, V130, P14120; Zhang HJ, 2011, ORG LETT, V13, P3900, DOI 10.1021/ol201431c	50	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0040-4020			TETRAHEDRON	Tetrahedron	JUL 1	2015	71	26-27					4570	4574		10.1016/j.tet.2015.01.066		5	Chemistry, Organic	Chemistry	CK4QG	WOS:000356207700025		
J	Sekimoto, T; Maruyama, H; Kiyono, S; Kondo, T; Shimada, T; Takahashi, M; Yokosuka, O; Yamaguchi, T				Sekimoto, Tadashi; Maruyama, Hitoshi; Kiyono, Soichiro; Kondo, Takayuki; Shimada, Taro; Takahashi, Masanori; Yokosuka, Osamu; Yamaguchi, Tadashi			LIVER STIFFNESS: A SIGNIFICANT RELATIONSHIP WITH THE WAVEFORM PATTERN IN THE HEPATIC VEIN	ULTRASOUND IN MEDICINE AND BIOLOGY			English	Article						Cirrhosis; Portal hypertension; Hepatic vein waveform; Liver stiffness	PORTAL-HYPERTENSION; HEPATOCELLULAR-CARCINOMA; TRANSIENT ELASTOGRAPHY; CIRRHOTIC-PATIENTS; DOPPLER FLOWMETRY; FIBROSIS; DISEASE; HEMODYNAMICS; ULTRASOUND; DIAGNOSIS	The aim of this prospective study was to assess the relationship between liver stiffness and hepatic vein waveform patterns in 42 patients with chronic hepatitis and 55 with cirrhosis. Liver stiffness measurement (LSM) values (FibroScan, Echosens, Paris, France) were significantly lower in the triphasic pattern group (11.3 +/- 8.4 kPa) than in the monophasic pattern (32.5 +/- 23.5 kPa, p = 0.001) and biphasic pattern (25.6 +/- 18.1 kPa, p = 0.001) groups, indicating no significant relationship with portal pressure. The ability to diagnose cirrhosis represented by the highest area under the receiver operating characteristic curve was 0.921 (83.6% sensitivity, 90.5% specificity, best cutoff value: 16.9 kPa) by LSM and 1.000 (best cutoff value: 19.4 kPa) by LSM combined with the monophasic pattern. This study revealed a close linkage between liver stiffness and hepatic vein waveform findings, resulting in a better understanding of hepatic vein hemodynamics and wider application of its analysis. (C) 2015 World Federation for Ultrasound in Medicine & Biology.	[Sekimoto, Tadashi; Maruyama, Hitoshi; Kiyono, Soichiro; Kondo, Takayuki; Shimada, Taro; Takahashi, Masanori; Yokosuka, Osamu] Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chuou Ku, Chiba 2608670, Japan; [Yamaguchi, Tadashi] Chiba Univ, Dept Res, Ctr Frontier Med Engn, Chuou Ku, Chiba 2608670, Japan	Maruyama, H (reprint author), Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chuou Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	maru-cib@umin.ac.jp					Albrecht T, 1999, LANCET, V353, P1579, DOI 10.1016/S0140-6736(98)06373-9; Rifai K, 2011, DIGEST LIVER DIS, V43, P491, DOI 10.1016/j.dld.2011.02.011; Williams R, 2006, HEPATOLOGY, V44, P521, DOI 10.1002/hep.21347; Chon YE, 2012, J CLIN GASTROENTEROL, V46, P518, DOI 10.1097/MCG.0b013e31825079f1; Huwart L, 2008, GASTROENTEROLOGY, V135, P32, DOI 10.1053/j.gastro.2008.03.076; Friedrich-Rust M, 2009, RADIOLOGY, V252, P595, DOI 10.1148/radiol.2523081928; COLLI A, 1994, AM J ROENTGENOL, V162, P833; Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001; BOLONDI L, 1990, J GASTROEN HEPATOL, V5, P459, DOI 10.1111/j.1440-1746.1990.tb01425.x; Poynard T, 2000, SEMIN LIVER DIS, V20, P47, DOI 10.1055/s-2000-9258; ZWIEBEL WJ, 1995, RADIOLOGY, V194, P807; Vizzutti F, 2007, HEPATOLOGY, V45, P1290, DOI 10.1002/hep.21665; Carrion JA, 2006, LIVER TRANSPLANT, V12, P1791, DOI 10.1002/lt.20857; Cardenas A, 2011, GUT, V60, P412, DOI 10.1136/gut.2009.179937; Sanyal AJ, 2008, GASTROENTEROLOGY, V134, P1715, DOI 10.1053/j.gastro.2008.03.007; TAYLOR KJW, 1990, RADIOLOGY, V174, P297; BOLONDI L, 1991, RADIOLOGY, V178, P513; Bedossa P, 2003, HEPATOLOGY, V38, P1449, DOI 10.1016/j.hep.2003.09.022; GAIANI S, 1989, HEPATOLOGY, V9, P815, DOI 10.1002/hep.1840090604; GRANT EG, 1989, AM J ROENTGENOL, V152, P707; Han JY, 2012, BRIT J RADIOL, V85, pE404, DOI 10.1259/bjr/74648924; Kawanaka H, 2008, J GASTROEN HEPATOL, V23, pE129, DOI 10.1111/j.1440-1746.2007.05155.x; Maruyama H, 2014, Clin Radiol, V69, pe140, DOI 10.1016/j.crad.2013.11.001; Mueller Sebastian, 2010, Hepat Med, V2, P49; Nissen NN, 2002, J CLIN GASTROENTEROL, V35, pS79, DOI 10.1097/00004836-200211002-00003; OHNISHI K, 1987, AM J GASTROENTEROL, V82, P507; OHTA M, 1994, AM J GASTROENTEROL, V89, P170; Parikh S, 2009, DIGEST DIS SCI, V54, P1178, DOI 10.1007/s10620-008-0491-8; Rodriguez-Vilarrupla A, 2007, ANN HEPATOL, V6, P28; Sudhamshu KC, 2006, WORLD J GASTROENTERO, V12, P5853; Tandon P, 2006, CLIN GASTROENTEROL H, V4, P1318, DOI 10.1016/j.cgh.2006.09.009	31	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-5629	1879-291X		ULTRASOUND MED BIOL	Ultrasound Med. Biol.	JUL	2015	41	7					1801	1807		10.1016/j.ultrasmedbio.2015.03.002		7	Acoustics; Radiology, Nuclear Medicine & Medical Imaging	Acoustics; Radiology, Nuclear Medicine & Medical Imaging	CJ9TI	WOS:000355845500002		
J	Kudo, N				Kudo, Nobuki			A SIMPLE TECHNIQUE FOR VISUALIZING ULTRASOUND FIELDS WITHOUT SCHLIEREN OPTICS	ULTRASOUND IN MEDICINE AND BIOLOGY			English	Article						Ultrasound field; Visualization; Optical method; Schlieren technique; Shadowgraphy; Focused shadowgraphy; Focused ultrasound; High-frequency ultrasound	ACOUSTOOPTIC DIFFRACTION; PULSED ULTRASOUND; WAVE-FIELDS; SOUND FIELD; SYSTEM; PRESSURE; RESOLUTION; PATTERNS; LIGHT	A simple technique designed for visualization of ultrasound fields without Schlieren optics is introduced. An optical system of direct shadowgraphy with diverging light, which consists of a point light source and a shadow screen, constituted the basic system, but the screen was replaced by focusing optics: a camera that makes a virtual screen at its focus plane. The proposed technique visualizes displacement of light deflected by ultrasound, and the use of focusing optics enables flexible settings of the virtual screen position and optical magnification. Insufficient sensitivity of shadowgraphy was overcome by elimination of non-deflecting light using image subtraction of shadowgrams taken with and without ultrasound exposure. A 1-MHz focused transducer for ultrasound therapy and a 20-MHz miniature transducer for intravascular imaging were used for experiments, and alternate pressure change in short-pulsed ultrasound was visualized, indicating the usefulness of the proposed technique for evaluation of medical ultrasound fields. (C) 2015 World Federation for Ultrasound in Medicine & Biology.	[Kudo, Nobuki] Hokkaido Univ, Grad Sch Informat Sci & Technol, Sapporo, Hokkaido 0600814, Japan	Kudo, N (reprint author), Hokkaido Univ, Grad Sch Informat Sci & Technol, Kita Ku, N14W9, Sapporo, Hokkaido 0600814, Japan.	kudo@bme.ist.hokudai.ac.jp			JSPS KAKENHI [23300182]	The author expresses sincere gratitude to the late Professor Katsuyuki Yamamoto for his scrupulous discussion that initiated the research. Supportive comments from Professor Koichi Shimizu were invaluable. The author is also grateful to Professor Shin-ichiro Umemura for permission to use his Schlieren system. This study was supported by JSPS KAKENHI Grant 23300182.	Pitts TA, 2001, IEEE T ULTRASON FERR, V48, P1686, DOI 10.1109/58.971722; Kudo N, 2009, BIOPHYS J, V96, P4866, DOI 10.1016/j.bpj.2009.02.072; Debye P, 1932, P NATL ACAD SCI USA, V18, P409, DOI 10.1073/pnas.18.6.409; Hargather MJ, 2007, SHOCK WAVES, V17, P215, DOI 10.1007/s00193-007-0108-8; DAVIES TP, 1981, OPT LASER TECHNOL, V13, P37, DOI 10.1016/0030-3992(81)90089-X; Neumann T, 2006, ULTRASONICS, V44, pE1561, DOI 10.1016/j.ultras.2006.05.209; Azuma T, 2002, JPN J APPL PHYS 1, V41, P3308, DOI 10.1143/JJAP.41.3308; BEACH KW, 1973, J OPT SOC AM, V63, P559, DOI 10.1364/JOSA.63.000559; Biele JK, 2003, SHOCK WAVES, V13, P167, DOI 10.1007/s00193-003-0203-4; Biss MM, 2009, SHOCK WAVES, VOL 1, PROCEEDINGS, P91, DOI 10.1007/978-3-540-85168-4_13; Charlebois T, 1995, MED ELECT        JUN, P66; Chung B, 2002, SPORTS MED, V32, P851, DOI 10.2165/00007256-200232130-00004; Hanafy A, 1991, P IEEE INT ULTR S, P1223; HANAFY A, 1979, ULTRASONIC IMAGING, V1, P295, DOI 10.1016/0161-7346(79)90023-3; HANAFY A, 1980, ULTRASONIC IMAGING, V2, P122, DOI 10.1016/0161-7346(80)90131-5; Harigane S, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.07HF07; Kudo N, 2004, J PHYS CONF SER, V1, P146, DOI [10.1088/1742-6596/1/1/033, 10.1088/1742-6596/1/1033]; Kudo N., 2010, P IEEE ULTRASON S, P829; Kudo N, 2006, AIP CONF PROC, V829, P614; Lucas R, 1932, CR HEBD ACAD SCI, V194, P2132; Miyasaka R, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.07KF24; NEIGHBORS TH, 1995, J ACOUST SOC AM, V98, P1751, DOI 10.1121/1.413439; Neumann T, 2006, ULTRASON, P244, DOI 10.1109/ULTSYM.2006.74; Omura R, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.07HC07; PITTS TA, 1994, ULTRASON, P1665, DOI 10.1109/ULTSYM.1994.401910; Rienitz J, 1997, ENDEAVOUR, V21, P77, DOI 10.1016/S0160-9327(97)01029-6; RIENITZ J, 1975, NATURE, V254, P293, DOI 10.1038/254293a0; Schneider B, 1996, IEEE T ULTRASON FERR, V43, P1181, DOI 10.1109/58.542062; Settles G, 2005, P 5 PAC S FLOW VIS I; Settles G.S., 2001, SCHLIEREN SHADOWGRAP; Shimazaki Y, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.07GF25; WAXLER RM, 1963, J RES NBS A PHYS CH, VA 67, P163, DOI 10.6028/jres.067A.016; WEIGHT JP, 1978, J ACOUST SOC AM, V63, P396, DOI 10.1121/1.381730; WILLARD GW, 1949, J ACOUST SOC AM, V21, P101, DOI 10.1121/1.1906472	34	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-5629	1879-291X		ULTRASOUND MED BIOL	Ultrasound Med. Biol.	JUL	2015	41	7					2071	2081		10.1016/j.ultrasmedbio.2015.03.004		11	Acoustics; Radiology, Nuclear Medicine & Medical Imaging	Acoustics; Radiology, Nuclear Medicine & Medical Imaging	CJ9TI	WOS:000355845500028		
J	Osugi, T; Murakami, I				Osugi, Takayuki; Murakami, Ikuya			Onset of background dynamic noise attenuates preview benefit in inefficient visual search	VISION RESEARCH			English	Article						Visual marking; Background change; Preview search	ATTENTIONAL CAPTURE; PRIORITIZING SELECTION; CHANGE BLINDNESS; ABRUPT ONSETS; TOP-DOWN; MARKING; INHIBITION; OBJECTS; MOTION; COLOR	When certain distractors (old items) appear before others (new items) during an inefficient visual search task, observers exclude the old items from the search (preview benefit), possibly because their locations are deprioritized relative to the locations of the new items. We examined whether participants were able to ignore task-irrelevant changes in a scene (i.e., the onset of repetitive changes, continual repetitive changes, and the cessation of repetitive changes in the background), while performing a preview search task. The results indicated that, when the noise continually changed position throughout each trial, or when dynamic noise was changed to static noise simultaneous with the appearance of the search display, the preview benefit remained. In contrast, when the static background noise was changed to dynamic background noise, simultaneous with the appearance of the search display, this task-irrelevant background event abolished the preview benefit on search efficiency. Therefore, we conclude that the onset of task-irrelevant repetitive changes in the background disrupts the process of inhibitory marking of old items. (C) 2015 Elsevier Ltd. All rights reserved.	[Osugi, Takayuki; Murakami, Ikuya] Univ Tokyo, Dept Psychol, Tokyo 1130033, Japan	Osugi, T (reprint author), Univ Tokyo, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	tosugi@fechner.c.u-tokyo.ac.jp			Japan Society for the Promotion of Science (JSPS) [LZ004]; JSPS [25119003, 2610611]	The present study was supported by the Japan Society for the Promotion of Science (JSPS) Funding Program for Next Generation World-Leading Researchers (NEXT, LZ004), by a JSPS Grant-in-Aid for Scientific Research on Innovative Areas (25119003), and by a Grant-in-Aid for JSPS Fellows (2610611). This research was also supported in part by the Research Fellowships of JSPS for Takayuki Osugi.	von Muhlenen A, 2013, J EXP PSYCHOL HUMAN, V39, P1279, DOI 10.1037/a0031537; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Olivers CNL, 2002, J EXP PSYCHOL HUMAN, V28, P22, DOI 10.1037//0096-1523.28.1.22; Braithwaite JJ, 2006, PERCEPT PSYCHOPHYS, V68, P290, DOI 10.3758/BF03193676; Watson DG, 2002, J EXP PSYCHOL HUMAN, V28, P379, DOI 10.1037//0096-1523.28.2.379; Yantis S, 1996, J EXP PSYCHOL HUMAN, V22, P1505, DOI 10.1037//0096-1523.22.6.1505; Theeuwes J, 1998, PSYCHOL SCI, V9, P379, DOI 10.1111/1467-9280.00071; Franconeri SL, 2005, PSYCHOL SCI, V16, P275, DOI 10.1111/j.0956-7976.2005.01528.x; Watson DG, 2005, PERCEPT PSYCHOPHYS, V67, P418, DOI 10.3758/BF03193321; Sobel KV, 2002, J EXP PSYCHOL HUMAN, V28, P1055, DOI 10.1037//0096-1523.28.5.1055; RYAN TA, 1960, PSYCHOL BULL, V57, P318, DOI 10.1037/h0044320; Osugi T, 2010, ATTEN PERCEPT PSYCHO, V72, P2144, DOI 10.3758/APP.72.8.2144; Osugi T, 2009, VISION RES, V49, P851, DOI 10.1016/j.visres.2009.03.002; Wolfe JM, 2002, VISION RES, V42, P2985, DOI 10.1016/S0042-6989(02)00388-7; Donk M, 2001, PERCEPT PSYCHOPHYS, V63, P891, DOI 10.3758/BF03194445; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; EGETH HE, 1984, J EXP PSYCHOL HUMAN, V10, P32, DOI 10.1037//0096-1523.10.1.32; Franconeri SL, 2003, PERCEPT PSYCHOPHYS, V65, P999, DOI 10.3758/BF03194829; HILLSTROM AP, 1994, PERCEPT PSYCHOPHYS, V55, P399, DOI 10.3758/BF03205298; Watson DG, 2000, PERCEPT PSYCHOPHYS, V62, P471, DOI 10.3758/BF03212099; FOLK CL, 1992, J EXP PSYCHOL HUMAN, V18, P1030, DOI 10.1037//0096-1523.18.4.1030; Yantis S, 1999, J EXP PSYCHOL HUMAN, V25, P661, DOI 10.1037//0096-1523.25.3.661; Abrams RA, 2005, PERCEPT PSYCHOPHYS, V67, P219, DOI 10.3758/BF03206486; Jiang YH, 2002, J EXP PSYCHOL HUMAN, V28, P717, DOI 10.1037//0096-1523.28.3.717; Humphreys GW, 2002, J EXP PSYCHOL HUMAN, V28, P640, DOI 10.1037//0096-1523.28.3.640; Al-Aidroos N, 2012, J EXP PSYCHOL HUMAN, V38, P643, DOI 10.1037/a0025707; Watson DG, 2010, J EXP PSYCHOL HUMAN, V36, P1391, DOI 10.1037/a0020565; FOLK CL, 1994, J EXP PSYCHOL HUMAN, V20, P317, DOI 10.1037/0096-1523.20.2.317; Abrams RA, 2003, PSYCHOL SCI, V14, P427, DOI 10.1111/1467-9280.01458; Watson DG, 1997, PSYCHOL REV, V104, P90, DOI 10.1037/0033-295X.104.1.90; Braithwaite JJ, 2003, PERCEPT PSYCHOPHYS, V65, P213, DOI 10.3758/BF03194796; Becker MW, 2007, PERCEPTION, V36, P1179, DOI 10.1068/p5750; Braithwaite JJ, 2005, PERCEPT PSYCHOPHYS, V67, P81; Irwin DE, 2013, PSYCHON B REV, V20, P128, DOI 10.3758/s13423-012-0327-6; JONIDES J, 1988, PERCEPT PSYCHOPHYS, V43, P346, DOI 10.3758/BF03208805; KAPTEIN NA, 1995, J EXP PSYCHOL HUMAN, V21, P1053, DOI 10.1037//0096-1523.21.5.1053; Kawahara J., 2012, J VISION, V12, P1; Kunar MA, 2003, J EXP PSYCHOL HUMAN, V29, P185, DOI 10.1037/0096-1523.29.1.185; Meinhardt G., 2014, PERCEPTION, V43, P63; Neider MB, 2006, VISION RES, V46, P2217, DOI 10.1016/j.visres.2006.01.006; Osugi T., 2012, Q J EXPT PSYCHOL, V66, P69; Osugi T, 2014, VISION RES, V95, P51, DOI 10.1016/j.visres.2013.12.006; von Muhlenen A, 2007, J EXP PSYCHOL HUMAN, V33, P1297, DOI 10.1037/0096-1523.33.6.1297; Watson DG, 2011, J EXP PSYCHOL HUMAN, V37, P1729, DOI 10.1037/a0023097	44	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0042-6989	1878-5646		VISION RES	Vision Res.	JUL	2015	112						33	44		10.1016/j.visres.2015.02.024		12	Neurosciences; Ophthalmology	Neurosciences & Neurology; Ophthalmology	CK3MV	WOS:000356121100004		
J	Umetsu, D; Dahmann, C				Umetsu, Daiki; Dahmann, Christian			Signals and mechanics shaping compartment boundaries in Drosophila	WILEY INTERDISCIPLINARY REVIEWS-DEVELOPMENTAL BIOLOGY			English	Article							DORSOVENTRAL LINEAGE RESTRICTION; DEVELOPMENTAL COMPARTMENTALIZATION; CELL-INTERACTIONS; IMAGINAL DISC; VENTRAL CELLS; HEDGEHOG; DORSAL; NOTCH; GENE; EXPRESSION	During animal development groups of cells with similar fates and functions often stay together and separate from cells with different fates. An example for this cellular behavior is the formation of compartments, groups of cells with similar fates that are separated by sharp boundaries from neighboring groups of cells. Compartments play important roles during patterning by serving as units of growth and gene expression. Boundaries between compartments are associated with organizers that secrete signaling molecules instructing growth and differentiation throughout the tissue. The straight shape of the boundary between compartments is important for maintaining the position and shape of the organizer and thus for precise patterning. The straight shape of compartment boundaries, however, is challenged by cell divisions and cell intercalations that take place in many developing tissues. Early work established a role for selector genes and signaling pathways in setting up and keeping boundaries straight. Recent work in Drosophila has now begun to further unravel the physical and cellular mechanisms that maintain compartment boundaries. Key to the separation of compartments is a local increase of actomyosin-dependent mechanical tension at cell junctions along the boundary. Increased mechanical tension acts as a barrier to cell mixing during cell division and influences cell rearrangements during cell intercalations along the compartment boundary in a way that the straight shape of the boundary is maintained. An important question for the future is how the signaling pathways that maintain the straight shape of compartment boundaries control mechanical tension along these boundaries. (C) 2015 Wiley Periodicals, Inc.	[Umetsu, Daiki] RIKEN Ctr Dev Biol, Kobe, Hyogo, Japan; [Dahmann, Christian] Tech Univ Dresden, Inst Genet, D-01062 Dresden, Germany	Dahmann, C (reprint author), Tech Univ Dresden, Inst Genet, D-01062 Dresden, Germany.	christian.dahmann@tu-dresden.de					Altabef M, 1997, DEVELOPMENT, V124, P4547; Blair SS, 1997, DEVELOPMENT, V124, P4053; DIAZBENJUMEA FJ, 1993, CELL, V75, P741, DOI 10.1016/0092-8674(93)90494-B; Krause M, 2003, ANNU REV CELL DEV BI, V19, P541, DOI 10.1146/annurev.cellbio.19.050103.103356; Becam I, 2011, DEVELOPMENT, V138, P3781, DOI 10.1242/dev.064774; Micchelli CA, 1999, NATURE, V401, P473; GARCIABELLIDO A, 1976, DEV BIOL, V48, P132, DOI 10.1016/0012-1606(76)90052-X; Farhadifar R, 2007, CURR BIOL, V17, P2095, DOI 10.1016/j.cub.2007.11.049; Mao YL, 2011, GENE DEV, V25, P131, DOI 10.1101/gad.610511; Arques CG, 2007, DEVELOPMENT, V134, P3713, DOI 10.1242/dev.02873; Aliee M, 2012, CURR BIOL, V22, P967, DOI 10.1016/j.cub.2012.03.070; BLAIR SS, 1994, DEVELOPMENT, V120, P1805; Dahmann C, 1999, TRENDS GENET, V15, P320, DOI 10.1016/S0168-9525(99)01774-6; Dahmann C, 2011, NAT REV GENET, V12, P43, DOI 10.1038/nrg2902; STEINBERG MS, 1963, SCIENCE, V141, P401, DOI 10.1126/science.141.3579.401; TABATA T, 1992, GENE DEV, V6, P2635, DOI 10.1101/gad.6.12b.2635; Lecuit T, 1996, NATURE, V381, P387, DOI 10.1038/381387a0; Monier B, 2010, NAT CELL BIOL, V12, P60, DOI 10.1038/ncb2005; STEINER E, 1976, Wilhelm Roux's Archives of Developmental Biology, V180, P9, DOI 10.1007/BF00848882; Lawrence PA, 1996, CELL, V85, P951, DOI 10.1016/S0092-8674(00)81297-0; Reymann AC, 2012, SCIENCE, V336, P1310, DOI 10.1126/science.1221708; STAVANS J, 1993, REP PROG PHYS, V56, P733, DOI 10.1088/0034-4885/56/6/002; Major RJ, 2005, DEVELOPMENT, V132, P3823, DOI 10.1242/dev.01957; Landsberg KP, 2009, CURR BIOL, V19, P1950, DOI 10.1016/j.cub.2009.10.021; Milan M, 2001, CELL, V106, P785, DOI 10.1016/S0092-8674(01)00489-5; ZECCA M, 1995, DEVELOPMENT, V121, P2265; Major RJ, 2006, DEV DYNAM, V235, P3051, DOI 10.1002/dvdy.20966; BRYANT PJ, 1970, DEV BIOL, V22, P389, DOI 10.1016/0012-1606(70)90160-0; MORATA G, 1975, NATURE, V255, P614, DOI 10.1038/255614a0; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; Rodriguez I, 1997, NATURE, V389, P614; Rauskolb C, 1999, NATURE, V401, P476; Dahmann C, 2000, CELL, V100, P411, DOI 10.1016/S0092-8674(00)80677-7; Calzolari S, 2014, EMBO J, V33, P686, DOI 10.1002/embj.201386003; Gibson WT, 2011, CELL, V144, P427, DOI 10.1016/j.cell.2010.12.035; Cavodeassi F, 2013, DEVELOPMENT, V140, P4193, DOI 10.1242/dev.097048; Monier B, 2011, CELL MOL LIFE SCI, V68, P1897, DOI 10.1007/s00018-011-0668-8; Umetsu D, 2014, CURR BIOL, V24, P1798, DOI 10.1016/j.cub.2014.06.052; COHEN B, 1992, GENE DEV, V6, P715, DOI 10.1101/gad.6.5.715; B Monier, 2010, NAT CELL BIOL S, V12, P61; Batlle E, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008227; Brodland GW, 2002, J BIOMECH ENG-T ASME, V124, P188, DOI 10.1115/1.1449491; Cooke JE, 2001, DEVELOPMENT, V128, P571; CRICK FHC, 1975, SCIENCE, V189, P340, DOI 10.1126/science.806966; Dominguez M, 1998, NATURE, V396, P276; GARCIABE.A, 1973, NATURE-NEW BIOL, V245, P251; Gettings M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000390; GUTHRIE S, 1991, J NEUROBIOL, V22, P742, DOI 10.1002/neu.480220709; Koelzer S, 2006, DEV BIOL, V289, P77, DOI 10.1016/j.ydbio.2005.10.008; KORNBERG T, 1981, DEV BIOL, V86, P363, DOI 10.1016/0012-1606(81)90194-9; OBROCHTA DA, 1985, NATURE, V313, P138, DOI 10.1038/313138a0; Sanson B, 2001, EMBO REP, V2, P1083, DOI 10.1093/embo-reports/kve255; Schlichting K, 2005, DEV BIOL, V279, P142, DOI 10.1016/j.ydbio.2004.12.008; Umetsu D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114340; VINCENT JP, 1992, CELL, V68, P923, DOI 10.1016/0092-8674(92)90035-B; Xu QL, 2013, WIRES DEV BIOL, V2, P735, DOI 10.1002/wdev.106	56	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1759-7684	1759-7692		WIRES DEV BIOL	Wiley Interdiscip. Rev.-Dev. Biol.	JUL-AUG	2015	4	4					407	417		10.1002/wdev.178		11	Developmental Biology	Developmental Biology	CJ8KR	WOS:000355749600006		
J	Akaishi, J; Sugino, K; Kameyama, K; Masaki, C; Matsuzu, K; Suzuki, A; Uruno, T; Ohkuwa, K; Shibuya, H; Kitagawa, W; Nagahama, M; Shimizu, K; Ito, K				Akaishi, Junko; Sugino, Kiminori; Kameyama, Kaori; Masaki, Chie; Matsuzu, Kenichi; Suzuki, Akifumi; Uruno, Takashi; Ohkuwa, Keiko; Shibuya, Hiroshi; Kitagawa, Wataru; Nagahama, Mitsuji; Shimizu, Kazuo; Ito, Koichi			Clinicopathologic Features and Outcomes in Patients with Diffuse Sclerosing Variant of Papillary Thyroid Carcinoma	WORLD JOURNAL OF SURGERY			English	Article							SINGLE INSTITUTION; FOLLOW-UP; EXPERIENCE; PROGNOSIS; JAPAN	Diffuse sclerosing variant (DSV) of papillary thyroid carcinoma (PTC) is a rare variant more common among younger patients. Excluding patients with microcarcinoma, 5848 patients with PTC underwent initial surgery between 1995 and 2011. Twenty-two patients (0.4 %) were histologically diagnosed with DSV, of whom 20 (91 %) were < 45 years old. We compared clinicopathologic characteristics and outcomes between patients with DSV and those with classical PTC < 45 years old. Univariate analysis by the Kaplan-Meier method in relation to cause-specific survival (CSS) and disease-free survival (DFS) rates was performed with regard to the following variables: sex; anti-thyroglobulin antibody (TgAb) positivity; presence of distant metastasis; pathological lymph node metastasis; extra-thyroidal invasion; and pathological variant (classical vs. DSV). The 20 patients with DSV < 45 years old comprised 18 females and 2 males. Frequencies of TgAb, pN1b, and local recurrence were higher in the DSV group than in the classical PTC group. Ten-year CSS and DFS rates for PTC patients < 45 years old were 99.7 and 88.6 % in the classical PTC group and 100 and 60.5 % in the DSV group. CSS rate did not differ between groups, but DFS rate was significantly lower in the DSV group than in the classical PTC group (p < 0.0001, log-rank test). Multivariate analysis identified DSV group and pN1b as prognostic factors for recurrence in young PTC patients. Most DSV patients were young and had a background of chronic thyroiditis. Outcomes for DSV were very good, but recurrence was more common than in classical PTC.	[Akaishi, Junko; Sugino, Kiminori; Masaki, Chie; Matsuzu, Kenichi; Suzuki, Akifumi; Uruno, Takashi; Ohkuwa, Keiko; Shibuya, Hiroshi; Kitagawa, Wataru; Nagahama, Mitsuji; Ito, Koichi] Ito Hosp, Dept Surg, Shibuya Ku, Tokyo 1508308, Japan; [Kameyama, Kaori] Keio Hosp, Dept Pathol, Shinjuku Ku, Tokyo 1608582, Japan; [Shimizu, Kazuo] Nippon Med Sch, Dept Endocrine Surg, Bunkyo Ku, Tokyo 113, Japan	Akaishi, J (reprint author), Ito Hosp, Dept Surg, Shibuya Ku, 4-3-6 Jingumae, Tokyo 1508308, Japan.	j-akaishi@ito-hospital.jp; k-sugino@ito-hospital.jp; kameyam@sc.itc.keio.ac.jp; c-masaki@ito-hospital.jp; k-matsuzu@ito-hospital.jp; a-suzuki@ito-hospital.jp; t-uruno@ito-hospital.jp; k-ohkuwa@ito-hospital.jp; h-shibuya@ito-hospital.jp; w-kitagawa@ito-hospital.jp; m-nagahama@ito-hospital.jp; kshimizu@nms.ac.jp; k-ito@ito-hospital.jp					Albareda M, 1998, THYROID, V8, P385, DOI 10.1089/thy.1998.8.385; VICKERY AL, 1985, SEMIN DIAGN PATHOL, V2, P90; Chow SM, 2003, EUR J SURG ONCOL, V29, P446, DOI 10.1016/S0748-7983(03)00005-2; HEDINGER C, 1989, CANCER, V63, P908, DOI 10.1002/1097-0142(19890301)63:5<908::AID-CNCR2820630520>3.0.CO;2-I; Koo JS, 2010, APMIS, V118, P744, DOI 10.1111/j.1600-0463.2010.02653.x; FUJIMOTO Y, 1990, CANCER, V66, P2306, DOI 10.1002/1097-0142(19901201)66:11<2306::AID-CNCR2820661109>3.0.CO;2-P; ZIMMERMAN D, 1988, SURGERY, V104, P1157; Koo JS, 2009, THYROID, V19, P1225, DOI 10.1089/thy.2009.0073; Regalbuto C, 2011, THYROID, V21, P383, DOI 10.1089/thy.2010.0331; Caplan R H, 1997, Endocr Pract, V3, P287; CARCANGIU ML, 1989, AM J SURG PATHOL, V13, P1041, DOI 10.1097/00000478-198912000-00006; Falvo L, 2006, AM SURGEON, V72, P438; Fukushima M, 2009, WORLD J SURG, V33, P958, DOI 10.1007/s00268-009-9940-6; GOMEZMORALES M, 1991, HISTOPATHOLOGY, V18, P427, DOI 10.1111/j.1365-2559.1991.tb00873.x; Gómez-Morales M, 1991, Clin Endocrinol (Oxf), V34, P432, DOI 10.1111/j.1365-2265.1991.tb00320.x; HAYASHI Y, 1990, ACTA PATHOL JAPON, V40, P193; Imamura Y, 2000, ENDOCR PATHOL, V11, P97, DOI 10.1385/EP:11:1:97; Kebapci N, 2002, J ENDOCRINOL INVEST, V25, P730; Khan AR, 1998, J ROY COLL SURG EDIN, V43, P20; Lam AKY, 2006, ANN SURG ONCOL, V13, P176, DOI 10.1245/ASO.2006.03.062; Lee JY, 2007, THYROID, V17, P567, DOI 10.1089/thy.2006.0321; Macák J, 1993, Cesk Patol, V29, P6; MIZUKAMI Y, 1990, ACTA PATHOL JAPON, V40, P676; Moreno EA, 1994, EUR J SURG ONCOL, V20, P7; SCHRODER S, 1990, VIRCHOWS ARCH A, V416, P367, DOI 10.1007/BF01605298; SOARES J, 1989, PATHOL RES PRACT, V185, P200; Takami H, 2014, WORLD J SURG, V38, P2002, DOI 10.1007/s00268-014-2498-y; Thompson LDR, 2005, ENDOCR PATHOL, V16, P331, DOI 10.1385/EP:16:4:331; WU PSC, 1989, CLIN ENDOCRINOL, V31, P535, DOI 10.1111/j.1365-2265.1989.tb01277.x	29	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-2313	1432-2323		WORLD J SURG	World J.Surg.	JUL	2015	39	7					1728	1735		10.1007/s00268-015-3021-9		8	Surgery	Surgery	CJ7SH	WOS:000355698900021		
J	Yokota, M; Kobayashi, A; Nomura, S; Nishizawa, Y; Ito, M; Nagai, K; Saito, N				Yokota, Mitsuru; Kobayashi, Akihiro; Nomura, Shogo; Nishizawa, Yuji; Ito, Masaaki; Nagai, Kanji; Saito, Norio			Patterns and Treatment of Recurrence Following Pulmonary Resection for Colorectal Metastases	WORLD JOURNAL OF SURGERY			English	Article							LIVER METASTASES; PROGNOSTIC ASSESSMENT; LUNG METASTASECTOMY; CANCER STATISTICS; SURVIVAL; CARCINOMA; OUTCOMES; SURGERY; TRIAL	Pulmonary resection is the best therapeutic option for lung metastases from colorectal cancer (CRC) today. However, recurrences are frequent following pulmonary resection. We aimed to evaluate the recurrence pattern and treatment of initial pulmonary resection for metastases from CRC. Data from 76 patients with recurrence after curative resection of primary CRC and lung metastases were reviewed. The primary outcome measure was overall survival (OS), defined as the interval between the date of recurrence after pulmonary resection and the date of death or last follow-up. Cox regression analyses were performed to identify the factors associated with OS. Recurrence sites after initial pulmonary resection were lung (n = 37), liver (n = 12), others (n = 11), and multiple (n = 16). Treatments for recurrence included surgery (n = 35), chemotherapy (n = 37), and palliative care (n = 4). Of 35 patients who underwent surgery, 22 had pulmonary resection, and 11 had hepatic resection, and 2 had other resection. The 3-year OS was 84.1 % for surgery, 38.9 % for chemotherapy, and 0 % for palliative care, respectively (p < 0.001). In the surgery group, there was no difference in survival between surgical treatments for pulmonary and hepatic recurrences (p = 0.503). Cox regression analyses identified three factors: disease-free interval (DFI) (HR 1.99, 95 % CI 1.03-3.83), surgery (HR 0.30, 95 % CI 0.12-0.72), and recurrence site (lung: HR 0.10, 95 % CI 0.04-0.28, liver: HR 0.08, 95 % CI 0.02-0.31). The most common recurrence site after resection of lung metastases was the lung. Although the relapse rate is high, surgery for isolated recurrences is a promising strategy, especially for patients with long DFI.	[Yokota, Mitsuru; Kobayashi, Akihiro; Nishizawa, Yuji; Ito, Masaaki; Saito, Norio] East Hosp, Natl Canc Ctr, Div Colorectal Surg, Kashiwa, Chiba 2778577, Japan; [Nomura, Shogo] East Hosp, Natl Canc Ctr, Clin Trial Sect, Res Ctr Innovat Oncol, Kashiwa, Chiba 2778577, Japan; [Nagai, Kanji] East Hosp, Natl Canc Ctr, Div Thorac Surg, Kashiwa, Chiba 2778577, Japan	Saito, N (reprint author), East Hosp, Natl Canc Ctr, Div Colorectal Surg, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan.	miyokota@east.ncc.go.jp; norsaito@east.ncc.go.jp			National Cancer Center (NCC) Research and Development Fund [23-A-14]	Grant support for this study was provided by a National Cancer Center (NCC) Research and Development Fund (23-A-14).	Andreoni Bruno, 2007, World J Surg Oncol, V5, P73, DOI 10.1186/1477-7819-5-73; de Jong MC, 2009, ANN SURG, V250, P440, DOI 10.1097/SLA.0b013e3181b4539b; Petrowsky H, 2002, ANN SURG, V235, P863, DOI 10.1097/00000658-200206000-00015; Mitry E, 2008, J CLIN ONCOL, V26, P4906, DOI 10.1200/JCO.2008.17.3781; Iida T, 2013, ANN SURG, V257, P1059, DOI 10.1097/SLA.0b013e31826eda3b; Borasio P, 2011, INT J COLORECTAL DIS, V26, P183, DOI 10.1007/s00384-010-1075-6; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Lin BR, 2009, ANN SURG ONCOL, V16, P1026, DOI 10.1245/s10434-008-0286-3; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Simmonds PC, 2006, BRIT J CANCER, V94, P982, DOI 10.1038/sj.bjc.6603033; Gonzalez M, 2013, ANN SURG ONCOL, V20, P572, DOI 10.1245/s10434-012-2726-3; Yedibela S, 2006, ANN SURG ONCOL, V13, P1538, DOI 10.1245/s10434-006-9100-2; Zabaleta J, 2011, EJSO-EUR J SURG ONC, V37, P786, DOI 10.1016/j.ejso.2011.05.014; Portier G, 2006, J CLIN ONCOL, V24, P4976, DOI 10.1200/JCO.2006.06.8353; Welter S, 2007, EUR J CARDIO-THORAC, V31, P167, DOI 10.1016/j.ejcts.2006.11.004; Ogata Y, 2005, WORLD J SURG, V29, P363, DOI 10.1007/s00268-004-7537-7; Tsikitis VL, 2009, J CLIN ONCOL, V27, P3671, DOI 10.1200/JCO.2008.20.7050; Park JS, 2010, ANN ONCOL, V21, P1285, DOI 10.1093/annonc/mdp475; Riquet M, 2010, ANN THORAC SURG, V89, P375, DOI 10.1016/j.athoracsur.2009.10.005; Watanabe K, 2009, BRIT J SURG, V96, P1058, DOI 10.1002/bjs.6682; Blackmon SH, 2012, ANN THORAC SURG, V94, P1802, DOI 10.1016/j.athoracsur.2012.07.014; Saito Y, 2002, J THORAC CARDIOV SUR, V124, P1007, DOI 10.1067/mtc.2002.125165; Welter S, 2007, ANN THORAC SURG, V84, P203, DOI 10.1016/j.athoracsur.2007.03.028; Rama N, 2009, EUR J CARDIO-THORAC, V35, P444, DOI 10.1016/j.ejcts.2008.10.047; Chen FS, 2010, WORLD J SURG, V34, P2373, DOI 10.1007/s00268-010-0695-x; Gonzalez M, 2012, WORLD J SURG, V36, P386, DOI 10.1007/s00268-011-1381-3; Koga R, 2006, JPN J CLIN ONCOL, V36, P643, DOI 10.1093/jjco/hyl076; Landes U, 2010, BMC SURG, V10, DOI 10.1186/1471-2482-10-17; Sa Cunha A, 2007, ARCH SURG-CHICAGO, V142, P1150, DOI DOI 10.1001/ARCHSURG.142.12.1144]; Sa Cunha Antonio, 2007, Arch Surg, V142, P1144, DOI 10.1001/archsurg.142.12.1144; Salah S, 2013, ANN SURG ONCOL, V20, P1955, DOI 10.1245/s10434-012-2860-y; Thelen A, 2007, EJSO-EUR J SURG ONC, V33, P324, DOI 10.1016/j.ejso.2006.10.016	32	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-2313	1432-2323		WORLD J SURG	World J.Surg.	JUL	2015	39	7					1758	1766		10.1007/s00268-015-3006-8		9	Surgery	Surgery	CJ7SH	WOS:000355698900025		
J	Ichikawa, D; Komatsu, S; Kubota, T; Okamoto, K; Konishi, H; Shiozaki, A; Fujiwara, H; Otsuji, E				Ichikawa, Daisuke; Komatsu, Shuhei; Kubota, Takeshi; Okamoto, Kazuma; Konishi, Hirotaka; Shiozaki, Atsushi; Fujiwara, Hitoshi; Otsuji, Eigo			Evaluation of the Safety and Feasibility of Laparoscopic Total Gastrectomy in Clinical Stage I Gastric Cancer Patients	WORLD JOURNAL OF SURGERY			English	Article							ASSISTED DISTAL GASTRECTOMY; LONG-TERM OUTCOMES; ESOPHAGOJEJUNOSTOMY; MULTICENTER; ANASTOMOSIS; TRIAL	This retrospective study was designed to assess the feasibility of laparoscopic total gastrectomy (LTG) in clinical stage I gastric cancer patients, and validate the appropriateness of the widespread adoption of LTG for experienced open surgeons. Eighty-eight patients with clinical stage I gastric cancer underwent LTG in our hospitals (n = 55) and affiliated hospitals (n = 33). Esophagojejunostomy was performed intracoporeally using a circular stapler with an incision in the left upper abdomen. We investigated the patients' clinicopathologic factor, and evaluated the effect of hospital volume on short-term outcomes. Fixed insertion of the anvil head was successfully achieved in all patients (lift-up method in 58 patients and transoral method in 28 patients), although 2 patients were converted to open surgery. The approach using a circular stapler through a small incision from the upper left quadrant of the abdomen facilitated a good laparoscopic visual field for the plane of the esophagojejunostomy. Fourteen patients developed Clavien-Dindo classification grade II or more postoperative complications, and the overall operative morbidity rate was 15.9 %. No anastomotic leakage was encountered in this series. No significant difference was observed in clinical outcomes between patients in the high- and low-volume hospital groups. Laparoscopic total gastrectomy can be performed safely on clinical stage I gastric cancer patients by surgeons with sufficient experience in open gastrectomy and therefore represents a feasible procedure that is not clinically impacted by hospital volume.	[Ichikawa, Daisuke; Komatsu, Shuhei; Kubota, Takeshi; Okamoto, Kazuma; Konishi, Hirotaka; Shiozaki, Atsushi; Fujiwara, Hitoshi; Otsuji, Eigo] Kyoto Prefectural Univ Med, Div Digest Surg, Dept Surg, Kamigyo Ku, Kyoto 6028566, Japan	Ichikawa, D (reprint author), Kyoto Prefectural Univ Med, Div Digest Surg, Dept Surg, Kamigyo Ku, 465 Kajii Cho, Kyoto 6028566, Japan.	ichikawa@koto.kpu-m.ac.jp					Wada N, 2014, GASTRIC CANCER, V17, P137, DOI 10.1007/s10120-013-0235-0; Nunobe S, 2011, J GASTROINTEST SURG, V15, P1520, DOI 10.1007/s11605-011-1489-7; Lee MS, 2013, SURG ENDOSC, V27, P2598, DOI 10.1007/s00464-013-2796-8; Chen K, 2013, WORLD J GASTROENTERO, V19, P5365, DOI 10.3748/wjg.v19.i32.5365; Yoshikawa T, 2013, GASTRIC CANCER, V16, P126, DOI 10.1007/s10120-012-0157-2; Shim JH, 2013, AM J SURG, V206, P346, DOI 10.1016/j.amjsurg.2012.11.011; Komatsu S, 2013, WORLD J GASTROENTERO, V19, P8696, DOI 10.3748/wjg.v19.i46.8696; Katai H, 2010, GASTRIC CANCER, V13, P238, DOI 10.1007/s10120-010-0565-0; Huscher CGS, 2005, ANN SURG, V241, P232, DOI 10.1097/01.sla.0000151892.35922.f2; Kinoshita T, 2010, SURG ENDOSC, V24, P2908, DOI 10.1007/s00464-010-1041-y; Hiki N, 2007, GASTRIC CANCER, V10, P181, DOI 10.1007/s10120-007-0433-8; Kitano S, 2007, ANN SURG, V245, P68, DOI 10.1097/01.sla.0000225364.03133.f8; Nagai E, 2013, SURGERY, V153, P732, DOI 10.1016/j.surg.2012.10.012; Ebihara Y, 2013, LANGENBECK ARCH SURG, V398, P475, DOI 10.1007/s00423-013-1051-z; Ichikawa D, 2012, LANGENBECK ARCH SURG, V397, P57, DOI 10.1007/s00423-011-0840-5; Ichikawa D, 2013, ANTICANCER RES, V33, P5165; Inaba K, 2010, J AM COLL SURGEONS, V211, pE25, DOI 10.1016/j.jamcollsurg.2010.09.005; Ito H, 2014, SURG ENDOSC, V28, P1929, DOI 10.1007/s00464-014-3417-x; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P113, DOI 10.1007/s10120-011-0042-4; Jeong O, 2014, ANN SURG ONCOL, V21, P2994, DOI 10.1245/s10434-014-3666-x; KITANO S, 1994, SURG LAPAROSC ENDOSC, V4, P146; Tsunoda S, 2014, WORLD J SURG, V38, P2662, DOI 10.1007/s00268-014-2611-2	22	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-2313	1432-2323		WORLD J SURG	World J.Surg.	JUL	2015	39	7					1782	1788		10.1007/s00268-015-3008-6		7	Surgery	Surgery	CJ7SH	WOS:000355698900028		
J	Igami, T; Ebata, T; Yokoyama, Y; Sugawara, G; Mizuno, T; Yamaguchi, J; Shimoyama, Y; Nagino, M				Igami, Tsuyoshi; Ebata, Tomoki; Yokoyama, Yukihiro; Sugawara, Gen; Mizuno, Takashi; Yamaguchi, Junpei; Shimoyama, Yoshie; Nagino, Masato			Combined Extrahepatic Bile Duct Resection for Locally Advanced Gallbladder Carcinoma: Does It Work?	WORLD JOURNAL OF SURGERY			English	Article							SURGICAL-TREATMENT; RADICAL RESECTION; PORTAL-VEIN; CANCER; INVASION; SURGERY; T2	Prophylactic combined extrahepatic bile duct resection remains controversial for locally advanced gallbladder carcinoma without extrahepatic bile duct invasion. The aim of this study is to resolve this issue and establish an appropriate surgery for locally advanced gallbladder carcinoma. A total of 52 patients underwent surgical resection combined with extrahepatic bile duct resection for locally advanced gallbladder carcinoma without extrahepatic bile duct invasion, and their medical records were retrospectively reviewed for microvessel invasion (MVI), including lymphatic, venous, and/or perineural invasions, around the extrahepatic bile duct. Of the 52 patients, 8 (15 %) had MVI around the extrahepatic bile duct. All of the 8 patients had Stage IV disease. According to a survival analysis of the 50 patients who tolerated surgery, MVIs around the extrahepatic bile duct and distant metastasis were identified as independent prognostic factors. Survival for patients with MVI around the extrahepatic bile duct was dismal, with a lack of 2-year survivors. MVI around the extrahepatic bile duct is a sign of extremely locally advanced gallbladder carcinoma; therefore, prophylactic combined bile duct resection has no survival impact for patients without extrahepatic bile duct invasion.	[Igami, Tsuyoshi; Ebata, Tomoki; Yokoyama, Yukihiro; Sugawara, Gen; Mizuno, Takashi; Yamaguchi, Junpei; Nagino, Masato] Nagoya Univ, Div Surg Oncol, Dept Surg, Grad Sch Med,Showa Ku, Nagoya, Aichi 4668550, Japan; [Shimoyama, Yoshie] Nagoya Univ, Dept Pathol & Clin Labs, Grad Sch Med, Nagoya, Aichi 4668550, Japan	Nagino, M (reprint author), Nagoya Univ, Div Surg Oncol, Dept Surg, Grad Sch Med,Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	nagino@med.nagoya-u.ac.jp					Chijiiwa K, 2001, J AM COLL SURGEONS, V192, P600, DOI 10.1016/S1072-7515(01)00814-6; Suzuki A, 2009, AM J SURG PATHOL, V33, P1601, DOI 10.1097/PAS.0b013e3181ae29d6; Choi SB, 2013, LANGENBECK ARCH SURG, V398, P1137, DOI 10.1007/s00423-013-1120-3; Shibata K, 2009, WORLD J SURG, V33, P1035, DOI 10.1007/s00268-009-9950-4; Ebata T, 2003, ANN SURG, V238, P720, DOI 10.1097/01.sla.0000094437.68038.a3; Suzuki S, 2004, WORLD J SURG, V28, P160, DOI 10.1007/s00268-003-7080-y; Kondo S, 2002, BRIT J SURG, V89, P179, DOI 10.1046/j.0007-1323.2001.02001.x; Foster JM, 2007, ANN SURG ONCOL, V14, P833, DOI 10.1245/s10434-006-9097-6; Nishio H, 2011, ANN SURG, V253, P953, DOI 10.1097/SLA.0b013e318216f5f3; Araida T, 2009, SURG TODAY, V39, P770, DOI 10.1007/s00595-009-3960-6; Chikamoto A, 2009, J HEPATO-BILIARY-PAN, V16, P557, DOI 10.1007/s00534-009-0101-y; D'Angelica Dalal KM, 2009, ANN SURG ONCOL, V16, P806; Donohue J H, 2001, J Hepatobiliary Pancreat Surg, V8, P530, DOI 10.1007/s005340100021; Nakata T, 2009, J HEPATO-BILIARY-PAN, V16, P75, DOI 10.1007/s00534-008-0008-z; NIMURA Y, 1991, BRIT J SURG, V78, P727, DOI 10.1002/bjs.1800780629; Sakamoto Y, 2006, J SURG ONCOL, V94, P298, DOI 10.1002/jso.20585; Shimizu Y, 2004, SURGERY, V136, P1012, DOI 10.1016/j.surg.2004.04.032; Sobin LH, 2009, TNM CLASSIFICATION M; Wiggers JK, 2014, HPB, V16, P635, DOI 10.1111/hpb.12188; Yamaguchi R, 2002, BRIT J SURG, V89, P1130, DOI 10.1046/j.1365-2168.2002.02184.x; Yokoyama Y, 2008, WORLD J SURG, V32, P621, DOI 10.1007/s00268-007-9324-8	21	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-2313	1432-2323		WORLD J SURG	World J.Surg.	JUL	2015	39	7					1810	1817		10.1007/s00268-015-3011-y		8	Surgery	Surgery	CJ7SH	WOS:000355698900033		
J	Tanaka, Y; Kubo, A; Ayabe, J; Watanabe, M; Maeda, M; Tsuura, Y; Tanaka, Y				Tanaka, Yusuke; Kubo, Atsuhiko; Ayabe, Junichi; Watanabe, Masahide; Maeda, Masahiro; Tsuura, Yukio; Tanaka, Yoshihide			Intrasellar Symptomatic Salivary Gland Rest with Inflammations	WORLD NEUROSURGERY			English	Article						Ectopic; Inflammation; Intrasellar; Salivary; Symptomatic	PITUITARY; CYST	BACKGROUND: Instances of ectopic salivary gland tissue within the pituitary gland are rare, they are mostly asymptomatic, and the underlying pathophysiology of symptomatic cases is unclear. We report a case of intrasellar salivary gland rest that presented clinical symptoms and clearly related to inflammatory changes. CASE DESCRIPTION: In the present case, headache, bitemporal hemianopia, and hormone abnormality led to the detection of ectopic salivary gland tissue within the pituitary gland of a 24-year-old man. Imaging revealed a wellcircumscribed intrasellar cystic lesion having a diameter of major axis of 16 mm, for which tumorectomy was performed using the nasal approach. The tumor was cystic with stringy content. Pathologic findings revealed that the lesion was composed principally of secretions lacking cell components, whereas the salivary gland tissue was found in the cyst wall. Dilated ducts due to the leakage of secretions were also observed. Acute and chronic inflammation was present around the salivary gland. CONCLUSIONS: Not only are instances of symptomatic ectopic salivary glands rare, but this was also the first case detected to be caused by the pathophysiology involving the leakage of secretions from an ectopic salivary gland and associated inflammation. We report this case to help elucidate the pathophysiology of the condition.	[Tanaka, Yusuke; Kubo, Atsuhiko; Ayabe, Junichi; Watanabe, Masahide; Maeda, Masahiro; Tanaka, Yoshihide] Yokosuka Kyosai Hosp, Dept Neurosurg, Yokosuka, Kanagawa, Japan; [Tsuura, Yukio] Yokosuka Kyosai Hosp, Dept Pathol, Yokosuka, Kanagawa, Japan	Tanaka, Y (reprint author), Yokosuka Kyosai Hosp, Dept Neurosurg, Yokosuka, Kanagawa, Japan.	yusuke_neurosurgery@yahoo.co.jp					Chen Chih-Hao, 2007, J Chin Med Assoc, V70, P215; Kato T, 1988, Neurol Med Chir (Tokyo), V28, P930, DOI 10.2176/nmc.28.930; SCHOCHET SS, 1974, ARCH PATHOL, V98, P193; Stefanits H, 2013, CLIN NEUROPATHOL, V32, P171, DOI 10.5414/NP300560; Tae HK, 2007, J KOREAN ENDOCR SOC, V22, P436; TATTER SB, 1995, ACTA NEUROCHIR, V135, P150, DOI 10.1007/BF02187760; Valentina R, 2013, INT J CLIN EXP PATHO, V6, P1437	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JUL	2015	84	1							UNSP 189.e13	10.1016/j.wneu.2015.02.018		6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CK5DK	WOS:000356242200034		
J	Namba, K; Higaki, A; Kaneko, N; Mashiko, T; Nemoto, S; Watanabe, E				Namba, Katsunari; Higaki, Ayuho; Kaneko, Naoki; Mashiko, Toshihiro; Nemoto, Shigeru; Watanabe, Eiju			Microcatheter Shaping for Intracranial Aneurysm Coiling Using the 3-Dimensional Printing Rapid Prototyping Technology: Preliminary Result in the First 10 Consecutive Cases	WORLD NEUROSURGERY			English	Article						Aneurysm; Coiling; Microcatheter shaping; Rapid prototyping; Three-dimensional printing	ENDOVASCULAR TREATMENT; EMBOLIZATION	OBJECTIVE: An optimal microcatheter is necessary for successful coiling of an intracranial aneurysm. The optimal shape may be predetermined before the endovascular surgery via the use of a 3-dimensional (3D) printing rapid prototyping technology. We report a preliminary series of intracranial aneurysms treated with a microcatheter shape determined by the patient's anatomy and configuration of the aneurysm, which was fabricated with a 3D printer aneurysm model. METHODS: A solid aneurysm model was fabricated with a 3D printer based on the data acquired from the 3D rotational angiogram. A hollow aneurysm model with an identical vessel and aneurysm lumen to the actual anatomy was constructed with use of the solid model as a mold. With use of the solid model, a microcatheter shaping mandrel was formed to identically line the 3D curvature of the parent vessel and the long axis of the aneurysm. With use of the mandrel, a test microcatheter was shaped and validated for the accuracy with the hollow model. All the planning processes were undertaken at least 1 day before treatment. The preshaped mandrel was then applied in the endovascular procedure. Ten consecutive intracranial aneurysms were coiled with the pre-planned shape of the microcatheter and evaluated for the clinical and anatomical outcomes and microcatheter accuracy and stability. RESULTS: All of pre-planned microcatheters matched the vessel and aneurysm anatomy. Seven required no microguidewire assistance in catheterizing the aneurysm whereas 3 required guiding of a microguidewire. All of the microcatheters accurately aligned the long axis of the aneurysm. The pre-planned microcatheter shapes demonstrated stability in all except in 1 large aneurysm case. CONCLUSION: When a 3D printing rapid type prototyping technology is used, a patient-specific and optimal microcatheter shape may be determined preoperatively.	[Namba, Katsunari] Jichi Med Univ, Div Neuroendovasc Surg, Ctr Endovasc Therapy, Mibu, Tochigi, Japan; [Higaki, Ayuho; Kaneko, Naoki; Mashiko, Toshihiro; Watanabe, Eiju] Jichi Med Univ, Dept Neurosurg, Mibu, Tochigi, Japan; [Nemoto, Shigeru] Tokyo Med & Dent Univ, Dept Endovasc Surg, Tokyo, Japan	Namba, K (reprint author), Jichi Med Univ, Div Neuroendovasc Surg, Ctr Endovasc Therapy, Mibu, Tochigi, Japan.	knamba@jichi.ac.jp					Wurm G, 2004, J NEUROSURG, V100, P139, DOI 10.3171/jns.2004.100.1.0139; Kimura T, 2009, NEUROSURGERY, V65, P719, DOI 10.1227/01.NEU.0000354350.88899.07; Murayama Y, 2003, J NEUROSURG, V98, P959, DOI 10.3171/jns.2003.98.5.0959; Roy D, 2001, STROKE, V32, P1998, DOI 10.1161/hs0901.095600; Kwon BJ, 2010, NEUROSURGERY, V67, P34, DOI 10.1227/01.NEU.0000370891.67129.2F; GUGLIELMI G, 1992, J NEUROSURG, V77, P515, DOI 10.3171/jns.1992.77.4.0515; Spottiswoode BS, 2013, STEREOT FUNCT NEUROS, V91, P162, DOI 10.1159/000345264; Muller A, 2003, J CRANIOFAC SURG, V14, P899; Hwang JH, 2011, NEURORADIOLOGY, V53, P349, DOI 10.1007/s00234-010-0735-0; Kalejs M, 2008, INTERACT CARDIOV TH, V8, P182, DOI 10.1510/icvts.2008.194134; Mashiko T, 2015, WORLD NEUROSURG, V83, P351, DOI 10.1016/j.wneu.2013.10.032	11	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JUL	2015	84	1					178	186		10.1016/j.wneu.2015.03.006		9	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CK5DK	WOS:000356242200030		
J	Ogawa, H; Kamada, K				Ogawa, Hiroshi; Kamada, Kyousuke			The Road to Nonawaking Functional Mapping Combining High Gamma Activity with Corticocortical Evoked Potential	WORLD NEUROSURGERY			English	Letter									[Ogawa, Hiroshi; Kamada, Kyousuke] Asahikawa Med Univ, Grad Sch Med, Dept Neurosurg, Asahikawa, Hokkaido, Japan	Kamada, K (reprint author), Asahikawa Med Univ, Grad Sch Med, Dept Neurosurg, Asahikawa, Hokkaido, Japan.	kamady-k@umin.ac.jp					Matsumoto R, 2004, BRAIN, V127, P2316, DOI 10.1093/brain/awh246; Ogawa H, 2014, WORLD NEUROSURG, V82	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JUL	2015	84	1					187	188		10.1016/j.wneu.2015.03.046		3	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CK5DK	WOS:000356242200032		
J	Hoshino, G; Ozawa, T				Hoshino, Gaku; Ozawa, Tohru			ANALYTIC SMOOTHING EFFECT FOR A SYSTEM OF SCHRODINGER EQUATIONS WITH TWO WAVE INTERACTION	ADVANCES IN DIFFERENTIAL EQUATIONS			English	Article							EVOLUTION-EQUATIONS; GLOBAL-SOLUTIONS; SCATTERING; EXISTENCE; NONLINEARITY; OPERATORS; SPACES; ORDER	We study the global Cauchy problem for a system of Schrodinger equations with two wave interaction of quadratic, cubic and quintic degrees. For sufficiently small data with exponential decay at infinity we prove the existence and uniqueness of global solutions which are analytic with respect to Galilei and/or pseudo-conformal generators for sufficiently small data with exponential decay at infinity. This paper is a sequel to our paper [22], where three wave interaction is studied. We also discuss the associated Lagrange structure.	[Hoshino, Gaku; Ozawa, Tohru] Waseda Univ, Dept Appl Phys, Tokyo 1698555, Japan	Hoshino, G (reprint author), Waseda Univ, Dept Appl Phys, Tokyo 1698555, Japan.						Ozawa T, 2010, J MATH ANAL APPL, V364, P492, DOI 10.1016/j.jmaa.2009.09.033; HAYASHI N, 1989, J FUNCT ANAL, V85, P307, DOI 10.1016/0022-1236(89)90039-6; Hoshino G, 2014, J MATH ANAL APPL, V419, P285, DOI 10.1016/j.jmaa.2014.04.057; DEBOUARD A, 1993, J DIFFER EQUATIONS, V104, P196, DOI 10.1006/jdeq.1993.1069; KATO T, 1986, ANN I H POINCARE-AN, V3, P455; Bona JL, 2006, J DIFFER EQUATIONS, V229, P186, DOI 10.1016/j.jde.2006.04.013; Robbiano L, 1999, DUKE MATH J, V100, P93, DOI 10.1215/S0012-7094-99-10003-2; Ozawa T, 2009, MATH Z, V261, P511, DOI 10.1007/s00209-008-0334-5; Kato K, 1996, OSAKA J MATH, V33, P863; CAZENAVE T, 1989, LECT NOTES MATH, V1394, P18; Nakanishi K, 2002, NODEA-NONLINEAR DIFF, V9, P45, DOI 10.1007/s00030-002-8118-9; Nakamura M, 1997, REV MATH PHYS, V9, P397; Hayashi N, 2012, COMMUN PART DIFF EQ, V37, P947, DOI 10.1080/03605302.2012.668256; STRICHARTZ RS, 1977, DUKE MATH J, V44, P705, DOI 10.1215/S0012-7094-77-04430-1; Nakanishi K, 2001, SIAM J MATH ANAL, V32, P1265, DOI 10.1137/S0036141000369083; HAYASHI N, 1990, ANN I H POINCARE-PHY, V52, P163; Hayashi N, 2011, DIFFER INTEGRAL EQU, V24, P417; HAYASHI N, 1990, COMMUN MATH PHYS, V129, P27, DOI 10.1007/BF02096777; Kato T, 1995, J ANAL MATH, V67, P281, DOI 10.1007/BF02787794; Robbiano L, 2000, COMMUN PART DIFF EQ, V25, P1891, DOI 10.1080/03605300008821571; SIMON JCH, 1985, COMMUN MATH PHYS, V99, P541, DOI 10.1007/BF01215909; HAYASHI N, 1988, ANN I H POINCARE-PHY, V48, P17; Ozawa T, 2005, OSAKA J MATH, V42, P737; Nakamitsu K, 2005, COMMUN MATH PHYS, V260, P117, DOI 10.1007/s00220-005-1405-7; Hayashi N, 2013, ANN I H POINCARE-AN, V30, P661, DOI 10.1016/j.anihpc.2012.10.007; Hayashi N, 1997, COMMUN MATH PHYS, V184, P273, DOI 10.1007/s002200050061; Keel M, 1998, AM J MATH, V120, P955, DOI 10.1353/ajm.1998.0039; GINIBRE J, 1994, ANN I H POINCARE-PHY, V60, P211; BONY JM, 1981, ANN SCI ECOLE NORM S, V14, P209; Cazenave T, 2003, COURANT LECT NOTES M, V10; Ginibre J., 1998, INTRO EQUATIONS SCHR; HAYASHI N, 1992, PHYSICA D, V55, P14, DOI 10.1016/0167-2789(92)90185-P; Hayashi N., 2011, DIFFER EQU APPL, V3, P415; Hoshino G., SPACE TIME ANAL SMOO; Hoshino G., ANAL SMOOTHING EFFEC; Hoshino G., 2013, DIFFER EQU APPL, V5, P395; Hoshino G., 2014, OSAKA J MATH, V51, P609; KATO T, 1987, ANN I H POINCARE-PHY, V46, P113; Kozono H, 2003, KYUSHU J MATH, V57, P303, DOI 10.2206/kyushujm.57.303; Nakamura M, 1998, J FUNCT ANAL, V155, P364, DOI 10.1006/jfan.1997.3236; Ogawa T., 2013, RIMS KOKYUROKU BESSA, V42, P153; Reed M., 1975, METHOD MATH PHYS; Stein E.M., 1971, INTRO FOURIER ANAL E; Sulem C., 1999, APPL MATH SCI, V139; Takuwa H., 2004, TSUKUBA J MATH, V28, P1; Tsutsumi Y., 1987, FUNK EKVA, V30, P115; YAJIMA K, 1987, COMMUN MATH PHYS, V110, P415, DOI 10.1007/BF01212420	47	0	0	KHAYYAM PUBL CO INC	ATHENS	PO BOX 429, ATHENS, OH 45701 USA	1079-9389			ADV DIFFERENTIAL EQU	Adv. Differ. Equat.	JUL-AUG	2015	20	7-8					697	716				20	Mathematics, Applied; Mathematics	Mathematics	CJ8TP	WOS:000355776700004		
J	Karim, C; Misawa, M				Karim, Corina; Misawa, Masashi			HOLDER REGULARITY FOR SINGULAR PARABOLIC SYSTEMS OF p-LAPLACIAN TYPE	ADVANCES IN DIFFERENTIAL EQUATIONS			English	Article								We study the regularity for nonlinear parabolic systems of p-Laplacian type, in the singular case 2m/m+2 < p < 2. We show an optimal condition on given external forces for a local Holder continuity. Actually, our main result recovers the classical one for linear equations. The proof is based on Campanato's direct approach with the intrinsic scaling to the evolutionary p-Laplace operator. The iteration scheme is performed similarly as in [18], however, with some technical care peculiar to the singular case.	[Karim, Corina; Misawa, Masashi] Kumamoto Univ, Grad Sch Sci & Technol, Dept Math, Kumamoto, Kumamoto 808555, Japan	Karim, C (reprint author), Brawijaya Univ, Fac Math & Nat Sci, Dept Math, Veteran 65145, Malang, Indonesia.				Directorate General of Higher Education Ministry of Education and Culture [1244/E4.4/K/2012]; Japan Society for the Promotion of Science [24540215]	Partially supported by Directorate General of Higher Education Ministry of Education and Culture No. 1244/E4.4/K/2012; Partially supported by the Grant-in-Aid for Scientific Research (C) No. 24540215 at Japan Society for the Promotion of Science	CHEN YZ, 1992, ARCH RATION MECH AN, V118, P257; Misawa M, 2013, J DIFFER EQUATIONS, V254, P847, DOI 10.1016/j.jde.2012.10.001; CHEN YZ, 1989, J REINE ANGEW MATH, V395, P102; Bogelein V, 2012, MATH Z, V270, P903, DOI 10.1007/s00209-010-0832-0; Bogelein V, 2013, MEM AM MATH SOC, V221, P1, DOI 10.1090/S0065-9266-2012-00664-2; CAMPANATO S, 1984, ANN MAT PUR APPL, V137, P83, DOI 10.1007/BF01789390; Campanato S., 1966, ANN MAT PUR APPL, V73, P55, DOI 10.1007/BF02415082; Choe H., 1992, NONLINEAR ANAL, V8, P235; Da Prato G., 1965, ANN MAT PUR APPL, V69, P383; Di Benedetto E., 1986, ANN SCU NORM SUP PIS, V13, P487; Dibenedetto E., 1993, DEGENERATE PARABOLIC; Duzaar F, 2005, ANN I H POINCARE-AN, V22, P705, DOI 10.1016/j.anihpc.2004.10.011; Duzaar F, 2011, MEM AM MATH SOC, V214, pIX, DOI 10.1090/S0065-9266-2011-00614-3; Giaquinta M, 1983, ANN MATH STUD, V105; Gilbarg D., 1983, ELLIPTIC PARTIAL DIF; Giusti E., 2005, DIRECT METHODS CALCU; Ladyzhenskaya O. A., 1968, TRANSL MATH MONOGR, V23; Misawa M, 2002, MANUSCRIPTA MATH, V109, P419, DOI 10.1007/s00229-002-0296-6; Scheven C, 2011, REV MAT IBEROAM, V27, P751	19	0	0	KHAYYAM PUBL CO INC	ATHENS	PO BOX 429, ATHENS, OH 45701 USA	1079-9389			ADV DIFFERENTIAL EQU	Adv. Differ. Equat.	JUL-AUG	2015	20	7-8					741	772				32	Mathematics, Applied; Mathematics	Mathematics	CJ8TP	WOS:000355776700006		
J	Kobayashi, Y; Tamaki, H				Kobayashi, Yasuaki; Tamaki, Hisao			A Fast and Simple Subexponential Fixed Parameter Algorithm for One-Sided Crossing Minimization	ALGORITHMICA			English	Article						Fixed parameter algorithm; Graph drawing; Subexponential time	COMPLEXITY; GRAPHS	We give a subexponential fixed parameter algorithm for one-sided crossing minimization. It runs in time, where n is the number of vertices of the given graph and parameter k is the number of crossings. The exponent of in this bound is asymptotically optimal assuming the Exponential Time Hypothesis and the previously best known algorithm runs in time. We achieve this significant improvement by the use of a certain interval graph naturally associated with the problem instance and a simple dynamic program on this interval graph. The linear dependency on n is also achieved through the use of this interval graph.	[Kobayashi, Yasuaki; Tamaki, Hisao] Meiji Univ, Kawasaki, Kanagawa, Japan	Kobayashi, Y (reprint author), Meiji Univ, Kawasaki, Kanagawa, Japan.	yasu0207@cs.meiji.ac.jp					Ailon N, 2008, J ACM, V55, DOI 10.1145/1411509.1411513; Karpinski M, 2010, LECT NOTES COMPUT SC, V6506, P3, DOI 10.1007/978-3-642-17517-6_3; EADES P, 1994, ALGORITHMICA, V11, P379, DOI 10.1007/BF01187020; SUGIYAMA K, 1981, IEEE T SYST MAN CYB, V11, P109, DOI 10.1109/TSMC.1981.4308636; Impagliazzo R, 2001, J COMPUT SYST SCI, V62, P367, DOI 10.1006/jcss.2000.1727; Impagliazzo R, 2001, J COMPUT SYST SCI, V63, P512, DOI 10.1006/jcss.2001.1774; Dujmovic V, 2004, ALGORITHMICA, V40, P15, DOI 10.1007/s00453-004-1093-2; Alon N, 2009, LECT NOTES COMPUT SC, V5555, P49, DOI 10.1007/978-3-642-02927-1_6; Munoz X, 2002, LECT NOTES COMPUT SC, V2265, P115; Bodlaender H. L., 1993, Acta Cybernetica, V11; Downey R., 1998, PARAMETERIZED COMPLE; Dujmovic V., 2008, J DISCRETE ALGORITHM, V6, P313, DOI 10.1016/j.jda.2006.12.008; Fernau H., 2010, LNCS, V6460, P337; Karp R., 1972, COMPLEXITY COMPUTER, P85, DOI DOI 10.1007/978-1-4684-2001-2_; Kenyon-Mathieu C., 2007, P 39 ANN ACM S THEOR, P95; Kobayashi Y, 2012, LECT NOTES COMPUT SC, V7501, P683, DOI 10.1007/978-3-642-33090-2_59; Lokshtanov Daniel, 2011, Bulletin of the European Association for Theoretical Computer Science, V105; Nagamochi H., 2005, DISCRETE COMPUT GEOM, V33, P569, DOI 10.1007/s00454-005-1168-0; Nagamochi H, 2005, THEOR COMPUT SCI, V332, P417, DOI 10.1016/j.tcs.2004.10.042	19	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0178-4617	1432-0541		ALGORITHMICA	Algorithmica	JUL	2015	72	3					778	790		10.1007/s00453-014-9872-x		13	Computer Science, Software Engineering; Mathematics, Applied	Computer Science; Mathematics	CK1BG	WOS:000355939800005		
J	Ogihara, S; Saito, R; Akikura, T; Iwama, A; Adachi, Y; Kaji, D; Kakinuma, K; Takahashi, H				Ogihara, Shinji; Saito, Ryoichi; Akikura, Teru; Iwama, Akiko; Adachi, Yukari; Kaji, Daiki; Kakinuma, Kyoka; Takahashi, Hiroshi			Characterization of Mucoid and Non-Mucoid Streptococcus pneumoniae Isolated From Outpatients	ANNALS OF LABORATORY MEDICINE			English	Article						Streptococcus pneumoniae; Mucoid colony; Antimicrobial susceptibility	PSEUDOMONAS-AERUGINOSA; CYSTIC-FIBROSIS; ANTIBIOTIC-RESISTANCE; SURVEILLANCE; VIRULENCE	Background: Streptococcus pneumoniae causes pneumonia, sepsis, and meningitis. This study aimed to investigate the clinical characteristics of mucoid and non-mucoid isolates of S. pneumoniae, and to explore the relationship between the isolate phenotypes and their antibiotic susceptibility. Methods: Clinical isolates from 3,453 non-repetitive S. pneumoniae (189 mucoid and 3,264 non-mucoid) infections obtained between January 2008 and December 2012 from outpatients at the Kimitsu-Central Hospital were evaluated. Results: Compared to the non-mucoid isolates, the mucoid phenotypes were more susceptible to certain antibiotics such as erythromycin, clarithromycin, and tetracycline as opposed to clindamycin, chloramphenicol, and rifampicin. The mucoid phenotype was isolated more frequently from schoolchildren, adults, and elderly adults in a variety of clinical sites, including otorrhea, genitalia, pus, and eye discharge than the non-mucoid phenotype. This suggested that mucoid isolates are more likely to be involved than non-mucoid isolates in various local infections. Systemic infection, which indicates invasiveness, was not associated with the mucoid or non-mucoid phenotype. Conclusions: The results of this study suggest that mucoid isolates tend to have higher susceptibility than non-mucoid isolates to antibiotics. To the best of our knowledge, mucoid and non-mucoid S. pneumoniae isolates considerably differ in terms of clinical isolation site and age-specific prevalence.	[Ogihara, Shinji] Tokyo Med & Dent Univ, Hosp Med, Dept Clin Lab, Tokyo 1138510, Japan; [Saito, Ryoichi] Tokyo Med & Dent Univ, Grad Sch Hlth Care Sci, Dept Microbiol & Immunol, Tokyo 1138510, Japan; [Akikura, Teru; Iwama, Akiko; Adachi, Yukari; Kaji, Daiki; Kakinuma, Kyoka; Takahashi, Hiroshi] Kimitsu Cent Hosp, Dept Clin Lab, Chiba, Japan	Ogihara, S (reprint author), Tokyo Med & Dent Univ, Hosp Med, Dept Clin Lab, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.	ogihara.shi@gmail.com					Adam D, 2002, J ANTIMICROB CHEMOTH, V50, P1, DOI 10.1093/jac/dkf801; Pastor P, 1998, CLIN INFECT DIS, V26, P590, DOI 10.1086/514589; Gryllos I, 2008, P NATL ACAD SCI USA, V105, P16755, DOI 10.1073/pnas.0803815105; Kim JO, 1998, J INFECT DIS, V177, P368; Chiba N, 2013, MICROB DRUG RESIST, V19, P308, DOI 10.1089/mdr.2012.0180; Song JH, 2004, ANTIMICROB AGENTS CH, V48, P2101, DOI 10.1128/AAC.48.6.2101-2107.2004; Ciofu O, 2001, J ANTIMICROB CHEMOTH, V48, P391, DOI 10.1093/jac/48.3.391; Baquero F, 1995, MICROB DRUG RESIST, V1, P115, DOI 10.1089/mdr.1995.1.115; Clinical and laboratory standard institute, 2014, M100S24 CLIN LAB STA; FINE MJ, 1990, AM J MED, V88, pN1; HENRICHSEN J, 1995, J CLIN MICROBIOL, V33, P2759; Kakuta R, 2014, TOHOKU J EXP MED, V232, P301; Mason EO, 2000, J ANTIMICROB CHEMOTH, V45, P623, DOI 10.1093/jac/45.5.623; Richter SS, 2008, J CLIN MICROBIOL, V46, P2184, DOI 10.1128/JCM.00461-08; Shawar RM, 1999, ANTIMICROB AGENTS CH, V43, P2877; SPEERT DP, 1990, J CLIN MICROBIOL, V28, P188; Versalovic J, 2011, MANUAL CLIN MICROBIO, V10th, P331	17	0	0	KOREAN SOC LABORATORY MEDICINE	SEOUL	KOREAN MEDICAL ASSOC BLDG, RM 602,302-75 ICHON 1-DONG, YONGSAN-GU, SEOUL, 140-721, SOUTH KOREA	2234-3806	2234-3814		ANN LAB MED	Ann. Lab. Med.	JUL	2015	35	4					410	415		10.3343/alm.2015.35.4.410		6	Medical Laboratory Technology	Medical Laboratory Technology	CJ6BB	WOS:000355576900004		
J	Charoensopharat, K; Thanonkeo, P; Thanonkeo, S; Yamada, M				Charoensopharat, Kanlayani; Thanonkeo, Pornthap; Thanonkeo, Sudarat; Yamada, Mamoru			Ethanol production from Jerusalem artichoke tubers at high temperature by newly isolated thermotolerant inulin-utilizing yeast Kluyveromyces marxianus using consolidated bioprocessing	ANTONIE VAN LEEUWENHOEK INTERNATIONAL JOURNAL OF GENERAL AND MOLECULAR MICROBIOLOGY			English	Article						Ethanol production; Jerusalem artichoke; Kluyveromyces marxianus; Thermotolerant yeast; Consolidated bioprocessing	SACCHAROMYCES-CEREVISIAE; BIOETHANOL PRODUCTION; FERMENTATION; EXPRESSION; GENE; DNA; MICROORGANISMS; METABOLISM; HYDROLYSIS; VIABILITY	Thermotolerant inulin-utilizing yeast strains were successfully isolated in this study. Among the isolated strains, Kluyveromyces marxianus DBKKU Y-102 was found to be the most effective strain for direct ethanol fermentation at high temperature from fresh Jerusalem artichoke (JA) tubers without inulin hydrolysis under consolidated bioprocessing (CBP). The maximum ethanol concentrations produced by this strain under the optimum culture conditions were 104.83 and 97.46 g L-1 at 37 and 40 A degrees C, respectively. Data from this study clearly demonstrated that the use of thermotolerant inulin-utilizing yeast K. marxianus for ethanol production from fresh JA tubers in the CBP process not only provided high levels of ethanol, but also could eliminate the addition of external enzyme for inulin hydrolysis, which might lead to the reduction of operating costs. The expression of genes involved in carbohydrate metabolism in K. marxianus DBKKU Y-102 during ethanol fermentation was investigated by real-time RT-PCR, and the results revealed that expression levels were distinctive depending on the growth phase and growth conditions. However, among the genes tested, adh4 and tdh2 were highly expressed under high temperature conditions in both exponential- and stationary-growth phases, suggesting that these genes might play a crucial role in acquiring thermotolerance ability in this organism under stress conditions.	[Charoensopharat, Kanlayani; Thanonkeo, Pornthap] Khon Kaen Univ, Fac Technol, Dept Biotechnol, Khon Kaen 40002, Thailand; [Thanonkeo, Pornthap] Khon Kaen Univ, Fermentat Res Ctr Value Added Agr Prod FerVAAP, Khon Kaen 40002, Thailand; [Thanonkeo, Sudarat] Mahasarakham Univ, Walai Rukhavej Bot Res Inst, Maha Sarakham 44150, Thailand; [Yamada, Mamoru] Yamaguchi Univ, Dept Biol Chem, Fac Agr, Yamaguchi 7538515, Japan	Thanonkeo, P (reprint author), Khon Kaen Univ, Fac Technol, Dept Biotechnol, Khon Kaen 40002, Thailand.	portha@kku.ac.th			Office of the Higher Education Commission, Thailand; National Research University (NRU) Project of Khon Kaen University [NRU543048]	This research was supported by the program of Strategic Scholarships for Frontier Research Network for the Ph.D. Program Thai Doctoral degree from the Office of the Higher Education Commission, Thailand. Apart of this works was also supported by the National Research University (NRU) Project of Khon Kaen University for P. Thanonkeo under the Project Number NRU543048.	Alexandre H, 1998, J IND MICROBIOL BIOT, V20, P20, DOI 10.1038/sj.jim.2900442; Anasontzis GE, 2011, J BIOTECHNOL, V152, P16, DOI 10.1016/j.jbiotec.2011.01.002; Huang J, 2011, BIORESOURCE TECHNOL, V102, P3923, DOI 10.1016/j.biortech.2010.11.112; Fonseca GG, 2008, APPL MICROBIOL BIOT, V79, P339, DOI 10.1007/s00253-008-1458-6; Kurtzman CP, 1998, ANTON LEEUW INT J G, V73, P331, DOI 10.1023/A:1001761008817; Razmovski RN, 2011, ROM BIOTECH LETT, V16, P6497; Okamoto K, 2011, ENZYME MICROB TECH, V48, P273, DOI 10.1016/j.enzmictec.2010.12.001; Negro MJ, 2006, APPL BIOCHEM BIOTECH, V132, P922, DOI 10.1385/ABAB:132:1:922; Lim SH, 2011, BIORESOURCE TECHNOL, V102, P2109, DOI 10.1016/j.biortech.2010.08.044; Olsson L, 1996, ENZYME MICROB TECH, V18, P312, DOI 10.1016/0141-0229(95)00157-3; Walter S, 2002, ANGEW CHEM INT EDIT, V41, P1098, DOI 10.1002/1521-3773(20020402)41:7<1098::AID-ANIE1098>3.0.CO;2-9; Chi ZM, 2009, APPL MICROBIOL BIOT, V82, P211, DOI 10.1007/s00253-008-1827-1; BARTHOMEUF C, 1991, J FERMENT BIOENG, V72, P491, DOI 10.1016/0922-338X(91)90063-M; Bai FW, 2004, J BIOTECHNOL, V110, P287, DOI 10.1016/j.jbiotec.2004.01.017; Silalertruksa T, 2010, ENERG POLICY, V38, P7476, DOI 10.1016/j.enpol.2010.08.034; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Zhang T, 2010, BIORESOURCE TECHNOL, V101, P8166, DOI 10.1016/j.biortech.2010.06.013; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Zhao CH, 2010, PROCESS BIOCHEM, V45, P1121, DOI 10.1016/j.procbio.2010.04.002; Limtong S, 2007, BIORESOURCE TECHNOL, V98, P3367, DOI 10.1016/j.biortech.2006.10.044; THOMAS KC, 1990, APPL ENVIRON MICROB, V56, P2046; Kusch H, 2008, INT J MED MICROBIOL, V298, P291, DOI 10.1016/j.ijmm.2007.03.020; Pratt PL, 2003, J I BREWING, V109, P218; BANAT IM, 1992, WORLD J MICROB BIOT, V8, P259, DOI 10.1007/BF01201874; Nonklang S, 2008, APPL ENVIRON MICROB, V74, P7514, DOI 10.1128/AEM.01854-08; Pereira FB, 2010, BIORESOURCE TECHNOL, V101, P7856, DOI 10.1016/j.biortech.2010.04.082; Hu N, 2012, APPL MICROBIOL BIOT, V95, P1359, DOI 10.1007/s00253-012-4240-8; Narendranath NV, 2005, APPL ENVIRON MICROB, V71, P2239, DOI 10.1128/AEM.71.5.2239-2243.2005; INGRAM LO, 1984, ADV MICROB PHYSIOL, V25, P253; Laopaiboon L, 2007, WORLD J MICROB BIOT, V23, P1497, DOI 10.1007/s11274-007-9383-x; Jin MJ, 2011, BIOTECHNOL BIOENG, V108, P1290, DOI 10.1002/bit.23059; Auesukaree C, 2012, J BIOSCI BIOENG, V114, P144, DOI 10.1016/j.jbiosc.2012.03.012; Lynd LR, 2005, CURR OPIN BIOTECH, V16, P577, DOI 10.1016/j.copbio.2005.08.009; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Yuan WJ, 2008, J APPL MICROBIOL, V105, P2076, DOI 10.1111/j.1365-2672.2008.03903.x; Birch RM, 2000, ENZYME MICROB TECH, V26, P678, DOI 10.1016/S0141-0229(00)00159-9; Castro RG, 1995, J MICROBIOL METH, V22, P51; CHUBEY BB, 1974, CAN I FOOD SC TECH J, V7, P98; COOPER TG, 1979, J BACTERIOL, V137, P1447; Dorell DG, 1977, CAN J PLANT SCI, V57, P591; Ge XY, 2005, FOOD TECHNOL BIOTECH, V43, P241; Ge XY, 2010, J MICROBIOL BIOTECHN, V20, P101, DOI 10.4014/jmb.0905.05032; GRUBB CF, 1993, BIOTECHNOL LETT, V15, P621, DOI 10.1007/BF00138552; Harju S, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-8; Hashem M., 2013, African Journal of Microbiology Research, V7, P4550; Ingledew WM, 1999, ALCOHOL TXB, P49; Kurtzman CP, 1998, YEASTS TAXONOMIC STU; Lertwattanasakul N, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0227-x; Lertwattanasakul N, 2011, AMB EXPRESS, V1, DOI 10.1186/2191-0855-1-20; Lertwattanasakul N, 2007, BIOSCI BIOTECH BIOCH, V71, P1170, DOI 10.1271/bbb.60622; Liang JJ, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/1472-6750-14-45; MCCRACKEN LD, 1982, BIOTECHNOL BIOENG, P91; Nuanpeng S, 2011, ELECT J BIOTECHNOL, V14; ODONNELL K, 1993, FUNGAL HOLOMORPH : MITOTIC, MEIOTIC AND PLEOMORPHIC SPECIATION IN FUNGAL SYSTEMATICS, P225; Ozmihci S, 2007, LETT APPL MICROBIOL, V44, P602, DOI 10.1111/j.1472-765X.2007.02132.x; Russell I, 2003, ALCOHOL TXB, P85; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Sootsuwan K, 2007, OPEN BIOTECHNOL J, V1, P52; Sree NK, 2000, BIORESOURCE TECHNOL, V72, P43, DOI 10.1016/S0960-8524(99)90097-4; SUMRADA R, 1978, J GEN MICROBIOL, V108, P45; Suranto Mustofa A, 2009, NUSANTARA BIOSCI, V1, P105; SWANTON CJ, 1992, CAN J PLANT SCI, V72, P1367; Szambelan K, 2005, ENG LIFE SCI, V5, P68, DOI 10.1002/elsc.200400052; Szambelan K., 2004, Acta Scientiarum Polonorum - Technologia Alimentaria, V3, P45; Thanonkeo P, 2011, AFR J BIOTECHNOL, V10, P10691; Thanonkeo P, 2010, AFR J BIOTECHNOL, V9, P3242; Thanonkeo P., 2007, BIOTECHNOLOGY, V6, P112, DOI [10.3923/biotech.2007.112.119, DOI 10.3923/BIOTECH.2007.112.119]; WALKER GM, 1994, CRIT REV BIOTECHNOL, V14, P311, DOI 10.3109/07388559409063643; Yee KL, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-75; Ying Z, 2010, J MICROBIOL BIOTECHN, V20, P1156, DOI [10.4014/jmb.0912.12036, DOI 10.4014/JMB.0912.12036]; Yuan WJ, 2011, J APPL MICROBIOL, V112, P38; Yuan WJ, 2010, J BIOTECHNOL, V150, pS367, DOI 10.1016/j.jbiotec.2010.09.435; ZOECKLEIN B.W., 1995, WINE ANAL PRODUCTION	73	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0003-6072	1572-9699		ANTON LEEUW INT J G	Antonie Van Leeuwenhoek	JUL	2015	108	1					173	190		10.1007/s10482-015-0476-5		18	Microbiology	Microbiology	CJ8KE	WOS:000355748200017		
J	Hamada, M; Shibata, C; Nurkanto, A; Ratnakomala, S; Lisdiyanti, P; Tamura, T; Suzuki, K				Hamada, Moriyuki; Shibata, Chiyo; Nurkanto, Arif; Ratnakomala, Shanti; Lisdiyanti, Puspita; Tamura, Tomohiko; Suzuki, Ken-ichiro			Tropicihabitans flavus gen. nov., sp. nov., a new member of the family Cellulomonadaceae (vol 107, pg 1299, 2015)	ANTONIE VAN LEEUWENHOEK INTERNATIONAL JOURNAL OF GENERAL AND MOLECULAR MICROBIOLOGY			English	Correction									[Hamada, Moriyuki; Shibata, Chiyo; Tamura, Tomohiko; Suzuki, Ken-ichiro] Natl Inst Technol & Evaluat NBRC, Biol Resource Ctr, Kisarazu, Chiba 2920818, Japan; [Nurkanto, Arif; Ratnakomala, Shanti; Lisdiyanti, Puspita] Indonesian Inst Sci LIPI, Cibinong 16911, Indonesia	Hamada, M (reprint author), Natl Inst Technol & Evaluat NBRC, Biol Resource Ctr, 2-5-8 Kazusakamatari, Kisarazu, Chiba 2920818, Japan.	hamada-moriyuki@nite.go.jp					Hamada M, 2015, ANTON LEEUW INT J G, V107, P1299, DOI 10.1007/s10482-015-0424-4	1	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0003-6072	1572-9699		ANTON LEEUW INT J G	Antonie Van Leeuwenhoek	JUL	2015	108	1					221	221		10.1007/s10482-015-0474-7		1	Microbiology	Microbiology	CJ8KE	WOS:000355748200021		
J	Ohara, RG; Ushimaru, A				Ohara, Ryohei G.; Ushimaru, Atushi			Plant beta-diversity is enhanced around grassland-forest edges within a traditional agricultural landscape	APPLIED VEGETATION SCIENCE			English	Article						Alpha-and beta-diversity; Forest edge; Light conditions; Resource heterogeneity; Semi-natural grassland; Soil moisture	VEGETATION; MICROCLIMATES; MANAGEMENT; ECOTONES; JAPAN; WATER	QuestionsAre there positive edge effects on beta- and alpha-diversity of plant species across semi-natural grassland-secondary forest gradients located within a traditional agricultural landscape? Is beta-diversity (dissimilarity in plant species composition between two given plots) well explained by environmental differences for both grasslands and forests? Do gradients of environmental factors created by forest edges influence spatial variation in alpha-diversity from edges to grasslands and forests? LocationSemi-natural grasslands and secondary forests (or conifer plantation) around paddy fields in a traditional agricultural landscape, western Japan. MethodsVegetation survey and environmental (soil water content and sunlight) measurements were conducted on 11 transects passing through grassland-forest ecosystems. Spatial variations in plant beta- and alpha-diversity and environmental variables and their relationships were examined. ResultsWe quantitatively demonstrated common positive edge effects on beta-diversity in both grasslands and forests. Our results suggest that among-edge variations in light conditions, which likely depend on edge aspect and forest type, promote high grassland plant beta-diversity in the vicinity of edges. However, the high beta-diversity of forest floor communities in the proximity of edges cannot be explained by this mechanism. Alpha-diversity tended to be lower within grassland plots located around edges than in grassland interiors, while the richness of the forest community increased toward the edge. This alpha-diversity pattern was suggested to be attributable to resource gradients created by the forest edges. ConclusionsAlthough plant alpha-diversity may not be consistently high in the vicinity of edges, beta-diversity in the communities bordering grassland-forest edges will generally be high in the traditional agricultural landscape. Thus, maintenance of environmental heterogeneity among grassland-forest edges in agricultural ecosystems should be prioritized for local biodiversity conservation.	[Ohara, Ryohei G.; Ushimaru, Atushi] Kobe Univ, Grad Sch Human Dev & Environm, Kobe, Hyogo 6578501, Japan	Ushimaru, A (reprint author), Kobe Univ, Grad Sch Human Dev & Environm, 3-11 Tsurukabuto, Kobe, Hyogo 6578501, Japan.	ryohei.g.ohara@gmail.com; ushimaru@kobe-u.ac.jp			Japan Society for the Promotion of Science [20770015, 23570024]	We thank all landowners for their hospitality, allowing us to investigate vegetation of the sites, Yoshiaki Takeda for considerable support in species identification, Masayoshi K. Hiraiwa, Takeshi Osawa and Yasuoki Takami for helping with statistical analyses, and Yuta Uematsu for field surveys. Dr. Vincent Pellissier and an anonymous reviewer gave us many constructive comments on the manuscript during the reviewing process. We also thank the members of the Biodiversity Laboratory and Evolutionary Ecology Laboratory of Kobe University for their valuable support. We do not have any conflict of interest. This research was supported by Grant-in-Aid for young scientists B (No. 20770015) and Scientific Research C (No. 23570024) from the Japan Society for the Promotion of Science.	Anderson D.R., 2002, PRACTICAL INFORM THE; WIENS JA, 1976, ANNU REV ECOL SYST, V7, P81, DOI 10.1146/annurev.es.07.110176.000501; Koyanagi T, 2009, BIOL CONSERV, V142, P1674, DOI 10.1016/j.biocon.2009.03.002; Uematsu Y, 2013, ECOL APPL, V23, P1357, DOI 10.1890/12-1939.1; Clough Y, 2007, J APPL ECOL, V44, P804, DOI 10.1111/j.1365-2664.2007.01294.x; Uchida K, 2014, ECOL MONOGR, V84, P637, DOI 10.1890/13-2170.1; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Dickie IA, 2005, ECOL LETT, V8, P1191, DOI 10.1111/j.1461-0248.2005.00822.x; Peterson DW, 2008, PLANT ECOL, V194, P5, DOI 10.1007/s11258-007-9270-4; CHEN JQ, 1993, AGR FOREST METEOROL, V63, P219, DOI 10.1016/0168-1923(93)90061-L; KAPOS V, 1989, J TROP ECOL, V5, P173; Uematsu Y, 2010, AGR ECOSYST ENVIRON, V135, P304, DOI 10.1016/j.agee.2009.10.010; Ries L, 2004, ECOLOGY, V85, P2917, DOI 10.1890/03-8021; Ludwig F, 2004, PLANT ECOL, V170, P93, DOI 10.1023/B:VEGE.0000019023.29636.92; HARRIS LD, 1988, CONSERV BIOL, V2, P330, DOI 10.1111/j.1523-1739.1988.tb00196.x; MATLACK GR, 1993, BIOL CONSERV, V66, P185, DOI 10.1016/0006-3207(93)90004-K; Veech JA, 2010, ECOLOGY, V91, P1988, DOI 10.1890/09-1140.1; Muller SC, 2007, PLANT ECOL, V189, P1, DOI 10.1007/s11258-006-9162-z; YOUNG A, 1994, BIOL CONSERV, V67, P63, DOI 10.1016/0006-3207(94)90010-8; Avon C, 2010, FOREST ECOL MANAG, V259, P1546, DOI 10.1016/j.foreco.2010.01.031; Chabrerie O, 2013, J VEG SCI, V24, P58, DOI 10.1111/j.1654-1103.2012.01449.x; Fukamachi K, 2001, LANDSCAPE ECOL, V16, P703, DOI 10.1023/A:1014464909698; Godefroid S, 2006, PLANT ECOL, V185, P107, DOI 10.1007/s11258-005-9088-x; Laurance WF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001017; Lindborg B., 2014, BIOL CONSERV, V169, P206; Lloyd KM, 2000, J VEG SCI, V11, P903, DOI 10.2307/3236560; MATLACK GR, 1994, J ECOL, V82, P113, DOI 10.2307/2261391; Nagaike T, 2005, IN ST WA MA, V3, P371; Osawa T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079978; Scheider N. A., 2012, PLOS ONE, V7; uczaj, 1997, FOLIA GEOBOTANICA PH, V32, P343; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190; WILLIAMSLINERA G, 1990, J ECOL, V78, P356, DOI 10.2307/2261117	33	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1402-2001	1654-109X		APPL VEG SCI	Appl. Veg. Sci.	JUL	2015	18	3					493	502		10.1111/avsc.12166		10	Plant Sciences; Ecology; Forestry	Plant Sciences; Environmental Sciences & Ecology; Forestry	CK1ZB	WOS:000356007400014		
J	Noguchi, J; Tanaka, H; Koyanagi, A; Miyake, K; Hata, T				Noguchi, Junko; Tanaka, Hirokazu; Koyanagi, Aya; Miyake, Kaoru; Hata, Toshiyuki			Three-dimensional power Doppler indices at 18-22 weeks' gestation for prediction of fetal growth restriction or pregnancy-induced hypertension	ARCHIVES OF GYNECOLOGY AND OBSTETRICS			English	Article						Placental vascular sonobiopsy; Three-dimensional power Doppler ultrasound; Placental vascularization; Fetal growth restriction; Pregnancy-induced hypertension, gestational hypertension; Preeclampsia	PLACENTAL VASCULAR SONOBIOPSY; PREECLAMPSIA; ULTRASOUND	Background We assessed placental perfusion based on placental vascular sonobiopsy (PVS) at 18-22 weeks of gestation in a low-risk population to predict fetal growth restriction (FGR) or pregnancy-induced hypertension [PIH; gestational hypertension (GH) and preeclampsia (PE)]. Methods PVS using three-dimensional (3D) power Doppler ultrasound with the VOCAL imaging analysis program was performed in 226 pregnancies [FGR, 25; appropriate-for-gestational age (AGA) 191; and large-for-gestational age (LGA), 10] [PIH, 13 (GH, 7 and PE, 6) and non-PIH, 213] at 18-22 weeks of gestation. 3D power Doppler indices such as the vascularization index (VI), flow index (FI), and vascularization flow index (VFI) using PVS were calculated in each placenta. Results There were no significant differences in VI, FI, or VFI values among FGR, AGA, and LGA pregnancies. No significant differences in VI, FI, or VFI values between PHI and non-PIH pregnancies were noted. There were also no significant differences in VI, FI, or VFI values between GH and PE pregnancies. Conclusions 3D power Doppler placental vascular indices at 18-22 weeks could not be used to predict high-risk pregnancies that develop FGR or PIH in a low-risk population.	[Noguchi, Junko; Tanaka, Hirokazu; Hata, Toshiyuki] Kagawa Univ, Grad Sch Med, Dept Perinatol & Gynecol, Miki, Kagawa 7610793, Japan; [Noguchi, Junko] Kagawa Prefectural Coll Hlth Sci, Dept Nursing, Takamatsu, Kagawa 7610123, Japan; [Koyanagi, Aya; Miyake, Kaoru] Miyake Clin, Dept Obstet & Gynecol, Okayama 7000204, Japan	Hata, T (reprint author), Kagawa Univ, Grad Sch Med, Dept Perinatol & Gynecol, 1750-1 Ikenobe, Miki, Kagawa 7610793, Japan.	toshi28@med.kagawa-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [24119004, 25462561]	The work reported in this paper was supported by a Grant-in-Aid for Scientific Research on Innovative Areas "Constructive Developmental Science" (No. 24119004), and a Research Grant (No. 25462561) from The Ministry of Education, Culture, Sports, Science and Technology, Japan.	American College of Obstetricians and Gynecologists Committee on Practice Bulletins: Obstetrics, 2002, OBSTET GYNECOL, V99, P159, DOI 10.1016/S0029-7844(01)01747-116175681; Hata T, 2011, PLACENTA, V32, P105, DOI 10.1016/j.placenta.2010.11.001; Zalud I, 2008, J CLIN ULTRASOUND, V36, P391, DOI 10.1002/jcu.20485; Noguchi J, 2009, PLACENTA, V30, P391, DOI 10.1016/j.placenta.2009.02.010; Costa J, 2010, J MATERN-FETAL NEO M, V23, P894, DOI 10.3109/14767051003649862; Odibo AO, 2011, PLACENTA, V32, P230, DOI 10.1016/j.placenta.2011.01.010; Mihu CM, 2012, J PERINAT MED, V40, P359, DOI 10.1515/jpm-2011-0105; Tuuli MG, 2010, PLACENTA, V31, P192, DOI 10.1016/j.placenta.2009.12.018; Raine-Fenning NJ, 2008, ULTRASOUND OBST GYN, V32, P540, DOI 10.1002/uog.6110; Campbell S, 2007, ULTRASOUND OBST GYN, V30, P917, DOI 10.1002/uog.5195; Kaufmann P, 2003, BIOL REPROD, V69, P1, DOI 10.1095/bioreprod.102.014977; Odeh M, 2011, PRENATAL DIAG, V31, P367, DOI 10.1002/pd.2697; Hafner E, 2010, PLACENTA, V31, P756, DOI 10.1016/j.placenta.2010.06.011; Pomorski M, 2012, ARCH GYNECOL OBSTET, V285, P331, DOI 10.1007/s00404-011-1968-9; Bozkurt N, 2010, CLIN EXP OBSTET GYN, V37, P26; Guito C, 2008, ULTRASOUND OBST GYN, V31, P171; Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928; Ogawa Y, 1998, ACTA NEONAT JPN, V34, P624	18	3	3	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0932-0067	1432-0711		ARCH GYNECOL OBSTET	Arch. Gynecol. Obstet.	JUL	2015	292	1					75	79		10.1007/s00404-014-3603-z		5	Obstetrics & Gynecology	Obstetrics & Gynecology	CJ7ES	WOS:000355657800011		
J	Asako, Y				Asako, Yasushi			One-Sided Games in a War of Attrition	B E JOURNAL OF THEORETICAL ECONOMICS			English	Article						war; attrition; Bayesian learning; asymmetric robustness	INCOMPLETE INFORMATION; REPUTATION; STRATEGIES; EXIT	This study develops a war-of-attrition model with the asymmetric feature that one player can be defeated by the other but not vice versa; that is, only one player has an exogenous probability of being forced to capitulate. With complete information, the equilibria are almost identical to the canonical war-of-attrition model. On the other hand, with incomplete information on a player's robustness, a war where both players fight for some duration emerges. Moreover, a player who is never defeated may capitulate in equilibrium, and this player will give in earlier if the other player's fighting costs are greater.	Waseda Univ, Sch Polit Sci & Econ, Shinjuku Ku, Tokyo 1698050, Japan	Asako, Y (reprint author), Waseda Univ, Sch Polit Sci & Econ, Shinjuku Ku, 1-6-1 Nishi Waseda, Tokyo 1698050, Japan.	yasushi.asako@aoni.waseda.jp					Kambe S, 1999, GAME ECON BEHAV, V28, P217, DOI 10.1006/game.1998.0700; Kydd AH, 2006, INT SECURITY, V31, P49, DOI 10.1162/isec.2006.31.1.49; Bulow J, 1999, AM ECON REV, V89, P175, DOI 10.1257/aer.89.1.175; GHEMAWAT P, 1985, RAND J ECON, V16, P184, DOI 10.2307/2555409; MILGROM PR, 1985, MATH OPER RES, V10, P619, DOI 10.1287/moor.10.4.619; Abreu D, 2000, ECONOMETRICA, V68, P85, DOI 10.1111/1468-0262.00094; FUDENBERG D, 1986, ECONOMETRICA, V54, P943, DOI 10.2307/1912845; KENNAN J, 1989, J APPL ECONOM, V4, pS87, DOI 10.1002/jae.3950040506; BLISS C, 1984, J PUBLIC ECON, V25, P1, DOI 10.1016/0047-2727(84)90041-0; FUDENBERG D, 1983, EUR ECON REV, V22, P3, DOI 10.1016/0014-2921(83)90087-9; Langlois CC, 2009, INT STUD QUART, V53, P1051; SMITH JM, 1974, J THEOR BIOL, V47, P209; Bishop T., 1978, J THEOR BIOL, V74, P377; Cannings C., 1978, J THEOR BIOL, V70, P85; Harsanyi J. C., 1973, International Journal of Game Theory, V2, DOI 10.1007/BF01737554; HENDRICKS K, 1988, INT ECON REV, V29, P663, DOI 10.2307/2526827; Horner J, 2011, ECON THEOR, V47, P1, DOI 10.1007/s00199-010-0524-3; Kim K, 2014, AM ECON J-MICROECON, V6, P37, DOI 10.1257/mic.6.2.37; KORNHAUSER L, 1989, ECONOMICA, V56, P15, DOI 10.2307/2554491; KREPS DM, 1982, J ECON THEORY, V27, P253, DOI 10.1016/0022-0531(82)90030-8; Myatt D. P., 2005, DISCUSSION PAPER SER, V160; NALEBUFF B, 1985, J THEOR BIOL, V113, P517, DOI 10.1016/S0022-5193(85)80036-9; O'Brien B., 1999, LONG WAR IRA SINN FE; ORDOVER JA, 1986, Q J ECON, V101, P879, DOI 10.2307/1884183; PONSATI C, 1995, MATH SOC SCI, V29, P239, DOI 10.1016/0165-4896(94)00771-Y; RILEY JG, 1980, J THEOR BIOL, V82, P383, DOI 10.1016/0022-5193(80)90244-1	26	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	1935-1704			BE J THEOR ECON	B E J. Theor. Econ.	JUL	2015	15	2					313	331		10.1515/bejte-2014-0078		19	Economics	Business & Economics	CJ6VX	WOS:000355634400007		
J	Tang, C; Mei, L; Pan, LY; Xiong, WY; Zhu, HB; Ruan, HF; Zou, CC; Tang, LF; Iguchi, T; Wu, XM				Tang, Chao; Mei, Liu; Pan, Liyu; Xiong, Wenyi; Zhu, Haibin; Ruan, Hongfeng; Zou, Chaochun; Tang, Lanfang; Iguchi, Takuma; Wu, Ximei			Hedgehog signaling through GLI1 and GLI2 is required for epithelial-mesenchymal transition in human trophoblasts	BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS			English	Article						Hedgehog signaling; Trophoblast; Epithelial-mesenchymal transition	VITAMIN-C TRANSPORTER-2; HUMAN CHORIOCARCINOMA CELLS; E-CADHERIN; TRANSCRIPTION FACTORS; MOLECULAR-MECHANISMS; DOWN-REGULATION; EXPRESSION; CANCER; SNAIL; PREECLAMPSIA	Background: Epithelial to mesenchymal transition (EMT) is critical for human placental development, trophoblastic differentiation, and pregnancy-associated diseases. Here, we investigated the effects of hedgehog (HH) signaling on EMT in human trophoblasts, and further explored the underlying mechanism. Methods: Human primary cytotrophoblasts and trophoblast-like JEG-3 cells were used as in vitro models. Quantitative real-time RT-PCR and Western blot analysis were performed to examine mRNA and protein levels, respectively. Lentiviruses expressing short hairpin RNA were used to knock down the target genes. Reporter assays and chromatin immunoprecipitation were performed to determine the transactivity. Cell migration, invasion and colony formation were accessed by wound healing, Matrigel-coated transwell, and colony formation assays, respectively. Results: Activation of HH signaling induced the transdifferentiation of cytotrophoblasts and trophoblast-like JEG-3 cells from epithelial to mesenchymal phenotypes, exhibiting the decreases in E-Cadherin expression as well as the increases in vimentin expression, invasion, migration and colony formation. Knockdown of GLI1 and GLI2 but not GLI3 attenuated HH-induced transdifferentiation, whereas GLI1 was responsible for the expression of HH-induced key EMT regulators including Snail1, Slug, and Twist, and both GLI1 and GLI2 acted directly as transcriptional repressor of CDH1 gene encoding E-Cadherin. Conclusion: HH through GLI1 and GLI2 acts as critical signals in supporting the physiological function of mature placenta. General significance: HH signaling through GM and GLI2 could be required for the maintenance of human pregnancy. (C) 2015 Elsevier B.V. All rights reserved.	[Tang, Chao; Mei, Liu; Pan, Liyu; Ruan, Hongfeng; Wu, Ximei] Zhejiang Univ, Sch Med, Dept Pharmacol, Hangzhou 310058, Zhejiang, Peoples R China; [Xiong, Wenyi; Zhu, Haibin; Zou, Chaochun; Tang, Lanfang] Zhejiang Univ, Sch Med, Affiliated Children Hosp, Hangzhou 310058, Zhejiang, Peoples R China; [Iguchi, Takuma] Osaka Univ, Dept Toxicol, Suita, Osaka, Japan	Wu, XM (reprint author), Zhejiang Univ, Sch Med, Dept Pharmacol, 688 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	xiwu@zju.edu.cn			973 Program [2011CB944403]; National Natural Science Foundation of China [30973580, 31071292, 81370713]; Natural Science Foundation of Zhejiang Province, China [R2110269]	We thank Dr. Sasaki for his generous donation of plasmid and Dr. Fanxin Long from Washington University in St. Louis for his advice and comments on this work. This work is supported by 973 Program (no. 2011CB944403), National Natural Science Foundation of China (no. 30973580, no. 31071292, no. 81370713), and Natural Science Foundation of Zhejiang Province, China (no. R2110269).	Abell AN, 2011, CELL STEM CELL, V8, P525, DOI 10.1016/j.stem.2011.03.008; Favaro R, 2009, NAT NEUROSCI, V12, P1248, DOI 10.1038/nn.2397; Mayhew TM, 2014, PLACENTA, V35, P229, DOI 10.1016/j.placenta.2014.01.011; Joost S, 2012, CANCER RES, V72, P88, DOI 10.1158/0008-5472.CAN-10-4621; Puisieux A, 2014, NAT CELL BIOL, V16, P488, DOI 10.1038/ncb2976; Kalluri R, 2009, J CLIN INVEST, V119, P1417, DOI 10.1172/JCI39675; Khan MI, 2014, ONCOTARGET, V5, P2462; Sun YY, 2011, REPROD SCI, V18, P1138, DOI 10.1177/1933719111408112; Wallace AE, 2012, HUM REPROD UPDATE, V18, P458, DOI 10.1093/humupd/dms015; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Omenetti A, 2008, J CLIN INVEST, V118, P3331, DOI 10.1172/JCI35875; Ding H, 2012, J AM SOC NEPHROL, V23, P801, DOI 10.1681/ASN.2011060614; Wu X, 2007, CELL DEATH DIFFER, V14, P1792, DOI 10.1038/sj.cdd.4402190; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; Blechschmidt K, 2007, VIRCHOWS ARCH, V450, P195, DOI 10.1007/s00428-006-0343-x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Chen JS, 2014, MOL CELL BIOCHEM, V393, P283, DOI 10.1007/s11010-014-2071-x; Nakaya Y, 2013, CANCER LETT, V341, P9, DOI 10.1016/j.canlet.2013.02.037; Kokkinos MI, 2010, PLACENTA, V31, P747, DOI 10.1016/j.placenta.2010.06.017; Min S, 2013, CANCER GENE THER, V20, P379, DOI 10.1038/cgt.2013.36; Robbins DJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002906; Meraviglia V, 2012, DIFFERENTIATION, V83, P260, DOI 10.1016/j.diff.2012.02.006; Katoh Y, 2008, INT J MOL MED, V22, P271, DOI 10.3892/ijmm_00000019; Chen LH, 2012, J CLIN ENDOCR METAB, V97, pE1667, DOI 10.1210/jc.2012-1753; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Fedorova L, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-15; Huang CCJ, 2010, MOL REPROD DEV, V77, P489, DOI 10.1002/mrd.21174; Javelaud D, 2012, FEBS LETT, V586, P2016, DOI 10.1016/j.febslet.2012.05.011; Jurisicova Andrea, 2005, Birth Defects Research, V75, P262, DOI 10.1002/bdrc.20053; KHONG TY, 1986, BRIT J OBSTET GYNAEC, V93, P1049, DOI 10.1111/j.1471-0528.1986.tb07830.x; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Li JN, 2011, J CLIN ENDOCR METAB, V96, pE899, DOI 10.1210/jc.2010-2852; Li W, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.545; Li X, 2007, ONCOGENE, V26, P4489, DOI 10.1038/sj.onc.1210241; Lim K.H., 1997, AM J PATHOL; Marini KD, 2011, GROWTH FACTORS, V29, P221, DOI 10.3109/08977194.2011.610756; Shida T, 2006, CANCER BIOL THER, V5, P1530; Tang C., 2015, CELL SIGNAL; Wang YJ, 2014, MOL HUM REPROD, V20, P799, DOI 10.1093/molehr/gau036; Wu XM, 2008, ENDOCRINOLOGY, V149, P73, DOI 10.1210/en.2007-0262; Xu XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043119; Yue DS, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/1756-9966-33-34	42	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-4165	1872-8006		BBA-GEN SUBJECTS	Biochim. Biophys. Acta-Gen. Subj.	JUL	2015	1850	7					1438	1448		10.1016/j.bbagen.2015.04.005		11	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CJ7YA	WOS:000355715100011		
J	Moriuchi, H; Unno, H; Goda, S; Tateno, H; Hirabayashi, J; Hatakeyama, T				Moriuchi, Hiromi; Unno, Hideaki; Goda, Shuichiro; Tateno, Hiroaki; Hirabayashi, Jun; Hatakeyama, Tomomitsu			Mannose-recognition mutant of the galactose/N-acetylgalactosamine-specific C-type lectin CEL-I engineered by site-directed mutagenesis	BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS			English	Article						Carbohydrate; C-type lectin; Site-directed mutagenesis; X-ray crystallography	SURFACTANT PROTEIN-D; CARBOHYDRATE-RECOGNITION; ANIMAL LECTINS; GLYCOCONJUGATE MICROARRAY; N-ACETYLGALACTOSAMINE; MARINE INVERTEBRATE; BINDING SPECIFICITY; CUCUMARIA-ECHINATA; LIGANDS; DOMAINS	Background: CEL-I is a galactose/N-acetylgalactosamine-specific C-type lectin isolated from the sea cucumber Cucumaria echinata. Its carbohydrate-binding site contains a QPD (Gin-Pro-Asp) motif, which is generally recognized as the galactose specificity-determining motif in the C-type lectins. In our previous study, replacement of the QPD motif by an EPN (Glu-Pro-Asn) motif led to a weak binding affinity for mannose.Therefore, we examined the effects of an additional mutation in the carbohydrate-binding site on the specificity of the lectin. Methods: Trp105 of EPN-CEL-I was replaced by a histidine residue using site-directed mutagenesis, and the binding affinity of the resulting mutant, EPNH-CEL-I, was examined by sugar-polyamidoamine dendrimer assay, isothermal titration calorimetry, and glycoconjugate microarray analysis. Tertiary structure of the EPNH-CEL-I/mannose complex was determined by X-ray crystallographic analysis. Results: Sugar-polyamidoamine dendrimer assay and glycoconjugate microarray analysis revealed a drastic change in the specificity of EPNH-CEL-I from galactose/N-acetylgalactosamine to mannose. The association constant of EPNH-CEL-I for mannose was determined to be 3.17 x 10(3) M-1 at 25 degrees C. Mannose specificity of EPNH-CEL-I was achieved by stabilization of the binding of mannose in a correct orientation, in which the EPN motif can form proper hydrogen bonds with 3- and 4-hydroxy groups of the bound mannose. Conclusions: Specificity of CEL-I can be engineered by mutating a limited number of amino acid residues in addition to the QPD/EPN motifs. General significance: Versatility of the C-type carbohydrate-recognition domain structure in the recognition of various carbohydrate chains could become a promising platform to develop novel molecular recognition proteins. (C) 2015 Elsevier B.V. All rights reserved.	[Moriuchi, Hiromi; Unno, Hideaki; Goda, Shuichiro; Hatakeyama, Tomomitsu] Nagasaki Univ, Lab Biomol Chem, Grad Sch Engn, Nagasaki 8528521, Japan; [Tateno, Hiroaki; Hirabayashi, Jun] Natl Inst Adv Ind Sci & Technol, Res Ctr Stem Cell Engn, Tsukuba, Ibaraki 3058568, Japan	Hatakeyama, T (reprint author), Nagasaki Univ, Biomol Chem Lab, Grad Sch Engn, 1-14 Bunkyo Machi, Nagasaki 8528521, Japan.	thata@nagasaki-u.ac.jp		Hatakeyama, Tomomitsu/0000-0002-9505-1980	Japan Society for the Promotion of Science (JSPS) [26450128, 10452872, 00346587]	We are grateful to Ms. Jinko Murakami and Ms. Keiko Hiemori for help in glycoconjugate microarray analysis. This work was supported by a Grants-in-Aid for Scientific Research (C) to TH (26450128) and Grants-in-Aid for Young Scientists (B) to HU (10452872) and SG (00346587) from the Japan Society for the Promotion of Science (JSPS).	Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Kolatkar AR, 1998, J BIOL CHEM, V273, P19502, DOI 10.1074/jbc.273.31.19502; Tateno H, 2008, GLYCOBIOLOGY, V18, P789, DOI 10.1093/glycob/cwn068; DRICKAMER K, 1988, J BIOL CHEM, V263, P9557; Powlesland AS, 2009, GLYCOBIOLOGY, V19, P899, DOI 10.1093/glycob/cwp065; DRICKAMER K, 1992, NATURE, V360, P183, DOI 10.1038/360183a0; Mourao-Sa D, 2011, EUR J IMMUNOL, V41, P3040, DOI 10.1002/eji.201141641; Kilpatrick DC, 2002, TRANSFUSION MED, V12, P335, DOI 10.1046/j.1365-3148.2002.00408.x; Kilpatrick DC, 2002, BBA-GEN SUBJECTS, V1572, P187, DOI 10.1016/S0304-4165(02)00308-2; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Drickamer K, 1999, CURR OPIN STRUC BIOL, V9, P585, DOI 10.1016/S0959-440X(99)00009-3; Powlesland AS, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-13; Mukherjee S, 2014, NATURE, V505, P103, DOI 10.1038/nature12729; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Cambi A, 2003, CURR OPIN CELL BIOL, V15, P539, DOI 10.1016/j.ceb.2003.08.004; Riboldi E, 2011, J BIOL CHEM, V286, P35329, DOI 10.1074/jbc.C111.290494; Ng KKS, 1996, J BIOL CHEM, V271, P663; Carlson TK, 2009, GLYCOBIOLOGY, V19, P1473, DOI 10.1093/glycob/cwp122; Hatakeyama T, 2011, J BIOL CHEM, V286, P10305, DOI 10.1074/jbc.M110.200576; Hatakeyama T, 2012, BIOSCI BIOTECH BIOCH, V76, P1999, DOI 10.1271/bbb.120520; Hatakeyama T, 2013, PROTEIN PEPTIDE LETT, V20, P796; HATAKEYAMA T, 1994, J BIOCHEM-TOKYO, V116, P209; Hatakeyama T, 2004, J BIOCHEM, V135, P101, DOI 10.1093/jb/mvh012; Hatakeyama T, 2007, J BIOL CHEM, V282, P37826, DOI 10.1074/jbc.M705604200; HATAKEYAMA T, 1995, BIOSCI BIOTECH BIOCH, V59, P1314; IOBST ST, 1994, J BIOL CHEM, V269, P15512; Kato Y., 2014, BIOSCI BIOTECH BIOCH, P1; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liu F, 2011, FISH SHELLFISH IMMUN, V31, P765, DOI 10.1016/j.fsi.2011.07.014; MCCORMACK FX, 1994, J BIOL CHEM, V269, P29801; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; N. Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50; Ng KKS, 2002, J BIOL CHEM, V277, P16088, DOI 10.1074/jbc.M200493200; OGASAWARA Y, 1995, J BIOL CHEM, V270, P14725; Powlesland AS, 2010, METHOD ENZYMOL, V480, P165, DOI 10.1016/S0076-6879(10)80009-6; Shimokawa M, 2012, GLYCOCONJUGATE J, V29, P457, DOI 10.1007/s10719-012-9401-6; Sugawara H, 2004, J BIOL CHEM, V279, P45219, DOI 10.1074/jbc.M408840200; Tateno H, 2014, METHODS MOL BIOL, V1200, P353, DOI 10.1007/978-1-4939-1292-6_30; Unno H, 2014, J BIOL CHEM, V289, P12805, DOI 10.1074/jbc.M113.541896; Wang H, 2008, BIOCHEMISTRY-US, V47, P710, DOI 10.1021/bi7020553	42	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-4165	1872-8006		BBA-GEN SUBJECTS	Biochim. Biophys. Acta-Gen. Subj.	JUL	2015	1850	7					1457	1465		10.1016/j.bbagen.2015.04.004		9	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CJ7YA	WOS:000355715100013		
J	Tanaka, N; Takahashi, S; Zhang, Y; Krausz, KW; Smith, PB; Patterson, AD; Gonzalez, FJ				Tanaka, Naoki; Takahashi, Shogo; Zhang, Yuan; Krausz, Kristopher W.; Smith, Philip B.; Patterson, Andrew D.; Gonzalez, Frank J.			Role of fibroblast growth factor 21 in the early stage of NASH induced by methionine- and choline-deficient diet	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE			English	Article						ER stress; Lipotoxicity; ATGL; PGC1 alpha; PPAR alpha	FATTY LIVER-DISEASE; ENDOPLASMIC-RETICULUM STRESS; ACTIVATED RECEPTOR-ALPHA; PPAR-ALPHA; NONALCOHOLIC STEATOHEPATITIS; MICE; FGF21; EXPRESSION; FIBROBLAST-GROWTH-FACTOR-21; LIPOAPOPTOSIS	Fibroblast growth factor 21 (FGF21) is a modulator of energy homeostasis and is increased in human nonalcoholic liver disease (NAFLD) and after feeding of methionine- and choline-deficient diet (MCD), a conventional inducer of murine nonalcoholic steatohepatitis (NASH). However, the significance of FGF21 induction in the occurrence of MCD-induced NASH remains undetermined. C57BL/6J Fgf21-null and wild-type mice were treated with MCD for 1 week. Hepatic Fgf21 mRNA was increased early after commencing MCD treatment independent of peroxisome proliferator-activated receptor (PPAR) a and farnesoid X receptor. While no significant differences in white adipose lipolysis were seen in both genotypes, hepatic triglyceride (TG) contents were increased in Fgf21-null mice, likely due to the up-regulation of genes encoding CD36 and phosphatidic acid phosphatase 2a/2c, involved in fatty acid (FA) uptake and diacylglycerol synthesis, respectively, and suppression of increased mRNAs encoding camitine palmitoyl-CoA transferase 1 alpha, PPAR gamma coactivator 1 alpha, and adipose TG lipase, which are associated with lipid clearance in the liver. The MCD-treated Fgf21-null mice showed increased hepatic endoplasmic reticulum (ER) stress. Exposure of primary hepatocytes to palmitic acid elevated the mRNA levels encoding DNA damage-inducible transcript 3, an indicator of ER stress, and FGF21 in a PPAR alpha-independent manner, suggesting that lipid-induced ER stress can enhance hepatic FGF21 expression. Collectively, FGF21 is elevated in the early stage of MCD-induced NASH likely to minimize hepatic lipid accumulation and ensuing ER stress. These results provide a possible mechanism on how FGF21 is increased in NAFLD/NASH. Published by Elsevier B.V.	[Tanaka, Naoki; Takahashi, Shogo; Krausz, Kristopher W.; Gonzalez, Frank J.] NCI, Lab Metab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Tanaka, Naoki] Shinshu Univ, Grad Sch Med, Dept Metab Regulat, Matsumoto, Nagano 390, Japan; [Zhang, Yuan] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, DC USA; [Smith, Philip B.; Patterson, Andrew D.] Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA; [Smith, Philip B.; Patterson, Andrew D.] Penn State Univ, Ctr Mol Toxicol & Carcinogenesis, University Pk, PA 16802 USA	Gonzalez, FJ (reprint author), NCI, Lab Metab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	gonzalef@mail.nih.gov			Intramural Research Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health [U554 ES16015, 1R01ES022186-01]	We thank Linda G. Byrd and John Buckley for providing technical assistance with the mouse studies. This study was supported by the Intramural Research Program, Center for Cancer Research, National Cancer Institute, U554 ES16015 and 1R01ES022186-01, National Institutes of Health.	Adams A. C., 2013, MOL METABOLISM, V2, P31, DOI DOI 10.1016/J.MOLMET.2012.08.007; Adams Andrew C, 2013, Mol Metab, V2, P205, DOI 10.1016/j.molmet.2013.05.005; Li HT, 2010, J HEPATOL, V53, P934, DOI [10.1016/j.jhep.2010.05.018, 10.1016/j.jhep.2010.07.003]; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI200523621; Dutchak PA, 2012, CELL, V148, P556, DOI 10.1016/j.cell.2011.11.062; Schaap FG, 2013, BIOCHIMIE, V95, P692, DOI 10.1016/j.biochi.2012.10.019; Yilmaz Y, 2010, EUR J CLIN INVEST, V40, P887, DOI 10.1111/j.1365-2362.2010.02338.x; Cazanave SC, 2010, AM J PHYSIOL-GASTR L, V299, pG236, DOI 10.1152/ajpgi.00091.2010; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Feingold KR, 2012, ENDOCRINOLOGY, V153, P2689, DOI 10.1210/en.2011-1496; Ye DW, 2014, HEPATOLOGY, V60, P977, DOI 10.1002/hep.27060; Hondares E, 2011, J BIOL CHEM, V286, P12983, DOI 10.1074/jbc.M110.215889; Kharitonenkov A, 2007, ENDOCRINOLOGY, V148, P774, DOI 10.1210/en.2006-1168; Li XF, 2009, FEBS LETT, V583, P3230, DOI 10.1016/j.febslet.2009.09.012; Wang T, 2010, J BIOL CHEM, V285, P7670, DOI 10.1074/jbc.M109.090175; Cyphert HA, 2012, J BIOL CHEM, V287, P25123, DOI 10.1074/jbc.M112.375907; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Jiang CT, 2015, J CLIN INVEST, V125, P386, DOI 10.1172/JCI76738; Aoyama T, 1998, J BIOL CHEM, V273, P5678, DOI 10.1074/jbc.273.10.5678; Gaich G, 2013, CELL METAB, V18, P333, DOI 10.1016/j.cmet.2013.08.005; Karaskov E, 2006, ENDOCRINOLOGY, V147, P3398, DOI 10.1210/en.2005-1494; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Tanaka N, 2012, HEPATOLOGY, V56, P118, DOI 10.1002/hep.25630; Johnson CL, 2009, GASTROENTEROLOGY, V137, P1795, DOI 10.1053/j.gastro.2009.07.064; Tanaka N, 2015, J BIOL CHEM, V290, P3092, DOI 10.1074/jbc.M114.605980; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Li HT, 2013, J HEPATOL, V58, P557, DOI 10.1016/j.jhep.2012.10.029; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Nishimura T, 2000, BBA-GENE STRUCT EXPR, V1492, P203, DOI 10.1016/S0167-4781(00)00067-1; Matsubara T, 2012, CELL METAB, V16, P634, DOI 10.1016/j.cmet.2012.10.006; Jiang S, 2014, J BIOL CHEM, V289, P29751, DOI 10.1074/jbc.M114.565960; Dushay J, 2010, GASTROENTEROLOGY, V139, P456, DOI 10.1053/j.gastro.2010.04.054; Chartoumpekis DV, 2011, MOL MED, V17, P736, DOI 10.2119/molmed.2011.00075; Ong KT, 2011, HEPATOLOGY, V53, P116, DOI 10.1002/hep.24006; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Arner P., 2008, FEBS LETT, V582, P1725; Cazanave SC, 2011, J BIOL CHEM, V286, P39336, DOI 10.1074/jbc.M111.280420; Cyphert HA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094996; Emanuelli, 2014, J CLIN INVEST, V124, P515; Fisher FM, 2014, GASTROENTEROLOGY, V147, P1073, DOI 10.1053/j.gastro.2014.07.044; Kharitonenkov Alexei, 2014, Mol Metab, V3, P221, DOI 10.1016/j.molmet.2013.12.003; Kliewer S.A., 2010, AM J CLIN NUTR, V91, p254S; Neuschwander-Tetri BA, 2010, HEPATOLOGY, V52, P774, DOI 10.1002/hep.23719; Ribas F, 2014, BIOCHEM J, V463, P191, DOI 10.1042/BJ20140403; Tanaka N, 2014, BBA-MOL CELL BIOL L, V1841, P1596, DOI 10.1016/j.bbalip.2014.08.015	46	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-4439	0006-3002		BBA-MOL BASIS DIS	Biochim. Biophys. Acta-Mol. Basis Dis.	JUL	2015	1852	7					1242	1252		10.1016/j.bbadis.2015.02.012		11	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	CJ7YB	WOS:000355715200003		
J	Ru, XC; Zheng, CB; Zhao, QN; Lan, HY; Huang, Y; Wan, S; Mori, YS; Yao, XQ				Ru, Xiaochen; Zheng, Changbo; Zhao, Qiannan; Lan, Hui-Yao; Huang, Yu; Wan, Song; Mori, Yasuo; Yao, Xiaoqiang			Transient receptor potential channel M2 contributes to neointimal hyperplasia in vascular walls	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE			English	Article						Neointimal hyperplasia; TRPM2; Vascular smooth muscle cell; Migration; Proliferation	SMOOTH-MUSCLE-CELLS; PULMONARY ARTERIAL; OXIDATIVE STRESS; TRP CHANNELS; CA2+ ENTRY; ATHEROSCLEROSIS; PROLIFERATION; EXPRESSION; DEATH; SUSCEPTIBILITY	Background: A hallmark of atherosclerosis is progressive intimal thickening (namely neointimal hyperplasia), which leads to occlusive vascular diseases. Over-production of reactive oxygen species (ROS) and alteration of Ca2+ signaling are among the key factors contributing to neointimal growth. In the present study, we investigated the role of TRPM2, a ROS-sensitive Ca2+ entry channel, in neointimal hyperplasia. Methods and results: Perivascular cuffs were used to induce neointimal hyperplasia in rat/mouse arteries. Immunostaining showed numerous TRPM2-positive smooth muscle cells in neointimal regions. ROS were over-produced and PCNA-positive proliferating cells were numerous in the neointimal regions. The neointimal hyperplasia was substantially reduced in Trpm2 knockout mice compared with wild-type mice. In the cultured rat/mouse aortic smooth muscle cells, H2O2 treatment was found to stimulate cell proliferation and migration. The effect of H2O2 was reduced by a TRPM2-specific blocking antibody TM2E3 or Trpm2 knockout The signaling molecules downstream of TRPM2 were found to be Axl and Akt Conclusions: These data suggest a critical functional role of TRPM2 in the progression of neointimal hyperplasia. The study also highlights the possibility of targeting TRPM2 as a potential therapeutic option for the treatment of occlusive vascular diseases. (C) 2015 Elsevier B.V. All rights reserved.	[Ru, Xiaochen] Huzhou Univ, Sch Med, Dept Basic Med Sci, Huzhou, Peoples R China; [Ru, Xiaochen] Huzhou Univ, Sch Nursing Sci, Huzhou, Peoples R China; [Ru, Xiaochen; Zheng, Changbo; Zhao, Qiannan; Huang, Yu; Yao, Xiaoqiang] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China; [Ru, Xiaochen; Zheng, Changbo; Zhao, Qiannan; Huang, Yu; Yao, Xiaoqiang] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Zheng, Changbo; Zhao, Qiannan; Yao, Xiaoqiang] Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen, Hong Kong, Peoples R China; [Lan, Hui-Yao] Chinese Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Wan, Song] Chinese Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Mori, Yasuo] Kyoto Univ, Dept Synthet Chem & Biol Chem, Grad Sch Engn, Kyoto 6158510, Japan	Yao, XQ (reprint author), Chinese Univ Hong Kong, Sch Biomed Sci, Lo Kwee Seong Integrated Biomed Sci Bldg, Rm 224-225, Hong Kong, Hong Kong, Peoples R China.	yao2068@cuhk.edu.hk			Hong Kong Research Grant Committee [CUHK478413, TBRS T13-706/11, AoE/M-05/12]; China National Science Foundation [31171100]; Huzhou University [RK30036]	This work was supported by grants from the Hong Kong Research Grant Committee CUHK478413, TBRS T13-706/11, AoE/M-05/12, the China National Science Foundation 31171100 and Group Research Grant from Huzhou University (RK30036).	Motwani JG, 1998, CIRCULATION, V97, P916; Yamamoto S, 2008, NAT MED, V14, P738, DOI 10.1038/nm1758; Barry-Lane PA, 2001, J CLIN INVEST, V108, P1513, DOI 10.1172/JCI11927; Ley K, 2011, ARTERIOSCL THROM VAS, V31, P1506, DOI 10.1161/ATVBAHA.110.221127; Thyberg J, 1998, HISTOL HISTOPATHOL, V13, P871; Zhang W, 2003, J BIOL CHEM, V278, P16222, DOI 10.1074/jbc.M300298200; Takeda R, 2005, CIRCULATION, V111, P1398, DOI 10.1161/01.CIR.0000158482.83179.DB; Yao XQ, 2005, CIRC RES, V97, P853, DOI 10.1161/01.RES.0000187473.85419.3e; Yu Y, 2004, P NATL ACAD SCI USA, V101, P13861, DOI 10.1073/pnas.0405908101; SCHWARTZ SM, 1995, CIRC RES, V77, P445; Dangwal S, 2011, ARTERIOSCL THROM VAS, V31, P624, DOI 10.1161/ATVBAHA.110.219105; House SJ, 2008, PFLUG ARCH EUR J PHY, V456, P769, DOI 10.1007/s00424-008-0491-8; Fuster JJ, 2010, CARDIOVASC RES, V86, P254, DOI 10.1093/cvr/cvp363; Yang XR, 2006, AM J PHYSIOL-LUNG C, V290, pL1267, DOI 10.1152/ajplung.00515.2005; Dhalla NS, 2000, J HYPERTENS, V18, P655, DOI 10.1097/00004872-200018060-00002; Li J, 2011, BRIT J PHARMACOL, V164, P382, DOI 10.1111/j.1476-5381.2011.01368.x; Newby AC, 2000, J PATHOL, V190, P300, DOI 10.1002/(SICI)1096-9896(200002)190:3<300::AID-PATH596>3.0.CO;2-I; Doran AC, 2008, ARTERIOSCL THROM VAS, V28, P812, DOI 10.1161/ATVBAHA.107.159327; Kumar B, 2006, CIRC RES, V98, P557, DOI 10.1161/01.RES.0000204724.29685.db; BOOTH RFG, 1989, ATHEROSCLEROSIS, V76, P257, DOI 10.1016/0021-9150(89)90109-3; Sensi M, 2011, J INVEST DERMATOL, V131, P2448, DOI 10.1038/jid.2011.218; Zhang S, 2004, AM J PHYSIOL-CELL PH, V287, pC1192, DOI 10.1152/ajpcell.00158.2004; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Lang YS, 2012, J PHARM PHARMACOL, V64, P597, DOI 10.1111/j.2042-7158.2011.01438.x; Hara Y, 2002, MOL CELL, V9, P163, DOI 10.1016/S1097-2765(01)00438-5; Xu QB, 2004, AM J PATHOL, V165, P1, DOI 10.1016/S0002-9440(10)63270-1; Dietrich A, 2011, ADV EXP MED BIOL, V704, P781, DOI 10.1007/978-94-007-0265-3_41; GEBRANE J, 1982, VIRCHOWS ARCH A, V396, P41, DOI 10.1007/BF00428499; George SJ, 2011, CIRCULATION, V124, pS135, DOI 10.1161/CIRCULATIONAHA.110.012732; HIROSUMI J, 1987, ATHEROSCLEROSIS, V64, P243, DOI 10.1016/0021-9150(87)90252-8; Kolisek M, 2005, MOL CELL, V18, P61, DOI 10.1016/j.molcel.2005.02.033; Konishi A, 2004, J BIOL CHEM, V279, P28766, DOI 10.1074/jbc.M401977200; Lazar HL, 2004, ANN THORAC SURG, V78, P730, DOI 10.1016/j.athorscur.2003.12.041; Leik CE, 2004, HYPERTENSION, V43, P837, DOI 10.1161/01.HYP.0000119191.33112.9c; LEVINE GN, 1995, CLIN CARDIOL, V18, P693; Miller BA, 2006, J MEMBRANE BIOL, V209, P31, DOI 10.1007/s00232-005-0839-3; Munaron L, 2004, CURR MED CHEM, V11, P1533; Napoli C, 2001, MAYO CLIN PROC, V76, P619; Sun L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043186; Xu SZ, 2006, CIRC RES, V98, P1381, DOI 10.1161/01.RES.0000225284.36490.a2; Xu SZ, 2005, NAT BIOTECHNOL, V23, P1289, DOI 10.1038/nbt1148	41	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-4439	0006-3002		BBA-MOL BASIS DIS	Biochim. Biophys. Acta-Mol. Basis Dis.	JUL	2015	1852	7					1360	1371		10.1016/j.bbadis.2015.03.014		12	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	CJ7YB	WOS:000355715200014		
J	Garcia-Contreras, R; Sugimoto, M; Umemura, N; Kaneko, M; Hatakeyama, Y; Soga, T; Tomita, M; Scougall-Vilchis, RJ; Contreras-Bulnes, R; Nakajima, H; Sakagami, H				Garcia-Contreras, Rene; Sugimoto, Masahiro; Umemura, Naoki; Kaneko, Miku; Hatakeyama, Yoko; Soga, Tomoyoshi; Tomita, Masaru; Scougall-Vilchis, Rogelio J.; Contreras-Bulnes, Rosalia; Nakajima, Hiroshi; Sakagami, Hiroshi			Alteration of metabolomic profiles by titanium dioxide nanoparticles in human gingivitis model	BIOMATERIALS			English	Article						Titanium dioxide nanoparticle; Inerleukin-1 beta; Inflammation; Human gingival fibroblast; Metabolomics	OXIDATIVE STRESS; CELLS; INFLAMMATION; IL-1-BETA; HYDROGEN; ARGININE; ACID	Although nanoparticles (NPs) has afforded considerable benefits in various fields of sciences, several reports have shown their harmful effects, suggesting the necessity of adequate risk assessment. To clarify the mechanism of titanium dioxide nanoparticles (TiO2 NPs)-enhanced gingival inflammation, we conducted the full-scale metabolomic analyses of human gingival fibroblast cells treated with IL-1 beta alone or in combination with TiO2 NPs. Observation with transmission electron microscope demonstrated the incorporation of TiO2 NPs into vacuoles of the cells. TiO2 NPs significantly enhanced the IL-1 beta-induced prostaglandin E-2 production and COX-1 and COX-2 protein expression. IL-1 beta reduced the intracellular concentrations of overall primary metabolites especially those of amino acid, urea cycle, polyamine, S-adenosylmethione and glutathione synthetic pathways. The addition of TiO2 NPs further augmented these IL-1 beta-induced metabolic changes, recommending careful use of dental materials containing TiO2 NPs towards patients with gingivitis or periodontitis. The impact of the present study is to identify the molecular targets of TiO2 NPs for the future establishment of new metabolic markers and therapeutic strategy of gingival inflammation. (C) 2015 Elsevier Ltd. All rights reserved.	[Garcia-Contreras, Rene] Autonomous Univ State Mexico, Fac Dent, Dent & Adv Studies Res Ctr CIEAO, Toluca, Mexico; [Sugimoto, Masahiro; Kaneko, Miku; Hatakeyama, Yoko; Soga, Tomoyoshi; Tomita, Masaru] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan; [Garcia-Contreras, Rene; Umemura, Naoki; Sakagami, Hiroshi] Meikai Univ, Sch Dent, Div Pharmacol, Sakado, Saitama 3500283, Japan; [Scougall-Vilchis, Rogelio J.] Autonomous Univ State Mexico, Fac Dent, Dept Orthodont, Toluca, Mexico; [Contreras-Bulnes, Rosalia] Autonomous Univ State Mexico, Fac Dent, Dept Pediat Dent, Toluca, Mexico; [Nakajima, Hiroshi] Meikai Univ, Sch Dent, Div Dent Biomat Sci, Sakado, Saitama 3500283, Japan	Sakagami, H (reprint author), Meikai Univ, Sch Dent, Dept Diagnost & Therapeut Sci, Div Pharmacol, Sakado, Saitama 3500283, Japan.	sakagami@dent.meikai.ac.jp	Garcia-Contreras, Rene/J-6613-2014; Scougall-Vilchis, Rogelio/O-5477-2015	Garcia-Contreras, Rene/0000-0003-3504-5519; Scougall-Vilchis, Rogelio/0000-0003-4671-0748	Ministry of Education, Culture, Sports, Science and Technology [25670897]; Meikai University School of Dentistry; Yamagata Prefectural Government; Tsuruoka City, Japan	We are very grateful Ms. Yumiko Kanda for her excellent technical assistant with operating the transmission electron microscope. This work was supported by Grant-in-Aid for Challenging Exploratory Research from The Ministry of Education, Culture, Sports, Science and Technology (Sakagami H. 25670897), research funds from Meikai University School of Dentistry and a research funds from the Yamagata Prefectural Government and Tsuruoka City, Japan.	Rajshankar D, 2012, FASEB J, V26, P4429, DOI 10.1096/fj.12-207381; Holen E, 2014, FISH SHELLFISH IMMUN, V37, P286, DOI 10.1016/j.fsi.2014.02.004; Garcia-Contreras R, 2014, IN VIVO, V28, P217; Sugimoto M, 2012, CURR BIOINFORM, V7, P96; Lara A, 2008, AM J RESP CRIT CARE, V178, P673, DOI 10.1164/rccm.200710-1542OC; Thurn KT, 2011, NANOMED-NANOTECHNOL, V7, P123, DOI 10.1016/j.nano.2010.09.004; King AL, 2014, P NATL ACAD SCI USA, V111, P3182, DOI 10.1073/pnas.1321871111; Kantoh K, 2010, IN VIVO, V24, P843; Sawada S, 2013, BIOMED RES-TOKYO, V34, P31; Youns M, 2011, CURR DRUG TARGETS, V12, P357; Sugimoto M, 2010, METABOLOMICS, V6, P78, DOI 10.1007/s11306-009-0178-y; Husain M, 2013, TOXICOL APPL PHARM, V269, P250, DOI 10.1016/j.taap.2013.03.018; Zhang G, 2013, NATURE, V497, P211, DOI 10.1038/nature12143; Bo Y, 2014, TOXICOL MECH METHOD, V24, P461, DOI 10.3109/15376516.2014.939321; Garcia-Contreras R, 2011, INT DENT J, V61, P297, DOI 10.1111/j.1875-595X.2011.00072.x; Yang PP, 2012, CHEM SOC REV, V41, P3679, DOI 10.1039/c2cs15308d; Cho WS, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-55; Bhowmick R, 2013, FREE RADICAL BIO MED, V57, P39, DOI 10.1016/j.freeradbiomed.2012.12.005; Roje S, 2006, PHYTOCHEMISTRY, V67, P1686, DOI 10.1016/j.phytochem.2006.04.019; Ono M, 2011, IN VIVO, V25, P763; Chen T, 2014, J FOOD DRUG ANAL, V22, P95, DOI 10.1016/j.jfda.2014.01.008; Soga T, 2006, J BIOL CHEM, V281, P16768, DOI 10.1074/jbc.M601876200; Gut P, 2013, NATURE, V502, P489, DOI 10.1038/nature12752; Bjelakovic G, 2010, AMINO ACIDS, V39, P29, DOI 10.1007/s00726-010-0489-3; Delgado-Buenrostro N.L., 2014, ENV TOXICOL; Garcia-Contreras R, 2014, IN VIVO, V28, P209; Huang YY, 2014, TOXICOL SCI, V138, P310, DOI 10.1093/toxsci/kfu013; Karbiner MS, 2013, LIFE SCI, V93, P503, DOI 10.1016/j.lfs.2013.08.003; Liu Q, 1996, METHOD ENZYMOL, V268, P311; Lucas K, 2013, NEUROENDOCRINOL LETT, V34, P723; Minois N, 2014, GERONTOLOGY, V60, P319, DOI 10.1159/000356748; Ratnasekhar C., 2015, NANOTOXICOLOGY, P1; Sugimoto M, 2012, METABOLOMICS, V8, P624, DOI 10.1007/s11306-011-0353-9; Wittmaack K, 2007, ENVIRON HEALTH PERSP, V115, P187, DOI 10.1289/ehp.9254; Yaplito-Lee J, 2013, MOL GENET METAB, V108, P161, DOI 10.1016/j.ymgme.2013.01.006; Ze YG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092230; Zhang L, 2008, CLIN PHARMACOL THER, V83, P761, DOI 10.1038/sj.clpt.6100400	37	2	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0142-9612	1878-5905		BIOMATERIALS	Biomaterials	JUL	2015	57						33	40		10.1016/j.biomaterials.2015.03.059		8	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	CJ2ZZ	WOS:000355354500004		
J	Hirobe, S; Azukizawa, H; Hanafusa, T; Matsuo, K; Quan, YS; Kamiyama, F; Katayama, I; Okada, N; Nakagawa, S				Hirobe, Sachiko; Azukizawa, Hiroaki; Hanafusa, Takaaki; Matsuo, Kazuhiko; Quan, Ying-Shu; Kamiyama, Fumio; Katayama, Ichiro; Okada, Naoki; Nakagawa, Shinsaku			Clinical study and stability assessment of a novel transcutaneous influenza vaccination using a dissolving microneedle patch	BIOMATERIALS			English	Article						Drug delivery; Hyaluronic acid; Immune response; ELISA	IMMUNIZATION; VACCINES; VIRUS; EFFICACY; PROTECTS; DEVICE; ADULTS; ARRAY	Transcutaneous immunization (TCI) is an attractive vaccination method compared with conventional injectable vaccines because it is easier to administer without pain. We developed a dissolving microneedle patch (MicroHyala, MH) made of hyaluronic acid and showed that transcutaneous vaccination using MH induced a strong immune response against various antigens in mice. In the present study, we investigated the clinical safety and efficacy of a novel transcutaneous influenza vaccine using MH (flu-MH), which contains trivalent influenza hemagglutinins (15 mu g each). Subjects of the TCI group were treated transcutaneously with flu-MH, and were compared with subjects who received subcutaneous injections of a solution containing 15 mu g of each influenza antigen (SCI group). No severe local or systemic adverse events were detected in either group and immune responses against A/H1N1 and A/H3N2 strains were induced equally in the TCI and SCI groups. Moreover, the efficacy of the vaccine against the B strain in the TCI group was stronger than that in the SCI group. Influenza vaccination using MH is promising for practical use as an easy and effective method to replace conventional injections systems. (C) 2015 Elsevier Ltd. All rights reserved.	[Hirobe, Sachiko; Matsuo, Kazuhiko; Okada, Naoki; Nakagawa, Shinsaku] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Biotechnol & Therapeut, Suita, Osaka 5650871, Japan; [Azukizawa, Hiroaki; Hanafusa, Takaaki; Katayama, Ichiro] Osaka Univ, Grad Sch Med, Dept Dermatol, Course Integrated Med, Suita, Osaka 5650871, Japan; [Quan, Ying-Shu; Kamiyama, Fumio] CosMED Pharmaceut Co Ltd, Minami Ku, Kyoto 6018014, Japan	Nakagawa, S (reprint author), Osaka Univ, Grad Sch Pharmaceut Sci, Lab Biotechnol & Therapeut, 1-6 Yamadaoka, Suita, Osaka 5650871, Japan.	okada@phs.osaka-u.ac.jp; nakagawa@phs.osaka-u.ac.jp			Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO) [08-17]; Health Labour Sciences Research Grant from the Ministry of Health, Labour and Welfare [KH23AC0040]; JSPS KAKENHI from the Ministry of Education, Culture, Sports, Science, and Technology of Japan [24390041, 23659079]	This work was supported by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO) is "08-17", by a Health Labour Sciences Research Grant from the Ministry of Health, Labour and Welfare is "KH23AC0040", and by JSPS KAKENHI Grant Number 24390041 and 23659079 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Ainai A, 2012, J MED VIROL, V84, P336, DOI 10.1002/jmv.22273; Matsuo K, 2012, J CONTROL RELEASE, V160, P495, DOI 10.1016/j.jconrel.2012.04.001; Celli S, 2011, NAT MED, V17, P744, DOI 10.1038/nm.2376; Matsuo K, 2013, VACCINE, V31, P2403, DOI 10.1016/j.vaccine.2013.03.022; Van Damme P, 2009, VACCINE, V27, P454, DOI 10.1016/j.vaccine.2008.10.077; Matsuo K, 2012, J CONTROL RELEASE, V161, P10, DOI 10.1016/j.jconrel.2012.01.033; Ouchi T, 2011, J EXP MED, V208, P2607, DOI 10.1084/jem.20111718; Zhu QY, 2009, P NATL ACAD SCI USA, V106, P7968, DOI 10.1073/pnas.0812652106; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Wong SS, 2013, CLIN MICROBIOL REV, V26, P476, DOI 10.1128/CMR.00097-12; Hirobe S, 2013, PHARM RES-DORDR, V30, P2664, DOI 10.1007/s11095-013-1092-6; Sullivan SP, 2010, NAT MED, V16, P915, DOI 10.1038/nm.2182; Fries LF, 2013, NEW ENGL J MED, V369, P2564, DOI 10.1056/NEJMc1313186; Hirobe S, 2013, EXPERT OPIN DRUG DEL, V10, P485, DOI 10.1517/17425247.2013.760542; Lee Young-Tae, 2014, Clin Exp Vaccine Res, V3, P12, DOI 10.7774/cevr.2014.3.1.12; Maher B, 2009, NATURE, V462, P154, DOI 10.1038/462154a; Valadas E, 2005, EUR J RADIOL, V55, P154, DOI 10.1016/j.ejrad.2005.04.013	17	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0142-9612	1878-5905		BIOMATERIALS	Biomaterials	JUL	2015	57						50	58		10.1016/j.biomaterials.2015.04.007		9	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	CJ2ZZ	WOS:000355354500006		
J	Furukawa, R; Yamada, Y; Kawamura, E; Harashima, H				Furukawa, Ryo; Yamada, Yuma; Kawamura, Eriko; Harashima, Hideyoshi			Mitochondrial delivery of antisense RNA by MITO-Porter results in mitochondrial RNA knockdown, and has a functional impact on mitochondria	BIOMATERIALS			English	Article						Mitochondria; Mitochondrial drug delivery; Mitochondrial RNA knockdown; MITO-Porter; Nucleic acids delivery; Nanotechnology	CYTOCHROME-C-OXIDASE; RIBOSOMAL-RNA; IN-VITRO; LEISHMANIA MITOCHONDRIA; MEDIATED DELIVERY; SIRNA DELIVERY; GENE DELIVERY; IMPORT; MEMBRANE; CELLS	Mitochondrial genome-targeting nucleic acids are promising therapeutic candidates for treating mitochondrial diseases. To date, a number of systems for delivering genetic information to the cytosol and the nucleus have been reported, and several successful gene therapies involving gene delivery targeted to the cytosol and the nucleus have been reported. However, much less progress has been made concerning mitochondrial gene delivery systems, and mitochondrial gene therapy has never been achieved. Here, we report on the mitochondrial delivery of an antisense RNA oligonucleotide (ASO) to perform mitochondrial RNA knockdown to regulate mitochondrial function. Mitochondrial delivery of the ASO was achieved using a combination of a MITO-Porter system, which contains mitochondrial fusogenic lipid envelopes for mitochondrial delivery via membrane fusion and D-arm, a mitochondrial import signal of tRNA to the matrix. Mitochondrial delivery of the ASO induces the knockdown of the targeted mitochondria-encoded mRNA and protein, namely cytochrome c oxidase subunit II, a component of the mitochondrial respiratory chain. Furthermore, the mitochondrial membrane potential was depolarized by the down regulation of the respiratory chain as the result of the mitochondrial delivery of ASO. This finding constitutes the first report to demonstrate that the nanocarrier-mediated mitochondrial genome targeting of antisense RNA effects mitochondrial function. (C) 2015 Elsevier Ltd. All rights reserved.	[Furukawa, Ryo; Yamada, Yuma; Kawamura, Eriko; Harashima, Hideyoshi] Hokkaido Univ, Fac Pharmaceut Sci, Lab Mol Design Pharmaceut, Kita Ku, Sapporo, Hokkaido 0600812, Japan	Harashima, H (reprint author), Hokkaido Univ, Fac Pharmaceut Sci, Lab Mol Design Pharmaceut, Kita Ku, Kita 12,Nishi 6, Sapporo, Hokkaido 0600812, Japan.	harasima@pharm.hokudai.ac.jp			Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation, Japan (NIBIO) [10-62]; Ministry of Education, Culture, Sports, Science and Technology of Japanese Government (MEXT) [23680053, 22229001]	This work was supported, in part, by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation, Japan (NIBIO) (project ID 10-62 to Y.Y.) and by a Grant-in-Aid for Young Scientists (A) (grant 23680053 to Y.Y.) and Scientific Research (S) (grant 22229001 to H.H.) from the Ministry of Education, Culture, Sports, Science and Technology of Japanese Government (MEXT). We thank Milton Feather for his helpful advice in writing the manuscript.	Akita H, 2011, J CONTROL RELEASE, V149, P58, DOI 10.1016/j.jconrel.2010.08.023; Flierl A, 2003, MOL THER, V7, P550, DOI 10.1016/S1525-0016(03)00037-6; Entelis NS, 2001, J BIOL CHEM, V276, P45642, DOI 10.1074/jbc.M103906200; Kakudo T, 2004, BIOCHEMISTRY-US, V43, P5618, DOI 10.1021/bi035802w; Khalil IA, 2006, J BIOL CHEM, V281, P3544, DOI 10.1074/jbc.M503202200; Sripada L, 2012, MITOCHONDRION, V12, P593, DOI 10.1016/j.mito.2012.10.009; Rubio MAT, 2008, P NATL ACAD SCI USA, V105, P9186, DOI 10.1073/pnas.0804283105; D'Souza GGM, 2003, J CONTROL RELEASE, V92, P189, DOI 10.1016/S0168-3659(03)00297-9; Smirnov A, 2010, J BIOL CHEM, V285, P30792, DOI 10.1074/jbc.M110.151183; Bhattacharyya SN, 2002, MOL CELL BIOL, V22, P4372, DOI 10.1128/MCB.22.12.4372-4382.2002; Capaldi RA, 1995, METHOD ENZYMOL, V260, P117, DOI 10.1016/0076-6879(95)60134-1; Huang L, 2011, J BIOL CHEM, V286, P24219, DOI 10.1074/jbc.M111.240259; Das S, 2012, CIRC RES, V110, P1596, DOI 10.1161/CIRCRESAHA.112.267732; Miyata K, 2012, CHEM SOC REV, V41, P2562, DOI 10.1039/c1cs15258k; Szczesny RJ, 2012, BBA-GENE REGUL MECH, V1819, P1027, DOI 10.1016/j.bbagrm.2011.11.010; Sato Y, 2012, J CONTROL RELEASE, V163, P267, DOI 10.1016/j.jconrel.2012.09.009; Chen JQ, 2009, BBA-MOL CELL RES, V1793, P1540, DOI 10.1016/j.bbamcr.2009.06.001; Reers M, 1995, METHOD ENZYMOL, V260, P406, DOI 10.1016/0076-6879(95)60154-6; Wu CG, 2009, AM J PHYSIOL-CELL PH, V297, pC928, DOI 10.1152/ajpcell.00045.2009; Gomes-da-Silva LC, 2012, ACCOUNTS CHEM RES, V45, P1163, DOI 10.1021/ar300048p; Borowski LS, 2013, NUCLEIC ACIDS RES, V41, P1223, DOI 10.1093/nar/gks1130; Smirnov A, 2011, GENE DEV, V25, P1289, DOI 10.1101/gad.624711; Duchene AM, 2009, CURR GENET, V55, P1, DOI 10.1007/s00294-008-0223-9; Li WJ, 2004, ADV DRUG DELIVER REV, V56, P967, DOI 10.1016/j.addr.2003.10.041; Yamada Y, 2008, ADV DRUG DELIVER REV, V60, P1439, DOI 10.1016/j.addr.2008.04.016; Nakamura T, 2012, ACCOUNTS CHEM RES, V45, P1113, DOI 10.1021/ar200254s; Bandiera S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020746; Bhattacharyya SN, 2000, MOL CELL BIOL, V20, P7410, DOI 10.1128/MCB.20.19.7410-7417.2000; Kolesnikova OA, 2004, HUM MOL GENET, V13, P2519, DOI 10.1093/hmg/ddh267; Liou GG, 2001, P NATL ACAD SCI USA, V98, P63, DOI 10.1073/pnas.011535498; Lyrawati D, 2011, PHARM RES, V28, P2848; Mahapatra S, 1998, NUCLEIC ACIDS RES, V26, P2037, DOI 10.1093/nar/26.9.2037; Mukherjee S, 2008, HUM MOL GENET, V17, P1292, DOI 10.1093/hmg/ddn017; SEIBEL P, 1995, NUCLEIC ACIDS RES, V23, P10, DOI 10.1093/nar/23.1.10; Wang DDH, 2009, J BIOL CHEM, V284, P20812, DOI 10.1074/jbc.M109.009605; Yamada Y., 2012, J NANOPART RES, V14, P1013; Yamada Y, 2011, MOL THER, V19, P1449, DOI 10.1038/mt.2011.99; Yamada Y, 2008, BBA-BIOMEMBRANES, V1778, P423, DOI 10.1016/j.bbamem.2007.11.002	38	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0142-9612	1878-5905		BIOMATERIALS	Biomaterials	JUL	2015	57						107	115		10.1016/j.biomaterials.2015.04.022		9	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	CJ2ZZ	WOS:000355354500011		
J	Li, GZ; Azuma, S; Sato, S; Minegishi, H; Nakamura, H				Li, Guangzhe; Azuma, Soyoko; Sato, Shinichi; Minegishi, Hidemitsu; Nakamura, Hiroyuki			ortho-Carboranylphenoxyacetanilides as inhibitors of hypoxia-inducible factor (HIF)-1 transcriptional activity and heat shock protein (HSP) 60 chaperon activity	BIOORGANIC & MEDICINAL CHEMISTRY LETTERS			English	Article						Hypoxia-inducible factor (HIF)-1 alpha; Carborane; Inhibitor; Angiogenesis; Heat shock protein (HSP) 60	CANCER; TARGET; HIF-1-ALPHA; CARBORANES; DISCOVERY; BINDING; HIF-1	ortho-Carboranylphenoxy derivatives were synthesized and evaluated for their ability to inhibit hypoxia-induced HIF-1 transcriptional activity using a cell-based reporter gene assay. Among the compounds synthesized, compound 1d showed the most significant inhibition of hypoxia-induced HIF-1 transcriptional activity with the IC50 of 0.53 mu M. Furthermore, compound 1h was found to possess the most significant inhibition of heat shock protein (HSP) 60 chaperon activity among the reported inhibitors: the IC50 toward the porcine heart malate dehydrogenase (MDH) refolding assay was 0.35 mu M. (C) 2015 Elsevier Ltd. All rights reserved.	[Li, Guangzhe; Sato, Shinichi; Minegishi, Hidemitsu; Nakamura, Hiroyuki] Tokyo Inst Technol, Chem Resources Lab, Midori Ku, Yokohama, Kanagawa 2268503, Japan; [Azuma, Soyoko; Minegishi, Hidemitsu] Gakushuin Univ, Fac Sci, Dept Life Sci, Toshima Ku, Tokyo 1718588, Japan	Nakamura, H (reprint author), Tokyo Inst Technol, Chem Resources Lab, Midori Ku, Nagatsuta Cho, Yokohama, Kanagawa 2268503, Japan.	hiro@res.titech.ac.jp	Nakamura, Hiroyuki/E-8627-2014	Nakamura, Hiroyuki/0000-0002-4511-2984	Ministry of Education, Culture, Sports, Science and Technology, Japan	This work was partially supported by a Grant-in-Aid for Scientific Research on Innovative Areas 'Chemical Biology of Natural Products' from The Ministry of Education, Culture, Sports, Science and Technology, Japan.	Nakamura H, 2013, BIOORG MED CHEM LETT, V23, P806, DOI 10.1016/j.bmcl.2012.11.081; Shimizu K, 2010, BIOORG MED CHEM LETT, V20, P1453, DOI 10.1016/j.bmcl.2009.12.037; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Ban HS, 2010, J AM CHEM SOC, V132, P11870, DOI 10.1021/ja104739t; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Nakamura H, 2014, DALTON T, V43, P4941, DOI 10.1039/c3dt52828f; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; SCHLESINGER MJ, 1990, J BIOL CHEM, V265, P12111; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Minegishi H, 2013, CHEMMEDCHEM, V8, P265, DOI 10.1002/cmdc.201200502; Ciocca DR, 2005, CELL STRESS CHAPERON, V10, P86, DOI 10.1379/CSC-99r.1; JINDAL S, 1989, MOL CELL BIOL, V9, P2279; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Itoh H, 1999, J BIOL CHEM, V274, P35147, DOI 10.1074/jbc.274.49.35147; Khalil AA, 2007, CANCER SCI, V98, P201, DOI 10.1111/j.1349-7006.2007.00374.x; Chapman E, 2009, BIOORG MED CHEM LETT, V19, P811, DOI 10.1016/j.bmcl.2008.12.015; Nakamura H, 2013, CURR PHARM DESIGN, V19, P441; Ban HS, 2011, EXPERT OPIN THER PAT, V21, P131, DOI 10.1517/13543776.2011.547477; Nielsen KL, 1998, MOL CELL, V2, P93, DOI 10.1016/S1097-2765(00)80117-3; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Nagumo Y, 2005, BIOCHEM J, V387, P835, DOI 10.1042/BJ20041355; Minegishi H, 2013, ACS MED CHEM LETT, V4, P297, DOI 10.1021/ml3004632; Bajramovic JJ, 2000, CELL STRESS CHAPERON, V5, P30, DOI 10.1379/1466-1268(2000)005<0030:TSKANM>2.0.CO;2; CAPPELLO F, 2008, J CANC BIOL THER, V7, P801; Cappello F, 2014, EXPERT OPIN THER TAR, V18, P185, DOI 10.1517/14728222.2014.856417; Cong ZQ, 2008, SYNTHESIS-STUTTGART, P2686, DOI 10.1055/s-2008-1067206; Hansen JJ, 2003, HUM GENET, V112, P71, DOI 10.1007/s00439-002-0837-9; Heilman-Miller SL, 2001, J MOL BIOL, V309, P57, DOI 10.1006/jmbi.2001.4660; Nail R., 2012, J MED CHEM, V55, P10564; Takeuchi A, 2012, MEDCHEMCOMM, V3, P1455, DOI 10.1039/c2md20134h; Wu DL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062014	31	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-894X	1464-3405		BIOORG MED CHEM LETT	Bioorg. Med. Chem. Lett.	JUL 1	2015	25	13					2624	2628		10.1016/j.bmcl.2015.04.088		5	Chemistry, Medicinal; Chemistry, Organic	Pharmacology & Pharmacy; Chemistry	CJ2VR	WOS:000355343300005		
J	Ohashi, M; Oyama, T; Miyachi, H				Ohashi, Masao; Oyama, Takuji; Miyachi, Hiroyuki			Different structures of the two peroxisome proliferator-activated receptor gamma (PPAR gamma) ligand-binding domains in homodimeric complex with partial agonist, but not full agonist	BIOORGANIC & MEDICINAL CHEMISTRY LETTERS			English	Article						PPAR; X-ray crystallographic analysis; Acylsulfonamide derivative; Homodimeric complex	ADIPOGENESIS; MECHANISM; ALPHA	We designed and synthesized acylsulfonamide derivative (3) as a human peroxisome proliferator-activated receptor gamma (hPPAR gamma) partial agonist by structural modification of hPPAR gamma full agonist 1. Co-crystallization of 3 with hPPAR gamma LBD afforded a homodimeric complex, and X-ray crystallographic analysis at 2.1 angstrom resolution showed that one of the LBDs adopts a fully active structure identical with that in the complex of rosiglitazone, a full agonist; however, the other LBD in the complex of 3 exhibits a different (non-fully active) structure. Interestingly, the apo-homodimer contained similar LBD structures. Intrigued by these results, we surveyed reported X-ray crystal structures of partial agonists complexed with hPPAR gamma LBD homodimer, and identified several types of LBD structures distinct from the fully active structure. In contrast, both LBDs in the rosiglitazone complex have the fully active structure. These results suggest hPPAR gamma partial agonists lack the ability to induce fully active LBD. The presence of at least one non-fully active LBD in the agonist complex may be a useful criterion to distinguish hPPAR gamma partial agonists from full agonists. (C) 2015 Elsevier Ltd. All rights reserved.	[Ohashi, Masao; Miyachi, Hiroyuki] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Kita Ku, Okayama 7008530, Japan; [Oyama, Takuji] Univ Yamanashi, Fac Life & Environm Sci, Dept Biotechnol, Kofu, Yamanashi 4008510, Japan	Miyachi, H (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Kita Ku, 1-1-1 Tsushima Naka, Okayama 7008530, Japan.	miyachi@pharm.okayama-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan; Terumo Foundation; Ministry of Education, Culture, Sports, Science and Technology (MEXT) [26293027]	This work was supported in part by a grant for Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan, Terumo Foundation and a Grant in-aid for Scientific Research KAKENHI (B) (grant number 26293027 to H.M.) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT). We also thank the SC-NMR Laboratory of Okayama University for NMR measurements.	Pochetti G, 2007, J BIOL CHEM, V282, P17314, DOI 10.1074/jbc.M702316200; Taygerly JP, 2013, BIOORGAN MED CHEM, V21, P979, DOI 10.1016/j.bmc.2012.11.058; Einstein M, 2008, MOL PHARMACOL, V73, P62, DOI 10.1124/mol.107.041202; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Bruning JB, 2007, STRUCTURE, V15, P1258, DOI 10.1016/j.str.2007.07.014; Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354; Geldmacher DS, 2011, ARCH NEUROL-CHICAGO, V68, P45, DOI 10.1001/archneurol.2010.229; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Kawai M, 2010, NAT REV ENDOCRINOL, V6, P629, DOI 10.1038/nrendo.2010.155; Nolte RT, 1998, NATURE, V395, P137; George A. K., 1980, J ORG CHEM, V45, P1175; Kuwabara N, 2012, J MED CHEM, V55, P893, DOI 10.1021/jm2014293; Liu WG, 2011, J MED CHEM, V54, P8541, DOI 10.1021/jm201061j; Nuclear Receptors Nomenclature Committee, 1999, CELL, V97, P161; Ohashi M., 2015, EUR J MED CHEM, V27, P53; Tachibana K., 2008, PPAR RES, V15; Tsujimura T, 2009, BIOL PHARM BULL, V32, P1991	17	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-894X	1464-3405		BIOORG MED CHEM LETT	Bioorg. Med. Chem. Lett.	JUL 1	2015	25	13					2639	2644		10.1016/j.bmcl.2015.04.076		6	Chemistry, Medicinal; Chemistry, Organic	Pharmacology & Pharmacy; Chemistry	CJ2VR	WOS:000355343300008		
J	Tsumoto, H; Ogasawara, D; Hashii, N; Suzuki, T; Akimoto, Y; Endo, T; Miura, Y				Tsumoto, Hiroki; Ogasawara, Daisuke; Hashii, Noritaka; Suzuki, Takayoshi; Akimoto, Yoshihiro; Endo, Tamao; Miura, Yuri			Enrichment of O-GlcNAc-modified peptides using novel thiol-alkyne and thiol-disulfide exchange	BIOORGANIC & MEDICINAL CHEMISTRY LETTERS			English	Article						O-GlcNAc; Enrichment; Thiol-alkyne; Thiol-disulfide exchange	ELECTRON-TRANSFER DISSOCIATION; LINKED N-ACETYLGLUCOSAMINE; GLCNACYLATION; PHOSPHORYLATION; IDENTIFICATION; METABOLISM; DISEASE; ROLES; SITES	We have developed a selective method for the enrichment of O-linked beta-N-acetylglucosamine (O-GlcNAc)-modified peptides, which uses a newly synthesized thiol-alkyne and a thiol-disulfide exchange. First, O-GlcNAc-modified peptides were enzymatically labeled with an azide-containing GalNAc analog. Then, the azide moiety was reacted with thiol-alkyne through a copper(I)-catalyzed azide-alkyne cycloaddition. The thiol-modified peptides were enriched with thiol-reactive resin through a thiol-disulfide exchange. At least 500 fmol of O-GlcNAc-modified peptides was selectively isolated from alpha-crystallin tryptic peptides and detected by mass spectrometry. This novel enrichment strategy could be used for O-GlcNAcome analysis of biological samples. (C) 2015 Elsevier Ltd. All rights reserved.	[Tsumoto, Hiroki; Endo, Tamao; Miura, Yuri] Tokyo Metropolitan Inst Gerontol, Res Team Mech Aging, Itabashi Ku, Tokyo 1730015, Japan; [Ogasawara, Daisuke; Suzuki, Takayoshi] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Sakyo Ku, Kyoto 6060823, Japan; [Hashii, Noritaka] Natl Inst Hlth Sci, Div Biol Chem & Biol, Setagaya Ku, Tokyo 1588501, Japan; [Akimoto, Yoshihiro] Kyorin Univ, Sch Med, Dept Anat, Mitaka, Tokyo 1818611, Japan	Miura, Y (reprint author), Tokyo Metropolitan Inst Gerontol, Res Team Mech Aging, Itabashi Ku, 35-2 Sakae Cho, Tokyo 1730015, Japan.	miura@center.tmig.or.jp					Dehennaut V, 2008, MOL CELL PROTEOMICS, V7, P2229, DOI 10.1074/mcp.M700494-MCP200; Suzuki T, 2012, J MED CHEM, V55, P9562, DOI 10.1021/jm300837y; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Groves JA, 2013, CELL STRESS CHAPERON, V18, P535, DOI 10.1007/s12192-013-0426-y; Wang ZH, 2010, MOL CELL PROTEOMICS, V9, P153, DOI 10.1074/mcp.M900268-MCP200; Overath T, 2012, MOL CELL PROTEOMICS, V11, P467, DOI 10.1074/mcp.M111.015966; Trinidad JC, 2012, MOL CELL PROTEOMICS, V11, P215, DOI 10.1074/mcp.O112.018366; Wells L, 2002, MOL CELL PROTEOMICS, V1, P791, DOI 10.1074/mcp.M200048-MCP200; Hanover JA, 2012, NAT REV MOL CELL BIO, V13, P312, DOI 10.1038/nrm3334; Forrester MT, 2009, NAT BIOTECHNOL, V27, P557, DOI 10.1038/nbt.1545; Klement E, 2010, J PROTEOME RES, V9, P2200, DOI 10.1021/pr900984h; Parker BL, 2011, J PROTEOME RES, V10, P1449, DOI 10.1021/pr100565j; Ma JF, 2013, EXPERT REV PROTEOMIC, V10, P365, DOI 10.1586/14789450.2013.820536; Ma ZY, 2014, J BIOL CHEM, V289, P34457, DOI 10.1074/jbc.R114.577718; Ruan HB, 2013, MOL CELL PROTEOMICS, V12, P3489, DOI 10.1074/mcp.R113.029751; Wang S., 2012, CHEM COMMUN, P5907; Zhao P, 2011, J PROTEOME RES, V10, P4088, DOI 10.1021/pr2002726; Zhu YP, 2014, J BIOL CHEM, V289, P34472, DOI 10.1074/jbc.R114.601351	18	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-894X	1464-3405		BIOORG MED CHEM LETT	Bioorg. Med. Chem. Lett.	JUL 1	2015	25	13					2645	2649		10.1016/j.bmcl.2015.04.082		5	Chemistry, Medicinal; Chemistry, Organic	Pharmacology & Pharmacy; Chemistry	CJ2VR	WOS:000355343300009		
J	Noda, A; Sakai, E; Kato, H; Losung, F; Mangindaan, REP; de Voogd, NJ; Yokosawa, H; Tsukamoto, S				Noda, Ai; Sakai, Eriko; Kato, Hikaru; Losung, Fitje; Mangindaan, Remy E. P.; de Voogd, Nicole J.; Yokosawa, Hideyoshi; Tsukamoto, Sachiko			Strongylophorines, meroditerpenoids from the marine sponge Petrosia corticata, function as proteasome inhibitors	BIOORGANIC & MEDICINAL CHEMISTRY LETTERS			English	Article						Strongylophorine; Meroditerpenoid; Petrosia corticata; Proteasome inhibitor	ACANTHOSTRONGYLOPHORA-INGENS; DRUG TARGETS; DURISSIMA; CANCER; SYSTEM	Two new strongylophorine derivatives, along with six known strongylophorines, were isolated from the marine sponge Petrosia corticata as proteasome inhibitors. Of these, a hemiacetal mixture of strongylophorines-13/-14 was the strongest inhibitor of the proteasome with an IC50 of 2.1 mu M. (C) 2015 Elsevier Ltd. All rights reserved.	[Noda, Ai; Sakai, Eriko; Kato, Hikaru; Tsukamoto, Sachiko] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Nat Med, Kumamoto 8620973, Japan; [Losung, Fitje; Mangindaan, Remy E. P.] Sam Ratulangi Univ, Fac Fisheries & Marine Sci, Manado 95115, Indonesia; [de Voogd, Nicole J.] Nat Biodivers Ctr, NL-2300 RA Leiden, Netherlands; [Yokosawa, Hideyoshi] Aichi Gakuin Univ, Sch Pharm, Chikusa Ku, Nagoya, Aichi 4648650, Japan	Tsukamoto, S (reprint author), Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Nat Med, Oe Honmachi 5-1, Kumamoto 8620973, Japan.	sachiko@kumamoto-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [18406002, 2593025]	We are grateful to Professor M. Namikoshi and Dr. K. Ukai of Tohoku Pharmaceutical University for collection of the sponge. We thank Dr. S. Ando of Department of Pharmaceutical Molecular Design, Graduate School of Pharmaceutical Sciences, Kumamoto University for valuable advice on preparation of 9. This work was financially supported in part by Grants-in-Aid for Scientific Research (Nos. 18406002 and 2593025 to S.T.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Thompson JL, 2013, ANN PHARMACOTHER, V47, P56, DOI 10.1345/aph.1R561; Liu J, 2015, BBA-REV CANCER, V1855, P50, DOI 10.1016/j.bbcan.2014.11.005; SALVA J, 1990, J ORG CHEM, V55, P1941, DOI 10.1021/jo00293a047; Furusato A, 2014, ORG LETT, V16, P3888, DOI 10.1021/ol5015569; Bedford L, 2011, NAT REV DRUG DISCOV, V10, P29, DOI 10.1038/nrd3321; Adams J, 2003, DRUG DISCOV TODAY, V8, P307, DOI 10.1016/S1359-6446(03)02647-3; Cohen P, 2010, CELL, V143, P686, DOI 10.1016/j.cell.2010.11.016; BRAEKMAN JC, 1978, B SOC CHIM BELG, V87, P917; El-Desoky AH, 2014, J NAT PROD, V77, P1536, DOI 10.1021/np500290a; Hoshino A, 2003, J NAT PROD, V66, P1600, DOI 10.1021/np030312q; Liu HW, 2005, J ASIAN NAT PROD RES, V7, P661, DOI 10.1080/1028602032000169604; Tsukamoto S, 2010, BIOORG MED CHEM LETT, V20, P3341, DOI 10.1016/j.bmcl.2010.04.029	12	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-894X	1464-3405		BIOORG MED CHEM LETT	Bioorg. Med. Chem. Lett.	JUL 1	2015	25	13					2650	2653		10.1016/j.bmcl.2015.04.075		4	Chemistry, Medicinal; Chemistry, Organic	Pharmacology & Pharmacy; Chemistry	CJ2VR	WOS:000355343300010		
J	Koura, M; Matsuda, T; Okuda, A; Watanabe, Y; Yamaguchi, Y; Kurobuchi, S; Matsumoto, Y; Shibuya, K				Koura, Minoru; Matsuda, Takayuki; Okuda, Ayumu; Watanabe, Yuichiro; Yamaguchi, Yuki; Kurobuchi, Sayaka; Matsumoto, Yuuki; Shibuya, Kimiyuki			Design, synthesis and pharmacology of 1,1-bistrifluoromethylcarbinol derivatives as liver X receptor beta-selective agonists	BIOORGANIC & MEDICINAL CHEMISTRY LETTERS			English	Article						Liver X receptor (LXR) beta-selective; LDL-C; 1,1-Bistrifluoromethylcarbinol; Anti-atherosclerosis	LIGAND-BINDING DOMAIN; CRYSTAL-STRUCTURE; SIGNALING PATHWAYS; DEFICIENT MICE; LXR-ALPHA; ATHEROSCLEROSIS; DISCOVERY; COMPLEX	A novel series of 1,3-bistrifluoromethylcarbinol derivatives that act as liver X receptor (LXR) beta-selective agonists was discovered. Structure-activity relationship studies led to the identification of molecule 62, which was more effective (E-max) and selective toward LXR beta than T0901317 and GW3965. Furthermore, 62 decreased LDL-C without elevating the plasma TG level and significantly suppressed the lipid-accumulation area in the aortic arch in a Bio F1B hamster fed a diet high in fat and cholesterol. We demonstrated that our LXRb agonist would be potentially useful as a hypolipidemic and anti-atherosclerotic agent. In this manuscript, we report the design, synthesis and pharmacology of 1,3-bistrifluoromethylcarbinol derivatives. (C) 2015 Elsevier Ltd. All rights reserved.	[Koura, Minoru; Matsuda, Takayuki; Okuda, Ayumu; Watanabe, Yuichiro; Yamaguchi, Yuki; Kurobuchi, Sayaka; Matsumoto, Yuuki; Shibuya, Kimiyuki] Kowa Co Ltd, Div Pharmaceut, Tokyo New Drug Res Labs, Tokyo 1890022, Japan	Shibuya, K (reprint author), Kowa Co Ltd, Div Pharmaceut, Tokyo New Drug Res Labs, 2-17-43 Noguchicho, Tokyo 1890022, Japan.	k-sibuya@kowa.co.jp					Joseph SB, 2002, P NATL ACAD SCI USA, V99, P7604, DOI 10.1073/pnas.112059299; [Anonymous], 2009, Int. Patent Appl, Patent No. [WO2009122707, 2009122707]; Quinet EM, 2006, MOL PHARMACOL, V70, P1340, DOI 10.1124/mol.106.022608; [Anonymous], 2008, Int. Patent Appl, Patent No. [WO2008065754, 2008065754]; Hoerer S, 2003, J MOL BIOL, V334, P853, DOI 10.1016/j.jmb.2003.10.033; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Calkin AC, 2012, NAT REV MOL CELL BIO, V13, P213, DOI 10.1038/nrm3312; Ikenoya M, 2007, ATHEROSCLEROSIS, V191, P290, DOI 10.1016/j.atherosclerosis.2006.05.048; [Anonymous], 2009, Int. Patent Appl, Patent No. [WO2009107387, 2009107387]; Svensson S, 2003, EMBO J, V22, P4625, DOI 10.1093/emboj/cdg456; Bucherer HT, 1934, J PRAKTISCHE CHEMIE, V140, P291; Fievet C, 2009, BIOCHEM PHARMACOL, V77, P1316, DOI 10.1016/j.bcp.2008.11.026; Terasaka N, 2003, FEBS LETT, V536, P6, DOI 10.1016/S0014-5793(02)03578-0; Calkin AC, 2010, ARTERIOSCL THROM VAS, V30, P1513, DOI 10.1161/ATVBAHA.109.191197; Williams S, 2003, J BIOL CHEM, V278, P27138, DOI 10.1074/jbc.M302260200; WILLY PJ, 1995, GENE DEV, V9, P1033, DOI 10.1101/gad.9.9.1033; WARE E, 1950, CHEM REV, V46, P403, DOI 10.1021/cr60145a001; Lund EG, 2003, ARTERIOSCL THROM VAS, V23, P1169, DOI 10.1161/01.ATV.0000056743.42348.59; Farnegardh M, 2003, J BIOL CHEM, V278, P38821, DOI 10.1074/jbc.M304842200; Tontonoz P, 2003, MOL ENDOCRINOL, V17, P985, DOI 10.1210/me.2003-0061; Bennett DJ, 2008, CURR MED CHEM, V15, P195; Bergs H, 1929, Ger. Pat., Patent No. [566,094, 566094]; Bucherer HT, 1934, J PRAKTISCHE CHEMIE, V140, P69; Friedel P., 1877, CR HEBD ACAD SCI, V84, P1392; Friedel P., 1877, CR HEBD ACAD SCI, V84, P1450; Li LP, 2006, BIOORG MED CHEM LETT, V16, P1638, DOI 10.1016/j.bmcl.2005.12.015; Matsuda T, 2015, BIOORG MED CHEM LETT, V25, P1274, DOI 10.1016/j.bmcl.2015.01.047; Michael J., 2003, CURR OPIN INVEST DR, V4, P1053; MITSUNOBU O, 1981, SYNTHESIS-STUTTGART, P1, DOI 10.1055/s-1981-29317; Nuclear Receptors Nomenclature Committee, 1999, CELL, V97, P161; Plat J, 2002, FASEB J, V16, DOI 10.1096/fj.01-0718hyp; Srivastava RAK, 2011, ATHEROSCLEROSIS, V214, P86, DOI 10.1016/j.atherosclerosis.2010.10.033; Zhang Y, 2009, CLIN LIPIDOL, V4, P29, DOI 10.2217/17584299.4.1.29	33	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-894X	1464-3405		BIOORG MED CHEM LETT	Bioorg. Med. Chem. Lett.	JUL 1	2015	25	13					2668	2674		10.1016/j.bmcl.2015.04.080		7	Chemistry, Medicinal; Chemistry, Organic	Pharmacology & Pharmacy; Chemistry	CJ2VR	WOS:000355343300014		
J	Yamada, H; Hasegawa, Y; Suzuki, Y; Imai, H; Matsuda, T; Kimura, Y; Toshimitsu, A; Aoyama, Y; Kondo, T				Yamada, Hisatsugu; Hasegawa, Yoshinori; Suzuki, Yuki; Imai, Hirohiko; Matsuda, Tetsuya; Kimura, Yu; Toshimitsu, Akio; Aoyama, Yasuhiro; Kondo, Teruyuki			Magnetic resonance imaging of tumor with a self-traceable polymer conjugated with an antibody fragment	BIOORGANIC & MEDICINAL CHEMISTRY LETTERS			English	Article						Tumor imaging; MRI; Self-traceable polymer; Anti-Her2 antibody; Active targeting	IN-VIVO; CANCER; F-19; NANOPARTICLES; AGENT; SIZE; THERAPEUTICS; ACCUMULATION; SPECTROSCOPY; INHIBITION	A C-13-enriched phosphorylcholine polymer (C-13-PMPC) as a self-traceable MR (magnetic resonance) tag was conjugated with a fragment (scFv) of Herceptin, a clinical antibody against antigen Her2. When injected in model mice bearing Her2(+) (gastric) and Her2(-) (pancreatic) tumors, the antibody-tag conjugate C-13-PMPC-scFv selectively accumulated in the Her2(+) tumor with a rapid build-up/decay (accumulation/clearance) profile and, with the use of the H-1-C-13 double-resonance (heteronuclear correlation) technique, the Her2(+) gastric tumor was clearly MR imaged. (C) 2015 Elsevier Ltd. All rights reserved.	[Yamada, Hisatsugu; Kondo, Teruyuki] Kyoto Univ, Ctr Promot Interdisciplinary Educ & Res, Adv Biomed Engn Res Unit, Nishikyo Ku, Kyoto 6158510, Japan; [Hasegawa, Yoshinori; Suzuki, Yuki; Toshimitsu, Akio; Kondo, Teruyuki] Kyoto Univ, Grad Sch Engn, Dept Energy & Hydrocarbon Chem, Nishikyo Ku, Kyoto 6158510, Japan; [Imai, Hirohiko; Matsuda, Tetsuya] Kyoto Univ, Grad Sch Informat, Dept Syst Sci, Sakyo Ku, Kyoto 6068501, Japan; [Kimura, Yu] Kyoto Univ, Ctr Promot Interdisciplinary Educ & Res, Res & Educ Unit Leaders Integrated Med Syst, Nishikyo Ku, Kyoto 6158510, Japan; [Toshimitsu, Akio] Kyoto Univ, Inst Chem Res, Div Multidisciplinary Chem, Kyoto 6110011, Japan; [Aoyama, Yasuhiro] Kyoto Univ, Nishikyo Ku, Kyoto 6158510, Japan	Aoyama, Y (reprint author), Kyoto Univ, Nishikyo Ku, Kyoto 6158510, Japan.	aoyama.yasuhiro.78z@st.kyoto-u.ac.jp; teruyuki@scl.kyoto-u.ac.jp			innovative Techno-Hub for Integrated Medical Bio-Imaging of the Project for Developing Innovation Systems, from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; JSPS, Japan [25350977]; JSPS [15K01819, 15H01403]; Princess Takamatsu Cancer Research Fund; Magnetic Health Science Foundation; SEI Group CSR Foundation	This work was supported by the innovative Techno-Hub for Integrated Medical Bio-Imaging of the Project for Developing Innovation Systems, from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, and partly by Grant-in-Aid No. 25350977 from JSPS, Japan. TK acknowledges financial support from JSPS Grant-in-Aid No. 15K01819, 15H01403, the Princess Takamatsu Cancer Research Fund, Magnetic Health Science Foundation, and SEI Group CSR Foundation. We thank Profs. Masahiro Shirakawa and Hidehito Tochio, and Drs. Shin Isogai, Kayo Imamura (Kyoto University) and Fumio Yamauchi (Canon Inc.) for their technical support and their kind gift of scFv used in this work. We also thank Prof. Shinsuke Sando (The University of Tokyo) for his valuable discussion.	CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; VANZIJL PCM, 1993, MAGNET RESON MED, V30, P544, DOI 10.1002/mrm.1910300504; Yu JX, 2005, CURR MED CHEM, V12, P819, DOI 10.2174/0929867053507342; Day SE, 2007, NAT MED, V13, P1382, DOI 10.1038/nm1650; Yamada H, 2015, J AM CHEM SOC, V137, P799, DOI 10.1021/ja510479v; Petros RA, 2010, NAT REV DRUG DISCOV, V9, P615, DOI 10.1038/nrd2591; Park TG, 2006, ADV DRUG DELIVER REV, V58, P467, DOI 10.1016/j.addr.2006.03.007; Hanaoka K, 2008, MAGN RESON IMAGING, V26, P608, DOI 10.1016/j.mri.2007.11.002; Duncan R, 2006, NAT REV CANCER, V6, P688, DOI 10.1038/nrc1958; Lewis AL, 2000, COLLOID SURFACE B, V18, P261, DOI 10.1016/S0927-7765(99)00152-6; Villaraza AJL, 2010, CHEM REV, V110, P2921, DOI 10.1021/cr900232t; Rolfe BE, 2014, J AM CHEM SOC, V136, P2413, DOI 10.1021/ja410351h; Lippert AR, 2011, J AM CHEM SOC, V133, P3776, DOI 10.1021/ja111589a; Walker-Samuel S, 2013, NAT MED, V19, P1067, DOI 10.1038/nm.3252; Harris JM, 2003, NAT REV DRUG DISCOV, V2, P214, DOI 10.1038/nrd1033; Davis ME, 2008, NAT REV DRUG DISCOV, V7, P771, DOI 10.1038/nrd2614; Cabral H, 2011, NAT NANOTECHNOL, V6, P815, DOI [10.1038/nnano.2011.166, 10.1038/NNANO.2011.166]; Kano MR, 2007, P NATL ACAD SCI USA, V104, P3460, DOI 10.1073/pnas.0611660104; Duncan R, 2013, CANCER CHEMOTH PHARM, V72, P417, DOI 10.1007/s00280-013-2209-7; Matsushita H, 2014, ANGEW CHEM INT EDIT, V53, P1008, DOI 10.1002/anie.201308500; Sosnovik DE, 2007, CURR OPIN BIOTECH, V18, P4, DOI 10.1016/j.copbio.2006.11.001; Tanner M, 2005, ANN ONCOL, V16, P273, DOI 10.1093/annonc/mdi064; Vernimmen D, 2003, BRIT J CANCER, V89, P899, DOI 10.1038/sj.bjc.6601200; Takaoka Y, 2009, NAT CHEM, V1, P557, DOI [10.1038/nchem.365, 10.1038/NCHEM.365]; Keefe AJ, 2012, NAT CHEM, V4, P60, DOI 10.1038/nchem.1213; Larson N, 2012, CHEM MATER, V24, P840, DOI 10.1021/cm2031569; MATSUMURA Y, 1986, CANCER RES, V46, P6387; Choi HS, 2007, NAT BIOTECHNOL, V25, P1165, DOI [10.1038/nbtl340, 10.1038/nbt1340]; Zhang SR, 2003, J AM CHEM SOC, V125, P15288, DOI 10.1021/ja038345f; Moro T, 2004, NAT MATER, V3, P829, DOI 10.1038/nmat1233; Fox ME, 2009, ACCOUNTS CHEM RES, V42, P1141, DOI 10.1021/ar900035f; Hudis C. A., 2007, NEW ENGL J MED, V357, P36; Ilium L., 1982, INT J PHARMACEUT, V12, P135, DOI 10.1016/0378-5173(82)90113-2; Joralemon M.J., 2010, CHEM COMMUN, P1377; Lobb EJ, 2001, J AM CHEM SOC, V123, P7913, DOI 10.1021/ja003906d; Mahon J, 2008, COLLOID POLYM SCI, V286, P1443, DOI 10.1007/s00396-008-1915-x; Shimizu Y, 2014, NANOMED-NANOTECHNOL, V10, P187, DOI 10.1016/j.nano.2013.06.009; Yamada H, 2012, ACS CHEM BIOL, V7, P535, DOI 10.1021/cb2003972; Yamaguchi K, 2011, ANAL METHODS-UK, V3, P1664, DOI 10.1039/c1ay05100h	39	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-894X	1464-3405		BIOORG MED CHEM LETT	Bioorg. Med. Chem. Lett.	JUL 1	2015	25	13					2675	2678		10.1016/j.bmcl.2015.04.072		4	Chemistry, Medicinal; Chemistry, Organic	Pharmacology & Pharmacy; Chemistry	CJ2VR	WOS:000355343300015		
J	Ichihara, H; Yamasaki, S; Hino, M; Ueoka, R; Matsumoto, Y				Ichihara, Hideaki; Yamasaki, Shuichi; Hino, Motoki; Ueoka, Ryuichi; Matsumoto, Yoko			Therapeutic effects of hybrid liposomes with downregulation of inflammatory cytokine for model mice of rheumatoid arthritis in vivo	BIOORGANIC & MEDICINAL CHEMISTRY LETTERS			English	Article						Hybrid liposomes; Rheumatoid arthritis; Collagen-induced arthritis mouse models; Chemotherapy; In vivo	APOPTOSIS; CHEMOTHERAPY; INDUCTION; ENANTIOSELECTIVITY; LEFLUNOMIDE; TOXICITY; EFFICACY; CELLS	Therapeutic effects of HL for a collagen-induced arthritis (CIA) mouse models of HL-23 composed of 95 mol % L-alpha-dimyristoylphosphatidylcholine (DMPC) and 5 mol % polyoxyethylenedodecylether (C-12(EO)(23)) in vivo were examined. Remarkably high therapeutic effects of HL-23 for CIA mouse models were obtained on the basis of clinical assessment of arthritis. The reduction of hyperplastic synovial membrane (pannus tissue) and destruction of the cartilage and bone by HL-23 was revealed on the basis of hematoxylin and eosin (HE) and safranin O staining. Furthermore, the downregulation of inflammatory cytokines such as interleukin (IL)-1 beta, tumor necrosis factor (TNF)-alpha, and IL-6 for CIA mouse models treated with HL-23 were investigated. Remarkably high therapeutic effects without joint swelling were obtained in CIA mouse models treated with HL-23. (C) 2015 The Authors. Published by Elsevier Ltd.	[Ichihara, Hideaki; Yamasaki, Shuichi; Hino, Motoki; Ueoka, Ryuichi; Matsumoto, Yoko] Sojo Univ, Grad Sch Engn, Div Appl Life Sci, Nishi Ku, Kumamoto 8600082, Japan	Matsumoto, Y (reprint author), Sojo Univ, Grad Sch Engn, Div Appl Life Sci, Nishi Ku, 4-22-1 Ikeda, Kumamoto 8600082, Japan.	matumoto@life.sojo-u.ac.jp			Ministry of Education, Science, and Culture of Japan [25289299, 25420843, 15k12527]	We thank Ryo Sakamoto and Arisa Kikumoto for technical assistance. This work was supported in part by a Grant-in-Aid for Science Research from the Ministry of Education, Science, and Culture of Japan (Nos. 25289299, 25420843 and 15k12527).	Caporali R, 2008, AUTOIMMUN REV, V8, P139, DOI 10.1016/j.autrev.2008.05.001; Matsumoto Y, 2005, INT J CANCER, V115, P377, DOI 10.1002/ijc.20882; Katchamart W, 2009, ANN RHEUM DIS, V68, P1105, DOI 10.1136/ard.2008.099861; Yoshitomi H, 2005, J EXP MED, V201, P949, DOI 10.1084/jem.20051758; Kitamura I, 1996, CANCER RES, V56, P3986; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; Feldmann M, 1996, CELL, V85, P307, DOI 10.1016/S0092-8674(00)81109-5; Ichihara H, 2008, ANTICANCER RES, V28, P1187; Janssen NM, 2000, ARCH INTERN MED, V160, P610, DOI 10.1001/archinte.160.5.610; David D.B., 2007, NATURE PROTOCOLS, V2, P1269; Hopkins AM, 2014, J CLIN PHARM THER, V39, P555, DOI 10.1111/jcpt.12189; Ichihara H, 2012, EUR J MED CHEM, V57, P143, DOI 10.1016/j.ejmech.2012.08.040; Ichihara H, 2011, BIOORG MED CHEM LETT, V21, P207, DOI 10.1016/j.bmcl.2010.11.035; Iwamoto Y, 2005, INT J PHARM, V292, P231, DOI 10.1016/j.ijpharm.2004.11.034; Juarranz Y., 2005, ARTHRITIS RES THER, V7, P1034; Shimoda S, 2009, INT J PHARMACEUT, V372, P162, DOI 10.1016/j.ijpharm.2009.01.011; Tebib J, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2740; UEOKA R, 1988, J AM CHEM SOC, V110, P1588, DOI 10.1021/ja00213a035; UEOKA R, 1985, J AM CHEM SOC, V107, P2185, DOI 10.1021/ja00293a067; van Roon EN, 2004, DRUG SAFETY, V27, P345, DOI 10.2165/00002018-200427050-00006; Yokota K, 2009, RHEUMATOL INT, V29, P459, DOI 10.1007/s00296-008-0694-5; Zhenlin H., 2011, ARTHRITIS RHEUM, V63, P949	22	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-894X	1464-3405		BIOORG MED CHEM LETT	Bioorg. Med. Chem. Lett.	JUL 1	2015	25	13					2686	2689		10.1016/j.bmcl.2015.04.083		4	Chemistry, Medicinal; Chemistry, Organic	Pharmacology & Pharmacy; Chemistry	CJ2VR	WOS:000355343300017		
J	Nakashima, S; Oda, Y; Nakamura, S; Liu, J; Onishi, K; Kawabata, M; Miki, H; Himuro, Y; Yoshikawa, M; Matsuda, H				Nakashima, Souichi; Oda, Yoshimi; Nakamura, Seikou; Liu, Jiang; Onishi, Koko; Kawabata, Miki; Miki, Hisako; Himuro, Yugo; Yoshikawa, Masayuki; Matsuda, Hisashi			Inhibitors of melanogenesis in B16 melanoma 4A5 cells from flower buds of Lawsonia inermis (Henna)	BIOORGANIC & MEDICINAL CHEMISTRY LETTERS			English	Article						Anti-melanogenic activity; Lawsonia inermis; Henna; Plasmin; Ayurvedic plant	CHINESE CAMELLIA-JAPONICA; TRITERPENE SAPONINS; OLEANANE-TYPE; TYROSINASE; LEAVES; BIOSYNTHESIS; EXPRESSION; FLAVONOIDS; PIGMENTATION; CONSTITUENTS	The methanolic extract of Lawsonia inermis L. (henna) showed significant inhibitory activity toward melanogenesis in B16 melanoma 4A5 cells. Among the constituents isolated from the methanolic extract, luteolin, quercetin, and (+/-)-eriodictyol showed stronger inhibitory activity than the reference compound, arbutin. Several structure-activity relationships of the flavonoids were suggested, and OGlc < H = OH at the 3-position, OGlc < OH at the 4'-position, and the double bond between the 2- and 3-positions were important. The active constituents suppressed tyrosinase, tyrosinase related protein (TRP)-1, and TRP-2 mRNA expression. The suppression was considered as one of the mechanisms of action. Furthermore, the methanolic extract and several constituents, including luteoloside and spiraeoside, showed anti-plasmin activity, which is considered to play a key role in UV-stimulated melanogenesis in human skin. (C) 2015 Elsevier Ltd. All rights reserved.	[Nakashima, Souichi; Oda, Yoshimi; Nakamura, Seikou; Liu, Jiang; Onishi, Koko; Kawabata, Miki; Miki, Hisako; Himuro, Yugo; Yoshikawa, Masayuki; Matsuda, Hisashi] Kyoto Pharmaceut Univ, Dept Pharmacognosy, Kyoto, Japan; [Nakashima, Souichi; Oda, Yoshimi] NTH Co Ltd, Shibuya Ku, Tokyo 1500013, Japan	Nakashima, S (reprint author), Kyoto Pharmaceut Univ, Dept Pharmacognosy, Kyoto, Japan.	nakashima@nthhenna.co.jp					Saadabi M. A. A., 2007, Research Journal of Biological Sciences, V2, P419; HEARING VJ, 1987, INT J BIOCHEM, V19, P1141, DOI 10.1016/0020-711X(87)90095-4; Nakashima S, 2010, BIOORGAN MED CHEM, V18, P2337, DOI 10.1016/j.bmc.2010.01.046; SLIMESTAD R, 1995, PHYTOCHEMISTRY, V40, P1537, DOI 10.1016/0031-9422(95)00383-I; SUMI H, 1987, EXPERIENTIA, V43, P1110, DOI 10.1007/BF01956052; Krasnov EA, 2006, CHEM NAT COMPD+, V42, P148, DOI 10.1007/s10600-006-0064-z; Matsumoto T, 2013, BIOORG MED CHEM LETT, V23, P5178, DOI 10.1016/j.bmcl.2013.07.010; Lee MY, 2010, J MICROBIOL BIOTECHN, V20, P988, DOI 10.4014/jmb.0905.05054; Nakamura S, 2013, BIOORGAN MED CHEM, V21, P779, DOI 10.1016/j.bmc.2012.11.038; Parvez S, 2006, PHYTOTHER RES, V20, P921, DOI 10.1002/ptr.1954; Matsuda H, 2009, BIOORGAN MED CHEM, V17, P6048, DOI 10.1016/j.bmc.2009.06.057; Flamini G, 2001, PHYTOCHEMISTRY, V57, P559, DOI 10.1016/S0031-9422(01)00066-8; Zhang XF, 2006, ARCH PHARM RES, V29, P1102, DOI 10.1007/BF02969299; Nakamura S, 2013, PHYTOCHEMISTRY, V92, P128, DOI 10.1016/j.phytochem.2013.04.012; [柴兴云 Chai Xingyun], 2004, [中国中药杂志, China Journal of Chinese Materia Medica], V29, P865; Choi MY, 2008, ARCH PHARM RES, V31, P1166, DOI 10.1007/s12272-001-1284-4; Fico G, 2007, PHYTOCHEMISTRY, V68, P1683, DOI 10.1016/j.phytochem.2007.04.019; Fujimoto K, 2012, CHEM PHARM BULL, V60, P1188, DOI 10.1248/cpb.c12-00473; Habbal O. A., 2007, AUST J MED HERBAL, V22, P1; HEARING VJ, 1982, J INVEST DERMATOL, V79, P16, DOI 10.1111/1523-1747.ep12510422; HORROW JC, 1991, CIRCULATION, V84, P2063; Jeong CH, 2004, BIOSCI BIOTECH BIOCH, V68, P1984, DOI 10.1271/bbb.68.1984; [贾凌云 Jia Lingyun], 2003, [中国药物化学杂志, Chinese Journal of Medicinal Chemistry], V13, P159; Kellam J. S., 1993, PHYTOCHEMISTRY, V33, P867; KITANAKA S, 1992, CHEM PHARM BULL, V40, P249; Kitdamrongtham W, 2014, CHEM BIODIVERS, V11, P73, DOI 10.1002/cbdv.201300266; KUZUMAKI T, 1993, EXP CELL RES, V207, P33, DOI 10.1006/excr.1993.1159; Liu Z., 2008, CHINA J CHIN MAT MED, V31, P995; Maeda K, 1998, J PHOTOCH PHOTOBIO B, V47, P136, DOI 10.1016/S1011-1344(98)00212-7; MISHIMA Y, 1994, PIGM CELL RES, V7, P376, DOI 10.1111/j.1600-0749.1994.tb00065.x; Morikawa T, 2014, J NAT MED-TOKYO, V68, P539, DOI 10.1007/s11418-014-0832-1; Na J. I., 2003, J EUR ACAD DERMATOL, V27, P1035; Nakamura S, 2012, CHEM PHARM BULL, V60, P752, DOI 10.1248/cpb.60.752; Nakamura S, 2013, BIOORGAN MED CHEM, V21, P1043, DOI 10.1016/j.bmc.2013.01.012; Nakamura S, 2010, CHEM PHARM BULL, V58, P690, DOI 10.1248/cpb.58.690; Perez B. A., 2000, AM J CLIN DERMATOL, V1, P261; PROTA G, 1988, MED RES REV, V8, P525, DOI 10.1002/med.2610080405; Shanks G. D., 1995, TUBERCLE, V71, P293; Syrovets T, 1997, BLOOD, V89, P4574; Takahashi M, 2012, J OLEO SCI, V61, P585, DOI 10.5650/jos.61.585; TRIPATHI RD, 1978, EXPERIENTIA, V34, P51, DOI 10.1007/BF01921895; Virador V, 2001, PIGM CELL RES, V14, P289, DOI 10.1034/j.1600-0749.2001.140410.x; WEIDE I, 1995, ADV PROSTAG THROMB L, V23, P325; Yamauchi K, 2014, BIOORGAN MED CHEM, V22, P3331, DOI 10.1016/j.bmc.2014.04.053; Zhang XY, 2003, CHIN J DERMATOVENERO, V2, P227; Zumrutdal ME, 2008, AFR J BIOTECHNOL, V7, P2781	46	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-894X	1464-3405		BIOORG MED CHEM LETT	Bioorg. Med. Chem. Lett.	JUL 1	2015	25	13					2702	2706		10.1016/j.bmcl.2015.04.052		5	Chemistry, Medicinal; Chemistry, Organic	Pharmacology & Pharmacy; Chemistry	CJ2VR	WOS:000355343300021		
J	Takahashi, B; Funami, H; Iwaki, T; Maruoka, H; Nagahira, A; Koyama, M; Kamiide, Y; Matsuo, T; Muto, T; Annoura, H				Takahashi, Bitoku; Funami, Hideaki; Iwaki, Takehiko; Maruoka, Hiroshi; Nagahira, Asako; Koyama, Makoto; Kamiide, Yoshiyuki; Matsuo, Tsuyoshi; Muto, Tsuyoshi; Annoura, Hirokazu			2-Aminoalkyl nicotinamide derivatives as pure inverse agonists of the ghrelin receptor	BIOORGANIC & MEDICINAL CHEMISTRY LETTERS			English	Article						GhrelinR; Inverse agonist; Anti-obesity; Nicotinamide	ANTAGONISTS; POTENT; IDENTIFICATION; OBESITY; DISCOVERY; RATS	New inverse agonists of the ghrelin receptor (ghrelinR) were obtained through high-throughput screening and subsequent structural modification of 2-aminoalkyl nicotinamide derivatives. The key structural feature to improve in vitro activity was the introduction of a diazabicyclo ring at the 5-position of the pyridine ring. The final product showed potent inverse agonist activity and, despite its low brain permeability, reduced food intake in both normal and obese mice. These results implied that peripheral ghrelinR activity is important for appetite control and that a peripheral ghrelinR inverse agonist could be an anti-obesity drug with reduced risk of central nervous system (CNS)-related side effects. (C) 2015 Elsevier Ltd. All rights reserved.	[Takahashi, Bitoku; Funami, Hideaki; Iwaki, Takehiko; Maruoka, Hiroshi; Nagahira, Asako; Koyama, Makoto; Kamiide, Yoshiyuki; Matsuo, Tsuyoshi; Muto, Tsuyoshi; Annoura, Hirokazu] Asubio Pharma Co Ltd, Chuo Ku, Kobe, Hyogo 6500047, Japan	Takahashi, B (reprint author), Asubio Pharma Co Ltd, Chuo Ku, 6-4-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	takahashi.bitoku.cz@asubio.co.jp					Date Y, 2002, GASTROENTEROLOGY, V123, P1120, DOI 10.1053/gast.2002.35954; Lovering F, 2009, J MED CHEM, V52, P6752, DOI 10.1021/jm901241e; Rudolph J, 2007, J MED CHEM, V50, P5202, DOI 10.1021/jm070071+; Ritchie TJ, 2009, DRUG DISCOV TODAY, V14, P1011, DOI 10.1016/j.drudis.2009.07.014; McCoull W, 2013, MEDCHEMCOMM, V4, P456, DOI 10.1039/c2md20340e; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; Kojima M, 2005, PHYSIOL REV, V85, P495, DOI 10.1152/physrev.00012.2004; Leeson PD, 2007, NAT REV DRUG DISCOV, V6, P881, DOI 10.1038/nrd2445; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Holst B, 2003, MOL ENDOCRINOL, V17, P2201, DOI 10.1210/me.2003-0069; Moulin A, 2008, J MED CHEM, V51, P689, DOI 10.1021/jm701292s; Bhattacharya SK, 2014, ACS MED CHEM LETT, V5, P474, DOI 10.1021/ml400473x; Fukuda H, 2004, SCAND J GASTROENTERO, V39, P1209, DOI 10.1080/00365520410007908; Garcia J, 2007, J CLIN ONCOL, V25, P9133; Hanrahan P, 2012, BIOORG MED CHEM LETT, V22, P2271, DOI 10.1016/j.bmcl.2012.01.078; Hotta M, 2009, ENDOCR J, V56, P1119, DOI 10.1507/endocrj.K09E-168; Lasseter KC, 2008, J CLIN PHARMACOL, V48, P193, DOI 10.1177/0091270007310380; Levinson B. J., 2012, J E SPEN J, V7, pe171; Mannhold R., 2008, J PHARM SCI, V98, P861; McClure KF, 2013, BIOORG MED CHEM LETT, V23, P5410, DOI 10.1016/j.bmcl.2013.07.044; McCoull W, 2014, J MED CHEM, V57, P6128, DOI 10.1021/jm500610n; Mihalic JT, 2012, BIOORG MED CHEM LETT, V22, P2046, DOI 10.1016/j.bmcl.2012.01.014; Pasternak A, 2009, BIOORG MED CHEM LETT, V19, P6237, DOI 10.1016/j.bmcl.2009.08.076; Puleo L, 2012, BIOORGAN MED CHEM, V20, P5623, DOI 10.1016/j.bmc.2012.07.018; Hill Stephen J., 2001, Current Opinion in Pharmacology, V1, P526, DOI 10.1016/S1471-4892(01)00091-1; Serby MD, 2006, J MED CHEM, V49, P2568, DOI 10.1021/jm0510934; Zhao HY, 2005, BIOORG MED CHEM LETT, V15, P1825, DOI 10.1016/j.bmcl.2005.02.026	27	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-894X	1464-3405		BIOORG MED CHEM LETT	Bioorg. Med. Chem. Lett.	JUL 1	2015	25	13					2707	2712		10.1016/j.bmcl.2015.04.040		6	Chemistry, Medicinal; Chemistry, Organic	Pharmacology & Pharmacy; Chemistry	CJ2VR	WOS:000355343300022		
J	Hikita, A; Iimura, T; Oshima, Y; Saitou, T; Yamamoto, S; Imamura, T				Hikita, Atsuhiko; Iimura, Tadahiro; Oshima, Yusuke; Saitou, Takashi; Yamamoto, Shin; Imamura, Takeshi			Analyses of bone modeling and remodeling using in vitro reconstitution system with two-photon microscopy	BONE			English	Article						Bone modeling; Bone remodeling; Two-photon microscopy; Osteoblasts; Osteoclasts; Osteocytes	REGULATORY MECHANISMS; CELLS; RESORPTION; OSTEOBLAST; OSTEOCYTES; SCLEROSTIN; MATRIX; RANKL; VIVO; DIFFERENTIATION	Bone modeling and remodeling are cellular events during which osteoblast lineage cells and osteoclasts interact. During these events, cells undergo drastic changes with time as they become differentiated. Their morphology, topology, and activity are affected by other cells and the extracellular matrices. Since the mechanisms underlying the cellular events of bone metabolism have not been elucidated, there is a need for systems to analyze these cellular networks and their microenvironments spatiotemporally at the cellular level. Here we report a novel in vitro system for reconstituting the bone cell network of osteoclasts, osteoblasts, and osteocytes in the mineralized nodule, allowing for observation of bone modeling and remodeling phenomena by 2-photon microscopy. Using this system, the change in morphology of osteoblasts from cuboidal to flat cells was observed and measured during the formation of mineralized nodules. Furthermore, the recruitment of osteoblasts to resorption pits and their replenishment by newly formed matrices were successfully observed, providing strong evidence for the coupling of bone resorption and bone formation at cellular level. During such remodeling cycle, flat osteoblasts that survived more than 7 weeks were recruited to resorption pits, where they became cuboidal osteoblasts that express osteocalcin. This novel system permitted the elucidation of cellular behavior during bone modeling and remodeling, and can be used to analyze cellular events involved in bone metabolism. (C) 2015 Elsevier Inc. All rights reserved.	[Hikita, Atsuhiko; Oshima, Yusuke; Yamamoto, Shin; Imamura, Takeshi] Ehime Univ, Grad Sch Med, Dept Mol Med Pathogenesis, Matsuyama, Ehime 7910295, Japan; [Hikita, Atsuhiko; Iimura, Tadahiro; Oshima, Yusuke; Saitou, Takashi; Imamura, Takeshi] Japan Sci & Technol Agcy JST, CREST, Matsuyama, Ehime, Japan; [Hikita, Atsuhiko; Iimura, Tadahiro; Oshima, Yusuke; Imamura, Takeshi] Ehime Univ, Div Bioimaging, Proteosci Ctr, Toon, Ehime 7910295, Japan; [Hikita, Atsuhiko] Univ Tokyo, Grad Sch Med, Dept Cartilage & Bone Regenerat Fujisoft, Tokyo 1130033, Japan; [Oshima, Yusuke; Saitou, Takashi; Imamura, Takeshi] Ehime Univ Hosp, Translat Res Ctr, Toon, Ehime, Japan; [Yamamoto, Shin] Ehime Univ, Dept Gastroenterol & Metabiol, Toon, Ehime 7910295, Japan	Hikita, A (reprint author), Univ Tokyo, Grad Sch Med, Dept Cartilage & Bone Regenerat Fujisoft, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.	ahikita-tky@umin.ac.jp; timamura-ind@umin.ac.jp			MEXT KAKENHI [22113004]; JSPS KAKENHI [22113001, 23390368, 26670667, 26293392, 24680060]; JSPS; Naito Foundation	We thank H. Ninomiya, N. Miyamoto, H. Yamamoto and S. Tomomatsu (Ehime University) for assistance and Dr. S. Tanaka (the University of Tokyo) for valuable discussions. Ctsk-Cre mice were provided by Dr. S. Kato (Soma Central Hospital). DMP1-Cre mice were provided by Dr. H. Takayanagi (the University of Tokyo). Constructs for lentivirus were provided by Dr. H. Miyoshi (RIKEN BioResource Center). This study was supported by MEXT KAKENHI grant number 22113004; JSPS KAKENHI grant numbers 22113001, 23390368, 26670667, 26293392; and 24680060; and the JSPS core-to-core program "Cooperative international framework in TGF-beta family signaling". T. Im. and A.H. were supported by the Naito Foundation.	PFEILSCHIFTER J, 1987, P NATL ACAD SCI USA, V84, P2024, DOI 10.1073/pnas.84.7.2024; Dhurjati R, 2006, TISSUE ENG, V12, P3045, DOI 10.1089/ten.2006.12.3045; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Maes C, 2010, DEV CELL, V19, P329, DOI 10.1016/j.devcel.2010.07.010; Ghajar CM, 2013, NAT CELL BIOL, V15, P807, DOI 10.1038/ncb2767; Everts V, 2002, J BONE MINER RES, V17, P77, DOI 10.1359/jbmr.2002.17.1.77; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; Andersen TL, 2009, AM J PATHOL, V174, P239, DOI 10.2353/ajpath.2009.080627; Fukuda T, 2013, NATURE, V497, P490, DOI 10.1038/nature12115; Takeshita S, 2013, J CLIN INVEST, V123, P3914, DOI 10.1172/JCI69493; Andersen TL, 2013, AM J PATHOL, V183, P235, DOI 10.1016/j.ajpath.2013.03.006; Kristensen HB, 2014, AM J PATHOL, V184, P778, DOI 10.1016/j.ajpath.2013.11.022; Miyoshi H, 1998, J VIROL, V72, P8150; Kim SW, 2012, J BONE MINER RES, V27, P2075, DOI 10.1002/jbmr.1665; Leung CT, 2012, NATURE, V482, P410, DOI 10.1038/nature10826; Miller MJ, 2003, P NATL ACAD SCI USA, V100, P2604, DOI 10.1073/pnas.2628040100; Zhao C, 2006, CELL METAB, V4, P111, DOI 10.1016/j.cmet.2006.05.012; Mazo IB, 2005, IMMUNITY, V22, P259, DOI 10.1016/j.immuni.2005.01.008; Matsumoto M, 2000, J BIOL CHEM, V275, P31155, DOI 10.1074/jbc.M001229200; Poole KES, 2005, FASEB J, V19, P1842, DOI 10.1096/fj.05-4221fje; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Tatsumi S, 2007, CELL METAB, V5, P464, DOI 10.1016/j.cmet.2007.05.001; Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979; Colnot C, 2004, DEV BIOL, V269, P55, DOI 10.1016/j.ydbio.2004.01.011; Delaisse Jean-Marie, 2014, Bonekey Rep, V3, P561, DOI 10.1038/bonekey.2014.56; Evensen L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005798; Honma M, 2013, J BONE MINER RES, V28, P1936, DOI 10.1002/jbmr.1941; HOWARD GA, 1981, P NATL ACAD SCI-BIOL, V78, P3204, DOI 10.1073/pnas.78.5.3204; Koga S, 2014, CANCER SCI, V105, P1299, DOI 10.1111/cas.12500; Krishnan V, 2014, J CELL PHYSIOL, V229, P453, DOI 10.1002/jcp.24464; Lee Ji-Won, 2014, Bonekey Rep, V3, P543, DOI 10.1038/bonekey.2014.38; Mulari MTK, 2004, CALCIFIED TISSUE INT, V75, P253, DOI 10.1007/s00223-004-0172-3; Nishiyama Y, 2015, ARCH ORAL BIOL, V60, P45, DOI 10.1016/j.archoralbio.2014.08.013; PARFITT AM, 1984, CALCIFIED TISSUE INT, V36, pS37, DOI 10.1007/BF02406132; PETERSEN OW, 1992, P NATL ACAD SCI USA, V89, P9064, DOI 10.1073/pnas.89.19.9064; Sims Natalie A, 2014, Bonekey Rep, V3, P481, DOI 10.1038/bonekey.2013.215; TAKAHASHI N, 1991, J BONE MINER RES, V6, P977; Tran Van P T, 1982, Anat Rec, V202, P445; Uchihashi K, 2013, BONE, V52, P102, DOI 10.1016/j.bone.2012.09.001; Watanabe T, 2012, BONE, V51, P447, DOI 10.1016/j.bone.2012.06.019	43	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	8756-3282	1873-2763		BONE	Bone	JUL	2015	76						5	17		10.1016/j.bone.2015.02.030		13	Endocrinology & Metabolism	Endocrinology & Metabolism	CJ7ZE	WOS:000355718100002		
J	Jung, I; Suzuki, Y				Jung, Insung; Suzuki, Yoko			Scaffolding strategies for wiki-based collaboration: Action research in a multicultural Japanese language program	BRITISH JOURNAL OF EDUCATIONAL TECHNOLOGY			English	Article							SCHOOL STUDENTS; EXAMPLES	Wikis can be used to encourage and support collaborative constructivist learning. However, their effectiveness depends upon the use of scaffolding strategies to guide the students in their use. This action research investigated three scaffolding strategies for wiki-based multicultural Japanese language learning: worked examples, grouping and peer assessment. It was found that the use of a template explaining the learning objectives and expected learning process was more effective than detailed worked examples. It was also found that heterogeneous grouping and internal and external peer review were important factors and that wiki-based collaborative learning can be culture laden and in conflict with traditional teaching and learning.	[Jung, Insung] Int Christian Univ, Educ, Tokyo, Japan; [Suzuki, Yoko] Int Christian Univ, Japanese Language Program, Tokyo, Japan	Jung, I (reprint author), 3-10-2 Osawa, Mitaka, Tokyo 1818585, Japan.	isjung@icu.ac.jp			Japan Society for the Promotion of Society	This research was funded by the 2008-2010 Grant-in-Aid for Scientific Research (Kakenhi) from the Japan Society for the Promotion of Society. Parts of early version of this paper were presented at the Korean Society for Educational Technology International Conference, "The Convergence of Human-Education-Technology in the Smart Learning Age," at Korea University, Seoul, South Korea, May 25-26, 2012.	WARD M, 1990, COGNITION INSTRUCT, V7, P1, DOI 10.1207/s1532690xci0701_1; Cole M, 2009, COMPUT EDUC, V52, P141, DOI 10.1016/j.compedu.2008.07.003; Mak B, 2008, SYSTEM, V36, P437, DOI 10.1016/j.system.2008.02.004; Li MM, 2013, COMPUT ASSIST LANG L, V26, P61, DOI 10.1080/09588221.2011.631142; Sweller J, 2006, LEARN INSTR, V16, P165, DOI 10.1016/j.learninstruc.2006.02.005; Kalyuga S, 2003, EDUC PSYCHOL-US, V38, P23, DOI 10.1207/S15326985EP3801_4; Land SM, 2003, ETR&D-EDUC TECH RES, V51, P65, DOI 10.1007/BF02504544; Bonk CJ, 2009, INTERNET HIGH EDUC, V12, P126, DOI 10.1016/j.iheduc.2009.04.002; Elola I, 2010, LANG LEARN TECHNOL, V14, P51; Kessler G, 2010, COMPUT ASSIST LANG L, V23, P41, DOI 10.1080/09588220903467335; Anzai Y., 2008, P WORLD C E LEARN CO, P547; Beaudoin M. F., 2002, Internet and Higher Education, V5, DOI 10.1016/S1096-7516(02)00086-6; Belland BR, 2010, ETR&D-EDUC TECH RES, V58, P285, DOI 10.1007/s11423-009-9139-4; Borg M., 2011, HOGRE UTBILDNING, V1, P111; Borthick A., 2000, ISSUES ACCOUNTING ED, V15, P181, DOI 10.2308/iace.2000.15.2.181; Bransford J. D., 2000, PEOPLE LEARN BRAIN M; Bruner J., 1983, CHILDS TALK LEARNING; Chaiklin S., 2003, VYGOTSKYS ED THEORY, P39; Chao Y. C. J., 2007, WORLD C ED MULT HYP; Chao Y. C. J., 2011, INTERACTIVE LEARNING, V19, P1; Clark R., 2006, EFFICIENCY LEARNING; Eriksen E. O., 2000, DEMOCRACY EUROPEAN U; Felder R. M., 2001, J COOPERATION COLLAB, V10, P69; Fischer M., 1998, J INTERACTIVE LEARNI, V9, P221; HOOPER S, 1988, J EDUC COMPUT RES, V4, P413, DOI 10.2190/T26C-3FTH-RNYP-TV30; Inaba A., 2000, CAN WE FORM ELECTIVE; Johnson D. W., 1999, LEARNING TOGETHER AL; Kim M., 2010, J KOREA HOME EC, V48, P49; Li M., 2012, CALL EJ, V13, P17; Lund Andreas, 2008, ReCALL, DOI 10.1017/S0958344008000414; Lundin Rebecca Wilson, 2008, Computers and Composition, V25, DOI 10.1016/j.compcom.2008.06.001; Lyman F., 2004, TEACHING COOPERATIVE, P83; Nunan D., 1990, 2 LANGUAGE TEACHER E, P62; Park J. S., 2010, STUDIES YOUTH WELFAR, V21, P35; Piezon S. L., 2005, ONLINE J DISTANCE LE, V8, P4; Renkl A, 1997, COGNITIVE SCI, V21, P1, DOI 10.1207/s15516709cog2101_1; Su F, 2010, INNOV EDUC TEACH INT, V47, P417, DOI 10.1080/14703297.2010.518428; Topping K.J., 2000, ASSESS EVAL HIGH EDU, V25, P146; Wierzbicka A., 2006, ENGLISH MEANING CULT; Wu A. S., 2002, P CSCL 2002 BOULD CO, P245, DOI 10.3115/1658616.1658651; Ge X, 2003, ETR&D-EDUC TECH RES, V51, P21, DOI 10.1007/BF02504515	41	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1013	1467-8535		BRIT J EDUC TECHNOL	Br. J. Educ. Technol.	JUL	2015	46	4					829	838		10.1111/bjet.12175		10	Education & Educational Research	Education & Educational Research	CJ9WS	WOS:000355854600018		
J	Iwamoto, J; Seki, A				Iwamoto, Jun; Seki, Azusa			Effect of Combined Teriparatide and Monthly Risedronate Therapy on Cancellous Bone Mass in Orchidectomized Rats: A Bone Histomorphometry Study	CALCIFIED TISSUE INTERNATIONAL			English	Article						Teriparatide; Risedronate; Cancellous bone; Bone histomorphometry; Orchidectomized rats	POSTMENOPAUSAL OSTEOPOROSIS; PARATHYROID-HORMONE; VERTEBRAL FRACTURES; RANDOMIZED-TRIAL; MATURE RATS; ADULT RATS; WOMEN; EFFICACY; VITAMIN-K-2; TURNOVER	This study investigated the effects of combined teriparatide (an anabolic agent) and monthly risedronate (an anti-resorptive agent) therapy on cancellous bone mass in orchidectomized (ORX) rats. Fifty 14-week-old male Sprague-Dawley rats were randomized into five groups of ten animals each: sham-operation + vehicle; ORX + vehicle; ORX + risedronate (90 mu g/kg subcutaneous, every 4 weeks); ORX + teriparatide (30 mu g/kg subcutaneous, three times per week); and ORX + risedronate + teriparatide. After the 12-week experimental period, cancellous bone in the tibial proximal metaphysis was examined by static and dynamic histomorphometric analyses. ORX decreased bone volume per total volume (BV/TV) and trabecular number (Tb.N), and increased trabecular separation (Tb.Sp). Risedronate increased BV/TV and Tb.N above the sham control values, while teriparatide prevented the ORX-induced decrease in BV/TV and increased trabecular width (Tb.Wi) above sham control levels. Risedronate decreased Tb.Sp below control values, while teriparatide prevented the ORX-induced increase in Tb.Sp. The combination of teriparatide and risedronate further increased BV/TV and Tb.N and decreased Tb.Sp as a result of suppression of bone remodeling, compared with teriparatide alone. These results suggest that teriparatide and monthly risedronate exert different effects on cancellous bone structure and thus have additive effects on cancellous bone mass in ORX rats.	[Iwamoto, Jun] Keio Univ, Sch Med, Inst Integrated Sports Med, Shinjuku Ku, Tokyo 1608582, Japan; [Seki, Azusa] Hamri Co Ltd, Koga, Ibaraki, Japan	Iwamoto, J (reprint author), Keio Univ, Sch Med, Inst Integrated Sports Med, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	jiwamoto@keio.jp			Asahi Kasei Pharma, Co. Ltd., Tokyo, Japan	This research was supported by Asahi Kasei Pharma, Co. Ltd., Tokyo, Japan.	Reginster JY, 2000, OSTEOPOROSIS INT, V11, P83, DOI 10.1007/s001980050010; Ringe JD, 2006, RHEUMATOL INT, V26, P427, DOI 10.1007/s00296-005-0004-4; Murad MH, 2012, J CLIN ENDOCR METAB, V97, P1871, DOI 10.1210/jc.2011-3060; McClung MR, 2001, NEW ENGL J MED, V344, P333, DOI 10.1056/NEJM200102013440503; Tsai JN, 2013, LANCET, V382, P50, DOI 10.1016/S0140-6736(13)60856-9; Mosekilde L, 2013, DRUGS, V73, P15, DOI 10.1007/s40265-012-0003-1; McClung MR, 2013, OSTEOPOROSIS INT, V24, P293, DOI 10.1007/s00198-012-2056-0; Nakamura T, 2012, J CLIN ENDOCR METAB, V97, P3097, DOI 10.1210/jc.2011-3479; Gabet Y, 2005, OSTEOPOROSIS INT, V16, P1436, DOI 10.1007/s00198-005-1876-6; Iwamoto J, 2014, BONE, V64, P88, DOI 10.1016/j.bone.2014.04.003; Iwamoto J, 2002, BONE, V30, P360, DOI 10.1016/S8756-3282(01)00687-1; Harris ST, 1999, JAMA-J AM MED ASSOC, V282, P1344, DOI 10.1001/jama.282.14.1344; GUNNESS M, 1995, J BONE MINER RES, V10, P1735; Cosman F, 2011, J BONE MINER RES, V26, P503, DOI 10.1002/jbmr.238; TURNER RT, 1989, J BONE MINER RES, V4, P557; Confavreux CB, 2012, EUR J ENDOCRINOL, V166, P735, DOI 10.1530/EJE-11-0959; Compston JE, 2007, BONE, V40, P1447, DOI 10.1016/j.bone.2006.09.008; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Diaz-Curiel M, 2008, HORM RES, V70, P93, DOI 10.1159/000139151; Iwamoto J, 2014, CHINESE J PHYSIOL, V57, P231, DOI 10.4077/CJP.2014.BAC242; Iwamoto J, 2008, J NUTR SCI VITAMINOL, V54, P11, DOI 10.3177/jnsv.54.11; Iwamoto J, 2003, J BONE MINER METAB, V21, P211, DOI 10.1007/s00774-003-0411-0; Iwamoto Jun, 2004, Keio J Med, V53, P12, DOI 10.2302/kjm.53.12; Iwamoto J, 2003, J BONE MINER RES, V18, P776, DOI 10.1359/jbmr.2003.18.4.776; Iwamoto J, 2003, MATURITAS, V44, P19, DOI 10.1016/S0378-5122(02)00315-8; Khedr NF, 2013, FUND CLIN PHARMACOL, V27, P526, DOI 10.1111/j.1472-8206.2012.01047.x; Montero M, 2010, AGING MALE, V13, P59, DOI 10.3109/13685530903536650; Ohlsson Claes, 2012, Bonekey Rep, V1, P2, DOI 10.1038/bonekey.2012.3; Shahnazari M, 2010, BONE, V46, P1267, DOI 10.1016/j.bone.2009.11.019; Walker MD, 2013, ENDOCRINE, V44, P237, DOI 10.1007/s12020-012-9819-4; Yamaura M, 1996, CALCIFIED TISSUE INT, V58, P52, DOI 10.1007/s002239900010	31	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0171-967X	1432-0827		CALCIFIED TISSUE INT	Calcif. Tissue Int.	JUL	2015	97	1					23	31		10.1007/s00223-015-0006-5		9	Endocrinology & Metabolism	Endocrinology & Metabolism	CK0AR	WOS:000355866600003		
J	Yoda, M; Imanishi, Y; Nagata, Y; Ohara, M; Yoda, K; Yamada, S; Mori, K; Inaba, M				Yoda, Maki; Imanishi, Yasuo; Nagata, Yuki; Ohara, Masaya; Yoda, Koichiro; Yamada, Shinsuke; Mori, Katsuhito; Inaba, Masaaki			Teriparatide Therapy Reduces Serum Phosphate and Intima-Media Thickness at the Carotid Wall Artery in Patients with Osteoporosis	CALCIFIED TISSUE INTERNATIONAL			English	Article						Atherosclerosis; Intima-media thickness; Osteoporosis; Phosphate; Teriparatide	CHRONIC KIDNEY-DISEASE; PARATHYROID-HORMONE; VASCULAR CALCIFICATION; HEMODIALYSIS-PATIENTS; AORTIC CALCIFICATION; PRIMARY HYPERPARATHYROIDISM; CARDIOVASCULAR-DISEASE; POSTMENOPAUSAL WOMEN; CONTROLLED-TRIAL; RENAL-DISEASE	Although cross-sectional and longitudinal studies report a relationship between osteoporosis and cardiovascular disorders (known as the bone-cardiovascular axis), the benefits of osteoporosis treatment on atherosclerosis are largely unclear. Teriparatide is a bone-forming agent that increases urinary phosphate excretion. Because elevated serum phosphate is associated with the development of atherosclerosis, the purpose of our study was to examine the relationship among lumbar spine bone mineral density (LS-BMD), intima-media thickness at the carotid artery (CA-IMT), and phosphate metabolism in response to daily teriparatide therapy. Osteoporotic patients (n = 28) with low LS-BMD (T-score < -2.5) and/or at least one vertebral fracture were treated with teriparatide (20 mu g/day) for 12 months. Metabolic bone markers, LS-BMD, and CA-IMT were measured over the course of treatment. The LS-BMD significantly increased by 0.046 +/- 0.038 g/cm(2) over the 12-month period (P < 0.001). CA-IMT decreased from 0.701 mm (interquartile range: 0.655-0.774 mm) at baseline to 0.525 mm (0.477-0.670 mm) at 12 months (P < 0.05); however, CA-IMT change was not significantly associated with LS-BMD change. Serum phosphate decreased after 1 month of teriparatide administration, and the change in serum phosphate at 1 months was associated with the change in CA-IMT at 12 months (rho = 0.431, P = 0.025). Teriparatide improved LS-BMD and CA-IMT, suggesting the existence of the bone-cardiovascular axis. The association between serum phosphate and CA-IMT suggests that the teriparatide decreased CA-IMT in part by reducing serum phosphate, a well-known vascular toxin, in addition to the improvement of bone-cardiovascular axis.	[Yoda, Maki; Imanishi, Yasuo; Nagata, Yuki; Ohara, Masaya; Yoda, Koichiro; Yamada, Shinsuke; Mori, Katsuhito; Inaba, Masaaki] Osaka City Univ, Grad Sch Med, Dept Metab Endocrinol & Mol Med, Abeno Ku, Osaka 5458585, Japan	Imanishi, Y (reprint author), Osaka City Univ, Grad Sch Med, Dept Metab Endocrinol & Mol Med, Abeno Ku, 1-4-3 Asahi Machi, Osaka 5458585, Japan.	imanishi@med.osaka-cu.ac.jp			Eli Lilly Japan K.K.	Masaaki Inaba reports grant support and lecture fees from Eli Lilly Japan K.K. Yasuo Imanishi and Katsuhito Mori report lecture fees from Eli Lilly Japan K.K. Maki Yoda, Yuki Nagata, Masaya Ohara, Koichiro Yoda, and Shinsuke Yamada have no conflicts of interest.	Anastasilakis AD, 2008, ENDOCR J, V55, P613, DOI 10.1507/endocrj.K07E-123; BRODEHL J, 1988, PEDIATR NEPHROL, V2, P183; OLEARY DH, 1991, STROKE, V22, P1155; Jono S, 2000, CIRC RES, V87, pE10; Russo D, 2007, KIDNEY INT, V72, P1255, DOI 10.1038/sj.ki.5002518; Ramasamy SK, 2014, NATURE, V507, P376, DOI 10.1038/nature13146; Gao P, 2001, J BONE MINER RES, V16, P605, DOI 10.1359/jbmr.2001.16.4.605; Kusumbe AP, 2014, NATURE, V507, P323, DOI 10.1038/nature13145; Suki WN, 2007, KIDNEY INT, V72, P1130, DOI 10.1038/sj.ki.5002466; London GM, 2008, J AM SOC NEPHROL, V19, P1827, DOI 10.1681/ASN.2007050622; Block GA, 2005, KIDNEY INT, V68, P1815, DOI 10.1111/j.1523-1755.2005.00600.x; Horwitz MJ, 2003, J CLIN ENDOCR METAB, V88, P1603, DOI 10.1210/jc.2002-020773; Six I, 2012, CARDIOVASC RES, V96, P130, DOI 10.1093/cvr/cvs240; Tanko LB, 2005, J BONE MINER RES, V20, P1912, DOI 10.1359/JBMR.050711; Hagstrom E, 2015, ATHEROSCLEROSIS, V238, P420, DOI 10.1016/j.atherosclerosis.2014.12.027; Ellam T, 2011, ARTERIOSCL THROM VAS, V31, P1988, DOI 10.1161/ATVBAHA.111.231001; Imai E, 2007, AM J KIDNEY DIS, V50, P927, DOI 10.1053/j.ajkd.2007.09.004; Chertow GM, 2002, KIDNEY INT, V62, P245, DOI 10.1046/j.1523-1755.2002.00434.x; Guerin AP, 2000, NEPHROL DIAL TRANSPL, V15, P1014, DOI 10.1093/ndt/15.7.1014; Tonelli M, 2005, CIRCULATION, V112, P2627, DOI 10.1161/CIRCULATIONAHA.105.553198; Genant HK, 1996, J BONE MINER RES, V11, P984; Collins TC, 2009, CIRCULATION, V119, P2305, DOI 10.1161/CIRCULATIONAHA.108.820993; Onufrak SJ, 2008, ATHEROSCLEROSIS, V199, P424, DOI 10.1016/j.atherosclerosis.2007.11.004; Schulz E, 2004, J CLIN ENDOCR METAB, V89, P4246, DOI 10.1210/jc.2003-030964; Kang JH, 2013, OSTEOPOROSIS INT, V24, P271, DOI 10.1007/s00198-012-2213-5; Dhingra R, 2007, ARCH INTERN MED, V167, P879, DOI 10.1001/archinte.167.9.879; Bots ML, 1997, CIRCULATION, V96, P1432; Leonard O, 2013, BRIT J CLIN PHARMACO, V76, P560, DOI 10.1111/bcp.12014; Yamazaki Y, 2002, J CLIN ENDOCR METAB, V87, P4957, DOI 10.1210/jc.2002-021105; Toussaint ND, 2011, NEPHROLOGY, V16, P290, DOI 10.1111/j.1440-1797.2010.01412.x; Prisby R, 2011, J BONE MINER RES, V26, P2583, DOI 10.1002/jbmr.459; Naves M, 2008, OSTEOPOROSIS INT, V19, P1161, DOI 10.1007/s00198-007-0539-1; Dobnig H, 1997, ENDOCRINOLOGY, V138, P4607, DOI 10.1210/en.138.11.4607; Kawata T, 2007, J AM SOC NEPHROL, V18, P2683, DOI 10.1681/ASN.2006070783; Deal C, 2005, J BONE MINER RES, V20, P1905, DOI 10.1359/JBMR.050714; Ishimura E, 2005, AM J KIDNEY DIS, V45, P859, DOI 10.1053/j.ajkd.2005.02.008; Kobayashi K, 2006, EUR J ENDOCRINOL, V154, P93, DOI 10.1530/eje.1.02053; Luckish A, 2008, BONE, V43, P279, DOI 10.1016/j.bone.2008.03.030; McClung MR, 2005, ARCH INTERN MED, V165, P1762, DOI 10.1001/archinte.165.15.1762; Okamoto K, 2010, LIFE SCI, V87, P686, DOI 10.1016/j.lfs.2010.10.006; Roche B, 2014, J BONE MINER RES, V29, P1608, DOI 10.1002/jbmr.2191; Shao JS, 2003, J BIOL CHEM, V278, P50195, DOI 10.1074/jbc.M308825200; Sridharan M, 2010, CALCIFIED TISSUE INT, V87, P398, DOI 10.1007/s00223-010-9414-8; Tahtela R, 1997, CLIN BIOCHEM, V30, P35, DOI 10.1016/S0009-9120(96)00134-8; Toussain ND, 2008, NEPHROL DIAL TRANSPL, V23, P586, DOI 10.1093/ndt/gfm660; Toussaint ND, 2012, NEPHROLOGY, V17, P433, DOI 10.1111/j.1440-1797.2012.01618.x; Tsujimoto M, 2011, BONE, V48, P798, DOI 10.1016/j.bone.2010.12.006; Yamazaki Y, 2013, J ATHEROSCLER THROMB, V20, P186	48	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0171-967X	1432-0827		CALCIFIED TISSUE INT	Calcif. Tissue Int.	JUL	2015	97	1					32	39		10.1007/s00223-015-0007-4		8	Endocrinology & Metabolism	Endocrinology & Metabolism	CK0AR	WOS:000355866600004		
J	Aikawa, Y; Agata, U; Kakutani, Y; Higano, M; Hattori, S; Ogata, H; Ezawa, I; Omi, N				Aikawa, Yuki; Agata, Umon; Kakutani, Yuya; Higano, Michito; Hattori, Satoshi; Ogata, Hitomi; Ezawa, Ikuko; Omi, Naomi			The Interaction of Voluntary Running Exercise and Food Restriction Induces Low Bone Strength and Low Bone Mineral Density in Young Female Rats	CALCIFIED TISSUE INTERNATIONAL			English	Article						Running; Food restriction; Bone strength; Young female rat; Low energy availability	ENERGY AVAILABILITY; SELF-STARVATION; ACTIVITY WHEELS; GROWING RATS; WOMEN; TURNOVER; CALCIUM; EXPENDITURE; INCREASES; MODEL	There is a concern that the combination of exercise with food intake reduction has a risk of reducing bone strength and bone mass in young female athletes. We examined the influence of the interaction of voluntary running exercise and food restriction on bone in young female rats. Seven-week-old female Sprague-Dawley rats were divided into four groups: the sedentary and ad libitum feeding group (SED), voluntary running exercise and ad libitum feeding group (EX), sedentary and 30 % food restriction group (SED-FR), and voluntary running exercise and 30 % food restriction group (EX-FR). The experiment lasted 12 weeks. Statistical analysis was carried out by two-way analysis of variance with exercise and restriction as the between-subjects factors. As a result, there were significant interactions of running and restriction on energy availability, breaking force, breaking energy, and bone mineral density (BMD). Breaking force and energy in the EX group were significantly higher than in the SED group; breaking force and energy were significantly lower in the EX-FR group than in the EX group, and breaking force in the EX-FR group was significantly lower than that in the SED-FR group. BMD in the EX-FR group was significantly lower than in the EX and SED-FR groups. These results suggest that food restriction induced low bone strength in young female rats engaging in voluntary running exercise. Also, through the interaction of exercise and food restriction, voluntary running exercise combined food restriction, unlike ad libitum feeding conditions, induced low bone strength, and low BMD in young female rats.	[Aikawa, Yuki; Agata, Umon; Kakutani, Yuya; Higano, Michito; Hattori, Satoshi] Univ Tsukuba, Comprehens Human Sci, Tsukuba, Ibaraki 3058572, Japan; [Ogata, Hitomi; Omi, Naomi] Univ Tsukuba, Fac Hlth & Sport Sci, Tsukuba, Ibaraki 3058572, Japan; [Ezawa, Ikuko] Japan Womens Univ, Dept Food & Nutr, Bunkyo Ku, Tokyo 1128681, Japan; [Omi, Naomi] Univ Tsukuba, Inst Hlth & Sports Sci, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058574, Japan	Omi, N (reprint author), Univ Tsukuba, Fac Hlth & Sport Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058572, Japan.	ominaomi@taiiku.tsukuba.ac.jp					ANANTHARAMANBARR HG, 1989, PHYSIOL BEHAV, V46, P259, DOI 10.1016/0031-9384(89)90265-5; Hind K, 2007, BONE, V40, P14, DOI 10.1016/j.bone.2006.07.006; Talbott SM, 1998, J NUTR, V128, P640; Talbott SM, 2001, J NUTR, V131, P2382; Stubbs RJ, 2004, AM J PHYSIOL-REG I, V286, pR350, DOI 10.1152/ajpregu.00196.2003; Ihle R, 2004, J BONE MINER RES, V19, P1231, DOI 10.1359/JBMR.040410; Weaver CM, 2002, ENDOCRINE, V17, P43, DOI 10.1385/ENDO:17:1:43; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903; Boutroy S, 2008, J BONE MINER RES, V23, P392, DOI 10.1359/JBMR.071108; Borer KT, 2005, SPORTS MED, V35, P779, DOI 10.2165/00007256-200535090-00004; Barrack MT, 2010, AM J CLIN NUTR, V92, P652, DOI 10.3945/ajcn.2009.28926; Loucks AB, 2011, J SPORT SCI, V29, pS7, DOI 10.1080/02640414.2011.588958; Hawkins J, 2010, J NUTR, V140, P31, DOI 10.3945/jn.109.111450; OMI N, 1994, J NUTR SCI VITAMINOL, V40, P443; Barrack Michelle T, 2013, Curr Rev Musculoskelet Med, V6, P195, DOI 10.1007/s12178-013-9168-9; DiMarco NM, 2007, J APPL PHYSIOL, V103, P1469, DOI 10.1152/japplphysiol.01137.2005; Erben RG, 2004, J BONE MINER RES, V19, P1827, DOI 10.1359/JBMR.040815; Ezawa I, 1979, J JPN SOC FOOD NUTR, V32, P329; Hattori S, 2014, J NUTR SCI VITAMINOL, V60, P35; Holy X, 2000, MED SCI SPORT EXER, V32, P1562; Lauder TD, 2000, ARCH PHYS MED REHAB, V81, P73, DOI 10.1016/S0003-9993(00)90225-9; Mardon J, 2009, PEDIATR RES, V66, P513, DOI 10.1203/PDR.0b013e3181b9b4bb; Nattiv Aurelia, 2007, Med Sci Sports Exerc, V39, P1867; NEWHALL KM, 1991, J BONE MINER RES, V6, P289; Nichols DL, 2007, SPORTS MED, V37, P1001, DOI 10.2165/00007256-200737110-00006; NIH, 2000, NIH CONSENSUS STATE, V17, P1; OMI N, 1994, BONE MINER, V24, P211, DOI 10.1016/S0169-6009(08)80138-9; ROUTTENB.A, 1967, J COMP PHYSIOL PSYCH, V64, P414, DOI 10.1037/h0025205; Shiga K, 2003, J NUTR, V133, P4207; Swift SN, 2012, J NUTR, V142, P1038, DOI 10.3945/jn.111.153361; Wang G, 1923, COMP PSYCHOL MONOGR, V2, P1; WOODS DJ, 1971, J COMP PHYSIOL PSYCH, V76, P84, DOI 10.1037/h0031047; Yanaka K, 2012, J PHYS FIT SPORTS ME, V1, P695	33	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0171-967X	1432-0827		CALCIFIED TISSUE INT	Calcif. Tissue Int.	JUL	2015	97	1					90	99		10.1007/s00223-015-0005-6		10	Endocrinology & Metabolism	Endocrinology & Metabolism	CK0AR	WOS:000355866600011		
J	Ohara, H; Nakamura, Y; Watanabe, Y; Cao, X; Yamazaki, Y; Izumi-Nakaseko, H; Ando, K; Yamazaki, H; Yamazaki, J; Ikeda, T; Sugiyama, A				Ohara, Hiroshi; Nakamura, Yuji; Watanabe, Yudai; Cao, Xin; Yamazaki, Yukiko; Izumi-Nakaseko, Hiroko; Ando, Kentaro; Yamazaki, Hiroshi; Yamazaki, Junichi; Ikeda, Takanori; Sugiyama, Atsushi			Azithromycin Can Prolong QT Interval and Suppress Ventricular Contraction, but Will Not Induce Torsade de Pointes	CARDIOVASCULAR TOXICOLOGY			English	Article						Azithromycin; Ventricular contraction; QT prolongation; I-Kr; Torsade de pointes; Atrioventricular block	VIVO CANINE MODEL; ANESTHETIZED DOGS; HEART-RATE; AV BLOCK; REPOLARIZATION; ANTIBIOTICS; VARIABILITY; BRADYCARDIA; ELECTROCARDIOGRAM; REFRACTORINESS	Azithromycin has been reported to increase the risk of death from cardiovascular causes among patients with high baseline risk. Since the information is still limited to bridge the gap between electrophysiological properties of azithromycin in vitro and cardiac death in patients, we initially assessed its electropharmacological effects in doses of 3 and 30 mg/kg, i.v., with the halothane-anesthetized dogs (n = 4). The low dose provided 5.2 times higher than the therapeutic concentration, whereas the high dose attained 17.0 times higher. The high dose delayed the ventricular repolarization in a reverse use-dependent manner, reflecting blockade of the rapid component of delayed rectifier K+ current, and the potency was relatively weak; namely, maximum change in QTc was +20 ms (+5.6 %). The high dose also induced the negative inotropic effect possibly through Ca2+ channel-independent pathway. In order to clarify proarrhythmic risk, 30 mg/kg, i.v., of azithromycin was examined with the chronic atrioventricular block dogs (n = 4). Azithromycin neither induced torsade de pointes nor affected beat-to-beat variability of repolarization. Thus, azithromycin can be considered to lack proarrhythmic potential, but caution has to be paid on its use for patients with left ventricular dysfunction.	[Ohara, Hiroshi; Nakamura, Yuji; Watanabe, Yudai; Cao, Xin; Yamazaki, Yukiko; Izumi-Nakaseko, Hiroko; Ando, Kentaro; Sugiyama, Atsushi] Toho Univ, Fac Med, Dept Pharmacol, Ota Ku, Tokyo 1438540, Japan; [Ohara, Hiroshi; Yamazaki, Yukiko; Yamazaki, Junichi; Ikeda, Takanori] Toho Univ, Div Cardiovasc Med, Dept Internal Med, Fac Med,Ota Ku, Tokyo 1438541, Japan; [Yamazaki, Hiroshi] Showa Pharmaceut Univ, Lab Drug Metab & Pharmacokinet, Machida, Tokyo 1948543, Japan	Sugiyama, A (reprint author), Toho Univ, Fac Med, Dept Pharmacol, Ota Ku, 5-21-16 Omori Nishi, Tokyo 1438540, Japan.	atsushi.sugiyama@med.toho-u.ac.jp	Yamazaki, Hiroshi/A-6081-2011	Yamazaki, Hiroshi/0000-0002-1068-4261	Japan Science and Technology Agency [AS2116907E]; Toho University School of Medicine [25-25]; Toho University [H25-3, H26-2]	This study was partially supported by the Japan Science and Technology Agency (#AS2116907E), the Project Research Grant of Toho University School of Medicine (No. 25-25) and Toho University Joint Research Fund (H25-3, H26-2). The authors thank Ms. Misako Nakatani, Mr. Yuki Suzuki and Dr. Norie Murayama for their technical supports.	Milberg P, 2002, J PHARMACOL EXP THER, V303, P218, DOI 10.1124/jpet.102.037911; Fridericia LS, 2003, ANN NONINVAS ELECTRO, V8, P343, DOI 10.1046/j.1542-474X.2003.08413.x; Ray WA, 2012, NEW ENGL J MED, V366, P1881, DOI 10.1056/NEJMoa1003833; Kezerashvili A, 2007, J INTERV CARD ELECTR, V18, P243, DOI 10.1007/s10840-007-9124-y; Thomsen MB, 2006, J AM COLL CARDIOL, V48, P1268, DOI 10.1016/j.jacc.2006.05.048; Samarendra P, 2001, PACE, V24, P1572, DOI 10.1046/j.1460-9592.2001.01572.x; Huang BH, 2007, PACE, V30, P1579; Thomsen MB, 2004, CIRCULATION, V110, P2453, DOI 10.1161/01.CIR.0000145162.64183.C8; Parnham MJ, 2014, PHARMACOL THERAPEUT, V143, P225, DOI 10.1016/j.pharmthera.2014.03.003; Svanstrom H, 2013, NEW ENGL J MED, V368, P1704, DOI 10.1056/NEJMoa1300799; Shiina H, 2000, JPN CIRC J, V64, P777, DOI 10.1253/jcj.64.777; Brennan M, 2001, IEEE T BIO-MED ENG, V48, P1342, DOI 10.1109/10.959330; Chiba K, 2004, EUR J PHARMACOL, V486, P189, DOI 10.1016/j.ejphar.2003.12.014; Ishizaka T, 2008, CIRC J, V72, P1003, DOI 10.1253/circj.72.1003; Kim MH, 2005, PACE, V28, P1221, DOI 10.1111/j.1540-8159.2005.50146.x; Kise H, 2010, BASIC CLIN PHARMACOL, V106, P288, DOI 10.1111/j.1742-7843.2009.00477.x; Santos N, 2010, REV PORT CARDIOL, V29, P139; Satoh T, 1996, CIRCULATION, V94, P217; Sharma K, 2013, BIOMED CHROMATOGR, V27, P1243, DOI 10.1002/bmc.2898; Sugiyama A, 2008, BRIT J PHARMACOL, V154, P1528, DOI 10.1038/bjp.2008.240; Sugiyama A, 2002, JPN J PHARMACOL, V88, P341, DOI 10.1254/jjp.88.341; Sugiyama A, 2002, JPN J PHARMACOL, V88, P414, DOI 10.1254/jjp.88.414; Takahara A, 2006, BRIT J PHARMACOL, V147, P634, DOI 10.1038/sj.bjp.0706493; TAMARGO J, 1982, EUR J PHARMACOL, V80, P285, DOI 10.1016/0014-2999(82)90073-5; Thomsen MB, 2006, BRIT J PHARMACOL, V149, P1039, DOI 10.1038/sj.bjp.0706900; Tilelli JA, 2006, PHARMACOTHERAPY, V26, P147, DOI 10.1592/phco.2006.26.1.147; VANDEWATER A, 1989, J PHARMACOL METHOD, V22, P207, DOI 10.1016/0160-5402(89)90015-6; Yoshida H, 2002, CIRC J, V66, P857, DOI 10.1253/circj.66.857	28	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1530-7905	1559-0259		CARDIOVASC TOXICOL	Cardiovasc. Toxicol.	JUL	2015	15	3					232	240		10.1007/s12012-014-9289-4		9	Cardiac & Cardiovascular Systems; Toxicology	Cardiovascular System & Cardiology; Toxicology	CJ8TL	WOS:000355776300005		
J	Harada, Y; Hirayama, H; Suzuki, T				Harada, Yoichiro; Hirayama, Hiroto; Suzuki, Tadashi			Generation and degradation of free asparagine-linked glycans	CELLULAR AND MOLECULAR LIFE SCIENCES			English	Review						Free N-glycan; Oligosaccharyltransferase; Pyrophosphatase; Peptide: N-glycanase; Yeast; Mammals	BETA-N-ACETYLGLUCOSAMINIDASE; RETICULUM-ASSOCIATED DEGRADATION; ALPHA-D-MANNOSIDASE; ER-ASSOCIATED DEGRADATION; OLIGOSACCHARYL TRANSFERASE COMPLEX; POLYMANNOSE-TYPE OLIGOSACCHARIDES; VACUOLE TARGETING PATHWAY; PROTEIN-QUALITY CONTROL; DOLICHYL PYROPHOSPHATE PHOSPHATASE; CYTOSOLIC-FREE OLIGOSACCHARIDES	Asparagine (N)-linked protein glycosylation, which takes place in the eukaryotic endoplasmic reticulum (ER), is important for protein folding, quality control and the intracellular trafficking of secretory and membrane proteins. It is known that, during N-glycosylation, considerable amounts of lipid-linked oligosaccharides (LLOs), the glycan donor substrates for N-glycosylation, are hydrolyzed to form free N-glycans (FNGs) by unidentified mechanisms. FNGs are also generated in the cytosol by the enzymatic deglycosylation of misfolded glycoproteins during ER-associated degradation. FNGs derived from LLOs and misfolded glycoproteins are eventually merged into one pool in the cytosol and the various glycan structures are processed to a near homogenous glycoform. This article summarizes the current state of our knowledge concerning the formation and catabolism of FNGs.	[Harada, Yoichiro; Hirayama, Hiroto; Suzuki, Tadashi] RIKEN, Global Res Cluster, RIKEN Max Planck Joint Res Ctr, Glycometabolome Team,Syst Glycobiol Res Grp, Wako, Saitama 3510198, Japan	Suzuki, T (reprint author), RIKEN, Global Res Cluster, RIKEN Max Planck Joint Res Ctr, Glycometabolome Team,Syst Glycobiol Res Grp, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	tsuzuki_gm@riken.jp			Mizutani Foundation for Glycoscience; CREST (Japan Science and Technology Agency); Kakiuchi Memorial Research Grant (The Japanese Biochemical Society); Ministry of Education, Culture, Sports, Science, and Technology of Japan [24770134, 26650040, 22570148, 25291030, 26110725]; Incentive Research Projects (RIKEN)	We are grateful to the members of Glycometabolome Team for sharing their passion for science as well as fruitful discussions. TS would like to thank Drs. Christine Szymanski and Harald Nothaft (University of Alberta, Canada) for their invaluable input on FNG generation in bacteria. Research regarding the generation and degradation of FNG by the Glycometabolome Team have been supported by the following research grants: Mizutani Foundation for Glycoscience, CREST (Japan Science and Technology Agency), Kakiuchi Memorial Research Grant (The Japanese Biochemical Society) (to T. S.); Grants-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (24770134 and 26650040 to Y. H.; 22570148, 25291030 and 26110725 to T. S.); Incentive Research Projects (RIKEN) to Y. H. and H. H.	ALDAHER S, 1992, BIOCHEM J, V286, P47; Need AC, 2012, J MED GENET, V49, P353, DOI 10.1136/jmedgenet-2012-100819; Blom D, 2004, EMBO J, V23, P650, DOI 10.1038/sj.emboj.7600090; Ruiz-Canada C, 2009, CELL, V136, P272, DOI 10.1016/j.cell.2008.11.047; Frank CG, 2005, GLYCOBIOLOGY, V15, P1156, DOI 10.1093/glycob/cwj002; Schollen E, 2005, EUR J MED GENET, V48, P153, DOI 10.1016/j.ejmg.2005.01.002; Yabu M, 2013, GLYCOBIOLOGY, V23, P634, DOI 10.1093/glycob/cws132; Suzuki T, 2014, BIOCHEM BIOPH RES CO, V453, P213, DOI 10.1016/j.bbrc.2014.05.075; Suzuki T, 2002, FASEB J, V16, DOI 10.1096/fj.01-0889rev; Zhang T, 2014, DNA CELL BIOL, V33, P477, DOI 10.1089/dna.2014.2452; REARICK JI, 1981, J BIOL CHEM, V256, P6255; Gao XD, 2008, J BIOL CHEM, V283, P32534, DOI 10.1074/jbc.M804060200; Fischl RM, 2011, PLANT MOL BIOL, V77, P275, DOI 10.1007/s11103-011-9808-7; PRIEM B, 1992, PLANT PHYSIOL, V98, P399, DOI 10.1104/pp.98.1.399; Suzuki T, 2007, SEMIN CELL DEV BIOL, V18, P762, DOI 10.1016/j.semcdb.2007.09.010; Kato T, 2007, J BIOL CHEM, V282, P22080, DOI 10.1074/jbc.M700805200; Hebert DN, 2010, SEMIN CELL DEV BIOL, V21, P526, DOI 10.1016/j.semcdb.2009.12.007; Chantret I, 2011, J BIOL CHEM, V286, P41786, DOI 10.1074/jbc.M111.251371; Gao NG, 2011, MOL BIOL CELL, V22, P2994, DOI 10.1091/mbc.E11-04-0286; MOORE SEH, 1990, J BIOL CHEM, V265, P13104; MOORE SEH, 1995, EMBO J, V14, P6034; Moriguchi K, 2007, J BIOCHEM, V142, P213, DOI 10.1093/jb/mvm128; Chavan M, 2005, J BIOL CHEM, V280, P22917, DOI 10.1074/jbc.M502858200; Bernon C, 2011, GLYCOBIOLOGY, V21, P363, DOI 10.1093/glycob/cwq169; Cherepanova NA, 2014, J CELL BIOL, V206, P525, DOI 10.1083/jcb.201404083; Harada Y, 2013, P NATL ACAD SCI USA, V110, P19366, DOI 10.1073/pnas.1312187110; Aebi M, 1996, GLYCOBIOLOGY, V6, P439, DOI 10.1093/glycob/6.4.439; Habibi-Babadi N, 2010, J NEUROSCI, V30, P1766, DOI 10.1523/JNEUROSCI.4962-08.2010; Glover KJ, 2005, P NATL ACAD SCI USA, V102, P14255, DOI 10.1073/pnas.0507311102; Masahara-Negishi Y, 2012, BBA-GEN SUBJECTS, V1820, P1457, DOI 10.1016/j.bbagen.2012.05.009; D'Alessio C, 2010, SEMIN CELL DEV BIOL, V21, P491, DOI 10.1016/j.semcdb.2009.12.014; Suzuki K, 2010, J BIOL CHEM, V285, P30019, DOI 10.1074/jbc.M110.143511; Yan AX, 2005, GLYCOBIOLOGY, V15, P1407, DOI 10.1093/glycob/cwj026; Chantret I, 2008, GLYCOBIOLOGY, V18, P210, DOI 10.1093/glycob/cwn003; PRIEM B, 1993, PLANT PHYSIOL, V102, P445, DOI 10.1104/pp.102.2.445; Wacker M, 2002, SCIENCE, V298, P1790, DOI 10.1126/science.298.5599.1790; FINGER A, 1993, EUR J BIOCHEM, V218, P565, DOI 10.1111/j.1432-1033.1993.tb18410.x; Hosokawa N, 2009, J BIOL CHEM, V284, P17061, DOI 10.1074/jbc.M809725200; Chang T, 2000, J BIOL CHEM, V275, P129, DOI 10.1074/jbc.275.1.129; Chantret I, 2003, BIOCHEM J, V373, P901, DOI 10.0142/BJ20030384; Kumano M, 1996, J BIOCHEM-TOKYO, V119, P991; Schulz BL, 2009, P NATL ACAD SCI USA, V106, P11061, DOI 10.1073/pnas.0812515106; Aebi M, 2010, TRENDS BIOCHEM SCI, V35, P74, DOI 10.1016/j.tibs.2009.10.001; Hirsch C, 2003, EMBO J, V22, P1036, DOI 10.1093/emboj/cdg107; Wu XH, 2003, HUM MUTAT, V22, P144, DOI 10.1002/humu.10239; Kim YC, 2013, PLANT PHYSIOL, V161, P455, DOI 10.1104/pp.112.208900; Aebi M, 2013, BBA-MOL CELL RES, V1833, P2430, DOI 10.1016/j.bbamcr.2013.04.001; Li GT, 2005, P NATL ACAD SCI USA, V102, P15809, DOI 10.1073/pnas.0507155102; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; Clerc S, 2009, J CELL BIOL, V184, P159, DOI 10.1083/jcb.200809198; Hosokawa N, 2008, J BIOL CHEM, V283, P20914, DOI 10.1074/jbc.M709336200; Suzuki T, 2006, GLYCOCONJUGATE J, V23, P291, DOI 10.1007/s10719-006-6975-x; Ohashi S, 1999, J BIOCHEM-TOKYO, V126, P852; SaintPol A, 1997, J CELL BIOL, V136, P45, DOI 10.1083/jcb.136.1.45; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Ninagawa S, 2014, J CELL BIOL, V206, P347, DOI 10.1083/jcb.201404075; Xu XH, 2004, FEBS LETT, V570, P155, DOI 10.1016/j.febslet.2004.06.039; TAGA EM, 1984, BIOCHEMISTRY-US, V23, P815, DOI 10.1021/bi00300a006; Nakamura K, 2008, BIOSCI BIOTECH BIOCH, V72, P2936, DOI 10.1271/bbb.80414; Huppa JB, 1997, IMMUNITY, V7, P113, DOI 10.1016/S1074-7613(00)80514-2; Kim I, 2006, J CELL BIOL, V172, P211, DOI 10.1083/jcb.200507149; TAKAHASHI N, 1977, BIOCHEM BIOPH RES CO, V76, P1194, DOI 10.1016/0006-291X(77)90982-2; PRIEM B, 1990, CR ACAD SCI III-VIE, V311, P411; Lizak C, 2011, NATURE, V474, P350, DOI 10.1038/nature10151; Suzuki T, 2000, J CELL BIOL, V149, P1039, DOI 10.1083/jcb.149.5.1039; BARNES G, 1984, MOL CELL BIOL, V4, P2381; Watanabe Y, 2010, J BIOL CHEM, V285, P30026, DOI 10.1074/jbc.M110.143545; Freeze HH, 2013, J BIOL CHEM, V288, P6936, DOI 10.1074/jbc.R112.429274; Quan EM, 2008, MOL CELL, V32, P870, DOI 10.1016/j.molcel.2008.11.017; COUTO JR, 1984, J BIOL CHEM, V259, P378; GETHING MJ, 1986, CELL, V46, P939, DOI 10.1016/0092-8674(86)90076-0; Scott SV, 2001, MOL CELL, V7, P1131, DOI 10.1016/S1097-2765(01)00263-5; Hampton RY, 2012, CURR OPIN CELL BIOL, V24, P460, DOI 10.1016/j.ceb.2012.05.010; Suzuki T, 2006, BIOCHEM J, V400, P33, DOI 10.1042/BJ20060945; Gao XD, 2005, J BIOL CHEM, V280, P36254, DOI 10.1074/jbc.M507569200; Hese K, 2009, GLYCOBIOLOGY, V19, P160, DOI 10.1093/glycob/cwn118; Yabu M, 2013, GLYCOCONJUGATE J, V30, P247, DOI 10.1007/s10719-012-9435-9; Sanyal S, 2009, P NATL ACAD SCI USA, V106, P767, DOI 10.1073/pnas.0810225106; Jamaluddin MFB, 2011, PROTEIN SCI, V20, P849, DOI 10.1002/pro.610; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Bickel T, 2005, J BIOL CHEM, V280, P34500, DOI 10.1074/jbc.M506358200; Nothaft H, 2009, P NATL ACAD SCI USA, V106, P15019, DOI 10.1073/pnas.0903078106; Hirayama H, 2010, J BIOL CHEM, V285, P12390, DOI 10.1074/jbc.M109.082081; Maattanen P, 2010, SEMIN CELL DEV BIOL, V21, P500, DOI 10.1016/j.semcdb.2010.03.006; Harada Y, 2009, P NATL ACAD SCI USA, V106, P6945, DOI 10.1073/pnas.0812489106; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Liu X, 2006, ANAL CHEM, V78, P6081, DOI 10.1021/ac060516m; Cipollo JF, 2002, GLYCOBIOLOGY, V12, P749, DOI 10.1093/glycob/cwf082; Kostova Z, 2003, EMBO J, V22, P2309, DOI 10.1093/emboj/cdg227; Cipollo JF, 2001, J BIOL CHEM, V276, P21828, DOI 10.1074/jbc.M010896200; Suzuki T, 2002, P NATL ACAD SCI USA, V99, P9691, DOI 10.1073/pnas.152333599; Haga Y, 2009, GLYCOBIOLOGY, V19, P987, DOI 10.1093/glycob/cwp075; Wang L, 2013, J BIOL CHEM, V288, P11887, DOI 10.1074/jbc.M112.425702; Ishizuka A, 2008, BIOCHEM J, V413, P227, DOI 10.1042/BJ20071562; Bas T, 2011, J BIOL CHEM, V286, P28150, DOI 10.1074/jbc.M111.235168; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Altmann F, 1998, EUR J BIOCHEM, V252, P118, DOI 10.1046/j.1432-1327.1998.2520118.x; Harada Y, 2013, J BIOL CHEM, V288, P32673, DOI 10.1074/jbc.M113.486985; Totani K, 2006, J BIOL CHEM, V281, P31502, DOI 10.1074/jbc.M605457200; Nothaft H, 2012, MOL CELL PROTEOMICS, V11, P1203, DOI 10.1074/mcp.M112.021519; Yu H, 1997, J BIOL CHEM, V272, P20800, DOI 10.1074/jbc.272.33.20800; SPIRO MJ, 1991, J BIOL CHEM, V266, P5311; Chantret I, 2002, J BIOL CHEM, V277, P25815, DOI 10.1074/jbc.M203285200; Yamashiro K, 1997, J BIOCHEM-TOKYO, V122, P1174; Sitia R, 2003, NATURE, V426, P891, DOI 10.1038/nature02262; Young NM, 2002, J BIOL CHEM, V277, P42530, DOI 10.1074/jbc.M206114200; Thiel C, 2003, J BIOL CHEM, V278, P22498, DOI 10.1074/jbc.M302850200; Helenius J, 2002, NATURE, V415, P447, DOI 10.1038/415447a; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; Seino J, 2013, J BIOL CHEM, V288, P26898, DOI 10.1074/jbc.M113.464503; Kelleher DJ, 2003, MOL CELL, V12, P101, DOI 10.1016/S1097-2765(03)00243-0; Gauss R, 2011, MOL CELL, V42, P782, DOI 10.1016/j.molcel.2011.04.027; Gao NG, 2005, J BIOL CHEM, V280, P17901, DOI 10.1074/jbc.M500510200; Shrimal S, 2013, J CELL BIOL, V201, P81, DOI 10.1083/jcb.201301031; Schwarz F, 2011, CURR OPIN STRUC BIOL, V21, P576, DOI 10.1016/j.sbi.2011.08.005; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Caramelo JJ, 2008, J BIOL CHEM, V283, P10221, DOI 10.1074/jbc.R700048200; Vuylsteker C, 2000, J EXP BOT, V51, P839, DOI 10.1093/jexbot/51.346.839; Hutchins MU, 2001, J BIOL CHEM, V276, P20491, DOI 10.1074/jbc.M101150200; Shintani T, 2004, J BIOL CHEM, V279, P29889, DOI 10.1074/jbc.M404399200; Alonzi DS, 2013, CELL MOL LIFE SCI, V70, P2799, DOI 10.1007/s00018-013-1304-6; Yue W, 2004, INT J CANCER, V108, P189, DOI 10.1002/ijc.11536; Szymanski CM, 1999, MOL MICROBIOL, V32, P1022, DOI 10.1046/j.1365-2958.1999.01415.x; PLUMMER TH, 1987, EUR J BIOCHEM, V163, P167, DOI 10.1111/j.1432-1033.1987.tb10751.x; Li GT, 2006, P NATL ACAD SCI USA, V103, P8348, DOI 10.1073/pnas.0602747103; Cossins J, 2013, BRAIN, V136, P944, DOI 10.1093/brain/awt010; Nothaft H, 2010, VIRULENCE, V1, P546, DOI 10.1073/pnas.0903078106; Shibatani T, 2005, BIOCHEMISTRY-US, V44, P5982, DOI 10.1021/bi047328f; Denzel MS, 2014, CELL, V156, P1167, DOI 10.1016/j.cell.2014.01.061; Chavan M, 2006, P NATL ACAD SCI USA, V103, P8947, DOI 10.1073/pnas.0603262103; Seko A, 1997, BBA-GEN SUBJECTS, V1335, P23, DOI 10.1016/S0304-4165(96)00118-3; Shintani T, 2002, DEV CELL, V3, P825, DOI 10.1016/S1534-5807(02)00373-8; TAKAHASHI N, 1978, J BIOCHEM-TOKYO, V84, P1467; ANUMULA KR, 1983, J BIOL CHEM, V258, P5274; Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; BAUMANN H, 1983, J BIOL CHEM, V258, P3942; BELARD M, 1988, BIOCHEM J, V255, P235; Berger S, 1996, PLANT PHYSIOL, V112, P259; Berger S, 1995, BIOCHIMIE, V77, P751, DOI 10.1016/0300-9084(96)88193-4; BERGER S, 1995, PHYTOCHEMISTRY, V39, P481, DOI 10.1016/0031-9422(95)00001-N; BISCHOFF J, 1986, J BIOL CHEM, V261, P4758; Bissar-Tadmouri N, 2014, AM J MED GENET A, V164, P164, DOI 10.1002/ajmg.a.36233; BREUER W, 1995, EUR J BIOCHEM, V228, P689, DOI 10.1111/j.1432-1033.1995.0689m.x; Burda P, 1999, BBA-GEN SUBJECTS, V1426, P239, DOI 10.1016/S0304-4165(98)00127-5; Burda P, 1999, GLYCOBIOLOGY, V9, P617, DOI 10.1093/glycob/9.6.617; Burda P, 1996, P NATL ACAD SCI USA, V93, P7160, DOI 10.1073/pnas.93.14.7160; Burda P, 1998, GLYCOBIOLOGY, V8, P455, DOI 10.1093/glycob/8.5.455; Butters TD, 2009, GLYCOCONJUGATE J, V26, P1109, DOI 10.1007/s10719-009-9231-3; CACAN R, 1980, EUR J BIOCHEM, V106, P473, DOI 10.1111/j.1432-1033.1980.tb04594.x; Caglayan AO, 2015, EUR J MED GENET, V58, P39, DOI 10.1016/j.ejmg.2014.08.008; Castro O, 2006, P NATL ACAD SCI USA, V103, P14756, DOI 10.1073/pnas.0607086103; Chantret I, 2003, J BIOL CHEM, V278, P9962, DOI 10.1074/jbc.M211950200; Chantret I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011734; Chien S, 1976, Biochem Biophys Res Commun, V76, P317; DEGASPERI R, 1992, BIOCHEM J, V286, P55; Diepold A, 2007, PLANT J, V52, P94, DOI 10.1111/j.1365-313X.2007.03215.x; Doerrler WT, 1999, P NATL ACAD SCI USA, V96, P13050, DOI 10.1073/pnas.96.23.13050; Durrant C, 2002, BIOCHEM J, V365, P239, DOI 10.1042/BJ20011786; Duvet S, 2004, GLYCOBIOLOGY, V14, P841, DOI 10.1093/glycob/cwh103; Duvet S, 2002, GLYCOBIOLOGY, V12, P95, DOI 10.1093/glycob/12.2.95; Dwivedi R, 2013, BIOPOLYMERS, V99, P772, DOI 10.1002/bip.22296; Enns GM, 2014, GENET MED, V16, P751, DOI 10.1038/gim.2014.22; Faugeron C, 1997, PLANT PHYSIOL BIOCH, V35, P73; Faugeron C, 1997, PLANT PHYSIOL BIOCH, V35, P891; Fernandez F, 2001, J BIOL CHEM, V276, P41455, DOI 10.1074/jbc.M105544200; Frank CG, 2004, AM J HUM GENET, V75, P146, DOI 10.1086/422367; Frank CG, 2008, NATURE, V454, pE3, DOI 10.1038/nature07165; Funakoshi Y, 2009, BBA-GEN SUBJECTS, V1790, P81, DOI 10.1016/j.bbagen.2008.09.009; Funakoshi Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010545; Gao Ningguo, 2013, Methods Mol Biol, V1022, P277, DOI 10.1007/978-1-62703-465-4_20; GERSHMAN H, 1981, J BIOL CHEM, V256, P7774; Grard T, 1996, BIOCHEM J, V316, P787; GRARD T, 1994, EUR J BIOCHEM, V223, P99, DOI 10.1111/j.1432-1033.1994.tb18970.x; Grubenmann CE, 2002, HUM MOL GENET, V11, P2331, DOI 10.1093/hmg/11.19.2331; HAEUW JF, 1991, EUR J BIOCHEM, V202, P1257, DOI 10.1111/j.1432-1033.1991.tb16498.x; HAEUW J-F, 1991, Glycobiology, V1, P487, DOI 10.1093/glycob/1.5.487; He LZ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1309; Higashidani A, 2009, MOL GENET METAB, V96, P268, DOI 10.1016/j.ymgme.2008.12.005; Hirayama H, 2011, GLYCOBIOLOGY, V21, P1341, DOI 10.1093/glycob/cwr073; Hirayama H, 2014, SEMIN CELL DEV BIOL, DOI [10.1016/j.semcdb.2014.11.009, DOI 10.1016/J.SEMCDB.2014.11.009]; Hosomi A, 2015, BBA-GEN SUBJECTS, V1850, P612, DOI 10.1016/j.bbagen.2014.12.008; Hosomi A, 2010, J BIOL CHEM, V285, P24324, DOI 10.1074/jbc.M109.095919; Hossain MA, 2010, J BIOCHEM, V147, P157, DOI 10.1093/jb/mvp157; HSU AF, 1974, P NATL ACAD SCI USA, V71, P2391, DOI 10.1073/pnas.71.6.2391; Huang CC, 2015, P NATL ACAD SCI USA, V112, P1398, DOI 10.1073/pnas.1414593112; Huang CC, 2015, BIOSCI BIOTECH BIOCH, V79, P553, DOI 10.1080/09168451.2014.991682; HUFFAKER TC, 1983, P NATL ACAD SCI-BIOL, V80, P7466, DOI 10.1073/pnas.80.24.7466; HUFFAKER TC, 1982, J BIOL CHEM, V257, P3203; Imbach T, 1999, P NATL ACAD SCI USA, V96, P6982, DOI 10.1073/pnas.96.12.6982; INOUE S, 1989, J BIOL CHEM, V264, P18520; ISHII K, 1989, J BIOL CHEM, V264, P1623; ISONO T, 2011, PLOS ONE, V0006; Isono T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096168; Iwai K, 1999, J BIOCHEM-TOKYO, V125, P70; IWASAKI M, 1992, J BIOL CHEM, V267, P24287; Iwatsuka K, 2013, J CHROMATOGR B, V928, P16, DOI 10.1016/j.jchromb.2013.03.010; Izquierdo L, 2009, EMBO J, V28, P2650, DOI 10.1038/emboj.2009.203; Karaivanova VK, 2000, GLYCOBIOLOGY, V10, P727, DOI 10.1093/glycob/10.7.727; Karaoglu D, 2001, BIOCHEMISTRY-US, V40, P12193, DOI 10.1021/bi0111911; Kato A, 2011, J BIOCHEM, V149, P415, DOI 10.1093/jb/mvq153; Kato T, 2002, GLYCOBIOLOGY, V12, P581, DOI 10.1093/glycob/cwf073; Kato T, 2007, J BIOCHEM, V142, P175, DOI 10.1093/jb/mvm117; Kato T, 1997, J BIOCHEM-TOKYO, V122, P1167; Katoh T, 2009, TRENDS GLYCOSCI GLYC, V21, P163, DOI 10.4052/tigg.21.163; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; Kelleher DJ, 2007, J CELL BIOL, V177, P29, DOI 10.1083/jcb.200611079; Kimura Y, 2002, BBA-GEN SUBJECTS, V1570, P38, DOI 10.1016/S0304-4165(02)00149-6; Kimura Y, 1998, BIOSCI BIOTECH BIOCH, V62, P253, DOI 10.1271/bbb.62.253; Kimura Y, 1996, BIOSCI BIOTECH BIOCH, V60, P228; Kimura Y, 1997, BIOSCI BIOTECH BIOCH, V61, P924; Kimura Y, 1998, BIOSCI BIOTECH BIOCH, V62, P412, DOI 10.1271/bbb.62.412; Kimura Y, 2000, J BIOCHEM-TOKYO, V127, P1013; Kimura Y, 2000, BIOSCI BIOTECH BIOCH, V64, P1847, DOI 10.1271/bbb.64.1847; Kimura Y, 2011, BIOSCI BIOTECH BIOCH, V75, P1019, DOI 10.1271/bbb.110148; Kimura Y, 1998, BBA-GEN SUBJECTS, V1381, P27, DOI 10.1016/S0304-4165(97)00155-4; Kitajima T, 2006, FEBS J, V273, P5074, DOI 10.1111/j.1742-4658.2006.05505.x; KMIECIK D, 1995, GLYCOBIOLOGY, V5, P483, DOI 10.1093/glycob/5.5.483; Kukushkin NV, 2011, BIOCHEM J, V438, P133, DOI 10.1042/BJ20110186; KURIYAMA M, 1981, J BIOL CHEM, V256, P2316; KURIYAMA M, 1981, JPN J EXP MED, V51, P129; LAU JTY, 1983, J BIOL CHEM, V258, P5255; LHERNOULD S, 1992, GLYCOCONJUGATE J, V9, P191, DOI 10.1007/BF00731164; LHERNOULD S, 1994, PLANT PHYSIOL, V106, P779, DOI 10.1104/pp.106.2.779; LHERNOULD S, 1995, GLYCOCONJUGATE J, V12, P94, DOI 10.1007/BF00731874; Li H, 2008, STRUCTURE, V16, P432, DOI 10.1016/j.str.2007.12.013; LI SC, 1981, BIOCHIM BIOPHYS ACTA, V660, P278, DOI 10.1016/0005-2744(81)90171-6; Isono T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060397; Maeda M, 2010, J BIOCHEM, V148, P681, DOI 10.1093/jb/mvq102; Maeda M, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00429; MATHUR R, 1984, BIOCHEM J, V222, P261; MATHUR R, 1988, BIOCHEM J, V253, P677; Michalski JC, 1996, GLYCOPROTEINS DIS NE, V30, P55; Might M, 2014, GENET MED, V16, P736, DOI 10.1038/gim.2014.23; Mohorko E, 2014, STRUCTURE, V22, P590, DOI 10.1016/j.str.2014.02.013; Moore SEH, 1998, GLYCOBIOLOGY, V8, P373, DOI 10.1093/glycob/8.4.373; MOORE SEH, 1994, J BIOL CHEM, V269, P12715; Morvan H, 1996, PLANT PHYSIOL BIOCH, V34, P335; Nakamura K, 2009, BIOSCI BIOTECH BIOCH, V73, P461, DOI 10.1271/bbb.80889; Nasab FP, 2008, MOL BIOL CELL, V19, P3758, DOI 10.1091/mbc.E08-05-0467; NILSSON I, 1993, J BIOL CHEM, V268, P5798; NISHIYAMA A, 1991, AGR BIOL CHEM TOKYO, V55, P1155; OGATAARAKAWA M, 1977, J BIOCHEM-TOKYO, V82, P611; OKU H, 1991, J BIOCHEM-TOKYO, V110, P29; OKU H, 1991, J BIOCHEM-TOKYO, V110, P982; Paciotti S, 2014, J BIOL CHEM, V289, P9611, DOI 10.1074/jbc.M114.550509; Park H, 2001, P NATL ACAD SCI USA, V98, P11163, DOI 10.1073/pnas.201393498; Peric D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011675; Pfeffer S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4072; Plancke Y, 1996, EUR J BIOCHEM, V235, P199, DOI 10.1111/j.1432-1033.1996.00199.x; PRIEM B, 1990, GLYCOCONJUGATE J, V7, P121, DOI 10.1007/BF01050375; PRIEM B, 1994, BIOCHEM SOC T, V22, P398; Reiss G, 1996, GLYCOBIOLOGY, V6, P493, DOI 10.1093/glycob/6.5.493; Rind N, 2010, HUM MOL GENET, V19, P1413, DOI 10.1093/hmg/ddq016; Rush JS, 2002, J BIOL CHEM, V277, P45226, DOI 10.1074/jbc.M207076200; Rush JS, 2008, J BIOL CHEM, V283, P4087, DOI 10.1074/jbc.M707067200; Rush JS, 2009, J BIOL CHEM, V284, P19835, DOI 10.1074/jbc.M109.000893; Saint-Pol A, 1999, J BIOL CHEM, V274, P13547, DOI 10.1074/jbc.274.19.13547; Schulz BL, 2009, MOL CELL PROTEOMICS, V8, P357, DOI 10.1074/mcp.M800219-MCP200; Schwarz M, 2004, AM J HUM GENET, V74, P472, DOI 10.1086/382492; Schwarz M, 2005, FEBS LETT, V579, P6564, DOI 10.1016/j.febslet.2005.10.063; Seko A, 1999, GLYCOBIOLOGY, V9, P887, DOI 10.1093/glycob/9.9.887; SEKO A, 1991, BIOCHEM BIOPH RES CO, V180, P1165, DOI 10.1016/S0006-291X(05)81318-X; SEKO A, 1991, J BIOL CHEM, V266, P22110; SHARMA C, 1981, EUR J BIOCHEM, V116, P101, DOI 10.1111/j.1432-1033.1981.tb05306.x; SHOUP VA, 1976, J BIOL CHEM, V251, P3845; Shrimal S, 2013, J CELL SCI, V126, P5513, DOI 10.1242/jcs.139584; Spirig U, 2005, GLYCOBIOLOGY, V15, P1396, DOI 10.1093/glycob/cwj025; Spiro MJ, 1997, J BIOL CHEM, V272, P29356, DOI 10.1074/jbc.272.46.29356; STAGLJAR I, 1994, P NATL ACAD SCI USA, V91, P5977, DOI 10.1073/pnas.91.13.5977; STARK NJ, 1979, ARCH BIOCHEM BIOPHYS, V192, P599, DOI 10.1016/0003-9861(79)90131-0; STRECKER G, 1977, EUR J BIOCHEM, V81, P165, DOI 10.1111/j.1432-1033.1977.tb11937.x; STRECKER G, 1977, EUR J BIOCHEM, V75, P391, DOI 10.1111/j.1432-1033.1977.tb11540.x; SUGIYAMA K, 1983, BIOCHEM BIOPH RES CO, V112, P155, DOI 10.1016/0006-291X(83)91810-7; Suzuki T, 2001, J BIOL CHEM, V276, P21601, DOI 10.1074/jbc.M100826200; Suzuki T, 1997, P NATL ACAD SCI USA, V94, P6244, DOI 10.1073/pnas.94.12.6244; Suzuki T, 2015, J BIOCHEM, V157, P23, DOI 10.1093/jb/mvu068; Suzuki T, 2007, BIOCHEM BIOPH RES CO, V358, P837, DOI 10.1016/j.bbrc.2007.04.199; TARENTINO AL, 1976, J BIOL CHEM, V251, P6537; Tian Y, 2008, CANCER SCI, V99, P2428, DOI 10.1111/j.1349-7006.2008.01019.x; TULSIANI DRP, 1987, J BIOL CHEM, V262, P6506; TURCO SJ, 1982, J BIOL CHEM, V257, P8674; Valderrama-Rincon JD, 2012, NAT CHEM BIOL, V8, P434, DOI [10.1038/nchembio.921, 10.1038/NCHEMBIO.921]; van Berkel MAA, 1999, GLYCOBIOLOGY, V9, P243, DOI 10.1093/glycob/9.3.243; VANPELT J, 1989, BIOL CHEM H-S, V370, P191, DOI 10.1515/bchm3.1989.370.1.191; VILLERS C, 1994, BIOCHEM J, V298, P135; Vleugels W, 2011, BIOCHIMIE, V93, P823, DOI 10.1016/j.biochi.2011.01.016; WELPLY JK, 1983, J BIOL CHEM, V258, P1856; Weng SA, 1996, ARCH BIOCHEM BIOPHYS, V325, P113, DOI 10.1006/abbi.1996.0014; WENG SA, 1993, J BIOL CHEM, V268, P25656; Winchester B, 2005, GLYCOBIOLOGY, V15, p1R, DOI 10.1093/glycob/cwi041; Xiang ZG, 2010, TRANSGENIC RES, V19, P67, DOI 10.1007/s11248-009-9299-3; Yamagishi M, 2002, J BIOCHEM, V132, P253; Yanagida K, 2006, GLYCOBIOLOGY, V16, P294, DOI 10.1093/glycob/cwj074; YET MG, 1988, J BIOL CHEM, V263, P118; YOSHIHISA T, 1990, J BIOL CHEM, V265, P22418; YOSHIHISA T, 1989, BIOCHEM BIOPH RES CO, V163, P908, DOI 10.1016/0006-291X(89)92308-5; Yunovitz H, 1996, PHYTOCHEMISTRY, V42, P607, DOI 10.1016/0031-9422(95)00956-6; YUNOVITZ H, 1994, PHYSIOL PLANTARUM, V90, P152, DOI 10.1034/j.1399-3054.1994.900122.x; YUNOVITZ H, 1994, PHYTOCHEMISTRY, V37, P663, DOI 10.1016/S0031-9422(00)90334-0	300	1	1	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	1420-682X	1420-9071		CELL MOL LIFE SCI	Cell. Mol. Life Sci.	JUL	2015	72	13					2509	2533		10.1007/s00018-015-1881-7		25	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	CJ8LF	WOS:000355751300004		
J	Hanaoka, K; Tanaka, W; Kayanuma, M; Shoji, M				Hanaoka, Kyohei; Tanaka, Wataru; Kayanuma, Megumi; Shoji, Mitsuo			A QM/MM study of the 5 '-AMP DNA hydrolysis of aprataxin	CHEMICAL PHYSICS LETTERS			English	Article							HISTIDINE TRIAD SUPERFAMILY; DISEASE PROTEIN APRATAXIN; NEURODEGENERATIVE DISEASE; MECHANISM; BINDING; SUBSTRATE; HYDROLASE; HINT; FHIT	Aprataxin is a DNA repair enzyme that hydrolyzes the abnormal 5'-AMP termini of broken DNAs. Based on quantum mechanical/molecular mechanical (QM/MM) calculations, we found that the catalytic reaction proceeds in three steps; substrate protonation, DNA deadenylation and histidine-AMP intermediate hydrolysis. The calculated activation energies for the second and third reactions are 19.0 and 10.5 kcal mol(-1), which can be attributed to a penta-coordinated AMP-phosphoryl formation and closing of a water molecule, respectively. We also found that a histidine-AMP intermediate is hydrolyzed easily in the third step when a water molecule closes within 3 angstrom to the phosphorus nucleus. (C) 2015 Elsevier B.V. All rights reserved.	[Hanaoka, Kyohei; Tanaka, Wataru; Shoji, Mitsuo] Univ Tsukuba, Grad Sch Pure & Appl Sci, Tsukuba, Ibaraki 3058577, Japan; [Kayanuma, Megumi] Univ Tsukuba, Grad Sch Syst & Informat Engn, Tsukuba, Ibaraki 3058577, Japan	Shoji, M (reprint author), Univ Tsukuba, Grad Sch Pure & Appl Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058577, Japan.	mshoji@ccs.tsukuba.ac.jp			Japan Society for the Promotion of Science for Young Scientists [26410002]	The numerical calculations for the present study have been carried out under the 'Interdisciplinary Computational Science Program' at the Center for Computational Sciences, University of Tsukuba. This research has been supported by Grants-in-Aid from Japan Society for the Promotion of Science for Young Scientists (C; No. 26410002).	Abend A, 1999, BIOCHEMISTRY-US, V38, P3668, DOI 10.1021/bi981895j; Valiev M, 2010, COMPUT PHYS COMMUN, V181, P1477, DOI 10.1016/j.cpc.2010.04.018; Huhta E, 2010, CARBOHYD RES, V345, P696, DOI 10.1016/j.carres.2009.12.026; Zhou X, 2013, BIOCHEMISTRY-US, V52, P3588, DOI [10.1021/bi301616c, 10.1021/61301616c]; Gueven N, 2004, HUM MOL GENET, V13, P1081, DOI 10.1093/hmg/ddh122; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Tumbale P, 2011, NAT STRUCT MOL BIOL, V18, P1189, DOI 10.1038/nsmb.2146; Brenner C, 2002, BIOCHEMISTRY-US, V41, P9003, DOI 10.1021/bi025942q; Lima CD, 1997, SCIENCE, V278, P286, DOI 10.1126/science.278.5336.286; Tumbale P, 2014, NATURE, V506, P111, DOI 10.1038/nature12824; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Ahel I, 2006, NATURE, V443, P713, DOI 10.1038/nature05164; Chou TF, 2007, J BIOL CHEM, V282, P4719, DOI 10.1074/jbc.M610530200; Gong Y, 2011, NAT STRUCT MOL BIOL, V18, P1297, DOI 10.1038/nsmb.2145; Kijas AW, 2006, J BIOL CHEM, V281, P13939, DOI 10.1074/jbc.M507946200; Krakowiak A, 2004, J BIOL CHEM, V279, P18711, DOI 10.1074/jbc.M314271200; Rass U, 2008, J BIOL CHEM, V283, P33994, DOI 10.1074/jbc.M807124200	17	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0009-2614	1873-4448		CHEM PHYS LETT	Chem. Phys. Lett.	JUL 1	2015	631						16	20		10.1016/j.cplett.2015.04.053		5	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	CJ6WR	WOS:000355636400004		
J	Amatatsu, Y				Amatatsu, Yoshiaki			Theoretical study on the torsional direction of simple ethylenoids after electronic relaxation at the conical intersection in the cis-trans photoisomerization	CHEMICAL PHYSICS LETTERS			English	Article							MOLECULAR ROTARY MOTOR; AB-INITIO; TOPOGRAPHICAL FEATURES; STILBENE; STYRENE; DYNAMICS; PHOTOCHEMISTRY; MECHANISMS; DESIGN; STATES	The conical intersections (CIXs) for the cis-trans photoisomerization of simple ethylenoids, such as ethylene, styrene and stilbene, have been calculated by complete active space self-consistent-field method. This is because we check if a simple relationship which is found in the case of fluorene-based ethylenoids is also true for simple ethylenoids. Thereby, the four CIXs, which are distinguished by the directions of wagging and rocking motions of the anionic part against the ethylenic bond, are found to be related with the torsional direction of the ethylenic bond after electronic relaxation at each CIX. (C) 2015 Elsevier B.V. All rights reserved.	Akita Univ, Grad Sch Engn & Resource Sci, Tegata Gakuen, Akita 0108502, Japan	Amatatsu, Y (reprint author), Akita Univ, Grad Sch Engn & Resource Sci, Tegata Gakuen, Akita 0108502, Japan.	amatatsu@ipc.akita-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [2503, 26104503]	This work is financially supported by Grant-in-Aid for Scientific Research on Innovative Areas 2503 (Studying the Function of Soft Molecular Systems by the Concerted Use of Theory and Experiment) (No. 26104503) from the Ministry of Education, Culture, Sports, Science and Technology.	Amatatsu Y, 1999, CHEM PHYS LETT, V314, P364, DOI 10.1016/S0009-2614(99)01042-8; Amatatsu Y, 2001, CHEM PHYS LETT, V344, P200, DOI 10.1016/S0009-2614(01)00755-2; Amatatsu Y, 2002, J COMPUT CHEM, V23, P950, DOI 10.1002/jcc.10078; Amatatsu Y, 2013, J PHYS CHEM A, V117, P12529, DOI 10.1021/jp4063912; Ioffe IN, 2013, J CHEM THEORY COMPUT, V9, P4973, DOI 10.1021/ct400647w; Tao HL, 2009, J PHYS CHEM A, V113, P13656, DOI 10.1021/jp9063565; Filatov M, 2013, J CHEM THEORY COMPUT, V9, P4526, DOI 10.1021/ct400598b; Ben-Nun M, 2000, CHEM PHYS, V259, P237, DOI 10.1016/S0301-0104(00)00194-4; Amatatsu Y, 2013, J PHYS CHEM A, V117, P3689, DOI 10.1021/jp401781a; Ben-Nun M, 2000, J PHYS CHEM A, V104, P5161, DOI 10.1021/jp994174i; BONACICKOUTECKY V, 1987, ANGEW CHEM INT EDIT, V26, P170, DOI 10.1002/anie.198701701; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; Amatatsu Y, 2012, J PHYS CHEM A, V116, P10182, DOI 10.1021/jp306414p; Harabuchi Y, 2014, J PHYS CHEM A, V118, P11987, DOI 10.1021/jp5072428; Amatatsu Y, 2011, J PHYS CHEM A, V115, P13611, DOI 10.1021/jp207238n; BEARPARK MJ, 1995, J AM CHEM SOC, V117, P6944, DOI 10.1021/ja00131a017; Ben-Nun M, 1998, CHEM PHYS LETT, V298, P57, DOI 10.1016/S0009-2614(98)01115-4; Lei YB, 2014, J PHYS CHEM A, V118, P9021, DOI 10.1021/jp5020109; Molina V, 2000, PHYS CHEM CHEM PHYS, V2, P2211, DOI 10.1039/a909174b; OHMINE I, 1985, J CHEM PHYS, V83, P2348, DOI 10.1063/1.449276; Quenneville J, 2003, J PHYS CHEM A, V107, P829, DOI 10.1021/jp021210w	21	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0009-2614	1873-4448		CHEM PHYS LETT	Chem. Phys. Lett.	JUL 1	2015	631						47	53		10.1016/j.cplett.2015.04.060		7	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	CJ6WR	WOS:000355636400010		
J	Ooe, H; Miyamoto, Y; Kuma, S; Sasao, N; Kawaguchi, K				Ooe, Hiroki; Miyamoto, Yuki; Kuma, Susumu; Sasao, Noboru; Kawaguchi, Kentarou			Infrared absorption spectra of SiF4 and its clusters in solid parahydrogen	CHEMICAL PHYSICS LETTERS			English	Article							MATRIX-ISOLATION SPECTROSCOPY; HIGH-RESOLUTION SPECTROSCOPY; SILICON TETRAFLUORIDE; MOLECULES; SF6; DIMERS; PHOTODISSOCIATION; PREDISSOCIATION; COMPLEXES; REGION	We observed infrared absorption spectra of tetrahedral silicon tetrafluoride (SiF4) and its clusters in solid parahydrogen. The spectra were assigned by a temporal change of the peak intensity with annealing and previous studies in the gas and other matrices. It was found that the SiF4 monomer does not rotate in solid parahydrogen in spite of its small size and the absence of the permanent electric dipole moment. The dimer spectra are similar to those in the gas phase except for complicated sub-structures. Some other peaks were tentatively assigned to trimer and larger clusters. Clusters with other impurities were also observed. (C) 2015 Elsevier B.V. All rights reserved.	[Ooe, Hiroki; Miyamoto, Yuki; Kawaguchi, Kentarou] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan; [Miyamoto, Yuki; Kuma, Susumu; Sasao, Noboru] Okayama Univ, Res Core Extreme Quantum World, Okayama 7008530, Japan	Miyamoto, Y (reprint author), Okayama Univ, Res Core Extreme Quantum World, Okayama 7008530, Japan.	miyamo-y@cc.okayama-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology [21104002, 21104003, 25820144]	This research was partially supported by Grant-in-Aid for Scientific Research on Innovative Areas 'Extreme quantum world opened up by atoms' (21104002 and 21104003) and Grant-in-Aid for Young Scientists B (25820144) from the Ministry of Education, Culture, Sports, Science, and Technology.	Abouaf-Marguin L, 2011, LOW TEMP PHYS+, V37, P357, DOI 10.1063/1.3593297; GERAEDTS J, 1981, CHEM PHYS LETT, V78, P277, DOI 10.1016/0009-2614(81)80016-4; HEIJMEN B, 1989, CHEM PHYS, V132, P331, DOI 10.1016/0301-0104(89)80028-X; Kettwich SC, 2008, PHYS CHEM CHEM PHYS, V10, P5564, DOI 10.1039/b806276e; Jacox ME, 1998, J PHYS CHEM REF DATA, V27, P115; Fajardo ME, 1998, J CHEM PHYS, V108, P4237, DOI 10.1063/1.475822; AULT BS, 1983, J AM CHEM SOC, V105, P5742, DOI 10.1021/ja00356a006; BONDYBEY VE, 1994, CHEM PHYS, V189, P137, DOI 10.1016/0301-0104(94)89003-X; Burtsev AP, 2005, OPT SPECTROSC+, V98, P227, DOI 10.1134/1.1870065; Du JH, 2011, J PHYS CHEM A, V115, P1040, DOI 10.1021/jp108769n; GOUGH TE, 1986, J PHYS CHEM-US, V90, P4026, DOI 10.1021/j100408a040; HEICKLEN J, 1964, SPECTROCHIM ACTA, V20, P295, DOI 10.1016/0371-1951(64)80026-6; Ignatov SK, 2006, CHEM PHYS, V324, P753, DOI 10.1016/j.chemphys.2006.01.018; JONES LH, 1984, J CHEM PHYS, V81, P5268, DOI 10.1063/1.447667; Katsuki H, 2002, J CHEM PHYS, V116, P8411, DOI 10.1063/1.1468883; Lindsay C.M., 2006, 61 INT S MOL SPECTR; MCDOWELL RS, 1982, J CHEM PHYS, V77, P4337, DOI 10.1063/1.444423; Miyamoto Y., 2011, J PHYS CHEM A, P14254; Momose T, 2004, VIB SPECTROSC, V34, P95, DOI 10.1016/j.vibspec.2003.06.001; Momose T, 1998, B CHEM SOC JPN, V71, P1, DOI 10.1246/bcsj.71.1; Ooe H, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4808035; SNELS M, 1987, CHEM PHYS LETT, V140, P543, DOI 10.1016/0009-2614(87)80483-9; SNELS M, 1986, CHEM PHYS, V109, P67, DOI 10.1016/0301-0104(86)80185-9; Tam S, 2000, LOW TEMP PHYS+, V26, P653, DOI 10.1063/1.1312391; URBAN RD, 1995, J CHEM PHYS, V102, P3017, DOI 10.1063/1.468611; URBAN RD, 1995, J CHEM PHYS, V103, P9132, DOI 10.1063/1.470024; VANBLADEL JWI, 1990, J CHEM PHYS, V92, P2837, DOI 10.1063/1.457930	27	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0009-2614	1873-4448		CHEM PHYS LETT	Chem. Phys. Lett.	JUL 1	2015	631						54	58		10.1016/j.cplett.2015.04.057		5	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	CJ6WR	WOS:000355636400011		
J	Nishiyama, K				Nishiyama, Katsuhiko			Dependence of glycine peptide behavior on thermal fluctuations on the surface of cathepsin K	CHEMICAL PHYSICS LETTERS			English	Article							MOLECULAR-DYNAMICS; DRUG-RESISTANCE; HIV-1 PROTEASES; DOCKING; INHIBITORS; AUTODOCK; SIMULATIONS	The binding behavior of 2-10Gly (peptides with between 2 and 10 glycine residues) to cathepsin K was investigated by molecular dynamics and docking simulations. 3Gly, 6-7Gly, and 9-10Gly was distributed on sites near the active center, although 2Gly, 4-5Gly, and 8Gly were not. The percentage of highly flexible residues was relatively lower in the distribution area of 2-10Gly, although the percentage of rigid residues was larger. Furthermore, the percentages varied significantly among the distribution areas. Delicate modification of the thermal fluctuations in proteins would enable regulation of peptide binding, and, in turn, the ability to control their functions. (C) 2015 Elsevier B.V. All rights reserved.	Tsuruoka Coll, Natl Inst Technol, Tsuruoka, Yamagata 9978511, Japan	Nishiyama, K (reprint author), Tsuruoka Coll, Natl Inst Technol, 104 Sawada, Tsuruoka, Yamagata 9978511, Japan.	nisiyama@asagi.waseda.jp			National Institute of Technology	This study is supported by National Institute of Technology.	BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Hu X, 2004, J MOL GRAPH MODEL, V22, P293, DOI 10.1016/j.jmgm.2003.11.002; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Itoh H, 2004, NATURE, V427, P465, DOI 10.1038/nature02212; Yuki H, 2012, BIOORGAN MED CHEM, V20, P775, DOI 10.1016/j.bmc.2011.12.004; Osterberg F, 2002, PROTEINS, V46, P34, DOI 10.1002/prot.10028; MCCAMMON JA, 1976, NATURE, V262, P325, DOI 10.1038/262325a0; Ma S, 2007, J AM CHEM SOC, V129, P13633, DOI 10.1021/ja074222; Cosconati S, 2010, EXPERT OPIN DRUG DIS, V5, P597, DOI 10.1517/17460441.2010.484460; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Forli S, 2012, J MED CHEM, V55, P623, DOI 10.1021/jm2005145; Case D.A., 2012, AMBER, P2012; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Drabik P, 2000, ACTA BIOCHIM POL, V47, P1061; Li D.W., 2009, PROTEINS, V131, P14610; Matsuyama S, 2010, J PHYS CHEM B, V114, P521, DOI 10.1021/jp908314f; Ode H, 2006, J AM CHEM SOC, V128, P7887, DOI 10.1021/ja060682b; Tanii T, 2001, JPN J APPL PHYS 2, V40, pL1135, DOI 10.1143/JJAP.40.L1135; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Yanagita H, 2012, ACS CHEM BIOL, V7, P552, DOI 10.1021/cb200332k; YGUERABI.J, 1970, J MOL BIOL, V51, P573, DOI 10.1016/0022-2836(70)90009-4	22	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0009-2614	1873-4448		CHEM PHYS LETT	Chem. Phys. Lett.	JUL 1	2015	631						83	86		10.1016/j.cplett.2015.05.003		4	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	CJ6WR	WOS:000355636400016		
J	Ferraris, JR; Ferraris, V; Acquier, AB; Sorroche, PB; Saez, MS; Ginaca, A; Mendez, CF				Ferraris, J. R.; Ferraris, V.; Acquier, A. B.; Sorroche, P. B.; Saez, M. S.; Ginaca, A.; Mendez, C. F.			Activation of the alternative pathway of complement during the acute phase of typical haemolytic uraemic syndrome	CLINICAL AND EXPERIMENTAL IMMUNOLOGY			English	Article						acute renal injury; alternative pathway; complement; HUS	THROMBOTIC THROMBOCYTOPENIC PURPURA; TERM-FOLLOW-UP; OXIDATIVE STRESS; ARGENTINA; HUS; C3; PLATELETS; CELLS; BINDS	Haemolytic uraemic syndrome (HUS) is characterized by haemolytic anaemia, thrombocytopenia and acute renal failure. We studied the activation state of classical and alternative pathways of complement during the acute phase of Shiga toxin-associated HUS by performing a prospective study of 18 patients and 17 age-matched healthy controls to evaluate C3, C3c, C4, C4d, Bb and SC5b-9 levels. SC5b-9 levels were increased significantly in all patients at admission compared to healthy and end-stage renal disease controls, but were significantly higher in patients presenting with oliguria compared to those with preserved diuresis. C3 and C4 levels were elevated significantly at admission in the non-oliguric group when compared to controls. No significant differences were found for C4d values, whereas factor Bb was elevated in all patients and significantly higher in oliguric patients when compared to both controls and non-oliguric individuals. A positive and significant association was detected when Bb formation was plotted as a function of plasma SC5b-9 at admission. Bb levels declined rapidly during the first week, with values not significantly different from controls by days 3 and 5 for non-oligurics and oligurics, respectively. Our data demonstrate the activation of the alternative pathway of complement during the acute phase of Stx-associated HUS. This finding suggests that complement activation may represent an important trigger for the cell damage that occurs during the syndrome.	[Ferraris, J. R.; Ferraris, V.] Hosp Italiano Buenos Aires, Serv Nefrol Pediat, Buenos Aires, DF, Argentina; [Ferraris, J. R.] Univ Buenos Aires, Sch Med, Dept Pediat, RA-1053 Buenos Aires, DF, Argentina; [Acquier, A. B.; Mendez, C. F.] Univ Buenos Aires, Sch Dent, Pharmacol Unit, RA-1053 Buenos Aires, DF, Argentina; [Acquier, A. B.; Mendez, C. F.] Univ Buenos Aires, Sch Med, Inst Biomed Res INBIOMED, RA-1053 Buenos Aires, DF, Argentina; [Acquier, A. B.; Mendez, C. F.] Natl Sci & Tech Res Council, Tokyo, Japan; [Sorroche, P. B.; Saez, M. S.] Hosp Italiano Buenos Aires, Cent Lab, Buenos Aires, DF, Argentina; [Ginaca, A.] Hosp Ninos Dr Ricardo Gutierrez, Serv Immunol, Buenos Aires, DF, Argentina	Ferraris, JR (reprint author), Hosp Italiano Buenos Aires, Serv Nefrol Pediat, Gascon 450,C1181ACH, Buenos Aires, DF, Argentina.	jorge.ferraris@hospitalitaliano.org.ar; cfmendez@fmed.uba.ar			Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 11420090100389]	Financial support from Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP 11420090100389) to C. F. M. is acknowledged.	Moshage H, 1997, J PATHOL, V181, P257, DOI 10.1002/(SICI)1096-9896(199703)181:3<257::AID-PATH756>3.0.CO;2-U; Warwicker P, 1998, KIDNEY INT, V53, P836, DOI 10.1046/j.1523-1755.1998.00824.x; Caprioli J, 2006, BLOOD, V108, P1267, DOI 10.1182/blood-2005-10-007252; Amer J, 2008, EXP HEMATOL, V36, P369, DOI 10.1016/j.exphem.2007.12.003; Collard CD, 2001, AM J PATHOL, V159, P1045, DOI 10.1016/S0002-9440(10)61779-8; Hart ML, 2004, MOL IMMUNOL, V41, P165, DOI 10.1016/j.molimm.2004.03.013; Noris M, 2012, NAT REV NEPHROL, V8, P622, DOI 10.1038/nrneph.2012.195; del Conde I, 2005, J EXP MED, V201, P871, DOI 10.1084/jem.20041497; Lapeyraque AL, 2011, NEW ENGL J MED, V364, P2561, DOI 10.1056/NEJMc1100859; Rivas M, 2006, MEDICINA-BUENOS AIRE, V66, P27; Morigi M, 2011, J IMMUNOL, V187, P172, DOI 10.4049/jimmunol.1100491; MONNENS L, 1980, CLIN NEPHROL, V13, P168; Stahl AL, 2011, BLOOD, V117, P5503, DOI 10.1182/blood-2010-09-309161; Besbas N, 2006, KIDNEY INT, V70, P423, DOI 10.1038/sj.ki.5001581; Orth D, 2009, J IMMUNOL, V182, P6394, DOI 10.4049/jimmunol.0900151; Stahl AL, 2006, BLOOD, V108, P167, DOI 10.1182/blood-2005-08-3219; Dunkelberger JR, 2010, CELL RES, V20, P34, DOI 10.1038/cr.2009.139; Garg AX, 2003, JAMA-J AM MED ASSOC, V290, P1360, DOI 10.1001/jama.290.10.1360; Collard CD, 2000, AM J PATHOL, V156, P1549, DOI 10.1016/S0002-9440(10)65026-2; Thurman JM, 2009, CLIN J AM SOC NEPHRO, V4, P1920, DOI 10.2215/CJN.02730409; Spizzirri FD, 1997, PEDIATR NEPHROL, V11, P156; Belardo M, 2012, ARCH ARGENT PEDIATR, V110, P417, DOI [10.1590/S0325-00752012000500009, 10.5546/aap.2012.416]; CAMERON JS, 1973, LANCET, V2, P975; Collard CD, 1999, MOL IMMUNOL, V36, P941, DOI 10.1016/S0161-5890(99)00116-9; Engstrom G, 2007, J HUM HYPERTENS, V21, P276, DOI 10.1038/sj.jhh.1002129; Ferraris V, 2011, NEPHROL DIAL TRANSPL, V26, P858, DOI 10.1093/ndt/gfq511; GIANANTO.CA, 1968, J PEDIATR-US, V72, P757, DOI 10.1016/S0022-3476(68)80427-5; KAPLAN BS, 1973, LANCET, V2, P1505; KIM Y, 1977, J LAB CLIN MED, V89, P845; KOCH FJ, 1981, AM J CLIN PATHOL, V76, P63; MUSCARI A, 1995, AM J MED, V98, P357, DOI 10.1016/S0002-9343(99)80314-3; Robson WL, 1992, NEPHRON, V3, P296; Wu ZH, 2007, J BIOL CHEM, V282, P22414, DOI 10.1074/jbc.M702321200	33	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0009-9104	1365-2249		CLIN EXP IMMUNOL	Clin. Exp. Immunol.	JUL	2015	181	1					118	125		10.1111/cei.12601		8	Immunology	Immunology	CJ9TA	WOS:000355844500011		
J	Muhammad, N; Murakami, T; Inoshima, Y; Ishiguro, N				Muhammad, N.; Murakami, T.; Inoshima, Y.; Ishiguro, N.			Long-term kinetics of AA amyloidosis and effects of inflammatory restimulation after disappearance of amyloid depositions in mice	CLINICAL AND EXPERIMENTAL IMMUNOLOGY			English	Article						AA-amyloid; cytokine; long-term kinetics; mice; SAA	NF-KAPPA-B; GENE-EXPRESSION; PROTEIN; DISEASE; CELLS; ACTIVATION; MECHANISMS	Amyloid A (AA) amyloidosis is characterized by extracellular pathogenic deposition of insoluble fibril protein in various body organs. Deposited amyloid generally remains in a variety of organs for long periods, but its disappearance has been reported after the precursor protein is diminished. The kinetics of AA deposition are not completely understood and, in particular, the roles of cells and cytokines in the deposition and clearance of amyloid remain unclear. In this study, we investigated the disappearance of amyloid depositions in mice over a 1-year period. AA amyloidosis was induced experimentally in mice by injecting amyloid-enhancing factor (AEF) and silver nitrate. Mice were killed at different time-points to examine the occurrence and disappearance of amyloid depositions. Maximum levels of amyloid depositions were observed at 20days after inoculation. Clearance of amyloid depositions was observed from the 40th day onwards, with only minute traces of amyloid present by 240 days. A second inflammatory stimulus consisting of AEF and silver nitrate was given at 330 or 430 days, after amyloid depositions had disappeared almost completely. After that, serum amyloid A was overproduced and redeposition of amyloid was observed, indicating that all mice were primed for aggressive amyloid depositions. After administration of the inflammatory stimuli, the proinflammatory environment was found to have increased levels of interleukin (IL)-6, while anti-inflammatory conditions were established by IL-10 as regression of amyloid deposition occurred. These results suggest that the proinflammatory and anti-inflammatory status have key roles in both amyloid deposition and clearance.	[Muhammad, N.; Murakami, T.; Inoshima, Y.; Ishiguro, N.] Gifu Univ, Dept Vet Med, Lab Food & Environm Hyg, United Grad Sch Vet Sci, Gifu 5011193, Japan; [Murakami, T.] Tokyo Univ Agr & Technol, Dept Vet Med, Tokyo, Japan	Ishiguro, N (reprint author), Gifu Univ, Dept Vet Med, Lab Food & Environm Hyg, 1-1 Yanagido, Gifu 5011193, Japan.	ishiguna@gifu-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [22380165, 25292171]	This research work was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (Project Code no. 22380165, 25292171).	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Rocha NP, 2012, MOL CELL NEUROSCI, V49, P77, DOI 10.1016/j.mcn.2011.09.005; Johan K, 1998, P NATL ACAD SCI USA, V95, P2558, DOI 10.1073/pnas.95.5.2558; PUCHTLER H, 1962, J HISTOCHEM CYTOCHEM, V10, P355; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; PRAS M, 1968, J CLIN INVEST, V47, P924; Nystrom SN, 2012, AMYLOID, V19, P138, DOI 10.3109/13506129.2012.711391; Simons JP, 2013, P NATL ACAD SCI USA, V110, P16115, DOI 10.1073/pnas.1306621110; Gillmore JD, 2001, LANCET, V358, P24, DOI 10.1016/S0140-6736(00)05252-1; BETTS JC, 1993, J BIOL CHEM, V268, P25624; Kim KS, 2013, NEUROBIOL AGING, V34, P2408, DOI 10.1016/j.neurobiolaging.2013.03.029; Town T, 2008, NAT MED, V14, P681, DOI 10.1038/nm1781; SKINNER M, 1977, LAB INVEST, V36, P420; Westermark GT, 2009, FEBS LETT, V583, P2685, DOI 10.1016/j.febslet.2009.04.026; Bodin K, 2010, NATURE, V468, P93, DOI 10.1038/nature09494; Murakami T, 2014, VET PATHOL, V51, P363, DOI 10.1177/0300985813511128; Morales R, 2009, CNS NEUROL DISORD-DR, V8, P363; Sabat R, 2010, CYTOKINE GROWTH F R, V21, P331, DOI 10.1016/j.cytogfr.2010.09.002; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Lachmann HJ, 2006, RHEUMATOLOGY, V45, P746, DOI 10.1093/rheumatology/kei279; Woldemeskel Moges, 2012, Veterinary Medicine International, P427296; Gorevic D., 2013, P NATL ACAD SCI USA, V110, P16291; GRUYS E, 1994, BAILLIERE CLIN RHEUM, V8, P599, DOI 10.1016/S0950-3579(05)80117-7; Hagihara K, 2005, GENES CELLS, V10, P1051, DOI 10.1111/j.1365-2443.2005.00900.x; HAWKINS PN, 1990, CLIN EXP IMMUNOL, V81, P325; Kluve-Beckerman B, 2011, AMYLOID, V18, P136, DOI 10.3109/13506129.2011.597464; Kuroiwa M, 2003, J ELECTRON MICROSC, V52, P407, DOI 10.1093/jmicro/52.4.407; Migita K, 2001, CLIN EXP IMMUNOL, V123, P408, DOI 10.1046/j.1365-2249.2001.01472.x; Mihara M, 2004, J RHEUMATOL, V31, P1132; Moore WK, 2001, ANNU REV IMMUNOL, V11, P683; Morales R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003537; Obici L, 2009, ARTHRIT CARE RES, V61, P1435, DOI 10.1002/art.24735; Sponarova J, 2013, AM J PATHOL, V182, P1297, DOI 10.1016/j.ajpath.2012.12.035; Torres KC, 2013, PROG NEURO-PSYCHOPH, V47, P40, DOI 10.1016/j.pnpbp.2013.07.021	34	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0009-9104	1365-2249		CLIN EXP IMMUNOL	Clin. Exp. Immunol.	JUL	2015	181	1					133	141		10.1111/cei.12615		9	Immunology	Immunology	CJ9TA	WOS:000355844500013		
J	Kobayashi, H; Sato, K; Niioka, T; Miura, H; Ito, H; Miura, M				Kobayashi, Hiroyuki; Sato, Kazuhiro; Niioka, Takenori; Miura, Hajime; Ito, Hiroshi; Miura, Masatomo			Relationship Among Gefitinib Exposure, Polymorphisms of Its Metabolizing Enzymes and Transporters, and Side Effects in Japanese Patients With Non-Small-Cell Lung Cancer	CLINICAL LUNG CANCER			English	Article						ABCG2; CYP2D6; Gefitinib; Hepatotoxicity; Trough concentration	TYROSINE KINASE INHIBITORS; P-GLYCOPROTEIN; CYTOCHROME-P450 ENZYMES; GENE POLYMORPHISMS; DRUG-RESISTANCE; MDR1 GENE; ABCG2; PROTEIN; PHARMACOKINETICS; EXPRESSION	We investigated the effect of genetic polymorphisms in patients with non-small-cell lung cancer receiving gefitinib treatment. No significant differences were found in gefitinib exposure or the frequency of diarrhea, skin rash, or hepatotoxicity among the cytochromes P450 (CYPs) CYP3A4, CYP3A5, and CYP2D6 and ATP-binding cassette (ABC) ABCG2 and ABCB1 genotypes. However, gefitinib exposure in patients with diarrhea or hepatotoxicity was significantly greater. Monitoring the plasma concentrations during gefitinib treatment might be beneficial. Introduction: The present study investigated the effects of patients' genetic variations in the pharmacokinetics of gefitinib at steady-state. We analyzed 31 Japanese patients with non-small-cell lung cancer (NSCLC) who had been treated with gefitinib. We focused on common polymorphisms within important gefitinib exposure genes, including cytochromes P450 (CYPs) CYP3A4*1G, CYP3A5 (*3), and CYP2D6 (*5 and *10) and ATP-binding cassette (ABC) ABCG2 (421C>A) and ABCB1 (1236C>T, 2677G>T/A, and 3435C>T). Materials and Methods: Fourteen days after beginning 250 mg of gefitinib therapy, when the patients were in steady-state, blood samples were collected just before and 1, 2, 4, 6, 8, 12, and 24 hours after oral gefitinib administration. The plasma concentrations of gefitinib were measured using high-performance liquid chromatography. Results: The median area under the concentration-time curve from 0 to 24 hours (AUC(0-24)) and trough plasma concentration (C-0) of gefitinib was 10,086 ng.h/mL (range, 3247-24,726 ng.h/mL) and 334 ng/mL (range, 77.9-813 ng/mL), respectively. No significant differences were found in the AUC0-24 or C0 for gefitinib or in the frequency of diarrhea, skin rash or hepatotoxicity among the CYP3A4, CYP3A5, lCYP2D6, ABCG2 (421C>A), and ABCB1 (1236C>T, 2677G>T/A, and 3435C>T) genotype groups. However, the AUC0-24 and C0 levels of gefitinib in the patients with diarrhea or hepatotoxicity were significantly greater than in those without (diarrhea: AUC0-24, 14,246 vs. 8918 ng.h/mL, P = .006; C0: 421 vs. 261 ng/mL, P = .002; hepatotoxicity: AUC0-24, 12,967 vs. 8473 ng.h/mL, P = .024; C0: 420 vs. 248 ng/mL, P = .002). Conclusion: The side effects from gefitinib were related to exposure but not genetic polymorphism. Therefore, therapeutic drug monitoring after beginning gefitinib therapy rather than the analysis of polymorphism before initiating therapy might be beneficial. (C) 2015 Elsevier Inc. All rights reserved.	[Kobayashi, Hiroyuki; Niioka, Takenori; Miura, Masatomo] Akita Univ Hosp, Dept Pharm, Akita 0108543, Japan; [Sato, Kazuhiro; Miura, Hajime; Ito, Hiroshi] Akita Univ, Grad Sch Med, Dept Cardiovasc & Resp Med, Akita 010, Japan	Miura, M (reprint author), Akita Univ Hosp, Dept Pharm, 1-1-1 Hondo, Akita 0108543, Japan.	m-miura@hos.akita-u.ac.jp			Japan Society for the Promotion of Science, Tokyo, Japan [23590168, 26460188]	This work was supported by the Japan Society for the Promotion of Science, Tokyo, Japan (grants 23590168 and 26460188).	Akasaka K, 2010, CANCER CHEMOTH PHARM, V66, P691, DOI 10.1007/s00280-009-1211-6; Li J, 2006, J NATL CANCER I, V98, P1714, DOI 10.1093/jnci/djj466; Imai Y, 2002, MOL CANCER THER, V1, P611; McKillop D, 2005, XENOBIOTICA, V35, P39, DOI 10.1080/00498250400026464; Siegel-Lakhai WS, 2005, ONCOLOGIST, V10, P579, DOI 10.1634/theoncologist.10-8-579; Cusatis G, 2006, J NATL CANCER I, V98, P1739, DOI 10.1093/jnci/djj469; Swaisland HC, 2006, CLIN PHARMACOKINET, V45, P633, DOI 10.2165/00003088-200645060-00006; Kobayashi D, 2005, DRUG METAB DISPOS, V33, P94, DOI 10.1124/dmd.104.001628; Swaisland HC, 2005, CLIN PHARMACOKINET, V44, P1165, DOI 10.2165/00003088-200544110-00004; Li J, 2007, CLIN CANCER RES, V13, P3731, DOI 10.1158/1078-0432.CCR-07-0088; Leggas M, 2006, CANCER RES, V66, P4802, DOI 10.1158/0008-5472.CAN-05-2915; Heon S, 2012, CLIN CANCER RES, V18, P4406, DOI 10.1158/1078-0432.CCR-12-0357; Yanase K, 2004, MOL CANCER THER, V3, P1119; Cascorbi I, 2001, CLIN PHARMACOL THER, V69, P169, DOI 10.1067/mcp.2001.114164; Wu LM, 2007, J SURG ONCOL, V96, P62, DOI 10.1002/jso.20774; Hirano M, 2005, MOL PHARMACOL, V68, P800, DOI 10.1124/mol.105.014019; Gao Y, 2008, EUR J CLIN PHARMACOL, V64, P877, DOI 10.1007/s00228-008-0502-x; Yang CH, 2005, CANCER RES, V65, P6943, DOI 10.1158/0008-5472.CAN-05-0641; Lemos C, 2011, PHARMACOGENOMICS, V12, P159, DOI [10.2217/pgs.10.172, 10.2217/PGS.10.172]; Takimoto T, 2013, CLIN LUNG CANCER, V14, P502, DOI 10.1016/j.cllc.2013.03.003; Zhang W, 2006, CLIN CHIM ACTA, V373, P99, DOI 10.1016/j.cca.2006.05.010; Fukuen S, 2002, PHARMACOGENETICS, V12, P331, DOI 10.1097/00008571-200206000-00009; Li J, 2007, CANCER BIOL THER, V6, P432; Ozvegy-Laczka C, 2004, MOL PHARMACOL, V65, P1485; Teh LK, 2012, DRUG METAB PHARMACOK, V27, P55, DOI 10.2133/dmpk.DMPK-11-RV-121; Kitazaki T, 2005, LUNG CANCER-J IASLC, V49, P337, DOI 10.1016/j.lungcan.2005.03.035; Fukushima-Uesaka Hiromi, 2004, Hum Mutat, V23, P100, DOI 10.1002/humu.9210; Harmsen S, 2013, EUR J PHARM SCI, V48, P644, DOI 10.1016/j.ejps.2012.12.019; Itoda Y, 2003, DRUG METAB PHARMACOK, V18, P212; McKillop D, 2004, XENOBIOTICA, V34, P917, DOI 10.1080/00498250400009171; Miura M, 2014, THER DRUG MONIT, V36, P24; Naveen Amrithraj Theophilus, 2006, Biol Pharm Bull, V29, P1655, DOI 10.1248/bpb.29.1655; Scheffler M, 2011, CLIN PHARMACOKINET, V50, P371, DOI 10.2165/11587020-000000000-00000; Tanaka H, 2001, INT J HEMATOL, V73, P206, DOI 10.1007/BF02981939; Zhao YY, 2011, MED ONCOL, V28, P697, DOI 10.1007/s12032-010-9541-0	35	1	1	CIG MEDIA GROUP, LP	DALLAS	3500 MAPLE AVENUE, STE 750, DALLAS, TX 75219-3931 USA	1525-7304	1938-0690		CLIN LUNG CANCER	Clin. Lung Cancer	JUL	2015	16	4					274	281		10.1016/j.cllc.2014.12.004		8	Oncology	Oncology	CJ7IH	WOS:000355667800004		
J	Nagura, A; Okamoto, K; Itoh, K; Imai, Y; Shimamoto, D; Hotta, Y				Nagura, Azusa; Okamoto, Kazuaki; Itoh, Kiyoharu; Imai, Yusuke; Shimamoto, Daisuke; Hotta, Yuji			The Ni-plated carbon fiber as a tracer for observation of the fiber orientation in the carbon fiber reinforced plastic with X-ray CT	COMPOSITES PART B-ENGINEERING			English	Article						Micro X-ray computed tomography (XCT); Carbon fiber; Non-destructive testing; Injection molding	TOMOGRAPHY; COMPOSITES	Microfocus X-ray computed tomography (XCT) is effective to evaluate the 3-dimensional (3D) structure (position and orientation) of the fillers in the composites. However, the observation of the carbon fiber (CF) in resin by XCT is not easy due to the small difference between X-ray attenuation coefficient of CF and that of resin. We conducted XCT scanning of carbon fiber reinforced plastics (CFRPs) containing Ni-plated CF. The fiber orientation can be clearly observed in CT images due to a large X-ray attenuation coefficient of Ni-plating. Ni-plated CF essentially showed the same fiber orientation as that of normal CF. We also carried out the 3D characterization of the fiber orientation in an injection-molded dumbbell specimen with weld line. The fibers around the weld line are oriented perpendicular to the longitudinal direction of the specimen. (C) 2015 Elsevier Ltd. All rights reserved.	[Nagura, Azusa; Okamoto, Kazuaki; Itoh, Kiyoharu] Nagoya Municipal Ind Res Inst, Atsuta Ku, Nagoya, Aichi 4560058, Japan; [Imai, Yusuke; Shimamoto, Daisuke; Hotta, Yuji] Natl Inst Adv Ind Sci & Technol, Adv Mfg Res Inst, Moriyama Ku, Nagoya, Aichi 4638560, Japan	Nagura, A (reprint author), Nagoya Municipal Ind Res Inst, Atsuta Ku, 3-4-41 Rokuban, Nagoya, Aichi 4560058, Japan.	nagura.azusa@nmiri.city.nagoya.jp; okamoto.kazuaki@nmiri.city.nagoya.jp; itoh.kiyoharu@nmiri.city.nagoya.jp; y-imai@aist.go.jp; d-shimamoto@aist.go.jp; y-hotta@aist.go.jp					Djukic LP, 2009, COMPOS PART A-APPL S, V40, P1870, DOI 10.1016/j.compositesa.2009.04.002; Arif MF, 2014, COMPOS PART B-ENG, V58, P487, DOI 10.1016/j.compositesb.2013.11.001; [Anonymous], 2011, J SOC MAT SCI JPN, DOI 10.2472/jsms.60.29; BAY RS, 1992, POLYM COMPOSITE, V13, P332, DOI 10.1002/pc.750130410; Schell JSU, 2006, COMPOS SCI TECHNOL, V66, P2016, DOI 10.1016/j.compscitech.2006.01.003; Djukic LP, 2013, APPL COMPOS MATER, V20, P1215, DOI 10.1007/s10443-013-9326-7; Cosmi F, 2011, COMPOS SCI TECHNOL, V71, P23, DOI 10.1016/j.compscitech.2010.09.016; Djukic Luke P, 2009, Composites Part A: Applied Science and Manufacturing, V40, DOI 10.1016/j.compositesa.2008.12.016; Gowayed Y, 2013, WOOD PUBL SER CIVIL, V45, P3, DOI 10.1533/9780857098955.1.3; Hosoya R, 2014, P AM SOC COMP 2014 2, P700; Hubbell J. H., TABLES XRAY MASS ATT; Kastner J, 2012, P 4 INT S NDT AER AU; Kastner J, 2012, P 18 WORLD C NOND TE, P9; Kopplmayr T, 2013, POLYM TEST, V32, P535, DOI 10.1016/j.polymertesting.2013.02.002; Lee DJ, 2010, KOREA-AUST RHEOL J, V22, P95; LIM JK, 1993, JSME INT J A-MECH M, V36, P319; Nishikawa Y, 2012, POLYMER, V53, P4287, DOI 10.1016/j.polymer.2012.07.040; Park SJ., 2014, CARBON FIBERS; Suzuki K., 2011, P ICCM18 C JEJ ISL S; Suzuki T., 2005, P 9 JAP INT SAMPE S, P14	20	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1359-8368	1879-1069		COMPOS PART B-ENG	Compos. Pt. B-Eng.	JUL	2015	76						38	43		10.1016/j.compositesb.2015.02.009		6	Engineering, Multidisciplinary; Materials Science, Composites	Engineering; Materials Science	CJ2ZE	WOS:000355352400005		
J	Takahashi, K; Namiki, K; Fujimura, T; Jeon, EB; Kim, HS				Takahashi, Kosuke; Namiki, Kensuke; Fujimura, Takahiro; Jeon, Eun-Beom; Kim, Hak-Sung			Instant electrode fabrication on carbon-fiber-reinforced plastic structures using metal nano-ink via flash light sintering for smart sensing	COMPOSITES PART B-ENGINEERING			English	Article						Smart materials; Adhesion; Electrical properties; Sintering	ELECTRICAL-RESISTANCE MEASUREMENT; DAMAGE DETECTION; COMPOSITES; LAMINATE; POLYMER	The electrical-resistance-change method (ERCM) is a potential smart-sensing technique for carbon-fiber-reinforced plastic (CFRP) structures. However, a practical way to fabricate electrodes on CFRP structures, such as ink-jet printing with metal nano-inks, is necessary to reduce the time required for the process. As metal nano-inks can be sintered in a few milliseconds under ambient conditions using white-flash-light irradiation from a xenon lamp, the parameters of flash-light sintering such as light energy, duration, and number of pulses were investigated. The light intensity, which is the light energy divided by duration, was found to be an indicator of whether low electrical resistance was attained along with strong adhesion to the CFRP plate. The contact resistance between the electrode and CFRP plate was also examined in a tensile test to confirm the durability. The electrode sintered by flash light with the properly selected parameters exhibited high quality and strain monitoring capability. (C) 2015 Elsevier Ltd. All rights reserved.	[Takahashi, Kosuke; Namiki, Kensuke; Fujimura, Takahiro] Tokyo Inst Technol, Dept Mech Sci & Engn, Meguro Ku, Tokyo 1528550, Japan; [Jeon, Eun-Beom; Kim, Hak-Sung] Hanyang Univ, Dept Mech Engn, Seoul 133791, South Korea; [Kim, Hak-Sung] Hanyang Univ, Inst Nano Sci & Technol, Seoul 133791, South Korea	Kim, HS (reprint author), Hanyang Univ, Inst Nano Sci & Technol, Seoul 133791, South Korea.	kima@hanyang.ac.kr			Japan Society for the Promotion of Science (JSPS); National Research Foundation of Korea (NRF) under the Japan-Korea Basic Scientific Cooperation Program [2012K2A2A4017699]; NRF grants - Ministry of Education [2012R1A6A1029029, 2013M2A2A9043280]	This project was supported by Japan Society for the Promotion of Science (JSPS) and National Research Foundation of Korea (NRF) under the Japan-Korea Basic Scientific Cooperation Program (2012K2A2A4017699). This work was also supported by NRF grants funded by the Ministry of Education (Nos. 2012R1A6A1029029 and 2013M2A2A9043280).	Ko SH, 2007, NANO LETT, V7, P1869, DOI 10.1021/nl070333v; Hwang HJ, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/48/485205; Abry JC, 2001, COMPOS SCI TECHNOL, V61, P855, DOI 10.1016/S0266-3538(00)00181-0; Greer JR, 2007, ACTA MATER, V55, P6345, DOI 10.1016/j.actamat.2007.07.040; SCHULTE K, 1989, COMPOS SCI TECHNOL, V36, P63, DOI 10.1016/0266-3538(89)90016-X; Wen J, 2011, COMPOS PART B-ENG, V42, P77, DOI 10.1016/j.compositesb.2010.08.005; Kessler SS, 2002, COMPOS PART B-ENG, V33, P87, DOI 10.1016/S1359-8368(01)00050-6; Todoroki A, 2009, COMPOS SCI TECHNOL, V69, P1841, DOI 10.1016/j.compscitech.2009.03.023; Han WS, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/39/395705; Kang JS, 2011, J ELECTRON MATER, V40, P2268, DOI 10.1007/s11664-011-1711-0; Park JS, 2010, COMPOS SCI TECHNOL, V70, P2154, DOI 10.1016/j.compscitech.2010.08.017; Todoroki A, 2002, COMPOS SCI TECHNOL, V62, P1151, DOI 10.1016/S0266-3538(02)00053-2; Angelidis N, 2004, COMPOS PART A-APPL S, V35, P1135, DOI 10.1016/j.compositesa.2004.03.020; Chung WH, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/3/035202; Lee DJ, 2011, J MICROMECH MICROENG, V21, DOI 10.1088/0960-1317/21/12/125023; Jeon EB, 2014, COMPOS PART A-APPL S, V66, P193, DOI 10.1016/j.compositesa.2014.08.002; Ogi K, 2005, COMPOS SCI TECHNOL, V65, P231, DOI 10.1016/j.compscitech.2004.07.005; Park JB, 2002, COMPOS PART A-APPL S, V33, P267, DOI 10.1016/S1359-835X(01)00097-5; Park JM, 2007, COMPOS PART B-ENG, V38, P847, DOI 10.1016/j.compositesb.2006.12.004; Park JS, 2008, J COMPOS MATER, V42, P2869, DOI 10.1177/0021998308097280; PARK SJ, 2013, ASIAN WOMEN, V29, P1, DOI DOI 10.1088/0960-1317/23/1/015013; Takahashi K, 2012, STRUCT HEALTH MONIT, V11, P367, DOI 10.1177/1475921711424519; Takahashi K, 2012, COMPOS PART B-ENG, V43, P833, DOI 10.1016/j.compositesb.2012.01.005; Todoroki A, 2007, J SOLID MECH MAT ENG, V1, P947, DOI 10.1299/jmmp.1.947	24	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1359-8368	1879-1069		COMPOS PART B-ENG	Compos. Pt. B-Eng.	JUL	2015	76						167	173		10.1016/j.compositesb.2015.02.012		7	Engineering, Multidisciplinary; Materials Science, Composites	Engineering; Materials Science	CJ2ZE	WOS:000355352400017		
J	Kageyama, H; Waditee-Sirisattha, R; Sirisattha, S; Tanaka, Y; Mahakhant, A; Takabe, T				Kageyama, Hakuto; Waditee-Sirisattha, Rungaroon; Sirisattha, Sophon; Tanaka, Yoshito; Mahakhant, Aparat; Takabe, Teruhiro			Improved Alkane Production in Nitrogen-Fixing and Halotolerant Cyanobacteria via Abiotic Stresses and Genetic Manipulation of Alkane Synthetic Genes	CURRENT MICROBIOLOGY			English	Article							APHANOTHECE-HALOPHYTICA; SALT STRESS; ACCUMULATION	Cyanobacteria possess the unique capacity to produce alkane. In this study, effects of nitrogen deficiency and salt stress on biosynthesis of alkanes were investigated in three kinds of cyanobacteria. Intracellular alkane accumulation was increased in nitrogen-fixing cyanobacterium Anabaena sp. PCC7120, but decreased in non-diazotrophic cyanobacterium Synechococcus elongatus PCC7942 and constant in a halotolerant cyanobacterium Aphanothece halophytica under nitrogen-deficient condition. We also found that salt stress increased alkane accumulation in Anabaena sp. PCC7120 and A. halophytica. The expression levels of two alkane synthetic genes were not upregulated significantly under nitrogen deficiency or salt stress in Anabaena sp. PCC7120. The transformant Anabaena sp. PCC7120 cells with additional alkane synthetic gene set from A. halophytica increased intracellular alkane accumulation level compared to control cells. These results provide a prospect to improve bioproduction of alkanes in nitrogen-fixing halotolerant cyanobacteria via abiotic stresses and genetic engineering.	[Kageyama, Hakuto; Tanaka, Yoshito; Takabe, Teruhiro] Meijo Univ, Grad Sch Environm & Human Sci, Nagoya, Aichi 4688502, Japan; [Waditee-Sirisattha, Rungaroon] Chulalongkorn Univ, Dept Microbiol, Fac Sci, Bangkok 10330, Thailand; [Sirisattha, Sophon; Mahakhant, Aparat] Thailand Inst Sci & Technol Res, Pathum Thani 12120, Thailand; [Takabe, Teruhiro] Meijo Univ, Res Inst, Nagoya, Aichi 4688502, Japan	Takabe, T (reprint author), Meijo Univ, Grad Sch Environm & Human Sci, Nagoya, Aichi 4688502, Japan.	takabe@meijo-u.ac.jp			Ministry of Education, Science and Culture of Japan; International Research Center for Natural Environmental Science of Meijo University	This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Science and Culture of Japan and the International Research Center for Natural Environmental Science of Meijo University.	Dismukes GC, 2008, CURR OPIN BIOTECH, V19, P235, DOI 10.1016/j.copbio.2008.05.007; Kageyama H, 2011, APPL ENVIRON MICROB, V77, P5178, DOI 10.1128/AEM.00667-11; Schirmer A, 2010, SCIENCE, V329, P559, DOI 10.1126/science.1187936; Howard TP, 2013, P NATL ACAD SCI USA, V110, P7636, DOI 10.1073/pnas.1215966110; Bhadauriya P, 2008, WORLD J MICROB BIOT, V24, P139, DOI 10.1007/s11274-007-9439-y; Breuer G, 2012, BIORESOURCE TECHNOL, V124, P217, DOI 10.1016/j.biortech.2012.08.003; Coates RC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085140; ELHAI J, 1993, FEMS MICROBIOL LETT, V114, P179, DOI 10.1111/j.1574-6968.1993.tb06570.x; Kaiser BK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058307; Waditee-Sirisattha R, 2012, ARCH MICROBIOL, V194, P909, DOI 10.1007/s00203-012-0824-z; Waditee-Sirisattha R, 2014, APPL ENVIRON MICROB, V80, P1763, DOI 10.1128/AEM.03729-13; Wang WH, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-69	12	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0343-8651	1432-0991		CURR MICROBIOL	Curr. Microbiol.	JUL	2015	71	1					115	120		10.1007/s00284-015-0833-7		6	Microbiology	Microbiology	CJ8KP	WOS:000355749400015		
J	Bakhsh, TA; Sadr, A; Mandurah, MM; Shimada, Y; Zakaria, O; Tagami, J				Bakhsh, Turki A.; Sadr, Alireza; Mandurah, Mona M.; Shimada, Yasushi; Zakaria, Osama; Tagami, Junji			In situ characterization of resin-dentin interfaces using conventional vs. cryofocused ion-beam milling	DENTAL MATERIALS			English	Article						FIB; TEM; Resin composite; Collagen; Dental adhesive; Teeth, dentin, nano-interaction zone; Cryo; Hybrid layer	TEM SPECIMEN PREPARATION; TRANSMISSION ELECTRON-MICROSCOPY; ULTRASTRUCTURAL EXAMINATION; COMPARATIVE SEM; TOMOGRAPHY; SAMPLES; TOOL	Objective. The introduction of focused ion beam (FIB) milling has facilitated preparation of hard tissue samples for transmission electron microscope (TEM). However, this technique generates high temperature that may alter or damage morphological features in biological tissue. Therefore, the aim of this study was to determine the effects of cryogenic cooling on the morphological features of dentin interfaces with dental restorative materials in samples prepared by FIB for TEM examination. Methods. After preparation of a cylindrical-shaped cavities in extracted, non-carious premolar teeth, the specimens were restored with dental adhesive/composite and categorized into two restorative materials groups; (PB) a combination of Clearfil Protect Bond (Kuraray Noritake Dental, Japan)/Estelite Sigma Quick composite (Tokuyama Dental, Japan), and (SB) Filtek Silorane restorative system (3M ESPE, USA). The specimens were subjected to interfacial cross-sectioning, followed by observation and area selection using confocal laser microscopy. Later, ultrathin sections were prepared using FIB with cryogenic cooling (PB-C) and (SB-C), or without cooling (PB-NC) and (SB-NC) that all were examined under TEM. Results. Resulting TEM images of the ultra-morphological features at the resin-dentin nano-interaction zone were improved when FIB preparation was conducted in the cryogenic condition and no sign of artifacts were detected. Significance. Conducting ion beam milling with cryogenic cooling was advantageous in minimizing the elevation in specimen temperature. This led to preservation of dentin microstructures that revealed additional information about substrates that are necessary for advanced characterization of tooth-biomaterial interactions. (C) 2015 Academy of Dental Materials. Published by Elsevier Ltd. All rights reserved.	[Bakhsh, Turki A.] King Abdulaziz Univ, Fac Dent, Dept Operat Dent, Jeddah 21589, Saudi Arabia; [Sadr, Alireza; Mandurah, Mona M.; Shimada, Yasushi; Tagami, Junji] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Cardiol & Operat Dent Dept, Bunkyo Ku, Tokyo 1138549, Japan; [Sadr, Alireza] Univ Washington, Sch Dent, Seattle, WA 98195 USA; [Zakaria, Osama] Pharos Univ, Fac Dent, Oral Surg, Alexandria, Egypt	Bakhsh, TA (reprint author), King Abdulaziz Univ, Fac Dent, Dept Operat Dent, POB 80209, Jeddah 21589, Saudi Arabia.	taabakhsh@kau.edu.sa			Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, Saudi Arabia	This work was funded by the Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, Saudi Arabia. The authors, therefore, acknowledge with thanks DSR technical and financial support.	SANO H, 1995, OPER DENT, V20, P160; Marshall GW, 1997, J DENT, V25, P441, DOI 10.1016/S0300-5712(96)00065-6; Nalla RK, 2005, MICRON, V36, P672, DOI 10.1016/j.micron.2005.05.011; Desbois G, 2008, GEOFLUIDS, V8, P60, DOI 10.1111/j.1468-8123.2007.00205.x; Giannuzzi LA, 1999, MICRON, V30, P197, DOI 10.1016/S0968-4328(99)00005-0; Giannuzzi LA, 1998, MICROSC RES TECHNIQ, V41, P285, DOI 10.1002/(SICI)1097-0029(19980515)41:4<285::AID-JEMT1>3.0.CO;2-Q; Bakhsh TA, 2011, DENT MATER, V27, P915, DOI 10.1016/j.dental.2011.05.003; Bakhsh TA, 2013, J DENT, V41, P60, DOI 10.1016/j.jdent.2012.10.003; Li J, 2006, MATER CHARACT, V57, P64, DOI 10.1016/j.matchar.2005.12.007; Marko M, 2007, NAT METHODS, V4, P215, DOI 10.1038/nmeth1014; Phaneuf MW, 1999, MICRON, V30, P277, DOI 10.1016/S0968-4328(99)00012-8; Thompson LE, 2006, MICROSC MICROANAL, V12, P156, DOI 10.1017/S1431927606060041; Friedmann A, 2011, ACTA BIOMATER, V7, P2499, DOI 10.1016/j.actbio.2011.02.024; Rykaczewski K, 2012, ACS NANO, V6, P9326, DOI 10.1021/nn304250e; Hauert R, 2012, ACTA BIOMATER, V8, P3170, DOI 10.1016/j.actbio.2012.04.016; Thompson GB, 2004, ULTRAMICROSCOPY, V100, P25, DOI 10.1016/j.ultramic.2004.01.010; Breschi L, 2003, AM J DENT, V16, P267; Coutinho E, 2009, DENT MATER, V25, P1325, DOI 10.1016/j.dental.2009.06.002; Crowell CD, 1934, J DENT RES, V14, P251, DOI 10.1177/00220345340140040201; Desbois G, 2013, J MICROSC-OXFORD, V249, P215, DOI 10.1111/jmi.12011; Dolph MC, 2014, NUCL INSTRUM METH B, V328, P33, DOI 10.1016/j.nimb.2014.02.126; Grandfield K, 2012, ADV MATER SCI ENG, V2012, P6; Kalin C, 1998, J DENT, V26, P511, DOI 10.1016/S0300-5712(98)00005-0; Nishimura Kozo, 2005, Journal of Medical and Dental Sciences, V52, P9; Nomoto R, 1994, Dent Mater J, V13, P198; Nurrohman H, 2012, DENT MATER, V28, pE89, DOI 10.1016/j.dental.2012.04.025; Tay F R, 1999, J Adhes Dent, V1, P103; VANMEERBEEK B, 1995, DENT MATER, V11, P87, DOI 10.1016/0109-5641(95)80039-5; VANMEERBEEK B, 1993, J DENT RES, V72, P495, DOI 10.1177/00220345930720020501; YU JE, 1991, J ELECTRON MICR TECH, V18, P315, DOI 10.1002/jemt.1060180314	30	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0109-5641	1879-0097		DENT MATER	Dent. Mater.	JUL	2015	31	7					833	844		10.1016/j.dental.2015.04.010		12	Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials	Dentistry, Oral Surgery & Medicine; Materials Science	CJ9HA	WOS:000355811900010		
J	Tanaka, Y; Reig, M; Casas, S; Aladjem, C; Cortina, JL				Tanaka, Yoshinobu; Reig, Monica; Casas, Sandra; Aladjem, Carlos; Luis Cortina, Jose			Computer simulation of ion-exchange membrane electrodialysis for salt concentration and reduction of RO discharged brine for salt production and marine environment conservation	DESALINATION			English	Article						Computer simulation; Concentration; Desalination; Electrodialysis; Ion exchange membrane; Reverse osmosis	REVERSE-OSMOSIS; DESALINATION PLANT; SEAWATER DESALINATION; WATER DESALINATION; MASS-TRANSFER; TRANSPORT; SYSTEM; IMPACT; MODEL	The salt discharged from reverse osmosis is concentrated by ion-exchange membrane electrodialysis to produce salt for industrial use and the salt concentration is reduced to seawater level for preventing environmental impact on marine ecosystems. The technology was evaluated experimentally and discussed with a computer simulation program of the electrodialysis system incorporated with U shape cells. The algorithm computes mass transport, energy consumption, electric current leakage, concentrate NaCl purity, pressure drop and limiting current density. The seawater reverse osmosis discharged brine was supplied to the electrodialysis pilot plant and it was operated changing current density and temperature taking benefit of seasoning variations. The computed energy consumption E-Nacl and NaCl concentration in concentrated solutions C-NaCl '' using developing algorithms provided a good description of the experimentally measured values with correlation coefficients of R(r) = 0.9 for E-NaCl and R(r) = 0.6 for C-NaCl ''. Then the reasonability of the developed algorithms is supported by the experimental set of data. The current leakage is nearly 3% for any electric current. The pump driving force is very low. The limiting current density is very high. In order to decrease salt concentration at the outlets of desalting cells to seawater level, it is necessary to increase desalting ratio to 0.5. This technique however increases Emu and decrease C-NaCl ''. In spite of this operating circumstance, E-NaCl and C-NaCl '' are comparable to the data in the salt manufacturing plant operation to produce edible salt. NaCl produced from in the reverse osmosis discharged brine electrodialysis is competitive in the edible salt market. (C) 2015 Elsevier B.V. All rights reserved.	[Tanaka, Yoshinobu] IEM Res, Ushiku, Ibaraki 3001216, Japan; [Reig, Monica; Casas, Sandra; Luis Cortina, Jose] UPC Barcelona TECH, Dept Chem Engn, Barcelona 08028, Spain; [Aladjem, Carlos] SOLVAY Iber SL, Martorell 08760, Spain; [Casas, Sandra; Luis Cortina, Jose] CETAQUA, Comella De Llobregat 08940, Spain	Tanaka, Y (reprint author), IEM Res, 1-46-3 Kamiya, Ushiku, Ibaraki 3001216, Japan.	fwis1202@mb.infoweb.ne.jp			Center for the Development of Industrial Technology (CDTI); Ministry of Economy and Innovation (MINECO) through the ZERODISCHARGE project [CTQ-2011-26799]; Research Agency of Catalunya [2014SGR50]; MINECO [BES-2012-051914]	The Center for the Development of Industrial Technology (CDTI), the Ministry of Economy and Innovation (MINECO) through the ZERODISCHARGE project (CTQ-2011-26799) and the Research Agency of Catalunya (Project 2014SGR50) have supported this project M. Reig thanks MINECO for her PhD grant BES-2012-051914. We would also like to acknowledge the EL Prat Desalination plant (ITAM-ATLL) and the SOLVIN Martorell teams for their valuable support.	Absar B, 2013, DESALIN WATER TREAT, V51, P5942, DOI 10.1080/19443994.2013.770192; Aldyama M., 1992, 322 JAP TOB SALT PUB; AMBAG, 2006, DES FEAS STUD MONT B; Nikonenko VV, 2008, CHEM ENG PROCESS, V47, P1118, DOI 10.1016/j.cep.2007.12.005; Moon P, 2004, SEPAR SCI TECHNOL, V39, P2531, DOI 10.1081/SS-200026714; Bebelis S, 2013, CHEM ENG RES DES, V91, P1998, DOI 10.1016/j.cherd.2013.08.029; Lee HJ, 2002, DESALINATION, V142, P267, DOI 10.1016/S0011-9164(02)00208-4; Perez-Gonzalez A, 2012, WATER RES, V46, P267, DOI 10.1016/j.watres.2011.10.046; Zhang Y, 2011, J MEMBRANE SCI, V378, P101, DOI 10.1016/j.memsci.2010.10.036; Park PK, 2012, WATER RES, V46, P3796, DOI 10.1016/j.watres.2012.04.021; Zimmerer CC, 1996, DESALINATION, V104, P129, DOI 10.1016/0011-9164(96)00035-5; Fidaleo M, 2005, J MEMBRANE SCI, V260, P90, DOI 10.1016/j.memsci.2005.01.048; Xu P, 2013, ENVIRON ENG SCI, V30, P502, DOI 10.1089/ees.2012.0348; Jiang CX, 2014, J MEMBRANE SCI, V450, P323, DOI 10.1016/j.memsci.2013.09.020; Tran ATK, 2012, CHEM ENG SCI, V79, P228, DOI 10.1016/j.ces.2012.06.001; Tsiakis P, 2005, DESALINATION, V173, P173, DOI 10.1016/j.desal.2004.08.031; Lattemann S, 2008, DESALINATION, V220, P1, DOI 10.1016/j.desal.2007.03.009; [Anonymous], 1998, SALT MAN PLANT TECHN; Reig M, 2014, DESALINATION, V342, P107, DOI 10.1016/j.desal.2013.12.021; Tanaka Y, 2003, J MEMBRANE SCI, V222, P71, DOI 10.1016/S0376-7388(03)00217-5; Casas S, 2011, SOLVENT EXTR ION EXC, V29, P488, DOI 10.1080/07366299.2011.573451; Tanaka Y, 2006, J MEMBRANE SCI, V281, P517, DOI 10.1016/j.memsci.2006.04.022; Tanaka Y, 2011, IND ENG CHEM RES, V50, P7494, DOI 10.1021/ie102386d; Brauns E, 2009, DESALINATION, V249, P1030, DOI 10.1016/j.desal.2009.04.015; Gacia E, 2007, ESTUAR COAST SHELF S, V72, P579, DOI 10.1016/j.ecss.2006.11.021; AVRIEL M, 1972, DESALINATION, V10, P113, DOI 10.1016/S0011-9164(00)80082-X; BELFORT G, 1970, DESALINATION, V8, P153, DOI 10.1016/S0011-9164(00)80227-1; Choi JS, 2015, J IND ENG CHEM, V21, P261, DOI 10.1016/j.jiec.2014.02.033; Danoun R., 2007, DES PLANTS POTENTIAL; Fujita T., 2009, B SOC SEA WATER SCI, V63, P15; Hani H., 1961, S36152258 JP, Patent No. JP S36-15258; Harned H.S., 1998, PHYS CHEM ELECTROLYT, P726; Kempton R., 2010, Water Science and Technology: Water Supply, V10, P416; Khordagui H., 2002, GULF ECOSYSTEM HLTH; Kim DY, 2013, KOREAN J CHEM ENG, V30, P1691, DOI 10.1007/s11814-013-0123-7; Latorre M., 2004, C IB GEST PLAN AG; McGovern RK, 2014, J MEMBRANE SCI, V469, P326, DOI 10.1016/j.memsci.2014.06.040; MEDRC, 2002, 98AS026 MEDRC; Mihara K., 1972, S473081 JP, Patent No. JP S47-3081; Mihara K., 1970, S4519980 JP, Patent No. JP S45-19980, *30693; Mizutani Y., 1971, S4642083 JP, Patent No. JP S46-42083; Qdais H. A., 2008, Desalination, V220, P16; Sadrzadeh M., 2007, DESALINATION, V206, P534; Sato K., 1974, SOC SEA WATER SCI JP, P10; Tanaka Y., 2015, ION EXCHANGE MEMBRAN; Tanaka Y, 2011, IND ENG CHEM RES, V50, P10765, DOI 10.1021/ie2005498; Tanaka Y., 2013, ENCY MEMBRANE SCI AT; Thomas A.D., 2006, DESALINATION WATER P; UNEP/MEDPOL, 2003, MAP TECHN REP SER, V139; Valipour M, 2012, J BASIC APPL SCI RES, V2, P12365; Valipour M., 2013, J CIVIL ENV ENG, V2013, P1, DOI DOI 10.4172/2165-784X.1000127; Voutchkov N, 2011, DESALINATION, V273, P205, DOI 10.1016/j.desal.2010.10.018; Wilson J.R., 1969, DEMINERALIZATION ELE, P265; YAMANE R, 1969, IND ENG CHEM PROC DD, V8, P159, DOI 10.1021/i260030a003	54	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0011-9164	1873-4464		DESALINATION	Desalination	JUL 1	2015	367						76	89		10.1016/j.desal.2015.03.022		14	Engineering, Chemical; Water Resources	Engineering; Water Resources	CJ3GN	WOS:000355371500009		
J	Suzuki, T				Suzuki, Takashi			BLOWUP IN INFINITE TIME FOR 2D SMOLUCHOWSKI-POISSON EQUATION	DIFFERENTIAL AND INTEGRAL EQUATIONS			English	Article							PARABOLIC-ELLIPTIC SYSTEM; RADIALLY SYMMETRIC-SOLUTIONS; KELLER-SEGEL MODEL; STATISTICAL-MECHANICS; 2-DIMENSIONAL DOMAINS; CHEMOTAXIS MODEL; SINGULAR LIMITS; UP SOLUTIONS; 8-PI-PROBLEM; AGGREGATION	We study the Smoluchowski-Poisson equation in two space dimensions provided with Dirichlet boundary condition for the Poisson part. For this equation, several profiles of blowup solution have been noticed. Here, we study blowup in infinite time in accordance with the residual vanishing and Hamiltonian control on collapse dynamics.	Osaka Univ, Dept Syst Innovat, Div Math Sci, Toyonaka, Osaka 5608531, Japan	Suzuki, T (reprint author), Osaka Univ, Dept Syst Innovat, Div Math Sci, Machikaneyamacho 1-3, Toyonaka, Osaka 5608531, Japan.				JST-CREST	Part of this work was done while the author was visiting Dipartimento di Matematicae Applicazioni, R. Caccioppoli, Universita degli Studi di Napoli Federico II, in May 2013. He thanks several kind invitations of Tonia Ricciardi and stimulative discussions with her colleagues. He is also supported partly by JST-CREST. Thanks are also due to Masashi Misawa for many warm suggestions.	Grossi M, 2011, ADV DIFFERENTIAL EQU, V16, P145; del Pino M, 2005, CALC VAR PARTIAL DIF, V24, P47, DOI 10.1007/s00526-004-0314-5; POINTIN YB, 1976, PHYS FLUIDS, V19, P1459, DOI 10.1063/1.861347; Senba T, 2002, J FUNCT ANAL, V191, P17, DOI 10.1006/jfan.2001.3802; KIESSLING MKH, 1993, COMMUN PUR APPL MATH, V46, P27, DOI 10.1002/cpa.3160460103; CHILDRESS S, 1981, MATH BIOSCI, V56, P217, DOI 10.1016/0025-5564(81)90055-9; Nagai T, 2001, J INEQUAL APPL, V6, P37, DOI 10.1155/S1025583401000042; KELLER EF, 1970, J THEOR BIOL, V26, P399, DOI 10.1016/0022-5193(70)90092-5; Sire C, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.046133; Nagai T, 2011, ADV DIFFERENTIAL EQU, V16, P839; Baraket S, 1998, CALC VAR PARTIAL DIF, V6, P1; Mizoguchi N, 1997, J DIFFER EQUATIONS, V134, P183, DOI 10.1006/jdeq.1996.3221; Biler P, 2006, TOPOL METHOD NONL AN, V27, P133; Senba T, 2002, ASYMPTOTIC ANAL, V32, P63; SIMON L, 1983, ANN MATH, V118, P525, DOI 10.2307/2006981; JOYCE G, 1973, J PLASMA PHYS, V10, P107; Esposito P, 2005, ANN I H POINCARE-AN, V22, P227, DOI 10.1016/j.anihpc.2004.12.001; Luckhaus S, 2012, ARCH RATION MECH AN, V206, P31, DOI 10.1007/s00205-012-0549-9; Suzuki T, 2013, J MATH PURE APPL, V100, P347, DOI 10.1016/j.matpur.2013.01.004; JAGER W, 1992, T AM MATH SOC, V329, P819, DOI 10.2307/2153966; Senba T, 2007, NONLINEAR ANAL-THEOR, V66, P1817, DOI 10.1016/j.na.2006.02.027; CHEN WX, 1991, DUKE MATH J, V63, P615, DOI 10.1215/S0012-7094-91-06325-8; Gajewski H, 1998, MATH NACHR, V195, P77, DOI 10.1002/mana.19981950106; Bartolucci D, 2014, MATH ANN, V359, P1, DOI 10.1007/s00208-013-0990-6; BILER P., 1998, ADV MATH SCI APPL, V8, P715; BILER P, 1994, NONLINEAR ANAL-THEOR, V23, P1189, DOI 10.1016/0362-546X(94)90101-5; Biler P, 2006, MATH METHOD APPL SCI, V29, P1563, DOI 10.1002/mma.743; Blanchet A., 2006, ELECTRON J DIFFER EQ, V2006, P1; Blanchet A, 2008, COMMUN PUR APPL MATH, V61, P1449, DOI 10.1002/cpa.20225; CAGLIOTI E, 1992, COMMUN MATH PHYS, V143, P501, DOI 10.1007/BF02099262; Cao DM, 2010, ADV MATH, V225, P2741, DOI 10.1016/j.aim.2010.05.012; Chang S.-Y.-A., 2003, LECT PARTIAL DIFFERE; Dolbeault J, 2009, DISCRETE CONT DYN S, V25, P109, DOI 10.3934/dcds.2009.25.109; Gladiali F., PREPRINT; Grossi M, 2010, J FUNCT ANAL, V259, P904, DOI 10.1016/j.jfa.2010.03.008; Henry D, 1981, LECT NOTES MATH, V840; Kavallaris N.I., 2009, SIAM J MATH ANAL, V41, P128; Lojasiewicz S., 1963, EQUATIONS DRIVEES PA, P117; Nagai T., 1995, ADV MATH SCI APPL, V5, P581; Nagai T, 1997, FUNKC EKVACIOJ-SER I, V40, P411; OHTSUKA H., 2007, ADV MATH SCI APPL, V17, P445; Onsager L., 1949, Supplemento al Nuovo Cimento, V6, DOI 10.1007/BF02780991; Senba T, 2011, APPL ANAL MATH METHO; Senba T., 2000, ADV MATH SCI APPL, V10, P191; Senba T., 2001, METHODS APPL ANAL, V8, P349; SENBA T., 2001, ADV DIFFERENTIAL EQU, V6, P21; SUZUKI T, 1992, ANN I H POINCARE-AN, V9, P367; Suzuki T, 2008, C MATH, V111, P11, DOI 10.4064/cm111-1-2; Suzuki T., ARXIV13115679; Suzuki T., 2008, MEAN FIELD THEORIES; Suzuki T, 1990, ASYMPTOTIC ANAL, V3, P173; Suzuki T., 1994, SEMILINEAR ELLIPTIC; Suzuki T., 1988, T AM MATH SOC, V39, P591; Suzuki T., 2005, FREE ENERGY SELF INT; Winkler M., PREPRINT	55	0	0	KHAYYAM PUBL CO INC	ATHENS	PO BOX 429, ATHENS, OH 45701 USA	0893-4983			DIFFER INTEGRAL EQU	Differ. Integral Equ.	JUL-AUG	2015	28	7-8					601	630				30	Mathematics, Applied; Mathematics	Mathematics	CJ8TQ	WOS:000355776800001		
J	Marciniak-Czochra, A; Nakayama, M; Takagi, I				Marciniak-Czochra, Anna; Nakayama, Madoka; Takagi, Izumi			PATTERN FORMATION IN A DIFFUSION-ODE MODEL WITH HYSTERESIS	DIFFERENTIAL AND INTEGRAL EQUATIONS			English	Article							RECEPTOR-BASED MODELS; HYDRA	Coupling diffusion process of signaling molecules with nonlinear interactions of intracellular processes and cellular growth/transformation leads to a system of reaction-diffusion equations coupled with ordinary differential equations (diffusion-ODE models), which differ from the usual reaction-diffusion systems. One of the mechanisms of pattern formation in such systems is based on the existence of multiple steady states and hysteresis in the ODE subsystem. Diffusion tries to average different states and is the cause of spatio-temporal patterns. In this paper, we provide a systematic description of stationary solutions of such systems having the form of transition or boundary layers. The solutions are discontinuous in the case of non-diffusing variables whose quasi-stationary dynamics exhibit hysteresis. The considered model is motivated by biological applications and elucidates a possible mechanism of formation of patterns with sharp transitions.	[Marciniak-Czochra, Anna] Heidelberg Univ, Inst Appl Math, D-69120 Heidelberg, Germany; [Marciniak-Czochra, Anna] Heidelberg Univ, BIOQUANT, D-69120 Heidelberg, Germany; [Nakayama, Madoka] Sendai Natl Coll Technol, Natori, Miyagi 9811239, Japan; [Takagi, Izumi] Tohoku Univ, Math Inst, Sendai, Miyagi 9808578, Japan	Marciniak-Czochra, A (reprint author), Heidelberg Univ, Inst Appl Math, Neuenheimer Feld 294, D-69120 Heidelberg, Germany.				European Research Council [210680]; Emmy Noether Programme of German Research Council (DFG); JSPS [22244010, 24654037, 26610027]	AM-C was supported by European Research Council Starting Grant No 210680 "Multiscale mathematical modelling of dynamics of structure formation in cell systems" and Emmy Noether Programme of German Research Council (DFG). MN and IT were supported in part by JSPS Grant-in-Aid for Scientific Research (A) #22244010 "Theory of Differential Equations Applied to Biological Pattern Formation-from Analysis to Synthesis". Also, IT acknowledges the support of JSPS Grant-in-Aid for Challenging Exploratory Research #24654037 "Turing's Diffusion-Driven-Instability Revisited - from a view point of global structure of solution sets" and #26610027 "Control of Patterns by Degenerate Reaction-Diffusion Systems of Several Components".	TAKAGI I, 1986, J DIFFER EQUATIONS, V61, P208, DOI 10.1016/0022-0396(86)90119-1; NISHIURA Y, 1982, SIAM J MATH ANAL, V13, P555, DOI 10.1137/0513037; GIERER A, 1972, KYBERNETIK, V12, P30, DOI 10.1007/BF00289234; Garroni M. G., 2009, REND MAT APPL, V29, P117; Kothe A., 2013, SPRINGER P MATH, V15, P153; MACWILLIAMS HK, 1982, J THEOR BIOL, V99, P681, DOI 10.1016/0022-5193(82)90194-1; Marciniak-Czochra A, 2008, SIAM J MATH ANAL, V40, P215, DOI 10.1137/050645269; Marciniak-Czochra A, 2003, J BIOL SYST, V11, P293, DOI 10.1142/S0218339003000889; Marciniak-Czochra A., 2012, J MATH PURE APPL, V99, P509; Marciniak-Czochra A, 2006, MATH BIOSCI, V199, P97, DOI 10.1016/j.mbs.2005.10.004; Marciniak-Czochra A, 2012, IMA J APPL MATH, V77, P855, DOI 10.1093/imamat/hxs052; MEINHARDT H, 1993, DEV BIOL, V157, P321, DOI 10.1006/dbio.1993.1138; Mimura M., 1981, HIROSHIMA MATH J, V11, P621; MIMURA M, 1980, SIAM J MATH ANAL, V11, P613, DOI 10.1137/0511057; Nakayama M., TOHOKU MATH PU UNPUB; Rothe F., 1984, LECT NOTES MATH, V1072; Sherrat J. A., 1995, FORMA, V10, P77; Smoller J., 1994, SHOCK WAVES REACTION; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012	19	0	0	KHAYYAM PUBL CO INC	ATHENS	PO BOX 429, ATHENS, OH 45701 USA	0893-4983			DIFFER INTEGRAL EQU	Differ. Integral Equ.	JUL-AUG	2015	28	7-8					655	694				40	Mathematics, Applied; Mathematics	Mathematics	CJ8TQ	WOS:000355776800003		
J	Kurokiba, M; Ogawa, T				Kurokiba, Masaki; Ogawa, Takayoshi			TWO DIMENSIONAL DRIFT-DIFFUSION SYSTEM IN A CRITICAL WEIGHTED SPACE	DIFFERENTIAL AND INTEGRAL EQUATIONS			English	Article							GLOBAL EXISTENCE; BESOV-SPACES; BLOW-UP; THRESHOLD; EQUATIONS; INEQUALITIES; CHEMOTAXIS; UNIQUENESS; CRITERION; MODEL	We establish the time local well-posedness of a multi-component parabolic-elliptic drift-diffusion model in two space dimensions in a scaling critical weighted space. This is a generalization of former result Kurokiba-Ogawa [20] and corresponds to the critical case for multiple system treated in Kurokiba [18]. In order to show the critical well-posedness, we introduce a refined version of Brezis-Gallouet inequality in term of the Besov space and apply it to the some weighted estimate in two dimensions.	[Kurokiba, Masaki] Muroran Inst Technol, Coll Liberal Arts, Math Sci Res Unit, Muroran, Hokkaido 0508585, Japan; [Ogawa, Takayoshi] Tohoku Univ, Math Inst, Sendai, Miyagi 9808578, Japan	Kurokiba, M (reprint author), Muroran Inst Technol, Coll Liberal Arts, Math Sci Res Unit, Muroran, Hokkaido 0508585, Japan.				JSPS [24540201, 25240702]	The work of the first author is partially supported by JSPS Grant-in-aid for Scientific Research C #24540201. The work of the second authors is partially supported by JSPS Grant-in-Aid Scientific Research S #25240702. The first author is grateful to anonymous referees for their helpful suggestion that improves the paper very much.	Biler P, 2000, ANN HENRI POINCARE, V1, P461, DOI 10.1007/s000230050003; Machihara S, 2013, TOHOKU MATH J, V65, P321; Kozono H, 2002, MATH Z, V242, P251, DOI 10.1007/s002090100332; Conca C, 2011, EUR J APPL MATH, V22, P553, DOI 10.1017/S0956792511000258; Nagai T, 2001, J INEQUAL APPL, V6, P37, DOI 10.1155/S1025583401000042; KELLER EF, 1970, J THEOR BIOL, V26, P399, DOI 10.1016/0022-5193(70)90092-5; BERGH J., 1976, INTERPOLATION SPACES; Biler P, 1995, C MATH, VLXVIII, P229; Biler P., 1998, ADV DIFF EQ, V3, P177; Biler Piotr, 1994, C MATH, V67, P297; Brezis H., 1980, Nonlinear Analysis Theory, Methods & Applications, V4, DOI 10.1016/0362-546X(80)90068-1; Conca C, 2012, APPL MATH LETT, V25, P352, DOI 10.1016/j.aml.2011.09.013; Espejo E, 2013, COMMUN PUR APPL ANAL, V12, P2627, DOI 10.3934/cpaa.2013.12.2627; Espejo EE, 2010, DIFFER INTEGRAL EQU, V23, P451; Espejo E.E., 2009, ANALYSIS, V29, P317, DOI 10.1524/anly.2009.1029; GAJEWSKI H, 1986, J MATH ANAL APPL, V113, P12, DOI 10.1016/0022-247X(86)90330-6; GAJEWSKI H, 1994, MATH MOD METH APPL S, V4, P121, DOI 10.1142/S021820259400008X; HERBST IW, 1977, COMMUN MATH PHYS, V53, P285, DOI 10.1007/BF01609852; Jiingel A., 1995, MATH MOD METH APPL S, V5, P497; Kurokiba M, 2006, COMMUN PUR APPL ANAL, V5, P97; Kurokiba M, 2008, J MATH ANAL APPL, V342, P1052, DOI 10.1016/j.jmaa.2007.11.017; Kurokiba M., 2003, DIFFERENTIAL INTEGRA, V16, P427; Kurokiba M, 2014, DIFFER INTEGRAL EQU, V27, P425; Nagai T., 1995, ADV MATH SCI APPL, V5, P581; Nagai T, 2001, NONLINEAR ANAL-THEOR, V47, P777, DOI 10.1016/S0362-546X(01)00222-X; Nagai T, 1997, FUNKC EKVACIOJ-SER I, V40, P411; Nagai T., 2000, HIROSHIMA MATH J, V30, P463; Ogawa T., 2013, REAL ANAL METHODS NO; Ogawa T, 2004, TOHOKU MATH J, V56, P65, DOI 10.2748/tmj/1113246381; SENBA T., 2001, ADV DIFFERENTIAL EQU, V6, P21; Triebel H., 1983, THEORY FUNCTION SPAC; Wolansky G, 2002, EUR J APPL MATH, V13, P641, DOI 10.1017/S0956792501004843	32	0	0	KHAYYAM PUBL CO INC	ATHENS	PO BOX 429, ATHENS, OH 45701 USA	0893-4983			DIFFER INTEGRAL EQU	Differ. Integral Equ.	JUL-AUG	2015	28	7-8					753	776				24	Mathematics, Applied; Mathematics	Mathematics	CJ8TQ	WOS:000355776800006		
J	Naito, Y				Naito, Yuki			GLOBAL ATTRACTIVITY AND CONVERGENCE RATE IN THE WEIGHTED NORM FOR A SUPERCRITICAL SEMILINEAR HEAT EQUATION	DIFFERENTIAL AND INTEGRAL EQUATIONS			English	Article							ELLIPTIC-EQUATIONS; POSITIVE SOLUTIONS; BEHAVIOR	We consider the behavior of solutions to the Cauchy problem for a semilinear heat equation with supercritical nonlinearity. We study the convergence of solutions to steady states in a weighted norm, and show the global attractivity property of steady states. We also give its convergence rate for a class of initial data. Proofs are given by a comparison method based on matched asymptotic expansion.	Ehime Univ, Dept Math, Matsuyama, Ehime 7908577, Japan	Naito, Y (reprint author), Ehime Univ, Dept Math, Matsuyama, Ehime 7908577, Japan.				Japan Society for the Promotion of Science [23540244]	This research was supported by the Grant-in-Aid for Scientific Research (C) (No. 23540244) Japan Society for the Promotion of Science.	GUI CF, 1992, COMMUN PUR APPL MATH, V45, P1153, DOI 10.1002/cpa.3160450906; WANG XF, 1993, T AM MATH SOC, V337, P549, DOI 10.2307/2154232; JOSEPH DD, 1973, ARCH RATION MECH AN, V49, P241; Gui CF, 2001, J DIFFER EQUATIONS, V169, P588, DOI 10.1006/jdeq.2000.3909; CHEN WX, 1991, DUKE MATH J, V63, P615, DOI 10.1215/S0012-7094-91-06325-8; Fila M., 2005, J DYN DIFFER EQU, V17, P249, DOI 10.1007/s10884-005-5405-2; GIDAS B, 1981, COMMUN PUR APPL MATH, V34, P525, DOI 10.1002/cpa.3160340406; Hoshino M, 2008, NONLINEAR ANAL-THEOR, V69, P3136, DOI 10.1016/j.na.2007.09.007; LI Y, 1992, J DIFFER EQUATIONS, V95, P304, DOI 10.1016/0022-0396(92)90034-K; Polacik P, 2003, MATH ANN, V327, P745, DOI 10.1007/s00208-003-0469-y; Stinner C, 2010, NODEA-NONLINEAR DIFF, V17, P213, DOI 10.1007/s00030-009-0050-9	11	0	0	KHAYYAM PUBL CO INC	ATHENS	PO BOX 429, ATHENS, OH 45701 USA	0893-4983			DIFFER INTEGRAL EQU	Differ. Integral Equ.	JUL-AUG	2015	28	7-8					777	800				24	Mathematics, Applied; Mathematics	Mathematics	CJ8TQ	WOS:000355776800007		
J	Ohtsuka, H; Takahashi, F				Ohtsuka, Hiroshi; Takahashi, Futoshi			LOCAL ASYMPTOTIC NONDEGENERACY FOR MULTI-BUBBLE SOLUTIONS TO THE BIHARMONIC LIOUVILLE-GEL'FAND PROBLEM IN DIMENSION FOUR	DIFFERENTIAL AND INTEGRAL EQUATIONS			English	Article							EXPONENTIAL NONLINEARITY; SINGULAR LIMITS; NON-DEGENERACY; EQUATION; BEHAVIOR	We consider the biharmonic Liouville-Gel'fand problem under the Navier boundary condition in four space dimension. Under the nondegeneracy assumption of blow up points of multiple blowing-up solutions, we prove several estimates for the linearized equations and obtain some convergence result. The result can be seen as a weaker version of the asymptotic nondegeneracy of multi-bubble solutions, which was recently established by Grossi-Ohtsuka-Suzuki in two-dimensional Laplacian case.	[Ohtsuka, Hiroshi] Kanazawa Univ, Inst Sci & Engn, Fac Math & Phys, Kanazawa, Ishikawa 9201192, Japan; [Takahashi, Futoshi] Osaka City Univ, Grad Sch Sci, Sumiyoshi Ku, Osaka 558, Japan; [Takahashi, Futoshi] Osaka City Univ, OCAMI, Sumiyoshi Ku, Osaka 558, Japan	Ohtsuka, H (reprint author), Kanazawa Univ, Inst Sci & Engn, Fac Math & Phys, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan.		Ohtsuka, Hiroshi/C-3346-2015	Ohtsuka, Hiroshi/0000-0002-4473-4255	JSPS [2254023, 23340038]	Part of this work was supported by JSPS Grant-in-Aid for Scientific Research (C) No.2254023 (H.O) and JSPS Grant-in-Aid for Scientific Research (B) No. 23340038 (F.T).	Grossi M, 2011, ADV DIFFERENTIAL EQU, V16, P145; Clapp M, 2008, ANN I H POINCARE-AN, V25, P1015, DOI 10.1016/j.anihpc.2007.09.002; Gladiali F, 2009, ANN I H POINCARE-AN, V26, P191, DOI 10.1016/j.anihpc.2007.10.004; Baraket S, 2007, ANN I H POINCARE-AN, V24, P875, DOI 10.1016/j.anihpc.2006.06.009; Lin CS, 1998, COMMENT MATH HELV, V73, P206, DOI 10.1007/s000140050052; Ben Ayed M, 2006, INDIANA U MATH J, V55, P1723; Gladiali F, 2004, COMMUN PART DIFF EQ, V29, P1335, DOI 10.1081/PDE-200037754; Kellogg O.D., 1970, FDN POTENTIAL THEORY; Lin CS, 2007, ANN SCUOLA NORM-SCI, V6, P599; Lin CS, 2003, COMMUN PUR APPL MATH, V56, P784, DOI 10.1002/cpa.10073; Ohtsuka H, 2013, J MATH ANAL APPL, V398, P692, DOI 10.1016/j.jmaa.2012.09.028; Suzuki T, 1990, ASYMPTOTIC ANAL, V3, P173; Takahashi F, 2007, CALC VAR PARTIAL DIF, V29, P509, DOI 10.1007/s00526-006-0080-7; Wei JC, 1996, COMMUN PART DIFF EQ, V21, P1451, DOI 10.1080/03605309608821234	14	0	0	KHAYYAM PUBL CO INC	ATHENS	PO BOX 429, ATHENS, OH 45701 USA	0893-4983			DIFFER INTEGRAL EQU	Differ. Integral Equ.	JUL-AUG	2015	28	7-8					801	822				22	Mathematics, Applied; Mathematics	Mathematics	CJ8TQ	WOS:000355776800008		
J	Cao, ZX; Wang, Q; Zheng, CL				Cao, Zhenxing; Wang, Quan; Zheng, Chaolei			Best hyperspectral indices for tracing leaf water status as determined from leaf dehydration experiments	ECOLOGICAL INDICATORS			English	Article						Hyperspectral indices; Derivative spectra; Leaf water status; Deciduous trees; Leaf dehydration	INDUCED TREE MORTALITY; REMOTE-SENSING DATA; SPECTRAL REFLECTANCE; OPTICAL-PROPERTIES; HIGHER-PLANTS; CHLOROPHYLL FLUORESCENCE; LIQUID WATER; RED EDGE; VEGETATION; STRESS	Leaf water status information is highly needed for monitoring plant physiological processes and assessing drought stress. Retrieval of leaf water status based on hyperspectral indices has been shown to be easy and rapid. However, a universal index that is applicable to various plants remains a considerable challenge, primarily due to the limited range of field-measured datasets. In this study, a leaf dehydration experiment was designed to obtain a relatively comprehensive dataset with ranges that are difficult to obtain in field measurements. The relative water content (RWC) and equivalent water thickness (EWT) were chosen as the surrogates of leaf water status. Moreover, five common types of hyperspectral indices including: single reflectance (R), wavelength difference (D), simple ratio (SR), normalized ratio (ND) and double difference (DDn) were applied to determine the best indices. The results indicate that values of original reflectance, reflectance difference and reflectance sensitivity increased significantly, particularly within the 350-700 nm and 1300-2500 nm domains, with a decrease in leaf water. The identified best indices for RWC and EWT, when all the species were considered together, were the first derivative reflectance based ND type index of dND (1415, 1530) and SR type index of dSR (1530, 1895), with R-2 values of 0.95 (p < 0.001) and 0.97 (p < 0.001), respectively, better than previously published indices. Even so, different best indices for different species were identified, most probably due to the differences in leaf anatomy and physiological processes during leaf dehydration. Although more plant species and field-measured datasets are still needed in future studies, the recommend indices based on derivative spectra provide a means to monitor drought-induced plant mortality in temperate climate regions. (C) 2015 Elsevier Ltd. All rights reserved.	[Cao, Zhenxing; Zheng, Chaolei] Shizuoka Univ, Grad Sch Sci & Technol, Shizuoka 4228529, Japan; [Wang, Quan] Shizuoka Univ, Grad Sch Agr, Shizuoka 4228529, Japan; [Zheng, Chaolei] Chinese Acad Sci, Inst Remote Sensing & Digital Earth, Beijing 100094, Peoples R China	Wang, Q (reprint author), Shizuoka Univ, Grad Sch Agr, Shizuoka 4228529, Japan.	aqwang@ipc.shizuoka.ac.jp	Wang, Quan/F-5424-2013	Wang, Quan/0000-0001-5483-0243	JSPS [25302001]	We thank the members of the Laboratory of Macroecology and the Institute of Silviculture, Shizuoka University, for their support in both field work and laboratory analyses. This study was partially supported by the JSPS project (Grant no. 25302001).	FILELLA I, 1994, INT J REMOTE SENS, V15, P1459; DEMETRIADESSHAH TH, 1990, REMOTE SENS ENVIRON, V33, P55, DOI 10.1016/0034-4257(90)90055-Q; Sims DA, 2002, REMOTE SENS ENVIRON, V81, P337, DOI 10.1016/S0034-4257(02)00010-X; HORLER DNH, 1983, INT J REMOTE SENS, V4, P273; Lawlor DW, 2002, PLANT CELL ENVIRON, V25, P275, DOI 10.1046/j.0016-8025.2001.00814.x; Brodribb TJ, 2003, PLANT PHYSIOL, V132, P2166, DOI 10.1104/pp.103.023879; Sun P, 2008, INT J REMOTE SENS, V29, P1725, DOI 10.1080/01431160701373754; Cheng YB, 2008, REMOTE SENS ENVIRON, V112, P363, DOI 10.1016/j.rse.2007.01.023; Jacquemoud S, 1996, REMOTE SENS ENVIRON, V56, P194, DOI 10.1016/0034-4257(95)00238-3; Gao BC, 1996, REMOTE SENS ENVIRON, V58, P257, DOI 10.1016/S0034-4257(96)00067-3; PENUELAS J, 1993, INT J REMOTE SENS, V14, P1887; McDowell N, 2008, NEW PHYTOL, V178, P719, DOI 10.1111/j.1469-8137.2008.02436.x; de Jong SM, 2014, INT J APPL EARTH OBS, V27, P128, DOI 10.1016/j.jag.2013.09.011; Ceccato P, 2002, REMOTE SENS ENVIRON, V82, P198, DOI 10.1016/S0034-4257(02)00036-6; Ceccato P, 2001, REMOTE SENS ENVIRON, V77, P22, DOI 10.1016/S0034-4257(01)00191-2; Serrano L, 2000, REMOTE SENS ENVIRON, V74, P570, DOI 10.1016/S0034-4257(00)00147-4; Wang Q, 2012, ECOL INDIC, V14, P56, DOI 10.1016/j.ecolind.2011.08.021; Sevanto S, 2014, PLANT CELL ENVIRON, V37, P153, DOI 10.1111/pce.12141; Sala A, 2010, NEW PHYTOL, V186, P274, DOI 10.1111/j.1469-8137.2009.03167.x; Seelig HD, 2008, INT J REMOTE SENS, V29, P3701, DOI 10.1080/01431160701772500; Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; DANSON FM, 1992, INT J REMOTE SENS, V13, P461; Sims DA, 2003, REMOTE SENS ENVIRON, V84, P526, DOI 10.1016/S0034-4257(02)00151-7; Augusti A, 2001, PHOTOSYNTH RES, V67, P79, DOI 10.1023/A:1010692632408; Foley S, 2006, REMOTE SENS ENVIRON, V103, P265, DOI 10.1016/j.rse.2005.06.014; HUNT ER, 1987, REMOTE SENS ENVIRON, V22, P429; Carter GA, 2001, AM J BOT, V88, P677, DOI 10.2307/2657068; Ceccato P, 2002, REMOTE SENS ENVIRON, V82, P188, DOI 10.1016/S0034-4257(02)00037-8; Penuelas J, 1997, INT J REMOTE SENS, V18, P2869, DOI 10.1080/014311697217396; Colombo R, 2008, REMOTE SENS ENVIRON, V112, P1820, DOI 10.1016/j.rse.2007.09.005; CARTER GA, 1993, AM J BOT, V80, P239, DOI 10.2307/2445346; Reddy AR, 2004, J PLANT PHYSIOL, V161, P1189, DOI 10.1016/j.jplph.2004.01.013; Cheng T, 2011, REMOTE SENS ENVIRON, V115, P659, DOI 10.1016/j.rse.2010.11.001; McDowell NG, 2013, NEW PHYTOL, V200, P304, DOI 10.1111/nph.12465; ROCK BN, 1988, REMOTE SENS ENVIRON, V24, P109, DOI 10.1016/0034-4257(88)90008-9; le Maire G, 2008, REMOTE SENS ENVIRON, V112, P3846, DOI 10.1016/j.rse.2008.06.005; CARTER GA, 1994, REMOTE SENS ENVIRON, V50, P295, DOI 10.1016/0034-4257(94)90079-5; Sarlikioti V, 2010, ANN APPL BIOL, V157, P81, DOI 10.1111/j.1744-7348.2010.00411.x; Zarco-Tejada PJ, 2003, REMOTE SENS ENVIRON, V85, P109, DOI 10.1016/S0034-4257(02)00197-9; CARTER GA, 1994, INT J REMOTE SENS, V15, P697; CARTER GA, 1991, AM J BOT, V78, P916, DOI 10.2307/2445170; Hardisky M.A., 1983, ISPRS J PHOTOGRAMM, V49, P77; JACQUEMOUD S, 1990, REMOTE SENS ENVIRON, V34, P75, DOI 10.1016/0034-4257(90)90100-Z; KNIPLING E B, 1970, Remote Sensing of Environment, V1, P155, DOI 10.1016/S0034-4257(70)80021-9; KOIKE T, 1986, Journal of the Japanese Forestry Society, V68, P425; Richardson AD, 2002, TREE PHYSIOL, V22, P499; Seelig HD, 2008, IRRIGATION SCI, V26, P407, DOI 10.1007/s00271-008-0105-4; Seelig HD, 2009, IRRIGATION SCI, V27, P357, DOI 10.1007/s00271-009-0152-5; Souza RP, 2004, ENVIRON EXP BOT, V51, P45, DOI 10.1016/S0098-8472(03)00059-5; TUCKER CJ, 1980, REMOTE SENS ENVIRON, V10, P23, DOI 10.1016/0034-4257(80)90096-6; Wang Q, 2012, HYDROL PROCESS, V26, P1230, DOI 10.1002/hyp.8221	51	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1470-160X	1872-7034		ECOL INDIC	Ecol. Indic.	JUL	2015	54						96	107		10.1016/j.ecolind.2015.02.027		12	Biodiversity Conservation; Environmental Sciences	Biodiversity & Conservation; Environmental Sciences & Ecology	CJ3EF	WOS:000355365500010		
J	Jin, PB; Li, PH; Wang, Q; Pu, Z				Jin, Pingbin; Li, Pingheng; Wang, Quan; Pu, Zhi			Developing and applying novel spectral feature parameters for classifying soil salt types in arid land	ECOLOGICAL INDICATORS			English	Article						Arid land; Soil salinity; Salt type; Hyperspectral; Feature parameter; Classification algorithm	RED-EDGE POSITION; BAND-DEPTH ANALYSIS; REFLECTANCE SPECTRA; LABORATORY EXPERIMENT; RIVER FLOODPLAINS; NEURAL NETWORKS; CLASSIFICATION; SALINITY; CONTAMINATION; VEGETATION	Soil salinization is a major desertification process that threatens especially the stability of arid ecosystems. There is an urgent need for intensive monitoring and quick assessment of salinization through remote sensing as a tool for combating desertification in such ecosystems. Recent researches have revealed that in order to retrieve soil salt contents accurately from hyperspectral reflectance, a pre-knowledge of salt types is required, which greatly outlines the spectral features of saline soil reflectance. In this study, a set of feature parameters have been developed after a thorough investigation of spectral responses to different soil salt types and salt contents for quick and accurate classification of soil salt types. The application has been validated using three independent datasets composed from: laboratory experiments (dataset I), insitu field measurements (dataset II), and satellite-borne Hyperion image (dataset III). For comparison, four other common classification algorithms have been validated using the same datasets. The results showed that the new approach proposed in this study performed well with not only single-type but also multipletype salts for which the four common algorithms performed rather fairly. Furthermore, validating using datasets II and III showed that the newly proposed approach had a stable performance while the other four failed, indicating the advantage of the new approach. The feature parameters developed in this study hence provide a novel and efficient approach for salt type classification from reflectance spectra, and we foresee its potential applications on large-scale soil salt type mapping towards better understanding soil salinity characterization from remote sensing data. (C) 2015 Elsevier Ltd. All rights reserved.	[Jin, Pingbin] Zhejiang Univ, Dept Geosci, Hangzhou 310027, Zhejiang, Peoples R China; [Li, Pingheng; Pu, Zhi] Chinese Acad Sci, Xinjiang Inst Ecol & Geog, Urumqi 830011, Peoples R China; [Wang, Quan] Shizuoka Univ, Grad Sch Agr, Shizuoka 4228529, Japan	Wang, Q (reprint author), Shizuoka Univ, Grad Sch Agr, Shizuoka 4228529, Japan.	aqwang@ipc.shizuoka.ac.jp	Wang, Quan/F-5424-2013	Wang, Quan/0000-0001-5483-0243	"973" Program [2012CB956204]; CAS [1074041001]; NSFC [41371364]	This study. was supported by the "973" Program (2012CB956204), the CAS project (grant no. 1074041001), and the NSFC project (No. 41371364).	le Maire G, 2004, REMOTE SENS ENVIRON, V89, P1, DOI 10.1016/j.rse.2003.09.004; Wang Q, 2012, GEODERMA, V170, P103, DOI 10.1016/j.geoderma.2011.10.015; Mutanga O, 2005, INT J REMOTE SENS, V26, P1093, DOI 10.1080/01431160512331326738; Farifteh J, 2006, GEODERMA, V130, P191, DOI 10.1016/j.geoderma.2005.02.003; Farifteh J, 2008, GEODERMA, V145, P196, DOI 10.1016/j.geoderma.2008.03.011; Goodenough DG, 2003, IEEE T GEOSCI REMOTE, V41, P1321, DOI 10.1109/TGRS.2003.813214; Clevers JGPW, 2004, INT J REMOTE SENS, V25, P3883, DOI 10.1080/01431160310001654473; Baranoski GVG, 2005, INT J REMOTE SENS, V26, P503, DOI 10.1080/01431160512331314029; Dawson TP, 1998, INT J REMOTE SENS, V19, P2133, DOI 10.1080/014311698214910; Ben-Dor E, 2006, GEODERMA, V131, P1, DOI 10.1016/j.geoderma.2005.02.011; Dematte JAM, 2006, GEODERMA, V135, P179, DOI 10.1016/j.geoderma.2005.12.002; Dehaan RL, 2002, REMOTE SENS ENVIRON, V80, P406, DOI 10.1016/S0034-4257(01)00321-2; Foody GM, 2002, REMOTE SENS ENVIRON, V80, P185, DOI 10.1016/S0034-4257(01)00295-4; Ben-Dor E, 2002, INT J REMOTE SENS, V23, P1043, DOI 10.1080/01431160010006962; Metternicht GI, 2003, REMOTE SENS ENVIRON, V85, P1, DOI 10.1016/S0034-4257(02)00188-8; Farifteh J, 2007, REMOTE SENS ENVIRON, V110, P59, DOI 10.1016/j.rse.2007.02.005; Curran PJ, 2001, REMOTE SENS ENVIRON, V76, P349, DOI 10.1016/S0034-4257(01)00182-1; Howari FM, 2002, J ENVIRON QUAL, V31, P1453; Kruse FA, 2003, IEEE T GEOSCI REMOTE, V41, P1388, DOI 10.1109/TGRS.2003.812908; Luo GP, 2003, SCI CHINA SER D, V46, P62, DOI 10.1360/03yd9006; [Anonymous], 1998, ACOUST SPEECH SIG PR; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Xu DQ, 2008, ADV SPACE RES, V41, P1800, DOI 10.1016/j.asr.2007.05.073; Kooistra L, 2004, ENVIRON POLLUT, V127, P281, DOI 10.1016/S0269-7491(03)00266-5; CONGALTON RG, 1991, REMOTE SENS ENVIRON, V37, P35, DOI 10.1016/0034-4257(91)90048-B; Dehaan R., 2003, INT J REMOTE SENS, V24, P1043; Denceux T, 2008, STUDIES FUZZINESS SO, V219, P737; FAO, 1988, FAO SOILS B, V39; Franco-Lopez H, 2001, REMOTE SENS ENVIRON, V77, P251, DOI 10.1016/S0034-4257(01)00209-7; Ghrefat HA, 2007, GEOMORPHOLOGY, V88, P57, DOI 10.1016/j.geomorph.2006.10.013; Hammerstrom D., 1993, IEEE SPECTRUM, V30, P46; Hill J, 2000, REMOTE SENS ENVIRON, V74, P557, DOI 10.1016/S0034-4257(00)00146-2; Hunt G. R., 1970, Modern Geology, V1; JIA XP, 1994, IEEE T GEOSCI REMOTE, V32, P274; Kokaly RF, 1999, REMOTE SENS ENVIRON, V67, P267, DOI 10.1016/S0034-4257(98)00084-4; Lobell DB, 2002, SOIL SCI SOC AM J, V66, P722; Mahmoud A.A., 2009, EUROPEAN J SCI RES, V26, P342; Masoudi M., 2006, Journal of Applied Sciences and Environmental Management, V10, P9; Mucherino A., 2009, OPERATIONAL RES, V9, P121; Nurnberger A., 2002, HDB DATA MINING KNOW, P304; Pu Z, 2010, THESIS CHINESE ACAD, P113; Richards J, 1993, REMOTE SENSING DIGIT; Richards LA, 1954, AGR HDB, V60; Taylor GR, 2001, INT GEOSCI REMOTE SE, P302, DOI 10.1109/IGARSS.2001.976138; Taylor G.R., 2004, P 12 AUSTR REM SENS; TAYLOR GR, 1994, P 1 INT REM SENS C E, V3, P504; Van der Meer F., 2004, INT J APPL EARTH OBS, V5, P55, DOI DOI 10.1016/J.JAG.2003.09.001; Vapnik V., 1998, STAT LEARNING THEORY; Wang Q, 2013, COMMUN SOIL SCI PLAN, V44, P1503, DOI 10.1080/00103624.2012.760574; Wang Q, 2012, IEEE T GEOSCI REMOTE, V50, P3950, DOI 10.1109/TGRS.2012.2187790; Wilkes AL, 1997, BRAIN COGNITION, V33, P295, DOI 10.1006/brcg.1997.0869	51	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1470-160X	1872-7034		ECOL INDIC	Ecol. Indic.	JUL	2015	54						116	123		10.1016/j.ecolind.2015.02.028		8	Biodiversity Conservation; Environmental Sciences	Biodiversity & Conservation; Environmental Sciences & Ecology	CJ3EF	WOS:000355365500012		
J	Yang, GF; Li, XN; Wang, JL; Lian, L; Ma, TJ				Yang, Guangfei; Li, Xianneng; Wang, Jianliang; Lian, Lian; Ma, Tieju			Modeling oil production based on symbolic regression	ENERGY POLICY			English	Article						Oil production; Hubbert theory; Symbolic regression	GLOBAL OIL; HUBBERT; PEAK; DISCOVERY; FORECAST	Numerous models have been proposed to forecast the future trends of oil production and almost all of them are based on some predefined assumptions with various uncertainties. In this study, we propose a novel data-driven approach that uses symbolic regression to model oil production. We validate our approach on both synthetic and real data, and the results prove that symbolic regression could effectively identify the true models beneath the oil production data and also make reliable predictions. Symbolic regression indicates that world oil production will peak in 2021, which broadly agrees with other techniques used by researchers. Our results also show that the rate of decline after the peak is almost half the rate of increase before the peak, and it takes nearly 12 years to drop 4% from the peak. These predictions are more optimistic than those in several other reports, and the smoother decline will provide the world, especially the developing countries, with more time to orchestrate mitigation plans. (c) 2015 Elsevier Ltd. All rights reserved.	[Yang, Guangfei] Dalian Univ Technol, Sch Management Sci & Engn, Dalian, Peoples R China; [Li, Xianneng] Waseda Univ, Grad Sch Informat Prod & Syst, Kitakyushu, Fukuoka, Japan; [Wang, Jianliang] China Univ Petr, Sch Business Adm, Beijing, Peoples R China; [Lian, Lian] Dalian Univ Technol, Sch Transportat & Logist, Dalian, Peoples R China; [Ma, Tieju] E China Univ Sci & Technol, Sch Business, Shanghai 200237, Peoples R China	Lian, L (reprint author), Dalian Univ Technol, Sch Transportat & Logist, Dalian, Peoples R China.	gfyang@dlut.edu.cn; xianneng.li@gmail.com; wangjianliang305@163.com; lian.lian@dlut.edu.cn; tjma@ecust.edu.cn			National Natural Science Foundation of China [71001016, 71031002, 71201016]	This work is supported by the National Natural Science Foundation of China (71001016, 71031002, and 71201016).	Sorrell S, 2010, ENERG POLICY, V38, P4990, DOI 10.1016/j.enpol.2010.04.020; Maggio G, 2009, ENERG POLICY, V37, P4761, DOI 10.1016/j.enpol.2009.06.053; Schmidt M, 2009, SCIENCE, V324, P81, DOI 10.1126/science.1165893; Can B, 2011, COMPUT IND ENG, V61, P447, DOI 10.1016/j.cie.2011.03.012; Aleklett K, 2010, ENERG POLICY, V38, P1398, DOI 10.1016/j.enpol.2009.11.021; Bentley RW, 2002, ENERG POLICY, V30, P189, DOI 10.1016/S0301-4215(01)00144-6; Kotanchek M, 2008, GEN EVOL COMP SER, P201, DOI 10.1007/978-0-387-76308-8_12; Khu ST, 2001, J AM WATER RESOUR AS, V37, P439, DOI 10.1111/j.1752-1688.2001.tb00980.x; Wang JL, 2013, ENERG POLICY, V57, P542, DOI 10.1016/j.enpol.2013.02.034; Bartlett AA, 2000, MATH GEOL, V32, P1, DOI 10.1023/A:1007587132700; Owen NA, 2010, ENERG POLICY, V38, P4743, DOI 10.1016/j.enpol.2010.02.026; Graham MJ, 2013, MON NOT R ASTRON SOC, V431, P2371, DOI 10.1093/mnras/stt329; Sahakyan AB, 2013, J PHYS CHEM B, V117, P1989, DOI 10.1021/jp3057306; Vladislavleva E, 2013, RENEW ENERG, V50, P236, DOI 10.1016/j.renene.2012.06.036; Hirsch RL, 2008, ENERG POLICY, V36, P881, DOI 10.1016/j.enpol.2007.11.009; Chapman I, 2014, ENERG POLICY, V64, P93, DOI 10.1016/j.enpol.2013.05.010; Brandt AR, 2007, ENERG POLICY, V35, P3074, DOI 10.1016/j.enpol.2006.11.004; Kotanchek ME, 2010, GEN EVOL COMP SER, P55, DOI 10.1007/978-1-4419-1626-6_4; Manson SM, 2005, AGR ECOSYST ENVIRON, V111, P47, DOI 10.1016/j.agee.2005.04.024; Wang JL, 2011, ENERG POLICY, V39, P7616, DOI 10.1016/j.enpol.2011.07.043; BOEM, 2014, BUR OC EN MAN BOEM D; Bongard J., 2007, P NATL ACAD SCI, V104; BP, 2013, BP STAT REV WORLD EN; Brandt AR, 2010, ENERGY, V35, P3958, DOI 10.1016/j.energy.2010.04.045; British Petroleum (BP), 2014, BP STAT REV WORLD EN; Campbell C.J., 1998, SCI AM, V278; China Electricity Council, 2011, RES REP DEV PLANN CH; Day D. T., 1909, AM REV REV, V39, P49; Deffeyes K.S., 2004, AGU FALL M, V1; EIA, 2013, DOEEIA04842013; Gates R., 2005, OIL SHOCKWAVE OIL CR; Han J., 2001, DATA MINING CONCEPTS; Hirsch R. L, 2005, ATL COUNC B, VXVI; Holland J. H., 1975, ADAPTATION NATURAL A; Hubbert M. K., 1956, M SO DISTR DIV PROD; Hubbert M. K., 1959, 44 ANN M AM ASS PETR, P43; HUBBERT M. K., 1982, NBS SPECIAL PUBLICAT, V631; IEA, 2012, WORLD EN OUTL 2012; IEA, 2013, WORLD EN OUTL 2013; International Energy Agency (LEA), 2010, WORLD ENERGY OUTLOOK; JainWorld.com, 2014, EL BLIND MEN; Jenkins Gilbert, 1986, OIL EC HDB; Kaufmann R. K., 1991, ENERGY, V13, P111; Kaufmann RK, 2001, ENERGY J, V22, P27; KEIJZER M, 2000, P EUROGP 2000 ED SCO, V1802, P76; Kontorovich AE, 2009, RUSS GEOL GEOPHYS+, V50, P237, DOI 10.1016/j.rgg.2009.03.001; Kotanchek M, 2007, GEN EVOL COMP SER, V4, P167, DOI 10.1007/978-0-387-49650-4_11; Koza J. R., 1992, GENETIC PROGRAMMING; Lin C., 2009, NATURAL RESOURCES RE, V18, P29, DOI 10.1007/s11053-008-9086-5; Martin B, 1995, HDB SCI TECHNOLOGY S, P506; MOHR S. H, 2008, NATURAL RESOURCES RE, V17, P1, DOI DOI 10.1007/S11053-008-9059-8; National People's Congress of People's Republic of China, 2011, 12 5 YEAR PLAN NAT E; OPEC, 2012, WORLD OIL OUTL 2012; Schindler J., 2008, CRUDE OIL SUPPLY OUT; Shell, 2011, SIGNALS SIGNPOSTS SH; Szklo A, 2007, ENERG POLICY, V35, P2360, DOI 10.1016/j.enpol.2006.08.014; Tao ZP, 2007, ENERG POLICY, V35, P2281, DOI 10.1016/j.enpol.2006.07.009; UKERC, 2009, 6 UKERC; Yang G, 2009, IEEJ T ELECTR ELECTR, V4, P248, DOI 10.1002/tee.20385; Yoshihara K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3612	60	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0301-4215	1873-6777		ENERG POLICY	Energy Policy	JUL	2015	82						48	61		10.1016/j.enpol.2015.02.016		14	Energy & Fuels; Environmental Sciences; Environmental Studies	Energy & Fuels; Environmental Sciences & Ecology	CJ3EX	WOS:000355367300005		
J	Kashcheeva, M; Tsui, KK				Kashcheeva, Mila; Tsui, Kevin K.			Political oil import diversification by financial and commercial traders	ENERGY POLICY			English	Article						International politics; Import diversification; Spot oil trading; Financial and commercial traders	WAR; EXPROPRIATION; MARKET; TRENDS; IMPACT; FIRMS; MODEL; RISK	International politics affects the oil trade. But do financial and commercial traders who participate in spot oil trading also respond to changes in international politics? We construct a firm-level dataset for all U.S. oil-importing companies over 1986-2008 to examine how these firms respond to increases in "political distance" between the U.S. and her trading partners, measured by divergence in their UN General Assembly voting patterns. Consistent with previous macro evidence, we first show that individual firms diversify their oil imports politically, even after controlling for unobserved firm heterogeneity. However, the political pattern of oil imports is not entirely driven by the concerns of hold-up risks, which exist when oil transactions via term contracts are associated with backward vertical FDI that is subject to expropriation. In particular, our results indicate that even financial and commercial traders significantly reduce their oil imports from U.S. political enemies. Interestingly, while these traders diversify their oil imports politically immediately after changes in international politics, other oil companies reduce their oil imports with a significant time lag. Our findings suggest that in designing regulations to avoid harmful repercussions on commodity and financial assets, policymakers need to understand the nature of political risk. (c) 2015 Elsevier Ltd. All rights reserved.	[Kashcheeva, Mila] JETRO, IDE, Mihama Ku, Chiba, Chiba 2618545, Japan; [Tsui, Kevin K.] Clemson Univ, John E Walker Dept Econ, Clemson, SC 29634 USA	Tsui, KK (reprint author), Clemson Univ, John E Walker Dept Econ, 228 Sirrine Hall, Clemson, SC 29634 USA.	Mila_Kashcheeva@ide.go.jp; ktsui@clemson.edu			IDE-JETRO	Support for this research was provided by IDE-JETRO. We thank seminar participants from the Hong Kong University of Science and Technology for helpful comments and discussions. All remaining errors are ours.	Acemoglu D, 2010, AM ECON REV, V100, P83, DOI 10.1257/aer.100.2.83; Adelman M. A., 1984, THE ENERGY JOURNAL, V5, P5; Cohen G, 2011, ENERG POLICY, V39, P4860, DOI 10.1016/j.enpol.2011.06.034; Levchenko AA, 2007, REV ECON STUD, V74, P791, DOI 10.1111/j.1467-937X.2007.00435.x; De Mesquita BB, 1999, AM POLIT SCI REV, V93, P791, DOI 10.2307/2586113; Dreher A, 2012, PUBLIC CHOICE, V151, P363, DOI 10.1007/s11127-010-9750-2; Dreher A, 2007, J LAW ECON, V50, P105, DOI 10.1086/508311; Jackson MO, 2007, AM ECON REV, V97, P1353, DOI 10.1257/aer.97.4.1353; Jensen NM, 2011, COMP POLIT STUD, V44, P662, DOI 10.1177/0010414011401208; Berger D, 2013, AM ECON REV, V103, P863, DOI 10.1257/aer.103.2.863; Hajzler C, 2012, REV WORLD ECON, V148, P119, DOI 10.1007/s10290-011-0103-0; Hamilton JD, 2009, ENERG J, V30, P179; Smith JL, 2009, J ECON PERSPECT, V23, P145, DOI 10.1257/jep.23.3.145; Alesina A, 2000, J ECON GROWTH, V5, P33, DOI 10.1023/A:1009874203400; Mitchener KJ, 2008, ECON J, V118, P1805, DOI 10.1111/j.1468-0297.2008.02192.x; THOMAS J, 1994, REV ECON STUD, V61, P81, DOI 10.2307/2297878; Blomberg SB, 2006, REV ECON STAT, V88, P599, DOI 10.1162/rest.88.4.599; Chester Edward W, 1983, US OIL DIPLOMACY 20; Findlay R, 2007, PRINC ECON HIST W WO, P1; Glick R, 2010, REV ECON STAT, V92, P102, DOI 10.1162/rest.2009.12023; Head Keith, 2010, J INT ECON, V81, P1; Jacks DS, 2011, J INT ECON, V83, P185, DOI 10.1016/j.jinteco.2010.10.008; KLEIN B, 1978, J LAW ECON, V21, P297, DOI 10.1086/466922; KOBRIN SJ, 1984, INT STUD QUART, V28, P329, DOI 10.2307/2600634; Leiby P, 2007, ORNLTM2007028; Loschel A, 2010, ENERG POLICY, V38, P1607, DOI 10.1016/j.enpol.2009.03.019; Michaels G, 2010, AM ECON J-APPL ECON, V2, P256, DOI 10.1257/app.2.3.256; Mityakov S, 2013, J LAW ECON, V56, P1091, DOI 10.1086/674132; Ruta Michele, 2012, ANNU REV RESOUR ECON, P4; Santos S., 2006, REV ECON STAT, V88, P641, DOI DOI 10.1162/REST.88.4.641; SUMMARY RM, 1989, REV ECON STAT, V71, P179, DOI 10.2307/1928068; WOLAK FA, 1991, AM ECON REV, V81, P514; Wolak FA, 1996, CONTRIB TO ECON ANAL, V234, P109	33	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0301-4215	1873-6777		ENERG POLICY	Energy Policy	JUL	2015	82						289	297		10.1016/j.enpol.2015.02.025		9	Energy & Fuels; Environmental Sciences; Environmental Studies	Energy & Fuels; Environmental Sciences & Ecology	CJ3EX	WOS:000355367300025		
J	Cronin, AL				Cronin, Adam L.			Individual and Group Personalities Characterise Consensus Decision-Making in an Ant	ETHOLOGY			English	Article						idiosyncrasy; consensus decision-making; house-hunting; formicidae; division of labour	MYRMECINA-NIPPONICA; COLLECTIVE BEHAVIOR; ANIMAL PERSONALITIES; PHEROMONE TRAILS; SOCIAL INSECTS; EVOLUTION; COLONIES; TASK; EXPERIENCE; SELECTION	Non-human animals can exhibit idiosyncratic behaviour across individuals in much in the same way as humans. Animals with specific personalities may have advantages in some environments, and this idiosyncrasy may thus be of considerable ecological and evolutionary importance. In group-living organisms, personality can occur at the level of the group as well as that of the individual. However, at present, we have very little understanding of the possible benefits of group-level personality, and how this is linked with individual personality. In this study, I examine the influence of individual and group personality during the process of colony migration in the Japanese ant, Myrmecina nipponica. These ants use a consensus decision process to decide among alternatives when searching for a new home. Individuals contribute to this process by scouting for new nest sites, recruiting nestmates by laying pheromone trails, and carrying brood to the new site, although whether these roles are consistent among individuals and how roles are distributed within and between colonies remain unclear. Individual contributions to the nest-site selection process were quantified over five repeated relocations in five colonies. Results demonstrate that contributions to the relocation effort were highly skewed within the colonies and that individuals were consistent in their contributions over repeated relocation events. Furthermore, the distribution of effort differed between colonies, indicating that intercolony differences in composition of behavioural types resulted in colony-level personality. While these differences did not lead to any detectable difference in relocation performance between colonies in the simple experimental arrangement used, colony personality could influence decision outcomes in more complex environments.	Iwate Univ, United Grad Sch Agr Sci, Morioka, Iwate 0208550, Japan	Cronin, AL (reprint author), Iwate Univ, United Grad Sch Agr Sci, 3-18-8 Ueda, Morioka, Iwate 0208550, Japan.	adamcronin@gmail.com			United Graduate School of Agriculture Iwate University;  [25440187]	I am grateful to Ayuka Nishimura, Honami Oohashi, Erica Saka, Chihiro Shimomura, Misako Takahashi and Sayaka Tonosaki for help with video analysis, and several anonymous referees for comments on this and an earlier version of the manuscript. This work was supported by funds from the United Graduate School of Agriculture Iwate University, and grant-in-aid for Scientific Research JSPS KAKENHI # 25440187 to ALC. The author declares no conflict of interest.	Conradt L, 2003, NATURE, V421, P155, DOI 10.1038/nature01294; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Kendall MG, 1939, ANN MATH STAT, V10, P275, DOI 10.1214/aoms/1177732186; Cote J, 2010, PHILOS T R SOC B, V365, P4065, DOI 10.1098/rstb.2010.0176; Stroeymeyt N, 2011, J EXP BIOL, V214, P3046, DOI 10.1242/jeb.059188; Modlmeier AP, 2014, BEHAV ECOL SOCIOBIOL, V68, P1929, DOI 10.1007/s00265-014-1799-3; Gardner A, 2009, J EVOLUTION BIOL, V22, P659, DOI 10.1111/j.1420-9101.2008.01681.x; Gordon DM, 1996, NATURE, V380, P121, DOI 10.1038/380121a0; Brown C, 2014, BEHAV ECOL, V25, P95, DOI 10.1093/beheco/art090; Sumpter DJT, 2009, PHILOS T R SOC B, V364, P743, DOI 10.1098/rstb.2008.0204; Sasaki T, 2013, P NATL ACAD SCI USA, V110, P13769, DOI 10.1073/pnas.1304917110; Pratt SC, 2005, BEHAV ECOL, V16, P488, DOI 10.1093/beheco/ari020; Hui A, 2014, ANIM BEHAV, V93, P261, DOI 10.1016/j.anbehav.2014.05.006; Conradt L, 2009, PHILOS T R SOC B, V364, P807, DOI 10.1098/rstb.2008.0257; Pruitt JN, 2014, ANIM BEHAV, V93, P87, DOI 10.1016/j.anbehav.2014.04.017; Modlmeier AP, 2012, P ROY SOC B-BIOL SCI, V279, P2142, DOI 10.1098/rspb.2011.2376; Reale D, 2010, PHILOS T R SOC B, V365, P3937, DOI 10.1098/rstb.2010.0222; [Anonymous], 2009, BEHAV ECOL, DOI DOI 10.1093/BEHECO/ARN129; Nonacs P, 2000, AM NAT, V156, P577, DOI 10.1086/316995; Johnstone RA, 2011, P NATL ACAD SCI USA, V108, P8373, DOI 10.1073/pnas.1102191108; Dyer JRG, 2008, ANIM BEHAV, V75, P461, DOI 10.1016/j.anbehav.2007.05.010; Pinter-Wollman N, 2012, BEHAV ECOL SOCIOBIOL, V66, P1407, DOI 10.1007/s00265-012-1396-2; Dussutour A, 2008, ANIM BEHAV, V76, P5, DOI 10.1016/j.anbehav.2007.12.009; Simons AM, 2004, TRENDS ECOL EVOL, V19, P453, DOI 10.1016/j.tree.2004.07.001; Bode NWF, 2012, BEHAV ECOL SOCIOBIOL, V66, P835, DOI 10.1007/s00265-012-1331-6; Wolf M, 2012, TRENDS ECOL EVOL, V27, P452, DOI 10.1016/j.tree.2012.05.001; BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289; Pruitt JN, 2011, P ROY SOC B-BIOL SCI, V278, P1209, DOI 10.1098/rspb.2010.1700; Couzin ID, 2002, J THEOR BIOL, V218, P1, DOI 10.1006/yjtbi.3065; Conradt L, 2009, AM NAT, V173, P304, DOI 10.1086/596532; Ravary F, 2007, CURR BIOL, V17, P1308, DOI 10.1016/j.cub.2007.06.047; Dall SRX, 2012, ECOL LETT, V15, P1189, DOI 10.1111/j.1461-0248.2012.01846.x; Wolf M, 2007, NATURE, V447, P581, DOI 10.1038/nature05835; Jandt JM, 2014, BIOL REV, V89, P48, DOI 10.1111/brv.12042; Dingemanse NJ, 2007, J ANIM ECOL, V76, P1128, DOI 10.1111/j.1365-2656.2007.01284.x; Jeanson R, 2014, BIOL REV, V89, P671, DOI 10.1111/brv.12074; Keiser CN, 2014, BEHAV ECOL SOCIOBIOL, V68, P839, DOI 10.1007/s00265-014-1696-9; Visscher PK, 2007, ANNU REV ENTOMOL, V52, P255, DOI 10.1146/annurev.ento.51.110104.151025; Bengston S., 2014, FRONT ECOL EVOL, V2, P81, DOI DOI 10.3389/FEV0.2014.00081; Bengston S. E., 2014, P ROY SOC LOND B BIO, V281; Bouchet DC, 2013, ECOL ENTOMOL, V38, P408, DOI 10.1111/een.12033; Bourke A, 1995, SOCIAL EVOLUTION ANT; Budaev S., 2011, FISH COGNITION BEHAV, P472; Camazine S., 2001, SELF ORG BIOL SYSTEM; Conradt L, 2007, P R SOC B, V274, P2317, DOI 10.1098/rspb.2007.0186; Cronin AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064668; Cronin A. L., 2014, J R SOC INTERFACE, V6; Cronin AL, 2014, ANIM COGN, V17, P1261, DOI 10.1007/s10071-014-0758-8; Cronin AL, 2013, BEHAV ECOL SOCIOBIOL, V67, P1643, DOI 10.1007/s00265-013-1575-9; Cronin AL, 2012, ANIM BEHAV, V84, P1243, DOI 10.1016/j.anbehav.2012.08.036; Dingemanse N. J., 2010, ANIMAL PERSONALITIES, P520; Hodgkin LK, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1700; Holldobler B., 1990, ANTS; Kao A. B., 2014, P ROY SOC LOND B BIO, V282; Langridge EA, 2004, BEHAV ECOL SOCIOBIOL, V56, P523, DOI 10.1007/s00265-004-0824-3; Miyazaki S, 2005, SOCIOBIOLOGY, V46, P363; Modlmeier AP, 2014, ANIM BEHAV, V89, P53, DOI 10.1016/j.anbehav.2013.12.020; Murakami T, 2000, ECOL ENTOMOL, V25, P341, DOI 10.1046/j.1365-2311.2000.00254.x; Nettle D, 2010, PHILOS T R SOC B, V365, P4043, DOI 10.1098/rstb.2010.0061; Pinter-Wollman N, 2012, CURR ZOOL, V58, P580; Planas-Sitja I, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2515; Pratt SC, 2010, ENCY ANIMAL BEHAV, V2, P534, DOI DOI 10.1016/B978-0-08-045337-8.00127-3); R Core Team, 2013, R LANG ENV STAT COMP; Robson SK, 1999, INFORMATION PROCESSING IN SOCIAL INSECTS, P239; SEELEY TD, 1982, BEHAV ECOL SOCIOBIOL, V11, P287, DOI 10.1007/BF00299306; Sumana A, 2013, BEHAV PROCESS, V97, P84, DOI 10.1016/j.beproc.2013.03.006; Sumpter DJT, 2010, COLLECTIVE ANIMAL BEHAVIOR, P1; Tripet F, 2004, ETHOLOGY, V110, P863, DOI 10.1111/j.1439-0310.2004.01023.x; WILSON DS, 1975, P NATL ACAD SCI USA, V72, P143, DOI 10.1073/pnas.72.1.143; Wilson EO, 1971, INSECT SOC, P548	70	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0179-1613	1439-0310		ETHOLOGY	Ethology	JUL	2015	121	7					703	713		10.1111/eth.12386		11	Psychology, Biological; Behavioral Sciences; Zoology	Psychology; Behavioral Sciences; Zoology	CJ9XP	WOS:000355857300008		
J	Sakamoto, A; Naito, H; Chow, CM				Sakamoto, Akihiro; Naito, Hisashi; Chow, Chin Moi			Hyperventilation-induced respiratory alkalosis falls short of countering fatigue during repeated maximal isokinetic contractions	EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY			English	Article						Hypocapnia; Peak torque; EMG amplitude; Setchenov phenomenon; Recovery	RESISTANCE EXERCISE PERFORMANCE; SODIUM-BICARBONATE INGESTION; INDUCED METABOLIC ALKALOSIS; INTENSE EXERCISE; VOLUNTARY HYPERVENTILATION; INCREASED EXCITABILITY; SPRINT PERFORMANCE; MUSCLE FATIGUE; BLOOD LACTATE; PH	Hyperventilation, implemented during recovery of repeated maximal sprints, has been shown to attenuate performance decrement. This study evaluated the effects of hyperventilation, using strength exercises, on muscle torque output and EMG amplitude. Fifteen power-trained athletes underwent maximal isokinetic knee extensions consisting of 12 repetitions x 8 sets at 60A degrees/s and 25 repetitions x 8 sets at 300A degrees/s. The inter-set interval was 40 s for both speeds. For the control condition, subjects breathed spontaneously during the interval period. For the hyperventilation condition, subjects hyperventilated for 30 s before each exercise set (50 breaths/min, PETCO2: 20-25 mmHg). EMG was recorded from the vastus medialis and lateralis muscles to calculate the mean amplitude for each contraction. Hyperventilation increased blood pH by 0.065-0.081 and lowered PCO2 by 8.3-10.3 mmHg from the control values (P < 0.001). Peak torque declined with repetition and set numbers for both speeds (P < 0.001), but the declining patterns were similar between conditions. A significant, but small enhancement in peak torque was observed with hyperventilation at 60A degrees/s during the initial repetition phase of the first (P = 0.032) and fourth sets (P = 0.040). EMG amplitude also declined with set number (P < 0.001) for both speeds and muscles, which was, however, not attenuated by hyperventilation. Despite a minor ergogenic effect in peak torque at 60A degrees/s, hyperventilation was not effective in attenuating the decrement in torque output at 300A degrees/s and decrement in EMG amplitude at both speeds during repeated sets of maximal isokinetic knee extensions.	[Sakamoto, Akihiro; Naito, Hisashi] Juntendo Univ, Inst Hlth & Sports Sci & Med, Chiba 2701695, Japan; [Chow, Chin Moi] Univ Sydney, Discipline Exercise & Sport Sci, Fac Hlth Sci, Lidcombe, NSW 2141, Australia	Sakamoto, A (reprint author), Juntendo Univ, Inst Hlth & Sports Sci & Med, 1-1 Hiraga Gakuendai, Chiba 2701695, Japan.	s_akihiro@hotmail.com; hnaitou@juntendo.ac.jp	Naito, Hisashi/F-5655-2011		Juntendo University, Institute of Health and Sports Science and Medicine [k1212]; JSPS KAKENHI [25750333]	This study was supported by Juntendo University, Institute of Health and Sports Science and Medicine (k1212), and by JSPS KAKENHI Grant Number 25750333. We would like to thank all the subjects for their participation and effort. We also thank the laboratory members at Juntendo University, Graduate School of Health and Sports Science for their assistance in data collection.	Sparing R, 2007, J APPL PHYSIOL, V102, P406, DOI 10.1152/japplphysiol.00770.2006; Bishop D, 2005, MED SCI SPORT EXER, V37, P759, DOI 10.1249/01.MSS.0000161803.44656.3C; MACEFIELD G, 1991, BRAIN, V114, P527, DOI 10.1093/brain/114.1.527; DAVIES SF, 1986, J APPL PHYSIOL, V61, P948; Seyal M, 1998, ELECTROMYOGR MOTOR C, V109, P263, DOI 10.1016/S0924-980X(98)00022-8; McMahon S, 2002, SPORTS MED, V32, P761, DOI 10.2165/00007256-200232120-00002; Nybo L, 2007, EXERC SPORT SCI REV, V35, P110, DOI 10.1097/jes.0b013e3180a031ec; MCCARTNEY N, 1986, J APPL PHYSIOL, V60, P1164; SAHLIN K, 1979, SCAND J CLIN LAB INV, V39, P551, DOI 10.3109/00365517909108833; Bishop D, 2004, MED SCI SPORT EXER, V36, P807, DOI 10.1249/01.MSS.0000126392.20025.17; Carr BM, 2013, EUR J APPL PHYSIOL, V113, P743, DOI 10.1007/s00421-012-2484-8; Rainoldi A, 2000, J ELECTROMYOGR KINES, V10, P327, DOI 10.1016/S1050-6411(00)00024-9; Nordlund MM, 2004, J APPL PHYSIOL, V96, P218, DOI 10.1152/japplphysiol.00650.2003; Green HJ, 1997, J SPORT SCI, V15, P247, DOI 10.1080/026404197367254; ASMUSSEN E, 1979, MED SCI SPORT EXER, V11, P313; Chin LMK, 2007, J PHYSIOL-LONDON, V583, P351, DOI 10.1113/jphysiol.2007.132837; DRUML W, 1991, CRIT CARE MED, V19, P1120, DOI 10.1097/00003246-199109000-00005; DUARTE J, 1995, J NEUROIMAGING, V5, P209; Forbes SC, 2007, J APPL PHYSIOL, V102, P1565, DOI 10.1152/japplphysiol.00895.2006; FUCHS F, 1970, BIOCHIM BIOPHYS ACTA, V221, P407, DOI 10.1016/0005-2795(70)90290-4; Hilbert M, 2012, J APPL PHYSIOL, V112, P571, DOI 10.1152/japplphysiol.00869.2010; Jubeau M, 2010, Scand J Med Sci Sports, V20, pe56, DOI 10.1111/j.1600-0838.2009.00897.x; KATZ RL, 1964, ANESTHESIOLOGY, V25, P781, DOI 10.1097/00000542-196411000-00009; Kawakami Y, 2000, J APPL PHYSIOL, V88, P1969; KOZAKCOLLINS K, 1994, MED SCI SPORT EXER, V26, P1510; Lavender G, 1989, Br J Sports Med, V23, P41; LINDINGER MI, 1990, CAN J PHYSIOL PHARM, V68, P820; MACLAREN DPM, 1989, EXERCISE SPORT SCI R, V17, P29; Marx JO, 2002, EUR J APPL PHYSIOL, V87, P72, DOI 10.1007/s00421-002-0591-7; MCCARTNEY N, 1983, J APPL PHYSIOL, V55, P225; McNaughton L, 1999, EUR J APPL PHYSIOL O, V80, P333, DOI 10.1007/s004210050600; MORROW JA, 1988, EUR J APPL PHYSIOL O, V58, P175, DOI 10.1007/BF00636623; NAKAMARU Y, 1970, BIOCHEM BIOPH RES CO, V41, P830, DOI 10.1016/0006-291X(70)90157-9; ORCHARDSON R, 1978, J PHYSIOL-LONDON, V275, P177; Portington KJ, 1998, MED SCI SPORT EXER, V30, P523, DOI 10.1097/00005768-199804000-00009; Sakamoto A, 2014, J STRENGTH COND RES, V28, P1119, DOI 10.1519/JSC.0b013e3182a1fe5c; Sakamoto A, 2012, EUR J APPL PHYSIOL, V112, P1015, DOI 10.1007/s00421-011-2059-0; UI M, 1966, BIOCHIM BIOPHYS ACTA, V124, P310, DOI 10.1016/0304-4165(66)90194-2; Walsh ML, 2006, APPL PHYSIOL NUTR ME, V31, P211, DOI 10.1139/H05-025; WEBSTER MJ, 1993, MED SCI SPORT EXER, V25, P960	40	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1439-6319	1439-6327		EUR J APPL PHYSIOL	Eur. J. Appl. Physiol.	JUL	2015	115	7					1453	1465		10.1007/s00421-015-3134-8		13	Physiology; Sport Sciences	Physiology; Sport Sciences	CK0CP	WOS:000355872200006		
J	Halievski, K; Henley, CL; Domino, L; Poort, JE; Fu, M; Katsuno, M; Adachi, H; Sobue, G; Breedlove, SM; Jordan, CL				Halievski, Katherine; Henley, Casey L.; Domino, Laurel; Poort, Jessica E.; Fu, Martina; Katsuno, Masahisa; Adachi, Hiroaki; Sobue, Gen; Breedlove, S. Marc; Jordan, Cynthia L.			Androgen-dependent loss of muscle BDNF mRNA in two mouse models of SBMA	EXPERIMENTAL NEUROLOGY			English	Article						Motoneuron disease; Neuromuscular disease; Neurodegenerative disease; Neurotrophic factor; Neurotrophin	BULBAR MUSCULAR-ATROPHY; AMYOTROPHIC-LATERAL-SCLEROSIS; MOTOR-NEURON DISEASE; NEUROTROPHIC FACTOR; RECEPTOR GENE; DIFFERENTIAL-DIAGNOSIS; SIGNALING PATHWAYS; KENNEDY DISEASE; WILD-TYPE; KINASE-B	Transgenic expression of neurotrophic factors in skeletal muscle has been found to protect mice from neuromuscular disease, including spinal bulbar muscular atrophy (SBMA), triggering renewed interest in neurotrophic factors as therapeutic agents for treating neuromuscular disease. Because SBMA is an androgen-dependent disease, and brain-derived neurotrophic factor (BDNF) mediates effects of androgens on neuromuscular systems, we asked whether BDNF expression is impaired in two different transgenic (Tg) mouse models of SBMA, the so called "97Q' and "myogenic" SBMA models. The 97Q model globally overexpresses a full length human AR with 97 glutamine repeats whereas the myogenic model of SBMA overexpresses a wild-type rat androgen receptor (AR) only in skeletal muscle fibers. Using quantitative PCR, we find that muscle BDNF mRNA declines in an androgen-dependent manner in both models, paralleling changes in motor function, with robust deficits (6-8 fold) in both fast and slow twitch muscles of impaired Tg males. Castration rescues or reverses disease-related deficits in muscle BDNF mRNA in both models, paralleling its effect on motor function. Moreover, when disease is acutely induced in Tg females, both motor function and muscle BDNF mRNA expression plummet, with the deficit in muscle BDNF emerging before overt motor dysfunction. That androgen-dependent motor dysfunction is tightly associated with a robust and early down-regulation of muscle BDNF mRNA suggests that BDNF delivered to skeletal muscle may have therapeutic value for SBMA. (C) 2015 Elsevier Inc. All rights reserved.	[Halievski, Katherine; Henley, Casey L.; Domino, Laurel; Poort, Jessica E.; Fu, Martina; Breedlove, S. Marc; Jordan, Cynthia L.] Michigan State Univ, Neurosci Program, E Lansing, MI 48824 USA; [Katsuno, Masahisa; Sobue, Gen] Nagoya Univ, Grad Sch Med, Dept Neurol, Showa Ku, Nagoya, Aichi 4668550, Japan; [Adachi, Hiroaki] Univ Occupat & Environm Hlth, Sch Med, Dept Neurol, Yahatanishi Ku, Kitakyushu, Fukuoka 8078555, Japan	Halievski, K (reprint author), Michigan State Univ, Neurosci Program, 293 Farm Lane,108 Giltner, E Lansing, MI 48824 USA.	halievsk@msu.edu	Adachi, Hiroaki/I-2669-2012	Adachi, Hiroaki/0000-0002-9302-4663	NIH [NS045195]; NSERC [PGS-M-382108]	This work was supported by NIH NS045195 (CLJ) and NSERC PGS-M-382108 (KH).	Park H, 2013, NAT REV NEUROSCI, V14, P7, DOI 10.1038/nrn3379; Kemp MQ, 2011, HUM MOL GENET, V20, P4475, DOI 10.1093/hmg/ddr380; Nedelsky NB, 2010, NEURON, V67, P936, DOI 10.1016/j.neuron.2010.08.034; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Clow C, 2010, MOL BIOL CELL, V21, P2182, DOI 10.1091/mbc.E10-02-0154; Aid T, 2007, J NEUROSCI RES, V85, P525, DOI 10.1002/jnr.21139; Monks DA, 2007, P NATL ACAD SCI USA, V104, P18259, DOI 10.1073/pnas.0705501104; Kulakowski SA, 2011, J APPL PHYSIOL, V111, P844, DOI 10.1152/japplphysiol.00070.2011; Cortes CJ, 2014, NEURON, V82, P295, DOI 10.1016/j.neuron.2014.03.001; Yu Z, 2006, J CLIN INVEST, V116, P2663, DOI 10.1172/JCI28773; Gomez-Pinilla F, 2002, J NEUROPHYSIOL, V88, P2187, DOI 10.1152/jn.00152.2002; Johansen JA, 2009, NEUROBIOL DIS, V34, P113, DOI 10.1016/j.nbd.2008.12.009; Gonzalez M, 1999, NEURON, V24, P567, DOI 10.1016/S0896-6273(00)81113-7; Chevalier-Larsen ES, 2004, J NEUROSCI, V24, P4778, DOI 10.1523/JNEUROSCI.0808-04.2004; Chahin N, 2009, MUSCLE NERVE, V40, P126, DOI 10.1002/mus.21310; MITSUMOTO H, 1994, SCIENCE, V265, P1107, DOI 10.1126/science.8066451; KENNEDY WR, 1968, NEUROLOGY, V18, P671; Sopher BL, 2004, NEURON, V41, P687, DOI 10.1016/S0896-6273(04)00082-0; Katsuno M, 2002, NEURON, V35, P843, DOI 10.1016/S0896-6273(02)00834-6; Verhovshek T, 2010, ENDOCRINOLOGY, V151, P253, DOI 10.1210/en.2009-1036; Lieberman AP, 2014, CELL REP, V7, P774, DOI 10.1016/j.celrep.2014.02.008; SOHRABJI F, 1995, P NATL ACAD SCI USA, V92, P11110, DOI 10.1073/pnas.92.24.11110; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Palazzolo I, 2009, NEURON, V63, P316, DOI 10.1016/j.neuron.2009.07.019; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; LOHOF AM, 1993, NATURE, V363, P350, DOI 10.1038/363350a0; Bosco DA, 2010, NAT NEUROSCI, V13, P1396, DOI 10.1038/nn.2660; KOLIATSOS VE, 1993, NEURON, V10, P359, DOI 10.1016/0896-6273(93)90326-M; FERLINI A, 1995, AM J MED GENET, V55, P105, DOI 10.1002/ajmg.1320550125; Garcia N, 2010, J PERIPHER NERV SYST, V15, P40, DOI 10.1111/j.1529-8027.2010.00250.x; JOBSIS GJ, 1995, J NEUROL SCI, V129, P56, DOI 10.1016/0022-510X(95)00064-9; Johansen JA, 2011, NEURODEGENER DIS, V8, P25, DOI 10.1159/000313682; Kinirons P, 2008, J NEUROL NEUROSUR PS, V79, P106, DOI 10.1136/jnnp.2006.101899; Korkmaz OT, 2014, NEUROSCI LETT, V566, P286, DOI 10.1016/j.neulet.2014.02.058; Kust BM, 2002, EXP NEUROL, V177, P419, DOI 10.1006/exnr.2002.8011; LASPADA AR, 1991, NATURE, V352, P77; Mariotti C, 2000, NEUROMUSCULAR DISORD, V10, P391, DOI 10.1016/S0960-8966(99)00132-7; Mo KG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012922; Osborne MC, 2007, J NEUROSCI RES, V85, P303, DOI 10.1002/jnr.21122; Ottem EN, 2007, ENDOCRINOLOGY, V148, P3655, DOI 10.1210/en.2007-0308; Ottem EN, 2013, NEUROSCIENCE, V239, P124, DOI 10.1016/j.neuroscience.2012.12.019; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pitts Elizabeth Vernon, 2006, Int Anesthesiol Clin, V44, P21, DOI 10.1097/00004311-200604420-00004; Renier KJ, 2014, ENDOCRINOLOGY, V155, P2624, DOI 10.1210/en.2013-1756; Sagot Y, 1998, J NEUROSCI, V18, P1132; Stoop R, 1996, J NEUROSCI, V16, P3256; Verhovshek T, 2013, NEUROSCIENCE, V239, P103, DOI 10.1016/j.neuroscience.2012.10.028; Yamamoto M, 1999, NEUROCHEM RES, V24, P785, DOI 10.1023/A:1020739831778	48	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	JUL	2015	269						224	232		10.1016/j.expneurol.2015.04.013		9	Neurosciences	Neurosciences & Neurology	CJ6YH	WOS:000355640600020		
J	Ikeda, H; Ikegami, M; Kai, M; Kamei, J				Ikeda, Hiroko; Ikegami, Megumi; Kai, Misa; Kamei, Junzo			Cannabinoid functions in the amygdala contribute to conditioned fear memory in streptozotocin-induced diabetic mice: Interaction with glutamatergic functions	EXPERIMENTAL NEUROLOGY			English	Article						Cannabinoid; Fear memory; Diabetes; Glutamatergic neurons; Amygdala; Mice	SYNAPTIC-TRANSMISSION; CB2 RECEPTORS; DEPRESSION; ANXIETY; HIPPOCAMPAL; ACTIVATION; ADULTS; BRAIN; 2-ARACHIDONOYLGLYCEROL; PREVALENCE	The role of cannabinoid systems in conditioned fear memory was investigated in streptozotocin (STZ)-induced diabetic mice. The cannabinoid receptor agonist WIN-55,212-2 (1 mg/kg, i.p.), when injected into normal mice after conditioning, significantly prolonged the duration of freezing behavior. This effect was significantly inhibited by the cannabinoid CB1 receptor antagonist AM 251 (3 mg/kg, s.c.), but not by the cannabinoid CB2 receptor antagonist AM 630 (1 mg/kg, s.c.). The duration of freezing in STZ-induced diabetic mice was significantly longer than that in non-diabetic mice. The injection of WIN-55,212-2 (1 mg/kg, i.p.) after conditioning significantly prolonged the duration of freezing in non-diabetic mice, but not in STZ-induced diabetic mice. In contrast, the injection of AM 251 (3 mg/kg, s.c.) after conditioning significantly shortened the duration of freezing in STZ-induced diabetic mice, but not in non-diabetic mice. The injection of AM 251 (3 mg/kg, s.c.) before conditioning or before testing did not significantly affect the duration of freezing in STZ-induced diabetic mice. The protein levels of cannabinoid CB1 receptors in the amygdala were increased in STZ-induced diabetic mice. In contrast, the protein levels of cannabinoid CB2 receptors and diacylglycerol lipase et, the enzyme that synthesizes endocannabinoid 2-arachidonoylglycerol, in the amygdala did not differ between non-diabetic and STZ-induced diabetic mice. None of these proteins in the hippocampus was different between non-diabetic and STZ-induced diabetic mice. The injection of AM 251 (50 ng/side) into the basolateral amygdala significantly inhibited the duration of freezing in STZ-induced diabetic mice. Since endocannabinoid is controlled by glutamatergic function, we further examined the role of glutamatergic function in the increased fear memory in STZ-induced diabetic mice. The amounts of glutamine and glutamic acid in the amygdala of STZ-induced diabetic mice were significantly increased compared to those in non-diabetic mice. The AMPA receptor antagonist NBQX (40 ng/side), when injected into the basolateral amygdala, significantly inhibited the duration of freezing in STZ-induced diabetic mice. Finally, AMPA (40 ng, icy.) significantly prolonged the duration of freezing in normal mice, and this effect was inhibited by AM 251 (3 mg/kg, s.c.). These results suggest that cannabinoid functions in the amygdala are increased in diabetic mice and that enhanced glutamatergic function in the amygdala of diabetic mice activates the endocannabinoid system, which enhances fear memory via cannabinoid CB, receptors. (C) 2015 Elsevier Inc. All rights reserved.	[Ikeda, Hiroko; Ikegami, Megumi; Kai, Misa; Kamei, Junzo] Hoshi Univ, Sch Pharm & Pharmaceut Sci, Dept Pathophysiol & Therapeut, Shinagawa Ku, Tokyo 1428501, Japan	Kamei, J (reprint author), Hoshi Univ, Sch Pharm & Pharmaceut Sci, Dept Pathophysiol & Therapeut, Shinagawa Ku, 2-4-41 Ebara, Tokyo 1428501, Japan.	kamei@hoshi.ac.jp			JSPS KAKENHI [26430024, 26860174]; Hoshi University Ohtani Research Grants; MEXT	We thank Ayaka Isono, Shihou Ogata, Yuko Kamiyama, Yui Kohama, Hiroyuki Furuya, Kaori Ito, Shu Ushiyama, Yuta Katsuta, Shota Suzuki, Chiaki Hasegawa, Daiki Bessho, Yuki Mishina, Yusuke Sone, Sao Yanagimoto, Kayo Yonemoto, Yu Harada and Waka Takada for their technical assistances. This study was supported by JSPS KAKENHI grant numbers 26430024 (HI) and 26860174 (MI), Hoshi University Ohtani Research Grants (HI), and MEXT-supported Program for the Strategic Research Foundation at Private Universities, 2008-2012 (JK) and 2014-2018 (HI, JK). The authors declare no financial conflict of interest.	Katona I, 2008, NAT MED, V14, P923, DOI 10.1038/nm.f.1869; Ikeda H, 2013, NEUROSCIENCE, V241, P126, DOI 10.1016/j.neuroscience.2013.03.023; Pettit DAD, 1998, J NEUROSCI RES, V51, P391; Garcia-Gutierrez MS, 2012, BRIT J PHARMACOL, V165, P951, DOI 10.1111/j.1476-5381.2011.01625.x; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; Hermanson DJ, 2013, NAT NEUROSCI, V16, P1291, DOI 10.1038/nn.3480; Sugiura T, 2006, PROG LIPID RES, V45, P405, DOI 10.1016/j.plipres.2006.03.003; Degroot A, 2006, MOL PHARMACOL, V70, P1236, DOI 10.1124/mol.106.024661; GAVARD JA, 1993, DIABETES CARE, V16, P1167, DOI 10.2337/diacare.16.8.1167; Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069; Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934; Mahan AL, 2012, TRENDS NEUROSCI, V35, P24, DOI 10.1016/j.tins.2011.06.007; Miyata S, 2004, NEUROPSYCHOPHARMACOL, V29, P461, DOI 10.1038/sj.npp.1300354; Ramikie TS, 2012, NEUROSCIENCE, V204, P38, DOI 10.1016/j.neuroscience.2011.08.037; Ohno-Shosaku T, 2001, NEURON, V29, P729, DOI 10.1016/S0896-6273(01)00247-1; Maren S, 2013, NAT REV NEUROSCI, V14, P417, DOI 10.1038/nrn3492; Katona I, 2001, J NEUROSCI, V21, P9506; Rubino T, 2008, NEUROPHARMACOLOGY, V54, P151, DOI 10.1016/j.neuropharm.2007.06.024; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Champaneri S, 2010, CURR DIABETES REP, V10, P396, DOI 10.1007/s11892-010-0148-9; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Tan HB, 2011, J NEUROSCI, V31, P5300, DOI 10.1523/JNEUROSCI.4718-10.2011; Murray RM, 2007, NAT REV NEUROSCI, V8, P885, DOI 10.1038/nrn2253; Ruehle S, 2012, J PSYCHOPHARMACOL, V26, P23, DOI 10.1177/0269881111408958; Lazary J, 2011, TRENDS PHARMACOL SCI, V32, P270, DOI 10.1016/j.tips.2011.02.013; Clapper JR, 2010, NAT NEUROSCI, V13, P1265, DOI 10.1038/nn.2632; Rey AA, 2012, NEUROPSYCHOPHARMACOL, V37, P2624, DOI 10.1038/npp.2012.123; Alijanpour S, 2013, NEUROSCIENCE, V245, P61, DOI 10.1016/j.neuroscience.2013.04.030; Tanimura A, 2010, NEURON, V65, P320, DOI 10.1016/j.neuron.2010.01.021; Katona I, 1999, J NEUROSCI, V19, P4544; Ikeda H, 2013, NEUROSCIENCE, V250, P446, DOI 10.1016/j.neuroscience.2013.07.040; Kamei J, 2003, PHARMACOL BIOCHEM BE, V75, P247, DOI 10.1016/S0091-3057(03)00080-7; Kamei J, 2001, JPN J PHARMACOL, V86, P47, DOI 10.1254/jjp.86.47; McLaughlin RJ, 2012, NEUROSCIENCE, V204, P134, DOI 10.1016/j.neuroscience.2011.07.052; Miyata S, 2007, BRAIN RES, V1147, P233, DOI 10.1016/j.brainres.2007.02.001; Nicoll R. A., 2001, NATURE, V410, P588; Pamplona FA, 2006, NEUROSCI LETT, V397, P88, DOI 10.1016/j.neulet.2005.12.026; Paxinos G, 2001, MOUSE BRAIN STEREOTA	38	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	JUL	2015	269						233	241		10.1016/j.expneurol.2015.04.012		9	Neurosciences	Neurosciences & Neurology	CJ6YH	WOS:000355640600021		
J	Hakimi, H; Goto, Y; Suganuma, K; Angeles, JMM; Kawai, S; Inoue, N; Kawazu, S				Hakimi, Hassan; Goto, Yasuyuki; Suganuma, Keisuke; Angeles, Jose Ma M.; Kawai, Satoru; Inoue, Noboru; Kawazu, Shin-ichiro			Development of monoclonal antibodies against Plasmodium falciparum thioredoxin peroxidase 1 and its possible application for malaria diagnosis	EXPERIMENTAL PARASITOLOGY			English	Article						Plasmodium falciparum; Malaria diagnosis; Rapid diagnostic test; Thioredoxin peroxidase 1	SCHISTOSOMA-JAPONICUM INFECTION; TANDEM REPEAT PROTEINS; 2-CYS PEROXIREDOXIN; 1-CYS PEROXIREDOXIN; P. VIVAX; TESTS; PARASITE; PFHRP2; SENSITIVITY; POPULATION	Rapid diagnostic tests (RDTs) have been considered as an ideal alternative for light microscopy to detect malaria parasites especially in remote areas. The development and improvement of RDTs is an area of intensive research in the last decade. To date, few parasite proteins have been targeted in RDTs which are known to have certain deficiencies and made the researchers to look for other promising candidates to address this problem. Plasmodium falciparum thioredoxin peroxidase I (PfTPx-1) is abundantly expressed in the cytoplasm of the parasite and well conserved across Plasmodium species, making this antigen a promising target for malaria diagnosis. Several monoclonal antibodies (mAbs) were produced against PfTPx-1. The binding affinities of mAbs were measured. Several immunochromatographic tests (ICTs) were developed using different combination of mAbs. All mAbs showed promising affinities to be used for diagnosis. The sensitivities of ICTs were evaluated using recombinant PfTPx-1 whose results lead us to the preparation of 4 different ICTs. These tests showed positive reaction with P. falciparum in vitro culture supernatant indicating the release of PfTPx-1 during schizont rupture. Altogether, these findings suggest that PfTPx-1 is a promising biomarker to diagnose P. falciparum infection. However, the diagnostic performance of this antigen should be further validated using clinical samples. (C) 2015 Elsevier Inc. All rights reserved.	[Hakimi, Hassan; Suganuma, Keisuke; Angeles, Jose Ma M.; Inoue, Noboru; Kawazu, Shin-ichiro] Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Obihiro, Hokkaido 0808555, Japan; [Hakimi, Hassan] Nagasaki Univ, Inst Trop Med NEKKEN, Dept Protozool, Nagasaki 8528523, Japan; [Goto, Yasuyuki] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo 1138657, Japan; [Kawai, Satoru] Dokkyo Med Univ, Dept Trop Med & Parasitol, Mibu, Tochigi 3210293, Japan	Kawazu, S (reprint author), Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Obihiro, Hokkaido 0808555, Japan.	skawazu@obihiro.ac.jp	Goto, Yasuyuki/E-9028-2011	Goto, Yasuyuki/0000-0002-8654-7888	Japan Society for the Promotion of Sciences [23390098]	This work was supported by a Grant-in-Aid for Scientific Research (23390098) from the Japan Society for the Promotion of Sciences.	Angeles JMM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001800; Kumar N, 2013, ACTA TROP, V125, P119, DOI 10.1016/j.actatropica.2012.09.015; Kawazu SI, 2008, PARASITOL INT, V57, P1, DOI 10.1016/j.parint.2007.08.001; McMorrow ML, 2011, CLIN MICROBIOL INFEC, V17, P1624, DOI 10.1111/j.1469-0691.2011.03639.x; Guirgis BSS, 2012, ANAL BIOANAL CHEM, V402, P1019, DOI 10.1007/s00216-011-5489-y; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Houze S, 2011, J CLIN MICROBIOL, V49, P2694, DOI 10.1128/JCM.00281-11; Baker J, 2005, J INFECT DIS, V192, P870, DOI 10.1086/432010; Gretes MC, 2012, ANTIOXID REDOX SIGN, V17, P608, DOI 10.1089/ars.2011.4404; Hakimi Hassan, 2013, Trop Med Health, V41, P55, DOI 10.2149/tmh.2012-30; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Lee N, 2006, J CLIN MICROBIOL, V44, P2773, DOI 10.1128/JCM.02557-05; Angeles JM, 2011, AM J TROP MED HYG, V85, P674, DOI 10.4269/ajtmh.2011.11-0245; FRIGUET B, 1985, J IMMUNOL METHODS, V77, P305, DOI 10.1016/0022-1759(85)90044-4; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeadbiomed.2005.02.026; Mouatcho JC, 2013, J MED MICROBIOL, V62, P1491, DOI 10.1099/jmm.0.052506-0; Kawazu S, 2001, MOL BIOCHEM PARASIT, V116, P73, DOI 10.1016/S0166-6851(01)00308-5; DAVIS JM, 1982, J IMMUNOL METHODS, V50, P161, DOI 10.1016/0022-1759(82)90222-8; Furuta T, 2008, EUR J IMMUNOL, V38, P1341, DOI 10.1002/eji.200738059; Gamboa D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008091; Hakimi H, 2013, EXP PARASITOL, V133, P101, DOI 10.1016/j.exppara.2012.10.018; Hakimi H, 2012, PARASITOL RES, V111, P525, DOI 10.1007/s00436-012-2864-3; Hatabu T, 2003, P NATL ACAD SCI USA, V100, P15942, DOI 10.1073/pnas.2534560100; Kattenberg JH, 2012, MABS-AUSTIN, V4, P120, DOI 10.4161/mabs.4.1.18529; Kumar N, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-298; Lee GC, 2011, AM J TROP MED HYG, V85, P989, DOI 10.4269/ajtmh.2011.11-0265; MAKLER MT, 1993, AM J TROP MED HYG, V48, P739; *MALERA CONS GROUP, 2011, PLOS MED, V0008; Piper RC, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-213; Thezenas ML, 2013, J PROTEOME RES, V12, P1211, DOI 10.1021/pr300858g; WHO, 2011, UN ACC MAL DIAGN TES; WHO-FIND-TDR, 2012, MAL RAP DIAGN TEST P; Yano K, 2005, PARASITOL INT, V54, P35, DOI 10.1016/j.parint.2004.08.005; Yano K, 2006, MOL BIOCHEM PARASIT, V148, P44, DOI 10.1016/j.molbiopara.2006.02.018; Zhao JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043549	35	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4894	1090-2449		EXP PARASITOL	Exp. Parasitol.	JUL	2015	154						62	66		10.1016/j.exppara.2015.04.018		5	Parasitology	Parasitology	CJ6YG	WOS:000355640500010		
J	Sakagami, T				Sakagami, T.			Remote nondestructive evaluation technique using infrared thermography for fatigue cracks in steel bridges	FATIGUE & FRACTURE OF ENGINEERING MATERIALS & STRUCTURES			English	Review						fatigue cracks; infrared thermography; nondestructive testing; self-reference lock-in thermography; steel bridge; thermoelasticity	THERMOELASTIC STRESS-ANALYSIS; LOCK-IN THERMOGRAPHY; INTENSITY FACTORS; ORTHOTROPIC DECKS; INVERSE ANALYSIS; SEPARATION; COMPONENTS; PHOTOELASTICITY; COMPOSITES; CONCRETE	Long-standing infrastructure is subject to structural deterioration. In this respect, steel bridges suffer fatigue cracks, which necessitate immediate inspection, structural integrity evaluation or repair. However, the inaccessibility of such structures makes inspection time consuming and labour intensive. Therefore, there is an urgent need for developing high-performance nondestructive evaluation (NDE) methods to assist in effective maintenance of such structures.Recently, use of infrared cameras in nondestructive testing has been attracting increasing interest, as they provide highly efficient remote and wide area measurements. This paper first reviews the current situation of nondestructive inspection techniques used for fatigue crack detection in steel bridges, and then presents remote NDE techniques using infrared thermography developed by the author for fatigue crack detection and structural integrity assessments. Furthermore, results of applying fatigue crack evaluation to a steel bridge using the newly developed NDE techniques are presented.	Kobe Univ, Grad Sch Engn, Dept Mech Engn, Nada Ku, Kobe, Hyogo 6578501, Japan	Sakagami, T (reprint author), Kobe Univ, Grad Sch Engn, Dept Mech Engn, Nada Ku, 1-1 Rokkodai Cho, Kobe, Hyogo 6578501, Japan.	sakagami@mech.kobe-u.ac.jp			Japan Society for the Promotion of Science [19206015, 23366057]; Ministry of Land, Infrastructure, Transport and Tourism; Casio Science Foundation	The author would particularly like to acknowledge Prof. Murakami for his valuable advice. Furthermore, the author would like to acknowledge all the co-authors of the papers referenced in this study. The research works shown in this paper were supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (A: 19206015, B: 23366057), and grants from the Ministry of Land, Infrastructure, Transport and Tourism and Casio Science Foundation.	Akai A., 2015, J SOC MAT S IN PRESS; Dulieu-Barton JM, 1998, J STRAIN ANAL ENG, V33, P93, DOI 10.1243/0309324981512841; Sakagami T, 2002, INFRARED PHYS TECHN, V43, P211, DOI 10.1016/S1350-4495(02)00141-X; Valluzzi MR, 2009, MATER STRUCT, V42, P25, DOI 10.1617/s11527-008-9364-z; Ya S, 2011, J BRIDGE ENG, V16, P492, DOI 10.1061/(ASCE)BE.1943-5592.0000181; Clark MR, 2003, NDT&E INT, V36, P265, DOI 10.1016/S0963-8695(02)00060-9; Qian J, 1996, ENG FRACT MECH, V55, P969, DOI 10.1016/S0013-7944(96)00071-9; Pfeil MS, 2005, J CONSTR STEEL RES, V61, P1172, DOI 10.1016/j.jcsr.2005.02.006; Pitarresi G, 2003, J STRAIN ANAL ENG, V38, P405, DOI 10.1243/03093240360713469; Beretta S, 2005, ENG FAIL ANAL, V12, P157, DOI 10.1016/j.engfailanal.2004.02.004; Nair A, 2010, ENG STRUCT, V32, P1704, DOI 10.1016/j.engstruct.2010.02.020; Diaz FA, 2004, FATIGUE FRACT ENG M, V27, P571, DOI 10.1111/j.1460-2695.2004.00782.x; Xiao ZG, 2008, INT J FATIGUE, V30, P1387, DOI 10.1016/j.ijfatigue.2007.10.008; Barone S, 1996, EXP MECH, V36, P318, DOI 10.1007/BF02328573; Barton E., 2010, P INT C STRUCT FAULT; Byrd LW, 2000, EXP MECH, V40, P10, DOI 10.1007/BF02327542; Choi D., 2008, P INT ORTH BRIDG C, V2008, P267; de Jong F. B. P, 2004, P ORTH BRIDG C 25 27, P489; Dulieu-Barton JM, 1999, STRAIN, V35, P35, DOI 10.1111/j.1475-1305.1999.tb01123.x; FENG Z, 1992, EXP MECH, V32, P89, DOI 10.1007/BF02324718; Hanai T., 2011, P 2011 INT FOR BRIDG, P203; Hayabusa K, 1999, JSME INT J A-SOLID M, V42, P618; He KY, 2004, EXP MECH, V44, P555, DOI 10.1177/0014485104049419; Hirabayashi M., 2008, DOBOKU GAKKAI RONB A, V64, P71, DOI 10.2208/jsceja.64.71; HUANG YM, 1990, EXP MECH, V30, P398, DOI 10.1007/BF02321511; Inoue H., 2000, P JSNDI FALL C, P89; Inoue H., 2006, P ANN M JSME KANT BR, P219; Izumi Y., 2009, P 12 INT C FRACT, P1; Izumi Y, 2010, EPJ WEB CONF, V6, DOI 10.1051/epjconf/20100638011; Izumi Y., 2008, P ASCE 2008 INT ORTH, P502; Izumi Y, 2010, J MOD OPTIC, V57, P1747, DOI 10.1080/09500340.2010.514066; Ju SH, 1997, EXP MECH, V37, P278, DOI 10.1007/BF02317419; Kamibayashi M., 2009, J JAPANESE SOC NONDE, V58, P556; Kamibayashi M., 2009, J JAPANESE SOC NONDE, V58, P563; Kaplan H., 2007, PRACTICAL APPL INFRA; Kawakami Y., 2011, PROCEDIA ENG, V14, P1059; Kim Y., 2007, Q J JWS, V25, P542, DOI 10.2207/qjjws.25.542; Kimura T., 2013, 3 INT S LAS ULTR ADV, P1; Kishimoto K, 1997, JSME INT J A-SOLID M, V40, P108; Lesniak J., 1998, P SEM SPRING C SOC E, P504; Lesniak JR, 1996, P SOC PHOTO-OPT INS, V2766, P210, DOI 10.1117/12.235377; Maldague X., 1993, NONDESTRUCTIVE EVALU; Maldague X., 2001, THEORY PRACTICE INFR; Miki C., 2013, BRIDGE ENG HDB, P496; Miki C, 2000, NON-DESTRUCTIVE TESTING IN CIVIL ENGINEERING 2000, P13, DOI 10.1016/B978-008043717-0/50002-7; Miki T., 2005, J JPN SOC CIVIL ENG, V780, P57; Moles M., 2005, 3 MENDT MIDDL E NOND; Muragishi O., 2005, KAWASAKI TECHNICAL R, V159, P56; Murakami Y, 1997, INT J SOLIDS STRUCT, V34, P4449, DOI 10.1016/S0020-7683(97)00052-8; National Institute for Land and Infrastructure Management Ministry of Land Infrastructure Transport and Tourism Japan, 2008, 471 NILIM MIN LAND I; Offermann S, 1997, EXP MECH, V37, P409, DOI 10.1007/BF02317306; Pijpers R., 2013, 3 ORTH BRIDG C P, P432; Pook LP, 1994, HDB FATIGUE CRACK PR, V2, P1027; RYALL TG, 1988, MECH MATER, V7, P205, DOI 10.1016/0167-6636(88)90020-8; Sakagami T., 2008, P 63 JSCE ANN M, P933; Sakagami T., 2009, SPIE P, V7299; Sakagami T, 2005, P SOC PHOTO-OPT INS, V5782, P379, DOI 10.1117/12.606148; Sakagami T, 2010, J MOD OPTIC, V57, P1738, DOI 10.1080/09500340.2010.511289; Sakagami T., 2013, P ASCE 2013 INT ORTH, P279; SAKAGAMI T, 1990, INT J PRES VES PIP, V44, P35, DOI 10.1016/0308-0161(90)90005-3; Sakagami T, 2002, INFRARED PHYS TECHN, V43, P311, DOI 10.1016/S1350-4495(02)00157-3; Sakagami T, 2004, JSME INT J A-SOLID M, V47, P298, DOI 10.1299/jsmea.47.298; Sakagami T., 2011, THERMOMECHANICS INFR, V7, P99; Sakagami T., 2014, P SOC PHOTO-OPT INS, V9105; Sakagami T., 2006, P SOC PHOTO-OPT INS, V6205; Shiozawa D, 2004, JSME INT J A-SOLID M, V47, P419, DOI 10.1299/jsmea.47.419; Shiozawa D., 2014, ADV MAT RES, V891, P606; SHIRATORI M, 1990, JSME INT J I-SOLID M, V33, P400; Shiratori M., 1989, T JPN SOC MECH ENG A, V55, P1646; Stanley P., 1986, P SEM SPRING C EXP M, P916; Sugiyama H., 2010, BRIDGE MAINTENANCE S, P2022; Tanaka K., 1974, Engineering Fracture Mechanics, V6, DOI 10.1016/0013-7944(74)90007-1; Tomlinson RA, 1999, STRAIN, V35, P49, DOI 10.1111/j.1475-1305.1999.tb01125.x; Tomlinson RA, 1997, FATIGUE FRACT ENG M, V20, P217, DOI 10.1111/j.1460-2695.1997.tb00279.x; Uomoto T., 2011, P INT FOR MECH NOV S, P31; Washer G., 2013, BRIDGE ENG HDB, P301; Washer GA, 1998, NDT&E INT, V31, P245, DOI 10.1016/S0963-8695(98)00009-7; Washer G, 2013, BRIDGE ENG HDB, P326; Wilkinson S, 2014, BDK8497726 FLOR DEP; Ya S., 2010, J STRUCT ENG A, V56A, P77; Yamada K., 2008, P INT ORTH BRIDG C, V2008, P98; Yates JR, 2008, ENG FRACT MECH, V75, P319, DOI 10.1016/j.engfracmech.2007.05.014; Yuge T., 2004, P INT ORTH BRIDG C A, P531	83	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	8756-758X	1460-2695		FATIGUE FRACT ENG M	Fatigue Fract. Eng. Mater. Struct.	JUL	2015	38	7					755	779		10.1111/ffe.12302		25	Engineering, Mechanical; Materials Science, Multidisciplinary	Engineering; Materials Science	CJ7LO	WOS:000355677000001		
J	Tanegashima, R; Ohara, I; Akebono, H; Kato, M; Sugeta, A				Tanegashima, R.; Ohara, I.; Akebono, H.; Kato, M.; Sugeta, A.			Cumulative fatigue damage evaluations on spot-welded joints using 590MPa-class automobile steel	FATIGUE & FRACTURE OF ENGINEERING MATERIALS & STRUCTURES			English	Article						fatigue damage; lap joints; mean stress effects; random loading; spot weld	HIGH-STRENGTH STEEL; LIFE PREDICTION; BEHAVIOR; FAILURE; FRACTURE; SHEET; SPECIMENS; TENSILE; STRESS; SHEAR	This study focused on local strain behaviour near the slit edge of spot-welded joints, where the fatigue crack initiated, and investigated methods of evaluating cumulative fatigue damage. A method of evaluating local strain amplitude by following modified Goodman's law gave almost the same result as an evaluation approach based on the external force and provided reasonable result on general strength design. An approach based on Smith-Watson-Topper's equation was easy to evaluate cumulative fatigue damage compared with the method based on modified Goodman's law and gave a good agreement with a criterion of the modified Miner's rule.	[Tanegashima, R.] Ritsumeikan Univ, Dept Mech Engn, Shiga 5258577, Japan; [Ohara, I.; Akebono, H.; Kato, M.; Sugeta, A.] Hiroshima Univ, Grad Sch Engn, Dept Mech Sci & Engn, Hiroshima 7398577, Japan	Sugeta, A (reprint author), Hiroshima Univ, Grad Sch Engn, Dept Mech Sci & Engn, 1-4-1 Kagamiyama, Hiroshima 7398577, Japan.	asugeta@hiroshima-u.ac.jp	Akebono, Hiroyuki/J-5890-2014		Japan Society for the Promotion of Science	The authors acknowledge the support of a Research Fellowship for Young Scientists from the Japan Society for the Promotion of Science.	Long X, 2007, INT J FATIGUE, V29, P879, DOI 10.1016/j.ijfatigue.2006.08.003; Newman JA, 1998, FATIGUE FRACT ENG M, V21, P1123, DOI 10.1046/j.1460-2695.1998.00099.x; Ma C, 2008, MAT SCI ENG A-STRUCT, V485, P334, DOI 10.1016/j.msea.2007.08.010; Uematsu Y, 2008, INT J FATIGUE, V30, P1956, DOI 10.1016/j.ijfatigue.2008.01.006; POOK LP, 1975, INT J FRACTURE, V11, P173, DOI 10.1007/BF00034726; Fujii T, 2011, PROCEDIA ENGINEER, V10, P1075, DOI 10.1016/j.proeng.2011.04.177; Tran VX, 2008, INT J FATIGUE, V30, P2175, DOI 10.1016/j.ijfatigue.2008.05.025; Lin SH, 2006, INT J FATIGUE, V28, P792, DOI 10.1016/j.ijfatigue.2005.08.003; Deng X, 2000, FINITE ELEM ANAL DES, V35, P17, DOI 10.1016/S0168-874X(99)00053-0; Pouranvari M, 2011, MATER DESIGN, V32, P1390, DOI 10.1016/j.matdes.2010.09.010; Hilditch TB, 2007, MATER DESIGN, V28, P2566, DOI 10.1016/j.matdes.2006.10.019; Brauser S, 2010, MAT SCI ENG A-STRUCT, V527, P7099, DOI 10.1016/j.msea.2010.07.091; Khan MI, 2008, SCI TECHNOL WELD JOI, V13, P294, DOI 10.1179/174329308X271733; Wang DA, 2005, INT J FATIGUE, V27, P581, DOI [10.1016/j.ijfatigue.2004.08.008, 10.1016/j.fatigue.2004.08.008]; SMITH KN, 1970, J MATER, V5, P767; Chao YJ, 2003, J ENG MATER-T ASME, V125, P125, DOI 10.1115/1.1555648; Daneshpour S, 2007, SCI TECHNOL WELD JOI, V12, P508, DOI 10.1179/174329307X213855; Endo T., 1974, B KYUSHU I TECHNOLOG, V28, P33; Erdogan F, 1963, T ASME, V85, P519, DOI DOI 10.1115/1.3656897; Ertas AH, 2008, P I MECH ENG C-J MEC, V222, P881, DOI 10.1243/09544062JMES787; Gaul G., 2011, INT J FATIGUE, V33, P740; Goodman J., 1914, MECH APPL ENG, V8th; Hassanifard S, 2009, STRAIN, V45, P489, DOI 10.1111/j.1475-1305.2008.00435.x; Henrysson HF, 2002, FATIGUE FRACT ENG M, V25, P1175, DOI 10.1046/j.1460-2695.2002.00537.x; Kang H. T., 2007, MATER DESIGN, V28, P873; Kim DH, 2009, MATER DESIGN, V30, P3286, DOI 10.1016/j.matdes.2009.01.002; Kulthida S., 2011, ENG FRACT MECH, V78, P1424; Lanciotti A, 2008, FATIGUE FRACT ENG M, V31, P76, DOI [10.1111/J.1460-2695.2007.01202.x, 10.1111/j.1460-2695.2007.01202.x]; Lee H, 2004, FATIGUE FRACT ENG M, V27, P245, DOI 10.1111/j.1460-2695.2004.00752.x; Linder J, 1998, FATIGUE FRACT ENG M, V21, P673, DOI 10.1046/j.1460-2695.1998.00038.x; Pang N., 2002, INT J FATIGUE, V24, P519; Paris P., 1963, T ASME J BASIC ENG, V85, P525; Pollard B., 1982, SAE TECHNICAL PAPER, V1982; Radj D., 1990, DESIGN ANAL FATIGUE; Rathbun R. W., 2003, WELD J, V79, p207s; Rupp A., 1995, SAE TECHNICAL PAPER; Sakai S., 1983, T JPN SOC MECH ENG A, V49, P18; SWELLAM MH, 1994, FATIGUE FRACT ENG M, V17, P1197, DOI 10.1111/j.1460-2695.1994.tb01408.x; Tanegashima R, 2013, INT J FATIGUE, V51, P121, DOI 10.1016/j.ijfatigue.2012.12.014; Yuuki R., 1985, T JAPAN SOC MECH ENG, V51, P1772	40	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	8756-758X	1460-2695		FATIGUE FRACT ENG M	Fatigue Fract. Eng. Mater. Struct.	JUL	2015	38	7					870	879		10.1111/ffe.12258		10	Engineering, Mechanical; Materials Science, Multidisciplinary	Engineering; Materials Science	CJ7LO	WOS:000355677000010		
J	Chen, JY; Zhang, H; Ma, JK; Tuchiya, T; Miao, YL				Chen, Jie Yu; Zhang, Han; Ma, Jinkui; Tuchiya, Tomohiro; Miao, Yelian			Determination of the Carbonyl Values for Frying Rapeseed Oil Using Near-Infrared Spectroscopy	FOOD ANALYTICAL METHODS			English	Article						Frying oil; Carbonyl value; Determination; Degradation; Near infrared spectroscopy; PLS regression	RAPID-DETERMINATION; DEGRADATION; CHEMISTRY	Near-infrared (NIR) spectroscopy was investigated as a method for analysis of the carbonyl value (CV) in frying oils. Two types of rapeseed oil were used to fry potatoes and 156 samples of frying oil were obtained. Transmission spectra of the samples were acquired directly using glass test tubes (13-mm diameter) as sample cells and an NIR spectrometer. Calibration models with very high accuracy based on the second derivative spectra in wavelength range of 1100-2200 nm were developed for predicting the CV using partial least-squares regression with full cross-validation. The coefficients of determination for calibration and standard error of cross-validation were 0.98 and 1.79 mu mol g(-1), respectively. The accuracy of the NIR calibration models was tested using the validation set, yielding the value for the root mean square of the prediction as 1.74 mu mol g(-1). The results demonstrate that the CV for frying oils can be accurately determined using NIR spectroscopy.	[Chen, Jie Yu; Zhang, Han; Tuchiya, Tomohiro] Akita Prefectural Univ, Fac Bioresource Sci, Akita 0100195, Japan; [Ma, Jinkui] Zhaoqing Univ, Sch Chem & Chem Engn, Zhaoqing 526061, Guangdong, Peoples R China; [Miao, Yelian] Nanjing Univ Technol, Coll Food & Light Ind Engn, Nanjing 210009, Peoples R China	Chen, JY (reprint author), Akita Prefectural Univ, Fac Bioresource Sci, Akita 0100195, Japan.	jiey_chen@akita-pu.ac.jp					Christy AA, 2004, ANAL SCI, V20, P935, DOI 10.2116/analsci.20.935; Chen JY, 2006, J AGR FOOD CHEM, V54, P9652, DOI 10.1021/jf061461s; Yavari AA, 2009, J AM OIL CHEM SOC, V86, P941, DOI 10.1007/s11746-009-1393-4; MADDEN HH, 1978, ANAL CHEM, V50, P1383, DOI 10.1021/ac50031a048; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Endo Y, 2001, J AM OIL CHEM SOC, V78, P1021, DOI 10.1007/s11746-001-0381-1; Chen JY, 2005, FOOD SCI TECHNOL RES, V11, P26, DOI 10.3136/fstr.11.26; HENICK AS, 1954, J AM OIL CHEM SOC, V31, P88, DOI 10.1007/BF02612488; BLUMENTHAL MM, 1991, FOOD TECHNOL-CHICAGO, V45, P68; Chen JY, 2004, J NEAR INFRARED SPEC, V12, P311; Chen Jie Yu, 2003, Appl Spectrosc, V57, P1399, DOI 10.1366/000370203322554572; Chen JY, 2007, JPN J FOOD ENG, V8, P209; Chen JY, 2007, FOOD SCI TECHNOL RES, V13, P291, DOI 10.3136/fstr.13.291; Chen JY, 2008, FOOD SCI TECHNOL RES, V14, P132, DOI 10.3136/fstr.14.132; CHIBA T, 1989, J AM OIL CHEM SOC, V66, P1588, DOI 10.1007/BF02636182; CLARK WL, 1991, FOOD TECHNOL-CHICAGO, V45, P84; Duckworth J, 2004, MATH DATA PREPROCESS, P115; Endo Y., 2003, Journal of Oleo Science, V52, P353; Gerde JA, 2007, J AM OIL CHEM SOC, V84, P519, DOI 10.1007/s11746-007-1068-y; Ito T, 2009, J COOKERY SCI JPN, V42, P117; JOCS, 2003, TENT 13 2003 CARB VA; Kumazawa H, 1965, J AM OIL CHEM SOC, V14, P167; Ma JK, 2014, FOOD SCI TECHNOL RES, V20, P217, DOI 10.3136/fstr.20.217; Martens H., 1989, MULTIVARIATE CALIBRA; Ng CL, 2011, J AGR FOOD CHEM, V59, P12286, DOI 10.1021/jf202740e; Ng CL, 2007, J AGR FOOD CHEM, V55, P593, DOI 10.1021/jf061841d; Ogutcu M, 2012, J AM OIL CHEM SOC, V89, P1823, DOI 10.1007/s11746-012-2087-x; Osborne B.G., 1993, PRACTICAL NIR SPECTR, P13; Tyagi VK, 1996, J AM OIL CHEM SOC, V73, P499, DOI 10.1007/BF02523926; WHITE PJ, 1991, FOOD TECHNOL-CHICAGO, V45, P75; Williams P. C., 2001, IMPLEMENTATION NEAR, V2, P145	31	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1936-9751	1936-976X		FOOD ANAL METHOD	Food Anal. Meth.	JUL	2015	8	6					1508	1514		10.1007/s12161-014-0032-3		7	Food Science & Technology	Food Science & Technology	CJ9CO	WOS:000355800200015		
J	Watanabe, A; Fukui, N; Suzuki, Y; Motegi, T; Igeta, H; Tsuneyama, N; Someya, T				Watanabe, Aiko; Fukui, Naoki; Suzuki, Yutaro; Motegi, Takaharu; Igeta, Hirofumi; Tsuneyama, Nobuto; Someya, Toshiyuki			Improvement of dumping syndrome and oversecretion of glucose-dependent insulinotropic polypeptide following a switch from olanzapine to quetiapine in a patient with schizophrenia	GENERAL HOSPITAL PSYCHIATRY			English	Editorial Material						Olanzapine; Quetiapine; Dumping syndrome; Hypoglycemia; Glucose-dependent insulinotropic polypeptide		Among the most important adverse effects of antipsychotics is abnormal glucose metabolism, which includes not only hyperglycemia but hyperinsulinemia and hypoglycemia. We have previously described five patients who experienced hypoglycemia during treatment with antipsychotics. Thus, an anamnesis of gastric surgery, which often causes dumping syndrome, and treatment with antipsychotics may synergistically induce hypoglycemia. We describe here a patient with schizophrenia under treatment of olanzapine and an anamnesis of gastric surgery, who experienced late dumping syndrome, hyperinsulinemia and overactivation of glucose-dependent insulinotropic polypeptide. Dumping syndrome, however, was improved after the patient was switched from olanzapine to quetiapine. (C) 2015 Elsevier Inc. All rights reserved.	[Watanabe, Aiko; Fukui, Naoki; Suzuki, Yutaro; Motegi, Takaharu; Igeta, Hirofumi; Tsuneyama, Nobuto; Someya, Toshiyuki] Niigata Univ, Grad Sch Med & Dent Sci, Dept Psychiat, Niigata 9518510, Japan	Fukui, N (reprint author), Niigata Univ, Grad Sch Med & Dent Sci, Dept Psychiat, Chuo Ku, 757 Asahimachidori Ichibancho, Niigata 9518510, Japan.	fukui@med.niigata-u.ac.jp			KAKENHI from Japan Society for the Promotion of Research [25461725]	This study was funded by a Grant-in-Aid for Scientific Research (KAKENHI) from the Japan Society for the Promotion of Research (#25461725) to Naoki Fukui.	Teff KL, 2013, DIABETES, V62, P3232, DOI 10.2337/db13-0430; Gebhard B, 2001, DIGEST DIS SCI, V46, P1915, DOI 10.1023/A:1010635131228; Sato D, 2013, ENDOCR J, V60, P847; Suzuki Y, 2009, BMJ-BRIT MED J, V26, pa1792	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0163-8343	1873-7714		GEN HOSP PSYCHIAT	Gen. Hosp. Psych.	JUL-AUG	2015	37	4							UNSP 372.e5	10.1016/j.genhosppsych.2015.03.012		2	Psychiatry	Psychiatry	CJ5UG	WOS:000355555800023		
J	Nakashima, E				Nakashima, Eiji			Radiation Dose Response Estimation with Emphasis on Low Dose Range Using Restricted Cubic Splines: Application to All Solid Cancer Mortality Data, 1950-2003, in Atomic Bomb Survivors	HEALTH PHYSICS			English	Article							NONCANCER DISEASES; REGRESSION-MODELS; HUMAN-CELLS	Using the all solid cancer mortality data set of the Life Span Study (LSS) cohort from 1950 to 2003 (LSS Report 14) data among atomic bomb survivors, excess relative risk (ERR) statistical analyses were performed using the second degree polynomial and the threshold and restricted cubic spline (RCS) dose response models. For the RCS models with 3 to 7 knots of equally spaced percentiles with margins in the dose range greater than 50 mGy, the dose response was assumed to be linear at less than 70 to 90 mGy. Due to the skewed dose distribution of atomic bomb survivors, the current knot system for the RCS analysis results in a detailed depiction of the dose response as less than approximately 0.5 Gy. The 6 knot RCS models for the all-solid cancer mortality dose response of the whole dose or less than 2 Gy were selected with the AIC model selection criterion and fit significantly better (p < 0.05) than the linear (L) model. The usual RCS includes the L-global model but not the quadratic (Q) nor linear-quadratic (LQ) global models. The authors extended the RCS to include L or LQ global models by putting L or LQ constraints on the cubic spline in the lower and upper tails, and the best RCS model selected with AIC criterion was the usual RCS with L-constraints in both the lower and upper tails. The selected RCS had a linear dose-response model in the lower dose range (i.e., < 0.2-0.3 Gy) and was compatible with the linear no-threshold (LNT) model in this dose range. The proposed method is also useful in describing the dose response of a specific cancer or non-cancer disease incidence/mortality.	Radiat Effects Res Fdn, Dept Stat, Minami Ku, Hiroshima 7320815, Japan	Nakashima, E (reprint author), Radiat Effects Res Fdn, Dept Stat, Minami Ku, Hijiyama Pk 5-2, Hiroshima 7320815, Japan.	nakasima@rerf.or.jp			Japanese ministry of Health, Labour and Welfare (MHLW); U.S. Department of Energy (USDOE); USDOE [DE-HS0000031]; RERF [2-75]	The author thanks K. Ozasa and H.M. Cullings at Radiation Effects Research Foundation (RERF) and RERF internal reviewers for their comments on the draft paper in preparation of this manuscript prior to submission. The company PacEdit reviewed the manuscript prior to submission. The Radiation Effects Research Foundation (RERF), Hiroshima and Nagasaki, is a public interest foundation funded by the Japanese ministry of Health, Labour and Welfare (MHLW) and the U.S. Department of Energy (USDOE). The research was also funded in part through USDOE award DE-HS0000031 to the National Academy of Sciences. This publication was supported by RERF research protocol #2-75. The views of the authors do not necessarily reflect those of the two governments.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Akaike H., 1973, 2 INT S INF THEOR, P267; Pierce DA, 1999, RADIAT RES, V152, P642, DOI 10.2307/3580260; GREENLAND S, 1995, EPIDEMIOLOGY, V6, P356, DOI 10.1097/00001648-199507000-00005; Sugiyama H, 2014, RADIAT RES, V181, P531, DOI 10.1667/RR13494.1; Ozasa K, 2012, RADIAT RES, V177, P229, DOI 10.1667/RR2629.1; [Anonymous], 1994, J R STAT SOC C-APPL; Corrao G, 2000, ADDICTION, V95, P1505, DOI 10.1046/j.1360-0443.2000.951015056.x; Desquilbet L, 2010, STAT MED, V29, P1037, DOI 10.1002/sim.3841; Preston DL, 2003, RADIAT RES, V160, P381, DOI 10.1667/RR3049; Neriishi K, 2012, RADIOLOGY, V265, P167, DOI 10.1148/radiol.12111947; ARMITAGE P, 1954, BRIT J CANCER, V8, P1, DOI 10.1038/bjc.1954.1; Preston DL, 2004, RADIAT RES, V162, P377, DOI 10.1667/RR3232; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; PIERCE DA, 1990, RADIAT RES, V123, P275, DOI 10.2307/3577733; OHTAKI M, 1985, JPN J CLIN ONCOL, V15, P325; Bargnardi V, 2004, AM J EPIDEMIOL, V159, P1077; Belsley David A., 1980, REGRESSION DIAGNOSTI; Burlakova EB, 1995, RADIAT PROT DOSIM, V62, P13; Castelnuovo A, 2006, ARCH INTERN MED, V166, P2437; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Doss M, 2012, RADIAT RES, V178, P244, DOI 10.1667/RR3039.1; GROSOVSKY AJ, 1985, P NATL ACAD SCI USA, V82, P2092, DOI 10.1073/pnas.82.7.2092; Harrell FE, 2001, REGRESSION MODELING; HARRELL FE, 1988, J NATL CANCER I, V80, P1198, DOI 10.1093/jnci/80.15.1198; Kotz S., 1985, ENCY STAT SCI; Luckey T. D., 1980, HORMESIS IONIZING RA; Nakamura N, 2012, UNDERSTAND LOW DOSE; PIJPE A, 2012, BMJ-BRIT MED J, V345, DOI DOI 10.1136/BMJ.E5660; Preston DL, 1993, EPICURE USERS GUIDE; Stone CJ, 1985, P STAT COMP SECT AM; United Nations Scientific Committee on the Effects of Atomic Radiation, 2012, REP 2012; Worgul B V, 2007, Radiat Res, V167, P233, DOI 10.1667/RR0298.1; Young RW, 2005, REASSESSMENT ATOMIC	35	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0017-9078	1538-5159		HEALTH PHYS	Health Phys.	JUL	2015	109	1					15	24		10.1097/HP.0000000000000293		10	Environmental Sciences; Public, Environmental & Occupational Health; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	Environmental Sciences & Ecology; Public, Environmental & Occupational Health; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	CJ6PL	WOS:000355615700003		
J	Snetkov, IL; Yasuhara, R; Starobor, AV; Mironov, EA; Palashov, OV				Snetkov, Ilya L.; Yasuhara, Ryo; Starobor, Aleksey V.; Mironov, Evgeniy A.; Palashov, Oleg V.			Thermo-Optical and Magneto-Optical Characteristics of Terbium Scandium Aluminum Garnet Crystals	IEEE JOURNAL OF QUANTUM ELECTRONICS			English	Article						Magneto-optical materials; Faraday effect; thermo-optic effects	THERMALLY-INDUCED DEPOLARIZATION; HIGH AVERAGE POWER; GALLIUM GARNET; FARADAY ISOLATORS; SINGLE-CRYSTALS; TGG CERAMICS; YAG LASER; COMPENSATION; BIREFRINGENCE; ORIENTATION	Magnetoactive materials are of considerable current interest, primarily for applications in nonreciprocal Faraday devices used for polarization control, optical isolation, optical switching, and modulation. The need for such devices is growing with laser power enhancement. They reduce risk of self-excitation of the amplifiers and optical elements damage and are a handy tool for organizing multipass schemes. However, at high average power of radiation these devices are subject to thermally induced effects that impair their operability and lead to increased losses and to the formation of phase distortions in the transmitted radiation. One of the methods to reduce thermally induced effects is to use in Faraday devices new magnetoactive materials with better thermo-optical properties. This paper is devoted to the study of thermo-optical and magneto-optical characteristics of a unique magnetoactive material-a terbium scandium aluminum garnet (TSAG) crystal. The TSAG has an extraordinary value of optical anisotropy parameter xi, a Verdet constant 25% higher than the traditionally used terbium gallium garnet crystal and the highest magneto-optical figure-of-merit known in magnetoactive materials at the moment.	[Snetkov, Ilya L.; Starobor, Aleksey V.; Mironov, Evgeniy A.; Palashov, Oleg V.] Russian Acad Sci, Inst Appl Phys, Nizhnii Novgorod 603950, Russia; [Yasuhara, Ryo] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Palashov, Oleg V.] Natl Res Univ, NI Lobachevsky State Univ Nizhni Novgorod, Nizhnii Novgorod 603950, Russia	Snetkov, IL (reprint author), Russian Acad Sci, Inst Appl Phys, Nizhnii Novgorod 603950, Russia.	snetkov@appl.scinnov.ru; yasuhara@nifs.ac.jp; astarobor@mail.ru; miea209@rambler.ru; palashov@appl.sci-nnov.ru			Japan Society for the Promotion of Science [26709072]; National Institute for Fusion Science [URSX205]; Government of the Russian Federation through the Institute of Applied Physics, Russian Academy of Sciences, Nizhny Novgorod, Russia [14.B25.31.0024]	This work was supported in part by the Japan Society for the Promotion of Science through the Grants-in-Aid for Scientific Research under Grant 26709072, in part by the National Institute for Fusion Science under Grant URSX205, and in part by the Mega-Grant of the Government of the Russian Federation under Grant 14.B25.31.0024 through the Institute of Applied Physics, Russian Academy of Sciences, Nizhny Novgorod, Russia.	Andreev NF, 2002, QUANTUM ELECTRON+, V32, P91, DOI 10.1070/QE2002v032n01ABEH002134; Khazanov EA, 1999, IEEE J QUANTUM ELECT, V35, P1116, DOI 10.1109/3.777210; JOINER RE, 1977, APPL PHYS LETT, V30, P485, DOI 10.1063/1.89458; BRANDLE CD, 1973, J CRYST GROWTH, V20, P1, DOI 10.1016/0022-0248(73)90029-8; Mironov EA, 2014, OPT EXPRESS, V22, P23226, DOI 10.1364/OE.22.023226; Chenais S, 2006, PROG QUANT ELECTRON, V30, P89, DOI 10.1016/j.pquantelec.2006.12.001; SCOTT WC, 1971, APPL PHYS LETT, V18, P3, DOI 10.1063/1.1653466; Khazanov E, 2002, APPL OPTICS, V41, P483, DOI 10.1364/AO.41.000483; PETROVSKII GT, 1991, J NON-CRYST SOLIDS, V130, P35, DOI 10.1016/0022-3093(91)90153-W; Snetkov IL, 2013, OPT EXPRESS, V21, P21254, DOI 10.1364/OE.21.021254; DIXON RW, 1967, J APPL PHYS, V38, P5149, DOI 10.1063/1.1709293; Vyatkin AG, 2013, OPT EXPRESS, V21, P22338, DOI 10.1364/OE.21.022338; VILLAVERDE AB, 1978, J PHYS C SOLID STATE, V11, pL495, DOI 10.1088/0022-3719/11/12/004; WESTENBERGER G, 1991, P SOC PHOTO-OPT INS, V1535, P113, DOI 10.1117/12.48307; Yasuhara R, 2014, OPT LETT, V39, P1145, DOI 10.1364/OL.39.001145; Snetkov I, 2012, OPT EXPRESS, V20, P13357, DOI 10.1364/OE.20.013357; [Anonymous], SINGL CRYST IS; SLACK GA, 1971, PHYS REV B-SOLID ST, V4, P592, DOI 10.1103/PhysRevB.4.592; Yasuhara R, 2013, OPT LETT, V38, P1751, DOI 10.1364/OL.38.001751; Vyatkin AG, 2011, J OPT SOC AM B, V28, P805, DOI 10.1364/JOSAB.28.000805; Snetkov IL, 2012, APPL PHYS B-LASERS O, V109, P239, DOI 10.1007/s00340-012-5183-6; Pawlak DA, 2001, J CRYST GROWTH, V226, P341, DOI 10.1016/S0022-0248(01)01378-1; Snetkov IL, 2014, IEEE J QUANTUM ELECT, V50, P434, DOI 10.1109/JQE.2014.2317231; Chen X, 1998, SOLID STATE ELECTRON, V42, P1765, DOI 10.1016/S0038-1101(98)00163-4; Chen X, 1999, SOLID STATE COMMUN, V110, P431, DOI 10.1016/S0038-1098(99)00083-6; Galazka Z, 2002, CRYST RES TECHNOL, V37, P407; Ganschow S., 1996, P SOC PHOTO-OPT INS, V3178, P55; Graydon O., 2014, NATURE PHOTON, V8, P813; Ivanov I., 2009, P CLEO EUR EQEC MUN, P1; Kagamitani Y, 2002, JPN J APPL PHYS 1, V41, P6020, DOI 10.1143/JJAP.41.6020; Kagamitani Y, 2004, J MATER RES, V19, P579, DOI 10.1557/jmr.2004.19.2.579; Khazanov E, 2004, IEEE J QUANTUM ELECT, V40, P1500, DOI 10.1109/JQE.2004.834766; Khazanov E., 2010, ADV SOLID STATE LASE, V3, P45; Khazanov E, 2002, APPL OPTICS, V41, P2947, DOI 10.1364/AO.41.002947; KOECHNER W, 1970, IEEE J QUANTUM ELECT, VQE 6, P557, DOI 10.1109/JQE.1970.1076529; Kuznetsov I, 2014, OPT MATER EXPRESS, V4, P2204, DOI 10.1364/OME.4.002204; Mrazkova Z., 2010, P SOC PHOTO-OPT INS, V7746; Nye J., 1964, PHYS PROPERTIES CRYS; OSTERINK LM, 1968, APPL PHYS LETT, V12, P128, DOI 10.1063/1.1651922; Postava K., 2009, P SOC PHOTO-OPT INS, V7353; Reiche P., 1996, Germany Patent DE, Patent No. [4 443 251 A1, 4443251]; RUBINSTEIN CB, 1964, J APPL PHYS, V35, P3069, DOI 10.1063/1.1713182; Snetkov Ilya, 2011, Opt Express, V19, P6366, DOI 10.1364/OE.19.006366; Snetkov IL, 2014, OPT EXPRESS, V22, P4144, DOI 10.1364/OE.22.004144; Soms L. N., 1979, Soviet Journal of Quantum Electronics, V9, DOI 10.1070/QE1979v009n12ABEH009807; Soms L. N., 1980, Soviet Journal of Quantum Electronics, V10, DOI 10.1070/QE1980v010n03ABEH009991; Starobor AV, 2011, J OPT SOC AM B, V28, P1409; Weber M. J., 1986, P SPIE INT SOC OPT E, V681, P75; Yasuhara R, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4904461; Yoshikawa A, 2002, MATER RES BULL, V37, P1, DOI 10.1016/S0025-5408(01)00788-7	50	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9197	1558-1713		IEEE J QUANTUM ELECT	IEEE J. Quantum Electron.	JUL	2015	51	7							7000307	10.1109/JQE.2015.2431611		7	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	CK0XP	WOS:000355929300001		
J	Minakawa, K; Hayashi, N; Mizuno, Y; Nakamura, K				Minakawa, Kazunari; Hayashi, Neisei; Mizuno, Yosuke; Nakamura, Kentaro			Thermal Memory Effect in Polymer Optical Fibers	IEEE PHOTONICS TECHNOLOGY LETTERS			English	Article						Polymer optical fibers; temperature sensing; optical time-domain reflectometry; thermal memory effect	TIME-DOMAIN REFLECTOMETRY; DISTRIBUTED STRAIN; BRAGG GRATINGS; TEMPERATURE; PROPOSAL; LIGHT; INDEX; MODE; SENSOR; OTDR	The basic properties of a thermal memory effect of polymer optical fibers (POFs) are experimentally investigated. We measure the thermally induced loss as a function of time at several high temperatures, and find that the loss becomes almost constant after heating for similar to 200 s. The loss remains unchanged even after the heated section is cooled to room temperature. We subsequently measure the optical time-domain reflectometry traces under three different conditions: 1) before a POF section is heated; 2) shortly after the POF section is heated at high temperature; and 3) after the heated section is cooled to room temperature. The traces measured under 2) and 3) are moderately identical, which indicates that the thermal memory effect can be exploited in developing excess-heat detecting system in future.	[Minakawa, Kazunari; Hayashi, Neisei; Mizuno, Yosuke; Nakamura, Kentaro] Tokyo Inst Technol, Precis & Intelligence Lab, Yokohama, Kanagawa 2268503, Japan	Minakawa, K (reprint author), Tokyo Inst Technol, Precis & Intelligence Lab, Yokohama, Kanagawa 2268503, Japan.	kminakawa@sonic.pi.titech.ac.jp; hayashi@sonic.pi.titech.ac.jp; ymizuno@sonic.pi.titech.ac.jp; knakamur@sonic.pi.titech.ac.jp			Japan Society for the Promotion of Science (JSPS) [25709032, 26630180]; General Sekiyu Foundation; Iwatani Naoji Foundation; SCAT Foundation;  [25007652]	This work was supported in part by the Grants-in-Aid for Young Scientists (A) under Grant 25709032, in part for the Challenging Exploratory Research under Grant 26630180 through the Japan Society for the Promotion of Science (JSPS), and in part by the Research Grants through the General Sekiyu Foundation, Iwatani Naoji Foundation, and SCAT Foundation. The work of N. Hayashi was supported by the Grant-in-Aid for JSPS Fellows under Grant 25007652.	Hayashi N, 2012, OPT EXPRESS, V20, P21101, DOI 10.1364/OE.20.021101; Garus D, 1996, OPT LETT, V21, P1402, DOI 10.1364/OL.21.001402; Hotate K, 2000, IEICE T ELECTRON, VE83C, P405; Koike K, 2014, POLYM ADVAN TECHNOL, V25, P204, DOI 10.1002/pat.3224; Hotate K, 2008, OPT EXPRESS, V16, P7881, DOI 10.1364/OE.16.007881; HILL KO, 1978, APPL PHYS LETT, V32, P647, DOI 10.1063/1.89881; BARNOSKI MK, 1977, APPL OPTICS, V16, P2375, DOI 10.1364/AO.16.002375; DAKIN JP, 1985, ELECTRON LETT, V21, P569, DOI 10.1049/el:19850402; Koike Y, 2009, NPG ASIA MATER, V1, P22, DOI 10.1038/asiamat.2009.2; Huang J, 2012, OPT LETT, V37, P4308, DOI 10.1364/OL.37.004308; Liehr S, 2010, MEAS SCI TECHNOL, V21, DOI 10.1088/0957-0233/21/1/017001; KURASHIMA T, 1993, IEICE T COMMUN, VE76B, P382; Hayashi N, 2014, J APPL PHYS, V115, DOI 10.1063/1.4875102; Koyamada Y, 2009, J LIGHTWAVE TECHNOL, V27, P1142, DOI 10.1109/JLT.2008.928957; Xiong Z, 1999, IEEE PHOTONIC TECH L, V11, P352, DOI 10.1109/68.748232; Mizuno Y, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3463038; Dobb H, 2005, OPT LETT, V30, P3296, DOI 10.1364/OL.30.003296; Mizuno Y, 2008, OPT EXPRESS, V16, P12148, DOI 10.1364/OE.16.012148; Chanda M., 1998, PLASTICS TECHNOLOGY, V3rd; Dong YK, 2014, OPT EXPRESS, V22, P26510, DOI 10.1364/OE.22.026510; Farahani MA, 1999, J LIGHTWAVE TECHNOL, V17, P1379, DOI 10.1109/50.779159; Hayashi N, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.112501; Hayashi N, 2014, J LIGHTWAVE TECHNOL, V32, P3999, DOI 10.1109/JLT.2014.2339361; Hayashi N, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4895041; Horiguchi T., 1989, J LIGHTW TECHNOL, V1, P107; Husdi IR, 2004, MEAS SCI TECHNOL, V15, P1553, DOI [10.1088/0957-0233/15/8/022, 10.1088/0233-15-8-023]; Kuzyk M. G., 2006, POLYM FIBER OPTICS M; Minakawa K, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.042502; Minardo A, 2014, IEEE PHOTONIC TECH L, V26, P387, DOI 10.1109/LPT.2013.2294878; Nakamura K, 2005, P SOC PHOTO-OPT INS, V5855, P807, DOI 10.1117/12.624221; Numata G, 2015, IEICE ELECTRON EXPR, V12, DOI 10.1587/elex.12.20141173; Numata G, 2014, IEEE PHOTONICS J, V6, DOI 10.1109/JPHOT.2014.2352637; Saunders C, 2007, MEAS SCI TECHNOL, V18, P615, DOI 10.1088/0957-0233/18/3/010; Ujihara H, 2014, IEICE ELECTRON EXPR, V11, DOI 10.1587/elex.11.20140707; Won PC, 2004, MEAS SCI TECHNOL, V15, P1501, DOI 10.1088/0957-0233/15/8/012	35	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1041-1135	1941-0174		IEEE PHOTONIC TECH L	IEEE Photonics Technol. Lett.	JUL 1	2015	27	13					1394	1397		10.1109/LPT.2015.2421950		4	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	CK1AK	WOS:000355937100011		
J	Zhang, SL; Huang, YK; Yaman, F; Inada, Y				Zhang, Shaoliang; Huang, Yue-Kai; Yaman, Fatih; Inada, Yoshihisa			Performance Study of 100-Gb/s Super-Nyquist QPSK and Nyquist 8QAM over 25-GHz Spacing	IEEE PHOTONICS TECHNOLOGY LETTERS			English	Article						8QAM; DSP; QPSK; super-Nyquist; long-haul; MLSE	TRANSMISSION	To enable a 100 Gb/s over 25-GHz long-haul transmission solution, Nyquist 8-ary quadrature-amplitude modulation (QAM) and super-Nyquist quadrature phase-shifted keying (QPSK) are promising candidates. Nyquist 8QAM is experimentally demonstrated to have slightly better nonlinear tolerance than super-Nyquist QPSK at the same bit rate. The super-Nyquist QPSK signal suffers higher performance fluctuation depending on bandwidth squeezing.	[Zhang, Shaoliang; Huang, Yue-Kai; Yaman, Fatih] NEC Labs Amer Inc, Princeton, NJ 08540 USA; [Inada, Yoshihisa] NEC Corp Ltd, Submarine Network Div, Minato 1080014, Japan	Zhang, SL (reprint author), NEC Labs Amer Inc, Princeton, NJ 08540 USA.	szhang@nec-labs.com; kai@nec-labs.com; fyaman@nec-labs.com; y-inada@ak.jp.nec.com					Li JQ, 2012, J LIGHTWAVE TECHNOL, V30, P1664, DOI 10.1109/JLT.2012.2190972; Pfau T, 2009, J LIGHTWAVE TECHNOL, V27, P989, DOI 10.1109/JLT.2008.2010511; Jia ZS, 2014, OPT EXPRESS, V22, P6047, DOI 10.1364/OE.22.006047; Yu JJ, 2013, OPT EXPRESS, V21, P15686, DOI 10.1364/OE.21.015686; Beppu S., 2014, P OFC, P1; Cai JX, 2014, J LIGHTWAVE TECHNOL, V32, P832, DOI 10.1109/JLT.2013.2284669; Chang D., 2012, P OPT FIB COMM C EXP, P1; Cho JH, 2012, OPT EXPRESS, V20, P7915, DOI 10.1364/OE.20.007915; Huang YK, 2011, PROC SPIE, V8309, DOI 10.1117/12.920491; Igarashi K., 2013, P ECOC, P1; Qian D., 2011, P ASME TURB EXP 2011, P1; Salsi M., 2013, P ECOC, P1; Yan M., 2013, P IEEE INT C MULT EX, P1; Zhang J., 2014, P OFC, P1; Zhang S., 2014, P OFC, P1	15	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1041-1135	1941-0174		IEEE PHOTONIC TECH L	IEEE Photonics Technol. Lett.	JUL 1	2015	27	13					1445	1448		10.1109/LPT.2015.2425352		4	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	CK1AK	WOS:000355937100024		
J	Guo, KJ; Halemano, K; Schmitt, K; Katuwal, M; Wang, YQ; Harper, MS; Heilman, KJ; Kuwata, T; Stephens, EB; Santiago, ML				Guo, Kejun; Halemano, Kalani; Schmitt, Kimberly; Katuwal, Miki; Wang, Yaqiong; Harper, Michael S.; Heilman, Karl J.; Kuwata, Takeo; Stephens, Edward B.; Santiago, Mario L.			Immunoglobulin V-H gene diversity and somatic hypermutation during SIV infection of rhesus macaques	IMMUNOGENETICS			English	Article						Antibody repertoire; Deaminase; Somatic hypermutation; Rhesus macaque; Simian immunodeficiency virus; APOBEC3G	IMMUNODEFICIENCY-VIRUS-INFECTION; CYTIDINE DEAMINASE AID; B-CELL SUBSETS; HIV-1 IN-VIVO; MONOCLONAL-ANTIBODIES; RETROVIRAL INFECTION; TYPE-1 INFECTION; LYMPHOID-TISSUES; APOBEC PROTEINS; IFN-ALPHA	B cell functional defects are associated with delayed neutralizing antibody development in pathogenic lentivirus infections. However, the timeframe for alterations in the antibody repertoire and somatic hypermutation (SHM) remains unclear. Here, we utilized the SIV/rhesus macaque (RM) model to investigate the dynamics of immunoglobulin V-H gene diversity and SHM following infection. Three RMs were infected with SIVmac239, and V(H)1, V(H)3, and V(H)4 genes were amplified from peripheral blood at 0, 2, 6, 24, and 36 weeks postinfection for next-generation sequencing. Analysis of over 3.8 million sequences against currently available RM germline V-H genes revealed a highly biased V-H gene repertoire in outbred RMs. SIV infection did not significantly perturb the predominant IgG1 response, but overall immunoglobulin SHM declined during the course of SIV infection. Moreover, SHM at the AID deamination hotspot, WRC, rapidly decreased and was suppressed throughout SIV infection. In contrast, a transient increase in mutations at the APOBEC3G deamination hotspot, CCC, coincided with a spike in APOBEC3G expression during acute SIV infection. The results outline a timetable for altered V-H gene repertoire and IgG SHM in the SIV/RM model and suggest a burst of APOBEC3G-mediated antibody SHM during acute SIV infection.	[Guo, Kejun; Halemano, Kalani; Harper, Michael S.; Heilman, Karl J.; Santiago, Mario L.] Univ Colorado Denver, Dept Med Immunol & Microbiol, Aurora, CO 80045 USA; [Schmitt, Kimberly; Katuwal, Miki; Wang, Yaqiong; Stephens, Edward B.] Univ Kansas, Med Ctr, Dept Microbiol Mol Genet & Immunol, Kansas City, KS 66160 USA; [Kuwata, Takeo] Kumamoto Univ, Ctr AIDS Res, Kumamoto 8600811, Japan	Stephens, EB (reprint author), Univ Kansas, Med Ctr, Dept Microbiol Mol Genet & Immunol, Kansas City, KS 66160 USA.	estephen@kumc.edu; mario.santiago@ucdenver.edu			National Institutes of Health [AI090795, AI108391]; University of Colorado Department of Medicine; American Society for Microbiology; Tim Gill Foundation	This work was supported by the National Institutes of Health [AI090795 to M.L.S., AI108391 to E.B.S.] and the University of Colorado Department of Medicine Early Career Scholar Program [to M.L.S.]. K.H. was the recipient of the Robert D. Watkins Predoctoral Fellowship from the American Society for Microbiology, and M.S.H. was partially supported by an endowment from the Tim Gill Foundation to the Division of Infectious Diseases.	Andris JS, 1997, MOL IMMUNOL, V34, P237, DOI 10.1016/S0161-5890(97)00021-7; Folkvord JM, 2005, AIDS RES HUM RETROV, V21, P363, DOI 10.1089/aid.2005.21.363; Bible JM, 2003, IMMUNOGENETICS, V54, P867, DOI 10.1007/s00251-003-0536-2; Das A, 2011, CLIN IMMUNOL, V140, P223, DOI 10.1016/j.clim.2011.04.018; Halemano K, 2014, P NATL ACAD SCI USA, V111, P7759, DOI 10.1073/pnas.1403361111; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Hasler J, 2012, SEMIN IMMUNOL, V24, P273, DOI 10.1016/j.smim.2012.05.004; Petrovas C, 2012, J CLIN INVEST, V122, P3281, DOI 10.1172/JCI63039; Peled JU, 2008, ANNU REV IMMUNOL, V26, P481, DOI 10.1146/annurev.immunol.26.021607.090236; Nagase H, 2001, CLIN IMMUNOL, V100, P250, DOI 10.1006/clim.2001.5054; Hart M, 2007, J IMMUNOL, V178, P8212; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758; Santiago ML, 2008, SCIENCE, V321, P1343, DOI 10.1126/science.1161121; Klein F, 2013, CELL, V153, P126, DOI 10.1016/j.cell.2013.03.018; Harper MS, 2013, J IMMUNOL, V190, P1583, DOI 10.4049/jimmunol.1202920; Malleret B, 2008, BLOOD, V112, P4598, DOI 10.1182/blood-2008-06-162651; Beale RCL, 2004, J MOL BIOL, V337, P585, DOI 10.1016/j.jmb.2004.01.046; Pillai SK, 2012, P NATL ACAD SCI USA, V109, P3035, DOI 10.1073/pnas.1111573109; Zhang ZQ, 2007, VIROLOGY, V361, P455, DOI 10.1016/j.virol.2006.12.006; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Stacey AR, 2009, J VIROL, V83, P3719, DOI 10.1128/JVI.01844-08; Imbeault M, 2011, J VIROL, V85, P2189, DOI 10.1128/JVI.01993-10; Malaspina A, 2005, J INFECT DIS, V191, P1442, DOI 10.1086/429298; De Milito A, 2001, AIDS, V15, P957, DOI 10.1097/00002030-200105250-00003; Tsuji-Kawahara S, 2010, J VIROL, V84, P6082, DOI 10.1128/JVI.02516-09; Hultquist JF, 2011, J VIROL, V85, P11220, DOI 10.1128/JVI.05238-11; ROGOZIN IB, 1992, BIOCHIM BIOPHYS ACTA, V1171, P11, DOI 10.1016/0167-4781(92)90134-L; Liddament MT, 2004, CURR BIOL, V14, P1385, DOI 10.1016/j.cub.2004.06.050; Moir S, 2009, NAT REV IMMUNOL, V9, P235, DOI 10.1038/nri2524; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Schmitt K, 2011, VIROLOGY, V419, P24, DOI 10.1016/j.virol.2011.07.017; JANOFF EN, 1993, J INFECT DIS, V167, P49; Langlois MA, 2009, J VIROL, V83, P11550, DOI 10.1128/JVI.01430-09; Malaspina A, 2006, P NATL ACAD SCI USA, V103, P2262, DOI 10.1073/pnas.0511094103; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Mehta HV, 2012, J IMMUNOL, V189, P4088, DOI 10.4049/jimmunol.1200777; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Lefranc MP, 2009, NUCLEIC ACIDS RES, V37, pD1006, DOI 10.1093/nar/gkn838; Hofmann-Lehmann R, 2000, AIDS RES HUM RETROV, V16, P1247, DOI 10.1089/08892220050117014; Xu Y, 2013, J VIROL, V87, P3760, DOI 10.1128/JVI.02497-12; Wiegand HL, 2004, EMBO J, V23, P2451, DOI 10.1038/sj.emboj.7600246; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Rahmberg AR, 2013, J VIROL, V87, P13917, DOI 10.1128/JVI.01757-13; Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Scinicariello F, 2004, IMMUNOLOGY, V111, P66, DOI 10.1046/j.1365-2567.2003.01767.x; Burton DR, 2012, CELL HOST MICROBE, V12, P396, DOI 10.1016/j.chom.2012.09.008; Malim MH, 2009, PHILOS T R SOC B, V364, P675, DOI 10.1098/rstb.2008.0185; Titanji K, 2010, J CLIN INVEST, V120, P3878, DOI 10.1172/JCI43271; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Barrett BS, 2014, VIROLOGY, V468, P601, DOI 10.1016/j.virol.2014.09.006; Bekker V, 2006, AIDS, V20, P2321, DOI 10.1097/QAD.0b013e3280113f29; Bowers E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0081913; Briney BS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100839; Connick E, 2014, J IMMUNOL, V193, P5613, DOI 10.4049/jimmunol.1401161; Conticello Silvestro G, 2007, Adv Immunol, V94, P37, DOI 10.1016/S0065-2776(06)94002-4; Helmuth EF, 2000, IMMUNOGENETICS, V51, P519, DOI 10.1007/s002510000170; Jern P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000367; Kroon FP, 1999, VACCINE, V17, P2941, DOI 10.1016/S0264-410X(99)00167-X; Kuhrt D, 2010, J VIROL, V84, P2466, DOI 10.1128/JVI.01966-09; Kuwata T, 2011, AIDS RES HUM RETROV, V27, P487, DOI 10.1089/aid.2010.0191; Kuwata T, 2013, J VIROL, V87, P5424, DOI 10.1128/JVI.00201-13; LANE HC, 1983, NEW ENGL J MED, V309, P453, DOI 10.1056/NEJM198308253090803; Levesque MC, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000107; Margolin DH, 1997, J VIROL, V71, P8582; Mussil B, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-77; Olivieri DN, 2015, IMMUNOGENETICS, V67, P211, DOI 10.1007/s00251-015-0830-9; Perise-Barrios AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039472; Petit V, 2009, J MOL BIOL, V385, P65, DOI 10.1016/j.jmb.2008.10.043; Pham P, 2008, J BIOL CHEM, V283, P31754, DOI 10.1074/jbc.M805524200; Refsland EW, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002800; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Sato S, 2008, J VIROL, V82, P9739, DOI 10.1128/JVI.00871-08; Schmitt K, 2009, VIROLOGY, V383, P362, DOI 10.1016/j.virol.2008.10.013; Smith DS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002284; Sundling C, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003752; Yeh WW, 2010, J VIROL, V84, P6018, DOI 10.1128/JVI.02741-09; Zheng NY, 2005, J EXP MED, V201, P1467, DOI 10.1084/jem.20042483	80	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0093-7711	1432-1211		IMMUNOGENETICS	Immunogenetics	JUL	2015	67	7					355	370		10.1007/s00251-015-0844-3		16	Genetics & Heredity; Immunology	Genetics & Heredity; Immunology	CJ8LE	WOS:000355751200002		
J	Kurokochi, Y; Sato, M				Kurokochi, Yoko; Sato, Masatoshi			Properties of binderless board made from rice straw: The morphological effect of particles	INDUSTRIAL CROPS AND PRODUCTS			English	Article						Rice straw; Board; Self-bonding; Water resistance; Wax-like substance	FIBERBOARDS; FIBERS; BAMBOO; PANELS	Binderless boards were manufactured from rice straw by hot-pressing in order to evaluate the morphological effect of particles from rice straw. For the morphological effect, we examined the influence of particle size and morphological parts of rice straw, respectively. Internal bonding (IB), thickness swelling (TS) and water absorption (WA) were measured as the properties of the boards. As a result, binderless boards were successfully manufactured from rice straw powder smaller than 1 mm. Regarding the effect of morphological part from rice straw, IB of the board made from stem powder was the highest, subsequently followed by leaf blade powder, and leaf sheath powder. IB tended to increase with decreasing ash and silica contents. Trichomes and wart-like protuberances on the epidermis of rice straw might inhibit the bonding between particles. The water resistance of binderless boards made from rice straw was high regardless of low IB. It is possible that wax-like substances on the epidermis of rice straw might contribute to the water resistance of the board. (C) 2015 Elsevier B.V. All rights reserved.	[Kurokochi, Yoko; Sato, Masatoshi] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan	Kurokochi, Y (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	7900739965@mail.ecc.u-tokyo.ac.jp; amsato@mail.ecc.u-tokyo.ac.jp					A5905 J.I.S., 2014, A5905 JIS JAP STAND; A5908 J.I.S., 2003, A5908 JIS JAP STAND; Rabemanolontsoa H, 2013, RSC ADV, V3, P3946, DOI 10.1039/c3ra22958k; Oberoi HS, 2012, J IND MICROBIOL BIOT, V39, P557, DOI 10.1007/s10295-011-1060-2; Hiziroglu S, 2007, FOREST PROD J, V57, P46; El-Kassas AM, 2013, MATER DESIGN, V50, P757, DOI 10.1016/j.matdes.2013.03.057; Li XJ, 2010, BIORESOURCE TECHNOL, V101, P4662, DOI 10.1016/j.biortech.2010.01.053; Zhang L, 2014, MATER DESIGN, V55, P19, DOI 10.1016/j.matdes.2013.09.066; Halvarsson S, 2009, IND CROP PROD, V29, P437, DOI 10.1016/j.indcrop.2008.08.007; IIYAMA K, 1994, APPL ENVIRON MICROB, V60, P1538; El-Zawawy WK, 2011, CARBOHYD POLYM, V84, P865, DOI 10.1016/j.carbpol.2010.12.022; Li XJ, 2011, IND CROP PROD, V33, P665, DOI 10.1016/j.indcrop.2011.01.004; Pan XJ, 1999, HOLZFORSCHUNG, V53, P49, DOI 10.1515/HF.1999.009; Inglesby MK, 2005, COLLOID SURFACE B, V43, P83, DOI 10.1016/j.colsurfb.2005.03.014; Boon JG, 2013, EUR J WOOD WOOD PROD, V71, P583, DOI 10.1007/s00107-013-0712-5; Hiziroglu S, 2005, FOREST PROD J, V55, P221; Hoshikawa K., 1989, GROWING RICE PLANT A; Jin SY, 2006, PROCESS BIOCHEM, V41, P1261, DOI 10.1016/j.procbio.2005.12.022; Matsuda T., 1985, JPN J CROP SCI, V54, P210; Okuda N., 2004, J WOOD SCI, V50, P62; Sun RC, 2002, J WOOD CHEM TECHNOL, V22, P1, DOI 10.1081/WCT-120004430; Velasquez JA, 2003, WOOD SCI TECHNOL, V37, P269, DOI 10.1007/s00226-003-0182-8; Wang JK, 2007, ANIM FEED SCI TECH, V136, P51, DOI 10.1016/j.anifeedsci.2006.08.017	23	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0926-6690	1872-633X		IND CROP PROD	Ind. Crop. Prod.	JUL	2015	69						55	59		10.1016/j.indcrop.2015.01.044		5	Agricultural Engineering; Agronomy	Agriculture	CJ3ED	WOS:000355365300008		
J	Kukula-Koch, W; Koch, W; Stasiak, N; Glowniak, K; Asakawa, Y				Kukula-Koch, Wirginia; Koch, Wojciech; Stasiak, Natalia; Glowniak, Kazimierz; Asakawa, Yoshinori			Quantitative standarization and CPC-based recovery of pharmacologically active components from Polygonum tinctorium Ait. leaf extracts	INDUSTRIAL CROPS AND PRODUCTS			English	Article						Polygonum tinctorium; Indigo; Indirubin; CPC; Counter-current chromatography; Traditional Chinese Medicine; Quantification; Extraction conditions	COUNTER-CURRENT CHROMATOGRAPHY; INDIGO; PURIFICATION; ANTIOXIDANT	Polygonum tinctorium Alt. (dyer's knotweed) is a commonly known Asian perennial containing indole alkaloids - indigo and indirubin. Its leaves constitute a pharmacopoeial material (Chinese Pharmacopoeia) known for its antineoplastic, antipsoriatic, antiviral and antibacterial actions. This article presents the results of a detailed study into the optimization of the extraction and separation (CPC-based purification) process, and also the quantitative analysis of the extracts. The applied extraction parameters considered the impact of the extraction temperature, its duration and the solvent selection on the quantitative analysis of both indigo and indirubin. The study concludes that a 30 min long extraction of the leaves, in a 2% solution of chloral hydrate in dichloromethane, was found to be most beneficial and reproductive. The compounds' poor solubility, low stability and high toxicity of the so far used solvents, were some of the challenges encountered. CPC purification by heptane:ethyl acetate:methanol:water (6:1:6:1) in ascending mode led to the most satisfactory results in terms of purity, solvent consumption and duration. The elaborated method can be used as a suitable tool for the detailed quantitative indigo and indirubin standardization in the leaves of the P. tinctorium. The indirubin recovery model may serve for further scale-up for industrial applications. (C) 2015 Elsevier B.V. All rights reserved.	[Kukula-Koch, Wirginia; Stasiak, Natalia; Glowniak, Kazimierz] Med Univ Lublin, Chair & Dept Pharmacognosy, Med Plant Unit, PL-20093 Lublin, Poland; [Koch, Wojciech] Med Univ Lublin, Chair & Dept Food & Nutr, PL-20093 Lublin, Poland; [Kukula-Koch, Wirginia; Koch, Wojciech; Asakawa, Yoshinori] Tokushima Bunri Univ, Fac Pharmaceut Sci, Dept Pharmaceut Chem, Tokushima 7708514, Japan	Kukula-Koch, W (reprint author), Med Univ Lublin, Chair & Dept Pharmacognosy, Med Plant Unit, 1 Chodzki Str, PL-20093 Lublin, Poland.	virginia.kukula@gmail.com		Kukula-Koch, Wirginia/0000-0001-7076-600X			Foucault AP, 1998, J CHROMATOGR A, V808, P3, DOI 10.1016/S0021-9673(98)00121-6; Ito Y, 1996, J CHROMATOGR A, V753, P1, DOI 10.1016/S0021-9673(96)00565-1; Berthod A, 2005, ANAL BIOANAL CHEM, V383, P327, DOI 10.1007/s00216-005-0016-7; Marston A, 2006, J CHROMATOGR A, V1112, P181, DOI 10.1016/j.chroma.2005.10.018; [Anonymous], 2005, PHARMACOPOEIA PEOPLE, VI; Heo BG, 2013, IND CROP PROD, V42, P429, DOI 10.1016/j.indcrop.2012.06.029; Falodun A, 2008, ACTA POL PHARM, V65, P571; Hunger K., 2007, CHEM PROPERTIES APPL; Islam S. u., 2013, J CLEAN PROD, V57, P2; Iwaki K, 2011, J ETHNOPHARMACOL, V134, P450, DOI 10.1016/j.jep.2010.12.041; Kim KS, 2012, LWT-FOOD SCI TECHNOL, V46, P500, DOI 10.1016/j.lwt.2011.11.017; Lu HT, 2012, PHYTOCHEM ANALYSIS, V23, P637, DOI 10.1002/pca.2366; Meijer L., 2006, INDIRUBIN RED SHADE; Stasiak N, 2014, ACTA POL PHARM, V71, P215; Toshio K., 2000, EUR J PHARMACOL, V410, P93; WOUTERS J, 1991, J SOC DYERS COLOUR, V107, P266; Zhong Y, 2005, ANTIVIR RES, V66, P119, DOI 10.1016/j.antiviral.2005.02.003	17	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0926-6690	1872-633X		IND CROP PROD	Ind. Crop. Prod.	JUL	2015	69						324	328		10.1016/j.indcrop.2015.02.048		5	Agricultural Engineering; Agronomy	Agriculture	CJ3ED	WOS:000355365300042		
J	Akao, S; Nagare, H; Maeda, M; Kondo, K; Fujiwara, T				Akao, S.; Nagare, H.; Maeda, M.; Kondo, K.; Fujiwara, T.			Combined use of sugars and nutrients derived from young maize plants for thermophilic L-lactic acid fermentation	INDUSTRIAL CROPS AND PRODUCTS			English	Article						Nutrient supplementation; Corn stover; Alkaline pretreatment; Enzymatic saccharification; Bacillus coagulans; Catch crop	L-LACTATE FERMENTATION; SIMULTANEOUS SACCHARIFICATION; ETHANOL-PRODUCTION; CORN STOVER; CATCH CROP; BIOMASS; JUICE; OPTIMIZATION; BIOREFINERY; SELECTION	Fermentation of lignocellulosic biomass requires auxiliary materials such as nutrients for fermentation. Because of the low prices of fermentation products such as bioethanol, the costs of nutrients are not negligible. We have developed the concept of using substances natively present in lignocellulosic biomass as nutrients for the downstream fermentation. The leaves and stalks of young dent corn plants were used as biomass and the nutrients were recovered by soaking them in water before alkaline pretreatment, followed by enzymatic saccharification and fermentation. Performing thermophilic L-lactic acid fermentation using these recovered nutrients support their use as commercially feasible alternatives. A level of recovered nutrients of 40% was sufficient to support the fermentation of recovered sugars derived from the same corn biomass. However, the amount of recovered nutrients required for fermentation was almost double that when using yeast extract based on the amounts of nitrogen and/or phosphorus added. The nitrogen and phosphorus balances in the process indicated that adding nutrients was crucial for promoting fermentation based on the amounts of nitrogen and phosphorus. The nutrients proposed were considered to be effective for fermenting biomass pretreated by alkaline, dilute add, and hydrothermal methods. (C) 2015 Elsevier B.V. All rights reserved.	[Akao, S.] Tottori Univ, Grad Sch Engn, Management Social Syst & Civil Engn, Tottori 6808552, Japan; [Nagare, H.; Maeda, M.] Okayama Univ, Grad Sch Environm & Life Sci, Okayama 7008530, Japan; [Kondo, K.; Fujiwara, T.] Kochi Univ, Res & Educ Fac, Nat Sci Cluster, Agr Unit, Kochi, Japan	Akao, S (reprint author), Tottori Univ, Grad Sch Engn, Management Social Syst & Civil Engn, 4-101 Koyama Minami, Tottori 6808552, Japan.	akao@sse.tottori-u.ac.jp			Japan Science and Technology Agency, CREST	This work was supported by the Japan Science and Technology Agency, CREST. The microbial strains were supplied by Riken Bioresource Center. The authors wish to thank Mr. Yamane for supplying the young corn biomass and Meiji Seika Kaisha Ltd., for supplying Meiselase.	Adney B, 1996, MEASUREMENT CELLULAS; Akao S, 2007, WATER RES, V41, P1774, DOI 10.1016/j.watres.2007.01.013; Akao S, 2012, ENVIRON TECHNOL, V33, P1523, DOI 10.1080/09593330.2012.669412; Dishisha T, 2013, BIORESOURCE TECHNOL, V135, P504, DOI 10.1016/j.biortech.2012.08.098; Hetenyi K, 2010, J CHEM TECHNOL BIOT, V85, P872, DOI 10.1002/jctb.2381; Lau MW, 2012, ENERG ENVIRON SCI, V5, P7100, DOI 10.1039/c2ee03596k; Kang L, 2011, BIORESOURCES, V6, P3791; Thomsen MH, 2005, APPL MICROBIOL BIOT, V68, P598, DOI 10.1007/s00253-005-0056-0; Lau MW, 2008, BIOTECHNOL BIOENG, V99, P529, DOI 10.1002/bit.21609; Fujiwara T, 2012, WATER SCI TECHNOL, V66, P1171, DOI 10.2166/wst.2012.246; GOULD JM, 1984, BIOTECHNOL BIOENG, V26, P46, DOI 10.1002/bit.260260110; Jorgensen H, 2009, APPL BIOCHEM BIOTECH, V153, P44, DOI 10.1007/s12010-008-8456-0; Andersen M, 2000, IND CROP PROD, V11, P129, DOI 10.1016/S0926-6690(99)00055-2; APHA, 1998, STANDARD METHODS EXA; Davis R., 2013, PROCESS DESIGN EC CO; Koreishi M., 2009, Seibutsu-kogaku Kaishi, V87, P216; Nagare H, 2012, WATER SCI TECHNOL, V66, P1110, DOI 10.2166/wst.2012.291; Park Y.W., 1996, HDB FOOD ANAL, P59; Rittmann B.E., 2001, ENV BIOTECHNOLOGY PR, P1; Selig M., 2008, ENZYMATIC SACCHARIFI; Sluiter A, 2008, DETERMINATION STRUCT; Smith AD, 2010, BIORESOURCE TECHNOL, V101, P9700, DOI 10.1016/j.biortech.2010.07.072; Sreenath HK, 2001, J BIOSCI BIOENG, V92, P518, DOI 10.1263/jbb.92.518; Thomsen MH, 2007, APPL MICROBIOL BIOT, V74, P540, DOI 10.1007/s00253-006-0694-x; Thomsen MH, 2008, J SCI FOOD AGR, V88, P976, DOI 10.1002/jsfa.3176; Uppugundla N, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-72; Venus J, 2006, ENG LIFE SCI, V6, P492, DOI 10.1002/elsc.200520136	27	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0926-6690	1872-633X		IND CROP PROD	Ind. Crop. Prod.	JUL	2015	69						440	446		10.1016/j.indcrop.2015.02.055		7	Agricultural Engineering; Agronomy	Agriculture	CJ3ED	WOS:000355365300058		
J	McIntyre, BAS; Kushwah, R; Mechael, R; Shapovalova, Z; Alev, C; Bhatia, M				McIntyre, Brendan A. S.; Kushwah, Rahul; Mechael, Rami; Shapovalova, Zoya; Alev, Cantas; Bhatia, Mickie			Innate immune response of human pluripotent stem cell-derived airway epithelium	INNATE IMMUNITY			English	Article						Airway epithelia; cellular differentiation; human embryonic stem cells; innate immune response; TNF-alpha	NECROSIS-FACTOR-ALPHA; 18S RIBOSOMAL-RNA; GENE-EXPRESSION; REAL-TIME; MURINE MACROPHAGES; TNF-ALPHA; INFLAMMATION; DIFFERENTIATION; VALIDATION; GENERATION	The acquisition of innate immune response is requisite to having bona fide differentiation of airway epithelium. Procedures developed to differentiate lung airway from human pluripotent stem cells (hPSCs) have demonstrated anecdotal evidence for innate immune response, but an in-depth exploration of response levels is lacking. Herein, using an established method of airway epithelial generation from hPSCs, we show that hPSC-derived epithelial cells are able to up-regulate expression of TNF, IL8 and IL1 in response to challenge with bacterial endotoxin LPS, but lack response from genes associated with innate immune response in other cell types. Further, stimulation of cells with TNF- resulted in auto-induction of TNF transcript, as well as cytokine responses of IL8 and IL1. The demonstration of innate immune induction in hPSC-derived airway epithelia gives further strength to the functionality of invitro protocols aimed at generating differentiated airway cells that can potentially be used in a translational setting. Finally, we propose that innate immune challenge of airway epithelium from human pluripotent stem cell sources be used as a robust validation of functional invitro differentiation.	[McIntyre, Brendan A. S.; Kushwah, Rahul; Mechael, Rami; Shapovalova, Zoya; Bhatia, Mickie] Michael G DeGroote Sch Med, McMaster Stem Cell & Canc Res Inst, Hamilton, ON, Canada; [Alev, Cantas] RIKEN Ctr Dev Biol CDB, Lab Early Embryogenesis, Kobe, Hyogo, Japan; [Mechael, Rami] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8S 4K1, Canada	Bhatia, M (reprint author), McMaster Univ, Stem Cell & Canc Res Inst, Fac Hlth Sci, 1280 Main St West,MDCL 5029, Hamilton, ON L8S 4K1, Canada.	mbhatia@mcmaster.ca			CIHR Emerging Team Grant; CIHR-Banting Fellowship	This work was supported by a CIHR Emerging Team Grant to M.B.; R.K. was supported by CIHR-Banting Fellowship.	FIELD M, 1991, RHEUMATOL INT, V11, P45, DOI 10.1007/BF00291144; LIEBER M, 1976, INT J CANCER, V17, P62, DOI 10.1002/ijc.2910170110; Unkel B, 2012, J CLIN INVEST, V122, P3652, DOI 10.1172/JCI62139; Huang SXL, 2014, NAT BIOTECHNOL, V32, P84, DOI 10.1038/nbt.2754; Kim J, 2010, LAB CHIP, V10, P43, DOI 10.1039/b911367c; Schmid H, 2003, KIDNEY INT, V64, P356, DOI 10.1046/j.1523-1755.2003.00074.x; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; McRitchie DI, 2000, CYTOKINE, V12, P644, DOI 10.1006/cyto.1999.0656; Sun D, 2005, AURIS NASUS LARYNX, V32, P243, DOI 10.1016/j.anl.2005.01.004; REDDEL RR, 1988, CANCER RES, V48, P1904; STADNYK AW, 1994, FASEB J, V8, P1041; Wong AP, 2012, NAT BIOTECHNOL, V30, P876, DOI 10.1038/nbt.2328; Zhou BH, 2005, NAT IMMUNOL, V6, P1047, DOI 10.1038/ni1247; Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; SIMON RH, 1995, J LAB CLIN MED, V126, P108; Schmittgen TD, 2000, J BIOCHEM BIOPH METH, V46, P69, DOI 10.1016/S0165-022X(00)00129-9; Eggleton P, 1999, CURR OPIN IMMUNOL, V11, P28, DOI 10.1016/S0952-7915(99)80006-5; Bas A, 2004, SCAND J IMMUNOL, V59, P566, DOI 10.1111/j.0300-9475.2004.01440.x; Lukasiak Sebastian, 2008, V429, P59, DOI 10.1007/978-1-60327-040-3_5; Rojas M, 2005, AM J PHYSIOL-LUNG C, V288, pL333, DOI 10.1152/ajplung.00334.2004; Cai CQ, 2000, J IMMUNOL, V165, P3978; Crotta S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003773; Groeneweg M, 2006, J LIPID RES, V47, P2259, DOI 10.1194/jlr.M600181-JLR200; Harder J, 2000, AM J RESP CELL MOL, V22, P714; Iannitti RG, 2013, AM J RESP CRIT CARE, V188, P1338, DOI 10.1164/rccm.201305-0986OC; Kim J, 2010, JOVE-J VIS EXP, P1749; Kushwah R, 2011, J IMMUNOL, V187, P4639, DOI 10.4049/jimmunol.1101967; McIntyre BAS, 2014, STEM CELL TRANSL MED, V3, P7, DOI 10.5966/sctm.2013-0119; Van Haute L, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-105; Wu J, 2008, CELL RES, V18, P649, DOI 10.1038/cr.2008.57; Xavier AM, 1999, AM J RESP CELL MOL, V21, P510	31	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1753-4259	1753-4267		INNATE IMMUN-LONDON	Innate Immun.	JUL	2015	21	5					504	511		10.1177/1753425914551074		8	Biochemistry & Molecular Biology; Immunology; Medicine, Research & Experimental; Microbiology	Biochemistry & Molecular Biology; Immunology; Research & Experimental Medicine; Microbiology	CJ6RA	WOS:000355619800005		
J	Jaelani, LM; Matsushita, B; Yang, W; Fukushima, T				Jaelani, Lalu Muhamad; Matsushita, Bunkei; Yang, Wei; Fukushima, Takehiko			An improved atmospheric correction algorithm for applying MERIS data to very turbid inland waters	INTERNATIONAL JOURNAL OF APPLIED EARTH OBSERVATION AND GEOINFORMATION			English	Article						Inland waters; Remote-sensing; Aerosol model; Turbidity of water body; Atmospheric correction; Bio-optical model	INHERENT OPTICAL-PROPERTIES; REMOTE-SENSING REFLECTANCE; OCEAN COLOR IMAGERY; LAKE KASUMIGAURA; LEAVING REFLECTANCE; SEAWIFS IMAGERY; CHLOROPHYLL-A; JAPAN; VALIDATION; RETRIEVAL	Atmospheric correction (AC) is a necessary process when quantitatively monitoring water quality parameters from satellite data. However, it is still a major challenge to carry out AC for turbid coastal and inland waters. In this study, we propose an improved AC algorithm named N-GWI (new standard Gordon and Wang's algorithms with an iterative process and a bio-optical model) for applying MERIS data to very turbid inland waters (i.e., waters with a water-leaving reflectance at 864.8 nm between 0.001 and 0.01). The N-GWI algorithm incorporates three improvements to avoid certain invalid assumptions that limit the applicability of the existing algorithms in very turbid inland waters. First, the N-GWI uses a fixed aerosol type (coastal aerosol) but permits aerosol concentration to vary at each pixel; this improvement omits a complicated requirement for aerosol model selection based only on satellite data. Second, it shifts the reference band from 670 nm to 754 nm to validate the assumption that the total absorption coefficient at the reference band can be replaced by that of pure water, and thus can avoid the uncorrected estimation of the total absorption coefficient at the reference band in very turbid waters. Third, the N-GWI generates a semi-analytical relationship instead of an empirical one for estimation of the spectral slope of particle backscattering. Our analysis showed that the N-GWI improved the accuracy of atmospheric correction in two very turbid Asian lakes (Lake Kasumigaura, Japan and Lake Dianchi, China), with a normalized mean absolute error (NMAE) of less than 22% for wavelengths longer than 620 nm. However, the N-GWI exhibited poor performance in moderately turbid waters (the NMAE values were larger than 83.6% in the four American coastal waters). The applicability of the N-GWI, which includes both advantages and limitations, was discussed. (C) 2015 Elsevier B.V. All rights reserved.	[Jaelani, Lalu Muhamad; Matsushita, Bunkei; Fukushima, Takehiko] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Jaelani, Lalu Muhamad] Inst Teknol Sepuluh Nopember, Geomat Engn Dept, Surabaya 60111, Indonesia; [Yang, Wei] Japan Agcy Marine Earth Sci & Technol, Dept Environm Geochem Cycle Res, Yokohama, Kanagawa 2370061, Japan	Jaelani, LM (reprint author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan.	matsushita.bunkei.gn@u.tsukuba.ac.jp	Yang, Wei/M-6620-2015; 	Yang, Wei/0000-0003-3342-7679; Jaelani, Lalu Muhamad/0000-0003-2663-9016	MEXT from Japan [25420555, 23404015]; Environment Research and Technology Development Fund of the Ministry of the Environment, Japan [S-9-4-(1)]; DIKTI scholarship, Directorate General of Higher Education, Ministry of Education and Culture, Republic of Indonesia	This research was supported in part by the Grants-in-Aid for Scientific Research of MEXT from Japan (No. 25420555 and No. 23404015), and also by the Environment Research and Technology Development Fund (S-9-4-(1)) of the Ministry of the Environment, Japan. The first author was supported by DIKTI scholarship, Directorate General of Higher Education, Ministry of Education and Culture, Republic of Indonesia. The MERIS L1B data were obtained from ESA Earth Observation Website. The in situ data used in this study was partly obtained from SeaBASS database. These data were contributed by Chuanmin Hu, Frank Muller-Karger, Gerardo Toro-Farmer, Maria Vega-Rodriguez, and Nelson Melo, The authors thank to all contributors and NASA Ocean Biology Processing Group for maintaining and distributing the SeaBASS database. The authors would also like to thank the two anonymous reviewers for their valuable comments on the manuscript.	Ammenberg P, 2002, INT J REMOTE SENS, V23, P1621, DOI 10.1080/01431160110071860; Oyama Y, 2009, ISPRS J PHOTOGRAMM, V64, P73, DOI 10.1016/j.isprsjprs.2008.04.005; Ruddick KG, 2006, LIMNOL OCEANOGR, V51, P1167; Mobley CD, 1999, APPL OPTICS, V38, P7442, DOI 10.1364/AO.38.007442; GORDON HR, 1994, APPL OPTICS, V33, P443, DOI 10.1364/AO.33.000443; Werdell PJ, 2005, REMOTE SENS ENVIRON, V98, P122, DOI 10.1016/j.rse.2005.07.001; Hu CM, 2012, APPL OPTICS, V51, P6045, DOI 10.1364/AO.51.006045; Ruddick KG, 2000, APPL OPTICS, V39, P897, DOI 10.1364/AO.39.000897; Yang W, 2011, REMOTE SENS ENVIRON, V115, P1247, DOI 10.1016/j.rse.2011.01.007; Gitelson AA, 2008, REMOTE SENS ENVIRON, V112, P3582, DOI 10.1016/j.rse.2008.04.015; Dekker AG, 2002, INT J REMOTE SENS, V23, P15, DOI 10.1080/01431160010006917; Hu CM, 2000, REMOTE SENS ENVIRON, V74, P195, DOI 10.1016/S0034-4257(00)00080-8; Bailey SW, 2010, OPT EXPRESS, V18, P7521, DOI 10.1364/OE.18.007521; Yang W, 2010, IEEE GEOSCI REMOTE S, V7, P655, DOI 10.1109/LGRS.2010.2044364; Siegel DA, 2000, APPL OPTICS, V39, P3582, DOI 10.1364/AO.39.003582; Lee ZP, 2002, APPL OPTICS, V41, P5755, DOI 10.1364/AO.41.005755; Guanter L, 2007, INT J REMOTE SENS, V28, P709, DOI 10.1080/01431160600815525; Santer R, 1999, INT J REMOTE SENS, V20, P1819, DOI 10.1080/014311699212506; Bailey S. W., 2006, MULTISENSOR APPROACH; Doerffer R., 2008, MERIS REGIONAL COAST; Gao L, 2005, ENVIRON GEOL, V48, P835, DOI 10.1007/s00254-005-0005-3; Gordon HR, 1997, J GEOPHYS RES-ATMOS, V102, P17081, DOI 10.1029/96JD02443; Guanter L, 2010, REMOTE SENS ENVIRON, V114, P467, DOI 10.1016/j.rse.2009.10.004; Jaelani LM, 2013, INT J REMOTE SENS, V34, P8967, DOI 10.1080/01431161.2013.860660; Lee Z.-P., 2006, REPORTS INT OCEAN CO; Matsushita B., 2009, J REMOTE SENS SOC JP, V29, P653; Mueller J. M., 2002, 2002210004 NASA, P1; Sathyendranath S., 2000, REPORTS INT OCEAN CO; Shi W, 2007, REMOTE SENS ENVIRON, V110, P149, DOI 10.1016/j.rse.2007.02.013; Shi W, 2009, REMOTE SENS ENVIRON, V113, P1587, DOI 10.1016/j.rse.2009.03.011; STUMPF R. P., 2003, 2003206892 NASA, V22, P51; Wang M., 2010, REPORTS INT OCEAN CO, V10, P83; Wang MH, 2009, REMOTE SENS ENVIRON, V113, P635, DOI 10.1016/j.rse.2008.11.005; Werdell P. J., 2002, CURRENT ARCHITECTURE, P1; Werdell P.J., 2003, EOS T AM GEOPHYS UN, V84, P377, DOI DOI 10.1029/2003E0380001; Yang W, 2013, IEEE T GEOSCI REMOTE, V51, P3761, DOI 10.1109/TGRS.2012.2220147; Yang W, 2011, IEEE T GEOSCI REMOTE, V49, P3381, DOI 10.1109/TGRS.2011.2126048	37	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-2434			INT J APPL EARTH OBS	Int. J. Appl. Earth Obs. Geoinf.	JUL	2015	39						128	141		10.1016/j.jag.2015.03.004		14	Remote Sensing	Remote Sensing	CJ3FD	WOS:000355367900015		
J	Kishi, T; Matsuo, Y; Ueki, N; Iizuka, Y; Nakamura, A; Sakanaka, K; Mizowaki, T; Hiraoka, M				Kishi, Takahiro; Matsuo, Yukinori; Ueki, Nami; Iizuka, Yusuke; Nakamura, Akira; Sakanaka, Katsuyuki; Mizowaki, Takashi; Hiraoka, Masahiro			Pretreatment Modified Glasgow Prognostic Score Predicts Clinical Outcomes After Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer	INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS			English	Article							C-REACTIVE PROTEIN; SYSTEMIC INFLAMMATORY RESPONSE; PLATINUM-BASED CHEMOTHERAPY; CURATIVE RESECTION; PERFORMANCE STATUS; COLORECTAL-CANCER; RADIOTHERAPY; SURVIVAL; RISK; ASSOCIATION	Purpose: This study aimed to evaluate the prognostic significance of the modified Glasgow Prognostic Score (mGPS) in patients with non-small cell lung cancer (NSCLC) who received stereotactic body radiation therapy (SBRT). Methods and Materials: Data from 165 patients who underwent SBRT for stage I NSCLC with histologic confirmation from January 1999 to September 2010 were collected retrospectively. Factors, including age, performance status, histology, Charlson comorbidity index, mGPS, and recursive partitioning analysis (RPA) class based on sex and T stage, were evaluated with regard to overall survival (OS) using the Cox proportional hazards model. The impact of the mGPS on cause of death and failure patterns was also analyzed. Results: The 3-year OS was 57.9%, with a median follow-up time of 3.5 years. A higher mGPS correlated significantly with poor OS (P<.001). The 3-year OS of lower mGPS patients was 66.4%, whereas that of higher mGPS patients was 44.5%. On multivariate analysis, mGPS and RPA class were significant factors for OS. A higher mGPS correlated significantly with lung cancer death (P=.019) and distant metastasis (P=.013). Conclusions: The mGPS was a significant predictor of clinical outcomes for SBRT in NSCLC patients. (C) 2015 Elsevier Inc. All rights reserved.	[Kishi, Takahiro; Matsuo, Yukinori; Ueki, Nami; Iizuka, Yusuke; Nakamura, Akira; Sakanaka, Katsuyuki; Mizowaki, Takashi; Hiraoka, Masahiro] Kyoto Univ, Grad Sch Med, Dept Radiat Oncol & Image Appl Therapy, Kyoto 6068507, Japan	Matsuo, Y (reprint author), Kyoto Univ, Grad Sch Med, Sakyo Ku, 54 Kawahara Cho, Kyoto 6068507, Japan.	ymatsuo@kuhp.kyoto-u.ac.jp			Japan Society for the Promotion of Science [25253078]	Supported by a Grant-in-Aid for Scientific Research (A) 25253078 from the Japan Society for the Promotion of Science.	Brown DJF, 2007, J CLIN PATHOL, V60, P705, DOI 10.1136/jcp.2005.033217; Satoh Y, 2012, EUR J RADIOL, V81, P3530, DOI 10.1016/j.ejrad.2011.11.047; McMillan DC, 2013, CANCER TREAT REV, V39, P534, DOI 10.1016/j.ctrv.2012.08.003; Proctor MJ, 2013, CANCER-AM CANCER SOC, V119, P2325, DOI 10.1002/cncr.28018; Khurana V, 2007, CHEST, V131, P1282, DOI 10.1378/chest.06-0931; McMillan DC, 2001, NUTR CANCER, V39, P210, DOI 10.1207/S15327914nc392_8; Baumann P, 2009, J CLIN ONCOL, V27, P3290, DOI 10.1200/JCO.2008.21.5681; Bradley JD, 2010, INT J RADIAT ONCOL, V77, P1146, DOI 10.1016/j.ijrobp.2009.06.017; Forrest LM, 2005, BRIT J CANCER, V92, P1834, DOI 10.1038/sj.bjc.6602591; Xu JL, 2012, CLIN LUNG CANCER, V13, P44, DOI 10.1016/j.cllc.2011.06.009; Crozier J, 2006, BRIT J CANCER, V94, P1833, DOI 10.1038/sj.bjc.6603185; Clarke K, 2012, RADIOTHER ONCOL, V104, P62, DOI 10.1016/j.radonc.2012.04.019; Shultz DB, 2014, CLIN LUNG CANCER, V15, P294, DOI 10.1016/j.cllc.2013.12.011; Olsen JR, 2011, INT J RADIAT ONCOL, V81, pE299, DOI 10.1016/j.ijrobp.2011.01.038; Kopek N, 2009, RADIOTHER ONCOL, V93, P402, DOI 10.1016/j.radonc.2009.06.002; Forrest LM, 2004, BRIT J CANCER, V90, P1704, DOI 10.1038/sj.bjc.6601789; Firat S, 2002, INT J RADIAT ONCOL, V52, P1047, DOI 10.1016/S0360-3016(01)02741-9; Koch A, 2009, J THORAC ONCOL, V4, P326, DOI 10.1097/JTO.0b013e31819578c8; Matsuo Y, 2011, INT J RADIAT ONCOL, V79, P1104, DOI 10.1016/j.ijrobp.2009.12.022; Lee DS, 2013, LUNG CANCER, V80, P172, DOI 10.1016/j.lungcan.2012.12.023; Albert MA, 2001, JAMA-J AM MED ASSOC, V286, P64, DOI 10.1001/jama.286.1.64; Burdick MJ, 2010, INT J RADIAT ONCOL, V78, P1033, DOI 10.1016/j.ijrobp.2009.09.081; Leung EYL, 2012, J THORAC ONCOL, V7, P655, DOI 10.1097/JTO.0b013e318244ffe1; Arrieta O, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-50; Barber MD, 2001, NUTR CANCER, V40, P118, DOI 10.1207/S15327914NC402_7; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Gagnon B, 2010, BRIT J CANCER, V102, P1113, DOI 10.1038/sj.bjc.6605603; Ikonomidis I, 1999, CIRCULATION, V100, P793; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Li Y, 2006, INFLAMM RES, V55, P216, DOI 10.1007/s00011-006-0074-0; Mahmoud Fade Aziz, 2002, Curr Oncol Rep, V4, P250, DOI 10.1007/s11912-002-0023-1; McMillan DC, 2003, BRIT J SURG, V90, P215, DOI 10.1002/bjs.4038; Sobin LH, 2009, TNM CLASSIFICATION M; Songur N, 2004, TUMORI, V90, P196; Surveillance Epidemiology and End Results Program, 2013, STAT SUMM CANC STAT; Takayama K, 2005, INT J RADIAT ONCOL, V61, P1565, DOI 10.1016/j.ijrobp.2004.12.066; Wilop S, 2008, ONKOLOGIE, V31, P665, DOI 10.1159/000165054; Wu DJ, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-84	38	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0360-3016	1879-355X		INT J RADIAT ONCOL	Int. J. Radiat. Oncol. Biol. Phys.	JUL 1	2015	92	3					619	626		10.1016/j.ijrobp.2015.02.018		8	Oncology; Radiology, Nuclear Medicine & Medical Imaging	Oncology; Radiology, Nuclear Medicine & Medical Imaging	CJ6WV	WOS:000355636800024		
J	Lei, XW; Nakatani, A				Lei, Xiao-Wen; Nakatani, Akihiro			A Deformation Mechanism for Ridge-Shaped Kink Structure in Layered Solids	JOURNAL OF APPLIED MECHANICS-TRANSACTIONS OF THE ASME			English	Article							CRACK-TIP FIELDS; SINGLE-CRYSTAL PLASTICITY; STRAIN LOCALIZATION; MOLECULAR-DYNAMICS; SHEAR BANDS; STRENGTH	A deformation mechanism for ridge-shaped kink structure (RSKS), a type of localized deformation, is studied with a discussion focusing on the kink deformation of a monocrystal with a single-slip system under a plane-strain condition. From a geometrical study of displacement continuity it is found that, to satisfy displacement continuity, the kink boundary formed by the deformation from an initially homogeneous structure must have symmetry. We propose a simple model of the RSKS deformation mode to accomplish plastic deformation from a compressive force parallel to the slip direction. First, important geometrical knowledge related to the RSKS formation mechanism is formulated analytically. Then, a simulation of a spring-mass model is performed to clarify the RSKS formation mechanism. The intensity of the angle-dependent force field is found to affect the deformation mode.	[Lei, Xiao-Wen; Nakatani, Akihiro] Osaka Univ, Dept Adapt Machine Syst, Suita, Osaka 5650871, Japan	Nakatani, A (reprint author), Osaka Univ, Dept Adapt Machine Syst, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	leixiaowen@ams.eng.osaka-u.ac.jp; nakatani@ams.eng.osaka-u.ac.jp			Ministry of Education, Science, Sport and Culture, Japan	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas, "Synchronized Long-Period Stacking Ordered Structure," from the Ministry of Education, Science, Sport and Culture, Japan.	Burgers JM, 1939, P K NED AKAD WETENSC, V42, P293; Flouriot S, 2003, INT J FRACTURE, V124, P43, DOI 10.1023/B:FRAC.0000009300.70477.ba; Kysar JW, 2002, ACTA MATER, V50, P2367, DOI 10.1016/S1359-6454(02)00070-8; Sabnis PA, 2012, INT J PLASTICITY, V28, P102, DOI 10.1016/j.ijplas.2011.06.003; Orowan E, 1942, NATURE, V149, P643, DOI 10.1038/149643a0; Hagihara K, 2010, INTERMETALLICS, V18, P267, DOI 10.1016/j.intermet.2009.07.014; Wadee MA, 2004, J MECH PHYS SOLIDS, V52, P1071, DOI 10.1016/j.jmps.2003.09.026; HESS JB, 1949, T AM I MIN MET ENG, V185, P599; Maillot B, 2006, J MECH PHYS SOLIDS, V54, P2030, DOI 10.1016/j.jmps.2006.04.004; Kawamura Y, 2001, MATER TRANS, V42, P1172, DOI 10.2320/matertrans.42.1172; Bigoni D., 2012, NONLINEAR SOLID MECH; Dewey J. F., 1965, TECTONOPHYSICS, V1, P459, DOI DOI 10.1016/0040-1951(65)90019-3; Drugan WJ, 2001, J MECH PHYS SOLIDS, V49, P2155, DOI 10.1016/S0022-5096(01)00041-2; Forest S, 2001, SCRIPTA MATER, V44, P953, DOI 10.1016/S1359-6462(00)00684-9; Forest S, 1998, ACTA MATER, V46, P3265, DOI 10.1016/S1359-6454(98)00012-3; FRANK FC, 1952, P PHYS SOC LOND B, V65, P811, DOI 10.1088/0370-1301/65/10/311; Gilman J. J., 1954, J MET, V6, P621; HORZ F, 1970, J GEOPHYS RES, V75, P965, DOI 10.1029/JB075i005p00965; Matsumoto R, 2013, MATER TRANS, V54, P686, DOI [10.2320/matertrans.M1201211, 10.2320/matertrans.MI201211]; MOHAN R, 1992, J MECH PHYS SOLIDS, V40, P315, DOI 10.1016/S0022-5096(05)80015-8; Mugge O., 1898, NEUES JB MINERAL GEO, V1, P71; Nakatani A, 1999, MATER SCI RES INT, V5, P241; Nakatani A, 2003, INT J FRACTURE, V122, P131, DOI 10.1023/B:FRAC.0000005775.10890.43; Patil SD, 2008, J ENG MATER-T ASME, V130, DOI 10.1115/1.2884330; Patil SD, 2009, SCRIPTA MATER, V61, P465, DOI 10.1016/j.scriptamat.2009.04.043; RICE JR, 1987, MECH MATER, V6, P317, DOI 10.1016/0167-6636(87)90030-5; Shimokawa T., 2008, J TEXT ENG, V54, P149; Starkey J., 1968, CONTRIB MINERAL PETR, V19, P133, DOI 10.1007/BF00635484; VANDERGIESSEN E, 1995, MODEL SIMUL MATER SC, V3, P689, DOI 10.1088/0965-0393/3/5/008	29	0	0	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0021-8936	1528-9036		J APPL MECH-T ASME	J. Appl. Mech.-Trans. ASME	JUL	2015	82	7			SI				071016	10.1115/1.4030328		6	Mechanics	Mechanics	CK1CB	WOS:000355941900017		
J	Mashima, I; Nakazawa, F				Mashima, Izumi; Nakazawa, Futoshi			Interaction between Streptococcus spp. and Veillonella tobetsuensis in the Early Stages of Oral Biofilm Formation	JOURNAL OF BACTERIOLOGY			English	Review							QUORUM-SENSING SIGNAL; GENUS VEILLONELLA; NEGATIVE COCCUS; DENTAL PLAQUE; SP NOV.; BACTERIAL DIVERSITY; EMENDED DESCRIPTION; ESCHERICHIA-COLI; CHILDHOOD CARIES; GNOTOBIOTIC-RATS	Dental plaque is a multispecies oral biofilm, the development of which is initiated by adherence of the pioneer Streptococcus spp. Oral Veillonella spp., including V. atypica, V. denticariosi, V. dispar, V. parvula, V. rogosae, and V. tobetsuensis, are known as early colonizers in oral biofilm formation. These species have been reported to coaggregate with Streptococcus spp. in a metabolic cooperation-dependent manner to form biofilms in human oral cavities, especially in the early stages of biofilm formation. However, in our previous study, Streptococcus gordonii showed biofilm formation to the greatest extent in the presence of V. tobetsuensis, without coaggregation between species. These results suggest that V. tobetsuensis produces signaling molecules that promote the proliferation of S. gordonii in biofilm formation. It is well known in many bacterial species that the quorum-sensing (QS) system regulates diverse functions such as biofilm formation. However, little is known about the QS system with autoinducers (AIs) with respect to Veillonella and Streptococcus spp. Recently, autoinducer 1 (AI-1) and AI-2 were detected and identified in the culture supernatants of V. tobetsuensis as strong signaling molecules in biofilm formation with S. gordonii. In particular, the supernatant from V. tobetsuensis showed the highest AI-2 activity among 6 oral Veillonella species, indicating that AIs, mainly AI-2, produced by V. tobetsuensis may be important factors and may facilitate biofilm formation of S. gordonii. Clarifying the mechanism that underlies the QS system between S. gordonii and V. tobetsuensis may lead to the development of novel methods for the prevention of oral infectious diseases caused by oral biofilms.	[Mashima, Izumi; Nakazawa, Futoshi] Hlth Sci Univ Hokkaido, Sch Dent, Dept Oral Microbiol, Ishikari, Hokkaido 06102, Japan; [Mashima, Izumi] Japan Soc Promot Sci, Chiyoda Ku, Tokyo, Japan	Nakazawa, F (reprint author), Hlth Sci Univ Hokkaido, Sch Dent, Dept Oral Microbiol, Ishikari, Hokkaido 06102, Japan.	nakazawa@hoku-iryo-u.ac.jp			JSPS [26462793]; Ministry of Education, Culture, Sports, Science and Technology; Research Institute of Personalized Health Sciences, Health Sciences University of Hokkaido [20142015]; Iwadare Scholarship Foundation	This study was supported in part by JSPS Kakenhi grant 26462793, a Grant-in-Aid for Scientific Research (C) from The Ministry of Education, Culture, Sports, Science and Technology, a Grant-in-Aid for the 20142015 Research Project of the Research Institute of Personalized Health Sciences, Health Sciences University of Hokkaido, and an Iwadare Scholarship from the Iwadare Scholarship Foundation.	Sperandio V, 2002, MOL MICROBIOL, V43, P809, DOI 10.1046/j.1365-2958.2002.02803.x; Becker MR, 2002, J CLIN MICROBIOL, V40, P1001, DOI 10.1128/JCM.40.3.1001-1009.2002; Diaz PI, 2006, APPL ENVIRON MICROB, V72, P2837, DOI 10.1128/AEM.72.4.2837-2848.2006; Lazazzera BA, 2000, CURR OPIN MICROBIOL, V3, P177, DOI 10.1016/S1369-5274(00)00072-2; SUNDQVIST G, 1992, ORAL MICROBIOL IMMUN, V7, P257, DOI 10.1111/j.1399-302X.1992.tb00584.x; Peters LB, 2001, J ENDODONT, V27, P76, DOI 10.1097/00004770-200102000-00002; Yoshida A, 2005, APPL ENVIRON MICROB, V71, P2372, DOI 10.1128/AEM.71.5.2372-2380.2005; Frias J, 2001, INFECT IMMUN, V69, P3431, DOI 10.1128/IAI.69.5.3431-3434.2001; Irie Y, 2008, CURR TOP MICROBIOL, V322, P67; McNab R, 2003, J BACTERIOL, V185, P274, DOI 10.1128/JB.185.1.274-284.2003; Khemaleelakul S, 2002, ORAL SURG ORAL MED O, V94, P746, DOI 10.1067/moe.2002.129535; Kanasi E, 2010, CARIES RES, V44, P485, DOI 10.1159/000320158; Keijser BJF, 2008, J DENT RES, V87, P1016, DOI 10.1177/154405910808701104; Bjarnsholt T, 2013, TRENDS MICROBIOL, V21, P466, DOI 10.1016/j.tim.2013.06.002; Marouni MJ, 2003, INFECT IMMUN, V71, P5633, DOI 10.1128/IAI.71.10.5633-5639.2003; Aas JA, 2007, J CLIN PERIODONTOL, V34, P189, DOI 10.1111/j.1600-051X.2006.01034.x; Chen X, 2002, NATURE, V415, P545, DOI 10.1038/415545a; Paster BJ, 2006, PERIODONTOL 2000, V42, P80, DOI 10.1111/j.1600-0757.2006.00174.x; Surette MG, 1998, P NATL ACAD SCI USA, V95, P7046, DOI 10.1073/pnas.95.12.7046; Vendeville A, 2005, NAT REV MICROBIOL, V3, P383, DOI 10.1038/nrmicro1146; Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; HUGHES CV, 1988, APPL ENVIRON MICROB, V54, P1957; Bik EM, 2010, ISME J, V4, P962, DOI 10.1038/ismej.2010.30; Kleerebezem M, 2004, PEPTIDES, V25, P1405, DOI 10.1016/j.peptides.2003.10.021; Henke JM, 2004, J BACTERIOL, V186, P6902, DOI 10.1128/JB.186.20.6902-6914.2004; Chalmers NI, 2008, J BACTERIOL, V190, P8145, DOI 10.1128/JB.00983-08; Periasamy S, 2010, J BACTERIOL, V192, P2965, DOI 10.1128/JB.01631-09; Stroeher UH, 2003, INFECT IMMUN, V71, P3206, DOI 10.1128/IAI.71.6.3206-3212.2003; Igarashi E, 2009, ORAL MICROBIOL IMMUN, V24, P310, DOI 10.1111/j.1399-302X.2009.00513.x; Arif N, 2008, INT J SYST EVOL MICR, V58, P581, DOI 10.1099/ijs.0.65093-0; Asin MAPJ, 2013, INFECTION, V41, P591, DOI 10.1007/s15010-012-0398-3; Aujoulat F, 2014, INT J SYST EVOL MICR, V64, P3526, DOI 10.1099/ijs.0.064451-0; BARNHART RA, 1983, AM J MED, V74, P902, DOI 10.1016/0002-9343(83)91083-5; BAUMGARTNER JC, 1991, J ENDODONT, V17, P380; Beighton D, 2008, ORAL MICROBIOL IMMUN, V23, P344, DOI 10.1111/j.1399-302X.2007.00424.x; Blehert DS, 2003, J BACTERIOL, V185, P4851, DOI 10.1128/JB.185.16.4851-4860.2003; Byun R, 2007, INT J SYST EVOL MICR, V57, P2844, DOI 10.1099/ijs.0.65096-0; Cephas KD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023503; Dang AT, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-153; DELWICHE EA, 1985, ANNU REV MICROBIOL, V39, P175; Egland PG, 2004, P NATL ACAD SCI USA, V101, P16971; Fisher RG, 1996, J CLIN MICROBIOL, V34, P3235; Fuqua C, 1996, ANNU REV MICROBIOL, V50, P727, DOI 10.1146/annurev.micro.50.1.727; GREAVES WL, 1984, SOUTHERN MED J, V77, P1211, DOI 10.1097/00007611-198409000-00048; Heller D, 2012, ARCH ORAL BIOL, V57, P973, DOI 10.1016/j.archoralbio.2012.02.003; Huang Z, 2009, J MOL MICROB BIOTECH, V17, P12, DOI 10.1159/000159193; Joint I, 2007, PHILOS T R SOC B, V362, P1115, DOI 10.1098/rstb.2007.2038; Jumas BE, 2004, INT J SYST EVOL MICR, V54, P1311; Kraatz M, 2008, INT J SYST EVOL MICR, V58, P2755, DOI [10.1099/ijs.0.2008/001032-0, 10.1099/ijs.0,2008/001032-0]; LOEWE L, 1946, AM HEART J, V32, P327, DOI 10.1016/0002-8703(46)90793-4; Lyon WR, 2001, MOL MICROBIOL, V42, P145, DOI 10.1046/j.1365-2958.2001.02616.x; Mancl AK, 2013, WOUND REPAIR REGEN, V21, P352; Maqsood AB, 2000, CLIN INFECT DIS, V31, P839; Marchandin H, 2001, EUR J CLIN MICROBIOL, V20, P340, DOI 10.1007/PL00011273; Mashima I, 2014, ANAEROBE, V28, P54, DOI 10.1016/j.anaerobe.2014.05.003; Mashima I, 2011, CURR MICROBIOL, V63, P403, DOI 10.1007/s00284-011-9993-2; Mashima I, 2012, DENT J HEAL SCI U HO, V31, P73; Mashima I, 2013, ANAEROBE, V22, P77, DOI 10.1016/j.anaerobe.2013.04.015; Mashima I, 2013, INT J SYST EVOL MICR, V63, P1443, DOI 10.1099/ijs.0.042515-0; MAYS TD, 1982, INT J SYST BACTERIOL, V32, P28; MCBRIDE BC, 1981, INFECT IMMUN, V33, P467; Meng C, 2013, INT J MOL SCI, V14, P18488; MIKX FHM, 1972, CARIES RES, V6, P211; MIKX FHM, 1975, ARCH ORAL BIOL, V20, P407, DOI 10.1016/0003-9969(75)90224-1; NYVAD B, 1987, SCAND J DENT RES, V95, P369; Palmer RJ, 2006, J BACTERIOL, V188, P4117, DOI 10.1128/JB.01958-05; Petersen FC, 2006, ANTON LEEUW INT J G, V90, P109, DOI 10.1007/s10482-006-9065-y; Ready D, 2012, INT J ANTIMICROB AG, V40, P188, DOI 10.1016/j.ijantimicag.2012.04.007; Ready D, 2006, ANTIMICROB AGENTS CH, V50, P2866, DOI 10.1128/AAC.00217-06; ROGOSA M, 1956, J BACTERIOL, V72, P533; Rogosa M., 1984, BERGEYS MANUAL SYSTE, V1, P680; ROGOSA M, 1965, J BACTERIOL, V90, P704; Rovery C, 2005, EMERG INFECT DIS, V11, P1112; Silva-Boghossian CM, 2013, J PERIODONTOL, V84, pE9, DOI 10.1902/jop.2013.120639; SUTTER VL, 1984, REV INFECT DIS, V6, pS62; TORTORELLO ML, 1983, INFECT IMMUN, V41, P423; VANDERHOEVEN JS, 1978, CARIES RES, V12, P142; Vroon DH, 1974, ANAEROBIC BACTERIA R, P585; WILLIAMS BL, 1979, J CLIN PERIODONTOL, V6, P210, DOI 10.1111/j.1600-051X.1979.tb01923.x; Wittgow W C Jr, 1975, J Endod, V1, P168, DOI 10.1016/S0099-2399(75)80115-4; Yagihashi Y, 2012, BMJ CASE REP	81	1	1	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0021-9193	1098-5530		J BACTERIOL	J. Bacteriol.	JUL	2015	197	13					2104	2111		10.1128/JB.02512-14		8	Microbiology	Microbiology	CJ6FQ	WOS:000355589700003		
J	Inoue, Y; Nakamura, A; Kondo, Y; Hamano, K; Satoh, S; Terauchi, Y				Inoue, Yuichiro; Nakamura, Akinobu; Kondo, Yoshinobu; Hamano, Kumiko; Satoh, Shinobu; Terauchi, Yasuo			A randomized controlled trial of liraglutide versus insulin detemir plus sitagliptin: Effective switch from intensive insulin therapy to the once-daily injection in patients with well-controlled type 2 diabetes	JOURNAL OF CLINICAL PHARMACOLOGY			English	Article						liraglutide; basal-bolus insulin regimen; patient's satisfaction; type 2 diabetes	PEPTIDE-1 RECEPTOR AGONISTS; JAPANESE PATIENTS; TREATMENT SATISFACTION; GLUCOSE INCREMENTS; BODY-COMPOSITION; RISK; MELLITUS; EFFICACY; SAFETY; COMPLICATIONS	This study aimed to compare the efficacy and safety of liraglutide versus insulin detemir plus sitagliptin in Japanese patients with type 2 diabetes treated with a basal-bolus insulin regimen. In this multicenter, open-label trial, 90 patients whose diabetes had been controlled well or moderately (glycated hemoglobin [HbA(1c)] 7.3%) with basal-bolus insulin regimen were randomly assigned to a liraglutide group or a detemir group and were followed up for 24 weeks. The primary end point was HbA(1c) change from baseline to 24 weeks. Of the 90 enrolled patients, 82 completed this trial. At 24 weeks, the mean changes in HbA(1c) from baseline were 0.1%+/- 0.9% versus 0.3%+/- 0.8% in the liraglutide versus detemir groups, respectively (P=.46). The overall satisfaction score for the Diabetes Treatment Satisfaction Questionnaire changed from 25.2 +/- 7.4 to 29.9 +/- 5.3 (P<.001) and from 26.4 +/- 6.1 to 28.3 +/- 6.4 (P=.12) in the liraglutide and detemir groups, respectively. Although the mean change difference in HbA(1c) between both groups was not significant, switching from a basal-bolus insulin regimen to liraglutide once daily improved patient satisfaction levels without loss of glycemic control.	[Inoue, Yuichiro; Nakamura, Akinobu; Kondo, Yoshinobu; Terauchi, Yasuo] Yokohama City Univ, Grad Sch Med, Dept Endocrinol & Metab, Yokohama, Kanagawa 2360004, Japan; [Nakamura, Akinobu] Hokkaido Univ, Grad Sch Med, Div Immunol & Metab, Dept Internal Med 2, Sapporo, Hokkaido, Japan; [Kondo, Yoshinobu; Satoh, Shinobu] Chigasaki Municipal Hosp, Dept Endocrinol & Metab, Chigasaki, Kanagawa, Japan; [Hamano, Kumiko] Kanto Rosai Hosp, Dept Diabet & Endocrinol, Kawasaki, Kanagawa, Japan	Terauchi, Y (reprint author), Yokohama City Univ, Grad Sch Med, Dept Endocrinol & Metab, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	terauchi@yokohama-cu.ac.jp			MSD; Ono Pharmaceutical Co, Ltd; Nippon Boehringer Ingelheim Co, Ltd; Novartis Pharma; Takeda Pharmaceutical Co, Ltd; Mitsubishi Tanabe Pharma Corp; Daiichi Sankyo Co, Ltd; Sanwa Kagaku Kenkyusho Co, Ltd; Novo Nordisk Pharma Ltd; Eli Lilly Japan; Sanofi; Dainippon Sumitomo Pharma Co, Ltd; Shionogi Co, Ltd; Bayer Yakuhin, Ltd; Astellas Pharma, Inc; Pfizer Japan, Inc; AstraZeneca	Yasuo Terauchi received honoraria for lectures from MSD K.K.; Ono Pharmaceutical Co, Ltd; Nippon Boehringer Ingelheim Co, Ltd; Novartis Pharma K.K.; Takeda Pharmaceutical Co, Ltd; Mitsubishi Tanabe Pharma Corp; Daiichi Sankyo Co, Ltd; Sanwa Kagaku Kenkyusho Co, Ltd; Kowa Pharmaceutical Co, Ltd; Novo Nordisk Pharma Ltd; Eli Lilly Japan K.K.; Sanofi K.K.; Shionogi & Co, Ltd; Bayer Yakuhin, Ltd; and AstraZeneca K.K. and obtained research support from MSD K.K.; Ono Pharmaceutical Co, Ltd; Nippon Boehringer Ingelheim Co, Ltd; Novartis Pharma K.K.; Takeda Pharmaceutical Co, Ltd; Mitsubishi Tanabe Pharma Corp; Daiichi Sankyo Co, Ltd; Sanwa Kagaku Kenkyusho Co, Ltd; Novo Nordisk Pharma Ltd; Eli Lilly Japan K.K.; Sanofi K.K.; Dainippon Sumitomo Pharma Co, Ltd; Shionogi & Co, Ltd; Bayer Yakuhin, Ltd; Astellas Pharma, Inc; Pfizer Japan, Inc; and AstraZeneca K.K. Yuichiro Inoue, Akinobu Nakamura, Yoshinobu Kondo, Kumiko Hamano, and Shinobu Satoh declare that they have no conflicts of interest.	Vilsboll T, 2007, DIABETES CARE, V30, P1608, DOI 10.2337/dc06-2593; Giugliano D, 2011, DIABETES CARE, V34, P510, DOI 10.2337/dc10-1710; Philis-Tsimikas A, 2006, CLIN THER, V28, P1569, DOI 10.1016/j.clinthera.2006.10.020; Bretzel RG, 2008, LANCET, V371, P1073, DOI 10.1016/S0140-6736(08)60485-7; Shichiri M, 2000, DIABETES CARE, V23, pB21; OHKUBO Y, 1995, DIABETES RES CLIN PR, V28, P103, DOI 10.1016/0168-8227(95)01064-K; Lind M, 2012, PRIM CARE DIABETES, V6, P41, DOI 10.1016/j.pcd.2011.09.002; Gregg EW, 2002, DIABETES CARE, V25, P61, DOI 10.2337/diacare.25.1.61; Whitmer RA, 2009, JAMA-J AM MED ASSOC, V301, P1565, DOI 10.1001/jama.2009.460; Russell-Jones D, 2009, DIABETOLOGIA, V52, P2046, DOI 10.1007/s00125-009-1472-y; Ott A, 1999, NEUROLOGY, V53, P1937; Davies M, 2013, DIABETES CARE, V36, P1368, DOI 10.2337/dc12-1333; Inzucchi SE, 2012, DIABETOLOGIA, V55, P1577, DOI 10.1007/s00125-012-2534-0; Monnier L, 2003, DIABETES CARE, V26, P881, DOI 10.2337/diacare.26.3.881; Davis SN, 2007, DIABETES CARE, V30, P2767, DOI 10.2337/dc06-2532; Kikuchi K, 2010, ENDOCR J, V57, P259; Lovejoy JC, 1996, METABOLISM, V45, P1119, DOI 10.1016/S0026-0495(96)90011-6; Kondo Y, 2013, J DIABETES INVEST, V4, P571, DOI 10.1111/jdi.12082; Kodama K, 2013, DIABETES CARE, V36, P1789, DOI 10.2337/dc12-1235; Taaffe DR, 2001, J BONE MINER RES, V16, P1343, DOI 10.1359/jbmr.2001.16.7.1343; Vilsboll T, 2010, DIABETES OBES METAB, V12, P167, DOI 10.1111/j.1463-1326.2009.01173.x; Cukierman T, 2005, DIABETOLOGIA, V48, P2460, DOI 10.1007/s00125-005-0023-4; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545; Flint A, 2011, ADV THER, V28, P213, DOI 10.1007/s12325-010-0110-x; Wright A, 1998, ANN INTERN MED, V128, P165; Li WX, 2010, CURR THER RES CLIN E, V71, P211, DOI 10.1016/j.curtheres.2010.08.003; Bradley C, 1994, HDB PSYCHOL DIABETES, P111; Chitnis AS, 2014, ADV THER, V31, P986, DOI 10.1007/s12325-014-0153-5; Davies M, 2011, DIABETIC MED, V28, P333, DOI 10.1111/j.1464-5491.2010.03074.x; SHAMOON H, 1993, NEW ENGL J MED, V329, P977; Gooderick D, 2011, BMJ CASE REP, DOI [10.1136/bcr.07.2011.4460, DOI 10.1136/BCR.07.2011.4460]; Ishii H, 2000, J CLIN EXP MED, V192, P809; Iwamoto Y, 2010, ENDOCR J, V57, P383; Iwao T, 2013, J DIABETES COMPLICAT, V27, P87, DOI 10.1016/j.jdiacomp.2012.07.001; Kozawa N, 2011, J DIABETES INVEST, V3, P294; Kubota Akira, 2012, J Clin Med Res, V4, P309; Maeda H, 2012, DIABETES RES CLIN PR, V95, pE20, DOI 10.1016/j.diabres.2011.10.011; Mori Y, 2011, DIABETES TECHNOL THE, V13, P1139, DOI 10.1089/dia.2011.0137; ORTIZ O, 1992, AM J CLIN NUTR, V55, P8; Secnik BK, 2006, HEALTH QUAL LIFE OUT, V4, P80; Swinnen SG, 2011, COCHRANE DB SYST REV, V7; Takai M, 2014, DIABETES RES CLIN PR, V103, pE30, DOI 10.1016/j.diabres.2013.12.045; Turner RC, 1998, LANCET, V352, P837; VANHORN LV, 1991, AM J EPIDEMIOL, V133, P9; Vilsboll T, 2012, BRIT MED J, V344, DOI 10.1136/bmj.d7771	45	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0091-2700	1552-4604		J CLIN PHARMACOL	J. Clin. Pharmacol.	JUL	2015	55	7					831	838		10.1002/jcph.483		8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CK0AJ	WOS:000355865700016		
J	Kashima, S; Inoue, K; Matsumoto, M; Akimoto, K				Kashima, Saori; Inoue, Kazuo; Matsumoto, Masatoshi; Akimoto, Kimihiko			Prevalence and characteristics of non-obese diabetes in Japanese men and women: the Yuport Medical Checkup Center Study	JOURNAL OF DIABETES			English	Article						body mass index; metabolic disease; non-obesity; prevalence; type 2 diabetes mellitus	BODY-MASS INDEX; CORONARY-HEART-DISEASE; ASIA-OCEANIA; WEIGHT-LOSS; RISK; OBESITY; CLASSIFICATION; MELLITUS; CRITERIA; INTERVENTION	BackgroundThis study examined the prevalence and characteristics of type 2 diabetes in non-obese subjects to compare their cardiometabolic markers to those without diabetes. MethodsData were used from 17098 men and 17199 women from a voluntary health checkup program between 1998 and 2006 conducted in Japan. The prevalence of diabetes (fasting plasma glucose7.0mmol/L, hemoglobin A1c6.5%, or known diabetes) was calculated in each subgroup of body mass index (group 1,<22; group 2, 22-25; group3, 25-27.5; and group 4, 27.5). The effect of diabetes and obesity on risk of an abnormal level of cardiometabolic marker was evaluated with a logistic regression model. ResultsIn men, the prevalence of diabetes was 9.5% in total, 6.4%, 9.4%, 11.3% and 16.2% in group1 through 4, respectively. In women, it accounted for 4.3% in total, 2.4%, 4.5%, 8.7% and 12.3% per group, respectively. Non-obese diabetic subjects (in group 1 and 2) accounted for 60.8% and 62.0% of all the diabetic subjects in men and women, respectively. Non-obese population accounted for 71.2% and 83.6% of all men and women, respectively. Levels of cardiometabolic markers were higher in diabetic subjects than in non-diabetic subjects in each subgroup. Diabetes was associated with each abnormal level of cardiometabolic marker independent of obesity. ConclusionOver 60% of the diabetic subjects in this Japanese population were not obese. Non-obese diabetes is not widely addressed and should be considered for increased public attention. The elevated levels of cardiometabolic markers may contribute to an increased risk of cardiovascular disease in non-obese diabetes.	[Kashima, Saori] Hiroshima Univ, Dept Publ Hlth & Hlth Policy, Inst Biomed & Hlth Sci, Hiroshima 7340037, Japan; [Matsumoto, Masatoshi] Hiroshima Univ, Dept Community Based Med Syst, Inst Biomed & Hlth Sci, Hiroshima 7340037, Japan; [Inoue, Kazuo] Teikyo Univ, Sch Med, Chiba Med Ctr, Dept Community Med, Chiba, Japan; [Akimoto, Kimihiko] Akimoto Occupat Hlth Consultant Off, Tokyo, Japan	Kashima, S (reprint author), Hiroshima Univ, Dept Publ Hlth & Hlth Policy, Inst Biomed & Hlth Sci, Minami Ku, 1-2-3 Kasumi, Hiroshima 7340037, Japan.	saori.ksm@gmail.com					Kanazawa M, 2002, ASIA PAC J CLIN NUTR, V11, pS732, DOI 10.1046/j.1440-6047.11.s8.19.x; Seino Y, 2010, J DIABETES INVEST, V1, P212, DOI 10.1111/j.2040-1124.2010.00074.x; MANSON JE, 1991, ARCH INTERN MED, V151, P1141, DOI 10.1001/archinte.151.6.1141; Ma RCW, 2013, ANN NY ACAD SCI, V1281, P64, DOI 10.1111/nyas.12098; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1; Hamman RF, 2006, DIABETES CARE, V29, P2102, DOI 10.2337/dc06-0560; Edelstein SL, 1997, DIABETES, V46, P701, DOI 10.2337/diabetes.46.4.701; Kodama S, 2012, AM J EPIDEMIOL, V176, P959, DOI 10.1093/aje/kws172; Kanazawa M, 2005, WORLD REV NUTR DIET, V94, P1, DOI 10.1159/000088200; KANNEL WB, 1971, AM J CARDIOL, V27, P335, DOI 10.1016/0002-9149(71)90428-0; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Carnethon MR, 2012, JAMA-J AM MED ASSOC, V308, P581, DOI 10.1001/jama.2012.9282; Arner P, 2001, DIABETES OBES METAB, V3, P11, DOI 10.1046/j.1463-1326.2001.00031.x; Barba C, 2004, LANCET, V363, P157; Boffetta P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019930; Chou PS, 1998, DIABETES CARE, V21, P1183, DOI 10.2337/diacare.21.7.1183; DEFRONZO RA, 1992, DIABETES CARE, V15, P318, DOI 10.2337/diacare.15.3.318; FRIEDEWA.WT, 1972, CLIN CHEM, V18, P499; Nakagami T, 2003, DIABETOLOGIA, V46, P1063, DOI 10.1007/s00125-003-1158-9; TURNER RC, 1995, DIABETES, V44, P1249; Holman RR, 2006, METABOLISM, V55, pS2, DOI 10.1016/j.metabol.2006.02.006; Inoue K, 2012, DIABETIC MED, V29, P1327; Inoue K, 2009, DIABETIC MED, V26, P1175, DOI 10.1111/j.1464-5491.2009.02850.x; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Liese AD, 1998, EPIDEMIOL REV, V20, P157; MATSUZAWA Y, 1990, DIABETES RES CLIN PR, V10, pS159, DOI 10.1016/0168-8227(90)90157-O; Ministry of Health Labour and Welfare Japan, 2004, REP SURV CURR STAT D; Ministry of Health Labour and Welfare. Japan, 2012, NAT HLTH NUTR SURV J; Racette SB, 2005, METABOLISM, V54, P960, DOI 10.1016/j.metabol.2005.02.013; Ranasinghe C, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-797; Saito Y., 2011, J JAPAN SOC STUDY OB, V17, P1; Vaag A, 1999, DAN MED BULL, V46, P197; Vaag A, 2007, APPL PHYSIOL NUTR ME, V32, P912, DOI 10.1139/H07-100; World Health Organisation, 2000, WHO TECH REP SER, V894, P1	34	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1753-0393	1753-0407		J DIABETES	J. Diabetes	JUL	2015	7	4					523	530		10.1111/1753-0407.12213		8	Endocrinology & Metabolism	Endocrinology & Metabolism	CJ9ZJ	WOS:000355862700013		
J	Kawada, T				Kawada, Tomoyuki			Association between smoking and depression in patients with type 2 diabetes	JOURNAL OF DIABETES			English	Letter							SAMPLE; ADULTS		[Kawada, Tomoyuki] Nippon Med Sch, Dept Hyg & Publ Hlth, Tokyo 1138602, Japan	Kawada, T (reprint author), Nippon Med Sch, Dept Hyg & Publ Hlth, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138602, Japan.	kawada@nms.ac.jp					Luger TM, 2014, ADDICT BEHAV, V39, P1418, DOI 10.1016/j.addbeh.2014.05.011; Tjora T, 2014, ADDICTION, V109, P1022, DOI 10.1111/add.12522; Clyde M, 2015, J DIABETES, V7, P95, DOI 10.1111/1753-0407.12141; Clyde M, 2013, CAN J DIABETES, V37, P150, DOI 10.1016/j.jcjd.2013.01.008; Nothlings U, 2010, J DIABETES, V2, P112, DOI 10.1111/j.1753-0407.2010.00069.x	5	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1753-0393	1753-0407		J DIABETES	J. Diabetes	JUL	2015	7	4					589	589		10.1111/1753-0407.12259		1	Endocrinology & Metabolism	Endocrinology & Metabolism	CJ9ZJ	WOS:000355862700020		
